	CHROM	POS	REF	ALT	Location	SYMBOL	Gene_full_name	VARIANT_CLASS	18-3364_GT	18-3364_VF	18-3364_AD	18-3364_DP	18-3364_GQ	18-3365_GT	18-3365_VF	18-3365_AD	18-3365_DP	18-3365_GQ	hiConfDeNovo	loConfDeNovo	Existing_variation	Genomic_region	CANONICAL	Feature	Feature_type	BIOTYPE	Consequence	INTRON	EXON	HGVSc	HGVSp	DISTANCE	STRAND	Interpro_domain	CLNSIG	CLNREVSTAT	CLNDN	OMIM_phenotype	Orphanet_disorder	Orphanet_association_type	HPO_name	PUBMED	gnomADg_AF	gnomADg_AC	gnomADg_AN	gnomADg_nhomalt	gnomADg_cov_median	gnomADg_cov_perc_20x	gnomADg_filter	gnomADg_popmax	gnomADg_AF_popmax	gnomADg_AC_popmax	gnomADg_AF_nfe	gnomADg_AC_nfe	gnomADe_AF	gnomADe_AC	gnomADe_AN	gnomADe_nhomalt	gnomADe_cov_median	gnomADe_cov_perc_20x	gnomADe_filter	gnomADe_popmax	gnomADe_AF_popmax	gnomADe_AC_popmax	gnomADe_AF_nfe	gnomADe_AC_nfe	kaviar_AF	kaviar_AC	CSVS_AF	CSVS_AC	FJD_MAF_AF	FJD_MAF_AC	denovoVariants_SAMPLE_CT	CADD_PHRED	CADD_RAW	MutScore	N_Pathogenic_pred	N_Benign_pred	N_predictions	Pathogenic_pred	Benign_pred	SpliceAI_SYMBOL	SpliceAI_DS_AG	SpliceAI_DS_AL	SpliceAI_DS_DG	SpliceAI_DS_DL	SpliceAI_DP_AG	SpliceAI_DP_AL	SpliceAI_DP_DG	SpliceAI_DP_DL	ada_score	rf_score	MaxEntScan_alt	MaxEntScan_diff	MaxEntScan_ref	LoFtool	ExACpLI	gnomAD_exomes_CCR	phastCons30way_mammalian	phyloP30way_mammalian	MGI_mouse_phenotype	GTEx_V8_gene	GTEx_V8_tissue	Expression_GNF-Atlas	Pathway_KEGG	GO_biological_process	GO_cellular_component	GO_molecular_function	Interactions_IntAct	Original_pos
126	chr1	1430857	T	C	chr1:1430857	ATAD3B	ATPase family, AAA domain containing 3B	SNV	0|1	0.16	16_3	19	78.0	0/0	0.0	33_0	33	99.0			rs773373214	SPLICING	YES	NM_031921.6	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	15/15		NM_031921.6:c.1615-8T>C			1.0						.	.	.		0.00109954	167.0	151882.0	1.0	32	0.97	PASS	nfe	0.00182837	124.0	0.00182837	124.0	0.000262262	63.0	240218.0	0.0	42	0.8	PASS	nfe	0.000379461	41.0	0.000379461	41.0	0.0000064	1						0.144	-0.432511		0	0	0			ATAD3B	0.0	0.0	0.0	0.0	29.0	8.0	29.0	34.0	5.59045017758309e-06	0.0	9.764	0.354	10.119	0.167	0.0				muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; skeleton phenotype; embryo phenotype; behavior/neurological phenotype ; mortality/aging ; 			.	.	mitochondrion organization;neutrophil degranulation	mitochondrion;mitochondrial inner membrane;plasma membrane;secretory granule membrane;ficolin-1-rich granule membrane	ATP binding;zinc ion binding	PLGRKT[29568061];USP11[19615732];COX4I1[29568061];MRPL58[20186120];ECSIT[24344204];HSPD1[29568061];TGOLN2[29568061];CHCHD2[27499296];AIFM1[29568061];C21orf33[27499296];MYC[21150319];COX14[29568061];CHCHD1[27499296];PRELID3B[27499296];MCCC2[27499296];EGLN3[26972000];JUN[25609649];PDHA1[29128334];USP20[19615732];RIPK4[26972000];DYRK1B[23602568];KSR2[27086506];COQ9[27499296];COQ10B[27499296];AGO3[19167051];SCO1[29568061];SOAT1[29128334];AGO1[17932509];PPP2R2D[28330616];CANX[29568061];NDUFAF5[27499296];LYRM7[27499296];SFXN1[29568061];NDUFAF1[24344204];TP53[22653443];CDK15[23602568];BET1[29568061];	1430857
127	chr1	1430858	T	C	chr1:1430858	ATAD3B	ATPase family, AAA domain containing 3B	SNV	0|1	0.16	16_3	19	78.0	0/0	0.0	33_0	33	99.0			rs760835310	SPLICING	YES	NM_031921.6	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	15/15		NM_031921.6:c.1615-7T>C			1.0						.	.	.		0.00108674	165.0	151830.0	1.0	32	0.97	AS_VQSR	nfe	0.0017993	122.0	0.0017993	122.0	0.000244866	59.0	240948.0	0.0	42	0.81	PASS	nfe	0.000369085	40.0	0.000369085	40.0	0.0000064	1						0.079	-0.515415		0	0	0			ATAD3B	0.0	0.0	0.0	0.0	-12.0	28.0	-12.0	28.0	2.12322960517469e-05	0.0	10.614	-0.495	10.119	0.167	0.0				muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; skeleton phenotype; embryo phenotype; behavior/neurological phenotype ; mortality/aging ; 			.	.	mitochondrion organization;neutrophil degranulation	mitochondrion;mitochondrial inner membrane;plasma membrane;secretory granule membrane;ficolin-1-rich granule membrane	ATP binding;zinc ion binding	PLGRKT[29568061];USP11[19615732];COX4I1[29568061];MRPL58[20186120];ECSIT[24344204];HSPD1[29568061];TGOLN2[29568061];CHCHD2[27499296];AIFM1[29568061];C21orf33[27499296];MYC[21150319];COX14[29568061];CHCHD1[27499296];PRELID3B[27499296];MCCC2[27499296];EGLN3[26972000];JUN[25609649];PDHA1[29128334];USP20[19615732];RIPK4[26972000];DYRK1B[23602568];KSR2[27086506];COQ9[27499296];COQ10B[27499296];AGO3[19167051];SCO1[29568061];SOAT1[29128334];AGO1[17932509];PPP2R2D[28330616];CANX[29568061];NDUFAF5[27499296];LYRM7[27499296];SFXN1[29568061];NDUFAF1[24344204];TP53[22653443];CDK15[23602568];BET1[29568061];	1430858
151	chr1	1534760	G	C	chr1:1534760	FNDC10	fibronectin type III domain containing 10	SNV	0/1	0.5	57_58	115	99.0	0/0	0.0	34_0	34	99.0			rs531027514	EXONIC	YES	NM_001242659.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001242659.2:c.636C>G	NP_001229588.1:p.Leu212%3D		-1.0						.	.	.		0.000118379	18.0	152054.0	0.0	32	0.97	PASS	amr	0.000785546	12.0	8.82768e-05	6.0	8.60626e-05	11.0	127814.0	0.0	15	0.41	PASS	amr	0.00029724	7.0	4.20221e-05	2.0	0.0000193	3	0.0	1.0				8.316	0.392472		0	0	0			C1orf233	0.0	0.0	0.0	0.0	5.0	-3.0	24.0	42.0								7.947566600			.			.	.	.	integral component of membrane	.	.	1534760
246	chr1	1647778	C	G	chr1:1647778	CDK11A	cyclin dependent kinase 11A	SNV	0/1	0.6	39_63	105	99.0	0/1	0.49	55_53	109	99.0			rs72901773,COSV62265990	SPLICING	YES	NM_001313896.2	Transcript	protein_coding	splice_region_variant,intron_variant	5/19		NM_001313896.2:c.458+7G>C			-1.0						.	.	.						32	0.89							0.470877	101441.0	215430.0	209.0	86	1.0	InbreedingCoeff	nfe	0.477648	46969.0	0.477648	46969.0	0.0000193,0.0096268	3,1497	0.153	493.0	0.47926	901.0		2.26	-0.025291		0	0	0			CDK11A	0.0	0.0	0.01	0.0	15.0	-41.0	7.0	33.0	1.93029776648406e-05	0.02					0.0				.			white blood cells;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;trigeminal ganglion;parietal lobe;testis;skeletal muscle;heart;	.	mitotic cell cycle;regulation of cell growth;regulation of transcription, DNA-templated;protein phosphorylation;apoptotic process;regulation of mRNA processing;regulation of cell cycle	nucleus;cytoplasm	protein kinase activity;protein serine/threonine kinase activity;cyclin-dependent protein serine/threonine kinase activity;ATP binding	RBM25[23602568];USP15[unassigned1312];HKR1[23602568];HSP90AB1[22939624];ZFP14[23602568];CHEK2[23178491];PSMD1[23602568];CCNL2[18216018];A2M[23602568];KPNA2[23602568];CCNL1[23178491;18216018];C18orf25[23602568];ZNF267[23602568];SPAG9[unassigned1312];IVNS1ABP[unassigned1312];HSP90AA1[19875381];NOP58[23602568];JUN[25609649];CDK11A[23178491];SMAD3[18729074];ZNF460[23602568];PDHA1[29128334];CSNK2A1[22113938;23602568;25852190];GADD45A[21988832];CDKN2A[23602568];CSNK2A2[23455922;23602568];PRPF40A[23602568];EPS15L1[unassigned1312];ZNF33A[23602568];CDC37[24189400;25036637];CSNK2B[23602568];MCM4[unassigned1312];SKIV2L[15231747];MCM6[unassigned1312];ZNF510[23602568];SRSF7[23178491];KPNB1[23602568];BCAR1[28007913];FKBP5[25036637];MCM2[unassigned1312];	1647778
249	chr1	1647814	T	C	chr1:1647814	CDK11A	cyclin dependent kinase 11A	SNV	0/1	0.56	77_102	182	99.0	0/1	0.49	87_87	176	99.0			rs72901775,COSV62264481	EXONIC	YES	NM_001313896.2	Transcript	protein_coding	synonymous_variant		5/20	NM_001313896.2:c.429A>G	NP_001300825.1:p.Glu143%3D		-1.0						.	.	.		6.62515e-06	1.0	150940.0	0.0	32	0.9	PASS	afr	2.43487e-05	1.0	0.0	0.0	0.468971	102290.0	218116.0	217.0	100	1.0	InbreedingCoeff	nfe	0.475687	47464.0	0.475687	47464.0	0.0200767	3122	0.173	565.0	0.49947	939.0		10.43	0.614453		0	0	0			CDK11A	0.0	0.0	0.02	0.0	-1.0	-29.0	-29.0	-3.0							0.0	20.395010472			.			white blood cells;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;trigeminal ganglion;parietal lobe;testis;skeletal muscle;heart;	.	mitotic cell cycle;regulation of cell growth;regulation of transcription, DNA-templated;protein phosphorylation;apoptotic process;regulation of mRNA processing;regulation of cell cycle	nucleus;cytoplasm	protein kinase activity;protein serine/threonine kinase activity;cyclin-dependent protein serine/threonine kinase activity;ATP binding	RBM25[23602568];USP15[unassigned1312];HKR1[23602568];HSP90AB1[22939624];ZFP14[23602568];CHEK2[23178491];PSMD1[23602568];CCNL2[18216018];A2M[23602568];KPNA2[23602568];CCNL1[23178491;18216018];C18orf25[23602568];ZNF267[23602568];SPAG9[unassigned1312];IVNS1ABP[unassigned1312];HSP90AA1[19875381];NOP58[23602568];JUN[25609649];CDK11A[23178491];SMAD3[18729074];ZNF460[23602568];PDHA1[29128334];CSNK2A1[22113938;23602568;25852190];GADD45A[21988832];CDKN2A[23602568];CSNK2A2[23455922;23602568];PRPF40A[23602568];EPS15L1[unassigned1312];ZNF33A[23602568];CDC37[24189400;25036637];CSNK2B[23602568];MCM4[unassigned1312];SKIV2L[15231747];MCM6[unassigned1312];ZNF510[23602568];SRSF7[23178491];KPNB1[23602568];BCAR1[28007913];FKBP5[25036637];MCM2[unassigned1312];	1647814
255	chr1	1647871	T	C	chr1:1647871	CDK11A	cyclin dependent kinase 11A	SNV	0/1	0.52	95_105	203	99.0	0/1	0.56	87_112	201	99.0			rs72909014,COSV62264925	EXONIC	YES	NM_001313896.2	Transcript	protein_coding	synonymous_variant		5/20	NM_001313896.2:c.372A>G	NP_001300825.1:p.Arg124%3D		-1.0						.	.	.		6.61735e-06	1.0	151118.0	0.0	32	0.9	PASS	nfe	1.47658e-05	1.0	1.47658e-05	1.0	0.464098	98736.0	212748.0	209.0	87	1.0	InbreedingCoeff	nfe	0.470811	46147.0	0.470811	46147.0	0.0170156	2646	0.169	549.0	0.5016	943.0		0.197	-0.388613		0	0	0			CDK11A	0.0	0.0	0.0	0.0	46.0	33.0	46.0	-16.0							0.0	20.395010472			.			white blood cells;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;trigeminal ganglion;parietal lobe;testis;skeletal muscle;heart;	.	mitotic cell cycle;regulation of cell growth;regulation of transcription, DNA-templated;protein phosphorylation;apoptotic process;regulation of mRNA processing;regulation of cell cycle	nucleus;cytoplasm	protein kinase activity;protein serine/threonine kinase activity;cyclin-dependent protein serine/threonine kinase activity;ATP binding	RBM25[23602568];USP15[unassigned1312];HKR1[23602568];HSP90AB1[22939624];ZFP14[23602568];CHEK2[23178491];PSMD1[23602568];CCNL2[18216018];A2M[23602568];KPNA2[23602568];CCNL1[23178491;18216018];C18orf25[23602568];ZNF267[23602568];SPAG9[unassigned1312];IVNS1ABP[unassigned1312];HSP90AA1[19875381];NOP58[23602568];JUN[25609649];CDK11A[23178491];SMAD3[18729074];ZNF460[23602568];PDHA1[29128334];CSNK2A1[22113938;23602568;25852190];GADD45A[21988832];CDKN2A[23602568];CSNK2A2[23455922;23602568];PRPF40A[23602568];EPS15L1[unassigned1312];ZNF33A[23602568];CDC37[24189400;25036637];CSNK2B[23602568];MCM4[unassigned1312];SKIV2L[15231747];MCM6[unassigned1312];ZNF510[23602568];SRSF7[23178491];KPNB1[23602568];BCAR1[28007913];FKBP5[25036637];MCM2[unassigned1312];	1647871
266	chr1	1647894		TTTCTT	chr1:1647893-1647894	CDK11A	cyclin dependent kinase 11A	insertion	0/1	0.44	82_65	149	99.0	0/1	0.58	58_81	140	99.0			rs144636354	EXONIC	YES	NM_001313896.2	Transcript	protein_coding	inframe_insertion		5/20	NM_001313896.2:c.344_349dup	NP_001300825.1:p.Lys115_Glu116dup		-1.0						.	.	.						32	0.9							0.400609	75377.0	188156.0	135.0	69	0.99	InbreedingCoeff_RF	sas	0.419059	10598.0	0.415297	34625.0	0.0001865,0.0155301	29,2415	0.063	207.0	0.5016	943.0		13.84	1.062714		0	0	0																		0.0				.			white blood cells;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;trigeminal ganglion;parietal lobe;testis;skeletal muscle;heart;	.	mitotic cell cycle;regulation of cell growth;regulation of transcription, DNA-templated;protein phosphorylation;apoptotic process;regulation of mRNA processing;regulation of cell cycle	nucleus;cytoplasm	protein kinase activity;protein serine/threonine kinase activity;cyclin-dependent protein serine/threonine kinase activity;ATP binding	RBM25[23602568];USP15[unassigned1312];HKR1[23602568];HSP90AB1[22939624];ZFP14[23602568];CHEK2[23178491];PSMD1[23602568];CCNL2[18216018];A2M[23602568];KPNA2[23602568];CCNL1[23178491;18216018];C18orf25[23602568];ZNF267[23602568];SPAG9[unassigned1312];IVNS1ABP[unassigned1312];HSP90AA1[19875381];NOP58[23602568];JUN[25609649];CDK11A[23178491];SMAD3[18729074];ZNF460[23602568];PDHA1[29128334];CSNK2A1[22113938;23602568;25852190];GADD45A[21988832];CDKN2A[23602568];CSNK2A2[23455922;23602568];PRPF40A[23602568];EPS15L1[unassigned1312];ZNF33A[23602568];CDC37[24189400;25036637];CSNK2B[23602568];MCM4[unassigned1312];SKIV2L[15231747];MCM6[unassigned1312];ZNF510[23602568];SRSF7[23178491];KPNB1[23602568];BCAR1[28007913];FKBP5[25036637];MCM2[unassigned1312];	1647893
331	chr1	1650797	A	G	chr1:1650797	CDK11A	cyclin dependent kinase 11A	SNV	0|1	0.92	4_45	49	33.0	0|1	0.8	10_41	51	99.0			rs1059830,COSV62264363	SPLICING	YES	NM_001313896.2	Transcript	protein_coding	missense_variant,splice_region_variant		4/20	NM_001313896.2:c.325T>C	NP_001300825.1:p.Trp109Arg		-1.0	.,.,.,.					.	.	.						33	0.91							0.499263	106344.0	213002.0	174.0	41	0.62	InbreedingCoeff	nfe	0.50002	50748.0	0.50002	50748.0	0.0130157	2024	0.17	531.0				19.32	1.947336	0.125	1	16	17	MutationTaster_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CDK11A	0.0	0.0	0.12	0.08	0.0	-30.0	-30.0	0.0			4.487	-1.297	3.191		0.0	89.701620717	0.489	-0.325	.			white blood cells;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;trigeminal ganglion;parietal lobe;testis;skeletal muscle;heart;	.	mitotic cell cycle;regulation of cell growth;regulation of transcription, DNA-templated;protein phosphorylation;apoptotic process;regulation of mRNA processing;regulation of cell cycle	nucleus;cytoplasm	protein kinase activity;protein serine/threonine kinase activity;cyclin-dependent protein serine/threonine kinase activity;ATP binding	RBM25[23602568];USP15[unassigned1312];HKR1[23602568];HSP90AB1[22939624];ZFP14[23602568];CHEK2[23178491];PSMD1[23602568];CCNL2[18216018];A2M[23602568];KPNA2[23602568];CCNL1[23178491;18216018];C18orf25[23602568];ZNF267[23602568];SPAG9[unassigned1312];IVNS1ABP[unassigned1312];HSP90AA1[19875381];NOP58[23602568];JUN[25609649];CDK11A[23178491];SMAD3[18729074];ZNF460[23602568];PDHA1[29128334];CSNK2A1[22113938;23602568;25852190];GADD45A[21988832];CDKN2A[23602568];CSNK2A2[23455922;23602568];PRPF40A[23602568];EPS15L1[unassigned1312];ZNF33A[23602568];CDC37[24189400;25036637];CSNK2B[23602568];MCM4[unassigned1312];SKIV2L[15231747];MCM6[unassigned1312];ZNF510[23602568];SRSF7[23178491];KPNB1[23602568];BCAR1[28007913];FKBP5[25036637];MCM2[unassigned1312];	1650797
338	chr1	1650801	T	C	chr1:1650801	CDK11A	cyclin dependent kinase 11A	SNV	0|1	0.92	4_44	48	36.0	0|1	0.8	10_41	51	99.0			rs1137004,COSV62265927	EXONIC	YES	NM_001313896.2	Transcript	protein_coding	synonymous_variant		4/20	NM_001313896.2:c.321A>G	NP_001300825.1:p.Glu107%3D		-1.0						.	.	.						33	0.91							0.49935	106017.0	212310.0	177.0	40	0.62	InbreedingCoeff	nfe	0.500148	50685.0	0.500148	50685.0	0.0110865,0.0015305	1724,238	0.17	531.0				18.08	1.784029		0	0	0			CDK11A	0.0	0.0	0.02	0.04	-32.0	-2.0	-34.0	-4.0							0.0	89.701620717			.			white blood cells;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;trigeminal ganglion;parietal lobe;testis;skeletal muscle;heart;	.	mitotic cell cycle;regulation of cell growth;regulation of transcription, DNA-templated;protein phosphorylation;apoptotic process;regulation of mRNA processing;regulation of cell cycle	nucleus;cytoplasm	protein kinase activity;protein serine/threonine kinase activity;cyclin-dependent protein serine/threonine kinase activity;ATP binding	RBM25[23602568];USP15[unassigned1312];HKR1[23602568];HSP90AB1[22939624];ZFP14[23602568];CHEK2[23178491];PSMD1[23602568];CCNL2[18216018];A2M[23602568];KPNA2[23602568];CCNL1[23178491;18216018];C18orf25[23602568];ZNF267[23602568];SPAG9[unassigned1312];IVNS1ABP[unassigned1312];HSP90AA1[19875381];NOP58[23602568];JUN[25609649];CDK11A[23178491];SMAD3[18729074];ZNF460[23602568];PDHA1[29128334];CSNK2A1[22113938;23602568;25852190];GADD45A[21988832];CDKN2A[23602568];CSNK2A2[23455922;23602568];PRPF40A[23602568];EPS15L1[unassigned1312];ZNF33A[23602568];CDC37[24189400;25036637];CSNK2B[23602568];MCM4[unassigned1312];SKIV2L[15231747];MCM6[unassigned1312];ZNF510[23602568];SRSF7[23178491];KPNB1[23602568];BCAR1[28007913];FKBP5[25036637];MCM2[unassigned1312];	1650801
341	chr1	1650832	A	G	chr1:1650832	CDK11A	cyclin dependent kinase 11A	SNV	1/1	0.95	3_53	56	84.0	0/1	0.85	9_50	59	51.0			rs72909030,COSV62264367	EXONIC	YES	NM_001313896.2	Transcript	protein_coding	missense_variant		4/20	NM_001313896.2:c.290T>C	NP_001300825.1:p.Val97Ala		-1.0	.,.,.,.,.,.,.					.	.	.		6.62497e-06	1.0	150944.0	0.0	33	0.9	AS_VQSR	afr	2.43475e-05	1.0	0.0	0.0	0.498437	108394.0	217468.0	178.0	35	0.63	InbreedingCoeff	nfe	0.499156	51474.0	0.499156	51474.0	0.0258643	4022	0.2	632.0				18.13	1.790671	0.045	0	18	18		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CDK11A	0.0	0.0	0.01	0.0	22.0	6.0	-35.0	2.0							0.0	30.804515156	0.991	-0.325	.			white blood cells;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;trigeminal ganglion;parietal lobe;testis;skeletal muscle;heart;	.	mitotic cell cycle;regulation of cell growth;regulation of transcription, DNA-templated;protein phosphorylation;apoptotic process;regulation of mRNA processing;regulation of cell cycle	nucleus;cytoplasm	protein kinase activity;protein serine/threonine kinase activity;cyclin-dependent protein serine/threonine kinase activity;ATP binding	RBM25[23602568];USP15[unassigned1312];HKR1[23602568];HSP90AB1[22939624];ZFP14[23602568];CHEK2[23178491];PSMD1[23602568];CCNL2[18216018];A2M[23602568];KPNA2[23602568];CCNL1[23178491;18216018];C18orf25[23602568];ZNF267[23602568];SPAG9[unassigned1312];IVNS1ABP[unassigned1312];HSP90AA1[19875381];NOP58[23602568];JUN[25609649];CDK11A[23178491];SMAD3[18729074];ZNF460[23602568];PDHA1[29128334];CSNK2A1[22113938;23602568;25852190];GADD45A[21988832];CDKN2A[23602568];CSNK2A2[23455922;23602568];PRPF40A[23602568];EPS15L1[unassigned1312];ZNF33A[23602568];CDC37[24189400;25036637];CSNK2B[23602568];MCM4[unassigned1312];SKIV2L[15231747];MCM6[unassigned1312];ZNF510[23602568];SRSF7[23178491];KPNB1[23602568];BCAR1[28007913];FKBP5[25036637];MCM2[unassigned1312];	1650832
384	chr1	1696774	C	T	chr1:1696774	NADK	NAD kinase	SNV	0/1	0.63	33_58	92	99.0	0/1	0.49	44_43	87	99.0			rs144624776	EXONIC	YES	NM_001198994.2	Transcript	protein_coding	synonymous_variant		2/14	NM_001198994.2:c.72G>A	NP_001185923.1:p.Ser24%3D		-1.0						.	.	.		0.000781866	119.0	152200.0	0.0	32	0.98	PASS	nfe	0.00141085	96.0	0.00141085	96.0	0.000749356	188.0	250882.0	0.0	58	0.93	PASS	nfe	0.00137603	156.0	0.00137603	156.0	0.0007267	113	0.001	4.0				0.493	-0.256024		0	0	0			NADK	0.0	0.0	0.0	0.0	-2.0	35.0	-25.0	38.0						0.501	0.0	2.608477253			.			ciliary ganglion;superior cervical ganglion;cingulate cortex;whole blood;adrenal gland;testis;	Nicotinate and nicotinamide metabolism	NADP biosynthetic process;phosphorylation;NAD metabolic process;positive regulation of insulin secretion involved in cellular response to glucose stimulus;ATP metabolic process	cytosol	NAD+ kinase activity;protein binding;ATP binding;metal ion binding	RTKN[unassigned1312];YWHAB[24255178];MAST3[unassigned1312];DENND1A[unassigned1312];ZBTB21[unassigned1312];CBY1[unassigned1312];TESK2[unassigned1312];FAM110A[unassigned1312];SYDE1[unassigned1312];SIPA1L1[unassigned1312];SH3PXD2A[unassigned1312];FAM110B[unassigned1312];FAM53C[unassigned1312];KIF13B[unassigned1312];NUDT18[16189514];KIF1C[unassigned1312];YWHAG[15324660;17353931];YWHAH[17979178];RALGPS2[unassigned1312];MAGI1[unassigned1312];GLRX3[16189514];KSR1[unassigned1312];NAV1[unassigned1312];KCTD3[unassigned1312];GAB2[unassigned1312];CDC25C[unassigned1312];YWHAZ[17353931;15161933];CDC25B[unassigned1312];GIGYF1[unassigned1312];TIAM1[unassigned1312];ZNF638[unassigned1312];CRY2[unassigned1304];EIF4E2[unassigned1312];PHLDB2[unassigned1312];HDAC4[unassigned1312];MAPKAP1[unassigned1312];PPM1H[unassigned1312];AGAP1[unassigned1312];RASAL2[unassigned1312];GIGYF2[unassigned1312];CAMSAP2[unassigned1312];SDCBP[25416956;unassigned1304];LIMA1[unassigned1312];FAM124B[unassigned1304];INPP5E[unassigned1312];MAP3K21[unassigned1312];SRGAP2[unassigned1312];SRSF12[unassigned1312];ANKRD34A[unassigned1312];USP21[unassigned1312];DENND4C[unassigned1312];CGN[unassigned1312];DCLK1[unassigned1312];PLEKHA7[unassigned1312];LRFN1[unassigned1312];LNX1[16189514;unassigned1304];NF1[unassigned1312];GRB2[18624398];LPIN3[unassigned1312];CDK16[unassigned1312];	1696774
392	chr1	2235513	G	A	chr1:2235513	SKI	SKI proto-oncogene	SNV	0/0	0.0	34_0	34	99.0	0/1	0.44	51_40	91	99.0			rs114345135	EXONIC	YES	NM_003036.4	Transcript	protein_coding	synonymous_variant		4/7	NM_003036.4:c.1446G>A	NP_003027.1:p.Ala482%3D		1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	Shprintzen-Goldberg_syndrome|not_specified|Cardiovascular_phenotype	Shprintzen-Goldberg syndrome, 182212 (3), Autosomal dominant	1p36 deletion syndrome;Shprintzen-Goldberg syndrome	Role in the phenotype of;Disease-causing germline mutation(s) in	Microcephaly;Arachnodactyly;Cryptorchidism;Micrognathia;Umbilical hernia;Downslanted palpebral fissures;Craniosynostosis;Muscular hypotonia;Hypertelorism;Strabismus;Failure to thrive;Apnea;Abnormality of the metaphysis;Ventriculomegaly;Arnold-Chiari malformation;Hypoplasia of the maxilla;Posteriorly rotated ears;Mitral regurgitation;Myopia;Abnormal form of the vertebral bodies;Narrow chest;Scoliosis;Genu valgum;Gastroesophageal reflux;Communicating hydrocephalus;Abnormal aortic valve morphology;High, narrow palate;Inguinal hernia;Ptosis;Aplasia/Hypoplasia of the abdominal wall musculature;Low-set ears;Joint stiffness;Joint hyperflexibility;Osteopenia;Dolichocephaly;Pectus carinatum;Elbow dislocation;Retrognathia;Telecanthus;Protruding ear;Conductive hearing impairment;Frontal bossing;Missing ribs;Pes planus;Hyperextensible skin;Pectus excavatum;Anteverted nares;Camptodactyly of finger;Intellectual disability;Mitral valve prolapse;Proptosis;High forehead;Aortic aneurysm;Brachyturricephaly;Umbilical hernia;Thin ribs;Generalized hypotonia;Joint hypermobility;Muscular hypotonia;Craniosynostosis;Metaphyseal widening;Joint contracture of the hand;Scoliosis;C1-C2 vertebral abnormality;Prominent forehead;Narrow palate;Global developmental delay;Metatarsus adductus;Pectus excavatum;Wide anterior fontanel;Dislocated radial head;Minimal subcutaneous fat;Inguinal hernia;Arnold-Chiari type I malformation;Myopia;Camptodactyly;Obstructive sleep apnea;High palate;Ptosis;Osteopenia;Genu recurvatum;Lateral clavicle hook;Mitral valve prolapse;Micrognathia;Pectus carinatum;Downslanted palpebral fissures;Pes planus;Gastroesophageal reflux;Dolichocephaly;Strabismus;Hyperextensible skin;Feeding difficulties in infancy;Arachnodactyly;Sporadic;Cryptorchidism;Abnormality of the pinna;Intellectual disability;Hypoplasia of the maxilla;Talipes equinovarus;Anteverted nares;Genu valgum;Supernumerary ribs;Low-set, posteriorly rotated ears;Joint laxity;Abdominal wall muscle weakness;Frontal bossing;Hydrocephalus;Hypertelorism;Telecanthus;Dental malocclusion;Autosomal dominant inheritance;Conductive hearing impairment;Microcephaly;Shallow orbits;Abnormal intestine morphology;Narrow mouth;Cataract;Stereotypy;Epicanthus;Short stature;Hemiplegia/hemiparesis;Nystagmus;Spinal canal stenosis;Rib fusion;Brachydactyly;Long philtrum;Strabismus;11 pairs of ribs;Polyphagia;Low-set, posteriorly rotated ears;Wide nasal bridge;Myopathy;Annular pancreas;Hypospadias;Camptodactyly of finger;Pointed chin;Optic atrophy;Telangiectasia;Hip dysplasia;Gastroesophageal reflux;Aortic arch aneurysm;Horizontal eyebrow;Brachycephaly;Scoliosis;Frontal bossing;Feeding difficulties in infancy;Kyphosis;Abnormal blistering of the skin;Lower limb asymmetry;Renal cyst;Bifid ribs;Patent ductus arteriosus;Muscular hypotonia;Failure to thrive;Obesity;Sensorineural hearing impairment;Joint stiffness;Poor speech;Self-injurious behavior;Depressed nasal ridge;Microtia;Dilated cardiomyopathy;Depressed nasal bridge;High hypermetropia;Seizure;Agenesis of corpus callosum;Pyloric stenosis;Microcephaly;Absent speech;Short foot;Delayed cranial suture closure;Abnormality of the neck;Abnormality of the anus;Cranial nerve paralysis;Abnormal heart valve morphology;Visual impairment;Autism;Hepatic steatosis;Abnormal cardiac septum morphology;Hypogonadism;Hypoplasia of penis;Intellectual disability;Abnormality of female external genitalia;Hydronephrosis;Hypothyroidism;Abnormality of the spleen;Generalized hirsutism;Neuroblastoma;Clinodactyly of the 5th finger;Gait disturbance;EEG abnormality;Foot polydactyly;Constipation;Ventriculomegaly;Deeply set eye;Cerebral cortical atrophy;Global developmental delay;Cryptorchidism;Conductive hearing impairment;Midface retrusion;Ocular albinism;Dysphagia;Tetralogy of Fallot;Macule	25741868	0.0055711	848.0	152214.0	4.0	32	0.97	PASS	nfe	0.00908343	618.0	0.00908343	618.0	0.00568085	1397.0	245914.0	11.0	95	0.95	PASS	nfe	0.00883202	967.0	0.00883202	967.0	0.0057812	899	0.005	17.0	0.00431	49.0		1.091	-0.137858		0	0	0			SKI	0.0	0.0	0.04	0.0	3.0	-22.0	3.0	34.0							0.98	72.518560894			cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; skeleton phenotype; nervous system phenotype ; limbs/digits/tail phenotype; vision/eye phenotype; mortality/aging ; cardiovascular system phenotype ; neoplasm; embryo phenotype; 			.	.	negative regulation of transcription by RNA polymerase II;neural tube closure;lens morphogenesis in camera-type eye;transcription, DNA-templated;transforming growth factor beta receptor signaling pathway;cell population proliferation;negative regulation of cell population proliferation;anterior/posterior axis specification;negative regulation of Schwann cell proliferation;myotube differentiation;olfactory bulb development;myelination in peripheral nervous system;positive regulation of Wnt signaling pathway;embryonic limb morphogenesis;BMP signaling pathway;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of BMP signaling pathway;negative regulation of histone deacetylation;negative regulation of activin receptor signaling pathway;somatic stem cell population maintenance;camera-type eye development;positive regulation of DNA binding;nose morphogenesis;negative regulation of cell differentiation;negative regulation of osteoblast differentiation;positive regulation of transcription by RNA polymerase II;negative regulation of fibroblast proliferation;camera-type eye morphogenesis;neuron development;skeletal muscle fiber development;cell motility;roof of mouth development;retina development in camera-type eye;face morphogenesis;bone morphogenesis;SMAD protein signal transduction;protein homotrimerization	nucleus;nucleoplasm;transcription factor complex;cytoplasm;centrosome;nuclear body;PML body;transcriptional repressor complex;protein-containing complex	DNA-binding transcription factor activity, RNA polymerase II-specific;transcription corepressor activity;protein binding;zinc ion binding;protein kinase binding;protein domain specific binding;ubiquitin protein ligase binding;SMAD binding;histone deacetylase inhibitor activity;repressing transcription factor binding	SMAD2[18729074;22442258;19032343;26977879];PRMT5[19032343];SMAD4[14525983;15231748;12419246;19032343;25609649;26977879];SMAD3[12857746;14525983;22442258;19032343];HDAC3[19032343];HDAC1[10049357];DYRK1B[23602568];PAX3[26977879];NLK[23602568];SMAD7[15128733;19032343];NCOR2[19032343];NCOR1[14525983;10049357;19032343];SIN3A[14525983;10049357];TBL1XR1[19032343];RNF165[23610558];	2235513
546	chr1	8923382	T	C	chr1:8923382	ENO1	enolase 1	SNV	0/0	0.0	33_0	33	99.0	0/1	0.5	42_42	84	99.0			rs151047591	EXONIC	YES	NM_001353346.3	Transcript	protein_coding	missense_variant		10/12	NM_001353346.3:c.1088A>G	NP_001340275.1:p.Asn363Ser		-1.0	Enolase, C-terminal TIM barrel domain&Enolase, C-terminal TIM barrel domain,Enolase, C-terminal TIM barrel domain&Enolase, C-terminal TIM barrel domain,Enolase, C-terminal TIM barrel domain&Enolase, C-terminal TIM barrel domain					.	.	.		0.000295737	45.0	152162.0	0.0	32	0.97	PASS	amr	0.000589082	9.0	0.000441099	30.0	0.000494382	124.0	250818.0	1.0	36	0.94	PASS	amr	0.00171273	59.0	0.00036152	41.0	0.0003601	56	0.002	5.0				21.0	2.146784	0.091	4	15	19	MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	ENO1	0.0	0.0	0.0	0.0	13.0	20.0	21.0	-2.0						0.774	0.01	0.000000000	0.999	1.138	growth/size/body region phenotype; embryo phenotype; mortality/aging ; 			lung;liver;tumor;whole brain;smooth muscle;heart;	Glycolysis / Gluconeogenesis	negative regulation of transcription by RNA polymerase II;gluconeogenesis;response to virus;positive regulation of plasminogen activation;negative regulation of cell growth;negative regulation of transcription, DNA-templated;positive regulation of muscle contraction;canonical glycolysis;negative regulation of hypoxia-induced intrinsic apoptotic signaling pathway;positive regulation of ATP biosynthetic process	phosphopyruvate hydratase complex;extracellular space;nucleus;cytoplasm;cytosol;plasma membrane;cell surface;membrane;M band;extracellular exosome;cell cortex region	magnesium ion binding;RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;RNA binding;phosphopyruvate hydratase activity;protein binding;protein homodimerization activity;cadherin binding;GTPase binding	ITGB1[23414517];ACHE[18194455];ATF2[22304920];HSP90AB1[23414517];COL14A1[23414517];FHL1[23414517];HSPB2[26465331];HIST2H2AB[30021884];DUX4[26816005];ACTB[15047060];HK2[23414517];RXFP3[28298427];MAP1LC3B[20562859];METTL14[29507755];MED13[23414517];CYSLTR2[28298427];PPP2R5E[23414517];SNAPC3[23414517];CHEK2[25640309];HEY2[23414517];EP300[21988832];MAP3K7[14743216];TEAD1[23414517];SGCG[23414517];GABARAPL2[20562859];GABARAPL1[20562859];HSDL2[30021884];AGTPBP1[16713569];KDM2A[23414517];RIPK2[14743216];H2AFX[20000738];ATP6AP2[26496610];YWHAZ[15324660;15161933;23414517];ARID1B[23414517];ZNF16[21874239];IFT88[27173435];NCOR1[23414517];ALDOA[23414517];OTUB1[26752685];TSG101[19549727];PCNA[20849852];SET[23414517];GLIS3[23414517];HTT[17500595];ZBTB44[23414517];GABARAP[20562859];TTN[23414517];SNX1[30021884];LONRF3[23414517];FLNC[23414517];IVNS1ABP[23414517];TRAPPC2[23414517];HSPA8[23414517];JUN[25609649];CBX5[23414517];VCAM1[22623428;19738201];NEK4[25798074];FN1[19738201];PDE4DIP[21569246];NFKB1[25609649];MAPK13[19135240];RAD52[19338310];DES[23414517];BCL6[23414517];BHLHE40[21988832];PAF1[23414517];TCAP[23414517];GRB2[18624398];P4HB[23414517];	8923382
669	chr1	12368706	T		chr1:12368706	VPS13D	vacuolar protein sorting 13 homolog D	sequence_alteration	0/1	0.3	16_7_0	23	98.0	0/2	0.2	20_8_12	40	86.0			rs750147071	SPLICING	YES	NM_015378.4	Transcript	protein_coding	splice_region_variant,intron_variant	27/69		NM_015378.4:c.6650+8del			1.0					Spinocerebellar ataxia, autosomal recessive 4, 607317 (3), Autosomal recessive	.	.	Abnormality of the cerebral white matter;Pes cavus;Babinski sign;Macrosaccadic oscillations;Dysarthria;Peripheral axonal neuropathy;Nystagmus;Spasticity;Hyperreflexia;Microcephaly;Tremor;Frequent falls;Variable expressivity;Autosomal recessive inheritance;Distal amyotrophy;Intellectual disability, mild;Myoclonus;Adult onset;Muscular hypotonia of the trunk;Gait ataxia;Ataxia;Dystonia;Hypermetric saccades;Fasciculations;Distal muscle weakness;Motor delay		0.00121687	171.0	140524.0	0.0	30	0.81	PASS	amr	0.00114318	16.0	0.00111076	71.0	0.246555	33815.0	137150.0	0.0	48	0.92	InbreedingCoeff	nfe	0.264934	16569.0	0.264934	16569.0	0.0002508,0.0007331,0.0000450,0.2042391	39,114,7,31760						5.383	0.169795		0	0	0			VPS13D	0.0	0.0	0.0	0.01	-39.0	19.0	-27.0	-7.0						0.655	1.0				mortality/aging ; 			ciliary ganglion;amygdala;prefrontal cortex;subthalamic nucleus;superior cervical ganglion;atrioventricular node;trigeminal ganglion;parietal lobe;skeletal muscle;globus pallidus;	.	protein targeting to vacuole;mitochondrion organization;protein retention in Golgi apparatus;positive regulation of mitophagy	cell;extrinsic component of membrane;extracellular exosome	.	GSK3B[29568061];PLGRKT[29568061];P4HA2[30021884];MGST3[29568061];MADD[12421765];ESR1[21182205];TOMM20[29568061];TOMM22[29568061];	12368705
680	chr1	12776218	C	C	chr1:12776218	AADACL3	arylacetamide deacetylase like 3	SNV	0/1	0.6	39_58	97	99.0	1/1	1.0	0_128	128	99.0			rs3000860	EXONIC	YES	NM_001103170.3	Transcript	protein_coding	synonymous_variant		1/4	NM_001103170.3:c.39A>C	NP_001096640.2:p.Cys13%3D		1.0						.	.	.						0	0.0											0	0.0							0.0000379,0.0000379,0.0000379,0.1693718	1,1,1,26338	0.35	1087.0				0.131	-0.445948		0	0	0			AADACL3	0.0	0.0	0.0	0.0	14.0	2.0	23.0	-39.0						0.92	0.0				.			.	.	.	integral component of membrane	carboxylic ester hydrolase activity	.	12776218
709	chr1	12854090	T	A	chr1:12854090	PRAMEF1	PRAME family member 1	SNV	0|1	0.22	68_19	87	99.0	0|1	0.08	71_6	77	38.0			rs79698223,COSV60004981,COSV60016926	EXONIC	YES	NM_023013.4	Transcript	protein_coding	stop_gained		3/4	NM_023013.4:c.314T>A	NP_075389.2:p.Leu105Ter		1.0						.	.	.						32	0.91							0.247492	30931.0	124978.0	38.0	100	0.99	InbreedingCoeff_RF	nfe	0.291538	15469.0	0.291538	15469.0	0.0001865	29	0.027	72.0				34.0	5.668333		3	3	6	MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	LRT_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRAMEF1	0.0	0.01	0.0	0.0	-23.0	-26.0	-26.0	-11.0						0.994	0.1		0.153	0.65	.			.	.	positive regulation of cell population proliferation;negative regulation of apoptotic process;negative regulation of cell differentiation;negative regulation of transcription, DNA-templated	cytoplasm	.	.	12854090
712	chr1	12854097	T	C	chr1:12854097	PRAMEF1	PRAME family member 1	SNV	0|1	0.2	74_18	92	99.0	0|1	0.09	72_7	79	77.0			rs76193255,COSV60004995	EXONIC	YES	NM_023013.4	Transcript	protein_coding	synonymous_variant		3/4	NM_023013.4:c.321T>C	NP_075389.2:p.Asp107%3D		1.0		Benign	criteria_provided,_single_submitter	not_specified		.	.	.	24033266					32	0.91							0.302512	46406.0	153402.0	49.0	100	1.0	InbreedingCoeff	nfe	0.345118	23691.0	0.345118	23691.0	0.0108036	1680	0.054	150.0				0.977	-0.154075		0	0	0			PRAMEF1	0.01	0.0	0.0	0.0	-33.0	24.0	-4.0	-18.0						0.994	0.1				.			.	.	positive regulation of cell population proliferation;negative regulation of apoptotic process;negative regulation of cell differentiation;negative regulation of transcription, DNA-templated	cytoplasm	.	.	12854097
713	chr1	12854105	A	G	chr1:12854105	PRAMEF1	PRAME family member 1	SNV	0|1	0.17	85_18	103	99.0	0|1	0.08	81_7	88	50.0			rs76648802,COSV60005012	EXONIC	YES	NM_023013.4	Transcript	protein_coding	missense_variant		3/4	NM_023013.4:c.329A>G	NP_075389.2:p.Glu110Gly		1.0		Benign	criteria_provided,_single_submitter	not_specified		.	.	.	24033266					32	0.91							0.281472	39383.0	139918.0	49.0	100	1.0	InbreedingCoeff	nfe	0.324347	19754.0	0.324347	19754.0	0.0002315	36	0.021	58.0				13.04	0.944959	0.073	3	16	19	SIFT,PolyPhen,PROVEAN_pred	Polyphen2_HDIV_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRAMEF1	0.0	0.01	0.0	0.0	-42.0	-41.0	-39.0	10.0						0.994	0.1		0.002	0.736	.			.	.	positive regulation of cell population proliferation;negative regulation of apoptotic process;negative regulation of cell differentiation;negative regulation of transcription, DNA-templated	cytoplasm	.	.	12854105
715	chr1	12854188	T	C	chr1:12854188	PRAMEF1	PRAME family member 1	SNV	0/1	0.21	99_26	125	99.0	0/0	0.11	83_10	93	12.0			rs76030350,COSV60005161	EXONIC	YES	NM_023013.4	Transcript	protein_coding	missense_variant		3/4	NM_023013.4:c.412T>C	NP_075389.2:p.Cys138Arg		1.0						.	.	.		1.9841e-05	3.0	151202.0	0.0	32	0.92	PASS	sas	0.000212495	1.0	1.47562e-05	1.0	0.0295228	4003.0	135590.0	78.0	100	1.0	RF	sas	0.0400528	637.0	0.0336031	1885.0	0.0008874	138	0.003	9.0				11.66	0.762725	0.177	4	16	20	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,PROVEAN_pred	SIFT,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRAMEF1	0.0	0.0	0.04	0.03	-32.0	-24.0	32.0	-24.0						0.994	0.1		0.001	-0.147	.			.	.	positive regulation of cell population proliferation;negative regulation of apoptotic process;negative regulation of cell differentiation;negative regulation of transcription, DNA-templated	cytoplasm	.	.	12854188
726	chr1	12856111	C	T	chr1:12856111	PRAMEF1	PRAME family member 1	SNV	0/1	0.51	47_48	95	99.0	0/1	0.42	60_43	103	99.0			rs61775054,COSV60005245	EXONIC	YES	NM_023013.4	Transcript	protein_coding	missense_variant		4/4	NM_023013.4:c.1391C>T	NP_075389.2:p.Pro464Leu		1.0						.	.	.		0.00333186	497.0	149166.0	1.0	29	0.85	PASS	nfe	0.00502707	338.0	0.00502707	338.0	0.488159	88880.0	182072.0	31.0	34	0.79	InbreedingCoeff	nfe	0.492364	42813.0	0.492364	42813.0	0.0021028	327	0.018	46.0				0.86	-0.173155	0.141	0	18	18		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRAMEF1	0.0	0.0	0.0	0.0	35.0	2.0	0.0	48.0						0.994	0.1		0.001	0.59	.			.	.	positive regulation of cell population proliferation;negative regulation of apoptotic process;negative regulation of cell differentiation;negative regulation of transcription, DNA-templated	cytoplasm	.	.	12856111
745	chr1	12907282	G	C	chr1:12907282	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.67	44_89	133	99.0	0|1	0.57	59_79	138	99.0			rs139731855,COSV58609836	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.861C>G	NP_001013653.1:p.Thr287%3D		-1.0						.	.	.						30	0.87							0.0914692	13094.0	143152.0	68.0	100	1.0	InbreedingCoeff_RF	nfe	0.098475	5605.0	0.098475	5605.0	0.0002444	38	0.073	213.0				0.359	-0.3028		0	0	0			HNRNPCL1	0.0	0.0	0.0	0.0	-10.0	-30.0	-33.0	-9.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907282
746	chr1	12907284	T	C	chr1:12907284	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.66	45_89	134	99.0	0|1	0.58	59_81	140	99.0			rs149796618,COSV58609567	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.859A>G	NP_001013653.1:p.Thr287Ala		-1.0						.	.	.						30	0.87							0.143169	18338.0	128086.0	284.0	100	1.0	InbreedingCoeff	nfe	0.165754	8538.0	0.165754	8538.0	0.0002508	39	0.071	205.0				0.092	-0.494748	0.095	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	-34.0	-12.0	-35.0	-30.0						0.881	0.01		0.002	-2.207	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907284
747	chr1	12907285	G	C	chr1:12907285	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.66	45_89	134	99.0	0|1	0.58	59_81	140	99.0			rs148930640,COSV58609633	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.858C>G	NP_001013653.1:p.Ser286Arg		-1.0						.	.	.						30	0.87							0.0876991	12575.0	143388.0	69.0	100	1.0	InbreedingCoeff	nfe	0.0941591	5365.0	0.0941591	5365.0	0.0002379	37	0.072	208.0				6.689	0.259995	0.18	2	14	16	SIFT,MutationTaster_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	-26.0	-13.0	-31.0	-36.0						0.881	0.01		0.002	0.262	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907285
748	chr1	12907316	T	C	chr1:12907316	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0/1	0.61	62_95	157	99.0	0/1	0.49	86_82	168	99.0			rs112607517,COSV58609639	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.827A>G	NP_001013653.1:p.Glu276Gly		-1.0						.	.	.		1.33216e-05	2.0	150132.0	0.0	30	0.87	PASS	nfe	2.95779e-05	2.0	2.95779e-05	2.0	0.0851479	12529.0	147144.0	57.0	100	1.0	RF	afr	0.0968827	864.0	0.0888032	5344.0	0.0012218	190	0.051	155.0				17.07	1.635624	0.116	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	-8.0	45.0	23.0	-38.0						0.881	0.01		0.009	-0.83	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907316
749	chr1	12907350	C	T	chr1:12907350	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.45	91_74	165	99.0	0|1	0.4	97_64	161	99.0			rs2359486,COSV58609648	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.793G>A	NP_001013653.1:p.Asp265Asn		-1.0						.	.	.						30	0.86							0.0224513	3199.0	142486.0	38.0	100	1.0	RF	amr	0.0542169	1188.0	0.0176183	1046.0	0.0018006	280	0.025	79.0				12.13	0.822435	0.134	1	16	17	SIFT	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	-21.0	11.0	22.0	5.0						0.881	0.01		0.005	0.238	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907350
750	chr1	12907351	A	G	chr1:12907351	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.45	91_74	165	99.0	0|1	0.4	97_64	161	99.0			rs2359485,COSV58612832	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.792T>C	NP_001013653.1:p.Asp264%3D		-1.0						.	.	.						30	0.86							0.0229617	3255.0	141758.0	38.0	100	1.0	PASS	amr	0.0549027	1196.0	0.0182883	1080.0	0.0017942	279	0.025	78.0				0.332	-0.314057		0	0	0			HNRNPCL1	0.0	0.0	0.0	0.0	10.0	-7.0	-11.0	21.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907351
751	chr1	12907370	A	T	chr1:12907370	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.34	90_47	137	99.0	0|1	0.28	94_37	131	99.0			rs2076063,COSV58609657	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.773T>A	NP_001013653.1:p.Val258Asp		-1.0						.	.	.		4.00673e-05	6.0	149748.0	0.0	30	0.86	PASS	sas	0.000214777	1.0	4.4426e-05	3.0	0.060616	6680.0	110202.0	362.0	100	1.0	InbreedingCoeff_RF	amr	0.131638	2216.0	0.0569163	2570.0	0.0018520	288	0.019	60.0				8.506	0.410086	0.074	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	-26.0	-9.0	50.0	2.0						0.881	0.01		0.004	-0.84	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907370
752	chr1	12907380	C	A	chr1:12907380	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.31	93_42	135	99.0	0|1	0.28	96_38	134	99.0			rs141207681,COSV58609675	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.763G>T	NP_001013653.1:p.Asp255Tyr		-1.0						.	.	.						30	0.86							0.00537224	1197.0	222812.0	60.0	100	1.0	RF	amr	0.0202795	621.0	0.00203436	207.0	0.0016913	263	0.002	5.0				17.61	1.719663	0.216	4	13	17	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	-19.0	29.0	2.0	-8.0						0.881	0.01		0.002	0.238	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907380
753	chr1	12907385	G	A	chr1:12907385	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.31	91_41	132	99.0	0|1	0.26	93_33	126	99.0			rs150590256,COSV58609612	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.758C>T	NP_001013653.1:p.Pro253Leu		-1.0						.	.	.						30	0.86							0.00922345	1798.0	194938.0	132.0	100	1.0	PASS	amr	0.0318678	835.0	0.00466561	413.0	0.1323760	20585	0.08	254.0				5.359	0.168265	0.175	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	-41.0	-24.0	-13.0	35.0						0.881	0.01		0.001	-0.739	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907385
754	chr1	12907400	G	A	chr1:12907400	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.25	100_34	134	99.0	0|1	0.21	100_26	126	99.0			rs149302457,COSV58611257	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.743C>T	NP_001013653.1:p.Ala248Val		-1.0						.	.	.						30	0.86							0.00859993	1886.0	219304.0	80.0	100	1.0	RF	amr	0.0272279	828.0	0.00411733	411.0	0.0424684	6604	0.004	13.0				22.0	2.293508	0.163	4	13	17	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	-39.0	9.0	38.0	-28.0						0.881	0.01		0.005	0.268	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907400
755	chr1	12907408	T	A	chr1:12907408	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.23	101_31	132	99.0	0|1	0.22	102_29	131	99.0			rs146075045,COSV58611265	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.735A>T	NP_001013653.1:p.Glu245Asp		-1.0						.	.	.						30	0.86							0.0101337	2167.0	213842.0	100.0	100	1.0	RF	amr	0.0310067	908.0	0.00521901	509.0	0.0809433	12587	0.004	13.0				0.003	-0.985592	0.014	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	1.0	-47.0	12.0	30.0						0.881	0.01		0.002	-0.751	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907408
756	chr1	12907438	A	G	chr1:12907438	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.31	104_47	151	99.0	0|1	0.27	102_38	140	99.0			rs115476478,COSV58609795	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.705T>C	NP_001013653.1:p.His235%3D		-1.0						.	.	.						30	0.86							0.0171505	3710.0	216320.0	100.0	100	1.0	PASS	amr	0.040272	1208.0	0.0109528	1079.0	0.0009968	155	0.008	24.0				0.367	-0.299327		0	0	0			HNRNPCL1	0.0	0.0	0.0	0.0	-29.0	5.0	7.0	0.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907438
757	chr1	12907446	C	T	chr1:12907446	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.33	99_48	147	99.0	0|1	0.28	99_38	137	99.0			rs116578678,COSV58612137	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.697G>A	NP_001013653.1:p.Glu233Lys		-1.0						.	.	.						30	0.86							0.023954	5186.0	216498.0	109.0	100	1.0	RF	amr	0.0491588	1461.0	0.0170038	1681.0	0.0009775	152	0.002	7.0				14.69	1.206582	0.146	0	16	16		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	-3.0	-37.0	3.0	1.0						0.881	0.01		0.001	0.238	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907446
758	chr1	12907450	T	C	chr1:12907450	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.33	100_49	149	99.0	0|1	0.28	99_38	137	99.0			rs148279364	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.693A>G	NP_001013653.1:p.Lys231%3D		-1.0						.	.	.						30	0.86							0.0236462	5103.0	215806.0	109.0	100	1.0	RF	amr	0.0489435	1450.0	0.0166528	1643.0	0.0009325	145	0.002	7.0				1.505	-0.089739		0	0	0			HNRNPCL1	0.0	0.0	0.0	0.0	-1.0	-2.0	-12.0	4.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907450
760	chr1	12907458	T	A	chr1:12907458	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.32	100_47	147	99.0	0|1	0.31	87_39	126	99.0			rs200282759,COSV58609578,COSV58610987	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.685A>T	NP_001013653.1:p.Met229Leu		-1.0						.	.	.						30	0.86							0.0223289	4757.0	213042.0	111.0	100	1.0	PASS	amr	0.0482474	1393.0	0.0155591	1519.0	0.0007974	124	0.002	6.0				0.632	-0.219265	0.08	0	17	17		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	12.0	7.0	43.0	-20.0						0.881	0.01		0.001	-0.874	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907458
761	chr1	12907465	A	G	chr1:12907465	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.31	96_43	139	99.0	0|1	0.3	89_39	128	99.0			rs75730135,COSV58612164	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.678T>C	NP_001013653.1:p.Ser226%3D		-1.0						.	.	.						30	0.86							0.020688	4383.0	211862.0	117.0	100	1.0	RF	amr	0.0465741	1335.0	0.0140124	1361.0	0.0017684	275	0.002	6.0				5.945	0.207063		0	0	0			HNRNPCL1	0.0	0.0	0.0	0.01	-17.0	-36.0	-27.0	42.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907465
762	chr1	12907469	C	G	chr1:12907469	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.31	97_43	140	99.0	0|1	0.31	84_37	121	99.0			rs200710956,COSV58612173	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.674G>C	NP_001013653.1:p.Ser225Thr		-1.0						.	.	.						30	0.86							0.0201771	4297.0	212964.0	119.0	100	1.0	RF	amr	0.0455331	1317.0	0.0134603	1312.0	0.0008424	131	0.002	6.0				14.88	1.242055	0.093	1	16	17	MutationTaster_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	1.0	-4.0	32.0	38.0						0.881	0.01		0.012	0.238	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907469
763	chr1	12907483	T	A	chr1:12907483	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0/1	0.3	94_40	134	99.0	0/1	0.31	75_34	109	99.0			rs142509787,COSV58612182	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.660A>T	NP_001013653.1:p.Ser220%3D		-1.0						.	.	.						30	0.86							0.0266759	5711.0	214088.0	132.0	100	1.0	PASS	amr	0.052336	1519.0	0.0200476	1970.0	0.0007009	109	0.002	6.0				6.527	0.248111		0	0	0			HNRNPCL1	0.0	0.0	0.01	0.0	41.0	-2.0	24.0	4.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907483
764	chr1	12907495	T	C	chr1:12907495	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.32	84_39	123	99.0	0|1	0.33	70_34	104	99.0			rs6669073,COSV58609619	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.648A>G	NP_001013653.1:p.Lys216%3D		-1.0						.	.	.						30	0.86							0.0378919	8125.0	214426.0	134.0	100	1.0	RF	amr	0.0645675	1823.0	0.0316048	3134.0	0.0027974	435	0.002	6.0				0.829	-0.178564		0	0	0			HNRNPCL1	0.0	0.0	0.0	0.01	29.0	-10.0	6.0	12.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907495
765	chr1	12907498	C	T	chr1:12907498	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.32	84_39	123	99.0	0|1	0.32	71_34	105	99.0			rs6702440,COSV58610500,COSV58614335	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.645G>A	NP_001013653.1:p.Val215%3D		-1.0						.	.	.		1.33308e-05	2.0	150028.0	0.0	30	0.86	PASS	eas	0.000388651	2.0	0.0	0.0	0.0390672	8360.0	213990.0	137.0	100	1.0	PASS	amr	0.0662079	1857.0	0.0328171	3255.0	0.0028102	437	0.002	6.0				2.06	-0.040385		0	0	0			HNRNPCL1	0.0	0.0	0.07	0.0	-17.0	26.0	3.0	-11.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907498
766	chr1	12907513	T	C	chr1:12907513	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.33	76_38	114	99.0	0|1	0.32	68_32	100	99.0			rs201121299,COSV58612123,COSV58612215	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.630A>G	NP_001013653.1:p.Lys210%3D		-1.0						.	.	.						30	0.86							0.047697	10308.0	216114.0	143.0	100	1.0	PASS	afr	0.0792256	974.0	0.0412953	4142.0	0.0012797	199	0.001	3.0				5.778	0.195797		0	0	0			HNRNPCL1	0.0	0.0	0.0	0.0	11.0	-5.0	-12.0	-6.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907513
767	chr1	12907518	T	A	chr1:12907518	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.34	73_38	111	99.0	0|1	0.32	67_32	100	99.0			rs201750607,COSV58611281	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.625A>T	NP_001013653.1:p.Ser209Cys		-1.0						.	.	.						30	0.86							0.0455548	9792.0	214950.0	146.0	100	0.99	RF	afr	0.0762446	925.0	0.0391372	3903.0	0.0012411	193	0.001	3.0				22.5	2.46992	0.169	5	13	18	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationTaster_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	48.0	-2.0	-17.0	-14.0						0.881	0.01		0.004	-0.773	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907518
768	chr1	12907519	C	A	chr1:12907519	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.35	70_38	108	99.0	0|1	0.32	66_32	99	99.0			rs6702447,COSV58612069	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.624G>T	NP_001013653.1:p.Gln208His		-1.0						.	.	.						30	0.86							0.0454071	9754.0	214812.0	146.0	100	0.99	RF	afr	0.0762446	925.0	0.0389827	3884.0	0.0012476	194	0.001	3.0				18.95	1.89941	0.123	4	14	18	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationTaster_pred	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.01	-3.0	47.0	4.0	-12.0						0.881	0.01		0.004	0.238	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907519
769	chr1	12907781	T	C	chr1:12907781	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.35	136_74	210	99.0	0|1	0.37	116_67	183	99.0			rs28441396,COSV58609685	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.362A>G	NP_001013653.1:p.Asp121Gly		-1.0						.	.	.		0.000100053	15.0	149920.0	0.0	30	0.86	PASS	eas	0.000388802	2.0	1.47964e-05	1.0	0.420962	41080.0	97586.0	495.0	100	1.0	InbreedingCoeff_RF	amr	0.477888	8926.0	0.394996	15378.0	0.0004566	71	0.02	61.0				5.772	0.195425	0.295	1	14	15	PROVEAN_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	1.0	-13.0	1.0	-6.0						0.881	0.01		0.0	-2.059	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907781
770	chr1	12907798	A	C	chr1:12907798	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.4	134_88	222	99.0	0|1	0.46	103_86	189	99.0			rs150096254,COSV58609693	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.345T>G	NP_001013653.1:p.Phe115Leu		-1.0						.	.	.		3.33253e-05	5.0	150036.0	0.0	30	0.86	AS_VQSR	afr	9.7924e-05	4.0	1.47916e-05	1.0	0.497033	74881.0	150656.0	538.0	100	1.0	InbreedingCoeff_RF	amr	0.51318	11992.0	0.494468	32627.0	0.0001736	27	0.004	13.0				4.698	0.126473	0.157	0	15	15		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	43.0	-30.0	34.0	-42.0						0.881	0.01		0.0	-1.936	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907798
771	chr1	12907802	C	T	chr1:12907802	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.41	136_93	229	99.0	0|1	0.46	104_88	192	99.0			rs138087690,COSV58609703	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.341G>A	NP_001013653.1:p.Gly114Asp		-1.0						.	.	.		1.99904e-05	3.0	150072.0	0.0	30	0.86	AS_VQSR	afr	4.8962e-05	2.0	1.47872e-05	1.0	0.500383	90265.0	180392.0	552.0	100	1.0	InbreedingCoeff_RF	amr	0.513034	13895.0	0.498461	40163.0	0.0010997	171	0.004	14.0				2.312	-0.021486	0.094	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	-34.0	-1.0	-24.0	-27.0						0.881	0.01		0.002	-0.803	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907802
772	chr1	12907803	C	T	chr1:12907803	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0|1	0.41	135_93	228	99.0	0|1	0.46	104_88	192	99.0			rs141460546,COSV58609713	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	missense_variant		2/2	NM_001013631.3:c.340G>A	NP_001013653.1:p.Gly114Ser		-1.0						.	.	.		1.99944e-05	3.0	150042.0	0.0	30	0.86	AS_VQSR	afr	4.89812e-05	2.0	1.47885e-05	1.0	0.500604	92851.0	185478.0	553.0	100	1.0	InbreedingCoeff	amr	0.512995	14093.0	0.498632	41549.0	0.0011832	184	0.006	18.0				14.1	1.104053	0.078	0	15	15		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPCL1	0.0	0.0	0.0	0.0	-2.0	-35.0	29.0	5.0						0.881	0.01		0.002	-0.914	.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907803
773	chr1	12907837	C	T	chr1:12907837	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0/1	0.55	137_166	303	99.0	0/1	0.57	115_155	270	99.0			rs1736811,COSV58610534	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.306G>A	NP_001013653.1:p.Ala102%3D		-1.0						.	.	.		0.00581923	872.0	149848.0	32.0	30	0.85	PASS	afr	0.00976822	397.0	0.00445359	301.0	0.502707	124787.0	248230.0	718.0	100	1.0	InbreedingCoeff	amr	0.513682	17683.0	0.500878	56476.0	0.0164819	2563	0.102	313.0				2.615	-0.000564		0	0	0			HNRNPCL1	0.0	0.0	0.0	0.0	-2.0	19.0	-5.0	20.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907837
774	chr1	12907885	T	C	chr1:12907885	HNRNPCL1	heterogeneous nuclear ribonucleoprotein C-like 1	SNV	0/1	0.33	258_127	385	99.0	0/1	0.39	181_115	296	99.0			rs848418,COSV58610545	EXONIC	YES	NM_001013631.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001013631.3:c.258A>G	NP_001013653.1:p.Ala86%3D		-1.0						.	.	.						0	0.0							0.495257	122795.0	247942.0	5.0	100	1.0	InbreedingCoeff	eas	0.499018	9145.0	0.496719	55415.0	0.0503267	7826	0.23	693.0				5.936	0.206461		0	0	0			HNRNPCL1	0.0	0.0	0.0	0.0	-11.0	-2.0	-28.0	24.0						0.881	0.01				.			.	.	.	nucleus	RNA binding	SRPK2[23602568];JUN[25609649];HNRNPCL1[unassigned1304];CEP135[26496610];UBE2I[unassigned1304];HNRNPCL2[unassigned1304];WTAP[29507755];METTL3[29507755];EIF2AK2[21903422];YBX1[22118625];DDX41[25920683];RNF4[unassigned1304];ESR2[21182203];PIAS2[unassigned1304];MAP1LC3B[20562859];RALYL[unassigned1304];MAP1LC3A[20562859];HNRNPD[26496610];RALY[unassigned1304];RAD54L2[unassigned1304];HNRNPC[unassigned1304];C20orf202[unassigned1304];YWHAG[17353931];TP63[20085233];	12907885
803	chr1	12942989	C	T	chr1:12942989	PRAMEF4	PRAME family member 4	SNV	0|1	0.46	80_68	148	99.0	0|1	0.54	52_62	114	99.0			rs148549660	EXONIC	YES	NM_001009611.4	Transcript	protein_coding	missense_variant		2/4	NM_001009611.4:c.227G>A	NP_001009611.2:p.Cys76Tyr		-1.0						.	.	.		0.00263402	392.0	148822.0	32.0	10	0.27	PASS	amr	0.00457254	66.0	0.00363901	245.0	0.00201029	500.0	248720.0	31.0	90	0.98	PASS	nfe	0.00306433	346.0	0.00306433	346.0	0.0015884	247	0.006	18.0				6.995	0.283192	0.077	1	19	20	PolyPhen	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRAMEF4	0.0	0.0	0.0	0.0	-18.0	-8.0	-19.0	1.0						0.993	0.07		0.0	-0.076	.			.	.	positive regulation of cell population proliferation;negative regulation of apoptotic process;negative regulation of cell differentiation;negative regulation of transcription, DNA-templated	cytoplasm	.	.	12942989
806	chr1	12979729	A	A	chr1:12979729	PRAMEF7	PRAME family member 7	SNV	0/1	0.41	119_84	203	99.0	0/1	0.25	170_57	227	99.0			rs1890766,COSV58277805	EXONIC	YES	NM_001012277.4	Transcript	protein_coding	synonymous_variant		4/4	NM_001012277.4:c.921G>A	NP_001012277.2:p.Ser307%3D		1.0						.	.	.						0	0.0							0.237738	51612.0	217096.0	509.0	32	0.74	InbreedingCoeff	amr	0.28074	8498.0	0.258788	24897.0	0.0277742	4319	0.023	68.0				0.102	-0.480611		0	0	0			PRAMEF7	0.0	0.01	0.0	0.0	30.0	-47.0	-4.0	20.0							0.18				.			.	.	positive regulation of cell population proliferation;negative regulation of apoptotic process;negative regulation of cell differentiation;negative regulation of transcription, DNA-templated	cytoplasm	.	.	12979729
808	chr1	13001312	C	G	chr1:13001312	PRAMEF6	PRAME family member 6	SNV	0/1	0.39	162_102	264	99.0	0/1	0.38	129_80	211	99.0			rs61779367,COSV61909822	EXONIC	YES	NM_001010889.2	Transcript	protein_coding	missense_variant		3/4	NM_001010889.2:c.371G>C	NP_001010889.1:p.Cys124Ser		-1.0	.,.					.	.	.		9.14597e-05	9.0	98404.0	0.0	13	0.18	PASS	sas	0.00175685	5.0	0.0	0.0	0.521689	129790.0	248788.0	6786.0	100	0.99	InbreedingCoeff	amr	0.536081	18379.0	0.521717	58858.0	0.0137681	2141	0.131	414.0				3.655	0.063798	0.042	2	16	18	MutationAssessor_pred,PROVEAN_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRAMEF6	0.0	0.0	0.0	0.0	-17.0	15.0	29.0	3.0							0.69		0.0	-2.724	.			.	.	positive regulation of cell population proliferation;negative regulation of apoptotic process;negative regulation of cell differentiation;negative regulation of transcription, DNA-templated	cytoplasm	.	.	13001312
809	chr1	13183225	T	C	chr1:13183225	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	SNV	0|1	0.39	100_64	164	99.0	0|1	0.36	74_41	115	99.0			rs28634306	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001136561.3:c.648A>G	NP_001130033.3:p.Lys216%3D		-1.0						.	.	.						31	0.92							0.49341	106313.0	215466.0	11.0	100	1.0	InbreedingCoeff	amr	0.499372	15900.0	0.492281	48594.0	0.0001672	26	0.007	22.0				4.261	0.099967		0	0	0			HNRNPCL2	0.0	0.0	0.03	0.02	29.0	-10.0	6.0	12.0											.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];	13183225
810	chr1	13183228	C	T	chr1:13183228	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	SNV	0|1	0.4	103_69	172	99.0	0|1	0.36	75_42	117	99.0			rs144054379	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001136561.3:c.645G>A	NP_001130033.3:p.Val215%3D		-1.0						.	.	.						31	0.92							0.494026	108823.0	220278.0	11.0	100	1.0	InbreedingCoeff	amr	0.499439	16036.0	0.492824	49652.0	0.0001672	26	0.007	22.0				0.476	-0.26139		0	0	0			HNRNPCL2	0.0	0.0	0.23	0.0	-17.0	20.0	3.0	-11.0											.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];	13183228
811	chr1	13183237	C	T	chr1:13183237	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	SNV	0|1	0.43	102_77	179	99.0	0|1	0.4	70_47	117	99.0			rs141111983	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001136561.3:c.636G>A	NP_001130033.3:p.Glu212%3D		-1.0						.	.	.		0.000100045	15.0	149932.0	0.0	31	0.92	PASS	eas	0.00126316	6.0	8.90525e-05	6.0	0.496417	116666.0	235016.0	11.0	100	1.0	InbreedingCoeff	amr	0.49979	16694.0	0.495226	52806.0	0.0004630	72	0.007	22.0				5.463	0.175029		0	0	0			HNRNPCL2	0.0	0.0	0.11	0.23	17.0	22.0	-6.0	0.0											.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];	13183237
812	chr1	13183238	T	C	chr1:13183238	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	SNV	0|1	0.42	101_73	174	99.0	0|1	0.41	69_48	117	99.0			rs75918656	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	missense_variant		2/2	NM_001136561.3:c.635A>G	NP_001130033.3:p.Glu212Gly		-1.0						.	.	.		0.00012003	18.0	149962.0	0.0	31	0.92	PASS	eas	0.0012621	6.0	0.000103925	7.0	0.496556	117217.0	236060.0	12.0	100	1.0	InbreedingCoeff	amr	0.499821	16737.0	0.495394	53021.0	0.0004630	72	0.007	22.0				6.729	0.262974		0	7	7		SIFT,PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	HNRNPCL2	0.0	0.0	0.0	0.21	0.0	10.0	-16.0	-1.0									0.004	-0.8	.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];	13183238
813	chr1	13183243	T	C	chr1:13183243	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	SNV	0|1	0.42	107_76	183	99.0	0|1	0.42	70_50	120	99.0			rs79873981	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001136561.3:c.630A>G	NP_001130033.3:p.Lys210%3D		-1.0						.	.	.						31	0.92							0.497474	118555.0	238314.0	11.0	100	1.0	InbreedingCoeff	amr	0.49991	16756.0	0.496568	53682.0	0.0001672	26	0.007	22.0				1.808	-0.061277		0	0	0			HNRNPCL2	0.0	0.0	0.02	0.0	-48.0	16.0	-12.0	-6.0											.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];	13183243
814	chr1	13183248	T	A	chr1:13183248	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	SNV	0|1	0.43	102_78	180	99.0	0|1	0.43	66_50	116	99.0			rs79256404	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	missense_variant		2/2	NM_001136561.3:c.625A>T	NP_001130033.3:p.Ser209Cys		-1.0						.	.	.						31	0.92							0.498422	119678.0	240114.0	11.0	100	1.0	InbreedingCoeff	amr	0.499881	16782.0	0.497795	54187.0	0.0001608	25	0.007	22.0				0.924	-0.162445		1	6	7	SIFT	PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	HNRNPCL2	0.0	0.0	0.0	0.0	48.0	-2.0	2.0	-11.0									0.022	0.28	.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];	13183248
816	chr1	13183439	C	C	chr1:13183439	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	SNV	1/1	1.0	0_390	390	99.0	1/1	0.99	0_336	339	99.0			rs28713604	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001136561.3:c.434A>G	NP_001130033.3:p.Arg145%3D		-1.0						.	.	.						0	0.0							0.753455	189167.0	251066.0	63635.0	100	1.0	InbreedingCoeff	sas	0.818351	25053.0	0.74262	84274.0	0.0643135	10001	0.288	894.0				8.782	0.436576		0	0	0			HNRNPCL2	0.0	0.0	0.0	0.0	12.0	-5.0	-38.0	-2.0											.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];	13183439
817	chr1	13183511	T	C	chr1:13183511	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	SNV	0|1	0.55	130_160	290	99.0	0|1	0.47	120_107	230	99.0			rs1737105	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	missense_variant		2/2	NM_001136561.3:c.362A>G	NP_001130033.3:p.Asp121Gly		-1.0						.	.	.		0.00130745	198.0	151440.0	1.0	31	0.92	PASS	eas	0.00193199	10.0	0.00133871	91.0	0.499895	123481.0	247014.0	16.0	100	1.0	InbreedingCoeff	sas	0.500066	15155.0	0.499785	55918.0	0.0118582	1844	0.072	205.0				3.836	0.074576		0	7	7		SIFT,PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	HNRNPCL2	0.0	0.0	0.0	0.0	1.0	-13.0	1.0	-6.0									0.002	-0.751	.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];	13183511
818	chr1	13183528	A	C	chr1:13183528	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	SNV	0|1	0.51	122_126	248	99.0	0|1	0.41	115_83	201	99.0			rs76937665	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	missense_variant		2/2	NM_001136561.3:c.345T>G	NP_001130033.3:p.Phe115Leu		-1.0						.	.	.		0.000112116	17.0	151628.0	0.0	31	0.92	PASS	eas	0.000386698	2.0	5.88339e-05	4.0	0.499536	112028.0	224264.0	13.0	100	1.0	InbreedingCoeff	sas	0.500036	13956.0	0.499404	51074.0	0.0020257	315	0.033	99.0				2.9	0.017874		0	7	7		SIFT,PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	HNRNPCL2	0.0	0.0	0.0	0.0	40.0	-30.0	-23.0	-42.0									0.001	-1.897	.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];	13183528
819	chr1	13183532	C	T	chr1:13183532	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	SNV	0|1	0.49	125_120	245	99.0	0|1	0.4	114_79	196	99.0			rs77505369	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	missense_variant		2/2	NM_001136561.3:c.341G>A	NP_001130033.3:p.Gly114Asp		-1.0						.	.	.		0.000105542	16.0	151598.0	0.0	31	0.92	PASS	amr	0.000328386	5.0	5.88218e-05	4.0	0.499369	106102.0	212472.0	13.0	100	1.0	InbreedingCoeff	sas	0.5	13298.0	0.499282	48653.0	0.0019935	310	0.029	90.0				2.348	-0.018929		0	7	7		SIFT,PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	HNRNPCL2	0.0	0.0	0.0	0.0	-34.0	-1.0	-24.0	30.0									0.003	-0.746	.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];	13183532
820	chr1	13183533	C	T	chr1:13183533	HNRNPCL2	heterogeneous nuclear ribonucleoprotein C-like 2	SNV	0|1	0.5	121_120	241	99.0	0|1	0.4	114_79	196	99.0			rs77556803	EXONIC	YES	NM_001136561.3	Transcript	protein_coding	missense_variant		2/2	NM_001136561.3:c.340G>A	NP_001130033.3:p.Gly114Ser		-1.0						.	.	.		0.000105546	16.0	151592.0	0.0	31	0.92	PASS	amr	0.000328429	5.0	5.88305e-05	4.0	0.499332	104693.0	209666.0	13.0	100	1.0	InbreedingCoeff	sas	0.5	13153.0	0.499231	48029.0	0.0019871	309	0.029	91.0				3.493	0.05412		0	7	7		SIFT,PolyPhen,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	HNRNPCL2	0.0	0.0	0.0	0.0	-2.0	-35.0	29.0	-28.0									0.004	-0.773	.			.	.	.	nucleus	RNA binding	PPP1R37[unassigned1304];RNF31[unassigned1774];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];ROCK2[30021884];TRADD[unassigned1774];MAST1[30021884];THUMPD2[30021884];GLT8D2[30021884];RNF4[unassigned1304];HMGN5[30021884];ERICH3[30021884];MRC1[30021884];RALY[unassigned1304;30021884];PHACTR4[30021884];ARHGEF11[30021884];ANXA2[30021884];BROX[30021884];FANCC[30021884];LRP1B[30021884];TRIT1[30021884];C2orf78[30021884];RALYL[unassigned1304];RPUSD1[30021884];AKAP9[30021884];TRIP11[30021884];VDAC2[30021884];PHIP[30021884];FSBP[30021884];CD247[24502978];HNRNPC[unassigned1304];SLC22A8[30021884];ECT2L[30021884];PLCB2[30021884];FREM2[30021884];	13183533
892	chr1	16353277	C		chr1:16353277	CLCNKA	chloride voltage-gated channel Ka	deletion	0|1	0.17	40_8	48	99.0	0|1	0.19	21_5	26	99.0			rs768429352	SPLICING	YES	NM_004070.4	Transcript	protein_coding	splice_region_variant,intron_variant	7/19		NM_004070.4:c.655+12del			1.0					Bartter syndrome, type 4b, digenic, 613090 (3), Digenic recessive	Infantile Bartter syndrome with sensorineural deafness	Disease-causing germline mutation(s) (loss of function) in	Renal salt wasting;Hyponatremia;Renal insufficiency;Hyperchloriduria;Sensorineural hearing impairment;Congenital onset;Hyporeflexia;Decreased glomerular filtration rate;Hypochloremia;Motor delay;Fetal polyuria;Polyhydramnios;Increased urinary potassium;Generalized hypotonia;Hypernatriuria;Intellectual disability;Hypokalemic hypochloremic metabolic alkalosis;Hyperaldosteronism;Muscular hypotonia;Hypokalemia;Premature birth;Edema;Failure to thrive;Polyuria;Heterogeneous		0.000146477	22.0	150194.0	0.0	32	0.96	PASS	amr	0.000264166	4.0	0.000118984	8.0	0.0	0.0	250332.0	0.0	100	1.0	AC0_RF				0.0	0.0					0.00117	12.0		11.88	0.791375		0	0	0			CLCNKA	0.0	0.0	0.0	0.02	-50.0	-26.0	8.0	-6.0						0.067	0.0				growth/size/body region phenotype; homeostasis/metabolism phenotype; mortality/aging ; cardiovascular system phenotype ; renal/urinary system phenotype; 			.	.	excretion;ion transmembrane transport;regulation of ion transmembrane transport;chloride transmembrane transport	plasma membrane;integral component of plasma membrane;chloride channel complex	voltage-gated chloride channel activity;identical protein binding;metal ion binding	KPRP[unassigned1304];C7orf31[unassigned1304];KRTAP21-2[unassigned1304];TCF12[unassigned1304];KRT34[unassigned1304];CLCNKA[17562318];PBX4[unassigned1304];KRT31[unassigned1304];IKZF3[unassigned1304];MBD3L1[unassigned1304];CYSRT1[unassigned1304];LHX3[unassigned1304];KRT39[unassigned1304];KRTAP4-12[unassigned1304];KRT37[unassigned1304];SLITRK5[unassigned1304];TRIB3[unassigned1304];TCF4[unassigned1304];ZNF511[unassigned1304];LINC00574[unassigned1304];LINC01600[unassigned1304];	16353276
997	chr1	17270682	C	T	chr1:17270682	CROCC	ciliary rootlet coiled-coil, rootletin	SNV	0/0	0.0	65_0	65	99.0	0/1	0.27	36_14	52	99.0			rs771957025	EXONIC	YES	NM_014675.5	Transcript	protein_coding	synonymous_variant		14/37	NM_014675.5:c.1896C>T	NP_055490.4:p.Ala632%3D		1.0						.	.	.		9.19311e-05	14.0	152288.0	0.0	48	0.99	PASS	sas	0.000413565	2.0	0.000102866	7.0	8.80116e-05	14.0	159070.0	0.0	31	0.56	PASS	sas	0.000217751	5.0	0.000113049	7.0	0.0000450	7	0.0	1.0				10.07	0.572283		0	0	0			CROCC	0.0	0.0	0.0	0.0	22.0	-44.0	-5.0	6.0						0.881	0.0				immune system phenotype; respiratory system phenotype; vision/eye phenotype; nervous system phenotype ; 			.	.	centrosome cycle;protein localization;centriole-centriole cohesion;epithelial structure maintenance;ciliary basal body organization;protein localization to organelle;photoreceptor cell maintenance;positive regulation of cilium assembly;establishment of organelle localization;positive regulation of protein localization to cilium	photoreceptor inner segment;centrosome;centriole;cytosol;plasma membrane;actin cytoskeleton;ciliary rootlet;extracellular exosome	actin binding;structural molecule activity;protein binding;kinesin binding	MYC[21150319];CEP152[26297806];G3BP1[26496610];HIST1H2BH[30021884];HDAC8[23752268];RNF152[21988832];GAPDH[30021884];PTBP3[22575643];	17270682
1034	chr1	17316239	G	A	chr1:17316239	ATP13A2	ATPase cation transporting 13A2	SNV	0/1	0.5	62_62	124	99.0	0/1	0.56	58_73	131	99.0			rs55889979	EXONIC	YES	NM_022089.4	Transcript	protein_coding	synonymous_variant		23/29	NM_022089.4:c.2556C>T	NP_071372.1:p.Ala852%3D		-1.0					Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive	ATP13A2-related juvenile neuronal ceroid lipofuscinosis;Kufor-Rakeb syndrome;Autosomal recessive spastic paraplegia type 78	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Slow saccadic eye movements;Anosmia;Dementia;Myoclonus;Gait disturbance;Psychotic episodes;Rapidly progressive;Torticollis;Paraparesis;Hallucinations;Autosomal recessive inheritance;Dysarthria;Distal sensory impairment;Rigidity;Hyperreflexia;Mask-like facies;Postural instability;Akinesia;Seizure;Anarthria;Tremor;Parkinsonism with favorable response to dopaminergic medication;Spastic paraplegia;Parkinsonism;Babinski sign;Spasticity;Hyposmia;Aggressive behavior;Supranuclear gaze palsy;Hypokinesia;Ataxia;Anarthria;Blepharospasm;Vertical supranuclear gaze palsy;Eyelid apraxia;Bradykinesia;Difficulty walking;Rigidity;Hyperreflexia in upper limbs;Stooped posture;Parkinsonism;Visual hallucinations;Dysphagia;Abnormality of the foot;Leg muscle stiffness;Dysarthria;Short attention span;Lethargy;Nystagmus;Dyskinesia;Bowel incontinence;Hyperactive patellar reflex;Confusion;Myoclonus;Abnormality of finger;Cerebral cortical atrophy;Fatigue;Dementia;Hypertonia;Babinski sign;Oculogyric crisis;Slow saccadic eye movements;Apathy;Difficulty in tongue movements;Fever;Lingual dystonia;Urinary incontinence;Hypomimic face;Generalized muscle weakness;Dysarthria;Cerebellar atrophy;Spastic tetraplegia;Nystagmus;Supranuclear gaze palsy;Cerebral cortical atrophy;Parkinsonism;Distal sensory impairment;Hyperreflexia;Babinski sign;Ataxia;Gait disturbance;Dementia;Autosomal recessive inheritance;Aggressive behavior;Hallucinations;Spastic paraplegia;Pes cavus;Muscle weakness;Postural instability;Cognitive impairment;Parkinsonism with favorable response to dopaminergic medication;Depressivity;Bradykinesia;Gait disturbance;Dystonia;Babinski sign;Fatigue;Postural tremor;Diffuse cerebral atrophy;Abnormal caudate nucleus morphology;Rigidity;Upgaze palsy;Dysarthria;Myoclonus;Cerebral cortical atrophy;Dysarthria;Hyperreflexia;Progressive gait ataxia;Progressive spastic paraplegia;Hypoplasia of the corpus callosum;Progressive pes cavus;Abnormality of the periventricular white matter;Cerebellar atrophy;Strabismus;Dystonia;EMG: axonal abnormality;Progressive extrapyramidal movement disorder;Sensory axonal neuropathy;Difficulty walking;Horizontal nystagmus;Dementia;Hallucinations;Babinski sign;Facial myokymia;Neurogenic bladder;Supranuclear gaze palsy;Progressive spastic quadriplegia;Progressive cerebellar ataxia		1.97109e-05	3.0	152200.0	0.0	33	0.98	PASS	amr	0.000130959	2.0	1.46968e-05	1.0	2.38815e-05	6.0	251240.0	0.0	91	1.0	PASS	amr	0.000144592	5.0	8.8039e-06	1.0	0.0000386	6	0.001	3.0	0.00044	5.0		12.05	0.812408		0	0	0			ATP13A2	0.0	0.0	0.0	0.0	26.0	-19.0	-30.0	-32.0						0.0289	0.0	7.947566600			cellular phenotype; behavior/neurological phenotype ; hematopoietic system phenotype; pigmentation phenotype; nervous system phenotype ; immune system phenotype; 			caudate nucleus;temporal lobe;amygdala;prefrontal cortex;cingulate cortex;cerebellum;pons;fetal brain;occipital lobe;subthalamic nucleus;whole brain;spinal cord;parietal lobe;globus pallidus;medulla oblongata;hypothalamus;thalamus;	Starch and sucrose metabolism;Folate biosynthesis	cellular calcium ion homeostasis;cellular iron ion homeostasis;cellular zinc ion homeostasis;regulation of mitochondrion organization;regulation of macroautophagy;regulation of autophagosome size;cellular cation homeostasis;regulation of intracellular protein transport;ion transmembrane transport;cellular response to oxidative stress;protein autophosphorylation;positive regulation of protein secretion;regulation of endopeptidase activity;zinc ion homeostasis;cellular response to manganese ion;cellular response to zinc ion;extracellular exosome biogenesis;ATP hydrolysis coupled cation transmembrane transport;negative regulation of neuron death;polyamine transmembrane transport;regulation of autophagy of mitochondrion;positive regulation of exosomal secretion;regulation of chaperone-mediated autophagy;autophagosome organization;regulation of glucosylceramidase activity;regulation of lysosomal protein catabolic process;negative regulation of lysosomal protein catabolic process;peptidyl-aspartic acid autophosphorylation	lysosome;lysosomal membrane;late endosome;multivesicular body;autophagosome;vesicle membrane;integral component of membrane;transport vesicle;vesicle;multivesicular body membrane;neuron projection;neuronal cell body;lysosomal lumen;integral component of lysosomal membrane	protein binding;ATP binding;zinc ion binding;ATPase activity;cation-transporting ATPase activity;manganese ion binding;phosphatidic acid binding;phosphatidylinositol-3,5-bisphosphate binding;cupric ion binding	OCA2[22645275];ATL3[26496610];GPR21[22645275];MYCBP2[22645275];ICAM2[22645275];ATP5MC2[22645275];CXCR4[22645275];UBE2J2[22645275];ACTB[22645275];DCAF7[22645275];HDAC6[22645275];CYGB[22645275];LRP6[22645275];PCMTD2[22645275];FUNDC2[22645275];LMAN2[22645275];FAM192A[22645275];SEC61B[22645275];EMC7[22645275];WDR83OS[22645275];BNIP3L[22645275];HSPA8[22645275];RTEL1-TNFRSF6B[26496610];CMTM6[21900206];F2R[22645275];NPY1R[22645275];HIPK1[22645275];PDIA6[22645275];PCDHB10[22645275];YIF1A[22645275];GAK[22645275];FAM111B[22645275];COL1A1[22645275];SPCS2[22645275];MEX3B[22645275];TSPAN14[22645275];CCKBR[22645275];SYT11[22645275];OSTC[22645275];AAK1[22645275];FKBP8[22645275];WDR5B[22645275];ACKR3[22645275];MYH9[26496610];FAM8A1[22645275];VAMP2[22645275];	17316239
1036	chr1	17323630	C	G	chr1:17323630	ATP13A2	ATPase cation transporting 13A2	SNV	0/1	0.49	58_55	113	99.0	0/1	0.45	64_52	116	99.0			rs55943100	EXONIC	YES	NM_022089.4	Transcript	protein_coding	synonymous_variant		12/29	NM_022089.4:c.1080G>C	NP_071372.1:p.Gly360%3D		-1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Kufor-Rakeb_syndrome|Spastic_paraplegia_78,_autosomal_recessive|not_provided	Spastic paraplegia 78, autosomal recessive, 617225 (3), Autosomal recessive; Kufor-Rakeb syndrome, 606693 (3), Autosomal recessive	ATP13A2-related juvenile neuronal ceroid lipofuscinosis;Kufor-Rakeb syndrome;Autosomal recessive spastic paraplegia type 78	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Slow saccadic eye movements;Anosmia;Dementia;Myoclonus;Gait disturbance;Psychotic episodes;Rapidly progressive;Torticollis;Paraparesis;Hallucinations;Autosomal recessive inheritance;Dysarthria;Distal sensory impairment;Rigidity;Hyperreflexia;Mask-like facies;Postural instability;Akinesia;Seizure;Anarthria;Tremor;Parkinsonism with favorable response to dopaminergic medication;Spastic paraplegia;Parkinsonism;Babinski sign;Spasticity;Hyposmia;Aggressive behavior;Supranuclear gaze palsy;Hypokinesia;Ataxia;Anarthria;Blepharospasm;Vertical supranuclear gaze palsy;Eyelid apraxia;Bradykinesia;Difficulty walking;Rigidity;Hyperreflexia in upper limbs;Stooped posture;Parkinsonism;Visual hallucinations;Dysphagia;Abnormality of the foot;Leg muscle stiffness;Dysarthria;Short attention span;Lethargy;Nystagmus;Dyskinesia;Bowel incontinence;Hyperactive patellar reflex;Confusion;Myoclonus;Abnormality of finger;Cerebral cortical atrophy;Fatigue;Dementia;Hypertonia;Babinski sign;Oculogyric crisis;Slow saccadic eye movements;Apathy;Difficulty in tongue movements;Fever;Lingual dystonia;Urinary incontinence;Hypomimic face;Generalized muscle weakness;Dysarthria;Cerebellar atrophy;Spastic tetraplegia;Nystagmus;Supranuclear gaze palsy;Cerebral cortical atrophy;Parkinsonism;Distal sensory impairment;Hyperreflexia;Babinski sign;Ataxia;Gait disturbance;Dementia;Autosomal recessive inheritance;Aggressive behavior;Hallucinations;Spastic paraplegia;Pes cavus;Muscle weakness;Postural instability;Cognitive impairment;Parkinsonism with favorable response to dopaminergic medication;Depressivity;Bradykinesia;Gait disturbance;Dystonia;Babinski sign;Fatigue;Postural tremor;Diffuse cerebral atrophy;Abnormal caudate nucleus morphology;Rigidity;Upgaze palsy;Dysarthria;Myoclonus;Cerebral cortical atrophy;Dysarthria;Hyperreflexia;Progressive gait ataxia;Progressive spastic paraplegia;Hypoplasia of the corpus callosum;Progressive pes cavus;Abnormality of the periventricular white matter;Cerebellar atrophy;Strabismus;Dystonia;EMG: axonal abnormality;Progressive extrapyramidal movement disorder;Sensory axonal neuropathy;Difficulty walking;Horizontal nystagmus;Dementia;Hallucinations;Babinski sign;Facial myokymia;Neurogenic bladder;Supranuclear gaze palsy;Progressive spastic quadriplegia;Progressive cerebellar ataxia		0.00014453	22.0	152218.0	0.0	31	0.96	PASS	amr	0.000457816	7.0	0.000176377	12.0	9.96572e-05	25.0	250860.0	0.0	100	1.0	PASS	nfe	0.000167753	19.0	0.000167753	19.0	0.0001029	16	0.001	3.0	0.00088	10.0		0.066	-0.54062		0	0	0			ATP13A2	0.0	0.01	0.0	0.0	40.0	37.0	2.0	25.0						0.0289	0.0	25.309348899			cellular phenotype; behavior/neurological phenotype ; hematopoietic system phenotype; pigmentation phenotype; nervous system phenotype ; immune system phenotype; 			caudate nucleus;temporal lobe;amygdala;prefrontal cortex;cingulate cortex;cerebellum;pons;fetal brain;occipital lobe;subthalamic nucleus;whole brain;spinal cord;parietal lobe;globus pallidus;medulla oblongata;hypothalamus;thalamus;	Starch and sucrose metabolism;Folate biosynthesis	cellular calcium ion homeostasis;cellular iron ion homeostasis;cellular zinc ion homeostasis;regulation of mitochondrion organization;regulation of macroautophagy;regulation of autophagosome size;cellular cation homeostasis;regulation of intracellular protein transport;ion transmembrane transport;cellular response to oxidative stress;protein autophosphorylation;positive regulation of protein secretion;regulation of endopeptidase activity;zinc ion homeostasis;cellular response to manganese ion;cellular response to zinc ion;extracellular exosome biogenesis;ATP hydrolysis coupled cation transmembrane transport;negative regulation of neuron death;polyamine transmembrane transport;regulation of autophagy of mitochondrion;positive regulation of exosomal secretion;regulation of chaperone-mediated autophagy;autophagosome organization;regulation of glucosylceramidase activity;regulation of lysosomal protein catabolic process;negative regulation of lysosomal protein catabolic process;peptidyl-aspartic acid autophosphorylation	lysosome;lysosomal membrane;late endosome;multivesicular body;autophagosome;vesicle membrane;integral component of membrane;transport vesicle;vesicle;multivesicular body membrane;neuron projection;neuronal cell body;lysosomal lumen;integral component of lysosomal membrane	protein binding;ATP binding;zinc ion binding;ATPase activity;cation-transporting ATPase activity;manganese ion binding;phosphatidic acid binding;phosphatidylinositol-3,5-bisphosphate binding;cupric ion binding	OCA2[22645275];ATL3[26496610];GPR21[22645275];MYCBP2[22645275];ICAM2[22645275];ATP5MC2[22645275];CXCR4[22645275];UBE2J2[22645275];ACTB[22645275];DCAF7[22645275];HDAC6[22645275];CYGB[22645275];LRP6[22645275];PCMTD2[22645275];FUNDC2[22645275];LMAN2[22645275];FAM192A[22645275];SEC61B[22645275];EMC7[22645275];WDR83OS[22645275];BNIP3L[22645275];HSPA8[22645275];RTEL1-TNFRSF6B[26496610];CMTM6[21900206];F2R[22645275];NPY1R[22645275];HIPK1[22645275];PDIA6[22645275];PCDHB10[22645275];YIF1A[22645275];GAK[22645275];FAM111B[22645275];COL1A1[22645275];SPCS2[22645275];MEX3B[22645275];TSPAN14[22645275];CCKBR[22645275];SYT11[22645275];OSTC[22645275];AAK1[22645275];FKBP8[22645275];WDR5B[22645275];ACKR3[22645275];MYH9[26496610];FAM8A1[22645275];VAMP2[22645275];	17323630
1060	chr1	17690207	G	A	chr1:17690207	PADI4	peptidyl arginine deiminase 4	SNV	0/1	0.44	40_32	73	99.0	0/0	0.0	38_0	38	99.0			rs200090088	EXONIC	YES	NM_012387.3	Transcript	protein_coding	missense_variant		16/16	NM_012387.3:c.1949G>A	NP_036519.2:p.Arg650His		1.0	Protein-arginine deiminase, C-terminal					.	.	Abnormality of the respiratory system;Vasculitis;Rheumatoid arthritis;Abnormality of blood and blood-forming tissues;Abnormality of the immune system;Abnormality of the nervous system		8.53881e-05	13.0	152246.0	0.0	33	0.98	PASS	amr	0.000130822	2.0	0.000102878	7.0	6.77086e-05	17.0	251076.0	0.0	59	1.0	PASS	nfe	0.000105803	12.0	0.000105803	12.0	0.0000450	7			0.00073	7.0		23.1	2.77387	0.26	8	10	18	SIFT,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	PADI4	0.0	0.0	0.0	0.0	23.0	-32.0	-23.0	-5.0						0.911	0.0	0.000000000	0.992	1.176	immune system phenotype; normal phenotype; mortality/aging ; growth/size/body region phenotype; hematopoietic system phenotype; 			skeletal muscle;bone marrow;	.	chromatin organization;nucleosome assembly;chromatin remodeling;cellular protein modification process;protein citrullination;arginine deiminase pathway;stem cell population maintenance;histone H3-R26 citrullination;histone citrullination;innate immune response	nucleus;nucleoplasm;cytoplasm;cytosol;protein-containing complex	protein-arginine deiminase activity;calcium ion binding;protein binding;arginine deiminase activity;arginine binding;protein homodimerization activity	STIP1[25036637];PPP5C[25036637];DNPEP[17353931];HSP90AB1[25036637];LRRK2[24510904];CDC37[25036637];ANXA4[25416956;unassigned1304];POU6F2[unassigned1304];TRIB3[unassigned1304];PADI4[25622091];FKBP5[25036637];	17690207
1070	chr1	19243457	G	C	chr1:19243457	IFFO2	intermediate filament family orphan 2	SNV	0/1	0.43	59_45	104	99.0	0/0	0.0	34_0	34	99.0			COSV62913576	EXONIC	YES	NM_001136265.2	Transcript	protein_coding	missense_variant		5/9	NM_001136265.2:c.1043C>G	NP_001129737.1:p.Ser348Trp		-1.0	Intermediate filament, rod domain&Intermediate filament, rod domain					.	.	.						32	0.97											55	0.6														26.6	3.860853	0.465	17	4	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred	IFFO2	0.0	0.0	0.0	0.0	25.0	22.0	14.0	-10.0							0.38	0.000000000	0.677	1.176	.			ciliary ganglion;trigeminal ganglion;skin;atrioventricular node;cerebellum peduncles;globus pallidus;cerebellum;	.	.	intermediate filament	.	.	19243457
1074	chr1	19523669	A	G	chr1:19523669	UBR4	ubiquitin protein ligase E3 component n-recognin 4	SNV	0/1	0.43	39_30	69	99.0	0/1	0.42	38_28	67	99.0			rs1297457898	EXONIC	YES	NM_020765.3	Transcript	protein_coding	synonymous_variant		8/106	NM_020765.3:c.984T>C	NP_065816.2:p.Asp328%3D		-1.0						.	.	.		6.56953e-06	1.0	152218.0	0.0	32	0.97	PASS	nfe	1.46998e-05	1.0	1.46998e-05	1.0					54	1.0														10.57	0.630189		0	0	0			UBR4	0.0	0.0	0.01	0.0	-8.0	1.0	-34.0	0.0						0.297	1.0	91.704720260			growth/size/body region phenotype; cellular phenotype; embryo phenotype; liver/biliary system phenotype; mortality/aging ; cardiovascular system phenotype ; nervous system phenotype ; 			.	.	ubiquitin-dependent protein catabolic process;viral process;protein ubiquitination;neutrophil degranulation	nucleoplasm;centrosome;cytosol;plasma membrane;membrane;integral component of membrane;specific granule membrane;tertiary granule membrane;ficolin-1-rich granule membrane	ubiquitin-protein transferase activity;protein binding;calmodulin binding;zinc ion binding	UBXN1[18775313];FAF1[18775313];FAF2[18775313];FOXK2[25609649];FOXK1[25609649];TPTE[28330616];ADRA1A[28298427];RAP1B[26496610];GOLGA2[29568061];TGOLN2[29568061];HIST1H3A[29568061];CHEK2[23178491];SERPINH1[30021884];UBXN7[18775313];NCK1[26496610];SRGN[21900206];HSPA8[29568061];VCAM1[22623428;19738201];UBE2B[19549727];MCRS1[17353931];XRCC3[26496610];PRPF40A[15231748];UBE2A[19549727];USF1[26496610];SEM1[24811749];MTNR1A[26514267];SCO1[29568061];MTNR1B[26514267];SASS6[26638075];AGTR1[28298427];GRB2[19380743];AURKAIP1[29568061];BIRC2[23524849];BIRC3[23524849];BET1[29568061];	19523669
1300	chr1	22191361	G	C	chr1:22191361	HSPG2	heparan sulfate proteoglycan 2	SNV	0/1	0.6	38_58	96	99.0	0/0	0.0	35_0	35	99.0			rs142736845	EXONIC	YES	NM_001291860.2	Transcript	protein_coding	missense_variant		36/97	NM_001291860.2:c.4604C>G	NP_001278789.1:p.Pro1535Arg		-1.0	Laminin EGF domain&Laminin EGF domain	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Lethal_Kniest-like_syndrome|Schwartz-Jampel_syndrome|not_specified|not_provided	Dyssegmental dysplasia, Silverman-Handmaker type, 224410 (3), Autosomal recessive; Schwartz-Jampel syndrome, type 1, 255800 (3), Autosomal recessive	Schwartz-Jampel syndrome;Dyssegmental dysplasia, Silverman-Handmaker type	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Umbilical hernia;Blue sclerae;Abnormality of the metaphysis;Atrial septal defect;Anisospondyly;Inguinal hernia;Joint stiffness;Disproportionate short-limb short stature;Cleft palate;Micrognathia;Depressed nasal ridge;Bowing of the long bones;Abnormality of pelvic girdle bone morphology;Respiratory insufficiency;Micromelia;Narrow chest;Narrow mouth;Micrognathia;Wide nasal bridge;Anisospondyly;Abnormality of the abdominal wall;Pulmonary hypoplasia;Short long bone;Thoracic hypoplasia;Overgrowth;Neonatal death;Posteriorly rotated ears;Disproportionate short-limb short stature;Autosomal recessive inheritance;Talipes equinovarus;Single umbilical artery;Malar flattening;Flat face;Short long bone;Bowing of the long bones;Cryptorchidism;Calvarial skull defect;Coxa valga;High pitched voice;Decreased testicular size;Anxiety;Scoliosis;Mask-like facies;Sprengel anomaly;Hyporeflexia;Ectopia lentis;Kyphosis;Osteoporosis;Pectus carinatum;Ptosis;Microcephaly;Abnormality of the pharynx;Abnormal eyebrow morphology;Elevated aldolase level;Microcornea;Wrist flexion contracture;Skeletal dysplasia;Short neck;Arrhythmia;Attention deficit hyperactivity disorder;Dysphonia;Increased number of teeth;Abnormality of immune system physiology;Testicular torsion;Micrognathia;Narrow mouth;Abnormality of the metaphysis;Apnea;Cachexia;Cleft palate;Hyperlordosis;Prenatal movement abnormality;Prominent nasal bridge;Visual impairment;Blepharophimosis;Aplasia/Hypoplasia affecting the eye;Abnormality of epiphysis morphology;Abnormality of the ribs;Everted lower lip vermilion;Long eyelashes in irregular rows;Weak voice;Skeletal muscle atrophy;Increased bone mineral density;Coxa vara;High palate;Abnormally ossified vertebrae;Malignant hyperthermia;Myotonia;Arthrogryposis multiplex congenita;Overfolded helix;Hip contracture;Odontogenic neoplasm;Skeletal muscle hypertrophy;Death in infancy;Full cheeks;Dental malocclusion;Metatarsus valgus;Inguinal hernia;Umbilical hernia;Joint stiffness;Polyhydramnios;Pulmonary arterial hypertension;Protrusio acetabuli;Low-set, posteriorly rotated ears;Elevated serum creatine kinase;Laryngomalacia;Abnormality of the ureter;Pectus excavatum;Wormian bones;Muscle weakness;Spinal rigidity;Strabismus;Respiratory insufficiency;Micromelia;Myopia;Hypertelorism;Platyspondyly;EMG abnormality;Intellectual disability;Delayed skeletal maturation;Flexion contracture of toe;Low anterior hairline;Blepharospasm;Pursed lips;Long philtrum;Abnormally straight spine;Flat face;Short stature;Cataract;Talipes equinovarus;Feeding difficulties in infancy;Generalized hirsutism;Genu valgum;Elbow dislocation;Myopathy;Nephrolithiasis;Pes planus;Distichiasis;Hip dysplasia;Gait disturbance;Hypertonia;Irritability;Shoulder flexion contracture;Myalgia;Trismus;Autosomal recessive inheritance;Narrow mouth;Short neck;Decreased testicular size;Anterior bowing of long bones;Coronal cleft vertebrae;Delayed skeletal maturation;Shoulder flexion contracture;Flexion contracture of toe;Low-set ears;Lumbar hyperlordosis;Myopia;Hip contracture;Malar flattening;Congenital hip dislocation;Overfolded helix;Intellectual disability;Weak voice;Pursed lips;Wrist flexion contracture;Pectus carinatum;Pes planus;Myotonia;Platyspondyly;Kyphoscoliosis;Narrow palpebral fissure;Generalized hirsutism;Abnormality of femoral epiphysis;Osteoporosis;Coxa valga;Short stature;Inguinal hernia;Talipes equinovarus;Blepharophimosis;Coxa vara;Hyporeflexia;Skeletal muscle atrophy;Joint contracture of the hand;Metaphyseal widening;Microcornea;Umbilical hernia;Full cheeks;Muscle weakness;High pitched voice;Long eyelashes in irregular rows;Micrognathia;Cataract;Malignant hyperthermia;Flat face;Ptosis;Skeletal muscle hypertrophy		0.00130066	198.0	152230.0	0.0	33	0.98	PASS	amr	0.00268149	41.0	0.00161655	110.0	0.00135109	316.0	233886.0	0.0	69	0.79	PASS	amr	0.0026727	91.0	0.00161689	165.0	0.0010997	171	0.006	19.0	0.00431	49.0		23.9	3.146679	0.161	11	10	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LRT_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	HSPG2	0.0	0.01	0.0	0.0	22.0	-26.0	-25.0	-11.0						0.588	0.0	0.000000000	0.224	0.224	growth/size/body region phenotype; integument phenotype ; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; immune system phenotype; cellular phenotype; behavior/neurological phenotype ; respiratory system phenotype; liver/biliary system phenotype; embryo phenotype; cardiovascular system phenotype ; hematopoietic system phenotype; mortality/aging ; vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype ; hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; skeleton phenotype; 			.	ECM-receptor interaction	retinoid metabolic process;angiogenesis;glycosaminoglycan biosynthetic process;glycosaminoglycan catabolic process;lipid metabolic process;receptor-mediated endocytosis;inflammatory response;brain development;negative regulation of angiogenesis;cell differentiation;extracellular matrix organization;cellular protein metabolic process;cardiovascular system development	extracellular region;basement membrane;extracellular space;Golgi lumen;plasma membrane;focal adhesion;lysosomal lumen;collagen-containing extracellular matrix;extracellular exosome;plasma membrane protein complex	amyloid-beta binding;calcium ion binding;protein binding;protein C-terminus binding;extracellular matrix structural constituent conferring compression resistance;low-density lipoprotein particle receptor binding	GRN[12900424;21596751];FLT1[21596751];PYHIN1[25665578];ATN1[16713569];FN1[19738201];CACNA1A[21078624];FGF1[24509440];KIF7[26496610];FGF2[24509440];ESR2[25604459];ADD1[26496610];GFI1B[16713569];PTTG1[26496610];KDR[23374253;21596751];GAR1[26496610];TCAP[23414517];GRB2[19380743];CCDC22[26496610];FGFR3[24509440];FGFR1[24509440];TMPO[26496610];	22191361
1379	chr1	24122750	C	T	chr1:24122750	GALE	UDP-galactose-4-epimerase	SNV	0/0	0.0	33_0	33	99.0	0/1	0.42	44_33	79	99.0			rs142332521	EXONIC	YES	NM_000403.4	Transcript	protein_coding	synonymous_variant		11/12	NM_000403.4:c.879G>A	NP_000394.2:p.Pro293%3D		-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	UDPglucose-4-epimerase_deficiency|not_specified	Galactose epimerase deficiency, 230350 (3), Autosomal recessive	Generalized galactose epimerase deficiency;Erythrocyte galactose epimerase deficiency	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Intellectual disability;Vomiting;Jaundice;Muscular hypotonia;Hepatomegaly;Generalized hypotonia;Delayed speech and language development;Splenomegaly;Delayed gross motor development;Global developmental delay;Galactosuria;Autosomal recessive inheritance;Aminoaciduria;Sensorineural hearing impairment;Hypergalactosemia;Failure to thrive		0.00216228	329.0	152154.0	0.0	32	0.96	PASS	sas	0.00352259	17.0	0.00345446	235.0	0.0023679	595.0	251278.0	2.0	100	1.0	PASS	sas	0.00385419	118.0	0.00316082	359.0	0.0022765	354	0.006	18.0	0.00526	60.0		7.754	0.343121		0	0	0			GALE	0.0	0.0	0.01	0.07	-7.0	5.0	-6.0	-25.0						0.0621	0.0	12.545683820			.			.	Galactose metabolism;Nucleotide sugars metabolism	galactose catabolic process;galactose catabolic process via UDP-galactose	cytosol	UDP-N-acetylglucosamine 4-epimerase activity;UDP-glucose 4-epimerase activity;identical protein binding;protein homodimerization activity	GALE[16189514;25416956;unassigned1304];FN1[19738201];	24122750
1497	chr1	26387820	G	A	chr1:26387820	TRIM63	tripartite motif containing 63	SNV	0/1	0.47	37_33	70	99.0	0/1	0.76	14_44	58	99.0			rs199936688	EXONIC	YES	NM_032588.4	Transcript	protein_coding	missense_variant		3/9	NM_032588.4:c.338C>T	NP_115977.2:p.Pro113Leu		-1.0						.	.	.		0.000210286	32.0	152174.0	0.0	32	0.98	PASS	nfe	0.000338076	23.0	0.000338076	23.0	0.000203152	51.0	251044.0	0.0	42	0.99	PASS	nfe	0.000325888	37.0	0.000325888	37.0	0.0001350	21						27.2	3.93468	0.483	10	11	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	TRIM63	0.0	0.0	0.0	0.0	5.0	-8.0	-11.0	-45.0						0.628	0.0	0.000000000	1.0	1.176	liver/biliary system phenotype; respiratory system phenotype; cardiovascular system phenotype ; mortality/aging ; adipose tissue phenotype ; muscle phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; 			.	.	muscle contraction;signal transduction;negative regulation of cardiac muscle hypertrophy;skeletal muscle atrophy;response to electrical stimulus involved in regulation of muscle adaptation;protein ubiquitination;response to glucocorticoid;response to interleukin-1	nucleus;cytoplasm;microtubule;Z disc;M band	ubiquitin-protein transferase activity;protein binding;zinc ion binding;titin binding	GFM1[18157088];GMEB1[18157088];ECHS1[18157088];LAMA2[23414517];MRPL19[18157088];FHL2[18157088];CCAR1[18157088];TTN[18157088;23414517];DCAF6[18157088];MRPL41[18157088];UXT[18157088];MRPL2[18157088];ATP5F1B[18157088];SGCB[23414517];TNNI2[18157088];TNNI3[18157088];FLNC[18157088];MYOZ1[18157088];LMCD1[18157088];NOMO1[18157088];MYBPC3[18157088];MYBPC2[23414517];SNAPIN[23414517];TRIM63[23414517];NEBL[18157088];NDUFA1[18157088];NEB[18157088];EEF1G[18157088];ACTA1[18157088];DES[18157088];ACTC1[18157088];TNNT1[18157088];EHHADH[unassigned1304];UQCRC1[18157088];TCAP[18157088];EIF3E[18157088];SQSTM1[18157088];TRIM54[23414517];TRIM55[23414517];	26387820
1510	chr1	26624479	C	A	chr1:26624479	UBXN11	UBX domain protein 11	SNV	0/1	0.56	35_44	79	99.0	0/1	0.39	46_30	76	99.0			rs61750046,COSV99042756	EXONIC	YES	NM_183008.2	Transcript	protein_coding	missense_variant		6/16	NM_183008.2:c.274G>T	NP_892120.2:p.Ala92Ser		-1.0	.,.,.,.,.,.,.,.,.,.					.	.	.		0.00476935	726.0	152222.0	3.0	31	0.97	PASS	nfe	0.00795074	541.0	0.00795074	541.0	0.00555792	1384.0	249014.0	5.0	68	0.95	PASS	nfe	0.00789045	892.0	0.00789045	892.0	0.0055754	867	0.01	32.0				14.59	1.189046	0.015	1	18	19	MutationTaster_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	UBXN11	0.0	0.0	0.12	0.04	31.0	7.0	7.0	-38.0						0.994	0.0	0.000000000	0.788	-0.29	.			.	.	proteasome-mediated ubiquitin-dependent protein catabolic process	cytoplasm;cytoskeleton	protein binding;ubiquitin binding	PRKAA1[25416956];WDR25[unassigned1304];TTC23[unassigned1304];VCP[29997244];SH2D4A[25416956];ZFYVE9[15231748];USHBP1[25416956;unassigned1304];RHOBTB3[25416956];CFAP206[16189514;25416956;unassigned1304];PPM1K[unassigned1304];RNF213[25416956];C14orf119[unassigned1304];EIF4E[25416956];ENKD1[25416956;unassigned1304];PRKAB2[25416956];ZGPAT[unassigned1304];VPS9D1[unassigned1304];NEK6[unassigned1304];TCEANC[unassigned1304];TRAF2[16189514;21516116;25416956;unassigned1304];IL16[unassigned1304];AES[25416956;unassigned1304];LENG1[unassigned1304];SCNM1[25416956];PRPF18[unassigned1304];PSMA1[25416956;unassigned1304];HGS[unassigned1304];PRPF31[unassigned1304];EIF4E2[25416956];PRR35[unassigned1304];SNRPB[unassigned1304];	26624479
1598	chr1	28365342	C	T	chr1:28365342	EYA3	EYA transcriptional coactivator and phosphatase 3	SNV	0/1	0.67	5_10	15	89.0	0/1	0.29	5_2	7	48.0			rs189558680	SPLICING	YES	NM_001990.4	Transcript	protein_coding	splice_region_variant,intron_variant	5/17		NM_001990.4:c.224+8G>A			-1.0						.	.	.		0.00139419	212.0	152060.0	0.0	32	0.97	PASS	nfe	0.00236695	161.0	0.00236695	161.0	0.00126994	296.0	233082.0	0.0	32	0.65	PASS	nfe	0.00233862	252.0	0.00233862	252.0	0.0012025	187	0.003	8.0				12.8	0.911655		0	0	0			EYA3	0.0	0.0	0.0	0.0	8.0	23.0	4.0	8.0	0.0001323453660344	0.004				0.237	1.0				skeleton phenotype; cardiovascular system phenotype ; respiratory system phenotype; behavior/neurological phenotype ; growth/size/body region phenotype; 			.	.	double-strand break repair;multicellular organism development;visual perception;anatomical structure morphogenesis;response to ionizing radiation;histone dephosphorylation;peptidyl-tyrosine dephosphorylation;positive regulation of DNA repair;anatomical structure development;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	nucleus;nucleoplasm;transcription factor complex;cytoplasm;centrosome	protein tyrosine phosphatase activity;protein binding;metal ion binding	H2AFX[19234442];ZDHHC17[24705354];CRK[25814554];	28365342
1607	chr1	28856395	T	C	chr1:28856395	RCC1	regulator of chromosome condensation 1	SNV	0/1	0.59	27_39	66	99.0	0/1	0.43	64_48	112	99.0			rs370351310	EXONIC	YES	NM_001048194.4	Transcript	protein_coding	missense_variant		2/11	NM_001048194.4:c.17T>C	NP_001041659.1:p.Ile6Thr		1.0	.,.,.,.,.,.,.,.,.,.,.					.	.	.		4.60193e-05	7.0	152110.0	0.0	30	0.94	PASS	amr	6.5591e-05	1.0	5.87976e-05	4.0	4.41866e-05	11.0	248944.0	0.0	41	0.98	PASS	nfe	8.98666e-05	10.0	8.98666e-05	10.0	0.0000514	8						18.78	1.876359	0.019	2	17	19	LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	RCC1	0.09	0.0	0.0	0.0	-20.0	27.0	49.0	47.0						0.121	0.19	0.000000000	1.0	1.138	.			.	.	G1/S transition of mitotic cell cycle;mitotic spindle organization;chromosome segregation;regulation of mitotic nuclear division;viral process;spindle assembly;protein heterotetramerization;cell division	chromatin;nuclear chromatin;condensed nuclear chromosome;nucleus;nucleoplasm;cytoplasm;nuclear membrane;protein-containing complex	chromatin binding;Ran guanyl-nucleotide exchange factor activity;protein binding;Ran GTPase binding;nucleosome binding;nucleosomal DNA binding;histone binding;sulfate binding;protein heterodimerization activity	BCAR3[17353931];FOXA1[25609649];NUP107[26496610];FOXE1[25609649];FAF1[21900206];FOXI2[25609649];CSAD[21900206];RBPJ[25609649];ACTB[21900206];FOXQ1[25609649];SPRED1[21900206];XPO1[11932251];FLAD1[21900206];TUBB3[21900206];NTMT1[20668449];HIST1H2AE[30021884];SDF4[21900206];DNM1L[29128334];CHGB[21900206];TLE1[21900206];KSR1[27086506];USP4[21900206];APLP1[21900206];RIPK4[26972000];FOXH1[25609649];HLA-B[17353931];VRK1[18617507];PRKAB1[17353931];FOXP1[25609649];HADHB[21900206];PKM[21900206];DDAH2[21900206];TRAF6[17353931];TNIK[17353931];LRIF1[21900206];CRELD2[21900206];TP53[21900206];KPNB1[26496610];OTUB1[26752685];KMT2B[21900206];WIZ[21900206];TRMT2A[21900206];PDHB[21900206];HDAC9[23752268];CCT7[21900206];DYNC1I1[21900206];NGFR[21900206];FOXB1[25609649];JUN[25609649];RANBP3[11932251];VCAM1[22623428;19738201];UBE2I[26496610];CSNK1A1[12062430];HMGA1[18850631];RPA1[21900206];FN1[19738201];NUP153[26496610];NUDT21[21900206];HIST1H4A[30021884];GNB2[21900206];CDK2AP2[21900206];UNC119[21900206];RAN[11336674;1961752;18617507;29997244];HOXD8[21900206];ZNF135[21900206];	28856395
1675	chr1	32800706	G	A	chr1:32800706	MARCKSL1	MARCKS like 1	SNV	0/1	0.48	36_33	69	99.0	0/1	0.52	29_31	60	99.0			rs8176777	SPLICING	YES	NM_023009.7	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/1		NM_023009.7:c.88-8C>T			-1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00437611	666.0	152190.0	2.0	32	0.97	PASS	nfe	0.00741002	504.0	0.00741002	504.0	0.00468197	825.0	176208.0	4.0	27	0.6	PASS	nfe	0.00711902	610.0	0.00711902	610.0	0.0048295	751	0.006	18.0				14.28	1.135053		0	0	0			MARCKSL1	0.05	0.01	0.0	0.0	-11.0	-50.0	-19.0	-50.0	4.76357584838511e-05	0.05	10.365	-0.723	9.642	0.409	0.65				reproductive system phenotype; nervous system phenotype ; vision/eye phenotype; immune system phenotype; embryo phenotype; hematopoietic system phenotype; mortality/aging ; 			.	.	positive regulation of cell population proliferation	cytoplasm;cytoskeleton;plasma membrane;extracellular exosome	actin binding;protein binding;calmodulin binding	SPHK1[25216046];PAX6[26496610];MAPK14[23602568];PLEKHA7[28877994];LOXL2[24863880];SOD1[29128334];TGOLN2[29568061];TMEM17[26638075];LAMP1[29568061];SOAT1[29128334];TMEM216[26638075];BCAR1[28007913];OTUB1[26752685];	32800706
1846	chr1	38040259	G	A	chr1:38040259	GNL2	G protein nucleolar 2	SNV	0/1	0.47	35_31	66	99.0	0/1	0.39	27_17	44	99.0			rs146116603	SPLICING	YES	NM_001323623.2	Transcript	protein_coding	splice_region_variant,intron_variant	12/16		NM_001323623.2:c.1506+7C>T			-1.0						.	.	.		0.00213057	324.0	152072.0	0.0	32	0.97	PASS	nfe	0.00299868	204.0	0.00299868	204.0	0.00233846	587.0	251020.0	2.0	41	0.96	PASS	nfe	0.00346036	393.0	0.00346036	393.0	0.0024565	382	0.003	8.0				1.764	-0.06515		0	0	0			GNL2	0.0	0.0	0.02	0.2	8.0	7.0	7.0	-40.0	0.0004984554706317	0.04				0.771	0.45				.			.	.	biological_process;ribosome biogenesis	nucleus;nucleolus;membrane	RNA binding;GTPase activity;GTP binding	USP36[19615732];RPL10[26496610];HNRNPU[26496610];MAGT1[30021884];MKI67[26949251];FBL[29568061];HIST1H3A[29568061];IFI16[25665578];G3BP1[19615732];G3BP2[19615732];LYAR[17353931];NPM1[26496610];KSR1[27086506];DDX56[17353931];RPS6[29568061];FOS[20195357];RRP1B[20926688];TUBG1[29568061];ESR1[21182205];ESR2[21182203];CDK8[29568061];CDK7[29568061];MDM2[21132010];MNDA[25665578];AURKAIP1[29568061];	38040259
1891	chr1	38323157	C	T	chr1:38323157	MTF1	metal regulatory transcription factor 1	SNV	0/1	0.46	94_80	175	99.0	0/1	0.54	62_73	135	99.0			rs199553408	EXONIC	YES	NM_005955.3	Transcript	protein_coding	synonymous_variant		2/11	NM_005955.3:c.174G>A	NP_005946.2:p.Leu58%3D		-1.0						.	.	.		2.62802e-05	4.0	152206.0	0.0	32	0.97	PASS	eas	0.000576923	3.0	0.0	0.0	0.000103395	26.0	251464.0	0.0	87	1.0	PASS	eas	0.000869849	16.0	0.0	0.0	0.0001350	21	0.0	1.0				13.47	1.005719		0	0	0			MTF1	0.0	0.06	0.0	0.0	-2.0	14.0	-23.0	-48.0						0.211	0.99	35.803019401			vision/eye phenotype; nervous system phenotype ; immune system phenotype; liver/biliary system phenotype; embryo phenotype; neoplasm; normal phenotype; mortality/aging ; hematopoietic system phenotype; cardiovascular system phenotype ; growth/size/body region phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			.	.	regulation of transcription by RNA polymerase II;response to oxidative stress;central nervous system development;response to metal ion;positive regulation of transcription by RNA polymerase II;response to cadmium ion	nucleus;nucleoplasm	RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;proximal promoter sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;transcription coactivator activity;protein binding;histone acetyltransferase binding;metal ion binding	AP1M1[16189514;19060904];	38323157
1943	chr1	39549918	ATGTCGGAGTGAGCGGTC		chr1:39549918-39549935	MACF1	microtubule-actin crosslinking factor 1	deletion	0/1	0.29	68_28	96	99.0	0/1	0.3	57_24	81	99.0			rs545520541	EXONIC	YES	NM_012090.5	Transcript	protein_coding	inframe_deletion		1/93	NM_012090.5:c.39_56del	NP_036222.3:p.Cys20_Ser25del		1.0					Lissencephaly 9 with complex brainstem malformation, 618325 (3), Autosomal dominant	.	.	Dysphagia;Seizure;Infantile onset;Global developmental delay;Absent speech;Hypoplasia of the corpus callosum;Hypoplasia of the brainstem;Short stature;Strabismus;Pachygyria;Facial asymmetry;Cerebellar hypoplasia;Spasticity;Autosomal dominant inheritance;Generalized hypotonia;Involuntary movements;Microcephaly		0.000164286	25.0	152174.0	0.0	32	0.97	PASS	nfe	0.000264628	18.0	0.000264628	18.0	0.000259063	65.0	250904.0	0.0	100	1.0	PASS	amr	0.000636574	22.0	0.000307914	35.0	0.0000257	4	0.001	3.0				20.3	2.063207		0	0	0																	0.458	1.0				mortality/aging ; respiratory system phenotype; embryo phenotype; nervous system phenotype ; integument phenotype ; cellular phenotype; homeostasis/metabolism phenotype; 			caudate nucleus;amygdala;prefrontal cortex;superior cervical ganglion;cingulate cortex;pons;atrioventricular node;spinal cord;parietal lobe;globus pallidus;hypothalamus;medulla oblongata;thalamus;	.	regulation of epithelial cell migration;Wnt signaling pathway;positive regulation of Wnt signaling pathway;regulation of cell migration;regulation of microtubule-based process;wound healing;Golgi to plasma membrane protein transport;intermediate filament cytoskeleton organization;positive regulation of axon extension;regulation of focal adhesion assembly	cytoplasm;Golgi apparatus;cytoskeleton;microtubule;intermediate filament;plasma membrane;actin cytoskeleton;membrane;ruffle membrane	RNA binding;actin binding;structural molecule activity;calcium ion binding;protein binding;ATPase activity;cadherin binding;microtubule minus-end binding;actin filament binding	CNTNAP2[12421765];SNAP47[26359495];GSK3B[29568061];PLXND1[12421765];NUMA1[30021884];MPG[17353931];NRXN1[12421765];FHL1[23414517];NRXN2[12421765];KATNB1[26929214];RPL6[30021884];RAB21[22705394];KIAA1107[26496610];BAG6[26496610];MAPK9[20936779];SYNCRIP[26496610];ATP5F1B[30021884];SAP18[17353931];NRCAM[12421765];DISC1[17043677];SKIL[15231748];ATF7IP[15231748];TANGO6[12421765];JUN[20936779];DAXX[26496610];SNAPIN[23414517];VCAM1[22623428;19738201];DTNBP1[17043677];FN1[19738201];CDC5L[20467437];APC[20936779];MTNR1B[26514267];KATNAL2[26929214];KATNBL1[26929214];CAPZA2[26496610];MYH9[26496610];OPTN[20195357];BCAR1[28007913];CNTNAP4[12421765];EXOC1[17043677];MAD2L1[26496610];	39549917
1949	chr1	39853104	G	A	chr1:39853104	MACF1	microtubule-actin crosslinking factor 1	SNV	0/0	0.0	34_0	34	99.0	0/1	0.48	46_44	91	99.0				EXONIC	YES	NM_012090.5	Transcript	protein_coding	missense_variant		52/93	NM_012090.5:c.8404G>A	NP_036222.3:p.Val2802Ile		1.0	.,.,.,.,.				Lissencephaly 9 with complex brainstem malformation, 618325 (3), Autosomal dominant	.	.	Dysphagia;Seizure;Infantile onset;Global developmental delay;Absent speech;Hypoplasia of the corpus callosum;Hypoplasia of the brainstem;Short stature;Strabismus;Pachygyria;Facial asymmetry;Cerebellar hypoplasia;Spasticity;Autosomal dominant inheritance;Generalized hypotonia;Involuntary movements;Microcephaly		6.57134e-06	1.0	152176.0	0.0	32	0.97	PASS	nfe	1.46972e-05	1.0	1.46972e-05	1.0					100	1.0														23.9	3.143577	0.102	6	14	20	PolyPhen,LRT_pred,MutationTaster_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-XF_coding_pred	MACF1	0.0	0.0	0.0	0.0	13.0	16.0	2.0	-37.0						0.458	1.0	41.941552608	0.929	1.176	mortality/aging ; respiratory system phenotype; embryo phenotype; nervous system phenotype ; integument phenotype ; cellular phenotype; homeostasis/metabolism phenotype; 			caudate nucleus;amygdala;prefrontal cortex;superior cervical ganglion;cingulate cortex;pons;atrioventricular node;spinal cord;parietal lobe;globus pallidus;hypothalamus;medulla oblongata;thalamus;	.	regulation of epithelial cell migration;Wnt signaling pathway;positive regulation of Wnt signaling pathway;regulation of cell migration;regulation of microtubule-based process;wound healing;Golgi to plasma membrane protein transport;intermediate filament cytoskeleton organization;positive regulation of axon extension;regulation of focal adhesion assembly	cytoplasm;Golgi apparatus;cytoskeleton;microtubule;intermediate filament;plasma membrane;actin cytoskeleton;membrane;ruffle membrane	RNA binding;actin binding;structural molecule activity;calcium ion binding;protein binding;ATPase activity;cadherin binding;microtubule minus-end binding;actin filament binding	CNTNAP2[12421765];SNAP47[26359495];GSK3B[29568061];PLXND1[12421765];NUMA1[30021884];MPG[17353931];NRXN1[12421765];FHL1[23414517];NRXN2[12421765];KATNB1[26929214];RPL6[30021884];RAB21[22705394];KIAA1107[26496610];BAG6[26496610];MAPK9[20936779];SYNCRIP[26496610];ATP5F1B[30021884];SAP18[17353931];NRCAM[12421765];DISC1[17043677];SKIL[15231748];ATF7IP[15231748];TANGO6[12421765];JUN[20936779];DAXX[26496610];SNAPIN[23414517];VCAM1[22623428;19738201];DTNBP1[17043677];FN1[19738201];CDC5L[20467437];APC[20936779];MTNR1B[26514267];KATNAL2[26929214];KATNBL1[26929214];CAPZA2[26496610];MYH9[26496610];OPTN[20195357];BCAR1[28007913];CNTNAP4[12421765];EXOC1[17043677];MAD2L1[26496610];	39853104
1953	chr1	39853640	A	C	chr1:39853640	MACF1	microtubule-actin crosslinking factor 1	SNV	0/1	0.5	60_61	122	99.0	0/0	0.0	46_0	46	99.0			rs147777128,COSV99048333	EXONIC	YES	NM_012090.5	Transcript	protein_coding	missense_variant		52/93	NM_012090.5:c.8940A>C	NP_036222.3:p.Gln2980His		1.0	.,.,.,.,.	Likely_benign	criteria_provided,_single_submitter	not_provided	Lissencephaly 9 with complex brainstem malformation, 618325 (3), Autosomal dominant	.	.	Dysphagia;Seizure;Infantile onset;Global developmental delay;Absent speech;Hypoplasia of the corpus callosum;Hypoplasia of the brainstem;Short stature;Strabismus;Pachygyria;Facial asymmetry;Cerebellar hypoplasia;Spasticity;Autosomal dominant inheritance;Generalized hypotonia;Involuntary movements;Microcephaly		0.00376014	572.0	152122.0	1.0	32	0.95	PASS	nfe	0.00573378	390.0	0.00573378	390.0	0.00418786	1049.0	250486.0	7.0	82	0.99	PASS	nfe	0.00637624	721.0	0.00637624	721.0	0.0040706	633	0.009	27.0				23.9	3.136535	0.291	12	8	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,ClinPred_pred,fathmm-XF_coding_pred	MACF1	0.0	0.0	0.0	0.0	9.0	2.0	9.0	2.0						0.458	1.0	0.000000000	1.0	1.312	mortality/aging ; respiratory system phenotype; embryo phenotype; nervous system phenotype ; integument phenotype ; cellular phenotype; homeostasis/metabolism phenotype; 			caudate nucleus;amygdala;prefrontal cortex;superior cervical ganglion;cingulate cortex;pons;atrioventricular node;spinal cord;parietal lobe;globus pallidus;hypothalamus;medulla oblongata;thalamus;	.	regulation of epithelial cell migration;Wnt signaling pathway;positive regulation of Wnt signaling pathway;regulation of cell migration;regulation of microtubule-based process;wound healing;Golgi to plasma membrane protein transport;intermediate filament cytoskeleton organization;positive regulation of axon extension;regulation of focal adhesion assembly	cytoplasm;Golgi apparatus;cytoskeleton;microtubule;intermediate filament;plasma membrane;actin cytoskeleton;membrane;ruffle membrane	RNA binding;actin binding;structural molecule activity;calcium ion binding;protein binding;ATPase activity;cadherin binding;microtubule minus-end binding;actin filament binding	CNTNAP2[12421765];SNAP47[26359495];GSK3B[29568061];PLXND1[12421765];NUMA1[30021884];MPG[17353931];NRXN1[12421765];FHL1[23414517];NRXN2[12421765];KATNB1[26929214];RPL6[30021884];RAB21[22705394];KIAA1107[26496610];BAG6[26496610];MAPK9[20936779];SYNCRIP[26496610];ATP5F1B[30021884];SAP18[17353931];NRCAM[12421765];DISC1[17043677];SKIL[15231748];ATF7IP[15231748];TANGO6[12421765];JUN[20936779];DAXX[26496610];SNAPIN[23414517];VCAM1[22623428;19738201];DTNBP1[17043677];FN1[19738201];CDC5L[20467437];APC[20936779];MTNR1B[26514267];KATNAL2[26929214];KATNBL1[26929214];CAPZA2[26496610];MYH9[26496610];OPTN[20195357];BCAR1[28007913];CNTNAP4[12421765];EXOC1[17043677];MAD2L1[26496610];	39853640
2024	chr1	41249887	C		chr1:41249887	KCNQ4	potassium voltage-gated channel subfamily Q member 4	deletion	0/0	0.0	27_0	27	81.0	0/1	0.2	8_2	10	39.0				EXONIC	YES	NM_004700.4	Transcript	protein_coding	frameshift_variant		1/14	NM_004700.4:c.125del	NP_004691.2:p.Pro42ArgfsTer97		1.0					Deafness, autosomal dominant 2A, 600101 (3), Autosomal dominant	Autosomal dominant non-syndromic sensorineural deafness type DFNA	Disease-causing germline mutation(s) in	Hearing impairment;Progressive;Autosomal dominant inheritance;Tinnitus						32	0.92											0	0.0																	0	0	0			KCNQ4	0.0	0.0	0.0	0.0	-30.0	11.0	-21.0	-37.0						0.0424	0.99				hearing/vestibular/ear phenotype; nervous system phenotype ; 			ciliary ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;	Cell Communication	potassium ion transport;sensory perception of sound;regulation of ion transmembrane transport;inner ear morphogenesis;potassium ion transmembrane transport	plasma membrane;voltage-gated potassium channel complex;basal plasma membrane;integral component of membrane	voltage-gated potassium channel activity;delayed rectifier potassium channel activity;potassium channel activity;protein binding;calmodulin binding	.	41249886
2035	chr1	41483806	TCC		chr1:41483806-41483808	SLFNL1	schlafen like 1	deletion	0/0	0.0	35_0	35	99.0	0/1	0.14	36_6	42	99.0			rs751622686	EXONIC	YES	NM_001377532.1	Transcript	protein_coding	inframe_deletion		2/4	NM_001377532.1:c.456_458del	NP_001364461.1:p.Glu152del		-1.0						.	.	.		7.89453e-05	12.0	152004.0	0.0	33	0.98	PASS	sas	0.000414079	2.0	2.94204e-05	2.0	0.00621708	628.0	101012.0	0.0	10	0.25	RF	sas	0.00788006	113.0	0.00518873	204.0	0.0000450,0.0006559	7,102	0.016	51.0				8.461	0.40587		0	0	0			SLFNL1	0.03	0.0	0.0	0.0	17.0	23.0	23.0	17.0						0.927	0.0				.			ciliary ganglion;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	.	.	.	ATP binding	.	41483805
2044	chr1	43002200	GA		chr1:43002200-43002201	CCDC30	coiled-coil domain containing 30	deletion	0/1	0.16	41_8	49	99.0	0/0	0.03	65_2	73	99.0			rs372826618	EXONIC	YES	NM_001080850.3	Transcript	protein_coding	frameshift_variant		3/17	NM_001080850.3:c.60_61del	NP_001074319.1:p.Lys21AlafsTer7		1.0						.	.	.		0.00011311	17.0	150296.0	0.0	31	0.95	PASS	nfe	0.000103885	7.0	0.000103885	7.0	0.0518314	5567.0	107406.0	0.0	58	0.93	RF	amr	0.0880018	1153.0	0.0411271	2096.0	0.0000386,0.0000129,0.0000965,0.1237460	6,2,15,19243	0.0	1.0				23.9	3.148538		0	0	0			CCDC30	0.0	0.0	0.0	0.0	5.0	3.0	-9.0	-13.0						0.969	0.0	0.000000000			.			trigeminal ganglion;superior cervical ganglion;skeletal muscle;globus pallidus;	.	.	.	.	BRAP[25820252];CCT6A[30021884];	43002199
2050	chr1	43108172	C	A	chr1:43108172	CCDC30	coiled-coil domain containing 30	SNV	0/1	0.52	30_32	62	99.0	0/0	0.0	36_0	36	99.0			rs145206338	EXONIC	YES	NM_001080850.3	Transcript	protein_coding	missense_variant		13/17	NM_001080850.3:c.1667C>A	NP_001074319.1:p.Ala556Asp		1.0	.,.,.					.	.	.		0.00152541	232.0	152090.0	1.0	32	0.96	PASS	amr	0.002424	37.0	0.00192556	131.0	0.00152806	368.0	240828.0	0.0	29	0.68	PASS	amr	0.00228282	73.0	0.00170237	188.0	0.0012347	192	0.005	17.0				19.88	2.019108	0.072	4	17	21	SIFT,PolyPhen,M-CAP_pred,MutationAssessor_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CCDC30	0.23	0.01	0.0	0.0	24.0	-28.0	24.0	-28.0						0.969	0.0		0.782	0.128	.			trigeminal ganglion;superior cervical ganglion;skeletal muscle;globus pallidus;	.	.	.	.	BRAP[25820252];CCT6A[30021884];	43108172
2255	chr1	46642137	G	A	chr1:46642137	LOC110117498-PIK3R3		SNV	0/1	0.5	50_50	101	99.0	0/1	0.62	40_65	105	99.0			rs1049431979	EXONIC	YES	NM_001303427.2	Transcript	protein_coding	missense_variant		1/10	NM_001303427.2:c.7C>T	NP_001290356.1:p.Pro3Ser		-1.0	.,.									7.88084e-05	12.0	152268.0	0.0	33	0.99	PASS	amr	0.000654022	10.0	1.46959e-05	1.0	0.000124842	16.0	128162.0	0.0	45	0.56	PASS	amr	0.00057509	14.0	2.10509e-05	1.0			0.001	3.0				15.12	1.287063	0.082	5	9	14	M-CAP_pred,MetaLR_pred,MutationTaster_pred,FATHMM_pred,fathmm-MKL_coding_pred	PolyPhen,MetaSVM_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	RP11-322N21.2	0.0	0.0	0.0	0.0	-33.0	4.0	2.0	-7.0								0.000000000	0.895	0.227										46642137
2256	chr1	46642137	G	A	chr1:46642137	P3R3URF		SNV	0/1	0.5	50_50	101	99.0	0/1	0.62	40_65	105	99.0			rs1049431979	EXONIC	YES	NM_001328655.2	Transcript	protein_coding	missense_variant		1/2	NM_001328655.2:c.7C>T	NP_001315584.1:p.Pro3Ser		-1.0	.,.									7.88084e-05	12.0	152268.0	0.0	33	0.99	PASS	amr	0.000654022	10.0	1.46959e-05	1.0	0.000124842	16.0	128162.0	0.0	45	0.56	PASS	amr	0.00057509	14.0	2.10509e-05	1.0			0.001	3.0				15.12	1.287063	0.082	6	9	15	SIFT,M-CAP_pred,MetaLR_pred,MutationTaster_pred,FATHMM_pred,fathmm-MKL_coding_pred	PolyPhen,MetaSVM_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	RP11-322N21.2	0.0	0.0	0.0	0.0	-33.0	4.0	2.0	-7.0								0.000000000	0.895	0.227										46642137
2311	chr1	48240865	G	A	chr1:48240865	TRABD2B	TraB domain containing 2B	SNV	0/1	0.44	61_48	109	99.0	0/0	0.0	38_0	38	99.0			rs189090484	EXONIC	YES	NM_001194986.2	Transcript	protein_coding	synonymous_variant		6/7	NM_001194986.2:c.1326C>T	NP_001181915.1:p.Asp442%3D		-1.0						.	.	.		0.00336342	512.0	152226.0	6.0	33	0.98	PASS	amr	0.006017	92.0	0.00417389	284.0	0.00253857	26.0	10242.0	0.0	2	0.0	PASS	amr	0.00378788	2.0	0.00297	20.0	0.0008617,0.0000322	134,5	0.009	27.0				12.41	0.859554		0	0	0			TRABD2B	0.0	0.0	0.0	0.04	-23.0	36.0	-6.0	-23.0							0.37				.			.	.	proteolysis;Wnt signaling pathway;negative regulation of Wnt signaling pathway;positive regulation of protein oligomerization;positive regulation of protein oxidation	integral component of plasma membrane;membrane;integral component of organelle membrane	metalloendopeptidase activity;protein binding;Wnt-protein binding;metal ion binding	.	48240865
2441	chr1	53980367	G	A	chr1:53980367	GLIS1	GLIS family zinc finger 1	SNV	0/1	0.42	63_46	110	99.0	0/0	0.0	35_0	35	99.0			rs142735388,COSV56555978	EXONIC	YES	NM_001367484.1	Transcript	protein_coding	missense_variant		8/11	NM_001367484.1:c.1814C>T	NP_001354413.1:p.Pro605Leu		-1.0	.,.					.	.	.		0.00344501	524.0	152104.0	3.0	32	0.95	PASS	nfe	0.00599788	408.0	0.00599788	408.0	0.00377603	946.0	250528.0	2.0	43	0.97	PASS	nfe	0.00625642	707.0	0.00625642	707.0	0.0037041	576	0.007	22.0				18.34	1.818654	0.103	3	16	19	MutationAssessor_pred,MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	GLIS1	0.0	0.0	0.0	0.0	8.0	27.0	20.0	0.0						0.136	0.1	0.000000000	0.439	0.227	normal phenotype; limbs/digits/tail phenotype; nervous system phenotype ; 			ciliary ganglion;pons;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skin;skeletal muscle;globus pallidus;	.	negative regulation of transcription by RNA polymerase II;positive regulation of transcription by RNA polymerase II	nucleus	RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;metal ion binding	ZDHHC23[unassigned1304];SPRR1A[unassigned1304];	53980367
2569	chr1	60139794	G	A	chr1:60139794	FGGY	FGGY carbohydrate kinase domain containing	SNV	0/1	0.4	45_30	75	99.0	0/0	0.0	33_0	33	99.0			rs145616341	EXONIC	YES	NM_001350790.2	Transcript	protein_coding	missense_variant		15/17	NM_001350790.2:c.1573G>A	NP_001337719.1:p.Ala525Thr		1.0	.,.,.,.					.	.	.		0.000131515	20.0	152074.0	0.0	32	0.97	PASS	amr	0.000392824	6.0	0.000132326	9.0	0.000160093	40.0	249854.0	0.0	50	0.91	PASS	sas	0.000361248	11.0	0.000221051	25.0	0.0001350	21						8.587	0.417714	0.026	3	16	19	M-CAP_pred,FATHMM_pred,LIST-S2_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FGGY	0.0	0.0	0.0	0.03	2.0	12.0	10.0	11.0						0.301	0.0	0.000000000	0.993	-0.555	.			pons;testis - seminiferous tubule;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;cerebellum;	.	pentose metabolic process;carbohydrate phosphorylation;neuron cellular homeostasis	cellular_component;cell	D-ribulokinase activity	MRPS22[30021884];	60139794
2579	chr1	60381688	C	T	chr1:60381688	CYP2J2	cytochrome P450 family 2 subfamily J member 2	SNV	0/0	0.0	37_0	37	99.0	0/1	0.6	33_49	82	99.0			rs1574257499	EXONIC	YES	NM_000775.4	Transcript	protein_coding	missense_variant		2/9	NM_000775.4:c.295G>A	NP_000766.2:p.Glu99Lys		-1.0						.	.	.						32	0.96											66	1.0														31.0	4.308834	0.509	18	3	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FATHMM_pred,PrimateAI_pred,DEOGEN2_pred	CYP2J2	0.0	0.0	0.0	0.0	-4.0	-1.0	-4.0	31.0						0.648	0.0	80.508204338	0.951	0.947	.			.	Arachidonic acid metabolism;Linoleic acid metabolism	organic acid metabolic process;icosanoid metabolic process;xenobiotic metabolic process;regulation of heart contraction;epoxygenase P450 pathway;exogenous drug catabolic process;linoleic acid metabolic process;oxidation-reduction process	cytoplasm;endoplasmic reticulum membrane;organelle membrane;intracellular membrane-bounded organelle;extracellular exosome	monooxygenase activity;iron ion binding;arachidonic acid epoxygenase activity;steroid hydroxylase activity;arachidonic acid 14,15-epoxygenase activity;arachidonic acid 11,12-epoxygenase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;heme binding;aromatase activity;linoleic acid epoxygenase activity	ZBTB25[21988832];ELOC[21988832];	60381688
2755	chr1	70742533	A		chr1:70742533	ANKRD13C	ankyrin repeat domain 13C	deletion	0/1	0.19	11_3	16	57.0	0/1	0.23	12_5	22	93.0			rs745401277	SPLICING	YES	NM_030816.5	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	9/12		NM_030816.5:c.1216-6del			-1.0						.	.	.		0.00161537	192.0	118858.0	0.0	31	0.9	AS_VQSR	nfe	0.00170698	95.0	0.00170698	95.0	0.333414	31591.0	94750.0	0.0	33	0.73	InbreedingCoeff	sas	0.401318	4567.0	0.323312	14582.0	0.0000322,0.0001479,0.1905803	5,23,29636						10.31	0.600189		0	0	0			ANKRD13C	0.0	0.0	0.0	0.0	-16.0	-20.0	-4.0	-7.0						0.19	1.0				.			ciliary ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;globus pallidus;	.	protein retention in ER lumen;regulation of receptor biosynthetic process;regulation of anoikis	endoplasmic reticulum;endoplasmic reticulum membrane;perinuclear region of cytoplasm	signaling receptor binding	CLDND2[unassigned1304];	70742532
2764	chr1	71418662	G		chr1:71418662	PTGER3	prostaglandin E receptor 3	deletion	0/0	0.0	36_0	36	99.0	0/1	0.41	44_31	75	99.0			rs568967213,COSV63037073	EXONIC	YES	NM_198718.2	Transcript	protein_coding	frameshift_variant		4/4	NM_198718.2:c.1185del	NP_942011.1:p.Asn395LysfsTer9		-1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00568533	865.0	152146.0	4.0	32	0.95	PASS	nfe	0.00901153	613.0	0.00901153	613.0	0.00540746	1351.0	249840.0	7.0	65	0.98	PASS	nfe	0.00833868	936.0	0.00833868	936.0	0.0000193,0.0050931	3,792	0.003	10.0				20.6	2.093973		0	0	0			PTGER3	0.0	0.0	0.01	0.0	48.0	-2.0	-14.0	10.0						0.556	0.79				immune system phenotype; renal/urinary system phenotype; behavior/neurological phenotype ; cardiovascular system phenotype ; muscle phenotype; homeostasis/metabolism phenotype; integument phenotype ; 			ciliary ganglion;temporal lobe;appendix;testis - seminiferous tubule;superior cervical ganglion;adipose tissue;trigeminal ganglion;skin;pons;kidney;uterus;atrioventricular node;skeletal muscle;	Calcium signaling pathway;Neuroactive ligand-receptor interaction	inflammatory response;G protein-coupled receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;phospholipase C-activating G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;cell death;intestine smooth muscle contraction;positive regulation of fever generation;negative regulation of gastric acid secretion	nuclear envelope;plasma membrane;integral component of plasma membrane;integral component of membrane	prostaglandin E receptor activity	CDA[25416956];RGS17[25416956];KRTAP10-7[25416956];KRTAP10-9[25416956];KRTAP10-8[25416956];INCA1[25416956];MEOX2[25416956];KRT31[25416956];NOTCH2NLA[25416956];KRT40[25416956];EFEMP2[25416956];KRT38[25416956];ADAMTSL4[25416956];REL[25416956];SPRY2[25416956];RGS20[25416956];TCF4[25416956];TRIM42[25416956];	71418661
2821	chr1	78435702	A		chr1:78435702	FUBP1	far upstream element binding protein 1	sequence_alteration	0/2	0.19	8_3_5	16	49.0	0/1	0.29	10_4_0	14	69.0			rs202224025	SPLICING	YES	NM_001376056.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/20		NM_001376056.1:c.121-3del			-1.0						.	.	.		0.00231481	323.0	139536.0	0.0	32	0.91	PASS	nfe	0.0020713	132.0	0.0020713	132.0	0.356458	38896.0	109118.0	0.0	20	0.5	InbreedingCoeff_RF	sas	0.40978	5296.0	0.346095	17999.0	0.0006045	94						5.832	0.199446		0	0	0			FUBP1	0.0	0.0	0.0	0.0	-9.0	30.0	-9.0	-20.0							1.0				cardiovascular system phenotype ; hematopoietic system phenotype; mortality/aging ; embryo phenotype; respiratory system phenotype; liver/biliary system phenotype; immune system phenotype; nervous system phenotype ; growth/size/body region phenotype; integument phenotype ; endocrine/exocrine gland phenotype; 			ciliary ganglion;appendix;fetal brain;testis - seminiferous tubule;subthalamic nucleus;lymph node;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	Glycolysis / Gluconeogenesis;Pentose phosphate pathway;Fructose and mannose metabolism;Carbon fixation;Insulin signaling pathway	regulation of transcription, DNA-templated;transcription by RNA polymerase II;positive regulation of gene expression	nucleus;nucleoplasm	single-stranded DNA binding;DNA-binding transcription factor activity;RNA binding;protein binding	ATF2[22304920];MDC1[29656893];CELF1[16169070];CRMP1[16169070];CHD3[16169070];BRCA1[29656893];MKI67[26949251];TIAL1[unassigned1304];PUF60[unassigned1304;20711187;29997244];U2AF2[unassigned1304];SNCG[17353931];SMN1[19928837];TP53BP1[29656893];MAPK1IP1L[unassigned1304];TLE1[16169070];VCAM1[22623428];PDHA1[29128334];USP22[21779003];VPS37C[unassigned1304];PRPF40B[unassigned1304];ANXA11[unassigned1304];DICER1[21858095];SOD1[29128334];RAB32[26496610];AIMP2[21285945;21988832];CEP170P1[26496610];KAT2A[21779003];SNW1[20467437];VIM[16169070];SNRPC[unassigned1304];SNRPA[unassigned1304];OTUB1[26752685];SNRPB[unassigned1304];PRR13[unassigned1304];	78435701
2835	chr1	78435702	A	AA	chr1:78435702	FUBP1	far upstream element binding protein 1	sequence_alteration	0/2	0.31	8_3_5	16	49.0	0/1	0.0	10_4_0	14	69.0			rs202224025	SPLICING	YES	NM_001376056.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/20		NM_001376056.1:c.121-3dup			-1.0						.	.	.		0.000543043	76.0	139952.0	0.0	32	0.91	PASS	amr	0.000788079	11.0	0.000281496	18.0	0.0278964	3044.0	109118.0	0.0	20	0.5	InbreedingCoeff_RF	amr	0.0463426	593.0	0.024401	1269.0	0.0001543,0.0000836	24,13						16.16	1.481231		0	0	0			FUBP1	0.0	0.0	0.0	0.0	-2.0	-9.0	-1.0	-20.0							1.0				cardiovascular system phenotype ; hematopoietic system phenotype; mortality/aging ; embryo phenotype; respiratory system phenotype; liver/biliary system phenotype; immune system phenotype; nervous system phenotype ; growth/size/body region phenotype; integument phenotype ; endocrine/exocrine gland phenotype; 			ciliary ganglion;appendix;fetal brain;testis - seminiferous tubule;subthalamic nucleus;lymph node;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	Glycolysis / Gluconeogenesis;Pentose phosphate pathway;Fructose and mannose metabolism;Carbon fixation;Insulin signaling pathway	regulation of transcription, DNA-templated;transcription by RNA polymerase II;positive regulation of gene expression	nucleus;nucleoplasm	single-stranded DNA binding;DNA-binding transcription factor activity;RNA binding;protein binding	ATF2[22304920];MDC1[29656893];CELF1[16169070];CRMP1[16169070];CHD3[16169070];BRCA1[29656893];MKI67[26949251];TIAL1[unassigned1304];PUF60[unassigned1304;20711187;29997244];U2AF2[unassigned1304];SNCG[17353931];SMN1[19928837];TP53BP1[29656893];MAPK1IP1L[unassigned1304];TLE1[16169070];VCAM1[22623428];PDHA1[29128334];USP22[21779003];VPS37C[unassigned1304];PRPF40B[unassigned1304];ANXA11[unassigned1304];DICER1[21858095];SOD1[29128334];RAB32[26496610];AIMP2[21285945;21988832];CEP170P1[26496610];KAT2A[21779003];SNW1[20467437];VIM[16169070];SNRPC[unassigned1304];SNRPA[unassigned1304];OTUB1[26752685];SNRPB[unassigned1304];PRR13[unassigned1304];	78435701
2998	chr1	84956162		TT	chr1:84956161-84956162	RPF1	ribosome production factor 1 homolog	insertion	0/1	0.29	4_4	14	99.0	0/0	0.0	27_0	27	72.0			rs11440073	SPLICING	YES	NM_025065.7	Transcript	protein_coding	splice_region_variant,intron_variant	5/8		NM_025065.7:c.616+16_616+17dup			1.0						.	.	.		0.000624708	91.0	145668.0	0.0	29	0.74	PASS	afr	0.00217533	87.0	3.04377e-05	2.0	0.00409015	478.0	116866.0	0.0	22	0.53	PASS	afr	0.0132779	131.0	0.00217753	123.0	0.0000257,0.0000064,0.0016334	4,1,254						15.59	1.377015		0	0	0																		0.0				.			.	.	rRNA processing	nucleolus;preribosome, large subunit precursor	RNA binding;protein binding	KRTAP10-7[25416956];LCOR[26496610];MNDA[25665578];RRP1B[20926688];MKI67[26949251];	84956161
3059	chr1	86435958	A	AA	chr1:86435958	COL24A1	collagen type XXIV alpha 1 chain	sequence_alteration	0/2	0.22	18_3_6	27	77.0	0/1	0.1	33_12_5	50	99.0			rs751533765	SPLICING	YES	NM_152890.7	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	21/59		NM_152890.7:c.2419-4dup			-1.0						.	.	.		0.0036184	515.0	142328.0	1.0	32	0.9	PASS	afr	0.00382896	149.0	0.0033643	218.0	0.0594167	6340.0	106704.0	0.0	39	0.6	InbreedingCoeff	amr	0.0863151	1018.0	0.0500787	2608.0	0.0001801,0.0000900	28,14						14.47	1.167975		0	0	0			COL24A1	0.03	0.0	0.0	0.0	-7.0	31.0	-7.0	-47.0						0.174	0.0				immune system phenotype; hematopoietic system phenotype; behavior/neurological phenotype ; growth/size/body region phenotype; 			.	.	extracellular matrix organization	extracellular region;collagen trimer;extracellular space;endoplasmic reticulum lumen;extracellular matrix;collagen-containing extracellular matrix	extracellular matrix structural constituent;protein binding;extracellular matrix structural constituent conferring tensile strength	APPBP2[25416956;unassigned1304];	86435957
3164	chr1	94506901	C	A	chr1:94506901	ABCA4	ATP binding cassette subfamily A member 4	SNV	0/0	0.0	36_0	36	99.0	0/1	0.49	46_45	91	99.0			rs1801269,CM138132,CM970009,COSV64674063	EXONIC	YES	NM_000350.3	Transcript	protein_coding	missense_variant		23/50	NM_000350.3:c.3386G>T	NP_000341.2:p.Arg1129Leu		-1.0	ABC transporter-like&AAA+ ATPase domain	Pathogenic/Likely_pathogenic	criteria_provided,_multiple_submitters,_no_conflicts	Retinal_dystrophy|Age-related_macular_degeneration_2|Stargardt_disease_1|Retinitis_pigmentosa_19|Cone-rod_dystrophy_3|not_provided	Retinal dystrophy, early-onset severe, 248200 (3), Autosomal recessive; Retinitis pigmentosa 19, 601718 (3), Autosomal recessive; {Macular degeneration, age-related, 2}, 153800 (3), Autosomal dominant; Cone-rod dystrophy 3, 604116 (3); Fundus flavimaculatus, 248200 (3), Autosomal recessive; Stargardt disease 1, 248200 (3), Autosomal recessive	Stargardt disease;Retinitis pigmentosa;Cone rod dystrophy	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Constriction of peripheral visual field;Attenuation of retinal blood vessels;Autosomal recessive inheritance;Rod-cone dystrophy;Nyctalopia;Retinal pigment epithelial atrophy;Optic disc pallor;Abnormal electroretinogram;Reduced visual acuity;Bone spicule pigmentation of the retina;Autosomal dominant inheritance;Visual loss;Autosomal recessive inheritance;Central scotoma;Color vision defect;Cone/cone-rod dystrophy;X-linked recessive inheritance;Nyctalopia;Reduced visual acuity;Retinal pigment epithelial atrophy;Central scotoma;Retinal pigment epithelial mottling;Color vision defect;Yellow/white lesions of the macula;Macular degeneration;Aplasia/Hypoplasia of the macula;Abnormality of visual evoked potentials;Paroxysmal involuntary eye movements;Retinal thinning;Abnormal choroid morphology;Abnormality of macular pigmentation;Abnormal foveal morphology;Photophobia;Visual impairment;Color vision defect;Abnormality of retinal pigmentation;Nyctalopia;Retinitis pigmentosa inversa;Autosomal recessive inheritance;Macular degeneration;Bull's eye maculopathy;Hyperinsulinemia;Optic atrophy;Nystagmus;Abnormal retinal vascular morphology;Obesity;Hypoplasia of penis;Cataract;Abnormality of retinal pigmentation;Keratoconus;Progressive night blindness;Ophthalmoplegia;Abnormal testis morphology;Atypical scarring of skin;Hyperreflexia;Sensorineural hearing impairment;Blindness;Type II diabetes mellitus;Conductive hearing impairment;Photophobia;Intellectual disability;Anteverted nares;Abnormal electroretinogram;Wide nasal bridge;Hypogonadism;Glaucoma;Macular degeneration;Autosomal dominant inheritance	28118664,23755871,19074458,9295268,17277736,25698705	0.000243287	37.0	152084.0	0.0	32	0.96	PASS	amr	0.00157109	24.0	0.000117609	8.0	0.000306236	77.0	251440.0	0.0	88	1.0	PASS	amr	0.00159015	55.0	0.000149466	17.0	0.0002379	37	0.006	21.0	0.00956	109.0		29.2	4.164422	1.0	18	3	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FATHMM_pred,PrimateAI_pred,ClinPred_pred	ABCA4	0.01	0.0	0.0	0.0	-20.0	19.0	-20.0	-38.0						0.0107	0.0	0.000000000	0.999	1.026	pigmentation phenotype; cardiovascular system phenotype ; hematopoietic system phenotype; vision/eye phenotype; nervous system phenotype ; skeleton phenotype; homeostasis/metabolism phenotype; immune system phenotype; 			.	ABC transporters	retinoid metabolic process;phospholipid transfer to membrane;lipid transport;visual perception;phototransduction, visible light;phospholipid translocation;photoreceptor cell maintenance;transmembrane transport	integral component of plasma membrane;membrane;intracellular membrane-bounded organelle;photoreceptor disc membrane	phospholipid-translocating ATPase activity;transporter activity;lipid transporter activity;eye pigment precursor transporter activity;ATP binding;phospholipid transporter activity;ATPase activity;ATPase activity, coupled to transmembrane movement of substances;phosphatidylethanolamine-translocating ATPase activity	KDM5B[24937458];RALY[30021884];	94506901
3219	chr1	100349693	G	T	chr1:100349693	AGL	amylo-alpha-1, 6-glucosidase, 4-alpha-glucanotransferase	SNV	0/0	0.0	12_0	12	36.0	0/1	0.67	1_2	3	26.0			rs1317312967	EXONIC	YES	NM_000028.2	Transcript	protein_coding	missense_variant		18/34	NM_000028.2:c.2326G>T	NP_000019.2:p.Val776Phe		1.0	Glycogen debranching enzyme, central domain,Glycogen debranching enzyme, central domain,Glycogen debranching enzyme, central domain,Glycogen debranching enzyme, central domain,.				Glycogen storage disease IIIa, 232400 (3), Autosomal recessive; Glycogen storage disease IIIb, 232400 (3), Autosomal recessive	Glycogen storage disease due to glycogen debranching enzyme deficiency	Disease-causing germline mutation(s) in	Hepatic fibrosis;Myopathy;Hyperlipidemia;Hypoglycemia;Autosomal recessive inheritance;Broad nasal tip;Depressed nasal bridge;Cardiomyopathy;Ventricular hypertrophy;Distal amyotrophy;Thin vermilion border;Midface retrusion;Muscle weakness;Malar flattening;Thin upper lip vermilion;Deeply set eye;Elevated hepatic transaminase;Elevated serum creatine kinase;Short stature;Hepatomegaly;Short stature;Hypertriglyceridemia;Immunodeficiency;Full cheeks;Myopathy;Hypoglycemia;Intellectual disability, mild						32	0.97											51	0.97														26.3	3.807483	0.574	12	9	21	SIFT,PolyPhen,LRT_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred	AGL	0.0	0.0	0.0	0.0	-17.0	1.0	-4.0	1.0						0.0357	0.0	51.152212932	0.999	0.224	muscle phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype ; respiratory system phenotype; liver/biliary system phenotype; mortality/aging ; vision/eye phenotype; limbs/digits/tail phenotype; skeleton phenotype; 			thyroid;tongue;prefrontal cortex;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Starch and sucrose metabolism	glycogen biosynthetic process;glycogen catabolic process;response to nutrient;neutrophil degranulation;response to glucocorticoid	extracellular region;nucleus;cytoplasm;cytosol;inclusion body;sarcoplasmic reticulum;secretory granule lumen;isoamylase complex;ficolin-1-rich granule lumen	glycogen debranching enzyme activity;4-alpha-glucanotransferase activity;amylo-alpha-1,6-glucosidase activity;protein binding;polysaccharide binding;polyubiquitin modification-dependent protein binding;beta-maltose 4-alpha-glucanotransferase activity	SH3GLB1[20562859];UVRAG[20562859];GABARAPL2[20562859];GABARAPL1[20562859];PRKAB2[20562859];SMAD3[15527767];PRKAA2[20562859];RASSF5[20562859];CBX1[21888893];APPL1[23414517];FOXA2[25609649];	100349693
3345	chr1	104076467		A	chr1:104076466-104076467	RNPC3	RNA binding region (RNP1, RRM) containing 3	insertion	0|1	0.25	9_3	12	43.0	0/0	0.11	18_3	27	13.0			rs748882456	EXONIC	YES	NM_017619.4	Transcript	protein_coding	frameshift_variant		3/15	NM_017619.4:c.358dup	NP_060089.1:p.Arg120LysfsTer3		1.0					Pituitary hormone deficiency, combined or isolated, 7, 618160 (3), Autosomal recessive	Isolated growth hormone deficiency type IA	Disease-causing germline mutation(s) in	Abdominal obesity;Postnatal growth retardation;Microcephaly;Frontal bossing;Short stature;Growth hormone deficiency;Delayed skeletal maturation;Autosomal recessive inheritance;Truncal obesity		0.000413333	56.0	135484.0	0.0	30	0.88	PASS	amr	0.000667062	9.0	0.000288887	18.0	0.122753	4930.0	40162.0	12.0	14	0.44	InbreedingCoeff	amr	0.140209	938.0	0.113275	1983.0	0.0002186,0.0002765,0.0131508	34,43,2045						32.0	4.50137		0	0	0			RNPC3	0.0	0.0	0.0	0.0	-35.0	-5.0	13.0	-5.0						0.697	0.53	43.162929326			.			.	.	mRNA splicing, via spliceosome;RNA splicing	nucleus;nucleoplasm;U12-type spliceosomal complex	U12 snRNA binding;pre-mRNA intronic binding	SMAD2[15231748];PRNP[18482256];ACTC1[30021884];NOLC1[30021884];PTBP3[22575643];	104076466
3384	chr1	109270482	T	C	chr1:109270482	FNDC7	fibronectin type III domain containing 7	SNV	0/0	0.0	47_0	47	99.0	0/1	0.39	59_39	99	99.0			rs369729211	EXONIC	YES	NM_001144937.3	Transcript	protein_coding	synonymous_variant		7/13	NM_001144937.3:c.1164T>C	NP_001138409.1:p.Val388%3D		1.0						.	.	.		1.97223e-05	3.0	152112.0	0.0	32	0.95	PASS	nfe	4.41176e-05	3.0	4.41176e-05	3.0	2.7837e-05	7.0	251464.0	0.0	89	1.0	PASS	amr	5.78269e-05	2.0	4.3956e-05	5.0	0.0000193	3						9.061	0.464437		0	0	0			FNDC7	0.16	0.0	0.0	0.0	-9.0	49.0	35.0	-3.0						0.412	0.0	74.821878940			hearing/vestibular/ear phenotype; homeostasis/metabolism phenotype; 			.	.	.	extracellular region	.	.	109270482
3427	chr1	109650648	A	T	chr1:109650648	C1orf194	chromosome 1 open reading frame 194	SNV	0/0	0.0	43_0	43	99.0	0|1	0.11	27_5	44	88.0			rs746312386,COSV64050095	EXONIC	YES	NM_001245025.3	Transcript	protein_coding	stop_gained		2/5	NM_001245025.3:c.93T>A	NP_001231954.1:p.Tyr31Ter		-1.0	.,.					.	.	.		0.0010173	141.0	138602.0	0.0	31	0.88	AS_VQSR	nfe	0.00155133	92.0	0.00155133	92.0	0.00164275	392.0	238624.0	14.0	67	0.97	RF	nfe	0.00250155	267.0	0.00250155	267.0	0.0000129	2	0.002	6.0				34.0	5.740854		3	3	6	MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	LRT_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	C1orf194	0.04	0.0	0.0	0.0	11.0	-28.0	-4.0	2.0						0.556	0.0	0.000000000	0.202	-0.892	.			.	.	.	.	.	.	109650648
3431	chr1	109650650	A	T	chr1:109650650	C1orf194	chromosome 1 open reading frame 194	SNV	0/0	0.0	43_0	43	99.0	0|1	0.14	27_5	35	88.0			rs374987922	EXONIC	YES	NM_001245025.3	Transcript	protein_coding	missense_variant		2/5	NM_001245025.3:c.91T>A	NP_001231954.1:p.Tyr31Asn		-1.0	.,.					.	.	.		5.75523e-05	8.0	139004.0	0.0	31	0.88	AS_VQSR	amr	0.000139412	2.0	0.0	0.0	0.000574914	138.0	240036.0	4.0	66	0.98	RF	nfe	0.00084659	91.0	0.00084659	91.0	0.0000129	2	0.002	5.0				15.75	1.405794	0.076	2	16	18	MutationAssessor_pred,PROVEAN_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	C1orf194	0.01	0.0	0.0	0.0	9.0	39.0	0.0	40.0						0.556	0.0	0.000000000	0.138	-0.078	.			.	.	.	.	.	.	109650650
3459	chr1	109793077	C	A	chr1:109793077	CELSR2	cadherin EGF LAG seven-pass G-type receptor 2	SNV	0/1	0.47	97_85	182	99.0	0/0	0.0	97_0	97	99.0			rs62623708	EXONIC	YES	NM_001408.3	Transcript	protein_coding	missense_variant		1/34	NM_001408.3:c.376C>A	NP_001399.1:p.Gln126Lys		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00353413	538.0	152230.0	3.0	32	0.98	PASS	amr	0.00654022	100.0	0.00576182	392.0	0.00303961	762.0	250690.0	4.0	85	1.0	PASS	nfe	0.00535705	606.0	0.00535705	606.0	0.0030353	472	0.002	5.0	0.00262	25.0		22.8	2.626677	0.064	2	16	18	SIFT,fathmm-MKL_coding_pred	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	CELSR2	0.0	0.0	0.0	0.0	42.0	3.0	-15.0	3.0						0.228	1.0	0.000000000	0.553	1.026	nervous system phenotype ; 			caudate nucleus;ciliary ganglion;amygdala;temporal lobe;prefrontal cortex;trigeminal ganglion;superior cervical ganglion;cingulate cortex;cerebellum;pons;fetal brain;occipital lobe;subthalamic nucleus;whole brain;spinal cord;parietal lobe;globus pallidus;medulla oblongata;thalamus;	.	regulation of transcription, DNA-templated;homophilic cell adhesion via plasma membrane adhesion molecules;G protein-coupled receptor signaling pathway;Wnt signaling pathway;neural plate anterior/posterior regionalization;regulation of cell-cell adhesion;dendrite morphogenesis;Wnt signaling pathway, planar cell polarity pathway	cytoplasm;plasma membrane;integral component of membrane	G protein-coupled receptor activity;calcium ion binding	KLF6[16169070];PHF10[16169070];SRC[17474147];LCA5[26638075];GARS[16169070];CRK[17474147];NCK1[17474147];	109793077
3542	chr1	111492547	A	G	chr1:111492547	LRIF1	ligand dependent nuclear receptor interacting factor 1	SNV	0/0	0.0	33_0	33	99.0	0/1	0.49	49_47	96	99.0			rs2232045,COSV99056614	EXONIC	YES	NM_018372.4	Transcript	protein_coding	missense_variant		3/4	NM_018372.4:c.1795T>C	NP_060842.3:p.Ser599Pro		-1.0	.,.,.				?Facioscapulohumeral muscular dystrophy 3, digenic, 619477 (3), Digenic recessive	.	.	.		0.00391523	596.0	152226.0	2.0	31	0.97	PASS	afr	0.00769565	319.0	0.00335097	228.0	0.00298322	750.0	251406.0	1.0	81	1.0	PASS	afr	0.00855069	139.0	0.00432702	492.0	0.0033247	517	0.003	8.0				15.38	1.335855	0.118	1	18	19	MutationAssessor_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LRIF1	0.0	0.0	0.0	0.0	11.0	8.0	7.0	9.0							0.0	0.000000000	0.984	0.284	.			.	.	regulation of transcription, DNA-templated;dosage compensation by inactivation of X chromosome	nuclear chromosome, telomeric region;Barr body;nucleus;microtubule organizing center;nuclear matrix	protein binding;retinoic acid receptor binding	CEP126[15383276];SUV39H2[21900206];CDKN1A[21900206];CRCP[unassigned1304];DDX42[26496610];CHD3[15383276];NOC2L[16189514];SMCHD1[26496610];CHAF1B[26496610];KAT5[15383276];ANXA7[21900206];RCC1[21900206];KAT7[15383276];TK1[21900206];GPRASP2[15383276];GIT1[15383276];PIAS4[15383276];ANXA1[21900206];TSC22D1[21900206];HAUS5[26496610];TCTE1[26638075];FEZ1[15383276];MVD[26496610];KCNE3[21900206];DCTN3[26496610];SUPT4H1[21900206];PPM1G[26496610];RAP1B[21900206];MTHFSD[26496610];NCKIPSD[26496610];TAF1D[21900206];PRKAR2A[unassigned1304];SMN1[21900206];BRD7[15383276];BANP[unassigned1304];BARD1[15383276];CBX5[20562864;21900206;27705803];SETDB1[15383276];OSBPL5[26496610];CBX3[21888893;27705803;unassigned1304];CBX1[27705803];IMMT[15383276];DNAJC13[26496610];WDYHV1[unassigned1304];GADD45G[15383276];FOSL2[unassigned1304];PIN1[21900206];CALR[21900206];ZNF410[unassigned1304];	111492547
3574	chr1	111966274	A	G	chr1:111966274	OVGP1	oviductal glycoprotein 1	SNV	0/1	0.47	37_33	70	99.0	0/0	0.0	38_0	38	99.0			rs200592736	EXONIC	YES	NM_002557.4	Transcript	protein_coding	missense_variant		5/11	NM_002557.4:c.374T>C	NP_002548.3:p.Ile125Thr		-1.0	Glycoside hydrolase family 18, catalytic domain&Chitinase II					.	.	.		8.53926e-05	13.0	152238.0	0.0	32	0.97	PASS	amr	0.000261643	4.0	0.000117588	8.0	7.16652e-05	18.0	251168.0	0.0	75	1.0	PASS	nfe	0.000132161	15.0	0.000132161	15.0	0.0001029	16						19.51	1.972162	0.386	8	13	21	SIFT,PolyPhen,LRT_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,LIST-S2_pred,fathmm-MKL_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	OVGP1	0.0	0.0	0.0	0.0	3.0	-13.0	-29.0	2.0						0.922	0.0	0.000000000	0.901	0.977	.			.	.	carbohydrate metabolic process;chitin catabolic process;binding of sperm to zona pellucida;female pregnancy;negative regulation of binding of sperm to zona pellucida	extracellular region;cytoplasm;cytosol;transport vesicle;egg coat;perivitelline space	chitinase activity;chitin binding	RASA4[16169070];ASL[21988832];	111966274
3681	chr1	115053500	C	A	chr1:115053500	TRIM33	tripartite motif containing 33	SNV	0/0	0.0	33_0	33	99.0	0/1	0.5	18_18	36	99.0			rs1473737278	EXONIC	YES	NM_015906.4	Transcript	protein_coding	synonymous_variant		1/20	NM_015906.4:c.198G>T	NP_056990.3:p.Gly66%3D		-1.0						Differentiated thyroid carcinoma	Part of a fusion gene in	.		6.58545e-06	1.0	151850.0	0.0	32	0.96	PASS	amr	6.55738e-05	1.0	0.0	0.0	0.0	0.0	64542.0	0.0	2	0.1	AC0				0.0	0.0								13.25	0.974675		0	0	0			TRIM33	0.0	0.0	0.0	0.0	2.0	-31.0	2.0	0.0						0.028	1.0				growth/size/body region phenotype; endocrine/exocrine gland phenotype; immune system phenotype; embryo phenotype; mortality/aging ; normal phenotype; neoplasm; nervous system phenotype ; digestive/alimentary phenotype; 			ciliary ganglion;caudate nucleus;amygdala;testis - seminiferous tubule;prefrontal cortex;cingulate cortex;superior cervical ganglion;skin;testis;pons;occipital lobe;fetal brain;subthalamic nucleus;testis - interstitial;dorsal root ganglion;atrioventricular node;parietal lobe;globus pallidus;medulla oblongata;	.	negative regulation of transcription by RNA polymerase II;protein ubiquitination;regulation of transforming growth factor beta receptor signaling pathway;negative regulation of BMP signaling pathway;negative regulation of transcription, DNA-templated	nucleus;nucleoplasm	DNA binding;ubiquitin-protein transferase activity;protein binding;zinc ion binding;co-SMAD binding;R-SMAD binding	MDC1[29656893];LDB1[20603019];FOXI1[25609649];RSF1[20603019];CHD4[20603019];YEATS4[20603019];BRCA1[29656893];LYL1[20603019];C17orf53[26496610];TRIM28[21531907];RB1CC1[20562859];RUVBL1[20603019];TRIM24[26496610;21531907];YAF2[20603019];FGA[26496610];PBRM1[20603019];SUPT16H[20603019];ACTL6A[20603019];TCF12[20603019];BAZ1B[20603019];CBFA2T2[20603019];CBFA2T3[20603019];SAP30[20603019];RUNX1[20603019];PTBP3[22575643];TAL1[20603019];VDAC2[26496610];NLGN3[25464930];BAZ2A[20603019];TP53BP1[29656893];MAPK6[29426014];SKIL[20603019];RUNX1T1[20603019];SMAD2[19135894;20603019];MBD3[20603019];SMARCE1[20603019];CBX8[20603019];SMAD4[19135894;20603019;21597466];JUN[25609649];RRM1[26496610];SMAD3[21597466];SSB[26496610];CBX3[20603019];CBX1[20603019];SMARCA5[20603019];SSRP1[20603019];SMARCA2[20603019];SMARCA4[20603019];CDK9[20603019];TDP1[20603019];TCF4[20603019;25609649];SSBP2[20603019];SSBP3[20603019];SSBP4[20603019];	115053500
3713	chr1	116937793	C	T	chr1:116937793	ATP1A1	ATPase Na+/K+ transporting subunit alpha 1	SNV	0/0	0.0	34_0	34	99.0	0/1	0.58	31_43	74	99.0			rs375738842	EXONIC	YES	NM_001160233.2	Transcript	protein_coding	synonymous_variant		13/23	NM_001160233.2:c.1722C>T	NP_001153705.1:p.Asp574%3D		1.0					Hypomagnesemia, seizures, and mental retardation 2, 618314 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2DD, 618036 (3), Autosomal dominant	Autosomal dominant Charcot-Marie-Tooth disease type 2DD	Disease-causing germline mutation(s) in	Muscle spasm;Hyporeflexia;Steppage gait;Areflexia;Foot dorsiflexor weakness;Autosomal dominant inheritance;Sensorimotor neuropathy;Slow progression;Pes cavus;Renal magnesium wasting;Autosomal dominant inheritance;Generalized-onset seizure;Self-biting;Hyperactivity;Status epilepticus;Polyuria;Hypokalemia;Hypomagnesemia;Global developmental delay;Ventriculomegaly;Renal potassium wasting		0.000151186	23.0	152130.0	0.0	32	0.97	PASS	amr	0.000589545	9.0	0.000102899	7.0	0.000111426	28.0	251288.0	0.0	71	0.98	PASS	amr	0.000549514	19.0	4.40133e-05	5.0	0.0000836	13						9.423	0.502076		0	0	0			ATP1A1	0.0	0.01	0.0	0.0	20.0	-37.0	3.0	19.0						0.0073	1.0	78.523197796			behavior/neurological phenotype ; cardiovascular system phenotype ; mortality/aging ; homeostasis/metabolism phenotype; muscle phenotype; 			pons;fetal thyroid;kidney;thyroid;subthalamic nucleus;whole brain;cingulate cortex;globus pallidus;cerebellum peduncles;cerebellum;medulla oblongata;	.	regulation of the force of heart contraction;regulation of sodium ion transport;cellular sodium ion homeostasis;regulation of blood pressure;establishment or maintenance of transmembrane electrochemical gradient;ATP hydrolysis coupled proton transport;dephosphorylation;cellular potassium ion homeostasis;negative regulation of glucocorticoid biosynthetic process;sodium ion export across plasma membrane;response to drug;negative regulation of heart contraction;positive regulation of heart contraction;positive regulation of striated muscle contraction;relaxation of cardiac muscle;membrane hyperpolarization;cellular response to mechanical stimulus;cellular response to steroid hormone stimulus;cardiac muscle cell action potential involved in contraction;regulation of cardiac muscle cell contraction;membrane repolarization;membrane repolarization during cardiac muscle cell action potential;cell communication by electrical coupling involved in cardiac conduction;response to glycoside;potassium ion import across plasma membrane	endosome;endoplasmic reticulum;Golgi apparatus;plasma membrane;sodium:potassium-exchanging ATPase complex;caveola;postsynaptic density;intercalated disc;membrane;integral component of membrane;basolateral plasma membrane;apical plasma membrane;T-tubule;protein-containing complex;sarcolemma;melanosome;myelin sheath;extracellular exosome;extracellular vesicle	sodium:potassium-exchanging ATPase activity;protein binding;ATP binding;phosphatase activity;protein kinase binding;protein domain specific binding;ankyrin binding;potassium ion binding;sodium ion binding;ADP binding;phosphatidylinositol 3-kinase binding;chaperone binding;steroid hormone binding	B4GALT2[30021884];ATF2[22304920];DYRK4[23602568];GOLT1B[26496610];CD81[30024968];TRADD[14743216];FASTKD3[20869947];ILK[25852190];SLC4A1[25012180];TUBA1C[26496610];MAP1LC3A[20562859];AIFM1[29568061];TCTN3[26638075];MYC[17314511];CDK20[23602568];IQCB1[21565611];GPR35[28298427];TNFRSF1B[14743216];ATP1B1[25012180;30021884];SDHA[29128334];GTF2F2[20195357];TNFRSF1A[14743216];VDAC1[29128334];ALDH7A1[30021884];OTUB1[26752685];TMEM63B[26496610];SRC[21278788];COX15[29128334];NDRG1[17220478];EGFR[16799092];ECPAS[26496610];NCSTN[26496610];IRAK1[25852190];ERBB2[24189400;26496610];E2F3[22157815];MAPK6[26972000];MAPK4[23602568];SNX6[16730713];SMAD2[20195357];HIPK4[23602568];JUN[25609649];SNAPIN[23414517];PDHA1[29128334];LIMK2[25852190];NCKAP5L[30021884];YIPF5[26496610];MBOAT1[26496610];ZFHX4[30021884];NFKB1[25609649];PLEKHA7[28877994];SOD1[29128334];TMEM17[26638075];AGO1[17932509];SFXN1[29568061];TPT1[16730713;21278788];EZH2[16169070];	116937793
3729	chr1	117944979	A	G	chr1:117944979	MAN1A2	mannosidase alpha class 1A member 2	SNV	0/0	0.0	36_0	36	99.0	0/1	0.44	56_44	100	99.0			rs140264006	EXONIC	YES	NM_006699.5	Transcript	protein_coding	synonymous_variant		2/13	NM_006699.5:c.474A>G	NP_006690.1:p.Pro158%3D		1.0						.	.	.		0.000164294	25.0	152166.0	1.0	32	0.96	PASS	sas	0.000829531	4.0	4.41047e-05	3.0	0.000115495	29.0	251094.0	0.0	57	0.99	PASS	amr	0.000376092	13.0	0.000123372	14.0	0.0001029	16	0.0	1.0	9e-05	1.0		11.09	0.693164		0	0	0			MAN1A2	0.0	0.0	0.0	0.05	1.0	23.0	0.0	-45.0						0.213	1.0	82.021070443			respiratory system phenotype; mortality/aging ; cardiovascular system phenotype ; homeostasis/metabolism phenotype; 			ciliary ganglion;pons;occipital lobe;prefrontal cortex;cingulate cortex;superior cervical ganglion;atrioventricular node;trigeminal ganglion;placenta;parietal lobe;skeletal muscle;globus pallidus;	N-Glycan biosynthesis;Glycan structures - biosynthesis 1	protein glycosylation;N-glycan processing;respiratory gaseous exchange;lung alveolus development;Golgi apparatus mannose trimming	Golgi membrane;endoplasmic reticulum;Golgi apparatus;membrane;integral component of membrane;extracellular exosome	mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;calcium ion binding	SP1[20195357];SMAD9[15231748];FOS[20195357];GTF2F2[20195357];	117944979
3732	chr1	118486119	A	G	chr1:118486119	WDR3	WD repeat domain 3	SNV	0/1	0.34	73_37	110	99.0	0/0	0.0	34_0	34	99.0			rs141364091,COSV100832475	EXONIC	YES	NM_006784.3	Transcript	protein_coding	missense_variant		11/27	NM_006784.3:c.1198A>G	NP_006775.1:p.Thr400Ala		1.0	WD40-repeat-containing domain					.	.	.		0.00193114	293.0	151724.0	0.0	31	0.96	PASS	nfe	0.00322334	219.0	0.00322334	219.0	0.00274828	691.0	251430.0	2.0	73	1.0	PASS	nfe	0.00424772	483.0	0.00424772	483.0	0.0005595,0.0026302	87,409	0.001	3.0				0.841	-0.176355	0.048	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	WDR3	0.02	0.0	0.0	0.0	-42.0	9.0	11.0	-26.0						0.815	0.0	0.000000000	0.024	-0.043	mortality/aging ; 			pons;ciliary ganglion;testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	.	rRNA processing	nucleus;nucleoplasm;nucleolus;nuclear membrane;small-subunit processome;Pwp2p-containing subcomplex of 90S preribosome	RNA binding	NOP56[26496610];USP36[19615732];JUN[25609649];USP43[19615732];CEP164[26638075];RPS6[29568061];HNRNPU[26496610];RRP1B[20926688];MKI67[26949251];ENO4[30021884];FBL[29568061];EXOSC5[26496610];PDE10A[16169070];MNDA[25665578];	118486119
3737	chr1	120468201	A	T	chr1:120468201	NOTCH2	notch 2	SNV	0/0	0.0	36_0	36	99.0	0/1	0.54	50_59	109	99.0			rs41313282,COSV56681418	EXONIC	YES	NM_024408.4	Transcript	protein_coding	missense_variant		25/34	NM_024408.4:c.4238T>A	NP_077719.2:p.Leu1413His		-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Hajdu-Cheney_syndrome|not_specified|not_provided	Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant	Acroosteolysis dominant type;Alagille syndrome due to a NOTCH2 point mutation	Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in	Wide nose;Hypospadias;Short neck;Crowded carpal bones;Dental malocclusion;Osteoporosis;Long philtrum;Dislocated radial head;Vertebral compression fractures;Synophrys;Low-set ears;High palate;Inguinal hernia;Foot acroosteolysis;Tall lumbar vertebral bodies;Cryptorchidism;Elongated sella turcica;Short nail;Autosomal dominant inheritance;Hydrocephalus;Coarse facial features;Pathologic fracture;Full cheeks;Downslanted palpebral fissures;Intestinal malrotation;Large earlobe;Osteolytic defects of the phalanges of the hand;Long eyelashes;Hirsutism;Umbilical hernia;Cervical instability;Osteopenia;Short stature;Conductive hearing impairment;Renal cyst;Abnormal cardiac septum morphology;Basilar impression;Wormian bones;Absent frontal sinuses;Telecanthus;Joint laxity;Failure to thrive;Genu valgum;Biconcave vertebral bodies;Thick eyebrow;Anteverted nares;Premature loss of teeth;Micrognathia;Kyphoscoliosis;Patent ductus arteriosus;Epicanthus;Hydrocephalus;Open bite;Wide nose;Micrognathia;Joint hyperflexibility;Hypospadias;Splenomegaly;Recurrent respiratory infections;Ventricular septal defect;Arnold-Chiari malformation;Wormian bones;Bone pain;Peripheral neuropathy;Hypertelorism;Kyphosis;Thickened skin;Hepatomegaly;Osteoporosis;Biconcave vertebral bodies;Brachydactyly;Wide nasal bridge;Dry skin;Abnormality of the voice;Decreased skull ossification;Coarse facial features;Hypoplasia of the zygomatic bone;Aortic valve stenosis;Coarse hair;Thin vermilion border;Macrocephaly;Osteopenia;Rough bone trabeculation;Syringomyelia;Generalized hirsutism;Inguinal hernia;Low anterior hairline;Telecanthus;Patellar dislocation;Headache;Multiple renal cysts;Cleft palate;Short neck;Myopia;Full cheeks;Scoliosis;Pectus carinatum;Periodontitis;Synophrys;Skin ulcer;Downturned corners of mouth;Bowing of the long bones;Partial absence of toe;Hearing impairment;Umbilical hernia;Thick eyebrow;Iris coloboma;Mitral stenosis;Hypoplastic 5th lumbar vertebrae;Cataract;Long philtrum;Delayed puberty;Recurrent fractures;Short stature;Intestinal malrotation;Skeletal dysplasia;Absent frontal sinuses;Abnormal fingernail morphology;Osteolysis;Low-set ears;Short distal phalanx of finger;Dolichocephaly;Arthralgia;Failure to thrive;Anteverted nares;Downslanted palpebral fissures;Narrow mouth;Short toe;Patent ductus arteriosus;Platybasia;Prominent occiput;Pointed chin;Posterior embryotoxon;Proteinuria;Autosomal dominant inheritance;Renal cyst;Pulmonic stenosis;Peripheral pulmonary artery stenosis;Hematuria;Tetralogy of Fallot;Renal insufficiency;Atrial septal defect;Hypertension;Triangular face;Broad forehead;Cholestatic liver disease;Renal tubular acidosis;Renal hypoplasia;Long nose	24728327	0.00368967	561.0	152046.0	1.0	32	0.96	PASS	amr	0.00615667	94.0	0.00554395	377.0	0.00330529	829.0	250810.0	1.0	100	0.99	PASS	nfe	0.00514527	583.0	0.00514527	583.0	0.0031639	492	0.008	24.0	0.00851	97.0		15.47	1.35318	0.221	2	17	19	PROVEAN_pred,DEOGEN2_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	NOTCH2	0.0	0.0	0.0	0.0	-2.0	34.0	7.0	16.0						0.0156	1.0	0.000000000	0.92	1.295	cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; muscle phenotype; endocrine/exocrine gland phenotype; taste/olfaction phenotype; integument phenotype ; growth/size/body region phenotype; embryo phenotype; skeleton phenotype; renal/urinary system phenotype; immune system phenotype; vision/eye phenotype; limbs/digits/tail phenotype; nervous system phenotype ; digestive/alimentary phenotype; neoplasm; pigmentation phenotype; reproductive system phenotype; normal phenotype; mortality/aging ; hematopoietic system phenotype; cardiovascular system phenotype ; liver/biliary system phenotype; respiratory system phenotype; 			ciliary ganglion;testis - seminiferous tubule;trigeminal ganglion;atrioventricular node;superior cervical ganglion;placenta;testis;skeletal muscle;	Notch signaling pathway	cell fate determination;marginal zone B cell differentiation;pulmonary valve morphogenesis;regulation of transcription, DNA-templated;transcription initiation from RNA polymerase II promoter;apoptotic process;cell cycle arrest;Notch signaling pathway;multicellular organism development;nervous system development;animal organ morphogenesis;negative regulation of gene expression;stem cell population maintenance;hemopoiesis;negative regulation of apoptotic process;negative regulation of growth rate;positive regulation of Ras protein signal transduction;bone remodeling;atrial septum morphogenesis;Notch signaling involved in heart development;positive regulation of ERK1 and ERK2 cascade;regulation of osteoclast development	Golgi membrane;extracellular region;nucleus;nucleoplasm;endoplasmic reticulum membrane;plasma membrane;integral component of plasma membrane;cell surface;membrane;receptor complex	calcium ion binding;protein binding;signaling receptor activity	ITIH5[25640309];NOTCH1[23022380];IL24[25640309];KLK5[25640309];HSCB[28380382];RBPJ[25609649;26496610];CST6[25640309];CRKL[18654987];PSMC3IP[25640309];TGOLN2[29568061];LAMP1[29568061];EPSTI1[25640309];HIF1AN[26972000];IL13RA2[25640309];MTA3[25640309];CCR2[28298427];ANKRD28[23414517;24255178];SMAD1[15231748];ST14[25640309];EGLN3[26972000];GOLM1[27569582];TMEM17[26638075];EZR[29568061];FAM84B[25640309];BET1[29568061];	120468201
3752	chr1	120611964	G	C	chr1:120611964	NOTCH2	notch 2	SNV	0/1	0.48	69_64	133	99.0	0/0	0.0	55_0	55	99.0			rs11810554,COSV56680365	EXONIC	YES	NM_024408.4	Transcript	protein_coding	missense_variant		1/34	NM_024408.4:c.57C>G	NP_077719.2:p.Cys19Trp		-1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	Hajdu-Cheney_syndrome|not_specified	Alagille syndrome 2, 610205 (3), Autosomal dominant; Hajdu-Cheney syndrome, 102500 (3), Autosomal dominant	Acroosteolysis dominant type;Alagille syndrome due to a NOTCH2 point mutation	Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in	Wide nose;Hypospadias;Short neck;Crowded carpal bones;Dental malocclusion;Osteoporosis;Long philtrum;Dislocated radial head;Vertebral compression fractures;Synophrys;Low-set ears;High palate;Inguinal hernia;Foot acroosteolysis;Tall lumbar vertebral bodies;Cryptorchidism;Elongated sella turcica;Short nail;Autosomal dominant inheritance;Hydrocephalus;Coarse facial features;Pathologic fracture;Full cheeks;Downslanted palpebral fissures;Intestinal malrotation;Large earlobe;Osteolytic defects of the phalanges of the hand;Long eyelashes;Hirsutism;Umbilical hernia;Cervical instability;Osteopenia;Short stature;Conductive hearing impairment;Renal cyst;Abnormal cardiac septum morphology;Basilar impression;Wormian bones;Absent frontal sinuses;Telecanthus;Joint laxity;Failure to thrive;Genu valgum;Biconcave vertebral bodies;Thick eyebrow;Anteverted nares;Premature loss of teeth;Micrognathia;Kyphoscoliosis;Patent ductus arteriosus;Epicanthus;Hydrocephalus;Open bite;Wide nose;Micrognathia;Joint hyperflexibility;Hypospadias;Splenomegaly;Recurrent respiratory infections;Ventricular septal defect;Arnold-Chiari malformation;Wormian bones;Bone pain;Peripheral neuropathy;Hypertelorism;Kyphosis;Thickened skin;Hepatomegaly;Osteoporosis;Biconcave vertebral bodies;Brachydactyly;Wide nasal bridge;Dry skin;Abnormality of the voice;Decreased skull ossification;Coarse facial features;Hypoplasia of the zygomatic bone;Aortic valve stenosis;Coarse hair;Thin vermilion border;Macrocephaly;Osteopenia;Rough bone trabeculation;Syringomyelia;Generalized hirsutism;Inguinal hernia;Low anterior hairline;Telecanthus;Patellar dislocation;Headache;Multiple renal cysts;Cleft palate;Short neck;Myopia;Full cheeks;Scoliosis;Pectus carinatum;Periodontitis;Synophrys;Skin ulcer;Downturned corners of mouth;Bowing of the long bones;Partial absence of toe;Hearing impairment;Umbilical hernia;Thick eyebrow;Iris coloboma;Mitral stenosis;Hypoplastic 5th lumbar vertebrae;Cataract;Long philtrum;Delayed puberty;Recurrent fractures;Short stature;Intestinal malrotation;Skeletal dysplasia;Absent frontal sinuses;Abnormal fingernail morphology;Osteolysis;Low-set ears;Short distal phalanx of finger;Dolichocephaly;Arthralgia;Failure to thrive;Anteverted nares;Downslanted palpebral fissures;Narrow mouth;Short toe;Patent ductus arteriosus;Platybasia;Prominent occiput;Pointed chin;Posterior embryotoxon;Proteinuria;Autosomal dominant inheritance;Renal cyst;Pulmonic stenosis;Peripheral pulmonary artery stenosis;Hematuria;Tetralogy of Fallot;Renal insufficiency;Atrial septal defect;Hypertension;Triangular face;Broad forehead;Cholestatic liver disease;Renal tubular acidosis;Renal hypoplasia;Long nose		5.92995e-05	9.0	151772.0	0.0	29	0.93	PASS	sas	0.000429	2.0	0.000103029	7.0	0.443417	90254.0	203542.0	5.0	37	0.79	InbreedingCoeff	eas	0.466803	7326.0	0.4595	43341.0	0.0209770	3262	0.047	154.0	0.41518	4249.0		21.3	2.18526	0.141	0	17	17		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	NOTCH2	0.0	0.0	0.0	0.0	-4.0	9.0	31.0	-16.0						0.0156	1.0		0.979	1.068	cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; muscle phenotype; endocrine/exocrine gland phenotype; taste/olfaction phenotype; integument phenotype ; growth/size/body region phenotype; embryo phenotype; skeleton phenotype; renal/urinary system phenotype; immune system phenotype; vision/eye phenotype; limbs/digits/tail phenotype; nervous system phenotype ; digestive/alimentary phenotype; neoplasm; pigmentation phenotype; reproductive system phenotype; normal phenotype; mortality/aging ; hematopoietic system phenotype; cardiovascular system phenotype ; liver/biliary system phenotype; respiratory system phenotype; 			ciliary ganglion;testis - seminiferous tubule;trigeminal ganglion;atrioventricular node;superior cervical ganglion;placenta;testis;skeletal muscle;	Notch signaling pathway	cell fate determination;marginal zone B cell differentiation;pulmonary valve morphogenesis;regulation of transcription, DNA-templated;transcription initiation from RNA polymerase II promoter;apoptotic process;cell cycle arrest;Notch signaling pathway;multicellular organism development;nervous system development;animal organ morphogenesis;negative regulation of gene expression;stem cell population maintenance;hemopoiesis;negative regulation of apoptotic process;negative regulation of growth rate;positive regulation of Ras protein signal transduction;bone remodeling;atrial septum morphogenesis;Notch signaling involved in heart development;positive regulation of ERK1 and ERK2 cascade;regulation of osteoclast development	Golgi membrane;extracellular region;nucleus;nucleoplasm;endoplasmic reticulum membrane;plasma membrane;integral component of plasma membrane;cell surface;membrane;receptor complex	calcium ion binding;protein binding;signaling receptor activity	ITIH5[25640309];NOTCH1[23022380];IL24[25640309];KLK5[25640309];HSCB[28380382];RBPJ[25609649;26496610];CST6[25640309];CRKL[18654987];PSMC3IP[25640309];TGOLN2[29568061];LAMP1[29568061];EPSTI1[25640309];HIF1AN[26972000];IL13RA2[25640309];MTA3[25640309];CCR2[28298427];ANKRD28[23414517;24255178];SMAD1[15231748];ST14[25640309];EGLN3[26972000];GOLM1[27569582];TMEM17[26638075];EZR[29568061];FAM84B[25640309];BET1[29568061];	120611964
3799	chr1	143767513	A	T	chr1:143767513	PPIAL4H	peptidylprolyl isomerase A like 4H	SNV	0|1	0.25	157_52	209	99.0	0|1	0.21	174_46	221	99.0			rs1553321469,COSV70086725	EXONIC	YES	NM_001368128.1	Transcript	protein_coding	missense_variant		1/1	NM_001368128.1:c.336T>A	NP_001355057.1:p.Phe112Leu		-1.0						.	.	.						0	0.0							0.471143	86418.0	183422.0	0.0	64	0.99	InbreedingCoeff_RF	eas	0.474587	6499.0	0.473518	39588.0	0.0046237	719	0.099	304.0				23.6	3.026866		2	0	2	SIFT,PolyPhen		PPIAL4G	0.0	0.01	0.0	0.0	31.0	2.0	4.0	11.0											.			.	.	.	.	.	.	143767513
3800	chr1	143767522	A	G	chr1:143767522	PPIAL4H	peptidylprolyl isomerase A like 4H	SNV	0|1	0.25	146_49	195	99.0	0|1	0.22	163_46	210	99.0			rs1553321475,COSV70086867	EXONIC	YES	NM_001368128.1	Transcript	protein_coding	synonymous_variant		1/1	NM_001368128.1:c.327T>C	NP_001355057.1:p.Gly109%3D		-1.0						.	.	.						0	0.0							0.462792	73607.0	159050.0	0.0	42	0.98	InbreedingCoeff_RF	afr	0.483066	5249.0	0.467658	34327.0	0.0032925	512	0.047	128.0				10.54	0.626498		0	0	0			PPIAL4G	0.01	0.01	0.0	0.02	46.0	-7.0	-43.0	47.0											.			.	.	.	.	.	.	143767522
3801	chr1	143767547	G	A	chr1:143767547	PPIAL4H	peptidylprolyl isomerase A like 4H	SNV	0/1	0.2	127_32	159	99.0	0/1	0.18	146_33	180	99.0			rs1553321483,COSV70086727	EXONIC	YES	NM_001368128.1	Transcript	protein_coding	missense_variant		1/1	NM_001368128.1:c.302C>T	NP_001355057.1:p.Ala101Val		-1.0						.	.	.						0	0.0							0.453886	77748.0	171294.0	0.0	43	0.96	InbreedingCoeff	afr	0.478031	5527.0	0.46085	36374.0	0.0147134	2288	0.052	164.0				24.2	3.260469		2	0	2	SIFT,PolyPhen		PPIAL4G	0.01	0.0	0.38	0.07	-32.0	28.0	2.0	22.0											.			.	.	.	.	.	.	143767547
3802	chr1	143767643	T	C	chr1:143767643	PPIAL4H	peptidylprolyl isomerase A like 4H	SNV	0/1	0.2	96_24	120	99.0	0/1	0.26	90_32	122	99.0			rs1553321535,COSV70086733	EXONIC	YES	NM_001368128.1	Transcript	protein_coding	missense_variant		1/1	NM_001368128.1:c.206A>G	NP_001355057.1:p.His69Arg		-1.0						.	.	.						0	0.0							0.241304	33675.0	139554.0	0.0	100	0.99	InbreedingCoeff_RF	eas	0.328465	4251.0	0.2079	13958.0	0.0169963	2643	0.034	103.0				1.462	-0.094101		0	2	2		SIFT,PolyPhen	PPIAL4G	0.0	0.0	0.0	0.0	30.0	-15.0	-14.0	30.0											.			.	.	.	.	.	.	143767643
3873	chr1	144852476	T	C	chr1:144852476	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.58	77_108	186	99.0	0/1	0.55	70_87	157	99.0			rs1616066,COSV57703953	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		40/40	NM_001350520.1:c.7509A>G	NP_001337449.1:p.Pro2503%3D		-1.0						.	.	.		3.28537e-05	5.0	152190.0	0.0	28	0.9	PASS	sas	0.000207125	1.0	2.93927e-05	2.0	0.499984	125303.0	250614.0	1.0	100	0.99	InbreedingCoeff	afr	0.5	8095.0	0.499982	56592.0	0.0314526	4891	0.132	380.0				6.48	0.244704		0	0	0			PDE4DIP	0.0	0.04	0.0	0.0	23.0	-33.0	9.0	47.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144852476
4028	chr1	144854180	T	C	chr1:144854180	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.19	98_23	121	99.0	0/1	0.19	113_27	140	99.0			rs4997148,COSV57703964	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		39/40	NM_001350520.1:c.7470A>G	NP_001337449.1:p.Ala2490%3D		-1.0						.	.	.		0.000135137	20.0	147998.0	0.0	28	0.89	AS_VQSR,PASS	eas,afr	0.000587314	3.0	0.000121326	8.0	0.49858	109553.0	219730.0	1.0	100	0.98	InbreedingCoeff	amr	0.498792	15279.0	0.498446	48757.0	0.0096332	1498	0.117	359.0				10.93	0.673951		0	0	0			PDE4DIP	0.02	0.0	0.07	0.0	31.0	-15.0	-15.0	3.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144854180
4129	chr1	144854528	G	G	chr1:144854528	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0|1	0.18	117_26	144	99.0	0/0	0.0	72_0	72	99.0			rs833192,COSV57674763	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		38/40	NM_001350520.1:c.7428T>C	NP_001337449.1:p.Ile2476%3D		-1.0						.	.	.		0.000230494	35.0	151848.0	0.0	34	0.96	PASS	afr	0.000482882	20.0	0.000103053	7.0	0.473723	74293.0	156828.0	0.0	100	1.0	InbreedingCoeff	eas	0.49271	7637.0	0.460189	29684.0	0.0100319	1560	0.048	148.0				11.24	0.710559		0	0	0			PDE4DIP	0.0	0.0	0.01	0.16	23.0	0.0	-10.0	0.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144854528
4134	chr1	144854537	C	C	chr1:144854537	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0|1	0.19	129_31	161	99.0	0/0	0.0	123_0	123	52.0			rs3851872,COSV57703052	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		38/40	NM_001350520.1:c.7419A>G	NP_001337449.1:p.Glu2473%3D		-1.0						.	.	.	28522829	0.000203811	31.0	152102.0	0.0	34	0.97	PASS	eas	0.00038625	2.0	0.000205852	14.0	0.480455	76648.0	159532.0	0.0	100	1.0	InbreedingCoeff	eas	0.492666	7591.0	0.471819	31794.0	0.0105721	1644	0.052	161.0				9.113	0.469735		0	0	0			PDE4DIP	0.0	0.0	0.0	0.09	50.0	-19.0	-19.0	-9.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144854537
4143	chr1	144854581	T	C	chr1:144854581	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0|1	0.16	183_35	219	99.0	0|1	0.12	137_18	156	99.0			rs78371650,COSV57672314	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		38/40	NM_001350520.1:c.7375A>G	NP_001337449.1:p.Thr2459Ala		-1.0						.	.	.		0.000400873	61.0	152168.0	0.0	31	0.92	PASS,PASS	afr,sas	0.00125428	52.0	7.35229e-05	5.0	0.487253	59250.0	121600.0	0.0	100	1.0	InbreedingCoeff_RF	sas	0.497668	8537.0	0.482813	23906.0	0.0023279	362	0.032	101.0				0.673	-0.209683		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	6.0	21.0	1.0	-32.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144854581
4156	chr1	144854594	G	T	chr1:144854594	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0|1	0.17	181_36	218	99.0	0|1	0.12	133_19	153	99.0			rs79028512,COSV57675041	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		38/40	NM_001350520.1:c.7362C>A	NP_001337449.1:p.Leu2454%3D		-1.0						.	.	.		0.0	0.0	152160.0	0.0	31	0.92	AC0,PASS	afr	0.00107046	44.0	0.0	0.0	0.493841	71517.0	144818.0	0.0	100	1.0	InbreedingCoeff	amr	0.49802	11065.0	0.494384	29666.0	0.0157874	2455	0.044	138.0				5.938	0.206602		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	8.0	-7.0	-12.0	21.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144854594
4161	chr1	144854598	C	T	chr1:144854598	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.36	134_75	210	99.0	0/1	0.38	92_58	151	99.0			rs3863691,COSV57672336	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		38/40	NM_001350520.1:c.7358G>A	NP_001337449.1:p.Arg2453Gln		-1.0						.	.	.		3.2903e-05	5.0	151962.0	0.0	30	0.92	PASS,PASS	afr,sas	7.25093e-05	3.0	1.4705e-05	1.0	0.5	125090.0	250180.0	0.0	100	1.0	InbreedingCoeff	nfe	0.5	56575.0	0.5	56575.0	0.0157617	2451	0.051	159.0				0.568	-0.235226		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	-11.0	4.0	17.0	-49.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144854598
4208	chr1	144855866	A	G	chr1:144855866	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.22	70_20	91	99.0	0/1	0.27	81_30	111	99.0			rs1698582,COSV57680805	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		37/40	NM_001350520.1:c.7173T>C	NP_001337449.1:p.Gly2391%3D		-1.0						.	.	.		0.000414599	63.0	151954.0	0.0	30	0.92	PASS	eas	0.000777001	4.0	0.000470547	32.0	0.483844	72205.0	149232.0	1.0	53	0.99	InbreedingCoeff	eas	0.492787	6832.0	0.479341	30164.0	0.0159417	2479	0.027	82.0				2.145	-0.033858		0	0	0			PDE4DIP	0.02	0.01	0.0	0.0	17.0	10.0	11.0	2.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144855866
4226	chr1	144856852	C	T	chr1:144856852	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.22	105_30	135	99.0	0/0	0.0	33_0	33	99.0			rs377520030,COSV57674703	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		36/40	NM_001350520.1:c.7119G>A	NP_001337449.1:p.Ala2373%3D		-1.0						.	.	.		0.000154943	9.0	58086.0	0.0	8	0.05	AS_VQSR,AS_VQSR	afr,afr	0.000516681	7.0	6.52997e-05	2.0	0.00992544	2436.0	245430.0	0.0	75	0.9	PASS	afr	0.0762782	1101.0	0.0061583	685.0	0.0005466	85	0.012	38.0				1.092	-0.137668		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	1.0	6.0	12.0	-36.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144856852
4290	chr1	144859789	C	T	chr1:144859789	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/0	0.0	80_0	80	99.0	0/1	0.2	109_27	136	99.0			rs150096209	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		34/40	NM_001350520.1:c.6781G>A	NP_001337449.1:p.Asp2261Asn		-1.0						.	.	.		0.00106221	158.0	148746.0	0.0	25	0.72	AS_VQSR	amr	0.00154778	23.0	0.0015467	104.0	0.000813566	204.0	250748.0	0.0	73	1.0	PASS	nfe	0.00121979	138.0	0.00121979	138.0	0.0007395	115	0.003	8.0				13.27	0.977534		0	0	0			PDE4DIP	0.0	0.0	0.0	0.02	-30.0	18.0	-33.0	-30.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144859789
4430	chr1	144865850	G	T	chr1:144865850	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.44	108_84	192	99.0	0/1	0.46	98_84	182	99.0			rs1613780,COSV57672370	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		31/40	NM_001350520.1:c.6216C>A	NP_001337449.1:p.Asp2072Glu		-1.0						.	.	.						24	0.71							0.5	125676.0	251352.0	0.0	100	1.0	InbreedingCoeff	nfe	0.5	56832.0	0.5	56832.0	0.0371566	5778	0.204	644.0				12.55	0.878033		0	0	0			PDE4DIP	0.0	0.0	0.0	0.01	-40.0	32.0	-44.0	-40.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144865850
4471	chr1	144866643	G	A	chr1:144866643	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.53	87_97	184	99.0	0/1	0.32	117_56	173	99.0			rs1620560,COSV57672397	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		30/40	NM_001350520.1:c.6085C>T	NP_001337449.1:p.Arg2029Cys		-1.0						.	.	.		6.58085e-06	1.0	151956.0	0.0	28	0.92	PASS	nfe	1.47016e-05	1.0	1.47016e-05	1.0	0.499992	125627.0	251258.0	0.0	100	1.0	InbreedingCoeff	afr	0.5	8125.0	0.499982	56796.0	0.0365393	5682	0.207	656.0				23.1	2.795841		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	-12.0	30.0	-49.0	-33.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144866643
4507	chr1	144868170	C	T	chr1:144868170	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.54	77_89	166	99.0	0/1	0.44	71_56	127	99.0			rs1628310,COSV57672418	SPLICING	YES	NM_001350520.1	Transcript	protein_coding	missense_variant,splice_region_variant		29/40	NM_001350520.1:c.5755G>A	NP_001337449.1:p.Ala1919Thr		-1.0						.	.	.						22	0.66							0.5	125641.0	251282.0	0.0	91	1.0	InbreedingCoeff	nfe	0.5	56799.0	0.5	56799.0	0.0333561	5187	0.201	626.0				18.77	1.875075		0	0	0			PDE4DIP	0.02	0.0	0.0	0.0	-28.0	2.0	-28.0	-18.0			7.781	0.471	8.253	0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144868170
4541	chr1	144871738	C	A	chr1:144871738	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0|1	0.53	90_101	192	99.0	0|1	0.4	85_57	143	99.0			rs1698605,COSV57672434	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		28/40	NM_001350520.1:c.5710G>T	NP_001337449.1:p.Ala1904Ser		-1.0						.	.	.						25	0.88							0.499996	125148.0	250298.0	0.0	65	1.0	InbreedingCoeff	nfe	0.5	56622.0	0.5	56622.0	0.0173629	2700	0.19	585.0				27.3	3.950838		0	0	0			PDE4DIP	0.0	0.0	0.02	0.0	-9.0	17.0	-42.0	-38.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144871738
4553	chr1	144871755	A	T	chr1:144871755	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0|1	0.57	94_126	221	99.0	0|1	0.42	95_70	166	99.0			rs1778159,COSV57672446	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		28/40	NM_001350520.1:c.5693T>A	NP_001337449.1:p.Val1898Glu		-1.0						.	.	.						25	0.88							0.499996	125322.0	250646.0	0.0	79	1.0	InbreedingCoeff	afr	0.5	8078.0	0.499991	56657.0	0.0203210	3160	0.19	584.0				17.46	1.697287		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	41.0	0.0	-1.0	13.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144871755
4559	chr1	144871782	A	G	chr1:144871782	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.58	85_121	207	99.0	0/1	0.48	93_86	180	99.0			rs1778158,COSV57672459	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		28/40	NM_001350520.1:c.5666T>C	NP_001337449.1:p.Leu1889Pro		-1.0						.	.	.						25	0.88							0.5	125355.0	250710.0	0.0	89	1.0	InbreedingCoeff	nfe	0.5	56700.0	0.5	56700.0	0.0156909	2440	0.198	617.0				21.9	2.27564		0	0	0			PDE4DIP	0.0	0.01	0.0	0.0	-50.0	14.0	-50.0	-14.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144871782
4572	chr1	144871889	A	C	chr1:144871889	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.58	38_53	91	99.0	0/1	0.53	43_50	94	99.0			rs1698606	SPLICING	YES	NM_001350520.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	27/39		NM_001350520.1:c.5567-8T>G			-1.0						.	.	.		6.56996e-06	1.0	152208.0	0.0	25	0.87	AS_VQSR	nfe	1.46959e-05	1.0	1.46959e-05	1.0	0.49998	123700.0	247410.0	0.0	41	0.87	InbreedingCoeff	afr	0.5	8075.0	0.499991	56010.0	0.0365457	5683	0.163	504.0				11.48	0.740576		0	0	0			PDE4DIP	0.0	0.08	0.0	0.0	-1.0	-8.0	-8.0	-34.0	8.18634908050367e-05	0.01	9.299	-0.276	9.023	0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144871889
4606	chr1	144873887	C	T	chr1:144873887	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.41	83_58	142	99.0	0/1	0.54	70_82	152	99.0			rs1699787,COSV57704265	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		27/40	NM_001350520.1:c.5556G>A	NP_001337449.1:p.Gln1852%3D		-1.0						.	.	.	26887787					29	0.95							0.5	125708.0	251416.0	0.0	100	1.0	InbreedingCoeff	nfe	0.5	56855.0	0.5	56855.0	0.0340313	5292	0.206	653.0				11.9	0.793268		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	-2.0	23.0	-10.0	-13.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144873887
4657	chr1	144874760	T	C	chr1:144874760	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.48	117_108	225	99.0	0/1	0.5	115_117	232	99.0			rs1610774,COSV57704290	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		26/40	NM_001350520.1:c.5334A>G	NP_001337449.1:p.Glu1778%3D		-1.0						.	.	.		7.58914e-05	11.0	144944.0	0.0	29	0.93	PASS	afr	0.000130263	5.0	3.06204e-05	2.0	0.500004	125718.0	251434.0	1.0	100	1.0	InbreedingCoeff	nfe	0.500009	56861.0	0.500009	56861.0	0.0365071	5677	0.207	655.0				12.19	0.830986		0	0	0			PDE4DIP	0.0	0.03	0.0	0.0	-1.0	24.0	-31.0	-35.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144874760
4667	chr1	144874815	T	C	chr1:144874815	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.22	174_50	224	99.0	0/1	0.3	145_63	208	99.0			rs1778155,COSV57681140	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		26/40	NM_001350520.1:c.5279A>G	NP_001337449.1:p.His1760Arg		-1.0						.	.	.	26959706,25961151	3.28433e-05	5.0	152238.0	0.0	29	0.95	PASS	afr	0.000120546	5.0	0.0	0.0	0.397831	89142.0	224070.0	0.0	100	1.0	InbreedingCoeff	eas	0.496466	8850.0	0.374192	37503.0	0.0286166	4450	0.111	337.0				0.399	-0.287429		0	0	0			PDE4DIP	0.0	0.02	0.0	0.0	5.0	-31.0	1.0	24.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144874815
4700	chr1	144877176	C	T	chr1:144877176	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.4	94_62	156	99.0	0/1	0.45	75_61	136	99.0			rs2762875,COSV57672477	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		24/40	NM_001350520.1:c.4997G>A	NP_001337449.1:p.Arg1666Gln		-1.0						.	.	.						18	0.31							0.49996	125245.0	250510.0	0.0	100	1.0	InbreedingCoeff	eas	0.5	9191.0	0.499973	56584.0	0.0339863	5285	0.201	625.0				19.54	1.976035		0	0	0			PDE4DIP	0.05	0.0	0.02	0.0	-2.0	-12.0	22.0	-16.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144877176
4731	chr1	144879090	T	C	chr1:144879090	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.26	125_45	171	99.0	0/1	0.18	117_25	142	99.0			rs1778120,COSV57699666	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		23/40	NM_001350520.1:c.4846A>G	NP_001337449.1:p.Lys1616Glu		-1.0						.	.	.	26201965					30	0.96							0.283688	66952.0	236006.0	0.0	100	1.0	InbreedingCoeff	sas	0.360893	10284.0	0.264775	28279.0	0.0175172	2724	0.071	211.0				21.8	2.263067		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	18.0	-13.0	-43.0	28.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144879090
4743	chr1	144879264	G	G	chr1:144879264	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.83	30_143	173	99.0	0/1	0.84	27_138	165	99.0			rs2798901,COSV57672501	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		23/40	NM_001350520.1:c.4672T>C	NP_001337449.1:p.Arg1558%3D		-1.0						.	.	.						0	0.0							0.69194	173706.0	251042.0	48185.0	100	1.0	InbreedingCoeff	eas	0.924913	17011.0	0.639127	72445.0	0.0720367	11202	0.291	907.0				13.71	1.041682		0	0	0			PDE4DIP	0.0	0.0	0.0	0.02	35.0	-47.0	-14.0	30.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144879264
4774	chr1	144880832	T	C	chr1:144880832	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.21	120_31	151	99.0	0/1	0.27	102_37	139	99.0			rs12568796,COSV57692249	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		22/40	NM_001350520.1:c.4282A>G	NP_001337449.1:p.Lys1428Glu		-1.0						.	.	.						22	0.73							0.244497	56157.0	229684.0	0.0	100	1.0	InbreedingCoeff	sas	0.331598	9046.0	0.253319	26368.0	0.0174208	2709	0.085	261.0				26.3	3.813461		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	29.0	26.0	-11.0	16.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144880832
4800	chr1	144882581	A	G	chr1:144882581	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.54	99_115	214	99.0	0/1	0.51	92_95	187	99.0			rs1699836,COSV57704362	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		20/40	NM_001350520.1:c.3927T>C	NP_001337449.1:p.Ile1309%3D		-1.0						.	.	.						20	0.57							0.499972	125638.0	251290.0	0.0	100	1.0	InbreedingCoeff	afr	0.5	8128.0	0.499991	56838.0	0.0333689	5189	0.173	539.0				1.871	-0.055846		0	0	0			PDE4DIP	0.01	0.0	0.01	0.0	6.0	-17.0	-21.0	44.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144882581
4809	chr1	144882823	C	T	chr1:144882823	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.48	119_109	229	99.0	0/1	0.54	117_136	253	99.0			rs1698647,COSV57672559	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		20/40	NM_001350520.1:c.3685G>A	NP_001337449.1:p.Ala1229Thr		-1.0						.	.	.		6.73319e-05	10.0	148518.0	0.0	20	0.6	AS_VQSR	eas	0.000817996	4.0	1.49272e-05	1.0	0.499976	125590.0	251192.0	0.0	100	1.0	InbreedingCoeff	afr	0.5	8124.0	0.499991	56802.0	0.0365393	5682	0.194	614.0				28.0	4.033896		0	0	0			PDE4DIP	0.0	0.0	0.0	0.05	43.0	-47.0	8.0	-47.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144882823
4850	chr1	144886197	A	T	chr1:144886197	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.51	101_104	205	99.0	0/1	0.48	102_95	197	99.0			rs1698624,COSV57672583	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		19/40	NM_001350520.1:c.3526T>A	NP_001337449.1:p.Phe1176Ile		-1.0						.	.	.						28	0.94							0.49998	125539.0	251088.0	1.0	100	1.0	InbreedingCoeff	nfe	0.5	56784.0	0.5	56784.0	0.0365200	5679	0.207	656.0				0.434	-0.274797		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	43.0	-9.0	1.0	38.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144886197
4983	chr1	144912233	C	T	chr1:144912233	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.46	82_71	153	99.0	0/1	0.45	95_78	174	99.0			rs1629011,COSV57672613	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		11/40	NM_001350520.1:c.2531G>A	NP_001337449.1:p.Arg844His		-1.0						.	.	.						19	0.39							0.5	125689.0	251378.0	0.0	76	1.0	InbreedingCoeff	nfe	0.5	56853.0	0.5	56853.0	0.0371566	5778	0.107	321.0				19.18	1.928911		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	-12.0	46.0	48.0	7.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144912233
5006	chr1	144915561	G	A	chr1:144915561	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.41	106_75	181	99.0	0/1	0.47	92_81	173	99.0			rs1778111,COSV57672649	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	stop_gained		10/40	NM_001350520.1:c.2353C>T	NP_001337449.1:p.Arg785Ter		-1.0						.	.	.						27	0.92							0.5	125741.0	251482.0	0.0	100	1.0	InbreedingCoeff	nfe	0.5	56881.0	0.5	56881.0	0.0325844	5067	0.199	629.0				34.0	5.71634		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	-21.0	41.0	2.0	-47.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144915561
5015	chr1	144915624	G	A	chr1:144915624	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.35	68_36	104	99.0	0/1	0.38	68_41	109	99.0			rs1778112,COSV57700531,COSV57704493	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		10/40	NM_001350520.1:c.2290C>T	NP_001337449.1:p.Leu764%3D		-1.0						.	.	.		0.00030928	47.0	151966.0	0.0	27	0.92	PASS	amr	0.00157729	24.0	0.000279486	19.0	0.459556	98571.0	214492.0	1.0	74	1.0	InbreedingCoeff	afr	0.497511	7796.0	0.478171	46899.0	0.0353367	5495	0.07	211.0				9.697	0.531768		0	0	0			PDE4DIP	0.02	0.01	0.0	0.0	-22.0	15.0	-22.0	7.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144915624
5070	chr1	144916748	C	G	chr1:144916748	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.52	42_46	88	99.0	0/1	0.47	44_39	83	99.0			rs1747930,COSV57672692	SPLICING	YES	NM_001350520.1	Transcript	protein_coding	missense_variant,splice_region_variant		9/40	NM_001350520.1:c.2096G>C	NP_001337449.1:p.Ser699Thr		-1.0						.	.	.		6.60005e-06	1.0	151514.0	0.0	28	0.94	AS_VQSR	afr	2.43262e-05	1.0	0.0	0.0	0.499996	125653.0	251308.0	0.0	77	1.0	InbreedingCoeff	afr	0.5	8107.0	0.499991	56837.0	0.0365393	5682	0.198	614.0				31.0	4.317591		0	0	0			PDE4DIP	0.02	0.02	0.0	0.0	1.0	-1.0	-43.0	1.0	0.966933262579569	0.886	6.31	-0.122	6.187	0.984		18.016300198			behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144916748
5098	chr1	144917546	A	G	chr1:144917546	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.52	61_68	130	99.0	0/1	0.55	71_88	159	99.0			rs1698682,COSV57704562	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		8/40	NM_001350520.1:c.2047T>C	NP_001337449.1:p.Leu683%3D		-1.0						.	.	.						23	0.71							0.499996	125735.0	251472.0	0.0	100	1.0	InbreedingCoeff	afr	0.5	8128.0	0.499991	56874.0	0.0365393	5682	0.207	656.0				12.61	0.885383		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	33.0	-37.0	-47.0	-43.0						0.984		42.247670036			behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144917546
5111	chr1	144917841	T	C	chr1:144917841	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.39	69_45	114	99.0	0/1	0.5	46_46	92	99.0			rs1698681,COSV57672908	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		7/40	NM_001350520.1:c.1934A>G	NP_001337449.1:p.His645Arg		-1.0						.	.	.						21	0.65							0.499996	125728.0	251458.0	0.0	100	1.0	InbreedingCoeff	nfe	0.5	56875.0	0.5	56875.0	0.0329574	5125	0.187	582.0				16.75	1.582734		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	7.0	-9.0	-22.0	-2.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144917841
5146	chr1	144918957	T	A	chr1:144918957	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.5	55_56	112	99.0	0/1	0.49	56_53	109	99.0			rs1061308,COSV57672941	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		6/40	NM_001350520.1:c.1718A>T	NP_001337449.1:p.Glu573Val		-1.0						.	.	.						24	0.81							0.5	125733.0	251466.0	0.0	96	1.0	InbreedingCoeff_RF	nfe	0.5	56874.0	0.5	56874.0	0.0363142	5647	0.21	653.0				28.0	4.0315		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	10.0	13.0	2.0	3.0						0.984					behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144918957
5200	chr1	144922583	G	A	chr1:144922583	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.33	55_27	82	99.0	0/1	0.32	65_30	95	99.0			rs1359300,COSV57672974	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		3/40	NM_001350520.1:c.1313C>T	NP_001337449.1:p.Ser438Leu		-1.0						.	.	.		0.000125003	19.0	151996.0	0.0	25	0.8	PASS	nfe	0.000206161	14.0	0.000206161	14.0	0.5	125719.0	251438.0	0.0	100	1.0	InbreedingCoeff	nfe	0.5	56865.0	0.5	56865.0	0.0365007	5676	0.197	623.0				22.4	2.412487		0	0	0			PDE4DIP	0.0	0.0	0.0	0.02	-11.0	45.0	13.0	-17.0						0.984		0.248138958			behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144922583
5287	chr1	144930596	C	A	chr1:144930596	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.35	91_50	143	99.0	0/1	0.6	48_72	120	99.0			rs2762867,COSV57704759	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	synonymous_variant		1/40	NM_001350520.1:c.1113G>T	NP_001337449.1:p.Pro371%3D		-1.0						.	.	.		1.31534e-05	2.0	152052.0	0.0	31	0.96	PASS	amr	6.54879e-05	1.0	1.47059e-05	1.0	0.499992	125680.0	251364.0	0.0	100	0.99	InbreedingCoeff	afr	0.5	8120.0	0.499982	56854.0	0.0365650	5686	0.207	654.0				13.01	0.940496		0	0	0			PDE4DIP	0.0	0.0	0.0	0.01	-13.0	-12.0	23.0	-12.0						0.984		2.651095876			behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144930596
5298	chr1	144930940	T	C	chr1:144930940	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.5	110_112	222	99.0	0/1	0.5	129_127	256	99.0			rs2147326,COSV57673001	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		1/40	NM_001350520.1:c.769A>G	NP_001337449.1:p.Lys257Glu		-1.0						.	.	.						31	0.97							0.5	125745.0	251490.0	0.0	100	1.0	InbreedingCoeff	nfe	0.5	56884.0	0.5	56884.0	0.0365521	5684	0.207	652.0				14.73	1.21444		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	0.0	-36.0	-21.0	31.0						0.984		18.016300198			behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144930940
5303	chr1	144931087	T	C	chr1:144931087	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/0	0.0	189_0	189	99.0	0/1	0.25	211_70	281	99.0			rs41315684,COSV57697851	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		1/40	NM_001350520.1:c.622A>G	NP_001337449.1:p.Thr208Ala		-1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.						31	0.98							0.218322	48960.0	224256.0	0.0	100	1.0	InbreedingCoeff	sas	0.316935	8594.0	0.230797	23160.0	0.0160253	2492	0.068	210.0				19.46	1.965706		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	22.0	-7.0	-23.0	20.0						0.984		2.651095876			behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144931087
5313	chr1	144931330	C	T	chr1:144931330	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.52	121_131	253	99.0	0/1	0.54	147_177	325	99.0			rs2762745,COSV57673006	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		1/40	NM_001350520.1:c.379G>A	NP_001337449.1:p.Ala127Thr		-1.0						.	.	.						31	0.96							0.5	125740.0	251480.0	0.0	100	1.0	InbreedingCoeff	nfe	0.5	56881.0	0.5	56881.0	0.0365585	5685	0.207	653.0				19.71	1.996595		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	-12.0	7.0	29.0	-31.0						0.984		18.016300198			behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144931330
5342	chr1	144931461	A	T	chr1:144931461	PDE4DIP	phosphodiesterase 4D interacting protein	SNV	0/1	0.28	152_61	215	99.0	0/1	0.28	161_63	224	99.0			rs41315685,COSV57695188	EXONIC	YES	NM_001350520.1	Transcript	protein_coding	missense_variant		1/40	NM_001350520.1:c.248T>A	NP_001337449.1:p.Leu83Gln		-1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.						32	0.97							0.238626	53130.0	222650.0	0.0	100	1.0	InbreedingCoeff	sas	0.33084	8756.0	0.246839	24791.0	0.0171635	2669	0.077	226.0				21.2	2.167414		0	0	0			PDE4DIP	0.0	0.0	0.0	0.0	48.0	-37.0	-39.0	-35.0						0.984		30.363341046			behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;fetal brain;occipital lobe;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;atrioventricular node;placenta;spinal cord;skeletal muscle;globus pallidus;thalamus;	.	cellular protein-containing complex assembly;regulation of Golgi organization	nucleus;cytoplasm;Golgi apparatus;centrosome;myofibril	protein binding;enzyme binding;protein-containing complex scaffold activity	ZNF512B[15231748];RTP5[25416956];MYOM1[unassigned1304];CDKN1A[21900206];KDM1A[23455924];SH2D4A[25416956];ZBTB24[unassigned1304];FHL1[21900206];PYGM[23414517];ENO1[21569246];PPP1R18[25416956];ENO3[21569246];CHCHD3[25416956];FAM74A4[25416956];ZNF408[25416956];ANKRD1[21569246];NEK2[21900206];TK1[21900206];PRKACA[23455922];PRKACB[23455922];ZNF124[unassigned1304];UTP14C[25416956];PIAS4[21988832];MYBPC3[21569246];CCDC198[25416956];MYBPC2[23414517];LMO4[25416956];AKTIP[23414517];MTUS2[25416956];ZFYVE21[25416956];TFIP11[25416956];AEN[25416956];KRT31[25416956];DYNLL1[26496610];MIF4GD[25416956];COMMD4[21569246];HAUS1[25416956];LENG1[25416956];SCNM1[25416956;unassigned1304];FAM161A[25416956];GOLGA8F[25416956];PRKAR1A[21569246];CEP57L1[unassigned1304];CLIP4[23414517];PFDN1[21900206];ZSCAN26[25416956];MAPRE3[unassigned1304];HIST1H2BH[30021884];TNIK[17043677];MAPRE1[25416956;26496610];TLN1[30021884];HOXB5[unassigned1304];LIN37[unassigned1304];ADH1B[21988832];CCDC146[unassigned1304];CWF19L2[unassigned1304];TULP3[23414517];UBE2J2[19549727];COX5A[21569246];ZBTB4[unassigned1304];OSGEP[21900206];SNX3[21569246];SDCBP[25416956;unassigned1304];KLC3[25416956];PRKAR2B[26496610];PRKAR2A[21569246];ZKSCAN3[unassigned1304];C1orf109[25416956;unassigned1304];TNNI3[21569246];SMN1[21900206];HOXC8[unassigned1304];ZNF587[unassigned1304];SNCA[21900206];PRNP[18482256];EGR2[26871637];NPM1[30021884];ZNF581[25416956;unassigned1304];NAA10[25416956;unassigned1304];CDC5L[17043677];IMMT[21900206;30021884];RYDEN[25416956];GADD45G[21900206];BYSL[25416956];GOLGA8DP[25416956];GFI1B[16713569];KRT18[21988832];FES[21900206];KRAS[21900206];PRPF31[25416956;25910212];ZNF414[unassigned1304];LAMTOR3[21900206];ZNF410[unassigned1304];FAM50B[unassigned1304];ZNF696[unassigned1304];BCAR1[28007913];	144931461
5746	chr1	145273302	A	G	chr1:145273302	NOTCH2NL		SNV	0/1	0.24	317_102	419	99.0	0/0	0.0	36_0	36	99.0			rs10910778,COSV61245492	EXONIC	YES	NM_001364006.1	Transcript	protein_coding	synonymous_variant		3/5	NM_001364006.1:c.195A>G	NP_001350935.1:p.Arg65%3D		1.0														11	0.16							0.31686	35764.0	112870.0	0.0	100	1.0	InbreedingCoeff	eas	0.385725	3156.0	0.342253	16871.0	0.0039099	608	0.057	166.0				12.43	0.861974		0	0	0			NOTCH2NL	0.0	0.0	0.01	0.0	-1.0	11.0	-47.0	11.0						0.595	0.0													145273302
5751	chr1	145273345	T	C	chr1:145273345	NOTCH2NL		SNV	0/1	0.26	406_140	546	99.0	0/0	0.0	36_0	36	99.0			rs10910779,COSV61245674	EXONIC	YES	NM_001364006.1	Transcript	protein_coding	missense_variant		3/5	NM_001364006.1:c.238T>C	NP_001350935.1:p.Ser80Pro		1.0														11	0.17							0.355107	40267.0	113394.0	0.0	100	1.0	InbreedingCoeff	eas	0.419084	3698.0	0.382087	18856.0	0.0024565	382	0.079	234.0				18.43	1.830846	0.062	1	9	10	fathmm-MKL_coding_pred	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	NOTCH2NL	0.0	0.0	0.0	0.0	-23.0	-32.0	-11.0	-32.0						0.595	0.0		0.966	0.082										145273345
5767	chr1	145281408	C	T	chr1:145281408	NOTCH2NL		SNV	0/1	0.21	341_92	433	99.0	0/0	0.0	33_0	33	99.0			rs3927729,COSV61246008	EXONIC	YES	NM_001364006.1	Transcript	protein_coding	missense_variant		4/5	NM_001364006.1:c.377C>T	NP_001350935.1:p.Pro126Leu		1.0														12	0.25							0.37818	50869.0	134510.0	0.0	100	1.0	InbreedingCoeff	eas	0.431957	4666.0	0.4036	24124.0	0.0020964	326	0.112	345.0				25.7	3.684163	0.734	7	3	10	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	MetaRNN_pred,PrimateAI_pred,ClinPred_pred	NOTCH2NL	0.0	0.0	0.0	0.0	-34.0	41.0	14.0	0.0						0.595	0.0		1.0	0.915										145281408
5774	chr1	145281613	C	A	chr1:145281613	NOTCH2NL		SNV	0|1	0.21	346_92	438	99.0	0/0	0.0	58_0	58	99.0			rs12120756,COSV61246020	EXONIC	YES	NM_001364006.1	Transcript	protein_coding	missense_variant		4/5	NM_001364006.1:c.582C>A	NP_001350935.1:p.Ser194Arg		1.0														9	0.13							0.38274	51079.0	133456.0	0.0	100	1.0	InbreedingCoeff	eas	0.436825	4529.0	0.40667	23961.0	0.0034469	536	0.128	382.0				17.76	1.740253	0.112	0	10	10		MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred	NOTCH2NL	0.0	0.0	0.0	0.0	-16.0	41.0	2.0	-18.0						0.595	0.0		0.173	0.056										145281613
5780	chr1	145281633	C	A	chr1:145281633	NOTCH2NL		SNV	0|1	0.21	333_86	419	99.0	0/0	0.0	58_0	58	99.0			rs28576333,COSV61245083	EXONIC	YES	NM_001364006.1	Transcript	protein_coding	missense_variant		4/5	NM_001364006.1:c.602C>A	NP_001350935.1:p.Pro201His		1.0										0.0	0.0	5644.0	0.0	8	0.12	AC0_AS_VQSR				0.0	0.0	0.365157	43637.0	119502.0	0.0	100	1.0	InbreedingCoeff	sas	0.413522	6532.0	0.389785	20109.0	0.0019935	310	0.123	366.0				24.4	3.323894	0.695	3	7	10	MutationTaster_pred,PrimateAI_pred,fathmm-MKL_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	NOTCH2NL	0.0	0.0	0.0	0.0	0.0	21.0	-7.0	-18.0						0.595	0.0		1.0	0.915										145281633
5792	chr1	145293515	G	G	chr1:145293515	NBPF10	NBPF member 10	SNV	0/0	0.0	138_0	138	99.0	0/1	0.21	166_45	212	99.0			rs12565078,COSV61245037	EXONIC	YES	NM_001039703.6	Transcript	protein_coding	synonymous_variant		1/86	NM_001039703.6:c.110A>G	NP_001034792.4:p.Ser37%3D		1.0						.	.	.		0.00047278	68.0	143830.0	4.0	21	0.57	PASS	amr	0.00187292	27.0	0.000261812	17.0	0.29197	39994.0	136980.0	0.0	100	1.0	InbreedingCoeff_RF	eas	0.380803	3872.0	0.326831	19704.0	0.0020064	312	0.046	132.0				0.014	-0.743632	0.018	0	0	0			NBPF10	0.0	0.0	0.0	0.0	-28.0	9.0	-9.0	-2.0							0.0				.			.	.	.	cytoplasm	RNA binding	NEK4[25798074];	145293515
5811	chr1	145296478	G	T	chr1:145296478	NBPF10	NBPF member 10	SNV	0/1	0.19	173_40	214	99.0	0/1	0.43	81_62	143	99.0			rs6663523,COSV61245165	EXONIC	YES	NM_001039703.6	Transcript	protein_coding	missense_variant		3/86	NM_001039703.6:c.400G>T	NP_001034792.4:p.Asp134Tyr		1.0	.,.,.,.,.					.	.	.						12	0.2							0.502464	109910.0	218742.0	3075.0	100	0.99	InbreedingCoeff	eas	0.530194	9447.0	0.496696	47809.0	0.0131122	2039	0.032	100.0				13.68	1.037915	0.012	1	9	10	SIFT	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	NBPF10	0.0	0.02	0.0	0.0	15.0	-15.0	-2.0	-15.0							0.0		0.0	-1.835	.			.	.	.	cytoplasm	RNA binding	NEK4[25798074];	145296478
5926	chr1	145368518	C	T	chr1:145368518	NBPF10	NBPF member 10	SNV	0/1	0.18	105_24	130	99.0	0/1	0.24	88_28	116	99.0			rs61813437,COSV61656315	EXONIC	YES	NM_001039703.6	Transcript	protein_coding	missense_variant		86/86	NM_001039703.6:c.10715C>T	NP_001034792.4:p.Ser3572Leu		1.0						.	.	.	23940540					0	0.0							0.00342483	676.0	197382.0	0.0	100	1.0	PASS	amr	0.00701222	171.0	0.000287497	27.0	0.0000386	6	0.008	24.0				18.86	1.887004		1	0	1	SIFT		NBPF10	0.0	0.0	0.0	0.0	32.0	-31.0	3.0	41.0							0.0				.			.	.	.	cytoplasm	RNA binding	NEK4[25798074];	145368518
5953	chr1	145561866	G	A	chr1:145561866	ANKRD35	ankyrin repeat domain 35	SNV	0/0	0.0	34_0	34	99.0	0/1	0.48	72_68	142	99.0			rs781970487,COSV100841732	EXONIC	YES	NM_144698.5	Transcript	protein_coding	missense_variant		10/14	NM_144698.5:c.1554G>A	NP_653299.4:p.Met518Ile		1.0						.	.	.		3.94146e-05	6.0	152228.0	0.0	32	0.97	PASS	amr	0.000196181	3.0	4.40943e-05	3.0	2.79736e-05	7.0	250236.0	0.0	100	0.99	PASS	amr	0.000115674	4.0	2.6477e-05	3.0	0.0000257	4	0.001	2.0				14.5	1.172481		0	2	2		SIFT,PolyPhen	ANKRD35	0.0	0.0	0.0	0.0	35.0	-49.0	-49.0	22.0						0.993	0.0	0.000000000			.			superior cervical ganglion;trigeminal ganglion;atrioventricular node;bone marrow;	.	.	.	.	VIM[21900206];	145561866
5991	chr1	146395447	A	G	chr1:146395447	NBPF14	NBPF member 14	SNV	0/1	0.46	15_13	28	99.0	0/1	0.63	7_12	19	99.0			rs587734201,COSV58766968	EXONIC	YES	NM_015383.2	Transcript	protein_coding	missense_variant		1/66	NM_015383.2:c.106A>G	NP_056198.2:p.Arg36Gly		1.0	.,.,.,.,.,.					.	.	.		1.37762e-05	2.0	145178.0	0.0	20	0.51	PASS	eas	0.000206271	1.0	1.49952e-05	1.0	0.456201	22290.0	48860.0	0.0	1	0.24	InbreedingCoeff_RF	amr	0.490825	4654.0	0.418361	8189.0	0.0074918	1165	0.009	27.0				8.559	0.415113	0.183	1	12	13	PROVEAN_pred	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	NBPF12	0.0	0.0	0.0	0.0	-24.0	2.0	-5.0	-26.0									0.004	0.416	.			.	.	.	cytoplasm	.	NEK4[25798074];MYB[20195357];	146395447
6386	chr1	147091005	C	T	chr1:147091005	BCL9	B cell CLL/lymphoma 9	SNV	0/1	0.45	98_82	181	99.0	0/0	0.0	34_0	34	99.0			rs61729410,COSV52346496	EXONIC	YES	NM_004326.4	Transcript	protein_coding	synonymous_variant		8/10	NM_004326.4:c.1044C>T	NP_004317.2:p.Pro348%3D		1.0						.	.	.		0.00080837	123.0	152158.0	0.0	32	0.97	PASS	sas	0.00518457	25.0	0.00101435	69.0	0.00145314	364.0	250492.0	4.0	93	0.97	PASS	sas	0.00637922	195.0	0.00125513	142.0	0.0014533	226	0.001	3.0	0.00184	21.0		0.608	-0.225091		0	0	0			BCL9	0.0	0.0	0.0	0.0	16.0	-37.0	21.0	-37.0						0.25	0.83	66.874955197			muscle phenotype; 			.	.	myotube differentiation involved in skeletal muscle regeneration;regulation of transforming growth factor beta receptor signaling pathway;somatic stem cell population maintenance;skeletal muscle cell differentiation;positive regulation of transcription by RNA polymerase II;canonical Wnt signaling pathway;beta-catenin-TCF complex assembly	nucleoplasm;cis-Golgi network;beta-catenin-TCF complex	transcription coactivator activity;protein binding;beta-catenin binding	PYGO1[18498752];PYGO2[17113272;21399610];CTNNB1[11955446];TCF4[11955446];CDC73[16630820;17113272];	147091005
6408	chr1	148252111	C	T	chr1:148252111	NBPF26	NBPF member 26	SNV	0/1	0.39	39_25	64	99.0	0/1	0.31	54_24	78	99.0			rs1142502,COSV65005900	EXONIC	YES	NM_001351372.1	Transcript	protein_coding	missense_variant		30/30	NM_001351372.1:c.3775G>A	NP_001338301.1:p.Gly1259Ser		-1.0	Neuroblastoma breakpoint family (NBPF) domain&Neuroblastoma breakpoint family (NBPF) domain&Neuroblastoma breakpoint family (NBPF) domain,.,Neuroblastoma breakpoint family (NBPF) domain&Neuroblastoma breakpoint family (NBPF) domain&Neuroblastoma breakpoint family (NBPF) domain,Neuroblastoma breakpoint family (NBPF) domain&Neuroblastoma breakpoint family (NBPF) domain&Neuroblastoma breakpoint family (NBPF) domain,Neuroblastoma breakpoint family (NBPF) domain&Neuroblastoma breakpoint family (NBPF) domain&Neuroblastoma breakpoint family (NBPF) domain,Neuroblastoma breakpoint family (NBPF) domain&Neuroblastoma breakpoint family (NBPF) domain&Neuroblastoma breakpoint family (NBPF) domain,.					.	.	.		7.91306e-05	12.0	151648.0	0.0	31	0.93	PASS	sas	0.00105042	5.0	8.82535e-05	6.0	0.0193291	2963.0	153292.0	0.0	96	0.99	PASS	amr	0.0363411	849.0	0.0133315	960.0	0.0000193	3	0.046	120.0				0.234	-0.364499	0.033	0	10	10		MetaLR_pred,MetaSVM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	NBPF20	0.23	0.0	0.0	0.0	-2.0	7.0	-2.0	0.0									0.0	-4.005	.			.	.	.	cytoplasm	.	.	148252111
6413	chr1	148579625	T	C	chr1:148579625	NBPF15	NBPF member 15	SNV	0/1	0.2	12_3	15	45.0	0/0	0.0	9_0	9	27.0			rs9438309,COSV64992400	EXONIC	YES	NM_001385448.1	Transcript	protein_coding	synonymous_variant		4/18	NM_001385448.1:c.195T>C	NP_001372377.1:p.Asp65%3D		1.0						.	.	.		5.34681e-05	8.0	149622.0	0.0	32	0.93	AS_VQSR	eas	0.00041511	2.0	4.45289e-05	3.0	0.000669808	112.0	167212.0	0.0	17	0.44	RF	afr	0.00709291	71.0	0.000281718	23.0	0.0002958	46	0.003	11.0				0.179	-0.402139		0	0	0			NBPF15	0.0	0.0	0.0	0.0	-19.0	-10.0	-39.0	-19.0							0.12				.			.	.	.	cytoplasm	.	PACS2[23455924];NEK4[25798074];F2RL1[28298427];	148579625
6626	chr1	150208111	G	A	chr1:150208111	ANP32E	acidic nuclear phosphoprotein 32 family member E	SNV	0/0	0.0	33_0	33	99.0	0/1	0.56	39_50	89	99.0			rs77006810	EXONIC	YES	NM_030920.5	Transcript	protein_coding	synonymous_variant		1/7	NM_030920.5:c.24C>T	NP_112182.1:p.Asn8%3D		-1.0						.	.	.		0.00467751	711.0	152004.0	5.0	32	0.96	PASS	nfe	0.00794305	540.0	0.00794305	540.0	0.0045993	1115.0	242428.0	3.0	32	0.73	PASS	nfe	0.00754409	823.0	0.00754409	823.0	0.0044050	685	0.009	27.0				14.18	1.118052		0	0	0			ANP32E	0.0	0.0	0.0	0.01	-12.0	46.0	-5.0	-30.0						0.58	0.98	31.605547965			normal phenotype; mortality/aging ; behavior/neurological phenotype ; 			prefrontal cortex;trigeminal ganglion;superior cervical ganglion;cerebellum peduncles;cerebellum;	.	negative regulation of catalytic activity;histone exchange	Swr1 complex;nucleus;cytoplasmic vesicle	phosphatase inhibitor activity;histone binding	SMAD2[20195357];NR4A2[20195357];HIST1H3A[29568061];UBA5[26496610];LMNA[29568061];FOS[20195357];HSCB[28380382];OTUB1[26752685];KPNA1[26496610];	150208111
6667	chr1	150443553	G	A	chr1:150443553	RPRD2	regulation of nuclear pre-mRNA domain containing 2	SNV	0/0	0.0	39_0	39	99.0	0/1	0.53	76_87	163	99.0			rs200740470	EXONIC	YES	NM_015203.5	Transcript	protein_coding	missense_variant		11/11	NM_015203.5:c.2129G>A	NP_056018.2:p.Arg710His		1.0	.,.					.	.	.		0.000269492	41.0	152138.0	0.0	32	0.96	PASS	nfe	0.000470381	32.0	0.000470381	32.0	0.000309033	77.0	249164.0	0.0	66	1.0	PASS	nfe	0.000513402	58.0	0.000513402	58.0	0.0002701	42	0.0	1.0				24.1	3.204729	0.347	5	15	20	SIFT,LRT_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred	PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	RPRD2	0.0	0.0	0.0	0.0	13.0	-9.0	13.0	43.0							1.0	0.000000000	1.0	1.176	.			.	.	mRNA 3'-end processing;snRNA transcription by RNA polymerase II	nucleoplasm;RNA polymerase II, holoenzyme	RNA polymerase II complex binding	UPF1[15231747];WWOX[16055720];DYNC1H1[26496610];MDC1[29656893];JUN[25609649];CSNK2A1[22113938];NCBP1[26496610];CTR9[26496610];SUPT5H[26496610];PPP1CA[22321011];MTNR1B[26514267];MYC[21150319];LEO1[26496610];POLR2G[26496610];HIF1AN[26972000];B9D2[26638075];HIST1H1B[30021884];	150443553
6679	chr1	150470990	C	T	chr1:150470990	TARS2	threonyl-tRNA synthetase 2, mitochondrial	SNV	0/0	0.0	34_0	34	99.0	0/1	0.33	41_20	61	99.0			rs41264465	EXONIC	YES	NM_025150.5	Transcript	protein_coding	synonymous_variant		11/18	NM_025150.5:c.1251C>T	NP_079426.2:p.Ala417%3D		1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_specified|not_provided	Combined oxidative phosphorylation deficiency 21, 615918 (3), Autosomal recessive	Combined oxidative phosphorylation defect type 21	Disease-causing germline mutation(s) in	Global developmental delay;Generalized hypotonia;Hypoplasia of the corpus callosum;Congenital onset;Hepatic steatosis;Autosomal recessive inheritance;Limb hypertonia;Muscular hypotonia of the trunk;Increased serum lactate		0.00527706	803.0	152168.0	5.0	32	0.96	PASS	nfe	0.00906953	617.0	0.00906953	617.0	0.00528592	1183.0	223802.0	4.0	31	0.69	PASS	nfe	0.0085543	902.0	0.0085543	902.0	0.0050352	783	0.011	35.0				12.65	0.891586		0	0	0			TARS2	0.1	0.03	0.0	0.0	12.0	-12.0	12.0	-21.0						0.405	0.0	18.688846410			.			.	Glycine, serine and threonine metabolism;Aminoacyl-tRNA biosynthesis	threonyl-tRNA aminoacylation;mitochondrial threonyl-tRNA aminoacylation;aminoacyl-tRNA metabolism involved in translational fidelity	cellular_component;cytoplasm;mitochondrial matrix	aminoacyl-tRNA editing activity;threonine-tRNA ligase activity;ATP binding;protein homodimerization activity	EIF4A2[17353931];PPP1R15A[29109149];JUN[25609649];FKBPL[25036637];ARL6IP1[unassigned1304];TARSL2[unassigned1304];FASTKD3[20869947];AHSA1[25036637];MRPL58[20186120];HSCB[28380382];COQ10A[27499296];TNFRSF10D[unassigned1304];HSPD1[29568061];COX6B1[27499296];SYPL1[unassigned1304];SLC17A9[unassigned1304];CDC37[25036637];CHORDC1[25036637];ASB6[unassigned1304];PLIN3[unassigned1304];FKBP7[unassigned1304];C6orf203[27499296];PDK1[29568061];	150470990
6943	chr1	151496009	A	C	chr1:151496009	CGN	cingulin	SNV	0/1	0.35	55_29	84	99.0	0/0	0.0	34_0	34	99.0			rs145912252	EXONIC	YES	NM_020770.3	Transcript	protein_coding	missense_variant		6/21	NM_020770.3:c.1240A>C	NP_065821.1:p.Lys414Gln		1.0						.	.	.		0.000525603	80.0	152206.0	1.0	32	0.98	PASS	amr	0.00248724	38.0	0.00039686	27.0	0.000356702	89.0	249508.0	0.0	30	0.81	PASS	amr	0.00117178	40.0	0.000362928	41.0	0.0003022	47	0.003	11.0				20.1	2.040648	0.053	2	14	16	fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	CGN	0.0	0.0	0.0	0.0	3.0	-18.0	-2.0	41.0						0.782	0.0	0.000000000	0.988	1.207	homeostasis/metabolism phenotype; craniofacial phenotype; growth/size/body region phenotype; digestive/alimentary phenotype; nervous system phenotype ; limbs/digits/tail phenotype; cardiovascular system phenotype ; mortality/aging ; embryo phenotype; 			.	Tight junction	transforming growth factor beta receptor signaling pathway;biological_process	plasma membrane;bicellular tight junction;myosin complex;cell junction	motor activity;actin binding;protein binding;cadherin binding	CRTC2[unassigned1312];PANK2[unassigned1312];PPP1R13B[unassigned1304];CRTC3[unassigned1312];RTKN[unassigned1312];YWHAB[17353931];MAST3[unassigned1312];DENND1A[unassigned1312];CBY1[unassigned1312];ZBTB21[unassigned1312];TESK2[unassigned1312];CWC25[unassigned1312];MTFR1L[unassigned1312];RPTOR[unassigned1312];SYDE1[unassigned1312];SIPA1L1[unassigned1312];SH3PXD2A[unassigned1312];MYO18A[26496610];KIF13B[unassigned1312];KIF1C[unassigned1312];KIF1B[unassigned1312];SYNPO[26496610];YWHAG[15324660;17353931];YWHAH[17979178];RALGPS2[unassigned1312];MAGI1[unassigned1312];KSR1[unassigned1312];NAV1[unassigned1312];KCTD3[unassigned1312];GAB2[unassigned1312];CDC25C[unassigned1312];YWHAZ[15161933];TANC2[unassigned1312];CDC25B[unassigned1312];LATS1[24255178];TIAM1[unassigned1312];GIGYF1[unassigned1312];TBC1D1[unassigned1312];MELK[unassigned1312];ZNF638[unassigned1312];EIF4E2[unassigned1312];PHLDB2[unassigned1312];DBN1[26496610];HDAC4[unassigned1312];HDAC5[unassigned1312];MAPKAP1[unassigned1312];PPM1H[unassigned1312];AGAP1[unassigned1312];DLST[29128334];IQGAP1[26496610];RASAL2[unassigned1312];GIGYF2[unassigned1312];CAMSAP2[unassigned1312];HDAC7[unassigned1312];LIMA1[unassigned1312];LARP1[unassigned1312];FGD6[unassigned1312];INPP5E[unassigned1312];MICALL1[unassigned1312];TP53BP2[unassigned1304];MAP3K21[unassigned1312];SFN[15778465];MYH11[26496610];SRGAP2[unassigned1312];RAB11FIP2[unassigned1312];NADK[unassigned1312];SRSF12[unassigned1312];STARD13[unassigned1312];OSBPL6[unassigned1312];CSNK1A1[unassigned1312];DENND4A[unassigned1312];DENND4C[unassigned1312];PTPN13[unassigned1312];PTPN14[unassigned1312];ESR2[21182203];PLEKHA7[unassigned1312;28877994];DCLK1[unassigned1312];TJP1[12023291];SH3RF3[unassigned1312];WEE1[unassigned1312];LRFN1[unassigned1312];MYO5C[26496610];CAPZA2[26496610];NF1[unassigned1312];LPIN3[unassigned1312];CDK16[unassigned1312];DCP1B[unassigned1312];	151496009
6948	chr1	151733380	A		chr1:151733380	MRPL9	mitochondrial ribosomal protein L9	deletion	0/1	0.21	7_3	14	18.0	0/1	0.44	2_4	9	44.0			rs755031728	SPLICING	YES	NM_031420.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	5/6		NM_031420.4:c.589-5del			-1.0						.	.	.	24033266	0.00219682	163.0	74198.0	1.0	0	0.3	PASS	sas	0.0058309	12.0	0.000409878	16.0					20	0.53							0.0000965,0.0045144	15,702						0.203	-0.384339		0	0	0			MRPL9	0.0	0.0	0.0	0.0	-37.0	-4.0	-4.0	-7.0						0.729	0.05				.			.	.	translation;mitochondrial translational elongation;mitochondrial translational termination	mitochondrion;mitochondrial inner membrane;mitochondrial ribosome;mitochondrial large ribosomal subunit	RNA binding;structural constituent of ribosome;protein binding	ITSN2[26496610];MRPL38[26496610];MRPL39[26496610];YBX1[22118625];MRPL37[26496610];MRPL34[26496610];SAT1[19060904];MRPL35[26496610];MRPL32[26496610];TMEM92[26496610];MRPL33[26496610];MRPL41[26496610];MRPL4[26496610];MRPL3[26496610];MRPL42[26496610];MRPL2[26496610];MRPL1[26496610];MRPL40[26496610];TK2[26496610];MRPL49[26496610];MRPS18A[26496610];MRPL47[26496610];MRPL48[26496610];MRPL45[26496610];MRPL46[26496610];MRPL43[26496610];MRPL44[26496610];MRPL52[26496610];MRPL53[26496610];MRPL50[26496610];MRPL51[26496610];CDC37[unassigned1304];THAP9[26496610];SDHAF4[27499296];AURKAIP1[29568061];MRPL18[26496610];MGST3[29568061];MRPL19[26496610];MRPL16[26496610];MRPL17[26496610];MRPL58[20186120;26496610];MRPL14[26496610];MRPS30[26496610];MRPL15[26496610];MRPL12[26496610];MRPL13[26496610];MRPL54[26496610];MRPL10[26496610];HSPD1[29568061];NLN[26496610];MRPL20[26496610];SLX4[19596235];MICALL1[26496610];CA12[16169070];GADD45GIP1[26496610];FAM9B[25416956];JUP[26496610];MRPL27[26496610];MRPL28[26496610];MRPL23[26496610];MRPL24[26496610];MRPL21[26496610];MRPL22[26496610];MRPL30[26496610];HNRNPK[unassigned1304];TRMT61B[29568061];EIF4G1[26496610];	151733379
6964	chr1	152185818	CA		chr1:152185818-152185819	HRNR	hornerin	deletion	1|1	1.0	0_3	3	9.0	0/0	0.0	50_0	50	99.0			rs768388262	EXONIC	YES	NM_001009931.3	Transcript	protein_coding	frameshift_variant		3/3	NM_001009931.3:c.8286_8287del	NP_001009931.1:p.His2762GlnfsTer9		-1.0						.	.	.		0.00597741	361.0	60394.0	1.0	0	0.14	AS_VQSR	amr	0.00758329	61.0	0.00709752	123.0	0.117582	15803.0	134400.0	7788.0	26	0.53	RF	nfe	0.193548	8753.0	0.193548	8753.0	0.0000064	1	0.001	4.0				22.6	2.542416		0	0	0			HRNR	0.0	0.0	0.0	0.0	-1.0	26.0	-2.0	-39.0							0.0				.			.	.	keratinization;cell envelope organization;neutrophil degranulation;establishment of skin barrier	cornified envelope;extracellular region;nucleus;cytoplasm;azurophil granule lumen;keratohyalin granule;perinuclear region of cytoplasm;collagen-containing extracellular matrix;extracellular exosome	calcium ion binding;structural constituent of epidermis;transition metal ion binding	OTUD4[19615732];IQCB1[21565611];PPP1R16B[28330616];GSTK1[17353931];PDHA1[29128334];WTAP[29507755];NEK4[25798074];PINX1[17353931];METTL3[29507755];FOXN3[25609649];PARK7[29128334];YWHAZ[15161933];SOD1[29128334];NR5A1[24635384];COQ2[29128334];METTL14[29507755];RAD51C[17353931];SOAT1[29128334];AGO2[17932509];BTK[21080425];CDK1[29128334];VDAC1[29128334];CDKN3[28330616];	152185817
6972	chr1	152193423	A	G	chr1:152193423	HRNR	hornerin	SNV	0/0	0.0	60_0	60	99.0	0/1	0.49	46_45	91	99.0			rs769944159	EXONIC	YES	NM_001009931.3	Transcript	protein_coding	missense_variant		3/3	NM_001009931.3:c.682T>C	NP_001009931.1:p.Ser228Pro		-1.0						.	.	.		3.95752e-05	6.0	151610.0	0.0	34	0.97	PASS	amr	0.000262329	4.0	0.0	0.0	2.78334e-05	7.0	251496.0	0.0	100	1.0	PASS	amr	0.000144542	5.0	1.75793e-05	2.0	0.0000193	3						11.87	0.789572	0.067	2	17	19	SIFT,MutationAssessor_pred	PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HRNR	0.0	0.0	0.0	0.0	31.0	39.0	-45.0	6.0							0.0		0.0	-0.589	.			.	.	keratinization;cell envelope organization;neutrophil degranulation;establishment of skin barrier	cornified envelope;extracellular region;nucleus;cytoplasm;azurophil granule lumen;keratohyalin granule;perinuclear region of cytoplasm;collagen-containing extracellular matrix;extracellular exosome	calcium ion binding;structural constituent of epidermis;transition metal ion binding	OTUD4[19615732];IQCB1[21565611];PPP1R16B[28330616];GSTK1[17353931];PDHA1[29128334];WTAP[29507755];NEK4[25798074];PINX1[17353931];METTL3[29507755];FOXN3[25609649];PARK7[29128334];YWHAZ[15161933];SOD1[29128334];NR5A1[24635384];COQ2[29128334];METTL14[29507755];RAD51C[17353931];SOAT1[29128334];AGO2[17932509];BTK[21080425];CDK1[29128334];VDAC1[29128334];CDKN3[28330616];	152193423
6977	chr1	152276762	T	A	chr1:152276762	FLG	filaggrin	SNV	0/0	0.0	38_0	38	99.0	0|1	0.14	42_7	49	99.0			rs12732870,COSV104425336,COSV64245333	EXONIC	YES	NM_002016.2	Transcript	protein_coding	missense_variant		3/3	NM_002016.2:c.10600A>T	NP_002007.1:p.Asn3534Tyr		-1.0					Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	.	.	Eczematoid dermatitis;Autosomal dominant inheritance;Asthma;Ichthyosis		0.0023146	302.0	130476.0	3.0	28	0.8	AS_VQSR	sas	0.00920568	35.0	0.00277506	176.0	0.000197949	49.0	247538.0	18.0	100	1.0	RF	sas	0.000335661	10.0	0.00017716	20.0	0.0007524	117			0.00651	62.0		8.817	0.439979	0.085	1	19	20	PolyPhen	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FLG	0.0	0.0	0.03	0.0	2.0	39.0	2.0	-14.0						0.995			0.0	-2.783	.			ciliary ganglion;skin;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	multicellular organism development;peptide cross-linking;keratinocyte differentiation;establishment of skin barrier;cornification	cornified envelope;nucleus;cytosol;intermediate filament;keratohyalin granule;intracellular membrane-bounded organelle;collagen-containing extracellular matrix	structural molecule activity;calcium ion binding;protein binding;structural constituent of epidermis;transition metal ion binding	MAP1LC3B[20562859];METTL14[29507755];SLX4[19596235];MAK[27173435;unassigned1312];USP1[19615732];KLK5[23629652];VHL[17353931];MAPT[26402096];FLNC[30021884];STK4[23386615];ESR2[21182203;25604459];	152276762
6978	chr1	152276777	G	A	chr1:152276777	FLG	filaggrin	SNV	0/0	0.0	38_0	38	99.0	0|1	0.13	41_6	47	99.0			rs12746216,COSV64250262	EXONIC	YES	NM_002016.2	Transcript	protein_coding	missense_variant		3/3	NM_002016.2:c.10585C>T	NP_002007.1:p.Pro3529Ser		-1.0					Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	.	.	Eczematoid dermatitis;Autosomal dominant inheritance;Asthma;Ichthyosis		0.00247581	324.0	130866.0	1.0	29	0.85	AS_VQSR	sas	0.00762943	28.0	0.00107087	68.0	0.000132428	33.0	249192.0	14.0	100	1.0	PASS	eas	0.000281183	5.0	0.000114863	13.0	0.0009968	155	0.001	3.0	0.00441	42.0		0.224	-0.370845	0.04	0	17	17		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FLG	0.0	0.0	0.0	0.0	-5.0	34.0	2.0	-13.0						0.995			0.0	-0.283	.			ciliary ganglion;skin;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	multicellular organism development;peptide cross-linking;keratinocyte differentiation;establishment of skin barrier;cornification	cornified envelope;nucleus;cytosol;intermediate filament;keratohyalin granule;intracellular membrane-bounded organelle;collagen-containing extracellular matrix	structural molecule activity;calcium ion binding;protein binding;structural constituent of epidermis;transition metal ion binding	MAP1LC3B[20562859];METTL14[29507755];SLX4[19596235];MAK[27173435;unassigned1312];USP1[19615732];KLK5[23629652];VHL[17353931];MAPT[26402096];FLNC[30021884];STK4[23386615];ESR2[21182203;25604459];	152276777
6979	chr1	152277309	G	A	chr1:152277309	FLG	filaggrin	SNV	0/0	0.0	38_0	38	99.0	0/1	0.37	78_45	123	99.0			rs34687484	EXONIC	YES	NM_002016.2	Transcript	protein_coding	synonymous_variant		3/3	NM_002016.2:c.10053C>T	NP_002007.1:p.Asp3351%3D		-1.0					Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	.	.	Eczematoid dermatitis;Autosomal dominant inheritance;Asthma;Ichthyosis		0.00355432	540.0	151928.0	3.0	29	0.91	PASS	sas	0.00584795	28.0	0.00542807	369.0	0.00390485	982.0	251482.0	11.0	100	1.0	PASS	sas	0.00571634	175.0	0.00511612	582.0	0.0036076	561	0.005	17.0	0.00567	54.0		0.002	-1.039605		0	0	0			FLG	0.0	0.0	0.0	0.0	24.0	-28.0	36.0	-5.0						0.995					.			ciliary ganglion;skin;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	multicellular organism development;peptide cross-linking;keratinocyte differentiation;establishment of skin barrier;cornification	cornified envelope;nucleus;cytosol;intermediate filament;keratohyalin granule;intracellular membrane-bounded organelle;collagen-containing extracellular matrix	structural molecule activity;calcium ion binding;protein binding;structural constituent of epidermis;transition metal ion binding	MAP1LC3B[20562859];METTL14[29507755];SLX4[19596235];MAK[27173435;unassigned1312];USP1[19615732];KLK5[23629652];VHL[17353931];MAPT[26402096];FLNC[30021884];STK4[23386615];ESR2[21182203;25604459];	152277309
6990	chr1	152281911	T	C	chr1:152281911	FLG	filaggrin	SNV	0/0	0.0	34_0	34	99.0	0|1	0.13	129_19	148	99.0			rs546421577,COSV64247184	EXONIC	YES	NM_002016.2	Transcript	protein_coding	synonymous_variant		3/3	NM_002016.2:c.5451A>G	NP_002007.1:p.Pro1817%3D		-1.0					Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	.	.	Eczematoid dermatitis;Autosomal dominant inheritance;Asthma;Ichthyosis		0.00223703	331.0	147964.0	0.0	29	0.89	AS_VQSR	sas	0.00521779	23.0	0.00139711	92.0	0.000570332	142.0	248978.0	0.0	100	1.0	PASS	afr	0.00295894	48.0	0.00015956	18.0	0.0000836	13	0.0	1.0	0.00808	77.0		0.006	-0.852045		0	0	0			FLG	0.0	0.0	0.0	0.0	26.0	-2.0	26.0	-2.0						0.995					.			ciliary ganglion;skin;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	multicellular organism development;peptide cross-linking;keratinocyte differentiation;establishment of skin barrier;cornification	cornified envelope;nucleus;cytosol;intermediate filament;keratohyalin granule;intracellular membrane-bounded organelle;collagen-containing extracellular matrix	structural molecule activity;calcium ion binding;protein binding;structural constituent of epidermis;transition metal ion binding	MAP1LC3B[20562859];METTL14[29507755];SLX4[19596235];MAK[27173435;unassigned1312];USP1[19615732];KLK5[23629652];VHL[17353931];MAPT[26402096];FLNC[30021884];STK4[23386615];ESR2[21182203;25604459];	152281911
6994	chr1	152282101	T	C	chr1:152282101	FLG	filaggrin	SNV	0/0	0.0	34_0	34	99.0	0|1	0.16	116_22	138	99.0			rs761680413,COSV64239131	EXONIC	YES	NM_002016.2	Transcript	protein_coding	missense_variant		3/3	NM_002016.2:c.5261A>G	NP_002007.1:p.Gln1754Arg		-1.0					Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	.	.	Eczematoid dermatitis;Autosomal dominant inheritance;Asthma;Ichthyosis		0.00182688	271.0	148340.0	0.0	30	0.92	AS_VQSR	sas	0.00875617	39.0	0.00220331	145.0	6.80218e-05	17.0	249920.0	0.0	100	1.0	PASS	sas	0.000165662	5.0	6.18276e-05	7.0	0.0000064	1			0.00913	87.0		0.032	-0.63782	0.095	0	18	18		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FLG	0.0	0.0	0.0	0.0	-44.0	-2.0	-43.0	-7.0						0.995			0.0	-2.317	.			ciliary ganglion;skin;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	multicellular organism development;peptide cross-linking;keratinocyte differentiation;establishment of skin barrier;cornification	cornified envelope;nucleus;cytosol;intermediate filament;keratohyalin granule;intracellular membrane-bounded organelle;collagen-containing extracellular matrix	structural molecule activity;calcium ion binding;protein binding;structural constituent of epidermis;transition metal ion binding	MAP1LC3B[20562859];METTL14[29507755];SLX4[19596235];MAK[27173435;unassigned1312];USP1[19615732];KLK5[23629652];VHL[17353931];MAPT[26402096];FLNC[30021884];STK4[23386615];ESR2[21182203;25604459];	152282101
6996	chr1	152282104	C	T	chr1:152282104	FLG	filaggrin	SNV	0/0	0.0	34_0	34	99.0	0|1	0.13	120_18	138	99.0			rs762948644	EXONIC	YES	NM_002016.2	Transcript	protein_coding	missense_variant		3/3	NM_002016.2:c.5258G>A	NP_002007.1:p.Gly1753Asp		-1.0					Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	.	.	Eczematoid dermatitis;Autosomal dominant inheritance;Asthma;Ichthyosis		0.00123959	184.0	148436.0	0.0	30	0.92	AS_VQSR	sas	0.00563317	25.0	0.00153295	101.0	0.0	0.0	250118.0	0.0	100	1.0	AC0_RF				0.0	0.0	0.0000064	1			0.00577	55.0		15.94	1.441607	0.147	5	15	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,PROVEAN_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FLG	0.0	0.0	0.0	0.0	40.0	-47.0	-46.0	1.0						0.995			0.0	0.005	.			ciliary ganglion;skin;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	multicellular organism development;peptide cross-linking;keratinocyte differentiation;establishment of skin barrier;cornification	cornified envelope;nucleus;cytosol;intermediate filament;keratohyalin granule;intracellular membrane-bounded organelle;collagen-containing extracellular matrix	structural molecule activity;calcium ion binding;protein binding;structural constituent of epidermis;transition metal ion binding	MAP1LC3B[20562859];METTL14[29507755];SLX4[19596235];MAK[27173435;unassigned1312];USP1[19615732];KLK5[23629652];VHL[17353931];MAPT[26402096];FLNC[30021884];STK4[23386615];ESR2[21182203;25604459];	152282104
6998	chr1	152282111	T	C	chr1:152282111	FLG	filaggrin	SNV	0/0	0.0	34_0	34	99.0	0|1	0.12	122_16	138	99.0			rs577966299,COSV64239135	EXONIC	YES	NM_002016.2	Transcript	protein_coding	missense_variant		3/3	NM_002016.2:c.5251A>G	NP_002007.1:p.Thr1751Ala		-1.0					Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	.	.	Eczematoid dermatitis;Autosomal dominant inheritance;Asthma;Ichthyosis		0.000645699	96.0	148676.0	0.0	30	0.92	AS_VQSR	sas	0.00224517	10.0	0.000786973	52.0	8.37281e-05	21.0	250812.0	0.0	100	1.0	PASS	afr	0.000184593	3.0	0.000132091	15.0	0.0001415	22			0.00346	33.0		0.001	-1.643312	0.127	0	18	18		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FLG	0.0	0.0	0.0	0.0	15.0	-37.0	-22.0	-23.0						0.995			0.0	-0.553	.			ciliary ganglion;skin;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	multicellular organism development;peptide cross-linking;keratinocyte differentiation;establishment of skin barrier;cornification	cornified envelope;nucleus;cytosol;intermediate filament;keratohyalin granule;intracellular membrane-bounded organelle;collagen-containing extracellular matrix	structural molecule activity;calcium ion binding;protein binding;structural constituent of epidermis;transition metal ion binding	MAP1LC3B[20562859];METTL14[29507755];SLX4[19596235];MAK[27173435;unassigned1312];USP1[19615732];KLK5[23629652];VHL[17353931];MAPT[26402096];FLNC[30021884];STK4[23386615];ESR2[21182203;25604459];	152282111
7006	chr1	152283053	G	A	chr1:152283053	FLG	filaggrin	SNV	0/0	0.0	34_0	34	99.0	0/1	0.46	38_33	71	99.0			rs12750571	EXONIC	YES	NM_002016.2	Transcript	protein_coding	missense_variant		3/3	NM_002016.2:c.4309C>T	NP_002007.1:p.Arg1437Cys		-1.0		Likely_benign	criteria_provided,_single_submitter	not_provided	Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	.	.	Eczematoid dermatitis;Autosomal dominant inheritance;Asthma;Ichthyosis		0.00477055	725.0	151974.0	4.0	30	0.92	PASS	nfe	0.00701471	477.0	0.00701471	477.0	0.00503018	1265.0	251482.0	12.0	100	1.0	PASS	nfe	0.00668976	761.0	0.00668976	761.0	0.0048166	749	0.01	31.0	0.00808	77.0		17.36	1.681481	0.098	4	15	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,MutationAssessor_pred	Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FLG	0.0	0.0	0.0	0.0	-24.0	-42.0	-7.0	-23.0						0.995			0.001	0.149	.			ciliary ganglion;skin;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	multicellular organism development;peptide cross-linking;keratinocyte differentiation;establishment of skin barrier;cornification	cornified envelope;nucleus;cytosol;intermediate filament;keratohyalin granule;intracellular membrane-bounded organelle;collagen-containing extracellular matrix	structural molecule activity;calcium ion binding;protein binding;structural constituent of epidermis;transition metal ion binding	MAP1LC3B[20562859];METTL14[29507755];SLX4[19596235];MAK[27173435;unassigned1312];USP1[19615732];KLK5[23629652];VHL[17353931];MAPT[26402096];FLNC[30021884];STK4[23386615];ESR2[21182203;25604459];	152283053
7012	chr1	152284541	G	A	chr1:152284541	FLG	filaggrin	SNV	0/0	0.0	34_0	34	99.0	0/1	0.21	92_25	117	99.0			rs138002269,COSV64245372,COSV64246254	EXONIC	YES	NM_002016.2	Transcript	protein_coding	missense_variant		3/3	NM_002016.2:c.2821C>T	NP_002007.1:p.Arg941Cys		-1.0					Ichthyosis vulgaris, 146700 (3), Autosomal recessive, Autosomal dominant; {Dermatitis, atopic, susceptibility to, 2}, 605803 (3)	.	.	Eczematoid dermatitis;Autosomal dominant inheritance;Asthma;Ichthyosis		0.00141924	212.0	149376.0	0.0	31	0.94	PASS	sas	0.00611888	28.0	0.00191542	127.0	0.00041531	101.0	243192.0	0.0	100	1.0	PASS	sas	0.00124043	35.0	0.000436546	48.0	0.0000064	1						21.8	2.255804	0.227	5	14	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationAssessor_pred	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FLG	0.0	0.0	0.0	0.0	39.0	7.0	2.0	-14.0						0.995			0.001	0.927	.			ciliary ganglion;skin;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	multicellular organism development;peptide cross-linking;keratinocyte differentiation;establishment of skin barrier;cornification	cornified envelope;nucleus;cytosol;intermediate filament;keratohyalin granule;intracellular membrane-bounded organelle;collagen-containing extracellular matrix	structural molecule activity;calcium ion binding;protein binding;structural constituent of epidermis;transition metal ion binding	MAP1LC3B[20562859];METTL14[29507755];SLX4[19596235];MAK[27173435;unassigned1312];USP1[19615732];KLK5[23629652];VHL[17353931];MAPT[26402096];FLNC[30021884];STK4[23386615];ESR2[21182203;25604459];	152284541
7028	chr1	152882772	ACAGCTGAAGCACCCGGAGCAGCAGGAGGG		chr1:152882772-152882801	IVL	involucrin	deletion	0/1	0.33	59_29	88	99.0	0/0	0.0	33_0	33	99.0			rs772656711	EXONIC	YES	NM_005547.4	Transcript	protein_coding	inframe_deletion		2/2	NM_005547.4:c.513_542del	NP_005538.2:p.Lys174_Leu183del		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00605012	899.0	148592.0	9.0	32	0.92	PASS	nfe	0.00914946	608.0	0.00914946	608.0	0.00205382	502.0	244422.0	5.0	28	0.7	PASS	nfe	0.00310458	342.0	0.00310458	342.0	0.0000064	1	0.005	16.0				12.63	0.888836		0	0	0																	0.945	0.0	0.000000000			homeostasis/metabolism phenotype; reproductive system phenotype; normal phenotype; 			.	.	response to UV-B;peptide cross-linking;isopeptide cross-linking via N6-(L-isoglutamyl)-L-lysine;keratinocyte differentiation;cornification	cornified envelope;cytoplasm;centrosome;cytosol;nuclear body;extracellular exosome	structural molecule activity;protein binding;protein binding, bridging	LACC1[27478939];PRMT5[26763441];ACD[21044950];HIST1H4A[26763441];GID8[27173435;unassigned1312];POT1[21044950];TANK[unassigned1774];DHRS2[30021884];WDR77[26763441];	152882771
7043	chr1	153431358	A	G	chr1:153431358	S100A7	S100 calcium binding protein A7	SNV	0/0	0.0	34_0	34	99.0	0|1	0.16	46_9	56	99.0			rs751199795	EXONIC	YES	NM_002963.4	Transcript	protein_coding	synonymous_variant		2/3	NM_002963.4:c.132T>C	NP_002954.2:p.Leu44%3D		-1.0						.	.	.		1.31491e-05	2.0	152102.0	0.0	33	0.95	AS_VQSR	sas	0.000208855	1.0	0.0	0.0	7.60944e-05	19.0	249690.0	0.0	54	0.99	RF	sas	0.000540358	16.0	1.76607e-05	2.0	0.0000064	1						6.562	0.250685		0	0	0			S100A7	0.0	0.0	0.04	0.0	-3.0	-7.0	-7.0	-1.0							0.55				.			.	.	response to reactive oxygen species;angiogenesis;epidermis development;positive regulation of T cell chemotaxis;antimicrobial humoral response;keratinocyte differentiation;response to lipopolysaccharide;neutrophil degranulation;innate immune response;defense response to Gram-negative bacterium;sequestering of metal ion;antimicrobial humoral immune response mediated by antimicrobial peptide;positive regulation of ERK1 and ERK2 cascade;positive regulation of granulocyte chemotaxis;positive regulation of monocyte chemotaxis	extracellular region;extracellular space;nucleus;cytoplasm;endoplasmic reticulum;cytosol;focal adhesion;azurophil granule lumen;collagen-containing extracellular matrix	calcium ion binding;protein binding;zinc ion binding;RAGE receptor binding	MAP3K3[14743216];VCAM1[22623428];L3MBTL2[27705803];S100A7L2[unassigned1304];EED[27705803];PCGF5[27705803];CD81[26212323];RASSF7[24366813];RANBP9[12421467];RASSF9[24366813];PPP2R2A[28330616];LIN9[17531812];IFIT1[21642987];MKI67[26949251];ESR1[21182205];RASSF10[24366813];AEBP2[27705803];PPP2R2B[19156129];CLVS2[unassigned1304];E2F6[27705803];PAK5[17353931];CFTR[17110338];	153431358
7044	chr1	153431364	G	A	chr1:153431364	S100A7	S100 calcium binding protein A7	SNV	0/0	0.0	34_0	34	99.0	0|1	0.16	45_9	55	99.0			rs754695637	EXONIC	YES	NM_002963.4	Transcript	protein_coding	synonymous_variant		2/3	NM_002963.4:c.126C>T	NP_002954.2:p.Asn42%3D		-1.0						.	.	.		6.57393e-06	1.0	152116.0	0.0	33	0.95	AS_VQSR	sas	0.00020842	1.0	0.0	0.0	5.60247e-05	14.0	249890.0	0.0	55	1.0	RF	sas	0.000336134	10.0	2.64831e-05	3.0	0.0000064	1	0.001	2.0				6.668	0.258413		0	0	0			S100A7	0.0	0.0	0.0	0.14	-9.0	-13.0	-7.0	-13.0							0.55				.			.	.	response to reactive oxygen species;angiogenesis;epidermis development;positive regulation of T cell chemotaxis;antimicrobial humoral response;keratinocyte differentiation;response to lipopolysaccharide;neutrophil degranulation;innate immune response;defense response to Gram-negative bacterium;sequestering of metal ion;antimicrobial humoral immune response mediated by antimicrobial peptide;positive regulation of ERK1 and ERK2 cascade;positive regulation of granulocyte chemotaxis;positive regulation of monocyte chemotaxis	extracellular region;extracellular space;nucleus;cytoplasm;endoplasmic reticulum;cytosol;focal adhesion;azurophil granule lumen;collagen-containing extracellular matrix	calcium ion binding;protein binding;zinc ion binding;RAGE receptor binding	MAP3K3[14743216];VCAM1[22623428];L3MBTL2[27705803];S100A7L2[unassigned1304];EED[27705803];PCGF5[27705803];CD81[26212323];RASSF7[24366813];RANBP9[12421467];RASSF9[24366813];PPP2R2A[28330616];LIN9[17531812];IFIT1[21642987];MKI67[26949251];ESR1[21182205];RASSF10[24366813];AEBP2[27705803];PPP2R2B[19156129];CLVS2[unassigned1304];E2F6[27705803];PAK5[17353931];CFTR[17110338];	153431364
7235	chr1	154294464	A	G	chr1:154294464	AQP10	aquaporin 10	SNV	0|1	0.25	55_18	73	99.0	0/0	0.0	33_0	33	99.0			rs201824170,COSV61474441	EXONIC	YES	NM_080429.3	Transcript	protein_coding	missense_variant		2/6	NM_080429.3:c.161A>G	NP_536354.2:p.Asn54Ser		1.0	.,.					.	.	.		0.0014042	199.0	141718.0	0.0	31	0.93	PASS	afr	0.00205166	78.0	0.00110254	70.0	0.0112483	2152.0	191318.0	0.0	45	0.93	RF	afr	0.0139957	171.0	0.0136547	1153.0	0.0000064	1						22.8	2.650404	0.109	5	15	20	PolyPhen,LRT_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	AQP10	0.0	0.0	0.0	0.0	1.0	45.0	34.0	-4.0						0.441	0.02		1.0	1.093	.			.	.	water transport;response to toxic substance;glycerol transport;urea transmembrane transport	plasma membrane;integral component of membrane	urea transmembrane transporter activity;water channel activity;glycerol channel activity;urea channel activity	CYBC1[unassigned1304];SYT2[unassigned1304];TMEM167B[unassigned1304];MGST3[unassigned1304];CISD2[unassigned1304];GPR37L1[unassigned1304];SSMEM1[unassigned1304];KIR2DL3[unassigned1304];LYVE1[unassigned1304];PVR[unassigned1304];GPR152[unassigned1304];PGRMC2[unassigned1304];ARL13B[unassigned1304];CREB3L1[unassigned1304];PLP1[unassigned1304];ERGIC3[unassigned1304];SCN3B[unassigned1304];NEMP1[unassigned1304];	154294464
7240	chr1	154294471	C	T	chr1:154294471	AQP10	aquaporin 10	SNV	0|1	0.21	63_17	80	99.0	0/0	0.0	33_0	33	99.0			rs200279756,COSV61474452	EXONIC	YES	NM_080429.3	Transcript	protein_coding	synonymous_variant		2/6	NM_080429.3:c.168C>T	NP_536354.2:p.Phe56%3D		1.0						.	.	.		0.000908875	130.0	143034.0	0.0	31	0.93	PASS	sas	0.00173385	8.0	0.000624083	40.0	0.0113923	2223.0	195132.0	0.0	44	0.93	PASS	nfe	0.0135831	1176.0	0.0135831	1176.0	0.0000064	1						13.3	0.981606		0	0	0			AQP10	0.0	0.0	0.0	0.0	38.0	-35.0	-11.0	12.0						0.441	0.02				.			.	.	water transport;response to toxic substance;glycerol transport;urea transmembrane transport	plasma membrane;integral component of membrane	urea transmembrane transporter activity;water channel activity;glycerol channel activity;urea channel activity	CYBC1[unassigned1304];SYT2[unassigned1304];TMEM167B[unassigned1304];MGST3[unassigned1304];CISD2[unassigned1304];GPR37L1[unassigned1304];SSMEM1[unassigned1304];KIR2DL3[unassigned1304];LYVE1[unassigned1304];PVR[unassigned1304];GPR152[unassigned1304];PGRMC2[unassigned1304];ARL13B[unassigned1304];CREB3L1[unassigned1304];PLP1[unassigned1304];ERGIC3[unassigned1304];SCN3B[unassigned1304];NEMP1[unassigned1304];	154294471
7405	chr1	155161257	G	A	chr1:155161257	MUC1	mucin 1, cell surface associated	SNV	0/0	0.0	13_0	13	21.0	0/1	0.75	2_9	12	16.0			rs867507334	EXONIC	YES	NM_001371720.1	Transcript	protein_coding	synonymous_variant		3/8	NM_001371720.1:c.2535C>T	NP_001358649.1:p.His845%3D		-1.0					Tubulointerstitial kidney disease, autosomal dominant, 2, 174000 (3), Autosomal dominant	MUC1-related autosomal dominant tubulointerstitial kidney disease	Disease-causing germline mutation(s) in	Renal salt wasting;Gout;Hypertension;Hypotension;Impaired renal uric acid clearance;Tubulointerstitial nephritis;Decreased glomerular filtration rate;Renal hypoplasia;Autosomal dominant inheritance;Renal cortical atrophy;Renal corticomedullary cysts;Tubular basement membrane disintegration;Anemia;Renal tubular atrophy;Adult onset;Stage 5 chronic kidney disease;Tubulointerstitial fibrosis;Glomerulosclerosis;Cerebral cortical atrophy;Elevated serum creatinine;Hyperuricemia						0	0.0							0.0	0.0	770.0	0.0	0	0.0	AC0				0.0	0.0								1.385	-0.10235		0	0	0			MUC1	0.0	0.0	0.0	0.0	-27.0	4.0	-3.0	-1.0							0.73				digestive/alimentary phenotype; neoplasm; normal phenotype; liver/biliary system phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; integument phenotype ; 			kidney;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;fetal lung;	.	stimulatory C-type lectin receptor signaling pathway;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;negative regulation of transcription by competitive promoter binding;O-glycan processing;cytokine-mediated signaling pathway;negative regulation of cell adhesion mediated by integrin;positive regulation of transcription from RNA polymerase II promoter in response to stress;regulation of transcription from RNA polymerase II promoter in response to stress;positive regulation of histone H4 acetylation;negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	nuclear chromatin;extracellular space;Golgi lumen;plasma membrane;integral component of plasma membrane;apical plasma membrane;vesicle;extracellular exosome	RNA polymerase II proximal promoter sequence-specific DNA binding;p53 binding;transcription coregulator activity;protein binding	CCDC167[unassigned1304];APP[unassigned1304];SLC35B4[unassigned1304];TTMP[unassigned1304];GOLT1B[unassigned1304];TMEM97[unassigned1304];AQP2[unassigned1304];AQP3[unassigned1304];AQP1[unassigned1304];TMEM147[unassigned1304];EP300[22869720];SMCO4[unassigned1304];TMEM14A[unassigned1304];BRICD5[unassigned1304];TMEM14C[unassigned1304];PAQR6[unassigned1304];ENTPD3[unassigned1304];ANKRD46[unassigned1304];CSGALNACT2[unassigned1304];ADIPOQ[unassigned1304];CLDN6[unassigned1304];PLPP6[unassigned1304];ADGRB3[unassigned1304];MIP[unassigned1304];NINJ2[unassigned1304];UNC50[unassigned1304];NINJ1[unassigned1304];MALL[unassigned1304];PPIF[unassigned1304];MYADM[unassigned1304];COL8A2[unassigned1304];INSIG2[unassigned1304];SMIM1[unassigned1304];EDDM3B[unassigned1304];HIF1A[22869720];TMEM121[unassigned1304];C2[unassigned1304];TMEM243[unassigned1304];TMEM128[unassigned1304];NEU1[unassigned1304];ABL1[16888623];HHATL[unassigned1304];TMEM120B[unassigned1304];JUN[20697347];TMEM86A[unassigned1304];ICMT[unassigned1304];BTN2A2[unassigned1304];GPR108[unassigned1304];CYP4F2[unassigned1304];TNFRSF10B[unassigned1304];NKG7[unassigned1304];TMEM98[unassigned1304];GDNF[unassigned1304];GRB2[20936779];C2CD2L[unassigned1304];BCL2L2[unassigned1304];PNLIPRP1[unassigned1304];ITGAM[unassigned1304];TECR[unassigned1304];OR10AG1[unassigned1304];TMEM187[unassigned1304];SERP2[unassigned1304];THBD[unassigned1304];ARV1[unassigned1304];MFSD5[unassigned1304];VKORC1[unassigned1304];CD53[unassigned1304];SFTPC[unassigned1304];APOA2[unassigned1304];EMP3[unassigned1304];RFT1[unassigned1304];CD47[unassigned1304];MET[22962849];VAMP5[unassigned1304];CEBPB[24043631];CLDND2[unassigned1304];NRAC[unassigned1304];SRC[11483589;11152665;21798038];ZDHHC21[unassigned1304];SELENOK[unassigned1304];EGFR[11483589;21258405;24658140];RHD[unassigned1304];MUC1[21798038];PLN[unassigned1304];U2AF2[22905162];MAL2[unassigned1304];EMC6[unassigned1304];CACNG1[unassigned1304];CYB5B[unassigned1304];CMTM7[unassigned1304];NDUFA3[unassigned1304];ADAM33[unassigned1304];TM6SF2[unassigned1304];ERG28[unassigned1304];CD68[unassigned1304];PPGB[unassigned1304];TMEM229B[unassigned1304];	155161257
7488	chr1	155449802	C	T	chr1:155449802	ASH1L	ASH1 like histone lysine methyltransferase	SNV	0/1	0.45	36_30	67	99.0	0/0	0.0	36_0	36	99.0			rs763045546,COSV64211785	EXONIC	YES	NM_001366177.2	Transcript	protein_coding	synonymous_variant		3/28	NM_001366177.2:c.2859G>A	NP_001353106.1:p.Arg953%3D		-1.0		Likely_benign	criteria_provided,_single_submitter	not_provided	Mental retardation, autosomal dominant 52, 617796 (3), Autosomal dominant	.	.	Anxiety;Autistic behavior;Cryptorchidism;Global developmental delay;Intellectual disability;Seizure;Absent speech;Feeding difficulties;Autosomal dominant inheritance;Abnormal facial shape;Hyperactivity;Infantile onset;Generalized hypotonia		6.57151e-06	1.0	152172.0	0.0	32	0.97	PASS	nfe	1.46994e-05	1.0	1.46994e-05	1.0	1.99214e-05	5.0	250986.0	0.0	100	1.0	PASS	nfe	4.40816e-05	5.0	4.40816e-05	5.0	0.0000129	2						10.65	0.639966		0	0	0			ASH1L	0.0	0.0	0.0	0.0	29.0	0.0	-6.0	1.0						0.00737	1.0	74.821878940			homeostasis/metabolism phenotype; growth/size/body region phenotype; integument phenotype ; endocrine/exocrine gland phenotype; adipose tissue phenotype ; respiratory system phenotype; behavior/neurological phenotype ; immune system phenotype; skeleton phenotype; renal/urinary system phenotype; vision/eye phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; reproductive system phenotype; mortality/aging ; embryo phenotype; 			.	Tight junction	skeletal system development;negative regulation of acute inflammatory response;DNA packaging;transcription by RNA polymerase II;cell-cell signaling;single fertilization;post-embryonic development;flagellated sperm motility;interleukin-6 production;negative regulation of I-kappaB kinase/NF-kappaB signaling;negative regulation of MAPK cascade;positive regulation of transcription by RNA polymerase II;decidualization;histone H3-K4 methylation;uterus morphogenesis;histone H3-K36 dimethylation;tarsal gland development;uterine gland development	nucleus;nucleoplasm;chromosome;Golgi apparatus;bicellular tight junction	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;chromatin binding;histone-lysine N-methyltransferase activity;histone methyltransferase activity (H3-K4 specific);metal ion binding;histone methyltransferase activity (H3-K36 specific)	SIKE1[26496610];OXTR[28298427];PARD6A[26496610];ARPC1B[30021884];HIST1H2BH[30021884];MESD[30021884];SMAD7[15231748];PLEC[30021884];	155449802
7534	chr1	155646332	G	A	chr1:155646332	YY1AP1	YY1 associated protein 1	SNV	0/1	0.58	17_25	43	99.0	0/0	0.0	37_0	37	76.0			rs201603249	SPLICING	YES	NM_001198903.1	Transcript	protein_coding	splice_region_variant,intron_variant	4/9		NM_001198903.1:c.738+7C>T			-1.0		Likely_benign	criteria_provided,_single_submitter	not_provided	Grange syndrome, 602531 (3), Autosomal recessive	Grange syndrome	Disease-causing germline mutation(s) in	Ventricular septal defect;Intellectual disability, borderline;Syndactyly;Arterial stenosis;Patent ductus arteriosus;Aortic regurgitation;Specific learning disability;Increased susceptibility to fractures;Short palm;Hypertension;Finger clinodactyly;Renal artery stenosis;Intellectual disability;Recurrent fractures;Decreased body weight;Carotid artery stenosis;Brachydactyly;Renovascular hypertension;Coronary artery stenosis;Bicuspid aortic valve;Autosomal recessive inheritance;Syndactyly		0.00126835	193.0	152166.0	0.0	32	0.97	PASS	nfe	0.00220504	150.0	0.00220504	150.0	0.00134843	339.0	251404.0	1.0	97	1.0	PASS	nfe	0.00214581	244.0	0.00214581	244.0	0.0014855	231	0.001	4.0				7.836	0.35003		0	0	0			YY1AP1	0.0	0.0	0.0	0.0	41.0	7.0	7.0	1.0	0.0003700301050884	0.002				0.942	0.0				.			white blood cells;testis - seminiferous tubule;testis - interstitial;atrioventricular node;trigeminal ganglion;testis;	.	cell population proliferation;cell differentiation;regulation of cell cycle	fibrillar center;nucleus;nucleoplasm;nucleolus;cytoplasm;Ino80 complex	protein binding	YY1[27939641;14744866];INO80C[27939641];PRKAB2[21988832];INO80E[27939641];ATXN1[16713569];EWSR1[16189514;21988832];ZFAT[21988832];SS18L2[unassigned1304];MDM2[21988832];VHL[17986458];MAPK14[20936779;21988832];MAPK8IP2[21900206];	155646332
7555	chr1	155733358	G	A	chr1:155733358	GON4L	gon-4 like	SNV	0/0	0.0	35_0	35	99.0	0/1	0.51	32_33	65	99.0			rs72706143	SPLICING	YES	NM_001282856.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	21/31		NM_001282856.2:c.4474-3C>T			-1.0						.	.	.		0.000755982	115.0	152120.0	0.0	31	0.96	PASS	nfe	0.00133749	91.0	0.00133749	91.0	0.000783038	117.0	149418.0	0.0	23	0.54	PASS	nfe	0.0016259	94.0	0.0016259	94.0	0.0002958	46	0.001	3.0	0.00049	5.0		14.79	1.225822		0	0	0			GON4L	0.11	0.13	0.0	0.0	-41.0	7.0	3.0	7.0	0.0514319737621202		1.807	0.602	2.409	0.572	1.0				neoplasm; hematopoietic system phenotype; immune system phenotype; 			pons;testis - seminiferous tubule;superior cervical ganglion;trigeminal ganglion;parietal lobe;skeletal muscle;globus pallidus;cerebellum;	.	regulation of transcription by RNA polymerase II;B cell differentiation;negative regulation of transcription, DNA-templated	nucleus;nucleoplasm;nuclear body	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;transcription corepressor activity	ITGB5[23414517];	155733358
7600	chr1	156514261	G	A	chr1:156514261	IQGAP3	IQ motif containing GTPase activating protein 3	SNV	0/0	0.0	37_0	37	99.0	0/1	0.43	51_39	90	99.0			rs1078890	EXONIC	YES	NM_178229.5	Transcript	protein_coding	missense_variant		20/38	NM_178229.5:c.2308C>T	NP_839943.3:p.His770Tyr		-1.0	IQ motif, EF-hand binding site&IQ motif, EF-hand binding site&IQ motif, EF-hand binding site					.	.	.	22883143	0.0024649	375.0	152136.0	1.0	32	0.97	PASS	sas	0.00621891	30.0	0.00227841	155.0	0.00338429	851.0	251456.0	8.0	73	1.0	PASS	sas	0.00826365	253.0	0.00201343	229.0	0.0027138	422	0.001	2.0	0.00105	12.0		18.06	1.78203	0.021	3	17	20	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred	SIFT,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	IQGAP3	0.0	0.03	0.0	0.0	-17.0	3.0	3.0	-9.0						0.641	0.0	0.000000000	0.935	0.228	.			ciliary ganglion;testis - interstitial;subthalamic nucleus;superior cervical ganglion;atrioventricular node;trigeminal ganglion;parietal lobe;skeletal muscle;globus pallidus;	Regulation of actin cytoskeleton	G1/S transition of mitotic cell cycle;activation of MAPK activity;Ras protein signal transduction;regulation of cell size;positive regulation of gene expression;negative regulation of gene expression;positive regulation of mammary gland epithelial cell proliferation;regulation of GTPase activity;ERK1 and ERK2 cascade;cellular response to organic substance	cytosol;cell-cell junction;lateral plasma membrane	calmodulin binding;Rho GTPase binding;myosin VI light chain binding	IQCB1[21565611];CCDC198[27107012];LRRK2[24725412];RIPK4[26972000];EPS15L1[30021884];TANK[unassigned1774];PTBP3[22575643];CDC42[26496610];KATNAL2[26929214];MYC[17314511];RAC1[27173435;unassigned1312];CALM1[25416956;unassigned1312];KIFAP3[27173435;unassigned1312];	156514261
7601	chr1	156640658	G	C	chr1:156640658	NES	nestin	SNV	0/0	0.0	42_0	42	57.0	0|1	0.08	55_5	62	99.0			rs1381982288	EXONIC	YES	NM_006617.2	Transcript	protein_coding	missense_variant		4/4	NM_006617.2:c.3322C>G	NP_006608.1:p.Leu1108Val		-1.0						.	.	.		0.000523271	74.0	141418.0	0.0	32	0.92	AS_VQSR	eas	0.00224775	9.0	0.000341891	22.0	8.05919e-06	2.0	248164.0	0.0	58	0.98	PASS	amr	2.90326e-05	1.0	8.93799e-06	1.0								11.18	0.704036	0.06	5	14	19	SIFT,M-CAP_pred,MetaLR_pred,MutationAssessor_pred,FATHMM_pred	PolyPhen,LRT_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	NES	0.0	0.0	0.0	0.0	-26.0	-46.0	1.0	-32.0						0.0569	0.0	7.947566600	0.03	1.176	cellular phenotype; growth/size/body region phenotype; embryo phenotype; nervous system phenotype ; mortality/aging ; behavior/neurological phenotype ; 			olfactory bulb;dorsal root ganglion;superior cervical ganglion;	Cell Communication	G2/M transition of mitotic cell cycle;central nervous system development;brain development;positive regulation of intermediate filament depolymerization;embryonic camera-type eye development;negative regulation of protein binding;negative regulation of catalytic activity;stem cell proliferation;positive regulation of neural precursor cell proliferation	cytoplasm;intermediate filament;intermediate filament cytoskeleton	molecular_function;structural molecule activity;intermediate filament binding	SLC35F6[26496610];RNF13[26496610];CHD7[26496610];CLTB[26496610];CLTA[26496610];GPATCH4[26496610];IDE[26496610];LMNB1[26496610];RRP9[26496610];GOLGA2[26496610];FAM81B[30021884];HSP90AA1[26496610];KRT8[30021884];KRT7[26496610];EBF2[30021884];POLRMT[26496610];HADHB[26496610];PKP4[26496610];GART[26496610];RPL10[26496610];LAMA1[26496610];FLII[26496610];UBR2[26496610];UBR1[26496610];AMBRA1[26496610];HIF1A[26496610];MRM1[26496610];ADD1[26496610];PRDX2[26496610];UBR5[26496610];MICALL2[26496610];SLC25A22[26496610];SF3B1[26496610];ATP9A[26496610];SVIL[26496610];DNAH12[30021884];GRTP1[26496610];TMEM132A[26496610];CCDC88A[26496610];CMSS1[26496610];LAS1L[26496610];GKAP1[26496610];IMPDH2[26496610];EIF3I[26496610];TNIP3[30021884];COL5A2[30021884];CEP162[26496610];CCSER2[30021884];NCAPD3[26496610];VIM[26496610;30021884];	156640658
7610	chr1	156737698	C	T	chr1:156737698	PRCC	proline rich mitotic checkpoint control factor	SNV	0/0	0.0	40_0	40	99.0	0/1	0.5	43_43	86	99.0			rs369138151	EXONIC	YES	NM_005973.5	Transcript	protein_coding	synonymous_variant		1/7	NM_005973.5:c.135C>T	NP_005964.3:p.Pro45%3D		1.0					Renal cell carcinoma, papillary, 605074 (3)	MiT family translocation renal cell carcinoma	Part of a fusion gene in	Papillary renal cell carcinoma;Autosomal dominant inheritance;Incomplete penetrance		4.59746e-05	7.0	152258.0	0.0	32	0.98	PASS	nfe	2.93927e-05	2.0	2.93927e-05	2.0	5.7785e-05	13.0	224972.0	0.0	43	0.64	PASS	amr	0.000277743	9.0	2.99868e-05	3.0	0.0000514	8						14.47	1.167811		0	0	0			PRCC	0.0	0.0	0.0	0.0	34.0	4.0	4.0	-34.0						0.116	0.92	56.603385902			.			superior cervical ganglion;heart;	.	mRNA splicing, via spliceosome;mitotic cell cycle checkpoint	nucleus;nucleoplasm;nuclear speck	protein binding	PRPF19[22365833];LRP8[26496610];EGFR[20029029];IWS1[26496610];SEPT7[unassigned1312];HSF2[26496610];CHORDC1[unassigned1312];HOMER3[26871637];PIM2[26496610];TP53BP1[29656893];RBM10[22365833];SCYL2[unassigned1312];PCK2[26496610];TOE1[22365833];SH3GLB1[unassigned1312];SEPT11[unassigned1312];SF3A2[17332742];PPIL2[22365833];CSNK2A1[22113938];SORT1[26496610];DIS3[unassigned1312];ZNF281[26496610];CDC5L[20467437];TMEM173[29251827];YWHAZ[26496610];COPZ1[unassigned1312];LSM2[22365833];SOD1[26496610];CEP170P1[26496610];CDK5[unassigned1312];GORASP2[unassigned1312];SUB1[unassigned1312];SARNP[unassigned1312];DNAJC10[30021884];DRG1[unassigned1312];	156737698
7646	chr1	157103922	T	C	chr1:157103922	ETV3	ETS variant 3	SNV	0/0	0.0	35_0	35	99.0	0/1	0.26	23_8	31	99.0			rs766539831	EXONIC	YES	NM_001145312.3	Transcript	protein_coding	missense_variant		4/5	NM_001145312.3:c.382A>G	NP_001138784.1:p.Ile128Val		-1.0	.,.					.	.	.						32	0.98							3.98124e-06	1.0	251178.0	0.0	39	0.95	PASS	nfe	8.79941e-06	1.0	8.79941e-06	1.0	0.0000064	1						22.6	2.526905	0.058	6	14	20	SIFT,MutationAssessor_pred,MutationTaster_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred	ETV3	0.0	0.0	0.0	0.0	24.0	-10.0	-38.0	-15.0							0.78	0.000000000	1.0	1.138	.			ciliary ganglion;liver;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	.	negative regulation of transcription by RNA polymerase II;regulation of transcription by RNA polymerase II;biological_process;negative regulation of cell population proliferation;cell differentiation;cellular response to granulocyte macrophage colony-stimulating factor stimulus	nuclear chromatin;nucleus;RNA polymerase II transcription repressor complex	RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;molecular_function;DEAD/H-box RNA helicase binding	NSD3[23455924];MYC[21150319];	157103922
7650	chr1	157559076	G	A	chr1:157559076	FCRL4	Fc receptor like 4	SNV	0/0	0.0	34_0	34	99.0	0/1	0.39	62_40	103	99.0			rs78796764,COSV54867394	EXONIC	YES	NM_031282.3	Transcript	protein_coding	synonymous_variant		3/12	NM_031282.3:c.225C>T	NP_112572.1:p.Leu75%3D		-1.0						.	.	.		0.00247076	376.0	152180.0	1.0	32	0.97	PASS	sas	0.00455864	22.0	0.00371895	253.0	0.00302645	761.0	251450.0	4.0	100	1.0	PASS	sas	0.00587928	180.0	0.00360471	410.0	0.0029260	455	0.003	11.0				0.034	-0.627439		0	0	0			FCRL4	0.0	0.0	0.0	0.0	-5.0	10.0	-3.0	-20.0						0.835	0.0	7.947566600			.			ciliary ganglion;atrioventricular node;	.	adaptive immune response	plasma membrane;cell surface;integral component of membrane	protein binding	NINJ2[unassigned1304];DERL1[unassigned1304];TFF2[21982860];ZNF76[unassigned1304];TFF1[21982860];DTX2[unassigned1304];SMN1[unassigned1304];	157559076
7667	chr1	158639530	T	A	chr1:158639530	SPTA1	spectrin alpha, erythrocytic 1	SNV	0/1	0.4	36_25	62	99.0	0/0	0.0	35_0	35	99.0				EXONIC	YES	NM_003126.4	Transcript	protein_coding	missense_variant		13/52	NM_003126.4:c.1646A>T	NP_003117.2:p.Asp549Val		-1.0	.,.				Spherocytosis, type 3, 270970 (3), Autosomal recessive; Elliptocytosis-2, 130600 (3), Autosomal dominant; Pyropoikilocytosis, 266140 (3), Autosomal recessive	Hereditary spherocytosis;Hereditary elliptocytosis	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Hemolytic anemia;Spherocytosis;Autosomal recessive inheritance;Autosomal dominant inheritance;Reticulocytosis;Hemolytic anemia;Elliptocytosis;Neonatal hyperbilirubinemia;Heterogeneous;Fever;Cholelithiasis;Postnatal growth retardation;Hydrops fetalis;Abdominal pain;Reticulocytosis;Frontal bossing;Stomatocytosis;Splenomegaly;Prolonged neonatal jaundice;Neonatal hyperbilirubinemia;Chills;Congenital hemolytic anemia;Elliptocytosis;Increased red cell osmotic fragility;Pyropoikilocytosis;Autosomal recessive inheritance;Hemolytic anemia;Elliptocytosis;Microspherocytosis;Restrictive cardiomyopathy;Pallor;Abdominal pain;Fever;Hypercoagulability;Growth delay;Reticulocytosis;Extramedullary hematopoiesis;Spherocytosis;Chills;Jaundice;Hepatomegaly;Abdominal distention;Ataxia;Myalgia;Gout;Splenomegaly;Hypofibrinogenemia;Muscle weakness;Maculopapular exanthema;Cholelithiasis;Spontaneous hemolytic crises;Increased red cell osmotic fragility;Increased mean corpuscular hemoglobin concentration;Skin ulcer;Hyperbilirubinemia						32	0.96											100	1.0											9e-05	1.0		23.4	2.931578	0.057	7	14	21	PolyPhen,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,ClinPred_pred,fathmm-MKL_coding_pred	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-XF_coding_pred	SPTA1	0.04	0.04	0.0	0.03	-6.0	46.0	16.0	-31.0						0.806	0.0	46.574266883	0.65	1.138	homeostasis/metabolism phenotype; growth/size/body region phenotype; integument phenotype ; behavior/neurological phenotype ; liver/biliary system phenotype; respiratory system phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; digestive/alimentary phenotype; nervous system phenotype ; cardiovascular system phenotype ; hematopoietic system phenotype; mortality/aging ; reproductive system phenotype; pigmentation phenotype; 			.	.	MAPK cascade;lymphocyte homeostasis;porphyrin-containing compound biosynthetic process;endoplasmic reticulum to Golgi vesicle-mediated transport;plasma membrane organization;actin filament organization;axon guidance;regulation of cell shape;hemopoiesis;positive regulation of protein binding;positive regulation of T cell proliferation;actin filament capping	cytosol;spectrin;spectrin-associated cytoskeleton;actin cytoskeleton;axon;intrinsic component of the cytoplasmic side of the plasma membrane;cuticular plate	Ras guanyl-nucleotide exchange factor activity;structural constituent of cytoskeleton;calcium ion binding;protein binding;protein heterodimerization activity;actin filament binding	SHC1[19380743];TSHZ2[unassigned1304];FASLG[19807924];SLC4A1[23219802];CBL[19380743];TXN2[unassigned1304];C21orf58[unassigned1304];EXOSC5[unassigned1304];UBASH3B[19380743];DGCR6L[unassigned1304];ZNF326[unassigned1304];CCDC185[unassigned1304];SPTBN1[12820899];VASP[16336193];GADD45GIP1[unassigned1304];PARP1[30021884];KRT75[unassigned1304];SPTB[12820899;20197550];ENAH[16336193];BCKDK[unassigned1304];ABI1[9593709];HIST3H3[30021884];BTK[21080425];PKP2[unassigned1304];ODF3B[unassigned1304];EVL[16336193];	158639530
7670	chr1	158747043	C	G	chr1:158747043	OR6N2	olfactory receptor family 6 subfamily N member 2	SNV	0/0	0.0	34_0	34	99.0	0/1	0.55	52_67	121	99.0			rs140526095,COSV59411570	EXONIC	YES	NM_001005278.1	Transcript	protein_coding	missense_variant		1/1	NM_001005278.1:c.383G>C	NP_001005278.1:p.Arg128Pro		-1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.		0.00397436	604.0	151974.0	1.0	32	0.96	PASS	nfe	0.00605865	412.0	0.00605865	412.0	0.00441059	1109.0	251440.0	1.0	80	1.0	PASS	nfe	0.00614592	699.0	0.00614592	699.0	0.0042121	655	0.009	28.0				21.7	2.251514	0.31	2	18	20	MutationAssessor_pred,PROVEAN_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR6N2	0.0	0.0	0.0	0.0	-47.0	33.0	22.0	4.0						0.745	0.02	0.000000000	0.998	1.026	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	158747043
7697	chr1	159683814	G	A	chr1:159683814	CRP	C-reactive protein	SNV	0/1	0.57	46_61	107	99.0	0/1	0.48	52_48	100	99.0			rs77832441,CM150492	EXONIC	YES	NM_000567.3	Transcript	protein_coding	missense_variant		2/2	NM_000567.3:c.176C>T	NP_000558.2:p.Thr59Met		-1.0	.,.,.,.	Uncertain_significance	no_assertion_criteria_provided	not_provided		.	.	.	25187575,26474449,23408856	0.00159864	243.0	152004.0	1.0	31	0.94	PASS	nfe	0.0028379	193.0	0.0028379	193.0	0.00144782	363.0	250722.0	0.0	100	1.0	PASS	nfe	0.00254855	289.0	0.00254855	289.0	0.0017492	272	0.002	7.0	0.00263	30.0		18.82	1.882214	0.545	9	12	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,PROVEAN_pred,fathmm-MKL_coding_pred	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	CRP	0.0	0.0	0.0	0.01	-28.0	-21.0	-26.0	-21.0						0.712	0.0	0.000000000	0.155	1.083	homeostasis/metabolism phenotype; immune system phenotype; cardiovascular system phenotype ; 			ciliary ganglion;beta cell islets;subthalamic nucleus;trigeminal ganglion;superior cervical ganglion;atrioventricular node;parietal lobe;skeletal muscle;	.	acute-phase response;inflammatory response;complement activation, classical pathway;opsonization;positive regulation of gene expression;negative regulation of macrophage derived foam cell differentiation;negative regulation of lipid storage;positive regulation of superoxide anion generation;innate immune response;defense response to Gram-positive bacterium;negative regulation of blood vessel diameter;regulation of interleukin-8 secretion	extracellular region;extracellular space	complement component C1q binding;calcium ion binding;protein binding;low-density lipoprotein particle binding;choline binding;identical protein binding;virion binding;low-density lipoprotein particle receptor binding	CRP[16642000];FCN2[17581635];HSPA5[30021884];LAMC3[21988832];RPL13A[21988832];MAPK8IP2[25814554];ESS2[21988832];GLUD1[21988832];FCGR2A[17785206];GMPPA[25416956];MAPK1[21988832];FCGR2C[17785206];MAPK3[18624398];	159683814
8123	chr1	165712556		A	chr1:165712555-165712556	TMCO1	transmembrane and coiled-coil domains 1	insertion	0/0	0.0	18_0	18	0.0	0/1	0.28	15_7	25	98.0			rs751227407	SPLICING	YES	NM_001256164.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	5/6		NM_001256164.1:c.375-8dup			-1.0		Benign	criteria_provided,_single_submitter	not_provided	Craniofacial dysmorphism, skeletal anomalies, and mental retardation syndrome, 213980 (3), Autosomal recessive	Cerebrofaciothoracic dysplasia	Disease-causing germline mutation(s) (loss of function) in	Narrow chest;Low-set, posteriorly rotated ears;Brachycephaly;Polyhydramnios;Cerebral cortical atrophy;Downslanted palpebral fissures;Wide mouth;Hypoplasia of the corpus callosum;Bifid ribs;Cleft palate;Cerebellar vermis hypoplasia;Cleft upper lip;Rib fusion;Hypertelorism;Midface retrusion;Hemivertebrae;Scoliosis;Ventriculomegaly;Thick eyebrow;Strabismus;Sprengel anomaly;Epicanthus;Short stature;Wide nose;Synophrys;Intellectual disability;Low posterior hairline;Hernia;Short nose;Coarse hair;Macrocephaly;Broad philtrum;Short neck;Cleft palate;Self-mutilation;Highly arched eyebrow;Sparse and thin eyebrow;Muscular hypotonia;Micrognathia;Inguinal hernia;Ptosis;Short neck;Sparse eyelashes;Low-set, posteriorly rotated ears;Microcephaly;Attention deficit hyperactivity disorder;Narrow forehead;Scoliosis;Low posterior hairline;Decreased fetal movement;Shawl scrotum;Overlapping toe;Postnatal growth retardation;Short stature;Polyhydramnios;Short nose;Gingival overgrowth;Wide nose;Abnormality of the kidney;Joint hypermobility;Autosomal recessive inheritance;Rib fusion;Hypertelorism;Long eyelashes;Posteriorly rotated ears;Strabismus;Sacral dimple;Growth hormone deficiency;Synophrys;Microdontia of primary teeth;Hypoplasia of the maxilla;Low anterior hairline;Bifid ribs;Anxiety;Bull's eye maculopathy;Hypoplasia of the corpus callosum;Cleft upper lip;Absent speech;Poliosis;Wide intermamillary distance;Thick eyebrow;Craniosynostosis;Postaxial hand polydactyly;Motor delay;Pes planus;Narrow chest;Atrial septal defect;Macrocephaly;Intellectual disability;Hemivertebrae;Flat face;Talipes equinovarus;Beaking of vertebral bodies;Epicanthus;Upslanted palpebral fissure;Low-set ears;Large for gestational age;High palate;Feeding difficulties;Brachycephaly;Supernumerary nipple;Neonatal hypotonia;Patent ductus arteriosus		0.00341111	326.0	95570.0	0.0	30	0.77	AS_VQSR	sas	0.00703364	23.0	0.00187086	82.0	0.0848718	13047.0	153726.0	0.0	44	0.89	InbreedingCoeff	eas	0.110033	1202.0	0.0792219	5498.0	0.0003087,0.0000579,0.0004116,0.0000129	48,9,64,2			0.00424	48.0		0.726	-0.198312		0	0	0			TMCO1	0.0	0.0	0.0	0.0	-19.0	-7.0	-19.0	26.0							0.0				homeostasis/metabolism phenotype; craniofacial phenotype; growth/size/body region phenotype; skeleton phenotype; nervous system phenotype ; mortality/aging ; behavior/neurological phenotype ; 			.	.	ER overload response;endoplasmic reticulum calcium ion homeostasis;calcium ion transmembrane transport	Golgi membrane;endoplasmic reticulum;integral component of endoplasmic reticulum membrane	calcium channel activity	GSTK1[17353931];JUN[25609649];TMEM63B[26496610];KMT2A[30021884];YIPF5[26496610];KIF14[26496610];HSCB[28380382];KNL1[30021884];CENPA[26496610];FAM177B[30021884];GH1[17353931];ATXN3[26496610];MPHOSPH9[30021884];TMBIM4[17353931];TCTN3[26638075];TCTN2[26638075];VHL[17353931];HIF1AN[26972000];MAPK6[26972000];	165712555
8127	chr1	166927240	G	A	chr1:166927240	ILDR2	immunoglobulin like domain containing receptor 2	SNV	0/0	0.0	46_0	46	99.0	0/1	0.4	87_59	147	99.0			rs756910329	EXONIC	YES	NM_199351.3	Transcript	protein_coding	missense_variant		2/10	NM_199351.3:c.145C>T	NP_955383.1:p.His49Tyr		-1.0	Immunoglobulin subtype,Immunoglobulin subtype,Immunoglobulin subtype,Immunoglobulin subtype,Immunoglobulin subtype,Immunoglobulin subtype,Immunoglobulin subtype					.	.	.		3.28571e-05	5.0	152174.0	0.0	32	0.96	PASS	afr	9.65158e-05	4.0	0.0	0.0	7.95665e-06	2.0	251362.0	0.0	100	1.0	PASS	afr	0.000123031	2.0	0.0	0.0	0.0000064	1						16.41	1.524092	0.118	2	18	20	LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	ILDR2	0.0	0.0	0.0	0.0	-6.0	36.0	31.0	-31.0						0.524	0.4	0.000000000	0.997	1.176	homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; 			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	.	response to glucose;insulin secretion;cell differentiation;pancreas development;homeostasis of number of cells within a tissue	endoplasmic reticulum membrane;integral component of membrane	.	SFN[15778465];HIST1H1B[30021884];HIST1H1C[30021884];	166927240
8148	chr1	167384806	C	T	chr1:167384806	POU2F1	POU class 2 homeobox 1	SNV	0/1	0.44	67_53	120	99.0	0/1	0.39	86_57	145	99.0			rs545723804,COSV54821266	EXONIC	YES	NM_002697.4	Transcript	protein_coding	missense_variant		16/16	NM_002697.4:c.2060C>T	NP_002688.3:p.Ala687Val		1.0	.,.,.,.					.	.	.		0.000118318	18.0	152132.0	0.0	31	0.96	PASS	amr	0.000458355	7.0	7.35056e-05	5.0	0.000226748	57.0	251380.0	0.0	88	1.0	PASS	amr	0.00112743	39.0	0.000123172	14.0	0.0001672	26	0.003	8.0				27.6	3.991335	0.262	15	6	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,PrimateAI_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	POU2F1	0.01	0.0	0.0	0.0	50.0	-24.0	-14.0	-44.0						0.181	0.91	0.000000000	0.998	1.026	endocrine/exocrine gland phenotype; taste/olfaction phenotype; integument phenotype ; growth/size/body region phenotype; craniofacial phenotype; nervous system phenotype ; mortality/aging ; hematopoietic system phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype ; embryo phenotype; vision/eye phenotype; 			pons;ciliary ganglion;dorsal root ganglion;cingulate cortex;superior cervical ganglion;atrioventricular node;testis;parietal lobe;skeletal muscle;	.	cytokine-mediated signaling pathway;snRNA transcription by RNA polymerase II;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II	nucleus;nucleoplasm;endoplasmic reticulum;intracellular membrane-bounded organelle;RNA polymerase II transcription factor complex	RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II core promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;RNA polymerase II general transcription initiation factor activity;sequence-specific DNA binding	FOXC2[25609649];FOXC1[25609649];ARRB1[unassigned1304];DMBX1[unassigned1304];FOXS1[25609649];FAM171A2[unassigned1304];PPIP5K2[unassigned1304];POGZ[25416956];ZMYM6[unassigned1304];SNIP1[unassigned1304];PRR20D[unassigned1304];TEAD1[8423815];LINC00311[unassigned1304];TEAD2[25609649];STOX1[unassigned1304];PLK3[25416956];ZC3H10[unassigned1304];ZFHX3[unassigned1304];POU2F1[25416956;unassigned1304];UBE2I[unassigned1304];NFYA[unassigned1304];KU-MEL-3[unassigned1304];RAB3IP[unassigned1304];POU6F2[unassigned1304];SNX24[unassigned1304];DDIT4L[unassigned1304];HCFC1[10629049];SP1[10976766;19070619];ARPC3[unassigned1304];SP4[25416956;unassigned1304];	167384806
8185	chr1	171168497	T	C	chr1:171168497	FMO2	flavin containing monooxygenase 2	SNV	0/0	0.0	34_0	34	99.0	0/1	0.4	36_25	62	99.0			rs140394156,COSV99070656	EXONIC	YES	NM_001460.5	Transcript	protein_coding	missense_variant		5/9	NM_001460.5:c.497T>C	NP_001451.2:p.Phe166Ser		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00410052	624.0	152176.0	1.0	32	0.95	PASS	amr	0.00687533	105.0	0.00643758	438.0	0.00396059	972.0	245418.0	2.0	28	0.71	PASS	amr	0.00599089	200.0	0.00597127	666.0	0.0037555	584	0.019	62.0	0.01342	153.0		29.7	4.232152		11	5	16	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,ClinPred_pred	FMO2	0.0	0.01	0.0	0.0	-36.0	-12.0	-12.0	-13.0						0.941	0.0	0.000000000	0.953	1.138	.			ciliary ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	Drug metabolism - cytochrome P450	organic acid metabolic process;NADP metabolic process;xenobiotic metabolic process;toxin metabolic process;drug metabolic process;NADPH oxidation;oxygen metabolic process	endoplasmic reticulum membrane;membrane;organelle membrane	monooxygenase activity;N,N-dimethylaniline monooxygenase activity;flavin adenine dinucleotide binding;NADP binding	.	171168497
8198	chr1	171504688	T	C	chr1:171504688	PRRC2C	proline rich coiled-coil 2C	SNV	0/0	0.0	33_0	33	99.0	0/1	0.52	36_39	75	99.0			rs144915557	EXONIC	YES	NM_001387844.1	Transcript	protein_coding	synonymous_variant		13/35	NM_001387844.1:c.1995T>C	NP_001374773.1:p.Tyr665%3D		1.0						.	.	.		0.000210197	32.0	152238.0	0.0	33	0.98	PASS	nfe	0.000279248	19.0	0.000279248	19.0	0.00028283	71.0	251034.0	0.0	68	1.0	PASS	amr	0.000404788	14.0	0.000246988	28.0	0.0002444	38	0.0	1.0				9.598	0.520895		0	0	0			PRRC2C	0.0	0.0	0.0	0.0	-46.0	10.0	48.0	-34.0							1.0	59.526883553			.			temporal lobe;olfactory bulb;testis - seminiferous tubule;prefrontal cortex;trigeminal ganglion;cingulate cortex;superior cervical ganglion;testis;adrenal cortex;pons;white blood cells;testis - interstitial;subthalamic nucleus;atrioventricular node;placenta;parietal lobe;globus pallidus;medulla oblongata;	.	hematopoietic progenitor cell differentiation	cytosol;membrane	RNA binding;protein C-terminus binding	GSK3B[29568061];HSPA8[29568061];GABARAPL1[20562859];VCAM1[22623428];RPL10[26496610];CSNK2A2[23455922];NR3C1[20195357];ESR2[21182203];SEM1[24811749];PPFIBP1[30021884];CANX[29568061];HIST3H3[30021884];MDM2[20195357];LCOR[26496610];PCBD1[20195357];HMGN3[30021884];BCAR1[28007913];	171504688
8203	chr1	171621386	G	A	chr1:171621386	MYOC	myocilin	SNV	0/1	0.43	84_64	149	99.0	0/0	0.0	36_0	36	99.0			rs145354114	EXONIC	YES	NM_000261.2	Transcript	protein_coding	synonymous_variant		1/3	NM_000261.2:c.366C>T	NP_000252.1:p.Gly122%3D		-1.0		Likely_benign	reviewed_by_expert_panel	Glaucoma_of_childhood|Glaucoma_1,_open_angle,_A|not_provided	Glaucoma 1A, primary open angle, 137750 (3), Autosomal dominant	Congenital glaucoma;Juvenile glaucoma	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Peripheral visual field loss;Glaucomatous visual field defect;Abnormal anterior chamber morphology;Open angle glaucoma;Ocular hypertension;Increased cup-to-disc ratio;Temporal optic disc pallor;Retinal vein occlusion;Central scotoma;Optic neuropathy;Abnormality iris morphology;Retinal arterial occlusion;High myopia;Visual loss;Nevus flammeus;Retinal detachment;Glaucoma;Autosomal dominant inheritance;Abnormal iris vasculature;Myopia;Glaucoma	30816137	0.0024047	366.0	152202.0	3.0	32	0.97	PASS	nfe	0.00389511	265.0	0.00389511	265.0	0.00258241	649.0	251316.0	0.0	86	1.0	PASS	sas	0.00369112	113.0	0.00328189	373.0	0.0023472	365	0.002	8.0	0.00246	28.0		0.347	-0.30745		0	0	0			MYOC	0.0	0.0	0.0	0.0	32.0	47.0	2.0	-44.0						0.209	0.0	51.083487825			vision/eye phenotype; normal phenotype; 			ciliary ganglion;thyroid;trachea;tongue;skeletal muscle;	.	osteoblast differentiation;negative regulation of cell-matrix adhesion;positive regulation of phosphatidylinositol 3-kinase signaling;skeletal muscle hypertrophy;myelination in peripheral nervous system;positive regulation of cell migration;neuron projection development;negative regulation of Rho protein signal transduction;non-canonical Wnt signaling pathway via JNK cascade;ERBB2-ERBB3 signaling pathway;regulation of MAPK cascade;clustering of voltage-gated sodium channels;positive regulation of stress fiber assembly;negative regulation of stress fiber assembly;positive regulation of focal adhesion assembly;positive regulation of protein kinase B signaling;positive regulation of mitochondrial depolarization;bone development;positive regulation of substrate adhesion-dependent cell spreading	extracellular space;mitochondrial outer membrane;mitochondrial inner membrane;mitochondrial intermembrane space;endoplasmic reticulum;rough endoplasmic reticulum;Golgi apparatus;cilium;cytoplasmic vesicle;node of Ranvier;collagen-containing extracellular matrix;extracellular exosome	fibronectin binding;frizzled binding;protein binding;receptor tyrosine kinase binding;myosin light chain binding;metal ion binding	SPARC[20926826];MYOC[11773029];MYL2[11773029];SGTA[unassigned1304];SPARCL1[20926826];	171621386
8228	chr1	172525158	G	A	chr1:172525158	SUCO	SUN domain containing ossification factor	SNV	0/1	0.69	15_33	48	99.0	0/0	0.0	34_0	34	99.0			rs114570278	EXONIC	YES	NM_016227.4	Transcript	protein_coding	synonymous_variant		4/23	NM_016227.4:c.912G>A	NP_057311.3:p.Lys304%3D		1.0						.	.	.		0.0036169	550.0	152064.0	1.0	32	0.97	PASS	amr	0.00563491	86.0	0.00548562	373.0	0.00334945	827.0	246906.0	1.0	32	0.86	PASS	nfe	0.00517001	579.0	0.00517001	579.0	0.0034340	534	0.01	30.0	0.00735	70.0		11.07	0.690027		0	0	0			SUCO	0.0	0.0	0.0	0.0	-30.0	-33.0	5.0	9.0							0.3	67.475283038			cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; growth/size/body region phenotype; renal/urinary system phenotype; skeleton phenotype; immune system phenotype; nervous system phenotype ; mortality/aging ; cardiovascular system phenotype ; hematopoietic system phenotype; behavior/neurological phenotype ; respiratory system phenotype; 			.	.	ossification;multicellular organism development;positive regulation of collagen biosynthetic process;protein folding in endoplasmic reticulum;positive regulation of osteoblast differentiation;regulation of bone remodeling	cytoplasm;rough endoplasmic reticulum;membrane;integral component of membrane;rough endoplasmic reticulum membrane	.	SLC35F6[26496610];PSMD11[26496610];RPL10[26496610];LAMA1[26496610];NDUFB11[26496610];ELOVL5[26496610];PREP[26496610];ISG20L2[26496610];TIMM23[26496610];GMCL1[26496610];PSTPIP1[17353931];NIPBL[26496610];HIST1H4A[30021884];MED24[26496610];BAP18[26496610];CALU[26496610];P4HB[26496610];PHLDA2[26496610];TNPO1[26496610];TAPT1[26496610];	172525158
8280	chr1	173823011	C	A	chr1:173823011	DARS2	aspartyl-tRNA synthetase 2, mitochondrial	SNV	0/1	0.54	31_37	68	99.0	0/0	0.0	35_0	35	99.0			rs149660059,COSV53405986	EXONIC	YES	NM_018122.5	Transcript	protein_coding	missense_variant		15/17	NM_018122.5:c.1642C>A	NP_060592.2:p.Leu548Met		1.0	Aminoacyl-tRNA synthetase, class II (D/K/N)&Aminoacyl-tRNA synthetase, class II,.,.,Aminoacyl-tRNA synthetase, class II (D/K/N)&Aminoacyl-tRNA synthetase, class II,.	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Leukoencephalopathy_with_brain_stem_and_spinal_cord_involvement-high_lactate_syndrome|not_specified|not_provided	Leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation, 611105 (3), Autosomal recessive	Leukoencephalopathy with brain stem and spinal cord involvement-high lactate syndrome	Disease-causing germline mutation(s) in	Increased CSF lactate;Peripheral axonal neuropathy;Tremor;Increased serum lactate;Unsteady gait;Generalized limb muscle atrophy;Spastic ataxia;Hearing impairment;Ptosis;Poor fine motor coordination;Slow saccadic eye movements;Flexion contracture;Hyporeflexia;Distal muscle weakness;Truncal ataxia;Difficulty walking;Seizure;Progressive cerebellar ataxia;Motor delay;Dysmyelinating leukodystrophy;Leg muscle stiffness;Hypoplasia of the corpus callosum;Clumsiness;Babinski sign;Optic atrophy;Abnormality of the dorsal column of the spinal cord;Muscular hypotonia;Cerebellar atrophy;Absent speech;Progressive spasticity;Impaired distal proprioception;Dysarthria;Slurred speech;Spastic/hyperactive bladder;Diplopia;Impaired pursuit initiation and maintenance;Cerebral atrophy;Mental deterioration;Impaired vibration sensation in the lower limbs;Polyneuropathy;Progressive inability to walk;Nystagmus;Intellectual disability;Impaired visuospatial constructive cognition;Ataxia;Spasticity;Cognitive impairment;Flexion contracture;Skeletal muscle atrophy;Slow progression;Hyporeflexia;Autosomal recessive inheritance;Leukoencephalopathy;Variable expressivity;Tremor;Muscle weakness;Motor delay;Dysarthria;Hyperreflexia;Nystagmus;Babinski sign;Peripheral axonal neuropathy	25741868	0.00406029	618.0	152206.0	4.0	32	0.97	PASS	sas	0.00413736	20.0	0.00352786	240.0	0.00439919	1106.0	251410.0	5.0	91	1.0	PASS	nfe	0.00358814	408.0	0.00358814	408.0	0.0036398	566	0.005	16.0	0.00649	74.0		23.2	2.825812	0.515	7	13	20	PolyPhen,Polyphen2_HDIV_pred,MutationTaster_pred,FATHMM_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	DARS2	0.0	0.0	0.0	0.0	-2.0	32.0	-30.0	32.0						0.406	0.0	0.000000000	0.988	1.026	mortality/aging ; 			ciliary ganglion;appendix;cingulate cortex;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	Alanine and aspartate metabolism;Aminoacyl-tRNA biosynthesis	tRNA aminoacylation for protein translation;tRNA aminoacylation;mitochondrial asparaginyl-tRNA aminoacylation	nucleus;mitochondrion;mitochondrial matrix	tRNA binding;aspartate-tRNA ligase activity;protein binding;ATP binding;protein homodimerization activity;aspartate-tRNA(Asn) ligase activity	AOC3[unassigned1304];FOXB1[25609649];BBS1[27173435;unassigned1312];EPHA8[21988832];MGST3[29568061];FOXH1[25609649];FOXI2[25609649];FBXO15[30021884];FOXL2[25609649];FOXL1[25609649];HSCB[28380382];HSPD1[29568061;30021884];AIFM1[29568061];DPYSL5[21988832];COL8A2[unassigned1304];PLP2[unassigned1304];CYB561[unassigned1304];TRMT61B[29568061];PDK1[29568061];	173823011
8591	chr1	186092080	T	C	chr1:186092080	HMCN1	hemicentin 1	SNV	0/0	0.0	43_0	43	99.0	0|1	0.53	17_19	36	99.0			rs200662005	SPLICING	YES	NM_031935.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	80/106		NM_031935.3:c.12230-3T>C			1.0		Uncertain_significance	criteria_provided,_single_submitter	not_provided	{Macular degeneration, age-related, 1}, 603075 (3), Autosomal dominant	.	.	Choroidal neovascularization;Progressive visual loss;Macular hemorrhage;Autosomal dominant inheritance;Macular degeneration;Foveal hypopigmentation;Macular drusen;Geographic atrophy		0.000137958	21.0	152220.0	0.0	33	0.96	PASS	amr	0.00104712	16.0	1.46981e-05	1.0	0.000164031	41.0	249952.0	0.0	92	1.0	PASS	amr	0.00112815	39.0	0.0	0.0	0.0001929	30	0.005	15.0	0.00386	44.0		8.649	0.423653		0	0	0			HMCN1	0.0	0.0	0.0	0.0	3.0	12.0	13.0	12.0	4.09166390641744e-05	0.0	9.529	-0.171	9.358	0.675	0.0				.			ciliary ganglion;subthalamic nucleus;dorsal root ganglion;skin;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skeletal muscle;globus pallidus;cerebellum;	.	cell cycle;homophilic cell adhesion via plasma membrane adhesion molecules;heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules;visual perception;response to bacterium;cell division	basement membrane;cell-cell adherens junction;cell cortex;cleavage furrow;collagen-containing extracellular matrix;extracellular exosome	extracellular matrix structural constituent;calcium ion binding;signaling receptor activity;protein homodimerization activity;cell adhesion molecule binding	B2M[30021884];	186092080
8644	chr1	196927114	A	G	chr1:196927114	CFHR2	complement factor H related 2	SNV	0/1	0.55	9_11	20	99.0	0/1	0.5	13_13	26	99.0			rs201349933	EXONIC	YES	NM_005666.4	Transcript	protein_coding	missense_variant		4/5	NM_005666.4:c.524A>G	NP_005657.1:p.Glu175Gly		1.0	.,Sushi/SCR/CCP domain&Sushi/SCR/CCP domain&Sushi/SCR/CCP domain&Sushi/SCR/CCP domain,.,Sushi/SCR/CCP domain&Sushi/SCR/CCP domain&Sushi/SCR/CCP domain&Sushi/SCR/CCP domain,.,.					.	.	.		1.97195e-05	3.0	152134.0	0.0	32	0.96	PASS	eas	0.00057759	3.0	0.0	0.0	1.59152e-05	4.0	251332.0	0.0	90	1.0	PASS	eas	0.000217486	4.0	0.0	0.0	0.0000193	3						22.1	2.322129	0.303	4	15	19	SIFT,M-CAP_pred,MutationAssessor_pred,PROVEAN_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CFHR2	0.03	0.0	0.0	0.0	-24.0	-12.0	0.0	-5.0						0.687	0.0	0.000000000	0.004	0.94	.			.	.	regulation of complement activation;negative regulation of protein binding;positive regulation of cytolysis	extracellular region;protein-containing complex	protein binding;protein homodimerization activity;protein heterodimerization activity	.	196927114
8751	chr1	202287283	C	G	chr1:202287283	LGR6	leucine rich repeat containing G protein-coupled receptor 6	SNV	0/1	0.48	60_57	118	99.0	0/1	0.55	42_51	93	99.0			rs145718977	EXONIC	YES	NM_001017403.2	Transcript	protein_coding	missense_variant		18/18	NM_001017403.2:c.1852C>G	NP_001017403.1:p.Leu618Val		1.0	.,.,.					.	.	.		5.91079e-05	9.0	152264.0	0.0	33	0.98	PASS	nfe	0.000102872	7.0	0.000102872	7.0	4.38072e-05	11.0	251100.0	0.0	63	0.99	PASS	nfe	7.92212e-05	9.0	7.92212e-05	9.0	0.0000064,0.0000386	1,6						24.1	3.207536	0.496	19	2	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PrimateAI_pred,BayesDel_addAF_pred	LGR6	0.0	0.0	0.0	0.0	28.0	4.0	-1.0	40.0						0.232	0.0	0.000000000	0.055	1.026	normal phenotype; 			ciliary ganglion;atrioventricular node;globus pallidus;	.	G protein-coupled receptor signaling pathway;Wnt signaling pathway;positive regulation of Wnt signaling pathway;positive regulation of cell migration;positive regulation of canonical Wnt signaling pathway;bone regeneration	plasma membrane;integral component of plasma membrane;vesicle;trans-Golgi network membrane	transmembrane signaling receptor activity;G protein-coupled receptor activity;protein binding;protein-hormone receptor activity	.	202287283
8848	chr1	203766895	C	T	chr1:203766895	ZBED6	zinc finger BED-type containing 6	SNV	0/1	0.55	43_53	96	99.0	0/1	0.47	57_52	110	99.0			rs142248061,COSV100142405	EXONIC	YES	NM_001174108.2	Transcript	protein_coding	missense_variant		1/1	NM_001174108.2:c.245C>T	NP_001167579.1:p.Ala82Val		1.0						.	.	.		0.00299027	455.0	152160.0	2.0	32	0.96	PASS	amr	0.00680717	104.0	0.00127889	87.0	0.00280114	373.0	133160.0	0.0	23	0.53	PASS	amr	0.00637808	155.0	0.0018844	98.0	0.0004952	77	0.009	27.0				22.7	2.562883	0.116	2	15	17	SIFT,MutationTaster_pred	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZBED6	0.0	0.0	0.0	0.0	8.0	6.0	-46.0	11.0								0.000000000	0.999	1.026	muscle phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; renal/urinary system phenotype; liver/biliary system phenotype; 			.	.	regulation of transcription by RNA polymerase II;negative regulation of transcription, DNA-templated	nucleus;nucleolus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding;protein dimerization activity	SMC6[26496610];	203766895
9017	chr1	206516261	C	T	chr1:206516261	SRGAP2	SLIT-ROBO Rho GTPase activating protein 2	SNV	0/1	0.39	25_16	41	99.0	0/1	0.55	18_23	42	99.0			rs201036189	EXONIC	YES	NM_015326.5	Transcript	protein_coding	missense_variant		1/20	NM_015326.5:c.64C>T	NP_056141.2:p.Arg22Trp		1.0	FCH domain&F-BAR domain&FCH domain,FCH domain&F-BAR domain&FCH domain,FCH domain&F-BAR domain&FCH domain					.	.	.						19	0.45							0.499667	111138.0	222424.0	1.0	35	0.64	InbreedingCoeff	eas	0.499875	8006.0	0.499593	49050.0	0.0027974	435	0.045	144.0	0.44631	823.0		28.2	4.057073		7	6	13	LRT_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,ClinPred_pred																		0.999	0.947	mortality/aging ; nervous system phenotype ; 			cerebellum peduncles;cerebellum;	Axon guidance	lamellipodium assembly involved in ameboidal cell migration;signal transduction;cell population proliferation;extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration;negative regulation of cell migration;substrate adhesion-dependent cell spreading;positive regulation of GTPase activity;filopodium assembly;neuron projection morphogenesis;actin filament severing;regulation of small GTPase mediated signal transduction;negative regulation of cell death;dendritic spine development;negative regulation of neuron migration	nucleus;cytoplasm;cytosol;plasma membrane;postsynaptic density;lamellipodium;cell junction;dendritic spine head;postsynaptic membrane;phagocytic vesicle	GTPase activator activity;protein binding;identical protein binding;protein homodimerization activity;Rac GTPase binding	RTKN[unassigned1312];YWHAB[24255178];MAST3[unassigned1312];CEP19[26638075];DENND1A[unassigned1312];ZBTB21[unassigned1312];CBY1[unassigned1312];TESK2[unassigned1312];FASLG[16318909;19807924];GPHN[26365803];EDC3[unassigned1312];ROBO1[26365803];RPTOR[unassigned1312];FAM110A[unassigned1312];SRGAP2C[22559944];SYDE1[unassigned1312];PCM1[26638075];SIPA1L1[unassigned1312];SH3PXD2A[unassigned1312];CHEK1[unassigned1312];FAM110B[unassigned1312];FAM53C[unassigned1312];KIF13B[unassigned1312];KIF1C[unassigned1312];KIF1B[unassigned1312];RAC1[20810653];YWHAG[15324660;17353931];YWHAH[17979178];RALGPS2[unassigned1312];MAGI1[unassigned1312];PRMT5[20810653];KSR1[unassigned1312];NAV1[unassigned1312];KCTD3[unassigned1312];GAB2[unassigned1312];CDC25C[unassigned1312];YWHAZ[15161933];HIST2H2BF[30021884];TANC2[unassigned1312];CDC25B[unassigned1312];TIAM1[unassigned1312];GIGYF1[unassigned1312];DEPDC1B[unassigned1312];MELK[unassigned1312];ZNF638[unassigned1312];TBC1D25[unassigned1312];EIF4E2[unassigned1312];AURKAIP1[29568061];EZR[29568061];PHLDB2[unassigned1312];UBA52[30021884];HDAC4[unassigned1312];MAPKAP1[unassigned1312];PPM1H[unassigned1312];HTT[17500595];AGAP1[unassigned1312];RASAL2[unassigned1312];GIGYF2[unassigned1312];CAMSAP2[unassigned1312];HDAC7[unassigned1312];LIMA1[unassigned1312];PAK1[20810653];LARP1[unassigned1312];INPP5E[unassigned1312];MAP3K21[unassigned1312];SH3BP4[unassigned1312];DISC1[17043677];SRGAP2[20810653;26365803];RAB11FIP2[unassigned1312];NADK[unassigned1312];SRSF12[unassigned1312];ANKRD34A[unassigned1312];STARD13[unassigned1312];OSBPL6[unassigned1312];DENND4A[unassigned1312];USP21[unassigned1312];DENND4C[unassigned1312];RAB3IP[unassigned1312];PLEKHA5[unassigned1312];YLPM1[26365803];CGN[unassigned1312];PTPN13[unassigned1312];PTPN14[unassigned1312];DCLK1[unassigned1312];PLEKHA7[unassigned1312];SH3RF3[unassigned1312];AFDN[unassigned1312];FMNL1[21148482];LRFN1[unassigned1312];NF1[unassigned1312];LPIN3[unassigned1312];CDK16[unassigned1312];	206516261
9045	chr1	206566904	T	C	chr1:206566904	SRGAP2	SLIT-ROBO Rho GTPase activating protein 2	SNV	0/1	0.48	54_50	104	99.0	0/1	0.56	37_48	85	99.0			rs2919105,COSV55332743	SPLICING	YES	NM_015326.5	Transcript	protein_coding	splice_region_variant,synonymous_variant		4/20	NM_015326.5:c.447T>C	NP_056141.2:p.Arg149%3D		1.0						.	.	.		3.97498e-05	6.0	150944.0	0.0	20	0.53	PASS	afr	0.00014595	6.0	0.0	0.0	0.499907	123253.0	246552.0	1.0	66	1.0	InbreedingCoeff	eas	0.499943	8844.0	0.499893	55815.0	0.0313175	4870	0.212	679.0	0.47722	880.0		17.08	1.637898		0	0	0														11.177	-0.139	11.039						mortality/aging ; nervous system phenotype ; 			cerebellum peduncles;cerebellum;	Axon guidance	lamellipodium assembly involved in ameboidal cell migration;signal transduction;cell population proliferation;extension of a leading process involved in cell motility in cerebral cortex radial glia guided migration;negative regulation of cell migration;substrate adhesion-dependent cell spreading;positive regulation of GTPase activity;filopodium assembly;neuron projection morphogenesis;actin filament severing;regulation of small GTPase mediated signal transduction;negative regulation of cell death;dendritic spine development;negative regulation of neuron migration	nucleus;cytoplasm;cytosol;plasma membrane;postsynaptic density;lamellipodium;cell junction;dendritic spine head;postsynaptic membrane;phagocytic vesicle	GTPase activator activity;protein binding;identical protein binding;protein homodimerization activity;Rac GTPase binding	RTKN[unassigned1312];YWHAB[24255178];MAST3[unassigned1312];CEP19[26638075];DENND1A[unassigned1312];ZBTB21[unassigned1312];CBY1[unassigned1312];TESK2[unassigned1312];FASLG[16318909;19807924];GPHN[26365803];EDC3[unassigned1312];ROBO1[26365803];RPTOR[unassigned1312];FAM110A[unassigned1312];SRGAP2C[22559944];SYDE1[unassigned1312];PCM1[26638075];SIPA1L1[unassigned1312];SH3PXD2A[unassigned1312];CHEK1[unassigned1312];FAM110B[unassigned1312];FAM53C[unassigned1312];KIF13B[unassigned1312];KIF1C[unassigned1312];KIF1B[unassigned1312];RAC1[20810653];YWHAG[15324660;17353931];YWHAH[17979178];RALGPS2[unassigned1312];MAGI1[unassigned1312];PRMT5[20810653];KSR1[unassigned1312];NAV1[unassigned1312];KCTD3[unassigned1312];GAB2[unassigned1312];CDC25C[unassigned1312];YWHAZ[15161933];HIST2H2BF[30021884];TANC2[unassigned1312];CDC25B[unassigned1312];TIAM1[unassigned1312];GIGYF1[unassigned1312];DEPDC1B[unassigned1312];MELK[unassigned1312];ZNF638[unassigned1312];TBC1D25[unassigned1312];EIF4E2[unassigned1312];AURKAIP1[29568061];EZR[29568061];PHLDB2[unassigned1312];UBA52[30021884];HDAC4[unassigned1312];MAPKAP1[unassigned1312];PPM1H[unassigned1312];HTT[17500595];AGAP1[unassigned1312];RASAL2[unassigned1312];GIGYF2[unassigned1312];CAMSAP2[unassigned1312];HDAC7[unassigned1312];LIMA1[unassigned1312];PAK1[20810653];LARP1[unassigned1312];INPP5E[unassigned1312];MAP3K21[unassigned1312];SH3BP4[unassigned1312];DISC1[17043677];SRGAP2[20810653;26365803];RAB11FIP2[unassigned1312];NADK[unassigned1312];SRSF12[unassigned1312];ANKRD34A[unassigned1312];STARD13[unassigned1312];OSBPL6[unassigned1312];DENND4A[unassigned1312];USP21[unassigned1312];DENND4C[unassigned1312];RAB3IP[unassigned1312];PLEKHA5[unassigned1312];YLPM1[26365803];CGN[unassigned1312];PTPN13[unassigned1312];PTPN14[unassigned1312];DCLK1[unassigned1312];PLEKHA7[unassigned1312];SH3RF3[unassigned1312];AFDN[unassigned1312];FMNL1[21148482];LRFN1[unassigned1312];NF1[unassigned1312];LPIN3[unassigned1312];CDK16[unassigned1312];	206566904
9214	chr1	212156041	A	G	chr1:212156041	INTS7	integrator complex subunit 7	SNV	0/1	0.26	31_11	42	99.0	0/1	0.61	24_37	61	99.0			rs146700490	EXONIC	YES	NM_015434.4	Transcript	protein_coding	missense_variant		9/20	NM_015434.4:c.1109T>C	NP_056249.1:p.Ile370Thr		-1.0	.,.,.,.					.	.	.		0.00355383	541.0	152230.0	3.0	32	0.97	PASS	amr	0.00543549	83.0	0.00536449	365.0	0.00388223	956.0	246250.0	2.0	36	0.74	PASS	nfe	0.0057792	642.0	0.0057792	642.0	0.0042057	654	0.011	35.0				26.6	3.855637	0.423	12	9	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationTaster_pred,PrimateAI_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	INTS7	0.0	0.0	0.1	0.0	38.0	-23.0	-23.0	20.0						0.41	0.86	0.000000000	0.998	1.312	.			.	.	DNA damage checkpoint;snRNA processing;snRNA 3'-end processing;snRNA transcription by RNA polymerase II;cellular response to ionizing radiation	nucleus;nucleoplasm;chromosome;cytoplasm;nuclear body;integrator complex	protein binding	RALA[26496610];GOLT1B[26496610];ACTR5[26496610];VPS26A[26496610];TMEM173[29251827];MKI67[26949251];CKAP5[26496610];TANK[unassigned1774];FGD1[26496610];PML[26496610];PPP2CA[28330616];ANLN[26496610];SYNCRIP[26496610];PPP2R1A[28330616];HNRNPD[26496610];KIF1C[26496610];BUB3[26496610];CA8[25910212];	212156041
9220	chr1	212194561		A	chr1:212194560-212194561	INTS7	integrator complex subunit 7	insertion	0/1	0.24	19_6	25	94.0	0/0	0.0	36_0	36	99.0			rs771470578	SPLICING	YES	NM_015434.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/19		NM_015434.4:c.95-7dup			-1.0						.	.	.		6.17818e-05	9.0	145674.0	0.0	32	0.94	PASS	sas	0.000216638	1.0	7.56681e-05	5.0	0.0122717	1634.0	133152.0	0.0	30	0.63	RF	amr	0.0226045	318.0	0.00985438	651.0	0.0001929,0.0001994,0.0116782	30,31,1816						0.988	-0.152474		0	0	0			INTS7	0.0	0.0	0.0	0.0	-6.0	45.0	-14.0	-26.0						0.41	0.86				.			.	.	DNA damage checkpoint;snRNA processing;snRNA 3'-end processing;snRNA transcription by RNA polymerase II;cellular response to ionizing radiation	nucleus;nucleoplasm;chromosome;cytoplasm;nuclear body;integrator complex	protein binding	RALA[26496610];GOLT1B[26496610];ACTR5[26496610];VPS26A[26496610];TMEM173[29251827];MKI67[26949251];CKAP5[26496610];TANK[unassigned1774];FGD1[26496610];PML[26496610];PPP2CA[28330616];ANLN[26496610];SYNCRIP[26496610];PPP2R1A[28330616];HNRNPD[26496610];KIF1C[26496610];BUB3[26496610];CA8[25910212];	212194560
9276	chr1	215914884		A	chr1:215914883-215914884	USH2A	usherin	insertion	0/0	0.0	30_0	30	75.0	0/1	0.14	18_4	28	57.0			rs34565443	SPLICING	YES	NM_206933.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	59/71		NM_206933.4:c.11549-5dup			-1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	Usher_syndrome,_type_2A|not_specified|not_provided	Usher syndrome, type 2A, 276901 (3), Autosomal recessive; Retinitis pigmentosa 39, 613809 (3)	Retinitis pigmentosa;Usher syndrome type 2	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Autosomal recessive inheritance;Attenuation of retinal blood vessels;Bone spicule pigmentation of the retina;Visual field defect;Rod-cone dystrophy;Abnormal electroretinogram;Cataract;Schizophrenia;Visual loss;Scotoma;Hemianopia;Nystagmus;Depressivity;Abnormal electroretinogram;Nyctalopia;Anxiety;Aplasia/Hypoplasia of the cerebellum;Hallucinations;Abnormality of dental enamel;Microdontia;Iris hypopigmentation;Ataxia;Carious teeth;Sensorineural hearing impairment;Cerebral cortical atrophy;Subcortical cerebral atrophy;Abnormality of dental color;Myopia;Hyperinsulinemia;Optic atrophy;Nystagmus;Abnormal retinal vascular morphology;Obesity;Hypoplasia of penis;Cataract;Abnormality of retinal pigmentation;Keratoconus;Progressive night blindness;Ophthalmoplegia;Abnormal testis morphology;Atypical scarring of skin;Hyperreflexia;Sensorineural hearing impairment;Blindness;Type II diabetes mellitus;Conductive hearing impairment;Photophobia;Intellectual disability;Anteverted nares;Abnormal electroretinogram;Wide nasal bridge;Hypogonadism;Glaucoma;Congenital sensorineural hearing impairment;Autosomal recessive inheritance;Rod-cone dystrophy	24033266	0.000930508	129.0	138634.0	1.0	32	0.91	PASS	nfe	0.000880171	56.0	0.000880171	56.0	0.0571712	6751.0	118084.0	0.0	48	0.88	PASS	amr	0.0767421	1207.0	0.0481454	2744.0	0.0001994,0.0403977,0.0001093	31,6282,17			0.00959	109.0		1.968	-0.047714		0	0	0			USH2A	0.08	0.0	0.0	0.0	-8.0	19.0	-8.0	2.0						0.924	0.0				nervous system phenotype ; hearing/vestibular/ear phenotype; vision/eye phenotype; 			ciliary ganglion;temporal lobe;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skin;adrenal gland;skeletal muscle;cerebellum;	.	visual perception;sensory perception of sound;hair cell differentiation;establishment of protein localization;photoreceptor cell maintenance;maintenance of animal organ identity;response to stimulus;sensory perception of light stimulus;inner ear receptor cell differentiation	photoreceptor inner segment;stereocilia ankle link;stereocilia ankle link complex;basement membrane;cytoplasm;integral component of membrane;apical plasma membrane;photoreceptor connecting cilium;stereocilium bundle;ciliary basal body;neuronal cell body;terminal bouton;stereocilium membrane;periciliary membrane compartment;USH2 complex	protein binding;collagen binding;myosin binding;protein homodimerization activity	USH1C[16301216];MAPT[26402096];ESR2[25604459];	215914883
9442	chr1	227171484	C	T	chr1:227171484	COQ8A	coenzyme Q8A	SNV	0/1	0.36	54_31	85	99.0	0/0	0.0	35_0	35	99.0			rs17849927	EXONIC	YES	NM_020247.5	Transcript	protein_coding	synonymous_variant		10/15	NM_020247.5:c.1185C>T	NP_064632.2:p.Ile395%3D		1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Coenzyme_Q10_deficiency,_primary,_4|not_specified|not_provided	Coenzyme Q10 deficiency, primary, 4, 612016 (3), Autosomal recessive	Autosomal recessive ataxia due to ubiquinone deficiency	Disease-causing germline mutation(s) in	Variable expressivity;Abnormal pyramidal sign;Seizure;Ataxia;Global developmental delay;Hyperreflexia;Myoclonus;Autosomal recessive inheritance;Lactic acidosis;Tremor;Increased intramyocellular lipid droplets;Cerebellar atrophy;Proximal muscle weakness;Intellectual disability;Generalized hypotonia;Exercise intolerance;Pes cavus;Hearing impairment;Increased CSF lactate;EMG abnormality;Strabismus;Focal T2 hypointense basal ganglia lesion;Seizure;Progressive cerebellar ataxia;Proximal muscle weakness;Central hypotonia;Abnormal pyramidal sign;Neurodevelopmental delay;Developmental regression;Exercise intolerance;Cerebellar atrophy;Myoclonus;Lactic acidosis;Tremor;Talipes cavus equinovarus;Increased serum lactate;Gynecomastia;Intellectual disability, moderate;Dystonia;Brisk reflexes		0.00532915	811.0	152182.0	6.0	34	0.98	PASS	nfe	0.00910187	619.0	0.00910187	619.0	0.00512039	1276.0	249200.0	5.0	100	0.97	PASS	nfe	0.00833497	936.0	0.00833497	936.0	0.0049452	769	0.007	22.0	0.00693	79.0		6.622	0.255047		0	0	0			ADCK3	0.0	0.0	0.0	0.0	12.0	-22.0	3.0	31.0								0.000000000			.			.	.	protein phosphorylation;ubiquinone biosynthetic process;phosphorylation	mitochondrion;integral component of membrane;extrinsic component of mitochondrial inner membrane	protein kinase activity;protein binding;ATP binding;kinase activity;ADP binding	GPI[27499296];STOML2[27499296];MAGED1[17353931];LRRK2[24725412];MRPL58[20186120];DTX2[25910212];MTIF3[unassigned1304];ABHD5[unassigned1304];MRM1[unassigned1304];STX10[unassigned1304];SMPD2[unassigned1304];IRAK2[21903422];ORMDL3[unassigned1304];MAL2[unassigned1304];RABAC1[16189514;25416956;unassigned1304;25910212];PDK2[27499296];RPRM[unassigned1304];SH3GLB1[unassigned1304;25910212];CCDC34[unassigned1304];DESI2[unassigned1304];CMTM4[unassigned1304];CMTM5[unassigned1304;25910212];RIPK4[26972000];CMTM6[unassigned1304];PBX3[unassigned1304];AGTRAP[25416956;unassigned1304;25910212];TFIP11[25416956;unassigned1304;25910212];COQ9[unassigned1304];JOSD2[unassigned1304];TPD52L2[unassigned1304];TMCO2[unassigned1304];COQ6[27499296];COX6B1[27499296];NDUFAF8[27499296];TMEM159[25416956;25910212];ADCK2[27499296];TMEM239[25416956;25910212];ADCK5[27499296];COQ8B[27499296];REEP6[25416956;unassigned1304;25910212];SLC25A5[27499296];	227171484
9460	chr1	228345440		GGGGGGGGGGGGGG	chr1:228345439-228345440	GJC2	gap junction protein gamma 2	insertion	0|1	0.24	15_5	21	99.0	0/0	0.0	33_0	33	99.0				SPLICING	YES	NM_020435.4	Transcript	protein_coding	splice_acceptor_variant	1/1		NM_020435.4:c.-19_-18insGGGGGGGGGGGGGG			1.0					Lymphatic malformation 3, 613480 (3), Autosomal dominant; ?Spastic paraplegia 44, autosomal recessive, 613206 (3), Autosomal recessive; Leukodystrophy, hypomyelinating, 2, 608804 (3), Autosomal recessive	Pelizaeus-Merzbacher-like disease due to GJC2 mutation;Autosomal recessive spastic paraplegia type 44;Milroy disease	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Dysarthria;Muscular hypotonia of the trunk;Ataxia;Rigidity;Sensory axonal neuropathy;Decreased motor nerve conduction velocity;Leukodystrophy;Seizure;Global developmental delay;Autosomal recessive inheritance;Spastic paraparesis;Infantile onset;Demyelinating motor neuropathy;Babinski sign;Rotary nystagmus;Cerebral hypomyelination;Poor speech;Cerebral atrophy;Facial palsy;Myopia;Progressive spasticity;Cognitive impairment;Optic atrophy;Choreoathetosis;Motor delay;Intention tremor;Dystonia;Head titubation;Urinary bladder sphincter dysfunction;Dysarthria;Pes cavus;Abnormal auditory evoked potentials;Abnormality of visual evoked potentials;Sensorineural hearing impairment;Seizure;Ataxia;Abnormality of somatosensory evoked potentials;Difficulty walking;Sensory impairment;Delayed gross motor development;Abnormal motor evoked potentials;Lower limb spasticity;CNS hypomyelination;Strabismus;Sensorineural hearing impairment;Pes cavus;Distal sensory impairment;Dysarthria;Hyperreflexia;Hypoplasia of the corpus callosum;Lower limb spasticity;Scoliosis;Spastic gait;Intention tremor;Cognitive impairment;Slow saccadic eye movements;Babinski sign;Upper limb spasticity;Dysmetria;Leukoencephalopathy;Autosomal recessive inheritance;Spastic paraplegia;Seizure;Urinary incontinence;Constipation;Specific learning disability;Ankle swelling;Pedal edema;Toenail dysplasia;Behavioral abnormality;Lichenification;Abnormal facial shape;Hyperkeratosis;Erysipelas;Angiosarcoma;Predominantly lower limb lymphedema;Neoplasm of the skin;Cellulitis;Epicanthus;Hydrocele testis;Varicose veins;Recurrent skin infections;Incomplete penetrance;Lymphedema;Cellulitis;Autosomal dominant inheritance		1.34865e-05	2.0	148296.0	0.0	33	0.95	AS_VQSR	sas	0.000215424	1.0	0.0	0.0					16	0.46											0.00059	6.0					0	0	0																		0.48				immune system phenotype; nervous system phenotype ; vision/eye phenotype; hematopoietic system phenotype; normal phenotype; mortality/aging ; behavior/neurological phenotype ; cellular phenotype; 			.	Cell Communication	regulation of protein phosphorylation;cell-cell signaling;brain development;response to toxic substance;positive regulation of gene expression;cell communication by electrical coupling;transmembrane transport;positive regulation of oligodendrocyte progenitor proliferation;positive regulation of calcium ion transmembrane transport;negative regulation of G1/S transition of mitotic cell cycle	gap junction;connexin complex;integral component of membrane;paranode region of axon;perikaryon;myelin sheath;proximal neuron projection	gap junction channel activity involved in cell communication by electrical coupling	CHRM2[28298427];PTGER4[28298427];LTB4R2[28298427];GPR35[28298427];ALB[15174051];F2RL1[28298427];ADRB2[28298427];	228345439
9461	chr1	228345913	GAG		chr1:228345913-228345915	GJC2	gap junction protein gamma 2	deletion	0/1	0.25	27_9	36	99.0	0/1	0.11	45_6	53	99.0			rs746050475	EXONIC	YES	NM_020435.4	Transcript	protein_coding	inframe_deletion		2/2	NM_020435.4:c.472_474del	NP_065168.2:p.Glu158del		1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Spastic_paraplegia|not_provided	Lymphatic malformation 3, 613480 (3), Autosomal dominant; ?Spastic paraplegia 44, autosomal recessive, 613206 (3), Autosomal recessive; Leukodystrophy, hypomyelinating, 2, 608804 (3), Autosomal recessive	Pelizaeus-Merzbacher-like disease due to GJC2 mutation;Autosomal recessive spastic paraplegia type 44;Milroy disease	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Dysarthria;Muscular hypotonia of the trunk;Ataxia;Rigidity;Sensory axonal neuropathy;Decreased motor nerve conduction velocity;Leukodystrophy;Seizure;Global developmental delay;Autosomal recessive inheritance;Spastic paraparesis;Infantile onset;Demyelinating motor neuropathy;Babinski sign;Rotary nystagmus;Cerebral hypomyelination;Poor speech;Cerebral atrophy;Facial palsy;Myopia;Progressive spasticity;Cognitive impairment;Optic atrophy;Choreoathetosis;Motor delay;Intention tremor;Dystonia;Head titubation;Urinary bladder sphincter dysfunction;Dysarthria;Pes cavus;Abnormal auditory evoked potentials;Abnormality of visual evoked potentials;Sensorineural hearing impairment;Seizure;Ataxia;Abnormality of somatosensory evoked potentials;Difficulty walking;Sensory impairment;Delayed gross motor development;Abnormal motor evoked potentials;Lower limb spasticity;CNS hypomyelination;Strabismus;Sensorineural hearing impairment;Pes cavus;Distal sensory impairment;Dysarthria;Hyperreflexia;Hypoplasia of the corpus callosum;Lower limb spasticity;Scoliosis;Spastic gait;Intention tremor;Cognitive impairment;Slow saccadic eye movements;Babinski sign;Upper limb spasticity;Dysmetria;Leukoencephalopathy;Autosomal recessive inheritance;Spastic paraplegia;Seizure;Urinary incontinence;Constipation;Specific learning disability;Ankle swelling;Pedal edema;Toenail dysplasia;Behavioral abnormality;Lichenification;Abnormal facial shape;Hyperkeratosis;Erysipelas;Angiosarcoma;Predominantly lower limb lymphedema;Neoplasm of the skin;Cellulitis;Epicanthus;Hydrocele testis;Varicose veins;Recurrent skin infections;Incomplete penetrance;Lymphedema;Cellulitis;Autosomal dominant inheritance		0.000186776	28.0	149912.0	0.0	32	0.94	PASS	sas	0.000829187	4.0	0.00020811	14.0	0.0825921	3454.0	41820.0	0.0	6	0.21	RF	afr	0.112217	248.0	0.0832239	1268.0	0.0000386,0.0001608	6,25			0.0125	134.0		12.91	0.9266		0	0	0			GJC2	0.0	0.0	0.0	0.0	10.0	4.0	-21.0	43.0							0.48				immune system phenotype; nervous system phenotype ; vision/eye phenotype; hematopoietic system phenotype; normal phenotype; mortality/aging ; behavior/neurological phenotype ; cellular phenotype; 			.	Cell Communication	regulation of protein phosphorylation;cell-cell signaling;brain development;response to toxic substance;positive regulation of gene expression;cell communication by electrical coupling;transmembrane transport;positive regulation of oligodendrocyte progenitor proliferation;positive regulation of calcium ion transmembrane transport;negative regulation of G1/S transition of mitotic cell cycle	gap junction;connexin complex;integral component of membrane;paranode region of axon;perikaryon;myelin sheath;proximal neuron projection	gap junction channel activity involved in cell communication by electrical coupling	CHRM2[28298427];PTGER4[28298427];LTB4R2[28298427];GPR35[28298427];ALB[15174051];F2RL1[28298427];ADRB2[28298427];	228345912
9500	chr1	230824254	C	T	chr1:230824254	COG2	component of oligomeric golgi complex 2	SNV	0/1	0.53	38_45	85	99.0	0/1	0.51	42_43	85	99.0			rs143945965	EXONIC	YES	NM_007357.3	Transcript	protein_coding	synonymous_variant		15/18	NM_007357.3:c.1740C>T	NP_031383.1:p.Phe580%3D		1.0					?Congenital disorder of glycosylation, type IIq, 617395 (3), Autosomal recessive	COG2-CDG	Disease-causing germline mutation(s) (loss of function) in	Diffuse cerebral atrophy;Infantile onset;Postnatal microcephaly;Hypoplasia of the corpus callosum;Small pituitary gland;Global developmental delay;Abnormal glycosylation;Autosomal recessive inheritance;Elevated hepatic transaminase;Seizure;Spastic tetraplegia;Generalized tonic seizure;Spastic tetraplegia;Decreased liver function;Postnatal microcephaly;Hypoplasia of the corpus callosum;Small pituitary gland;Global developmental delay;Decreased circulating copper concentration;Decreased serum ceruloplasmin;Hepatosplenomegaly;Diffuse cerebral atrophy		0.000466804	71.0	152098.0	0.0	32	0.96	PASS	afr	0.00159382	66.0	7.35056e-05	5.0	0.000151105	38.0	251480.0	0.0	81	1.0	PASS	afr	0.00172244	28.0	4.39537e-05	5.0	0.0001736	27	0.0	1.0	0.00042	4.0		12.26	0.839802		0	0	0			COG2	0.02	0.0	0.0	0.0	15.0	-33.0	-14.0	50.0						0.832	0.0	35.803019401			homeostasis/metabolism phenotype; growth/size/body region phenotype; hematopoietic system phenotype; 			.	.	endoplasmic reticulum to Golgi vesicle-mediated transport;intra-Golgi vesicle-mediated transport;Golgi organization;protein transport	Golgi membrane;Golgi stack;cytosol;Golgi transport complex;trans-Golgi network membrane	protein binding;protein transporter activity;protein-containing complex binding	CEP68[unassigned1304];MAPK8[26496610];RNASEH2A[26496610];COG4[15047703];HNRNPD[26496610];MTUS2[25416956;unassigned1304];LZTS1[unassigned1304];NUP58[26496610];	230824254
9504	chr1	230841882	T	A	chr1:230841882	AGT	angiotensinogen	SNV	0/1	0.49	71_68	139	99.0	0/1	0.45	71_58	129	99.0				EXONIC	YES	NM_001382817.3	Transcript	protein_coding	synonymous_variant		3/5	NM_001382817.3:c.894A>T	NP_001369746.2:p.Ser298%3D		-1.0					Renal tubular dysgenesis, 267430 (3), Autosomal recessive; {Preeclampsia, susceptibility to} (3); {Hypertension, essential, susceptibility to}, 145500 (3), Multifactorial	Renal tubular dysgenesis of genetic origin	Disease-causing germline mutation(s) in	Widely patent fontanelles and sutures;Renotubular dysgenesis;Potter facies;Microcephaly;Hypotension;Pulmonary hypoplasia;Respiratory insufficiency;Autosomal recessive inheritance;Oligohydramnios;Anuria;Abnormality of the urinary system;Elevated mean arterial pressure;Multifactorial inheritance;Elevated systolic blood pressure;Elevated diastolic blood pressure						32	0.96											86	1.0									0.0	0.0	9e-05	1.0		3.095	0.030009		0	0	0			AGT	0.09	0.0	0.0	0.0	-40.0	-2.0	-22.0	-2.0						0.0694	0.0	25.309348899			behavior/neurological phenotype ; liver/biliary system phenotype; mortality/aging ; reproductive system phenotype; cardiovascular system phenotype ; nervous system phenotype ; immune system phenotype; renal/urinary system phenotype; growth/size/body region phenotype; adipose tissue phenotype ; muscle phenotype; homeostasis/metabolism phenotype; 			.	Renin-angiotensin system	regulation of cell growth;positive regulation of cytokine production;kidney development;blood vessel remodeling;regulation of blood volume by renin-angiotensin;renin-angiotensin regulation of aldosterone production;regulation of renal output by angiotensin;regulation of heart rate;regulation of blood vessel diameter by renin-angiotensin;renal system process;angiotensin-mediated drinking behavior;positive regulation of extracellular matrix constituent secretion;protein import into nucleus;cellular sodium ion homeostasis;cell surface receptor signaling pathway;G protein-coupled receptor signaling pathway;G protein-coupled receptor signaling pathway coupled to cGMP nucleotide second messenger;phospholipase C-activating G protein-coupled receptor signaling pathway;activation of phospholipase C activity;positive regulation of cytosolic calcium ion concentration;nitric oxide mediated signal transduction;cell-cell signaling;female pregnancy;aging;regulation of blood pressure;associative learning;regulation of signaling receptor activity;positive regulation of activation of Janus kinase activity;positive regulation of endothelial cell migration;positive regulation of cardiac muscle hypertrophy;positive regulation of cardiac muscle cell apoptotic process;positive regulation of macrophage derived foam cell differentiation;positive regulation of cholesterol esterification;negative regulation of endopeptidase activity;positive regulation of neuron projection development;regulation of norepinephrine secretion;positive regulation of phosphatidylinositol 3-kinase signaling;artery smooth muscle contraction;response to muscle activity involved in regulation of muscle adaptation;negative regulation of angiogenesis;regulation of lipid metabolic process;regulation of vasoconstriction;negative regulation of cell growth;positive regulation of cellular protein metabolic process;response to estradiol;positive regulation of superoxide anion generation;positive regulation of NAD(P)H oxidase activity;negative regulation of tissue remodeling;low-density lipoprotein particle remodeling;operant conditioning;regulation of renal sodium excretion;positive regulation of renal sodium excretion;regulation of cell population proliferation;vasodilation;positive regulation of nitric oxide biosynthetic process;positive regulation of epidermal growth factor receptor signaling pathway;positive regulation of blood pressure;positive regulation of transcription, DNA-templated;positive regulation of insulin receptor signaling pathway;fibroblast proliferation;positive regulation of fibroblast proliferation;regulation of long-term neuronal synaptic plasticity;smooth muscle cell proliferation;cytokine secretion;positive regulation of inflammatory response;positive regulation of peptidyl-tyrosine phosphorylation;positive regulation of NF-kappaB transcription factor activity;negative regulation of neurotrophin TRK receptor signaling pathway;stress-activated MAPK cascade;regulation of calcium ion transport;regulation of transmission of nerve impulse;cell growth involved in cardiac muscle cell development;positive regulation of protein tyrosine kinase activity;ERK1 and ERK2 cascade;uterine smooth muscle contraction;cellular response to mechanical stimulus;positive regulation of branching involved in ureteric bud morphogenesis;regulation of extracellular matrix assembly;positive regulation of gap junction assembly;regulation of cardiac conduction;cellular response to angiotensin;positive regulation of vascular smooth muscle cell proliferation;positive regulation of vascular associated smooth muscle cell migration;positive regulation of L-lysine import across plasma membrane;positive regulation of L-arginine import across plasma membrane;positive regulation of reactive oxygen species metabolic process;positive regulation of extrinsic apoptotic signaling pathway	extracellular region;extracellular space;cytosol;extracellular exosome;blood microparticle	serine-type endopeptidase inhibitor activity;hormone activity;protein binding;growth factor activity;type 1 angiotensin receptor binding;type 2 angiotensin receptor binding	GSDMB[21988832];EWSR1[16189514];AGTR1[23597562];GRB2[18624398];PRCP[20517885];REN[20927107];AGTR2[23597562];	230841882
9533	chr1	232649788	G	C	chr1:232649788	SIPA1L2	signal induced proliferation associated 1 like 2	SNV	0/1	0.52	59_63	122	99.0	0/0	0.0	35_0	35	99.0			rs373443675	EXONIC	YES	NM_020808.5	Transcript	protein_coding	missense_variant		3/23	NM_020808.5:c.1298C>G	NP_065859.3:p.Ser433Cys		-1.0	.,.					.	.	.		0.000118244	18.0	152228.0	0.0	32	0.98	PASS	sas	0.0008285	4.0	0.000117571	8.0	9.62835e-05	24.0	249264.0	0.0	100	1.0	PASS	sas	0.00019613	6.0	8.84533e-05	10.0	0.0000643	10						20.4	2.076701	0.211	5	15	20	M-CAP_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	SIPA1L2	0.0	0.0	0.0	0.0	45.0	-7.0	1.0	-7.0						0.134	1.0	0.000000000	0.861	1.176	.			ciliary ganglion;occipital lobe;dorsal root ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;parietal lobe;medulla oblongata;	.	biological_process;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction	cellular_component	GTPase activator activity	DDX6[27107012;unassigned1304];EGLN3[26972000];SF3B2[30021884];CEP135[26638075];YWHAB[24255178];ODF2[26638075];TCEANC[unassigned1304];DYRK1B[23602568];RPGRIP1L[26638075];ESR2[21182203];CEP128[26638075];ORC5[21988832];LATS1[24255178];AP3M1[25416956;unassigned1304];SSX2IP[26638075];NINL[26638075];TGM2[21988832];	232649788
9565	chr1	235301497	AA		chr1:235301497-235301498	RBM34	RNA binding motif protein 34	sequence_alteration	0/1	0.32	8_6_5	19	28.0	1/2	0.41	5_11_11	27	99.0			rs367780945	SPLICING	YES	NM_015014.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	6/10		NM_015014.4:c.702-9_702-8del			-1.0						.	.	.		0.000718316	97.0	135038.0	0.0	28	0.65	PASS	amr	0.000975976	13.0	0.000499742	31.0	0.0580364	7980.0	137500.0	0.0	21	0.54	InbreedingCoeff	sas	0.0716358	1136.0	0.0591808	3956.0	0.0000836	13						1.886	-0.054572		0	0	0			RBM34	0.0	0.0	0.0	0.0	-7.0	-1.0	-2.0	0.0						0.507	0.0				.			.	.	.	nucleus;nucleolus	RNA binding	GABARAPL2[20562859];SRPK3[23602568];GABARAPL1[20562859];JUN[25609649];HDAC11[23752268];RPS6[29568061];HNRNPU[26496610];RRP1B[20926688];MKI67[26949251];RAB11A[29568061];TGOLN2[29568061];FBL[29568061];HIST1H3A[29568061];IFI16[25665578];ZC3H18[29298432];MNDA[25665578];IKBKG[20098747];AURKAIP1[29568061];BET1[29568061];	235301496
9604	chr1	236714293	AA		chr1:236714293-236714294	HEATR1	HEAT repeat containing 1	deletion	0/1	0.33	2_3	9	78.0	0/0	0.0	6_0	11	27.0			rs55866014	SPLICING	YES	NM_018072.6	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	44/44		NM_018072.6:c.6347-4_6347-3del			-1.0						.	.	.		7.25826e-05	10.0	137774.0	0.0	16	0.48	PASS	afr	0.000106123	4.0	4.66926e-05	3.0	0.0353107	2381.0	67430.0	0.0	28	0.7	PASS	sas	0.0495297	337.0	0.0327632	954.0	0.0000064,0.0198773	1,3091						12.39	0.856074		0	0	0			HEATR1	0.0	0.0	0.0	0.0	-14.0	-2.0	-20.0	50.0						0.195	1.0				.			.	.	maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);rRNA processing;positive regulation of transcription by RNA polymerase I;positive regulation of rRNA processing	fibrillar center;nucleoplasm;nucleolus;mitochondrion;membrane;90S preribosome;small-subunit processome;t-UTP complex	RNA binding;protein binding	FOXB1[25609649];JUN[25609649];VCAM1[22623428];FOXE1[25609649];FOXG1[25609649];HDAC11[23752268];FOXH1[25609649];RPS6[29568061];FOXI1[25609649];OCRL[25107275];FOXL1[25609649];SMC6[26496610];RRP1B[20926688];TANK[unassigned1774];TTBK1[17353931];FOXQ1[25609649];FBL[29568061];PTP4A3[17353931];XRN1[15231747];MYC[17353931];VPS52[25416956];STOM[27173435;unassigned1312];C18orf21[30021884];AAGAB[25416956];	236714292
9614	chr1	236762931	A		chr1:236762931	HEATR1	HEAT repeat containing 1	deletion	0/0	0.0	34_0	34	81.0	0/1	0.53	17_19	36	99.0			rs34496316	SPLICING	YES	NM_018072.6	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	3/44		NM_018072.6:c.360-7del			-1.0						.	.	.		0.00356127	541.0	151912.0	3.0	32	0.96	PASS	nfe	0.00622169	423.0	0.00622169	423.0	0.00354386	830.0	234208.0	1.0	32	0.68	PASS	nfe	0.00591754	641.0	0.00591754	641.0	0.0000193,0.0034083	3,530	0.004	14.0				5.831	0.199339		0	0	0			HEATR1	0.0	0.04	0.0	0.0	20.0	-6.0	-6.0	-5.0						0.195	1.0				.			.	.	maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);rRNA processing;positive regulation of transcription by RNA polymerase I;positive regulation of rRNA processing	fibrillar center;nucleoplasm;nucleolus;mitochondrion;membrane;90S preribosome;small-subunit processome;t-UTP complex	RNA binding;protein binding	FOXB1[25609649];JUN[25609649];VCAM1[22623428];FOXE1[25609649];FOXG1[25609649];HDAC11[23752268];FOXH1[25609649];RPS6[29568061];FOXI1[25609649];OCRL[25107275];FOXL1[25609649];SMC6[26496610];RRP1B[20926688];TANK[unassigned1774];TTBK1[17353931];FOXQ1[25609649];FBL[29568061];PTP4A3[17353931];XRN1[15231747];MYC[17353931];VPS52[25416956];STOM[27173435;unassigned1312];C18orf21[30021884];AAGAB[25416956];	236762930
9655	chr1	240256668	A	C	chr1:240256668	FMN2	formin 2	SNV	0/1	0.47	65_58	123	99.0	0/1	0.54	60_71	131	99.0			rs146681532	EXONIC	YES	NM_001305424.2	Transcript	protein_coding	missense_variant		1/19	NM_001305424.2:c.1259A>C	NP_001292353.1:p.Lys420Thr		1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	not_specified|not_provided	Intellectual developmental disorder, autosomal recessive 47, 616193 (3), Autosomal recessive	Autosomal recessive non-syndromic intellectual disability	Disease-causing germline mutation(s) in	Dystonia;Cerebral atrophy;Cerebral visual impairment;Autistic behavior;Intellectual disability, mild;Generalized hypotonia;Hypoplasia of the corpus callosum;Poor speech;Multifocal epileptiform discharges;Large basal ganglia;Stereotypy;Hypsarrhythmia;Microcephaly;Motor delay;Hyperactivity;Absent septum pellucidum;Delayed speech and language development;Intellectual disability, moderate;Chorea;Nasogastric tube feeding;Impulsivity;Sleep disturbance;Epileptic spasm;Short attention span;Global developmental delay;Depressivity;Intellectual disability, severe;Cortical dysplasia;Polymicrogyria;Abnormal facial shape;Generalized-onset seizure;Dyskinesia;Focal-onset seizure;Spasticity;Poor speech;Infantile onset;Global developmental delay;Intellectual disability;Focal impaired awareness seizure;Generalized hypotonia;Autosomal recessive inheritance	25741868	0.00322823	490.0	151786.0	1.0	33	0.98	PASS	nfe	0.00524053	356.0	0.00524053	356.0	0.00326866	811.0	248114.0	3.0	48	0.92	PASS	nfe	0.00497369	552.0	0.00497369	552.0	0.0035497	552	0.007	23.0	0.00605	69.0		25.1	3.54353	0.526	13	8	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	FMN2	0.0	0.0	0.0	0.0	47.0	2.0	47.0	-9.0						0.659	0.99	0.000000000	1.0	1.101	reproductive system phenotype; behavior/neurological phenotype ; 			ciliary ganglion;amygdala;olfactory bulb;prefrontal cortex;cingulate cortex;trigeminal ganglion;superior cervical ganglion;cerebellum;pons;occipital lobe;subthalamic nucleus;whole brain;atrioventricular node;parietal lobe;medulla oblongata;hypothalamus;	.	cellular response to DNA damage stimulus;multicellular organism development;protein transport;vesicle-mediated transport;intracellular signal transduction;polar body extrusion after meiotic divisions;negative regulation of protein catabolic process;negative regulation of apoptotic process;intracellular transport;oogenesis;establishment of meiotic spindle localization;homologous chromosome movement towards spindle pole involved in homologous chromosome segregation;formin-nucleated actin cable assembly;cellular response to hypoxia;positive regulation of double-strand break repair	nucleus;nucleolus;endoplasmic reticulum membrane;spindle;cytosol;plasma membrane;microvillus;cell cortex;actin cytoskeleton;cytoplasmic vesicle membrane;perinuclear region of cytoplasm	molecular_function;actin binding	MANF[30021884];	240256668
9663	chr1	240370224	G	C	chr1:240370224	FMN2	formin 2	SNV	0/1	0.52	65_70	135	99.0	0/0	0.0	38_0	38	99.0			rs137903301,COSV60436667,COSV60441127	EXONIC	YES	NM_001305424.2	Transcript	protein_coding	synonymous_variant		6/19	NM_001305424.2:c.2124G>C	NP_001292353.1:p.Val708%3D		1.0					Intellectual developmental disorder, autosomal recessive 47, 616193 (3), Autosomal recessive	Autosomal recessive non-syndromic intellectual disability	Disease-causing germline mutation(s) in	Dystonia;Cerebral atrophy;Cerebral visual impairment;Autistic behavior;Intellectual disability, mild;Generalized hypotonia;Hypoplasia of the corpus callosum;Poor speech;Multifocal epileptiform discharges;Large basal ganglia;Stereotypy;Hypsarrhythmia;Microcephaly;Motor delay;Hyperactivity;Absent septum pellucidum;Delayed speech and language development;Intellectual disability, moderate;Chorea;Nasogastric tube feeding;Impulsivity;Sleep disturbance;Epileptic spasm;Short attention span;Global developmental delay;Depressivity;Intellectual disability, severe;Cortical dysplasia;Polymicrogyria;Abnormal facial shape;Generalized-onset seizure;Dyskinesia;Focal-onset seizure;Spasticity;Poor speech;Infantile onset;Global developmental delay;Intellectual disability;Focal impaired awareness seizure;Generalized hypotonia;Autosomal recessive inheritance		5.91452e-05	9.0	152168.0	0.0	32	0.97	PASS	nfe	0.000132326	9.0	0.000132326	9.0	4.37421e-05	11.0	251474.0	0.0	100	1.0	PASS	nfe	8.79013e-05	10.0	8.79013e-05	10.0	0.0000386	6	0.0	1.0	9e-05	1.0		0.603	-0.226274		0	0	0			FMN2	0.0	0.0	0.0	0.0	-4.0	-3.0	4.0	-3.0						0.659	0.99	7.947566600			reproductive system phenotype; behavior/neurological phenotype ; 			ciliary ganglion;amygdala;olfactory bulb;prefrontal cortex;cingulate cortex;trigeminal ganglion;superior cervical ganglion;cerebellum;pons;occipital lobe;subthalamic nucleus;whole brain;atrioventricular node;parietal lobe;medulla oblongata;hypothalamus;	.	cellular response to DNA damage stimulus;multicellular organism development;protein transport;vesicle-mediated transport;intracellular signal transduction;polar body extrusion after meiotic divisions;negative regulation of protein catabolic process;negative regulation of apoptotic process;intracellular transport;oogenesis;establishment of meiotic spindle localization;homologous chromosome movement towards spindle pole involved in homologous chromosome segregation;formin-nucleated actin cable assembly;cellular response to hypoxia;positive regulation of double-strand break repair	nucleus;nucleolus;endoplasmic reticulum membrane;spindle;cytosol;plasma membrane;microvillus;cell cortex;actin cytoskeleton;cytoplasmic vesicle membrane;perinuclear region of cytoplasm	molecular_function;actin binding	MANF[30021884];	240370224
9684	chr1	243329376	C	T	chr1:243329376	CEP170	centrosomal protein 170	SNV	0/0	0.0	34_0	34	99.0	0/1	0.54	30_35	65	99.0			rs201085675	EXONIC	YES	NM_014812.3	Transcript	protein_coding	missense_variant		13/20	NM_014812.3:c.1886G>A	NP_055627.2:p.Gly629Asp		-1.0	.,.,.					.	.	.		0.000131435	20.0	152166.0	0.0	32	0.96	PASS	amr	0.000392824	6.0	0.000146998	10.0	0.000175327	43.0	245256.0	0.0	41	0.84	PASS	amr	0.00044027	15.0	0.000216724	24.0	0.0001350	21	0.0	1.0				21.0	2.140229	0.088	2	17	19	MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	CEP170	0.03	0.0	0.0	0.0	-22.0	40.0	-26.0	31.0						0.871			0.998	1.026	.			caudate nucleus;ciliary ganglion;amygdala;prefrontal cortex;trigeminal ganglion;superior cervical ganglion;cingulate cortex;cerebellum;pons;occipital lobe;fetal brain;dorsal root ganglion;spinal cord;parietal lobe;skeletal muscle;globus pallidus;hypothalamus;medulla oblongata;thalamus;	.	.	centrosome;centriole;spindle;cytosol;microtubule;plasma membrane;centriolar subdistal appendage	protein binding	CEP120[26638075];UBE3A[29426014];SMC3[26496610];CCAR2[27173435;unassigned1312];DCAF7[27173435;unassigned1312];CRKL[26638075];CEP128[26638075];NARS[26638075];HERC2[29426014];MYC[21150319];TEKT2[27173435;unassigned1312];MB21D2[26638075];KIFAP3[27173435;unassigned1312];GTSE1[26638075];TMSB10[26638075];AGFG1[26638075];CDK5RAP2[26297806];CEP135[26638075];CSNK2A1[27173435;unassigned1312];CEP131[26638075];CSNK2A2[26638075];OCRL[26638075];RPGRIP1L[26638075];MTAP[26638075];ZC2HC1A[26638075];MAP7D3[26638075];MAP7D1[26638075];CSNK2B[27173435;unassigned1312];CFTR[17110338];CEP104[26638075];TXNDC9[26638075];SHC1[26638075];FBF1[26638075];SLAIN2[26638075];WDR62[26496610;26638075;27173435;unassigned1312;26297806];HMMR[26638075];SKA3[26638075];CAMSAP1[26638075];SKA1[26638075];MTMR6[26638075];INAVA[29420262];SDCBP[26638075];CCNB1[26638075];CYB5R3[30021884];KIF3A[23386061;unassigned1312];PRKAR2B[26496610];NPHP1[26638075];INPP5E[unassigned1312];FAM83D[26638075];HSPA8[29568061];SNAPIN[23414517];CCDC138[26638075];CCDC13[24816561];ODF2[26638075];NEBL[26638075];PPP1R21[26638075];RAB3IP[unassigned1312];DCLK1[26638075];ERVK3-1[26638075];TRIP6[26638075];SASS6[26638075];FGFR1OP[26496610];GRB2[26638075];CC2D1A[26638075];CEP89[26638075];COX20[30021884];YWHAE[27173435;unassigned1312];YWHAB[24255178];SETD7[26638075];CBY1[27173435;unassigned1312];ARRB2[26638075];LIMD1[26638075];TCHP[26638075];PCM1[26638075];LASP1[26638075];TUBA1A[27291054];CNTRL[26638075];PEA15[26638075];CEP170B[26638075];NCK2[26638075];CEP290[26638075];NINL[26638075];NCK1[26638075];YWHAH[26638075];UNC45A[26638075];OFD1[26638075];ACTR2[26638075];UPF1[26638075];GPX4[26638075];CKAP2[26638075];HAUS3[26638075];HAUS6[26638075];YWHAZ[15161933];VAV2[18654987];WRAP73[26638075];KIF2A[26496610;26638075];NME7[26638075];KIF2C[26496610;26638075];KIFC3[26496610];ARHGEF2[26638075];MAPRE1[26496610;26638075];MTPN[26638075];CAMK2D[26638075];LUZP1[26638075];DCTN1[26638075];XIAP[26638075];KATNB1[26929214];TTK[26638075];CBL[26638075];FAAP20[26638075];IFT74[26638075];TNKS2[22153077];HAUS8[26638075];KIAA0753[26638075];HS1BP3[26638075];ASCC3[26638075];CCDC77[26638075];DISC1[17043677];MAPK6[26972000;29426014];EGLN3[26972000];RRM2[26638075];SPAG5[26638075];CSNK1A1[26638075];LCA5[26638075];SCLT1[26638075];PPP1CA[22321011];KLHL9[26638075];CEP170P1[20360068;26496610];NEDD1[26638075];NIN[26638075];NECAP2[26638075];NEURL4[29426014];MIS18A[26638075];SNX17[26638075];CENPJ[26638075];CEP162[26638075];DRG2[26638075];GOPC[26638075];SUGT1[26638075];SMAP2[26638075];CEP44[26638075];HSPA1A[26638075];	243329376
9688	chr1	243433520	G	T	chr1:243433520	SDCCAG8	serologically defined colon cancer antigen 8	SNV	0/0	0.0	35_0	35	99.0	0/1	0.28	58_23	81	99.0			rs149928402	EXONIC	YES	NM_001350248.2	Transcript	protein_coding	missense_variant		2/19	NM_001350248.2:c.181G>T	NP_001337177.1:p.Ala61Ser		1.0		Uncertain_significance	criteria_provided,_single_submitter	Senior-Loken_syndrome_7|Bardet-Biedl_syndrome_16	Senior-Loken syndrome 7, 613615 (3), Autosomal recessive; Bardet-Biedl syndrome 16, 615993 (3), Autosomal recessive	Senior-Loken syndrome;Bardet-Biedl syndrome	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in	Hearing impairment;Intellectual disability;Respiratory distress;Recurrent otitis media;Global developmental delay;Retinal degeneration;Renal agenesis;Renal dysplasia;Rod-cone dystrophy;Renal cyst;Hypogonadism;Obesity;Renal insufficiency;Cognitive impairment;External genital hypoplasia;Autosomal recessive inheritance;Bronchiolitis;Hearing impairment;Cryptorchidism;Hypoplasia of the ovary;Low-set, posteriorly rotated ears;Hypogonadism;Nephrotic syndrome;Nystagmus;Multicystic kidney dysplasia;Generalized hirsutism;Short stature;Obesity;Abnormal electroretinogram;Hepatic fibrosis;Pigmentary retinopathy;Neurological speech impairment;Short neck;Downslanted palpebral fissures;Postaxial hand polydactyly;Finger syndactyly;Skeletal muscle atrophy;Hypertension;Intellectual disability;Prominent nasal bridge;Hypoplasia of penis;Medial flaring of the eyebrow;Retinal degeneration;Autosomal recessive inheritance;Nephronophthisis;Progressive visual loss;Premature ovarian insufficiency;Nephronophthisis;Hypertension;Short stature;Global developmental delay;Cone-shaped epiphysis;Abnormality of retinal pigmentation;Retinal dystrophy;Cataract;Abnormality of bone mineral density;Ataxia;Congenital hepatic fibrosis;Stage 5 chronic kidney disease		0.000144569	22.0	152176.0	0.0	32	0.97	PASS	amr	0.000392465	6.0	0.000132287	9.0	0.000175176	44.0	251176.0	0.0	100	0.98	PASS	amr	0.000462909	16.0	0.00021129	24.0	0.0001415	22	0.001	3.0	0.00114	13.0		0.001	-1.515123	0.009	0	16	16		LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SDCCAG8	0.0	0.01	0.0	0.0	5.0	-22.0	35.0	39.0						0.879	0.0	0.000000000	0.0	-1.071	mortality/aging ; digestive/alimentary phenotype; nervous system phenotype ; limbs/digits/tail phenotype; vision/eye phenotype; renal/urinary system phenotype; growth/size/body region phenotype; craniofacial phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			.	.	G2/M transition of mitotic cell cycle;neuron migration;centrosome cycle;regulation of G2/M transition of mitotic cell cycle;establishment of cell polarity;microtubule organizing center organization;tube formation;ciliary basal body-plasma membrane docking	centrosome;centriole;cytosol;cell-cell junction;centriolar satellite	protein binding	OFD1[26638075;27173435;unassigned1312];TRAF6[17353931];CEP164[22863007];SRSF2[22863007];UBE2N[27173435;unassigned1312];TSC1[17355907];ZNF423[22863007];TNS2[25814554];	243433520
9752	chr1	247615245	T	C	chr1:247615245	OR2B11	olfactory receptor family 2 subfamily B member 11	SNV	0|1	0.29	80_32	112	99.0	0/0	0.0	78_0	78	99.0			rs766055554	EXONIC	YES	NM_001004492.1	Transcript	protein_coding	missense_variant		1/1	NM_001004492.1:c.40A>G	NP_001004492.1:p.Lys14Glu		-1.0	.,.,.					.	.	.		7.64362e-06	1.0	130828.0	0.0	33	0.95	PASS	nfe	1.72402e-05	1.0	1.72402e-05	1.0	2.41365e-05	6.0	248586.0	0.0	74	1.0	PASS	amr	8.68608e-05	3.0	2.65487e-05	3.0	0.0000129	2						0.001	-1.662605	0.09	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR2B11	0.0	0.0	0.04	0.0	11.0	-32.0	-18.0	-32.0						0.743	0.02	0.000000000	0.005	0.179	.			dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	247615245
9771	chr1	248202123	C	T	chr1:248202123	OR2L2	olfactory receptor family 2 subfamily L member 2	SNV	0/0	0.0	37_0	37	99.0	0/1	0.48	31_29	60	99.0			rs138290082,COSV63554714	EXONIC	YES	NM_001385855.1	Transcript	protein_coding	missense_variant		3/3	NM_001385855.1:c.554C>T	NP_001372784.1:p.Thr185Met		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.		0.00159721	243.0	152140.0	0.0	32	0.96	PASS	amr	0.00301205	46.0	0.00233707	159.0	0.00119327	300.0	251410.0	0.0	100	1.0	PASS	nfe	0.00199613	227.0	0.00199613	227.0	0.0011897	185	0.003	9.0				16.17	1.483082	0.098	4	16	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR2L2	0.0	0.06	0.0	0.0	39.0	-9.0	-6.0	22.0						0.809	0.0	0.000000000	0.0	-1.093	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;biological_process;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	molecular_function;G protein-coupled receptor activity;olfactory receptor activity	.	248202123
9780	chr1	248525135	G	A	chr1:248525135	OR2T4	olfactory receptor family 2 subfamily T member 4	SNV	0|1	0.16	156_29	186	99.0	0/0	0.0	42_0	42	99.0			rs76721536,COSV63543576	EXONIC	YES	NM_001004696.1	Transcript	protein_coding	missense_variant		1/1	NM_001004696.1:c.253G>A	NP_001004696.1:p.Ala85Thr		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.		0.00091776	133.0	144918.0	0.0	32	0.93	PASS	eas	0.00191245	9.0	0.000580969	38.0	0.147613	24300.0	164620.0	0.0	100	1.0	InbreedingCoeff_RF	eas	0.258688	2501.0	0.120491	9693.0	0.0100190	1558	0.064	198.0				0.044	-0.595756	0.035	0	18	18		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR2T4	0.0	0.0	0.0	0.0	35.0	-35.0	35.0	19.0						0.571	0.34	17.819573669	0.0	-2.316	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	248525135
9781	chr1	248525138	C	T	chr1:248525138	OR2T4	olfactory receptor family 2 subfamily T member 4	SNV	0|1	0.16	156_29	186	99.0	0/0	0.0	42_0	42	99.0			rs75096121,COSV63543582	EXONIC	YES	NM_001004696.1	Transcript	protein_coding	missense_variant		1/1	NM_001004696.1:c.256C>T	NP_001004696.1:p.His86Tyr		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.		0.0010314	150.0	145434.0	0.0	32	0.93	PASS	sas	0.00245317	11.0	0.000656388	43.0	0.152176	25438.0	167162.0	0.0	100	1.0	InbreedingCoeff_RF	eas	0.262826	2582.0	0.125537	10230.0	0.0099933	1554	0.054	166.0				12.35	0.851347	0.122	2	16	18	SIFT,PROVEAN_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR2T4	0.0	0.0	0.0	0.0	32.0	-33.0	16.0	32.0						0.571	0.34	17.819573669	0.002	-0.089	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	248525138
9986	chr10	6483893	G	A	chr10:6483893	PRKCQ	protein kinase C theta	SNV	0/1	0.55	39_47	86	99.0	0/1	0.47	39_36	76	99.0			rs370703516,COSV54105311	EXONIC	YES	NM_001323265.1	Transcript	protein_coding	missense_variant		16/18	NM_001323265.1:c.1798C>T	NP_001310194.1:p.Arg600Trp		-1.0	Protein kinase domain&Protein kinase domain&Protein kinase domain&Novel protein kinase C theta, catalytic domain,Protein kinase domain&Protein kinase domain&Protein kinase domain&Novel protein kinase C theta, catalytic domain,.					.	.	.		2.62898e-05	4.0	152150.0	0.0	32	0.97	PASS	afr	4.82812e-05	2.0	2.93997e-05	2.0	1.99224e-05	5.0	250974.0	0.0	47	0.96	PASS	sas	3.27182e-05	1.0	2.64303e-05	3.0	0.0000129	2						23.8	3.106634	0.259	7	14	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,PROVEAN_pred,ClinPred_pred,LIST-S2_pred	Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRKCQ	0.0	0.0	0.0	0.0	-15.0	-12.0	-32.0	-38.0						0.288	0.97	0.000000000	0.59	0.161	endocrine/exocrine gland phenotype; adipose tissue phenotype ; growth/size/body region phenotype; homeostasis/metabolism phenotype; cellular phenotype; vision/eye phenotype; muscle phenotype; nervous system phenotype ; pigmentation phenotype; neoplasm; hematopoietic system phenotype; cardiovascular system phenotype ; reproductive system phenotype; mortality/aging ; respiratory system phenotype; immune system phenotype; 			trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Tight junction;T cell receptor signaling pathway;Adipocytokine signaling pathway	regulation of cell growth;regulation of transcription, DNA-templated;membrane protein ectodomain proteolysis;inflammatory response;axon guidance;peptidyl-serine phosphorylation;platelet activation;positive regulation of telomere maintenance via telomerase;positive regulation of interleukin-17 production;positive regulation of interleukin-4 production;intracellular signal transduction;Fc-epsilon receptor signaling pathway;positive regulation of T cell proliferation;positive regulation of interleukin-2 biosynthetic process;regulation of megakaryocyte differentiation;negative regulation of insulin receptor signaling pathway;T cell receptor signaling pathway;positive regulation of T cell activation;positive regulation of NF-kappaB transcription factor activity;positive regulation of telomerase activity;cell chemotaxis;negative regulation of T cell apoptotic process;regulation of platelet aggregation;positive regulation of telomere capping;positive regulation of T-helper 17 type immune response;positive regulation of T-helper 2 cell activation	immunological synapse;microtubule organizing center;cytosol;plasma membrane;aggresome	protein kinase activity;protein serine/threonine kinase activity;protein kinase C activity;protein binding;ATP binding;metal ion binding	MEF2A[20178747];HSP90AB1[22939624];GLRX3[10636891];PRKCD[23455922];BCL10[17363905];PRKCZ[17588663];MALT1[17363905];PKM[24606918];LCK[21964608];HSF1[23352416];BTK[11788586];CD28[21964608];FYN[10383400];LCP2[21983831];MARK3[17363905];MAP4K3[21983831];CARD11[22528498];	6483893
10007	chr10	7285631	C	T	chr10:7285631	SFMBT2	Scm like with four mbt domains 2	SNV	0|1	0.49	29_29	59	99.0	0|1	0.39	48_32	82	99.0			rs748858766,COSV62815543	EXONIC	YES	NM_001387889.1	Transcript	protein_coding	missense_variant		9/21	NM_001387889.1:c.1009G>A	NP_001374818.1:p.Asp337Asn		-1.0	.,.					.	.	.		6.58588e-06	1.0	151840.0	0.0	32	0.95	PASS	afr	2.4226e-05	1.0	0.0	0.0	1.19638e-05	3.0	250756.0	0.0	50	0.99	PASS	sas	3.26883e-05	1.0	8.8241e-06	1.0	0.0000064	1						26.6	3.856549	0.215	12	9	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	SFMBT2	0.0	0.07	0.0	0.0	-20.0	36.0	36.0	-18.0						0.386	1.0	0.000000000	0.241	1.026	.			ciliary ganglion;dorsal root ganglion;atrioventricular node;	.	regulation of transcription, DNA-templated;negative regulation of gene expression;negative regulation of nucleic acid-templated transcription	nucleus;aggresome;nuclear speck;intracellular membrane-bounded organelle	transcription corepressor activity;protein binding;histone binding	L3MBTL3[unassigned1304];SCML2[unassigned1304];LYPLA1[unassigned1304];PHC1[unassigned1304];SLF2[unassigned1304];TFAP4[unassigned1304];SCML1[unassigned1304];SCMH1[unassigned1304];UBE2O[unassigned1304];	7285631
10211	chr10	16737156		T	chr10:16737155-16737156	RSU1	Ras suppressor protein 1	insertion	0/1	0.22	25_7	32	80.0	0/0	0.0	40_0	40	84.0			rs781689051,COSV61716297	SPLICING	YES	NM_012425.4	Transcript	protein_coding	splice_acceptor_variant	7/8		NM_012425.4:c.599-2dup			-1.0						.	.	.		5.47405e-05	4.0	73072.0	0.0	24	0.59	PASS	amr	0.000124938	1.0	2.83946e-05	1.0	5.61672e-05	9.0	160236.0	0.0	26	0.7	PASS	amr	0.000207297	4.0	2.58011e-05	2.0	0.0000707,0.0000064	11,1						26.1	3.772289		0	0	0			RSU1	0.0	0.01	0.0	0.01	-24.0	-1.0	-1.0	-29.0						0.684	0.05				.			ciliary ganglion;temporal lobe;testis - seminiferous tubule;adipose tissue;trigeminal ganglion;skin;superior cervical ganglion;pons;subthalamic nucleus;atrioventricular node;placenta;skeletal muscle;globus pallidus;	.	signal transduction;regulation of cell-substrate adhesion;positive regulation of cell-substrate adhesion;positive regulation of GTPase activity	cytosol;focal adhesion;extracellular exosome	protein binding	GSK3B[21900206];NUDCD1[29021621];GCNT1[23027862];FN1[19738201];ILK[17353931;23455922;25852190;26496610];SUGT1[25036637];LRCH3[24255178];LIMS1[23414517;25416956];	16737155
10214	chr10	16737157	G	T	chr10:16737157	RSU1	Ras suppressor protein 1	SNV	0/1	0.61	10_19	31	99.0	0/0	0.0	13_0	17	59.0			rs201585770	SPLICING	YES	NM_012425.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	7/8		NM_012425.4:c.599-3C>A			-1.0						.	.	.		0.00168722	148.0	87718.0	1.0	17	0.45	PASS	amr	0.00353913	36.0	0.00132001	56.0	0.00185339	259.0	139744.0	0.0	28	0.72	PASS	amr	0.0063101	105.0	0.00150421	100.0	0.0008424	131	0.001	2.0				15.43	1.346156		0	0	0			RSU1	0.0	0.01	0.0	0.01	-26.0	-3.0	-3.0	-31.0	0.628033314416547	0.5	8.765	3.694	12.459	0.684	0.05				.			ciliary ganglion;temporal lobe;testis - seminiferous tubule;adipose tissue;trigeminal ganglion;skin;superior cervical ganglion;pons;subthalamic nucleus;atrioventricular node;placenta;skeletal muscle;globus pallidus;	.	signal transduction;regulation of cell-substrate adhesion;positive regulation of cell-substrate adhesion;positive regulation of GTPase activity	cytosol;focal adhesion;extracellular exosome	protein binding	GSK3B[21900206];NUDCD1[29021621];GCNT1[23027862];FN1[19738201];ILK[17353931;23455922;25852190;26496610];SUGT1[25036637];LRCH3[24255178];LIMS1[23414517;25416956];	16737157
10233	chr10	17646049		A	chr10:17646048-17646049	HACD1	3-hydroxyacyl-CoA dehydratase 1	insertion	0/1	0.25	9_3	12	45.0	0/0	0.0	5_0	5	9.0			rs76004443	SPLICING	YES	NM_014241.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/6		NM_014241.4:c.258-3dup			-1.0		Benign	criteria_provided,_single_submitter	not_provided		Congenital fiber-type disproportion myopathy	Disease-causing germline mutation(s) (loss of function) in	Ptosis;Reduced tendon reflexes;Failure to thrive;High palate;Tented upper lip vermilion;Ankle flexion contracture;Ophthalmoplegia;Joint laxity;Generalized muscle weakness;Dilated cardiomyopathy;Pectus excavatum;Muscular hypotonia;Polyhydramnios;Type 1 muscle fiber atrophy;Intellectual disability;Decreased fetal movement;Calf muscle hypertrophy;Flexion contracture of finger;Kyphoscoliosis;Hyperlordosis;Short stature;Poor suck;Pulmonary hypoplasia;Motor delay;Long face;Respiratory insufficiency due to muscle weakness;Recurrent respiratory infections;Mildly elevated creatine kinase;Scapular winging;EMG: myopathic abnormalities;Micrognathia;Waddling gait;Reduced vital capacity;Hip contracture;Cryptorchidism;Talipes equinovarus;Fatigable weakness of bulbar muscles;Elbow flexion contracture;Knee flexion contracture;Weak cry;Congenital hip dislocation		0.000130834	19.0	145222.0	0.0	31	0.93	PASS	afr	0.000201613	8.0	9.12992e-05	6.0	0.0190527	1831.0	96102.0	0.0	26	0.62	PASS	amr	0.0316165	275.0	0.0158193	776.0	0.0000514,0.0000193,0.0035497	8,3,552						15.74	1.403667		0	0	0			HACD1	0.0	0.0	0.0	0.0	-2.0	-16.0	-16.0	-26.0											muscle phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; 			.	.	multicellular organism development;sphingolipid biosynthetic process;fatty acid elongation;long-chain fatty-acyl-CoA biosynthetic process;very long-chain fatty acid biosynthetic process	endoplasmic reticulum membrane;integral component of membrane	3-hydroxyacyl-CoA dehydratase activity;3R-hydroxyacyl-CoA dehydratase activity;very-long-chain 3-hydroxyacyl-CoA dehydratase activity;3-hydroxy-arachidoyl-CoA dehydratase activity;3-hydroxy-behenoyl-CoA dehydratase activity;3-hydroxy-lignoceroyl-CoA dehydratase activity	TPM4[28330616];RPN2[28330616];CSE1L[28330616];TECR[unassigned1304];RPN1[28330616];ATP2A2[28330616];PHB[28330616];ATP2B1[28330616];PHB2[28330616];CPLX4[unassigned1304];CORO1C[28330616];MYO1B[28330616];XPO1[28330616];GNB1[28330616];TMEM106C[unassigned1304];RNF170[unassigned1304];	17646048
10347	chr10	21108445	G	A	chr10:21108445	NEBL	nebulette	SNV	0/0	0.0	36_0	36	99.0	0/1	0.53	27_31	58	99.0			COSV101009259	SPLICING	YES	NM_006393.3	Transcript	protein_coding	missense_variant,splice_region_variant		20/28	NM_006393.3:c.1963C>T	NP_006384.1:p.Leu655Phe		-1.0						Familial isolated dilated cardiomyopathy	Candidate gene tested in	Palmoplantar keratoderma;EMG abnormality;Lipoatrophy;Dilated cardiomyopathy;Elevated serum creatine kinase;Abnormality of neutrophils;Sensorineural hearing impairment;Myopathy						32	0.95											100	1.0											9e-05	1.0		23.2	2.854272	0.114	3	16	19	SIFT,MutationTaster_pred,fathmm-MKL_coding_pred	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	NEBL	0.06	0.0	0.0	0.01	0.0	-35.0	-6.0	-35.0	0.0080344261813254	0.21	7.458	-0.339	7.119	0.97	0.0	69.273254431	0.907	0.245	.			.	.	muscle fiber development;cardiac muscle thin filament assembly	stress fiber;Z disc;I band;extracellular exosome	protein binding;tropomyosin binding;cytoskeletal protein binding;structural constituent of muscle;filamin binding;actin filament binding	NUTM1[25416956];DCTN1[26638075];CCDC125[unassigned1304];PIK3R3[unassigned1304];MIPOL1[25416956];CEP128[26638075];GOLGA2[25416956];FLJ13057[25416956];CEP70[unassigned1304];HOMER3[25416956];CEP170[26638075];TRIM27[25416956];LZTS2[25416956];PIBF1[unassigned1304];FAM9B[25416956];TRIM63[18157088];ZGPAT[26871637];SMURF2[18157088];SPAG5[unassigned1304];CCDC136[25416956];SCLT1[26638075];TRAF2[25416956;unassigned1304];TRAF1[25416956];ZDHHC17[24705354];ESR2[21182203];MED28[16964398];GOLGA6A[unassigned1304];ACAP1[unassigned1304];QARS[unassigned1304];ZYX[11423549];KIFC3[unassigned1304];GAPDH[30021884];MAD1L1[25416956;unassigned1304];VCL[unassigned1304];	21108445
10372	chr10	22830818	G	A	chr10:22830818	PIP4K2A	phosphatidylinositol-5-phosphate 4-kinase type 2 alpha	SNV	0/1	0.5	67_66	133	99.0	0/0	0.0	44_0	44	99.0			rs138502306	EXONIC	YES	NM_005028.5	Transcript	protein_coding	synonymous_variant		8/10	NM_005028.5:c.951C>T	NP_005019.2:p.Pro317%3D		-1.0						Precursor B-cell acute lymphoblastic leukemia	Major susceptibility factor in	.		0.000427305	65.0	152116.0	0.0	32	0.95	PASS	amr	0.000981804	15.0	0.000588045	40.0	0.000399626	100.0	250234.0	0.0	49	0.93	PASS	amr	0.00086886	30.0	0.000513392	58.0	0.0003408	53	0.002	5.0	0.00109	2.0		3.118	0.031463		0	0	0			PIP4K2A	0.0	0.0	0.0	0.0	-18.0	7.0	3.0	24.0						0.301	0.79	50.807847503			growth/size/body region phenotype; mortality/aging ; normal phenotype; neoplasm; 			caudate nucleus;amygdala;temporal lobe;prefrontal cortex;superior cervical ganglion;cingulate cortex;cerebellum peduncles;cerebellum;bone marrow;pons;occipital lobe;subthalamic nucleus;whole brain;parietal lobe;spinal cord;globus pallidus;hypothalamus;medulla oblongata;thalamus;	Inositol phosphate metabolism;Phosphatidylinositol signaling system;Regulation of actin cytoskeleton	phospholipid metabolic process;phosphatidylinositol biosynthetic process;regulation of autophagy;regulation of phosphatidylinositol 3-kinase signaling;megakaryocyte development;phosphatidylinositol phosphorylation;positive regulation of autophagosome assembly	nucleoplasm;autophagosome;cytosol;plasma membrane	ATP binding;1-phosphatidylinositol-4-phosphate 5-kinase activity;1-phosphatidylinositol-5-phosphate 4-kinase activity;1-phosphatidylinositol-3-phosphate 4-kinase activity	GSTK1[21988832];JUN[25609649];CSNK2A2[23455922];EPB41L3[24366813];MEIS3[unassigned1304];	22830818
10384	chr10	23287191	C	T	chr10:23287191	ARMC3	armadillo repeat containing 3	SNV	0/1	0.55	51_63	114	99.0	0/0	0.0	35_0	35	99.0			rs148414986	EXONIC	YES	NM_173081.5	Transcript	protein_coding	synonymous_variant		11/19	NM_173081.5:c.1290C>T	NP_775104.2:p.Pro430%3D		1.0						.	.	.		0.00091326	139.0	152202.0	0.0	33	0.98	PASS	amr	0.00163613	25.0	0.00141106	96.0	0.000862774	213.0	246878.0	1.0	75	0.79	PASS	amr	0.00140647	48.0	0.00139348	155.0	0.0007974	124	0.002	7.0				8.358	0.396303		0	0	0			ARMC3	0.0	0.0	0.0	0.0	19.0	-5.0	19.0	-30.0						0.951	0.0	64.009282377			.			ciliary ganglion;testis - seminiferous tubule;testis - interstitial;atrioventricular node;superior cervical ganglion;testis;	.	.	extracellular exosome	.	CRACR2A[30021884];HSD17B12[30021884];	23287191
10385	chr10	23393150	A	G	chr10:23393150	MSRB2	methionine sulfoxide reductase B2	SNV	0/1	0.49	44_42	86	99.0	0/0	0.0	33_0	33	99.0			rs181802942	EXONIC	YES	NM_012228.4	Transcript	protein_coding	missense_variant		2/5	NM_012228.4:c.196A>G	NP_036360.3:p.Thr66Ala		1.0	Peptide methionine sulphoxide reductase MrsB&Peptide methionine sulphoxide reductase MrsB&Peptide methionine sulphoxide reductase MrsB					.	.	.		0.00095905	146.0	152234.0	0.0	32	0.96	PASS	nfe	0.00151399	103.0	0.00151399	103.0	0.000983998	244.0	247968.0	1.0	37	0.88	PASS	nfe	0.00168511	190.0	0.00168511	190.0	0.0008939	139	0.002	5.0				20.1	2.035187	0.199	8	11	19	LRT_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	MSRB2	0.0	0.0	0.0	0.0	-9.0	23.0	23.0	-42.0						0.541	0.0	0.000000000	0.858	1.312	.			.	.	actin filament polymerization;protein repair;cellular response to oxidative stress;oxidation-reduction process	mitochondrion;cytosol	actin binding;zinc ion binding;peptide-methionine (R)-S-oxide reductase activity;L-methionine-(R)-S-oxide reductase activity	TRAF2[unassigned1304];NMES1[27499296];ZDHHC17[24705354];CHCHD1[27499296];	23393150
10429	chr10	25273744	T	C	chr10:25273744	ENKUR	enkurin, TRPC channel interacting protein	SNV	0/1	0.55	27_33	60	99.0	0/0	0.0	37_0	37	99.0			rs33980615,COSV99044398	EXONIC	YES	NM_145010.4	Transcript	protein_coding	missense_variant		5/6	NM_145010.4:c.685A>G	NP_659447.1:p.Arg229Gly		-1.0	Enkurin domain&Enkurin domain,Enkurin domain&Enkurin domain,Enkurin domain&Enkurin domain					.	.	.		0.00503444	766.0	152152.0	2.0	32	0.96	PASS	nfe	0.0066451	452.0	0.0066451	452.0	0.00463859	1165.0	251154.0	6.0	50	0.98	PASS	nfe	0.0063844	725.0	0.0063844	725.0	0.0042764	665	0.011	36.0				23.9	3.135433	0.204	3	16	19	SIFT,PROVEAN_pred,fathmm-MKL_coding_pred	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	ENKUR	0.0	0.03	0.0	0.0	0.0	29.0	40.0	-1.0						0.406	0.0	0.000000000	0.993	1.138	digestive/alimentary phenotype; immune system phenotype; liver/biliary system phenotype; growth/size/body region phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; 			.	.	.	acrosomal vesicle;sperm principal piece	calmodulin binding;SH3 domain binding	OPA1[30021884];LRRK2[24510904];CFAP45[unassigned1304];	25273744
10482	chr10	28233185	C	T	chr10:28233185	ARMC4	armadillo repeat containing 4	SNV	0/0	0.0	34_0	34	99.0	0/1	0.51	47_50	98	99.0			rs140569195,COSV100536698,COSV59476566	EXONIC	YES	NM_001290020.2	Transcript	protein_coding	missense_variant		12/20	NM_001290020.2:c.1709G>A	NP_001276949.1:p.Arg570Gln		-1.0		Uncertain_significance	criteria_provided,_single_submitter	Primary_ciliary_dyskinesia_23|not_provided		Primary ciliary dyskinesia	Disease-causing germline mutation(s) (loss of function) in	Hydrocephalus;Pectus excavatum;Chronic otitis media;Tachypnea;Impaired nasal mucociliary clearance;Delayed speech and language development;Asthma;Atelectasis;Headache;Ectopic pregnancy;Nasal polyposis;Clubbing of fingers;Pulmonary obstruction;Asplenia;Scoliosis;Reduced sperm motility;Respiratory distress;Immotile cilia;Chronic sinusitis;Infertility;Chronic bronchitis;Corneal dystrophy;Glue ear;Pneumonia;Spontaneous abortion;Conductive hearing impairment;Recurrent respiratory infections;Situs inversus totalis;Cough;Bronchiectasis;Ventriculomegaly;Rhinitis;Halitosis;Bronchiectasis;Respiratory insufficiency due to defective ciliary clearance;Autosomal recessive inheritance;Recurrent otitis media;Situs inversus totalis;Ciliary dyskinesia;Chronic bronchitis;Rhinitis;Recurrent sinusitis		0.000828315	126.0	152116.0	1.0	32	0.95	PASS	amr	0.00274977	42.0	0.000249926	17.0	0.000474206	119.0	250946.0	0.0	64	0.98	PASS	afr	0.0020936	34.0	0.000290795	33.0	0.0003730	58	0.003	8.0				22.3	2.374288	0.1	3	16	19	MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	ARMC4	0.0	0.0	0.0	0.01	-2.0	42.0	-1.0	-34.0						0.38	0.0	0.000000000	0.873	-0.265	growth/size/body region phenotype; muscle phenotype; immune system phenotype; cellular phenotype; respiratory system phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; mortality/aging ; digestive/alimentary phenotype; nervous system phenotype ; 			ciliary ganglion;testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;testis;skeletal muscle;	.	cilium movement;regulation of cilium beat frequency;determination of left/right symmetry;heart development;ventricular system development;outer dynein arm assembly	axoneme;ciliary base	.	NR4A2[unassigned1304];HSP90B1[30021884];	28233185
10579	chr10	33199296	T	G	chr10:33199296	ITGB1	integrin subunit beta 1	SNV	0/0	0.0	34_0	34	99.0	0/1	0.24	35_11	46	99.0			rs150610387	EXONIC	YES	NM_033668.2	Transcript	protein_coding	synonymous_variant		13/16	NM_033668.2:c.2019A>C	NP_391988.1:p.Val673%3D		-1.0						.	.	.		0.00021678	33.0	152228.0	0.0	32	0.96	PASS	amr	0.000392722	6.0	0.000293962	20.0	0.000339159	85.0	250620.0	0.0	46	0.98	PASS	sas	0.000490966	15.0	0.00030874	35.0	0.0000514	8	0.0	1.0	0.00107	9.0		6.94	0.279017		0	0	0			ITGB1	0.07	0.0	0.0	0.19	2.0	-2.0	-49.0	3.0						0.0195	0.91	35.496764506			craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; cardiovascular system phenotype ; hematopoietic system phenotype; growth/size/body region phenotype; reproductive system phenotype; normal phenotype; integument phenotype ; mortality/aging ; vision/eye phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype ; hearing/vestibular/ear phenotype; skeleton phenotype; renal/urinary system phenotype; immune system phenotype; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype ; embryo phenotype; pigmentation phenotype; neoplasm; 			ciliary ganglion;uterus;dorsal root ganglion;adipose tissue;uterus corpus;superior cervical ganglion;smooth muscle;placenta;skeletal muscle;	Axon guidance;Focal adhesion;ECM-receptor interaction;Cell adhesion molecules (CAMs);Leukocyte transendothelial migration;Regulation of actin cytoskeleton;Pathogenic Escherichia coli infection;EPEC;Small cell lung cancer	G1/S transition of mitotic cell cycle;in utero embryonic development;cell fate specification;cell migration involved in sprouting angiogenesis;phagocytosis;cellular defense response;homophilic cell adhesion via plasma membrane adhesion molecules;leukocyte cell-cell adhesion;cell-matrix adhesion;calcium-independent cell-matrix adhesion;transforming growth factor beta receptor signaling pathway;integrin-mediated signaling pathway;positive regulation of cell population proliferation;germ cell migration;visual learning;regulation of collagen catabolic process;cell migration;cytokine-mediated signaling pathway;formation of radial glial scaffolds;cell projection organization;lamellipodium assembly;B cell differentiation;extracellular matrix organization;cell-substrate adhesion;receptor internalization;cell adhesion mediated by integrin;cell-cell adhesion mediated by integrin;heterotypic cell-cell adhesion;negative regulation of Rho protein signal transduction;positive regulation of apoptotic process;stress fiber assembly;positive regulation of GTPase activity;sarcomere organization;negative regulation of cell differentiation;positive regulation of angiogenesis;viral entry into host cell;mesodermal cell differentiation;axon extension;dendrite morphogenesis;regulation of immune response;modulation of chemical synaptic transmission;leukocyte migration;leukocyte tethering or rolling;regulation of cell cycle;positive regulation of protein kinase B signaling;cardiac muscle cell differentiation;cellular response to low-density lipoprotein particle stimulus;basement membrane organization;positive regulation of protein localization to plasma membrane;positive regulation of signaling receptor activity;negative regulation of anoikis	ruffle;cytoplasm;plasma membrane;focal adhesion;integrin complex;external side of plasma membrane;cell surface;intercalated disc;membrane;lamellipodium;filopodium;neuromuscular junction;cleavage furrow;ruffle membrane;integrin alpha1-beta1 complex;integrin alpha2-beta1 complex;integrin alpha3-beta1 complex;integrin alpha7-beta1 complex;integrin alpha8-beta1 complex;integrin alpha10-beta1 complex;integrin alpha11-beta1 complex;myelin sheath abaxonal region;sarcolemma;melanosome;dendritic spine;receptor complex;membrane raft;perinuclear region of cytoplasm;recycling endosome;extracellular exosome;invadopodium membrane;glial cell projection;Schaffer collateral - CA1 synapse;glutamatergic synapse;integral component of synaptic membrane	virus receptor activity;fibronectin binding;protease binding;actin binding;integrin binding;protein binding;coreceptor activity;C-X3-C chemokine binding;laminin binding;protein-containing complex binding;cadherin binding;metal ion binding;protein heterodimerization activity;cell adhesion molecule binding;collagen binding involved in cell-matrix adhesion	ITGB1[14681217];ATF2[22304920];COL18A1[17615292];SCYL3[30021884];YWHAB[11313964];CD81[30024968];PTPRO[28330616];FHL2[10906324];ENO1[23414517];HSCB[28380382];ECSIT[24344204];CX3CL1[24789099];CRKL[19168626];EPS8[12606711];LAMP1[29568061];TCTN3[26638075];TCTN2[26638075];EMILIN1[12456677];ITGAV[22178926];TNS2[12606711];ANKS1B[12606711];PDIA3[17170699];RFC5[30021884];ITGA4[14681217;20159608;10604475;1542691];ITGA3[30021884];ITGA2[14681217;21947080;10397731];ADAM17[22413019];CCNE2[30021884];TMEM216[26638075];CANX[29568061];ITGB1BP1[11919189];ITGA6[2649503];ITGA5[12724312;16099422;21947080;22178926;30021884];ANGPTL4[21397862];CD47[10397731];TLN1[11279249];ENG[22940691];CD63[16917503];RABGAP1[12606711];PHLPP1[30021884];ATL3[26496610];KMT2A[30021884];DNAH8[30021884];PXN[10604475];CSF2RB[20802515];PDHB[21988832];AGER[30021884];RAB21[16754960];TGOLN2[29568061];MNT[30021884];SHARPIN[21947080];LMNA[29568061];FLNA[15225631;17690686;9722563;10604475;18177638];E2F3[22157815];CD58[30021884];LYN[20159608;14593208];PTPN1[21806020];NPM1[30021884];VCAM1[22623428;19738201];PLA2G2A[25398877];FN1[21985969;19738201;24789099];FBXO34[30021884];EIF2AK4[30021884];FABP3[20802519];TMEM17[26638075];CD9[23289620];BRWD1[30021884];RAB5A[16754960];LAMTOR5[23414517];	33199296
10690	chr10	35929253	CGCCCG		chr10:35929253-35929258	FZD8	frizzled class receptor 8	deletion	0/1	0.25	6_2	8	67.0	0/0	0.0	12_0	12	21.0			rs909127689	EXONIC	YES	NM_031866.3	Transcript	protein_coding	inframe_deletion		1/1	NM_031866.3:c.1100_1105del	NP_114072.1:p.Ala367_Gly368del		-1.0						.	.	.		0.00133097	194.0	145758.0	0.0	30	0.89	PASS	afr	0.00366706	149.0	0.000456302	30.0	0.0	0.0	11344.0	0.0	5	0.01	AC0				0.0	0.0	0.0000386	6						17.15	1.648652		0	0	0																	0.12					mortality/aging ; normal phenotype; renal/urinary system phenotype; 			.	Wnt signaling pathway;Melanogenesis;Colorectal cancer;Basal cell carcinoma	negative regulation of transcription by RNA polymerase II;angiogenesis;G protein-coupled receptor signaling pathway;neuron differentiation;T cell differentiation in thymus;non-canonical Wnt signaling pathway;positive regulation of JUN kinase activity;positive regulation of transcription by RNA polymerase II;canonical Wnt signaling pathway	Golgi apparatus;plasma membrane;integral component of membrane;Wnt-Frizzled-LRP5/6 complex	G protein-coupled receptor activity;signaling receptor binding;protein binding;Wnt-protein binding;PDZ domain binding;ubiquitin protein ligase binding;Wnt-activated receptor activity	SDCBP[18256285];WNT3A[22682250];	35929252
10751	chr10	38241095	T	C	chr10:38241095	ZNF25	zinc finger protein 25	SNV	0/0	0.0	35_0	35	99.0	0/1	0.51	28_32	63	99.0			rs367617049	EXONIC	YES	NM_001329647.2	Transcript	protein_coding	missense_variant		7/7	NM_001329647.2:c.1343A>G	NP_001316576.1:p.His448Arg		-1.0	Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type					.	.	.		3.28433e-05	5.0	152238.0	0.0	33	0.98	PASS	amr	0.00013089	2.0	2.93936e-05	2.0	7.16477e-05	17.0	237272.0	0.0	47	0.74	PASS	eas	0.000223164	4.0	5.54068e-05	6.0	0.0000257	4	0.001	3.0				22.8	2.617085	0.793	10	10	20	SIFT,PolyPhen,LRT_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred	Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-XF_coding_pred	ZNF25	0.0	0.0	0.0	0.0	-36.0	-5.0	-36.0	-45.0						0.757	0.0	0.000000000	1.0	1.137	.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	HEMGN[22712502];SCRN1[unassigned1304];ADRB2[28298427];	38241095
10811	chr10	38343859	G	A	chr10:38343859	ZNF33A	zinc finger protein 33A	SNV	0/1	0.39	31_20	51	99.0	0/0	0.0	35_0	35	99.0			rs147330965,COSV56727277	EXONIC	YES	NM_001278177.2	Transcript	protein_coding	synonymous_variant		5/5	NM_001278177.2:c.870G>A	NP_001265106.1:p.Pro290%3D		1.0						.	.	.		0.00276628	421.0	152190.0	0.0	33	0.98	PASS	nfe	0.00486564	331.0	0.00486564	331.0	0.00289834	726.0	250488.0	1.0	64	0.99	PASS	nfe	0.0052399	593.0	0.0052399	593.0	0.0029838	464	0.001	4.0				0.046	-0.588792		0	0	0			ZNF33A	0.0	0.0	0.0	0.0	6.0	-8.0	-9.0	31.0						0.918	0.0				.			.	.	regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;metal ion binding	CBX6[21282530];CDK11A[23602568];VPS50[26496610];	38343859
10914	chr10	45958981	C	G	chr10:45958981	MARCH8	membrane associated ring-CH-type finger 8	SNV	0/1	0.41	89_61	150	99.0	0/0	0.0	71_0	71	99.0			rs145714792	EXONIC	YES	NM_001282866.2	Transcript	protein_coding	missense_variant		5/8	NM_001282866.2:c.706G>C	NP_001269795.1:p.Gly236Arg		-1.0						.	.	.		0.00528079	804.0	152250.0	3.0	33	0.98	PASS	nfe	0.00749603	510.0	0.00749603	510.0	0.00699516	1044.0	149246.0	11.0	59	0.58	PASS	nfe	0.00824256	454.0	0.00824256	454.0	0.0017556	273	0.009	29.0				0.874	-0.170655		0	11	11		SIFT,PolyPhen,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MARCH8	0.08	0.0	0.0	0.0	17.0	38.0	-39.0	16.0						0.845	0.0	0.000000000	0.0	-2.034	.			superior cervical ganglion;fetal liver;bone marrow;	.	protein polyubiquitination;adaptive immune response	lysosome;lysosomal membrane;endosome;integral component of membrane;cytoplasmic vesicle membrane;early endosome membrane	ubiquitin-protein transferase activity;zinc ion binding	CYB5B[unassigned1304];FA2H[unassigned1304];GOSR2[unassigned1304];ARR3[unassigned1304];TMEM14C[unassigned1304];	45958981
10944	chr10	46222900	G	C	chr10:46222900	WASHC2C	WASH complex subunit 2C	SNV	0/0	0.0	33_0	33	99.0	0/1	0.45	42_34	76	99.0			rs763664635	EXONIC	YES	NM_001367395.1	Transcript	protein_coding	synonymous_variant		2/31	NM_001367395.1:c.39G>C	NP_001354324.1:p.Pro13%3D		1.0						.	.	.		1.97083e-05	3.0	152220.0	0.0	32	0.98	PASS	amr	6.54108e-05	1.0	2.93971e-05	2.0	4.13757e-05	10.0	241688.0	0.0	53	0.88	PASS	amr	0.000234014	8.0	0.0	0.0	0.0000129	2						6.443	0.242008		0	0	0			FAM21C	0.0	0.0	0.01	0.01	-35.0	-8.0	-6.0	29.0											.			.	.	protein transport;retrograde transport, endosome to Golgi;regulation of substrate adhesion-dependent cell spreading;retrograde transport, endosome to plasma membrane;negative regulation of barbed-end actin filament capping	nucleolus;endosome;early endosome;cytosol;plasma membrane;early endosome membrane;intracellular membrane-bounded organelle;WASH complex	protein binding;phosphatidylinositol-4,5-bisphosphate binding;phosphatidylinositol-3,4,5-trisphosphate binding;phosphatidylinositol-5-phosphate binding;phosphatidylinositol-3-phosphate binding;phosphatidylinositol-3,4-bisphosphate binding;phosphatidylinositol-4-phosphate binding;phosphatidylinositol-3,5-bisphosphate binding;retromer complex binding	TGOLN2[29568061];ATXN1[16713569];FKBP15[20923837];STK38L[30108113];VPS26A[26496610];CEP128[26638075];	46222900
11070	chr10	46965727	G	A	chr10:46965727	SYT15	synaptotagmin 15	SNV	0/1	0.59	86_124	210	99.0	0/1	0.47	140_125	267	99.0			rs1889849,COSV65431103	EXONIC	YES	NM_031912.5	Transcript	protein_coding	synonymous_variant		5/8	NM_031912.5:c.810C>T	NP_114118.2:p.Ala270%3D		-1.0						.	.	.		7.01243e-06	1.0	142604.0	0.0	22	0.61	AS_VQSR	amr	6.89655e-05	1.0	0.0	0.0	0.50662	122987.0	242760.0	2400.0	61	0.99	InbreedingCoeff	afr	0.529404	7958.0	0.50875	56400.0	0.0363077	5646	0.208	654.0				6.84	0.271326		0	0	0			SYT15	0.0	0.0	0.0	0.0	-24.0	-12.0	-8.0	-23.0						0.99	0.0	24.802902514			.			.	.	regulation of dopamine secretion;vesicle-mediated transport;calcium ion regulated exocytosis;regulation of calcium ion-dependent exocytosis;cellular response to calcium ion	plasma membrane;integral component of membrane;exocytic vesicle	SNARE binding;phosphatidylserine binding;calcium ion binding;calcium-dependent phospholipid binding;clathrin binding	GPR152[unassigned1304];ATP6V0E1[unassigned1304];NEK4[25798074];GPX8[unassigned1304];FAM209A[unassigned1304];CLEC2D[unassigned1304];	46965727
11077	chr10	46967672	C	T	chr10:46967672	SYT15	synaptotagmin 15	SNV	0/1	0.55	126_157	284	99.0	0/1	0.47	179_162	342	99.0			rs2152530,COSV65432959	EXONIC	YES	NM_031912.5	Transcript	protein_coding	synonymous_variant		4/8	NM_031912.5:c.405G>A	NP_114118.2:p.Pro135%3D		-1.0						.	.	.		0.0	0.0	135660.0	0.0	20	0.55	AC0_AS_VQSR				0.0	0.0	0.512233	126707.0	247362.0	3059.0	100	0.99	InbreedingCoeff	afr	0.565707	8489.0	0.509829	57059.0	0.0372145	5787	0.169	486.0				0.745	-0.194583		0	0	0			SYT15	0.0	0.02	0.0	0.0	-2.0	46.0	-2.0	-10.0						0.99	0.0	25.968552785			.			.	.	regulation of dopamine secretion;vesicle-mediated transport;calcium ion regulated exocytosis;regulation of calcium ion-dependent exocytosis;cellular response to calcium ion	plasma membrane;integral component of membrane;exocytic vesicle	SNARE binding;phosphatidylserine binding;calcium ion binding;calcium-dependent phospholipid binding;clathrin binding	GPR152[unassigned1304];ATP6V0E1[unassigned1304];NEK4[25798074];GPX8[unassigned1304];FAM209A[unassigned1304];CLEC2D[unassigned1304];	46967672
11449	chr10	46999592		ATGAGGGAG	chr10:46999591-46999592	GPRIN2	G protein regulated inducer of neurite outgrowth 2	insertion	0/1	0.57	78_104	182	99.0	0/1	0.47	105_93	198	99.0			rs112620425	EXONIC	YES	NM_001385299.1	Transcript	protein_coding	inframe_insertion		6/6	NM_001385299.1:c.784_792dup	NP_001372228.1:p.Met262_Glu264dup		1.0						.	.	.	29267878					74	0.91											98	1.0							0.0044629,0.0456644	694,7101	0.057	180.0				6.366	0.236491		0	0	0																		0.0	7.530829162			.			.	.	.	.	protein binding	YWHAE[16189514];PLSCR1[16189514];KRTAP4-12[16189514];SPRY2[16189514];SFN[16189514;15778465];TRIP13[16189514];HTR4[28298427];DYNLL2[16189514];MDFI[16189514];	46999591
11555	chr10	47000019	G	A	chr10:47000019	GPRIN2	G protein regulated inducer of neurite outgrowth 2	SNV	0/1	0.21	197_53	250	99.0	0/1	0.17	218_45	263	99.0			rs150696937,COSV104685066	EXONIC	YES	NM_001385299.1	Transcript	protein_coding	missense_variant		6/6	NM_001385299.1:c.1211G>A	NP_001372228.1:p.Arg404Gln		1.0						.	.	.		0.00262543	398.0	151594.0	0.0	76	1.0	PASS	nfe	0.00375595	254.0	0.00375595	254.0	0.00272793	682.0	250006.0	0.0	97	1.0	PASS	nfe	0.00367875	415.0	0.00367875	415.0	0.0043986	684	0.01	33.0				21.3	2.178806		0	0	0			GPRIN2	0.0	0.0	0.0	0.0	2.0	-45.0	4.0	-44.0							0.0	0.000000000			.			.	.	.	.	protein binding	YWHAE[16189514];PLSCR1[16189514];KRTAP4-12[16189514];SPRY2[16189514];SFN[16189514;15778465];TRIP13[16189514];HTR4[28298427];DYNLL2[16189514];MDFI[16189514];	47000019
11731	chr10	47087474	T	T	chr10:47087474	NPY4R	neuropeptide Y receptor Y4	SNV	1/1	0.99	2_459	462	99.0	0/1	0.84	80_410	491	99.0			rs1400624272,COSV65398057	EXONIC	YES	NM_005972.6	Transcript	protein_coding	synonymous_variant		3/3	NM_005972.6:c.691C>T	NP_005963.4:p.Leu231%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.						0	0.0							0.759215	190806.0	251320.0	65149.0	100	1.0	InbreedingCoeff	eas	0.98929	18197.0	0.69711	79260.0	0.0592782	9218	0.301	952.0				9.829	0.546295		0	0	0			NPY4R	0.0	0.0	0.0	0.0	36.0	-24.0	-26.0	2.0							0.0	59.348343019			behavior/neurological phenotype ; reproductive system phenotype; normal phenotype; skeleton phenotype; growth/size/body region phenotype; integument phenotype ; endocrine/exocrine gland phenotype; adipose tissue phenotype ; homeostasis/metabolism phenotype; 			.	Neuroactive ligand-receptor interaction	G protein-coupled receptor signaling pathway;neuropeptide signaling pathway	plasma membrane;integral component of plasma membrane;membrane	pancreatic polypeptide receptor activity;G protein-coupled receptor activity;peptide hormone binding	.	47087474
11732	chr10	47087680	T	T	chr10:47087680	NPY4R	neuropeptide Y receptor Y4	SNV	1/1	1.0	0_435	436	99.0	0/1	0.86	71_425	497	99.0			rs1438263240,COSV65398346	EXONIC	YES	NM_005972.6	Transcript	protein_coding	synonymous_variant		3/3	NM_005972.6:c.897C>T	NP_005963.4:p.His299%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.						0	0.0							0.759139	190837.0	251386.0	65148.0	100	1.0	InbreedingCoeff	eas	0.98929	18197.0	0.697052	79259.0	0.0548989	8537	0.326	1032.0				7.14	0.294516		0	0	0			NPY4R	0.0	0.0	0.0	0.0	20.0	-39.0	18.0	-39.0							0.0	7.530829162			behavior/neurological phenotype ; reproductive system phenotype; normal phenotype; skeleton phenotype; growth/size/body region phenotype; integument phenotype ; endocrine/exocrine gland phenotype; adipose tissue phenotype ; homeostasis/metabolism phenotype; 			.	Neuroactive ligand-receptor interaction	G protein-coupled receptor signaling pathway;neuropeptide signaling pathway	plasma membrane;integral component of plasma membrane;membrane	pancreatic polypeptide receptor activity;G protein-coupled receptor activity;peptide hormone binding	.	47087680
11734	chr10	47087731	T	T	chr10:47087731	NPY4R	neuropeptide Y receptor Y4	SNV	1/1	1.0	0_445	447	99.0	0/1	0.87	70_451	521	99.0			rs1375949574	EXONIC	YES	NM_005972.6	Transcript	protein_coding	synonymous_variant		3/3	NM_005972.6:c.948C>T	NP_005963.4:p.Cys316%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.						0	0.0							0.759132	190867.0	251428.0	65156.0	100	1.0	InbreedingCoeff	eas	0.98929	18197.0	0.697012	79267.0	0.0815284	12678	0.361	1141.0				7.316	0.308088		0	0	0			NPY4R	0.0	0.0	0.0	0.0	43.0	-31.0	-33.0	-3.0							0.0	24.802902514			behavior/neurological phenotype ; reproductive system phenotype; normal phenotype; skeleton phenotype; growth/size/body region phenotype; integument phenotype ; endocrine/exocrine gland phenotype; adipose tissue phenotype ; homeostasis/metabolism phenotype; 			.	Neuroactive ligand-receptor interaction	G protein-coupled receptor signaling pathway;neuropeptide signaling pathway	plasma membrane;integral component of plasma membrane;membrane	pancreatic polypeptide receptor activity;G protein-coupled receptor activity;peptide hormone binding	.	47087731
11737	chr10	47087830	A	A	chr10:47087830	NPY4R	neuropeptide Y receptor Y4	SNV	1/1	0.99	2_406	410	99.0	0/1	0.83	68_349	419	99.0			rs1440744958,COSV65398349	EXONIC	YES	NM_005972.6	Transcript	protein_coding	synonymous_variant		3/3	NM_005972.6:c.1047G>A	NP_005963.4:p.Ser349%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.						0	0.0							0.758867	190808.0	251438.0	65092.0	100	1.0	InbreedingCoeff	eas	0.98929	18197.0	0.697056	79272.0	0.0813162	12645	0.352	1114.0				0.176	-0.40422		0	0	0			NPY4R	0.0	0.0	0.0	0.0	23.0	-23.0	44.0	21.0							0.0	2.479659119			behavior/neurological phenotype ; reproductive system phenotype; normal phenotype; skeleton phenotype; growth/size/body region phenotype; integument phenotype ; endocrine/exocrine gland phenotype; adipose tissue phenotype ; homeostasis/metabolism phenotype; 			.	Neuroactive ligand-receptor interaction	G protein-coupled receptor signaling pathway;neuropeptide signaling pathway	plasma membrane;integral component of plasma membrane;membrane	pancreatic polypeptide receptor activity;G protein-coupled receptor activity;peptide hormone binding	.	47087830
11758	chr10	49393688	C	A	chr10:49393688	FRMPD2	FERM and PDZ domain containing 2	SNV	0/1	0.48	29_27	56	99.0	0/0	0.0	35_0	35	99.0			rs116266683,COSV100564373	SPLICING	YES	NM_001018071.4	Transcript	protein_coding	missense_variant,splice_region_variant		18/29	NM_001018071.4:c.2267G>T	NP_001018081.4:p.Gly756Val		-1.0	.,.,.					.	.	.		0.00564411	859.0	152194.0	5.0	33	0.97	PASS	amr	0.00994895	152.0	0.00842275	573.0	0.00568539	1429.0	251346.0	8.0	73	1.0	PASS	nfe	0.00804139	914.0	0.00804139	914.0	0.0056783	883	0.017	54.0				24.2	3.265208	0.31	6	14	20	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	FRMPD2	0.0	0.78	0.0	0.0	-19.0	0.0	45.0	0.0	0.975676940719179	0.814	7.676	2.044	9.72	0.895	0.0	0.000000000	0.032	0.947	.			ciliary ganglion;olfactory bulb;testis - seminiferous tubule;trigeminal ganglion;atrioventricular node;superior cervical ganglion;	.	bicellular tight junction assembly	cytoplasm;cytoskeleton;bicellular tight junction;basolateral plasma membrane	protein binding;1-phosphatidylinositol binding	.	49393688
11801	chr10	49985002	A	C	chr10:49985002	WDFY4	WDFY family member 4	SNV	0/1	0.34	48_25	73	99.0	0/1	0.59	31_44	75	99.0			rs763023223	EXONIC	YES	NM_020945.2	Transcript	protein_coding	missense_variant		16/62	NM_020945.2:c.3071A>C	NP_065996.1:p.Glu1024Ala		1.0						.	.	.		3.28455e-05	5.0	152228.0	0.0	33	0.98	PASS	nfe	5.87872e-05	4.0	5.87872e-05	4.0	0.000107134	17.0	158680.0	0.0	28	0.58	PASS	sas	0.000219722	5.0	0.000193867	12.0	0.0000257	4						29.0	4.147323	0.521	15	5	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred	WDFY4	0.0	0.0	0.0	0.07	27.0	-34.0	-5.0	27.0								0.000000000	1.0	1.312	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;atrioventricular node;skin;superior cervical ganglion;skeletal muscle;globus pallidus;	.	.	integral component of membrane	.	PLOD1[30021884];	49985002
11814	chr10	50285339	C	T	chr10:50285339	VSTM4	V-set and transmembrane domain containing 4	SNV	0/0	0.0	43_0	43	99.0	0/1	0.41	59_41	101	99.0			rs45489505,COSV60530209	EXONIC	YES	NM_001031746.5	Transcript	protein_coding	missense_variant		4/8	NM_001031746.5:c.559G>A	NP_001026916.2:p.Val187Met		-1.0						.	.	.		0.00352205	536.0	152184.0	1.0	33	0.98	PASS	nfe	0.00529147	360.0	0.00529147	360.0	0.00435609	1095.0	251372.0	6.0	75	1.0	PASS	nfe	0.00585917	666.0	0.00585917	666.0	0.0042700	664	0.006	20.0				15.28	1.316677	0.029	3	17	20	SIFT,MutationAssessor_pred,LIST-S2_pred	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	VSTM4	0.0	0.0	0.0	0.0	-4.0	32.0	10.0	1.0							0.16	0.000000000	0.515	-0.284	.			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;atrioventricular node;	.	.	extracellular region;plasma membrane;integral component of membrane	.	TGM1[unassigned1304];PPP1CC[21382349];KRTAP12-3[unassigned1304];CYSRT1[unassigned1304];FKBP7[unassigned1304];LBR[30021884];MDFI[unassigned1304];STX1A[unassigned1304];KRTAP1-1[unassigned1304];	50285339
11819	chr10	50530449		A	chr10:50530448-50530449	C10orf71	chromosome 10 open reading frame 71	insertion	0/0	0.0	6_0	8	17.0	0/1	0.5	3_3	6	48.0			rs111281265	SPLICING	YES	NM_001135196.2	Transcript	protein_coding	splice_region_variant,5_prime_UTR_variant		3/3	NM_001135196.2:c.-132dup			1.0						.	.	.		0.00169142	249.0	147214.0	0.0	32	0.89	PASS	afr	0.00506715	203.0	0.000465354	31.0					0	0.0							0.0025400,0.0022746,0.0000758	67,60,2						13.58	1.022701		0	0	0			C10orf71	0.0	0.03	0.0	0.0	0.0	-1.0	-1.0	1.0						0.779	0.0				.			.	.	.	.	.	.	50530448
11929	chr10	51623147	C	T	chr10:51623147	TIMM23	translocase of inner mitochondrial membrane 23	SNV	0/1	0.61	26_41	67	99.0	0/1	0.46	29_25	54	99.0			rs1554911984,COSV53465159	EXONIC	YES	NM_006327.4	Transcript	protein_coding	missense_variant		1/7	NM_006327.4:c.68G>A	NP_006318.1:p.Gly23Glu		-1.0						.	.	.		1.31366e-05	2.0	152246.0	0.0	33	0.97	PASS	afr	4.82253e-05	2.0	0.0	0.0	0.505198	82224.0	162756.0	928.0	13	0.41	InbreedingCoeff	sas	0.506769	10856.0	0.506715	33732.0	0.0124627	1938	0.028	86.0				22.1	2.319248		1	1	2	PolyPhen	SIFT	TIMM23	0.0	0.0	0.02	0.0	-3.0	6.0	-5.0	-42.0							0.6				skeleton phenotype; normal phenotype; mortality/aging ; behavior/neurological phenotype ; integument phenotype ; 			testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;testis;skeletal muscle;	.	protein targeting to mitochondrion;protein import into mitochondrial matrix	mitochondrion;mitochondrial inner membrane;TIM23 mitochondrial import inner membrane translocase complex;mitochondrial intermembrane space;integral component of mitochondrial inner membrane	protein binding;protein transmembrane transporter activity;P-P-bond-hydrolysis-driven protein transmembrane transporter activity	NDUFA13[24344204];RNASEK[unassigned1304];GOLT1A[unassigned1304];AQP6[unassigned1304];MIEF1[21701560];TIMM50[23260140];BABAM1[19615732];ATXN3[26496610];EBP[unassigned1304];TMEM88[unassigned1304];OXCT1[27499296];CREB3L1[unassigned1304];TIMM17B[unassigned1304;23263864];SCN3B[unassigned1304];TMEM14B[unassigned1304];FANCI[26496610];GSTK1[17353931];JAGN1[unassigned1304];BRF2[17353931];TMEM86B[unassigned1304];SUCO[26496610];TIMM21[23260140];PML[26496610];COX6B1[27499296];FAM210B[unassigned1304];MAD2L2[29656893];PTP4A3[17353931];PINK1[24357652];NDUFAF8[27499296];FXYD3[unassigned1304];TMEM56[unassigned1304];	51623147
12048	chr10	53458131	T	C	chr10:53458131	CSTF2T	cleavage stimulation factor subunit 2 tau variant	SNV	0/0	0.0	39_0	39	99.0	0/1	0.44	77_62	141	99.0				EXONIC	YES	NM_015235.3	Transcript	protein_coding	synonymous_variant		1/1	NM_015235.3:c.1179A>G	NP_056050.1:p.Gly393%3D		-1.0						.	.	.						32	0.96											100	1.0											9e-05	1.0		11.05	0.687649		0	0	0			CSTF2T	0.0	0.0	0.0	0.0	-30.0	-23.0	45.0	-46.0						0.42	0.23	35.496764506			reproductive system phenotype; 			caudate nucleus;atrioventricular node;parietal lobe;	.	mRNA splicing, via spliceosome;termination of RNA polymerase II transcription;mRNA 3'-end processing;pre-mRNA cleavage required for polyadenylation	nucleoplasm;mRNA cleavage and polyadenylation specificity factor complex	RNA binding;mRNA binding;protein binding	COL17A1[unassigned1304];ATP23[unassigned1304];STH[unassigned1304];AKAP8L[unassigned1304];FOXI1[unassigned1304];GOLGA2[21516116];LASP1[unassigned1304];FAM168B[unassigned1304];FIP1L1[26496610];CTAG1A[unassigned1304];UBQLN1[16189514;25416956;unassigned1304];SMYD3[unassigned1304];UBQLN4[16713569];MAPK3[26496610];UBQLN2[unassigned1304];PKNOX2[unassigned1304];SPAG8[unassigned1304];CPSF3[26496610];FOXJ2[unassigned1304];AES[unassigned1304];CEP170P1[26496610];TOX2[unassigned1304];MYO1C[26496610];HGS[25416956];CTDSP1[unassigned1304];	53458131
12074	chr10	61868656	G	C	chr10:61868656	ANK3	ankyrin 3	SNV	0/0	0.0	37_0	37	99.0	0/1	0.52	58_65	124	99.0			rs55680239	EXONIC	YES	NM_020987.5	Transcript	protein_coding	synonymous_variant		27/44	NM_020987.5:c.3105C>G	NP_066267.2:p.Pro1035%3D		-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_specified|not_provided	Mental retardation, autosomal recessive, 37, 615493 (3), Autosomal recessive	ANK3-related intellectual disability-sleep disturbance syndrome	Disease-causing germline mutation(s) in	Aggressive behavior;Intellectual disability, moderate;Seizure;Generalized hypotonia;Bruxism;Autosomal recessive inheritance;Spasticity;Hyperactivity;Delayed speech and language development;Intellectual disability, mild;Large for gestational age;Autistic behavior;Macrocephaly;Spasticity;Aggressive behavior;Intellectual disability, moderate;Hyperactivity;Muscular hypotonia;Bruxism;Seizure	25741868	0.00224817	342.0	152124.0	0.0	32	0.96	PASS	nfe	0.00345517	235.0	0.00345517	235.0	0.00187047	470.0	251274.0	0.0	80	1.0	PASS	nfe	0.00269361	306.0	0.00269361	306.0	0.0019228	299	0.003	9.0	0.00272	31.0		9.962	0.561286		0	0	0			ANK3	0.0	0.0	0.0	0.15	-30.0	33.0	-33.0	33.0						0.202	1.0	7.530829162			nervous system phenotype ; renal/urinary system phenotype; behavior/neurological phenotype ; respiratory system phenotype; mortality/aging ; 			ciliary ganglion;caudate nucleus;temporal lobe;amygdala;prefrontal cortex;superior cervical ganglion;cingulate cortex;trigeminal ganglion;cerebellum peduncles;cerebellum;pons;fetal brain;occipital lobe;subthalamic nucleus;atrioventricular node;parietal lobe;spinal cord;skeletal muscle;globus pallidus;hypothalamus;medulla oblongata;thalamus;	.	mitotic cytokinesis;endoplasmic reticulum to Golgi vesicle-mediated transport;plasma membrane organization;cytoskeletal anchoring at plasma membrane;signal transduction;axonogenesis;neuromuscular junction development;positive regulation of gene expression;positive regulation of cell communication by electrical coupling;positive regulation of sodium ion transport;magnesium ion homeostasis;neuronal action potential;positive regulation of homotypic cell-cell adhesion;Golgi to plasma membrane protein transport;regulation of potassium ion transport;establishment of protein localization;positive regulation of membrane potential;cellular response to magnesium ion;membrane assembly;protein localization to plasma membrane;maintenance of protein location in plasma membrane;positive regulation of protein targeting to membrane;protein localization to axon;positive regulation of membrane depolarization during cardiac muscle cell action potential;negative regulation of delayed rectifier potassium channel activity;positive regulation of sodium ion transmembrane transporter activity;positive regulation of cation channel activity	lysosome;endoplasmic reticulum;Golgi apparatus;cytosol;plasma membrane;bicellular tight junction;basal plasma membrane;cell surface;intercalated disc;spectrin-associated cytoskeleton;membrane;basolateral plasma membrane;lateral plasma membrane;sarcoplasmic reticulum;Z disc;T-tubule;dendrite;neuromuscular junction;node of Ranvier;sarcolemma;neuron projection;costamere;axon initial segment;postsynaptic membrane	structural constituent of cytoskeleton;protein binding;cytoskeletal protein binding;spectrin binding;protein binding, bridging;ion channel binding;cadherin binding	SMAD2[15231748;20195357];IVNS1ABP[unassigned1312];SPAG9[unassigned1312];CCT3[30021884];USP15[unassigned1312];SMAD3[15231748];PCNA[26496610];GTF3C4[unassigned1312];NAB2[unassigned1304];MICAL3[27528609];AP3B1[19934039];KIF11[26496610];EPS15L1[unassigned1312];TMEM17[26638075];MCM4[unassigned1312];H1FX[30021884];FLNC[21223964];MCM6[unassigned1312];SCN5A[19805355];MAPK6[20936779];EZR[29568061];PLEC[21223964];MCM2[unassigned1312];HMGN1[30021884];	61868656
12088	chr10	63977012	AAAAAA		chr10:63977012-63977017	RTKN2	rhotekin 2	sequence_alteration	1/2	0.13	0_2_13	15	8.0	1/2	0.5	1_5_4	10	86.0			rs5785514	SPLICING	YES	NM_145307.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	8/11		NM_145307.4:c.889-9_889-4del			-1.0						.	.	.		0.000435456	63.0	144676.0	0.0	0	0.05	PASS	sas	0.00087184	4.0	0.000272339	18.0	0.0579038	5677.0	98042.0	0.0	14	0.42	PASS	eas	0.089748	520.0	0.0524597	2619.0	0.0000965,0.0607637	15,9449						0.76	-0.191618		0	0	0																	0.909	0.0				.			testis - seminiferous tubule;testis - interstitial;trigeminal ganglion;atrioventricular node;testis;	.	signal transduction;positive regulation of cell population proliferation;hemopoiesis;positive regulation of NF-kappaB transcription factor activity;positive regulation of NIK/NF-kappaB signaling;negative regulation of intrinsic apoptotic signaling pathway	nucleus;cytoplasm	.	IGHG1[15174051];PACSIN1[20936779];	63977011
12095	chr10	69714726	T	G	chr10:69714726	HERC4	HECT and RLD domain containing E3 ubiquitin protein ligase 4	SNV	0/1	0.32	15_7	22	99.0	0/0	0.0	30_0	30	90.0			rs61755666,COSV99517773	EXONIC	YES	NM_022079.3	Transcript	protein_coding	synonymous_variant		19/26	NM_022079.3:c.2211A>C	NP_071362.1:p.Pro737%3D		-1.0						.	.	.		0.00125529	191.0	152156.0	1.0	32	0.97	PASS	sas	0.00993377	48.0	0.00127904	87.0	0.00189993	440.0	231588.0	4.0	43	0.67	PASS	sas	0.00841812	230.0	0.00132312	141.0	0.0020128	313	0.002	6.0				11.68	0.765524		0	0	0			HERC4	0.0	0.0	0.0	0.0	-6.0	30.0	-26.0	-6.0						0.409	0.99	36.424945637			reproductive system phenotype; cardiovascular system phenotype ; skeleton phenotype; hearing/vestibular/ear phenotype; cellular phenotype; 			ciliary ganglion;testis - interstitial;subthalamic nucleus;dorsal root ganglion;atrioventricular node;superior cervical ganglion;skin;trigeminal ganglion;skeletal muscle;globus pallidus;	.	spermatogenesis;protein ubiquitination;cell differentiation	fibrillar center;cytosol	ubiquitin-protein transferase activity	RB1[26496610];HSP90AB1[22939624];DNAJC7[26496610];BAG3[26496610];TRADD[unassigned1774];GMNN[26496610];NUF2[26496610];	69714726
12147	chr10	70210008	A		chr10:70210008	DNA2	DNA replication helicase/nuclease 2	deletion	0/1	0.32	15_7	22	99.0	0/0	0.06	17_1	18	26.0			rs34191745	SPLICING	YES	NM_001080449.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	5/20		NM_001080449.3:c.720-4del			-1.0		Benign	no_assertion_criteria_provided	not_provided	?Seckel syndrome 8, 615807 (3), Autosomal recessive; Progressive external ophthalmoplegia with mitochondrial DNA deletions, autosomal dominant 6, 615156 (3), Autosomal dominant	DNA2-related mitochondrial DNA deletion syndrome	Disease-causing germline mutation(s) in	Slender build;Obstructive sleep apnea;Muscle spasm;Slow progression;Progressive external ophthalmoplegia;Elevated serum creatine kinase;Gowers sign;External ophthalmoplegia;Gait disturbance;Myalgia;Autosomal dominant inheritance;Generalized amyotrophy;Limb-girdle muscle weakness;Ptosis;Facial palsy;Exertional dyspnea;Exercise intolerance;Progressive external ophthalmoplegia;Limb-girdle muscle weakness;Depressivity;Exertional dyspnea;Mitochondrial myopathy;Hyperlordosis;Generalized hypotonia;Decreased facial expression;Myopathy;Gowers sign;Decreased fetal movement;Difficulty walking;Slender build;Multiple joint contractures;Obstructive sleep apnea;Muscle spasm;Myalgia;Congenital ptosis;Elevated creatine kinase after exercise;Decreased mitochondrial number;Kyphoscoliosis;Global developmental delay;Spinal cord compression;Ectopic kidney;Micrognathia;Convex nasal ridge;Intellectual disability;Autosomal recessive inheritance;Microcephaly;Short stature		0.00194677	273.0	140232.0	2.0	31	0.88	PASS	sas	0.00473186	21.0	0.000826317	53.0	0.32768	17660.0	53894.0	0.0	14	0.44	InbreedingCoeff_RF	sas	0.347364	2451.0	0.340619	7589.0	0.0002058,0.0005273,0.0749563	32,82,11656						2.753	0.008489		0	0	0			DNA2	0.0	0.0	0.0	0.01	23.0	-3.0	-34.0	-16.0							0.0				mortality/aging ; neoplasm; cellular phenotype; 			trigeminal ganglion;skeletal muscle;	DNA replication	DNA replication checkpoint;telomere maintenance;DNA double-strand break processing;DNA replication;mitochondrial DNA replication;base-excision repair;telomere maintenance via semi-conservative replication;DNA duplex unwinding;DNA replication, Okazaki fragment processing;DNA replication, removal of RNA primer;mitochondrial DNA repair;G-quadruplex DNA unwinding;positive regulation of DNA replication;replication fork reversal;nucleic acid phosphodiester bond hydrolysis;t-circle formation;mitotic telomere maintenance via semi-conservative replication	nuclear chromosome, telomeric region;nucleus;nucleoplasm;cytoplasm;mitochondrion;gamma DNA polymerase complex;mitochondrial nucleoid	DNA binding;DNA helicase activity;RNA binding;helicase activity;nuclease activity;protein binding;ATP binding;ATPase activity;site-specific endodeoxyribonuclease activity, specific for altered base;5'-flap endonuclease activity;5'-3' DNA helicase activity;single-stranded DNA-dependent ATPase activity;metal ion binding;4 iron, 4 sulfur cluster binding	WDHD1[22570476];PLEC[30021884];	70210007
12245	chr10	72083635	C	T	chr10:72083635	LRRC20	leucine rich repeat containing 20	SNV	0/0	0.0	33_0	33	99.0	0/1	0.48	51_47	98	99.0			rs765468297	EXONIC	YES	NM_001278211.2	Transcript	protein_coding	synonymous_variant		4/5	NM_001278211.2:c.384G>A	NP_001265140.1:p.Glu128%3D		-1.0						.	.	.		1.31361e-05	2.0	152252.0	0.0	33	0.98	PASS	afr	2.41127e-05	1.0	1.46955e-05	1.0	2.78691e-05	7.0	251174.0	0.0	70	1.0	PASS	afr	6.15764e-05	1.0	5.28467e-05	6.0	0.0000450	7						10.64	0.638927		0	0	0			LRRC20	0.0	0.0	0.01	0.0	-2.0	-1.0	-12.0	-16.0						0.325	0.14	66.594394388			.			trigeminal ganglion;atrioventricular node;skeletal muscle;	.	.	.	protein binding	TOM1[unassigned1304];ZBED1[25416956;unassigned1304];	72083635
12252	chr10	72360140	C	T	chr10:72360140	PRF1	perforin 1	SNV	0/1	0.41	57_41	99	99.0	0/0	0.0	33_0	33	99.0			rs112883709,COSV64614723	EXONIC	YES	NM_001083116.3	Transcript	protein_coding	synonymous_variant		2/3	NM_001083116.3:c.519G>A	NP_001076585.1:p.Thr173%3D		-1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Familial_hemophagocytic_lymphohistiocytosis_2|not_specified	Hemophagocytic lymphohistiocytosis, familial, 2, 603553 (3), Autosomal recessive; Aplastic anemia, 609135 (3); Lymphoma, non-Hodgkin, 605027 (3)	Familial hemophagocytic lymphohistiocytosis;Fatal post-viral neurodegenerative disorder;Idiopathic aplastic anemia	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in	Meningitis;Lymphadenopathy;Seizure;Thrombocytopenia;Increased intracranial pressure;Prolonged prothrombin time;Hemophagocytosis;Hypertriglyceridemia;Increased CSF protein;CSF pleocytosis;Hypofibrinogenemia;Increased serum ferritin;Generalized edema;Leukopenia;Global developmental delay;Hypoalbuminemia;Jaundice;Anemia;Encephalitis;Tetraplegia;Coma;Hepatomegaly;Ataxia;Hemiplegia;Hypertonia;Hyponatremia;Increased total bilirubin;Irritability;Hypoproteinemia;Failure to thrive;Splenomegaly;Generalized hypotonia;Autosomal recessive inheritance;Aplastic anemia;Bone marrow hypocellularity;Lymphoma;Epistaxis;Bone marrow hypocellularity;Reticulocytopenia;Anemia;Gingival bleeding;Recurrent infections;Neutropenia;Pancytopenia;Ecchymosis;Retinal hemorrhage;Thrombocytopenia		0.00051919	79.0	152160.0	0.0	32	0.97	PASS	nfe	0.000602746	41.0	0.000602746	41.0	0.00062504	157.0	251184.0	0.0	86	1.0	PASS	nfe	0.00067851	77.0	0.00067851	77.0	0.0005916	92	0.001	3.0	0.00088	10.0		1.905	-0.052935		0	0	0			PRF1	0.0	0.0	0.0	0.0	-2.0	43.0	43.0	0.0						0.0351	0.0	2.479659119			liver/biliary system phenotype; behavior/neurological phenotype ; reproductive system phenotype; normal phenotype; mortality/aging ; hematopoietic system phenotype; cardiovascular system phenotype ; neoplasm; nervous system phenotype ; immune system phenotype; integument phenotype ; growth/size/body region phenotype; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			whole blood;	Natural killer cell mediated cytotoxicity;Type I diabetes mellitus;Autoimmune thyroid disease;Allograft rejection;Graft-versus-host disease	immunological synapse formation;T cell mediated cytotoxicity;defense response to tumor cell;immune response to tumor cell;apoptotic process;cellular defense response;cytolysis;protein homooligomerization;defense response to virus;positive regulation of killing of cells of other organism;transmembrane transport	extracellular region;cytosol;plasma membrane;membrane;integral component of membrane;endosome lumen;cytolytic granule	calcium ion binding;protein binding;wide pore channel activity;identical protein binding	SRGN[11911826];CYSRT1[unassigned1304];DDX24[16169070];PRF1[21685908;21037563];GZMB[11911826];KRT31[25416956;unassigned1304];NOTCH2NLA[unassigned1304];	72360140
12253	chr10	72360291	C	T	chr10:72360291	PRF1	perforin 1	SNV	0/1	0.55	65_79	144	99.0	0/0	0.0	33_0	33	99.0			rs139336186,CM071929,COSV64616043	EXONIC	YES	NM_001083116.3	Transcript	protein_coding	missense_variant		2/3	NM_001083116.3:c.368G>A	NP_001076585.1:p.Arg123His		-1.0	.,Membrane attack complex component/perforin (MACPF) domain,Membrane attack complex component/perforin (MACPF) domain	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Familial_hemophagocytic_lymphohistiocytosis_2|not_specified|not_provided	Hemophagocytic lymphohistiocytosis, familial, 2, 603553 (3), Autosomal recessive; Aplastic anemia, 609135 (3); Lymphoma, non-Hodgkin, 605027 (3)	Familial hemophagocytic lymphohistiocytosis;Fatal post-viral neurodegenerative disorder;Idiopathic aplastic anemia	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in	Meningitis;Lymphadenopathy;Seizure;Thrombocytopenia;Increased intracranial pressure;Prolonged prothrombin time;Hemophagocytosis;Hypertriglyceridemia;Increased CSF protein;CSF pleocytosis;Hypofibrinogenemia;Increased serum ferritin;Generalized edema;Leukopenia;Global developmental delay;Hypoalbuminemia;Jaundice;Anemia;Encephalitis;Tetraplegia;Coma;Hepatomegaly;Ataxia;Hemiplegia;Hypertonia;Hyponatremia;Increased total bilirubin;Irritability;Hypoproteinemia;Failure to thrive;Splenomegaly;Generalized hypotonia;Autosomal recessive inheritance;Aplastic anemia;Bone marrow hypocellularity;Lymphoma;Epistaxis;Bone marrow hypocellularity;Reticulocytopenia;Anemia;Gingival bleeding;Recurrent infections;Neutropenia;Pancytopenia;Ecchymosis;Retinal hemorrhage;Thrombocytopenia		0.000486183	74.0	152206.0	0.0	32	0.98	PASS	nfe	0.000499794	34.0	0.000499794	34.0	0.000523982	130.0	248100.0	0.0	79	0.97	PASS	nfe	0.000463929	52.0	0.000463929	52.0	0.0004694	73	0.0	1.0	0.00079	9.0		9.805	0.543659	0.109	3	17	20	SIFT,M-CAP_pred,FATHMM_pred	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRF1	0.0	0.0	0.0	0.0	-4.0	44.0	-23.0	-22.0						0.0351	0.0	0.000000000	0.0	-0.283	liver/biliary system phenotype; behavior/neurological phenotype ; reproductive system phenotype; normal phenotype; mortality/aging ; hematopoietic system phenotype; cardiovascular system phenotype ; neoplasm; nervous system phenotype ; immune system phenotype; integument phenotype ; growth/size/body region phenotype; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			whole blood;	Natural killer cell mediated cytotoxicity;Type I diabetes mellitus;Autoimmune thyroid disease;Allograft rejection;Graft-versus-host disease	immunological synapse formation;T cell mediated cytotoxicity;defense response to tumor cell;immune response to tumor cell;apoptotic process;cellular defense response;cytolysis;protein homooligomerization;defense response to virus;positive regulation of killing of cells of other organism;transmembrane transport	extracellular region;cytosol;plasma membrane;membrane;integral component of membrane;endosome lumen;cytolytic granule	calcium ion binding;protein binding;wide pore channel activity;identical protein binding	SRGN[11911826];CYSRT1[unassigned1304];DDX24[16169070];PRF1[21685908;21037563];GZMB[11911826];KRT31[25416956;unassigned1304];NOTCH2NLA[unassigned1304];	72360291
12263	chr10	72489891	C	T	chr10:72489891	ADAMTS14	ADAM metallopeptidase with thrombospondin type 1 motif 14	SNV	0/1	0.55	53_64	117	99.0	0/1	0.51	50_53	103	99.0			rs41307534	EXONIC	YES	NM_139155.3	Transcript	protein_coding	missense_variant		6/22	NM_139155.3:c.988C>T	NP_631894.2:p.Arg330Cys		1.0	.,Peptidase M12B, ADAM/reprolysin&Peptidase M12B, ADAM/reprolysin					.	.	.		0.0025092	382.0	152240.0	1.0	32	0.98	PASS	sas	0.00992966	48.0	0.00357195	243.0	0.0036699	912.0	248508.0	10.0	54	0.99	PASS	sas	0.0127828	391.0	0.00356242	401.0	0.0036719	571	0.002	7.0				29.5	4.203576	0.801	12	8	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	ADAMTS14	0.08	0.01	0.0	0.0	5.0	-33.0	5.0	14.0						0.73	0.0	0.000000000	0.991	0.947	.			.	.	proteolysis;collagen fibril organization;collagen catabolic process	extracellular region	metalloendopeptidase activity;metal ion binding	.	72489891
12306	chr10	73558133	G	C	chr10:73558133	CDH23	cadherin related 23	SNV	0/1	0.43	52_40	92	99.0	0/1	0.41	50_35	85	99.0			rs56013867,COSV56470036	EXONIC	YES	NM_022124.6	Transcript	protein_coding	synonymous_variant		50/70	NM_022124.6:c.6852G>C	NP_071407.4:p.Leu2284%3D		1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Usher_syndrome_type_1|Usher_syndrome_type_1D|Deafness,_autosomal_recessive_12|not_specified|not_provided	Usher syndrome, type 1D, 601067 (3), Autosomal recessive, Digenic recessive; {Pituitary adenoma 5, multiple types}, 617540 (3), Autosomal dominant; Usher syndrome, type 1D/F digenic, 601067 (3), Autosomal recessive, Digenic recessive; Deafness, autosomal recessive 12, 601386 (3), Autosomal recessive	Prolactinoma;Usher syndrome type 1;Familial isolated pituitary adenoma;Autosomal recessive non-syndromic sensorineural deafness type DFNB;TSH-secreting pituitary adenoma;Cushing disease	Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Major susceptibility factor in	Autosomal recessive inheritance;Prelingual sensorineural hearing impairment;Abnormality of the eye;Autosomal dominant inheritance;Adult onset;Incomplete penetrance;Pituitary adenoma;Cranial nerve VI palsy;Osteoporosis;Abnormal hair quantity;Female hypogonadism;Ptosis;Adrenocorticotropin deficient adrenal insufficiency;Enlarged pituitary gland;Oculomotor nerve palsy;Diplopia;Goiter;Blindness;Sudden loss of visual acuity;Internal ophthalmoplegia;Infertility;Weight loss;Increased circulating gonadotropin level;Increased circulating prolactin concentration;Adrenocorticotropic hormone deficiency;Osteopenia;Growth hormone excess;Pallor;Palpitations;Tremor;Irregular menstruation;Increased thyroid-stimulating hormone level;Secondary growth hormone deficiency;Impotence;Euthyroid hyperthyroxinemia;Fourth cranial nerve palsy;Decreased circulating ACTH level;Delayed puberty;Decreased fertility in females;Hypotension;Vomiting;Hypertension;Gynecomastia;Supraventricular arrhythmia;Vertigo;Progressive visual loss;Headache;Seizure;Male hypogonadism;Decreased female libido;Pericardial effusion;Bitemporal hemianopia;Hypogonadotropic hypogonadism;Easy fatigability;Decreased fertility in males;Hyperhidrosis;Periodic hypokalemic paresis;Hypokalemia;Fatigue;Abnormal visual field test;Ventricular arrhythmia;Congestive heart failure;Thyroid crisis;Infertility;Sleep disturbance;Bipolar affective disorder;Onychomycosis;Recurrent skin infections;Psychosis;Pituitary adenoma;Headache;Round face;Hypertension;Truncal obesity;Metrorrhagia;Acne;Abdominal pain;Immunodeficiency;Recurrent fractures;Osteoporosis;Avascular necrosis;Visual loss;Myopathy;Bruising susceptibility;Failure to thrive;Telangiectasia of the skin;Cataract;Hypokalemia;Cardiomyopathy;Premature ovarian insufficiency;Menorrhagia;Lethargy;Adrenal hyperplasia;Diabetes mellitus;Generalized hirsutism;Venous thrombosis;Anxiety;Thin skin;Depressivity;Generalized hyperpigmentation;Lipodystrophy;Nephrolithiasis;Fatigue;Hallucinations;Anxiety;Abnormal cochlea morphology;Aplasia/Hypoplasia of the cerebellum;Iris hypopigmentation;Schizophrenia;Abnormal electroretinogram;Subcortical cerebral atrophy;Cerebral cortical atrophy;Abnormality of dental enamel;Global developmental delay;High hypermetropia;Visual loss;Sensorineural hearing impairment;Scotoma;Depressivity;Intellectual disability;Hemianopia;Nyctalopia;Vestibular hypofunction;Cataract;Ataxia;Blindness;Hypogonadotropic hypogonadism;Amenorrhea;Internal ophthalmoplegia;Irregular menstruation;Easy fatigability;Cranial nerve VI palsy;Dyspareunia;Sudden loss of visual acuity;Decreased circulating ACTH level;Growth hormone excess;Vertigo;Bitemporal hemianopia;Galactorrhea;Headache;Hypotension;Decreased female libido;Secondary growth hormone deficiency;Oculomotor nerve palsy;Pallor;Female hypogonadism;Impotence;Decreased fertility in females;Pituitary hypothyroidism;Osteopenia;Delayed puberty;Seizure;Progressive visual loss;Adrenocorticotropin deficient adrenal insufficiency;Abnormal hair quantity;Fatigue;Fourth cranial nerve palsy;Osteoporosis;Decreased fertility in males;Male hypogonadism;Ptosis;Gynecomastia;Vomiting;Adrenocorticotropic hormone deficiency;Diplopia;Rod-cone dystrophy;Autosomal recessive inheritance;Vestibular dysfunction;Hearing impairment	24033266,18429043	0.00471779	718.0	152190.0	3.0	32	0.98	PASS	amr	0.00883161	135.0	0.00618863	421.0	0.00454155	1132.0	249254.0	4.0	75	1.0	PASS	amr	0.00596998	206.0	0.00574275	649.0	0.0039034	607	0.01	34.0	0.01236	141.0		9.364	0.495806		0	0	0			CDH23	0.0	0.0	0.0	0.0	25.0	-17.0	7.0	23.0						0.591	0.05	24.802902514			cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; behavior/neurological phenotype ; vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype ; hearing/vestibular/ear phenotype; reproductive system phenotype; 			pons;ciliary ganglion;testis - interstitial;subthalamic nucleus;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;globus pallidus;cerebellum;	.	calcium ion transport;homophilic cell adhesion via plasma membrane adhesion molecules;visual perception;sensory perception of sound;locomotory behavior;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;photoreceptor cell maintenance;response to stimulus;sensory perception of light stimulus;equilibrioception;regulation of cytosolic calcium ion concentration;inner ear receptor cell stereocilium organization	plasma membrane;membrane;integral component of membrane;stereocilium	calcium ion binding;protein binding	SLC9A3R2[27173435;unassigned1312];NCKAP1[27173435;unassigned1312];CYFIP1[27173435;unassigned1312];NXN[27173435;unassigned1312];ABI1[27173435;unassigned1312];USH1C[19297620];GOPC[27173435;unassigned1312];WASF1[27173435;unassigned1312];	73558133
12324	chr10	73983690	A	C	chr10:73983690	ANAPC16	anaphase promoting complex subunit 16	SNV	0/1	0.4	29_19	48	99.0	0/0	0.0	36_0	36	99.0			rs147603657,COSV54964689	EXONIC	YES	NM_001242546.2	Transcript	protein_coding	synonymous_variant		3/5	NM_001242546.2:c.18A>C	NP_001229475.1:p.Ser6%3D		1.0						.	.	.		0.000874333	133.0	152116.0	0.0	31	0.96	PASS	amr	0.00144224	22.0	0.00122005	83.0	0.000965297	241.0	249664.0	0.0	33	0.79	PASS	nfe	0.00140514	159.0	0.00140514	159.0	0.0009389	146	0.002	7.0				6.744	0.264104		0	0	0			ANAPC16	0.0	0.06	0.0	0.01	11.0	-44.0	-44.0	18.0							0.07	81.182994486			.			.	.	cell cycle;protein ubiquitination;anaphase-promoting complex-dependent catabolic process;cell division;regulation of mitotic cell cycle phase transition	kinetochore;condensed chromosome kinetochore;nucleoplasm;anaphase-promoting complex;cytosol	.	ANAPC13[20360068];ANAPC15[26496610];ANAPC7[20360068];BUB1B[20360068];HSF2BP[unassigned1304];ANAPC10[20360068;27509861];CDC20[20360068];CDC23[20360068;26496610];HIST1H3A[29568061];CDC26[20360068];CDC16[20360068;26496610];CDC27[20360068];ANAPC4[20360068;26083744];ANAPC5[20360068];CFAP97[26496610];ANAPC1[20360068];ANAPC2[20360068;25043029;26083744;27120157];	73983690
12557	chr10	77159860	G	C	chr10:77159860	ZNF503	zinc finger protein 503	SNV	0|1	0.11	63_9	84	99.0	0/0	0.0	52_0	52	0.0			rs1214970160	EXONIC	YES	NM_032772.6	Transcript	protein_coding	synonymous_variant		2/2	NM_032772.6:c.588C>G	NP_116161.2:p.Gly196%3D		-1.0						.	.	.		0.00105165	128.0	121714.0	0.0	31	0.83	AS_VQSR	sas	0.00608643	20.0	0.000529362	30.0	0.000520086	66.0	126902.0	0.0	52	0.57	RF	amr	0.00106465	22.0	0.000145313	7.0								1.765	-0.065029		0	0	0			ZNF503	0.0	0.0	0.0	0.0	5.0	-40.0	5.0	-22.0							0.89	0.000000000			.			.	.	negative regulation of cell population proliferation;negative regulation of gene expression;neural precursor cell proliferation;G1 to G0 transition involved in cell differentiation	nucleus	nucleic acid binding;metal ion binding	PROP1[unassigned1304];FOXH1[unassigned1304];ARID5A[unassigned1304];ATN1[unassigned1304];KRTAP19-1[unassigned1304];DTX2[unassigned1304];KLC1[26496610];TENT5B[unassigned1304];ARID1B[30021884];DCAF7[27705803];AES[unassigned1304];CEP170P1[26496610];KRTAP6-2[unassigned1304];KRTAP3-3[unassigned1304];	77159860
12566	chr10	77159863	A	C	chr10:77159863	ZNF503	zinc finger protein 503	SNV	0|1	0.1	61_8	81	99.0	0/0	0.0	55_0	55	0.0			rs1240925223	EXONIC	YES	NM_032772.6	Transcript	protein_coding	synonymous_variant		2/2	NM_032772.6:c.585T>G	NP_116161.2:p.Gly195%3D		-1.0						.	.	.		0.000907098	96.0	105832.0	0.0	30	0.76	AS_VQSR	sas	0.00486787	14.0	0.000401332	20.0	0.000370555	49.0	132234.0	0.0	56	0.57	RF	sas	0.000946498	19.0	0.000100507	5.0								9.936	0.558373		0	0	0			ZNF503	0.0	0.0	0.0	0.0	11.0	-43.0	35.0	2.0							0.89	0.000000000			.			.	.	negative regulation of cell population proliferation;negative regulation of gene expression;neural precursor cell proliferation;G1 to G0 transition involved in cell differentiation	nucleus	nucleic acid binding;metal ion binding	PROP1[unassigned1304];FOXH1[unassigned1304];ARID5A[unassigned1304];ATN1[unassigned1304];KRTAP19-1[unassigned1304];DTX2[unassigned1304];KLC1[26496610];TENT5B[unassigned1304];ARID1B[30021884];DCAF7[27705803];AES[unassigned1304];CEP170P1[26496610];KRTAP6-2[unassigned1304];KRTAP3-3[unassigned1304];	77159863
12660	chr10	88416964	T	G	chr10:88416964	OPN4	opsin 4	SNV	0/0	0.0	33_0	33	99.0	0/1	0.46	49_42	91	99.0			rs41297165	EXONIC	YES	NM_001030015.3	Transcript	protein_coding	synonymous_variant		3/11	NM_001030015.3:c.303T>G	NP_001025186.1:p.Arg101%3D		1.0						.	.	.		0.00226678	345.0	152198.0	2.0	32	0.96	PASS	nfe	0.00364556	248.0	0.00364556	248.0	0.00231602	576.0	248702.0	1.0	52	0.98	PASS	nfe	0.00345993	385.0	0.00345993	385.0	0.0022186	345	0.005	16.0				6.352	0.235479		0	0	0			OPN4	0.0	0.14	0.0	0.15	22.0	-12.0	-1.0	20.0						0.923	0.0	37.693687612			cellular phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype ; nervous system phenotype ; vision/eye phenotype; normal phenotype; 			pons;ciliary ganglion;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	.	G protein-coupled receptor signaling pathway;visual perception;phototransduction;detection of visible light;protein-chromophore linkage;regulation of circadian rhythm;rhythmic process;cellular response to light stimulus	integral component of plasma membrane;integral component of membrane;photoreceptor disc membrane	11-cis retinal binding;G protein-coupled photoreceptor activity	UBQLN2[unassigned1304];	88416964
12662	chr10	88417867	G		chr10:88417867	OPN4	opsin 4	deletion	0/0	0.0	35_0	35	99.0	0/1	0.55	40_49	89	99.0			rs571378526	EXONIC	YES	NM_001030015.3	Transcript	protein_coding	frameshift_variant		4/11	NM_001030015.3:c.403del	NP_001025186.1:p.Ala135ProfsTer35		1.0						.	.	.		0.00171496	261.0	152190.0	1.0	32	0.97	PASS	nfe	0.00260172	177.0	0.00260172	177.0	0.00196858	495.0	251450.0	1.0	66	1.0	PASS	nfe	0.00280449	319.0	0.00280449	319.0	0.0000193,0.0017556	3,273	0.003	9.0				25.6	3.6633		0	0	0			OPN4	0.01	0.04	0.04	0.0	3.0	2.0	-29.0	29.0						0.923	0.0	0.000000000			cellular phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype ; nervous system phenotype ; vision/eye phenotype; normal phenotype; 			pons;ciliary ganglion;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	.	G protein-coupled receptor signaling pathway;visual perception;phototransduction;detection of visible light;protein-chromophore linkage;regulation of circadian rhythm;rhythmic process;cellular response to light stimulus	integral component of plasma membrane;integral component of membrane;photoreceptor disc membrane	11-cis retinal binding;G protein-coupled photoreceptor activity	UBQLN2[unassigned1304];	88417866
12695	chr10	89474844	T	G	chr10:89474844	PAPSS2	3'-phosphoadenosine 5'-phosphosulfate synthase 2	SNV	0/1	0.28	35_14	50	99.0	0/1	0.38	35_21	56	99.0			rs753353561	EXONIC	YES	NM_001015880.2	Transcript	protein_coding	missense_variant		6/13	NM_001015880.2:c.742T>G	NP_001015880.1:p.Ser248Ala		1.0	ATP-sulfurylase PUA-like domain&Sulphate adenylyltransferase&Sulphate adenylyltransferase,.				Brachyolmia 4 with mild epiphyseal and metaphyseal changes, 612847 (3), Autosomal recessive	Autosomal recessive brachyolmia;Spondyloepimetaphyseal dysplasia, PAPSS2 type	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Short stature;Premature pubarche;Platyspondyly;Kyphoscoliosis;Lumbar scoliosis;Hirsutism;Secondary amenorrhea;Spondyloepimetaphyseal dysplasia;Lower limb undergrowth;Autosomal recessive inheritance;Acne;Bowing of the legs;Brachydactyly;Irregular vertebral endplates						33	0.97							7.96768e-06	2.0	251014.0	0.0	80	0.99	PASS	nfe	1.76208e-05	2.0	1.76208e-05	2.0	0.0000322	5	0.0	1.0	0.00018	2.0		15.18	1.298743	0.048	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PAPSS2	0.0	0.0	0.0	0.0	1.0	17.0	15.0	11.0						0.891	0.0	0.000000000	0.914	-0.184	limbs/digits/tail phenotype; digestive/alimentary phenotype; skeleton phenotype; immune system phenotype; mortality/aging ; growth/size/body region phenotype; craniofacial phenotype; homeostasis/metabolism phenotype; 			ciliary ganglion;dorsal root ganglion;smooth muscle;superior cervical ganglion;atrioventricular node;trigeminal ganglion;adrenal gland;adrenal cortex;	Purine metabolism;Selenoamino acid metabolism;Sulfur metabolism	sulfate assimilation;skeletal system development;blood coagulation;phosphorylation;3'-phosphoadenosine 5'-phosphosulfate biosynthetic process;bone development	cytosol	adenylylsulfate kinase activity;sulfate adenylyltransferase (ATP) activity;ATP binding;nucleotidyltransferase activity	DAPK1[29513927];CEP19[unassigned1304];HSF2BP[unassigned1304];VHL[17353931];	89474844
12720	chr10	90768680	G	A	chr10:90768680	FAS	Fas cell surface death receptor	SNV	0/1	0.28	54_21	75	99.0	0/1	0.43	28_22	51	99.0			rs28362318,COSV100570909	EXONIC	YES	NM_000043.6	Transcript	protein_coding	synonymous_variant		4/9	NM_000043.6:c.369G>A	NP_000034.1:p.Gln123%3D		1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Autoimmune_lymphoproliferative_syndrome_type_1|not_specified|not_provided	Squamous cell carcinoma, burn scar-related, somatic (3); Autoimmune lymphoproliferative syndrome, type IA, 601859 (3), Autosomal dominant; {Autoimmune lymphoproliferative syndrome}, 601859 (3), Autosomal dominant	Beh�et disease;Autoimmune lymphoproliferative syndrome;Autoimmune lymphoproliferative syndrome;Vogt-Koyanagi-Harada disease	Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in;Major susceptibility factor in	Iron deficiency anemia;Chronic noninfectious lymphadenopathy;Antinuclear antibody positivity;Autoimmune hemolytic anemia;Increased circulating IgG level;Coombs-positive hemolytic anemia;Antiphospholipid antibody positivity;Increased circulating IgM level;Decreased lymphocyte apoptosis;Increased circulating IgA level;Rheumatoid factor positive;Eosinophilia;Antineutrophil antibody positivity;Smooth muscle antibody positivity;Hepatomegaly;Vasculitis;Autoimmune thrombocytopenia;Platelet antibody positive;Splenomegaly;Autosomal dominant inheritance;Follicular hyperplasia;Increased proportion of HLA DR+ T cells;Neutropenia in presence of anti-neutropil antibodies;Reduced delayed hypersensitivity;Urticaria;Elevated proportion of CD4-negative, CD8-negative, alpha-beta regulatory T cells;Hemoptysis;Malabsorption;Nausea and vomiting;Gastrointestinal hemorrhage;Developmental regression;Myositis;Arthritis;Endocarditis;Retrobulbar optic neuritis;Keratoconjunctivitis sicca;Immunologic hypersensitivity;Mitral regurgitation;Anorexia;Memory impairment;Vasculitis;Oral ulcer;Splenomegaly;Abnormal myocardium morphology;Arterial thrombosis;Pleural effusion;Retinopathy;Encephalitis;Fever;Photophobia;Cerebral ischemia;Pulmonary infiltrates;Cranial nerve paralysis;Irritability;Abnormal blistering of the skin;Gait disturbance;Lymphadenopathy;Cataract;Meningitis;Weight loss;Migraine;Increased intracranial pressure;Confusion;Arthralgia;Hyperreflexia;Myocardial infarction;Gangrene;Acne;Venous thrombosis;Fatigue;Vertigo;Myalgia;Abdominal pain;Glomerulopathy;Renal insufficiency;Paresthesia;Papule;Ataxia;Pulmonary embolism;Avascular necrosis;Recurrent aphthous stomatitis;Hemiparesis;Aortic regurgitation;Blindness;Pleuritis;Pancreatitis;Seizure;Subcutaneous nodule;Pericarditis;Abnormal pyramidal sign;Orchitis;Panniculitis;Hodgkin lymphoma;Chronic noninfectious lymphadenopathy;Glomerulonephritis;Bone marrow hypocellularity;Decreased circulating total IgM;B-cell lymphoma;Uveitis;Thyroiditis;Urticaria;Increased circulating IgG level;Splenomegaly;Eosinophilia;Increased circulating IgA level;Thyroid adenoma;Basal cell carcinoma;Seizure;Arthritis;Autoimmune hemolytic anemia;Increased B cell count;Recurrent aphthous stomatitis;Vasculitis;Decreased proportion of CD4-positive helper T cells;Abnormal proportion of CD8-positive T cells;Bruising susceptibility;Hepatomegaly;Gastritis;Elevated proportion of CD4-negative, CD8-negative, alpha-beta regulatory T cells;Thyroid carcinoma;T-cell lymphoma;Autoimmune thrombocytopenia;Colitis;Fibroadenoma of the breast;Bone marrow hypercellularity;Renal insufficiency;Hepatitis;Reticulocytosis;Antinuclear antibody positivity;Increased circulating IgE level;Hydrops fetalis;Antineutrophil antibody positivity;Antiphospholipid antibody positivity;Abnormal vitamin B12 level;Neoplasm of the tongue;Headache;Decreased circulating IgG level;Decreased specific anti-polysaccharide antibody level;Hepatocellular carcinoma;Systemic lupus erythematosus;Burkitt lymphoma;Abnormal serum interleukin level;Abnormal proportion of CD4-positive T cells;Coombs-positive hemolytic anemia;Rheumatoid factor positive;Premature ovarian insufficiency;Pulmonary infiltrates;Pulmonary fibrosis;Hypersplenism;Neutropenia in presence of anti-neutropil antibodies;Panniculitis;Hodgkin lymphoma;Chronic noninfectious lymphadenopathy;Glomerulonephritis;Bone marrow hypocellularity;Decreased circulating total IgM;B-cell lymphoma;Uveitis;Thyroiditis;Urticaria;Increased circulating IgG level;Splenomegaly;Eosinophilia;Increased circulating IgA level;Thyroid adenoma;Basal cell carcinoma;Seizure;Arthritis;Autoimmune hemolytic anemia;Increased B cell count;Recurrent aphthous stomatitis;Vasculitis;Decreased proportion of CD4-positive helper T cells;Abnormal proportion of CD8-positive T cells;Bruising susceptibility;Hepatomegaly;Gastritis;Elevated proportion of CD4-negative, CD8-negative, alpha-beta regulatory T cells;Thyroid carcinoma;T-cell lymphoma;Autoimmune thrombocytopenia;Colitis;Fibroadenoma of the breast;Bone marrow hypercellularity;Renal insufficiency;Hepatitis;Reticulocytosis;Antinuclear antibody positivity;Increased circulating IgE level;Hydrops fetalis;Antineutrophil antibody positivity;Antiphospholipid antibody positivity;Abnormal vitamin B12 level;Neoplasm of the tongue;Headache;Decreased circulating IgG level;Decreased specific anti-polysaccharide antibody level;Hepatocellular carcinoma;Systemic lupus erythematosus;Burkitt lymphoma;Abnormal serum interleukin level;Abnormal proportion of CD4-positive T cells;Coombs-positive hemolytic anemia;Rheumatoid factor positive;Premature ovarian insufficiency;Pulmonary infiltrates;Pulmonary fibrosis;Hypersplenism;Neutropenia in presence of anti-neutropil antibodies;Visual impairment;Abnormal eyebrow morphology;Premature graying of hair;Hypopigmented skin patches;Poliosis;Sensorineural hearing impairment;Glaucoma;Retinal detachment;Abnormal eyelash morphology;Vitiligo;Short stature;Cognitive impairment;Sparse scalp hair;Cataract	25741868,19669200	0.0052431	798.0	152200.0	4.0	33	0.98	PASS	nfe	0.00806949	549.0	0.00806949	549.0	0.00619994	1559.0	251454.0	18.0	100	1.0	PASS	nfe	0.0075703	861.0	0.0075703	861.0	0.0057748	898	0.015	48.0	0.01315	150.0		12.89	0.923961		0	0	0			FAS	0.0	0.2	0.0	0.01	-47.0	-34.0	8.0	16.0						0.0628	0.73	86.956000527			neoplasm; pigmentation phenotype; normal phenotype; mortality/aging ; reproductive system phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; behavior/neurological phenotype ; liver/biliary system phenotype; respiratory system phenotype; skeleton phenotype; renal/urinary system phenotype; immune system phenotype; vision/eye phenotype; craniofacial phenotype; limbs/digits/tail phenotype; nervous system phenotype ; hearing/vestibular/ear phenotype; digestive/alimentary phenotype; endocrine/exocrine gland phenotype; integument phenotype ; growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			ciliary ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;	MAPK signaling pathway;Cytokine-cytokine receptor interaction;p53 signaling pathway;Apoptosis;Natural killer cell mediated cytotoxicity;Type I diabetes mellitus;Autoimmune thyroid disease;Allograft rejection;Graft-versus-host disease	positive regulation of protein phosphorylation;apoptotic process;activation of cysteine-type endopeptidase activity involved in apoptotic process;immune response;signal transduction;regulation of stress-activated MAPK cascade;cellular response to amino acid starvation;Fas signaling pathway;regulation of apoptotic process;positive regulation of apoptotic process;negative regulation of apoptotic process;protein-containing complex assembly;cellular response to mechanical stimulus;cellular response to hyperoxia;apoptotic signaling pathway;extrinsic apoptotic signaling pathway;necroptotic signaling pathway;regulation of extrinsic apoptotic signaling pathway via death domain receptors;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;positive regulation of apoptotic signaling pathway;positive regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway	cytosol;plasma membrane;cell surface;integral component of membrane;nuclear body;death-inducing signaling complex;CD95 death-inducing signaling complex;membrane raft;extracellular exosome	transmembrane signaling receptor activity;protein binding;calmodulin binding;kinase binding;signaling receptor activity;identical protein binding	RIF1[16169070];SRC[18328427;20696918];PDCD6[11606059];CRMP1[16169070];FASLG[12887920;21803845;25241761;24025841];BAG6[21988832];CCND3[21988832];MAPK8[25241761];MAP1LC3B[20956295];CASP8[11717445;12887920;16498403;17159907;18328427;21625644;17047155;21803845;20956295;21713032;26942442];RAP1A[25241761];SUMO1[11112409];CASP10[11717445];INPP5D[11786908];UBQLN1[21988832];RIPK1[7538908];FYN[17159908];FADD[11717445;7536190;7538907;16498403;17159907;18328427;21382479;21625644;21803845;25241761;19118384;20935634;21713032;26942442];PLCG1[20696918];BID[25241761];MAP3K5[11495919;25241761];MBD4[21988832];DAXX[11003656;11495919;25241761];ATP6V0B[21988832];YES1[18328427;21713032];GADD45A[21988832];CAV1[21382479;20956295];PRKCA[25241761];CFLAR[21625644;21803845];PTPN13[10918185;12724420];APOA5[21988832];PML[21803845];RHOA[25241761];EEF1A1[16169070];ERG28[16169070];TMX1[21988832];LCK[20696918];DNAJC5[29997244];FAS[7536190;7538908;21382479];TCAP[21988832];PML-RAR[21803845];CTNNB1[25241761];HNRNPC[21988832];CALM1[14594800];	90768680
12834	chr10	93841263		A	chr10:93841262-93841263	CPEB3	cytoplasmic polyadenylation element binding protein 3	insertion	0/0	0.0	54_0	54	99.0	0/1	0.22	43_13	59	99.0			rs536165859	SPLICING	YES	NM_014912.5	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	8/9		NM_014912.5:c.1688-5dup			-1.0						.	.	.		0.0006267	88.0	140418.0	0.0	32	0.93	PASS	amr	0.00106929	15.0	0.000808583	52.0	0.0245635	3126.0	127262.0	1.0	37	0.86	RF	amr	0.0390704	538.0	0.0208921	1319.0	0.0001865,0.0358576,0.0004823	29,5576,75						12.9	0.924957		0	0	0			CPEB3	0.0	0.0	0.0	0.0	34.0	-4.0	-36.0	-27.0						0.0637	0.99				nervous system phenotype ; behavior/neurological phenotype ; reproductive system phenotype; homeostasis/metabolism phenotype; 			pons;kidney;thyroid;trigeminal ganglion;superior cervical ganglion;skeletal muscle;cerebellum;	.	negative regulation of transcription by RNA polymerase II;translation;long-term memory;negative regulation of translation;positive regulation of translation;regulation of synaptic plasticity;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;regulation of dendritic spine development;positive regulation of dendritic spine development;3'-UTR-mediated mRNA destabilization;cellular response to amino acid stimulus;positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;negative regulation of cytoplasmic translational elongation;positive regulation of mRNA polyadenylation;negative regulation of cytoplasmic translation	nucleus;cytoplasm;postsynaptic density;CCR4-NOT complex;cell junction;dendrite;neuron projection;synapse;postsynaptic membrane;apical dendrite;messenger ribonucleoprotein complex	translation repressor activity, mRNA regulatory element binding;RNA binding;mRNA 3'-UTR binding;protein binding;translation factor activity, RNA binding;RNA stem-loop binding;mRNA 3'-UTR AU-rich region binding;ribosome binding	EGLN3[26972000];CNOT7[21336257];TOB2[21336257];TOB1[21336257];	93841262
12838	chr10	94109550	T	C	chr10:94109550	MARCH5	membrane associated ring-CH-type finger 5	SNV	0/1	0.46	25_21	46	99.0	0/0	0.0	33_0	33	99.0			rs140663239	EXONIC	YES	NM_017824.5	Transcript	protein_coding	synonymous_variant		5/6	NM_017824.5:c.676T>C	NP_060294.1:p.Leu226%3D		1.0						.	.	.		0.00294342	448.0	152204.0	3.0	32	0.97	PASS	sas	0.00517384	25.0	0.0048802	332.0	0.00330649	831.0	251324.0	1.0	55	0.99	PASS	nfe	0.00467207	531.0	0.00467207	531.0	0.0033504	521	0.004	12.0				12.49	0.869627		0	0	0			MARCH5	0.0	0.0	0.13	0.39	35.0	-10.0	44.0	-6.0						0.143	0.9	41.689754618			growth/size/body region phenotype; 			dorsal root ganglion;atrioventricular node;superior cervical ganglion;skeletal muscle;	.	protein polyubiquitination;protein autoubiquitination;protein localization to mitochondrion;regulation of mitochondrial fission;positive regulation of mitochondrial fission;negative regulation of cell aging	mitochondrion;mitochondrial outer membrane;endoplasmic reticulum;endoplasmic reticulum membrane;membrane;integral component of membrane	ubiquitin-protein transferase activity;protein binding;zinc ion binding;GTPase binding	SAR1A[unassigned1304];AQP6[unassigned1304];STMN4[unassigned1304];SGPL1[unassigned1304];UBC[16874301];BNIP1[unassigned1304];MFN2[16936636];DENR[16874301;16936636];FIS1[16874301];UBE2I[19549727];TIMMDC1[unassigned1304];BIK[unassigned1304];AKTIP[19549727];ODF4[unassigned1304];GPX8[unassigned1304];MANBAL[unassigned1304];YIF1A[unassigned1304];UBE2W[19549727;25416956;unassigned1304];CREB3[21516116];SCD[unassigned1304];UBE2T[19549727];TMEM139[unassigned1304];UBE2N[19549727];RTN4IP1[unassigned1304];FATE1[25416956];ERGIC3[unassigned1304];PTPN5[unassigned1304];	94109550
12893	chr10	95079636	G	A	chr10:95079636	MYOF	myoferlin	SNV	0/1	0.58	22_30	52	99.0	0/0	0.0	33_0	33	99.0			rs146626145	EXONIC	YES	NM_013451.4	Transcript	protein_coding	missense_variant		49/54	NM_013451.4:c.5591C>T	NP_038479.1:p.Ala1864Val		-1.0	.,C2 domain&C2 domain&Ferlin, sixth C2 domain				?Angioedema, hereditary, 7, 619366 (3), Autosomal dominant	.	.	.		0.00198073	301.0	151964.0	3.0	32	0.96	PASS	nfe	0.00339696	231.0	0.00339696	231.0	0.00245373	612.0	249416.0	2.0	57	1.0	PASS	nfe	0.00393033	445.0	0.00393033	445.0	0.0024437	380	0.001	3.0				24.8	3.458316	0.491	9	11	20	SIFT,LRT_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	MYOF	0.0	0.06	0.0	0.04	5.0	21.0	2.0	10.0						0.0903	0.0	0.000000000	0.969	1.176	muscle phenotype; growth/size/body region phenotype; cardiovascular system phenotype ; 			superior cervical ganglion;	.	plasma membrane repair;glycerol metabolic process;muscle contraction;myoblast fusion;blood circulation;regulation of vascular endothelial growth factor receptor signaling pathway;T-tubule organization;cellular response to heat;muscle fiber development	nuclear envelope;plasma membrane;caveola;integral component of membrane;cytoplasmic vesicle membrane;cytoplasmic vesicle;nuclear membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding;phospholipid binding	ATP6V1A[21674799];SCARB2[26496610];LGALS3BP[26496610];RAB5C[26496610];TMEM63B[26496610];GOLT1B[26496610];XRCC3[26496610];YWHAZ[15161933];PLEKHA7[28877994];BAG6[26496610];LAMP1[29568061];SAMD1[26496610];RAB7A[26496610];	95079636
13193	chr10	98380244	C	T	chr10:98380244	PIK3AP1	phosphoinositide-3-kinase adaptor protein 1	SNV	0/1	0.53	53_59	112	99.0	0/0	0.0	33_0	33	99.0			rs147512410,COSV59532532	EXONIC	YES	NM_152309.3	Transcript	protein_coding	synonymous_variant		12/17	NM_152309.3:c.1806G>A	NP_689522.2:p.Thr602%3D		-1.0		Benign	criteria_provided,_single_submitter	Infantile_spasms		.	.	.		0.00068359	104.0	152138.0	0.0	32	0.95	PASS	nfe	0.00101429	69.0	0.00101429	69.0	0.00067666	170.0	251234.0	0.0	96	1.0	PASS	nfe	0.00107453	122.0	0.00107453	122.0	0.0005723	89	0.003	9.0				0.281	-0.337958		0	0	0			PIK3AP1	0.0	0.0	0.0	0.0	-31.0	-10.0	-31.0	-36.0						0.0355	1.0	94.820452524			immune system phenotype; hematopoietic system phenotype; 			.	.	positive regulation of phosphatidylinositol 3-kinase signaling;toll-like receptor 2 signaling pathway;toll-like receptor 4 signaling pathway;toll-like receptor 7 signaling pathway;toll-like receptor 9 signaling pathway;phosphatidylinositol phosphorylation;regulation of inflammatory response;positive regulation of protein kinase B signaling	cytosol;plasma membrane;membrane	phosphatidylinositol 3-kinase regulatory subunit binding;identical protein binding;phosphatidylinositol-4,5-bisphosphate 3-kinase activity	DMBX1[unassigned1304];ITSN1[18654987];NCK2[unassigned1304];GRB2[21988832;21706016];	98380244
13311	chr10	99968849	T	G	chr10:99968849	R3HCC1L	R3H domain and coiled-coil containing 1 like	SNV	0/0	0.0	33_0	33	99.0	0/1	0.42	56_42	99	99.0			rs139345451,COSV99040722	EXONIC	YES	NM_001256619.2	Transcript	protein_coding	missense_variant		5/11	NM_001256619.2:c.978T>G	NP_001243548.2:p.Ser326Arg		1.0	.,.,.,.					.	.	.		0.00285928	435.0	152136.0	1.0	32	0.97	PASS	amr	0.00510939	78.0	0.00427778	291.0	0.00303592	760.0	250336.0	2.0	100	1.0	PASS	nfe	0.00512548	578.0	0.00512548	578.0	0.0031253	486	0.003	9.0				10.88	0.667806	0.066	1	19	20	SIFT	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	R3HCC1L	0.0	0.0	0.0	0.0	0.0	-22.0	-1.0	-6.0							0.0	0.000000000	0.904	1.138	behavior/neurological phenotype ; 			.	.	.	exon-exon junction complex	protein binding	EEF1G[30021884];EGLN3[26972000];CCDC103[25416956];CEP19[26638075];MKS1[26638075];POC1A[26638075];EZR[29568061];	99968849
13366	chr10	100174841	G	C	chr10:100174841	PYROXD2	pyridine nucleotide-disulphide oxidoreductase domain 2	SNV	0/1	0.48	78_73	151	99.0	0/0	0.0	40_0	40	99.0			rs117431460,COSV57267685,COSV99054694	EXONIC	YES	NM_032709.3	Transcript	protein_coding	missense_variant		1/16	NM_032709.3:c.52C>G	NP_116098.2:p.Pro18Ala		-1.0						.	.	.		0.00646331	984.0	152244.0	4.0	33	0.98	PASS	nfe	0.0086853	591.0	0.0086853	591.0	0.00651563	1637.0	251242.0	8.0	67	0.99	PASS	nfe	0.00811771	923.0	0.00811771	923.0	0.0059098	919	0.006	19.0				10.26	0.594281	0.014	1	17	18	MutationAssessor_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PYROXD2	0.0	0.0	0.01	0.0	-4.0	-11.0	-36.0	33.0						0.949	0.0	0.000000000	0.075	1.176	.			.	.	oxidation-reduction process	.	protein binding;oxidoreductase activity	MYL4[21988832];APPBP2[25416956];CSNK2B[21900206];	100174841
13394	chr10	101090246	G	A	chr10:101090246	CNNM1	cyclin and CBS domain divalent metal cation transport mediator 1	SNV	0/1	0.49	90_87	177	99.0	0/0	0.0	34_0	34	99.0			rs144944413	EXONIC	YES	NM_001345887.2	Transcript	protein_coding	missense_variant		1/12	NM_001345887.2:c.1102G>A	NP_001332816.1:p.Ala368Thr		1.0	CNNM, transmembrane domain&CNNM, transmembrane domain	Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00120218	183.0	152224.0	0.0	33	0.98	PASS	amr	0.00385924	59.0	0.00119041	81.0	0.00124935	244.0	195302.0	1.0	53	0.58	PASS	nfe	0.00145338	122.0	0.00145338	122.0	0.0009775	152	0.002	5.0				24.1	3.217895	0.172	7	12	19	SIFT,LRT_pred,M-CAP_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,LIST-S2_pred	PolyPhen,MetaLR_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CNNM1	0.0	0.0	0.0	0.0	-28.0	1.0	-28.0	1.0							0.91	0.000000000	0.984	1.163	.			temporal lobe;testis - seminiferous tubule;prefrontal cortex;cingulate cortex;trigeminal ganglion;testis;pons;subthalamic nucleus;testis - interstitial;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;	.	ion transport	plasma membrane;integral component of membrane;dendrite;neuronal cell body	protein binding	PTP4A1[unassigned1304;28330616];PTP4A2[28330616];HSF2BP[unassigned1304];	101090246
13398	chr10	101295200	CGC		chr10:101295200-101295202	NKX2-3	NK2 homeobox 3	deletion	0/0	0.0	53_0	53	99.0	0/1	0.16	21_4	25	88.0			rs753948982	EXONIC	YES	NM_145285.3	Transcript	protein_coding	inframe_deletion		2/2	NM_145285.3:c.843_845del	NP_660328.2:p.Ala286del		1.0						.	.	.		6.77479e-05	10.0	147606.0	0.0	32	0.9	PASS	sas	0.000418936	2.0	3.01087e-05	2.0	0.00488177	192.0	39330.0	0.0	0	0.03	PASS	afr	0.00898204	3.0	0.0043946	67.0	0.0000064	1			0.00078	1.0		17.43	1.692395		0	0	0			NKX2-3	0.0	0.0	0.0	0.0	-33.0	32.0	-33.0	32.0							0.8				immune system phenotype; skeleton phenotype; digestive/alimentary phenotype; mortality/aging ; hematopoietic system phenotype; cardiovascular system phenotype ; respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; 			.	.	leukocyte homeostasis;plasma cell differentiation;triglyceride metabolic process;biological_process;gland morphogenesis;cell differentiation;macrophage differentiation;regulation of cell population proliferation;odontogenesis of dentin-containing tooth;CD4-positive, alpha-beta T cell differentiation;positive regulation of transcription by RNA polymerase II;lymph node development;spleen development;Peyer's patch development;post-embryonic digestive tract morphogenesis;leukocyte migration	cellular_component;nucleus	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;molecular_function;DNA-binding transcription factor activity;sequence-specific DNA binding	NFATC1[21803625];ZNF212[18255255];	101295199
13403	chr10	101591737	T	C	chr10:101591737	ABCC2	ATP binding cassette subfamily C member 2	SNV	0/0	0.0	33_0	33	99.0	0/1	0.49	26_25	51	99.0			rs45441199,COSV64987176	EXONIC	YES	NM_000392.5	Transcript	protein_coding	missense_variant		23/32	NM_000392.5:c.3107T>C	NP_000383.2:p.Ile1036Thr		1.0	ABC transporter type 1, transmembrane domain&ABC transporter type 1, transmembrane domain,ABC transporter type 1, transmembrane domain&ABC transporter type 1, transmembrane domain	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Dubin-Johnson_syndrome|not_specified|not_provided	Dubin-Johnson syndrome, 237500 (3), Autosomal recessive	Dubin-Johnson syndrome	Disease-causing germline mutation(s) in	Conjugated hyperbilirubinemia;Jaundice;Biliary tract abnormality;Autosomal recessive inheritance;Fatigue;Abdominal pain;Abnormality of coagulation;Jaundice;Fever;Biliary tract abnormality;Hepatomegaly;Abnormal urinary color;Conjugated hyperbilirubinemia;Abnormality of the gastric mucosa	30420678	0.00482089	734.0	152254.0	4.0	32	0.97	PASS	nfe	0.00815649	555.0	0.00815649	555.0	0.00499058	1255.0	251474.0	3.0	100	1.0	PASS	nfe	0.00821084	934.0	0.00821084	934.0	0.0052732	820	0.007	24.0	0.00552	63.0		17.97	1.769993	0.28	8	11	19	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,LIST-S2_pred	PolyPhen,LRT_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ABCC2	0.0	0.08	0.0	0.0	-3.0	15.0	-4.0	15.0						0.0978	0.0	0.000000000	0.034	1.138	renal/urinary system phenotype; homeostasis/metabolism phenotype; liver/biliary system phenotype; hematopoietic system phenotype; 			.	ABC transporters	bilirubin transport;transmembrane transport;ATP hydrolysis coupled anion transmembrane transport	plasma membrane;integral component of plasma membrane;cell surface;membrane;apical plasma membrane	protein binding;ATP binding;organic anion transmembrane transporter activity;bilirubin transmembrane transporter activity;ATPase activity, coupled to transmembrane movement of substances;ATPase-coupled anion transmembrane transporter activity	HNRNPDL[30021884];UBQLN1[21988832];SHANK3[21988832];AZIN1[21988832];NFKB1[21988832];MCPH1[21988832];	101591737
13566	chr10	103372126	A	G	chr10:103372126	FBXW4	F-box and WD repeat domain containing 4	SNV	0/1	0.49	46_44	90	99.0	0/0	0.0	35_0	35	99.0			rs35614606	EXONIC	YES	NM_022039.4	Transcript	protein_coding	synonymous_variant		7/9	NM_022039.4:c.1410T>C	NP_071322.2:p.Tyr470%3D		-1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	Split_hand-foot_malformation_3|not_specified|not_provided		.	.	.		0.005427	826.0	152202.0	3.0	33	0.98	PASS	amr	0.00771948	118.0	0.00562921	383.0	0.00572681	1380.0	240972.0	5.0	29	0.7	PASS	nfe	0.00605239	670.0	0.00605239	670.0	0.0053182	827	0.007	23.0	0.00956	109.0		6.418	0.240245		0	0	0			FBXW4	0.0	0.0	0.0	0.0	-1.0	-27.0	-32.0	-27.0						0.459	0.0				skeleton phenotype; embryo phenotype; mortality/aging ; limbs/digits/tail phenotype; 			.	.	protein polyubiquitination;positive regulation of mesenchymal cell proliferation;ubiquitin-dependent protein catabolic process;Wnt signaling pathway;embryonic limb morphogenesis;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;embryonic digit morphogenesis;post-translational protein modification;cartilage development	ubiquitin ligase complex;cytosol;SCF ubiquitin ligase complex	molecular_function;ubiquitin-protein transferase activity;protein binding	RNF32[21163940];SLX4IP[19596235];CDC37[21163940];MAST1[21163940];CUL1[14603323];ECSIT[21163940];SKP1[22632967;27705803;20596027];	103372126
13756	chr10	106035070	G	A	chr10:106035070	GSTO2	glutathione S-transferase omega 2	SNV	0/0	0.0	35_0	35	99.0	0/1	0.41	48_33	81	99.0			rs34400162	EXONIC	YES	NM_183239.2	Transcript	protein_coding	missense_variant		3/7	NM_183239.2:c.121G>A	NP_899062.1:p.Val41Ile		1.0	.,Glutathione S-transferase, N-terminal&Glutathione S-transferase, N-terminal,.	Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.	22494505	0.0017028	259.0	152102.0	0.0	32	0.96	PASS	afr	0.00572298	237.0	0.000102905	7.0	0.000561127	141.0	251280.0	0.0	53	0.97	PASS	afr	0.00560345	91.0	0.000140763	16.0	0.0005595	87	0.0	1.0	0.00163	3.0		19.51	1.97237	0.114	4	16	20	MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	GSTO2	0.0	0.01	0.0	0.0	9.0	-10.0	22.0	-10.0						0.641	0.0	0.000000000	0.726	1.176	cardiovascular system phenotype ; integument phenotype ; 			ciliary ganglion;testis - seminiferous tubule;testis - interstitial;atrioventricular node;testis;	Glutathione metabolism;Metabolism of xenobiotics by cytochrome P450;Drug metabolism - cytochrome P450	xenobiotic metabolic process;L-ascorbic acid metabolic process;oxidation-reduction process;cellular response to arsenic-containing substance;cellular oxidant detoxification;glutathione derivative biosynthetic process	cytosol;extracellular exosome	glutathione transferase activity;protein binding;oxidoreductase activity;identical protein binding;glutathione dehydrogenase (ascorbate) activity;methylarsonate reductase activity	TFAP2A[25416956;unassigned1304;25910212];SMARCC1[unassigned1304];GSTO2[25416956;unassigned1304];GCA[unassigned1304];POLR1C[unassigned1304];INCA1[unassigned1304];MUM1[25416956];KLHL10[unassigned1304];WDYHV1[unassigned1304];HOXC8[unassigned1304];PFDN5[unassigned1304];SAV1[22570112];	106035070
13760	chr10	111877102	A	G	chr10:111877102	ADD3	adducin 3	SNV	0/1	0.31	9_4	13	60.0	0/0	0.0	30_0	30	90.0			rs140299264,COSV53325275	SPLICING	YES	NM_016824.5	Transcript	protein_coding	splice_region_variant,synonymous_variant		5/15	NM_016824.5:c.489A>G	NP_058432.1:p.Val163%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided	Cerebral palsy, spastic quadriplegic, 3, 617008 (3), Autosomal recessive	Inherited congenital spastic tetraplegia	Disease-causing germline mutation(s) (loss of function) in	Global developmental delay;Autosomal recessive inheritance;Supranuclear gaze palsy;Gray matter heterotopia;Spastic tetraplegia;Variable expressivity;Poor speech;Cognitive impairment;Dysphagia;Nystagmus;Infantile onset;Microcephaly;Seizure;Spastic diplegia;Exotropia;Abnormal pyramidal sign		0.00515722	783.0	151826.0	5.0	32	0.96	PASS	nfe	0.00788374	536.0	0.00788374	536.0	0.00490944	1197.0	243816.0	5.0	35	0.76	PASS	nfe	0.00749578	835.0	0.00749578	835.0	0.0050995	793	0.005	17.0				14.18	1.118327		0	0	0			ADD3	0.03	0.0	0.01	0.0	-2.0	3.0	7.0	-3.0			12.686	-0.471	12.215	0.209	0.95	3.778356637			hematopoietic system phenotype; normal phenotype; 			ciliary ganglion;caudate nucleus;olfactory bulb;amygdala;prefrontal cortex;cingulate cortex;trigeminal ganglion;superior cervical ganglion;pons;thyroid;occipital lobe;subthalamic nucleus;dorsal root ganglion;atrioventricular node;spinal cord;parietal lobe;globus pallidus;hypothalamus;medulla oblongata;thalamus;	.	barbed-end actin filament capping;actin filament bundle assembly;transmembrane transport	condensed nuclear chromosome;nucleoplasm;cytosol;cytoskeleton;plasma membrane;brush border;cell-cell junction;cell cortex;postsynaptic density;membrane;plasma membrane raft	structural molecule activity;structural constituent of cytoskeleton;calmodulin binding;spectrin binding;actin filament binding	STAT5A[26496610];JUN[25609649];MCM7[23764002];HSPB1[25277244];HTT[17500595];OPRM1[28298427];HDAC8[23752268];MYO19[26496610];ADD1[26496610];TCTE1[26638075];PLEKHA7[28877994];ATXN1[23275563];TMEM17[26638075];LAMP1[29568061];CAPZA2[26496610];AGTR1[28298427];SYNPO[26496610];MAPRE1[26496610];EZR[29568061];BCAR1[28007913];	111877102
13779	chr10	114044364	G	A	chr10:114044364	TECTB	tectorin beta	SNV	0/0	0.0	34_0	34	99.0	0/1	0.46	67_57	124	99.0			rs762759658,COSV65595032	EXONIC	YES	NM_058222.3	Transcript	protein_coding	missense_variant		3/11	NM_058222.3:c.148G>A	NP_478129.1:p.Val50Ile		1.0	Zona pellucida domain&Zona pellucida domain&Zona pellucida domain,Zona pellucida domain&Zona pellucida domain&Zona pellucida domain,Zona pellucida domain&Zona pellucida domain&Zona pellucida domain,Zona pellucida domain&Zona pellucida domain&Zona pellucida domain					.	.	.		3.94249e-05	6.0	152188.0	0.0	33	0.97	PASS	amr	0.000196412	3.0	0.0	0.0	3.9826e-06	1.0	251092.0	0.0	39	0.95	PASS				0.0	0.0	0.0000064	1						16.85	1.598991	0.107	3	16	19	LRT_pred,MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	TECTB	0.0	0.0	0.0	0.0	9.0	1.0	9.0	-1.0						0.419	0.0	0.000000000	0.996	0.225	hearing/vestibular/ear phenotype; nervous system phenotype ; 			.	.	.	extracellular region;plasma membrane;extracellular matrix;anchored component of membrane	extracellular matrix structural constituent	.	114044364
13823	chr10	114711333	C	T	chr10:114711333	TCF7L2	transcription factor 7 like 2	SNV	0/1	0.44	39_31	70	99.0	0/0	0.0	34_0	34	99.0			rs143305771,COSV60512161	EXONIC	YES	NM_001367943.1	Transcript	protein_coding	synonymous_variant		3/15	NM_001367943.1:c.348C>T	NP_001354872.1:p.Leu116%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided	{Diabetes mellitus, type 2, susceptibility to}, 125853 (3), Autosomal dominant	Autosomal dominant non-syndromic intellectual disability;Primary sclerosing cholangitis;Pitt-Hopkins syndrome;Fuchs endothelial corneal dystrophy	Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Type II diabetes mellitus;Increased waist to hip ratio;Insulin resistance;Autosomal dominant inheritance;Late onset		0.00192284	285.0	148218.0	1.0	29	0.85	PASS	sas	0.00669456	32.0	0.00215161	143.0	0.00245805	460.0	187140.0	4.0	23	0.6	PASS	sas	0.00735534	180.0	0.00204382	175.0	0.0019163	298	0.002	7.0	0.00418	47.0	1.0	8.922	0.450376		0	0	0			TCF7L2	0.0	0.0	0.0	0.0	-2.0	-9.0	28.0	33.0						0.0268	0.99	90.047781295			adipose tissue phenotype ; endocrine/exocrine gland phenotype; integument phenotype ; growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; limbs/digits/tail phenotype; nervous system phenotype ; digestive/alimentary phenotype; muscle phenotype; neoplasm; mortality/aging ; cardiovascular system phenotype ; behavior/neurological phenotype ; liver/biliary system phenotype; respiratory system phenotype; embryo phenotype; skeleton phenotype; renal/urinary system phenotype; vision/eye phenotype; 			subthalamic nucleus;trigeminal ganglion;superior cervical ganglion;cingulate cortex;hypothalamus;thalamus;	Wnt signaling pathway;Adherens junction;Melanogenesis;Colorectal cancer;Endometrial cancer;Prostate cancer;Thyroid cancer;Basal cell carcinoma;Acute myeloid leukemia	negative regulation of transcription by RNA polymerase II;blood vessel development;regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II;cell cycle arrest;Wnt signaling pathway, calcium modulating pathway;cell population proliferation;response to glucose;positive regulation of heparan sulfate proteoglycan biosynthetic process;pancreas development;positive regulation of insulin secretion;positive regulation of protein binding;regulation of hormone metabolic process;glucose homeostasis;negative regulation of DNA-binding transcription factor activity;maintenance of DNA repeat elements;canonical Wnt signaling pathway involved in positive regulation of epithelial to mesenchymal transition;fat cell differentiation;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of protein export from nucleus;myoblast fate commitment;regulation of smooth muscle cell proliferation;positive regulation of protein kinase B signaling;canonical Wnt signaling pathway;negative regulation of canonical Wnt signaling pathway;beta-catenin-TCF complex assembly;negative regulation of type B pancreatic cell apoptotic process;negative regulation of extrinsic apoptotic signaling pathway	nuclear chromatin;nucleus;nucleoplasm;transcription factor complex;PML body;protein-DNA complex;beta-catenin-TCF7L2 complex	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II repressing transcription factor binding;chromatin binding;DNA-binding transcription factor activity;protein binding;beta-catenin binding;transcription factor binding;protein kinase binding;nuclear hormone receptor binding;sequence-specific DNA binding;transcription regulatory region DNA binding;gamma-catenin binding;armadillo repeat domain binding	INTS11[unassigned1304];JRK[21399610];KRTAP21-2[unassigned1304];KCNE4[27107012];CRX[unassigned1304];FBLN1[21988832];FOXM1[22014570];UFSP1[unassigned1304];BPIFA1[unassigned1304];FAM171A2[unassigned1304];FAM168B[unassigned1304];CYSRT1[unassigned1304];KRTAP7-1[unassigned1304];KRTAP6-2[unassigned1304];KRTAP6-1[unassigned1304];E2F3[22157815];PRR20D[unassigned1304];TGIF1[25873176];DAXX[16569639];XRCC6[17283121];PRKAB2[unassigned1304];C19orf54[unassigned1304];UBE2I[21988832];PARP1[17283121];RBPMS[27107012];JUP[unassigned1304];MSX2[unassigned1304];XRCC5[17283121];TSC1[unassigned1304];TRAF1[unassigned1304];CNFN[unassigned1304];RUNX3[18772112];KRTAP19-5[unassigned1304];HIC1[16724116];AES[unassigned1304];SMUG1[unassigned1304];PSMA3[21988832];CCNG2[27107012];BAALC-AS2[unassigned1304];CTNNB1[11713475;16442529;16569639;16724116;11713476;17283121;18772112;19816403;22014570;19202075;20126258;22056988];TNIK[19816403];	114711333
14044	chr10	123243230	G	A	chr10:123243230	FGFR2	fibroblast growth factor receptor 2	SNV	0/0	0.0	35_0	35	99.0	0/1	0.49	26_25	51	99.0			rs753103160	EXONIC	YES	NM_022970.3	Transcript	protein_coding	synonymous_variant		17/18	NM_022970.3:c.2286C>T	NP_075259.4:p.Leu762%3D		-1.0		Likely_benign	criteria_provided,_single_submitter	not_provided	Bent bone dysplasia syndrome, 614592 (3), Autosomal dominant; LADD syndrome, 149730 (3), Autosomal dominant; Scaphocephaly, maxillary retrusion, and mental retardation, 609579 (3); Antley-Bixler syndrome without genital anomalies or disordered steroidogenesis, 207410 (3), Autosomal dominant; Scaphocephaly and Axenfeld-Rieger anomaly (3); Jackson-Weiss syndrome, 123150 (3), Autosomal dominant; Gastric cancer, somatic, 613659 (3); Craniofacial-skeletal-dermatologic dysplasia, 101600 (3), Autosomal dominant; Apert syndrome, 101200 (3), Autosomal dominant; Pfeiffer syndrome, 101600 (3), Autosomal dominant; Craniosynostosis, nonspecific (3); Beare-Stevenson cutis gyrata syndrome, 123790 (3), Autosomal dominant; Crouzon syndrome, 123500 (3), Autosomal dominant; Saethre-Chotzen syndrome, 101400 (3), Autosomal dominant	Saethre-Chotzen syndrome;Crouzon disease;Apert syndrome;Familial scaphocephaly syndrome, McGillivray type;Antley-Bixler syndrome;Jackson-Weiss syndrome;Cutis gyrata-acanthosis nigricans-craniosynostosis syndrome;Lacrimoauriculodentodigital syndrome;FGFR2-related bent bone dysplasia;Pfeiffer syndrome type 3;Pfeiffer syndrome type 2;Pfeiffer syndrome type 1	Candidate gene tested in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (gain of function) in	Abnormality of the cervical spine;Optic atrophy;Lambdoidal craniosynostosis;Abnormality of the nasopharynx;Atresia of the external auditory canal;Craniofacial dysostosis;Hypoplasia of the maxilla;Brachycephaly;Frontal bossing;Dysgerminoma;Strabismus;Sleep apnea;Keratitis;Sagittal craniosynostosis;Coronal craniosynostosis;Conjunctivitis;Mandibular prognathia;Hypertelorism;Visual impairment;Autosomal dominant inheritance;Conductive hearing impairment;Shallow orbits;Dental crowding;Intellectual disability;Seizure;Micrognathia;Bell-shaped thorax;Overfolding of the superior helices;Gingival overgrowth;Natal tooth;Brachydactyly;Hypertelorism;Midface retrusion;Metopic depression;Extramedullary hematopoiesis;Incomplete ossification of pubis;Low-set ears;Congenital stationary night blindness;Steep acetabular roof;Megalocornea;Bowing of the legs;Osteopenia;Hirsutism;Decreased calvarial ossification;Coronal craniosynostosis;Clitoral hypertrophy;Abnormality of the periosteum;Hepatosplenomegaly;Hypoplastic ischia;Short clavicles;Plagiocephaly;Malar flattening;Shallow orbits;Ptosis;Hallux valgus;Variable expressivity;Microtia;Brachycephaly;Strabismus;Flat face;Hypoplasia of the maxilla;Abnormality of pelvic girdle bone morphology;Flat forehead;Autosomal dominant inheritance;Skull asymmetry;Partial duplication of the distal phalanx of the 2nd finger;Buphthalmos;Short stature;Abnormal heart morphology;Breast carcinoma;Hypertelorism;Clinodactyly of the 5th finger;Prominent crus of helix;Narrow nose;Intellectual disability;Hearing impairment;Radioulnar synostosis;Brachydactyly;Partial duplication of the distal phalanx of the 3rd finger;Lambdoidal craniosynostosis;Facial asymmetry;Low anterior hairline;Abnormal nasolacrimal system morphology;Abnormality of cardiovascular system morphology;Convex nasal ridge;Absent first metatarsal;Intellectual disability, moderate;Cleft of chin;Narrow palate;Coronal craniosynostosis;Low-set ears;Cleft palate;Oxycephaly;Parietal foramina;Toe syndactyly;Delayed cranial suture closure;High forehead;Long nose;Bilateral single transverse palmar creases;Short stature;Convex nasal ridge;Clinodactyly of the 5th finger;Microtia;Abnormal form of the vertebral bodies;Cleft palate;Epicanthus;Hyperlordosis;Amblyopia;Migraine;Scoliosis;Prominent crus of helix;Finger syndactyly;Conductive hearing impairment;Seizure;Cryptorchidism;Hallux valgus;Narrow palate;Sleep apnea;Brachycephaly;Hypotelorism;Prominent nasal bridge;Brachydactyly;Narrow internal auditory canal;High forehead;Hypertelorism;Proximal radio-ulnar synostosis;Low anterior hairline;Optic atrophy;Facial asymmetry;Ptosis;Abnormality of cardiovascular system morphology;Abnormality of the antihelix;Triphalangeal thumb;Hypoplasia of the maxilla;Open bite;Blepharospasm;Sensorineural hearing impairment;Increased intracranial pressure;Depressed nasal bridge;External ear malformation;Broad thumb;Delayed cranial suture closure;Low-set ears;Craniosynostosis;Strabismus;Intellectual disability, moderate;Plagiocephaly;Cloverleaf skull;Optic atrophy;Ectopic anus;Feeding difficulties in infancy;Hypertelorism;Absent septum pellucidum;Depressed nasal bridge;Narrow palate;Broad forehead;Convex nasal ridge;Morphological abnormality of the semicircular canal;Downslanted palpebral fissures;Facial asymmetry;Ovarian neoplasm;Brachyturricephaly;Frontal bossing;Acrobrachycephaly;Broad thumb;Respiratory insufficiency;Ventriculomegaly;Cervical C5/C6 vertebrae fusion;Toe syndactyly;Corneal erosion;Conductive hearing impairment;Hypertension;Flat face;Proptosis;Esophageal atresia;Sensorineural hearing impairment;Strabismus;Midface retrusion;Mandibular prognathia;Micromelia;Abnormality of cardiovascular system morphology;Hydrocephalus;Hypoplasia of the maxilla;Arnold-Chiari malformation;Bifid uvula;Intellectual disability;Large fontanelles;Choanal atresia;Agenesis of corpus callosum;Finger syndactyly;Aplasia/Hypoplasia of the thumb;Delayed eruption of teeth;Visual impairment;Increased intracranial pressure;Convex nasal ridge;Narrow internal auditory canal;Abnormal sacrum morphology;Frontal bossing;Iris coloboma;Optic atrophy;High forehead;Hypoplasia of the maxilla;Turricephaly;Hypertelorism;Headache;Midface retrusion;Abnormal facial shape;Cerebellar hypoplasia;Acanthosis nigricans;Brachycephaly;Narrow palate;Multiple suture craniosynostosis;Conductive hearing impairment;Conjunctivitis;Strabismus;Proptosis;Arnold-Chiari malformation;Ptosis;Hydrocephalus;Amblyopia;Melanocytic nevus;Respiratory insufficiency;Hypopigmented skin patches;Choanal atresia;Coronal craniosynostosis;Gingival overgrowth;Low-set ears;Autosomal dominant inheritance;Midface retrusion;Short clavicles;Micrognathia;Bell-shaped thorax;Malar flattening;Abnormally large globe;Hepatosplenomegaly;Hirsutism;Hypertelorism;Clitoral hypertrophy;Brachydactyly;Humeroradial synostosis;Choanal stenosis;Intellectual disability;Malar flattening;Stenosis of the external auditory canal;Camptodactyly;Coronal craniosynostosis;Lambdoidal craniosynostosis;Femoral bowing;Narrow chest;Long philtrum;Proptosis;Frontal bossing;Abnormal renal morphology;Upper airway obstruction;Hypoplastic labia majora;Rocker bottom foot;Choanal atresia;Hydrocephalus;Fused labia minora;Brachycephaly;Atrial septal defect;Autosomal dominant inheritance;Abnormality of the pinna;Flexion contracture;Depressed nasal bridge;Autosomal recessive inheritance;Arachnodactyly;Ulnar bowing;Narrow pelvis bone;Midface retrusion;Wide anterior fontanel;Vaginal atresia;Stomach cancer;Somatic mutation;Increased level of L-fucose in urine;Turricephaly;Midface retrusion;Mandibular prognathia;Frontal bossing;Abnormal palate morphology;Proptosis;Broad metatarsal;Strabismus;Preaxial foot polydactyly;Convex nasal ridge;2-3 toe syndactyly;Hypertelorism;Short metatarsal;Abnormality of fibula morphology;Underdeveloped supraorbital ridges;Symphalangism affecting the phalanges of the hand;Hypoplasia of the maxilla;Ptosis;Split foot;Broad hallux phalanx;Nasolacrimal duct obstruction;Coronal hypospadias;Broad hallux;Hypoplasia of the lacrimal punctum;Hypertelorism;Xerostomia;Small thenar eminence;Absence of Stensen duct;Broad forehead;Bilateral triphalangeal thumbs;Corneal perforation;Hypoplasia of dental enamel;Hypoplasia of the radius;Lacrimal gland hypoplasia;Alacrima;Aplasia of the parotid gland;Nephrosclerosis;Limbal stem cell deficiency;Dacryocystitis;Hyperextensible skin;Absent lacrimal punctum;Partial duplication of thumb phalanx;Hypoplasia of the ulna;Renal agenesis;Telecanthus;Absent radius;Cupped ear;Carious teeth;Recurrent corneal erosions;Lacrimal gland aplasia;Absent proximal phalanx of thumb;Autosomal dominant inheritance;Hypodontia;Delayed eruption of primary teeth;Radial deviation of the 3rd finger;Downslanted palpebral fissures;Hypoplastic lacrimal duct;Conical incisor;Periorbital fullness;2-3 finger syndactyly;Clinodactyly of the 5th finger;Preaxial polydactyly;Mixed hearing impairment;Autosomal dominant inheritance;Broad metatarsal;Broad hallux;Hallux varus;Midface retrusion;2-3 toe syndactyly;Calcaneonavicular fusion;Malar flattening;Craniosynostosis;Short metatarsal;Trigonocephaly;Open bite;Midface retrusion;Ventriculomegaly;High palate;Dolichocephaly;Toe syndactyly;Mandibular prognathia;Upslanted palpebral fissure;Intellectual disability, mild;High forehead;Broad hallux phalanx;Macrocephaly;Hypertelorism;Proptosis;Cryptorchidism;Visceral angiomatosis;Palmoplantar cutis gyrata;Prominent scrotal raphe;Midface retrusion;Hypertension;Dolichocephaly;Acanthosis nigricans;Abnormality of the pancreas;Abnormality of vision;Subcutaneous nodule;Cloverleaf skull;Reduced number of teeth;Hypertelorism;Depressed nasal bridge;Ptosis;Optic atrophy;Hearing abnormality;Anteriorly placed anus;Downslanted palpebral fissures;Hypoplasia of the zygomatic bone;Thickened helices;Macrotia;Hydrocephalus;Cleft palate;Palmoplantar keratoderma;Umbilical hernia;Anteverted nares;Craniosynostosis;Turricephaly;Aplasia/Hypoplasia of the earlobes;Preauricular skin furrow;Melanocytic nevus;Respiratory distress;Narrow mouth;Narrow palate;Choanal atresia;Bifid scrotum;Malar flattening;Abnormality of the nail;Agenesis of corpus callosum;Anteriorly placed anus;Skin tags;Malar flattening;Small nail;Proptosis;Global developmental delay;Palmoplantar cutis laxa;Prominent scrotal raphe;Choanal atresia;Downslanted palpebral fissures;Preauricular skin furrow;Autosomal dominant inheritance;Narrow palate;Craniosynostosis;Limited elbow extension;Midface retrusion;Hydrocephalus;Choanal stenosis;Hypertelorism;Respiratory distress;Acanthosis nigricans;Cloverleaf skull;Low-set, posteriorly rotated ears;Bifid scrotum;Vaginal atresia;Delayed eruption of teeth;Ventriculomegaly;Overriding aorta;Ventricular septal defect;Hydronephrosis;Arachnoid cyst;Narrow palate;Malar flattening;Pyloric stenosis;Synostosis of carpal bones;Broad distal phalanx of the thumb;Bifid uvula;Abnormal morphology of the limbic system;Coronal craniosynostosis;Broad distal hallux;Arnold-Chiari type I malformation;Esophageal atresia;Megalencephaly;Hydrocephalus;Hypertelorism;Strabismus;Intellectual disability;Shallow orbits;Flat face;Cryptorchidism;Agenesis of corpus callosum;Growth abnormality;High forehead;Chronic otitis media;Preaxial hand polydactyly;Delayed cranial suture closure;Downslanted palpebral fissures;Dental malocclusion;Midface retrusion;Mandibular prognathia;Humeroradial synostosis;Autosomal dominant inheritance;Broad forehead;Depressed nasal bridge;Brachyturricephaly;Choanal atresia;Anomalous tracheal cartilage;Choanal stenosis;Posterior fossa cyst;Acne;Cervical C5/C6 vertebrae fusion;Acrobrachycephaly;Ectopic anus;Hearing impairment;Large fontanelles;Cutaneous finger syndactyly;Postaxial hand polydactyly;Absent septum pellucidum;Intellectual disability;Dolichocephaly;Midface retrusion;Limitation of joint mobility;Anal atresia;Tracheomalacia;Finger syndactyly;Hypertelorism;Cleft palate;Choanal atresia;Small hand;High forehead;Low-set ears;Intestinal malrotation;Laryngomalacia;Hydronephrosis;Amblyopia;Proptosis;Arnold-Chiari malformation;Broad hallux phalanx;Increased intracranial pressure;Hallux varus;Broad thumb;Intellectual disability;Aqueductal stenosis;Depressed nasal bridge;Vesicoureteral reflux;Short foot;Toe syndactyly;Short nose;High palate;Horseshoe kidney;Hearing impairment;Short hallux;Seizure;Brachyturricephaly;Stenosis of the external auditory canal;Respiratory distress;Short foot;Finger syndactyly;Visual loss;Hallux varus;Malar flattening;Choanal atresia;Broad hallux phalanx;Aqueductal stenosis;Cloverleaf skull;Limitation of joint mobility;Atresia of the external auditory canal;Small hand;Proptosis;Increased intracranial pressure;Tracheomalacia;Global developmental delay;Hypertelorism;Intellectual disability;High palate;Intestinal malrotation;High forehead;Laryngomalacia;Respiratory distress;Depressed nasal bridge;Anal atresia;Hydrocephalus;Seizure;Short nose;Cleft palate;Low-set ears;Deviation of the thumb;Toe syndactyly;Arnold-Chiari malformation;Short hallux;Broad thumb;Hearing impairment;Toe syndactyly;Short hallux;Aqueductal stenosis;Short foot;Finger syndactyly;Hallux varus;Broad thumb;Proptosis;Bicoronal synostosis;Brachycephaly;High palate;Aplasia/Hypoplasia of the thumb;Short palm;Hypertelorism;Short nose;Low-set ears;Depressed nasal bridge;Midface retrusion;Broad hallux phalanx;High forehead;Long philtrum;Abnormality of the ribs;Anteverted nares;Brachycephaly;Camptodactyly of finger;Cleft palate;Joint stiffness;Arachnodactyly;Abnormality of cardiovascular system morphology;Downslanted palpebral fissures;Hypoplasia of the zygomatic bone;Craniosynostosis;Proptosis;Elbow ankylosis;Talipes;Femoral bowing;Hypertelorism;Narrow mouth;Strabismus;Turricephaly;Choanal atresia;Narrow chest;Low-set, posteriorly rotated ears;Delayed cranial suture closure;Narrow pelvis bone;Frontal bossing;Recurrent fractures;Short nose;Abnormal renal morphology;Underdeveloped supraorbital ridges;Mandibular prognathia;Hypertelorism;Choanal stenosis;Humeroradial synostosis;Elbow ankylosis;Intellectual disability;Finger syndactyly;High palate;Choanal atresia;Autosomal dominant inheritance;Cloverleaf skull;Dental crowding;Bronchomalacia;Hydrocephalus;Brachyturricephaly;Coronal craniosynostosis;Short nose;Broad hallux;Downslanted palpebral fissures;Strabismus;Shallow orbits;Hypoplasia of the maxilla;Short middle phalanx of toe;Depressed nasal bridge;Broad thumb;Arnold-Chiari malformation;Cartilaginous trachea;Shortening of all middle phalanges of the fingers		1.97101e-05	3.0	152206.0	0.0	32	0.95	PASS	nfe	4.4093e-05	3.0	4.4093e-05	3.0	3.58466e-05	9.0	251070.0	0.0	92	0.95	PASS	nfe	6.16089e-05	7.0	6.16089e-05	7.0	0.0000386	6			0.00026	3.0		11.11	0.694903		0	0	0			FGFR2	0.0	0.0	0.0	0.0	-37.0	44.0	24.0	-18.0						0.00179	1.0	41.766699407			behavior/neurological phenotype ; liver/biliary system phenotype; respiratory system phenotype; embryo phenotype; pigmentation phenotype; neoplasm; hematopoietic system phenotype; cardiovascular system phenotype ; normal phenotype; mortality/aging ; reproductive system phenotype; vision/eye phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype ; hearing/vestibular/ear phenotype; skeleton phenotype; renal/urinary system phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype ; craniofacial phenotype; muscle phenotype; 			caudate nucleus;ciliary ganglion;amygdala;trachea;prefrontal cortex;trigeminal ganglion;cerebellum;fetal thyroid;uterus;occipital lobe;whole brain;spinal cord;skeletal muscle;globus pallidus;thalamus;temporal lobe;appendix;cingulate cortex;superior cervical ganglion;fetal lung;fetal liver;cerebellum peduncles;pons;thyroid;subthalamic nucleus;atrioventricular node;parietal lobe;hypothalamus;medulla oblongata;	MAPK signaling pathway;Regulation of actin cytoskeleton;Prostate cancer	negative regulation of transcription by RNA polymerase II;MAPK cascade;angiogenesis;ureteric bud development;in utero embryonic development;epithelial to mesenchymal transition;positive regulation of mesenchymal cell proliferation;outflow tract septum morphogenesis;membranous septum morphogenesis;endochondral bone growth;apoptotic process;transmembrane receptor protein tyrosine kinase signaling pathway;cell-cell signaling;axonogenesis;positive regulation of cell population proliferation;fibroblast growth factor receptor signaling pathway;regulation of smoothened signaling pathway;post-embryonic development;embryonic pattern specification;animal organ morphogenesis;regulation of cell fate commitment;positive regulation of phospholipase activity;morphogenesis of embryonic epithelium;peptidyl-tyrosine phosphorylation;orbitofrontal cortex development;ventricular zone neuroblast division;pyramidal neuron development;gland morphogenesis;positive regulation of Wnt signaling pathway;bone mineralization;lung development;epithelial cell differentiation;midbrain development;otic vesicle formation;hair follicle morphogenesis;response to lipopolysaccharide;lacrimal gland development;regulation of osteoblast proliferation;multicellular organism growth;organ growth;fibroblast growth factor receptor signaling pathway involved in negative regulation of apoptotic process in bone marrow cell;fibroblast growth factor receptor signaling pathway involved in hemopoiesis;fibroblast growth factor receptor signaling pathway involved in positive regulation of cell proliferation in bone marrow;fibroblast growth factor receptor signaling pathway involved in orbitofrontal cortex development;phosphatidylinositol-3-phosphate biosynthetic process;regulation of multicellular organism growth;regulation of fibroblast growth factor receptor signaling pathway;wound healing;inner ear morphogenesis;odontogenesis;positive regulation of MAPK cascade;cell fate commitment;response to ethanol;regulation of osteoblast differentiation;positive regulation of cell cycle;positive regulation of transcription by RNA polymerase II;protein autophosphorylation;phosphatidylinositol phosphorylation;lung alveolus development;mesodermal cell differentiation;embryonic digestive tract morphogenesis;embryonic organ morphogenesis;digestive tract development;embryonic organ development;reproductive structure development;positive regulation of smooth muscle cell proliferation;embryonic cranial skeleton morphogenesis;skeletal system morphogenesis;epidermis morphogenesis;branching morphogenesis of a nerve;mesenchymal cell differentiation;positive regulation of epithelial cell proliferation;negative regulation of epithelial cell proliferation;regulation of smooth muscle cell differentiation;positive regulation of cell division;positive regulation of protein kinase B signaling;ventricular cardiac muscle tissue morphogenesis;positive regulation of cardiac muscle cell proliferation;limb bud formation;bone development;bone morphogenesis;branching involved in prostate gland morphogenesis;branching involved in salivary gland morphogenesis;bud elongation involved in lung branching;lung lobe morphogenesis;lung-associated mesenchyme development;positive regulation of epithelial cell proliferation involved in lung morphogenesis;prostate gland morphogenesis;prostate epithelial cord elongation;prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis;squamous basal epithelial stem cell differentiation involved in prostate gland acinus development;fibroblast growth factor receptor signaling pathway involved in mammary gland specification;lateral sprouting from an epithelium;mammary gland bud formation;epithelial cell proliferation involved in salivary gland morphogenesis;branch elongation involved in salivary gland morphogenesis;branching involved in labyrinthine layer morphogenesis;regulation of branching involved in prostate gland morphogenesis;regulation of morphogenesis of a branching structure;mesenchymal cell differentiation involved in lung development;mesenchymal cell proliferation involved in lung development;regulation of ERK1 and ERK2 cascade;positive regulation of ERK1 and ERK2 cascade;cellular response to retinoic acid;cellular response to transforming growth factor beta stimulus;positive regulation of canonical Wnt signaling pathway	nucleus;nucleoplasm;cytoplasm;Golgi apparatus;plasma membrane;integral component of plasma membrane;cell cortex;cell surface;membrane;integral component of membrane;cytoplasmic vesicle;intracellular membrane-bounded organelle;receptor complex;excitatory synapse;collagen-containing extracellular matrix	protein tyrosine kinase activity;transmembrane receptor protein tyrosine kinase activity;fibroblast growth factor-activated receptor activity;Ras guanyl-nucleotide exchange factor activity;protein binding;ATP binding;heparin binding;1-phosphatidylinositol-3-kinase activity;fibroblast growth factor binding;protein homodimerization activity;phosphatidylinositol-4,5-bisphosphate 3-kinase activity	ERRFI1[25640309];BEX2[25640309];BEX1[25640309];LRRK1[24947832];FGF1[10618369;25241761;23597563;11069186];FGF2[11390973;17981115;10830168;26267536];CTGF[23142580];RHOBTB2[25640309];FGF5[25241761];LAPTM4B[25594178];FGF7[1309608];FGF8[25241761];PDLIM2[25640309];PLCG1[25241761;24440983];S100A14[25640309];FGF23[25241761];MTA3[25640309];HOXC6[25640309];RASL10B[25640309];GLCE[25640309];YWHAZ[18332103];PPM1A[21988832];MMP14[20798051];PKM[24606918];ANOS1[19696444];GRB2[22726438;24440983];TFF1[25640309];FGFR3[23972473];FGFR2[22726438;19060208];FGF10[12591959;25241761];	123243230
14084	chr10	123847081	C	T	chr10:123847081	TACC2	transforming acidic coiled-coil containing protein 2	SNV	0/0	0.0	140_0	140	99.0	0/1	0.51	83_86	169	99.0			rs376809823,COSV57767428	EXONIC	YES	NM_206862.4	Transcript	protein_coding	missense_variant		4/23	NM_206862.4:c.5066C>T	NP_996744.4:p.Ala1689Val		1.0	.,.,.,.,.					.	.	.		6.56909e-05	10.0	152228.0	0.0	33	0.98	PASS	amr	0.000196207	3.0	8.82016e-05	6.0	7.97124e-05	20.0	250902.0	0.0	79	1.0	PASS	amr	0.000202417	7.0	0.000105874	12.0	0.0000772	12	0.0	1.0				8.937	0.451899	0.029	1	17	18	SIFT	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	TACC2	0.0	0.0	0.0	0.0	-3.0	-31.0	-2.0	25.0						0.843	0.0	0.000000000	0.0	-0.213	normal phenotype; 			ciliary ganglion;subthalamic nucleus;dorsal root ganglion;skin;atrioventricular node;trigeminal ganglion;superior cervical ganglion;placenta;skeletal muscle;globus pallidus;	.	microtubule cytoskeleton organization;mitotic spindle organization;cell population proliferation;cerebral cortex development	nucleoplasm;cytoplasm;microtubule organizing center;cytosol;plasma membrane	nuclear hormone receptor binding	CTR9[26496610];TTK[15304323];SLAIN2[26496610];FTSJ1[17353931];CKAP5[20360068;26496610];GRAMD4[unassigned1304];TOMM20[29568061];CLK2[unassigned1304];TGM1[unassigned1304];TUBA1A[27291054];CANX[29568061];CLVS2[unassigned1304];HMG20B[16169070];TACC1[26496610];KIF21A[26496610];BORCS6[unassigned1304];	123847081
14133	chr10	125521390	C	G	chr10:125521390	CPXM2	carboxypeptidase X, M14 family member 2	SNV	0/1	0.55	34_41	75	99.0	0/0	0.0	42_0	42	99.0			rs142483883,COSV53872252,COSV53873700	SPLICING	YES	NM_198148.3	Transcript	protein_coding	missense_variant,splice_region_variant		11/14	NM_198148.3:c.1775G>C	NP_937791.2:p.Gly592Ala		-1.0	Peptidase M14, carboxypeptidase A&Peptidase M14, carboxypeptidase A,Peptidase M14, carboxypeptidase A&Peptidase M14, carboxypeptidase A&AEBP1/CPX, carboxypeptidase domain					.	.	.		0.00318111	484.0	152148.0	2.0	32	0.95	PASS	nfe	0.00330727	225.0	0.00330727	225.0	0.00317652	785.0	247126.0	4.0	32	0.81	PASS	nfe	0.00318741	354.0	0.00318741	354.0	0.0027845	433	0.001	2.0				27.2	3.940255	0.774	13	7	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	CPXM2	0.0	0.0	0.01	0.0	2.0	-2.0	2.0	1.0	0.947664168139827	0.636	7.47	-0.52	6.95	0.287	0.0	0.000000000	0.894	1.01	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;	.	peptide metabolic process;protein processing	extracellular space	metallocarboxypeptidase activity;zinc ion binding	.	125521390
14257	chr10	126678087	C	T	chr10:126678087	CTBP2	C-terminal binding protein 2	SNV	0|1	0.64	38_67	105	99.0	0|1	0.57	51_69	120	99.0			rs78981424,COSV58338376	EXONIC	YES	NM_022802.3	Transcript	protein_coding	stop_retained_variant		9/9	NM_022802.3:c.2958G>A	NP_073713.2:p.Ter986%3D		-1.0						.	.	.						31	0.96							0.0004214	94.0	223066.0	0.0	64	0.99	RF	afr	0.00184857	25.0	0.000533257	52.0	0.0000322	5	0.001	2.0				13.48	1.007284		0	0	0			CTBP2	0.0	0.0	0.03	0.0	44.0	-16.0	-16.0	-8.0						0.0302	0.66				muscle phenotype; growth/size/body region phenotype; embryo phenotype; skeleton phenotype; nervous system phenotype ; cardiovascular system phenotype ; mortality/aging ; 			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Wnt signaling pathway;Notch signaling pathway;Chronic myeloid leukemia	negative regulation of cell population proliferation;synaptic vesicle docking;viral genome replication;positive regulation of chromatin binding;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of retinoic acid receptor signaling pathway;maintenance of presynaptic active zone structure;white fat cell differentiation;oxidation-reduction process;cellular response to leukemia inhibitory factor	nucleus;transcriptional repressor complex;cell junction;photoreceptor ribbon synapse;presynaptic active zone cytoplasmic component;glutamatergic synapse;GABA-ergic synapse;presynaptic cytosol	chromatin binding;transcription coactivator activity;transcription corepressor activity;protein binding;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;protein kinase binding;retinoic acid receptor binding;protein-containing complex binding;NAD binding;structural constituent of presynaptic active zone	MDC1[29656893];CCNH[21988832];FOXI2[25609649];IKZF1[21516116;25416956;unassigned1304];IKZF2[25416956];ACTG1[21988832];FOXQ1[25609649];CAPN7[unassigned1304];CWC22[26496610];VRTN[unassigned1304];HOXA5[unassigned1304];LMO4[unassigned1304];SOX13[21988832;unassigned1304];DYRK1B[23602568];HIC1[19486893];FOXP2[25416956;unassigned1304];FOXP1[25609649];SHISA6[unassigned1304];CACNB2[unassigned1304];CACNB3[unassigned1304];MARF1[unassigned1312];CACNB4[unassigned1304];ZFPM1[21988832];HOXB5[25416956;unassigned1304];TSHZ3[25416956;unassigned1304];CTBP2[unassigned1304];CTBP1[21988832;25416956;26496610;27107012];CSTF2[unassigned1304];BAZ2B[16189514;25416956;unassigned1304];GLIS2[unassigned1304];SDCBP[unassigned1304];RAB11FIP1[26496610];DVL2[21988832];HOXC5[unassigned1304];TP53BP1[29656893];MARK3[26496610];RAI2[16189514;25416956];ENKD1[unassigned1304];ZBTB18[25416956;unassigned1304];XRCC6[21988832];JUN[25609649];UBE2I[21988832];DTNB[unassigned1304];NEK6[unassigned1304];HELZ[unassigned1312];FLI1[25416956];RPS28[21988832];QARS[unassigned1304];RPS29[21988832];BCL3[21988832];EIF4G1[unassigned1304];ZNF512B[15231748];C15orf39[21988832];RBM26[26496610];CCDC120[unassigned1304];FOXE1[25609649];ZC3H3[26496610];FHL3[27107012];BRCA1[29656893];RPS4X[21988832];RPL7A[21988832];RBM4[26496610];FUNDC1[25416956];KYNU[unassigned1304];DMRTB1[25416956;26871637];CCR5[21988832];RBBP8NL[unassigned1304];TEAD3[16189514];TGIF1[16189514;21516116;25416956;25910212];CEP68[unassigned1304];BCAS3[25416956];AKTIP[16189514];CTPS2[21988832];PROX1[21988832];AES[unassigned1304];DUSP21[unassigned1304];LCOR[27705803;25416956];MVD[26496610];ANG[28777577];PLCB1[25416956];LCORL[unassigned1304];ZNF750[25416956];PPP1R15A[21988832];CATSPER1[unassigned1304];PRKAA2[unassigned1304];GPALPP1[26496610];ZBTB42[unassigned1304];NOL4[16189514;25416956];STX11[21988832];RNF135[unassigned1304];FOXS1[25609649];NRIP1[16189514];RBBP8[21988832;26807646];RPL17[21988832];CASP8AP2[21988832];FOXB1[25609649];EGLN3[unassigned1304];KLF3[unassigned1304];NOL4L[25416956];TRIML2[unassigned1304];LNX1[unassigned1304];RIMBP3[25416956];ZNF217[26496610];MSRB3[unassigned1304];	126678087
14264	chr10	126678092	G	A	chr10:126678092	CTBP2	C-terminal binding protein 2	SNV	0|1	0.63	39_67	106	99.0	0|1	0.59	51_73	124	99.0			rs73373169	EXONIC	YES	NM_022802.3	Transcript	protein_coding	stop_gained		9/9	NM_022802.3:c.2953C>T	NP_073713.2:p.Gln985Ter		-1.0	.,.,.,.,.,.					.	.	.						31	0.96							0.00265146	523.0	197250.0	0.0	65	0.99	RF	afr	0.00915272	105.0	0.00345093	287.0	0.0619405	9632	0.002	5.0				40.0	7.965291		5	1	6	LRT_pred,MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	fathmm-XF_coding_pred	CTBP2	0.0	0.0	0.0	0.06	-21.0	39.0	2.0	-21.0						0.0302	0.66		0.998	0.214	muscle phenotype; growth/size/body region phenotype; embryo phenotype; skeleton phenotype; nervous system phenotype ; cardiovascular system phenotype ; mortality/aging ; 			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Wnt signaling pathway;Notch signaling pathway;Chronic myeloid leukemia	negative regulation of cell population proliferation;synaptic vesicle docking;viral genome replication;positive regulation of chromatin binding;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of retinoic acid receptor signaling pathway;maintenance of presynaptic active zone structure;white fat cell differentiation;oxidation-reduction process;cellular response to leukemia inhibitory factor	nucleus;transcriptional repressor complex;cell junction;photoreceptor ribbon synapse;presynaptic active zone cytoplasmic component;glutamatergic synapse;GABA-ergic synapse;presynaptic cytosol	chromatin binding;transcription coactivator activity;transcription corepressor activity;protein binding;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;protein kinase binding;retinoic acid receptor binding;protein-containing complex binding;NAD binding;structural constituent of presynaptic active zone	MDC1[29656893];CCNH[21988832];FOXI2[25609649];IKZF1[21516116;25416956;unassigned1304];IKZF2[25416956];ACTG1[21988832];FOXQ1[25609649];CAPN7[unassigned1304];CWC22[26496610];VRTN[unassigned1304];HOXA5[unassigned1304];LMO4[unassigned1304];SOX13[21988832;unassigned1304];DYRK1B[23602568];HIC1[19486893];FOXP2[25416956;unassigned1304];FOXP1[25609649];SHISA6[unassigned1304];CACNB2[unassigned1304];CACNB3[unassigned1304];MARF1[unassigned1312];CACNB4[unassigned1304];ZFPM1[21988832];HOXB5[25416956;unassigned1304];TSHZ3[25416956;unassigned1304];CTBP2[unassigned1304];CTBP1[21988832;25416956;26496610;27107012];CSTF2[unassigned1304];BAZ2B[16189514;25416956;unassigned1304];GLIS2[unassigned1304];SDCBP[unassigned1304];RAB11FIP1[26496610];DVL2[21988832];HOXC5[unassigned1304];TP53BP1[29656893];MARK3[26496610];RAI2[16189514;25416956];ENKD1[unassigned1304];ZBTB18[25416956;unassigned1304];XRCC6[21988832];JUN[25609649];UBE2I[21988832];DTNB[unassigned1304];NEK6[unassigned1304];HELZ[unassigned1312];FLI1[25416956];RPS28[21988832];QARS[unassigned1304];RPS29[21988832];BCL3[21988832];EIF4G1[unassigned1304];ZNF512B[15231748];C15orf39[21988832];RBM26[26496610];CCDC120[unassigned1304];FOXE1[25609649];ZC3H3[26496610];FHL3[27107012];BRCA1[29656893];RPS4X[21988832];RPL7A[21988832];RBM4[26496610];FUNDC1[25416956];KYNU[unassigned1304];DMRTB1[25416956;26871637];CCR5[21988832];RBBP8NL[unassigned1304];TEAD3[16189514];TGIF1[16189514;21516116;25416956;25910212];CEP68[unassigned1304];BCAS3[25416956];AKTIP[16189514];CTPS2[21988832];PROX1[21988832];AES[unassigned1304];DUSP21[unassigned1304];LCOR[27705803;25416956];MVD[26496610];ANG[28777577];PLCB1[25416956];LCORL[unassigned1304];ZNF750[25416956];PPP1R15A[21988832];CATSPER1[unassigned1304];PRKAA2[unassigned1304];GPALPP1[26496610];ZBTB42[unassigned1304];NOL4[16189514;25416956];STX11[21988832];RNF135[unassigned1304];FOXS1[25609649];NRIP1[16189514];RBBP8[21988832;26807646];RPL17[21988832];CASP8AP2[21988832];FOXB1[25609649];EGLN3[unassigned1304];KLF3[unassigned1304];NOL4L[25416956];TRIML2[unassigned1304];LNX1[unassigned1304];RIMBP3[25416956];ZNF217[26496610];MSRB3[unassigned1304];	126678092
14276	chr10	126678123	T		chr10:126678123	CTBP2	C-terminal binding protein 2	deletion	0|1	0.54	65_79	145	99.0	0|1	0.55	65_81	146	99.0			rs140913543	EXONIC	YES	NM_022802.3	Transcript	protein_coding	frameshift_variant		9/9	NM_022802.3:c.2922del	NP_073713.2:p.Lys974AsnfsTer33		-1.0						.	.	.						31	0.96							0.0506432	8417.0	166202.0	0.0	58	0.99	RF	afr	0.0797054	725.0	0.0685376	4623.0	0.0000322	5						33.0	5.289769		0	0	0			CTBP2	0.0	0.0	0.0	0.0	9.0	44.0	-43.0	4.0						0.0302	0.66				muscle phenotype; growth/size/body region phenotype; embryo phenotype; skeleton phenotype; nervous system phenotype ; cardiovascular system phenotype ; mortality/aging ; 			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Wnt signaling pathway;Notch signaling pathway;Chronic myeloid leukemia	negative regulation of cell population proliferation;synaptic vesicle docking;viral genome replication;positive regulation of chromatin binding;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of retinoic acid receptor signaling pathway;maintenance of presynaptic active zone structure;white fat cell differentiation;oxidation-reduction process;cellular response to leukemia inhibitory factor	nucleus;transcriptional repressor complex;cell junction;photoreceptor ribbon synapse;presynaptic active zone cytoplasmic component;glutamatergic synapse;GABA-ergic synapse;presynaptic cytosol	chromatin binding;transcription coactivator activity;transcription corepressor activity;protein binding;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;protein kinase binding;retinoic acid receptor binding;protein-containing complex binding;NAD binding;structural constituent of presynaptic active zone	MDC1[29656893];CCNH[21988832];FOXI2[25609649];IKZF1[21516116;25416956;unassigned1304];IKZF2[25416956];ACTG1[21988832];FOXQ1[25609649];CAPN7[unassigned1304];CWC22[26496610];VRTN[unassigned1304];HOXA5[unassigned1304];LMO4[unassigned1304];SOX13[21988832;unassigned1304];DYRK1B[23602568];HIC1[19486893];FOXP2[25416956;unassigned1304];FOXP1[25609649];SHISA6[unassigned1304];CACNB2[unassigned1304];CACNB3[unassigned1304];MARF1[unassigned1312];CACNB4[unassigned1304];ZFPM1[21988832];HOXB5[25416956;unassigned1304];TSHZ3[25416956;unassigned1304];CTBP2[unassigned1304];CTBP1[21988832;25416956;26496610;27107012];CSTF2[unassigned1304];BAZ2B[16189514;25416956;unassigned1304];GLIS2[unassigned1304];SDCBP[unassigned1304];RAB11FIP1[26496610];DVL2[21988832];HOXC5[unassigned1304];TP53BP1[29656893];MARK3[26496610];RAI2[16189514;25416956];ENKD1[unassigned1304];ZBTB18[25416956;unassigned1304];XRCC6[21988832];JUN[25609649];UBE2I[21988832];DTNB[unassigned1304];NEK6[unassigned1304];HELZ[unassigned1312];FLI1[25416956];RPS28[21988832];QARS[unassigned1304];RPS29[21988832];BCL3[21988832];EIF4G1[unassigned1304];ZNF512B[15231748];C15orf39[21988832];RBM26[26496610];CCDC120[unassigned1304];FOXE1[25609649];ZC3H3[26496610];FHL3[27107012];BRCA1[29656893];RPS4X[21988832];RPL7A[21988832];RBM4[26496610];FUNDC1[25416956];KYNU[unassigned1304];DMRTB1[25416956;26871637];CCR5[21988832];RBBP8NL[unassigned1304];TEAD3[16189514];TGIF1[16189514;21516116;25416956;25910212];CEP68[unassigned1304];BCAS3[25416956];AKTIP[16189514];CTPS2[21988832];PROX1[21988832];AES[unassigned1304];DUSP21[unassigned1304];LCOR[27705803;25416956];MVD[26496610];ANG[28777577];PLCB1[25416956];LCORL[unassigned1304];ZNF750[25416956];PPP1R15A[21988832];CATSPER1[unassigned1304];PRKAA2[unassigned1304];GPALPP1[26496610];ZBTB42[unassigned1304];NOL4[16189514;25416956];STX11[21988832];RNF135[unassigned1304];FOXS1[25609649];NRIP1[16189514];RBBP8[21988832;26807646];RPL17[21988832];CASP8AP2[21988832];FOXB1[25609649];EGLN3[unassigned1304];KLF3[unassigned1304];NOL4L[25416956];TRIML2[unassigned1304];LNX1[unassigned1304];RIMBP3[25416956];ZNF217[26496610];MSRB3[unassigned1304];	126678122
14293	chr10	126678128	T	A	chr10:126678128	CTBP2	C-terminal binding protein 2	SNV	0|1	0.54	67_79	147	99.0	0|1	0.55	67_81	148	99.0			rs76370804,COSV58332861	EXONIC	YES	NM_022802.3	Transcript	protein_coding	missense_variant		9/9	NM_022802.3:c.2917A>T	NP_073713.2:p.Thr973Ser		-1.0	.,.,.,.,.,.					.	.	.						31	0.96							0.0605716	10059.0	166068.0	0.0	56	0.99	PASS	afr	0.0888215	820.0	0.0823152	5592.0	0.0000322	5	0.06	180.0				20.1	2.039171	0.134	2	16	18	FATHMM_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	CTBP2	0.0	0.0	0.0	0.0	3.0	38.0	20.0	-1.0						0.0302	0.66		1.0	1.124	muscle phenotype; growth/size/body region phenotype; embryo phenotype; skeleton phenotype; nervous system phenotype ; cardiovascular system phenotype ; mortality/aging ; 			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Wnt signaling pathway;Notch signaling pathway;Chronic myeloid leukemia	negative regulation of cell population proliferation;synaptic vesicle docking;viral genome replication;positive regulation of chromatin binding;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of retinoic acid receptor signaling pathway;maintenance of presynaptic active zone structure;white fat cell differentiation;oxidation-reduction process;cellular response to leukemia inhibitory factor	nucleus;transcriptional repressor complex;cell junction;photoreceptor ribbon synapse;presynaptic active zone cytoplasmic component;glutamatergic synapse;GABA-ergic synapse;presynaptic cytosol	chromatin binding;transcription coactivator activity;transcription corepressor activity;protein binding;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;protein kinase binding;retinoic acid receptor binding;protein-containing complex binding;NAD binding;structural constituent of presynaptic active zone	MDC1[29656893];CCNH[21988832];FOXI2[25609649];IKZF1[21516116;25416956;unassigned1304];IKZF2[25416956];ACTG1[21988832];FOXQ1[25609649];CAPN7[unassigned1304];CWC22[26496610];VRTN[unassigned1304];HOXA5[unassigned1304];LMO4[unassigned1304];SOX13[21988832;unassigned1304];DYRK1B[23602568];HIC1[19486893];FOXP2[25416956;unassigned1304];FOXP1[25609649];SHISA6[unassigned1304];CACNB2[unassigned1304];CACNB3[unassigned1304];MARF1[unassigned1312];CACNB4[unassigned1304];ZFPM1[21988832];HOXB5[25416956;unassigned1304];TSHZ3[25416956;unassigned1304];CTBP2[unassigned1304];CTBP1[21988832;25416956;26496610;27107012];CSTF2[unassigned1304];BAZ2B[16189514;25416956;unassigned1304];GLIS2[unassigned1304];SDCBP[unassigned1304];RAB11FIP1[26496610];DVL2[21988832];HOXC5[unassigned1304];TP53BP1[29656893];MARK3[26496610];RAI2[16189514;25416956];ENKD1[unassigned1304];ZBTB18[25416956;unassigned1304];XRCC6[21988832];JUN[25609649];UBE2I[21988832];DTNB[unassigned1304];NEK6[unassigned1304];HELZ[unassigned1312];FLI1[25416956];RPS28[21988832];QARS[unassigned1304];RPS29[21988832];BCL3[21988832];EIF4G1[unassigned1304];ZNF512B[15231748];C15orf39[21988832];RBM26[26496610];CCDC120[unassigned1304];FOXE1[25609649];ZC3H3[26496610];FHL3[27107012];BRCA1[29656893];RPS4X[21988832];RPL7A[21988832];RBM4[26496610];FUNDC1[25416956];KYNU[unassigned1304];DMRTB1[25416956;26871637];CCR5[21988832];RBBP8NL[unassigned1304];TEAD3[16189514];TGIF1[16189514;21516116;25416956;25910212];CEP68[unassigned1304];BCAS3[25416956];AKTIP[16189514];CTPS2[21988832];PROX1[21988832];AES[unassigned1304];DUSP21[unassigned1304];LCOR[27705803;25416956];MVD[26496610];ANG[28777577];PLCB1[25416956];LCORL[unassigned1304];ZNF750[25416956];PPP1R15A[21988832];CATSPER1[unassigned1304];PRKAA2[unassigned1304];GPALPP1[26496610];ZBTB42[unassigned1304];NOL4[16189514;25416956];STX11[21988832];RNF135[unassigned1304];FOXS1[25609649];NRIP1[16189514];RBBP8[21988832;26807646];RPL17[21988832];CASP8AP2[21988832];FOXB1[25609649];EGLN3[unassigned1304];KLF3[unassigned1304];NOL4L[25416956];TRIML2[unassigned1304];LNX1[unassigned1304];RIMBP3[25416956];ZNF217[26496610];MSRB3[unassigned1304];	126678128
14304	chr10	126678171	C	G	chr10:126678171	CTBP2	C-terminal binding protein 2	SNV	0/1	0.27	102_39	142	99.0	0/1	0.16	113_21	134	99.0			rs765157987,COSV58338132	EXONIC	YES	NM_022802.3	Transcript	protein_coding	synonymous_variant		9/9	NM_022802.3:c.2874G>C	NP_073713.2:p.Pro958%3D		-1.0						.	.	.						31	0.96							0.0150773	2813.0	186572.0	0.0	44	0.95	PASS	eas	0.0231092	308.0	0.0217781	1701.0	0.0000064	1	0.001	3.0				9.887	0.552774		0	0	0			CTBP2	0.0	0.0	0.0	0.0	-5.0	-23.0	18.0	4.0						0.0302	0.66				muscle phenotype; growth/size/body region phenotype; embryo phenotype; skeleton phenotype; nervous system phenotype ; cardiovascular system phenotype ; mortality/aging ; 			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Wnt signaling pathway;Notch signaling pathway;Chronic myeloid leukemia	negative regulation of cell population proliferation;synaptic vesicle docking;viral genome replication;positive regulation of chromatin binding;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of retinoic acid receptor signaling pathway;maintenance of presynaptic active zone structure;white fat cell differentiation;oxidation-reduction process;cellular response to leukemia inhibitory factor	nucleus;transcriptional repressor complex;cell junction;photoreceptor ribbon synapse;presynaptic active zone cytoplasmic component;glutamatergic synapse;GABA-ergic synapse;presynaptic cytosol	chromatin binding;transcription coactivator activity;transcription corepressor activity;protein binding;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;protein kinase binding;retinoic acid receptor binding;protein-containing complex binding;NAD binding;structural constituent of presynaptic active zone	MDC1[29656893];CCNH[21988832];FOXI2[25609649];IKZF1[21516116;25416956;unassigned1304];IKZF2[25416956];ACTG1[21988832];FOXQ1[25609649];CAPN7[unassigned1304];CWC22[26496610];VRTN[unassigned1304];HOXA5[unassigned1304];LMO4[unassigned1304];SOX13[21988832;unassigned1304];DYRK1B[23602568];HIC1[19486893];FOXP2[25416956;unassigned1304];FOXP1[25609649];SHISA6[unassigned1304];CACNB2[unassigned1304];CACNB3[unassigned1304];MARF1[unassigned1312];CACNB4[unassigned1304];ZFPM1[21988832];HOXB5[25416956;unassigned1304];TSHZ3[25416956;unassigned1304];CTBP2[unassigned1304];CTBP1[21988832;25416956;26496610;27107012];CSTF2[unassigned1304];BAZ2B[16189514;25416956;unassigned1304];GLIS2[unassigned1304];SDCBP[unassigned1304];RAB11FIP1[26496610];DVL2[21988832];HOXC5[unassigned1304];TP53BP1[29656893];MARK3[26496610];RAI2[16189514;25416956];ENKD1[unassigned1304];ZBTB18[25416956;unassigned1304];XRCC6[21988832];JUN[25609649];UBE2I[21988832];DTNB[unassigned1304];NEK6[unassigned1304];HELZ[unassigned1312];FLI1[25416956];RPS28[21988832];QARS[unassigned1304];RPS29[21988832];BCL3[21988832];EIF4G1[unassigned1304];ZNF512B[15231748];C15orf39[21988832];RBM26[26496610];CCDC120[unassigned1304];FOXE1[25609649];ZC3H3[26496610];FHL3[27107012];BRCA1[29656893];RPS4X[21988832];RPL7A[21988832];RBM4[26496610];FUNDC1[25416956];KYNU[unassigned1304];DMRTB1[25416956;26871637];CCR5[21988832];RBBP8NL[unassigned1304];TEAD3[16189514];TGIF1[16189514;21516116;25416956;25910212];CEP68[unassigned1304];BCAS3[25416956];AKTIP[16189514];CTPS2[21988832];PROX1[21988832];AES[unassigned1304];DUSP21[unassigned1304];LCOR[27705803;25416956];MVD[26496610];ANG[28777577];PLCB1[25416956];LCORL[unassigned1304];ZNF750[25416956];PPP1R15A[21988832];CATSPER1[unassigned1304];PRKAA2[unassigned1304];GPALPP1[26496610];ZBTB42[unassigned1304];NOL4[16189514;25416956];STX11[21988832];RNF135[unassigned1304];FOXS1[25609649];NRIP1[16189514];RBBP8[21988832;26807646];RPL17[21988832];CASP8AP2[21988832];FOXB1[25609649];EGLN3[unassigned1304];KLF3[unassigned1304];NOL4L[25416956];TRIML2[unassigned1304];LNX1[unassigned1304];RIMBP3[25416956];ZNF217[26496610];MSRB3[unassigned1304];	126678171
14318	chr10	126678177	G	T	chr10:126678177	CTBP2	C-terminal binding protein 2	SNV	0/1	0.41	74_52	127	99.0	0/1	0.45	68_55	123	99.0			rs758205726,COSV58332750	EXONIC	YES	NM_022802.3	Transcript	protein_coding	missense_variant		9/9	NM_022802.3:c.2868C>A	NP_073713.2:p.Asn956Lys		-1.0	.,.,.,.,.,.					.	.	.						31	0.96							0.00255323	519.0	203272.0	0.0	41	0.93	RF	afr	0.00774864	91.0	0.00311865	273.0	0.0814899	12672						23.0	2.734124	0.103	6	13	19	SIFT,MutationTaster_pred,FATHMM_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	CTBP2	0.0	0.0	0.0	0.0	-46.0	-11.0	12.0	-11.0						0.0302	0.66		1.0	1.176	muscle phenotype; growth/size/body region phenotype; embryo phenotype; skeleton phenotype; nervous system phenotype ; cardiovascular system phenotype ; mortality/aging ; 			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Wnt signaling pathway;Notch signaling pathway;Chronic myeloid leukemia	negative regulation of cell population proliferation;synaptic vesicle docking;viral genome replication;positive regulation of chromatin binding;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of retinoic acid receptor signaling pathway;maintenance of presynaptic active zone structure;white fat cell differentiation;oxidation-reduction process;cellular response to leukemia inhibitory factor	nucleus;transcriptional repressor complex;cell junction;photoreceptor ribbon synapse;presynaptic active zone cytoplasmic component;glutamatergic synapse;GABA-ergic synapse;presynaptic cytosol	chromatin binding;transcription coactivator activity;transcription corepressor activity;protein binding;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;protein kinase binding;retinoic acid receptor binding;protein-containing complex binding;NAD binding;structural constituent of presynaptic active zone	MDC1[29656893];CCNH[21988832];FOXI2[25609649];IKZF1[21516116;25416956;unassigned1304];IKZF2[25416956];ACTG1[21988832];FOXQ1[25609649];CAPN7[unassigned1304];CWC22[26496610];VRTN[unassigned1304];HOXA5[unassigned1304];LMO4[unassigned1304];SOX13[21988832;unassigned1304];DYRK1B[23602568];HIC1[19486893];FOXP2[25416956;unassigned1304];FOXP1[25609649];SHISA6[unassigned1304];CACNB2[unassigned1304];CACNB3[unassigned1304];MARF1[unassigned1312];CACNB4[unassigned1304];ZFPM1[21988832];HOXB5[25416956;unassigned1304];TSHZ3[25416956;unassigned1304];CTBP2[unassigned1304];CTBP1[21988832;25416956;26496610;27107012];CSTF2[unassigned1304];BAZ2B[16189514;25416956;unassigned1304];GLIS2[unassigned1304];SDCBP[unassigned1304];RAB11FIP1[26496610];DVL2[21988832];HOXC5[unassigned1304];TP53BP1[29656893];MARK3[26496610];RAI2[16189514;25416956];ENKD1[unassigned1304];ZBTB18[25416956;unassigned1304];XRCC6[21988832];JUN[25609649];UBE2I[21988832];DTNB[unassigned1304];NEK6[unassigned1304];HELZ[unassigned1312];FLI1[25416956];RPS28[21988832];QARS[unassigned1304];RPS29[21988832];BCL3[21988832];EIF4G1[unassigned1304];ZNF512B[15231748];C15orf39[21988832];RBM26[26496610];CCDC120[unassigned1304];FOXE1[25609649];ZC3H3[26496610];FHL3[27107012];BRCA1[29656893];RPS4X[21988832];RPL7A[21988832];RBM4[26496610];FUNDC1[25416956];KYNU[unassigned1304];DMRTB1[25416956;26871637];CCR5[21988832];RBBP8NL[unassigned1304];TEAD3[16189514];TGIF1[16189514;21516116;25416956;25910212];CEP68[unassigned1304];BCAS3[25416956];AKTIP[16189514];CTPS2[21988832];PROX1[21988832];AES[unassigned1304];DUSP21[unassigned1304];LCOR[27705803;25416956];MVD[26496610];ANG[28777577];PLCB1[25416956];LCORL[unassigned1304];ZNF750[25416956];PPP1R15A[21988832];CATSPER1[unassigned1304];PRKAA2[unassigned1304];GPALPP1[26496610];ZBTB42[unassigned1304];NOL4[16189514;25416956];STX11[21988832];RNF135[unassigned1304];FOXS1[25609649];NRIP1[16189514];RBBP8[21988832;26807646];RPL17[21988832];CASP8AP2[21988832];FOXB1[25609649];EGLN3[unassigned1304];KLF3[unassigned1304];NOL4L[25416956];TRIML2[unassigned1304];LNX1[unassigned1304];RIMBP3[25416956];ZNF217[26496610];MSRB3[unassigned1304];	126678177
14326	chr10	126678180	G	A	chr10:126678180	CTBP2	C-terminal binding protein 2	SNV	0|1	0.17	102_21	124	99.0	0|1	0.31	84_37	121	99.0			rs546918459,COSV58338049	EXONIC	YES	NM_022802.3	Transcript	protein_coding	synonymous_variant		9/9	NM_022802.3:c.2865C>T	NP_073713.2:p.His955%3D		-1.0						.	.	.		6.57056e-06	1.0	152194.0	0.0	31	0.96	PASS	nfe	1.46994e-05	1.0	1.46994e-05	1.0	7.31951e-05	17.0	232256.0	0.0	38	0.91	RF	afr	0.000441241	6.0	7.67784e-05	8.0	0.0000064	1	0.0	1.0				10.59	0.632844		0	0	0			CTBP2	0.0	0.0	0.0	0.0	-14.0	40.0	9.0	-17.0						0.0302	0.66				muscle phenotype; growth/size/body region phenotype; embryo phenotype; skeleton phenotype; nervous system phenotype ; cardiovascular system phenotype ; mortality/aging ; 			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Wnt signaling pathway;Notch signaling pathway;Chronic myeloid leukemia	negative regulation of cell population proliferation;synaptic vesicle docking;viral genome replication;positive regulation of chromatin binding;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of retinoic acid receptor signaling pathway;maintenance of presynaptic active zone structure;white fat cell differentiation;oxidation-reduction process;cellular response to leukemia inhibitory factor	nucleus;transcriptional repressor complex;cell junction;photoreceptor ribbon synapse;presynaptic active zone cytoplasmic component;glutamatergic synapse;GABA-ergic synapse;presynaptic cytosol	chromatin binding;transcription coactivator activity;transcription corepressor activity;protein binding;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;protein kinase binding;retinoic acid receptor binding;protein-containing complex binding;NAD binding;structural constituent of presynaptic active zone	MDC1[29656893];CCNH[21988832];FOXI2[25609649];IKZF1[21516116;25416956;unassigned1304];IKZF2[25416956];ACTG1[21988832];FOXQ1[25609649];CAPN7[unassigned1304];CWC22[26496610];VRTN[unassigned1304];HOXA5[unassigned1304];LMO4[unassigned1304];SOX13[21988832;unassigned1304];DYRK1B[23602568];HIC1[19486893];FOXP2[25416956;unassigned1304];FOXP1[25609649];SHISA6[unassigned1304];CACNB2[unassigned1304];CACNB3[unassigned1304];MARF1[unassigned1312];CACNB4[unassigned1304];ZFPM1[21988832];HOXB5[25416956;unassigned1304];TSHZ3[25416956;unassigned1304];CTBP2[unassigned1304];CTBP1[21988832;25416956;26496610;27107012];CSTF2[unassigned1304];BAZ2B[16189514;25416956;unassigned1304];GLIS2[unassigned1304];SDCBP[unassigned1304];RAB11FIP1[26496610];DVL2[21988832];HOXC5[unassigned1304];TP53BP1[29656893];MARK3[26496610];RAI2[16189514;25416956];ENKD1[unassigned1304];ZBTB18[25416956;unassigned1304];XRCC6[21988832];JUN[25609649];UBE2I[21988832];DTNB[unassigned1304];NEK6[unassigned1304];HELZ[unassigned1312];FLI1[25416956];RPS28[21988832];QARS[unassigned1304];RPS29[21988832];BCL3[21988832];EIF4G1[unassigned1304];ZNF512B[15231748];C15orf39[21988832];RBM26[26496610];CCDC120[unassigned1304];FOXE1[25609649];ZC3H3[26496610];FHL3[27107012];BRCA1[29656893];RPS4X[21988832];RPL7A[21988832];RBM4[26496610];FUNDC1[25416956];KYNU[unassigned1304];DMRTB1[25416956;26871637];CCR5[21988832];RBBP8NL[unassigned1304];TEAD3[16189514];TGIF1[16189514;21516116;25416956;25910212];CEP68[unassigned1304];BCAS3[25416956];AKTIP[16189514];CTPS2[21988832];PROX1[21988832];AES[unassigned1304];DUSP21[unassigned1304];LCOR[27705803;25416956];MVD[26496610];ANG[28777577];PLCB1[25416956];LCORL[unassigned1304];ZNF750[25416956];PPP1R15A[21988832];CATSPER1[unassigned1304];PRKAA2[unassigned1304];GPALPP1[26496610];ZBTB42[unassigned1304];NOL4[16189514;25416956];STX11[21988832];RNF135[unassigned1304];FOXS1[25609649];NRIP1[16189514];RBBP8[21988832;26807646];RPL17[21988832];CASP8AP2[21988832];FOXB1[25609649];EGLN3[unassigned1304];KLF3[unassigned1304];NOL4L[25416956];TRIML2[unassigned1304];LNX1[unassigned1304];RIMBP3[25416956];ZNF217[26496610];MSRB3[unassigned1304];	126678180
14341	chr10	126678189	T	C	chr10:126678189	CTBP2	C-terminal binding protein 2	SNV	0/1	0.3	73_32	106	99.0	0/1	0.29	81_33	114	99.0			rs780617077,COSV58333804	EXONIC	YES	NM_022802.3	Transcript	protein_coding	synonymous_variant		9/9	NM_022802.3:c.2856A>G	NP_073713.2:p.Pro952%3D		-1.0						.	.	.						31	0.96							0.00066892	150.0	224242.0	0.0	36	0.87	RF	afr	0.00221304	30.0	0.000793986	79.0	0.0000064	1						6.818	0.269694		0	0	0			CTBP2	0.0	0.0	0.0	0.0	-41.0	-23.0	0.0	-23.0						0.0302	0.66				muscle phenotype; growth/size/body region phenotype; embryo phenotype; skeleton phenotype; nervous system phenotype ; cardiovascular system phenotype ; mortality/aging ; 			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Wnt signaling pathway;Notch signaling pathway;Chronic myeloid leukemia	negative regulation of cell population proliferation;synaptic vesicle docking;viral genome replication;positive regulation of chromatin binding;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of retinoic acid receptor signaling pathway;maintenance of presynaptic active zone structure;white fat cell differentiation;oxidation-reduction process;cellular response to leukemia inhibitory factor	nucleus;transcriptional repressor complex;cell junction;photoreceptor ribbon synapse;presynaptic active zone cytoplasmic component;glutamatergic synapse;GABA-ergic synapse;presynaptic cytosol	chromatin binding;transcription coactivator activity;transcription corepressor activity;protein binding;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;protein kinase binding;retinoic acid receptor binding;protein-containing complex binding;NAD binding;structural constituent of presynaptic active zone	MDC1[29656893];CCNH[21988832];FOXI2[25609649];IKZF1[21516116;25416956;unassigned1304];IKZF2[25416956];ACTG1[21988832];FOXQ1[25609649];CAPN7[unassigned1304];CWC22[26496610];VRTN[unassigned1304];HOXA5[unassigned1304];LMO4[unassigned1304];SOX13[21988832;unassigned1304];DYRK1B[23602568];HIC1[19486893];FOXP2[25416956;unassigned1304];FOXP1[25609649];SHISA6[unassigned1304];CACNB2[unassigned1304];CACNB3[unassigned1304];MARF1[unassigned1312];CACNB4[unassigned1304];ZFPM1[21988832];HOXB5[25416956;unassigned1304];TSHZ3[25416956;unassigned1304];CTBP2[unassigned1304];CTBP1[21988832;25416956;26496610;27107012];CSTF2[unassigned1304];BAZ2B[16189514;25416956;unassigned1304];GLIS2[unassigned1304];SDCBP[unassigned1304];RAB11FIP1[26496610];DVL2[21988832];HOXC5[unassigned1304];TP53BP1[29656893];MARK3[26496610];RAI2[16189514;25416956];ENKD1[unassigned1304];ZBTB18[25416956;unassigned1304];XRCC6[21988832];JUN[25609649];UBE2I[21988832];DTNB[unassigned1304];NEK6[unassigned1304];HELZ[unassigned1312];FLI1[25416956];RPS28[21988832];QARS[unassigned1304];RPS29[21988832];BCL3[21988832];EIF4G1[unassigned1304];ZNF512B[15231748];C15orf39[21988832];RBM26[26496610];CCDC120[unassigned1304];FOXE1[25609649];ZC3H3[26496610];FHL3[27107012];BRCA1[29656893];RPS4X[21988832];RPL7A[21988832];RBM4[26496610];FUNDC1[25416956];KYNU[unassigned1304];DMRTB1[25416956;26871637];CCR5[21988832];RBBP8NL[unassigned1304];TEAD3[16189514];TGIF1[16189514;21516116;25416956;25910212];CEP68[unassigned1304];BCAS3[25416956];AKTIP[16189514];CTPS2[21988832];PROX1[21988832];AES[unassigned1304];DUSP21[unassigned1304];LCOR[27705803;25416956];MVD[26496610];ANG[28777577];PLCB1[25416956];LCORL[unassigned1304];ZNF750[25416956];PPP1R15A[21988832];CATSPER1[unassigned1304];PRKAA2[unassigned1304];GPALPP1[26496610];ZBTB42[unassigned1304];NOL4[16189514;25416956];STX11[21988832];RNF135[unassigned1304];FOXS1[25609649];NRIP1[16189514];RBBP8[21988832;26807646];RPL17[21988832];CASP8AP2[21988832];FOXB1[25609649];EGLN3[unassigned1304];KLF3[unassigned1304];NOL4L[25416956];TRIML2[unassigned1304];LNX1[unassigned1304];RIMBP3[25416956];ZNF217[26496610];MSRB3[unassigned1304];	126678189
14348	chr10	126678190	G	A	chr10:126678190	CTBP2	C-terminal binding protein 2	SNV	0|1	0.16	90_17	108	99.0	0|1	0.28	83_33	116	99.0			rs745378265,COSV58333850	EXONIC	YES	NM_022802.3	Transcript	protein_coding	missense_variant		9/9	NM_022802.3:c.2855C>T	NP_073713.2:p.Pro952Leu		-1.0	.,.,.,.,.,.					.	.	.						31	0.96							0.000106084	25.0	235662.0	0.0	36	0.87	RF	afr	0.000837287	12.0	8.48272e-05	9.0	0.0000064	1						24.6	3.393819	0.361	11	7	18	SIFT,LRT_pred,MetaLR_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,MetaSVM_pred,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,ClinPred_pred	CTBP2	0.0	0.0	0.0	0.0	-24.0	45.0	-1.0	48.0						0.0302	0.66		1.0	1.176	muscle phenotype; growth/size/body region phenotype; embryo phenotype; skeleton phenotype; nervous system phenotype ; cardiovascular system phenotype ; mortality/aging ; 			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Wnt signaling pathway;Notch signaling pathway;Chronic myeloid leukemia	negative regulation of cell population proliferation;synaptic vesicle docking;viral genome replication;positive regulation of chromatin binding;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of retinoic acid receptor signaling pathway;maintenance of presynaptic active zone structure;white fat cell differentiation;oxidation-reduction process;cellular response to leukemia inhibitory factor	nucleus;transcriptional repressor complex;cell junction;photoreceptor ribbon synapse;presynaptic active zone cytoplasmic component;glutamatergic synapse;GABA-ergic synapse;presynaptic cytosol	chromatin binding;transcription coactivator activity;transcription corepressor activity;protein binding;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;protein kinase binding;retinoic acid receptor binding;protein-containing complex binding;NAD binding;structural constituent of presynaptic active zone	MDC1[29656893];CCNH[21988832];FOXI2[25609649];IKZF1[21516116;25416956;unassigned1304];IKZF2[25416956];ACTG1[21988832];FOXQ1[25609649];CAPN7[unassigned1304];CWC22[26496610];VRTN[unassigned1304];HOXA5[unassigned1304];LMO4[unassigned1304];SOX13[21988832;unassigned1304];DYRK1B[23602568];HIC1[19486893];FOXP2[25416956;unassigned1304];FOXP1[25609649];SHISA6[unassigned1304];CACNB2[unassigned1304];CACNB3[unassigned1304];MARF1[unassigned1312];CACNB4[unassigned1304];ZFPM1[21988832];HOXB5[25416956;unassigned1304];TSHZ3[25416956;unassigned1304];CTBP2[unassigned1304];CTBP1[21988832;25416956;26496610;27107012];CSTF2[unassigned1304];BAZ2B[16189514;25416956;unassigned1304];GLIS2[unassigned1304];SDCBP[unassigned1304];RAB11FIP1[26496610];DVL2[21988832];HOXC5[unassigned1304];TP53BP1[29656893];MARK3[26496610];RAI2[16189514;25416956];ENKD1[unassigned1304];ZBTB18[25416956;unassigned1304];XRCC6[21988832];JUN[25609649];UBE2I[21988832];DTNB[unassigned1304];NEK6[unassigned1304];HELZ[unassigned1312];FLI1[25416956];RPS28[21988832];QARS[unassigned1304];RPS29[21988832];BCL3[21988832];EIF4G1[unassigned1304];ZNF512B[15231748];C15orf39[21988832];RBM26[26496610];CCDC120[unassigned1304];FOXE1[25609649];ZC3H3[26496610];FHL3[27107012];BRCA1[29656893];RPS4X[21988832];RPL7A[21988832];RBM4[26496610];FUNDC1[25416956];KYNU[unassigned1304];DMRTB1[25416956;26871637];CCR5[21988832];RBBP8NL[unassigned1304];TEAD3[16189514];TGIF1[16189514;21516116;25416956;25910212];CEP68[unassigned1304];BCAS3[25416956];AKTIP[16189514];CTPS2[21988832];PROX1[21988832];AES[unassigned1304];DUSP21[unassigned1304];LCOR[27705803;25416956];MVD[26496610];ANG[28777577];PLCB1[25416956];LCORL[unassigned1304];ZNF750[25416956];PPP1R15A[21988832];CATSPER1[unassigned1304];PRKAA2[unassigned1304];GPALPP1[26496610];ZBTB42[unassigned1304];NOL4[16189514;25416956];STX11[21988832];RNF135[unassigned1304];FOXS1[25609649];NRIP1[16189514];RBBP8[21988832;26807646];RPL17[21988832];CASP8AP2[21988832];FOXB1[25609649];EGLN3[unassigned1304];KLF3[unassigned1304];NOL4L[25416956];TRIML2[unassigned1304];LNX1[unassigned1304];RIMBP3[25416956];ZNF217[26496610];MSRB3[unassigned1304];	126678190
14360	chr10	126678196	C	T	chr10:126678196	CTBP2	C-terminal binding protein 2	SNV	0|1	0.15	87_15	103	99.0	0|1	0.21	78_21	99	99.0			rs756741005	EXONIC	YES	NM_022802.3	Transcript	protein_coding	missense_variant		9/9	NM_022802.3:c.2849G>A	NP_073713.2:p.Gly950Asp		-1.0	.,.,.,.,.,.					.	.	.						31	0.96							0.000167028	39.0	233494.0	0.0	35	0.84	RF	afr	0.00112692	16.0	0.000114229	12.0	0.0000064	1						27.9	4.019291	0.328	14	6	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,ClinPred_pred	CTBP2	0.0	0.0	0.0	0.0	39.0	-30.0	-7.0	1.0						0.0302	0.66		0.999	1.026	muscle phenotype; growth/size/body region phenotype; embryo phenotype; skeleton phenotype; nervous system phenotype ; cardiovascular system phenotype ; mortality/aging ; 			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Wnt signaling pathway;Notch signaling pathway;Chronic myeloid leukemia	negative regulation of cell population proliferation;synaptic vesicle docking;viral genome replication;positive regulation of chromatin binding;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of retinoic acid receptor signaling pathway;maintenance of presynaptic active zone structure;white fat cell differentiation;oxidation-reduction process;cellular response to leukemia inhibitory factor	nucleus;transcriptional repressor complex;cell junction;photoreceptor ribbon synapse;presynaptic active zone cytoplasmic component;glutamatergic synapse;GABA-ergic synapse;presynaptic cytosol	chromatin binding;transcription coactivator activity;transcription corepressor activity;protein binding;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;protein kinase binding;retinoic acid receptor binding;protein-containing complex binding;NAD binding;structural constituent of presynaptic active zone	MDC1[29656893];CCNH[21988832];FOXI2[25609649];IKZF1[21516116;25416956;unassigned1304];IKZF2[25416956];ACTG1[21988832];FOXQ1[25609649];CAPN7[unassigned1304];CWC22[26496610];VRTN[unassigned1304];HOXA5[unassigned1304];LMO4[unassigned1304];SOX13[21988832;unassigned1304];DYRK1B[23602568];HIC1[19486893];FOXP2[25416956;unassigned1304];FOXP1[25609649];SHISA6[unassigned1304];CACNB2[unassigned1304];CACNB3[unassigned1304];MARF1[unassigned1312];CACNB4[unassigned1304];ZFPM1[21988832];HOXB5[25416956;unassigned1304];TSHZ3[25416956;unassigned1304];CTBP2[unassigned1304];CTBP1[21988832;25416956;26496610;27107012];CSTF2[unassigned1304];BAZ2B[16189514;25416956;unassigned1304];GLIS2[unassigned1304];SDCBP[unassigned1304];RAB11FIP1[26496610];DVL2[21988832];HOXC5[unassigned1304];TP53BP1[29656893];MARK3[26496610];RAI2[16189514;25416956];ENKD1[unassigned1304];ZBTB18[25416956;unassigned1304];XRCC6[21988832];JUN[25609649];UBE2I[21988832];DTNB[unassigned1304];NEK6[unassigned1304];HELZ[unassigned1312];FLI1[25416956];RPS28[21988832];QARS[unassigned1304];RPS29[21988832];BCL3[21988832];EIF4G1[unassigned1304];ZNF512B[15231748];C15orf39[21988832];RBM26[26496610];CCDC120[unassigned1304];FOXE1[25609649];ZC3H3[26496610];FHL3[27107012];BRCA1[29656893];RPS4X[21988832];RPL7A[21988832];RBM4[26496610];FUNDC1[25416956];KYNU[unassigned1304];DMRTB1[25416956;26871637];CCR5[21988832];RBBP8NL[unassigned1304];TEAD3[16189514];TGIF1[16189514;21516116;25416956;25910212];CEP68[unassigned1304];BCAS3[25416956];AKTIP[16189514];CTPS2[21988832];PROX1[21988832];AES[unassigned1304];DUSP21[unassigned1304];LCOR[27705803;25416956];MVD[26496610];ANG[28777577];PLCB1[25416956];LCORL[unassigned1304];ZNF750[25416956];PPP1R15A[21988832];CATSPER1[unassigned1304];PRKAA2[unassigned1304];GPALPP1[26496610];ZBTB42[unassigned1304];NOL4[16189514;25416956];STX11[21988832];RNF135[unassigned1304];FOXS1[25609649];NRIP1[16189514];RBBP8[21988832;26807646];RPL17[21988832];CASP8AP2[21988832];FOXB1[25609649];EGLN3[unassigned1304];KLF3[unassigned1304];NOL4L[25416956];TRIML2[unassigned1304];LNX1[unassigned1304];RIMBP3[25416956];ZNF217[26496610];MSRB3[unassigned1304];	126678196
14374	chr10	126678206	T	A	chr10:126678206	CTBP2	C-terminal binding protein 2	SNV	0|0	0.1	71_8	80	30.0	0|1	0.2	74_19	93	99.0			rs749745328	EXONIC	YES	NM_022802.3	Transcript	protein_coding	missense_variant		9/9	NM_022802.3:c.2839A>T	NP_073713.2:p.Ile947Phe		-1.0	.,.,.,.,.,.					.	.	.						31	0.96							9.94973e-05	23.0	231162.0	0.0	29	0.77	RF	afr	0.000559441	8.0	4.81232e-05	5.0	0.0000064	1						22.4	2.444278	0.159	6	12	18	SIFT,MutationTaster_pred,FATHMM_pred,BayesDel_addAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	CTBP2	0.0	0.0	0.0	0.0	-40.0	50.0	46.0	6.0						0.0302	0.66		1.0	1.138	muscle phenotype; growth/size/body region phenotype; embryo phenotype; skeleton phenotype; nervous system phenotype ; cardiovascular system phenotype ; mortality/aging ; 			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Wnt signaling pathway;Notch signaling pathway;Chronic myeloid leukemia	negative regulation of cell population proliferation;synaptic vesicle docking;viral genome replication;positive regulation of chromatin binding;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of retinoic acid receptor signaling pathway;maintenance of presynaptic active zone structure;white fat cell differentiation;oxidation-reduction process;cellular response to leukemia inhibitory factor	nucleus;transcriptional repressor complex;cell junction;photoreceptor ribbon synapse;presynaptic active zone cytoplasmic component;glutamatergic synapse;GABA-ergic synapse;presynaptic cytosol	chromatin binding;transcription coactivator activity;transcription corepressor activity;protein binding;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;protein kinase binding;retinoic acid receptor binding;protein-containing complex binding;NAD binding;structural constituent of presynaptic active zone	MDC1[29656893];CCNH[21988832];FOXI2[25609649];IKZF1[21516116;25416956;unassigned1304];IKZF2[25416956];ACTG1[21988832];FOXQ1[25609649];CAPN7[unassigned1304];CWC22[26496610];VRTN[unassigned1304];HOXA5[unassigned1304];LMO4[unassigned1304];SOX13[21988832;unassigned1304];DYRK1B[23602568];HIC1[19486893];FOXP2[25416956;unassigned1304];FOXP1[25609649];SHISA6[unassigned1304];CACNB2[unassigned1304];CACNB3[unassigned1304];MARF1[unassigned1312];CACNB4[unassigned1304];ZFPM1[21988832];HOXB5[25416956;unassigned1304];TSHZ3[25416956;unassigned1304];CTBP2[unassigned1304];CTBP1[21988832;25416956;26496610;27107012];CSTF2[unassigned1304];BAZ2B[16189514;25416956;unassigned1304];GLIS2[unassigned1304];SDCBP[unassigned1304];RAB11FIP1[26496610];DVL2[21988832];HOXC5[unassigned1304];TP53BP1[29656893];MARK3[26496610];RAI2[16189514;25416956];ENKD1[unassigned1304];ZBTB18[25416956;unassigned1304];XRCC6[21988832];JUN[25609649];UBE2I[21988832];DTNB[unassigned1304];NEK6[unassigned1304];HELZ[unassigned1312];FLI1[25416956];RPS28[21988832];QARS[unassigned1304];RPS29[21988832];BCL3[21988832];EIF4G1[unassigned1304];ZNF512B[15231748];C15orf39[21988832];RBM26[26496610];CCDC120[unassigned1304];FOXE1[25609649];ZC3H3[26496610];FHL3[27107012];BRCA1[29656893];RPS4X[21988832];RPL7A[21988832];RBM4[26496610];FUNDC1[25416956];KYNU[unassigned1304];DMRTB1[25416956;26871637];CCR5[21988832];RBBP8NL[unassigned1304];TEAD3[16189514];TGIF1[16189514;21516116;25416956;25910212];CEP68[unassigned1304];BCAS3[25416956];AKTIP[16189514];CTPS2[21988832];PROX1[21988832];AES[unassigned1304];DUSP21[unassigned1304];LCOR[27705803;25416956];MVD[26496610];ANG[28777577];PLCB1[25416956];LCORL[unassigned1304];ZNF750[25416956];PPP1R15A[21988832];CATSPER1[unassigned1304];PRKAA2[unassigned1304];GPALPP1[26496610];ZBTB42[unassigned1304];NOL4[16189514;25416956];STX11[21988832];RNF135[unassigned1304];FOXS1[25609649];NRIP1[16189514];RBBP8[21988832;26807646];RPL17[21988832];CASP8AP2[21988832];FOXB1[25609649];EGLN3[unassigned1304];KLF3[unassigned1304];NOL4L[25416956];TRIML2[unassigned1304];LNX1[unassigned1304];RIMBP3[25416956];ZNF217[26496610];MSRB3[unassigned1304];	126678206
14383	chr10	126678208	A	G	chr10:126678208	CTBP2	C-terminal binding protein 2	SNV	0|1	0.1	71_8	80	99.0	0|1	0.22	68_19	87	99.0			rs769170896	EXONIC	YES	NM_022802.3	Transcript	protein_coding	missense_variant		9/9	NM_022802.3:c.2837T>C	NP_073713.2:p.Ile946Thr		-1.0	.,.,.,.,.,.					.	.	.						31	0.96							8.1731e-05	19.0	232470.0	0.0	29	0.76	RF	afr	0.000413451	6.0	4.78313e-05	5.0	0.0000064	1						26.1	3.770712	0.43	11	9	20	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,ClinPred_pred,LIST-S2_pred	CTBP2	0.0	0.0	0.0	0.0	48.0	-42.0	44.0	49.0						0.0302	0.66		1.0	1.312	muscle phenotype; growth/size/body region phenotype; embryo phenotype; skeleton phenotype; nervous system phenotype ; cardiovascular system phenotype ; mortality/aging ; 			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Wnt signaling pathway;Notch signaling pathway;Chronic myeloid leukemia	negative regulation of cell population proliferation;synaptic vesicle docking;viral genome replication;positive regulation of chromatin binding;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of retinoic acid receptor signaling pathway;maintenance of presynaptic active zone structure;white fat cell differentiation;oxidation-reduction process;cellular response to leukemia inhibitory factor	nucleus;transcriptional repressor complex;cell junction;photoreceptor ribbon synapse;presynaptic active zone cytoplasmic component;glutamatergic synapse;GABA-ergic synapse;presynaptic cytosol	chromatin binding;transcription coactivator activity;transcription corepressor activity;protein binding;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;protein kinase binding;retinoic acid receptor binding;protein-containing complex binding;NAD binding;structural constituent of presynaptic active zone	MDC1[29656893];CCNH[21988832];FOXI2[25609649];IKZF1[21516116;25416956;unassigned1304];IKZF2[25416956];ACTG1[21988832];FOXQ1[25609649];CAPN7[unassigned1304];CWC22[26496610];VRTN[unassigned1304];HOXA5[unassigned1304];LMO4[unassigned1304];SOX13[21988832;unassigned1304];DYRK1B[23602568];HIC1[19486893];FOXP2[25416956;unassigned1304];FOXP1[25609649];SHISA6[unassigned1304];CACNB2[unassigned1304];CACNB3[unassigned1304];MARF1[unassigned1312];CACNB4[unassigned1304];ZFPM1[21988832];HOXB5[25416956;unassigned1304];TSHZ3[25416956;unassigned1304];CTBP2[unassigned1304];CTBP1[21988832;25416956;26496610;27107012];CSTF2[unassigned1304];BAZ2B[16189514;25416956;unassigned1304];GLIS2[unassigned1304];SDCBP[unassigned1304];RAB11FIP1[26496610];DVL2[21988832];HOXC5[unassigned1304];TP53BP1[29656893];MARK3[26496610];RAI2[16189514;25416956];ENKD1[unassigned1304];ZBTB18[25416956;unassigned1304];XRCC6[21988832];JUN[25609649];UBE2I[21988832];DTNB[unassigned1304];NEK6[unassigned1304];HELZ[unassigned1312];FLI1[25416956];RPS28[21988832];QARS[unassigned1304];RPS29[21988832];BCL3[21988832];EIF4G1[unassigned1304];ZNF512B[15231748];C15orf39[21988832];RBM26[26496610];CCDC120[unassigned1304];FOXE1[25609649];ZC3H3[26496610];FHL3[27107012];BRCA1[29656893];RPS4X[21988832];RPL7A[21988832];RBM4[26496610];FUNDC1[25416956];KYNU[unassigned1304];DMRTB1[25416956;26871637];CCR5[21988832];RBBP8NL[unassigned1304];TEAD3[16189514];TGIF1[16189514;21516116;25416956;25910212];CEP68[unassigned1304];BCAS3[25416956];AKTIP[16189514];CTPS2[21988832];PROX1[21988832];AES[unassigned1304];DUSP21[unassigned1304];LCOR[27705803;25416956];MVD[26496610];ANG[28777577];PLCB1[25416956];LCORL[unassigned1304];ZNF750[25416956];PPP1R15A[21988832];CATSPER1[unassigned1304];PRKAA2[unassigned1304];GPALPP1[26496610];ZBTB42[unassigned1304];NOL4[16189514;25416956];STX11[21988832];RNF135[unassigned1304];FOXS1[25609649];NRIP1[16189514];RBBP8[21988832;26807646];RPL17[21988832];CASP8AP2[21988832];FOXB1[25609649];EGLN3[unassigned1304];KLF3[unassigned1304];NOL4L[25416956];TRIML2[unassigned1304];LNX1[unassigned1304];RIMBP3[25416956];ZNF217[26496610];MSRB3[unassigned1304];	126678208
14395	chr10	126678221	C	A	chr10:126678221	CTBP2	C-terminal binding protein 2	SNV	0/0	0.0	47_0	47	99.0	0/1	0.3	69_29	98	99.0			rs77752853,COSV58333348	EXONIC	YES	NM_022802.3	Transcript	protein_coding	missense_variant		9/9	NM_022802.3:c.2824G>T	NP_073713.2:p.Ala942Ser		-1.0	.,.,.,.,.,.					.	.	.						31	0.96							1.68369e-05	4.0	237574.0	0.0	29	0.78	RF	afr	6.45745e-05	1.0	2.79481e-05	3.0	0.0003087	48						23.6	3.028597	0.075	7	11	18	SIFT,MutationTaster_pred,FATHMM_pred,BayesDel_addAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_noAF_pred,ClinPred_pred	CTBP2	0.0	0.0	0.0	0.0	-10.0	46.0	27.0	-24.0						0.0302	0.66		1.0	1.026	muscle phenotype; growth/size/body region phenotype; embryo phenotype; skeleton phenotype; nervous system phenotype ; cardiovascular system phenotype ; mortality/aging ; 			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Wnt signaling pathway;Notch signaling pathway;Chronic myeloid leukemia	negative regulation of cell population proliferation;synaptic vesicle docking;viral genome replication;positive regulation of chromatin binding;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of retinoic acid receptor signaling pathway;maintenance of presynaptic active zone structure;white fat cell differentiation;oxidation-reduction process;cellular response to leukemia inhibitory factor	nucleus;transcriptional repressor complex;cell junction;photoreceptor ribbon synapse;presynaptic active zone cytoplasmic component;glutamatergic synapse;GABA-ergic synapse;presynaptic cytosol	chromatin binding;transcription coactivator activity;transcription corepressor activity;protein binding;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;protein kinase binding;retinoic acid receptor binding;protein-containing complex binding;NAD binding;structural constituent of presynaptic active zone	MDC1[29656893];CCNH[21988832];FOXI2[25609649];IKZF1[21516116;25416956;unassigned1304];IKZF2[25416956];ACTG1[21988832];FOXQ1[25609649];CAPN7[unassigned1304];CWC22[26496610];VRTN[unassigned1304];HOXA5[unassigned1304];LMO4[unassigned1304];SOX13[21988832;unassigned1304];DYRK1B[23602568];HIC1[19486893];FOXP2[25416956;unassigned1304];FOXP1[25609649];SHISA6[unassigned1304];CACNB2[unassigned1304];CACNB3[unassigned1304];MARF1[unassigned1312];CACNB4[unassigned1304];ZFPM1[21988832];HOXB5[25416956;unassigned1304];TSHZ3[25416956;unassigned1304];CTBP2[unassigned1304];CTBP1[21988832;25416956;26496610;27107012];CSTF2[unassigned1304];BAZ2B[16189514;25416956;unassigned1304];GLIS2[unassigned1304];SDCBP[unassigned1304];RAB11FIP1[26496610];DVL2[21988832];HOXC5[unassigned1304];TP53BP1[29656893];MARK3[26496610];RAI2[16189514;25416956];ENKD1[unassigned1304];ZBTB18[25416956;unassigned1304];XRCC6[21988832];JUN[25609649];UBE2I[21988832];DTNB[unassigned1304];NEK6[unassigned1304];HELZ[unassigned1312];FLI1[25416956];RPS28[21988832];QARS[unassigned1304];RPS29[21988832];BCL3[21988832];EIF4G1[unassigned1304];ZNF512B[15231748];C15orf39[21988832];RBM26[26496610];CCDC120[unassigned1304];FOXE1[25609649];ZC3H3[26496610];FHL3[27107012];BRCA1[29656893];RPS4X[21988832];RPL7A[21988832];RBM4[26496610];FUNDC1[25416956];KYNU[unassigned1304];DMRTB1[25416956;26871637];CCR5[21988832];RBBP8NL[unassigned1304];TEAD3[16189514];TGIF1[16189514;21516116;25416956;25910212];CEP68[unassigned1304];BCAS3[25416956];AKTIP[16189514];CTPS2[21988832];PROX1[21988832];AES[unassigned1304];DUSP21[unassigned1304];LCOR[27705803;25416956];MVD[26496610];ANG[28777577];PLCB1[25416956];LCORL[unassigned1304];ZNF750[25416956];PPP1R15A[21988832];CATSPER1[unassigned1304];PRKAA2[unassigned1304];GPALPP1[26496610];ZBTB42[unassigned1304];NOL4[16189514;25416956];STX11[21988832];RNF135[unassigned1304];FOXS1[25609649];NRIP1[16189514];RBBP8[21988832;26807646];RPL17[21988832];CASP8AP2[21988832];FOXB1[25609649];EGLN3[unassigned1304];KLF3[unassigned1304];NOL4L[25416956];TRIML2[unassigned1304];LNX1[unassigned1304];RIMBP3[25416956];ZNF217[26496610];MSRB3[unassigned1304];	126678221
14410	chr10	126678241	G	C	chr10:126678241	CTBP2	C-terminal binding protein 2	SNV	0/0	0.0	47_0	47	99.0	0|1	0.17	65_13	78	99.0			rs113985797,COSV100456172	EXONIC	YES	NM_022802.3	Transcript	protein_coding	missense_variant		9/9	NM_022802.3:c.2804C>G	NP_073713.2:p.Ala935Gly		-1.0	.,.,.,.,.,.					.	.	.						31	0.96							1.36242e-05	3.0	220196.0	0.0	28	0.73	RF	afr	6.74491e-05	1.0	1.0045e-05	1.0	0.0000386	6						24.5	3.338661	0.104	9	10	19	SIFT,MutationTaster_pred,FATHMM_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred	CTBP2	0.0	0.0	0.0	0.0	50.0	26.0	5.0	11.0						0.0302	0.66		0.983	1.176	muscle phenotype; growth/size/body region phenotype; embryo phenotype; skeleton phenotype; nervous system phenotype ; cardiovascular system phenotype ; mortality/aging ; 			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Wnt signaling pathway;Notch signaling pathway;Chronic myeloid leukemia	negative regulation of cell population proliferation;synaptic vesicle docking;viral genome replication;positive regulation of chromatin binding;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of retinoic acid receptor signaling pathway;maintenance of presynaptic active zone structure;white fat cell differentiation;oxidation-reduction process;cellular response to leukemia inhibitory factor	nucleus;transcriptional repressor complex;cell junction;photoreceptor ribbon synapse;presynaptic active zone cytoplasmic component;glutamatergic synapse;GABA-ergic synapse;presynaptic cytosol	chromatin binding;transcription coactivator activity;transcription corepressor activity;protein binding;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;protein kinase binding;retinoic acid receptor binding;protein-containing complex binding;NAD binding;structural constituent of presynaptic active zone	MDC1[29656893];CCNH[21988832];FOXI2[25609649];IKZF1[21516116;25416956;unassigned1304];IKZF2[25416956];ACTG1[21988832];FOXQ1[25609649];CAPN7[unassigned1304];CWC22[26496610];VRTN[unassigned1304];HOXA5[unassigned1304];LMO4[unassigned1304];SOX13[21988832;unassigned1304];DYRK1B[23602568];HIC1[19486893];FOXP2[25416956;unassigned1304];FOXP1[25609649];SHISA6[unassigned1304];CACNB2[unassigned1304];CACNB3[unassigned1304];MARF1[unassigned1312];CACNB4[unassigned1304];ZFPM1[21988832];HOXB5[25416956;unassigned1304];TSHZ3[25416956;unassigned1304];CTBP2[unassigned1304];CTBP1[21988832;25416956;26496610;27107012];CSTF2[unassigned1304];BAZ2B[16189514;25416956;unassigned1304];GLIS2[unassigned1304];SDCBP[unassigned1304];RAB11FIP1[26496610];DVL2[21988832];HOXC5[unassigned1304];TP53BP1[29656893];MARK3[26496610];RAI2[16189514;25416956];ENKD1[unassigned1304];ZBTB18[25416956;unassigned1304];XRCC6[21988832];JUN[25609649];UBE2I[21988832];DTNB[unassigned1304];NEK6[unassigned1304];HELZ[unassigned1312];FLI1[25416956];RPS28[21988832];QARS[unassigned1304];RPS29[21988832];BCL3[21988832];EIF4G1[unassigned1304];ZNF512B[15231748];C15orf39[21988832];RBM26[26496610];CCDC120[unassigned1304];FOXE1[25609649];ZC3H3[26496610];FHL3[27107012];BRCA1[29656893];RPS4X[21988832];RPL7A[21988832];RBM4[26496610];FUNDC1[25416956];KYNU[unassigned1304];DMRTB1[25416956;26871637];CCR5[21988832];RBBP8NL[unassigned1304];TEAD3[16189514];TGIF1[16189514;21516116;25416956;25910212];CEP68[unassigned1304];BCAS3[25416956];AKTIP[16189514];CTPS2[21988832];PROX1[21988832];AES[unassigned1304];DUSP21[unassigned1304];LCOR[27705803;25416956];MVD[26496610];ANG[28777577];PLCB1[25416956];LCORL[unassigned1304];ZNF750[25416956];PPP1R15A[21988832];CATSPER1[unassigned1304];PRKAA2[unassigned1304];GPALPP1[26496610];ZBTB42[unassigned1304];NOL4[16189514;25416956];STX11[21988832];RNF135[unassigned1304];FOXS1[25609649];NRIP1[16189514];RBBP8[21988832;26807646];RPL17[21988832];CASP8AP2[21988832];FOXB1[25609649];EGLN3[unassigned1304];KLF3[unassigned1304];NOL4L[25416956];TRIML2[unassigned1304];LNX1[unassigned1304];RIMBP3[25416956];ZNF217[26496610];MSRB3[unassigned1304];	126678241
14422	chr10	126678246	A	G	chr10:126678246	CTBP2	C-terminal binding protein 2	SNV	0/0	0.0	47_0	47	99.0	0|1	0.15	66_12	78	99.0			rs114432763,COSV58336314	EXONIC	YES	NM_022802.3	Transcript	protein_coding	synonymous_variant		9/9	NM_022802.3:c.2799T>C	NP_073713.2:p.Gly933%3D		-1.0						.	.	.						31	0.96							4.65008e-06	1.0	215050.0	0.0	27	0.67	RF	afr	6.70691e-05	1.0	0.0	0.0	0.0010611	165						6.967	0.281089		0	0	0			CTBP2	0.0	0.0	0.0	0.0	45.0	10.0	11.0	6.0						0.0302	0.66				muscle phenotype; growth/size/body region phenotype; embryo phenotype; skeleton phenotype; nervous system phenotype ; cardiovascular system phenotype ; mortality/aging ; 			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Wnt signaling pathway;Notch signaling pathway;Chronic myeloid leukemia	negative regulation of cell population proliferation;synaptic vesicle docking;viral genome replication;positive regulation of chromatin binding;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of retinoic acid receptor signaling pathway;maintenance of presynaptic active zone structure;white fat cell differentiation;oxidation-reduction process;cellular response to leukemia inhibitory factor	nucleus;transcriptional repressor complex;cell junction;photoreceptor ribbon synapse;presynaptic active zone cytoplasmic component;glutamatergic synapse;GABA-ergic synapse;presynaptic cytosol	chromatin binding;transcription coactivator activity;transcription corepressor activity;protein binding;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;protein kinase binding;retinoic acid receptor binding;protein-containing complex binding;NAD binding;structural constituent of presynaptic active zone	MDC1[29656893];CCNH[21988832];FOXI2[25609649];IKZF1[21516116;25416956;unassigned1304];IKZF2[25416956];ACTG1[21988832];FOXQ1[25609649];CAPN7[unassigned1304];CWC22[26496610];VRTN[unassigned1304];HOXA5[unassigned1304];LMO4[unassigned1304];SOX13[21988832;unassigned1304];DYRK1B[23602568];HIC1[19486893];FOXP2[25416956;unassigned1304];FOXP1[25609649];SHISA6[unassigned1304];CACNB2[unassigned1304];CACNB3[unassigned1304];MARF1[unassigned1312];CACNB4[unassigned1304];ZFPM1[21988832];HOXB5[25416956;unassigned1304];TSHZ3[25416956;unassigned1304];CTBP2[unassigned1304];CTBP1[21988832;25416956;26496610;27107012];CSTF2[unassigned1304];BAZ2B[16189514;25416956;unassigned1304];GLIS2[unassigned1304];SDCBP[unassigned1304];RAB11FIP1[26496610];DVL2[21988832];HOXC5[unassigned1304];TP53BP1[29656893];MARK3[26496610];RAI2[16189514;25416956];ENKD1[unassigned1304];ZBTB18[25416956;unassigned1304];XRCC6[21988832];JUN[25609649];UBE2I[21988832];DTNB[unassigned1304];NEK6[unassigned1304];HELZ[unassigned1312];FLI1[25416956];RPS28[21988832];QARS[unassigned1304];RPS29[21988832];BCL3[21988832];EIF4G1[unassigned1304];ZNF512B[15231748];C15orf39[21988832];RBM26[26496610];CCDC120[unassigned1304];FOXE1[25609649];ZC3H3[26496610];FHL3[27107012];BRCA1[29656893];RPS4X[21988832];RPL7A[21988832];RBM4[26496610];FUNDC1[25416956];KYNU[unassigned1304];DMRTB1[25416956;26871637];CCR5[21988832];RBBP8NL[unassigned1304];TEAD3[16189514];TGIF1[16189514;21516116;25416956;25910212];CEP68[unassigned1304];BCAS3[25416956];AKTIP[16189514];CTPS2[21988832];PROX1[21988832];AES[unassigned1304];DUSP21[unassigned1304];LCOR[27705803;25416956];MVD[26496610];ANG[28777577];PLCB1[25416956];LCORL[unassigned1304];ZNF750[25416956];PPP1R15A[21988832];CATSPER1[unassigned1304];PRKAA2[unassigned1304];GPALPP1[26496610];ZBTB42[unassigned1304];NOL4[16189514;25416956];STX11[21988832];RNF135[unassigned1304];FOXS1[25609649];NRIP1[16189514];RBBP8[21988832;26807646];RPL17[21988832];CASP8AP2[21988832];FOXB1[25609649];EGLN3[unassigned1304];KLF3[unassigned1304];NOL4L[25416956];TRIML2[unassigned1304];LNX1[unassigned1304];RIMBP3[25416956];ZNF217[26496610];MSRB3[unassigned1304];	126678246
14433	chr10	126678260		GATGAATTTCTTGCTGGTCTATTTCCCACCAAA	chr10:126678259-126678260	CTBP2	C-terminal binding protein 2	insertion	0/0	0.0	47_0	47	99.0	0|1	0.12	58_8	66	99.0			rs747713301	EXONIC	YES	NM_022802.3	Transcript	protein_coding	inframe_insertion		9/9	NM_022802.3:c.2785_2786insTTTGGTGGGAAATAGACCAGCAAGAAATTCATC	NP_073713.2:p.Pro928_Pro929insLeuTrpTrpGluIleAspGlnGlnGluIleHis		-1.0						.	.	.						31	0.96							0.0	0.0	217570.0	0.0	24	0.62	AC0_RF				0.0	0.0								21.2	2.166282		0	0	0																	0.0302	0.66				muscle phenotype; growth/size/body region phenotype; embryo phenotype; skeleton phenotype; nervous system phenotype ; cardiovascular system phenotype ; mortality/aging ; 			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Wnt signaling pathway;Notch signaling pathway;Chronic myeloid leukemia	negative regulation of cell population proliferation;synaptic vesicle docking;viral genome replication;positive regulation of chromatin binding;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of retinoic acid receptor signaling pathway;maintenance of presynaptic active zone structure;white fat cell differentiation;oxidation-reduction process;cellular response to leukemia inhibitory factor	nucleus;transcriptional repressor complex;cell junction;photoreceptor ribbon synapse;presynaptic active zone cytoplasmic component;glutamatergic synapse;GABA-ergic synapse;presynaptic cytosol	chromatin binding;transcription coactivator activity;transcription corepressor activity;protein binding;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor;protein kinase binding;retinoic acid receptor binding;protein-containing complex binding;NAD binding;structural constituent of presynaptic active zone	MDC1[29656893];CCNH[21988832];FOXI2[25609649];IKZF1[21516116;25416956;unassigned1304];IKZF2[25416956];ACTG1[21988832];FOXQ1[25609649];CAPN7[unassigned1304];CWC22[26496610];VRTN[unassigned1304];HOXA5[unassigned1304];LMO4[unassigned1304];SOX13[21988832;unassigned1304];DYRK1B[23602568];HIC1[19486893];FOXP2[25416956;unassigned1304];FOXP1[25609649];SHISA6[unassigned1304];CACNB2[unassigned1304];CACNB3[unassigned1304];MARF1[unassigned1312];CACNB4[unassigned1304];ZFPM1[21988832];HOXB5[25416956;unassigned1304];TSHZ3[25416956;unassigned1304];CTBP2[unassigned1304];CTBP1[21988832;25416956;26496610;27107012];CSTF2[unassigned1304];BAZ2B[16189514;25416956;unassigned1304];GLIS2[unassigned1304];SDCBP[unassigned1304];RAB11FIP1[26496610];DVL2[21988832];HOXC5[unassigned1304];TP53BP1[29656893];MARK3[26496610];RAI2[16189514;25416956];ENKD1[unassigned1304];ZBTB18[25416956;unassigned1304];XRCC6[21988832];JUN[25609649];UBE2I[21988832];DTNB[unassigned1304];NEK6[unassigned1304];HELZ[unassigned1312];FLI1[25416956];RPS28[21988832];QARS[unassigned1304];RPS29[21988832];BCL3[21988832];EIF4G1[unassigned1304];ZNF512B[15231748];C15orf39[21988832];RBM26[26496610];CCDC120[unassigned1304];FOXE1[25609649];ZC3H3[26496610];FHL3[27107012];BRCA1[29656893];RPS4X[21988832];RPL7A[21988832];RBM4[26496610];FUNDC1[25416956];KYNU[unassigned1304];DMRTB1[25416956;26871637];CCR5[21988832];RBBP8NL[unassigned1304];TEAD3[16189514];TGIF1[16189514;21516116;25416956;25910212];CEP68[unassigned1304];BCAS3[25416956];AKTIP[16189514];CTPS2[21988832];PROX1[21988832];AES[unassigned1304];DUSP21[unassigned1304];LCOR[27705803;25416956];MVD[26496610];ANG[28777577];PLCB1[25416956];LCORL[unassigned1304];ZNF750[25416956];PPP1R15A[21988832];CATSPER1[unassigned1304];PRKAA2[unassigned1304];GPALPP1[26496610];ZBTB42[unassigned1304];NOL4[16189514;25416956];STX11[21988832];RNF135[unassigned1304];FOXS1[25609649];NRIP1[16189514];RBBP8[21988832;26807646];RPL17[21988832];CASP8AP2[21988832];FOXB1[25609649];EGLN3[unassigned1304];KLF3[unassigned1304];NOL4L[25416956];TRIML2[unassigned1304];LNX1[unassigned1304];RIMBP3[25416956];ZNF217[26496610];MSRB3[unassigned1304];	126678259
14715	chr10	134021632	G	A	chr10:134021632	STK32C	serine/threonine kinase 32C	SNV	0/1	0.52	52_57	110	99.0	0/0	0.0	33_0	33	99.0			rs769367120,COSV53836990	EXONIC	YES	NM_001318878.2	Transcript	protein_coding	missense_variant		12/12	NM_001318878.2:c.1382C>T	NP_001305807.1:p.Pro461Leu		-1.0	.,.					.	.	.		1.97065e-05	3.0	152234.0	0.0	35	0.99	PASS	nfe	4.41034e-05	3.0	4.41034e-05	3.0	2.62803e-05	3.0	114154.0	0.0	2	0.3	PASS	nfe	4.92595e-05	3.0	4.92595e-05	3.0	0.0000129	2						0.777	-0.188148	0.009	2	17	19	SIFT,M-CAP_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	STK32C	0.01	0.0	0.0	0.0	-31.0	23.0	23.0	-20.0						0.617	0.31		0.0	-0.534	.			temporal lobe;whole brain;superior cervical ganglion;globus pallidus;	.	peptidyl-serine phosphorylation;intracellular signal transduction	.	protein serine/threonine kinase activity;ATP binding;metal ion binding	HSP90AB1[22939624];HGS[unassigned1304];GRB2[20936779];RPRM[17353931];	134021632
14732	chr10	134622104	G	A	chr10:134622104	CFAP46	cilia and flagella associated protein 46	SNV	0/0	0.0	34_0	34	99.0	0/1	0.48	47_44	91	99.0			rs148457914	EXONIC	YES	NM_001200049.3	Transcript	protein_coding	missense_variant		58/58	NM_001200049.3:c.7969C>T	NP_001186978.2:p.Arg2657Cys		-1.0						.	.	.		0.0016691	254.0	152178.0	0.0	32	0.97	PASS	nfe	0.00308687	210.0	0.00308687	210.0	0.00157997	385.0	243676.0	1.0	58	0.95	PASS	nfe	0.00246872	266.0	0.00246872	266.0	0.0016270	253	0.001	3.0				0.013	-0.750238	0.069	0	17	17		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CFAP46	0.0	0.0	0.0	0.0	44.0	-10.0	-5.0	0.0								0.000000000	0.0	-1.357	.			.	.	axoneme assembly;cilium movement involved in cell motility	axoneme	.	HMGA1[30021884];HIST1H1E[30021884];HIST2H2BE[30021884];	134622104
14757	chr10	135084467	G	A	chr10:135084467	ADAM8	ADAM metallopeptidase domain 8	SNV	0/0	0.0	92_0	92	99.0	0/1	0.48	65_59	124	99.0			rs200740125,COSV69865361	EXONIC	YES	NM_001109.5	Transcript	protein_coding	synonymous_variant		14/23	NM_001109.5:c.1482C>T	NP_001100.3:p.Asn494%3D		-1.0						.	.	.		0.000210236	32.0	152210.0	0.0	34	0.97	PASS	amr	0.00111213	17.0	0.000117609	8.0	0.00019267	48.0	249130.0	0.0	78	1.0	PASS	amr	0.000840336	29.0	0.000115869	13.0	0.0001801	28	0.003	9.0				4.974	0.143626		0	0	0			ADAM8	0.0	0.0	0.01	0.0	26.0	5.0	-1.0	3.0							0.0	2.479659119			normal phenotype; hematopoietic system phenotype; homeostasis/metabolism phenotype; immune system phenotype; skeleton phenotype; cellular phenotype; 			.	.	cell morphogenesis;angiogenesis;leukocyte migration involved in inflammatory response;positive regulation of acute inflammatory response;proteolysis;inflammatory response;positive regulation of protein processing;regulation of cell-cell adhesion;extracellular matrix disassembly;positive regulation of T cell differentiation in thymus;neutrophil degranulation;positive regulation of MAP kinase activity;negative regulation of neuron apoptotic process;positive regulation of innate immune response;positive regulation of bone resorption;positive regulation of cell adhesion;lymphocyte chemotaxis;positive regulation of protein secretion;positive regulation of membrane protein ectodomain proteolysis;positive regulation of NF-kappaB transcription factor activity;positive regulation of protein kinase B signaling;positive regulation of thymocyte apoptotic process;cellular response to hypoxia;cell-cell adhesion;positive regulation of tumor necrosis factor (ligand) superfamily member 11 production;positive regulation of neutrophil extravasation;positive regulation of fibronectin-dependent thymocyte migration;positive regulation of eosinophil migration	podosome;cytoplasm;plasma membrane;integral component of plasma membrane;cell surface;phagolysosome;dense core granule membrane;specific granule membrane;specific granule;tertiary granule;tertiary granule membrane;alpha9-beta1 integrin-vascular cell adhesion molecule-1 complex;alpha9-beta1 integrin-ADAM8 complex;ficolin-1-rich granule membrane	metalloendopeptidase activity;serine-type endopeptidase activity;calcium ion binding;protein binding;metallopeptidase activity;zinc ion binding;protein self-association;cell adhesion molecule binding	FST[15574124];FSTL3[15574124];	135084467
14761	chr10	135099038	G	A	chr10:135099038	TUBGCP2	tubulin gamma complex associated protein 2	SNV	0/1	0.64	41_74	115	99.0	0/1	0.56	44_56	100	99.0			rs148546996	EXONIC	YES	NM_001256617.2	Transcript	protein_coding	missense_variant		13/19	NM_001256617.2:c.1901C>T	NP_001243546.1:p.Thr634Met		-1.0	.,.,.,.,.				Pachygyria, microcephaly, developmental delay, and dysmorphic facies, with or without seizures, 618737 (3), Autosomal recessive	.	.	.		0.000413896	63.0	152212.0	1.0	32	0.97	PASS	amr	0.00307753	47.0	0.000205737	14.0	0.000565901	137.0	242092.0	0.0	28	0.74	PASS	amr	0.00326481	108.0	0.000191854	21.0	0.0005080	79	0.005	15.0				27.2	3.945656	0.297	10	11	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	TUBGCP2	0.0	0.0	0.0	0.0	-5.0	37.0	-25.0	-46.0						0.721	0.0	0.000000000	0.497	1.133	.			pons;dorsal root ganglion;trigeminal ganglion;	.	mitotic cell cycle;microtubule nucleation;cytoplasmic microtubule organization;spindle assembly;meiotic cell cycle;microtubule nucleation by interphase microtubule organizing center;protein-containing complex assembly	spindle pole;equatorial microtubule organizing center;gamma-tubulin complex;nucleoplasm;centrosome;microtubule organizing center;cytosol;cytoplasmic microtubule;gamma-tubulin small complex;membrane	protein binding;gamma-tubulin binding;microtubule minus-end binding	LGALS3BP[26496610];SAV1[24255178];DPP4[18275857];XPO1[26496610];MYC[17314511];CNTRL[26638075];BTRC[19615732];SRSF10[26496610];NINL[26638075];JUN[25609649];SCAF11[26496610];CEP152[26638075];RIPK4[26972000];CDC5L[20467437];WWP2[26496610];LRWD1[26496610];TUBG2[27015882];TUBG1[26496610;27015882;29568061];MZT1[20360068;26496610];NFKB2[14743216];MZT2B[20360068;26496610];NEDD1[26496610];MZT2A[26496610];ASPM[28436967];SNW1[20467437];RAD51[26496610];NME7[26496610];AKAP9[19242490];TUBGCP5[26496610];TUBGCP6[20360068;26496610];TUBGCP3[20360068;26496610];TUBGCP4[20360068;26496610];	135099038
14794	chr10	135440214	G	C	chr10:135440214	FRG2B	FSHD region gene 2 family member B	SNV	0|1	0.24	130_41	171	99.0	0|1	0.2	105_27	132	99.0			rs75987380,COSV71042476	EXONIC	YES	NM_001080998.2	Transcript	protein_coding	missense_variant		1/4	NM_001080998.2:c.33C>G	NP_001074467.1:p.His11Gln		-1.0	.,.	Benign	criteria_provided,_single_submitter	not_specified		.	.	.	24033266					33	0.95							0.362879	74483.0	205256.0	156.0	69	0.96	InbreedingCoeff	nfe	0.382157	35335.0	0.382157	35335.0	0.0010611	165	0.006	18.0				0.741	-0.195335	0.268	1	17	18	PROVEAN_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FRG2B	0.0	0.0	0.0	0.0	-46.0	-16.0	-45.0	39.0							0.15		0.006	0.387	.			.	.	.	nucleus	.	.	135440214
14795	chr10	135440216	G	A	chr10:135440216	FRG2B	FSHD region gene 2 family member B	SNV	0|1	0.24	130_41	171	99.0	0|1	0.2	105_27	132	99.0			rs79777505,COSV71042480	EXONIC	YES	NM_001080998.2	Transcript	protein_coding	missense_variant		1/4	NM_001080998.2:c.31C>T	NP_001074467.1:p.His11Tyr		-1.0	.,.	Benign	criteria_provided,_single_submitter	not_specified		.	.	.	24033266					33	0.95							0.358194	71497.0	199604.0	157.0	70	0.98	InbreedingCoeff_RF	nfe	0.37888	34250.0	0.37888	34250.0	0.0010868	169	0.006	18.0				8.782	0.436533	0.244	2	16	18	SIFT,PROVEAN_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FRG2B	0.0	0.0	0.0	0.0	-48.0	-33.0	31.0	-47.0							0.15		0.008	0.387	.			.	.	.	nucleus	.	.	135440216
14916	chr11	280596	G	T	chr11:280596	NLRP6	NLR family pyrin domain containing 6	SNV	0/0	0.0	52_0	52	99.0	0/1	0.56	17_22	39	99.0				EXONIC	YES	NM_138329.2	Transcript	protein_coding	missense_variant		4/8	NM_138329.2:c.862G>T	NP_612202.2:p.Gly288Trp		1.0	.,NACHT nucleoside triphosphatase&NACHT nucleoside triphosphatase					.	.	.						33	0.97											5	0.04														22.8	2.644859	0.055	4	16	20	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	NLRP6	0.0	0.0	0.0	0.0	3.0	28.0	-2.0	-24.0						0.53			0.0	0.047	endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; immune system phenotype; cellular phenotype; behavior/neurological phenotype ; neoplasm; cardiovascular system phenotype ; hematopoietic system phenotype; mortality/aging ; digestive/alimentary phenotype; renal/urinary system phenotype; 			pons;ciliary ganglion;subthalamic nucleus;dorsal root ganglion;skin;atrioventricular node;trigeminal ganglion;superior cervical ganglion;skeletal muscle;globus pallidus;	.	negative regulation of inflammatory response to antigenic stimulus;inflammatory response;G protein-coupled receptor signaling pathway;response to bacterium;regulation of autophagy;negative regulation of toll-like receptor signaling pathway;wound healing;negative regulation of I-kappaB kinase/NF-kappaB signaling;innate immune response;regulation of inflammatory response;regulation of mucus secretion;negative regulation of ERK1 and ERK2 cascade	plasma membrane;nuclear membrane;inflammasome complex	vasopressin receptor activity;ATP binding	PAN2[19615732;14583602;24880343];TNRC6C[21981923];MARF1[unassigned1312];HELZ[unassigned1312];PABPC1[23340509;17595167];TNRC6A[21981923];TNRC6B[21981923];	280596
14922	chr11	290888	G	A	chr11:290888	PGGHG	protein-glucosylgalactosylhydroxylysine glucosidase	SNV	0/0	0.0	41_0	41	99.0	0|1	0.4	62_41	103	99.0			rs150075556	EXONIC	YES	NM_025092.5	Transcript	protein_coding	synonymous_variant		4/14	NM_025092.5:c.681G>A	NP_079368.3:p.Leu227%3D		1.0						.	.	.		0.00550656	838.0	152182.0	6.0	33	0.97	PASS	sas	0.00889901	43.0	0.00742407	505.0	0.0069978	1745.0	249364.0	16.0	60	0.98	PASS	sas	0.0094945	290.0	0.00854541	959.0	0.0070738	1100	0.013	34.0				6.563	0.250689		0	0	0			ATHL1	0.03	0.0	0.0	0.0	19.0	-20.0	19.0	-1.0								55.686278902			.			.	.	carbohydrate metabolic process;trehalose catabolic process	cell wall;cytosol	alpha,alpha-trehalase activity;protein-glucosylgalactosylhydroxylysine glucosidase activity	.	290888
14937	chr11	369845	CTG		chr11:369845-369847	B4GALNT4	beta-1,4-N-acetyl-galactosaminyltransferase 4	deletion	0/0	0.0	34_0	34	99.0	0/1	0.14	36_6	44	99.0			rs760432344	EXONIC	YES	NM_178537.5	Transcript	protein_coding	inframe_deletion		1/20	NM_178537.5:c.64_66del	NP_848632.2:p.Leu22del		1.0						.	.	.		5.51526e-05	8.0	145052.0	0.0	26	0.78	PASS	amr	0.000204388	3.0	1.52667e-05	1.0	0.0176056	15.0	852.0	0.0	0	0.0	PASS	afr	0.0714286	1.0	0.00968992	5.0	0.0000064	1	0.007	17.0	0.01774	161.0		15.12	1.286328		0	0	0			B4GALNT4	0.0	0.0	0.0	0.0	-19.0	-16.0	-13.0	1.0							0.82				.			caudate nucleus;amygdala;occipital lobe;prefrontal cortex;globus pallidus;medulla oblongata;	.	.	integral component of membrane;Golgi cisterna membrane	acetylgalactosaminyltransferase activity;N-acetyl-beta-glucosaminyl-glycoprotein 4-beta-N-acetylgalactosaminyltransferase activity	.	369844
15030	chr11	726090	C	T	chr11:726090	EPS8L2	EPS8 like 2	SNV	0/1	0.53	35_39	74	99.0	0/0	0.0	37_0	37	99.0			rs372782084	SPLICING	YES	NM_022772.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	17/20		NM_022772.4:c.1681-8C>T			1.0					Deafness autosomal recessive 106, 617637 (3), Autosomal recessive	Autosomal recessive non-syndromic sensorineural deafness type DFNB	Disease-causing germline mutation(s) in	Hearing impairment;Autosomal recessive inheritance		0.000224654	34.0	151344.0	0.0	31	0.92	PASS	nfe	0.000428449	29.0	0.000428449	29.0	0.000242339	49.0	202196.0	0.0	18	0.42	PASS	nfe	0.000399052	34.0	0.000399052	34.0	0.0001801	28						7.988	0.363134		0	0	0			EPS8L2	0.0	0.0	0.0	0.0	17.0	37.0	18.0	37.0	0.0006069284281363	0.012	10.63	0.089	10.719	0.602	0.0				hearing/vestibular/ear phenotype; nervous system phenotype ; 			kidney;superior cervical ganglion;	.	Rho protein signal transduction;sensory perception of sound;regulation of Rho protein signal transduction;positive regulation of ruffle assembly	cytosol;plasma membrane;vesicle;stereocilium bundle;stereocilium tip;ruffle membrane;protein-containing complex;extracellular exosome	actin binding;Rho guanyl-nucleotide exchange factor activity;protein binding;Rac guanyl-nucleotide exchange factor activity;cadherin binding	SNW1[20467437];RPL23[21988832];LRRK2[24947832];CDC5L[20467437];RIN3[25814554];CD3E[17617578];PTK2[21900206];TNS2[25814554];PLEKHA7[28877994];	726090
15355	chr11	1024844	C	G	chr11:1024844	MUC6	mucin 6, oligomeric mucus/gel-forming	SNV	0/1	0.46	57_48	105	99.0	0/0	0.0	40_0	40	99.0				SPLICING	YES	NM_005961.3	Transcript	protein_coding	missense_variant,splice_region_variant		24/33	NM_005961.3:c.3225G>C	NP_005952.2:p.Lys1075Asn		-1.0	Uncharacterised domain, cysteine-rich&von Willebrand factor, type D domain&Uncharacterised domain, cysteine-rich					.	.	.						34	0.99											49	0.96														34.0	5.797869	0.819	12	7	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	MUC6	0.0	0.0	0.21	0.46	3.0	50.0	-22.0	0.0	0.999996180559411	1.0	1.662	6.264	7.926	0.987	0.0	31.671786548	0.935	0.943	.			.	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;maintenance of gastrointestinal epithelium	extracellular region;Golgi lumen;plasma membrane	extracellular matrix structural constituent	.	1024844
15370	chr11	1253969	A	G	chr11:1253969	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0|1	0.42	105_76	182	99.0	0|1	0.34	95_50	145	99.0			rs72846370,COSV71589756	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		17/49	NM_002458.3:c.2034A>G	NP_002449.2:p.Val678%3D		1.0		Benign	criteria_provided,_single_submitter	not_specified	{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis	24033266					35	0.98							0.173726	22000.0	126636.0	0.0	37	0.75	InbreedingCoeff_RF	sas	0.249111	4341.0	0.188416	10228.0	0.0019485	303	0.016	54.0	0.32991	3763.0		6.657	0.257617		0	0	0			MUC5B	0.0	0.0	0.0	0.0	-5.0	4.0	31.0	24.0						0.243	1.0	92.056945532			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1253969
15371	chr11	1253976	A	G	chr11:1253976	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0|1	0.42	104_76	181	99.0	0|1	0.34	88_45	133	99.0			rs76956995,COSV71589766	EXONIC	YES	NM_002458.3	Transcript	protein_coding	missense_variant		17/49	NM_002458.3:c.2041A>G	NP_002449.2:p.Ser681Gly		1.0	Uncharacterised domain, cysteine-rich&Uncharacterised domain, cysteine-rich	Likely_benign	no_assertion_criteria_provided	Idiopathic_Pulmonary_Fibrosis	{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						35	0.98							0.0917424	11190.0	121972.0	0.0	32	0.73	RF	sas	0.152159	2283.0	0.0983973	5157.0	0.0019099	297	0.014	46.0	0.32334	3688.0		8.669	0.425615	0.186	1	16	17	PolyPhen	SIFT,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC5B	0.0	0.0	0.0	0.0	-3.0	-12.0	17.0	28.0						0.243	1.0	92.056945532	0.161	-0.143	immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1253976
15372	chr11	1253980	A	G	chr11:1253980	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0|1	0.43	94_72	167	99.0	0|1	0.34	85_43	128	99.0			rs202127660,COSV71589772	EXONIC	YES	NM_002458.3	Transcript	protein_coding	missense_variant		17/49	NM_002458.3:c.2045A>G	NP_002449.2:p.Asp682Gly		1.0	Uncharacterised domain, cysteine-rich&Uncharacterised domain, cysteine-rich	Likely_benign	no_assertion_criteria_provided	Idiopathic_Pulmonary_Fibrosis	{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						35	0.98							0.0514392	6630.0	128890.0	0.0	30	0.72	RF	sas	0.0916195	1360.0	0.0540738	3029.0	0.0018906	294	0.015	50.0	0.32062	3657.0		8.451	0.404947	0.026	0	17	17		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC5B	0.0	0.0	0.0	0.0	33.0	-16.0	13.0	20.0						0.243	1.0	92.056945532	0.331	-0.126	immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1253980
15374	chr11	1258175	C	T	chr11:1258175	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0|1	0.43	108_81	190	99.0	0|1	0.35	95_52	147	99.0			rs80092233,COSV71594278	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		25/49	NM_002458.3:c.3078C>T	NP_002449.2:p.Cys1026%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis		0.000184051	28.0	152132.0	0.0	33	0.98	PASS	afr	0.00060334	25.0	4.41228e-05	3.0	0.0885192	8418.0	95098.0	0.0	12	0.11	RF	sas	0.165559	1345.0	0.0757978	3311.0	0.0586287	9117	0.025	83.0	0.13607	1552.0		10.46	0.617746		0	0	0			MUC5B	0.02	0.0	0.0	0.0	45.0	-20.0	-2.0	47.0						0.243	1.0	79.364435481			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1258175
15375	chr11	1258192	A	T	chr11:1258192	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0|1	0.43	120_92	214	99.0	0|1	0.39	101_65	166	99.0			rs76589014,COSV71590129	EXONIC	YES	NM_002458.3	Transcript	protein_coding	missense_variant		25/49	NM_002458.3:c.3095A>T	NP_002449.2:p.Asn1032Ile		1.0	von Willebrand factor, type D domain&von Willebrand factor, type D domain&von Willebrand factor, type D domain				{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98							0.0830945	8409.0	101198.0	0.0	14	0.19	RF	sas	0.151244	1422.0	0.073025	3411.0	0.0017877	278	0.017	57.0	0.15772	1799.0		22.3	2.396167	0.259	6	13	19	SIFT,PolyPhen,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	MUC5B	0.01	0.01	0.0	0.0	28.0	-32.0	30.0	37.0						0.243	1.0	82.418554501	0.0	-0.103	immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1258192
15376	chr11	1258197	A	G	chr11:1258197	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0|1	0.43	121_93	216	99.0	0|1	0.4	104_68	172	99.0			rs78674028,COSV71590132	EXONIC	YES	NM_002458.3	Transcript	protein_coding	missense_variant		25/49	NM_002458.3:c.3100A>G	NP_002449.2:p.Ile1034Val		1.0	von Willebrand factor, type D domain&von Willebrand factor, type D domain&von Willebrand factor, type D domain				{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98							0.0846457	8750.0	103372.0	0.0	14	0.24	RF	sas	0.149278	1468.0	0.0764333	3613.0	0.0017877	278	0.015	48.0	0.16334	1863.0		0.015	-0.730612	0.027	0	17	17		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC5B	0.0	0.04	0.0	0.0	-42.0	23.0	25.0	23.0						0.243	1.0	82.418554501	0.011	-0.887	immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1258197
15377	chr11	1258199	C	T	chr11:1258199	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0|1	0.43	124_96	222	99.0	0|1	0.41	105_72	177	99.0			rs80200632,COSV71593511	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		25/49	NM_002458.3:c.3102C>T	NP_002449.2:p.Ile1034%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98							0.087391	8841.0	101166.0	0.0	15	0.25	RF	sas	0.151806	1471.0	0.0794113	3658.0	0.0017877	278	0.019	63.0	0.17894	2041.0		9.203	0.479041		0	0	0			MUC5B	0.26	0.04	0.0	0.01	21.0	-39.0	21.0	23.0						0.243	1.0	82.418554501			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1258199
15378	chr11	1258217	T	G	chr11:1258217	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0|1	0.48	129_119	250	99.0	0|1	0.44	113_89	202	99.0			rs74648489,COSV71593514	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		25/49	NM_002458.3:c.3120T>G	NP_002449.2:p.Arg1040%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98							0.0729777	7053.0	96646.0	0.0	17	0.39	RF	sas	0.11619	1154.0	0.0717829	3097.0	0.0017813	277	0.022	73.0	0.24198	2760.0		1.011	-0.149128		0	0	0			MUC5B	0.0	0.08	0.0	0.02	42.0	3.0	12.0	5.0						0.243	1.0	46.691060751			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1258217
15379	chr11	1258226	C	T	chr11:1258226	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0|1	0.5	128_129	259	99.0	0|1	0.44	120_94	214	99.0			rs55700357,COSV71593518,COSV71594601	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		25/49	NM_002458.3:c.3129C>T	NP_002449.2:p.Ser1043%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis		0.00270043	411.0	152198.0	4.0	33	0.98	PASS	afr	0.00921459	382.0	0.000117623	8.0	0.0676875	6268.0	92602.0	1.0	18	0.43	RF	sas	0.104322	980.0	0.0660662	2714.0	0.0019163	298	0.026	84.0	0.276	3148.0		1.647	-0.075862		0	0	0			MUC5B	0.0	0.01	0.0	0.0	22.0	-6.0	3.0	-4.0						0.243	1.0	46.691060751			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1258226
15380	chr11	1258240	C	T	chr11:1258240	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0|1	0.55	118_144	264	99.0	0|1	0.47	116_103	219	99.0			rs77287508,COSV71589719,COSV71592058	EXONIC	YES	NM_002458.3	Transcript	protein_coding	missense_variant		25/49	NM_002458.3:c.3143C>T	NP_002449.2:p.Ala1048Val		1.0	von Willebrand factor, type D domain				{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98							0.0526244	4620.0	87792.0	0.0	19	0.47	RF	sas	0.071087	654.0	0.0548993	2147.0	0.0018006	280	0.025	82.0	0.32877	3750.0		0.295	-0.330964	0.006	0	17	17		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC5B	0.0	0.01	0.0	0.0	19.0	-20.0	-18.0	-11.0						0.243	1.0	93.754061070	0.0	-1.288	immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1258240
15381	chr11	1258241	A	G	chr11:1258241	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0|1	0.55	118_144	264	99.0	0|1	0.47	114_103	217	99.0			rs79773885,COSV71589729	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		25/49	NM_002458.3:c.3144A>G	NP_002449.2:p.Ala1048%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98							0.0575908	4647.0	80690.0	0.0	19	0.48	RF	sas	0.0761398	658.0	0.0606495	2159.0	0.0018006	280	0.025	81.0	0.32991	3763.0		0.206	-0.382512		0	0	0			MUC5B	0.01	0.0	0.0	0.0	-21.0	18.0	0.0	-19.0						0.243	1.0	93.754061070			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1258241
15382	chr11	1258283	G	A	chr11:1258283	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0|1	0.53	129_145	276	99.0	0|1	0.51	117_121	239	99.0			rs78669250,COSV71589742,COSV71594415	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		25/49	NM_002458.3:c.3186G>A	NP_002449.2:p.Pro1062%3D		1.0		Benign	criteria_provided,_single_submitter	not_specified	{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis	24033266	2.62864e-05	4.0	152170.0	0.0	33	0.98	PASS	amr	6.54279e-05	1.0	1.47037e-05	1.0	0.326614	38447.0	117714.0	0.0	22	0.58	InbreedingCoeff	sas	0.361131	5084.0	0.33916	17618.0	0.0035176	547	0.065	201.0	0.4659	5314.0		0.471	-0.262977		0	0	0			MUC5B	0.06	0.0	0.0	0.0	2.0	19.0	2.0	43.0						0.243	1.0	95.973112222			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1258283
15383	chr11	1258286	C	T	chr11:1258286	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0|1	0.53	130_149	281	99.0	0|1	0.5	125_125	251	99.0			rs77996005,COSV71589885	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		25/49	NM_002458.3:c.3189C>T	NP_002449.2:p.Asp1063%3D		1.0		Benign	criteria_provided,_single_submitter	not_specified	{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis	24033266	0.000111686	17.0	152212.0	0.0	33	0.98	PASS	sas	0.000413736	2.0	0.000117606	8.0	0.334102	41561.0	124396.0	0.0	23	0.59	InbreedingCoeff	sas	0.366136	5432.0	0.348686	19313.0	0.0019485	303	0.067	207.0	0.46703	5327.0		1.116	-0.134464		0	0	0			MUC5B	0.0	0.0	0.0	0.0	16.0	-27.0	-40.0	40.0						0.243	1.0	95.973112222			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1258286
15384	chr11	1258295	A	G	chr11:1258295	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0|1	0.54	129_151	282	99.0	0|1	0.5	124_124	249	99.0			rs79118814,COSV71589886	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		25/49	NM_002458.3:c.3198A>G	NP_002449.2:p.Ala1066%3D		1.0		Likely_benign	criteria_provided,_single_submitter	not_specified	{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis	24033266					33	0.98							0.368597	53375.0	144806.0	0.0	24	0.62	InbreedingCoeff	sas	0.400329	6812.0	0.383733	25410.0	0.0019549	304	0.08	242.0	0.47396	5406.0		2.588	-0.002327		0	0	0			MUC5B	0.0	0.0	0.0	0.0	7.0	37.0	31.0	-3.0						0.243	1.0	95.973112222			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1258295
15392	chr11	1260145	T	C	chr11:1260145	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0/1	0.27	148_55	204	99.0	0/1	0.27	130_49	179	99.0			rs75799984,COSV71591607	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		26/49	NM_002458.3:c.3342T>C	NP_002449.2:p.Cys1114%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98											79	0.58							0.0015241	237	0.016	51.0	0.01797	205.0		7.954	0.360193		0	0	0			MUC5B	0.0	0.0	0.0	0.0	-44.0	-29.0	-4.0	22.0						0.243	1.0	63.144663278			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1260145
15397	chr11	1260157	G	C	chr11:1260157	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0|1	0.29	156_64	221	99.0	0|1	0.3	137_60	197	99.0			rs78678736	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		26/49	NM_002458.3:c.3354G>C	NP_002449.2:p.Ser1118%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98											87	0.59							0.0015112	235	0.01	34.0	0.04506	514.0		5.136	0.153911		0	0	0			MUC5B	0.0	0.0	0.0	0.0	-41.0	-32.0	10.0	-43.0						0.243	1.0	63.144663278			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1260157
15402	chr11	1260160	T	G	chr11:1260160	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0|1	0.29	157_64	221	99.0	0|1	0.31	134_59	193	99.0			rs78177850	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		26/49	NM_002458.3:c.3357T>G	NP_002449.2:p.Gly1119%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98											87	0.58							0.0015305	238	0.01	34.0	0.04673	533.0		6.169	0.222565		0	0	0			MUC5B	0.0	0.0	0.0	0.0	-35.0	-44.0	-46.0	-2.0						0.243	1.0	63.144663278			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1260160
15407	chr11	1260163	C	T	chr11:1260163	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0|1	0.29	153_64	217	99.0	0/1	0.32	127_59	186	99.0			rs79220674,COSV101500982,COSV71591608	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		26/49	NM_002458.3:c.3360C>T	NP_002449.2:p.Gly1120%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis		4.59963e-05	7.0	152186.0	0.0	33	0.98	PASS	afr	9.65437e-05	4.0	2.93971e-05	2.0	5.31237e-05	10.0	188240.0	0.0	87	0.59	PASS	afr	0.000190042	2.0	4.96524e-05	4.0	0.0015884	247	0.01	32.0	0.04524	516.0		1.596	-0.080665		0	0	0			MUC5B	0.0	0.0	0.0	0.0	43.0	-47.0	-5.0	4.0						0.243	1.0	0.460690294			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1260163
15413	chr11	1260175	T	C	chr11:1260175	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0/1	0.31	142_65	207	99.0	0/1	0.31	126_57	183	99.0			rs75760167,COSV71589947	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		26/49	NM_002458.3:c.3372T>C	NP_002449.2:p.Cys1124%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98											94	0.59							0.0014855	231	0.01	34.0	0.01867	213.0		7.99	0.363316		0	0	0			MUC5B	0.0	0.0	0.0	0.0	-4.0	31.0	-4.0	50.0						0.243	1.0	60.874268431			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1260175
15418	chr11	1260193	T	C	chr11:1260193	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0/1	0.33	127_62	189	99.0	0/1	0.33	110_53	163	99.0			rs74763753,COSV71589949	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		26/49	NM_002458.3:c.3390T>C	NP_002449.2:p.Ala1130%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98											90	0.58							0.0014148	220	0.009	31.0	0.01508	172.0		9.552	0.515922		0	0	0			MUC5B	0.0	0.0	0.0	0.0	-20.0	13.0	32.0	34.0						0.243	1.0	82.422249921			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1260193
15425	chr11	1260214	C	T	chr11:1260214	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0|1	0.3	122_53	175	99.0	0|1	0.29	110_46	156	99.0			rs79585387,COSV71596776	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		26/49	NM_002458.3:c.3411C>T	NP_002449.2:p.His1137%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98											84	0.58							0.0014083	219	0.006	19.0	0.03069	350.0		0.065	-0.541187		0	0	0			MUC5B	0.0	0.0	0.0	0.01	-8.0	11.0	43.0	13.0						0.243	1.0	0.000000000			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1260214
15432	chr11	1260217	C	A	chr11:1260217	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0|1	0.29	127_53	180	99.0	0|1	0.28	111_44	155	99.0			rs79638064,COSV71592285	EXONIC	YES	NM_002458.3	Transcript	protein_coding	missense_variant		26/49	NM_002458.3:c.3414C>A	NP_002449.2:p.Asp1138Glu		1.0	Uncharacterised domain, cysteine-rich&Uncharacterised domain, cysteine-rich				{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis						33	0.98							0.0	0.0	178860.0	0.0	85	0.58	AC0				0.0	0.0	0.0014019	218	0.007	23.0	0.03139	358.0		2.651	0.001815	0.081	1	17	18	M-CAP_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC5B	0.0	0.0	0.0	0.01	-11.0	8.0	44.0	8.0						0.243	1.0	0.047227790	0.014	-0.214	immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1260217
15436	chr11	1260219	C	T	chr11:1260219	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0|1	0.29	128_53	181	99.0	0|1	0.27	110_41	151	99.0			rs75935363,COSV71592287	EXONIC	YES	NM_002458.3	Transcript	protein_coding	missense_variant		26/49	NM_002458.3:c.3416C>T	NP_002449.2:p.Ala1139Val		1.0	Uncharacterised domain, cysteine-rich&Uncharacterised domain, cysteine-rich				{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis		6.57194e-05	10.0	152162.0	0.0	33	0.98	PASS	afr	9.65298e-05	4.0	4.41073e-05	3.0	5.57631e-05	10.0	179330.0	0.0	84	0.58	PASS	afr	0.000103907	1.0	1.33053e-05	1.0	0.0014083	219	0.007	23.0	0.032	365.0		4.687	0.125836	0.031	1	17	18	M-CAP_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC5B	0.0	0.0	0.0	0.0	-13.0	8.0	6.0	8.0						0.243	1.0	0.000000000	0.007	0.016	immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1260219
15440	chr11	1260220	G	A	chr11:1260220	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0|1	0.29	128_52	180	99.0	0|1	0.27	108_40	148	99.0			rs61733358,COSV71596777	EXONIC	YES	NM_002458.3	Transcript	protein_coding	synonymous_variant		26/49	NM_002458.3:c.3417G>A	NP_002449.2:p.Ala1139%3D		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis		1.31418e-05	2.0	152186.0	0.0	33	0.98	PASS				0.0	0.0	0.00012612	23.0	182366.0	1.0	86	0.58	PASS	sas	0.00044865	11.0	2.60342e-05	2.0	0.0014533	226	0.007	23.0	0.03235	369.0		0.435	-0.2745		0	0	0			MUC5B	0.0	0.0	0.0	0.0	2.0	7.0	37.0	5.0						0.243	1.0	88.302115862			immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1260220
15446	chr11	1266068	C	T	chr11:1266068	MUC5B	mucin 5B, oligomeric mucus/gel-forming	SNV	0/1	0.5	92_93	185	99.0	0/1	0.49	82_80	162	99.0			rs192038475	EXONIC	YES	NM_002458.3	Transcript	protein_coding	missense_variant		31/49	NM_002458.3:c.7958C>T	NP_002449.2:p.Pro2653Leu		1.0					{Pulmonary fibrosis, idiopathic, susceptibility to}, 178500 (3), Autosomal dominant	Diffuse panbronchiolitis;Idiopathic pulmonary fibrosis	Major susceptibility factor in;Major susceptibility factor in	Bronchiectasis;Pulmonary insufficiency;Exertional dyspnea;Clubbing of fingers;Reticular pattern on pulmonary HRCT;Gastroesophageal reflux;Ground-glass opacification on pulmonary HRCT;Cough;Pulmonary fibrosis;Crackles;Honeycomb lung;Alveolar cell carcinoma;Increased circulating antibody level;Clubbing;Exertional dyspnea;Clubbing of fingers;Pneumonia;Cough;Pulmonary arterial hypertension;Pulmonary fibrosis;Autosomal dominant inheritance;Cirrhosis		4.60478e-05	7.0	152016.0	0.0	30	0.94	PASS	sas	0.000207383	1.0	0.0	0.0	3.62036e-05	9.0	248594.0	0.0	100	1.0	PASS	afr	0.000259774	4.0	8.88383e-06	1.0	0.0000386	6			0.00021	2.0		12.24	0.836608	0.08	1	17	18	SIFT	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC5B	0.0	0.0	0.0	0.0	-29.0	24.0	-20.0	-28.0						0.243	1.0		0.0	-0.079	immune system phenotype; hearing/vestibular/ear phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular space;Golgi lumen;plasma membrane;intracellular membrane-bounded organelle;extracellular exosome	protein binding	.	1266068
15584	chr11	3249628	G	A	chr11:3249628	MRGPRE	MAS related GPR family member E	SNV	0/1	0.56	52_66	118	99.0	0/0	0.0	73_0	73	99.0			rs1466220352,COSV101100021	EXONIC	YES	NM_001039165.4	Transcript	protein_coding	synonymous_variant		2/2	NM_001039165.4:c.402C>T	NP_001034254.2:p.Arg134%3D		-1.0						.	.	.						33	0.98							0.0	0.0	223266.0	0.0	32	0.69	AC0_RF				0.0	0.0								10.69	0.644895		0	0	0			MRGPRE	0.0	0.0	0.0	0.0	48.0	-6.0	13.0	48.0						0.548	0.0	0.152187420			behavior/neurological phenotype ; integument phenotype ; 			.	.	G protein-coupled receptor signaling pathway	plasma membrane;integral component of membrane	G protein-coupled receptor activity	.	3249628
15592	chr11	3381799	AA		chr11:3381799-3381800	ZNF195	zinc finger protein 195	sequence_alteration	0/1	0.0	13_6_0	19	91.0	0/2	0.21	13_0_4	19	61.0			rs369559162	SPLICING	YES	NM_001130520.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	5/5		NM_001130520.3:c.443-5_443-4del			-1.0						.	.	.		8.75998e-05	9.0	102740.0	0.0	28	0.79	AS_VQSR	amr	0.000203169	2.0	4.1132e-05	2.0	0.0158638	1582.0	99724.0	0.0	24	0.6	InbreedingCoeff_RF	sas	0.0203283	213.0	0.0151453	740.0	0.0000643,0.0000193	10,3						1.871	-0.055829		0	0	0			ZNF195	0.0	0.02	0.0	0.0	28.0	-3.0	-3.0	30.0						0.513	0.73				.			ciliary ganglion;testis - interstitial;subthalamic nucleus;trigeminal ganglion;cingulate cortex;superior cervical ganglion;skeletal muscle;	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;zinc ion binding	CBX5[20562864];	3381798
15694	chr11	4842839	A	G	chr11:4842839	OR51F2	olfactory receptor family 51 subfamily F member 2	SNV	0/0	0.0	34_0	34	99.0	0/1	0.44	69_55	124	99.0			rs185898822,COSV59064452	EXONIC	YES	NM_001004753.2	Transcript	protein_coding	missense_variant		1/1	NM_001004753.2:c.188A>G	NP_001004753.2:p.Tyr63Cys		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.		0.00214742	326.0	151810.0	0.0	32	0.95	PASS	sas	0.00707155	34.0	0.00213411	145.0	0.00283195	711.0	251064.0	5.0	85	0.99	PASS	sas	0.00758418	232.0	0.00229095	260.0	0.0025015	389	0.007	23.0				16.11	1.472782	0.156	3	13	16	SIFT,MutationAssessor_pred,MutationTaster_pred	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR51F2	0.0	0.01	0.06	0.01	27.0	21.0	-6.0	-10.0						0.741	0.0	0.000000000	0.864	0.315	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	PDIA6[30021884];	4842839
15705	chr11	5255650	G	A	chr11:5255650	HBD	hemoglobin subunit delta	SNV	0/1	0.51	37_41	80	99.0	0/1	0.52	31_34	65	99.0			rs35406175,CM104419,CM931132	EXONIC	YES	NM_000519.4	Transcript	protein_coding	missense_variant		1/3	NM_000519.4:c.14C>T	NP_000510.1:p.Thr5Ile		-1.0	Globin,Globin,Globin,Globin,Globin,Globin	Uncertain_significance	criteria_provided,_single_submitter	delta_Thalassemia	Thalassemia due to Hb Lepore (3); Thalassemia, delta- (3)	Delta-beta-thalassemia;Hemoglobin Lepore-beta-thalassemia syndrome	Disease-causing germline mutation(s) in;Part of a fusion gene in	Microcytic anemia;Abnormal hemoglobin	8364213	0.00138622	211.0	152212.0	0.0	32	0.97	PASS	amr	0.00202826	31.0	0.00202816	138.0	0.00143341	360.0	251150.0	1.0	100	1.0	PASS	nfe	0.00209688	238.0	0.00209688	238.0	0.0013312	207	0.004	14.0	0.00219	25.0		15.64	1.384726	0.45	10	10	20	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,fathmm-XF_coding_pred	HBD	0.0	0.0	0.0	0.0	18.0	41.0	11.0	0.0						0.138	0.0	0.000000000	0.892	1.075	.			atrioventricular node;bone marrow;	.	blood coagulation;oxygen transport;hydrogen peroxide catabolic process;protein heterooligomerization;cellular oxidant detoxification	cytosol;hemoglobin complex;haptoglobin-hemoglobin complex;blood microparticle	peroxidase activity;oxygen carrier activity;protein binding;oxygen binding;heme binding;haptoglobin binding;hemoglobin alpha binding;organic acid binding;metal ion binding	HBZ[25416956;unassigned1304];HBQ1[25416956];HBA1[unassigned1304];BCAR1[28007913];	5255650
15721	chr11	5566076	G	A	chr11:5566076	OR52H1	olfactory receptor family 52 subfamily H member 1	SNV	0/1	0.46	81_68	149	99.0	0/1	0.48	73_67	140	99.0			rs139835065,COSV59505097	EXONIC	YES	NM_001005289.3	Transcript	protein_coding	synonymous_variant		2/2	NM_001005289.3:c.678C>T	NP_001005289.1:p.Tyr226%3D		-1.0						.	.	.		0.0022207	338.0	152204.0	1.0	33	0.94	PASS	amr	0.00359759	55.0	0.00257202	175.0	0.00283115	709.0	250428.0	2.0	100	1.0	PASS	sas	0.00375866	115.0	0.00291553	329.0	0.0026366	410	0.002	7.0	0.00294	28.0		0.01	-0.792014		0	0	0			OR52H1	0.02	0.01	0.0	0.0	-41.0	25.0	-4.0	-13.0						0.708	0.01	24.802902514			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	5566076
15722	chr11	5602987	T	C	chr11:5602987	OR52B6	olfactory receptor family 52 subfamily B member 6	SNV	0/0	0.0	46_0	46	99.0	0/1	0.41	61_43	104	99.0			rs1309278782	EXONIC	YES	NM_001005162.2	Transcript	protein_coding	missense_variant		1/1	NM_001005162.2:c.881T>C	NP_001005162.2:p.Ile294Thr		1.0	GPCR, rhodopsin-like, 7TM					.	.	.						32	0.95							4.00744e-06	1.0	249536.0	0.0	100	1.0	PASS	amr	2.89654e-05	1.0	0.0	0.0								23.4	2.938934	0.451	10	10	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-XF_coding_pred	OR52B6	0.01	0.0	0.0	0.02	-35.0	13.0	-48.0	-36.0						0.665	0.07	0.000000000	1.0	1.024	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	5602987
15748	chr11	5878609	G	C	chr11:5878609	OR52E8	olfactory receptor family 52 subfamily E member 8	SNV	0/1	0.48	63_57	120	99.0	0/0	0.0	39_0	39	99.0			rs148345924,COSV66206741,COSV66209534	EXONIC	YES	NM_001005168.1	Transcript	protein_coding	missense_variant		1/1	NM_001005168.1:c.324C>G	NP_001005168.1:p.Phe108Leu		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.		0.00368802	552.0	149674.0	9.0	31	0.89	PASS	amr	0.00454186	69.0	0.00422046	287.0	0.0043992	1102.0	250500.0	15.0	100	1.0	PASS	nfe	0.00465346	528.0	0.00465346	528.0	0.0039034	607	0.007	23.0				22.3	2.379318	0.38	6	13	19	SIFT,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred	PolyPhen,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR52E8	0.0	0.0	0.0	0.0	-30.0	19.0	33.0	-35.0						0.62	0.02	0.000000000	0.522	1.132	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	5878609
15752	chr11	6024009	G	C	chr11:6024009	OR56A4	olfactory receptor family 56 subfamily A member 4	SNV	0/1	0.51	50_53	104	99.0	0/0	0.0	35_0	35	99.0			rs368204471	EXONIC	YES	NM_001005179.4	Transcript	protein_coding	missense_variant		3/3	NM_001005179.4:c.214C>G	NP_001005179.3:p.Leu72Val		-1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.		5.91281e-05	9.0	152212.0	0.0	32	0.97	PASS	nfe	8.81808e-05	6.0	8.81808e-05	6.0	4.78191e-05	12.0	250946.0	0.0	72	0.98	PASS	nfe	7.04784e-05	8.0	7.04784e-05	8.0	0.0000450	7						12.93	0.928836	0.043	2	18	20	PolyPhen,LIST-S2_pred	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR56A4	0.0	0.0	0.0	0.0	13.0	-36.0	1.0	-35.0						0.745	0.31	0.000000000	0.998	1.176	.			.	Olfactory transduction	synaptic transmission, dopaminergic;adenylate cyclase-modulating G protein-coupled receptor signaling pathway;adenylate cyclase-inhibiting dopamine receptor signaling pathway;regulation of dopamine secretion;response to drug;behavioral response to cocaine;detection of chemical stimulus involved in sensory perception of smell;adenylate cyclase-activating adrenergic receptor signaling pathway	plasma membrane;integral component of plasma membrane	dopamine neurotransmitter receptor activity, coupled via Gi/Go;adrenergic receptor activity;olfactory receptor activity;dopamine binding	.	6024009
15815	chr11	6913281	T	C	chr11:6913281	OR2D2	olfactory receptor family 2 subfamily D member 2	SNV	0/1	0.49	49_49	99	99.0	0/0	0.0	102_0	102	99.0			rs74917712	EXONIC	YES	NM_003700.1	Transcript	protein_coding	missense_variant		1/1	NM_003700.1:c.451A>G	NP_003691.1:p.Ser151Gly		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.		0.00390502	594.0	152112.0	3.0	32	0.94	PASS	amr	0.00615747	94.0	0.00530976	361.0	0.00432472	1084.0	250652.0	8.0	100	1.0	PASS	sas	0.00565138	173.0	0.00511982	579.0	0.0037555	584	0.006	20.0				22.8	2.650312	0.297	3	18	21	PolyPhen,LRT_pred,PROVEAN_pred	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR2D2	0.0	0.0	0.0	0.0	21.0	-2.0	-11.0	-20.0						0.917	0.0	0.000000000	0.998	1.126	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;sensory perception of smell;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	6913281
16011	chr11	8752313	CGGCGA		chr11:8752313-8752318	ST5	suppression of tumorigenicity 5	deletion	0/1	0.44	76_60	136	99.0	0/1	0.44	85_66	151	99.0			rs777563076	EXONIC	YES	NM_001376495.1	Transcript	protein_coding	inframe_deletion		7/24	NM_001376495.1:c.519_524del	NP_001363424.1:p.Arg174_Arg175del		-1.0						.	.	.		0.000854207	130.0	152188.0	0.0	33	0.98	PASS	amr	0.00163591	25.0	0.00132283	90.0	0.000727073	180.0	247568.0	0.0	81	0.98	PASS	nfe	0.00134722	150.0	0.00134722	150.0	0.0005723	89	0.002	5.0	0.00263	30.0		20.9	2.134646		0	0	0																	0.39	1.0	0.000000000			.			uterus;trigeminal ganglion;superior cervical ganglion;atrioventricular node;testis;	.	.	.	Rab guanyl-nucleotide exchange factor activity	SMAD2[15231748];PPP1CB[26496610];ANLN[26496610];ABL1[9632734];MYO18A[26496610];MYH9[26496610];GRB2[9632734];SFN[15778465];HNRNPC[30021884];MYO19[26496610];LLGL2[26496610];	8752312
16018	chr11	9069032	C	T	chr11:9069032	SCUBE2	signal peptide, CUB domain and EGF like domain containing 2	SNV	0/1	0.47	58_51	109	99.0	0/0	0.0	33_0	33	99.0			rs72550810,COSV58541834	EXONIC	YES	NM_001367977.2	Transcript	protein_coding	missense_variant		16/23	NM_001367977.2:c.1873G>A	NP_001354906.1:p.Val625Ile		-1.0	.,.,.,.					.	.	.		0.00267985	407.0	151874.0	2.0	32	0.94	PASS	nfe	0.0036768	250.0	0.0036768	250.0	0.00287089	721.0	251142.0	2.0	100	1.0	PASS	nfe	0.00366752	416.0	0.00366752	416.0	0.0028295	440	0.002	8.0	0.00351	40.0		17.24	1.663868	0.016	3	16	19	FATHMM_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	SCUBE2	0.0	0.0	0.0	0.0	-27.0	48.0	48.0	-33.0						0.156	0.0	0.000000000	0.569	0.077	cellular phenotype; growth/size/body region phenotype; skeleton phenotype; limbs/digits/tail phenotype; 			superior cervical ganglion;	.	multicellular organism development	extracellular region;extracellular space;cell surface	calcium ion binding;lipid binding	.	9069032
16030	chr11	9200465	T	C	chr11:9200465	DENND5A	DENN domain containing 5A	SNV	0/0	0.0	33_0	33	99.0	0/1	0.42	52_37	89	99.0			rs78439449	EXONIC	YES	NM_015213.4	Transcript	protein_coding	synonymous_variant		7/23	NM_015213.4:c.1611A>G	NP_056028.2:p.Gln537%3D		-1.0		Likely_benign	criteria_provided,_single_submitter	not_provided	Developmental and epileptic encephalopathy 49, 617281 (3), Autosomal recessive	.	.	Dandy-Walker malformation;Autosomal recessive inheritance;Prominent nose;Short philtrum;Optic atrophy;Microcephaly;Cerebral calcification;Hyperreflexia;Muscular hypotonia of the trunk;Profound global developmental delay;Hydrocephalus;Long eyelashes;Frontal bossing;Absent speech;Thick upper lip vermilion;Epileptic encephalopathy;Macrotia;Myoclonus;Seizure;Spasticity;Coarse facial features;EEG abnormality;Open mouth		0.00417948	636.0	152172.0	8.0	32	0.96	PASS	nfe	0.00615887	419.0	0.00615887	419.0	0.00427167	1074.0	251424.0	4.0	95	1.0	PASS	nfe	0.00576886	656.0	0.00576886	656.0	0.0042700	664	0.014	44.0				10.18	0.584863		0	0	0			DENND5A	0.0	0.0	0.0	0.0	-1.0	-36.0	31.0	15.0						0.395	0.99	66.362371342			.			caudate nucleus;occipital lobe;prefrontal cortex;whole brain;parietal lobe;spinal cord;medulla oblongata;hypothalamus;cerebellum;	.	negative regulation of neuron projection development;retrograde transport, endosome to Golgi	Golgi membrane;trans-Golgi network;cytosol;retromer complex	Rab guanyl-nucleotide exchange factor activity	GOLGA6L9[unassigned1304];TRADD[unassigned1774];CSNK2B[21900206];TRAF2[unassigned1774];PRKCZ[21900206];	9200465
16313	chr11	18596967	A		chr11:18596967	UEVLD	UEV and lactate/malate dehyrogenase domains	sequence_alteration	0/2	0.0	10_0_3	13	41.0	0/1	0.17	11_3_2	18	49.0			rs35906676	SPLICING	YES	NM_001040697.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	2/11		NM_001040697.4:c.128-8del			-1.0						.	.	.		0.000604207	79.0	130750.0	0.0	31	0.81	AS_VQSR	amr	0.00123476	16.0	0.000382085	23.0	0.259659	25001.0	96284.0	0.0	38	0.8	InbreedingCoeff	eas	0.367282	2070.0	0.250113	12170.0	0.0007588,0.2299041,0.0006559,0.0000129	118,35751,102,2						0.665	-0.211483		0	0	0			UEVLD	0.0	0.05	0.0	0.0	17.0	-7.0	-7.0	15.0						0.324	0.0				immune system phenotype; hematopoietic system phenotype; 			superior cervical ganglion;	.	carbohydrate metabolic process;cellular protein modification process;biological_process;protein transport;carboxylic acid metabolic process;oxidation-reduction process	extracellular exosome	molecular_function;oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor	LRSAM1[19549727];SDF2L1[19549727];NEK4[25798074];TRADD[unassigned1774];TRAF2[unassigned1774];DTX3[19549727];RNF4[19549727];TANK[unassigned1774];RNF114[19549727];SHARPIN[unassigned1774];TNIP1[unassigned1774];TNIP2[unassigned1774];TRAF6[19549727];GALM[19549727];RBCK1[unassigned1774];BIRC2[unassigned1774];	18596966
16393	chr11	27384717	G	A	chr11:27384717	CCDC34	coiled-coil domain containing 34	SNV	0/1	0.37	60_36	97	99.0	0/0	0.0	37_0	37	99.0				EXONIC	YES	NM_030771.2	Transcript	protein_coding	missense_variant		1/6	NM_030771.2:c.25C>T	NP_110398.1:p.Pro9Ser		-1.0	.,.					.	.	.						32	0.98											12	0.21														1.938	-0.050232	0.017	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CCDC34	0.0	0.0	0.0	0.0	24.0	-44.0	2.0	-49.0						0.842	0.0		0.0	-0.833	.			testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;trigeminal ganglion;testis;globus pallidus;	.	.	.	.	TMEM86B[unassigned1304];COQ8A[unassigned1304];	27384717
16409	chr11	30253508	G	T	chr11:30253508	FSHB	follicle stimulating hormone subunit beta	SNV	0/1	0.55	36_45	82	99.0	0/0	0.0	38_0	38	99.0			rs6170	EXONIC	YES	NM_001382289.1	Transcript	protein_coding	missense_variant		2/3	NM_001382289.1:c.59G>T	NP_001369218.1:p.Ser20Ile		1.0	Glycoprotein hormone subunit beta,Glycoprotein hormone subunit beta,Glycoprotein hormone subunit beta	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Hypogonadotropic_hypogonadism_24_without_anosmia|not_provided	Hypogonadotropic hypogonadism 24 without anosmia, 229070 (3), Autosomal recessive	Isolated follicle stimulating hormone deficiency	Disease-causing germline mutation(s) (loss of function) in	Delayed menarche;Hyperplasia of the Leydig cells;Abnormal sperm morphology;Delayed skeletal maturation;Testicular atrophy;Oligomenorrhea;Decreased serum testosterone level;Bilateral breast hypoplasia;Sparse pubic hair;Hypogonadotropic hypogonadism;Decreased serum estradiol;Gonadotropin deficiency;Male hypogonadism;Azoospermia;Sparse axillary hair;Female hypogonadism;Decreased female libido;Primary amenorrhea;Decreased testicular size;Oligospermia;Abnormality of metabolism/homeostasis;Azoospermia;Hypogonadism;Infertility;Primary amenorrhea;Delayed skeletal maturation;Autosomal recessive inheritance;Decreased muscle mass;Decreased testicular size		0.00226087	344.0	152154.0	1.0	33	0.97	PASS	amr	0.00359995	55.0	0.00310185	211.0	0.00217528	546.0	251002.0	3.0	93	1.0	PASS	nfe	0.00313101	355.0	0.00313101	355.0	0.0022443	349	0.005	15.0	0.0043	49.0		21.1	2.153711	0.052	4	15	19	MutationTaster_pred,FATHMM_pred,DEOGEN2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	FSHB	0.0	0.0	0.0	0.0	35.0	-15.0	2.0	1.0						0.353	0.01	0.000000000	0.688	1.176	endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; reproductive system phenotype; 			pituitary;temporal lobe;cerebellum peduncles;	Neuroactive ligand-receptor interaction;GnRH signaling pathway	progesterone biosynthetic process;transforming growth factor beta receptor signaling pathway;G protein-coupled receptor signaling pathway;female gamete generation;female pregnancy;positive regulation of cell population proliferation;hormone-mediated signaling pathway;regulation of signaling receptor activity;positive regulation of steroid biosynthetic process;peptide hormone processing;positive regulation of cell migration;follicle-stimulating hormone signaling pathway;regulation of osteoclast differentiation;positive regulation of bone resorption;positive regulation of transcription by RNA polymerase II;Sertoli cell proliferation	extracellular region;extracellular space;cytoplasm;follicle-stimulating hormone complex	hormone activity;protein binding;follicle-stimulating hormone activity	FSHR[15662415;22802634];CGA[11222739;15662415;22802634];GPHA2[12045258];	30253508
16438	chr11	34154579	C	T	chr11:34154579	NAT10	N-acetyltransferase 10	SNV	0/1	0.53	34_38	72	99.0	0/0	0.0	33_0	33	99.0			rs139767479	EXONIC	YES	NM_024662.3	Transcript	protein_coding	missense_variant		16/29	NM_024662.3:c.1624C>T	NP_078938.3:p.Pro542Ser		1.0	GNAT domain,.,GNAT domain					.	.	.		0.00131432	200.0	152170.0	0.0	32	0.95	PASS	sas	0.00372517	18.0	0.00141127	96.0	0.00147544	371.0	251450.0	1.0	78	1.0	PASS	sas	0.00209055	64.0	0.00164398	187.0	0.0015305	238	0.004	14.0				28.8	4.126171	0.914	17	4	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FATHMM_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred	NAT10	0.01	0.0	0.0	0.0	-6.0	-15.0	15.0	-6.0							0.0	0.000000000	1.0	1.023	immune system phenotype; mortality/aging ; hematopoietic system phenotype; 			superior cervical ganglion;	.	rRNA modification;negative regulation of telomere maintenance via telomerase;tRNA acetylation;rRNA acetylation involved in maturation of SSU-rRNA	nuclear chromosome, telomeric region;nucleus;nucleoplasm;telomerase holoenzyme complex;nucleolus;membrane;midbody	RNA binding;protein binding;ATP binding;N-acetyltransferase activity;DNA polymerase binding;rRNA cytidine N-acetyltransferase activity	RPL10[26496610];HNRNPU[26496610];YBX1[25497084];THUMPD1[25653167];AURKB[29568061];TGOLN2[29568061];SYNCRIP[26496610];FBL[29568061];NUDCD3[25036637];HIST1H3A[29568061];BAG2[25036637];IFI16[25665578];TFG[26496610];E2F3[22157815];RPS2[30021884];LYAR[17353931];NOP56[26496610];NUDC[25036637];JUN[25609649];NPM1[26496610];VCAM1[22623428];RPS6[29568061];FN1[19738201];CDC5L[20467437];CACYBP[25036637];RRP1B[20926688];SIRT1[19343720];ESR1[21182205];MEX3C[22863774];ESR2[21182203];RAB11A[29568061];PPP5C[25036637];IBTK[26496610];CDK7[29568061];NEURL4[29426014];AGO1[17932509];NCL[30021884];CANX[29568061];MNDA[25665578];TOP1[15848144];VIM[26496610];AURKAIP1[29568061];	34154579
16549	chr11	45265669	G	A	chr11:45265669	SYT13	synaptotagmin 13	SNV	0/1	0.47	74_67	142	99.0	0/1	0.43	63_47	110	99.0			rs151134010	EXONIC	YES	NM_020826.3	Transcript	protein_coding	synonymous_variant		6/6	NM_020826.3:c.1215C>T	NP_065877.1:p.Ser405%3D		-1.0						.	.	.		0.000696406	106.0	152210.0	0.0	32	0.97	PASS	amr	0.00196386	30.0	0.000514388	35.0	0.000603392	151.0	250252.0	1.0	60	1.0	PASS	amr	0.000983341	34.0	0.000423968	48.0	0.0004116	64	0.001	3.0				11.53	0.746307		0	0	0			SYT13	0.0	0.0	0.0	0.0	-37.0	33.0	-9.0	-44.0						0.413	0.22				.			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;atrioventricular node;	.	regulation of dopamine secretion;vesicle-mediated transport;calcium ion regulated exocytosis;regulation of calcium ion-dependent exocytosis;cellular response to calcium ion	plasma membrane;integral component of plasma membrane;transport vesicle;intracellular membrane-bounded organelle;exocytic vesicle;presynapse	SNARE binding;phosphatidylserine binding;calcium ion binding;calcium-dependent phospholipid binding;syntaxin binding;clathrin binding	NCL[30021884];	45265669
16555	chr11	45924519	G	A	chr11:45924519	MAPK8IP1	mitogen-activated protein kinase 8 interacting protein 1	SNV	0/0	0.0	34_0	34	99.0	0/1	0.53	47_54	101	99.0			rs368904071,COSV99571431,COSV99571717	EXONIC	YES	NM_005456.4	Transcript	protein_coding	missense_variant		5/12	NM_005456.4:c.1201G>A	NP_005447.1:p.Gly401Arg		1.0	.,.				{Diabetes mellitus, noninsulin-dependent}, 125853 (3), Autosomal dominant	.	.	Type II diabetes mellitus;Increased waist to hip ratio;Insulin resistance;Autosomal dominant inheritance;Late onset		1.97119e-05	3.0	152192.0	0.0	32	0.98	PASS	sas	0.000206782	1.0	2.94031e-05	2.0	2.39741e-05	6.0	250270.0	0.0	100	0.94	PASS	afr	6.20194e-05	1.0	3.53932e-05	4.0	0.0000322	5			9e-05	1.0		18.37	1.82181	0.183	2	17	19	LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	MAPK8IP1	0.0	0.0	0.0	0.0	2.0	11.0	-22.0	14.0						0.0389	1.0	0.000000000	0.997	1.176	mortality/aging ; liver/biliary system phenotype; behavior/neurological phenotype ; nervous system phenotype ; endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			caudate nucleus;ciliary ganglion;amygdala;testis - seminiferous tubule;prefrontal cortex;trigeminal ganglion;testis;cerebellum;occipital lobe;whole brain;spinal cord;skeletal muscle;globus pallidus;thalamus;olfactory bulb;temporal lobe;superior cervical ganglion;cingulate cortex;cerebellum peduncles;pons;testis - interstitial;subthalamic nucleus;dorsal root ganglion;atrioventricular node;parietal lobe;medulla oblongata;	MAPK signaling pathway	regulation of transcription, DNA-templated;JUN phosphorylation;vesicle-mediated transport;negative regulation of JUN kinase activity;regulation of JNK cascade;positive regulation of JNK cascade;regulation of CD8-positive, alpha-beta T cell proliferation;negative regulation of intrinsic apoptotic signaling pathway	nucleus;cytoplasm;endoplasmic reticulum membrane;cytosol;plasma membrane;mitochondrial membrane;dendritic growth cone;axonal growth cone;cell body;dentate gyrus mossy fiber;synapse;perinuclear region of cytoplasm	protein kinase inhibitor activity;MAP-kinase scaffold activity;protein binding;JUN kinase binding;kinesin binding;mitogen-activated protein kinase kinase binding;mitogen-activated protein kinase kinase kinase binding	APP[11724784];MAPK8[18286207;16840345];RECQL5[16169070];ITGB3[12606711];ERBB2[16273093];CANX[18286207];TAB1[18286207];VRK2[18286207];MAP2K7[18286207;16840345];MAP3K7[18286207;17709393;16840345];EGFR[16273093];MAPK8IP1[18286207];	45924519
16557	chr11	45944554	C	G	chr11:45944554	LARGE2	LARGE xylosyl- and glucuronyltransferase 2	SNV	0/1	0.64	24_42	66	99.0	0/0	0.0	39_0	39	99.0			rs199993922,COSV100334419	EXONIC	YES	NM_001300721.2	Transcript	protein_coding	missense_variant		2/14	NM_001300721.2:c.121C>G	NP_001287650.1:p.Arg41Gly		1.0	.,.,.					.	.	.		0.00464601	704.0	151528.0	6.0	34	0.97	PASS	amr	0.00892623	136.0	0.00649082	440.0	0.00661836	137.0	20700.0	4.0	2	0.0	PASS	nfe	0.00948367	72.0	0.00948367	72.0	0.0021800	339	0.012	40.0	0.01565	170.0		0.031	-0.64027	0.019	0	18	18		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	GYLTL1B	0.0	0.0	0.22	0.0	-26.0	4.0	-39.0	-2.0									0.0	-2.626	normal phenotype; 			.	.	protein O-linked glycosylation;protein O-linked mannosylation;muscle cell cellular homeostasis	Golgi membrane;Golgi apparatus;integral component of membrane	protein binding;glucuronosyltransferase activity;transferase activity, transferring glycosyl groups;manganese ion binding;UDP-xylosyltransferase activity;xylosyltransferase activity	B4GAT1[19587235];	45944554
16735	chr11	48285770	C	T	chr11:48285770	OR4X1	olfactory receptor family 4 subfamily X member 1 (gene/pseudogene)	SNV	0/1	0.64	35_64	100	99.0	0/1	0.48	49_46	95	99.0			rs79872488,COSV60722391,COSV60723458	EXONIC	YES	NM_001004726.1	Transcript	protein_coding	missense_variant		1/1	NM_001004726.1:c.358C>T	NP_001004726.1:p.Arg120Cys		1.0	GPCR, rhodopsin-like, 7TM					.	.	.		0.00570625	868.0	152114.0	3.0	32	0.95	PASS	amr	0.0093005	142.0	0.00733478	499.0	0.00608128	1526.0	250934.0	8.0	82	1.0	PASS	amr	0.00835792	289.0	0.00763433	865.0	0.0059420	924	0.021	67.0				20.5	2.08792	0.384	8	11	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	OR4X1	0.0	0.0	0.0	0.0	-37.0	21.0	-16.0	15.0						0.638	0.0	0.000000000	0.019	-1.385	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48285770
16737	chr11	48346604	T	G	chr11:48346604	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0|1	0.13	118_17	135	99.0	0/1	0.1	94_11	106	99.0			rs75647397,COSV60583203	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.31T>G	NP_001004702.2:p.Phe11Val		1.0	.,.					.	.	.		1.31425e-05	2.0	152178.0	0.0	32	0.97	PASS	amr	0.000130924	2.0	0.0	0.0	0.420385	26322.0	62614.0	0.0	96	1.0	InbreedingCoeff_RF	afr	0.443382	1762.0	0.403676	10410.0	0.0083728	1302	0.101	292.0				15.34	1.327974	0.132	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.0	0.0	0.0	0.01	38.0	21.0	-1.0	29.0						0.694	0.01	46.121634545	0.983	0.099	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48346604
16739	chr11	48346615	G	A	chr11:48346615	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0|1	0.12	116_16	132	99.0	0/1	0.1	94_11	106	99.0			rs73463988,COSV60585298	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001004702.2:c.42G>A	NP_001004702.2:p.Gly14%3D		1.0						.	.	.						32	0.97							0.447062	33907.0	75844.0	0.0	94	1.0	InbreedingCoeff_RF	sas	0.463775	4865.0	0.431236	12994.0	0.0194850	3030	0.095	272.0				10.83	0.660795		0	0	0			OR4C3	0.0	0.0	0.01	0.0	2.0	10.0	18.0	-36.0						0.694	0.01	66.594394388			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48346615
16741	chr11	48346661	TGCTGATCT		chr11:48346661-48346669	OR4C3	olfactory receptor family 4 subfamily C member 3	deletion	0|1	0.17	144_29	173	99.0	0/1	0.15	110_20	132	99.0			rs138704181	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	inframe_deletion		1/1	NM_001004702.2:c.89_97del	NP_001004702.2:p.Leu30_Ile32del		1.0						.	.	.						32	0.97							0.446916	42129.0	94266.0	0.0	72	1.0	InbreedingCoeff_RF	sas	0.485133	6983.0	0.419153	15652.0	0.0044629,0.0260958,0.0000064	694,4058,1	0.032	101.0				15.73	1.402376		0	0	0																	0.694	0.01	83.430448619			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48346660
16743	chr11	48346681	G	A	chr11:48346681	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0|1	0.18	137_31	168	99.0	0/1	0.22	102_29	133	99.0			rs78490540,COSV60583076	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001004702.2:c.108G>A	NP_001004702.2:p.Thr36%3D		1.0						.	.	.		3.28701e-05	5.0	152114.0	0.0	32	0.96	PASS	sas	0.000207211	1.0	2.94023e-05	2.0	0.490813	70573.0	143788.0	0.0	86	1.0	InbreedingCoeff_RF	sas	0.497459	10768.0	0.48628	28958.0	0.0297227	4622	0.086	242.0				3.795	0.072134		0	0	0			OR4C3	0.0	0.0	0.0	0.01	42.0	30.0	-27.0	-48.0						0.694	0.01	2.368861211			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48346681
16745	chr11	48346729	G	C	chr11:48346729	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0/1	0.28	108_41	149	99.0	0/1	0.31	87_41	131	99.0			rs73463990,COSV60586573	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001004702.2:c.156G>C	NP_001004702.2:p.Thr52%3D		1.0						.	.	.						32	0.96							0.499988	125134.0	250274.0	1.0	100	1.0	InbreedingCoeff	sas	0.500033	15272.0	0.499982	56547.0	0.0364299	5665	0.193	606.0				0.112	-0.467306		0	0	0			OR4C3	0.0	0.0	0.0	0.0	-24.0	-6.0	-24.0	33.0						0.694	0.01	2.368861211			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48346729
16746	chr11	48346791	C	T	chr11:48346791	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0/1	0.39	91_57	148	99.0	0/1	0.38	93_58	152	99.0			rs73463994,COSV60583214	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.218C>T	NP_001004702.2:p.Ser73Phe		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.96							0.499992	125671.0	251346.0	1.0	100	1.0	InbreedingCoeff	amr	0.500029	17293.0	0.499974	56836.0	0.0270668	4209	0.185	578.0				21.9	2.270305	0.391	4	12	16	SIFT,LRT_pred,MutationAssessor_pred,fathmm-MKL_coding_pred	PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	OR4C3	0.0	0.0	0.0	0.0	41.0	-6.0	27.0	-29.0						0.694	0.01	17.413679903	0.004	0.9	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48346791
16747	chr11	48346822	A	C	chr11:48346822	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0/1	0.4	105_71	176	99.0	0/1	0.38	105_66	172	99.0			rs73463997,COSV60587301	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001004702.2:c.249A>C	NP_001004702.2:p.Ser83%3D		1.0						.	.	.						32	0.96							0.499996	125692.0	251386.0	2.0	100	1.0	InbreedingCoeff	amr	0.500029	17292.0	0.499982	56848.0	0.0279478	4346	0.205	646.0				4.683	0.125563		0	0	0			OR4C3	0.0	0.0	0.0	0.0	10.0	2.0	29.0	2.0						0.694	0.01	7.450055530			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48346822
16748	chr11	48346843	C	T	chr11:48346843	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0/1	0.42	111_80	191	99.0	0/1	0.39	110_71	182	99.0			rs73463998,COSV60587308	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001004702.2:c.270C>T	NP_001004702.2:p.Ile90%3D		1.0						.	.	.						32	0.96							0.499992	125686.0	251376.0	2.0	100	1.0	InbreedingCoeff	amr	0.500029	17295.0	0.499982	56840.0	0.0274848	4274	0.206	650.0				7.803	0.347285		0	0	0			OR4C3	0.0	0.0	0.0	0.0	25.0	-11.0	4.0	49.0						0.694	0.01	29.903524068			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48346843
16749	chr11	48346916	G	C	chr11:48346916	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0|1	0.41	124_89	215	99.0	0|1	0.45	102_85	188	99.0			rs77069283,COSV60583093	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.343G>C	NP_001004702.2:p.Val115Leu		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.96							0.499972	125455.0	250924.0	0.0	100	1.0	InbreedingCoeff	afr	0.5	8105.0	0.499938	56700.0	0.0043600	678	0.131	391.0				20.4	2.0747	0.187	1	15	16	SIFT	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.0	0.01	0.0	0.0	36.0	1.0	-24.0	30.0						0.694	0.01	17.413679903	0.905	1.038	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48346916
16750	chr11	48346924	T	C	chr11:48346924	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0|1	0.42	125_93	220	99.0	0|1	0.46	105_90	196	99.0			rs72911454,COSV60587323	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001004702.2:c.351T>C	NP_001004702.2:p.Ala117%3D		1.0						.	.	.						32	0.96							0.499976	125336.0	250684.0	0.0	100	1.0	InbreedingCoeff	eas	0.5	9175.0	0.499965	56642.0	0.0068101	1059	0.126	387.0				11.79	0.778889		0	0	0			OR4C3	0.01	0.0	0.0	0.0	-7.0	28.0	22.0	-32.0						0.694	0.01	29.903524068			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48346924
16751	chr11	48346932	G	A	chr11:48346932	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0|1	0.4	131_89	222	99.0	0|1	0.45	106_86	193	99.0			rs80285195,COSV60583226	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.359G>A	NP_001004702.2:p.Arg120His		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.		0.00147318	224.0	152052.0	0.0	32	0.96	PASS	sas	0.00581154	28.0	0.000102914	7.0	0.49998	124940.0	249890.0	6.0	100	1.0	InbreedingCoeff	sas	0.500131	15265.0	0.499947	56480.0	0.0035562	553	0.122	386.0				23.2	2.843786	0.446	5	11	16	MetaLR_pred,MutationAssessor_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,LRT_pred,MetaSVM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	OR4C3	0.0	0.0	0.0	0.01	29.0	-15.0	-40.0	14.0						0.694	0.01	7.450055530	0.989	1.038	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48346932
16752	chr11	48346961	A	T	chr11:48346961	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0|1	0.38	127_79	208	99.0	0|1	0.42	98_72	171	99.0			rs75493089,COSV60583115	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.388A>T	NP_001004702.2:p.Asn130Tyr		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.96							0.499826	120618.0	241320.0	1.0	100	1.0	InbreedingCoeff	eas	0.5	8590.0	0.499909	54757.0	0.0158195	2460	0.114	362.0				12.97	0.934852	0.217	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.0	0.0	0.0	0.0	43.0	-44.0	-2.0	19.0						0.694	0.01	29.903524068	0.795	0.116	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48346961
16753	chr11	48346962	A	G	chr11:48346962	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0|1	0.38	127_79	208	99.0	0|1	0.42	98_72	171	99.0			rs74589050,COSV60583123	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.389A>G	NP_001004702.2:p.Asn130Ser		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.96							0.499951	122924.0	245872.0	1.0	100	1.0	InbreedingCoeff	eas	0.5	8900.0	0.499928	55601.0	0.0158710	2468	0.114	362.0				21.4	2.194415	0.392	3	13	16	SIFT,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	OR4C3	0.0	0.0	0.0	0.0	42.0	-45.0	-16.0	18.0						0.694	0.01	29.903524068	0.785	1.156	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48346962
16754	chr11	48346999	T	G	chr11:48346999	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0/1	0.36	139_79	220	99.0	0/1	0.34	123_64	188	99.0			rs72473367,COSV60587170	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001004702.2:c.426T>G	NP_001004702.2:p.Leu142%3D		1.0						.	.	.						32	0.96							0.499879	123575.0	247210.0	1.0	100	1.0	InbreedingCoeff	afr	0.5	7932.0	0.499785	55809.0	0.0328673	5111	0.113	334.0				10.63	0.637313		0	0	0			OR4C3	0.0	0.02	0.06	0.0	-47.0	5.0	0.0	-19.0						0.694	0.01	2.368861211			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48346999
16755	chr11	48347014	G	A	chr11:48347014	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0|1	0.33	151_74	226	99.0	0|1	0.35	127_68	197	99.0			rs72473368,COSV60583237	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	stop_gained		1/1	NM_001004702.2:c.441G>A	NP_001004702.2:p.Trp147Ter		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.96							0.499943	123285.0	246598.0	1.0	100	1.0	InbreedingCoeff	sas	0.5	15122.0	0.499901	55712.0	0.0212663	3307	0.16	477.0				36.0	6.627865		5	1	6	LRT_pred,MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	fathmm-XF_coding_pred	OR4C3	0.03	0.0	0.0	0.0	31.0	-17.0	24.0	-15.0						0.694	0.01	7.450055530	0.424	1.028	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48347014
16756	chr11	48347023	C	T	chr11:48347023	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0|1	0.34	153_78	232	99.0	0|1	0.34	124_65	191	99.0			rs67077733,COSV60587368	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001004702.2:c.450C>T	NP_001004702.2:p.Gly150%3D		1.0						.	.	.		6.57255e-06	1.0	152148.0	0.0	32	0.96	PASS	nfe	1.47042e-05	1.0	1.47042e-05	1.0	0.499947	123478.0	246982.0	2.0	100	1.0	InbreedingCoeff	afr	0.5	7938.0	0.499902	55843.0	0.0332210	5166	0.177	538.0				10.42	0.613231		0	0	0			OR4C3	0.01	0.01	0.0	0.0	22.0	-19.0	-43.0	38.0						0.694	0.01	35.288785949			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48347023
16757	chr11	48347067	C	T	chr11:48347067	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0/1	0.37	122_73	196	99.0	0/1	0.36	112_63	176	99.0			rs73464001,COSV60583244	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.494C>T	NP_001004702.2:p.Pro165Leu		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.		1.31458e-05	2.0	152140.0	0.0	32	0.95	PASS	amr	0.000130873	2.0	0.0	0.0	0.499943	123712.0	247452.0	1.0	100	1.0	InbreedingCoeff	eas	0.5	8994.0	0.499902	55937.0	0.0305909	4757	0.197	621.0				25.6	3.654485	0.433	9	9	18	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MetaLR_pred,MetaSVM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	OR4C3	0.0	0.0	0.0	0.0	-22.0	7.0	42.0	0.0						0.694	0.01	35.288785949	0.621	0.9	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48347067
16758	chr11	48347100	C	T	chr11:48347100	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0/1	0.36	109_63	173	99.0	0/1	0.38	117_72	190	99.0			rs73465905,COSV60583249	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.527C>T	NP_001004702.2:p.Ala176Val		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.95							0.499885	121362.0	242780.0	0.0	94	1.0	InbreedingCoeff	eas	0.5	8877.0	0.499788	54295.0	0.0267389	4158	0.165	485.0				15.66	1.389022	0.137	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.04	0.0	0.0	0.01	27.0	42.0	-17.0	42.0						0.694	0.01	84.872268861	0.949	0.101	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48347100
16759	chr11	48347124	A	G	chr11:48347124	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0|1	0.35	110_59	170	99.0	0|1	0.43	107_83	191	99.0			rs79019124,COSV60583256	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.551A>G	NP_001004702.2:p.Glu184Gly		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.95							0.499687	108703.0	217542.0	0.0	82	1.0	InbreedingCoeff	eas	0.5	8036.0	0.49942	46470.0	0.0097554	1517	0.111	350.0				23.1	2.770121	0.169	2	14	16	SIFT,MutationAssessor_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.01	0.04	0.0	0.01	19.0	3.0	-41.0	18.0						0.694	0.01	24.802902514	0.024	1.145	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48347124
16760	chr11	48347130	C	G	chr11:48347130	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0|1	0.35	111_60	172	99.0	0|1	0.44	108_85	194	99.0			rs77395846,COSV60583260	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.557C>G	NP_001004702.2:p.Ala186Gly		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.95							0.499603	103085.0	206334.0	0.0	79	1.0	InbreedingCoeff	eas	0.499934	7625.0	0.499297	43337.0	0.0082120	1277	0.045	141.0				22.5	2.495023	0.284	3	13	16	SIFT,MutationAssessor_pred,fathmm-MKL_coding_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	OR4C3	0.01	0.0	0.0	0.0	-3.0	46.0	12.0	-21.0						0.694	0.01	24.802902514	0.419	0.9	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48347130
16761	chr11	48347142	C	T	chr11:48347142	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0|1	0.35	112_60	172	99.0	0|1	0.41	112_79	192	99.0			rs79891698,COSV60583100	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.569C>T	NP_001004702.2:p.Thr190Met		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.		5.91584e-05	9.0	152134.0	0.0	32	0.95	PASS	nfe	8.81964e-05	6.0	8.81964e-05	6.0	0.499488	104382.0	208978.0	0.0	78	1.0	InbreedingCoeff	sas	0.499822	14008.0	0.499106	44090.0	0.0019742	307	0.051	160.0				22.6	2.510158	0.408	6	12	18	SIFT,PolyPhen,LRT_pred,MutationAssessor_pred,MutationTaster_pred,fathmm-MKL_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	OR4C3	0.01	0.01	0.0	0.02	34.0	-15.0	-3.0	0.0						0.694	0.01	51.637905936	0.015	0.9	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48347142
16762	chr11	48347144	T	C	chr11:48347144	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0|1	0.36	108_60	168	99.0	0|1	0.41	111_79	191	99.0			rs79124801,COSV60583106	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.571T>C	NP_001004702.2:p.Tyr191His		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.95							0.499497	105189.0	210590.0	0.0	78	1.0	InbreedingCoeff	sas	0.499893	14065.0	0.499116	44621.0	0.0019742	307	0.05	159.0				3.814	0.073273	0.059	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.0	0.01	0.0	0.03	3.0	-17.0	30.0	-2.0						0.694	0.01	51.637905936	0.0	0.107	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48347144
16763	chr11	48347267	T	C	chr11:48347267	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0/1	0.42	111_79	190	99.0	0/1	0.35	117_65	185	99.0			rs73465910,COSV60583276	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.694T>C	NP_001004702.2:p.Cys232Arg		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.96							0.499447	105631.0	211496.0	0.0	81	1.0	InbreedingCoeff	amr	0.499803	15223.0	0.499178	45559.0	0.0348544	5420	0.203	641.0				7.675	0.336588	0.414	1	17	18	PROVEAN_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.01	0.0	0.0	0.0	-22.0	-15.0	-23.0	-35.0						0.694	0.01	35.288785949	0.0	-1.943	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48347267
16764	chr11	48347306	G	T	chr11:48347306	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0/1	0.37	106_61	167	99.0	0/1	0.29	107_46	158	99.0			rs73465911,COSV60583284	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.733G>T	NP_001004702.2:p.Val245Phe		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.		1.31477e-05	2.0	152118.0	0.0	32	0.96	PASS	nfe	2.93971e-05	2.0	2.93971e-05	2.0	0.496085	86677.0	174722.0	0.0	82	0.99	InbreedingCoeff_RF	sas	0.498784	12306.0	0.493925	35285.0	0.0308417	4796	0.202	633.0				22.7	2.587147	0.337	7	11	18	SIFT,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_addAF_pred,fathmm-MKL_coding_pred	PolyPhen,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	OR4C3	0.0	0.0	0.0	0.0	-3.0	-47.0	21.0	-1.0						0.694	0.01	46.121634545	0.713	1.053	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48347306
16765	chr11	48347342	G	A	chr11:48347342	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0|1	0.4	67_45	112	99.0	0|1	0.29	66_28	95	99.0			rs76958755,COSV60583129	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.769G>A	NP_001004702.2:p.Val257Met		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.97							0.445505	40827.0	91642.0	0.0	69	0.94	InbreedingCoeff	sas	0.463871	6150.0	0.439437	16674.0	0.0040321	627	0.121	364.0				0.637	-0.217911	0.091	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.01	0.0	0.0	0.0	28.0	-4.0	-15.0	-1.0						0.694	0.01	59.223313297	0.649	0.216	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48347342
16766	chr11	48347346	A	T	chr11:48347346	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0|1	0.39	65_42	107	99.0	0|1	0.3	63_28	92	99.0			rs74590631,COSV60583294	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.773A>T	NP_001004702.2:p.His258Leu		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.97							0.397426	32550.0	81902.0	0.0	67	0.91	InbreedingCoeff_RF	sas	0.417138	4717.0	0.398622	14006.0	0.0040449	629	0.113	356.0				16.05	1.461317	0.101	1	15	16	SIFT	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.04	0.0	0.0	0.0	24.0	2.0	-19.0	-41.0						0.694	0.01	80.412657112	0.538	-0.058	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48347346
16767	chr11	48347358	C	T	chr11:48347358	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0|1	0.33	61_30	91	99.0	0|1	0.34	49_26	76	99.0			rs76274696,COSV60583302	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.785C>T	NP_001004702.2:p.Thr262Ile		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.97							0.355474	27294.0	76782.0	0.0	69	0.91	InbreedingCoeff_RF	sas	0.374948	3586.0	0.350626	11699.0	0.0036012	560	0.106	334.0				17.07	1.63624	0.234	1	15	16	SIFT	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.05	0.0	0.0	0.0	12.0	1.0	12.0	-31.0						0.694	0.01	80.412657112	0.849	0.921	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48347358
16768	chr11	48347363	C	T	chr11:48347363	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0|1	0.33	56_27	83	99.0	0|1	0.36	46_26	73	99.0			rs77814753,COSV60583311	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	missense_variant		1/1	NM_001004702.2:c.790C>T	NP_001004702.2:p.Pro264Ser		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.		6.57462e-06	1.0	152100.0	0.0	32	0.97	PASS				0.0	0.0	0.373657	29143.0	77994.0	0.0	70	0.89	InbreedingCoeff_RF	sas	0.392218	3770.0	0.365048	12251.0	0.0034211	532	0.106	335.0				0.006	-0.866978	0.086	0	16	16		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4C3	0.02	0.0	0.0	0.0	7.0	1.0	-36.0	-38.0						0.694	0.01	80.412657112	0.457	-0.737	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48347363
16769	chr11	48347392	T	C	chr11:48347392	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0/1	0.3	39_17	56	99.0	0/1	0.33	31_15	46	99.0			rs79127479,COSV60586675	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001004702.2:c.819T>C	NP_001004702.2:p.Tyr273%3D		1.0						.	.	.						32	0.97							0.363675	33085.0	90974.0	0.0	66	0.79	InbreedingCoeff_RF	sas	0.366979	3992.0	0.362575	14131.0	0.0199609	3104	0.121	378.0				1.091	-0.137879		0	0	0			OR4C3	0.03	0.01	0.0	0.0	-22.0	45.0	1.0	34.0						0.694	0.01	3.920796073			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48347392
16770	chr11	48347419	A	G	chr11:48347419	OR4C3	olfactory receptor family 4 subfamily C member 3	SNV	0/1	0.32	25_12	37	99.0	0/1	0.28	23_9	32	99.0			rs73465913,COSV60585745	EXONIC	YES	NM_001004702.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001004702.2:c.846A>G	NP_001004702.2:p.Pro282%3D		1.0						.	.	.						32	0.97							0.464548	48876.0	105212.0	0.0	47	0.68	InbreedingCoeff	nfe	0.469802	22247.0	0.469802	22247.0	0.0219094	3407	0.128	383.0				0.814	-0.181191		0	0	0			OR4C3	0.02	0.0	0.0	0.0	-49.0	18.0	27.0	-44.0						0.694	0.01	46.627587668			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	48347419
17010	chr11	57958438	G	T	chr11:57958438	OR9Q2	olfactory receptor family 9 subfamily Q member 2	SNV	0/1	0.52	63_69	132	99.0	0/1	0.52	65_71	136	99.0			COSV61112251	EXONIC	YES	NM_001005283.3	Transcript	protein_coding	missense_variant		2/2	NM_001005283.3:c.476G>T	NP_001005283.1:p.Arg159Leu		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.						32	0.97											100	1.0														21.1	2.151509	0.204	5	16	21	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,PROVEAN_pred,ClinPred_pred	SIFT,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR9Q2	0.0	0.0	0.0	0.0	12.0	-11.0	4.0	38.0						0.815	0.0	0.000000000	0.191	1.175	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;sensory perception of smell;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity;odorant binding	MYH9[30021884];	57958438
17075	chr11	60971041	A	G	chr11:60971041	PGA3	pepsinogen 3, group I (pepsinogen A)	SNV	0/0	0.0	23_0	23	63.0	0/1	0.7	19_44	63	99.0			rs78669446	EXONIC	YES	NM_001079807.4	Transcript	protein_coding	missense_variant		1/9	NM_001079807.4:c.5A>G	NP_001073275.1:p.Lys2Arg		1.0						.	.	.		0.00489478	742.0	151590.0	1.0	30	0.91	PASS	nfe	0.00761264	516.0	0.00761264	516.0	0.00452738	1136.0	250918.0	1.0	100	1.0	PASS	nfe	0.0070522	799.0	0.0070522	799.0	0.0004694	73	0.002	5.0			1.0	16.77	1.586151	0.087	1	16	17	fathmm-MKL_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	PGA3	0.0	0.0	0.02	0.0	-23.0	2.0	0.0	17.0							0.65	0.000000000	0.997	1.294	.			.	.	proteolysis;digestion;protein catabolic process;cellular protein metabolic process	extracellular exosome;multivesicular body lumen	aspartic-type endopeptidase activity;peptidase activity	.	60971041
17182	chr11	63533335	TCC		chr11:63533335-63533337	C11orf95	chromosome 11 open reading frame 95	deletion	0/1	0.15	66_12	78	99.0	0/0	0.0	34_0	34	99.0			rs750330160	EXONIC	YES	NM_001144936.2	Transcript	protein_coding	inframe_deletion		2/5	NM_001144936.2:c.579_581del	NP_001138408.1:p.Glu200del		-1.0						.	.	.		0.000458612	69.0	150454.0	0.0	32	0.97	PASS	eas	0.00173947	9.0	0.000505111	34.0	0.146344	10120.0	69152.0	0.0	8	0.12	RF	eas	0.194012	972.0	0.137117	3706.0	0.0000836,0.0002315,0.0072217	13,36,1123	0.001	3.0				10.93	0.673095		0	0	0			C11orf95	0.0	0.0	0.0	0.0	-10.0	-16.0	33.0	35.0											.			ciliary ganglion;fetal brain;prefrontal cortex;subthalamic nucleus;whole brain;trigeminal ganglion;superior cervical ganglion;atrioventricular node;	.	negative regulation of transcription, DNA-templated	.	nucleic acid binding	.	63533334
17198	chr11	63885572	C	T	chr11:63885572	FLRT1	fibronectin leucine rich transmembrane protein 1	SNV	0/0	0.0	130_0	130	99.0	0/1	0.48	66_62	129	99.0			rs147439962	EXONIC	YES	NM_013280.5	Transcript	protein_coding	synonymous_variant		3/3	NM_013280.5:c.1833C>T	NP_037412.2:p.Ile611%3D		1.0		Benign	criteria_provided,_single_submitter	Peripheral_neuropathy		Spastic paraplegia-optic atrophy-neuropathy syndrome	Disease-causing germline mutation(s) in	Distal lower limb amyotrophy;Optic atrophy;Difficulty walking;Exaggerated startle response;Dysarthria;Optic disc pallor;Hyperhidrosis;Nystagmus;Pes cavus;Hyporeflexia of lower limbs;Scoliosis;Delayed gross motor development;Peripheral axonal neuropathy;Hyperreflexia proximally;Decreased number of peripheral myelinated nerve fibers;Progressive spastic paraplegia;Multiple joint contractures;Impaired vibration sensation in the lower limbs		0.00638432	972.0	152248.0	4.0	34	0.98	PASS	nfe	0.00765614	521.0	0.00765614	521.0	0.00652596	1635.0	250538.0	9.0	65	0.96	PASS	nfe	0.00758686	859.0	0.00758686	859.0	0.0062571	973	0.006	19.0				8.473	0.406949		0	0	0			FLRT1	0.0	0.0	0.0	0.0	28.0	-48.0	-37.0	50.0						0.0504	0.55	35.288785949			normal phenotype; 			pons;trigeminal ganglion;superior cervical ganglion;parietal lobe;	.	cell adhesion;fibroblast growth factor receptor signaling pathway;dendrite development;positive regulation of synapse assembly;neuron projection extension	extracellular space;endoplasmic reticulum membrane;plasma membrane;integral component of plasma membrane;cell-cell junction;focal adhesion;cytoplasmic vesicle membrane;extracellular matrix;cytoplasmic vesicle;neuronal cell body membrane;neuron projection terminus;perinuclear region of cytoplasm	fibroblast growth factor receptor binding;protein binding, bridging	APP[26960425];FLRT2[16440004];GPR35[28298427];	63885572
17512	chr11	64974020	G	T	chr11:64974020	CAPN1	calpain 1	SNV	0/1	0.5	66_67	135	99.0	0/0	0.0	34_0	34	99.0			rs1335436521,COSV54197550	EXONIC	YES	NM_005186.4	Transcript	protein_coding	synonymous_variant		13/22	NM_005186.4:c.1440G>T	NP_005177.2:p.Leu480%3D		1.0					Spastic paraplegia 76, autosomal recessive, 616907 (3), Autosomal recessive	Autosomal recessive spastic paraplegia type 76	Disease-causing germline mutation(s) (loss of function) in	Hyperreflexia in upper limbs;Ankle clonus;Pes cavus;Skeletal muscle atrophy;Lower limb spasticity;Lower limb muscle weakness;Pes valgus;Dysarthria;Abnormality of eye movement;Limb ataxia;Gait ataxia;Babinski sign;Peripheral neuropathy;Lower limb hyperreflexia;Scoliosis;Functional abnormality of the bladder;Dysarthria;Urinary incontinence;Scoliosis;Hyperreflexia in upper limbs;Sensory axonal neuropathy;Lower limb muscle weakness;Dysmetria;Babinski sign;Spastic paraplegia;Pes valgus;Autosomal recessive inheritance;Nystagmus;Difficulty walking;Pes cavus;Lower limb hyperreflexia;Skeletal muscle atrophy;Distal sensory impairment;Gait ataxia						32	0.97							8.03155e-06	2.0	249018.0	0.0	100	1.0	PASS	amr	2.89687e-05	1.0	8.86226e-06	1.0			0.001	2.0				10.85	0.663828		0	0	0			CAPN1	0.0	0.01	0.01	0.0	5.0	-16.0	6.0	-16.0						0.5	0.0	74.536482548			cardiovascular system phenotype ; hematopoietic system phenotype; mortality/aging ; normal phenotype; embryo phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			.	Apoptosis	proteolysis;positive regulation of cell population proliferation;regulation of macroautophagy;receptor catabolic process;neutrophil degranulation;regulation of catalytic activity;mammary gland involution;cornification;self proteolysis;regulation of NMDA receptor activity	extracellular region;cytoplasm;mitochondrion;lysosome;cytosol;plasma membrane;focal adhesion;membrane;extracellular exosome;ficolin-1-rich granule lumen	endopeptidase activity;calcium-dependent cysteine-type endopeptidase activity;calcium ion binding;protein binding	ANKRD17[26496610];CAST[26496610];PDIA3[30021884];PTPN1[9407132;19712109];VCAM1[22623428];STAT3[21988832];F2R[25241761];CEP164[26638075];COG1[26496610];ARRB2[17620599];GRIN2B[25241761];TIRAP[23023391];RCAN1[15935327];POLA2[26496610];NEURL4[29426014];CAPNS1[19712109;26496610];TNIP2[unassigned1774];KATNA1[26496610];EZR[22805611];CARS2[26496610];CLEC4G[18624398];BCAR1[28007913];	64974020
17543	chr11	65325326	CAG		chr11:65325326-65325328	LTBP3	latent transforming growth factor beta binding protein 3	deletion	0/1	0.2	12_3	15	89.0	0/0	0.0	32_0	32	60.0			rs71036212	EXONIC	YES	NM_001130144.3	Transcript	protein_coding	inframe_deletion		1/28	NM_001130144.3:c.103_105del	NP_001123616.1:p.Leu35del		-1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Dental_anomalies_and_short_stature|Geleophysic_dysplasia_3|not_provided	Dental anomalies and short stature, 601216 (3), Autosomal recessive; Geleophysic dysplasia 3, 617809 (3), Autosomal dominant	Acromicric dysplasia;Geleophysic dysplasia;Brachyolmia-amelogenesis imperfecta syndrome	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Oligodontia;Intervertebral space narrowing;Hypoplasia of the maxilla;Mandibular prognathia;Microdontia;Autosomal recessive inheritance;Platyspondyly;Widely spaced teeth;Narrow vertebral interpedicular distance;Amelogenesis imperfecta;Hypertrichosis;Mitral valve prolapse;Delayed skeletal maturation;Herniation of intervertebral nuclei;Short stature;Autosomal dominant inheritance;Subglottic stenosis;Short foot;Depressed nasal bridge;Delayed skeletal maturation;Sleep apnea;Hepatomegaly;Round face;Brachydactyly;Bulbous nose;Dyspnea;Limb undergrowth;Anteverted nares;Pneumonia;Long philtrum;Short stature;Thickened skin;Wide nasal bridge;Hoarse voice;Tracheal stenosis;Polyhydramnios;Epiphyseal dysplasia;Respiratory failure;Thick vermilion border;Short metacarpal;Short nose;Severe short stature;Small hand;Abnormality of epiphysis morphology;Brachydactyly;Decreased nerve conduction velocity;Narrow mouth;Ovoid vertebral bodies;Hoarse voice;Anteverted nares;Thick lower lip vermilion;Fifth metacarpal with ulnar notch;Joint stiffness;Short palm;Round face;Abnormality of femur morphology;Long eyelashes;Long philtrum;Abnormal eyebrow morphology;Delayed skeletal maturation;Bulbous nose		0.00227434	339.0	149054.0	0.0	30	0.8	PASS	afr	0.00337276	138.0	0.00254141	170.0	0.0651832	2153.0	33030.0	1.0	1	0.05	PASS	afr	0.0829694	38.0	0.0549679	686.0	0.0000322,0.0025594	5,398			0.03376	351.0		15.05	1.274438		0	0	0			LTBP3	0.0	0.0	0.0	0.0	44.0	-49.0	-33.0	-14.0						0.0559	1.0				vision/eye phenotype; skeleton phenotype; immune system phenotype; behavior/neurological phenotype ; respiratory system phenotype; mortality/aging ; growth/size/body region phenotype; craniofacial phenotype; 			thyroid;	.	transforming growth factor beta activation;positive regulation of mesenchymal stem cell proliferation;positive regulation of mesenchymal stem cell differentiation	extracellular region;collagen-containing extracellular matrix;extracellular exosome	calcium ion binding;transforming growth factor beta binding	GORASP2[21988832];CCNG1[21988832];PELI2[21988832];CACNA1A[21078624];PRPF40A[15231748];PIK3R2[21988832];RAC1[21988832];	65325325
17560	chr11	65394881	G	A	chr11:65394881	PCNX3	pecanex 3	SNV	0/1	0.5	30_30	60	99.0	0/1	0.4	40_27	67	99.0			rs117574905,COSV63134683	EXONIC	YES	NM_032223.4	Transcript	protein_coding	missense_variant		22/35	NM_032223.4:c.3530G>A	NP_115599.2:p.Arg1177Gln		1.0						.	.	.		0.00373894	569.0	152182.0	0.0	32	0.97	PASS	nfe	0.00671683	457.0	0.00671683	457.0	0.00350557	857.0	244468.0	6.0	45	0.98	PASS	nfe	0.00635882	710.0	0.00635882	710.0	0.0036398,0.0000386	566,6	0.003	11.0				24.7	3.428812	0.253	7	14	21	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	PCNXL3	0.0	0.01	0.0	0.0	2.0	-32.0	2.0	-32.0								0.000000000	0.992	1.176	.			.	.	.	integral component of membrane	.	LIMA1[26496610];	65394881
17571	chr11	65546763	G	A	chr11:65546763	AP5B1	adaptor related protein complex 5 subunit beta 1	SNV	0/1	0.49	59_57	116	99.0	0/0	0.0	34_0	34	99.0			rs201041158,COSV57503167	EXONIC	YES	NM_138368.5	Transcript	protein_coding	missense_variant		2/2	NM_138368.5:c.1201C>T	NP_612377.4:p.Leu401Phe		-1.0		Uncertain_significance	criteria_provided,_single_submitter	Hereditary_spastic_paraplegia		.	.	.		0.0031266	476.0	152242.0	1.0	33	0.98	PASS	nfe	0.00540874	368.0	0.00540874	368.0	0.00309785	726.0	234356.0	1.0	27	0.71	PASS	nfe	0.00528879	556.0	0.00528879	556.0	0.0035497	552	0.004	13.0				25.6	3.65202	0.068	7	7	14	SIFT,PolyPhen,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred	AP5B1	0.0	0.0	0.0	0.0	-11.0	48.0	-11.0	48.0							0.0	0.000000000	0.955	1.176	.			.	.	protein transport;endosomal transport	lysosomal membrane;AP-type membrane coat adaptor complex	protein binding	CAMK2B[25416956];NIF3L1[25416956];AP5M1[22022230];AP5S1[22022230];	65546763
17574	chr11	65547075	G	A	chr11:65547075	AP5B1	adaptor related protein complex 5 subunit beta 1	SNV	0/1	0.44	70_54	124	99.0	0/0	0.0	34_0	34	99.0			rs367659364,COSV57503186	EXONIC	YES	NM_138368.5	Transcript	protein_coding	synonymous_variant		2/2	NM_138368.5:c.889C>T	NP_612377.4:p.Leu297%3D		-1.0						.	.	.		0.00461825	703.0	152222.0	1.0	33	0.98	PASS	amr	0.00784827	120.0	0.00704205	479.0	0.00428542	1005.0	234516.0	2.0	29	0.79	PASS	nfe	0.00685326	714.0	0.00685326	714.0	0.0040063	623	0.006	19.0				17.01	1.625752		0	0	0			AP5B1	0.0	0.0	0.0	0.0	-15.0	30.0	-6.0	-47.0							0.0	67.075583346			.			.	.	protein transport;endosomal transport	lysosomal membrane;AP-type membrane coat adaptor complex	protein binding	CAMK2B[25416956];NIF3L1[25416956];AP5M1[22022230];AP5S1[22022230];	65547075
17613	chr11	66392825	C	T	chr11:66392825	RBM14	RNA binding motif protein 14	SNV	0/1	0.39	56_36	92	99.0	0/1	0.59	50_73	123	99.0			rs139642034,COSV104628323	EXONIC	YES	NM_006328.4	Transcript	protein_coding	missense_variant		2/3	NM_006328.4:c.1478C>T	NP_006319.1:p.Ala493Val		1.0						.	.	.		0.00272868	415.0	152088.0	0.0	32	0.97	PASS	amr	0.00444793	68.0	0.00422195	287.0	0.00283423	682.0	240630.0	4.0	92	0.85	PASS	nfe	0.00430351	472.0	0.00430351	472.0	0.0023665	368	0.009	27.0				23.1	2.762022	0.075	9	11	20	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationTaster_pred,FATHMM_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	RBM14	0.0	0.0	0.0	0.0	27.0	-27.0	17.0	-27.0						0.00799	0.99	0.000000000	0.999	0.13	.			ciliary ganglion;thymus;white blood cells;testis - seminiferous tubule;subthalamic nucleus;prefrontal cortex;testis - interstitial;atrioventricular node;testis;cerebellum;	.	activation of innate immune response;DNA replication;DNA repair;DNA recombination;response to hormone;histone deacetylation;intracellular estrogen receptor signaling pathway;glucocorticoid receptor signaling pathway;innate immune response;positive regulation of transcription by RNA polymerase II;negative regulation of centriole replication;SMAD protein signal transduction;centriole assembly	nucleus;nucleoplasm;transcription factor complex;nucleolus;cytoplasm;mediator complex;nuclear speck;ribonucleoprotein complex	transcription coregulator activity;RNA binding;protein binding;nuclear receptor transcription coactivator activity;protein binding, bridging	SMARCB1[30108113];MCM7[23764002];HDAC11[23752268];CLTC[26496610];ATN1[unassigned1304];UBE3A[29426014];YBX1[25497084];USE1[19369418];METTL14[29507755];MAP1LC3A[20562859];HOMER3[unassigned1304];GTSE1[26496610];SKP1[27705803];GABARAPL1[20562859];ANXA1[23754495];ATRX[unassigned1312];AP3B1[unassigned1312];DICER1[21858095];PTBP3[22575643];JMJD6[24498420];GAK[26496610];CANX[29568061];MATR3[26496610];NAF1[unassigned1312];KHDRBS2[unassigned1304];FBF1[26638075];DDX20[unassigned1312];HDAC9[23752268];GABARAP[20562859];TGOLN2[29568061];POLD1[unassigned1312];LMNA[29568061];ZC3H18[29298432];HNRNPA1[26496610];JUN[25609649];VCAM1[22623428];AUTS2[25519132];SEC16A[26496610];EIF2AK1[unassigned1312];EAF1[unassigned1312];NBEAL2[29187380];RRP1B[20926688];ESR1[21182205];MEX3C[22863774];MAPK15[23602568];QKI[16713569];ESR2[21182203];RAB11A[29568061];SNW1[20467437];HNRNPK[26871637];MFAP1[unassigned1312];ABI1[26496610];RAB9A[29568061];CRLF3[26871637];CDK14[23602568];NFKBID[unassigned1304];BET1[29568061];	66392825
17685	chr11	67395679	G	A	chr11:67395679	NUDT8	nudix hydrolase 8	SNV	0/1	0.54	64_75	139	99.0	0/0	0.0	35_0	35	99.0			rs61738767	EXONIC	YES	NM_001243750.2	Transcript	protein_coding	missense_variant		4/4	NM_001243750.2:c.449C>T	NP_001230679.1:p.Thr150Met		-1.0	NUDIX hydrolase domain					.	.	.		0.00312011	475.0	152238.0	2.0	33	0.98	PASS	nfe	0.00517404	352.0	0.00517404	352.0	0.00302098	750.0	248264.0	2.0	55	0.99	PASS	nfe	0.00481603	539.0	0.00481603	539.0	0.0030482	474	0.002	7.0				18.92	1.895705	0.036	3	18	21	SIFT,PolyPhen,LIST-S2_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	NUDT8	0.06	0.0	0.0	0.0	1.0	43.0	-5.0	39.0							0.0	0.000000000	0.562	-0.176	.			ciliary ganglion;kidney;liver;	Starch and sucrose metabolism;Folate biosynthesis	.	.	hydrolase activity;metal ion binding	SPRYD4[27499296];NME4[27499296];HSPD1[29568061];	67395679
17865	chr11	71260034	T	A	chr11:71260034	KRTAP5-9	keratin associated protein 5-9	SNV	0/1	0.41	67_47	114	99.0	0/1	0.56	46_60	107	99.0			rs202087444	EXONIC	YES	NM_005553.4	Transcript	protein_coding	missense_variant		1/1	NM_005553.4:c.331T>A	NP_005544.4:p.Cys111Ser		1.0						.	.	.		0.00032236	48.0	148902.0	0.0	32	0.94	PASS	amr	0.000987622	15.0	0.000353087	24.0	0.000366006	92.0	251362.0	0.0	100	1.0	PASS	amr	0.00127256	44.0	0.000334031	38.0	0.0003473	54	0.001	3.0				20.5	2.089072	0.496	3	14	17	SIFT,MutationAssessor_pred,PROVEAN_pred	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	KRTAP5-9	0.0	0.01	0.0	0.04	2.0	-1.0	-8.0	3.0						0.812	0.0		0.002	0.493	.			.	.	epidermis development;keratinization	cytosol;keratin filament	protein binding	MAPKBP1[25416956;unassigned1304];SCARB1[25416956];CHIC2[25416956;unassigned1304];TUSC5[unassigned1304];ZBTB24[25416956];KLHL38[25416956;unassigned1304];MT1M[unassigned1304];COMT[25416956];UXT[unassigned1304];TGM1[unassigned1304];LCE1A[unassigned1304];LCE1B[25416956;unassigned1304];CYSRT1[unassigned1304];TBC1D10C[25416956];HOXA1[25416956;unassigned1304];GSC2[unassigned1304];PHLDA1[unassigned1304];RNF111[21516116;25416956];TMEM8A[unassigned1304];ENPP7[unassigned1304];ZNF440[unassigned1304];PRKAB2[25416956;unassigned1304];SPINK2[25416956];ATG9A[25416956];CTNNBIP1[unassigned1304];HPCAL1[25416956];ZFYVE21[25416956];FLT3LG[unassigned1304];LCE1E[unassigned1304];LCE1F[unassigned1304];LCE1C[unassigned1304];LCE1D[unassigned1304];LCE2B[unassigned1304];LCE2C[unassigned1304];HOXB9[25416956];LCE2A[25416956;unassigned1304];FAM161A[25416956;unassigned1304];KRTAP4-12[25416956;unassigned1304];ZNF837[unassigned1304];KRTAP4-11[25416956;unassigned1304];ZNF439[25416956;unassigned1304];ADAM12[unassigned1304];TYRO3[21516116;25416956];COL8A1[unassigned1304];FAM76B[25416956;unassigned1304];LY6H[25416956];PDE9A[unassigned1304];GNE[25416956;unassigned1304];KPRP[unassigned1304];BEX2[25416956];KRTAP10-10[unassigned1304];KRTAP10-11[25416956;unassigned1304];NTM[25416956];SDC3[25416956;26871637;25910212];C10orf62[25416956];CHRD[25416956;unassigned1304];SPATA3[unassigned1304];NLK[25416956];KLK8[unassigned1304];SDCBP[25416956;unassigned1304];FAM124B[25416956];MOBP[unassigned1304];HLCS[unassigned1304];PTPMT1[25416956;unassigned1304];ALDH3B1[unassigned1304];NPBWR2[25416956];KRTAP5-11[unassigned1304];KRTAP4-4[unassigned1304];KRTAP4-2[25416956;unassigned1304];OTX1[25416956;unassigned1304];IGFBP6[unassigned1304];LELP1[unassigned1304];SLC15A3[unassigned1304];ZNF266[25416956];ENKD1[unassigned1304];KRTAP12-1[25416956;unassigned1304];SMCP[25416956;unassigned1304];KRTAP12-3[unassigned1304];KRTAP12-2[25416956;unassigned1304];UBE2I[unassigned1304];TCEANC[25416956;unassigned1304];KRTAP4-5[unassigned1304];DCDC2[unassigned1304];WDYHV1[25416956;unassigned1304];NOTCH2NLA[25416956;unassigned1304];BMP7[25416956;unassigned1304];GGN[unassigned1304];NR4A3[unassigned1304];ALPP[25416956;unassigned1304];NMU[25416956;unassigned1304];ZNF417[25416956;unassigned1304];PIN1[unassigned1304];ZNF414[unassigned1304];ZNF655[unassigned1304];GLP1R[unassigned1304];CTSZ[21516116;25416956;unassigned1304];MEOX2[25416956;unassigned1304];PCSK5[25416956;unassigned1304];CKS1B[25416956];HHEX[unassigned1304];FAM74A4[25416956;unassigned1304];ADAMTSL5[unassigned1304];LCE5A[unassigned1304];ADAMTSL4[25416956;unassigned1304];ZNF408[unassigned1304];HEY2[unassigned1304];KRTAP5-3[unassigned1304];KRTAP5-2[unassigned1304];ZNF124[25416956;unassigned1304];KRTAP11-1[unassigned1304];KRTAP5-9[unassigned1304];KRTAP9-4[25416956];GLRX3[25416956;unassigned1304];KRTAP9-3[unassigned1304];KRTAP5-6[25416956;unassigned1304];KRTAP9-2[25416956;unassigned1304];KRTAP5-4[unassigned1304];JOSD1[25416956];KRTAP9-8[unassigned1304];SLC22A23[25416956];C11orf87[25416956];SCNM1[unassigned1304];PSMA1[25416956;unassigned1304];CRY2[unassigned1304];CRH[unassigned1304];SLC25A10[25416956;26871637];DOCK2[25416956;unassigned1304];DNASE1L3[unassigned1304];CREB5[21516116;unassigned1304];CATSPER1[25416956;unassigned1304];GRN[unassigned1304];RAMP3[25416956];NUFIP2[25416956];CRCT1[25416956;unassigned1304];SEMA3B[unassigned1304];NTN4[21516116;25416956;unassigned1304];SPG7[21516116];LCE2D[unassigned1304];NKD1[unassigned1304];HSPD1[25416956];LCE3C[25416956;unassigned1304];LCE3D[unassigned1304];P2RY6[unassigned1304];LCE3A[unassigned1304];NCLN[25416956];RASD1[unassigned1304];WNT11[unassigned1304];LCE3B[unassigned1304];CHRNG[unassigned1304];RGS20[25416956;unassigned1304];KRTAP2-3[unassigned1304];MST065[25416956];SLC13A5[unassigned1304];EMC7[unassigned1304];CNNM3[25416956;unassigned1304];ZNF587[25416956;unassigned1304];NPDC1[25416956;unassigned1304];HSD3B7[unassigned1304];LINGO1[unassigned1304];KRTAP10-5[25416956;unassigned1304];ZNF581[25416956];KRTAP10-7[25416956];YIPF3[25416956];KRTAP10-6[unassigned1304];KRTAP10-9[25416956;unassigned1304];KRTAP10-8[25416956;unassigned1304];DMRT3[25416956];RYDEN[25416956;unassigned1304];FAH[25416956];DHRS1[25416956];LCE3E[25416956;unassigned1304];POU4F2[unassigned1304];PFKL[25416956];P2RX4[25416956];ABHD17A[21516116];LCE4A[25416956;unassigned1304];TCEA2[25416956];LNX1[unassigned1304];VWC2[unassigned1304];SPRY2[25416956];SPRY1[unassigned1304];NAXD[25416956];P4HB[unassigned1304];NECTIN3[unassigned1304];NECTIN2[25416956];ZNF696[unassigned1304];	71260034
18049	chr11	77790698	G	A	chr11:77790698	NDUFC2	NADH:ubiquinone oxidoreductase subunit C2	SNV	0/1	0.52	59_65	124	99.0	0/0	0.0	50_0	50	99.0			rs774129991	EXONIC	YES	NM_004549.6	Transcript	protein_coding	synonymous_variant		1/3	NM_004549.6:c.93C>T	NP_004540.1:p.Leu31%3D		-1.0					Mitochondrial complex I deficiency, nuclear type 36, 619170 (3), Autosomal recessive	.	.	.		3.28455e-05	5.0	152228.0	0.0	31	0.94	PASS	nfe	5.87872e-05	4.0	5.87872e-05	4.0	2.70263e-05	6.0	222006.0	0.0	21	0.54	PASS	nfe	5.08782e-05	5.0	5.08782e-05	5.0	0.0000257	4						6.846	0.271812		0	0	0			NDUFC2	0.0	0.0	0.0	0.0	-47.0	44.0	-3.0	-1.0						0.493	0.63	42.656693184,42.656693184			.			ciliary ganglion;liver;cingulate cortex;skin;superior cervical ganglion;trigeminal ganglion;cerebellum;pons;subthalamic nucleus;dorsal root ganglion;whole brain;atrioventricular node;adrenal gland;skeletal muscle;globus pallidus;	Oxidative phosphorylation	mitochondrial electron transport, NADH to ubiquinone;mitochondrial respiratory chain complex I assembly;neutrophil degranulation	cytoplasm;mitochondrion;mitochondrial inner membrane;mitochondrial respiratory chain complex I;plasma membrane;integral component of membrane;azurophil granule membrane	NADH dehydrogenase (ubiquinone) activity	COA3[23260140];NDUFA13[24344204];NDUFAF8[27499296];NDUFA6[12611891];OPA3[27499296];NDUFAF4[27499296];NDUFA2[19688755];HSCB[28380382];NIT1[27499296];COQ10A[27499296];DHRS4[27499296];	77790698
18052	chr11	77790698	G	A	chr11:77790698	NDUFC2-KCTD14	NDUFC2-KCTD14 readthrough	SNV	0/1	0.52	59_65	124	99.0	0/0	0.0	50_0	50	99.0			rs774129991	EXONIC	YES	NM_001203260.2	Transcript	protein_coding	synonymous_variant		1/4	NM_001203260.2:c.93C>T	NP_001190189.1:p.Leu31%3D		-1.0						.	.	.		3.28455e-05	5.0	152228.0	0.0	31	0.94	PASS	nfe	5.87872e-05	4.0	5.87872e-05	4.0	2.70263e-05	6.0	222006.0	0.0	21	0.54	PASS	nfe	5.08782e-05	5.0	5.08782e-05	5.0	0.0000257	4						6.846	0.271812		0	0	0			NDUFC2-KCTD14	0.0	0.0	0.0	0.0	-47.0	44.0	-3.0	-1.0							0.63	42.656693184,42.656693184			.			.	.	mitochondrial electron transport, NADH to ubiquinone	mitochondrion;mitochondrial inner membrane;mitochondrial respiratory chain complex I;integral component of membrane;respirasome	NADH dehydrogenase (ubiquinone) activity	.	77790698
18258	chr11	86519603	C	T	chr11:86519603	PRSS23	serine protease 23	SNV	0/1	0.49	77_73	150	99.0	0/0	0.0	33_0	33	99.0			rs138223208	EXONIC	YES	NM_001293180.2	Transcript	protein_coding	synonymous_variant		2/2	NM_001293180.2:c.918C>T	NP_001280109.1:p.Tyr306%3D		1.0						.	.	.		0.000348263	53.0	152184.0	0.0	32	0.98	PASS	nfe	0.000632074	43.0	0.000632074	43.0	0.00032227	81.0	251342.0	0.0	96	1.0	PASS	nfe	0.000545621	62.0	0.000545621	62.0	0.0003794	59	0.001	3.0				10.17	0.583365		0	0	0			PRSS23	0.0	0.0	0.0	0.0	-46.0	4.0	-4.0	45.0						0.211	0.0	55.593586126			.			.	.	proteolysis;post-translational protein modification;cellular protein metabolic process	nucleus;endoplasmic reticulum lumen;extracellular exosome	serine-type endopeptidase activity	RPL4[16169070];PHF23[16169070];SHMT1[16169070];CTR9[26496610];NOC4L[16169070];NOP9[26496610];ACTG1[16169070];FXR1[16169070];RECQL4[16169070];TMEM222[16169070];ODF2L[16169070];NIPBL[16169070];RACGAP1[16169070];GRK6[16169070];CHP1[16169070];B2M[16169070];SEC11C[unassigned1304];GATD1[16169070];PDPK1[16169070];HSPA4[16169070];TRAPPC4[16169070];TCF12[16169070];TENT5A[26496610];MAPK8IP2[16169070];EFNA3[16169070];H1F0[30021884];SRPRA[26496610];BAX[26496610];NCAPD3[16169070];PPIA[16169070];SLC25A6[16169070];	86519603
18266	chr11	88068257		A	chr11:88068256-88068257	CTSC	cathepsin C	insertion	0/1	0.18	11_3	17	29.0	0/1	0.21	18_6	28	99.0			rs11326739	SPLICING	YES	NM_001814.6	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/6		NM_001814.6:c.173-7dup			-1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Periodontitis,_aggressive,_1|Papillon-Lefèvre_syndrome|Haim-Munk_syndrome|not_specified|not_provided	Periodontitis 1, juvenile, 170650 (3), Autosomal recessive; Haim-Munk syndrome, 245010 (3), Autosomal recessive; Papillon-Lefevre syndrome, 245000 (3), Autosomal recessive	Haim-Munk syndrome;Papillon-Lef�vre syndrome	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in	Abnormality of the skin;Severe periodontitis;Premature loss of teeth;Heterogeneous;Autosomal recessive inheritance;Gingival recession;Severe periodontitis;Osteolytic defects of the phalanges of the hand;Autosomal recessive inheritance;Arachnodactyly;Tapering pointed ends of distal finger phalanges;Onychogryposis;Recurrent bacterial skin infections;Congenital palmoplantar keratosis;Pes planus;Severe periodontitis;Choroid plexus calcification;Autosomal recessive inheritance;Palmoplantar hyperkeratosis;Atrophy of alveolar ridges;Premature loss of teeth;Sparse body hair;Cerebral calcification;Recurrent cutaneous abscess formation;Osteolysis;Abnormal fingernail morphology;Palmoplantar hyperkeratosis;Hypertrichosis;Hypopigmented skin patches;Squamous cell carcinoma;Recurrent respiratory infections;Nail dystrophy;Liver abscess;Melanoma;Premature loss of primary teeth;Palmoplantar keratoderma;Atrophy of alveolar ridges;Severe periodontitis;Generalized hirsutism;Gingivitis;Arachnodactyly;Chronic furunculosis;Pustule;Reduced number of teeth;Cigarette-paper scars	24033266	0.00187082	202.0	107974.0	2.0	28	0.74	PASS	afr	0.00359688	106.0	0.00103646	51.0	0.135542	17997.0	132778.0	0.0	38	0.85	InbreedingCoeff	eas	0.170297	1767.0	0.128813	7651.0	0.0002830,0.0002572,0.0000450,0.0000064	44,40,7,1			0.00795	88.0		10.5	0.622363		0	0	0			CTSC	0.0	0.0	0.0	0.0	-15.0	-6.0	-28.0	-22.0						0.165	0.0				cellular phenotype; homeostasis/metabolism phenotype; integument phenotype ; growth/size/body region phenotype; behavior/neurological phenotype ; immune system phenotype; nervous system phenotype ; normal phenotype; hematopoietic system phenotype; 			lung;kidney;trachea;white blood cells;lymph node;whole blood;placenta;	.	T cell mediated cytotoxicity;proteolysis;endoplasmic reticulum to Golgi vesicle-mediated transport;apoptotic process;immune response;aging;response to organic substance;neutrophil degranulation;COPII vesicle coating;proteolysis involved in cellular protein catabolic process;positive regulation of proteolysis involved in cellular protein catabolic process;positive regulation of apoptotic signaling pathway	Golgi membrane;extracellular region;extracellular space;nucleoplasm;lysosome;endoplasmic reticulum lumen;centrosome;membrane;COPII-coated ER to Golgi transport vesicle;endoplasmic reticulum-Golgi intermediate compartment membrane;azurophil granule lumen;intracellular membrane-bounded organelle;collagen-containing extracellular matrix;extracellular exosome	cysteine-type endopeptidase activity;serine-type endopeptidase activity;protein binding;cysteine-type peptidase activity;peptidase activator activity involved in apoptotic process;phosphatase binding;chloride ion binding;identical protein binding;protein self-association;chaperone binding	SGO1[26496610];MAPK8[26496610];RBM8A[26496610];G3BP1[26496610];FGFR1OP[26496610];CST7[18256700];SAE1[26496610];CTSC[17353931];TBC1D16[26496610];	88068256
18274	chr11	89531802	AA		chr11:89531802-89531803	TRIM49	tripartite motif containing 49	deletion	0/1	0.33	4_2	6	54.0	0/0	0.0	6_0	7	18.0			rs369308066	SPLICING	YES	NM_020358.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	7/7		NM_020358.2:c.860-6_860-5del			-1.0						.	.	.		0.000897722	58.0	64608.0	3.0	18	0.47	PASS	afr	0.0024707	35.0	0.000437394	15.0	0.0740949	7654.0	103300.0	0.0	20	0.5	InbreedingCoeff	sas	0.0888062	1098.0	0.0719633	3480.0	0.0001286,0.0373624	20,5810						1.238	-0.11914		0	0	0			TRIM49	0.0	0.0	0.0	0.0	-4.0	-28.0	-49.0	-21.0							0.65				.			.	.	.	.	protein binding;zinc ion binding;protein kinase binding	MINDY3[unassigned1304];POM121[unassigned1304];HSP90AB1[22939624];CKS1B[unassigned1304];	89531801
18304	chr11	93886666	T	C	chr11:93886666	PANX1	pannexin 1	SNV	0/1	0.37	46_27	73	99.0	0/0	0.0	39_0	39	99.0			rs369757341	EXONIC	YES	NM_015368.4	Transcript	protein_coding	missense_variant		2/5	NM_015368.4:c.191T>C	NP_056183.2:p.Ile64Thr		1.0	.,.				Oocyte maturation defect 7, 618550 (3), Autosomal dominant	.	.	Female infertility;Increased oocyte death;Autosomal dominant inheritance		5.25493e-05	8.0	152238.0	0.0	32	0.97	PASS	nfe	7.34862e-05	5.0	7.34862e-05	5.0	1.98864e-05	5.0	251428.0	0.0	52	1.0	PASS	nfe	3.51735e-05	4.0	3.51735e-05	4.0	0.0000193	3						25.5	3.650858	0.846	15	6	21	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,DEOGEN2_pred	PANX1	0.11	0.01	0.0	0.0	-9.0	38.0	17.0	-9.0						0.57	0.0	0.000000000	0.998	1.049	homeostasis/metabolism phenotype; cellular phenotype; nervous system phenotype ; vision/eye phenotype; immune system phenotype; behavior/neurological phenotype ; respiratory system phenotype; hematopoietic system phenotype; 			dorsal root ganglion;atrioventricular node;	.	response to ischemia;cation transport;calcium ion transport;cell-cell signaling;response to ATP;protein hexamerization;positive regulation of interleukin-1 alpha secretion;positive regulation of interleukin-1 beta secretion;calcium ion transmembrane transport	endoplasmic reticulum;endoplasmic reticulum membrane;plasma membrane;gap junction;membrane;integral component of membrane;bleb;protein-containing complex	protease binding;signaling receptor binding;calcium channel activity;wide pore channel activity;leak channel activity;ion channel binding;protein heterodimerization activity;actin filament binding;gap junction hemi-channel activity;scaffold protein binding	FAXDC2[unassigned1304];BUD31[28298427];APOA2[unassigned1304];AQP2[unassigned1304];TNF[unassigned1304];WFDC2[unassigned1304];CASP7[20944749];TMEM17[26638075];BAG3[26496610];CDC37[26496610];CASP3[20944749];SLC38A7[unassigned1304];FBXO7[26496610];VAMP5[unassigned1304];BCL2L2[unassigned1304];APOL2[unassigned1304];FDFT1[unassigned1304];	93886666
18322	chr11	94533444	G	A	chr11:94533444	AMOTL1	angiomotin like 1	SNV	0/0	0.0	36_0	36	99.0	0/1	0.53	45_51	97	99.0			rs138059525,CM174013,COSV54418231	EXONIC	YES	NM_130847.3	Transcript	protein_coding	missense_variant		3/13	NM_130847.3:c.1088G>A	NP_570899.1:p.Arg363Gln		1.0	.,.					.	.	.	30595370	0.00629435	958.0	152200.0	5.0	32	0.97	PASS	nfe	0.00893723	608.0	0.00893723	608.0	0.00668085	1645.0	246226.0	7.0	49	0.9	PASS	nfe	0.00824929	921.0	0.00824929	921.0	0.0059420	924	0.009	27.0				25.1	3.520073	0.343	8	12	20	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	AMOTL1	0.0	0.0	0.03	0.02	2.0	0.0	25.0	0.0						0.671	0.31	0.000000000	0.998	1.101	.			.	Tight junction	angiogenesis;establishment of cell polarity involved in ameboidal cell migration;Wnt signaling pathway;actin cytoskeleton organization;regulation of cell migration;hippo signaling;positive regulation of blood vessel endothelial cell migration	cytosol;bicellular tight junction;COP9 signalosome;apical plasma membrane;lamellipodium;cytoplasmic vesicle	protein binding;identical protein binding	YAP1[24366813;24255178;25751139];WWTR1[20972459];UHRF1BP1L[unassigned1312];CDADC1[unassigned1312];MAGI2[17353931];DDHD1[unassigned1312];MPP5[24366813];TANK[unassigned1774];IFFO1[unassigned1312];AMOT[19615732;24366813;24255178];LATS1[24255178];HMBOX1[unassigned1312];COPS5[18850735];SCML1[unassigned1312];TNIP2[unassigned1774];COBLL1[unassigned1312];CAPZA2[26496610];TLK2[unassigned1312];NF2[21481793;24366813];IKBKG[unassigned1774];	94533444
18342	chr11	96117149	G	A	chr11:96117149	CCDC82	coiled-coil domain containing 82	SNV	0/1	0.63	23_40	63	99.0	0/0	0.0	33_0	33	99.0			rs148541924	EXONIC	YES	NM_001318736.2	Transcript	protein_coding	missense_variant		5/11	NM_001318736.2:c.763C>T	NP_001305665.1:p.Arg255Cys		-1.0	.,.,.,.,.,.,.,.,.,.,.,.,.					.	.	.		0.000342096	52.0	152004.0	0.0	32	0.97	PASS	nfe	0.000647802	44.0	0.000647802	44.0	0.000343448	86.0	250402.0	0.0	48	0.96	PASS	nfe	0.000617992	70.0	0.000617992	70.0	0.0002958	46	0.0	1.0				15.52	1.363468	0.15	1	18	19	PROVEAN_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CCDC82	0.0	0.0	0.0	0.02	-23.0	-9.0	-6.0	-23.0						0.916	0.0	0.000000000	0.948	1.155	.			superior cervical ganglion;parietal lobe;globus pallidus;medulla oblongata;	.	.	.	.	MED12[26496610];TINF2[26496610];COPS7A[26496610];VHL[17353931];NETO2[26496610];SGF29[26496610];MARK2[26496610];	96117149
18393	chr11	102587155	AAAA		chr11:102587155-102587158	MMP8	matrix metallopeptidase 8	deletion	0/1	0.4	2_2	5	97.0	0/0	0.0	0_0	5	14.0			rs751481811	SPLICING	YES	NM_002424.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	5/9		NM_002424.3:c.785-8_785-5del			-1.0						.	.	.		0.000444891	39.0	87662.0	0.0	22	0.63	PASS	amr	0.0011811	9.0	0.000400878	19.0					25	0.6							0.0000064,0.0285137	1,4434			0.00243	26.0		1.674	-0.073325		0	0	0			MMP8	0.01	0.0	0.0	0.0	27.0	-14.0	-3.0	-4.0						0.938	0.0				homeostasis/metabolism phenotype; neoplasm; immune system phenotype; 			dorsal root ganglion;superior cervical ganglion;bone marrow;	.	proteolysis;positive regulation of gene expression;negative regulation of gene expression;extracellular matrix disassembly;extracellular matrix organization;collagen catabolic process;negative regulation of interleukin-10 production;positive regulation of interleukin-6 production;endodermal cell differentiation;neutrophil degranulation;positive regulation of DNA binding;positive regulation of MAPK cascade;positive regulation of nitric oxide biosynthetic process;positive regulation of JNK cascade;regulation of neuroinflammatory response;positive regulation of neuroinflammatory response;positive regulation of NIK/NF-kappaB signaling;positive regulation of reactive oxygen species biosynthetic process;regulation of microglial cell activation;positive regulation of microglial cell activation;positive regulation of tumor necrosis factor secretion	extracellular region;extracellular space;specific granule lumen;collagen-containing extracellular matrix;tertiary granule lumen	endopeptidase activity;metalloendopeptidase activity;serine-type endopeptidase activity;zinc ion binding	.	102587154
18399	chr11	102743847	A		chr11:102743847	MMP12	matrix metallopeptidase 12	deletion	0/1	0.19	13_3	16	42.0	0/0	0.0	17_0	17	48.0			rs552593852	SPLICING	YES	NM_002426.6	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/10		NM_002426.6:c.103-5del			-1.0						.	.	.		7.34773e-05	11.0	149706.0	0.0	32	0.95	PASS	afr	0.00017183	7.0	4.45117e-05	3.0	0.000294837	54.0	183152.0	0.0	28	0.74	RF	nfe	0.000415559	35.0	0.000415559	35.0								1.962	-0.048239		0	0	0			MMP12	0.0	0.01	0.0	0.0	-50.0	-6.0	-33.0	-37.0											integument phenotype ; immune system phenotype; homeostasis/metabolism phenotype; respiratory system phenotype; reproductive system phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; nervous system phenotype ; 			appendix;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	.	negative regulation of transcription by RNA polymerase II;proteolysis;protein import into nucleus;extracellular matrix disassembly;extracellular matrix organization;collagen catabolic process;wound healing, spreading of epidermal cells;positive regulation of transcription by RNA polymerase II;regulation of defense response to virus by host;positive regulation of epithelial cell proliferation involved in wound healing;elastin catabolic process;negative regulation of type I interferon-mediated signaling pathway;positive regulation of type I interferon-mediated signaling pathway;cellular response to virus;positive regulation of interferon-alpha secretion;negative regulation of endothelial cell-matrix adhesion via fibronectin	extracellular region;extracellular space;nucleus;cytoplasm;extracellular matrix	core promoter binding;endopeptidase activity;metalloendopeptidase activity;serine-type endopeptidase activity;calcium ion binding;collagen binding;zinc ion binding;sequence-specific DNA binding	ELN[20345904];HNRNPC[30021884];	102743846
18401	chr11	102826025	A	G	chr11:102826025	MMP13	matrix metallopeptidase 13	SNV	0/0	0.0	39_0	39	99.0	0/1	0.42	41_30	71	99.0			rs553953391	EXONIC	YES	NM_002427.4	Transcript	protein_coding	synonymous_variant		2/10	NM_002427.4:c.318T>C	NP_002418.1:p.Val106%3D		-1.0					?Spondyloepimetaphyseal dysplasia, Missouri type, 602111 (3), Autosomal dominant; Metaphyseal anadysplasia 1, 602111 (3), Autosomal dominant; Metaphyseal dysplasia, Spahr type, 250400 (3), Autosomal recessive	Metaphyseal anadysplasia;Metaphyseal anadysplasia;Metaphyseal chondrodysplasia, Spahr type;Spondyloepimetaphyseal dysplasia, Missouri type	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Abnormality of ulnar metaphysis;Short stature;Bowing of the long bones;Aplasia/Hypoplasia of the radius;Abnormality of the lower limb;Abnormality of epiphysis morphology;Joint stiffness;Abnormality of ulnar metaphysis;Short stature;Bowing of the long bones;Aplasia/Hypoplasia of the radius;Abnormality of the lower limb;Abnormality of epiphysis morphology;Joint stiffness;Tibial bowing;Radial bowing;Pear-shaped vertebrae;Osteoarthritis;Platyspondyly;Waddling gait;Rhizomelia;Delayed skeletal maturation;Flared metaphysis;Flared, irregular rib ends;Ulnar bowing;Irregular sclerotic endplates;Limited elbow extension;Spondyloepimetaphyseal dysplasia;Coxa vara;Femoral bowing;Flattened epiphysis;Autosomal dominant inheritance;Metaphyseal cupping;Genu varum;Flared iliac wings;Small epiphyses;Scoliosis;Genu varum;Abnormality of epiphysis morphology;Progressive leg bowing;Reduced bone mineral density;Delayed skeletal maturation;Hip dysplasia;Short lower limbs;Gait disturbance;Metaphyseal chondrodysplasia;Disproportionate short stature;Carious teeth;Hyperlordosis;Metaphyseal sclerosis;Autosomal recessive inheritance;Metaphyseal chondrodysplasia;Short lower limbs;Metaphyseal widening;Disproportionate short stature;Progressive leg bowing;Motor delay;Genu valgum;Abnormality of the head;Waddling gait;Spondyloepimetaphyseal dysplasia;Tibial bowing;Femoral bowing;Coxa vara;Abnormality of the metaphysis;Osteoarthritis;Short stature;Short lower limbs;Genu varum;Pear-shaped vertebrae;Limitation of joint mobility;Abnormality of epiphysis morphology		4.59976e-05	7.0	152182.0	0.0	32	0.97	PASS	amr	0.000196284	3.0	0.0	0.0	2.38665e-05	6.0	251398.0	0.0	100	1.0	PASS	amr	0.000115727	4.0	8.79384e-06	1.0	0.0000129	2						11.06	0.689069		0	0	0			MMP13	0.0	0.0	0.02	0.08	-18.0	14.0	-44.0	14.0						0.858	0.0	41.689754618			homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; skeleton phenotype; limbs/digits/tail phenotype; cardiovascular system phenotype ; 			ciliary ganglion;testis - seminiferous tubule;testis - interstitial;atrioventricular node;trigeminal ganglion;superior cervical ganglion;globus pallidus;	.	endochondral ossification;growth plate cartilage development;proteolysis;extracellular matrix disassembly;extracellular matrix organization;bone mineralization;collagen catabolic process;cellular protein metabolic process;bone morphogenesis	extracellular region;extracellular space;extracellular matrix	metalloendopeptidase activity;serine-type endopeptidase activity;calcium ion binding;collagen binding;zinc ion binding	.	102826025
18411	chr11	103022933	A	G	chr11:103022933	DYNC2H1	dynein cytoplasmic 2 heavy chain 1	SNV	0/0	0.0	21_0	21	63.0	0|1	0.33	20_10	30	99.0			rs201310509	EXONIC	YES	NM_001080463.2	Transcript	protein_coding	synonymous_variant		21/90	NM_001080463.2:c.3015A>G	NP_001073932.1:p.Leu1005%3D		1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Jeune_thoracic_dystrophy|not_specified|not_provided	Short-rib thoracic dysplasia 3 with or without polydactyly, 613091 (3), Autosomal recessive, Digenic recessive	Jeune syndrome;Short rib-polydactyly syndrome, Verma-Naumoff type;Short rib-polydactyly syndrome, Majewski type;Short rib-polydactyly syndrome, Saldino-Noonan type	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Lateral clavicle hook;Bifid tongue;Postaxial polydactyly;Horizontal ribs;Cleft palate;Intestinal malrotation;Preaxial polydactyly;Ambiguous genitalia;Autosomal recessive inheritance;Short ribs;Brachydactyly;Absent tibia;Cerebellar cyst;Polycystic kidney dysplasia;Thoracic hypoplasia;Cone-shaped epiphysis;Renal dysplasia;Micropenis;Hypoplasia of the ulna;Femoral bowing;Lateral clavicle hook;Scoliosis;Digenic inheritance;Agenesis of corpus callosum;Talipes equinovarus;Metaphyseal widening;Short stature;Cleft upper lip;Acetabular spurs;Enlarged kidney;Anal atresia;Hamartoma of tongue;Metaphyseal spurs;Fibular hypoplasia;Aplasia/Hypoplasia of the lungs;Postaxial foot polydactyly;Abnormality of the clavicle;Abnormality of retinal pigmentation;Short foot;Cone-shaped epiphysis;Short stature;Feeding difficulties in infancy;Toe syndactyly;Brachydactyly;Abnormality of the liver;Abnormality of the sternum;Nephropathy;Abnormality of the ribs;Postaxial hand polydactyly;Skeletal dysplasia;Renal insufficiency;Micromelia;Short thorax;Nephronophthisis;Abnormality of pelvic girdle bone morphology;Narrow chest;Abnormality of the metaphysis;Respiratory insufficiency;Dandy-Walker malformation;Lethal skeletal dysplasia;Frontal bossing;Ectopic anus;Cleft upper lip;Cataract;Uterus didelphys;Hypoplasia of penis;Disproportionate short-limb short stature;Abnormal pelvis bone ossification;Narrow chest;Abnormality of the metaphysis;Agenesis of corpus callosum;Macrocephaly;Abdominal distention;Esophageal atresia;Pulmonary hypoplasia;Short ribs;Short palm;Long philtrum;Short foot;Bifid tongue;Bifid epiglottis;Ambiguous genitalia;Renal cyst;Abnormality of cardiovascular system morphology;Epicanthus;Postaxial hand polydactyly;Preaxial hand polydactyly;Facial cleft;Respiratory insufficiency;Absent or minimally ossified vertebral bodies;Wide nose;Cerebellar hypoplasia;Hydrops fetalis;Renal hypoplasia;Omphalocele;Micromelia;Cryptorchidism;Hydronephrosis;Depressed nasal bridge;Micrognathia;Congenital hepatic fibrosis;Urethrovaginal fistula;Anal atresia;Short thorax		0.00123542	187.0	151366.0	0.0	31	0.93	PASS	afr	0.00325132	134.0	0.000191413	13.0	0.000426396	105.0	246250.0	0.0	38	0.89	PASS	afr	0.00311931	48.0	0.000187349	21.0	0.0004501	70	0.001	3.0	0.00167	19.0		11.01	0.682985		0	0	0			DYNC2H1	0.01	0.0	0.02	0.0	-49.0	2.0	-5.0	-18.0						0.998	0.0	0.000000000			cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; respiratory system phenotype; renal/urinary system phenotype; skeleton phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype ; vision/eye phenotype; cardiovascular system phenotype ; mortality/aging ; embryo phenotype; 			pons;ciliary ganglion;testis - seminiferous tubule;subthalamic nucleus;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;testis;skeletal muscle;globus pallidus;	.	microtubule-based movement;Golgi organization;multicellular organism development;intraciliary retrograde transport;intraciliary transport involved in cilium assembly;cilium assembly	Golgi apparatus;cytoplasmic dynein complex;microtubule;plasma membrane;cilium;axoneme;dynein complex;motile cilium;extracellular exosome;ciliary tip	motor activity;ATP binding;ATP-dependent microtubule motor activity, minus-end-directed;dynein light chain binding;dynein intermediate chain binding;dynein light intermediate chain binding	DYNC2H1[21723285];JUN[25609649];GDI1[26496610];TIGD6[26496610];PPP2R3C[26496610];MTNR1B[26514267];USP50[19615732];TANK[unassigned1774];HNRNPA1L2[30021884];PEX14[21525035];SPC24[26496610];MFSD4B[unassigned1312];	103022933
18486	chr11	107965214	CA		chr11:107965214-107965215	CUL5	cullin 5	deletion	0/0	0.0	22_0	22	60.0	0/1	0.14	12_2	14	48.0				EXONIC	YES	NM_003478.6	Transcript	protein_coding	frameshift_variant		14/19	NM_003478.6:c.1542_1543del	NP_003469.2:p.His514GlnfsTer3		1.0						.	.	.						33	0.96											24	0.61																	0	0	0			CUL5	0.0	0.0	0.0	0.01	-44.0	-6.0	48.0	28.0						0.286	1.0	0.000000000,0.000000000			immune system phenotype; mortality/aging ; homeostasis/metabolism phenotype; 			.	Ubiquitin mediated proteolysis	G1/S transition of mitotic cell cycle;ubiquitin-dependent protein catabolic process;cell cycle arrest;cell population proliferation;negative regulation of cell population proliferation;viral process;protein ubiquitination;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;ERBB2 signaling pathway;proteasome-mediated ubiquitin-dependent protein catabolic process;post-translational protein modification;calcium ion transmembrane transport;intrinsic apoptotic signaling pathway	cytosol;SCF ubiquitin ligase complex;cullin-RING ubiquitin ligase complex;Cul5-RING ubiquitin ligase complex	ubiquitin-protein transferase activity;calcium channel activity;protein binding;ubiquitin protein ligase binding;signaling receptor activity;ubiquitin protein ligase activity	CBFB[24402281];DCUN1D1[19617556];HTT[17500595];DCUN1D2[19617556];NEDD8[18274552;18805092];ASB12[16325183];ARRB2[17620599];RNF7[21516116;25416956;unassigned1304];YBX1[25497084];HSCB[24606901];CCNDBP1[25416956];MKI67[26949251];GOLGA2[25416956];SOCS2[29997244];SOCS3[15601820];RAB40C[15601820];ERBB2[19933325];ARIH2[24076655];ELOA[19037258];ELOB[24402281];ELOC[24402281];SMAD2[15231748];JUN[25609649];COG6[unassigned1304];CCNB1IP1[unassigned1304];RBX1[18805092];SOX30[21988832];SPSB2[15601820];COPS6[19615732];SPSB1[15601820];ASB6[16325183];UBA3[18805092];ASB7[16325183];CCDC22[23563313];ASB2[16325183];PTPN5[21988832];KANK4[unassigned1304];ASB1[16325183];UBE2M[18805092];SPSB4[15601820];HSPA1A[19933325];	107965213
18513	chr11	108170506	A	C	chr11:108170506	ATM	ATM serine/threonine kinase	SNV	0/1	0.28	23_9	32	99.0	0/0	0.0	34_0	34	99.0			rs1800059,CM980141,COSV53724445	EXONIC	YES	NM_001351834.2	Transcript	protein_coding	missense_variant		35/64	NM_001351834.2:c.5071A>C	NP_001338763.1:p.Ser1691Arg		1.0	.,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Malignant_tumor_of_breast|Ataxia-telangiectasia_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|Breast_and/or_ovarian_cancer|not_provided	Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)	Ataxia-telangiectasia;Ataxia-telangiectasia variant;B-cell chronic lymphocytic leukemia;Mantle cell lymphoma	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in	Somatic mutation;Autosomal dominant inheritance;Heterogeneous;Breast carcinoma;Weight loss;Abnormality of the gastrointestinal tract;B-cell lymphoma;Lymphadenopathy;Abnormality of bone marrow cell morphology;Anorexia;Fatigue;Splenomegaly;Fever;Autosomal recessive inheritance;Dysarthria;Ataxia;Elevated alpha-fetoprotein;Choreoathetosis;Diabetes mellitus;Seizure;Abnormal spermatogenesis;Leukemia;Decreased proportion of CD4-positive helper T cells;Dystonia;Nystagmus;Hypoplasia of the thymus;Conjunctival telangiectasia;Sinusitis;Decreased circulating IgA level;Female hypogonadism;Abnormal hair morphology;Lymphoma;Tremor;Strabismus;Myoclonus;Short stature;Decreased circulating IgG2 level;Defective B cell differentiation;Recurrent bronchitis;Non-Hodgkin lymphoma;Glucose intolerance;Hodgkin lymphoma;Delayed puberty;Reduced tendon reflexes;Cafe-au-lait spot;Bronchiectasis;Spasticity;Skeletal muscle atrophy;Tremor;Lymphopenia;Type II diabetes mellitus;Hypopigmentation of hair;Aplasia/Hypoplasia of the skin;Gait disturbance;Seizure;Cellular immunodeficiency;Strabismus;Abnormality of chromosome stability;Polycystic ovaries;Dysarthria;Abnormal testis morphology;Nystagmus;Recurrent respiratory infections;Premature graying of hair;Neoplasm;Delayed puberty;Failure to thrive;Multiple cafe-au-lait spots;Elevated hepatic transaminase;Short stature;Cognitive impairment;Mucosal telangiectasiae;Decreased circulating antibody level;Ataxia;Aplasia/Hypoplasia of the thymus;Telangiectasia of the skin	24728327,29458332,19431188	0.00160309	244.0	152206.0	1.0	32	0.96	PASS	nfe	0.00238095	162.0	0.00238095	162.0	0.00175933	442.0	251232.0	2.0	100	1.0	PASS	nfe	0.00291548	331.0	0.00291548	331.0	0.0018585	289	0.002	6.0	0.00196	20.0		17.55	1.710208	0.153	1	18	19	fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	ATM	0.02	0.06	0.0	0.0	-11.0	24.0	23.0	-40.0						0.782	0.0	0.000000000	0.988	1.312	nervous system phenotype ; immune system phenotype; embryo phenotype; behavior/neurological phenotype ; mortality/aging ; reproductive system phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; adipose tissue phenotype ; neoplasm; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; integument phenotype ; growth/size/body region phenotype; 			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;	Cell cycle;p53 signaling pathway;Apoptosis	DNA damage checkpoint;telomere maintenance;DNA double-strand break processing;response to hypoxia;pre-B cell allelic exclusion;DNA replication;double-strand break repair via nonhomologous end joining;protein phosphorylation;cellular response to DNA damage stimulus;DNA damage induced protein phosphorylation;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;cell cycle arrest;mitotic spindle assembly checkpoint;reciprocal meiotic recombination;signal transduction;intrinsic apoptotic signaling pathway in response to DNA damage;response to ionizing radiation;regulation of autophagy;positive regulation of gene expression;histone phosphorylation;peptidyl-serine phosphorylation;positive regulation of cell migration;negative regulation of B cell proliferation;regulation of telomere maintenance via telomerase;positive regulation of telomere maintenance via telomerase;positive regulation of histone phosphorylation;phosphatidylinositol-3-phosphate biosynthetic process;peptidyl-serine autophosphorylation;regulation of apoptotic process;positive regulation of apoptotic process;positive regulation of DNA damage response, signal transduction by p53 class mediator;positive regulation of neuron apoptotic process;positive regulation of cell adhesion;positive regulation of transcription by RNA polymerase II;protein autophosphorylation;regulation of telomerase activity;histone mRNA catabolic process;cellular response to retinoic acid;cellular response to gamma radiation;cellular response to X-ray;cellular response to nitrosative stress;signal transduction involved in mitotic G2 DNA damage checkpoint;replicative senescence;establishment of RNA localization to telomere;establishment of protein-containing complex localization to telomere;regulation of cellular response to heat;regulation of signal transduction by p53 class mediator;positive regulation of DNA catabolic process;regulation of microglial cell activation;negative regulation of TORC1 signaling;negative regulation of telomere capping;positive regulation of telomere maintenance via telomere lengthening;positive regulation of telomerase catalytic core complex assembly;regulation of cellular response to gamma radiation	chromosome, telomeric region;nuclear chromosome, telomeric region;nucleus;nucleoplasm;nucleolus;cytoplasmic vesicle;DNA repair complex	DNA binding;protein serine/threonine kinase activity;DNA-dependent protein kinase activity;protein binding;ATP binding;1-phosphatidylinositol-3-kinase activity;protein-containing complex binding;protein dimerization activity;protein N-terminus binding	MDC1[12607005;29656893];ERRFI1[25640309];MT-ND4[25640309];MTRR[26496610];IL24[25640309];GMNN[26496610];BHLHE41[26496610];BRCA1[29656893];AATF[17157788];PPP1CC[17274640];ODR4[26496610];MYC[21150319];RUVBL1[20371770];IKBKG[18583959];NBN[25895060];UTP15[26496610];BCAS3[25640309];ZER1[26496610];ATMIN[17525732];ACTL6B[25640309];MAP1S[25640309];H2AFX[16858402;22451927];MINK1[26496610];P3H2[26496610];PPP2R5C[21460856];TERF1[11375976;15314656];SMC1A[11877377];TERF2[15314656];YWHAZ[30021884];TTI2[20810650];TTI1[20810650];RRM2B[19015526];PEX5[26344566];TFF1[25640309];TP53[10864201];TELO2[18160036;20801936];SRSF8[26496610];RBM47[26496610];MTMR3[26496610];NOTCH1[25895060];FECH[25640309];BRAT1[16452482];RNF8[18001825];CRX[27107012];NOLC1[26496610];CD99L2[26496610];NREP[25640309];NSD3[25640309];BAG6[26496610];ABL1[11375976;9168117];SFN[20843328];ZNF821[25640309];VHL[17353931];TP53BP1[22621922;29656893];MTA3[25640309];DCAF13[26496610];HSPA8[25640309];NDUFA8[26496610];RRM1[19015526];NRDC[26496610];OSGIN1[25640309];HMGA2[26045162];PPP1CA[17274640];FBXO31[19412162];NR4A1[25640309];SNW1[20467437];PER3[21070773];NAT2[25640309];TDP1[19851285];ALB[15174051];NABP2[18449195];ATM[20360068];TPT1[22451927];TAF1[26496610];	108170506
18519	chr11	108202247	T	C	chr11:108202247	ATM	ATM serine/threonine kinase	SNV	0/0	0.0	39_0	39	99.0	0/1	0.4	37_25	62	99.0			rs587781365,CM0910522	EXONIC	YES	NM_001351834.2	Transcript	protein_coding	missense_variant		52/64	NM_001351834.2:c.7592T>C	NP_001338763.1:p.Met2531Thr		1.0	PIK-related kinase,PIK-related kinase	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Ataxia-telangiectasia_syndrome|Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	Lymphoma, B-cell non-Hodgkin, somatic (3); Ataxia-telangiectasia, 208900 (3), Autosomal recessive; {Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; T-cell prolymphocytic leukemia, somatic (3); Lymphoma, mantle cell, somatic (3)	Ataxia-telangiectasia;Ataxia-telangiectasia variant;B-cell chronic lymphocytic leukemia;Mantle cell lymphoma	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing somatic mutation(s) in;Disease-causing somatic mutation(s) in	Somatic mutation;Autosomal dominant inheritance;Heterogeneous;Breast carcinoma;Weight loss;Abnormality of the gastrointestinal tract;B-cell lymphoma;Lymphadenopathy;Abnormality of bone marrow cell morphology;Anorexia;Fatigue;Splenomegaly;Fever;Autosomal recessive inheritance;Dysarthria;Ataxia;Elevated alpha-fetoprotein;Choreoathetosis;Diabetes mellitus;Seizure;Abnormal spermatogenesis;Leukemia;Decreased proportion of CD4-positive helper T cells;Dystonia;Nystagmus;Hypoplasia of the thymus;Conjunctival telangiectasia;Sinusitis;Decreased circulating IgA level;Female hypogonadism;Abnormal hair morphology;Lymphoma;Tremor;Strabismus;Myoclonus;Short stature;Decreased circulating IgG2 level;Defective B cell differentiation;Recurrent bronchitis;Non-Hodgkin lymphoma;Glucose intolerance;Hodgkin lymphoma;Delayed puberty;Reduced tendon reflexes;Cafe-au-lait spot;Bronchiectasis;Spasticity;Skeletal muscle atrophy;Tremor;Lymphopenia;Type II diabetes mellitus;Hypopigmentation of hair;Aplasia/Hypoplasia of the skin;Gait disturbance;Seizure;Cellular immunodeficiency;Strabismus;Abnormality of chromosome stability;Polycystic ovaries;Dysarthria;Abnormal testis morphology;Nystagmus;Recurrent respiratory infections;Premature graying of hair;Neoplasm;Delayed puberty;Failure to thrive;Multiple cafe-au-lait spots;Elevated hepatic transaminase;Short stature;Cognitive impairment;Mucosal telangiectasiae;Decreased circulating antibody level;Ataxia;Aplasia/Hypoplasia of the thymus;Telangiectasia of the skin		3.28986e-05	5.0	151982.0	0.0	32	0.95	PASS	nfe	5.88339e-05	4.0	5.88339e-05	4.0	4.37818e-05	11.0	251246.0	0.0	48	0.98	PASS	nfe	9.67645e-05	11.0	9.67645e-05	11.0	0.0000386	6						18.09	1.785748	0.342	3	16	19	M-CAP_pred,MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	ATM	0.0	0.0	0.0	0.0	-14.0	-28.0	37.0	-33.0						0.782	0.0	0.000000000	1.0	1.118	nervous system phenotype ; immune system phenotype; embryo phenotype; behavior/neurological phenotype ; mortality/aging ; reproductive system phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; adipose tissue phenotype ; neoplasm; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; integument phenotype ; growth/size/body region phenotype; 			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;	Cell cycle;p53 signaling pathway;Apoptosis	DNA damage checkpoint;telomere maintenance;DNA double-strand break processing;response to hypoxia;pre-B cell allelic exclusion;DNA replication;double-strand break repair via nonhomologous end joining;protein phosphorylation;cellular response to DNA damage stimulus;DNA damage induced protein phosphorylation;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;cell cycle arrest;mitotic spindle assembly checkpoint;reciprocal meiotic recombination;signal transduction;intrinsic apoptotic signaling pathway in response to DNA damage;response to ionizing radiation;regulation of autophagy;positive regulation of gene expression;histone phosphorylation;peptidyl-serine phosphorylation;positive regulation of cell migration;negative regulation of B cell proliferation;regulation of telomere maintenance via telomerase;positive regulation of telomere maintenance via telomerase;positive regulation of histone phosphorylation;phosphatidylinositol-3-phosphate biosynthetic process;peptidyl-serine autophosphorylation;regulation of apoptotic process;positive regulation of apoptotic process;positive regulation of DNA damage response, signal transduction by p53 class mediator;positive regulation of neuron apoptotic process;positive regulation of cell adhesion;positive regulation of transcription by RNA polymerase II;protein autophosphorylation;regulation of telomerase activity;histone mRNA catabolic process;cellular response to retinoic acid;cellular response to gamma radiation;cellular response to X-ray;cellular response to nitrosative stress;signal transduction involved in mitotic G2 DNA damage checkpoint;replicative senescence;establishment of RNA localization to telomere;establishment of protein-containing complex localization to telomere;regulation of cellular response to heat;regulation of signal transduction by p53 class mediator;positive regulation of DNA catabolic process;regulation of microglial cell activation;negative regulation of TORC1 signaling;negative regulation of telomere capping;positive regulation of telomere maintenance via telomere lengthening;positive regulation of telomerase catalytic core complex assembly;regulation of cellular response to gamma radiation	chromosome, telomeric region;nuclear chromosome, telomeric region;nucleus;nucleoplasm;nucleolus;cytoplasmic vesicle;DNA repair complex	DNA binding;protein serine/threonine kinase activity;DNA-dependent protein kinase activity;protein binding;ATP binding;1-phosphatidylinositol-3-kinase activity;protein-containing complex binding;protein dimerization activity;protein N-terminus binding	MDC1[12607005;29656893];ERRFI1[25640309];MT-ND4[25640309];MTRR[26496610];IL24[25640309];GMNN[26496610];BHLHE41[26496610];BRCA1[29656893];AATF[17157788];PPP1CC[17274640];ODR4[26496610];MYC[21150319];RUVBL1[20371770];IKBKG[18583959];NBN[25895060];UTP15[26496610];BCAS3[25640309];ZER1[26496610];ATMIN[17525732];ACTL6B[25640309];MAP1S[25640309];H2AFX[16858402;22451927];MINK1[26496610];P3H2[26496610];PPP2R5C[21460856];TERF1[11375976;15314656];SMC1A[11877377];TERF2[15314656];YWHAZ[30021884];TTI2[20810650];TTI1[20810650];RRM2B[19015526];PEX5[26344566];TFF1[25640309];TP53[10864201];TELO2[18160036;20801936];SRSF8[26496610];RBM47[26496610];MTMR3[26496610];NOTCH1[25895060];FECH[25640309];BRAT1[16452482];RNF8[18001825];CRX[27107012];NOLC1[26496610];CD99L2[26496610];NREP[25640309];NSD3[25640309];BAG6[26496610];ABL1[11375976;9168117];SFN[20843328];ZNF821[25640309];VHL[17353931];TP53BP1[22621922;29656893];MTA3[25640309];DCAF13[26496610];HSPA8[25640309];NDUFA8[26496610];RRM1[19015526];NRDC[26496610];OSGIN1[25640309];HMGA2[26045162];PPP1CA[17274640];FBXO31[19412162];NR4A1[25640309];SNW1[20467437];PER3[21070773];NAT2[25640309];TDP1[19851285];ALB[15174051];NABP2[18449195];ATM[20360068];TPT1[22451927];TAF1[26496610];	108202247
18554	chr11	111636116	A	G	chr11:111636116	PPP2R1B	protein phosphatase 2 scaffold subunit Abeta	SNV	0/0	0.0	36_0	36	99.0	0/1	0.68	12_25	37	99.0			rs185613790	SPLICING	YES	NM_181699.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/15		NM_181699.3:c.115-8T>C			-1.0					Lung cancer, somatic, 211980 (3)	.	.	Somatic mutation;Alveolar cell carcinoma;Autosomal dominant inheritance;Autosomal recessive inheritance		0.000223329	34.0	152242.0	0.0	33	0.98	PASS	nfe	0.000440904	30.0	0.000440904	30.0	0.000235918	58.0	245848.0	0.0	49	0.85	PASS	nfe	0.000462708	52.0	0.000462708	52.0	0.0003344	52	0.0	1.0	0.00062	7.0		8.669	0.425648		0	0	0			PPP2R1B	0.01	0.01	0.0	0.0	35.0	-22.0	6.0	-14.0	0.0001768498156746	0.01	7.356	-0.283	7.073	0.491	0.0				hematopoietic system phenotype; reproductive system phenotype; immune system phenotype; 			pons;ciliary ganglion;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;trigeminal ganglion;parietal lobe;testis;skeletal muscle;medulla oblongata;	Wnt signaling pathway;TGF-beta signaling pathway;Tight junction;Long-term depression	protein dephosphorylation;regulation of phosphoprotein phosphatase activity;apoptotic process involved in morphogenesis;positive regulation of extrinsic apoptotic signaling pathway in absence of ligand	protein phosphatase type 2A complex;cytoplasm;membrane raft;extracellular exosome	protein serine/threonine phosphatase activity;protein binding;protein phosphatase regulator activity	DOCK5[19156129];TRAF3IP3[18782753];RORC[23555304];PPP2R2A[17540176;26496610;28330616];PARK7[17540176];PPP4R1[26496610];PPP2R1B[23555304];PPP2R5E[17540176;23555304];PPP2R1A[18782753;26496610];FGFR1OP2[26496610];NUP62[25435324];NCBP1[26496610];DAPK1[21172653];ANXA5[17540176];PPP2R5A[17540176;18782753];PPP2R5D[17540176;23555304;26496610];PPP2R5C[16456541;17540176];CTTNBP2NL[18782753];SGO2[16541025];SIKE1[18782753;26496610];ESPL1[24781523];CSNK2B[23555304];MCM3[17540176];ULK2[20562859];SIK2[16306228];RAB7A[17540176];RALA[17540176];USP53[19615732];HDAC1[17540176];CTTNBP2[18782753];STRN4[18782753];STRN3[17540176;18782753;24366813;26496610];HSPD1[17540176];PPP2CA[17540176;19156129;18715871;18782753;8392071;26496610;28330616];PRDX2[17540176];PPP2CB[19156129;26496610];STRIP1[18782753];PDCD10[18782753];PRDX1[17540176];MAP3K3[14743216];ZRANB1[19615732];PPP2R3A[8392071];EEF2[17540176];RAB11A[17540176];NFKB2[14743216];MOB4[18782753];SNW1[20467437];PPP2R2C[18782753;28330616];STK24[18782753;23455922];CDK4[17540176];PPP2R2B[19156129;28330616];STK25[18782753;23455922];TNIP3[19615732];SLMAP[24366813];PPP2R2D[19156129;28330616];BHLHE40[23555304];CDK1[17540176];RAB18[17540176];FGFR1OP[17540176];STRN[17540176;24366813;26496610];	111636116
18688	chr11	113078691	G	A	chr11:113078691	NCAM1	neural cell adhesion molecule 1	SNV	0/0	0.0	35_0	35	99.0	0/1	0.37	51_30	81	99.0			rs537306763,COSV57521040	EXONIC	YES	NM_001242607.2	Transcript	protein_coding	missense_variant		8/22	NM_001242607.2:c.883G>A	NP_001229536.1:p.Glu295Lys		1.0	Immunoglobulin I-set&Immunoglobulin-like domain&Immunoglobulin subtype,Immunoglobulin I-set&Immunoglobulin-like domain&Immunoglobulin subtype,Immunoglobulin I-set&Immunoglobulin-like domain&Immunoglobulin subtype,Immunoglobulin I-set&Immunoglobulin-like domain&Immunoglobulin subtype,Immunoglobulin I-set&Immunoglobulin-like domain&Immunoglobulin subtype,Immunoglobulin I-set&Immunoglobulin-like domain&Immunoglobulin subtype,.,Immunoglobulin I-set&Immunoglobulin-like domain&Immunoglobulin subtype,.,.,.					.	.	.		6.57384e-06	1.0	152118.0	0.0	32	0.96	PASS	afr	2.41406e-05	1.0	0.0	0.0	8.1825e-06	2.0	244424.0	0.0	59	0.77	PASS	afr	6.63306e-05	1.0	0.0	0.0	0.0000257	4						25.5	3.646707	0.32	13	5	18	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationTaster_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,MetaLR_pred,MetaSVM_pred,MetaRNN_pred,PrimateAI_pred	NCAM1	0.0	0.0	0.0	0.01	33.0	6.0	-3.0	33.0								98.711458822	0.929	1.083	mortality/aging ; behavior/neurological phenotype ; vision/eye phenotype; nervous system phenotype ; cellular phenotype; 			ciliary ganglion;caudate nucleus;amygdala;olfactory bulb;prefrontal cortex;cingulate cortex;superior cervical ganglion;cerebellum peduncles;cerebellum;pons;occipital lobe;fetal brain;subthalamic nucleus;whole brain;dorsal root ganglion;spinal cord;parietal lobe;skeletal muscle;globus pallidus;hypothalamus;medulla oblongata;thalamus;	Cell adhesion molecules (CAMs)	MAPK cascade;cell adhesion;axon guidance;viral entry into host cell;interferon-gamma-mediated signaling pathway;commissural neuron axon guidance;regulation of semaphorin-plexin signaling pathway	Golgi membrane;cytosol;plasma membrane;external side of plasma membrane;cell surface;membrane;integral component of membrane;anchored component of membrane;collagen-containing extracellular matrix	virus receptor activity;Ras guanyl-nucleotide exchange factor activity	UCHL1[23061666];ATXN1[23275563];RHEB[21988832];NCAM1[21115007];	113078691
18727	chr11	113563835	C	T	chr11:113563835	TMPRSS5	transmembrane serine protease 5	SNV	0/0	0.0	43_0	43	99.0	0/1	0.51	38_41	81	99.0				EXONIC	YES	NM_030770.4	Transcript	protein_coding	missense_variant		9/13	NM_030770.4:c.922G>A	NP_110397.2:p.Asp308Asn		-1.0	Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain					.	.	.		6.57471e-06	1.0	152098.0	0.0	32	0.96	PASS	nfe	1.47024e-05	1.0	1.47024e-05	1.0					32	0.6														25.1	3.522952	0.807	20	1	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PrimateAI_pred	TMPRSS5	0.0	0.09	0.0	0.02	-42.0	19.0	42.0	-42.0							0.0	82.309123171	0.061	1.026	.			pons;ciliary ganglion;superior cervical ganglion;trigeminal ganglion;	.	proteolysis;receptor-mediated endocytosis	plasma membrane;integral component of membrane;neuronal cell body	serine-type endopeptidase activity;scavenger receptor activity;peptidase activity	TFAP2A[24835590];	113563835
18731	chr11	113614696	C	T	chr11:113614696	ZW10	zw10 kinetochore protein	SNV	0/0	0.0	35_0	35	99.0	0/1	0.29	42_17	59	99.0			rs1261352747,COSV52316124	EXONIC	YES	NM_004724.4	Transcript	protein_coding	missense_variant		10/16	NM_004724.4:c.1339G>A	NP_004715.1:p.Val447Ile		-1.0						.	.	.						33	0.98							7.96172e-06	2.0	251202.0	0.0	70	1.0	PASS	amr	5.78202e-05	2.0	0.0	0.0								5.554	0.180986	0.017	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZW10	0.0	0.0	0.0	0.0	-6.0	48.0	-8.0	1.0						0.757	0.05	0.000000000	0.296	0.12	.			ciliary ganglion;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;parietal lobe;testis;skeletal muscle;globus pallidus;	.	mitotic sister chromatid segregation;establishment of mitotic spindle orientation;endoplasmic reticulum to Golgi vesicle-mediated transport;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;Golgi organization;mitotic metaphase plate congression;mitotic cell cycle checkpoint;mitotic spindle assembly checkpoint;regulation of exit from mitosis;protein transport;protein localization to kinetochore;cell division;meiotic cell cycle;protein-containing complex assembly	kinetochore;condensed chromosome kinetochore;spindle pole;nucleus;endoplasmic reticulum;endoplasmic reticulum membrane;kinetochore microtubule;cytosol;membrane;Dsl1/NZR complex;RZZ complex	protein binding;centromeric DNA binding	COPB2[24056303];NBAS[19369418;20462495;24056303];ZWILCH[15824131;20462495];STX18[19369418;24056303];BUB1B[15824131];MKI67[26949251];USE1[19369418];C19orf25[15824131];LDHD[26496610];STOM[27173435;unassigned1312];KNTC1[15824131;20462495];BUB1[15824131];DYNC1I1[15824131];PHLDA3[17353931];GSTK1[17353931];UVRAG[24056303];BRF2[17353931];TSC22D1[17353931];XRCC3[26496610];SLC33A1[26496610];FN1[19738201];ZWINT[15824131;16732327];NDC80[16732327];RINT1[15824131;20462495;24056303];PTP4A3[17353931];MAPT[26402096];MAD1L1[15824131];	113614696
18766	chr11	113699949	G	A	chr11:113699949	USP28	ubiquitin specific peptidase 28	SNV	0/0	0.0	33_0	33	99.0	0/1	0.36	70_39	109	99.0			rs200601018,COSV99136014	EXONIC	YES	NM_001346252.2	Transcript	protein_coding	synonymous_variant		10/26	NM_001346252.2:c.1029C>T	NP_001333181.1:p.Pro343%3D		-1.0						.	.	.		0.000111738	17.0	152142.0	0.0	32	0.97	PASS	nfe	0.000205822	14.0	0.000205822	14.0	0.000147282	37.0	251218.0	0.0	47	0.98	PASS	nfe	0.000299296	34.0	0.000299296	34.0	0.0001093	17	0.0	1.0				8.301	0.391049		0	0	0			USP28	0.0	0.0	0.0	0.0	-19.0	-5.0	-30.0	49.0						0.763	0.03	55.748692685			immune system phenotype; hematopoietic system phenotype; cellular phenotype; 			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	DNA damage checkpoint;DNA repair;ubiquitin-dependent protein catabolic process;cellular response to DNA damage stimulus;Ras protein signal transduction;cell population proliferation;response to ionizing radiation;protein deubiquitination;regulation of protein stability;cellular response to UV;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator	nucleoplasm;cytosol;nuclear body;protein-containing complex	cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;protein binding;thiol-dependent ubiquitinyl hydrolase activity	USP25[19615732];AQR[19615732];MTNR1A[26514267];SUMO2[19615732];FOXK1[25609649];TP53BP1[19615732;29656893];TP53[22653443];PPP1CA[25593058];	113699949
18836	chr11	116658645	G	A	chr11:116658645	ZPR1	ZPR1 zinc finger	SNV	0/0	0.0	36_0	36	99.0	0/1	0.57	32_44	77	99.0			rs367894029	EXONIC	YES	NM_003904.5	Transcript	protein_coding	missense_variant		1/14	NM_003904.5:c.62C>T	NP_003895.1:p.Ala21Val		-1.0					?Growth restriction, hypoplastic kidneys, alopecia, and distinctive facies, 619321 (3), Autosomal recessive	.	.	.		0.000663627	101.0	152194.0	0.0	33	0.98	PASS	nfe	0.000970132	66.0	0.000970132	66.0	0.00119858	100.0	83432.0	0.0	7	0.07	PASS	nfe	0.00103862	32.0	0.00103862	32.0	0.0003987	62	0.0	1.0				6.084	0.216607	0.097	1	18	19	M-CAP_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZPR1	0.0	0.0	0.0	0.0	50.0	-46.0	2.0	0.0									0.0	-0.16	mortality/aging ; embryo phenotype; cellular phenotype; 			.	.	microtubule cytoskeleton organization;inner cell mass cell proliferation;trophectodermal cell proliferation;mRNA processing;signal transduction;cell population proliferation;RNA splicing;positive regulation of gene expression;spinal cord development;Cajal body organization;regulation of myelination;positive regulation of RNA splicing;DNA endoreduplication;positive regulation of protein import into nucleus;positive regulation of growth;axon development;cellular response to epidermal growth factor stimulus;positive regulation of transcription involved in G1/S transition of mitotic cell cycle;apoptotic process involved in development;pre-mRNA catabolic process;negative regulation of motor neuron apoptotic process	nucleus;nucleoplasm;nucleolus;cytoplasm;Cajal body;axon;growth cone;SMN complex;neuronal cell body;perikaryon;perinuclear region of cytoplasm;Gemini of coiled bodies	protein binding;zinc ion binding;receptor tyrosine kinase binding;translation initiation factor binding	MPP3[21988832];CDK5RAP2[16169070];	116658645
18899	chr11	117789423	G	A	chr11:117789423	TMPRSS13	transmembrane serine protease 13	SNV	0/0	0.0	41_0	41	99.0	0/1	0.46	74_64	138	99.0			rs199724994	EXONIC	YES	NM_001077263.3	Transcript	protein_coding	missense_variant		2/13	NM_001077263.3:c.152C>T	NP_001070731.1:p.Pro51Leu		-1.0	.,.,.,.,.					.	.	.		0.00200606	303.0	151042.0	2.0	33	0.95	PASS	nfe	0.00198752	135.0	0.00198752	135.0	0.00225484	561.0	248798.0	1.0	100	1.0	PASS	nfe	0.00177535	200.0	0.00177535	200.0	0.0017813	277						10.82	0.66023	0.187	3	14	17	SIFT,MetaLR_pred,FATHMM_pred	PolyPhen,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TMPRSS13	0.0	0.0	0.0	0.01	-48.0	42.0	23.0	-35.0						0.344	0.0		0.002	0.893	homeostasis/metabolism phenotype; integument phenotype ; normal phenotype; 			dorsal root ganglion;atrioventricular node;superior cervical ganglion;placenta;parietal lobe;globus pallidus;	.	proteolysis;receptor-mediated endocytosis	integral component of membrane;blood microparticle	serine-type endopeptidase activity;scavenger receptor activity	.	117789423
18918	chr11	117860305	G	A	chr11:117860305	IL10RA	interleukin 10 receptor subunit alpha	SNV	0/1	0.73	23_61	84	99.0	0/0	0.0	33_0	33	99.0			rs4252303,COSV57139876	EXONIC	YES	NM_001558.4	Transcript	protein_coding	missense_variant		3/7	NM_001558.4:c.337G>A	NP_001549.2:p.Val113Ile		1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Inflammatory_bowel_disease_28,_autosomal_recessive	Inflammatory bowel disease 28, early onset, autosomal recessive, 613148 (3), Autosomal recessive	Immune dysregulation-inflammatory bowel disease-arthritis-recurrent infections syndrome	Disease-causing germline mutation(s) (loss of function) in	Pyoderma;Perianal abscess;Hematochezia;Enterocolitis;Autosomal recessive inheritance;Folliculitis		0.00628927	957.0	152164.0	5.0	33	0.97	PASS	amr	0.00981547	150.0	0.00962952	655.0	0.00679793	1709.0	251400.0	11.0	100	1.0	PASS	nfe	0.0105365	1198.0	0.0105365	1198.0	0.0069452	1080	0.021	68.0	0.02353	268.0		0.001	-1.235579	0.055	0	18	18		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	IL10RA	0.0	0.0	0.0	0.0	-19.0	-4.0	26.0	30.0						0.137	0.97	0.000000000	0.0	-2.213	homeostasis/metabolism phenotype; cellular phenotype; hematopoietic system phenotype; immune system phenotype; digestive/alimentary phenotype; 			white blood cells;atrioventricular node;superior cervical ganglion;whole blood;	Cytokine-cytokine receptor interaction;Jak-STAT signaling pathway	cytokine-mediated signaling pathway;response to lipopolysaccharide;regulation of synapse organization	plasma membrane;integral component of membrane	cytokine receptor activity;interleukin-10 receptor activity;protein binding;interleukin-10 binding;signaling receptor activity	IL10[11485736;12513909;15837194;20462497];CMTM3[unassigned1304];SLC7A14[unassigned1304];C16orf58[unassigned1304];C1QL4[unassigned1304];SELENOK[unassigned1304];TMUB2[unassigned1304];TMEM242[unassigned1304];NIPAL4[unassigned1304];PLPP6[unassigned1304];PQLC1[unassigned1304];SLC38A7[unassigned1304];YIPF6[unassigned1304];SMCO4[unassigned1304];BTRC[unassigned1304];CDS2[unassigned1304];	117860305
18996	chr11	118997714	G	A	chr11:118997714	HINFP	histone H4 transcription factor	SNV	0/1	0.42	65_48	113	99.0	0/0	0.0	35_0	35	99.0			rs143017588	EXONIC	YES	NM_001351957.2	Transcript	protein_coding	synonymous_variant		2/10	NM_001351957.2:c.60G>A	NP_001338886.1:p.Gly20%3D		1.0						.	.	.		0.00483593	736.0	152194.0	4.0	33	0.97	PASS	amr	0.00831478	127.0	0.00714286	486.0	0.00438726	1103.0	251410.0	8.0	55	0.98	PASS	amr	0.00772257	267.0	0.00674404	767.0	0.0042828	666	0.013	42.0				10.97	0.678392		0	0	0			HINFP	0.0	0.0	0.0	0.02	-40.0	-11.0	-7.0	-11.0						0.381	0.98	7.450055530			embryo phenotype; mortality/aging ; 			testis;	.	DNA damage checkpoint;G1/S transition of mitotic cell cycle;regulation of transcription involved in G1/S transition of mitotic cell cycle;negative regulation of transcription by RNA polymerase II;in utero embryonic development;DNA repair;transcription, DNA-templated;regulation of transcription, DNA-templated;regulation of gene expression;positive regulation of gene expression;negative regulation of gene expression;establishment of protein localization;myoblast differentiation;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated	nucleus;nucleoplasm;nucleolus;Cajal body	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA binding;chromatin binding;DNA-binding transcription factor activity;transcription coactivator activity;protein binding;enzyme binding;histone binding;transcription regulatory region DNA binding;metal ion binding	TRIM39[21516116];CCDC36[21516116];NDUFAB1[unassigned1304];HSPB1[25277244];TRAF2[16189514];TP53[21516116];	118997714
19037	chr11	119983135	T	C	chr11:119983135	TRIM29	tripartite motif containing 29	SNV	0/0	0.0	34_0	34	99.0	0/1	0.51	47_49	96	99.0			rs746634988	EXONIC	YES	NM_012101.4	Transcript	protein_coding	missense_variant		9/9	NM_012101.4:c.1754A>G	NP_036233.2:p.Asn585Ser		-1.0	.,.,.,.					.	.	.						32	0.96							3.98676e-06	1.0	250830.0	0.0	54	0.92	PASS	nfe	8.81228e-06	1.0	8.81228e-06	1.0	0.0000064	1						22.2	2.353598	0.079	5	15	20	SIFT,LRT_pred,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred	PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	TRIM29	0.0	0.0	0.0	0.0	49.0	18.0	-34.0	6.0						0.628	0.0	0.000000000	0.977	0.207	homeostasis/metabolism phenotype; growth/size/body region phenotype; adipose tissue phenotype ; 			ciliary ganglion;tonsil;trachea;tongue;liver;testis - seminiferous tubule;trigeminal ganglion;superior cervical ganglion;skin;subthalamic nucleus;atrioventricular node;placenta;skeletal muscle;globus pallidus;	Cell cycle;p53 signaling pathway;Apoptosis	negative regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;innate immune response;cell-cell adhesion;negative regulation of protein localization to nucleus	lysosome;cell-cell adherens junction	p53 binding;DNA-binding transcription factor activity;protein binding;zinc ion binding;identical protein binding;cadherin binding involved in cell-cell adhesion	GSK3B[19249679];DCTN1[26496610];PKN3[26496610];BOD1L1[26496610];CLTA[26496610];GCC1[16189514];KLHL13[26496610];EGFR[15657067];JAKMIP2[16189514];SYNE1[26496610];GOLGA2[16189514;21516116;25416956];CRACR2A[16189514];HINT1[7644499];FXR2[16189514];CHCHD3[26496610];TRIM29[16189514;unassigned1304];CEP70[16189514;25416956];DVL2[19249679];SACS[26496610];TRIM27[26496610];LZTS2[16189514;25416956];ANKS1A[unassigned1304];DISC1[unassigned1304];TRIM23[25416956];FOXD4[25609649];UBE2I[16189514];ACTN3[unassigned1304];CCDC57[unassigned1304];SEC16A[26496610];TUBB[26496610];CARD9[25416956];CAD[26496610];AXIN1[19249679];KRT35[unassigned1304];SMAD9[15231748];MTUS2[unassigned1304];MLH1[16189514];ACTL8[26496610];RAB32[26496610];TSGA10[16189514];MYO15B[16189514];TRIP6[25416956];NFKBID[unassigned1304];MAD1L1[16189514;25416956;unassigned1304];	119983135
19057	chr11	121030874	A	G	chr11:121030874	TBCEL-TECTA		SNV	0/0	0.0	33_0	33	99.0	0/1	0.38	48_30	78	99.0			rs147354818	EXONIC	YES	NM_001378761.1	Transcript	protein_coding	missense_variant		21/30	NM_001378761.1:c.5677A>G	NP_001365690.1:p.Ile1893Val		1.0	von Willebrand factor, type D domain&von Willebrand factor, type D domain&von Willebrand factor, type D domain,von Willebrand factor, type D domain&von Willebrand factor, type D domain&von Willebrand factor, type D domain,von Willebrand factor, type D domain&von Willebrand factor, type D domain&von Willebrand factor, type D domain	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Deafness,_autosomal_dominant_12|Deafness,_autosomal_recessive_21|not_specified|not_provided						0.00115619	176.0	152224.0	1.0	33	0.97	PASS	nfe	0.00180765	123.0	0.00180765	123.0	0.001177	296.0	251486.0	1.0	99	1.0	PASS	nfe	0.00169646	193.0	0.00169646	193.0	0.0010804	168	0.001	2.0	0.00123	14.0		13.03	0.942473	0.155	0	17	17		LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TECTA	0.0	0.0	0.0	0.0	-30.0	29.0	44.0	-16.0								0.000000000	0.999	1.311										121030874
19058	chr11	121030874	A	G	chr11:121030874	TECTA	tectorin alpha	SNV	0/0	0.0	33_0	33	99.0	0/1	0.38	48_30	78	99.0			rs147354818	EXONIC	YES	NM_005422.4	Transcript	protein_coding	missense_variant		15/24	NM_005422.4:c.4720A>G	NP_005413.2:p.Ile1574Val		1.0	von Willebrand factor, type D domain&von Willebrand factor, type D domain&von Willebrand factor, type D domain,von Willebrand factor, type D domain&von Willebrand factor, type D domain&von Willebrand factor, type D domain,von Willebrand factor, type D domain&von Willebrand factor, type D domain&von Willebrand factor, type D domain	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Deafness,_autosomal_dominant_12|Deafness,_autosomal_recessive_21|not_specified|not_provided	Deafness, autosomal dominant 8/12, 601543 (3), Autosomal dominant; Deafness, autosomal recessive 21, 603629 (3), Autosomal recessive	Autosomal dominant non-syndromic sensorineural deafness type DFNA;Autosomal recessive non-syndromic sensorineural deafness type DFNB	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sensorineural hearing impairment;Autosomal dominant inheritance;Sensorineural hearing impairment;Autosomal recessive inheritance		0.00115619	176.0	152224.0	1.0	33	0.97	PASS	nfe	0.00180765	123.0	0.00180765	123.0	0.001177	296.0	251486.0	1.0	99	1.0	PASS	nfe	0.00169646	193.0	0.00169646	193.0	0.0010804	168	0.001	2.0	0.00123	14.0		13.03	0.942473	0.155	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TECTA	0.0	0.0	0.0	0.0	-30.0	29.0	44.0	-16.0						0.229	0.0	0.000000000	0.999	1.311	hearing/vestibular/ear phenotype; nervous system phenotype ; behavior/neurological phenotype ; 			atrioventricular node;superior cervical ganglion;skeletal muscle;	.	cell-matrix adhesion;sensory perception of sound	extracellular region;plasma membrane;anchored component of membrane;collagen-containing extracellular matrix;extracellular exosome	extracellular matrix structural constituent	NEK4[25798074];	121030874
19062	chr11	121477938	G	T	chr11:121477938	SORL1	sortilin related receptor 1	SNV	0/1	0.39	48_32	82	99.0	0/0	0.0	36_0	36	99.0			rs774446927	EXONIC	YES	NM_003105.6	Transcript	protein_coding	missense_variant		37/48	NM_003105.6:c.5105G>T	NP_003096.2:p.Arg1702Met		1.0	Fibronectin type III&Fibronectin type III&Fibronectin type III&Fibronectin type III,Fibronectin type III&Fibronectin type III&Fibronectin type III&Fibronectin type III,Fibronectin type III&Fibronectin type III&Fibronectin type III&Fibronectin type III,Fibronectin type III&Fibronectin type III&Fibronectin type III&Fibronectin type III,Fibronectin type III&Fibronectin type III&Fibronectin type III&Fibronectin type III					Early-onset autosomal dominant Alzheimer disease	Disease-causing germline mutation(s) in	Memory impairment;Confusion;Dysgraphia;Myoclonus;Cerebral cortical atrophy;Abnormality of vision;Deposits immunoreactive to beta-amyloid protein;Neurofibrillary tangles;Intellectual disability;Hypertonia;Parkinsonism;Abnormal social behavior;Finger agnosia;Agitation;Language impairment;Semantic dementia;Aphasia;Hallucinations;Disinhibition;Seizure;Oculomotor apraxia;Ataxia		1.31468e-05	2.0	152128.0	0.0	33	0.97	PASS	amr	0.000130924	2.0	0.0	0.0	6.3632e-05	16.0	251446.0	0.0	59	0.99	PASS	amr	0.000462561	16.0	0.0	0.0	0.0000386	6	0.001	2.0	0.0014	16.0		29.7	4.227497	0.16	10	11	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationTaster_pred,MetaRNN_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred	SORL1	0.07	0.0	0.0	0.0	-39.0	46.0	37.0	-15.0						0.0875	0.02	0.000000000	0.991	1.176	nervous system phenotype ; behavior/neurological phenotype ; cardiovascular system phenotype ; muscle phenotype; homeostasis/metabolism phenotype; 			caudate nucleus;temporal lobe;amygdala;liver;prefrontal cortex;cingulate cortex;whole blood;cerebellum peduncles;cerebellum;pons;occipital lobe;subthalamic nucleus;whole brain;parietal lobe;spinal cord;globus pallidus;medulla oblongata;hypothalamus;thalamus;	.	protein targeting;protein targeting to lysosome;lipid transport;post-Golgi vesicle-mediated transport;receptor-mediated endocytosis;cholesterol metabolic process;regulation of smooth muscle cell migration;negative regulation of protein binding;negative regulation of protein oligomerization;protein localization to Golgi apparatus;negative regulation of MAP kinase activity;cellular protein metabolic process;protein retention in Golgi apparatus;positive regulation of protein catabolic process;negative regulation of neurogenesis;protein maturation;positive regulation of protein exit from endoplasmic reticulum;negative regulation of neuron death;negative regulation of amyloid-beta formation;positive regulation of choline O-acetyltransferase activity;negative regulation of tau-protein kinase activity;positive regulation of ER to Golgi vesicle-mediated transport;positive regulation of early endosome to recycling endosome transport;negative regulation of aspartic-type endopeptidase activity involved in amyloid precursor protein catabolic process;negative regulation of metalloendopeptidase activity involved in amyloid precursor protein catabolic process;positive regulation of protein localization to early endosome;negative regulation of neurofibrillary tangle assembly;positive regulation of endocytic recycling	Golgi membrane;extracellular space;nuclear envelope lumen;endosome;early endosome;endoplasmic reticulum;Golgi apparatus;trans-Golgi network;integral component of plasma membrane;endosome membrane;membrane;Golgi cisterna;low-density lipoprotein particle;recycling endosome;extracellular exosome	amyloid-beta binding;transmembrane signaling receptor activity;low-density lipoprotein particle receptor activity;protein binding;low-density lipoprotein particle binding;ADP-ribosylation factor binding	LRPAP1[17326667];APP[25643321];DYRK3[23602568];FOXI2[25609649];POU6F2[unassigned1304];RHOH[unassigned1304];APOA5[17326667];PPP1CA[22321011];GGA2[11821067];GGA1[11821067];APOE[17326667];CEP97[unassigned1312];CFTR[17110338];GLYR1[unassigned1304];	121477938
19207	chr11	124747839	G	T	chr11:124747839	ROBO3	roundabout guidance receptor 3	SNV	0|1	0.56	37_48	85	99.0	0/0	0.0	40_0	40	99.0			rs75098003,COSV101185225	EXONIC	YES	NM_022370.4	Transcript	protein_coding	missense_variant		21/28	NM_022370.4:c.2993G>T	NP_071765.2:p.Gly998Val		1.0	.,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Gaze_palsy,_familial_horizontal,_with_progressive_scoliosis_1|not_provided	Gaze palsy, familial horizontal, with progressive scoliosis, 1, 607313 (3), Autosomal recessive	Horizontal gaze palsy with progressive scoliosis	Disease-causing germline mutation(s) in	Cerebellar hypoplasia;Hypoplasia of the pons;Thoracolumbar scoliosis;Progressive ophthalmoplegia;Horizontal supranuclear gaze palsy;Autosomal recessive inheritance;Congenital onset;Sensorineural hearing impairment;Kyphosis;Cognitive impairment;Horizontal supranuclear gaze palsy;Short neck;Nystagmus;Seizure;Scoliosis		0.00168881	257.0	152178.0	0.0	32	0.97	PASS	nfe	0.00307208	209.0	0.00307208	209.0	0.00179036	407.0	227328.0	2.0	31	0.63	PASS	nfe	0.0030329	304.0	0.0030329	304.0	0.0016141	251	0.003	10.0	0.00422	48.0		24.8	3.430913	0.48	12	7	19	SIFT,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MetaRNN_pred,DEOGEN2_pred,ClinPred_pred	ROBO3	0.05	0.01	0.01	0.0	18.0	-6.0	-2.0	47.0						0.572	0.03	0.000000000	0.998	1.176	embryo phenotype; respiratory system phenotype; behavior/neurological phenotype ; mortality/aging ; nervous system phenotype ; hearing/vestibular/ear phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			.	Axon guidance	homophilic cell adhesion via plasma membrane adhesion molecules;axon guidance;axon midline choice point recognition;Roundabout signaling pathway;chemoattraction of axon;dendrite self-avoidance;commissural neuron axon guidance	plasma membrane;integral component of membrane;axon	protein binding;cell-cell adhesion mediator activity	NELL2[26586761];CCDC57[25416956;unassigned1304];LNX1[25416956];APOA1[15174051];MTUS2[25416956];PICK1[unassigned1304];HSF2BP[unassigned1304];RBMX[25416956];	124747839
19338	chr11	126276006	C	T	chr11:126276006	ST3GAL4	ST3 beta-galactoside alpha-2,3-sialyltransferase 4	SNV	0/1	0.51	35_37	72	99.0	0/0	0.0	35_0	35	99.0			rs190884962	EXONIC	YES	NM_001348397.2	Transcript	protein_coding	missense_variant		3/12	NM_001348397.2:c.19C>T	NP_001335326.1:p.Arg7Trp		1.0						.	.	.		0.00524503	798.0	152144.0	5.0	32	0.97	PASS	amr	0.00798325	122.0	0.00795401	541.0	0.00500593	785.0	156814.0	1.0	60	0.59	PASS	nfe	0.00805097	489.0	0.00805097	489.0	0.0022315	347	0.012	37.0	0.01375	131.0		18.93	1.89705		2	0	2	SIFT,PolyPhen		ST3GAL4	0.0	0.0	0.0	0.02	-35.0	-15.0	-16.0	47.0						0.422	0.44				hematopoietic system phenotype; behavior/neurological phenotype ; immune system phenotype; nervous system phenotype ; homeostasis/metabolism phenotype; cellular phenotype; 			ciliary ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;adrenal gland;parietal lobe;adrenal cortex;skeletal muscle;	Keratan sulfate biosynthesis;Glycosphingolipid biosynthesis - lactoseries;Glycan structures - biosynthesis 1;Glycan structures - biosynthesis 2	protein glycosylation;glycoprotein biosynthetic process;glycolipid biosynthetic process;oligosaccharide biosynthetic process;O-glycan processing;keratan sulfate biosynthetic process;lipid glycosylation;cognition;sialylation;protein sialylation	Golgi membrane;extracellular region;membrane;integral component of membrane;Golgi cisterna membrane	beta-galactoside (CMP) alpha-2,3-sialyltransferase activity;sialyltransferase activity;monosialoganglioside sialyltransferase activity	ARHGDIA[16169070];	126276006
19479	chr11	130066278	C	T	chr11:130066278	ST14	suppression of tumorigenicity 14	SNV	0/0	0.0	35_0	35	99.0	0/1	0.55	40_48	88	99.0				EXONIC	YES	NM_021978.4	Transcript	protein_coding	synonymous_variant		10/19	NM_021978.4:c.1158C>T	NP_068813.1:p.Tyr386%3D		1.0					Ichthyosis, congenital, autosomal recessive 11, 602400 (3), Autosomal recessive	Ichthyosis-hypotrichosis syndrome	Disease-causing germline mutation(s) in	Curly hair;Congenital ichthyosiform erythroderma;Photophobia;Autosomal recessive inheritance;Corneal opacity;Sparse and thin eyebrow;Hyperkeratosis;Sparse hair;Photophobia;Brittle hair;Pili torti;Blepharitis;Hypohidrosis;Sparse hair;Ichthyosis						33	0.96											96	0.68														7.944	0.359303		0	0	0			ST14	0.0	0.0	0.0	0.0	10.0	-29.0	-21.0	0.0						0.0733	0.85	90.883148355			endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype ; homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; digestive/alimentary phenotype; nervous system phenotype ; limbs/digits/tail phenotype; hematopoietic system phenotype; mortality/aging ; behavior/neurological phenotype ; embryo phenotype; immune system phenotype; vision/eye phenotype; 			atrioventricular node;trigeminal ganglion;	.	neural tube closure;proteolysis;keratinocyte differentiation;epithelial cell morphogenesis involved in placental branching;cornification	extracellular space;plasma membrane;integral component of plasma membrane;basolateral plasma membrane;extrinsic component of plasma membrane	endopeptidase activity;serine-type endopeptidase activity;serine-type peptidase activity	NOTCH2[25640309];CDKN2C[25640309];TGFB1[25640309];AHNAK[30021884];RGS16[21988832];MST1[22087277];PHB[25640309];STK11[25640309];CASP8[25640309];RAD51[25640309];APC[25640309];CHEK2[25640309];AKT1[25640309];IGFBP7[22750143];	130066278
19491	chr11	130286172	C	T	chr11:130286172	ADAMTS8	ADAM metallopeptidase with thrombospondin type 1 motif 8	SNV	0/0	0.0	34_0	34	99.0	0/1	0.47	68_61	129	99.0			rs760656228,COSV57296714	EXONIC	YES	NM_007037.6	Transcript	protein_coding	missense_variant		4/9	NM_007037.6:c.1150G>A	NP_008968.4:p.Gly384Arg		-1.0	Peptidase M12B, ADAM/reprolysin&Peptidase M12B, ADAM/reprolysin					.	.	.		3.28524e-05	5.0	152196.0	0.0	32	0.98	PASS	amr	6.54279e-05	1.0	1.46985e-05	1.0	7.49272e-05	14.0	186848.0	0.0	40	0.59	PASS	amr	7.21033e-05	2.0	3.74607e-05	3.0	0.0000386	6	0.0	1.0				28.8	4.121318	0.693	18	3	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,PrimateAI_pred,DEOGEN2_pred	ADAMTS8	0.05	0.0	0.0	0.0	-2.0	18.0	-2.0	-9.0						0.513	0.0	0.000000000	0.987	1.026	.			superior cervical ganglion;skeletal muscle;	.	proteolysis;negative regulation of cell population proliferation;phosphate ion transmembrane transport	collagen-containing extracellular matrix	metalloendopeptidase activity;integrin binding;heparin binding;metallopeptidase activity;zinc ion binding;low-affinity phosphate transmembrane transporter activity	.	130286172
19582	chr12	176372	G	A	chr12:176372	IQSEC3	IQ motif and Sec7 domain 3	SNV	0/1	0.34	52_27	79	99.0	0/1	0.37	41_24	65	99.0			rs782213176	EXONIC	YES	NM_001170738.2	Transcript	protein_coding	synonymous_variant		1/14	NM_001170738.2:c.324G>A	NP_001164209.1:p.Ala108%3D		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.000808052	123.0	152218.0	0.0	34	0.98	PASS	amr	0.00196232	30.0	0.00116129	79.0	0.000778527	105.0	134870.0	0.0	20	0.5	PASS	amr	0.00139768	34.0	0.000994297	53.0	0.0000064	1						6.298	0.231679		0	0	0																	0.35	0.93				skeleton phenotype; adipose tissue phenotype ; growth/size/body region phenotype; 			ciliary ganglion;temporal lobe;amygdala;prefrontal cortex;cingulate cortex;trigeminal ganglion;cerebellum peduncles;cerebellum;pons;occipital lobe;subthalamic nucleus;whole brain;atrioventricular node;parietal lobe;globus pallidus;medulla oblongata;	.	actin cytoskeleton organization;regulation of ARF protein signal transduction	cytoplasm;postsynaptic density;cell junction;postsynaptic membrane;inhibitory synapse;glycinergic synapse;GABA-ergic synapse;postsynaptic specialization of symmetric synapse	ARF guanyl-nucleotide exchange factor activity	.	176372
19585	chr12	235011	C	T	chr12:235011	IQSEC3	IQ motif and Sec7 domain 3	SNV	0|1	0.46	78_67	146	99.0	0|1	0.51	76_78	154	99.0			rs200670002	EXONIC	YES	NM_001170738.2	Transcript	protein_coding	missense_variant		3/14	NM_001170738.2:c.836C>T	NP_001164209.1:p.Thr279Met		1.0						.	.	.		0.00240467	366.0	152204.0	0.0	33	0.97	PASS	nfe	0.00398424	271.0	0.00398424	271.0	0.00237934	309.0	129868.0	3.0	16	0.45	PASS	nfe	0.00460662	228.0	0.00460662	228.0	0.0008167	127	0.002	5.0				14.76	1.219549	0.128	2	16	18	M-CAP_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	IQSEC3	0.0	0.0	0.0	0.0	-34.0	-16.0	-35.0	46.0						0.35	0.93		0.998	0.962	skeleton phenotype; adipose tissue phenotype ; growth/size/body region phenotype; 			ciliary ganglion;temporal lobe;amygdala;prefrontal cortex;cingulate cortex;trigeminal ganglion;cerebellum peduncles;cerebellum;pons;occipital lobe;subthalamic nucleus;whole brain;atrioventricular node;parietal lobe;globus pallidus;medulla oblongata;	.	actin cytoskeleton organization;regulation of ARF protein signal transduction	cytoplasm;postsynaptic density;cell junction;postsynaptic membrane;inhibitory synapse;glycinergic synapse;GABA-ergic synapse;postsynaptic specialization of symmetric synapse	ARF guanyl-nucleotide exchange factor activity	.	235011
19769	chr12	6174410	A	G	chr12:6174410	VWF	von Willebrand factor	SNV	0/1	0.43	54_40	94	99.0	0/1	0.48	42_39	81	99.0			rs780724123	EXONIC	YES	NM_000552.5	Transcript	protein_coding	missense_variant		11/52	NM_000552.5:c.1186T>C	NP_000543.3:p.Phe396Leu		-1.0	von Willebrand factor, type D domain&von Willebrand factor, type D domain&VWFC domain&VWFC domain&von Willebrand factor, type D domain				von Willebrand disease, type 1, 193400 (3), Autosomal dominant; von Willebrand disease, types 2A, 2B, 2M, and 2N, 613554 (3), Autosomal recessive, Autosomal dominant; von Willebrand disease, type 3, 277480 (3), Autosomal recessive	Von Willebrand disease type 1;Von Willebrand disease type 2A;Von Willebrand disease type 2M;Von Willebrand disease type 2B;Von Willebrand disease type 2N;Von Willebrand disease type 3	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Autosomal recessive inheritance;Menorrhagia;Variable expressivity;Epistaxis;Autosomal dominant inheritance;Thrombocytopenia;Bruising susceptibility;Bruising susceptibility;Epistaxis;Gastrointestinal hemorrhage;Autosomal dominant inheritance;Joint hemorrhage;Prolonged bleeding time;Menorrhagia;Reduced factor VIII activity;Mitral valve prolapse;Impaired platelet aggregation;Incomplete penetrance;Abnormality of the genitourinary system;Prolonged whole-blood clotting time;Aortic valve stenosis;Gastrointestinal angiodysplasia;Joint hemorrhage;Epistaxis;Impaired platelet aggregation;Menorrhagia;Reduced von Willebrand factor activity;Thrombocytopenia;Reduced factor VIII activity;Bruising susceptibility;Prolonged bleeding time;Prolonged bleeding after surgery;Autosomal recessive inheritance;Persistent bleeding after trauma						33	0.97							3.98038e-06	1.0	251232.0	0.0	100	0.97	PASS	nfe	8.79863e-06	1.0	8.79863e-06	1.0	0.0000064	1	0.0	1.0	9e-05	1.0		26.3	3.801579	0.512	15	6	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred	VWF	0.0	0.0	0.0	0.0	11.0	-6.0	-46.0	12.0						0.0306	0.0	0.000000000	0.977	1.312	digestive/alimentary phenotype; nervous system phenotype ; immune system phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; mortality/aging ; homeostasis/metabolism phenotype; cellular phenotype; 			.	Cell Communication;Focal adhesion;ECM-receptor interaction;Complement and coagulation cascades	platelet degranulation;cell adhesion;blood coagulation;blood coagulation, intrinsic pathway;hemostasis;response to wounding;platelet activation;extracellular matrix organization;cell-substrate adhesion;protein homooligomerization	extracellular region;endoplasmic reticulum;platelet alpha granule;platelet alpha granule lumen;Weibel-Palade body;collagen-containing extracellular matrix;extracellular exosome	protease binding;integrin binding;extracellular matrix structural constituent;protein binding;collagen binding;immunoglobulin binding;identical protein binding;protein homodimerization activity;protein N-terminus binding;chaperone binding	ZNF512B[15231748];MAP3K3[20936779];VWF[21857647;17895385;18182488;18492805];CACNA1A[21078624];GP1BA[12183630;15039442];CKAP4[30021884];F8[18492805];HIST1H4A[30021884];ADAMTS13[16221672;25512528;18492805];ATXN7[21078624];HIST3H3[30021884];ITGAV[1694173];RAC1[21988832];SOCS4[21988832];OPTN[23414517];	6174410
19784	chr12	6568037	T	C	chr12:6568037	TAPBPL	TAP binding protein like	SNV	0/1	0.51	68_71	139	99.0	0/1	0.47	94_84	179	99.0			rs138882385	EXONIC	YES	NM_018009.5	Transcript	protein_coding	synonymous_variant		5/7	NM_018009.5:c.1131T>C	NP_060479.3:p.Gly377%3D		1.0						.	.	.		0.00396982	604.0	152148.0	3.0	32	0.97	PASS	nfe	0.00592333	403.0	0.00592333	403.0	0.00384615	967.0	251420.0	2.0	88	1.0	PASS	nfe	0.00563635	641.0	0.00563635	641.0	0.0036205	563	0.009	30.0				7.629	0.332825		0	0	0			TAPBPL	0.09	0.01	0.04	0.24	-16.0	-1.0	18.0	-2.0						0.883	0.0	71.671666872			.			white blood cells;thyroid;liver;trigeminal ganglion;	.	immune system process;negative regulation of antigen processing and presentation of peptide antigen via MHC class I	Golgi membrane;endoplasmic reticulum membrane;plasma membrane;integral component of membrane	protein binding;protein-containing complex binding	TEPSIN[unassigned1304];PM20D2[unassigned1304];CYSRT1[unassigned1304];KRTAP10-8[unassigned1304];KRT35[unassigned1304];HLA-B[26439010];KRT34[unassigned1304];TCF4[unassigned1304];HLA-A[24163410;26439010];NOTCH2NLA[unassigned1304];KRT31[unassigned1304];GLYR1[unassigned1304];	6568037
19907	chr12	6884585	A	T	chr12:6884585	LAG3	lymphocyte activating 3	SNV	1/1	1.0	0_129	129	99.0	1/1	0.98	2_131	134	99.0			rs149434241	EXONIC	YES	NM_002286.6	Transcript	protein_coding	missense_variant		5/8	NM_002286.6:c.928A>T	NP_002277.4:p.Thr310Ser		1.0	.,Immunoglobulin-like domain&Immunoglobulin subtype	Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00583619	888.0	152154.0	5.0	33	0.97	PASS	nfe	0.00890888	606.0	0.00890888	606.0	0.00551592	1387.0	251454.0	10.0	100	1.0	PASS	nfe	0.00898604	1022.0	0.00898604	1022.0	0.0055240	859	0.008	26.0				7.717	0.340041	0.016	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LAG3	0.0	0.0	0.0	0.0	7.0	34.0	-2.0	38.0						0.399	0.11	0.000000000	0.651	-0.155	homeostasis/metabolism phenotype; behavior/neurological phenotype ; hematopoietic system phenotype; nervous system phenotype ; immune system phenotype; 			ciliary ganglion;testis - seminiferous tubule;superior cervical ganglion;	.	cell surface receptor signaling pathway;antigen processing and presentation of exogenous peptide antigen via MHC class II;negative regulation of interleukin-2 biosynthetic process;positive regulation of natural killer cell mediated cytotoxicity;negative regulation of T cell activation	plasma membrane;external side of plasma membrane;integral component of membrane	antigen binding;transmembrane signaling receptor activity;MHC class II protein binding	.	6884585
20006	chr12	9020598	A	G	chr12:9020598	A2ML1	alpha-2-macroglobulin like 1	SNV	0/1	0.39	59_39	99	99.0	0/1	0.59	42_61	104	99.0			rs201478459	EXONIC	YES	NM_144670.6	Transcript	protein_coding	missense_variant		30/36	NM_144670.6:c.3878A>G	NP_653271.3:p.Asn1293Ser		1.0	.,.,.	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_specified|not_provided	{Otitis media, susceptibility to}, 166760 (3), Autosomal dominant	Noonan syndrome	Disease-causing germline mutation(s) in	High palate;Micrognathia;Webbed neck;Abnormality of the spleen;Wide intermamillary distance;Scoliosis;Pectus carinatum;Strabismus;Pulmonary artery stenosis;Triangular face;Aplasia/Hypoplasia of the abdominal wall musculature;Dysarthria;Low posterior hairline;Coarse hair;Clinodactyly of the 5th finger;Abnormal dermatoglyphics;High forehead;Muscular hypotonia;Melanocytic nevus;Aplasia of the semicircular canal;Thickened nuchal skin fold;Radioulnar synostosis;Midface retrusion;Short stature;Enlarged thorax;Sensorineural hearing impairment;Thick lower lip vermilion;Lymphedema;Feeding difficulties in infancy;Abnormal pulmonary valve morphology;Hypogonadotropic hypogonadism;Cryptorchidism;Abnormal platelet function;Delayed skeletal maturation;Pectus excavatum;Joint hyperflexibility;Brachydactyly;Abnormality of coagulation;Thickened helices;Cystic hygroma;Muscle weakness;Arrhythmia;Hypertelorism;Low-set, posteriorly rotated ears;Nystagmus;Ptosis;Abnormal bleeding;Hepatomegaly;Proptosis;Downslanted palpebral fissures;Abnormal hair quantity;Recurrent otitis media;Autosomal dominant inheritance;Polygenic inheritance		0.000578088	88.0	152226.0	0.0	33	0.97	PASS	nfe	0.000808348	55.0	0.000808348	55.0	0.000581339	145.0	249424.0	0.0	95	1.0	PASS	nfe	0.00091036	103.0	0.00091036	103.0	0.0005273	82	0.001	3.0				2.944	0.020668	0.035	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	A2ML1	0.0	0.0	0.0	0.0	1.0	-16.0	-42.0	-26.0						0.96	0.0	0.000000000	0.001	-0.833	.			ciliary ganglion;pons;tongue;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;globus pallidus;	.	negative regulation of endopeptidase activity;regulation of endopeptidase activity	extracellular space;extracellular exosome	serine-type endopeptidase inhibitor activity;peptidase inhibitor activity	FOXD4[25609649];FOXH1[25609649];ECH1[29426014];RASSF9[24366813];NFKB1[25609649];	9020598
20140	chr12	11546253	G	A	chr12:11546253	PRB2	proline rich protein BstNI subfamily 2	SNV	0|1	0.23	78_23	101	99.0	0|1	0.23	96_28	124	99.0			rs373504228,COSV66982057	EXONIC	YES	NM_006248.4	Transcript	protein_coding	synonymous_variant		3/4	NM_006248.4:c.759C>T	NP_006239.3:p.Pro253%3D		-1.0						.	.	.		0.00254281	147.0	57810.0	0.0	9	0.08	PASS	afr	0.00570125	50.0	0.00158007	52.0	0.00204319	426.0	208498.0	0.0	48	0.92	PASS	afr	0.0210194	193.0	0.000582222	59.0	0.0000772	12	0.003	9.0				0.047	-0.586082		0	0	0			PRB2	0.0	0.0	0.0	0.0	-23.0	-50.0	-4.0	11.0						0.954	0.0				.			.	.	biological_process	cellular_component;extracellular region	molecular_function	ASPH[unassigned1304];MIEF2[unassigned1304];	11546253
20163	chr12	15679082	C	T	chr12:15679082	PTPRO	protein tyrosine phosphatase, receptor type O	SNV	0/1	0.55	30_37	67	99.0	0/1	0.57	45_60	105	99.0			rs754853238,COSV99839225	EXONIC	YES	NM_030667.3	Transcript	protein_coding	missense_variant		12/27	NM_030667.3:c.2050C>T	NP_109592.1:p.Arg684Cys		1.0	Fibronectin type III&Fibronectin type III,.				Nephrotic syndrome, type 6, 614196 (3), Autosomal recessive	Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial sclerosis;Familial idiopathic steroid-resistant nephrotic syndrome with minimal changes;Familial idiopathic steroid-resistant nephrotic syndrome with diffuse mesangial proliferation;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Focal segmental glomerulosclerosis;Edema;Variable expressivity;Nephrotic syndrome;Tubulointerstitial fibrosis;Proteinuria;Autosomal recessive inheritance;Hypoalbuminemia		6.57428e-06	1.0	152108.0	0.0	32	0.96	PASS	nfe	1.4699e-05	1.0	1.4699e-05	1.0					100	1.0									0.0	1.0	9e-05	1.0		32.0	4.670063	0.381	20	1	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MutationAssessor_pred	PTPRO	0.01	0.0	0.0	0.0	26.0	-6.0	-7.0	1.0						0.15	0.3	0.000000000	1.0	1.026	normal phenotype; cardiovascular system phenotype ; nervous system phenotype ; renal/urinary system phenotype; behavior/neurological phenotype ; 			fetal brain;dorsal root ganglion;superior cervical ganglion;globus pallidus;	.	cell morphogenesis;monocyte chemotaxis;regulation of glomerular filtration;negative regulation of glomerular filtration;protein dephosphorylation;axon guidance;negative regulation of cell-substrate adhesion;negative regulation of neuron projection development;lamellipodium assembly;glomerulus development;peptidyl-tyrosine dephosphorylation;slit diaphragm assembly;regulation of synapse organization;glomerular visceral epithelial cell differentiation;negative regulation of canonical Wnt signaling pathway;negative regulation of retinal ganglion cell axon guidance	plasma membrane;integral component of plasma membrane;integral component of membrane;apical plasma membrane;lateral plasma membrane;lamellipodium;axon;growth cone;neuron projection;dendritic spine;extracellular exosome;glutamatergic synapse;GABA-ergic synapse;integral component of postsynaptic density membrane	protein tyrosine phosphatase activity;transmembrane receptor protein tyrosine phosphatase activity;protein binding;phosphatase activity;Wnt-protein binding;protein homodimerization activity	ITGB1[28330616];SH3GL3[21900206];TFRC[28330616];PTPRO[15978577];PXN[19167335];WAS[19167335];CBL[19167335];ACTG1[16169070];CORO1C[28330616];CDH2[19167335];DPYSL4[21900206];ERBB2[19167335];CSK[19167335];MAPK3[19167335];SH3GL1[21900206];PDGFRB[19167335];NTRK1[19167335];NSF[19167335];SDF2L1[28330616];YTHDF3[28330616];PDPK1[19167335];INSR[19167335];GAB1[19167335];YWHAZ[21900206];EPOR[19167335];PDIA4[28330616];DNAJC3[28330616];TEC[19167335];DPPA4[21900206];LCK[19167335];PTK7[28330616];DNAJB11[28330616];CTNNB1[19167335];PLXNB2[28330616];HYOU1[28330616];TEK[19167335];MET[19167335;28330616];	15679082
20167	chr12	15776224	A		chr12:15776224	EPS8	epidermal growth factor receptor pathway substrate 8	sequence_alteration	0/2	0.17	14_4_6	24	79.0	0/1	0.25	18_8_4	32	99.0			rs35885542	SPLICING	YES	NM_004447.6	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	19/20		NM_004447.6:c.2226-3del			-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_specified|not_provided	?Deafness, autosomal recessive 102, 615974 (3), Autosomal recessive	Autosomal recessive non-syndromic sensorineural deafness type DFNB	Disease-causing germline mutation(s) (loss of function) in	Profound hearing impairment;Autosomal recessive inheritance;Congenital onset		0.00336078	458.0	136278.0	0.0	31	0.78	PASS	nfe	0.0033963	210.0	0.0033963	210.0	0.351351	39404.0	112150.0	0.0	26	0.6	InbreedingCoeff	sas	0.404617	5451.0	0.367872	19470.0	0.0000579,0.0000514	9,8						0.101	-0.482486		0	0	0			EPS8	0.01	0.0	0.0	0.0	24.0	-7.0	-20.0	-30.0							0.95				cellular phenotype; nervous system phenotype ; hearing/vestibular/ear phenotype; normal phenotype; behavior/neurological phenotype ; 			uterus;adipose tissue;superior cervical ganglion;	.	signal transduction;epidermal growth factor receptor signaling pathway;Rho protein signal transduction;cell population proliferation;adult locomotory behavior;regulation of cell shape;positive regulation of signal transduction;exit from mitosis;Rac protein signal transduction;regulation of actin filament length;actin cytoskeleton reorganization;regulation of Rho protein signal transduction;dendritic cell migration;behavioral response to ethanol;barbed-end actin filament capping;actin filament bundle assembly;actin crosslink formation;actin polymerization-dependent cell motility;regulation of postsynaptic membrane neurotransmitter receptor levels;positive regulation of ruffle assembly;cellular response to leukemia inhibitory factor	plasma membrane;brush border;cell cortex;postsynaptic density;NMDA selective glutamate receptor complex;cell junction;growth cone;vesicle;stereocilium;stereocilium tip;ruffle membrane;extracellular exosome;glutamatergic synapse	actin binding;SH3/SH2 adaptor activity;protein binding;Rac guanyl-nucleotide exchange factor activity;Rac GTPase binding	USP6NL[8700527];ITGB1[12606711];ITGB5[12606711];ITGB3[12606711];CD3E[17617578];CXCL2[21988832];DNALI1[16169070];C19orf25[25416956];SERPINA5[25814554];EPS8[16189514];PCM1[16189514];MAP1LC3B[21900206];BAIAP2L1[21098279;22921828];SCRN3[21988832];BORCS6[25416956];TPRN[21988832];PROSER2[21988832];FBXW5[23314863];CASK[16688213];ARMC1[21988832];CSNK2B[21988832];SOS1[16520382];ALDH7A1[21988832];CFTR[17110338];SLC27A4[21988832];SF3B3[21988832];ADAM22[21988832];CBL[25814554];TEX28[16189514];TANK[unassigned1774];EGFR[24658140];MRPL20[16169070];BLOC1S6[16189514];CCDC85B[16189514];NACC2[21988832];INPP5J[25416956];CTNNA3[21988832];RUNX1T1[25416956];ANKRD28[24255178];C6orf141[25814554];SMARCE1[25416956];XRCC6[21988832];BAIAP2[15289329;16189514;24076653;25814554;25416956;19564905;24584464];C8orf33[21900206];NFKB2[21988832];GULP1[21988832];BYSL[25416956];BCKDK[21988832];GOLGA8DP[25416956];AIMP2[16189514];ZZZ3[21988832];HOOK2[16189514];MYO15A[16169070];TDP2[21988832];RFXAP[21988832];RCAN3[25814554];RSPH14[25814554];GRB2[25416956];HNRNPC[25416956];XAGE2[25814554];MAP3K11[21988832];	15776223
20170	chr12	15784453	C	T	chr12:15784453	EPS8	epidermal growth factor receptor pathway substrate 8	SNV	0/1	0.31	60_27	87	99.0	0/1	0.56	52_65	117	99.0			rs149793749	EXONIC	YES	NM_004447.6	Transcript	protein_coding	missense_variant		18/21	NM_004447.6:c.1967G>A	NP_004438.3:p.Arg656His		-1.0	.,.,.,.,.,.,.,.,.,.,.,.,.,.	Uncertain_significance	criteria_provided,_multiple_submitters,_no_conflicts	not_provided	?Deafness, autosomal recessive 102, 615974 (3), Autosomal recessive	Autosomal recessive non-syndromic sensorineural deafness type DFNB	Disease-causing germline mutation(s) (loss of function) in	Profound hearing impairment;Autosomal recessive inheritance;Congenital onset		0.000256592	39.0	151992.0	0.0	32	0.96	PASS	nfe	0.000499809	34.0	0.000499809	34.0	0.000242726	61.0	251312.0	0.0	100	1.0	PASS	nfe	0.000484163	55.0	0.000484163	55.0	0.0002637	41						25.2	3.558331	0.111	7	14	21	PolyPhen,Polyphen2_HDIV_pred,MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	EPS8	0.0	0.04	0.0	0.0	-13.0	39.0	-17.0	20.0							0.95	0.000000000	0.949	1.026	cellular phenotype; nervous system phenotype ; hearing/vestibular/ear phenotype; normal phenotype; behavior/neurological phenotype ; 			uterus;adipose tissue;superior cervical ganglion;	.	signal transduction;epidermal growth factor receptor signaling pathway;Rho protein signal transduction;cell population proliferation;adult locomotory behavior;regulation of cell shape;positive regulation of signal transduction;exit from mitosis;Rac protein signal transduction;regulation of actin filament length;actin cytoskeleton reorganization;regulation of Rho protein signal transduction;dendritic cell migration;behavioral response to ethanol;barbed-end actin filament capping;actin filament bundle assembly;actin crosslink formation;actin polymerization-dependent cell motility;regulation of postsynaptic membrane neurotransmitter receptor levels;positive regulation of ruffle assembly;cellular response to leukemia inhibitory factor	plasma membrane;brush border;cell cortex;postsynaptic density;NMDA selective glutamate receptor complex;cell junction;growth cone;vesicle;stereocilium;stereocilium tip;ruffle membrane;extracellular exosome;glutamatergic synapse	actin binding;SH3/SH2 adaptor activity;protein binding;Rac guanyl-nucleotide exchange factor activity;Rac GTPase binding	USP6NL[8700527];ITGB1[12606711];ITGB5[12606711];ITGB3[12606711];CD3E[17617578];CXCL2[21988832];DNALI1[16169070];C19orf25[25416956];SERPINA5[25814554];EPS8[16189514];PCM1[16189514];MAP1LC3B[21900206];BAIAP2L1[21098279;22921828];SCRN3[21988832];BORCS6[25416956];TPRN[21988832];PROSER2[21988832];FBXW5[23314863];CASK[16688213];ARMC1[21988832];CSNK2B[21988832];SOS1[16520382];ALDH7A1[21988832];CFTR[17110338];SLC27A4[21988832];SF3B3[21988832];ADAM22[21988832];CBL[25814554];TEX28[16189514];TANK[unassigned1774];EGFR[24658140];MRPL20[16169070];BLOC1S6[16189514];CCDC85B[16189514];NACC2[21988832];INPP5J[25416956];CTNNA3[21988832];RUNX1T1[25416956];ANKRD28[24255178];C6orf141[25814554];SMARCE1[25416956];XRCC6[21988832];BAIAP2[15289329;16189514;24076653;25814554;25416956;19564905;24584464];C8orf33[21900206];NFKB2[21988832];GULP1[21988832];BYSL[25416956];BCKDK[21988832];GOLGA8DP[25416956];AIMP2[16189514];ZZZ3[21988832];HOOK2[16189514];MYO15A[16169070];TDP2[21988832];RFXAP[21988832];RCAN3[25814554];RSPH14[25814554];GRB2[25416956];HNRNPC[25416956];XAGE2[25814554];MAP3K11[21988832];	15784453
20171	chr12	15834240	TAA		chr12:15834240-15834242	EPS8	epidermal growth factor receptor pathway substrate 8	deletion	0/0	0.0	22_0	22	52.0	0/1	0.23	10_3	13	80.0			rs201331879	SPLICING	YES	NM_004447.6	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	2/20		NM_004447.6:c.60-6_60-4del			-1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	not_provided	?Deafness, autosomal recessive 102, 615974 (3), Autosomal recessive	Autosomal recessive non-syndromic sensorineural deafness type DFNB	Disease-causing germline mutation(s) (loss of function) in	Profound hearing impairment;Autosomal recessive inheritance;Congenital onset		0.00249115	366.0	146920.0	1.0	29	0.79	PASS	afr	0.00576586	230.0	0.000868004	58.0	0.0105929	1620.0	152932.0	1.0	27	0.57	PASS	sas	0.0213316	371.0	0.00957997	744.0	0.0010932,0.0045915	170,714						13.1	0.95255		0	0	0			EPS8	0.01	0.0	0.0	0.0	-3.0	-34.0	8.0	-49.0							0.95				cellular phenotype; nervous system phenotype ; hearing/vestibular/ear phenotype; normal phenotype; behavior/neurological phenotype ; 			uterus;adipose tissue;superior cervical ganglion;	.	signal transduction;epidermal growth factor receptor signaling pathway;Rho protein signal transduction;cell population proliferation;adult locomotory behavior;regulation of cell shape;positive regulation of signal transduction;exit from mitosis;Rac protein signal transduction;regulation of actin filament length;actin cytoskeleton reorganization;regulation of Rho protein signal transduction;dendritic cell migration;behavioral response to ethanol;barbed-end actin filament capping;actin filament bundle assembly;actin crosslink formation;actin polymerization-dependent cell motility;regulation of postsynaptic membrane neurotransmitter receptor levels;positive regulation of ruffle assembly;cellular response to leukemia inhibitory factor	plasma membrane;brush border;cell cortex;postsynaptic density;NMDA selective glutamate receptor complex;cell junction;growth cone;vesicle;stereocilium;stereocilium tip;ruffle membrane;extracellular exosome;glutamatergic synapse	actin binding;SH3/SH2 adaptor activity;protein binding;Rac guanyl-nucleotide exchange factor activity;Rac GTPase binding	USP6NL[8700527];ITGB1[12606711];ITGB5[12606711];ITGB3[12606711];CD3E[17617578];CXCL2[21988832];DNALI1[16169070];C19orf25[25416956];SERPINA5[25814554];EPS8[16189514];PCM1[16189514];MAP1LC3B[21900206];BAIAP2L1[21098279;22921828];SCRN3[21988832];BORCS6[25416956];TPRN[21988832];PROSER2[21988832];FBXW5[23314863];CASK[16688213];ARMC1[21988832];CSNK2B[21988832];SOS1[16520382];ALDH7A1[21988832];CFTR[17110338];SLC27A4[21988832];SF3B3[21988832];ADAM22[21988832];CBL[25814554];TEX28[16189514];TANK[unassigned1774];EGFR[24658140];MRPL20[16169070];BLOC1S6[16189514];CCDC85B[16189514];NACC2[21988832];INPP5J[25416956];CTNNA3[21988832];RUNX1T1[25416956];ANKRD28[24255178];C6orf141[25814554];SMARCE1[25416956];XRCC6[21988832];BAIAP2[15289329;16189514;24076653;25814554;25416956;19564905;24584464];C8orf33[21900206];NFKB2[21988832];GULP1[21988832];BYSL[25416956];BCKDK[21988832];GOLGA8DP[25416956];AIMP2[16189514];ZZZ3[21988832];HOOK2[16189514];MYO15A[16169070];TDP2[21988832];RFXAP[21988832];RCAN3[25814554];RSPH14[25814554];GRB2[25416956];HNRNPC[25416956];XAGE2[25814554];MAP3K11[21988832];	15834239
20295	chr12	21791379	C	A	chr12:21791379	LDHB	lactate dehydrogenase B	SNV	0/1	0.26	17_6	23	99.0	0/1	0.71	6_15	21	85.0			rs147896432	EXONIC	YES	NM_001315537.2	Transcript	protein_coding	synonymous_variant		6/8	NM_001315537.2:c.621G>T	NP_001302466.1:p.Val207%3D		-1.0		Uncertain_significance	criteria_provided,_single_submitter	Lactate_dehydrogenase_B_deficiency	[Lactate dehydrogenase-B deficiency], 614128 (3)	Glycogen storage disease due to lactate dehydrogenase H-subunit deficiency	Disease-causing germline mutation(s) in	.		0.000697953	105.0	150440.0	1.0	31	0.92	PASS	amr	0.00286552	43.0	0.000740521	50.0	0.000665344	167.0	250998.0	1.0	70	1.0	PASS	amr	0.00263204	91.0	0.00052843	60.0	0.0004244	66	0.009	28.0	0.00658	75.0		11.0	0.681348		0	0	0			LDHB	0.01	0.0	0.0	0.0	-19.0	25.0	11.0	0.0						0.331	0.0	91.653501902			homeostasis/metabolism phenotype; 			caudate nucleus;amygdala;temporal lobe;prefrontal cortex;cingulate cortex;pons;kidney;occipital lobe;subthalamic nucleus;tumor;parietal lobe;spinal cord;globus pallidus;hypothalamus;medulla oblongata;thalamus;	Glycolysis / Gluconeogenesis;Cysteine metabolism;Pyruvate metabolism;Propanoate metabolism	carbohydrate metabolic process;pyruvate metabolic process;oxidation-reduction process	cytoplasm;cytosol;membrane;membrane raft;extracellular exosome	L-lactate dehydrogenase activity;protein binding;identical protein binding	ATF2[22304920];LRRK2[24725412];DLST[29128334];LDHB[25416956;unassigned1304];SDCBP[unassigned1304];LDHA[21988832;25416956;unassigned1304;25910212];METTL14[29507755];TBK1[14743216];PPP4R1[26496610];TUBA1A[27291054];NUDCD1[29021621];TUBB3[27291054];RAC3[20195357];DNM1L[29128334];ATP6V0A1[27622334];JUN[25609649];VCAM1[22623428;19738201];STAT1[26966684];H2AFX[20000738];FN1[19738201];TERF1[21044950];SDHA[29128334];YWHAZ[15161933];CKAP5[26496610];PLEKHA7[28877994];MAPK13[19135240];PTBP3[22575643];SOD1[29128334];RAD52[19338310];COQ2[29128334];SOAT1[29128334];PEX5[25416956];POT1[21044950];DUX4L9[26816005];DLD[29128334];OTUB1[26752685];	21791379
20711	chr12	32875454	C	T	chr12:32875454	DNM1L	dynamin 1 like	SNV	0/1	0.23	27_8	35	99.0	0/1	0.17	37_8	46	99.0			rs118169466,COSV56773730	EXONIC	YES	NM_001278464.2	Transcript	protein_coding	synonymous_variant		10/21	NM_001278464.2:c.1005C>T	NP_001265393.1:p.Tyr335%3D		1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_specified|not_provided	Optic atrophy 5, 610708 (3), Autosomal dominant; Encephalopathy, lethal, due to defective mitochondrial peroxisomal fission 1, 614388 (3), Autosomal recessive, Autosomal dominant	DNM1L-related encephalopathy due to mitochondrial and peroxisomal fission defect;Autosomal dominant optic atrophy, classic form	Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in	Areflexia;Death in infancy;Global developmental delay;Generalized hypotonia;Feeding difficulties;Abnormal pyramidal sign;Oculomotor apraxia;Lactic acidosis;Autosomal recessive inheritance;Variable expressivity;Deeply set eye;Optic atrophy;Encephalopathy;Microcephaly;Decreased fetal movement;Pointed chin;Status epilepticus;Autosomal dominant inheritance;Cerebral atrophy;Horizontal nystagmus;Failure to thrive;Epileptic encephalopathy;Strabismus;Progressive;Atrophy/Degeneration affecting the brainstem;Nystagmus;Cataract;Hypothyroidism;Central scotoma;Skeletal muscle atrophy;Moderately reduced visual acuity;Global developmental delay;Basal ganglia calcification;Myopathy;Cerebellar atrophy;Hallucinations;Scapular winging;Migraine;Hemiparesis;Sensorimotor neuropathy;Color vision defect;Ptosis;Duane anomaly;Ataxia;Gait disturbance;Weakness of facial musculature;Diabetes mellitus;Abnormality of the periventricular white matter;Hypogonadism;Sensorineural hearing impairment;Spastic paraplegia;Seizure;Dysphagia;Fatigue;Morning glory anomaly;Areflexia;Feeding difficulties;Ophthalmoplegia;Temporal optic disc pallor;Myalgia;Optic atrophy;Corpus callosum atrophy;Pes cavus;Dementia;Macrocytic anemia;Central scotoma;Slow progression;Optic atrophy;Autosomal dominant inheritance;Tritanomaly;Slow decrease in visual acuity		0.00462616	704.0	152178.0	3.0	32	0.97	PASS	nfe	0.00758467	516.0	0.00758467	516.0	0.00519506	1305.0	251200.0	5.0	60	1.0	PASS	nfe	0.00839219	953.0	0.00839219	953.0	0.0052989	824	0.009	29.0	0.0064	73.0		8.149	0.377346		0	0	0			DNM1L	0.0	0.0	0.0	0.0	-31.0	-3.0	-25.0	1.0						0.129	0.18	98.177523203			integument phenotype ; growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; nervous system phenotype ; muscle phenotype; mortality/aging ; cardiovascular system phenotype ; behavior/neurological phenotype ; respiratory system phenotype; liver/biliary system phenotype; embryo phenotype; skeleton phenotype; vision/eye phenotype; 			pons;caudate nucleus;amygdala;occipital lobe;subthalamic nucleus;cingulate cortex;parietal lobe;globus pallidus;medulla oblongata;thalamus;	.	mitochondrial fission;release of cytochrome c from mitochondria;dynamin family protein polymerization involved in mitochondrial fission;mitochondrion organization;endoplasmic reticulum organization;apoptotic mitochondrial changes;negative regulation of mitochondrial fusion;regulation of mitochondrion organization;peroxisome fission;regulation of protein oligomerization;synaptic vesicle recycling via endosome;positive regulation of apoptotic process;positive regulation of GTPase activity;mitochondrial fragmentation involved in apoptotic process;intracellular distribution of mitochondria;synaptic vesicle endocytosis;positive regulation of protein secretion;protein complex oligomerization;protein homotetramerization;heart contraction;positive regulation of dendritic spine morphogenesis;membrane fusion;necroptotic process;mitochondrion morphogenesis;protein localization to mitochondrion;positive regulation of mitochondrial fission;mitochondrial membrane fission;positive regulation of release of cytochrome c from mitochondria;cellular response to oxygen-glucose deprivation;execution phase of apoptosis;regulation of peroxisome organization;positive regulation of synaptic vesicle endocytosis;regulation of autophagy of mitochondrion;regulation of ATP metabolic process;cellular response to thapsigargin;response to flavonoid;response to hypobaric hypoxia;positive regulation of synaptic vesicle exocytosis;positive regulation of intrinsic apoptotic signaling pathway	Golgi membrane;cytoplasm;mitochondrion;mitochondrial outer membrane;peroxisome;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;cytosol;microtubule;brush border;clathrin-coated pit;membrane;cell junction;synaptic vesicle membrane;mitochondrial membrane;protein-containing complex;intracellular membrane-bounded organelle;perinuclear region of cytoplasm;postsynapse;presynaptic endocytic zone membrane;mitochondrion-derived vesicle	GTPase activity;GTPase activator activity;protein binding;GTP binding;microtubule binding;lipid binding;Rab GTPase binding;clathrin binding;GTP-dependent protein binding;ubiquitin protein ligase binding;protein homodimerization activity;protein-containing complex binding;BH2 domain binding	HSP90AA4P[29128334];RPL30[29128334];EIF4A3[29128334];PARK7[29128334];TOMM20[29568061];TOMM22[29568061];UBE2L3[29128334];EEF1B2[29128334];PNN[29128334];POTEKP[29128334];PCMT1[29128334];TRIM28[29128334];PSMD2[29128334];RUVBL2[29128334];RUVBL1[29128334];MAGEA1[18330356];HIST1H2AE[29128334];RCC1[29128334];PLS3[29128334];MAGEA3[18330356];SH3GL1[18330356];SKP1[29128334];EIF2S3B[29128334];TPM3[29128334];ACTN1[29128334];TPM1[29128334];SCRIB[24550280];ACTN4[29128334];PDIA6[29128334];ILF2[29128334];ACLY[29128334];RBMXL2[29128334];DDX39B[29128334];MTHFD1[29128334];SUB1[29128334];CDC37[29128334];SCG3[18330356];ERH[29128334];TAGLN2[29128334];RPL27[29128334];KCTD12[29128334];HPRT1[29128334];TLN1[29128334];EZR[29128334];PFN1[29128334];PPIA[26496610;29128334];RPL28[29128334];KPNB1[29128334];LLGL2[26496610];VCP[29128334];PLGRKT[29568061];RBM8A[29128334];CDCA5[26496610];MGST3[29568061];IQGAP1[29128334];TXN[29128334];MYL12A[29128334];HSP90B1[29128334];STIP1[29128334];PRDX2[29128334];LDHB[29128334];LDHA[29128334];HSPH1[29128334];HNRNPDL[29128334];LARS[29128334];COX14[29568061];MYH11[29128334];DARS[29128334];UBE2H[19549727];XRCC6[29128334];XRCC5[29128334];HSPA4[29128334];EEF2[29128334];ESR1[21217774];PRDX6[29128334];HSP90AA5P[29128334];EIF2S1[29128334];PAICS[29128334];GFAP[29128334];SNW1[20467437];NACA[29128334];CAPRIN1[29128334];FASN[29128334];CDK1[29128334];SFXN1[29568061];RNPS1[29128334];UBA1[29128334];SAE1[29128334];HNRNPA1L2[29128334];BCL2L1[18250306;23792689];YWHAE[29128334];ARF1[29128334];YWHAB[29128334];LRRK2[22639965;22228096;23813973;24282027];PTBP1[29128334];ACTR1A[29128334];AIFM1[29568061];YWHAQ[29128334];RARS[29128334];SUMO2[29128334];DNM1L[20850011;21701560;23584531];EIF5A[29128334];CCT2[29128334];TPI1[29128334];DCD[29128334];PRMT1[29128334];PGAM1[29128334];AHSA1[29128334];SAFB[29128334];YWHAZ[29128334];SIRT3[16169070];NME1[29128334];EEF1G[29128334];PSMA4[29128334];EEF1D[29128334];PGAM5[22265414];GARS[29128334];PFDN2[29128334];HNRNPH3[29128334];PABPC1[29128334];SNRPGP15[29128334];TKT[29128334];ALDOA[29128334];DBN1[29128334];AHCY[29128334];DCTN2[29128334];SF3B6[29128334];RPL12[29128334];TIMM13[29128334];DDX21[29128334];MIEF2[21508961];MIEF1[21701560];PDHB[29128334];MFF[26358295];HSD17B10[29128334];HSPD1[21274005];GANAB[29128334];SAMM50[27059175];MAT2A[29128334];RBBP4[29128334];SAP18[29128334];CKB[29128334];BUB3[29128334];CCT8[29128334];CCT7[29128334];RTRAF[29128334];HSP90AB3P[29128334];DYNC1H1[29128334];RANBP1[29128334];RRM2[18330356];SSB[29128334];MDH2[29128334];CKMT1A[29128334];CDC5L[20467437];NAP1L1[29128334];HNRNPAB[29128334];PEX14[21525035];SOD1[29128334];DNAJA1[29128334];PSMC5[29128334];PSMC6[29128334];PSMC3[29128334];PSMC4[29128334];RPA3[29128334];PSMC1[29128334];IMPDH2[29128334];PSMC2[29128334];SERBP1[29128334];ACIN1[29128334];EIF3F[29128334];ABCE1[29128334];EIF3D[29128334];EIF3A[29128334];EIF3B[29128334];	32875454
20717	chr12	33049590	C	T	chr12:33049590	PKP2	plakophilin 2	SNV	0/1	0.47	60_55	117	99.0	0/1	0.46	47_40	87	99.0			rs143004808,CM061172	EXONIC	YES	NM_004572.4	Transcript	protein_coding	missense_variant		1/14	NM_004572.4:c.76G>A	NP_004563.2:p.Asp26Asn		-1.0	.,.	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Cardiomyopathy|Hypertrophic_cardiomyopathy|Arrhythmogenic_right_ventricular_dysplasia_9|Arrhythmogenic_right_ventricular_cardiomyopathy|not_specified|Cardiovascular_phenotype|not_provided	Arrhythmogenic right ventricular dysplasia 9, 609040 (3), Autosomal dominant	Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;Brugada syndrome;Left ventricular noncompaction	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in	Trifascicular block;Supraventricular tachycardia;Right bundle branch block;ST segment elevation;Syncope;Paroxysmal ventricular tachycardia;First degree atrioventricular block;Ventricular fibrillation;Cardiac arrest;Sick sinus syndrome;Dilatation;Autosomal dominant inheritance;Right ventricular cardiomyopathy;Ventricular arrhythmia;Syncope;Dilatation of the ventricular cavity;Sudden cardiac death;Palpitations	18414213,25741868,24033266,23861362,29288195,16567567,17556197,19955750,25224718	0.00706899	1076.0	152214.0	12.0	33	0.98	PASS	nfe	0.00911416	620.0	0.00911416	620.0	0.0084583	1427.0	168710.0	14.0	16	0.44	PASS	nfe	0.009735	709.0	0.009735	709.0	0.0057426	893	0.009	31.0	0.01089	124.0		27.9	4.026781	0.195	11	9	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,PrimateAI_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	PKP2	0.0	0.0	0.0	0.0	-5.0	15.0	-5.0	50.0						0.399	0.0	0.000000000	0.994	0.955	mortality/aging ; cardiovascular system phenotype ; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; 			superior cervical ganglion;trigeminal ganglion;	.	desmosome assembly;cell-cell junction assembly;heart development;positive regulation of sodium ion transport;keratinization;adherens junction maintenance;intermediate filament bundle assembly;maintenance of animal organ identity;ventricular cardiac muscle tissue morphogenesis;cornification;protein localization to plasma membrane;cardiac muscle cell action potential involved in contraction;ventricular cardiac muscle cell action potential;cell-cell signaling involved in cardiac conduction;cell communication by electrical coupling involved in cardiac conduction;bundle of His cell-Purkinje myocyte adhesion involved in cell communication;regulation of heart rate by cardiac conduction;cell-cell adhesion;regulation of ventricular cardiac muscle cell action potential	cornified envelope;nucleus;nucleoplasm;cytoplasm;intermediate filament;plasma membrane;cell-cell junction;adherens junction;cell-cell adherens junction;intercalated disc;integral component of membrane;cell junction;desmosome;messenger ribonucleoprotein complex	protein kinase C binding;protein binding;sodium channel regulator activity;intermediate filament binding;protein-containing complex scaffold activity;ion channel binding;alpha-catenin binding;cadherin binding;cell adhesive protein binding involved in bundle of His cell-Purkinje myocyte communication	MCM7[23764002];YWHAB[24255178];MAST3[25852190];CCDC125[unassigned1304];HSPB2[26465331];ILK[25852190];FHL3[unassigned1304];MKI67[26949251];EGFR[15657067];NCKIPSD[unassigned1304];GOLGA2[unassigned1304];SPTA1[unassigned1304];LAMP1[29568061];ERBB2[24189400];SFN[15778465];CCHCR1[unassigned1304];MARK3[12941695];GTSE1[26496610];YWHAH[17979178];NDEL1[25416956;25910212];DSP[25225338];PLEKHG4[unassigned1304];TRMT10C[18984158];ACTN3[unassigned1304];SEC16A[26496610];CARD9[unassigned1304];KRT8[10852826];SMAD9[15231748];MTUS2[25416956;unassigned1304;25910212];FOS[20195357];KRT5[10852826];RPGRIP1L[26638075];KRT31[unassigned1304];YWHAZ[12941695];CLK2[23602568];KRT18[10852826];TMEM17[26638075];RABEP1[unassigned1304];APC[26496610];HOOK2[unassigned1304];KRT14[10852826];MATR3[26496610];GTF2IRD1[26275350];VIM[10852826];ROPN1[unassigned1304];	33049590
20731	chr12	42538320	G	A	chr12:42538320	GXYLT1	glucoside xylosyltransferase 1	SNV	0|1	0.24	37_12	50	99.0	0|1	0.18	29_7	38	99.0			rs112525075,COSV55135896	EXONIC	YES	NM_173601.2	Transcript	protein_coding	synonymous_variant		1/8	NM_173601.2:c.129C>T	NP_775872.1:p.Ala43%3D		-1.0						.	.	.		0.00656696	649.0	98828.0	0.0	34	0.89	AS_VQSR	sas	0.00824176	27.0	0.00607409	262.0	4.17746e-05	3.0	71814.0	0.0	4	0.17	PASS	afr	0.00112613	1.0	7.56086e-05	2.0	0.0006624	103						13.33	0.986049		0	0	0			GXYLT1	0.0	0.0	0.0	0.0	34.0	31.0	2.0	3.0						0.217	0.99				.			ciliary ganglion;dorsal root ganglion;skin;trigeminal ganglion;superior cervical ganglion;	.	O-glycan processing	integral component of membrane	UDP-xylosyltransferase activity	RIPK2[17353931];TRAF6[17353931];CANX[29568061];FBXO11[17353931];ATG5[17353931];	42538320
20739	chr12	42538334	C	A	chr12:42538334	GXYLT1	glucoside xylosyltransferase 1	SNV	0|1	0.24	37_12	50	99.0	0|1	0.13	31_5	38	99.0			rs181558534,COSV55135912	EXONIC	YES	NM_173601.2	Transcript	protein_coding	missense_variant		1/8	NM_173601.2:c.115G>T	NP_775872.1:p.Gly39Trp		-1.0	.,.					.	.	.	30448225	0.00602986	605.0	100334.0	0.0	34	0.89	AS_VQSR	sas	0.00721587	24.0	0.00551253	242.0	1.28166e-05	1.0	78024.0	0.0	4	0.2	PASS	nfe	3.33778e-05	1.0	3.33778e-05	1.0	0.0005788	90						22.0	2.308512	0.149	4	15	19	Polyphen2_HDIV_pred,M-CAP_pred,PrimateAI_pred,ClinPred_pred	SIFT,PolyPhen,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	GXYLT1	0.0	0.0	0.0	0.0	43.0	50.0	-17.0	18.0						0.217	0.99		0.619	0.718	.			ciliary ganglion;dorsal root ganglion;skin;trigeminal ganglion;superior cervical ganglion;	.	O-glycan processing	integral component of membrane	UDP-xylosyltransferase activity	RIPK2[17353931];TRAF6[17353931];CANX[29568061];FBXO11[17353931];ATG5[17353931];	42538334
20746	chr12	42538340	C	A	chr12:42538340	GXYLT1	glucoside xylosyltransferase 1	SNV	0|1	0.21	43_12	56	99.0	0|1	0.13	31_5	38	99.0			rs1054641167,COSV55137547	EXONIC	YES	NM_173601.2	Transcript	protein_coding	missense_variant		1/8	NM_173601.2:c.109G>T	NP_775872.1:p.Gly37Cys		-1.0	.,.					.	.	.		0.00538143	546.0	101460.0	0.0	34	0.89	AS_VQSR	sas	0.00623515	21.0	0.00493554	219.0					5	0.24							0.0005659	88						19.62	1.98584	0.097	1	18	19	M-CAP_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	GXYLT1	0.0	0.0	0.0	0.0	37.0	14.0	50.0	0.0						0.217	0.99		0.13	0.001	.			ciliary ganglion;dorsal root ganglion;skin;trigeminal ganglion;superior cervical ganglion;	.	O-glycan processing	integral component of membrane	UDP-xylosyltransferase activity	RIPK2[17353931];TRAF6[17353931];CANX[29568061];FBXO11[17353931];ATG5[17353931];	42538340
20752	chr12	42538349	T	C	chr12:42538349	GXYLT1	glucoside xylosyltransferase 1	SNV	0|1	0.22	42_12	55	99.0	0|1	0.11	40_5	47	90.0			rs1217002731,COSV55137571	EXONIC	YES	NM_173601.2	Transcript	protein_coding	missense_variant		1/8	NM_173601.2:c.100A>G	NP_775872.1:p.Thr34Ala		-1.0	.,.					.	.	.		0.00448692	462.0	102966.0	0.0	34	0.89	AS_VQSR	sas	0.00473373	16.0	0.00436536	197.0					7	0.26							0.0005209	81						14.52	1.175543	0.035	0	18	18		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	GXYLT1	0.0	0.0	0.0	0.0	2.0	28.0	41.0	3.0						0.217	0.99		0.081	0.031	.			ciliary ganglion;dorsal root ganglion;skin;trigeminal ganglion;superior cervical ganglion;	.	O-glycan processing	integral component of membrane	UDP-xylosyltransferase activity	RIPK2[17353931];TRAF6[17353931];CANX[29568061];FBXO11[17353931];ATG5[17353931];	42538349
20757	chr12	42538352	C	A	chr12:42538352	GXYLT1	glucoside xylosyltransferase 1	SNV	0|1	0.2	42_11	54	99.0	0|1	0.11	40_5	47	90.0			rs1262821887,COSV55137589	EXONIC	YES	NM_173601.2	Transcript	protein_coding	stop_gained		1/8	NM_173601.2:c.97G>T	NP_775872.1:p.Gly33Ter		-1.0	.,.					.	.	.		0.0042568	440.0	103364.0	0.0	34	0.89	AS_VQSR	sas	0.00473653	16.0	0.00392624	178.0					8	0.27							0.0005080	79						36.0	6.533515		4	1	5	MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	fathmm-XF_coding_pred	GXYLT1	0.0	0.0	0.0	0.0	25.0	-1.0	2.0	0.0						0.217	0.99		0.395	0.875	.			ciliary ganglion;dorsal root ganglion;skin;trigeminal ganglion;superior cervical ganglion;	.	O-glycan processing	integral component of membrane	UDP-xylosyltransferase activity	RIPK2[17353931];TRAF6[17353931];CANX[29568061];FBXO11[17353931];ATG5[17353931];	42538352
20761	chr12	42538356	T	C	chr12:42538356	GXYLT1	glucoside xylosyltransferase 1	SNV	0|1	0.2	44_11	56	99.0	0|1	0.1	42_5	49	84.0			rs1190979768,COSV55137608	EXONIC	YES	NM_173601.2	Transcript	protein_coding	synonymous_variant		1/8	NM_173601.2:c.93A>G	NP_775872.1:p.Glu31%3D		-1.0						.	.	.		0.00392925	407.0	103582.0	0.0	34	0.89	AS_VQSR	afr	0.00443042	125.0	0.00352469	160.0					8	0.28							0.0004952	77						10.13	0.579036		0	0	0			GXYLT1	0.0	0.0	0.0	0.0	-1.0	21.0	34.0	4.0						0.217	0.99				.			ciliary ganglion;dorsal root ganglion;skin;trigeminal ganglion;superior cervical ganglion;	.	O-glycan processing	integral component of membrane	UDP-xylosyltransferase activity	RIPK2[17353931];TRAF6[17353931];CANX[29568061];FBXO11[17353931];ATG5[17353931];	42538356
20763	chr12	42538366	A	T	chr12:42538366	GXYLT1	glucoside xylosyltransferase 1	SNV	0|1	0.16	50_10	61	99.0	0|1	0.1	41_5	48	87.0			rs1480511883,COSV55141669	EXONIC	YES	NM_173601.2	Transcript	protein_coding	missense_variant		1/8	NM_173601.2:c.83T>A	NP_775872.1:p.Val28Glu		-1.0	.,.					.	.	.		0.00264227	294.0	111268.0	0.0	34	0.89	AS_VQSR	afr	0.00304555	92.0	0.0022417	110.0					9	0.29														19.68	1.99306	0.126	3	14	17	M-CAP_pred,PrimateAI_pred,BayesDel_addAF_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	GXYLT1	0.0	0.0	0.0	0.0	7.0	11.0	24.0	2.0						0.217	0.99		0.916	1.112	.			ciliary ganglion;dorsal root ganglion;skin;trigeminal ganglion;superior cervical ganglion;	.	O-glycan processing	integral component of membrane	UDP-xylosyltransferase activity	RIPK2[17353931];TRAF6[17353931];CANX[29568061];FBXO11[17353931];ATG5[17353931];	42538366
20767	chr12	42538367	C	T	chr12:42538367	GXYLT1	glucoside xylosyltransferase 1	SNV	0|1	0.16	50_10	61	99.0	0|1	0.11	40_5	47	90.0			rs749751445,COSV55140873	EXONIC	YES	NM_173601.2	Transcript	protein_coding	missense_variant		1/8	NM_173601.2:c.82G>A	NP_775872.1:p.Val28Met		-1.0	.,.					.	.	.		0.00246173	275.0	111710.0	0.0	34	0.9	AS_VQSR	afr	0.00289245	88.0	0.00211073	104.0	8.55915e-06	1.0	116834.0	0.0	9	0.29	RF				0.0	0.0	0.0000064	1						17.71	1.734204	0.093	3	15	18	M-CAP_pred,PrimateAI_pred,LIST-S2_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	GXYLT1	0.0	0.0	0.0	0.0	-2.0	10.0	-1.0	6.0						0.217	0.99		0.919	0.875	.			ciliary ganglion;dorsal root ganglion;skin;trigeminal ganglion;superior cervical ganglion;	.	O-glycan processing	integral component of membrane	UDP-xylosyltransferase activity	RIPK2[17353931];TRAF6[17353931];CANX[29568061];FBXO11[17353931];ATG5[17353931];	42538367
20771	chr12	42538371	G	C	chr12:42538371	GXYLT1	glucoside xylosyltransferase 1	SNV	0|1	0.15	50_9	59	99.0	0|1	0.09	41_4	45	45.0			rs1423027315,COSV99787642	EXONIC	YES	NM_173601.2	Transcript	protein_coding	synonymous_variant		1/8	NM_173601.2:c.78C>G	NP_775872.1:p.Leu26%3D		-1.0						.	.	.		0.00224357	255.0	113658.0	0.0	34	0.9	AS_VQSR	afr	0.00274761	85.0	0.0018901	95.0					10	0.29														10.16	0.583026		0	0	0			GXYLT1	0.0	0.0	0.0	0.0	6.0	-17.0	49.0	-10.0						0.217	0.99	8.418291941			.			ciliary ganglion;dorsal root ganglion;skin;trigeminal ganglion;superior cervical ganglion;	.	O-glycan processing	integral component of membrane	UDP-xylosyltransferase activity	RIPK2[17353931];TRAF6[17353931];CANX[29568061];FBXO11[17353931];ATG5[17353931];	42538371
20800	chr12	43826278	A		chr12:43826278	ADAMTS20	ADAM metallopeptidase with thrombospondin type 1 motif 20	deletion	0/0	0.0	39_0	39	99.0	0/1	0.2	25_8	41	99.0			rs201811876	SPLICING	YES	NM_025003.5	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	20/38		NM_025003.5:c.2932-7del			-1.0						.	.	.		0.000778416	112.0	143882.0	0.0	29	0.68	PASS	nfe	0.000751995	49.0	0.000751995	49.0	0.0670078	8107.0	120986.0	1.0	43	0.82	InbreedingCoeff_RF	sas	0.0786474	1035.0	0.0772246	4117.0	0.0000386,0.0000129,0.0999717	6,2,15546						0.182	-0.399626		0	0	0			ADAMTS20	0.09	0.0	0.0	0.0	-14.0	-6.0	19.0	-14.0						0.85	0.0				limbs/digits/tail phenotype; nervous system phenotype ; digestive/alimentary phenotype; mortality/aging ; pigmentation phenotype; embryo phenotype; cellular phenotype; craniofacial phenotype; integument phenotype ; growth/size/body region phenotype; 			.	.	proteolysis;positive regulation of signal transduction;extracellular matrix organization;negative regulation of apoptotic process;positive regulation of melanocyte differentiation	extracellular space;collagen-containing extracellular matrix	metalloendopeptidase activity;zinc ion binding	NEK4[25798074];MYC[21150319];	43826277
20840	chr12	48181902	G	A	chr12:48181902	HDAC7	histone deacetylase 7	SNV	0/1	0.58	30_42	73	99.0	0/1	0.48	54_50	104	99.0			rs143706913	EXONIC	YES	NM_001368046.1	Transcript	protein_coding	missense_variant		20/26	NM_001368046.1:c.2323C>T	NP_001354975.1:p.Pro775Ser		-1.0	.,.,.,Histone deacetylase domain,Histone deacetylase domain					.	.	.		0.00168189	256.0	152210.0	0.0	32	0.96	PASS	amr	0.00431824	66.0	0.00199882	136.0	0.00166452	417.0	250522.0	3.0	52	0.92	PASS	amr	0.00238081	82.0	0.00183755	208.0	0.0013697	213	0.005	17.0				21.5	2.219048	0.518	8	9	17	M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LRT_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	HDAC7	0.0	0.0	0.0	0.0	18.0	27.0	-5.0	-3.0						0.229	1.0	0.000000000	0.998	-0.123	craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; mortality/aging ; cardiovascular system phenotype ; embryo phenotype; 			.	.	negative regulation of transcription by RNA polymerase II;vasculogenesis;cell-cell junction assembly;protein sumoylation;negative regulation of interleukin-2 production;negative regulation of osteoblast differentiation;histone H3 deacetylation;positive regulation of cell migration involved in sprouting angiogenesis;negative regulation of NIK/NF-kappaB signaling	histone deacetylase complex;nucleus;nucleoplasm;cytoplasm;cytosol	chromatin binding;transcription corepressor activity;protein kinase C binding;protein binding;SUMO transferase activity;protein kinase binding;NAD-dependent histone deacetylase activity (H3-K14 specific);activating transcription factor binding;metal ion binding;repressing transcription factor binding;14-3-3 protein binding	YWHAE[23752268];RTKN[unassigned1312];CALCOCO2[21516116;25416956;unassigned1304];YWHAB[23752268;24255178];MAST3[unassigned1312];DENND1A[unassigned1312];CBY1[unassigned1312];ZBTB21[unassigned1312];TESK2[unassigned1312];LDB2[unassigned1304];MEOX2[unassigned1304];GOLGA6L9[unassigned1304];SIPA1L1[unassigned1312];YWHAQ[23752268];SH3PXD2A[unassigned1312];KIF13B[unassigned1312];RAC3[unassigned1304];RAC1[unassigned1304];SLC16A3[unassigned1304];YWHAG[15324660;17353931;23752268];YWHAH[17979178;23752268;26496610];MAGI1[unassigned1312];MEF2C[23752268];KSR1[unassigned1312];ACOT11[unassigned1304];ARID5A[unassigned1304];RRAS2[unassigned1304];NME4[unassigned1304];KCTD3[unassigned1312];C3orf36[unassigned1304];YWHAZ[15161933;20224040;23752268];FOXP3[17360565];KLF16[unassigned1304];NCOR2[23752268];RIPPLY1[25416956;unassigned1304];GIGYF1[unassigned1312];NCOR1[23752268];TBL1XR1[23752268];FAM173A[unassigned1304];ZNF638[unassigned1312];PRKD2[17962809];EIF4E2[unassigned1312];GLYR1[unassigned1304];HDAC3[23752268];PPM1H[unassigned1312];KRBA2[unassigned1304];EGFR[24658140];CDC42[unassigned1304];SDCBP[26787460];LIMA1[unassigned1312];MIEN1[unassigned1304];NRIP2[unassigned1304];TIAF1[unassigned1304];INPP5E[unassigned1312];SFN[15778465;23752268;18339811];TBL1X[23752268];SRGAP2[unassigned1312];LINC01600[unassigned1304];DDIT4L[unassigned1304];CGN[unassigned1312];GNG12[unassigned1304];INADL[unassigned1304];DCLK1[unassigned1312];GNMT[21516116];LRFN1[unassigned1312];REL[25416956;unassigned1304];BRWD1[unassigned1304];	48181902
20861	chr12	48381439	G	A	chr12:48381439	COL2A1	collagen type II alpha 1 chain	SNV	0/1	0.58	45_63	108	99.0	0/1	0.35	71_39	110	99.0			rs201575114	EXONIC	YES	NM_001844.5	Transcript	protein_coding	synonymous_variant		19/54	NM_001844.5:c.1176C>T	NP_001835.3:p.Arg392%3D		-1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	not_provided	?Vitreoretinopathy with phalangeal epiphyseal dysplasia, 619248 (3), Autosomal dominant; Czech dysplasia, 609162 (3), Autosomal dominant; Achondrogenesis, type II or hypochondrogenesis, 200610 (3), Autosomal dominant; Spondyloperipheral dysplasia, 271700 (3), Autosomal dominant; SMED Strudwick type, 184250 (3), Autosomal dominant; ?Epiphyseal dysplasia, multiple, with myopia and deafness, 132450 (3), Autosomal dominant; SED congenita, 183900 (3), Autosomal dominant; Kniest dysplasia, 156550 (3), Autosomal dominant; Stickler syndrome, type I, nonsyndromic ocular, 609508 (3), Autosomal dominant; Osteoarthritis with mild chondrodysplasia, 604864 (3), Autosomal dominant; Stickler syndrome, type I, 108300 (3), Autosomal dominant; Platyspondylic skeletal dysplasia, Torrance type, 151210 (3), Autosomal dominant; Spondyloepiphyseal dysplasia, Stanescu type, 616583 (3), Autosomal dominant; Avascular necrosis of the femoral head, 608805 (3), Autosomal dominant; Legg-Calve-Perthes disease, 150600 (3), Autosomal dominant	Multiple epiphyseal dysplasia, Beighton type;Legg-Calv�-Perthes disease;Czech dysplasia, metatarsal type;Kniest dysplasia;Weissenbacher- Zweymuller syndrome;Spondyloperipheral dysplasia-short ulna syndrome;Autosomal dominant rhegmatogenous retinal detachment;Spondyloepiphyseal dysplasia, Stanescu type;Mild spondyloepiphyseal dysplasia due to COL2A1 mutation with early-onset osteoarthritis;Spondyloepimetaphyseal dysplasia congenita, Strudwick type;Achondrogenesis type 2;Hypochondrogenesis;Spondylometaphyseal dysplasia, 'corner fracture' type;Spondylometaphyseal dysplasia, Schmidt type;Stickler syndrome type 1;Dysspondyloenchondromatosis;Familial avascular necrosis of femoral head;Platyspondylic dysplasia, Torrance type;Spondyloepiphyseal dysplasia congenita	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Narrow chest;Cleft palate;Limitation of joint mobility;Hearing impairment;Osteoarthritis;Abnormality of epiphysis morphology;Short neck;Broad forehead;Short stature;Retinal detachment;Scoliosis;Platyspondyly;Glaucoma;Talipes equinovarus;Cataract;Flat face;Coxa vara;Short thorax;Myopia;Micromelia;Skeletal dysplasia;Hyperlordosis;Nystagmus;Hypertelorism;Kyphosis;Limited hip movement;Impairment of activities of daily living;Groin pain;Short stepped shuffling gait;Flattened femoral head;Hip pain;Lower limb asymmetry;Hip osteoarthritis;Restrictive ventilatory defect;Vitreoretinopathy;Muscular hypotonia;Limited elbow movement;Coxa vara;Short neck;Retinal detachment;Pectus carinatum;Kyphosis;Autosomal dominant inheritance;Malar flattening;Flat face;Waddling gait;Platyspondyly;Hip dislocation;Limited hip movement;Flattened epiphysis;Cleft palate;Talipes equinovarus;Hypoplasia of the odontoid process;Cervical myelopathy;Ovoid vertebral bodies;Delayed pubic bone ossification;Myopia;Generalized hypotonia;Respiratory distress;Lumbar hyperlordosis;Delayed calcaneal ossification;Limitation of knee mobility;Barrel-shaped chest;Spondyloepiphyseal dysplasia;Scoliosis;Neonatal short-trunk short stature;Tracheomalacia;Umbilical hernia;Autosomal dominant inheritance;Hip dislocation;Enlarged joints;Coronal cleft vertebrae;Short neck;Conductive hearing impairment;Respiratory distress;Motor delay;Cleft palate;Round face;Splayed epiphyses;Myopia;Platyspondyly;Retinal detachment;Hip contracture;Gait disturbance;Lumbar kyphoscoliosis;Midface retrusion;Coxa vara;Abnormal cartilage collagen;Depressed nasal bridge;Dumbbell-shaped long bone;Inguinal hernia;Proptosis;Cataract;Recurrent otitis media;Hypoplastic pelvis;Flared metaphysis;Malar flattening;Delayed epiphyseal ossification;Flattened, squared-off epiphyses of tubular bones;Disproportionate short-trunk short stature;Autosomal dominant inheritance;Avascular necrosis of the capital femoral epiphysis;Delayed skeletal maturation;Short stature;Multifactorial inheritance;C1-C2 subluxation;Cleft palate;Metaphyseal dappling;Narrow greater sciatic notch;Pectus carinatum;Protuberant abdomen;Hypoplasia of the odontoid process;Hypoplastic pubic bone;Club-shaped proximal femur;Coxa vara;Hyperlordosis;Inguinal hernia;Autosomal dominant inheritance;Pes planus;Genu valgum;Metaphyseal irregularity;Scoliosis;Brachydactyly;Myopia;Severe short stature;Spondyloepimetaphyseal dysplasia;Platyspondyly;Delayed pubic bone ossification;Anterior rib cupping;Coxa vara;Platyspondyly;Gait disturbance;Abnormality of epiphysis morphology;Hypertelorism;Abnormality of the metaphysis;Kyphosis;Disproportionate short stature;Spondyloepimetaphyseal dysplasia;Osteoarthritis;Short thorax;Respiratory distress;Myopia;Flat face;Hyperlordosis;Retinal detachment;Genu valgum;Abnormality of the sternum;Short femoral neck;Micromelia;Talipes equinovarus;Scoliosis;Genu varum;Cleft palate;Hypoplasia of the odontoid process;Metaphyseal irregularity;Ovoid vertebral bodies;Mild short stature;Coxa vara;Hyperlordosis;Scoliosis;Recurrent fractures;Kyphosis;Genu valgum;Tetralogy of Fallot;Abnormality of the wrist;Pes planus;Hypoplasia of the odontoid process;Spondylometaphyseal dysplasia;Micromelia;Beaking of vertebral bodies;Platyspondyly;Cataract;Glaucoma;Scoliosis;Morbus Scheuermann;Osteoarthritis;Midface retrusion;Membranous vitreous appearance;Mitral valve prolapse;Bifid uvula;Cleft palate;Arachnodactyly;Kyphosis;Arthropathy;Spondyloepiphyseal dysplasia;Autosomal dominant inheritance;Submucous cleft hard palate;Blindness;Pierre-Robin sequence;Pectus excavatum;Sensorineural hearing impairment;Anteverted nares;Disproportionate tall stature;Depressed nasal bridge;Irregular femoral epiphysis;Spondylolisthesis;Retinal detachment;Malar flattening;Myopia;Conductive hearing impairment;Short stature;Micromelia;Hypoplastic pelvis;Metaphyseal dysplasia;Genu valgum;Joint dislocation;Platyspondyly;Abnormality of the wrist;Spondylometaphyseal dysplasia;Short long bone;Myopia;Kyphoscoliosis;Joint stiffness;Short stature;Platyspondyly;Knee osteoarthritis;Hip osteoarthritis;Beaking of vertebral bodies;Heberden's node;Autosomal dominant inheritance;Irregular vertebral endplates;Schmorl's node;Narrow iliac wings;Short femoral neck;Irregular vertebral endplates;Short metatarsal;Waddling gait;Growth abnormality;Arthralgia;Flat capital femoral epiphysis;Short toe;Platyspondyly;Flexion contracture;Thoracic kyphosis;Narrow femoral neck;Short metacarpal;Intervertebral space narrowing;Coxa vara;Scoliosis;Autosomal dominant inheritance;Prominent forehead;Genu varum;Narrow chest;Short foot;Pulmonary hypoplasia;Hypoplastic pelvis;Metaphyseal cupping;Short palm;Abnormality of the carpal bones;Polyhydramnios;Depressed nasal bridge;Hypoplastic scapulae;Micromelia;Cleft palate;Disproportionate short-limb short stature;Skeletal dysplasia;Short distal phalanx of finger;Hypoplasia of the capital femoral epiphysis;Abdominal distention;Malar flattening;Hydrops fetalis;Low-set ears;Platyspondyly;Short thorax;Cystic hygroma;Postaxial hand polydactyly;Aplasia/Hypoplasia of the lungs;Abnormality of cardiovascular system morphology;Micromelia;Macrocephaly;Frontal bossing;Narrow chest;Short neck;Umbilical hernia;Flat face;Hydrops fetalis;Long philtrum;Thickened nuchal skin fold;Abdominal distention;Lethal skeletal dysplasia;Short nose;Abnormal enchondral ossification;Disproportionate short-limb short stature;Anteverted nares;Polyhydramnios;Micrognathia;Femoral hernia;Arthralgia;Stiff neck;Spondyloepiphyseal dysplasia;Autosomal dominant inheritance;Platyspondyly;Beaking of vertebral bodies;Trismus;Coxa valga;Hypoplastic ilia;Kyphoscoliosis;Autosomal dominant inheritance;Asteroid hyalosis;Brachydactyly;Flat face;Conductive hearing impairment;Myopia;Coxa valga;Retinal thinning;Short stature;Epiphyseal dysplasia;Genu valgum;Cataract;Narrow mouth;Short phalanx of finger;Round face;Cartilage destruction;Skeletal muscle atrophy;Short stature;Avascular necrosis;Delayed skeletal maturation;Joint dislocation;Arthralgia;Abnormality of the dentition;Myopia;Autosomal dominant inheritance;Rhegmatogenous retinal detachment;Abnormal vitreous humor morphology;Short ribs;Protuberant abdomen;Thin ribs;Short neck;Lethal skeletal dysplasia;Macrocephaly;Flat acetabular roof;Abnormality of the abdominal wall;Neonatal short-limb short stature;Narrow chest;Severe limb shortening;Coarse facial features;Severe platyspondyly;Disc-like vertebral bodies;Metaphyseal cupping;Hypoplastic ischia;Short long bone;Hypoplastic pubic bone;Decreased cranial base ossification;Autosomal dominant inheritance;Hypoplastic ilia;Stillbirth;Broad long bones;Abdominal distention;Disproportionate short-trunk short stature;Disproportionate short-limb short stature;Absent vertebral body mineralization;Edema;Short ribs;Short long bone;Cleft palate;Hypoplastic iliac wing;Autosomal dominant inheritance;Cystic hygroma;Horizontal ribs;Polyhydramnios;Barrel-shaped chest;Hydrops fetalis;Short tubular bones of the hand;Abnormality of the foot;Coxa vara;Genu varum;Ovoid vertebral bodies;Hypoplasia of the odontoid process;Short femoral neck;Waddling gait;Spondylometaphyseal dysplasia;Autosomal dominant inheritance;Scoliosis;Pectus carinatum;Metaphyseal irregularity;Short stature;Hyperconvex vertebral body endplates;Hypoplasia of the maxilla;Arthralgia;Osteoarthritis;Mitral valve prolapse;Retinal detachment;Platyspondyly;Short nose;Sensorineural hearing impairment;Abnormality of vertebral epiphysis morphology;Skeletal dysplasia;Cleft palate;Intellectual disability;Proptosis;Myopia;Long philtrum;Visual loss;Joint hyperflexibility;Cataract;Abnormal vitreous humor morphology;Epiphyseal dysplasia;Genu valgum;Conductive hearing impairment;Anonychia;Retinal dysplasia;Myopia;Cataract;Round face;Narrow mouth;Flat face;Short palm;Short toe;Flat capital femoral epiphysis;Spondyloepiphyseal dysplasia;Short distal phalanx of the 5th finger;Kyphosis;Hypoplasia of the ulna;Flat acetabular roof;Short metatarsal;Barrel-shaped chest;Short stature;Midface retrusion;Shortening of all middle phalanges of the fingers;Limited elbow extension;Short distal phalanx of the 2nd finger;Short thumb;Short distal phalanx of finger;Autosomal dominant inheritance;Malar flattening;Acetabular spurs;Pugilistic facies;Shortening of all proximal phalanges of the fingers;Broad palm;Short foot;Sensorineural hearing impairment;Platyspondyly;Cone-shaped epiphyses of the phalanges of the hand;Short distal phalanx of the 3rd finger;Pectus carinatum;Brachydactyly;Short metacarpal;Broad thumb;Absent styloid process of ulna;Short distal phalanx of the 4th finger;Micrognathia;Osteoarthritis;Hyperlordosis;Hip dislocation;Skeletal dysplasia;Joint stiffness;Flattened, squared-off epiphyses of tubular bones;Scoliosis;Enlarged thorax;Kyphosis;Dumbbell-shaped long bone;Respiratory distress;Vitreoretinopathy;Hypoplastic pelvis;Rhizomelia;Depressed nasal bridge;Midface retrusion;Platyspondyly;Coxa vara;Flared metaphysis;Ptosis;Short thorax;Disproportionate short-trunk short stature;Myopia;Retinopathy;Cataract;Cleft palate;Tracheomalacia;Micromelia;Glaucoma;Glossoptosis;Tracheal stenosis;Hearing impairment;Round face;Ectopia lentis;Retinal detachment;Proptosis;Avascular necrosis of the capital femoral epiphysis;Autosomal dominant inheritance;Generalized osteoporosis;Glossoptosis;Malar flattening;Sensorineural hearing impairment;Osteoarthritis;Cleft palate;Arthralgia;Pectus excavatum;Pectus carinatum;Abnormal metacarpal morphology;Long philtrum;Exostoses;Micrognathia;Abnormality of fibula morphology;Delayed skeletal maturation;Anisospondyly;Pretibial blistering;Exostoses;Multiple enchondromatosis;Spondylometaphyseal dysplasia;Intellectual disability;Lower limb asymmetry;Enlarged joints;Osteoarthritis;Vertebral segmentation defect;Short stature;Abnormality of ulnar metaphysis;Skin erosion;Platyspondyly;Genu valgum;Generalized joint laxity;Joint dislocation;Cerebral calcification;Kyphoscoliosis;Metaphyseal enchondromatosis;Short stature;Limitation of joint mobility;Short metacarpal;Abnormality of vertebral epiphysis morphology;Hypoplasia of the ulna;Type E brachydactyly;Platyspondyly;Abnormality of pelvic girdle bone morphology;Abnormality of the metaphysis;Cone-shaped epiphysis;Pectus carinatum;Micromelia		0.0005128	78.0	152106.0	0.0	32	0.96	PASS	amr	0.00170269	26.0	0.000146998	10.0	0.000375269	93.0	247822.0	0.0	83	0.87	PASS	amr	0.00136509	47.0	0.000169398	19.0	0.0004566	71	0.002	7.0	0.00474	54.0		1.57	-0.083236		0	0	0			COL2A1	0.0	0.0	0.0	0.0	7.0	16.0	17.0	-10.0						0.00641	1.0	18.286834048			homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; adipose tissue phenotype ; growth/size/body region phenotype; behavior/neurological phenotype ; embryo phenotype; skeleton phenotype; renal/urinary system phenotype; immune system phenotype; vision/eye phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype ; hearing/vestibular/ear phenotype; cardiovascular system phenotype ; normal phenotype; mortality/aging ; respiratory system phenotype; 			pons;ciliary ganglion;appendix;trachea;dorsal root ganglion;uterus corpus;trigeminal ganglion;atrioventricular node;superior cervical ganglion;fetal liver;	Cell Communication;Focal adhesion;ECM-receptor interaction	skeletal system development;cartilage condensation;tissue homeostasis;endochondral ossification;chondrocyte differentiation;heart morphogenesis;proteoglycan metabolic process;central nervous system development;visual perception;sensory perception of sound;regulation of gene expression;extracellular matrix organization;collagen fibril organization;notochord development;inner ear morphogenesis;regulation of immune response;cartilage development;roof of mouth development;limb bud formation;embryonic skeletal joint morphogenesis;cartilage development involved in endochondral bone morphogenesis;otic vesicle development;cellular response to BMP stimulus;anterior head development;negative regulation of extrinsic apoptotic signaling pathway in absence of ligand	extracellular region;collagen trimer;collagen type II trimer;basement membrane;extracellular space;endoplasmic reticulum lumen;extracellular matrix;collagen-containing extracellular matrix	extracellular matrix structural constituent;extracellular matrix structural constituent conferring tensile strength;MHC class II protein binding;identical protein binding;proteoglycan binding;metal ion binding;platelet-derived growth factor binding	HYAL1[21988832];KEAP1[unassigned1304];COCH[19013156];RELA[21988832];	48381439
21110	chr12	49319159	AGC		chr12:49319159-49319161	FKBP11	FK506 binding protein 11	deletion	0/0	0.0	55_0	55	99.0	0/1	0.12	37_5	42	99.0			rs745622342	EXONIC	YES	NM_016594.3	Transcript	protein_coding	inframe_deletion		1/6	NM_016594.3:c.51_53del	NP_057678.1:p.Leu18del		-1.0						.	.	.		6.57791e-06	1.0	152024.0	0.0	32	0.96	PASS	amr	6.55222e-05	1.0	0.0	0.0	0.00111589	232.0	207906.0	0.0	47	0.67	PASS	nfe	0.00131559	123.0	0.00131559	123.0	0.0001286,0.0021864	20,340	0.006	20.0				18.42	1.829012		0	0	0			FKBP11	0.0	0.0	0.0	0.0	-3.0	-8.0	-3.0	-9.0						0.633	0.0	0.000000000			skeleton phenotype; immune system phenotype; hematopoietic system phenotype; 			white blood cells;trachea;pancreas;prostate;	.	protein peptidyl-prolyl isomerization	membrane;integral component of membrane	peptidyl-prolyl cis-trans isomerase activity	RELA[21988832];	49319158
21113	chr12	49364277	C	T	chr12:49364277	WNT10B	Wnt family member 10B	SNV	0/1	0.59	46_66	112	99.0	0/1	0.53	53_62	116	99.0			rs373412829,COSV56405244	EXONIC	YES	NM_003394.4	Transcript	protein_coding	synonymous_variant		2/5	NM_003394.4:c.36G>A	NP_003385.2:p.Ser12%3D		-1.0		Benign	criteria_provided,_single_submitter	not_provided	Tooth agenesis, selective, 8, 617073 (3), Autosomal dominant; Split-hand/foot malformation 6, 225300 (3), Autosomal recessive	Isolated split hand-split foot malformation;Oligodontia	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Sensorineural hearing impairment;Split hand;Absent hand;Finger syndactyly;Oligodactyly;Aniridia;Autosomal dominant inheritance;Dry skin;Selective tooth agenesis;Sparse hair;Sparse eyebrow;Microdontia;Split foot;Autosomal recessive inheritance;Hand oligodactyly;Toe syndactyly;Incomplete penetrance;Finger syndactyly;Foot oligodactyly;Split hand;Micrognathia;Oligodontia;Microdontia;Hypoplasia of the maxilla		0.000873885	133.0	152194.0	0.0	32	0.98	PASS	amr	0.00130839	20.0	0.000984802	67.0	0.00115079	271.0	235490.0	1.0	79	0.75	PASS	amr	0.00138338	46.0	0.00126781	134.0	0.0011511	179	0.002	5.0	0.00377	43.0		14.22	1.124044		0	0	0			WNT10B	0.0	0.0	0.0	0.0	-2.0	-47.0	-34.0	-10.0						0.764	0.0	25.600110523			muscle phenotype; behavior/neurological phenotype ; 			ciliary ganglion;caudate nucleus;pons;temporal lobe;subthalamic nucleus;cingulate cortex;atrioventricular node;parietal lobe;globus pallidus;	Wnt signaling pathway;Hedgehog signaling pathway;Melanogenesis;Basal cell carcinoma	G2/M transition of mitotic cell cycle;negative regulation of transcription by RNA polymerase II;chondrocyte differentiation;lipid metabolic process;cell cycle arrest;smoothened signaling pathway;positive regulation of cell population proliferation;regulation of signaling receptor activity;positive regulation of G2/M transition of mitotic cell cycle;myoblast differentiation involved in skeletal muscle regeneration;Wnt signaling pathway;neuron differentiation;positive regulation of bone mineralization;positive regulation of epithelial cell differentiation;regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of apoptotic process;cell fate commitment;negative regulation of fat cell differentiation;positive regulation of osteoblast differentiation;positive regulation of RNA polymerase II transcriptional preinitiation complex assembly;regulation of skeletal muscle tissue development;skeletal muscle fiber development;negative regulation of epithelial cell proliferation;protein stabilization;sensory perception of taste;positive regulation of DNA-binding transcription factor activity;positive regulation of timing of anagen;canonical Wnt signaling pathway;bone trabecula formation;fungiform papilla development;cellular response to retinoic acid;cellular response to cAMP;cellular response to parathyroid hormone stimulus;hematopoietic stem cell proliferation;positive regulation of canonical Wnt signaling pathway;negative regulation of cold-induced thermogenesis	extracellular region;extracellular space	frizzled binding;receptor ligand activity	.	49364277
21158	chr12	49722938	C		chr12:49722938	TROAP	trophinin associated protein	deletion	0/1	0.36	56_32	88	99.0	0/1	0.44	41_32	73	99.0			rs567298366	SPLICING	YES	NM_005480.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	9/14		NM_005480.4:c.1021-3del			1.0						.	.	.		0.0012857	195.0	151668.0	0.0	32	0.96	PASS	amr	0.00177445	27.0	0.00161898	110.0	0.00114918	289.0	251484.0	1.0	100	1.0	PASS	nfe	0.00167891	191.0	0.00167891	191.0	0.0010546	164	0.002	7.0	0.00228	26.0		16.41	1.524287		0	0	0			TROAP	0.01	0.18	0.0	0.0	20.0	7.0	-31.0	11.0						0.186	0.0				.			testis - seminiferous tubule;superior cervical ganglion;atrioventricular node;testis;	.	cell adhesion	cytoplasm	protein binding	TROAP[9560222];CLTC[26496610];DCAF7[27705803];KRT40[25416956];TRO[9560222];ERBB4[17360433];TP53BP2[unassigned1304];OIP5[unassigned1304];NINL[26638075];TRIM23[19060904;25416956];BANP[25416956];EGLN3[26972000];C19orf54[unassigned1304];KRT8[9560222];DYRK1A[23602568];SPICE1[26638075];DYRK1B[23602568;unassigned1304];TRAF2[25416956;unassigned1774];KRT31[25416956];NOTCH2NLA[unassigned1304];BYSL[9560222];GIGYF1[unassigned1304];KRT18[9560222];MAPRE3[21516116;25416956;unassigned1304];MAPRE1[25416956;unassigned1304];	49722937
21272	chr12	50747939	C	A	chr12:50747939	FAM186A	family with sequence similarity 186 member A	SNV	0/1	0.58	51_73	126	99.0	0/1	0.41	74_52	126	99.0				EXONIC	YES	NM_001145475.3	Transcript	protein_coding	missense_variant		4/8	NM_001145475.3:c.2676G>T	NP_001138947.1:p.Glu892Asp		-1.0	.,.					.	.	.						32	0.96											68	0.59														1.982	-0.046645	0.018	0	18	18		SIFT,PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	FAM186A	0.0	0.0	0.0	0.0	-22.0	-1.0	2.0	-25.0								51.515152495	0.009	0.104	.			.	.	.	.	.	SMARCB1[30108113];	50747939
21466	chr12	53342951	G	A	chr12:53342951	KRT18	keratin 18	SNV	0|1	0.31	27_12	39	99.0	0/0	0.0	25_0	25	0.0			rs201179094,COSV66316611	SPLICING	YES	NM_199187.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/7		NM_199187.2:c.-1-6G>A			1.0					Cirrhosis, cryptogenic, 215600 (3), Autosomal recessive; {Cirrhosis, noncryptogenic, susceptibility to}, 215600 (3), Autosomal recessive	.	.	Autosomal dominant inheritance;Cirrhosis;Increased circulating antibody level;Chronic active hepatitis;Esophageal varix;Micronodular cirrhosis;Increased level of L-fucose in urine;Autosomal recessive inheritance;Lethargy;Fever;Pulmonary arterial hypertension;Increased level of propylene glycol in blood;Hypertension;Jaundice;Abdominal distention		0.00864997	494.0	57110.0	0.0	27	0.57	AS_VQSR	afr	0.00904697	146.0	0.00720608	184.0	2.42978e-05	6.0	246936.0	0.0	83	0.99	PASS	nfe	5.40015e-05	6.0	5.40015e-05	6.0	0.0000193	3			0.00038	4.0		15.07	1.27798		0	0	0			KRT18	0.95	0.22	0.0	0.0	2.0	6.0	6.0	-27.0	0.253992180722828	0.698	5.387	4.401	9.788	0.0333	0.62				mortality/aging ; liver/biliary system phenotype; embryo phenotype; growth/size/body region phenotype; 			.	Cell Communication;Pathogenic Escherichia coli infection;EPEC	cell cycle;anatomical structure morphogenesis;viral process;keratinization;tumor necrosis factor-mediated signaling pathway;Golgi to plasma membrane CFTR protein transport;negative regulation of apoptotic process;intermediate filament cytoskeleton organization;cornification;extrinsic apoptotic signaling pathway;hepatocyte apoptotic process;cell-cell adhesion	nucleolus;cytoplasm;microtubule organizing center;cytosol;intermediate filament;cell-cell adherens junction;centriolar satellite;keratin filament;perinuclear region of cytoplasm;extracellular exosome;cell periphery	RNA binding;structural molecule activity;protein binding;scaffold protein binding;cadherin binding involved in cell-cell adhesion	ATF2[22304920];AHCTF1[30021884];CCNI[21988832];USP32[19615732];TRADD[11684708];TXNDC11[21988832];HSPB1[25277244];MEIKIN[30021884];TXN2[21988832];GOLGA2[25416956;25910212];FRAT1[21988832];METTL14[29507755];YWHAQ[10954706];PSTPIP2[26871637];MACROD1[20035625];EP300[21988832];NEFL[26871637];ARL6IP4[30021884];TEKT4[unassigned1304];BBS7[18000879];IKBKG[21988832];KPNA2[21988832];CCHCR1[unassigned1304];HRAS[21988832];KRT6C[unassigned1304;30021884];BBS4[18000879];YWHAG[20936779];KRT6A[unassigned1304];PIAS4[21988832];KRT71[unassigned1304];FGA[10954706];EXOC8[16189514];METTL3[29507755];KRT8[14756564;10954706;11684708;21988832;10852826;unassigned1304;30021884];KRT79[unassigned1304];LDOC1[16189514];IRAK3[30021884];DYNLL1[26496610];YWHAZ[15314064;20618440;19357195];HAUS1[25416956];PPM1B[17353931];HGS[16189514;26871637;unassigned1304;25910212];NME7[16189514;unassigned1304];KIAA2026[30021884];PKP2[10852826];EFHC1[unassigned1304];POT1[21988832];PKP1[10852826];CCDC42[30021884];KIFC3[unassigned1304];RAF1[15314064];CFTR[22038833];PLEC[30021884];SMARCD1[21988832];KRT81[unassigned1304];BECN1[23112296];GRN[21988832];TSG101[19549727;unassigned1304];SHC1[12577067];YTHDC1[21988832];TROAP[9560222];CCDC146[25416956];ORC5[21988832];CCNB3[30021884];CLEC3B[17353931];SYCE1[25910212];SNTG2[30021884];DNAJB6[10954706];CCDC85B[16189514];C1orf109[unassigned1304];BBS2[18000879];BBS1[18000879];GIT2[21988832];VCAM1[22623428;19738201];SEC16A[26496610];FN1[19738201];CDC5L[21988832];PDE4DIP[21988832];MCC[17353931];LILRB3[26769854];BYSL[9560222];PEX5L[30021884];CD4[30021884];KRT18[25416956];KRT15[16189514];CNTN1[30021884];GRB2[12577067];TUBGCP4[16189514];VIM[30021884];RCOR3[unassigned1304];	53342951
21531	chr12	53343092	G	T	chr12:53343092	KRT18	keratin 18	SNV	0/1	0.16	49_9	58	99.0	0/0	0.0	44_0	44	99.0			rs1437036447	EXONIC	YES	NM_199187.2	Transcript	protein_coding	synonymous_variant		2/8	NM_199187.2:c.135G>T	NP_954657.1:p.Arg45%3D		1.0					Cirrhosis, cryptogenic, 215600 (3), Autosomal recessive; {Cirrhosis, noncryptogenic, susceptibility to}, 215600 (3), Autosomal recessive	.	.	Autosomal dominant inheritance;Cirrhosis;Increased circulating antibody level;Chronic active hepatitis;Esophageal varix;Micronodular cirrhosis;Increased level of L-fucose in urine;Autosomal recessive inheritance;Lethargy;Fever;Pulmonary arterial hypertension;Increased level of propylene glycol in blood;Hypertension;Jaundice;Abdominal distention		0.00537769	732.0	136118.0	0.0	39	0.98	AS_VQSR	afr	0.00595013	220.0	0.00504002	306.0					61	0.97											9e-05	1.0		11.98	0.804102		0	0	0			KRT18	0.0	0.0	0.0	0.0	24.0	-22.0	-2.0	30.0						0.0333	0.62	0.737567813			mortality/aging ; liver/biliary system phenotype; embryo phenotype; growth/size/body region phenotype; 			.	Cell Communication;Pathogenic Escherichia coli infection;EPEC	cell cycle;anatomical structure morphogenesis;viral process;keratinization;tumor necrosis factor-mediated signaling pathway;Golgi to plasma membrane CFTR protein transport;negative regulation of apoptotic process;intermediate filament cytoskeleton organization;cornification;extrinsic apoptotic signaling pathway;hepatocyte apoptotic process;cell-cell adhesion	nucleolus;cytoplasm;microtubule organizing center;cytosol;intermediate filament;cell-cell adherens junction;centriolar satellite;keratin filament;perinuclear region of cytoplasm;extracellular exosome;cell periphery	RNA binding;structural molecule activity;protein binding;scaffold protein binding;cadherin binding involved in cell-cell adhesion	ATF2[22304920];AHCTF1[30021884];CCNI[21988832];USP32[19615732];TRADD[11684708];TXNDC11[21988832];HSPB1[25277244];MEIKIN[30021884];TXN2[21988832];GOLGA2[25416956;25910212];FRAT1[21988832];METTL14[29507755];YWHAQ[10954706];PSTPIP2[26871637];MACROD1[20035625];EP300[21988832];NEFL[26871637];ARL6IP4[30021884];TEKT4[unassigned1304];BBS7[18000879];IKBKG[21988832];KPNA2[21988832];CCHCR1[unassigned1304];HRAS[21988832];KRT6C[unassigned1304;30021884];BBS4[18000879];YWHAG[20936779];KRT6A[unassigned1304];PIAS4[21988832];KRT71[unassigned1304];FGA[10954706];EXOC8[16189514];METTL3[29507755];KRT8[14756564;10954706;11684708;21988832;10852826;unassigned1304;30021884];KRT79[unassigned1304];LDOC1[16189514];IRAK3[30021884];DYNLL1[26496610];YWHAZ[15314064;20618440;19357195];HAUS1[25416956];PPM1B[17353931];HGS[16189514;26871637;unassigned1304;25910212];NME7[16189514;unassigned1304];KIAA2026[30021884];PKP2[10852826];EFHC1[unassigned1304];POT1[21988832];PKP1[10852826];CCDC42[30021884];KIFC3[unassigned1304];RAF1[15314064];CFTR[22038833];PLEC[30021884];SMARCD1[21988832];KRT81[unassigned1304];BECN1[23112296];GRN[21988832];TSG101[19549727;unassigned1304];SHC1[12577067];YTHDC1[21988832];TROAP[9560222];CCDC146[25416956];ORC5[21988832];CCNB3[30021884];CLEC3B[17353931];SYCE1[25910212];SNTG2[30021884];DNAJB6[10954706];CCDC85B[16189514];C1orf109[unassigned1304];BBS2[18000879];BBS1[18000879];GIT2[21988832];VCAM1[22623428;19738201];SEC16A[26496610];FN1[19738201];CDC5L[21988832];PDE4DIP[21988832];MCC[17353931];LILRB3[26769854];BYSL[9560222];PEX5L[30021884];CD4[30021884];KRT18[25416956];KRT15[16189514];CNTN1[30021884];GRB2[12577067];TUBGCP4[16189514];VIM[30021884];RCOR3[unassigned1304];	53343092
21584	chr12	53877168	C	G	chr12:53877168	MAP3K12	mitogen-activated protein kinase kinase kinase 12	SNV	0/1	0.54	38_45	83	99.0	0/1	0.39	48_31	79	99.0			rs116442897	EXONIC	YES	NM_001193511.2	Transcript	protein_coding	missense_variant		10/14	NM_001193511.2:c.1578G>C	NP_001180440.1:p.Arg526Ser		-1.0	.,.,.					.	.	.		1.31468e-05	2.0	152128.0	0.0	32	0.97	PASS	eas	0.00038625	2.0	0.0	0.0	3.97668e-06	1.0	251466.0	0.0	87	1.0	PASS	eas	5.43656e-05	1.0	0.0	0.0	0.0000129	2						24.2	3.236367	0.11	8	13	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,ClinPred_pred,LIST-S2_pred	Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MAP3K12	0.0	0.0	0.0	0.04	-35.0	24.0	-3.0	-35.0						0.0529	1.0	0.000000000	0.995	1.026	cellular phenotype; homeostasis/metabolism phenotype; vision/eye phenotype; mortality/aging ; nervous system phenotype ; 			pons;whole brain;trigeminal ganglion;cingulate cortex;skeletal muscle;cerebellum peduncles;cerebellum;	MAPK signaling pathway	MAPK cascade;protein phosphorylation;JNK cascade;activation of JNKK activity;activation of JUN kinase activity;histone phosphorylation;peptidyl-serine phosphorylation;peptidyl-threonine phosphorylation;intracellular signal transduction;positive regulation of transcription, DNA-templated;protein autophosphorylation;positive regulation of ERK1 and ERK2 cascade;negative regulation of motor neuron apoptotic process	cytoplasm;cytosol;plasma membrane;membrane;growth cone	protein kinase activity;protein serine/threonine kinase activity;JUN kinase kinase kinase activity;protein binding;ATP binding;protein kinase binding;protein homodimerization activity	HSP90AB1[22939624];TSC22D1[16169070];RPL18A[16169070];RGS1[16169070];MAPK6[21900206];FRA10AC1[16169070];EGFR[20029029];FTL[16169070];	53877168
21623	chr12	54910758	G	A	chr12:54910758	NCKAP1L	NCK associated protein 1 like	SNV	0/1	0.54	25_29	54	99.0	0/1	0.42	32_23	55	99.0			rs140540603	EXONIC	YES	NM_005337.5	Transcript	protein_coding	synonymous_variant		11/31	NM_005337.5:c.1077G>A	NP_005328.2:p.Pro359%3D		1.0					Immunodeficiency 72 with autoinflammation, 618982 (3), Autosomal recessive	.	.	.		0.000256343	39.0	152140.0	0.0	32	0.95	PASS	amr	0.000589159	9.0	0.000176398	12.0	0.000425488	107.0	251476.0	0.0	70	1.0	PASS	amr	0.00176341	61.0	0.000228559	26.0	0.0003987	62	0.003	9.0				11.07	0.689931		0	0	0			NCKAP1L	0.0	0.0	0.01	0.0	2.0	18.0	18.0	10.0						0.664	0.99	2.249973002			endocrine/exocrine gland phenotype; growth/size/body region phenotype; cellular phenotype; immune system phenotype; homeostasis/metabolism phenotype; respiratory system phenotype; liver/biliary system phenotype; reproductive system phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; renal/urinary system phenotype; 			pons;white blood cells;superior cervical ganglion;trigeminal ganglion;skeletal muscle;bone marrow;	Regulation of actin cytoskeleton	cell morphogenesis;B cell homeostasis;myeloid cell homeostasis;chemotaxis;cell migration;maintenance of cell polarity;cell projection assembly;neutrophil chemotaxis;positive regulation of actin filament polymerization;cortical actin cytoskeleton organization;positive regulation of B cell proliferation;activation of protein kinase activity;negative regulation of interleukin-17 production;negative regulation of interleukin-6 production;positive regulation of cell adhesion mediated by integrin;erythrocyte homeostasis;negative regulation of myosin-light-chain-phosphatase activity;Fc-gamma receptor signaling pathway involved in phagocytosis;positive regulation of T cell proliferation;positive regulation of phosphorylation;response to drug;T cell homeostasis;negative regulation of apoptotic process;neutrophil degranulation;positive regulation of CD4-positive, alpha-beta T cell differentiation;positive regulation of CD8-positive, alpha-beta T cell differentiation;positive regulation of GTPase activity;positive regulation of B cell differentiation;positive regulation of gamma-delta T cell differentiation;positive regulation of lymphocyte differentiation;positive regulation of erythrocyte differentiation;vascular endothelial growth factor receptor signaling pathway;neuron projection morphogenesis;erythrocyte development;B cell receptor signaling pathway;positive regulation of phagocytosis, engulfment;protein-containing complex assembly;actin polymerization-dependent cell motility;positive regulation of neutrophil chemotaxis	cytosol;plasma membrane;integral component of plasma membrane;membrane;secretory granule membrane;SCAR complex;extracellular exosome;ficolin-1-rich granule membrane	GTPase activator activity;protein binding;protein kinase activator activity;protein-containing complex binding;Rac GTPase binding	NOTCH1[23022380];HIST3H3[30021884];GAS7[16055720];	54910758
21654	chr12	55820959		A	chr12:55820958-55820959	OR6C76	olfactory receptor family 6 subfamily C member 76	insertion	0/0	0.07	23_2	30	15.0	0/1	0.4	15_10	25	99.0			rs57387180	EXONIC	YES	NM_001005183.1	Transcript	protein_coding	frameshift_variant		1/1	NM_001005183.1:c.933dup	NP_001005183.1:p.His312ThrfsTer?		1.0						.	.	.		0.00135398	188.0	138850.0	0.0	27	0.71	PASS	eas	0.00622665	30.0	0.000865869	55.0	0.115986	13286.0	114548.0	0.0	19	0.48	InbreedingCoeff	eas	0.238266	1929.0	0.105462	5901.0	0.0001286,0.0000193,0.0824995,0.0001608,0.0001158,0.0000129	20,3,12829,25,18,2						24.7	3.424758		0	0	0			OR6C76	0.01	0.01	0.0	0.01	2.0	3.0	-29.0	-42.0						0.806	0.0	51.515152495			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	55820958
21655	chr12	55846489	C	A	chr12:55846489	OR6C2	olfactory receptor family 6 subfamily C member 2	SNV	0/1	0.5	61_64	127	99.0	0/1	0.42	68_50	118	99.0			rs138582074,COSV59515875	EXONIC	YES	NM_054105.2	Transcript	protein_coding	synonymous_variant		2/2	NM_054105.2:c.492C>A	NP_473446.1:p.Leu164%3D		1.0						.	.	.		0.00349899	532.0	152044.0	7.0	32	0.97	PASS	amr	0.0082688	126.0	0.00248566	169.0	0.0041985	1054.0	251042.0	11.0	100	1.0	PASS	amr	0.00668712	231.0	0.00292722	332.0	0.0034404	535	0.004	14.0				0.026	-0.664738		0	0	0			OR6C2	0.0	0.0	0.0	0.0	2.0	36.0	2.0	46.0						0.685	0.66	7.271167287			.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;sensory perception of smell;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	55846489
21879	chr12	57864531	G	T	chr12:57864531	GLI1	GLI family zinc finger 1	SNV	0/1	0.5	78_79	157	99.0	0/1	0.51	80_84	164	99.0			rs138680284	EXONIC	YES	NM_005269.3	Transcript	protein_coding	missense_variant		12/12	NM_005269.3:c.2008G>T	NP_005260.1:p.Ala670Ser		1.0	.,.,.,.				Polydactyly, preaxial I, 174400 (3), Autosomal recessive; Polydactyly, postaxial, type A8, 618123 (3), Autosomal recessive	Ellis Van Creveld syndrome	Disease-causing germline mutation(s) (loss of function) in	Neonatal short-limb short stature;Capitate-hamate fusion;Delayed skeletal maturation;Hypoplastic toenails;Abnormal morphology of female internal genitalia;Hand polydactyly;Aplasia/Hypoplasia of the lungs;Cubitus valgus;Hypospadias;Atrioventricular canal defect;Hydroureter;Strabismus;Emphysema;Abnormal oral frenulum morphology;Situs inversus totalis;Failure to thrive;Hypodontia;Atrial septal defect;Abnormal heart valve morphology;Delayed eruption of teeth;Acute leukemia;Intellectual disability;Synostosis of carpal bones;Abnormal hair quantity;Abnormal oral mucosa morphology;Abnormality of pelvic girdle bone morphology;Foot polydactyly;Cryptorchidism;Genu valgum;Thin vermilion border;Abnormality of bone marrow cell morphology;Short distal phalanx of finger;Narrow chest;Ventricular septal defect;Epispadias;Conical incisor;Intrauterine growth retardation;Microdontia;Micromelia;Abnormal fingernail morphology;Renal hypoplasia/aplasia;Short thorax;Nail dysplasia;Partial duplication of thumb phalanx;Radial deviation of thumb terminal phalanx;Autosomal recessive inheritance;Autosomal dominant inheritance;Preaxial hand polydactyly;Autosomal recessive inheritance;Genu valgum;Short stature;Postaxial polydactyly		0.000565039	86.0	152202.0	0.0	32	0.98	PASS	nfe	0.000999471	68.0	0.000999471	68.0	0.000707151	176.0	248886.0	0.0	42	0.95	PASS	nfe	0.00123153	138.0	0.00123153	138.0	0.0007717	120	0.002	8.0	0.00271	5.0		13.45	1.003738	0.022	1	18	19	MutationTaster_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	GLI1	0.0	0.0	0.0	0.0	-41.0	4.0	-41.0	-22.0						0.786	0.0	0.000000000	0.639	1.176	neoplasm; reproductive system phenotype; normal phenotype; mortality/aging ; respiratory system phenotype; behavior/neurological phenotype ; embryo phenotype; renal/urinary system phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype ; endocrine/exocrine gland phenotype; growth/size/body region phenotype; cellular phenotype; 			testis - interstitial;superior cervical ganglion;	Hedgehog signaling pathway;Basal cell carcinoma	osteoblast differentiation;smoothened signaling pathway;spermatogenesis;ventral midline development;positive regulation of cell population proliferation;regulation of smoothened signaling pathway;response to wounding;epidermal cell differentiation;dorsal/ventral pattern formation;proximal/distal pattern formation;cerebellar cortex morphogenesis;smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation;pituitary gland development;lung development;prostate gland development;regulation of osteoblast differentiation;positive regulation of DNA replication;positive regulation of smoothened signaling pathway;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;digestive tract morphogenesis;notochord regression;positive regulation of cardiac muscle cell proliferation;canonical Wnt signaling pathway;negative regulation of canonical Wnt signaling pathway;liver regeneration;positive regulation of cell cycle G1/S phase transition;regulation of hepatocyte proliferation	nucleus;nucleoplasm;cytoplasm;cytosol;axoneme;ciliary tip;ciliary base	RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;chromatin binding;protein binding;microtubule binding;transcription regulatory region DNA binding;metal ion binding	YWHAE[19996099];CATSPER1[unassigned1304];TTC26[25609649];PRKAA2[25416956];MRE11[25609649];KIAA1211[25609649];CRYBA4[25910212];GCC1[25416956];SNX33[25609649];GLI1[25609649];AQP1[unassigned1304];FXR1[25609649];IFT74[25609649];ZMYM3[25609649];STK36[10806483;25241761];SUFU[10564661;22439934;25241761;24217340;24311597;25609649;unassigned1304];HIST1H1E[25490446];VHL[23395608];TRIM27[25609649];TRIM42[25416956];PRKCI[23446420];SMARCC2[25609649];RPL21[25609649];KIF7[25609649];SIRT1[25490446];SMARCA4[25609649];ITCH[20818436];RAD50[25609649];HIST1H4A[25490446];DES[25609649];RPS6KB1[22439934];P4HA1[25609649];CDK4[22094256];IFT81[25609649];PIN1[unassigned1304];BCOR[25490446];ALLC[25609649];TP53[25609649];FARSB[25609649];	57864531
21889	chr12	57909119	A	C	chr12:57909119	MARS	methionyl-tRNA synthetase	SNV	0/1	0.57	25_33	58	99.0	0/1	0.55	23_28	51	99.0			rs140573721	SPLICING	YES	NM_004990.4	Transcript	protein_coding	splice_region_variant,synonymous_variant		18/21	NM_004990.4:c.2391A>C	NP_004981.2:p.Thr797%3D		1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Interstitial_lung_and_liver_disease|Charcot-Marie-Tooth_disease,_axonal,_type_2u|Charcot-Marie-Tooth_disease|not_specified|not_provided		Autosomal recessive spastic paraplegia type 70;Autosomal dominant Charcot-Marie-Tooth disease type 2U;Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	.		0.000689764	105.0	152226.0	0.0	32	0.97	PASS	amr	0.00124329	19.0	0.000926035	63.0	0.000776191	193.0	248650.0	0.0	38	0.95	PASS	nfe	0.00109636	124.0	0.00109636	124.0	0.0007653	119						11.64	0.760901		0	0	0			MARS	0.05	0.0	0.0	0.26	-16.0	2.0	-32.0	0.0	9.3235239264681e-05	0.04	6.049	-0.377	5.672	0.963	0.0	2.249973002			.			pons;ciliary ganglion;testis - seminiferous tubule;trigeminal ganglion;superior cervical ganglion;cingulate cortex;parietal lobe;testis;cerebellum;	Methionine metabolism;Selenoamino acid metabolism;Aminoacyl-tRNA biosynthesis	tRNA aminoacylation for protein translation;methionyl-tRNA aminoacylation;cellular response to starvation;rRNA transcription;cellular response to insulin stimulus;cellular response to platelet-derived growth factor stimulus;cellular response to epidermal growth factor stimulus;positive regulation of transcription of nucleolar large rRNA by RNA polymerase I	nucleolus;cytoplasm;cytosol;membrane;aminoacyl-tRNA synthetase multienzyme complex;extracellular exosome	tRNA binding;methionine-tRNA ligase activity;ATP binding	USH1C[30021884];ILK[17353931];DLST[29128334];DUX4[26816005];RELA[14743216];PPM1F[16169070];MAP1LC3A[20562859];MYC[17353931;17314511];OXER1[30021884];IKBKG[14743216];MAP3K3[14743216];GABARAPL2[20562859];HSP90AA1[10913161];JUN[25609649];MAP3K1[14743216];BRF2[17353931];VCAM1[22623428];PDHA1[29128334];TFE3[17353931];HLA-B[17353931];CASK[21988832];MCC[17353931];PRKAB1[17353931];ESR1[25604459];NFKB2[14743216];TNFRSF10D[17353931];WRAP73[17353931];PPP5C[25036637];COQ2[29128334];RPS27[21900206];HNRNPUL1[16169070];TNNT1[21900206];GIPC1[17353931];TRAF6[17353931];MDM2[20195357];PKN2[26496610];EEF1E1[24212136];	57909119
21913	chr12	58131251	G	T	chr12:58131251	AGAP2	ArfGAP with GTPase domain, ankyrin repeat and PH domain 2	SNV	0/1	0.56	47_60	107	99.0	0/1	0.59	34_48	82	99.0			rs201146586	EXONIC	YES	NM_001122772.3	Transcript	protein_coding	missense_variant		1/19	NM_001122772.3:c.779C>A	NP_001116244.1:p.Ala260Asp		-1.0						.	.	.		0.000926997	141.0	152104.0	0.0	32	0.98	PASS	sas	0.0018649	9.0	0.00149996	102.0	0.00110419	264.0	239090.0	3.0	70	0.83	PASS	nfe	0.00176451	189.0	0.00176451	189.0	0.0010096	157	0.003	9.0				22.7	2.594254	0.101	1	16	17	SIFT	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	AGAP2	0.0	0.0	0.0	0.0	-33.0	-6.0	19.0	2.0						0.494	1.0	0.000000000	0.807	1.085	liver/biliary system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; integument phenotype ; 			caudate nucleus;temporal lobe;amygdala;prefrontal cortex;trigeminal ganglion;cingulate cortex;superior cervical ganglion;cerebellum;pons;occipital lobe;subthalamic nucleus;atrioventricular node;parietal lobe;globus pallidus;medulla oblongata;	.	protein transport;negative regulation of protein catabolic process;negative regulation of neuron apoptotic process;positive regulation of GTPase activity;positive regulation of 1-phosphatidylinositol-3-kinase activity	nucleus;nucleolus;cytoplasm;mitochondrion;membrane;extracellular exosome	GTPase activity;GTPase activator activity;protein binding;GTP binding;metal ion binding	STAT5A[20075866];KRT17[30021884];INSR[21720388];M-RIP[20368287];	58131251
21957	chr12	62783462	A	G	chr12:62783462	USP15	ubiquitin specific peptidase 15	SNV	0/0	0.0	5_0	5	15.0	0/1	0.33	6_3	9	57.0			rs61760205,COSV99738209	EXONIC	YES	NM_001252078.2	Transcript	protein_coding	synonymous_variant		13/22	NM_001252078.2:c.1635A>G	NP_001239007.1:p.Glu545%3D		1.0						.	.	.		0.00469132	714.0	152196.0	2.0	32	0.97	PASS	nfe	0.00798271	543.0	0.00798271	543.0	0.00428415	1073.0	250458.0	5.0	61	0.96	PASS	nfe	0.00733853	831.0	0.00733853	831.0	0.0041478	645	0.009	28.0	0.0087	99.0		10.5	0.621772		0	0	0			USP15	0.02	0.0	0.0	0.0	-48.0	-39.0	15.0	17.0						0.482	0.99	41.356491622			mortality/aging ; hematopoietic system phenotype; immune system phenotype; 			superior cervical ganglion;trigeminal ganglion;fetal liver;skeletal muscle;	.	ubiquitin-dependent protein catabolic process;transforming growth factor beta receptor signaling pathway;protein deubiquitination;BMP signaling pathway;monoubiquitinated protein deubiquitination;histone H2B conserved C-terminal lysine deubiquitination;pathway-restricted SMAD protein phosphorylation	nucleus;cytoplasm;mitochondrion;cytosol	cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;transforming growth factor beta receptor binding;protein binding;thiol-dependent ubiquitinyl hydrolase activity;identical protein binding;SMAD binding;ubiquitin modification-dependent histone binding	CD40[17353931];MCM7[unassigned1312];FAM107A[17353931];CALML3[19615732];SMC3[unassigned1312];PHB2[17353931];GOLGA2[unassigned1304];PPP4R2[unassigned1312];ME2[17353931];SPDL1[25416956];LGALS7[19615732];TRIM21[25416956];SOX4[unassigned1312];VSIG8[19615732];DFFA[17353931];ADSL[19615732];PGAM2[19615732];TEX11[unassigned1304];KRT35[19615732];KRT34[19615732];PPP4R3A[unassigned1312];ANK3[unassigned1312];EPS15L1[unassigned1312];KRT31[19615732];SMC1A[unassigned1312];GAPVD1[unassigned1312];RNF40[19615732];BCR[unassigned1312];PRPF4[19615732];MYH2[19615732];PRPF3[19615732];GEMIN4[unassigned1304];TUT1[19615732];MCM4[unassigned1312];PPIH[19615732];RELCH[unassigned1312];MCM6[unassigned1312];ALDOA[19615732];MYH4[19615732];BIRC2[23524849];MAD1L1[25416956;unassigned1304];BIRC3[23524849];MCM2[unassigned1312];LRRC15[19615732];KRT81[19615732];GTF3C2[unassigned1312];USP15[22001210];PSMD11[19615732];GTF3C4[unassigned1312];NOTCH1[23022380];ATL3[26496610];URM1[21209336];MEPCE[19615732];KRT85[19615732];SELENBP1[19615732];KRT33B[19615732];BAG6[26496610];SBNO1[unassigned1312];TCEAL4[26496610];UBC[19373254];MKNK2[26496610];HSF1[unassigned1312];CSTF1[19615732];CKB[19615732];PIBF1[unassigned1304];SPAG9[unassigned1312];IVNS1ABP[unassigned1312];CDK11A[unassigned1312];SGTB[26496610];CCDC57[25416956];SORT1[26496610];CARD9[25416956];TMEM132A[26496610];PLK1[27173435;unassigned1312];INCA1[21750715];FN1[19738201];CFLAR[17353931];UBE2G2[17353931];LSM4[19615732];LSM2[19615732];SEM1[24811749];GOLGA6A[unassigned1304];LSM8[19615732];WEE1[unassigned1312];NEURL4[29426014];LSM6[19615732];FABP4[19615732];ID1[26496610];PRPF31[19615732];NOP53[27824081];FERMT3[26496610];ATG2B[unassigned1312];	62783462
22072	chr12	70965009	G	A	chr12:70965009	PTPRB	protein tyrosine phosphatase, receptor type B	SNV	0/1	0.45	55_46	102	99.0	0/0	0.0	38_0	38	99.0			rs149998223	EXONIC	YES	NM_001109754.4	Transcript	protein_coding	missense_variant		13/34	NM_001109754.4:c.3167C>T	NP_001103224.1:p.Thr1056Ile		-1.0	.,Fibronectin type III&Fibronectin type III&Fibronectin type III,.,.,Fibronectin type III&Fibronectin type III&Fibronectin type III,Fibronectin type III&Fibronectin type III&Fibronectin type III,Fibronectin type III&Fibronectin type III&Fibronectin type III					.	.	.		0.00118276	180.0	152186.0	0.0	32	0.97	PASS	amr	0.00418793	64.0	0.00148442	101.0	0.00145481	362.0	248830.0	0.0	63	0.99	PASS	amr	0.00400046	138.0	0.00178372	201.0	0.0013440	209	0.006	19.0	0.00326	6.0		27.2	3.944437	0.443	13	8	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	PTPRB	0.0	0.0	0.0	0.0	-9.0	23.0	5.0	-3.0						0.753	0.94	0.000000000	0.974	1.176	homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; growth/size/body region phenotype; integument phenotype ; cardiovascular system phenotype ; mortality/aging ; embryo phenotype; 			atrioventricular node;trigeminal ganglion;superior cervical ganglion;skeletal muscle;globus pallidus;	Adherens junction	angiogenesis;protein dephosphorylation;phosphate-containing compound metabolic process;dephosphorylation;peptidyl-tyrosine dephosphorylation;neutrophil degranulation	plasma membrane;integral component of plasma membrane;specific granule membrane;receptor complex;tertiary granule membrane	transmembrane receptor protein tyrosine phosphatase activity;protein binding	ALK[19167335];FLT1[22016384];PXN[19167335];WAS[19167335];RRBP1[30021884];CBL[19167335];EGFR[19167335];CORO1C[28330616];GHR[12907755;19167335];PCMT1[28330616];CDH2[19167335];ERBB2[19167335];MAPK1[12840032];CSK[19167335];MAPK3[19167335;12840032];ILKAP[28330616];PDGFRB[19167335];NTRK1[19167335];NSF[19167335];PDPK1[19167335];INSR[19167335];GAB1[19167335];RPA1[28330616];GRIN2B[19167335];EPOR[19167335];PTPRB[15978577];TEC[19167335];LCK[19167335];MADD[30021884];CTNNB1[19167335];TEK[19167335];CALM1[28330616];MET[16101282];	70965009
22082	chr12	72028608	AA		chr12:72028608-72028609	ZFC3H1	zinc finger C3H1-type containing	sequence_alteration	0/2	0.0	9_0_8	19	99.0	1/2	0.22	2_4_12	18	54.0			rs34399921	SPLICING	YES	NM_144982.5	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	10/34		NM_144982.5:c.2239-4_2239-3del			-1.0						.	.	.		0.000118559	17.0	143388.0	0.0	0	0.26	PASS	nfe	0.000166884	11.0	0.000166884	11.0	0.0168468	2400.0	142460.0	0.0	18	0.43	InbreedingCoeff	nfe	0.0213449	1537.0	0.0213449	1537.0	0.0000386,0.0000064,0.0262630	6,1,4084						14.26	1.130718		0	0	0			ZFC3H1	0.12	0.0	0.0	0.0	-6.0	2.0	-19.0	-6.0						0.22	1.0				.			.	.	RNA processing	exosome (RNase complex);extracellular space;nucleus;nucleolus	RNA binding;protein binding;metal ion binding	RBM27[26496610];UNC119B[26496610];APP[26496610];KHDRBS2[25416956];DOCK8[25416956];ZC3H3[26496610];HTT[23275563];BUB1B[25852190];LENG8[26496610];ADAR[26496610];HSF2BP[unassigned1304];GOLGA2[25416956];DCAF1[26496610];ACTR1A[26496610];CCDC85B[16189514];PAPOLG[26496610];MYB[20195357];CEP70[25416956];MYH13[26496610];RPL36[30021884];HIST1H1E[30021884];MTREX[26496610];TRIM27[25416956];BUB3[26496610];TP53BP1[29656893];EIF2B1[26496610];NINL[16189514];PIBF1[unassigned1304];EXOSC1[26496610];HIST1H1B[30021884];HIST1H1C[30021884];SRGN[26496610];PCID2[26496610];CSNK2A1[22113938];SPAG5[25416956];COG6[unassigned1304];CCDC57[25416956];MRPS25[26496610];CADPS[unassigned1304];THOC1[26496610];MTUS2[25416956];ZDHHC17[24705354];HNRNPK[25416956];MKRN3[unassigned1304];MPHOSPH6[26496610];	72028607
22223	chr12	93772200		GCTGCTGGTG	chr12:93772199-93772200	NUDT4	nudix hydrolase 4	insertion	0/0	0.0	42_0	42	99.0	0/1	0.13	61_9	70	99.0			rs1413783500	SPLICING	YES	NM_199040.4	Transcript	protein_coding	splice_region_variant,intron_variant	1/4		NM_199040.4:c.99+2_99+3insGCTGCTGGTG			1.0						.	.	.						32	0.96											13	0.34							0.0000707	11						15.44	1.348509		0	0	0																	0.506	0.16				.			pons;subthalamic nucleus;superior cervical ganglion;trigeminal ganglion;skeletal muscle;globus pallidus;	.	calcium-mediated signaling;cyclic-nucleotide-mediated signaling;intracellular signal transduction;inositol phosphate metabolic process;diphosphoinositol polyphosphate metabolic process;diadenosine pentaphosphate catabolic process;diadenosine hexaphosphate catabolic process;adenosine 5'-(hexahydrogen pentaphosphate) catabolic process	nucleus;cytoplasm;cytosol	endopolyphosphatase activity;protein binding;diphosphoinositol-polyphosphate diphosphatase activity;snoRNA binding;bis(5'-adenosyl)-hexaphosphatase activity;bis(5'-adenosyl)-pentaphosphatase activity;metal ion binding;m7G(5')pppN diphosphatase activity;inositol diphosphate tetrakisphosphate diphosphatase activity;inositol bisdiphosphate tetrakisphosphate diphosphatase activity;inositol diphosphate pentakisphosphate diphosphatase activity;inositol-1-diphosphate-2,3,4,5,6-pentakisphosphate diphosphatase activity;inositol-3-diphosphate-1,2,4,5,6-pentakisphosphate diphosphatase activity;inositol-5-diphosphate-1,2,3,4,6-pentakisphosphate diphosphatase activity;inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 1-diphosphatase activity;inositol-1,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity;inositol-3,5-bisdiphosphate-2,3,4,6-tetrakisphosphate 5-diphosphatase activity	KEAP1[25416956];	93772199
22247	chr12	94697526	C	A	chr12:94697526	PLXNC1	plexin C1	SNV	0/0	0.0	8_0	8	0.0	0|1	0.5	3_3	6	82.0				SPLICING	YES	NM_005761.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	28/30		NM_005761.3:c.4387-6C>A			1.0						.	.	.		0.00115058	80.0	69530.0	0.0	18	0.47	AS_VQSR	sas	0.00847458	17.0	0.000785878	26.0					15	0.38														0.377	-0.295582		0	0	0			PLXNC1	0.04	0.0	0.0	0.0	10.0	6.0	39.0	23.0	0.0006022489530694	0.272	9.73	3.013	12.744	0.304	1.0				nervous system phenotype ; normal phenotype; cellular phenotype; 			ciliary ganglion;white blood cells;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;whole blood;skeletal muscle;	Axon guidance	cell adhesion;negative regulation of cell adhesion;regulation of cell shape;regulation of cell migration;regulation of GTPase activity;positive regulation of axonogenesis;semaphorin-plexin signaling pathway involved in axon guidance	semaphorin receptor complex;plasma membrane;integral component of plasma membrane;membrane	signaling receptor binding;protein binding;semaphorin receptor activity	SEMA7A[20727575];	94697526
22262	chr12	94697542	C	A	chr12:94697542	PLXNC1	plexin C1	SNV	0/0	0.0	10_0	10	0.0	0|1	0.21	11_3	14	58.0				EXONIC	YES	NM_005761.3	Transcript	protein_coding	missense_variant		29/31	NM_005761.3:c.4397C>A	NP_005752.1:p.Thr1466Asn		1.0	Plexin, cytoplasmic RasGAP domain,Plexin, cytoplasmic RasGAP domain,Plexin, cytoplasmic RasGAP domain					.	.	.		3.93645e-05	5.0	127018.0	0.0	29	0.76	AS_VQSR	sas	0.000278552	1.0	0.0	0.0					21	0.52														26.1	3.765768	0.63	14	7	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	PLXNC1	0.0	0.01	0.0	0.0	0.0	-6.0	-1.0	46.0						0.304	1.0	93.743730876	0.998	1.026	nervous system phenotype ; normal phenotype; cellular phenotype; 			ciliary ganglion;white blood cells;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;whole blood;skeletal muscle;	Axon guidance	cell adhesion;negative regulation of cell adhesion;regulation of cell shape;regulation of cell migration;regulation of GTPase activity;positive regulation of axonogenesis;semaphorin-plexin signaling pathway involved in axon guidance	semaphorin receptor complex;plasma membrane;integral component of plasma membrane;membrane	signaling receptor binding;protein binding;semaphorin receptor activity	SEMA7A[20727575];	94697542
22276	chr12	94697543	T	A	chr12:94697543	PLXNC1	plexin C1	SNV	0/0	0.0	10_0	10	0.0	0|1	0.21	11_3	14	58.0			COSV51575447	EXONIC	YES	NM_005761.3	Transcript	protein_coding	synonymous_variant		29/31	NM_005761.3:c.4398T>A	NP_005752.1:p.Thr1466%3D		1.0						.	.	.		5.03112e-05	7.0	139134.0	0.0	30	0.81	AS_VQSR	eas	0.000249626	1.0	3.10414e-05	2.0					21	0.53														9.224	0.481221		0	0	0			PLXNC1	0.09	0.0	0.0	0.0	-7.0	22.0	45.0	22.0						0.304	1.0	93.743730876			nervous system phenotype ; normal phenotype; cellular phenotype; 			ciliary ganglion;white blood cells;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;whole blood;skeletal muscle;	Axon guidance	cell adhesion;negative regulation of cell adhesion;regulation of cell shape;regulation of cell migration;regulation of GTPase activity;positive regulation of axonogenesis;semaphorin-plexin signaling pathway involved in axon guidance	semaphorin receptor complex;plasma membrane;integral component of plasma membrane;membrane	signaling receptor binding;protein binding;semaphorin receptor activity	SEMA7A[20727575];	94697543
22292	chr12	95453763	AAAA		chr12:95453763-95453766	NR2C1	nuclear receptor subfamily 2 group C member 1	sequence_alteration	2/2	1.0	0_0_3	3	9.0	0/1	0.2	2_2_1	5	28.0			rs79760875	SPLICING	YES	NM_003297.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	3/13		NM_003297.4:c.286-6_286-3del			-1.0						.	.	.		3.4425e-05	3.0	87146.0	0.0	26	0.68	PASS	afr	4.55415e-05	1.0	4.47427e-05	2.0	0.022984	879.0	38244.0	0.0	14	0.27	PASS	eas	0.0402955	120.0	0.0203588	345.0	0.0000064,0.0005916	1,92						6.809	0.268961		0	0	0			NR2C1	0.0	0.0	0.0	0.0	39.0	-24.0	-40.0	-12.0						0.0729	0.98				hematopoietic system phenotype; normal phenotype; 			ciliary ganglion;pons;appendix;subthalamic nucleus;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;testis;skeletal muscle;	.	negative regulation of transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;steroid hormone mediated signaling pathway;positive regulation of retinoic acid receptor signaling pathway	nucleoplasm;PML body	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA binding;steroid hormone receptor activity;protein binding;zinc ion binding;signaling receptor activity;protein homodimerization activity;histone deacetylase binding	RARA[unassigned1304];TP53BP1[29656893];ESR1[12093804];NUDT3[21900206];	95453762
22403	chr12	96641188	G	A	chr12:96641188	ELK3	ELK3, ETS transcription factor	SNV	0/0	0.0	35_0	35	99.0	0/1	0.43	71_54	125	99.0			rs28444655,COSV99957770	EXONIC	YES	NM_005230.4	Transcript	protein_coding	missense_variant		3/5	NM_005230.4:c.678G>A	NP_005221.2:p.Met226Ile		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00101849	155.0	152186.0	0.0	32	0.97	PASS	nfe	0.00192534	131.0	0.00192534	131.0	0.00148895	374.0	251184.0	2.0	100	1.0	PASS	nfe	0.00289679	329.0	0.00289679	329.0	0.0018006	280	0.0	1.0	0.00073	7.0		22.4	2.421888	0.175	4	15	19	LRT_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	ELK3	0.0	0.0	0.0	0.0	8.0	1.0	-3.0	-1.0						0.499	0.1	0.000000000	1.0	1.101	homeostasis/metabolism phenotype; behavior/neurological phenotype ; respiratory system phenotype; cardiovascular system phenotype ; mortality/aging ; vision/eye phenotype; immune system phenotype; 			ciliary ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	.	negative regulation of transcription by RNA polymerase II;angiogenesis;regulation of transcription by RNA polymerase II;signal transduction;cell differentiation;wound healing;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II	nucleus;nucleoplasm;mitochondrion	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;protein binding;purine-rich negative regulatory element binding	BPIFA1[unassigned1304];CDC37[22939624];SP4[unassigned1304];DDIT4L[unassigned1304];GRB2[17474147];PIK3R1[17474147;25416956];CRK[26871637];PFDN5[unassigned1304];NCK1[17474147];	96641188
22409	chr12	97084946	G	A	chr12:97084946	CFAP54	cilia and flagella associated protein 54	SNV	0/0	0.0	34_0	34	99.0	0/1	0.46	38_32	70	99.0			rs1000427407	EXONIC	YES	NM_001367885.1	Transcript	protein_coding	missense_variant		45/69	NM_001367885.1:c.6317G>A	NP_001354814.1:p.Arg2106His		1.0						.	.	.		2.63144e-05	4.0	152008.0	0.0	32	0.96	PASS	amr	0.000130993	2.0	1.47098e-05	1.0	2.79085e-05	7.0	250820.0	0.0	53	0.94	PASS	amr	0.000203099	7.0	0.0	0.0	0.0000450	7						5.355	0.168004	0.074	0	14	14		LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CFAP54	0.0	0.03	0.0	0.0	17.0	-40.0	-40.0	38.0								0.000000000	0.063	-0.126	craniofacial phenotype; cellular phenotype; cardiovascular system phenotype ; reproductive system phenotype; mortality/aging ; nervous system phenotype ; skeleton phenotype; respiratory system phenotype; 			.	.	spermatogenesis;cell differentiation;cilium assembly;cilium movement involved in cell motility	axoneme	.	NPM1[30021884];AP2B1[30021884];	97084946
22598	chr12	104126807	C	T	chr12:104126807	STAB2	stabilin 2	SNV	0/1	0.5	60_59	119	99.0	0/1	0.4	54_36	90	99.0			rs117118859	EXONIC	YES	NM_017564.10	Transcript	protein_coding	synonymous_variant		51/69	NM_017564.10:c.5307C>T	NP_060034.9:p.Ile1769%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00282679	430.0	152116.0	0.0	32	0.95	PASS	nfe	0.00505659	344.0	0.00505659	344.0	0.00269636	676.0	250708.0	2.0	53	0.99	PASS	nfe	0.00488628	553.0	0.00488628	553.0	0.0028681	446	0.007	21.0				11.01	0.683549		0	0	0			STAB2	0.18	0.08	0.0	0.0	23.0	-23.0	-17.0	-16.0						0.0771	0.0	35.288785949			renal/urinary system phenotype; neoplasm; mortality/aging ; normal phenotype; cardiovascular system phenotype ; respiratory system phenotype; liver/biliary system phenotype; homeostasis/metabolism phenotype; muscle phenotype; 			ciliary ganglion;appendix;trigeminal ganglion;skin;superior cervical ganglion;occipital lobe;subthalamic nucleus;dorsal root ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;	.	angiogenesis;endocytosis;receptor-mediated endocytosis;cell adhesion;hyaluronan catabolic process;defense response to bacterium;defense response to Gram-positive bacterium;oxidation-reduction process	cytosol;plasma membrane;integral component of plasma membrane;external side of plasma membrane;endocytic vesicle membrane	low-density lipoprotein particle receptor activity;scavenger receptor activity;calcium ion binding;protein binding;hyaluronic acid binding;protein disulfide oxidoreductase activity;low-density lipoprotein particle binding	NPM1[30021884];TMSB4X[18519035];	104126807
22689	chr12	106763107	T	C	chr12:106763107	POLR3B	RNA polymerase III subunit B	SNV	0/1	0.4	15_10	25	99.0	0/0	0.0	35_0	35	99.0			rs766007096	EXONIC	YES	NM_018082.6	Transcript	protein_coding	synonymous_variant		5/28	NM_018082.6:c.282T>C	NP_060552.4:p.Thr94%3D		1.0					Leukodystrophy, hypomyelinating, 8, with or without oligodontia and/or hypogonadotropic hypogonadism, 614381 (3), Autosomal recessive; Charcot-Marie-Tooth disease, demyelinating, type 1I, 619742 (3), Autosomal dominant	Hypomyelination-hypogonadotropic hypogonadism-hypodontia syndrome;Endosteal sclerosis-cerebellar hypoplasia syndrome	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Hypodontia;Hypergonadotropic hypogonadism;CNS hypomyelination;Ataxia;Drooling;Optic atrophy;Oligodontia;Cerebral cortical atrophy;Hypogonadotropic hypogonadism;Dysmetria;Autosomal recessive inheritance;Leukodystrophy;CNS hypomyelination;Dysarthria;Delayed puberty;Abnormal upper motor neuron morphology;Spasticity;Nystagmus;Myopia;Hyperreflexia;Global developmental delay;Postural tremor;Babinski sign;Short stature;Dystonia;Hypoplasia of the corpus callosum;Hypodontia;Progressive;Peripheral neuropathy;Dysphagia;Cerebellar atrophy;Gynecomastia;Micropenis;Decreased testicular size;Autosomal recessive inheritance;Cryptorchidism;Autosomal dominant inheritance;Hypogonadotropic hypogonadism;Sparse pubic hair;Primary amenorrhea;Infertility;Sparse axillary hair;Dysmetria;Short stature;Myopia;Hypoplasia of the corpus callosum;Spasticity;Dysdiadochokinesis;Autosomal recessive inheritance;Intention tremor;Oligodontia;Dysarthria;Cerebral hypomyelination;Cerebellar atrophy;Leukodystrophy;Horizontal nystagmus;Dysphagia;Hypodontia;Impaired horizontal smooth pursuit;Delayed eruption of teeth;Intellectual disability, mild;Hypogonadotropic hypogonadism;Hyperreflexia		7.22629e-05	11.0	152222.0	0.0	32	0.96	PASS	amr	0.000589237	9.0	2.93945e-05	2.0	6.76213e-05	17.0	251400.0	0.0	100	1.0	PASS	amr	0.000231281	8.0	6.15666e-05	7.0	0.0000579	9			0.00026	3.0		11.5	0.743147		0	0	0			POLR3B	0.0	0.0	0.0	0.0	-16.0	8.0	21.0	-6.0						0.956	0.0	69.206963287			.			pons;ciliary ganglion;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;	Purine metabolism;Pyrimidine metabolism;RNA polymerase	transcription by RNA polymerase III;positive regulation of interferon-beta production;innate immune response;positive regulation of innate immune response;defense response to virus	nucleoplasm;RNA polymerase III complex;cytosol	RNA polymerase III activity;DNA binding;DNA-directed 5'-3' RNA polymerase activity;ribonucleoside binding;metal ion binding	GSK3A[26496610];DSN1[26496610];RIPK4[26972000];POLR3E[26496610];CHM[19615732];POLR2F[26496610];MATR3[26496610];KSR2[27086506];SDHA[30021884];SERF2[30021884];	106763107
22810	chr12	111317868	A	G	chr12:111317868	CCDC63	coiled-coil domain containing 63	SNV	0/1	0.57	33_43	76	99.0	0/0	0.0	35_0	35	99.0			rs370767542	EXONIC	YES	NM_152591.3	Transcript	protein_coding	synonymous_variant		6/12	NM_152591.3:c.648A>G	NP_689804.1:p.Gln216%3D		1.0						.	.	.		0.000230033	35.0	152152.0	0.0	32	0.96	PASS	amr	0.00144187	22.0	4.40995e-05	3.0	0.000282488	71.0	251338.0	0.0	75	1.0	PASS	amr	0.000983057	34.0	3.52026e-05	4.0	0.0001672	26						6.615	0.254544		0	0	0			CCDC63	0.0	0.0	0.0	0.0	1.0	-47.0	23.0	-12.0						0.961	0.0	81.895523201			.			.	.	cilium movement;spermatid development;outer dynein arm assembly	axoneme	.	HIST1H2BH[30021884];HIST1H2BD[30021884];	111317868
22818	chr12	112036754	GCTGCT		chr12:112036754-112036759	ATXN2	ataxin 2	sequence_alteration	1/2	0.11	0_4_32	36	69.0	2/2	0.05	0_2_37	39	38.0			rs10560189	EXONIC	YES	NM_001372574.1	Transcript	protein_coding	inframe_deletion		1/25	NM_001372574.1:c.80_85del	NP_001359503.1:p.Gln27_Gln28del		-1.0					{Amyotrophic lateral sclerosis, susceptibility to, 13}, 183090 (3), Autosomal dominant; Spinocerebellar ataxia 2, 183090 (3), Autosomal dominant; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Autosomal dominant, Multifactorial	Amyotrophic lateral sclerosis;Spinocerebellar ataxia type 2	Major susceptibility factor in;Disease-causing germline mutation(s) in	Laryngospasm;Nausea and vomiting;Dyspnea;Anxiety;Pain;Paralysis;Agitation;Generalized muscle weakness;Depressivity;Amyotrophic lateral sclerosis;Xerostomia;Fatigable weakness of respiratory muscles;Muscle spasm;Fatigable weakness of swallowing muscles;Skeletal muscle atrophy;Neurodegeneration;Emotional lability;Spasticity;Respiratory failure;Fatigue;Supranuclear ophthalmoplegia;Gait ataxia;Hyperactive deep tendon reflexes;Olivopontocerebellar hypoplasia;Nystagmus;Dystonia;Progressive cerebellar ataxia;Postural tremor;Chorea;Dysarthria;Abnormality of the substantia nigra;Hyporeflexia;Dementia;Cerebral cortical atrophy;Cerebellar Purkinje layer atrophy;Muscle spasm;Abnormal cell morphology;Generalized hypotonia;Spinal cord posterior columns myelin loss;Slow saccadic eye movements;Abnormality of the spinocerebellar tracts;Fasciculations;Kinetic tremor;Parkinsonism;Abnormal cortical gyration;Cerebral white matter atrophy;Urinary bladder sphincter dysfunction;Limb ataxia;Spinocerebellar tract degeneration;Generalized hypotonia;Dysmetric saccades;Postural instability;Spasticity;Slow saccadic eye movements;Muscular hypotonia;Olivopontocerebellar atrophy;Dilated fourth ventricle;Fasciculations;Dysarthria;Dysdiadochokinesis;Dementia;Rigidity;Ophthalmoplegia;Rod-cone dystrophy;Hyporeflexia;Impaired vibratory sensation;Postural tremor;Progressive cerebellar ataxia;Genetic anticipation;Autosomal dominant inheritance;Dysmetria;Bradykinesia;Gaze-evoked nystagmus;Distal amyotrophy;Oculomotor apraxia;Dysphagia;Parkinsonism;Impaired horizontal smooth pursuit;Myoclonus;Rigidity;Sporadic;Constipation;Sleep disturbance;Depressivity;Dementia;Bradykinesia;Abnormal autonomic nervous system physiology;Substantia nigra gliosis;Resting tremor;Dysarthria;Mask-like facies;Parkinsonism;Insidious onset;Hallucinations;Postural instability;Micrographia;Dysphagia;Dystonia;Tremor;Autosomal dominant inheritance;Personality changes;Neuronal loss in central nervous system;Urinary urgency;Weak voice;Progressive;Short stepped shuffling gait;Lewy bodies		0.000227596	33.0	144994.0	0.0	11	0.32	PASS	eas	0.00184275	9.0	0.000225252	15.0					4	0.25							0.0000064,0.0009325	1,145			0.06257	596.0		15.29	1.318668		0	0	0																	0.374	1.0				adipose tissue phenotype ; endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype ; liver/biliary system phenotype; mortality/aging ; reproductive system phenotype; nervous system phenotype ; 			.	.	negative regulation of receptor internalization;regulation of translation;regulation of cytoplasmic mRNA processing body assembly;RNA metabolic process;cytoplasmic mRNA processing body assembly;stress granule assembly;RNA transport	cytoplasm;Golgi apparatus;trans-Golgi network;cytosol;polysome;cytoplasmic stress granule;membrane;perinuclear region of cytoplasm;ribonucleoprotein complex	RNA binding;epidermal growth factor receptor binding;protein binding;protein C-terminus binding	SH3GL3[16115810;16713569;18602463];DDX6[17392519];RPL10[26496610];YEATS4[26496610];BAG6[16713569];ZNRD1[16713569];ATXN1[16713569];SUMO3[17000644];G3BP1[23209657];IDH3B[16713569];PLS3[16115810];VHL[17353931];HIF1AN[29426014];SH3GL2[16115810;16713569;18602463];CHGB[16169070];HSPA8[29568061];RBFOX1[16713569];JUN[25609649];ACTN2[16713569];ACTN1[16713569];SEC16A[26496610];NCOA4[16713569];TDRD7[16713569];NBEAL2[29187380];DICER1[21858095];ATXN2L[23209657];GFI1B[16713569];KIF1BP[16713569];MNDA[25665578];LCP1[16115810];PABPC1[15663938;17392519;20181956];TARDBP[20740007];	112036753
22825	chr12	112036797	C		chr12:112036797	ATXN2	ataxin 2	deletion	0/0	0.0	34_0	34	75.0	0|1	0.17	39_8	48	99.0			rs780952627,COSV66483304	EXONIC	YES	NM_001372574.1	Transcript	protein_coding	frameshift_variant		1/25	NM_001372574.1:c.42del	NP_001359503.1:p.Gln14HisfsTer32		-1.0					{Amyotrophic lateral sclerosis, susceptibility to, 13}, 183090 (3), Autosomal dominant; Spinocerebellar ataxia 2, 183090 (3), Autosomal dominant; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Autosomal dominant, Multifactorial	Amyotrophic lateral sclerosis;Spinocerebellar ataxia type 2	Major susceptibility factor in;Disease-causing germline mutation(s) in	Laryngospasm;Nausea and vomiting;Dyspnea;Anxiety;Pain;Paralysis;Agitation;Generalized muscle weakness;Depressivity;Amyotrophic lateral sclerosis;Xerostomia;Fatigable weakness of respiratory muscles;Muscle spasm;Fatigable weakness of swallowing muscles;Skeletal muscle atrophy;Neurodegeneration;Emotional lability;Spasticity;Respiratory failure;Fatigue;Supranuclear ophthalmoplegia;Gait ataxia;Hyperactive deep tendon reflexes;Olivopontocerebellar hypoplasia;Nystagmus;Dystonia;Progressive cerebellar ataxia;Postural tremor;Chorea;Dysarthria;Abnormality of the substantia nigra;Hyporeflexia;Dementia;Cerebral cortical atrophy;Cerebellar Purkinje layer atrophy;Muscle spasm;Abnormal cell morphology;Generalized hypotonia;Spinal cord posterior columns myelin loss;Slow saccadic eye movements;Abnormality of the spinocerebellar tracts;Fasciculations;Kinetic tremor;Parkinsonism;Abnormal cortical gyration;Cerebral white matter atrophy;Urinary bladder sphincter dysfunction;Limb ataxia;Spinocerebellar tract degeneration;Generalized hypotonia;Dysmetric saccades;Postural instability;Spasticity;Slow saccadic eye movements;Muscular hypotonia;Olivopontocerebellar atrophy;Dilated fourth ventricle;Fasciculations;Dysarthria;Dysdiadochokinesis;Dementia;Rigidity;Ophthalmoplegia;Rod-cone dystrophy;Hyporeflexia;Impaired vibratory sensation;Postural tremor;Progressive cerebellar ataxia;Genetic anticipation;Autosomal dominant inheritance;Dysmetria;Bradykinesia;Gaze-evoked nystagmus;Distal amyotrophy;Oculomotor apraxia;Dysphagia;Parkinsonism;Impaired horizontal smooth pursuit;Myoclonus;Rigidity;Sporadic;Constipation;Sleep disturbance;Depressivity;Dementia;Bradykinesia;Abnormal autonomic nervous system physiology;Substantia nigra gliosis;Resting tremor;Dysarthria;Mask-like facies;Parkinsonism;Insidious onset;Hallucinations;Postural instability;Micrographia;Dysphagia;Dystonia;Tremor;Autosomal dominant inheritance;Personality changes;Neuronal loss in central nervous system;Urinary urgency;Weak voice;Progressive;Short stepped shuffling gait;Lewy bodies		0.00160628	227.0	141320.0	2.0	31	0.88	PASS	afr	0.00465017	153.0	0.000433405	29.0	0.00213573	206.0	96454.0	0.0	6	0.35	RF	eas	0.00251731	16.0	0.00174565	61.0					0.00819	78.0		19.46	1.965572		0	0	0			ATXN2	0.0	0.0	0.0	0.0	-3.0	21.0	18.0	5.0						0.374	1.0				adipose tissue phenotype ; endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype ; liver/biliary system phenotype; mortality/aging ; reproductive system phenotype; nervous system phenotype ; 			.	.	negative regulation of receptor internalization;regulation of translation;regulation of cytoplasmic mRNA processing body assembly;RNA metabolic process;cytoplasmic mRNA processing body assembly;stress granule assembly;RNA transport	cytoplasm;Golgi apparatus;trans-Golgi network;cytosol;polysome;cytoplasmic stress granule;membrane;perinuclear region of cytoplasm;ribonucleoprotein complex	RNA binding;epidermal growth factor receptor binding;protein binding;protein C-terminus binding	SH3GL3[16115810;16713569;18602463];DDX6[17392519];RPL10[26496610];YEATS4[26496610];BAG6[16713569];ZNRD1[16713569];ATXN1[16713569];SUMO3[17000644];G3BP1[23209657];IDH3B[16713569];PLS3[16115810];VHL[17353931];HIF1AN[29426014];SH3GL2[16115810;16713569;18602463];CHGB[16169070];HSPA8[29568061];RBFOX1[16713569];JUN[25609649];ACTN2[16713569];ACTN1[16713569];SEC16A[26496610];NCOA4[16713569];TDRD7[16713569];NBEAL2[29187380];DICER1[21858095];ATXN2L[23209657];GFI1B[16713569];KIF1BP[16713569];MNDA[25665578];LCP1[16115810];PABPC1[15663938;17392519;20181956];TARDBP[20740007];	112036796
22835	chr12	112036799	GC		chr12:112036799-112036800	ATXN2	ataxin 2	deletion	0/0	0.0	33_0	33	78.0	0|1	0.17	39_8	48	99.0			rs772627768	EXONIC	YES	NM_001372574.1	Transcript	protein_coding	frameshift_variant		1/25	NM_001372574.1:c.39_40del	NP_001359503.1:p.Gln14AlafsTer75		-1.0					{Amyotrophic lateral sclerosis, susceptibility to, 13}, 183090 (3), Autosomal dominant; Spinocerebellar ataxia 2, 183090 (3), Autosomal dominant; {Parkinson disease, late-onset, susceptibility to}, 168600 (3), Autosomal dominant, Multifactorial	Amyotrophic lateral sclerosis;Spinocerebellar ataxia type 2	Major susceptibility factor in;Disease-causing germline mutation(s) in	Laryngospasm;Nausea and vomiting;Dyspnea;Anxiety;Pain;Paralysis;Agitation;Generalized muscle weakness;Depressivity;Amyotrophic lateral sclerosis;Xerostomia;Fatigable weakness of respiratory muscles;Muscle spasm;Fatigable weakness of swallowing muscles;Skeletal muscle atrophy;Neurodegeneration;Emotional lability;Spasticity;Respiratory failure;Fatigue;Supranuclear ophthalmoplegia;Gait ataxia;Hyperactive deep tendon reflexes;Olivopontocerebellar hypoplasia;Nystagmus;Dystonia;Progressive cerebellar ataxia;Postural tremor;Chorea;Dysarthria;Abnormality of the substantia nigra;Hyporeflexia;Dementia;Cerebral cortical atrophy;Cerebellar Purkinje layer atrophy;Muscle spasm;Abnormal cell morphology;Generalized hypotonia;Spinal cord posterior columns myelin loss;Slow saccadic eye movements;Abnormality of the spinocerebellar tracts;Fasciculations;Kinetic tremor;Parkinsonism;Abnormal cortical gyration;Cerebral white matter atrophy;Urinary bladder sphincter dysfunction;Limb ataxia;Spinocerebellar tract degeneration;Generalized hypotonia;Dysmetric saccades;Postural instability;Spasticity;Slow saccadic eye movements;Muscular hypotonia;Olivopontocerebellar atrophy;Dilated fourth ventricle;Fasciculations;Dysarthria;Dysdiadochokinesis;Dementia;Rigidity;Ophthalmoplegia;Rod-cone dystrophy;Hyporeflexia;Impaired vibratory sensation;Postural tremor;Progressive cerebellar ataxia;Genetic anticipation;Autosomal dominant inheritance;Dysmetria;Bradykinesia;Gaze-evoked nystagmus;Distal amyotrophy;Oculomotor apraxia;Dysphagia;Parkinsonism;Impaired horizontal smooth pursuit;Myoclonus;Rigidity;Sporadic;Constipation;Sleep disturbance;Depressivity;Dementia;Bradykinesia;Abnormal autonomic nervous system physiology;Substantia nigra gliosis;Resting tremor;Dysarthria;Mask-like facies;Parkinsonism;Insidious onset;Hallucinations;Postural instability;Micrographia;Dysphagia;Dystonia;Tremor;Autosomal dominant inheritance;Personality changes;Neuronal loss in central nervous system;Urinary urgency;Weak voice;Progressive;Short stepped shuffling gait;Lewy bodies		0.000203352	28.0	137692.0	0.0	32	0.89	PASS	sas	0.000626043	3.0	0.000103833	7.0	0.00183146	171.0	93368.0	0.0	6	0.35	RF	eas	0.00245614	14.0	0.00167795	56.0	0.0000064	1			0.00651	62.0		23.2	2.832508		0	0	0			ATXN2	0.0	0.0	0.0	0.0	-8.0	19.0	6.0	3.0						0.374	1.0				adipose tissue phenotype ; endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype ; liver/biliary system phenotype; mortality/aging ; reproductive system phenotype; nervous system phenotype ; 			.	.	negative regulation of receptor internalization;regulation of translation;regulation of cytoplasmic mRNA processing body assembly;RNA metabolic process;cytoplasmic mRNA processing body assembly;stress granule assembly;RNA transport	cytoplasm;Golgi apparatus;trans-Golgi network;cytosol;polysome;cytoplasmic stress granule;membrane;perinuclear region of cytoplasm;ribonucleoprotein complex	RNA binding;epidermal growth factor receptor binding;protein binding;protein C-terminus binding	SH3GL3[16115810;16713569;18602463];DDX6[17392519];RPL10[26496610];YEATS4[26496610];BAG6[16713569];ZNRD1[16713569];ATXN1[16713569];SUMO3[17000644];G3BP1[23209657];IDH3B[16713569];PLS3[16115810];VHL[17353931];HIF1AN[29426014];SH3GL2[16115810;16713569;18602463];CHGB[16169070];HSPA8[29568061];RBFOX1[16713569];JUN[25609649];ACTN2[16713569];ACTN1[16713569];SEC16A[26496610];NCOA4[16713569];TDRD7[16713569];NBEAL2[29187380];DICER1[21858095];ATXN2L[23209657];GFI1B[16713569];KIF1BP[16713569];MNDA[25665578];LCP1[16115810];PABPC1[15663938;17392519;20181956];TARDBP[20740007];	112036798
22870	chr12	113565932	C	T	chr12:113565932	RASAL1	RAS protein activator like 1	SNV	0/0	0.0	34_0	34	99.0	0/1	0.45	48_40	88	99.0			rs61741904	EXONIC	YES	NM_001193520.1	Transcript	protein_coding	synonymous_variant		4/22	NM_001193520.1:c.174G>A	NP_001180449.1:p.Thr58%3D		-1.0						.	.	.		0.000841906	128.0	152036.0	1.0	32	0.95	PASS	nfe	0.00138256	94.0	0.00138256	94.0	0.000744338	187.0	251230.0	0.0	85	1.0	PASS	nfe	0.00124868	142.0	0.00124868	142.0	0.0007074	110	0.001	4.0				0.081	-0.51143		0	0	0			RASAL1	0.0	0.01	0.0	0.0	-28.0	46.0	-35.0	0.0						0.862	0.0	17.284441283			.			amygdala;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;	.	MAPK cascade;signal transduction;positive regulation of GTPase activity;negative regulation of Ras protein signal transduction;cellular response to calcium ion;positive regulation of dendrite extension	cytosol;plasma membrane	GTPase activator activity;phospholipid binding;metal ion binding	.	113565932
22978	chr12	120106129	G	T	chr12:120106129	PRKAB1	protein kinase AMP-activated non-catalytic subunit beta 1	SNV	0/1	0.5	51_52	103	99.0	0/0	0.0	38_0	38	99.0			rs61748075,COSV57554656,COSV57554760	EXONIC	YES	NM_006253.5	Transcript	protein_coding	missense_variant		1/7	NM_006253.5:c.80G>T	NP_006244.2:p.Gly27Val		1.0	.,.,.					.	.	.		0.00114275	174.0	152264.0	1.0	33	0.98	PASS	amr	0.00353218	54.0	0.0014402	98.0	0.00107523	267.0	248318.0	1.0	29	0.83	PASS	amr	0.00265816	90.0	0.00139642	157.0	0.0009582	149	0.006	18.0				23.2	2.824965	0.261	6	12	18	LRT_pred,MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	PRKAB1	0.0	0.0	0.0	0.0	19.0	48.0	-2.0	-37.0						0.364	0.05	0.000000000	1.0	1.176	growth/size/body region phenotype; adipose tissue phenotype ; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; vision/eye phenotype; mortality/aging ; normal phenotype; cardiovascular system phenotype ; hematopoietic system phenotype; liver/biliary system phenotype; behavior/neurological phenotype ; immune system phenotype; skeleton phenotype; nervous system phenotype ; 			ciliary ganglion;pons;kidney;dorsal root ganglion;atrioventricular node;superior cervical ganglion;testis;skeletal muscle;	Insulin signaling pathway;Adipocytokine signaling pathway	protein phosphorylation;fatty acid biosynthetic process;cell cycle arrest;signal transduction;positive regulation of gene expression;macroautophagy;nail development;regulation of catalytic activity;protein heterooligomerization;positive regulation of cold-induced thermogenesis	nucleus;nucleoplasm;cytoplasm;cytosol;nucleotide-activated protein kinase complex	protein kinase activity;AMP-activated protein kinase activity;protein binding;protein kinase binding	RPL3[17353931];RPL31[17353931];UBE2D3[17353931];PREP[17353931];BCCIP[17353931];CISD1[17353931];SRP14[17353931];NUDT5[17353931];UBE2L3[17353931];EFTUD2[17353931];NPEPPS[17353931];PSMD6[17353931];IPO9[17353931];TRIM28[17353931];RUVBL2[17353931];KIF5B[17353931];COTL1[17353931];RPL36[17353931];RCC1[17353931];PSMD1[17353931];VPS35[17353931];CDK5RAP3[17353931];TGM3[20562859];NSF[20562859];RPS9[17353931];PRKAB2[17353931;20562859];USP5[17353931];MIF[17353931];PGD[17353931];PDIA6[17353931];PRKAB1[20562859];PDIA4[17353931];NUP93[17353931];ACLY[17353931];HNRNPUL1[17353931];EWSR1[17353931];CDC37[17353931];CMPK1[17353931];FSCN1[17353931];ULK2[20562859];ERH[17353931];ULK1[25686248;21072212];HPRT1[17353931];EZR[17353931];SNRNP200[17353931];PFN2[17353931];COPB2[17353931];LRRC59[17353931];SET[17353931];PSMD14[17353931];SHMT2[17353931];TARSL2[17353931];HSPA4L[17353931];GMPS[17353931];TARS[17353931];ACAT2[17353931];RTN4[17353931];GSPT1[17353931];MYL12A[17353931];EPB41L5[17353931];CYB5R3[17353931];GRPEL1[17353931];DHX36[17353931];MYH10[17353931];ATP5MF[17353931];PDHA1[17353931];API5[17353931];ST13[17353931];RCC2[17353931];GOT2[17353931];MSN[17353931];PA2G4[17353931];CCDC88A[17353931];EIF2S3[17353931];EIF6[17353931];UBE2N[17353931];PIN1[17353931];CYCS[17353931];GRB2[18624398];CNIH4[17353931];EIF4G1[17353931];NXT1[17353931];MRPS16[17353931];MCM7[17353931];MAST3[25852190];GDI2[17353931];CLTC[17353931];FHL1[17353931];PRKAG1[18480843;20562859;21988832;unassigned1304;22363791];PRKAG2[20562859];ETFA[17353931];SYNCRIP[17353931];GYS1[17353931];TRMT112[17353931];SEC61A1[17353931];CASP14[20562859];BUD23[17353931];CBR1[17353931;20562859];NUDC[17353931];PARP1[17353931];SSR4[17353931];CACYBP[17353931];CTPS1[17353931];RANGAP1[17353931];TSN[17353931];DNM2[17353931];DDB1[17353931];HADHA[17353931];PSMA6[17353931];EEF1D[17353931];CSDE1[17353931];STRAP[17353931];SLC25A10[17353931];MCM5[17353931];PFDN2[17353931];PABPC1[17353931];PAFAH1B2[17353931];RAB7A[17353931];VAMP3[17353931];OTUB1[17353931];MTPN[17353931];PDXK[17353931];FH[17353931];PRKAA1[16306228;18480843;20562859;23455922;25852190;22363791];ECHS1[17353931];OAT[17353931];PRKAA2[20562859;unassigned1304];SF3B6[17353931];DDX20[17353931];DDX21[17353931];PSMA7[17353931];MRM3[17353931];MAT2A[17353931];PSMB3[17353931];EBLN2[17353931];MAPK6[21900206];ABCF1[17353931];NDUFA7[16169070];RRM1[17353931];PCGF6[17353931];SF3A1[17353931];SSB[17353931];F10[16169070];QPCTL[17353931];RPL35A[17353931];UFM1[17353931];EIF3M[17353931];FABP5[17353931];EIF3K[17353931];PSMC3[17353931];PSMC4[17353931];MARS[17353931];VMA21[17353931];CAPZA1[17353931];ATP5PO[17353931];EIF3H[17353931];TSR1[17353931];FAM98B[17353931];EIF3E[17353931];PLP2[17353931];PFKP[17353931];	120106129
23081	chr12	123213957	C	T	chr12:123213957	HCAR1	hydroxycarboxylic acid receptor 1	SNV	0/0	0.0	33_0	33	99.0	0/1	0.53	57_64	121	99.0			rs149671074,COSV63675182	EXONIC	YES	NM_032554.4	Transcript	protein_coding	synonymous_variant		1/1	NM_032554.4:c.930G>A	NP_115943.1:p.Pro310%3D		-1.0						.	.	.		0.000131527	20.0	152060.0	1.0	32	0.96	PASS	eas	0.00019253	1.0	4.40995e-05	3.0	0.000238578	60.0	251490.0	0.0	100	1.0	PASS	eas	0.00108731	20.0	5.27408e-05	6.0	0.0001994	31						0.243	-0.358698		0	0	0			HCAR1	0.0	0.0	0.0	0.0	-2.0	42.0	4.0	-43.0							0.14	0.000000000			homeostasis/metabolism phenotype; 			globus pallidus;	.	G protein-coupled receptor signaling pathway	plasma membrane;integral component of membrane	G protein-coupled receptor activity	.	123213957
23159	chr12	124246906	G	A	chr12:124246906	DNAH10	dynein axonemal heavy chain 10	SNV	0/0	0.0	9_0	9	0.0	0/1	0.64	5_9	14	99.0			rs991075697	EXONIC	YES	NM_001372106.1	Transcript	protein_coding	stop_gained		1/79	NM_001372106.1:c.23G>A	NP_001359035.1:p.Trp8Ter		1.0					Spermatogenic failure 56, 619515 (3), Autosomal recessive	.	.	.		8.54218e-05	13.0	152186.0	1.0	32	0.97	PASS	amr	6.54108e-05	1.0	1.47024e-05	1.0					0	0.0														21.3	2.18385		1	0	1	fathmm-MKL_coding_pred		DNAH10	0.0	0.0	0.0	0.0	2.0	47.0	-3.0	15.0						0.919	0.0		1.0	1.006	.			.	.	microtubule-based movement	cytoplasm;microtubule;cilium;dynein complex	ATP binding;ATP-dependent microtubule motor activity, minus-end-directed;dynein light chain binding;dynein intermediate chain binding;dynein light intermediate chain binding	CANX[29568061];HIST3H3[30021884];HIST1H2BH[30021884];HIST2H2BF[30021884];	124246906
23285	chr12	129822317	C	T	chr12:129822317	TMEM132D	transmembrane protein 132D	SNV	0/1	0.52	62_67	129	99.0	0/0	0.0	38_0	38	99.0			rs150095683	EXONIC	YES	NM_133448.3	Transcript	protein_coding	synonymous_variant		4/9	NM_133448.3:c.1161G>A	NP_597705.2:p.Val387%3D		-1.0						.	.	.		0.000426901	65.0	152260.0	0.0	33	0.99	PASS	sas	0.00310302	15.0	0.000235149	16.0	0.000904404	227.0	250994.0	1.0	47	0.98	PASS	sas	0.00241941	74.0	0.000449197	51.0	0.0008810	137	0.001	2.0				0.071	-0.53026		0	0	0			TMEM132D	0.0	0.0	0.0	0.0	23.0	45.0	3.0	-45.0						0.329	1.0	35.288785949			.			.	.	negative regulation of phosphatase activity	integral component of membrane	protein binding	PPP1CA[19389623];	129822317
23312	chr12	132209985	C	A	chr12:132209985	SFSWAP	splicing factor SWAP	SNV	0/1	0.5	68_67	135	99.0	0/0	0.0	39_0	39	99.0			rs148634870	EXONIC	YES	NM_001261411.2	Transcript	protein_coding	synonymous_variant		5/19	NM_001261411.2:c.642C>A	NP_001248340.1:p.Arg214%3D		1.0						.	.	.		4.5997e-05	7.0	152184.0	1.0	33	0.96	PASS	nfe	2.9391e-05	2.0	2.9391e-05	2.0	1.59062e-05	4.0	251474.0	0.0	97	1.0	PASS	nfe	3.51642e-05	4.0	3.51642e-05	4.0	0.0000193	3	0.0	1.0				11.74	0.772694		0	0	0			SFSWAP	0.0	0.0	0.0	0.0	21.0	9.0	21.0	-6.0							1.0	60.343235778			behavior/neurological phenotype ; hearing/vestibular/ear phenotype; 			ciliary ganglion;amygdala;testis - seminiferous tubule;prefrontal cortex;cingulate cortex;trigeminal ganglion;superior cervical ganglion;pons;subthalamic nucleus;dorsal root ganglion;parietal lobe;globus pallidus;medulla oblongata;	.	alternative mRNA splicing, via spliceosome;mRNA 5'-splice site recognition;negative regulation of mRNA splicing, via spliceosome	nucleus	RNA binding;protein binding	JUN[25609649];NEIL3[26496610];DLST[29128334];RNPS1[17353931];KSR2[27086506];SF1[26420826];	132209985
23320	chr12	132400525	C	T	chr12:132400525	ULK1	unc-51 like autophagy activating kinase 1	SNV	0/1	0.49	78_74	152	99.0	0/1	0.5	74_73	147	99.0			rs545641034	EXONIC	YES	NM_003565.4	Transcript	protein_coding	missense_variant		19/28	NM_003565.4:c.1699C>T	NP_003556.2:p.Arg567Cys		1.0						.	.	.		0.000105165	16.0	152142.0	0.0	33	0.96	PASS	eas	0.000385802	2.0	5.88183e-05	4.0	0.000125821	31.0	246382.0	0.0	60	0.99	PASS	amr	0.00040615	14.0	8.21408e-05	9.0	0.0001093	17	0.002	5.0				22.5	2.494028	0.28	7	12	19	SIFT,LRT_pred,M-CAP_pred,MutationAssessor_pred,PROVEAN_pred,DEOGEN2_pred,fathmm-MKL_coding_pred	PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	ULK1	0.02	0.0	0.0	0.0	9.0	-31.0	3.0	-11.0						0.315	0.96	0.000000000	0.261	0.947	cellular phenotype; mortality/aging ; hematopoietic system phenotype; immune system phenotype; 			.	Regulation of autophagy;mTOR signaling pathway	autophagosome assembly;protein phosphorylation;autophagy;signal transduction;protein localization;regulation of autophagy;macroautophagy;regulation of macroautophagy;peptidyl-serine phosphorylation;peptidyl-threonine phosphorylation;neuron projection regeneration;neuron projection development;negative regulation of protein complex assembly;cellular response to nutrient levels;response to starvation;protein autophosphorylation;axon extension;autophagy of host cells involved in interaction with symbiont;positive regulation of autophagosome assembly	phagophore assembly site;cytoplasm;mitochondrial outer membrane;autophagosome;endoplasmic reticulum membrane;cytosol;membrane;axon;guanyl-nucleotide exchange factor complex;phagophore assembly site membrane;recycling endosome;extrinsic component of omegasome membrane;extrinsic component of phagophore assembly site membrane;extrinsic component of autophagosome membrane;Atg1/ULK1 kinase complex	protein serine/threonine kinase activity;protein binding;ATP binding;kinase activity;Rab GTPase binding;identical protein binding;protein-containing complex binding;GTPase binding	PRKAA1[20562859;25686248;21072212];PRKAA2[20562859;21072212];USP10[20562859];PRKAG1[20562859;25686248;21072212];HTT[25686248];CBLB[26593251];AMBRA1[23524951;25438055];ZFYVE1[28712572];GABARAP[17353931;20562859];RPTOR[25686248];MAP1LC3B[20562859;24290141];PCM1[28712572];MAP1LC3A[24290141];MAP1LC3C[20562859;24290141];ATG101[23392225;19597335;25686248];RB1CC1[20562859;23392225;23524951;25686248];G3BP1[20562859];SESN2[25040165];TBC1D14[22613832];NRBF2[20562859];ATG5[23392225];NTRK1[17389358];GABARAPL2[20562859];GABARAPL1[20562859];PDPK1[26593251];ATG9A[22613832];ATG13[20562859;23392225;19597335;23524951;25686248];PRKAB1[25686248;21072212];MTOR[23524951;25686248];NIPSNAP2[20562859];PPP1CA[22321011];OCLN[16616143];ATG16L1[23392225];TBC1D5[24603492];CDC37[20562859];FEZ1[22354037];TRAF6[23524951];ATG4B[20562859];ULK1[20562859;23524951];SQSTM1[17389358];C9orf72[27334615;29950492];	132400525
23327	chr12	132426147	G	A	chr12:132426147	PUS1	pseudouridine synthase 1	SNV	0/1	0.54	74_89	164	99.0	0/0	0.0	34_0	34	99.0			rs144648926	EXONIC	YES	NM_025215.6	Transcript	protein_coding	synonymous_variant		5/6	NM_025215.6:c.855G>A	NP_079491.2:p.Lys285%3D		1.0		Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_provided	Myopathy, lactic acidosis, and sideroblastic anemia 1, 600462 (3), Autosomal recessive	Mitochondrial myopathy and sideroblastic anemia	Disease-causing germline mutation(s) in	Increased serum lactate;Lactic acidosis;Microcytic anemia;Erythroid hyperplasia;Exercise intolerance;Cytochrome C oxidase-negative muscle fibers;Pappenheimer bodies;Generalized limb muscle atrophy;High palate;Failure to thrive;Increased serum ferritin;Sideroblastic anemia;Pallor;Autosomal recessive inheritance;Delayed puberty;Microcephaly;Hypochromic anemia;Progressive muscle weakness;Intellectual disability;Micrognathia;Distichiasis;Micrognathia;Distichiasis;Intellectual disability;High palate;Kyphosis;Glaucoma;Lactic acidosis;Long philtrum;Scoliosis;Myopathy;EMG abnormality;Microcephaly;Delayed puberty;Muscular hypotonia;Mitochondrial myopathy;Anemia;Generalized limb muscle atrophy;Short nose		0.000105105	16.0	152228.0	0.0	33	0.97	PASS	amr	0.000327225	5.0	0.000102887	7.0	9.14629e-05	23.0	251468.0	0.0	100	1.0	PASS	amr	0.000433626	15.0	7.03321e-05	8.0	0.0000707	11	0.0	1.0	0.00026	3.0		10.79	0.656105		0	0	0			PUS1	0.0	0.0	0.0	0.0	25.0	1.0	36.0	-6.0						0.684	0.02	0.000000000			behavior/neurological phenotype ; growth/size/body region phenotype; muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			skeletal muscle;	.	tRNA pseudouridine synthesis;mitochondrial tRNA pseudouridine synthesis;mRNA pseudouridine synthesis	nucleus;mitochondrion;mitochondrial matrix	tRNA binding;steroid receptor RNA activator RNA binding;RNA binding;pseudouridine synthase activity;tRNA pseudouridine synthase activity	CEP19[26638075];MGST3[29568061];MRPL58[20186120];HSCB[28380382];	132426147
23387	chr12	133202911	G	A	chr12:133202911	POLE	DNA polymerase epsilon, catalytic subunit	SNV	0/1	0.58	28_40	69	99.0	0/1	0.56	35_45	80	99.0			rs769766403	SPLICING	YES	NM_006231.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	45/48		NM_006231.4:c.6331-8C>T			-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Colorectal_cancer,_susceptibility_to,_12|not_specified|not_provided	{Colorectal cancer, susceptibility to, 12}, 615083 (3), Autosomal dominant; FILS syndrome, 615139 (3), Autosomal recessive; IMAGE-I syndrome, 618336 (3), Autosomal recessive	Facial dysmorphism-immunodeficiency-livedo-short stature syndrome;Polymerase proofreading-related adenomatous polyposis	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Malar flattening;Bone pain;Relative macrocephaly;Telangiectases of the cheeks;Recurrent respiratory infections;Congenital onset;Abnormal facial shape;Autosomal recessive inheritance;Immunodeficiency;Short stature;Broad forehead;Adenomatous colonic polyposis;Endometrial carcinoma;Adenocarcinoma of the colon;Colorectal polyposis;Breast carcinoma;Brain neoplasm;Carcinoma;Autosomal dominant inheritance;Adult onset;Colorectal polyposis;Cryptorchidism;Muscular hypotonia;Micromelia;Adrenal hypoplasia;Hypospadias;Depressed nasal bridge;Hydronephrosis;Low-set ears;Hypogonadism;Frontal bossing;Metaphyseal dysplasia;Intrauterine growth retardation;Bilateral cryptorchidism;Eczema;Hypospadias;Growth hormone deficiency;Seizure;T-cell lymphoma;Decreased body weight;Microtia;Low-set ears;Immunodeficiency;Autosomal recessive inheritance;Feeding difficulties;Clinodactyly;Intrauterine growth retardation;Long nose;Scoliosis;Microcephaly;Posteriorly rotated ears;Osteopenia;Micropenis;Frontal bossing;Severe short stature;Hodgkin lymphoma;Congenital adrenal hypoplasia;Metaphyseal dysplasia;Narrow nose;Short neck;Broad neck;Micrognathia;Relative macrocephaly		6.57047e-05	10.0	152196.0	0.0	33	0.97	PASS	amr	0.000392619	6.0	2.93927e-05	2.0	0.000100584	25.0	248548.0	0.0	71	0.99	PASS	amr	0.000521739	18.0	5.37933e-05	6.0	0.0000900	14	0.002	6.0				7.14	0.294487		0	0	0			POLE	0.0	0.01	0.0	0.0	-8.0	-41.0	-40.0	-8.0	0.0006295925815805	0.022	9.098	0.294	9.392	0.864	0.0				integument phenotype ; immune system phenotype; neoplasm; mortality/aging ; hematopoietic system phenotype; 			ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;testis;	Purine metabolism;Pyrimidine metabolism;DNA replication;Base excision repair;Nucleotide excision repair	G1/S transition of mitotic cell cycle;mitotic cell cycle;DNA synthesis involved in DNA repair;DNA replication;leading strand elongation;base-excision repair, gap-filling;nucleotide-excision repair, DNA gap filling;DNA replication proofreading;embryonic organ development;nucleic acid phosphodiester bond hydrolysis	nucleus;nucleoplasm;plasma membrane;epsilon DNA polymerase complex	nucleotide binding;DNA binding;chromatin binding;DNA-directed DNA polymerase activity;protein binding;zinc ion binding;single-stranded DNA 3'-5' exodeoxyribonuclease activity;4 iron, 4 sulfur cluster binding	KDM4A[23871696];FOXB1[25609649];FOXE1[25609649];LRRK2[24947832];FOXG1[25609649];RIPK4[26972000];STK19[14667819];FOXL1[25609649];BRCA1[29656893];POLE4[10801849];FOXQ1[25609649];SNW1[20467437];POLE2[10801849;unassigned1304];MYC[17353931;17314511];POLE3[10801849];UHRF1BP1[30021884];	133202911
23389	chr12	133237754	A	AA	chr12:133237754	POLE	DNA polymerase epsilon, catalytic subunit	sequence_alteration	0/1	0.07	40_15_5	69	99.0	0/2	0.15	33_4_7	47	58.0			rs369732588	SPLICING	YES	NM_006231.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	24/48		NM_006231.4:c.2865-4dup			-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Hereditary_cancer-predisposing_syndrome|not_specified|not_provided	{Colorectal cancer, susceptibility to, 12}, 615083 (3), Autosomal dominant; FILS syndrome, 615139 (3), Autosomal recessive; IMAGE-I syndrome, 618336 (3), Autosomal recessive	Facial dysmorphism-immunodeficiency-livedo-short stature syndrome;Polymerase proofreading-related adenomatous polyposis	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Malar flattening;Bone pain;Relative macrocephaly;Telangiectases of the cheeks;Recurrent respiratory infections;Congenital onset;Abnormal facial shape;Autosomal recessive inheritance;Immunodeficiency;Short stature;Broad forehead;Adenomatous colonic polyposis;Endometrial carcinoma;Adenocarcinoma of the colon;Colorectal polyposis;Breast carcinoma;Brain neoplasm;Carcinoma;Autosomal dominant inheritance;Adult onset;Colorectal polyposis;Cryptorchidism;Muscular hypotonia;Micromelia;Adrenal hypoplasia;Hypospadias;Depressed nasal bridge;Hydronephrosis;Low-set ears;Hypogonadism;Frontal bossing;Metaphyseal dysplasia;Intrauterine growth retardation;Bilateral cryptorchidism;Eczema;Hypospadias;Growth hormone deficiency;Seizure;T-cell lymphoma;Decreased body weight;Microtia;Low-set ears;Immunodeficiency;Autosomal recessive inheritance;Feeding difficulties;Clinodactyly;Intrauterine growth retardation;Long nose;Scoliosis;Microcephaly;Posteriorly rotated ears;Osteopenia;Micropenis;Frontal bossing;Severe short stature;Hodgkin lymphoma;Congenital adrenal hypoplasia;Metaphyseal dysplasia;Narrow nose;Short neck;Broad neck;Micrognathia;Relative macrocephaly		0.00380143	510.0	134160.0	1.0	31	0.84	AS_VQSR	afr	0.00797519	288.0	0.00145542	90.0	0.0864538	9249.0	106982.0	0.0	27	0.61	InbreedingCoeff	eas	0.119388	968.0	0.0728243	3630.0	0.0005981,0.0000322,0.0006559,0.0000900,0.0000579	93,5,102,14,9						6.978	0.281891		0	0	0			POLE	0.0	0.0	0.0	0.0	-3.0	40.0	-46.0	-2.0						0.864	0.0				integument phenotype ; immune system phenotype; neoplasm; mortality/aging ; hematopoietic system phenotype; 			ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;testis;	Purine metabolism;Pyrimidine metabolism;DNA replication;Base excision repair;Nucleotide excision repair	G1/S transition of mitotic cell cycle;mitotic cell cycle;DNA synthesis involved in DNA repair;DNA replication;leading strand elongation;base-excision repair, gap-filling;nucleotide-excision repair, DNA gap filling;DNA replication proofreading;embryonic organ development;nucleic acid phosphodiester bond hydrolysis	nucleus;nucleoplasm;plasma membrane;epsilon DNA polymerase complex	nucleotide binding;DNA binding;chromatin binding;DNA-directed DNA polymerase activity;protein binding;zinc ion binding;single-stranded DNA 3'-5' exodeoxyribonuclease activity;4 iron, 4 sulfur cluster binding	KDM4A[23871696];FOXB1[25609649];FOXE1[25609649];LRRK2[24947832];FOXG1[25609649];RIPK4[26972000];STK19[14667819];FOXL1[25609649];BRCA1[29656893];POLE4[10801849];FOXQ1[25609649];SNW1[20467437];POLE2[10801849;unassigned1304];MYC[17353931;17314511];POLE3[10801849];UHRF1BP1[30021884];	133237753
23413	chr12	133375067		A	chr12:133375066-133375067	GOLGA3	golgin A3	insertion	0/1	0.21	38_10	48	99.0	0/0	0.0	52_0	52	99.0			rs112384794	SPLICING	YES	NM_005895.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	8/23		NM_005895.4:c.1801-4dup			-1.0						.	.	.		0.00278723	411.0	147458.0	4.0	31	0.93	PASS	afr	0.00977361	392.0	4.51074e-05	3.0	0.0299744	3955.0	131946.0	0.0	34	0.75	PASS	amr	0.0448479	625.0	0.0212597	1423.0	0.0000322,0.0144948,0.0001093	5,2254,17			0.00202	23.0		0.844	-0.1759		0	0	0			GOLGA3	0.02	0.0	0.0	0.0	-12.0	18.0	-20.0	-12.0						0.462	0.99				endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; reproductive system phenotype; hematopoietic system phenotype; 			.	.	intra-Golgi vesicle-mediated transport;spermatogenesis	Golgi membrane;nucleus;nucleoplasm;nucleolus;cytoplasm;Golgi apparatus;cytosol;membrane;Golgi transport complex;Golgi cisterna membrane;extrinsic component of Golgi membrane	transporter activity;protein binding;cadherin binding	TSNAX[26496610];RNF31[unassigned1774];CENPU[26496610];PDHA1[29128334];PLGRKT[29568061];SORT1[26496610];MGST3[29568061];TRAF2[20562859];TOMM20[29568061];ESR2[21182203];TOMM22[29568061];GOLGA2[29568061];TGOLN2[29568061];SYNCRIP[26496610];LAMP1[29568061];ATXN7[21078624];TMEM216[26638075];RPS3[30021884];COX14[29568061];IKBKG[14743216];CNTROB[26496610];ACBD3[17711851];RETREG2[26496610];BET1[29568061];	133375066
23573	chr13	24466041	A	C	chr13:24466041	C1QTNF9B	C1q and TNF related 9B	SNV	0/1	0.23	203_59	262	99.0	0/0	0.0	43_0	43	99.0			rs140408648,COSV65944529	EXONIC	YES	NM_001007537.2	Transcript	protein_coding	missense_variant		3/3	NM_001007537.2:c.389T>G	NP_001007538.1:p.Val130Gly		-1.0	.,.					.	.	.		0.00201581	305.0	151304.0	0.0	34	0.98	PASS	amr	0.0030347	46.0	0.00301196	203.0	0.00270856	672.0	248102.0	0.0	45	0.95	PASS	nfe	0.00444126	496.0	0.00444126	496.0	0.0000579	9	0.004	12.0				22.3	2.391623	0.256	9	10	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MutationTaster_pred,FATHMM_pred,BayesDel_addAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	C1QTNF9B	0.0	0.0	0.0	0.0	7.0	-28.0	33.0	2.0							0.04		0.048	1.299	homeostasis/metabolism phenotype; muscle phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; growth/size/body region phenotype; liver/biliary system phenotype; nervous system phenotype ; behavior/neurological phenotype ; 			.	.	.	extracellular region;collagen trimer	protein binding	ADIPOQ[19666007];C1QTNF9[19666007];	24466041
23575	chr13	24466041	A	C	chr13:24466041	C1QTNF9B-AS1		SNV	0/1	0.23	203_59	262	99.0	0/0	0.0	43_0	43	99.0			rs140408648,COSV65944529	EXONIC	YES	NM_001348112.2	Transcript	protein_coding	missense_variant		4/4	NM_001348112.2:c.322A>C	NP_001335041.1:p.Thr108Pro		1.0										0.00201581	305.0	151304.0	0.0	34	0.98	PASS	amr	0.0030347	46.0	0.00301196	203.0	0.00270856	672.0	248102.0	0.0	45	0.95	PASS	nfe	0.00444126	496.0	0.00444126	496.0	0.0000579	9	0.004	12.0				22.3	2.391623	0.256	1	1	2	SIFT	PolyPhen	C1QTNF9B	0.0	0.0	0.0	0.0	7.0	-28.0	33.0	2.0																				24466041
23601	chr13	25067866	A	G	chr13:25067866	PARP4	poly(ADP-ribose) polymerase family member 4	SNV	0/1	0.55	20_24	44	99.0	0/0	0.0	36_0	36	99.0			rs776620914	EXONIC	YES	NM_006437.4	Transcript	protein_coding	synonymous_variant		8/34	NM_006437.4:c.747T>C	NP_006428.2:p.Leu249%3D		-1.0						.	.	.		2.6293e-05	4.0	152132.0	0.0	32	0.97	PASS	amr	0.000130839	2.0	1.47007e-05	1.0	1.99886e-05	5.0	250142.0	0.0	51	0.9	PASS	amr	0.000117357	4.0	0.0	0.0	0.0000257	4						8.936	0.451841		0	0	0			PARP4	0.03	0.0	0.06	0.0	5.0	-7.0	-39.0	-7.0						0.988	0.0				normal phenotype; 			.	Base excision repair	DNA repair;cellular protein modification process;protein ADP-ribosylation;inflammatory response;cellular response to DNA damage stimulus;cell death;response to drug;regulation of telomerase activity	nucleus;cytoplasm;cytosol;spindle microtubule;membrane;extracellular exosome;ribonucleoprotein complex	DNA binding;NAD+ ADP-ribosyltransferase activity;protein binding;enzyme binding	CCT6A[23414517];EGLN3[26972000];COP1[25117710];SNW1[20467437];SMAD3[21988832];CLTC[26496610];	25067866
23603	chr13	25265211	G	A	chr13:25265211	ATP12A	ATPase H+/K+ transporting non-gastric alpha2 subunit	SNV	0/1	0.48	75_70	145	99.0	0/0	0.0	34_0	34	99.0			rs61739266,COSV54516694	EXONIC	YES	NM_001185085.2	Transcript	protein_coding	synonymous_variant		8/23	NM_001185085.2:c.909G>A	NP_001172014.1:p.Thr303%3D		1.0						.	.	.		0.00029566	45.0	152202.0	0.0	32	0.97	PASS	eas	0.00153965	8.0	4.40917e-05	3.0	0.000282313	71.0	251494.0	0.0	100	1.0	PASS	eas	0.00271828	50.0	5.27389e-05	6.0	0.0002444	38						6.292	0.231231		0	0	0			ATP12A	0.05	0.03	0.0	0.0	44.0	-19.0	44.0	39.0						0.058	0.0	0.000000000			growth/size/body region phenotype; homeostasis/metabolism phenotype; renal/urinary system phenotype; digestive/alimentary phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;atrioventricular node;superior cervical ganglion;	Oxidative phosphorylation	cellular sodium ion homeostasis;regulation of pH;establishment or maintenance of transmembrane electrochemical gradient;ATP hydrolysis coupled proton transport;cellular potassium ion homeostasis;sodium ion export across plasma membrane;potassium ion import across plasma membrane	plasma membrane;potassium:proton exchanging ATPase complex;basolateral plasma membrane	sodium:potassium-exchanging ATPase activity;ATP binding;potassium:proton exchanging ATPase activity;metal ion binding	MME[17342744];NPY[21988832];GNAI3[21988832];PPIB[21988832];	25265211
23607	chr13	25283957	G	A	chr13:25283957	ATP12A	ATPase H+/K+ transporting non-gastric alpha2 subunit	SNV	0/1	0.42	35_25	60	99.0	0/0	0.0	34_0	34	99.0			rs77438081,COSV99517133	EXONIC	YES	NM_001185085.2	Transcript	protein_coding	synonymous_variant		19/23	NM_001185085.2:c.2772G>A	NP_001172014.1:p.Gly924%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00543814	828.0	152258.0	2.0	32	0.98	PASS	sas	0.00972682	47.0	0.00725958	494.0	0.00696405	1751.0	251434.0	10.0	94	1.0	PASS	sas	0.00855762	262.0	0.00819427	932.0	0.0067265	1046	0.006	18.0				5.884	0.202926		0	0	0			ATP12A	0.0	0.0	0.0	0.0	-43.0	9.0	9.0	-48.0						0.058	0.0	50.453010370			growth/size/body region phenotype; homeostasis/metabolism phenotype; renal/urinary system phenotype; digestive/alimentary phenotype; 			ciliary ganglion;trachea;trigeminal ganglion;atrioventricular node;superior cervical ganglion;	Oxidative phosphorylation	cellular sodium ion homeostasis;regulation of pH;establishment or maintenance of transmembrane electrochemical gradient;ATP hydrolysis coupled proton transport;cellular potassium ion homeostasis;sodium ion export across plasma membrane;potassium ion import across plasma membrane	plasma membrane;potassium:proton exchanging ATPase complex;basolateral plasma membrane	sodium:potassium-exchanging ATPase activity;ATP binding;potassium:proton exchanging ATPase activity;metal ion binding	MME[17342744];NPY[21988832];GNAI3[21988832];PPIB[21988832];	25283957
23640	chr13	27847166	C	T	chr13:27847166	RASL11A	RAS like family 11 member A	SNV	0/1	0.57	30_39	69	99.0	0/0	0.0	36_0	36	99.0			rs41291668	SPLICING	YES	NM_206827.2	Transcript	protein_coding	splice_region_variant,synonymous_variant		4/4	NM_206827.2:c.264C>T	NP_996563.1:p.Ile88%3D		1.0						.	.	.		0.00584123	889.0	152194.0	8.0	32	0.97	PASS	nfe	0.00890626	606.0	0.00890626	606.0	0.00543244	1360.0	250348.0	5.0	56	0.99	PASS	nfe	0.00887726	1001.0	0.00887726	1001.0	0.0054983	855	0.018	56.0				14.11	1.105423		0	0	0			RASL11A	0.0	0.01	0.0	0.0	19.0	9.0	18.0	9.0			7.976	0.399	8.375	0.395	0.01	73.020503233			.			ciliary ganglion;atrioventricular node;superior cervical ganglion;	.	signal transduction;positive regulation of transcription by RNA polymerase I	nucleolus;membrane	GTPase activity;GTP binding	.	27847166
23685	chr13	30097576	C	T	chr13:30097576	SLC7A1	solute carrier family 7 member 1	SNV	0/1	0.49	75_72	147	99.0	0/0	0.0	34_0	34	99.0			rs34941634	EXONIC	YES	NM_003045.5	Transcript	protein_coding	synonymous_variant		7/13	NM_003045.5:c.876G>A	NP_003036.1:p.Ala292%3D		-1.0						.	.	.		0.000696589	106.0	152170.0	0.0	32	0.96	PASS	amr	0.00130787	20.0	0.000720228	49.0	0.000625304	157.0	251078.0	1.0	88	1.0	PASS	amr	0.000925283	32.0	0.000783313	89.0	0.0006366	99	0.006	19.0	0.00434	8.0		1.473	-0.092979		0	0	0			SLC7A1	0.0	0.0	0.0	0.0	41.0	43.0	3.0	-33.0						0.0567	0.57	50.453010370			growth/size/body region phenotype; cellular phenotype; mortality/aging ; hematopoietic system phenotype; 			.	.	amino acid transport;L-arginine import across plasma membrane;L-ornithine transmembrane transport;L-lysine transmembrane transport	plasma membrane;integral component of plasma membrane;membrane;protein-containing complex	L-ornithine transmembrane transporter activity;protein binding;amino acid transmembrane transporter activity;arginine transmembrane transporter activity;L-lysine transmembrane transporter activity	HERPUD2[unassigned1304];PNLIPRP1[unassigned1304];CD40[unassigned1304];SEC23A[unassigned1304];LEPROT[unassigned1304];TUSC5[unassigned1304];GALNT15[unassigned1304];WRB[unassigned1304];AQP6[unassigned1304];COMT[unassigned1304];MFF[unassigned1304];GPR152[unassigned1304];CD79A[unassigned1304];SLC39A9[unassigned1304];CREB3L1[unassigned1304];CCL4[unassigned1304];ORMDL3[unassigned1304];EMC6[unassigned1304];SMCO4[unassigned1304];MAPK6[26972000];CDIPT[unassigned1304];SCN3B[unassigned1304];TMEM14A[unassigned1304];SLC18A2[unassigned1304];CERS4[unassigned1304];OR1D4[unassigned1304];SLC10A6[unassigned1304];ST6GAL2[unassigned1304];GIF[unassigned1304];YIPF4[unassigned1304];SACM1L[unassigned1304];SLC33A1[26496610];APOA2[unassigned1304];SLC52A1[unassigned1304];RNF144A[unassigned1304];TMEM17[26638075];STIM1[unassigned1304];GLB1[unassigned1304];ADGRB3[unassigned1304];TMEM237[unassigned1304];PTPN9[unassigned1304];TMBIM6[unassigned1304];CMTM2[unassigned1304];FATE1[25416956;unassigned1304];ATP6V0C[unassigned1304];	30097576
23700	chr13	31713236	T	C	chr13:31713236	HSPH1	heat shock protein family H (Hsp110) member 1	SNV	0/0	0.0	23_0	23	60.0	0/1	0.76	11_34	45	99.0			rs376620526,COSV104535888	EXONIC	YES	NM_001286504.1	Transcript	protein_coding	synonymous_variant		15/18	NM_001286504.1:c.1995A>G	NP_001273433.1:p.Gln665%3D		-1.0						.	.	.		2.6303e-05	4.0	152074.0	0.0	32	0.97	PASS	amr	6.55308e-05	1.0	0.0	0.0	1.19762e-05	3.0	250496.0	0.0	55	0.99	PASS	eas	5.4407e-05	1.0	1.76769e-05	2.0	0.0000064	1						6.826	0.270259		0	0	0			HSPH1	0.32	0.02	0.0	0.0	-1.0	-23.0	-1.0	-12.0						0.503	0.98	52.993057664			homeostasis/metabolism phenotype; cellular phenotype; nervous system phenotype ; 			ciliary ganglion;caudate nucleus;amygdala;testis - seminiferous tubule;prefrontal cortex;cingulate cortex;testis;pons;occipital lobe;fetal brain;subthalamic nucleus;testis - interstitial;atrioventricular node;parietal lobe;globus pallidus;hypothalamus;medulla oblongata;thalamus;	.	receptor-mediated endocytosis;response to unfolded protein;positive regulation of MHC class I biosynthetic process;regulation of catalytic activity;chaperone cofactor-dependent protein refolding;positive regulation of NK T cell activation;regulation of cellular response to heat	extracellular region;nucleus;nucleoplasm;cytoplasm;cytosol;microtubule;protein-containing complex;extracellular exosome;endocytic vesicle lumen	adenyl-nucleotide exchange factor activity;protein binding;ATP binding;alpha-tubulin binding	YAP1[24366813];PPP1R15A[29109149];PHLPP2[28330616];ATF2[22304920];CEP104[26638075];HSP90AB1[16263121];BUB1B[25852190];ILK[25852190];CHD3[16169070];PTPN23[28330616];RELA[14743216];GABARAP[20562859];MAP1LC3B[20562859];MAP1LC3A[20562859];TUBA1A[27291054];TUBB3[27291054];MYC[17314511];TP53BP2[24366813];MAPK6[26972000];DNM1L[29128334];GABARAPL2[20562859];HSPA8[29568061];GABARAPL1[20562859];JUN[25609649];STIL[26638075];MAP3K1[14743216];HSPA5[26496610];METTL3[29507755];HSPA2[25036637];YWHAZ[15161933];MEX3C[22863774];PLEKHA7[28877994];VAV2[18654987];NR4A1[20195357];NF2[24366813];PTPN7[28330616];MAPT[26402096];PPEF1[28330616];DLD[29128334];OTUB1[26752685];	31713236
23709	chr13	32893207	T	A	chr13:32893207	BRCA2	BRCA2, DNA repair associated	SNV	0/1	0.36	8_5	14	99.0	0/0	0.0	19_0	19	54.0			rs81002830,CD075337,CS033491,COSV66448762,COSV66457916	SPLICING	YES	NM_000059.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	2/26		NM_000059.4:c.68-7T>A			1.0		Benign	reviewed_by_expert_panel	Hereditary_breast_and_ovarian_cancer_syndrome|Malignant_tumor_of_breast|Fanconi_anemia,_complementation_group_D1|Breast-ovarian_cancer,_familial_2|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_specified|Breast_and/or_ovarian_cancer|not_provided	Fanconi anemia, complementation group D1, 605724 (3), Autosomal recessive; {Glioblastoma 3}, 613029 (3), Autosomal recessive; {Medulloblastoma}, 155255 (3), Autosomal recessive, Somatic mutation, Autosomal dominant; {Prostate cancer}, 176807 (3), Somatic mutation, Autosomal dominant; {Breast-ovarian cancer, familial, 2}, 612555 (3), Autosomal dominant; {Breast cancer, male, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant; {Pancreatic cancer 2}, 613347 (3); Wilms tumor, 194070 (3), Somatic mutation, Autosomal dominant	Fanconi anemia;Nephroblastoma;Familial prostate cancer;Hereditary site-specific ovarian cancer syndrome;Hereditary breast and ovarian cancer syndrome;Hereditary breast cancer;Familial pancreatic carcinoma;Inherited cancer-predisposing syndrome due to biallelic BRCA2 mutations	Disease-causing germline mutation(s) in;Candidate gene tested in;Major susceptibility factor in;Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in;Major susceptibility factor in;Disease-causing germline mutation(s) in	Somatic mutation;Autosomal dominant inheritance;Heterogeneous;Breast carcinoma;Microcephaly;Chromosomal breakage induced by crosslinking agents;Autosomal recessive inheritance;Bone marrow hypocellularity;Cafe-au-lait spot;Intrauterine growth retardation;Short stature;Anal atresia;T-cell acute lymphoblastic leukemias;Short thumb;Failure to thrive;Acute myeloid leukemia;Hematuria;Neoplasm of the liver;Hypertension;Abdominal pain;Nephroblastoma;Neoplasm of the lung;Weight loss;Lymphadenopathy;Fever;Aniridia;Autosomal recessive inheritance;Glioblastoma multiforme;Astrocytoma;Medulloblastoma;Elevated hepatic transaminase;Breast carcinoma;Weight loss;Melanoma;Poor appetite;Ovarian carcinoma;Colon cancer;Nausea and vomiting;Back pain;Hepatosplenomegaly;Functional intestinal obstruction;Peritoneal abscess;Diabetes mellitus;Exocrine pancreatic insufficiency;Pancreatic adenocarcinoma;Anorexia;Intermittent diarrhea;Extrahepatic cholestasis;Neoplasm of the liver;Intestinal pseudo-obstruction;Abdominal pain;Lymphadenopathy;Jaundice;Chronic fatigue;Medulloblastoma;Autosomal dominant inheritance;Incomplete penetrance;Autosomal recessive inheritance;Primary peritoneal carcinoma;Melanoma;Neoplasm of the pancreas;Prostate cancer;Breast carcinoma;Ovarian neoplasm;Abnormal fallopian tube morphology;Hydroureter;Hypopigmented skin patches;Cranial nerve paralysis;Umbilical hernia;Epicanthus;Weight loss;Choanal atresia;Myelodysplasia;Hypogonadism;Scoliosis;Hip dislocation;Recurrent urinary tract infections;Abnormality of the hypothalamus-pituitary axis;Short palpebral fissure;Hypertrophic cardiomyopathy;High palate;Aplasia/Hypoplasia of the iris;Decreased fertility in males;Aplasia/Hypoplasia of fingers;Toe syndactyly;Irregular hyperpigmentation;Almond-shaped palpebral fissure;Tetralogy of Fallot;Astigmatism;Pyridoxine-responsive sideroblastic anemia;Meckel diverticulum;Hypertelorism;Sloping forehead;Ptosis;Anal atresia;Cryptorchidism;Intellectual disability;Facial asymmetry;Visual impairment;Upslanted palpebral fissure;Duodenal stenosis;Abnormality of the liver;Aplasia/Hypoplasia of the uvula;Abnormal carotid artery morphology;Hypospadias;Nystagmus;Multiple cafe-au-lait spots;Renal insufficiency;Clinodactyly of the 5th finger;Bicornuate uterus;Abnormality of chromosome stability;Strabismus;Micrognathia;Hypoplasia of the ulna;Proptosis;Atrial septal defect;Abnormal aortic valve morphology;Abnormality of femur morphology;Cataract;Microphthalmia;Hydrocephalus;Ventriculomegaly;Aganglionic megacolon;Absent testis;Hearing impairment;Arteriovenous malformation;Azoospermia;Renal hypoplasia/aplasia;Thrombocytopenia;Finger syndactyly;Oligohydramnios;External ear malformation;Global developmental delay;Aplasia/Hypoplasia of the radius;Reduced bone mineral density;Clubbing of toes;Microcephaly;Abnormal aortic morphology;Frontal bossing;Dolichocephaly;Spina bifida;Leukopenia;Tracheoesophageal fistula;Patent ductus arteriosus;Abnormality of the preputium;Hyperreflexia;Short stature;Abnormal localization of kidney;Cleft palate;Triphalangeal thumb;Intrauterine growth retardation;Pes planus;Autosomal dominant inheritance;Somatic mutation;Prostate cancer;Neoplasm of the pancreas;Nephroblastoma;Somatic mutation;Autosomal dominant inheritance;Heterogeneous;Multifactorial inheritance;Breast carcinoma;Ovarian neoplasm;Autosomal dominant inheritance	25741868,24033266,22144684,20927582,18627636,10923033,21702907,21673748,22505045,18284688,22848303,20215541,18693280,27495310,23249957,24607278,17233897,23633455,21939546,22666503,14647210,10449599,25146914,10534775,12237285,17971607,29460995	0.00281866	429.0	152200.0	1.0	33	0.97	PASS	amr	0.0071999	110.0	0.00223424	152.0	0.00287243	712.0	247874.0	3.0	53	0.93	PASS	amr	0.00258796	89.0	0.00242157	272.0	0.0020321	316	0.003	9.0	0.0037	42.0		9.008	0.459057		0	0	0			BRCA2	0.0	0.05	0.0	0.0	40.0	7.0	7.0	-16.0	0.0171255032066044	0.102	4.642	1.461	6.103	0.0896	0.0				limbs/digits/tail phenotype; nervous system phenotype ; digestive/alimentary phenotype; immune system phenotype; skeleton phenotype; embryo phenotype; behavior/neurological phenotype ; normal phenotype; mortality/aging ; reproductive system phenotype; hematopoietic system phenotype; neoplasm; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; integument phenotype ; growth/size/body region phenotype; 			.	Homologous recombination;Pancreatic cancer	mitotic cytokinesis;telomere maintenance via recombination;double-strand break repair via homologous recombination;oocyte maturation;inner cell mass cell proliferation;nucleotide-excision repair;double-strand break repair;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;male meiosis I;brain development;cell aging;response to X-ray;response to UV-C;response to gamma radiation;hemopoiesis;regulation of cytokinesis;negative regulation of mammary gland epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;histone H3 acetylation;histone H4 acetylation;positive regulation of transcription, DNA-templated;positive regulation of mitotic cell cycle;replication fork protection;centrosome duplication;establishment of protein localization to telomere;mitotic recombination-dependent replication fork processing	nuclear chromosome, telomeric region;lateral element;nucleus;nucleoplasm;centrosome;cytosol;secretory granule;protein-containing complex;BRCA2-MAGE-D1 complex	protease binding;single-stranded DNA binding;histone acetyltransferase activity;protein binding;protein C-terminus binding;H3 histone acetyltransferase activity;H4 histone acetyltransferase activity;identical protein binding;gamma-tubulin binding	MDC1[29656893];PCNA[22293751];USP11[26649820];BRCA1[22193777;19369211;29656893];PDS5B[22293751];BRCA2[21601571;25282148];SMC3[22293751];CDC45[22293751];XPO1[24013206];RAD21[22293751];ABL1[17474147];HMG20B[21399666];ZC3H18[29298432];FYN[17474147];TP53BP1[29656893];MTA2[19703393];MAPK6[26972000];POLH[24485656];EGLN3[26972000];PARP1[18990703];XRCC3[24141787;26496610];RPA1[12527904];RPA2[12527904];RAD23A[16712842];PALB2[19609323;22193777;22293751;24141787;24485656;17420451;19369211;26649820];SEM1[10373512;22293751;16205630;24013206];NEURL4[29426014];RAD51[12442171;10551859;9560268;15800615;17541404;19303847;21601571;21399666;22116401;22293751;17515903;17515904;18264088;19628690;20729832;20729859;25282148];RAD51C[24141787];FANCD2[15115758;18212739];KATNAL2[26929214];NCL[30021884];DMC1[17541404;20729832];GRB2[17474147];SYCP3[22116401];TP53[20421506];	32893207
23769	chr13	38320595	AA		chr13:38320595-38320596	TRPC4	transient receptor potential cation channel subfamily C member 4	sequence_alteration	1/2	0.14	0_4_25	29	26.0	1/2	0.12	1_3_21	25	10.0			rs35278654	SPLICING	YES	NM_003306.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	2/10		NM_003306.3:c.379-4_379-3del			-1.0						.	.	.		0.00215609	315.0	146098.0	0.0	0	0.0	PASS	nfe	0.0020041	133.0	0.0020041	133.0	0.326394	31576.0	96742.0	0.0	22	0.49	RF	amr	0.369675	4686.0	0.322744	13756.0	0.0000450,0.0064436,0.2650736	7,1002,41220			0.40937	4666.0		9.903	0.554585		0	0	0			TRPC4	0.0	0.01	0.0	0.0	-48.0	-2.0	-1.0	-21.0						0.541	0.97				muscle phenotype; normal phenotype; cardiovascular system phenotype ; behavior/neurological phenotype ; nervous system phenotype ; 			pons;temporal lobe;uterus;subthalamic nucleus;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;parietal lobe;skeletal muscle;	.	calcium ion transport;manganese ion transport;gamma-aminobutyric acid secretion;oligodendrocyte differentiation;regulation of cytosolic calcium ion concentration;calcium ion import;calcium ion transmembrane transport	plasma membrane;integral component of plasma membrane;caveola;cell-cell junction;cell surface;basolateral plasma membrane;cortical cytoskeleton;cation channel complex;calcium channel complex	calcium channel activity;protein binding;beta-catenin binding;store-operated calcium channel activity;cadherin binding;inositol 1,4,5 trisphosphate binding	MX1[15757897];ITPR2[11163362];PHB[30021884];	38320594
23803	chr13	39598699	AA		chr13:39598699-39598700	PROSER1	proline and serine rich 1	deletion	0/1	0.22	7_2	9	45.0	0/1	0.25	6_4	16	99.0			rs67984592	SPLICING	YES	NM_025138.5	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	6/12		NM_025138.5:c.481-7_481-6del			-1.0						.	.	.		0.00020019	24.0	119886.0	0.0	26	0.61	PASS	afr	0.000240645	8.0	0.00018074	10.0	0.0154857	1258.0	81236.0	0.0	14	0.41	PASS	afr	0.0206741	119.0	0.0128887	451.0	0.0000193,0.0000386,0.0062506	3,6,972						7.181	0.297678		0	0	0			PROSER1	0.0	0.0	0.0	0.0	-24.0	-5.0	-5.0	-26.0							0.74				.			ciliary ganglion;testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;placenta;testis;skeletal muscle;	.	.	.	.	EGLN3[26972000];TOMM20[29568061];	39598698
23814	chr13	40298638	TA		chr13:40298638-40298639	COG6	component of oligomeric golgi complex 6	deletion	0/0	0.0	8_0	8	21.0	0|1	0.33	6_3	9	67.0			rs1491507046,COSV62995331	SPLICING	YES	NM_020751.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	16/18		NM_020751.3:c.1693-7_1693-6del			1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Congenital_disorder_of_glycosylation_type_2L|Shaheen_syndrome|Congenital_disorder_of_glycosylation|not_specified	Shaheen syndrome, 615328 (3), Autosomal recessive; Congenital disorder of glycosylation, type IIl, 614576 (3), Autosomal recessive	Hypohidrosis-enamel hypoplasia-palmoplantar keratoderma-intellectual disability syndrome;COG6-CGD	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Hypohidrosis;Carious teeth;Mild microcephaly;Delayed speech and language development;Delayed social development;Recurrent respiratory infections;Intellectual disability;Recurrent fever;Palmoplantar hyperkeratosis;Hepatitis;Broad nasal tip;Sparse lateral eyebrow;Postnatal microcephaly;Thick vermilion border;Hypoplasia of dental enamel;Autosomal recessive inheritance;Hypohidrosis;Carious teeth;Intellectual disability;Delayed speech and language development;Palmoplantar hyperkeratosis;Hypoplasia of dental enamel;Congenital onset;Microcephaly;Hyperbilirubinemia;Splenomegaly;Chronic diarrhea;Cerebral atrophy;Anemia;Ventriculomegaly;Hypohidrosis;Inflammation of the large intestine;Autosomal recessive inheritance;Thrombocytopenia;Decreased circulating antibody level;Proximal tubulopathy;Abnormal bleeding;Hyperkeratosis;Micronodular cirrhosis;Global developmental delay;Failure to thrive;Immunodeficiency;Pancytopenia;Retrognathia;Epicanthus;Hepatomegaly;Postaxial polydactyly;Generalized hypotonia;Microcephaly;Cholestasis;Congenital onset;Macrovesicular hepatic steatosis;Impaired T cell function;Loss of consciousness;Death in infancy;Recurrent infections;Muscular hypotonia of the trunk;Seizure;Intrauterine growth retardation;Type II transferrin isoform profile;Elevated hepatic transaminase;Intellectual disability		0.00295821	382.0	129132.0	2.0	12	0.5	PASS	sas	0.00934579	32.0	0.00313537	189.0	0.0925326	17430.0	188366.0	409.0	32	0.73	RF	amr	0.166268	3617.0	0.077166	6867.0	0.0002122,0.0004823	33,75			0.02134	215.0		0.923	-0.162576		0	0	0			COG6	0.0	0.01	0.0	0.0	18.0	8.0	18.0	8.0						0.969	0.0				nervous system phenotype ; skeleton phenotype; immune system phenotype; liver/biliary system phenotype; embryo phenotype; cardiovascular system phenotype ; hematopoietic system phenotype; normal phenotype; 			ciliary ganglion;testis - seminiferous tubule;subthalamic nucleus;atrioventricular node;trigeminal ganglion;superior cervical ganglion;globus pallidus;	.	endoplasmic reticulum to Golgi vesicle-mediated transport;intra-Golgi vesicle-mediated transport;protein transport;glycosylation	Golgi membrane;Golgi transport complex;trans-Golgi network membrane	protein binding	RTP5[unassigned1304];CCDC120[unassigned1304];MCM7[27107012];DOCK8[unassigned1304];PPP1R18[unassigned1304];UFSP1[unassigned1304];GOLGA2[27107012];FAM110A[unassigned1304];CSRP2[unassigned1304];GRAP2[27107012];TMSB4X[unassigned1304];MGC50722[unassigned1304];CCHCR1[27107012;unassigned1304];CCDC92[27107012];SNAP29[unassigned1304];TBC1D22B[unassigned1304];WASHC3[unassigned1304];CCDC116[unassigned1304];LMO4[unassigned1304];COG4[19651599];TTC7B[unassigned1304];LGALS14[27107012];RAB3IL1[unassigned1304];IGFN1[unassigned1304];GEM[unassigned1304];SCNM1[27107012;unassigned1304];PSMA1[unassigned1304];OAS1[unassigned1304];ARHGEF5[27107012;unassigned1304];NUP58[unassigned1304];GAS8[unassigned1304];SNRPB[unassigned1304];KANK2[unassigned1304];SMARCD1[unassigned1304];POM121[unassigned1304];CUL5[unassigned1304];TSHZ3[unassigned1304];PPP1R32[unassigned1304];MRI1[unassigned1304];BCL10[27107012;unassigned1304];CNN1[27107012];ATXN7[21078624];PSMB1[unassigned1304];RAB6B[27107012;unassigned1304];CNNM3[unassigned1304];RUNX1T1[unassigned1304];TSNAX[unassigned1304];JUN[25609649];NDUFA5[27107012];DTNB[unassigned1304];PLEKHA2[unassigned1304];ZBTB16[27107012;unassigned1304];NEK6[unassigned1304];ZFC3H1[unassigned1304];WDYHV1[27107012;unassigned1304];BAIAP2[unassigned1304];ESR2[25604459];FANCG[27107012];FAM90A1[27107012;unassigned1304];SYT17[unassigned1304];TSGA10[unassigned1304];QARS[unassigned1304];MFAP1[unassigned1304];ZNF417[unassigned1304];RSPH14[unassigned1304];SNAI1[unassigned1304];FNDC11[unassigned1304];MKRN3[unassigned1304];SPG21[unassigned1304];	40298637
23950	chr13	47263286	G	A	chr13:47263286	LRCH1	leucine rich repeats and calponin homology domain containing 1	SNV	0/1	0.53	8_10	19	99.0	0/1	0.35	41_23	65	99.0			rs766707360,COSV60848595	EXONIC	YES	NM_001164211.2	Transcript	protein_coding	synonymous_variant		7/20	NM_001164211.2:c.969G>A	NP_001157683.2:p.Ser323%3D		1.0						.	.	.		9.2121e-05	14.0	151974.0	0.0	33	0.98	PASS	nfe	0.000191283	13.0	0.000191283	13.0	0.000209022	52.0	248778.0	0.0	55	0.84	PASS	amr	0.000775379	26.0	0.000194487	22.0	0.0001415	22						2.839	0.014001		0	0	0			LRCH1	0.08	0.04	0.0	0.06	2.0	-14.0	2.0	50.0						0.161	0.98	90.595026895			hematopoietic system phenotype; immune system phenotype; cellular phenotype; 			ciliary ganglion;atrioventricular node;	.	negative regulation of GTPase activity;cellular response to chemokine;negative regulation of T cell migration	cytoplasm	protein binding	MOB1B[24255178];MOB1A[24255178];EGLN3[26972000];SMAD3[18729074];NOTCH1[23022380];DOCK8[24255178;25416956];DOCK7[24255178];LRCH3[24255178];TMEM14A[unassigned1304];	47263286
23995	chr13	50125569	T	C	chr13:50125569	RCBTB1	RCC1 and BTB domain containing protein 1	SNV	0/1	0.4	49_32	81	99.0	0/0	0.0	35_0	35	99.0			rs746325362	EXONIC	YES	NM_001352500.2	Transcript	protein_coding	synonymous_variant		8/13	NM_001352500.2:c.747A>G	NP_001339429.1:p.Thr249%3D		-1.0					Retinal dystrophy with or without extraocular anomalies, 617175 (3), Autosomal recessive	Reticular dystrophy of the retinal pigment epithelium	Disease-causing germline mutation(s) in	Secondary amenorrhea;Premature ovarian insufficiency;Autosomal recessive inheritance;Pulmonary fibrosis;Reduced visual acuity;Retinal dystrophy;Goiter		1.31368e-05	2.0	152244.0	0.0	32	0.97	PASS	nfe	2.93936e-05	2.0	2.93936e-05	2.0	2.38686e-05	6.0	251376.0	0.0	56	1.0	PASS	nfe	4.39823e-05	5.0	4.39823e-05	5.0	0.0000129	2			0.00021	2.0		10.77	0.654631		0	0	0			RCBTB1	0.0	0.0	0.0	0.0	35.0	7.0	-14.0	36.0						0.462	0.0	95.638616071			.			pons;ciliary ganglion;amygdala;thyroid;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;atrioventricular node;trigeminal ganglion;	.	chromatin organization;cell cycle	nucleus;cytoplasm	.	FOXR2[25609649];GABARAPL2[20562859];MAP1LC3B[20562859];GABARAPL1[20562859];MAP1LC3A[20562859];HSP90AB1[22939624];NUDCD1[29021621];GABARAP[20562859];PTBP3[22575643];	50125569
24057	chr13	72440357	G	A	chr13:72440357	DACH1	dachshund family transcription factor 1	SNV	0/1	0.67	28_56	84	99.0	0/1	0.49	50_49	99	99.0			rs754515488	EXONIC	YES	NM_001366712.1	Transcript	protein_coding	missense_variant		1/12	NM_001366712.1:c.545C>T	NP_001353641.1:p.Thr182Ile		-1.0	.,SKI/SNO/DAC domain,SKI/SNO/DAC domain,SKI/SNO/DAC domain					.	.	.		6.58354e-06	1.0	151894.0	0.0	30	0.92	PASS				0.0	0.0	4.07043e-06	1.0	245674.0	0.0	31	0.88	PASS	nfe	9.02869e-06	1.0	9.02869e-06	1.0	0.0000064	1						19.91	2.022626	0.317	6	8	14	M-CAP_pred,MutationTaster_pred,PrimateAI_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	DACH1	0.0	0.0	0.0	0.0	9.0	-48.0	-15.0	30.0						0.0471	1.0	0.000000000	1.0	1.085	behavior/neurological phenotype ; respiratory system phenotype; mortality/aging ; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			caudate nucleus;ciliary ganglion;trigeminal ganglion;	.	negative regulation of transcription by RNA polymerase II;suckling behavior;regulation of transcription, DNA-templated;transcription by RNA polymerase II;respiratory gaseous exchange;cell population proliferation;negative regulation of transcription by competitive promoter binding;negative regulation of cell migration;regulation of nuclear cell cycle DNA replication;negative regulation of transcription, DNA-templated;development of primary female sexual characteristics;negative regulation of fibroblast proliferation;negative regulation of cell proliferation involved in contact inhibition;negative regulation of DNA biosynthetic process	nucleus;transcription factor complex;cytoplasm	RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;protein binding	SMAD4[14525983];JUN[25609649];SMAD3[14525983];UBE2I[16189514];AHCYL1[25416956;unassigned1304];ZCCHC10[25416956];RNF14[25416956;unassigned1304];MMTAG2[25416956];NCOR1[14525983];NAGK[16189514;21516116;25416956;unassigned1304];DACH1[25416956];PRKAR1B[unassigned1304];SIN3A[14525983];U2AF2[25416956];PPIG[25416956];FGF12[25416956;unassigned1304];SRSF11[unassigned1304];FOXA2[25609649];	72440357
24059	chr13	72440659	GCCGCCGCC		chr13:72440659-72440667	DACH1	dachshund family transcription factor 1	sequence_alteration	2/2	0.0	0_0_29	29	88.0	1/2	0.11	0_4_34	38	66.0			rs748058171	EXONIC	YES	NM_001366712.1	Transcript	protein_coding	coding_sequence_variant		1/12	NM_001366712.1:c.241_249del			-1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.						21	0.7							0.00342372	25.0	7302.0	0.0	0	0.0	RF	afr	0.0833333	1.0	0.00393701	6.0	0.0000257,0.0001736	4,27						13.79	1.055051		0	0	0																	0.0471	1.0				behavior/neurological phenotype ; respiratory system phenotype; mortality/aging ; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			caudate nucleus;ciliary ganglion;trigeminal ganglion;	.	negative regulation of transcription by RNA polymerase II;suckling behavior;regulation of transcription, DNA-templated;transcription by RNA polymerase II;respiratory gaseous exchange;cell population proliferation;negative regulation of transcription by competitive promoter binding;negative regulation of cell migration;regulation of nuclear cell cycle DNA replication;negative regulation of transcription, DNA-templated;development of primary female sexual characteristics;negative regulation of fibroblast proliferation;negative regulation of cell proliferation involved in contact inhibition;negative regulation of DNA biosynthetic process	nucleus;transcription factor complex;cytoplasm	RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription repressor activity, RNA polymerase II-specific;protein binding	SMAD4[14525983];JUN[25609649];SMAD3[14525983];UBE2I[16189514];AHCYL1[25416956;unassigned1304];ZCCHC10[25416956];RNF14[25416956;unassigned1304];MMTAG2[25416956];NCOR1[14525983];NAGK[16189514;21516116;25416956;unassigned1304];DACH1[25416956];PRKAR1B[unassigned1304];SIN3A[14525983];U2AF2[25416956];PPIG[25416956];FGF12[25416956;unassigned1304];SRSF11[unassigned1304];FOXA2[25609649];	72440658
24102	chr13	79175688	G	A	chr13:79175688	POU4F1	POU class 4 homeobox 1	SNV	0/1	0.5	50_50	100	99.0	0/1	0.38	57_36	94	99.0			rs147924260	EXONIC	YES	NM_006237.4	Transcript	protein_coding	synonymous_variant		2/2	NM_006237.4:c.1122C>T	NP_006228.3:p.Phe374%3D		-1.0					Ataxia, intention tremor, and hypotonia syndrome, childhood-onset, 619352 (3), Autosomal dominant	.	.	.		0.000926486	141.0	152188.0	0.0	31	0.96	PASS	nfe	0.001896	129.0	0.001896	129.0	0.000836327	210.0	251098.0	1.0	82	1.0	PASS	nfe	0.00167242	190.0	0.00167242	190.0	0.0008489	132	0.001	2.0				12.48	0.868137		0	0	0			POU4F1	0.0	0.0	0.0	0.0	-10.0	20.0	30.0	-20.0								91.973940093			nervous system phenotype ; vision/eye phenotype; embryo phenotype; behavior/neurological phenotype ; normal phenotype; mortality/aging ; 			.	.	negative regulation of transcription by RNA polymerase II;suckling behavior;ventricular compact myocardium morphogenesis;axonogenesis;synapse assembly;mesoderm development;heart development;positive regulation of gene expression;negative regulation of gene expression;cell migration in hindbrain;trigeminal nerve development;central nervous system neuron differentiation;habenula development;neuron projection development;positive regulation of apoptotic process;negative regulation of programmed cell death;negative regulation of neuron apoptotic process;positive regulation of osteoclast differentiation;positive regulation of transcription by RNA polymerase II;neuron fate specification;sensory system development;peripheral nervous system neuron development;regulation of neurogenesis;regulation of DNA-binding transcription factor activity;proprioception involved in equilibrioception;innervation;positive regulation of cell cycle arrest;cellular response to cytokine stimulus;cellular response to estradiol stimulus;intrinsic apoptotic signaling pathway by p53 class mediator;regulation of signal transduction by p53 class mediator;positive regulation of transcription regulatory region DNA binding;negative regulation of transcription elongation by RNA polymerase I	nuclear chromatin;nucleus;nucleoplasm;cytoplasm;neuron projection	RNA polymerase II distal enhancer sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;chromatin binding;single-stranded DNA binding;transcription coactivator activity;transcription corepressor activity;sequence-specific DNA binding;GTPase binding	MAPRE3[unassigned1304];	79175688
24119	chr13	95363653	G	A	chr13:95363653	SOX21	SRY-box 21	SNV	0/1	0.14	29_5	36	77.0	0/0	0.0	44_0	44	81.0			rs1322837592,COSV65375485	EXONIC	YES	NM_007084.4	Transcript	protein_coding	synonymous_variant		1/1	NM_007084.4:c.651C>T	NP_009015.1:p.Ala217%3D		-1.0						.	.	.		0.0	0.0	143782.0	0.0	31	0.87	AC0_AS_VQSR				0.0	0.0	0.000325521	1.0	3072.0	0.0	0	0.0	PASS				0.0	0.0	0.0000257	4						4.754	0.129912		0	0	0			SOX21	0.0	0.0	0.0	0.0	10.0	-33.0	32.0	-7.0											endocrine/exocrine gland phenotype; integument phenotype ; 			.	.	negative regulation of transcription by RNA polymerase II;hair follicle development;regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II;central nervous system development;cell differentiation;neuron differentiation;positive regulation of transcription by RNA polymerase II;stem cell differentiation	cellular_component;nucleus;nuclear transcription factor complex	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity	.	95363653
24128	chr13	95363661	CC		chr13:95363661-95363662	SOX21	SRY-box 21	deletion	0|1	0.14	30_5	35	89.0	0/0	0.0	36_0	36	60.0				EXONIC	YES	NM_007084.4	Transcript	protein_coding	frameshift_variant		1/1	NM_007084.4:c.642_643del	NP_009015.1:p.Ala215GlyfsTer80		-1.0						.	.	.						31	0.87											0	0.0																	0	0	0			SOX21	0.0	0.0	0.0	0.0	-40.0	3.0	25.0	3.0											endocrine/exocrine gland phenotype; integument phenotype ; 			.	.	negative regulation of transcription by RNA polymerase II;hair follicle development;regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II;central nervous system development;cell differentiation;neuron differentiation;positive regulation of transcription by RNA polymerase II;stem cell differentiation	cellular_component;nucleus;nuclear transcription factor complex	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity	.	95363660
24139	chr13	99109476	G	A	chr13:99109476	STK24	serine/threonine kinase 24	SNV	0/1	0.38	88_54	143	99.0	0/1	0.45	58_48	106	99.0			rs55953606,COSV64822487	EXONIC	YES	NM_003576.5	Transcript	protein_coding	missense_variant		10/11	NM_003576.5:c.1241C>T	NP_003567.2:p.Ala414Val		-1.0	.,.,.,.,.					.	.	.		0.00293089	446.0	152172.0	1.0	33	0.97	PASS	nfe	0.00473265	322.0	0.00473265	322.0	0.00317197	796.0	250948.0	0.0	48	0.97	PASS	nfe	0.0050215	570.0	0.0050215	570.0	0.0032925	512	0.003	8.0				23.5	2.979655	0.109	6	12	18	MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	STK24	0.0	0.0	0.0	0.0	2.0	-44.0	2.0	-44.0						0.303	0.8	0.000000000	0.895	1.176	hematopoietic system phenotype; renal/urinary system phenotype; immune system phenotype; homeostasis/metabolism phenotype; 			.	MAPK signaling pathway	MAPK cascade;protein phosphorylation;signal transduction;intrinsic apoptotic signaling pathway in response to oxidative stress;cellular response to starvation;signal transduction by protein phosphorylation;negative regulation of cell migration;stress-activated protein kinase signaling cascade;activation of protein kinase activity;response to hydrogen peroxide;protein autophosphorylation;regulation of axon regeneration;neuron projection morphogenesis;execution phase of apoptosis	nucleus;nucleoplasm;nucleolus;cytoplasm;Golgi apparatus;cytosol;membrane;extracellular exosome	protein kinase activity;protein serine/threonine kinase activity;protein binding;ATP binding;cadherin binding;metal ion binding	TRAF3IP3[18782753];CEP19[26638075];HSCB[28380382];SYNCRIP[17353931];STK11[25640309];JPH3[17353931];PPP2R1B[18782753;23455922];PPP2R1A[17353931;18782753;23455922];FGFR1OP2[18782753;23455922;26496610];DSP[17353931];CCT3[18782753];PROSER2[23455922];CCT2[18782753];PDCD6IP[17353931];AHSA1[17353931];DYNLL1[23455922];CTTNBP2NL[18782753;23455922];VAV2[18654987];SIKE1[18782753;23455922;26496610];EWSR1[17353931];TCP1[18782753];MATR3[17353931];HNRNPH3[17353931];DDX5[17353931];CTTNBP2[18782753;23455922];STRN4[17353931;18782753;23455922];STRN3[17353931;18782753;23455922;24366813;24255178;26496610];PPP2CA[18782753;23455922;26496610];PPP2CB[17353931;23455922;26496610];STRIP1[18782753;25531779];STRIP2[18782753;23455922;25531779];PDCD10[16189514;17353931;17657516;18782753;21516116;23455922;25416956;unassigned1304;23541896];ERBB2[25640309];G3BP2[17353931];APOD[17353931];TRY8[17353931];CCT8[18782753];CCT7[18782753];CCT5[18782753];CCT4[18782753];HNRNPA3[17353931];NEK4[25798074];CDC5L[20467437];MCC[17353931];LRPPRC[26496610];MOB4[17353931;18782753;23455922];CCT6A[18782753];STK25[17353931;18782753;23455922];SLMAP[17353931;18782753;23455922;24366813];STK26[18782753;23455922];STRN[17353931;18782753;23455922;26496610];WRAP53[26496610];	99109476
24249	chr13	103338721	T	C	chr13:103338721	METTL21C	methyltransferase like 21C	SNV	0/1	0.47	37_34	73	99.0	0/1	0.47	37_33	70	99.0			rs138041652	EXONIC	YES	NM_001010977.3	Transcript	protein_coding	missense_variant		4/4	NM_001010977.3:c.455A>G	NP_001010977.1:p.Asn152Ser		-1.0						.	.	.		0.00230609	351.0	152206.0	0.0	33	0.97	PASS	sas	0.00393375	19.0	0.00389477	265.0	0.00294413	739.0	251008.0	4.0	52	0.99	PASS	nfe	0.00458424	520.0	0.00458424	520.0	0.0031125	484	0.003	9.0				25.1	3.521938	0.708	11	10	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	METTL21C	0.0	0.0	0.0	0.0	45.0	-30.0	-23.0	-4.0							0.0	0.000000000	1.0	1.138	.			ciliary ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;	.	protein methylation;skeletal muscle tissue development;hormone-mediated apoptotic signaling pathway;regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;peptidyl-lysine methylation;cellular response to dexamethasone stimulus	nucleus;protein-containing complex	protein binding;protein-lysine N-methyltransferase activity;heat shock protein binding	ELOC[25416956;unassigned1304];	103338721
24384	chr13	112722816	CGCCGC		chr13:112722816-112722821	SOX1	SRY-box 1	deletion	0/0	0.0	29_0	29	63.0	0/1	0.67	3_10	15	96.0			rs755129510	EXONIC	YES	NM_005986.3	Transcript	protein_coding	inframe_deletion		1/1	NM_005986.3:c.855_860del	NP_005977.2:p.Ala287_Ala288del		1.0						.	.	.		0.000729735	100.0	137036.0	0.0	32	0.86	PASS	amr	0.00085751	12.0	0.000617303	39.0	0.000231321	2.0	8646.0	0.0	0	0.0	PASS	nfe	0.000233863	1.0	0.000233863	1.0	0.0001479	23						17.19	1.655458		0	0	0																						cellular phenotype; muscle phenotype; growth/size/body region phenotype; embryo phenotype; immune system phenotype; vision/eye phenotype; nervous system phenotype ; mortality/aging ; behavior/neurological phenotype ; 			ciliary ganglion;liver;superior cervical ganglion;atrioventricular node;trigeminal ganglion;parietal lobe;skeletal muscle;	.	neuron migration;lens morphogenesis in camera-type eye;chromatin organization;regulation of transcription, DNA-templated;central nervous system development;ventral spinal cord interneuron specification;forebrain neuron development;cell differentiation;neuron differentiation;positive regulation of transcription by RNA polymerase II;cellular response to leukemia inhibitory factor	nucleus;nuclear transcription factor complex	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;protein binding	STAT3[20929579];	112722815
24438	chr13	113771900	CGCGGTGCTGGGTGGGTACCACTCTCCCCTGTCCGAC		chr13:113771900-113771936	F7	coagulation factor VII	deletion	0|1	0.38	36_22	58	99.0	0/0	0.0	42_0	42	99.0			rs1309684522	SPLICING	YES	NM_000131.4	Transcript	protein_coding	splice_donor_variant,splice_donor_5th_base_variant,coding_sequence_variant,intron_variant	8/8	8/9	NM_000131.4:c.805+7_805+43del			1.0		Uncertain_significance	criteria_provided,_single_submitter	Factor_VII_deficiency	{Myocardial infarction, decreased susceptibility to}, 608446 (3); Factor VII deficiency, 227500 (3), Autosomal recessive	Congenital factor VII deficiency	Disease-causing germline mutation(s) in	Menorrhagia;Epistaxis;Intracranial hemorrhage;Autosomal recessive inheritance;Reduced factor VII activity;Intramuscular hematoma;Joint hemorrhage;Abnormal bleeding;Variable expressivity;Epistaxis;Bruising susceptibility;Prolonged prothrombin time;Intracranial hemorrhage;Post-partum hemorrhage;Gastrointestinal hemorrhage;Joint hemorrhage;Ovarian cyst;Prolonged bleeding after surgery;Gingival bleeding;Abnormality of the umbilical cord;Menorrhagia		0.002638	400.0	151630.0	0.0	33	0.92	PASS	nfe	0.00402133	273.0	0.00402133	273.0	0.000470506	118.0	250794.0	0.0	60	0.99	PASS	nfe	0.000741539	84.0	0.000741539	84.0	0.0000386	6			0.00289	33.0		24.0	3.195628		0	0	0																	0.0655	0.0	0.000000000			homeostasis/metabolism phenotype; craniofacial phenotype; adipose tissue phenotype ; growth/size/body region phenotype; skeleton phenotype; cardiovascular system phenotype ; mortality/aging ; normal phenotype; 			ciliary ganglion;liver;superior cervical ganglion;trigeminal ganglion;fetal liver;	Complement and coagulation cascades	response to hypoxia;positive regulation of leukocyte chemotaxis;endoplasmic reticulum to Golgi vesicle-mediated transport;blood coagulation;blood coagulation, extrinsic pathway;circadian rhythm;response to carbon dioxide;positive regulation of platelet-derived growth factor receptor signaling pathway;protein processing;positive regulation of blood coagulation;positive regulation of cell migration;animal organ regeneration;response to estradiol;response to vitamin K;response to genistein;response to estrogen;positive regulation of positive chemotaxis;positive regulation of protein kinase B signaling;response to growth hormone;response to cholesterol;response to thyroxine;response to Thyroid stimulating hormone;response to 2,3,7,8-tetrachlorodibenzodioxine;response to astaxanthin;response to thyrotropin-releasing hormone	extracellular region;extracellular space;endoplasmic reticulum lumen;Golgi lumen;plasma membrane;vesicle;serine-type peptidase complex	serine-type endopeptidase activity;signaling receptor binding;calcium ion binding;protein binding;serine-type peptidase activity	F7[15522303;15664864];BECN1[20562859];GABARAPL1[20562859];SLX4[19596235];USP49[19615732];DMWD[19615732];ALB[15174051];UIMC1[19615732];IKBKG[14743216];RCHY1[21988832];F3[15522303;15664864;25241761;9414278;8940045;8598903];	113771899
24458	chr13	113852552	T	C	chr13:113852552	PCID2	PCI domain containing 2	SNV	0/1	0.29	45_19	65	99.0	0/1	0.5	30_30	60	99.0			rs149143185	EXONIC	YES	NM_001320656.2	Transcript	protein_coding	synonymous_variant		3/15	NM_001320656.2:c.153A>G	NP_001307585.1:p.Gln51%3D		-1.0						.	.	.		0.00218745	333.0	152232.0	1.0	33	0.97	PASS	sas	0.00620091	30.0	0.00289561	197.0	0.00323982	801.0	247236.0	3.0	46	0.75	PASS	sas	0.0081531	239.0	0.00334928	378.0	0.0031703	493	0.002	6.0				8.803	0.438643		0	0	0			PCID2	0.0	0.0	0.0	0.0	31.0	26.0	5.0	-47.0						0.262	0.0	97.173250383			immune system phenotype; digestive/alimentary phenotype; hematopoietic system phenotype; mortality/aging ; cellular phenotype; endocrine/exocrine gland phenotype; 			testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;testis;	.	posttranscriptional tethering of RNA polymerase II gene DNA at nuclear periphery;transcription elongation from RNA polymerase II promoter;poly(A)+ mRNA export from nucleus;negative regulation of apoptotic process;regulation of mRNA stability;positive regulation of B cell differentiation;positive regulation of transcription, DNA-templated;spleen development;nuclear retention of pre-mRNA at the site of transcription;positive regulation of mitotic cell cycle spindle assembly checkpoint;negative regulation of cysteine-type endopeptidase activity	cellular_component;transcriptionally active chromatin;transcription export complex 2	double-stranded DNA binding;RNA binding;protein binding	SMAD2[18729074];BRF2[17353931];TMEM63B[26496610];NEK6[17353931];RPS6[29568061];ZFC3H1[26496610];ILK[17353931];LENG8[unassigned1304];KIF11[26496610];RRP1B[20926688];IKZF3[25416956];SEM1[16189514;unassigned1304;22343721];CDK8[29568061];MCM3AP[22343721];NCBP3[26382858];AURKAIP1[29568061];	113852552
24614	chr14	19553642	A	G	chr14:19553642	POTEG	POTE ankyrin domain family member G	SNV	0/1	0.22	160_45	205	99.0	0/1	0.2	146_37	183	99.0			rs57000026,COSV69152662	EXONIC	YES	NM_001005356.3	Transcript	protein_coding	missense_variant		1/11	NM_001005356.3:c.226A>G	NP_001005356.1:p.Ser76Gly		1.0						.	.	.						0	0.0							0.00296192	603.0	203584.0	63.0	100	0.81	PASS	afr	0.00563818	69.0	0.00225297	211.0	0.0020257	315						0.004	-0.931677		0	2	2		SIFT,PolyPhen	POTEG	0.0	0.0	0.0	0.0	28.0	2.0	-42.0	-7.0											.			.	.	.	.	.	.	19553642
24617	chr14	19553795	G	A	chr14:19553795	POTEG	POTE ankyrin domain family member G	SNV	0/1	0.25	304_103	407	99.0	0/1	0.29	257_104	361	99.0			rs76596948,COSV69152576	EXONIC	YES	NM_001005356.3	Transcript	protein_coding	missense_variant		1/11	NM_001005356.3:c.379G>A	NP_001005356.1:p.Ala127Thr		1.0						.	.	.		0.00147116	106.0	72052.0	0.0	18	0.46	AS_VQSR,PASS	sas,eas	0.00257164	7.0	0.00163379	54.0	0.0473361	9217.0	194714.0	26.0	50	1.0	PASS	amr	0.0752954	1950.0	0.0498656	4231.0	0.0807439	12556	0.008	25.0				15.77	1.410093	0.137	2	14	16	SIFT,PolyPhen	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	POTEG	0.0	0.0	0.0	0.0	12.0	-49.0	-31.0	16.0									0.001	0.562	.			.	.	.	.	.	.	19553795
24630	chr14	21502001	G	A	chr14:21502001	RNASE13	ribonuclease A family member 13 (inactive)	SNV	0/1	0.52	44_48	92	99.0	0/1	0.54	41_48	89	99.0			rs779827802	EXONIC	YES	NM_001012264.4	Transcript	protein_coding	synonymous_variant		2/2	NM_001012264.4:c.447C>T	NP_001012264.1:p.Ile149%3D		-1.0						.	.	.		7.22999e-05	11.0	152144.0	0.0	32	0.96	PASS	amr	0.000392773	6.0	7.34862e-05	5.0	4.77209e-05	12.0	251462.0	0.0	100	1.0	PASS	amr	8.67604e-05	3.0	7.91195e-05	9.0	0.0000450	7	0.001	3.0				21.7	2.247601		0	0	0			RNASE13	0.0	0.0	0.0	0.0	25.0	4.0	5.0	10.0						0.513	0.0	0.000000000,34.893533698			.			.	.	RNA phosphodiester bond hydrolysis	extracellular region	nucleic acid binding;ribonuclease activity	.	21502001
24640	chr14	21679658	A	G	chr14:21679658	HNRNPC	heterogeneous nuclear ribonucleoprotein C (C1/C2)	SNV	0|1	0.1	48_6	59	99.0	0|1	0.11	51_7	63	99.0			rs201035478	EXONIC	YES	NM_031314.3	Transcript	protein_coding	synonymous_variant		8/9	NM_031314.3:c.744T>C	NP_112604.2:p.Asn248%3D		-1.0						.	.	.						31	0.91							1.21982e-05	3.0	245938.0	0.0	49	0.93	RF	nfe	2.70822e-05	3.0	2.70822e-05	3.0	0.0000064	1						10.64	0.639084		0	0	0			HNRNPC	0.0	0.0	0.0	0.0	-29.0	-7.0	-22.0	0.0						0.379	0.99				embryo phenotype; mortality/aging ; 			.	.	mRNA splicing, via spliceosome;osteoblast differentiation;RNA splicing;RNA metabolic process;negative regulation of telomere maintenance via telomerase;ATP-dependent chromatin remodeling;3'-UTR-mediated mRNA stabilization	nuclear chromatin;extracellular region;nucleus;nucleoplasm;spliceosomal complex;telomerase holoenzyme complex;cytosol;actin cytoskeleton;membrane;protein-containing complex;extracellular exosome;catalytic step 2 spliceosome	RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;RNA binding;mRNA 3'-UTR binding;protein binding;poly(U) RNA binding;nucleosomal DNA binding;identical protein binding;telomerase RNA binding;N6-methyladenosine-containing RNA binding	EIF4A3[14730019;23084401];HNRNPU[26496610];IFIT1[21642987];RPL9[unassigned1304];EPS8[25416956];TEPSIN[26496610];ZFYVE26[25416956];KAT5[unassigned1304];MYC[17353931;21150319];MAGOH[23084401];KPNA4[25416956;unassigned1304];KMT5A[30021884];BTRC[21988832];KPNA2[21988832;25416956];C20orf202[unassigned1304];KPNA3[16189514;19447967;25416956];CCDC93[26496610];ACAD10[30021884];PIAS4[unassigned1304];PPP1R16B[unassigned1304];GABARAPL2[20562859];GABARAPL1[20562859];CSNK2A1[22113938];LMO3[16189514;unassigned1304];LMO2[25416956;unassigned1304];DICER1[21858095];SND1[30021884];GTPBP3[unassigned1304];ILF3[18337511];CCNE2[30021884];CDC37[unassigned1304];AKAP9[30021884];VDAC2[30021884];MATR3[26496610];OR5A2[30021884];KHDRBS3[19447967];RBM8A[11546873];GABARAP[20562859];TTBK1[30021884];CAMSAP2[30021884];SDCBP[25416956;unassigned1304];FXR2[16189514];CLEC7A[30021884];NLRP3[26496610];ZC3H18[29298432];TTLL13P[30021884];CCDC33[30021884];AP1M1[16189514;unassigned1304];SRPK2[23602568];SYT4[30021884];JUN[25609649];NOP14[30021884];UBE2I[16189514;25416956];VCAM1[22623428];NEK4[25798074];AUTS2[30021884];ALYREF[11546873];EIF2AK2[21903422];PHKB[16189514];UPF3A[11546873];WDYHV1[unassigned1304];MRPL23[30021884];CLK3[23602568];DNAJC17[30021884];NFKB2[14743216];SRPK1[23602568];GH1[17353931];RALYL[16189514;19447967;25416956;unassigned1304];SNW1[20467437];AGO4[19167051];AGO1[17932509];AGO2[17932509];HNRNPD[22365833;26496610];RSPH14[unassigned1304];PIN1[16189514];GRB2[30021884];TCF4[30021884];HNRNPC[16189514;21516116;22365833;25416956;unassigned1304];CEP85[30021884];HNRNPA1L2[30021884];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];CELF1[22365833];ARRB2[17620599];YBX1[22118625;25497084];DDX41[25920683];MEOX2[unassigned1304];DMBX1[unassigned1304];MAP1LC3B[20562859];METTL14[29507755];MAP1LC3A[20562859];TUBA1A[27291054];SUMO1[25416956;unassigned1304];PSD2[30021884];RBPMS2[unassigned1304];NCK2[unassigned1304];IKBKE[17353931];L1RE1[24267889];APOBEC1[unassigned1304];NCBP1[19262567];H2AFX[20000738];PAX6[unassigned1304];TNFRSF1B[14743216];ZNF57[30021884];YWHAZ[15161933;20618440];PTBP2[22365833];NR5A1[24635384];MMP12[30021884];F8[30021884];TRAF6[17353931];PITPNM3[30021884];PICK1[unassigned1304];TOP1[15848144];ECT2L[30021884];SSX2IP[30021884];CCDC40[30021884];PPP1R15A[29109149];FYTTD1[30021884];SASH3[30021884];SMARCD1[21988832];MAGEH1[30021884];SF3B2[22365833];DDX21[15034300;30021884];HTT[17500595];RNF4[unassigned1304];CUX2[30021884];PUF60[17353931];CCDC85B[16189514];EMC2[unassigned1304];NOTO[unassigned1304];RALY[22365833;unassigned1304;30021884];NCAM2[30021884];HNRNPA1[11546873;22446626;26496610;30021884];SUMO1P1[25416956;unassigned1304];DISC1[unassigned1304];ZNF581[16189514];GPKOW[30021884];CDKN2A[17955473];UTP3[30021884];CNBP[17353931];ZNF804A[30021884];LAPTM5[30021884];CDC5L[20467437;30021884];SEMA4F[30021884];PKDREJ[30021884];ADAM30[30021884];LBX1[unassigned1304];PLEKHA7[28877994];PPP1CA[25593058];MAB21L3[unassigned1304];SNX18[unassigned1304];GPAM[30021884];ST5[30021884];TNIP3[30021884];HNRNPA2B1[30021884];RBM41[16189514;21516116;25416956];FAS[21988832];KRAS[16189514];FSBP[30021884];CD247[24502978];CLEC2D[30021884];	21679658
24644	chr14	21679660	T	G	chr14:21679660	HNRNPC	heterogeneous nuclear ribonucleoprotein C (C1/C2)	SNV	0|1	0.1	48_6	59	99.0	0|1	0.11	51_7	63	99.0			rs199624650	EXONIC	YES	NM_031314.3	Transcript	protein_coding	missense_variant		8/9	NM_031314.3:c.742A>C	NP_112604.2:p.Asn248His		-1.0	.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.					.	.	.						31	0.92							1.22178e-05	3.0	245544.0	0.0	48	0.93	RF	nfe	2.71272e-05	3.0	2.71272e-05	3.0	0.0000064	1						21.9	2.286211	0.084	3	15	18	MutationTaster_pred,PrimateAI_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	HNRNPC	0.0	0.0	0.0	0.0	41.0	-31.0	-24.0	-2.0						0.379	0.99		1.0	1.12	embryo phenotype; mortality/aging ; 			.	.	mRNA splicing, via spliceosome;osteoblast differentiation;RNA splicing;RNA metabolic process;negative regulation of telomere maintenance via telomerase;ATP-dependent chromatin remodeling;3'-UTR-mediated mRNA stabilization	nuclear chromatin;extracellular region;nucleus;nucleoplasm;spliceosomal complex;telomerase holoenzyme complex;cytosol;actin cytoskeleton;membrane;protein-containing complex;extracellular exosome;catalytic step 2 spliceosome	RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;RNA binding;mRNA 3'-UTR binding;protein binding;poly(U) RNA binding;nucleosomal DNA binding;identical protein binding;telomerase RNA binding;N6-methyladenosine-containing RNA binding	EIF4A3[14730019;23084401];HNRNPU[26496610];IFIT1[21642987];RPL9[unassigned1304];EPS8[25416956];TEPSIN[26496610];ZFYVE26[25416956];KAT5[unassigned1304];MYC[17353931;21150319];MAGOH[23084401];KPNA4[25416956;unassigned1304];KMT5A[30021884];BTRC[21988832];KPNA2[21988832;25416956];C20orf202[unassigned1304];KPNA3[16189514;19447967;25416956];CCDC93[26496610];ACAD10[30021884];PIAS4[unassigned1304];PPP1R16B[unassigned1304];GABARAPL2[20562859];GABARAPL1[20562859];CSNK2A1[22113938];LMO3[16189514;unassigned1304];LMO2[25416956;unassigned1304];DICER1[21858095];SND1[30021884];GTPBP3[unassigned1304];ILF3[18337511];CCNE2[30021884];CDC37[unassigned1304];AKAP9[30021884];VDAC2[30021884];MATR3[26496610];OR5A2[30021884];KHDRBS3[19447967];RBM8A[11546873];GABARAP[20562859];TTBK1[30021884];CAMSAP2[30021884];SDCBP[25416956;unassigned1304];FXR2[16189514];CLEC7A[30021884];NLRP3[26496610];ZC3H18[29298432];TTLL13P[30021884];CCDC33[30021884];AP1M1[16189514;unassigned1304];SRPK2[23602568];SYT4[30021884];JUN[25609649];NOP14[30021884];UBE2I[16189514;25416956];VCAM1[22623428];NEK4[25798074];AUTS2[30021884];ALYREF[11546873];EIF2AK2[21903422];PHKB[16189514];UPF3A[11546873];WDYHV1[unassigned1304];MRPL23[30021884];CLK3[23602568];DNAJC17[30021884];NFKB2[14743216];SRPK1[23602568];GH1[17353931];RALYL[16189514;19447967;25416956;unassigned1304];SNW1[20467437];AGO4[19167051];AGO1[17932509];AGO2[17932509];HNRNPD[22365833;26496610];RSPH14[unassigned1304];PIN1[16189514];GRB2[30021884];TCF4[30021884];HNRNPC[16189514;21516116;22365833;25416956;unassigned1304];CEP85[30021884];HNRNPA1L2[30021884];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];CELF1[22365833];ARRB2[17620599];YBX1[22118625;25497084];DDX41[25920683];MEOX2[unassigned1304];DMBX1[unassigned1304];MAP1LC3B[20562859];METTL14[29507755];MAP1LC3A[20562859];TUBA1A[27291054];SUMO1[25416956;unassigned1304];PSD2[30021884];RBPMS2[unassigned1304];NCK2[unassigned1304];IKBKE[17353931];L1RE1[24267889];APOBEC1[unassigned1304];NCBP1[19262567];H2AFX[20000738];PAX6[unassigned1304];TNFRSF1B[14743216];ZNF57[30021884];YWHAZ[15161933;20618440];PTBP2[22365833];NR5A1[24635384];MMP12[30021884];F8[30021884];TRAF6[17353931];PITPNM3[30021884];PICK1[unassigned1304];TOP1[15848144];ECT2L[30021884];SSX2IP[30021884];CCDC40[30021884];PPP1R15A[29109149];FYTTD1[30021884];SASH3[30021884];SMARCD1[21988832];MAGEH1[30021884];SF3B2[22365833];DDX21[15034300;30021884];HTT[17500595];RNF4[unassigned1304];CUX2[30021884];PUF60[17353931];CCDC85B[16189514];EMC2[unassigned1304];NOTO[unassigned1304];RALY[22365833;unassigned1304;30021884];NCAM2[30021884];HNRNPA1[11546873;22446626;26496610;30021884];SUMO1P1[25416956;unassigned1304];DISC1[unassigned1304];ZNF581[16189514];GPKOW[30021884];CDKN2A[17955473];UTP3[30021884];CNBP[17353931];ZNF804A[30021884];LAPTM5[30021884];CDC5L[20467437;30021884];SEMA4F[30021884];PKDREJ[30021884];ADAM30[30021884];LBX1[unassigned1304];PLEKHA7[28877994];PPP1CA[25593058];MAB21L3[unassigned1304];SNX18[unassigned1304];GPAM[30021884];ST5[30021884];TNIP3[30021884];HNRNPA2B1[30021884];RBM41[16189514;21516116;25416956];FAS[21988832];KRAS[16189514];FSBP[30021884];CD247[24502978];CLEC2D[30021884];	21679660
24649	chr14	21679666	C	T	chr14:21679666	HNRNPC	heterogeneous nuclear ribonucleoprotein C (C1/C2)	SNV	0|1	0.11	44_6	55	99.0	0|1	0.12	48_7	60	99.0			rs200585285,COSV60147835	EXONIC	YES	NM_031314.3	Transcript	protein_coding	missense_variant		8/9	NM_031314.3:c.736G>A	NP_112604.2:p.Glu246Lys		-1.0	.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.					.	.	.						31	0.92							1.63062e-05	4.0	245306.0	0.0	47	0.91	RF	nfe	3.6203e-05	4.0	3.6203e-05	4.0	0.0000064	1						25.2	3.57014	0.309	6	12	18	SIFT,MutationAssessor_pred,MutationTaster_pred,PrimateAI_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	HNRNPC	0.0	0.0	0.0	0.0	48.0	-37.0	3.0	-8.0						0.379	0.99		1.0	1.01	embryo phenotype; mortality/aging ; 			.	.	mRNA splicing, via spliceosome;osteoblast differentiation;RNA splicing;RNA metabolic process;negative regulation of telomere maintenance via telomerase;ATP-dependent chromatin remodeling;3'-UTR-mediated mRNA stabilization	nuclear chromatin;extracellular region;nucleus;nucleoplasm;spliceosomal complex;telomerase holoenzyme complex;cytosol;actin cytoskeleton;membrane;protein-containing complex;extracellular exosome;catalytic step 2 spliceosome	RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;RNA binding;mRNA 3'-UTR binding;protein binding;poly(U) RNA binding;nucleosomal DNA binding;identical protein binding;telomerase RNA binding;N6-methyladenosine-containing RNA binding	EIF4A3[14730019;23084401];HNRNPU[26496610];IFIT1[21642987];RPL9[unassigned1304];EPS8[25416956];TEPSIN[26496610];ZFYVE26[25416956];KAT5[unassigned1304];MYC[17353931;21150319];MAGOH[23084401];KPNA4[25416956;unassigned1304];KMT5A[30021884];BTRC[21988832];KPNA2[21988832;25416956];C20orf202[unassigned1304];KPNA3[16189514;19447967;25416956];CCDC93[26496610];ACAD10[30021884];PIAS4[unassigned1304];PPP1R16B[unassigned1304];GABARAPL2[20562859];GABARAPL1[20562859];CSNK2A1[22113938];LMO3[16189514;unassigned1304];LMO2[25416956;unassigned1304];DICER1[21858095];SND1[30021884];GTPBP3[unassigned1304];ILF3[18337511];CCNE2[30021884];CDC37[unassigned1304];AKAP9[30021884];VDAC2[30021884];MATR3[26496610];OR5A2[30021884];KHDRBS3[19447967];RBM8A[11546873];GABARAP[20562859];TTBK1[30021884];CAMSAP2[30021884];SDCBP[25416956;unassigned1304];FXR2[16189514];CLEC7A[30021884];NLRP3[26496610];ZC3H18[29298432];TTLL13P[30021884];CCDC33[30021884];AP1M1[16189514;unassigned1304];SRPK2[23602568];SYT4[30021884];JUN[25609649];NOP14[30021884];UBE2I[16189514;25416956];VCAM1[22623428];NEK4[25798074];AUTS2[30021884];ALYREF[11546873];EIF2AK2[21903422];PHKB[16189514];UPF3A[11546873];WDYHV1[unassigned1304];MRPL23[30021884];CLK3[23602568];DNAJC17[30021884];NFKB2[14743216];SRPK1[23602568];GH1[17353931];RALYL[16189514;19447967;25416956;unassigned1304];SNW1[20467437];AGO4[19167051];AGO1[17932509];AGO2[17932509];HNRNPD[22365833;26496610];RSPH14[unassigned1304];PIN1[16189514];GRB2[30021884];TCF4[30021884];HNRNPC[16189514;21516116;22365833;25416956;unassigned1304];CEP85[30021884];HNRNPA1L2[30021884];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];CELF1[22365833];ARRB2[17620599];YBX1[22118625;25497084];DDX41[25920683];MEOX2[unassigned1304];DMBX1[unassigned1304];MAP1LC3B[20562859];METTL14[29507755];MAP1LC3A[20562859];TUBA1A[27291054];SUMO1[25416956;unassigned1304];PSD2[30021884];RBPMS2[unassigned1304];NCK2[unassigned1304];IKBKE[17353931];L1RE1[24267889];APOBEC1[unassigned1304];NCBP1[19262567];H2AFX[20000738];PAX6[unassigned1304];TNFRSF1B[14743216];ZNF57[30021884];YWHAZ[15161933;20618440];PTBP2[22365833];NR5A1[24635384];MMP12[30021884];F8[30021884];TRAF6[17353931];PITPNM3[30021884];PICK1[unassigned1304];TOP1[15848144];ECT2L[30021884];SSX2IP[30021884];CCDC40[30021884];PPP1R15A[29109149];FYTTD1[30021884];SASH3[30021884];SMARCD1[21988832];MAGEH1[30021884];SF3B2[22365833];DDX21[15034300;30021884];HTT[17500595];RNF4[unassigned1304];CUX2[30021884];PUF60[17353931];CCDC85B[16189514];EMC2[unassigned1304];NOTO[unassigned1304];RALY[22365833;unassigned1304;30021884];NCAM2[30021884];HNRNPA1[11546873;22446626;26496610;30021884];SUMO1P1[25416956;unassigned1304];DISC1[unassigned1304];ZNF581[16189514];GPKOW[30021884];CDKN2A[17955473];UTP3[30021884];CNBP[17353931];ZNF804A[30021884];LAPTM5[30021884];CDC5L[20467437;30021884];SEMA4F[30021884];PKDREJ[30021884];ADAM30[30021884];LBX1[unassigned1304];PLEKHA7[28877994];PPP1CA[25593058];MAB21L3[unassigned1304];SNX18[unassigned1304];GPAM[30021884];ST5[30021884];TNIP3[30021884];HNRNPA2B1[30021884];RBM41[16189514;21516116;25416956];FAS[21988832];KRAS[16189514];FSBP[30021884];CD247[24502978];CLEC2D[30021884];	21679666
24655	chr14	21679670	T	C	chr14:21679670	HNRNPC	heterogeneous nuclear ribonucleoprotein C (C1/C2)	SNV	0|1	0.11	44_6	55	99.0	0|1	0.11	50_7	62	99.0			rs201216721,COSV60147846	EXONIC	YES	NM_031314.3	Transcript	protein_coding	synonymous_variant		8/9	NM_031314.3:c.732A>G	NP_112604.2:p.Lys244%3D		-1.0						.	.	.						31	0.92							2.46875e-05	6.0	243038.0	0.0	45	0.9	RF	nfe	4.58262e-05	5.0	4.58262e-05	5.0	0.0000064	1						12.31	0.845489		0	0	0			HNRNPC	0.0	0.0	0.0	0.0	31.0	50.0	-12.0	-1.0						0.379	0.99				embryo phenotype; mortality/aging ; 			.	.	mRNA splicing, via spliceosome;osteoblast differentiation;RNA splicing;RNA metabolic process;negative regulation of telomere maintenance via telomerase;ATP-dependent chromatin remodeling;3'-UTR-mediated mRNA stabilization	nuclear chromatin;extracellular region;nucleus;nucleoplasm;spliceosomal complex;telomerase holoenzyme complex;cytosol;actin cytoskeleton;membrane;protein-containing complex;extracellular exosome;catalytic step 2 spliceosome	RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;RNA binding;mRNA 3'-UTR binding;protein binding;poly(U) RNA binding;nucleosomal DNA binding;identical protein binding;telomerase RNA binding;N6-methyladenosine-containing RNA binding	EIF4A3[14730019;23084401];HNRNPU[26496610];IFIT1[21642987];RPL9[unassigned1304];EPS8[25416956];TEPSIN[26496610];ZFYVE26[25416956];KAT5[unassigned1304];MYC[17353931;21150319];MAGOH[23084401];KPNA4[25416956;unassigned1304];KMT5A[30021884];BTRC[21988832];KPNA2[21988832;25416956];C20orf202[unassigned1304];KPNA3[16189514;19447967;25416956];CCDC93[26496610];ACAD10[30021884];PIAS4[unassigned1304];PPP1R16B[unassigned1304];GABARAPL2[20562859];GABARAPL1[20562859];CSNK2A1[22113938];LMO3[16189514;unassigned1304];LMO2[25416956;unassigned1304];DICER1[21858095];SND1[30021884];GTPBP3[unassigned1304];ILF3[18337511];CCNE2[30021884];CDC37[unassigned1304];AKAP9[30021884];VDAC2[30021884];MATR3[26496610];OR5A2[30021884];KHDRBS3[19447967];RBM8A[11546873];GABARAP[20562859];TTBK1[30021884];CAMSAP2[30021884];SDCBP[25416956;unassigned1304];FXR2[16189514];CLEC7A[30021884];NLRP3[26496610];ZC3H18[29298432];TTLL13P[30021884];CCDC33[30021884];AP1M1[16189514;unassigned1304];SRPK2[23602568];SYT4[30021884];JUN[25609649];NOP14[30021884];UBE2I[16189514;25416956];VCAM1[22623428];NEK4[25798074];AUTS2[30021884];ALYREF[11546873];EIF2AK2[21903422];PHKB[16189514];UPF3A[11546873];WDYHV1[unassigned1304];MRPL23[30021884];CLK3[23602568];DNAJC17[30021884];NFKB2[14743216];SRPK1[23602568];GH1[17353931];RALYL[16189514;19447967;25416956;unassigned1304];SNW1[20467437];AGO4[19167051];AGO1[17932509];AGO2[17932509];HNRNPD[22365833;26496610];RSPH14[unassigned1304];PIN1[16189514];GRB2[30021884];TCF4[30021884];HNRNPC[16189514;21516116;22365833;25416956;unassigned1304];CEP85[30021884];HNRNPA1L2[30021884];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];CELF1[22365833];ARRB2[17620599];YBX1[22118625;25497084];DDX41[25920683];MEOX2[unassigned1304];DMBX1[unassigned1304];MAP1LC3B[20562859];METTL14[29507755];MAP1LC3A[20562859];TUBA1A[27291054];SUMO1[25416956;unassigned1304];PSD2[30021884];RBPMS2[unassigned1304];NCK2[unassigned1304];IKBKE[17353931];L1RE1[24267889];APOBEC1[unassigned1304];NCBP1[19262567];H2AFX[20000738];PAX6[unassigned1304];TNFRSF1B[14743216];ZNF57[30021884];YWHAZ[15161933;20618440];PTBP2[22365833];NR5A1[24635384];MMP12[30021884];F8[30021884];TRAF6[17353931];PITPNM3[30021884];PICK1[unassigned1304];TOP1[15848144];ECT2L[30021884];SSX2IP[30021884];CCDC40[30021884];PPP1R15A[29109149];FYTTD1[30021884];SASH3[30021884];SMARCD1[21988832];MAGEH1[30021884];SF3B2[22365833];DDX21[15034300;30021884];HTT[17500595];RNF4[unassigned1304];CUX2[30021884];PUF60[17353931];CCDC85B[16189514];EMC2[unassigned1304];NOTO[unassigned1304];RALY[22365833;unassigned1304;30021884];NCAM2[30021884];HNRNPA1[11546873;22446626;26496610;30021884];SUMO1P1[25416956;unassigned1304];DISC1[unassigned1304];ZNF581[16189514];GPKOW[30021884];CDKN2A[17955473];UTP3[30021884];CNBP[17353931];ZNF804A[30021884];LAPTM5[30021884];CDC5L[20467437;30021884];SEMA4F[30021884];PKDREJ[30021884];ADAM30[30021884];LBX1[unassigned1304];PLEKHA7[28877994];PPP1CA[25593058];MAB21L3[unassigned1304];SNX18[unassigned1304];GPAM[30021884];ST5[30021884];TNIP3[30021884];HNRNPA2B1[30021884];RBM41[16189514;21516116;25416956];FAS[21988832];KRAS[16189514];FSBP[30021884];CD247[24502978];CLEC2D[30021884];	21679670
24659	chr14	21679677	A	G	chr14:21679677	HNRNPC	heterogeneous nuclear ribonucleoprotein C (C1/C2)	SNV	0|1	0.11	44_6	55	99.0	0|1	0.13	42_7	54	99.0			rs199780783	EXONIC	YES	NM_031314.3	Transcript	protein_coding	missense_variant		8/9	NM_031314.3:c.725T>C	NP_112604.2:p.Val242Ala		-1.0	.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.					.	.	.						31	0.92							1.24198e-05	3.0	241550.0	0.0	43	0.88	RF	nfe	2.77095e-05	3.0	2.77095e-05	3.0	0.0000064	1						13.46	1.005294	0.012	1	17	18	MutationTaster_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HNRNPC	0.0	0.0	0.0	0.0	43.0	37.0	-19.0	2.0						0.379	0.99		0.987	0.277	embryo phenotype; mortality/aging ; 			.	.	mRNA splicing, via spliceosome;osteoblast differentiation;RNA splicing;RNA metabolic process;negative regulation of telomere maintenance via telomerase;ATP-dependent chromatin remodeling;3'-UTR-mediated mRNA stabilization	nuclear chromatin;extracellular region;nucleus;nucleoplasm;spliceosomal complex;telomerase holoenzyme complex;cytosol;actin cytoskeleton;membrane;protein-containing complex;extracellular exosome;catalytic step 2 spliceosome	RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;RNA binding;mRNA 3'-UTR binding;protein binding;poly(U) RNA binding;nucleosomal DNA binding;identical protein binding;telomerase RNA binding;N6-methyladenosine-containing RNA binding	EIF4A3[14730019;23084401];HNRNPU[26496610];IFIT1[21642987];RPL9[unassigned1304];EPS8[25416956];TEPSIN[26496610];ZFYVE26[25416956];KAT5[unassigned1304];MYC[17353931;21150319];MAGOH[23084401];KPNA4[25416956;unassigned1304];KMT5A[30021884];BTRC[21988832];KPNA2[21988832;25416956];C20orf202[unassigned1304];KPNA3[16189514;19447967;25416956];CCDC93[26496610];ACAD10[30021884];PIAS4[unassigned1304];PPP1R16B[unassigned1304];GABARAPL2[20562859];GABARAPL1[20562859];CSNK2A1[22113938];LMO3[16189514;unassigned1304];LMO2[25416956;unassigned1304];DICER1[21858095];SND1[30021884];GTPBP3[unassigned1304];ILF3[18337511];CCNE2[30021884];CDC37[unassigned1304];AKAP9[30021884];VDAC2[30021884];MATR3[26496610];OR5A2[30021884];KHDRBS3[19447967];RBM8A[11546873];GABARAP[20562859];TTBK1[30021884];CAMSAP2[30021884];SDCBP[25416956;unassigned1304];FXR2[16189514];CLEC7A[30021884];NLRP3[26496610];ZC3H18[29298432];TTLL13P[30021884];CCDC33[30021884];AP1M1[16189514;unassigned1304];SRPK2[23602568];SYT4[30021884];JUN[25609649];NOP14[30021884];UBE2I[16189514;25416956];VCAM1[22623428];NEK4[25798074];AUTS2[30021884];ALYREF[11546873];EIF2AK2[21903422];PHKB[16189514];UPF3A[11546873];WDYHV1[unassigned1304];MRPL23[30021884];CLK3[23602568];DNAJC17[30021884];NFKB2[14743216];SRPK1[23602568];GH1[17353931];RALYL[16189514;19447967;25416956;unassigned1304];SNW1[20467437];AGO4[19167051];AGO1[17932509];AGO2[17932509];HNRNPD[22365833;26496610];RSPH14[unassigned1304];PIN1[16189514];GRB2[30021884];TCF4[30021884];HNRNPC[16189514;21516116;22365833;25416956;unassigned1304];CEP85[30021884];HNRNPA1L2[30021884];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];CELF1[22365833];ARRB2[17620599];YBX1[22118625;25497084];DDX41[25920683];MEOX2[unassigned1304];DMBX1[unassigned1304];MAP1LC3B[20562859];METTL14[29507755];MAP1LC3A[20562859];TUBA1A[27291054];SUMO1[25416956;unassigned1304];PSD2[30021884];RBPMS2[unassigned1304];NCK2[unassigned1304];IKBKE[17353931];L1RE1[24267889];APOBEC1[unassigned1304];NCBP1[19262567];H2AFX[20000738];PAX6[unassigned1304];TNFRSF1B[14743216];ZNF57[30021884];YWHAZ[15161933;20618440];PTBP2[22365833];NR5A1[24635384];MMP12[30021884];F8[30021884];TRAF6[17353931];PITPNM3[30021884];PICK1[unassigned1304];TOP1[15848144];ECT2L[30021884];SSX2IP[30021884];CCDC40[30021884];PPP1R15A[29109149];FYTTD1[30021884];SASH3[30021884];SMARCD1[21988832];MAGEH1[30021884];SF3B2[22365833];DDX21[15034300;30021884];HTT[17500595];RNF4[unassigned1304];CUX2[30021884];PUF60[17353931];CCDC85B[16189514];EMC2[unassigned1304];NOTO[unassigned1304];RALY[22365833;unassigned1304;30021884];NCAM2[30021884];HNRNPA1[11546873;22446626;26496610;30021884];SUMO1P1[25416956;unassigned1304];DISC1[unassigned1304];ZNF581[16189514];GPKOW[30021884];CDKN2A[17955473];UTP3[30021884];CNBP[17353931];ZNF804A[30021884];LAPTM5[30021884];CDC5L[20467437;30021884];SEMA4F[30021884];PKDREJ[30021884];ADAM30[30021884];LBX1[unassigned1304];PLEKHA7[28877994];PPP1CA[25593058];MAB21L3[unassigned1304];SNX18[unassigned1304];GPAM[30021884];ST5[30021884];TNIP3[30021884];HNRNPA2B1[30021884];RBM41[16189514;21516116;25416956];FAS[21988832];KRAS[16189514];FSBP[30021884];CD247[24502978];CLEC2D[30021884];	21679677
24663	chr14	21679678	C	A	chr14:21679678	HNRNPC	heterogeneous nuclear ribonucleoprotein C (C1/C2)	SNV	0|1	0.11	42_6	53	99.0	0|1	0.13	42_7	54	99.0			rs200722780,COSV60145025	EXONIC	YES	NM_031314.3	Transcript	protein_coding	missense_variant		8/9	NM_031314.3:c.724G>T	NP_112604.2:p.Val242Leu		-1.0	.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.					.	.	.						31	0.92							2.06901e-05	5.0	241662.0	0.0	43	0.87	PASS	sas	3.38318e-05	1.0	2.77034e-05	3.0	0.0000064	1						14.01	1.090242	0.01	2	16	18	MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	HNRNPC	0.01	0.0	0.0	0.0	42.0	36.0	-40.0	-20.0						0.379	0.99		0.979	-0.368	embryo phenotype; mortality/aging ; 			.	.	mRNA splicing, via spliceosome;osteoblast differentiation;RNA splicing;RNA metabolic process;negative regulation of telomere maintenance via telomerase;ATP-dependent chromatin remodeling;3'-UTR-mediated mRNA stabilization	nuclear chromatin;extracellular region;nucleus;nucleoplasm;spliceosomal complex;telomerase holoenzyme complex;cytosol;actin cytoskeleton;membrane;protein-containing complex;extracellular exosome;catalytic step 2 spliceosome	RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;RNA binding;mRNA 3'-UTR binding;protein binding;poly(U) RNA binding;nucleosomal DNA binding;identical protein binding;telomerase RNA binding;N6-methyladenosine-containing RNA binding	EIF4A3[14730019;23084401];HNRNPU[26496610];IFIT1[21642987];RPL9[unassigned1304];EPS8[25416956];TEPSIN[26496610];ZFYVE26[25416956];KAT5[unassigned1304];MYC[17353931;21150319];MAGOH[23084401];KPNA4[25416956;unassigned1304];KMT5A[30021884];BTRC[21988832];KPNA2[21988832;25416956];C20orf202[unassigned1304];KPNA3[16189514;19447967;25416956];CCDC93[26496610];ACAD10[30021884];PIAS4[unassigned1304];PPP1R16B[unassigned1304];GABARAPL2[20562859];GABARAPL1[20562859];CSNK2A1[22113938];LMO3[16189514;unassigned1304];LMO2[25416956;unassigned1304];DICER1[21858095];SND1[30021884];GTPBP3[unassigned1304];ILF3[18337511];CCNE2[30021884];CDC37[unassigned1304];AKAP9[30021884];VDAC2[30021884];MATR3[26496610];OR5A2[30021884];KHDRBS3[19447967];RBM8A[11546873];GABARAP[20562859];TTBK1[30021884];CAMSAP2[30021884];SDCBP[25416956;unassigned1304];FXR2[16189514];CLEC7A[30021884];NLRP3[26496610];ZC3H18[29298432];TTLL13P[30021884];CCDC33[30021884];AP1M1[16189514;unassigned1304];SRPK2[23602568];SYT4[30021884];JUN[25609649];NOP14[30021884];UBE2I[16189514;25416956];VCAM1[22623428];NEK4[25798074];AUTS2[30021884];ALYREF[11546873];EIF2AK2[21903422];PHKB[16189514];UPF3A[11546873];WDYHV1[unassigned1304];MRPL23[30021884];CLK3[23602568];DNAJC17[30021884];NFKB2[14743216];SRPK1[23602568];GH1[17353931];RALYL[16189514;19447967;25416956;unassigned1304];SNW1[20467437];AGO4[19167051];AGO1[17932509];AGO2[17932509];HNRNPD[22365833;26496610];RSPH14[unassigned1304];PIN1[16189514];GRB2[30021884];TCF4[30021884];HNRNPC[16189514;21516116;22365833;25416956;unassigned1304];CEP85[30021884];HNRNPA1L2[30021884];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];CELF1[22365833];ARRB2[17620599];YBX1[22118625;25497084];DDX41[25920683];MEOX2[unassigned1304];DMBX1[unassigned1304];MAP1LC3B[20562859];METTL14[29507755];MAP1LC3A[20562859];TUBA1A[27291054];SUMO1[25416956;unassigned1304];PSD2[30021884];RBPMS2[unassigned1304];NCK2[unassigned1304];IKBKE[17353931];L1RE1[24267889];APOBEC1[unassigned1304];NCBP1[19262567];H2AFX[20000738];PAX6[unassigned1304];TNFRSF1B[14743216];ZNF57[30021884];YWHAZ[15161933;20618440];PTBP2[22365833];NR5A1[24635384];MMP12[30021884];F8[30021884];TRAF6[17353931];PITPNM3[30021884];PICK1[unassigned1304];TOP1[15848144];ECT2L[30021884];SSX2IP[30021884];CCDC40[30021884];PPP1R15A[29109149];FYTTD1[30021884];SASH3[30021884];SMARCD1[21988832];MAGEH1[30021884];SF3B2[22365833];DDX21[15034300;30021884];HTT[17500595];RNF4[unassigned1304];CUX2[30021884];PUF60[17353931];CCDC85B[16189514];EMC2[unassigned1304];NOTO[unassigned1304];RALY[22365833;unassigned1304;30021884];NCAM2[30021884];HNRNPA1[11546873;22446626;26496610;30021884];SUMO1P1[25416956;unassigned1304];DISC1[unassigned1304];ZNF581[16189514];GPKOW[30021884];CDKN2A[17955473];UTP3[30021884];CNBP[17353931];ZNF804A[30021884];LAPTM5[30021884];CDC5L[20467437;30021884];SEMA4F[30021884];PKDREJ[30021884];ADAM30[30021884];LBX1[unassigned1304];PLEKHA7[28877994];PPP1CA[25593058];MAB21L3[unassigned1304];SNX18[unassigned1304];GPAM[30021884];ST5[30021884];TNIP3[30021884];HNRNPA2B1[30021884];RBM41[16189514;21516116;25416956];FAS[21988832];KRAS[16189514];FSBP[30021884];CD247[24502978];CLEC2D[30021884];	21679678
24671	chr14	21679703	T	A	chr14:21679703	HNRNPC	heterogeneous nuclear ribonucleoprotein C (C1/C2)	SNV	0|1	0.12	32_5	41	99.0	0|1	0.12	33_5	42	99.0			rs200073326,COSV100193503	EXONIC	YES	NM_031314.3	Transcript	protein_coding	synonymous_variant		8/9	NM_031314.3:c.699A>T	NP_112604.2:p.Ser233%3D		-1.0						.	.	.						31	0.93							1.69119e-05	4.0	236520.0	0.0	34	0.79	RF	sas	3.44542e-05	1.0	2.84247e-05	3.0	0.0002122	33						11.7	0.767823		0	0	0			HNRNPC	0.0	0.02	0.0	0.0	17.0	43.0	-34.0	-45.0						0.379	0.99				embryo phenotype; mortality/aging ; 			.	.	mRNA splicing, via spliceosome;osteoblast differentiation;RNA splicing;RNA metabolic process;negative regulation of telomere maintenance via telomerase;ATP-dependent chromatin remodeling;3'-UTR-mediated mRNA stabilization	nuclear chromatin;extracellular region;nucleus;nucleoplasm;spliceosomal complex;telomerase holoenzyme complex;cytosol;actin cytoskeleton;membrane;protein-containing complex;extracellular exosome;catalytic step 2 spliceosome	RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;RNA binding;mRNA 3'-UTR binding;protein binding;poly(U) RNA binding;nucleosomal DNA binding;identical protein binding;telomerase RNA binding;N6-methyladenosine-containing RNA binding	EIF4A3[14730019;23084401];HNRNPU[26496610];IFIT1[21642987];RPL9[unassigned1304];EPS8[25416956];TEPSIN[26496610];ZFYVE26[25416956];KAT5[unassigned1304];MYC[17353931;21150319];MAGOH[23084401];KPNA4[25416956;unassigned1304];KMT5A[30021884];BTRC[21988832];KPNA2[21988832;25416956];C20orf202[unassigned1304];KPNA3[16189514;19447967;25416956];CCDC93[26496610];ACAD10[30021884];PIAS4[unassigned1304];PPP1R16B[unassigned1304];GABARAPL2[20562859];GABARAPL1[20562859];CSNK2A1[22113938];LMO3[16189514;unassigned1304];LMO2[25416956;unassigned1304];DICER1[21858095];SND1[30021884];GTPBP3[unassigned1304];ILF3[18337511];CCNE2[30021884];CDC37[unassigned1304];AKAP9[30021884];VDAC2[30021884];MATR3[26496610];OR5A2[30021884];KHDRBS3[19447967];RBM8A[11546873];GABARAP[20562859];TTBK1[30021884];CAMSAP2[30021884];SDCBP[25416956;unassigned1304];FXR2[16189514];CLEC7A[30021884];NLRP3[26496610];ZC3H18[29298432];TTLL13P[30021884];CCDC33[30021884];AP1M1[16189514;unassigned1304];SRPK2[23602568];SYT4[30021884];JUN[25609649];NOP14[30021884];UBE2I[16189514;25416956];VCAM1[22623428];NEK4[25798074];AUTS2[30021884];ALYREF[11546873];EIF2AK2[21903422];PHKB[16189514];UPF3A[11546873];WDYHV1[unassigned1304];MRPL23[30021884];CLK3[23602568];DNAJC17[30021884];NFKB2[14743216];SRPK1[23602568];GH1[17353931];RALYL[16189514;19447967;25416956;unassigned1304];SNW1[20467437];AGO4[19167051];AGO1[17932509];AGO2[17932509];HNRNPD[22365833;26496610];RSPH14[unassigned1304];PIN1[16189514];GRB2[30021884];TCF4[30021884];HNRNPC[16189514;21516116;22365833;25416956;unassigned1304];CEP85[30021884];HNRNPA1L2[30021884];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];CELF1[22365833];ARRB2[17620599];YBX1[22118625;25497084];DDX41[25920683];MEOX2[unassigned1304];DMBX1[unassigned1304];MAP1LC3B[20562859];METTL14[29507755];MAP1LC3A[20562859];TUBA1A[27291054];SUMO1[25416956;unassigned1304];PSD2[30021884];RBPMS2[unassigned1304];NCK2[unassigned1304];IKBKE[17353931];L1RE1[24267889];APOBEC1[unassigned1304];NCBP1[19262567];H2AFX[20000738];PAX6[unassigned1304];TNFRSF1B[14743216];ZNF57[30021884];YWHAZ[15161933;20618440];PTBP2[22365833];NR5A1[24635384];MMP12[30021884];F8[30021884];TRAF6[17353931];PITPNM3[30021884];PICK1[unassigned1304];TOP1[15848144];ECT2L[30021884];SSX2IP[30021884];CCDC40[30021884];PPP1R15A[29109149];FYTTD1[30021884];SASH3[30021884];SMARCD1[21988832];MAGEH1[30021884];SF3B2[22365833];DDX21[15034300;30021884];HTT[17500595];RNF4[unassigned1304];CUX2[30021884];PUF60[17353931];CCDC85B[16189514];EMC2[unassigned1304];NOTO[unassigned1304];RALY[22365833;unassigned1304;30021884];NCAM2[30021884];HNRNPA1[11546873;22446626;26496610;30021884];SUMO1P1[25416956;unassigned1304];DISC1[unassigned1304];ZNF581[16189514];GPKOW[30021884];CDKN2A[17955473];UTP3[30021884];CNBP[17353931];ZNF804A[30021884];LAPTM5[30021884];CDC5L[20467437;30021884];SEMA4F[30021884];PKDREJ[30021884];ADAM30[30021884];LBX1[unassigned1304];PLEKHA7[28877994];PPP1CA[25593058];MAB21L3[unassigned1304];SNX18[unassigned1304];GPAM[30021884];ST5[30021884];TNIP3[30021884];HNRNPA2B1[30021884];RBM41[16189514;21516116;25416956];FAS[21988832];KRAS[16189514];FSBP[30021884];CD247[24502978];CLEC2D[30021884];	21679703
24674	chr14	21679710	T	G	chr14:21679710	HNRNPC	heterogeneous nuclear ribonucleoprotein C (C1/C2)	SNV	0|1	0.14	30_5	37	99.0	0|1	0.13	29_5	38	99.0			rs200789242,COSV100193504,COSV60147816	EXONIC	YES	NM_031314.3	Transcript	protein_coding	missense_variant		8/9	NM_031314.3:c.692A>C	NP_112604.2:p.Asp231Ala		-1.0	.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.,.					.	.	.						31	0.93							1.76297e-05	4.0	226890.0	0.0	34	0.77	PASS	sas	3.55417e-05	1.0	2.99802e-05	3.0	0.0001608	25						22.2	2.359415	0.114	3	15	18	MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	HNRNPC	0.01	0.03	0.0	0.0	36.0	10.0	-3.0	-41.0						0.379	0.99		0.999	1.12	embryo phenotype; mortality/aging ; 			.	.	mRNA splicing, via spliceosome;osteoblast differentiation;RNA splicing;RNA metabolic process;negative regulation of telomere maintenance via telomerase;ATP-dependent chromatin remodeling;3'-UTR-mediated mRNA stabilization	nuclear chromatin;extracellular region;nucleus;nucleoplasm;spliceosomal complex;telomerase holoenzyme complex;cytosol;actin cytoskeleton;membrane;protein-containing complex;extracellular exosome;catalytic step 2 spliceosome	RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;RNA binding;mRNA 3'-UTR binding;protein binding;poly(U) RNA binding;nucleosomal DNA binding;identical protein binding;telomerase RNA binding;N6-methyladenosine-containing RNA binding	EIF4A3[14730019;23084401];HNRNPU[26496610];IFIT1[21642987];RPL9[unassigned1304];EPS8[25416956];TEPSIN[26496610];ZFYVE26[25416956];KAT5[unassigned1304];MYC[17353931;21150319];MAGOH[23084401];KPNA4[25416956;unassigned1304];KMT5A[30021884];BTRC[21988832];KPNA2[21988832;25416956];C20orf202[unassigned1304];KPNA3[16189514;19447967;25416956];CCDC93[26496610];ACAD10[30021884];PIAS4[unassigned1304];PPP1R16B[unassigned1304];GABARAPL2[20562859];GABARAPL1[20562859];CSNK2A1[22113938];LMO3[16189514;unassigned1304];LMO2[25416956;unassigned1304];DICER1[21858095];SND1[30021884];GTPBP3[unassigned1304];ILF3[18337511];CCNE2[30021884];CDC37[unassigned1304];AKAP9[30021884];VDAC2[30021884];MATR3[26496610];OR5A2[30021884];KHDRBS3[19447967];RBM8A[11546873];GABARAP[20562859];TTBK1[30021884];CAMSAP2[30021884];SDCBP[25416956;unassigned1304];FXR2[16189514];CLEC7A[30021884];NLRP3[26496610];ZC3H18[29298432];TTLL13P[30021884];CCDC33[30021884];AP1M1[16189514;unassigned1304];SRPK2[23602568];SYT4[30021884];JUN[25609649];NOP14[30021884];UBE2I[16189514;25416956];VCAM1[22623428];NEK4[25798074];AUTS2[30021884];ALYREF[11546873];EIF2AK2[21903422];PHKB[16189514];UPF3A[11546873];WDYHV1[unassigned1304];MRPL23[30021884];CLK3[23602568];DNAJC17[30021884];NFKB2[14743216];SRPK1[23602568];GH1[17353931];RALYL[16189514;19447967;25416956;unassigned1304];SNW1[20467437];AGO4[19167051];AGO1[17932509];AGO2[17932509];HNRNPD[22365833;26496610];RSPH14[unassigned1304];PIN1[16189514];GRB2[30021884];TCF4[30021884];HNRNPC[16189514;21516116;22365833;25416956;unassigned1304];CEP85[30021884];HNRNPA1L2[30021884];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];CELF1[22365833];ARRB2[17620599];YBX1[22118625;25497084];DDX41[25920683];MEOX2[unassigned1304];DMBX1[unassigned1304];MAP1LC3B[20562859];METTL14[29507755];MAP1LC3A[20562859];TUBA1A[27291054];SUMO1[25416956;unassigned1304];PSD2[30021884];RBPMS2[unassigned1304];NCK2[unassigned1304];IKBKE[17353931];L1RE1[24267889];APOBEC1[unassigned1304];NCBP1[19262567];H2AFX[20000738];PAX6[unassigned1304];TNFRSF1B[14743216];ZNF57[30021884];YWHAZ[15161933;20618440];PTBP2[22365833];NR5A1[24635384];MMP12[30021884];F8[30021884];TRAF6[17353931];PITPNM3[30021884];PICK1[unassigned1304];TOP1[15848144];ECT2L[30021884];SSX2IP[30021884];CCDC40[30021884];PPP1R15A[29109149];FYTTD1[30021884];SASH3[30021884];SMARCD1[21988832];MAGEH1[30021884];SF3B2[22365833];DDX21[15034300;30021884];HTT[17500595];RNF4[unassigned1304];CUX2[30021884];PUF60[17353931];CCDC85B[16189514];EMC2[unassigned1304];NOTO[unassigned1304];RALY[22365833;unassigned1304;30021884];NCAM2[30021884];HNRNPA1[11546873;22446626;26496610;30021884];SUMO1P1[25416956;unassigned1304];DISC1[unassigned1304];ZNF581[16189514];GPKOW[30021884];CDKN2A[17955473];UTP3[30021884];CNBP[17353931];ZNF804A[30021884];LAPTM5[30021884];CDC5L[20467437;30021884];SEMA4F[30021884];PKDREJ[30021884];ADAM30[30021884];LBX1[unassigned1304];PLEKHA7[28877994];PPP1CA[25593058];MAB21L3[unassigned1304];SNX18[unassigned1304];GPAM[30021884];ST5[30021884];TNIP3[30021884];HNRNPA2B1[30021884];RBM41[16189514;21516116;25416956];FAS[21988832];KRAS[16189514];FSBP[30021884];CD247[24502978];CLEC2D[30021884];	21679710
24681	chr14	21679718	CATCTC		chr14:21679718-21679723	HNRNPC	heterogeneous nuclear ribonucleoprotein C (C1/C2)	deletion	0/0	0.0	35_0	35	66.0	0|1	0.11	27_4	35	87.0			rs1328879559	SPLICING	YES	NM_031314.3	Transcript	protein_coding	inframe_deletion,splice_region_variant		8/9	NM_031314.3:c.679_684del	NP_112604.2:p.Glu227_Met228del		-1.0						.	.	.						31	0.94											32	0.72														20.6	2.096049		0	0	0																	0.379	0.99				embryo phenotype; mortality/aging ; 			.	.	mRNA splicing, via spliceosome;osteoblast differentiation;RNA splicing;RNA metabolic process;negative regulation of telomere maintenance via telomerase;ATP-dependent chromatin remodeling;3'-UTR-mediated mRNA stabilization	nuclear chromatin;extracellular region;nucleus;nucleoplasm;spliceosomal complex;telomerase holoenzyme complex;cytosol;actin cytoskeleton;membrane;protein-containing complex;extracellular exosome;catalytic step 2 spliceosome	RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;RNA binding;mRNA 3'-UTR binding;protein binding;poly(U) RNA binding;nucleosomal DNA binding;identical protein binding;telomerase RNA binding;N6-methyladenosine-containing RNA binding	EIF4A3[14730019;23084401];HNRNPU[26496610];IFIT1[21642987];RPL9[unassigned1304];EPS8[25416956];TEPSIN[26496610];ZFYVE26[25416956];KAT5[unassigned1304];MYC[17353931;21150319];MAGOH[23084401];KPNA4[25416956;unassigned1304];KMT5A[30021884];BTRC[21988832];KPNA2[21988832;25416956];C20orf202[unassigned1304];KPNA3[16189514;19447967;25416956];CCDC93[26496610];ACAD10[30021884];PIAS4[unassigned1304];PPP1R16B[unassigned1304];GABARAPL2[20562859];GABARAPL1[20562859];CSNK2A1[22113938];LMO3[16189514;unassigned1304];LMO2[25416956;unassigned1304];DICER1[21858095];SND1[30021884];GTPBP3[unassigned1304];ILF3[18337511];CCNE2[30021884];CDC37[unassigned1304];AKAP9[30021884];VDAC2[30021884];MATR3[26496610];OR5A2[30021884];KHDRBS3[19447967];RBM8A[11546873];GABARAP[20562859];TTBK1[30021884];CAMSAP2[30021884];SDCBP[25416956;unassigned1304];FXR2[16189514];CLEC7A[30021884];NLRP3[26496610];ZC3H18[29298432];TTLL13P[30021884];CCDC33[30021884];AP1M1[16189514;unassigned1304];SRPK2[23602568];SYT4[30021884];JUN[25609649];NOP14[30021884];UBE2I[16189514;25416956];VCAM1[22623428];NEK4[25798074];AUTS2[30021884];ALYREF[11546873];EIF2AK2[21903422];PHKB[16189514];UPF3A[11546873];WDYHV1[unassigned1304];MRPL23[30021884];CLK3[23602568];DNAJC17[30021884];NFKB2[14743216];SRPK1[23602568];GH1[17353931];RALYL[16189514;19447967;25416956;unassigned1304];SNW1[20467437];AGO4[19167051];AGO1[17932509];AGO2[17932509];HNRNPD[22365833;26496610];RSPH14[unassigned1304];PIN1[16189514];GRB2[30021884];TCF4[30021884];HNRNPC[16189514;21516116;22365833;25416956;unassigned1304];CEP85[30021884];HNRNPA1L2[30021884];HNRNPCL1[unassigned1304];HNRNPCL2[unassigned1304];CELF1[22365833];ARRB2[17620599];YBX1[22118625;25497084];DDX41[25920683];MEOX2[unassigned1304];DMBX1[unassigned1304];MAP1LC3B[20562859];METTL14[29507755];MAP1LC3A[20562859];TUBA1A[27291054];SUMO1[25416956;unassigned1304];PSD2[30021884];RBPMS2[unassigned1304];NCK2[unassigned1304];IKBKE[17353931];L1RE1[24267889];APOBEC1[unassigned1304];NCBP1[19262567];H2AFX[20000738];PAX6[unassigned1304];TNFRSF1B[14743216];ZNF57[30021884];YWHAZ[15161933;20618440];PTBP2[22365833];NR5A1[24635384];MMP12[30021884];F8[30021884];TRAF6[17353931];PITPNM3[30021884];PICK1[unassigned1304];TOP1[15848144];ECT2L[30021884];SSX2IP[30021884];CCDC40[30021884];PPP1R15A[29109149];FYTTD1[30021884];SASH3[30021884];SMARCD1[21988832];MAGEH1[30021884];SF3B2[22365833];DDX21[15034300;30021884];HTT[17500595];RNF4[unassigned1304];CUX2[30021884];PUF60[17353931];CCDC85B[16189514];EMC2[unassigned1304];NOTO[unassigned1304];RALY[22365833;unassigned1304;30021884];NCAM2[30021884];HNRNPA1[11546873;22446626;26496610;30021884];SUMO1P1[25416956;unassigned1304];DISC1[unassigned1304];ZNF581[16189514];GPKOW[30021884];CDKN2A[17955473];UTP3[30021884];CNBP[17353931];ZNF804A[30021884];LAPTM5[30021884];CDC5L[20467437;30021884];SEMA4F[30021884];PKDREJ[30021884];ADAM30[30021884];LBX1[unassigned1304];PLEKHA7[28877994];PPP1CA[25593058];MAB21L3[unassigned1304];SNX18[unassigned1304];GPAM[30021884];ST5[30021884];TNIP3[30021884];HNRNPA2B1[30021884];RBM41[16189514;21516116;25416956];FAS[21988832];KRAS[16189514];FSBP[30021884];CD247[24502978];CLEC2D[30021884];	21679717
24741	chr14	23599006	G	A	chr14:23599006	SLC7A8	solute carrier family 7 member 8	SNV	0/1	0.35	27_15	43	99.0	0/1	0.22	45_13	58	99.0			rs150723302	SPLICING	YES	NM_012244.4	Transcript	protein_coding	splice_region_variant,synonymous_variant		9/11	NM_012244.4:c.1116C>T	NP_036376.2:p.Cys372%3D		-1.0						.	.	.		0.000440112	67.0	152234.0	0.0	33	0.97	PASS	nfe	0.000822997	56.0	0.000822997	56.0	0.000354754	89.0	250878.0	0.0	43	0.97	PASS	nfe	0.000696981	79.0	0.000696981	79.0	0.0003151	49	0.001	2.0				14.1	1.105173		0	0	0			SLC7A8	0.0	0.0	0.0	0.0	10.0	2.0	2.0	-35.0			6.189	0.284	6.472	0.135	0.0	2.168479693			behavior/neurological phenotype ; nervous system phenotype ; 			kidney;superior cervical ganglion;trigeminal ganglion;placenta;testis;	.	amino acid transmembrane transport;cellular amino acid metabolic process;amino acid transport;response to toxic substance;organic cation transport;neutral amino acid transport;leukocyte migration;metal ion homeostasis;toxin transport;L-alpha-amino acid transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;basolateral plasma membrane	protein binding;organic cation transmembrane transporter activity;amino acid transmembrane transporter activity;neutral amino acid transmembrane transporter activity;L-amino acid transmembrane transporter activity;toxin transmembrane transporter activity;peptide antigen binding	SLC30A2[unassigned1304];NDUFA3[unassigned1304];DERL1[unassigned1304];AQP6[unassigned1304];SLC3A2[unassigned1304];SYNJ2BP[unassigned1304];MFF[unassigned1304];COMT[unassigned1304];AGPAT4[unassigned1304];TMEM60[unassigned1304];SMPD2[unassigned1304];SNORC[unassigned1304];TMEM65[unassigned1304];ABHD16A[unassigned1304];REEP4[unassigned1304];NINJ2[unassigned1304];MFSD3[unassigned1304];YIPF6[unassigned1304];TMEM208[unassigned1304];TMEM14B[unassigned1304];SLC25A46[unassigned1304];SIGLEC5[unassigned1304];	23599006
24837	chr14	24617616	A	G	chr14:24617616	RNF31	ring finger protein 31	SNV	0/1	0.43	95_73	168	99.0	0/1	0.43	74_55	129	99.0			rs773851158	EXONIC	YES	NM_017999.5	Transcript	protein_coding	synonymous_variant		3/21	NM_017999.5:c.489A>G	NP_060469.4:p.Leu163%3D		1.0						Autoinflammatory syndrome with pyogenic bacterial infection and amylopectinosis	Disease-causing germline mutation(s) in	.		6.58137e-06	1.0	151944.0	0.0	32	0.98	PASS	sas	0.000207039	1.0	0.0	0.0					77	0.97														8.449	0.404717		0	0	0			RNF31	0.0	0.01	0.0	0.0	-13.0	7.0	-1.0	6.0						0.427	1.0	58.993465454			mortality/aging ; hematopoietic system phenotype; immune system phenotype; 			superior cervical ganglion;trigeminal ganglion;skeletal muscle;	.	protein polyubiquitination;I-kappaB kinase/NF-kappaB signaling;regulation of tumor necrosis factor-mediated signaling pathway;CD40 signaling pathway;positive regulation of I-kappaB kinase/NF-kappaB signaling;T cell receptor signaling pathway;positive regulation of NF-kappaB transcription factor activity;protein linear polyubiquitination;positive regulation of protein targeting to mitochondrion	cytosol;cytoplasmic side of plasma membrane;CD40 receptor complex;LUBAC complex	ubiquitin-protein transferase activity;protein binding;ubiquitin protein ligase binding;ubiquitin binding;metal ion binding	RNF31[unassigned1774];RTN3[unassigned1774];TSSC4[25416956];HNRNPCL2[unassigned1774];GDI1[unassigned1774];CD82[unassigned1774];CCDC24[25416956];DNAH8[unassigned1774];UBE2D2[26789245];HM13[unassigned1774];ATN1[16713569];TNFAIP3[23032186;unassigned1774];TNF[23032186;23955153;unassigned1774];SAV1[22570112];SOCS3[21988832];GOLGA3[unassigned1774];ATXN1[16713569];SHARPIN[23032186;23104095;21455180;21455181;22158122;24141947;unassigned1774];SPR[unassigned1774];ATXN7[21078624];IKBKG[21811235;23032186;21455180;unassigned1774];SMAD3[21988832];NOS3[21163940];KRTAP9-2[25416956];VASN[25416956];AES[25416956];GFI1B[16713569];REEP5[unassigned1774];TNIP1[unassigned1774];RBCK1[17006537;22430200;22791023;21455180;21455181;24141947;29997244;unassigned1774];SNRPC[25416956];BIRC2[23524849;unassigned1774];BIRC3[23524849];	24617616
24953	chr14	29236624	CCA		chr14:29236624-29236626	FOXG1	forkhead box G1	deletion	0/1	0.17	20_4	24	99.0	0/0	0.0	42_0	42	99.0			rs587783630	EXONIC	YES	NM_005249.5	Transcript	protein_coding	inframe_deletion		1/1	NM_005249.5:c.159_161del	NP_005240.3:p.His57del		1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Rett_syndrome,_congenital_variant|History_of_neurodevelopmental_disorder|not_specified|not_provided	Rett syndrome, congenital variant, 613454 (3), Autosomal dominant	14q12 microdeletion syndrome;14q11.2 microduplication syndrome;Atypical Rett syndrome	Role in the phenotype of;Role in the phenotype of;Disease-causing germline mutation(s) in	Microcephaly;Abnormality of the antihelix;Protruding ear;Agenesis of corpus callosum;Kyphosis;Mandibular prognathia;Stereotypy;Epicanthus;Everted lower lip vermilion;Tented upper lip vermilion;Blepharophimosis;Depressed nasal bridge;Palpebral edema;Intellectual disability, severe;Bulbous nose;Growth delay;Prominent metopic ridge;Downslanted palpebral fissures;Feeding difficulties;Excessive salivation;Smooth philtrum;Gastroesophageal reflux;Developmental regression;Seizure;Short nose;Muscular hypotonia;Scoliosis;Absent speech;Macroglossia;Seizure;Apraxia;Bruxism;Poor eye contact;Hypoplasia of the corpus callosum;Dystonia;Scoliosis;Spasticity;Tongue thrusting;Simplified gyral pattern;Talipes equinovarus;Athetosis;Sporadic;EEG abnormality;Intellectual disability, severe;Autosomal dominant inheritance;Developmental regression;Pachygyria;Kyphosis;Dyskinesia;Progressive microcephaly;Pes planus;Chorea;Motor delay;Gastroesophageal reflux;Neonatal hypotonia;Constipation;Irritability;Delayed myelination;Drooling	18414213	4.19252e-05	6.0	143112.0	0.0	30	0.87	PASS	amr	6.8937e-05	1.0	6.14931e-05	4.0	0.00149324	209.0	139964.0	0.0	10	0.35	RF	amr	0.00230769	51.0	0.00117643	68.0	0.0008167,0.0000064	127,1			0.00424	42.0		11.75	0.774123		0	0	0			FOXG1	0.0	0.0	0.0	0.0	4.0	1.0	4.0	1.0								0.000000000			hematopoietic system phenotype; cardiovascular system phenotype ; mortality/aging ; normal phenotype; pigmentation phenotype; embryo phenotype; behavior/neurological phenotype ; respiratory system phenotype; immune system phenotype; skeleton phenotype; digestive/alimentary phenotype; nervous system phenotype ; hearing/vestibular/ear phenotype; craniofacial phenotype; vision/eye phenotype; growth/size/body region phenotype; integument phenotype ; taste/olfaction phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; 			caudate nucleus;amygdala;temporal lobe;testis - seminiferous tubule;prefrontal cortex;superior cervical ganglion;cingulate cortex;testis;pons;fetal brain;occipital lobe;subthalamic nucleus;testis - interstitial;whole brain;parietal lobe;globus pallidus;medulla oblongata;	.	regulation of transcription by RNA polymerase II;brain development;aging;negative regulation of transcription, DNA-templated	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;sequence-specific DNA binding	LGALS3BP[25609649];TCERG1[25609649];VARS[25609649];RIF1[25609649];CHD4[25609649];ADAR[25609649];HOXC13[25609649];SMC3[25609649];SMC4[25609649];NSDHL[25609649];SALL1[25609649];ZMYM2[25609649];ZMYM3[25609649];POGZ[25609649];POLE[25609649];KPNA1[25609649];RBM33[30021884];HELLS[25609649];PLEKHG4[25609649];SCRIB[25609649];ZBTB33[25609649];SMC1A[25609649];EEF1G[16169070];DDX39A[25609649];EEF1D[25609649];HNRNPUL2[25609649];ADNP[25609649];SNRNP200[25609649];TP53[25609649];GTF3C3[25609649];HDAC2[25609649];NUP205[25609649];GTF3C5[25609649];SATB1[25609649];SATB2[25609649];FOXG1[25609649];HEATR1[25609649];AKAP8[25609649];WIZ[25609649];RNF219[25609649];RRBP1[25609649];PDS5A[25609649];BTAF1[25609649];LARP1[25609649];CUX1[25609649];ORC2[25609649];UBR5[25609649];SYMPK[25609649];SNX9[25609649];NDUFV2[25609649];GBF1[25609649];SMARCA5[25609649];NR2F1[25609649];MYO9B[25609649];LRWD1[25609649];PUM1[25609649];SMARCA1[25609649];GATAD2B[25609649];GDF9[16169070];MOV10[25609649];CPS1[25609649];P4HA1[25609649];NCAPD2[25609649];NCAPD3[25609649];	29236623
24980	chr14	35550228	GAA		chr14:35550228-35550230	FAM177A1	family with sequence similarity 177 member A1	deletion	0/0	0.0	15_0	15	20.0	0/1	0.18	14_3	17	84.0			rs756991070	SPLICING	YES	NM_173607.5	Transcript	protein_coding	inframe_deletion,splice_region_variant		5/5	NM_173607.5:c.523_525del	NP_775878.2:p.Glu175del		1.0						.	.	.		0.00010077	15.0	148854.0	0.0	31	0.92	PASS	eas	0.000390168	2.0	7.40938e-05	5.0	0.00133385	261.0	195674.0	0.0	21	0.58	RF	sas	0.00260417	62.0	0.00116849	101.0	0.0038906,0.0000257	605,4	0.004	13.0				27.1	3.931397		0	0	0			FAM177A1	1.0	1.0	0.0	0.0	4.0	1.0	8.0	5.0						0.231	0.0				.			amygdala;testis - seminiferous tubule;testis - interstitial;prefrontal cortex;whole brain;cingulate cortex;testis;hypothalamus;	.	.	.	.	JAGN1[unassigned1304];DPM3[unassigned1304];SGPL1[unassigned1304];AQP6[unassigned1304];PBX3[unassigned1304];STK38L[30108113];FATE1[unassigned1304];	35550227
25024	chr14	39788502	TT		chr14:39788502-39788503	MIA2	MIA SH3 domain ER export factor 2	deletion	0/0	0.0	7_0	7	7.0	0/1	0.5	2_2	4	65.0			rs556166758	SPLICING	YES	NM_001329214.3	Transcript	protein_coding	splice_region_variant,intron_variant	23/28		NM_001329214.3:c.3367+16_3367+17del			1.0						.	.	.		1.40847e-05	2.0	141998.0	0.0	32	0.91	PASS	nfe	1.55058e-05	1.0	1.55058e-05	1.0	0.00112222	95.0	84654.0	0.0	21	0.53	RF	amr	0.0026362	21.0	0.00105619	45.0	0.0012411	193						9.228	0.481547		0	0	0			CTAGE5	0.0	0.0	0.0	0.0	-7.0	-17.0	-12.0	-3.0						0.914	0.0				homeostasis/metabolism phenotype; 			pons;ciliary ganglion;temporal lobe;atrioventricular node;superior cervical ganglion;trigeminal ganglion;parietal lobe;skeletal muscle;medulla oblongata;	.	endoplasmic reticulum to Golgi vesicle-mediated transport;protein secretion;vesicle cargo loading;lipoprotein transport	endoplasmic reticulum membrane;integral component of membrane;endoplasmic reticulum exit site	lipoprotein transporter activity	CEP57[25416956];MAGEB18[25416956;unassigned1304];SS18L1[25416956];RASAL2[25416956];HSCB[28380382];AES[25416956];PSMA3[25416956];TRAF6[17353931];ALB[15174051];ABL1[17474147];GRB2[21988832];EMILIN1[25416956];CCHCR1[25416956];TTC23L[25416956;unassigned1304];	39788501
25048	chr14	45433640	C	T	chr14:45433640	FAM179B		SNV	0/0	0.0	34_0	34	99.0	0/1	0.48	33_30	63	99.0			rs146425772	EXONIC	YES	NM_001308120.2	Transcript	protein_coding	synonymous_variant		1/20	NM_001308120.2:c.2016C>T	NP_001295049.1:p.Asn672%3D		1.0										0.00182069	277.0	152140.0	1.0	32	0.97	PASS	nfe	0.00185245	126.0	0.00185245	126.0	0.00234887	553.0	235432.0	5.0	35	0.74	PASS	nfe	0.00208868	223.0	0.00208868	223.0	0.0019871	309						9.108	0.469196		0	0	0			FAM179B	0.0	0.0	0.0	0.02	-27.0	4.0	-2.0	30.0						0.929	0.0	51.768713289												45433640
25093	chr14	50760969		A	chr14:50760968-50760969	L2HGDH	L-2-hydroxyglutarate dehydrogenase	insertion	0/0	0.0	26_0	31	87.0	0/1	0.21	26_7	34	84.0			rs368650202	SPLICING	YES	NM_024884.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	3/9		NM_024884.3:c.409-5dup			-1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	not_provided	L-2-hydroxyglutaric aciduria, 236792 (3), Autosomal recessive	L-2-hydroxyglutaric aciduria	Disease-causing germline mutation(s) in	Behavioral abnormality;Dysphasia;Aplasia/Hypoplasia of the cerebellum;Seizure;Muscular hypotonia;Neoplasm of the nervous system;Encephalitis;Abnormality of extrapyramidal motor function;Intellectual disability, progressive;Macrocephaly;Spastic tetraparesis;Intellectual disability, severe;Abnormal pyramidal sign;Hearing impairment;Intellectual disability, severe;Abnormality of extrapyramidal motor function;Dysphasia;Strabismus;Corpus callosum atrophy;L-2-hydroxyglutaric aciduria;Infantile onset;Nystagmus;Optic atrophy;Morphological abnormality of the pyramidal tract;Leukoencephalopathy;Cerebellar atrophy;Spastic tetraparesis;L-2-hydroxyglutaric acidemia;Gliosis;Intellectual disability, progressive;Seizure;Autosomal recessive inheritance;Global brain atrophy;Severe demyelination of the white matter;Developmental regression		0.000411378	56.0	136128.0	0.0	32	0.92	PASS	eas	0.00124224	6.0	0.000302712	19.0	0.0403731	3800.0	94122.0	0.0	46	0.96	PASS	amr	0.0630132	660.0	0.0313706	1479.0	0.0001350,0.0291954,0.0002186	21,4540,34			0.0051	58.0		8.31	0.391922		0	0	0			L2HGDH	0.0	0.03	0.0	0.0	-4.0	-11.0	-16.0	-4.0						0.36	0.31				behavior/neurological phenotype ; nervous system phenotype ; homeostasis/metabolism phenotype; 			superior cervical ganglion;globus pallidus;	Butanoate metabolism	2-oxoglutarate metabolic process;cellular protein metabolic process;oxidation-reduction process	mitochondrion;mitochondrial inner membrane;integral component of membrane;integral component of mitochondrial inner membrane	(S)-2-hydroxy-acid oxidase activity;2-hydroxyglutarate dehydrogenase activity	ATL3[26496610];HSCB[28380382];COQ6[27499296];COX6B1[27499296];	50760968
25102	chr14	51224761	G	A	chr14:51224761	NIN	ninein	SNV	0/1	0.48	68_63	132	99.0	0/1	0.56	51_66	117	99.0			rs41313507,COSV99813222	EXONIC	YES	NM_020921.4	Transcript	protein_coding	missense_variant		18/31	NM_020921.4:c.2987C>T	NP_065972.4:p.Ala996Val		-1.0	.,.,.,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	not_specified|not_provided	?Seckel syndrome 7, 614851 (3), Autosomal recessive	Microcephalic primordial dwarfism, Dauber type	Disease-causing germline mutation(s) in	Hip dysplasia;Madelung deformity;Prominent nose;Obesity;Delayed skeletal maturation;Microcephaly;Severe postnatal growth retardation;Primary amenorrhea;Microtia;Abnormality of the carpal bones;Clinodactyly of the 5th finger;Short middle phalanx of the 5th finger;Seizure;Lumbar scoliosis;Global developmental delay;Severe intrauterine growth retardation;Hypotelorism;Short stature;Bilateral breast hypoplasia;Subglottic stenosis;Limb undergrowth;Intellectual disability, severe;Autosomal recessive inheritance;Abnormality of the carpal bones;Intellectual disability, severe;Microcephaly;Seizure;Hypoplasia of the uterus;Hypotelorism;Hip dysplasia;Microtia;Primary amenorrhea;Prominent nose;Severe global developmental delay;Clinodactyly;Intrauterine growth retardation;Central hypothyroidism;Lumbar scoliosis;Madelung deformity;Delayed skeletal maturation;Severe short stature	25741868	0.00236596	360.0	152158.0	0.0	33	0.97	PASS	nfe	0.00391027	266.0	0.00391027	266.0	0.00223903	563.0	251448.0	0.0	100	1.0	PASS	nfe	0.00388565	442.0	0.00388565	442.0	0.0022507	350	0.007	22.0	0.00525	50.0		0.009	-0.796511	0.011	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	NIN	0.0	0.0	0.0	0.0	-15.0	21.0	-5.0	-34.0						0.943	0.0	0.000000000	0.31	-0.068	behavior/neurological phenotype ; cardiovascular system phenotype ; hearing/vestibular/ear phenotype; nervous system phenotype ; 			.	.	protein localization;centriole-centriole cohesion;corpus callosum morphogenesis;corticospinal tract morphogenesis;positive regulation of microtubule polymerization;microtubule anchoring at centrosome;collateral sprouting;positive regulation of axonogenesis;centrosome localization;centrosome-templated microtubule nucleation	pericentriolar material;spindle pole;nucleus;nucleolus;centrosome;centriole;plasma membrane;dendrite;microtubule minus-end;axonal growth cone;apical part of cell;mitotic spindle;mitotic spindle pole;ciliary transition fiber;centriolar subdistal appendage	calcium ion binding;protein binding;GTP binding;kinase binding	GPATCH1[26638075];WDR83[26638075];TTF2[26638075];AMOT[19615732];CEP128[26638075];EIF4ENIF1[26638075];CSPP1[26638075];PMPCB[26638075];HMGN3[26638075];RAB2A[26638075];CEP131[26638075];ECH1[26638075];DYNC1LI1[26638075];DYNC1LI2[26638075];TXLNA[26638075];MAP7D3[26638075];TP53[26638075];SNU13[26638075];HMMR[26638075];CCNB2[26638075];CCNB1[26638075];DHX35[26638075];MYH13[26496610];TP53BP2[26638075];ISOC1[26638075];CEP192[26638075];PIBF1[26638075];FAM83B[26638075];CARMIL2[26638075];CCDC138[26638075];CEP350[26638075];PLK1[26638075];RASSF8[26638075];ANLN[26638075];DIAPH3[26638075];ARPC3[26638075];FGFR1OP[26638075];CC2D1A[26638075];GSK3B[11004522;15147888;17139249];CEP164[26638075];KIAA1671[26638075];KIF14[26638075];BICD1[17139249];TTC28[26638075];TCHP[26638075];PCM1[26638075];ACTR1A[26638075];DBT[26638075];CNTRL[26638075];CEP170[26638075];ERC1[26638075];HIST1H1A[30021884];ARFGEF3[26638075];YWHAH[26638075];UNC45A[26638075];IQCB1[26638075];OFD1[26638075];UPF1[26638075];ACTR2[26638075];AXIN1[19390532];CKAP2[26638075];HAUS4[26638075];HAUS3[26638075];HAUS6[26638075];HAUS5[26638075];HAUS1[26638075];POC5[26638075];PALLD[26638075];NME7[26638075];SSX2IP[26638075];DYNC1I2[26638075];CAMK2D[26638075];AHCY[26638075];DCTN2[26638075];LUZP1[26638075];DCTN1[26638075];DOT1L[26496610];TTK[26638075];HECTD1[26638075];HAUS8[26638075];HAUS7[26638075];ENTR1[26638075];CLASP1[26638075];RTRAF[15147888];CLASP2[26638075];DYNC1H1[26638075];SVIL[26638075];CSNK1A1[26638075];MGA[26638075];NCKAP5L[26638075];AP3D1[26638075];SAMD4B[26638075];BAIAP2[26638075];TJP1[26638075];CENPE[26638075];NEDD1[26638075];ABI1[15048123];BAX[26496610];SPC24[26638075];TNRC6B[26638075];	51224761
25114	chr14	51370807	C	T	chr14:51370807	ABHD12B	abhydrolase domain containing 12B	SNV	0/1	0.5	29_30	60	99.0	0/1	0.44	30_24	54	99.0			rs149870138,COSV53585072	EXONIC	YES	NM_001206673.2	Transcript	protein_coding	missense_variant		12/13	NM_001206673.2:c.958C>T	NP_001193602.1:p.Arg320Cys		1.0	.,.					.	.	.		0.0016432	250.0	152142.0	0.0	32	0.96	PASS	amr	0.00281598	43.0	0.00235156	160.0	0.00188488	472.0	250414.0	3.0	61	0.94	PASS	amr	0.00287841	99.0	0.00250706	284.0	0.0017299	269	0.004	14.0				11.52	0.745059	0.042	1	18	19	MutationAssessor_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ABHD12B	0.02	0.01	0.0	0.0	14.0	-15.0	-15.0	26.0						0.914	0.0	0.000000000	0.002	-2.366	.			.	.	.	.	hydrolase activity	THRAP3[30021884];	51370807
25176	chr14	55509919	G	A	chr14:55509919	SOCS4	suppressor of cytokine signaling 4	SNV	0/0	0.0	35_0	35	99.0	0/1	0.38	65_40	105	99.0			rs146421724	EXONIC	YES	NM_199421.2	Transcript	protein_coding	missense_variant		3/3	NM_199421.2:c.160G>A	NP_955453.1:p.Gly54Ser		1.0	.,.,.					.	.	.	28508493	0.00153108	233.0	152180.0	0.0	32	0.98	PASS	amr	0.00438769	67.0	0.00149925	102.0	0.0015749	396.0	251444.0	2.0	100	1.0	PASS	amr	0.00398959	138.0	0.00168824	192.0	0.0014405	224	0.011	35.0				0.231	-0.366325	0.068	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SOCS4	0.0	0.0	0.0	0.0	-33.0	0.0	-33.0	0.0						0.78	0.0	0.000000000	0.0	-0.55	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;skeletal muscle;	Jak-STAT signaling pathway;Insulin signaling pathway;Type II diabetes mellitus	negative regulation of epidermal growth factor-activated receptor activity;protein ubiquitination;positive regulation of proteasomal ubiquitin-dependent protein catabolic process;intracellular signal transduction;regulation of growth	.	protein binding	VWF[21988832];TNK2[25814554];PIK3R3[25814554];MPP5[25814554];FRS3[25814554];NR4A1[21988832];RBP7[25814554];PINK1[25814554];MDFIC[21988832];SPRY1[21988832];GRB2[25814554];TEKT4[unassigned1304];ELOC[16643902;17997974];CNMD[25814554];LDHAL6B[25814554];	55509919
25190	chr14	57676707	T		chr14:57676707	EXOC5	exocyst complex component 5	deletion	0/0	0.0	14_0	14	39.0	0/1	0.29	5_2	7	60.0				EXONIC	YES	NM_006544.4	Transcript	protein_coding	frameshift_variant		16/18	NM_006544.4:c.1686del	NP_006535.1:p.Glu563LysfsTer7		-1.0						.	.	.						32	0.97											29	0.67																	0	0	0			EXOC5	0.0	0.0	0.0	0.0	50.0	48.0	-34.0	-35.0							1.0				cardiovascular system phenotype ; mortality/aging ; renal/urinary system phenotype; 			.	.	establishment of planar polarity;exocytosis;post-Golgi vesicle-mediated transport;Golgi to plasma membrane transport;protein transport;vesicle docking;homeostasis of number of cells within a tissue;protein localization to plasma membrane;epithelial cell apoptotic process;non-motile cilium assembly	exocyst;cytoplasm;cytosol;midbody	protein binding;Ral GTPase binding;protein N-terminus binding	ICA1[21988832];DEUP1[25416956;unassigned1304];ENO2[25416956];CCDC102B[25416956];HDDC3[25416956];PYCARD[25416956];EDRF1[25416956];PSTPIP1[26871637];ZNF609[27173435;unassigned1312];CDH2[21988832];TXNL4A[25416956];IFT57[unassigned1304];TNPO2[21516116;25416956];MAGEA6[25416956;unassigned1304];TTC23L[25416956];RAB8A[27173435;unassigned1312];MAGEA3[unassigned1304];PRKCG[16713569];IQCB1[27173435;unassigned1312];NSF[27173435;unassigned1312];FGA[unassigned1304];EXOC8[27173435;unassigned1312];EXOC7[27173435;unassigned1312];USP2[unassigned1304];THOC1[unassigned1304];SOX10[21988832];FRMD6[25416956];OAS1[25416956;unassigned1304;25910212];TXLNB[25416956];STIM1[27173435;unassigned1312];HGS[26871637];EXOC4[27173435;unassigned1312];KXD1[25416956];EXOC3[27173435;unassigned1312];EXOC6[27173435;unassigned1304;unassigned1312];EXOC5[25416956];KIFC3[unassigned1304];C1orf216[unassigned1304];EXOC2[27173435;unassigned1312];SPACA9[25416956];EXOC1[27173435;unassigned1312];ACTR3B[21988832];TBX21[21988832];ZNF783[unassigned1304];BARD1[25416956];RAB4A[25416956;unassigned1304];RAB4B[25416956;unassigned1304];CRYBB1[unassigned1304];EXOC6B[27173435;unassigned1304;unassigned1312];CDC5L[20467437];PTK6[25416956;unassigned1304];SNW1[20467437];RAB14[25416956;unassigned1304];ADCK1[21988832];BRMS1L[25416956];	57676706
25389	chr14	62187212	G	C	chr14:62187212	HIF1A	hypoxia inducible factor 1 subunit alpha	SNV	0/1	0.42	51_38	90	99.0	0/0	0.0	36_0	36	99.0			rs61755705	EXONIC	YES	NM_001243084.1	Transcript	protein_coding	missense_variant		2/15	NM_001243084.1:c.220G>C	NP_001230013.1:p.Val74Leu		1.0	Myc-type, basic helix-loop-helix (bHLH) domain&Myc-type, basic helix-loop-helix (bHLH) domain&Myc-type, basic helix-loop-helix (bHLH) domain,Myc-type, basic helix-loop-helix (bHLH) domain&Myc-type, basic helix-loop-helix (bHLH) domain&Myc-type, basic helix-loop-helix (bHLH) domain,.,.					.	.	.		0.00213538	325.0	152198.0	2.0	32	0.97	PASS	nfe	0.00305712	208.0	0.00305712	208.0	0.00195944	491.0	250582.0	0.0	55	0.93	PASS	nfe	0.00253095	287.0	0.00253095	287.0	0.0018585	289	0.002	6.0	0.00324	37.0		23.0	2.714208	0.385	9	12	21	SIFT,Polyphen2_HDIV_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	HIF1A	0.0	0.0	0.0	0.32	-50.0	-1.0	20.0	-1.0						0.433	0.98	0.000000000	1.0	1.176	homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype ; endocrine/exocrine gland phenotype; behavior/neurological phenotype ; respiratory system phenotype; liver/biliary system phenotype; immune system phenotype; skeleton phenotype; renal/urinary system phenotype; digestive/alimentary phenotype; nervous system phenotype ; limbs/digits/tail phenotype; vision/eye phenotype; cardiovascular system phenotype ; hematopoietic system phenotype; mortality/aging ; normal phenotype; neoplasm; embryo phenotype; 			smooth muscle;fetal lung;adrenal cortex;	mTOR signaling pathway;Renal cell carcinoma	angiogenesis;response to hypoxia;neural crest cell migration;epithelial to mesenchymal transition;embryonic placenta development;B-1 B cell homeostasis;positive regulation of endothelial cell proliferation;heart looping;positive regulation of neuroblast proliferation;connective tissue replacement involved in inflammatory response wound healing;outflow tract morphogenesis;cardiac ventricle morphogenesis;lactate metabolic process;regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;cellular iron ion homeostasis;signal transduction;lactation;visual learning;response to iron ion;regulation of gene expression;vascular endothelial growth factor production;positive regulation of vascular endothelial growth factor production;positive regulation of gene expression;negative regulation of gene expression;positive regulation of epithelial cell migration;positive regulation of receptor biosynthetic process;response to muscle activity;positive regulation of macroautophagy;protein deubiquitination;cytokine-mediated signaling pathway;axonal transport of mitochondrion;neural fold elevation formation;cerebral cortex development;negative regulation of bone mineralization;positive regulation of vascular endothelial growth factor receptor signaling pathway;negative regulation of TOR signaling;oxygen homeostasis;positive regulation of chemokine production;regulation of transforming growth factor beta2 production;collagen metabolic process;embryonic hemopoiesis;positive regulation of insulin secretion involved in cellular response to glucose stimulus;hemoglobin biosynthetic process;glucose homeostasis;mRNA transcription by RNA polymerase II;positive regulation of blood vessel endothelial cell migration;regulation of transcription from RNA polymerase II promoter in response to oxidative stress;post-translational protein modification;positive regulation of erythrocyte differentiation;positive regulation of angiogenesis;positive regulation of glycolytic process;positive regulation of transcription, DNA-templated;negative regulation of growth;positive regulation of transcription by RNA polymerase II;muscle cell cellular homeostasis;positive regulation of hormone biosynthetic process;digestive tract morphogenesis;positive regulation of nitric-oxide synthase activity;cartilage development;elastin metabolic process;intestinal epithelial cell maturation;epithelial cell differentiation involved in mammary gland alveolus development;iris morphogenesis;retina vasculature development in camera-type eye;regulation of transcription from RNA polymerase II promoter in response to hypoxia;positive regulation of transcription from RNA polymerase II promoter in response to hypoxia;positive regulation of chemokine-mediated signaling pathway;negative regulation of thymocyte apoptotic process;cellular response to interleukin-1;cellular response to hypoxia;dopaminergic neuron differentiation;hypoxia-inducible factor-1alpha signaling pathway;positive regulation of pri-miRNA transcription by RNA polymerase II;negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway;positive regulation of autophagy of mitochondrion;regulation of aerobic respiration;negative regulation of reactive oxygen species metabolic process;negative regulation of mesenchymal cell apoptotic process	nucleus;nucleoplasm;transcription factor complex;cytoplasm;cytosol;nuclear body;nuclear speck;motile cilium;protein-containing complex;RNA polymerase II transcription factor complex;axon cytoplasm	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;p53 binding;DNA-binding transcription factor activity;protein binding;transcription factor binding;enzyme binding;protein kinase binding;protein domain specific binding;ubiquitin protein ligase binding;histone acetyltransferase binding;nuclear hormone receptor binding;histone deacetylase binding;sequence-specific DNA binding;protein heterodimerization activity;Hsp90 protein binding;E-box binding	ANKRD37[23746844];HSP90AB1[18538669];FAF2[18775313];BHLHE41[22801492];ARRB1[21685944];MED15[23746844];MED12[23746844];SEPT9[16424018];MED14[23746844];MED13[23746844];SUMO1[20661221;24434214];SUMO3[19680224];EP300[15261140;17382325;19071119;19680224;20603618;23746844;24421387;18268343;26751287];UBXN7[18775313];DGCR8[26766590];SSX4[16189514];ELOB[12050673;12004076;17353276];HIF1AN[12446723;19071119;26972000;26752685;17003112;26751287];ELOC[12050673;12004076;17353276];PIAS4[20661221];USP8[24378640];HSP90AA1[18538669];CSNK2A1[17382325];ARNT[9704006;20932347;20603618;20562859;21620138;24434214;26496610;19168635];SENP3[19680224];MID2[26496610];PIAS1[26496610];MED23[23746844];KAT2B[16543236];AR[17426252];PKM[21620138];PSMA4[22801492];FDX1[26496610];TCEANC2[26496610];HIST1H2BH[30021884];FBP1[25043030];HDAC4[19071119];YAP1[25438054];HDAC5[19071119];VCP[18775313];HDAC2[25241761];NOTCH1[18427106];HDAC1[16511565];MAX[17418410];CUL2[18323857];UTP23[26496610];ZNF518A[26496610];FOXO3[18268343];HIF1A[20562859;12050673];UACA[26496610];PSMA7[11389899];ARNTL[25416956];NLN[26496610];MUC1[22869720];MTA1[16511565];OS9[15721254];STC2[23746844];MIC13[26496610];DROSHA[26766590];VHL[16511565;15721254;17986458;18323857;21602890;12050673;12004076;11292862;17353276;26496610;25438054];BANP[20562859];EGLN1[15474027;16511565;20840591;17353276;19604478];ESRRA[18509053];EGLN3[15474027;16511565;15721254;17353276;26972000;25416956];CREBBP[17382325;21602890];RWDD3[17956732];XBP1[24670641];EGLN2[15474027;16511565;17353276];SMAD3[28471448];NAA10[16288748;16638120];CBX4[24434214];PCGF2[21602890];CEP350[26496610];EAF2[24421387];LYSMD2[26496610];FN1[26496610];PLEKHA5[26496610];TTC1[26496610];NBEAL1[26496610];ESR1[21182205];MED13L[23746844];TSGA10[16777103];CDK8[23746844];SP1[17024177];GKAP1[26496610];MAFG[18538669];CTNNB1[24650032];MAFK[18538669];NES[26496610];	62187212
25588	chr14	69349648	G	A	chr14:69349648	ACTN1	actinin alpha 1	SNV	0/1	0.55	55_67	122	99.0	0/1	0.48	64_58	122	99.0			rs555037578,CM154194,COSV51990148	EXONIC	YES	NM_001130004.2	Transcript	protein_coding	missense_variant		15/22	NM_001130004.2:c.1760C>T	NP_001123476.1:p.Ala587Val		-1.0	.,.,.,.,.,.				Bleeding disorder, platelet-type, 15, 615193 (3), Autosomal dominant	Autosomal dominant macrothrombocytopenia	Disease-causing germline mutation(s) in	Increased mean platelet volume;Platelet anisocytosis;Autosomal dominant inheritance;Epistaxis;Anisocytosis;Thrombocytopenia		4.59994e-05	7.0	152176.0	0.0	33	0.98	PASS	sas	0.000206954	1.0	5.8801e-05	4.0	4.37501e-05	11.0	251428.0	0.0	100	1.0	PASS	amr	0.000173451	6.0	4.3953e-05	5.0	0.0000450	7						23.6	3.033422	0.137	5	14	19	LRT_pred,MutationTaster_pred,PrimateAI_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	ACTN1	0.0	0.0	0.07	0.0	2.0	37.0	2.0	-2.0						0.4	1.0	0.000000000	0.997	1.176	.			lung;	Focal adhesion;Adherens junction;Tight junction;Leukocyte transendothelial migration;Regulation of actin cytoskeleton;Systemic lupus erythematosus	platelet degranulation;actin filament organization;platelet activation;platelet formation;platelet morphogenesis;regulation of apoptotic process;focal adhesion assembly;actin filament bundle assembly;negative regulation of cellular component movement;actin filament network formation;actin crosslink formation;platelet aggregation;postsynapse organization;positive regulation of nucleic acid-templated transcription	stress fiber;ruffle;extracellular region;extracellular space;cytoplasm;cytosol;actin filament;plasma membrane;brush border;cell-cell junction;fascia adherens;focal adhesion;Z disc;platelet alpha granule lumen;pseudopodium;cell projection;extracellular exosome;glutamatergic synapse	double-stranded RNA binding;integrin binding;calcium ion binding;protein binding;vinculin binding;nuclear receptor transcription coactivator activity;protein homodimerization activity;ion channel binding;actin filament binding;structural constituent of postsynapse	ATF2[22304920];HSP90AB1[16263121];TRAF3IP1[20391533];PLEK[19722192];HSPB1[25277244];PARK7[29128334];DUX4[26816005];ACTB[26879394];COIL[16713569];PPP1CB[26496610];EPM2AIP1[25416956;unassigned1304];MYOZ1[16189514;unassigned1304];KPNA2[21988832];SYNPO[26496610;30021884];DNM1L[29128334];MYOZ2[25416956;unassigned1304;25910212];PIAS4[21988832];PDHX[21988832];SUN2[22555292];GABARAPL1[20562859];ACTN3[unassigned1304];DYNLT1[unassigned1304];ACTN2[25910212];ACTN1[11423549;25416956];USP2[unassigned1304];SCRIB[24550280];KCTD6[25416956];MTNR1A[26514267];PSMA1[21988832];OAS1[25416956;25910212];SYNPO2L[unassigned1304];MTNR1B[26514267];MYOT[26871637];BTK[21080425];MYH9[26496610];MAPRE1[26496610];EZR[29568061];FXN[16713569];DLD[29128334];DBN1[26496610];NKAPD1[unassigned1304];NUMBL[21988832];SRC[16291744];COX15[29128334];CAMK2A[12223541;25241761];CACNA1A[21078624];PSEN1[21163940];IQGAP1[26496610];TXN[unassigned1304];TTN[11101506];SLC9A3R2[27173435;unassigned1312];ATXN2[16713569];ATXN7[21078624];CTNNA1[25241761];MICALL2[25416956;unassigned1304];C14orf119[unassigned1304];HSF5[25036637];MAGEA11[16189514];PDLIM7[26496610];PTPN1[16291744];GIT2[21988832];JUN[25609649];XRCC4[16189514];GTF2H1[21988832];ESR1[21182205];MYO19[26496610];EIF2S1[unassigned1304];ESR2[21182203;25604459];PLEKHA7[28877994];GADD45G[unassigned1304];ANLN[26496610];GFI1B[16713569];RPS27[21988832];APC[20936779];APPBP2[unassigned1304];CAPZA2[26496610];ZYX[11423549];LNX1[unassigned1304];GRB2[12577067];SPERT[25416956];BCAR1[28007913];	69349648
25702	chr14	73720604	C	A	chr14:73720604	PAPLN	papilin, proteoglycan like sulfated glycoprotein	SNV	0/0	0.0	37_0	37	99.0	0/1	0.51	49_52	101	99.0			rs146030488	EXONIC	YES	NM_001365906.3	Transcript	protein_coding	missense_variant		12/27	NM_001365906.3:c.1237C>A	NP_001352835.1:p.Pro413Thr		1.0	.,.,.,.					.	.	.		0.00285887	435.0	152158.0	0.0	33	0.97	PASS	nfe	0.00502897	342.0	0.00502897	342.0	0.00284922	711.0	249542.0	2.0	59	0.98	PASS	nfe	0.00471305	531.0	0.00471305	531.0	0.0030932	481	0.004	13.0				24.6	3.371392	0.39	11	9	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	PAPLN	0.01	0.0	0.0	0.0	-42.0	-6.0	14.0	-23.0						0.97	0.0	0.000000000	0.798	1.026	homeostasis/metabolism phenotype; 			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	.	proteolysis;negative regulation of endopeptidase activity	extracellular region	serine-type endopeptidase inhibitor activity;peptidase activity	TFAP2C[24835590];	73720604
25890	chr14	76249487	T	C	chr14:76249487	TTLL5	tubulin tyrosine ligase like 5	SNV	0/1	0.46	29_25	54	99.0	0/0	0.0	33_0	33	99.0			rs185326652	SPLICING	YES	NM_015072.5	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	25/31		NM_015072.5:c.2603-3T>C			1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	not_specified|not_provided	Cone-rod dystrophy 19, 615860 (3), Autosomal recessive	Cone rod dystrophy	Disease-causing germline mutation(s) (loss of function) in	Photophobia;Visual impairment;Color vision defect;Abnormality of retinal pigmentation;Nyctalopia;Cone/cone-rod dystrophy;Retinal dystrophy;Autosomal recessive inheritance		0.00181297	276.0	152236.0	2.0	32	0.97	PASS	amr	0.00386176	59.0	0.0028951	197.0	0.00186238	444.0	238404.0	1.0	46	0.79	PASS	amr	0.00317118	106.0	0.00281994	311.0	0.0017556	273	0.005	17.0				11.92	0.795718		0	0	0			TTLL5	0.05	0.0	0.0	0.0	3.0	39.0	28.0	3.0	7.76693606193073e-05	0.002	11.843	-0.735	11.108	0.959	0.0				reproductive system phenotype; cellular phenotype; 			ciliary ganglion;testis - seminiferous tubule;trigeminal ganglion;superior cervical ganglion;testis;pons;testis - interstitial;dorsal root ganglion;atrioventricular node;uterus corpus;parietal lobe;skeletal muscle;globus pallidus;	.	protein polyglutamylation;retina development in camera-type eye	nucleus;centrosome;cytosol;microtubule;plasma membrane;cilium	ATP binding;tubulin-glutamic acid ligase activity	OFD1[26496610];CDKN1A[16169070];PCM1[26638075];CEP135[26496610];PTTG1[26496610];CCDC14[26496610];GAR1[26496610];FGFR1OP[26496610];CEP128[26638075];	76249487
25914	chr14	77493762	TGCTGCTGC		chr14:77493762-77493770	IRF2BPL	interferon regulatory factor 2 binding protein like	sequence_alteration	1/2	0.11	0_4_34	38	57.0	0/2	0.04	12_1_14	27	99.0			rs200317113	EXONIC	YES	NM_024496.4	Transcript	protein_coding	inframe_deletion		1/1	NM_024496.4:c.366_374del	NP_078772.1:p.Gln125_Gln127del		-1.0					Neurodevelopmental disorder with regression, abnormal movements, loss of speech, and seizures, 618088 (3), Autosomal dominant	.	.	Intellectual disability;Nystagmus;Cerebellar atrophy;Choreoathetosis;Dysmetria;Dysarthria;Loss of speech;Cerebral atrophy;Seizure;Dysphagia;Esotropia;Generalized hypotonia;Dystonia;Developmental regression;Spasticity;Progressive;Global developmental delay;Corpus callosum atrophy;Autosomal dominant inheritance;Weakness of facial musculature		0.00089612	128.0	142838.0	0.0	6	0.29	PASS	afr	0.00262675	103.0	0.000261185	17.0	0.00514135	343.0	66714.0	0.0	4	0.22	PASS	amr	0.0111804	122.0	0.00401763	93.0	0.0000193,0.0021028	3,327						13.59	1.024151		0	0	0																		0.97				.			skin;cerebellum;	.	negative regulation of transcription by RNA polymerase II;positive regulation of transcription by RNA polymerase II;development of secondary female sexual characteristics	extracellular space;nucleus;nucleoplasm	RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription activator activity, RNA polymerase II-specific;molecular_function;metal ion binding	RNF169[21252943];UBE2Q1[19690564];IRF2[21903422];MKI67[26949251];	77493761
26031	chr14	92258906	A		chr14:92258906	TC2N	tandem C2 domains, nuclear	deletion	0/1	0.4	3_2	5	42.0	0/0	0.0	10_0	10	30.0			rs757388124	SPLICING	YES	NM_001128596.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	8/11		NM_001128596.3:c.856-4del			-1.0						.	.	.		0.00404762	597.0	147494.0	1.0	32	0.93	PASS	amr	0.00642587	95.0	0.00431216	287.0	0.0116313	1261.0	108414.0	3.0	20	0.52	RF	eas	0.0152077	123.0	0.012528	670.0	0.0000322,0.0111766	5,1738						0.198	-0.388098		0	0	0			TC2N	0.0	0.01	0.0	0.0	-4.0	-3.0	-26.0	-3.0						0.996	0.01				.			.	.	.	cellular_component;nucleus	molecular_function	.	92258905
26070	chr14	92583867	G	A	chr14:92583867	NDUFB1	NADH:ubiquinone oxidoreductase subunit B1	SNV	0/1	0.31	46_21	67	99.0	0/1	0.43	30_23	53	99.0			rs151054506,COSV54098153	EXONIC	YES	NM_004545.4	Transcript	protein_coding	missense_variant		2/3	NM_004545.4:c.115C>T	NP_004536.3:p.Arg39Trp		-1.0	.,.,.,.,.					.	.	.		0.000421147	64.0	151966.0	0.0	32	0.96	PASS	nfe	0.000705799	48.0	0.000705799	48.0	0.000449526	113.0	251376.0	0.0	84	1.0	PASS	nfe	0.000774103	88.0	0.000774103	88.0	0.0004694	73			0.00098	10.0		24.9	3.478207	0.225	15	5	20	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,LRT_pred,PrimateAI_pred,DEOGEN2_pred,ClinPred_pred	NDUFB1	0.0	0.0	0.02	0.0	24.0	32.0	-9.0	-25.0						0.48	0.31	0.000000000	0.986	0.133	.			kidney;temporal lobe;liver;whole brain;skeletal muscle;cerebellum;hypothalamus;medulla oblongata;thalamus;	Oxidative phosphorylation	mitochondrial electron transport, NADH to ubiquinone;mitochondrial respiratory chain complex I assembly	mitochondrion;mitochondrial inner membrane;mitochondrial respiratory chain complex I;integral component of membrane;nuclear speck	NADH dehydrogenase (ubiquinone) activity	NDUFA9[24344204];NDUFAF8[27499296];NDUFA6[12611891];NDUFA5[16189514];GOLT1B[26496610];EWSR1[16189514];NDUFAF4[27499296];HSCB[28380382];NIT1[27499296];	92583867
26189	chr14	96794878	A		chr14:96794878	ATG2B	autophagy related 2B	deletion	0|1	0.16	21_4	25	37.0	0/1	0.27	24_9	33	99.0			rs542534443,COSV63424323	SPLICING	YES	NM_018036.7	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	13/41		NM_018036.7:c.1975-6del			-1.0						.	.	.		0.000858188	122.0	142160.0	1.0	32	0.93	PASS	eas	0.00160128	8.0	0.000525372	34.0	0.0962983	9896.0	102764.0	0.0	27	0.72	RF	amr	0.14263	1438.0	0.0870047	4550.0	0.0556449,0.0000064	8653,1						1.104	-0.136119		0	0	0			ATG2B	0.01	0.0	0.0	0.0	-5.0	-15.0	-35.0	-5.0						0.835	0.0				.			ciliary ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;	.	autophagosome assembly;autophagy of mitochondrion	phagophore assembly site;nucleoplasm;lipid droplet;extrinsic component of membrane;phagophore assembly site membrane	.	SPAG9[unassigned1312];GSK3B[29568061];USP15[unassigned1312];NEK4[25798074];HDAC11[23752268];WDR45[20562859];PDIA6[30021884];ATG2A[20562859];POC1A[26638075];MCM4[unassigned1312];ZSCAN26[26496610];MCM6[unassigned1312];CEP89[26638075];MCM2[unassigned1312];	96794877
26198	chr14	99641544	CTC		chr14:99641544-99641546	BCL11B	B cell CLL/lymphoma 11B	deletion	0/1	0.14	67_11	79	99.0	0/1	0.13	73_11	87	99.0			rs761352760	EXONIC	YES	NM_138576.4	Transcript	protein_coding	inframe_deletion		4/4	NM_138576.4:c.1627_1629del	NP_612808.1:p.Glu543del		-1.0		Benign	criteria_provided,_single_submitter	not_provided	Intellectual developmental disorder with dysmorphic facies, speech delay, and T-cell abnormalities, 618092 (3), Autosomal dominant; Immunodeficiency 49, 617237 (3), Autosomal dominant	.	.	Global developmental delay;Unsteady gait;Hypertelorism;Narrow mouth;Hypodontia;Spasticity;Oligodontia;Hypermetropia;Thin eyebrow;Short palpebral fissure;Eosinophilia;Epicanthus;Myopia;Long philtrum;Asthma;Myopathic facies;Thin upper lip vermilion;Microdontia;Anxiety;Generalized hypotonia;Intellectual disability;Recurrent infections;Autosomal dominant inheritance;Prominent nose;Delayed speech and language development;Feeding difficulties;Delayed ability to walk;Upslanted palpebral fissure;Cutis laxa;Umbilical hernia;Short palpebral fissure;Intellectual disability;Congenital onset;Seizure;Severe combined immunodeficiency;Generalized hypotonia;Autosomal dominant inheritance;Micrognathia;Spastic tetraplegia;Short philtrum;Lymphopenia;Myopathic facies;Global developmental delay;Hypertelorism;Absent speech;Eosinophilia;Posteriorly rotated ears;Natal tooth;Inflammatory abnormality of the skin;Hirsutism;Wormian bones;Pulmonary artery stenosis		0.00178829	268.0	149864.0	2.0	32	0.93	PASS	amr	0.00616793	93.0	0.00187405	126.0	0.0716006	5886.0	82206.0	1.0	26	0.54	PASS	eas	0.0947689	529.0	0.0701377	2313.0	0.0000193,0.0001415	3,22						18.81	1.880953		0	0	0			BCL11B	0.0	0.0	0.0	0.0	30.0	24.0	-14.0	1.0							0.93	0.000000000			craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; integument phenotype ; mortality/aging ; hematopoietic system phenotype; growth/size/body region phenotype; vision/eye phenotype; skeleton phenotype; immune system phenotype; behavior/neurological phenotype ; neoplasm; 			thymus;superior cervical ganglion;	.	keratinocyte development;epithelial cell morphogenesis;regulation of transcription, DNA-templated;negative regulation of cell population proliferation;regulation of keratinocyte proliferation;regulation of lipid metabolic process;striatal medium spiny neuron differentiation;commitment of neuronal cell to specific neuron type in forebrain;post-embryonic camera-type eye development;T cell differentiation in thymus;T cell receptor V(D)J recombination;hematopoietic stem cell migration;odontogenesis of dentin-containing tooth;negative regulation of apoptotic process;positive T cell selection;regulation of neuron differentiation;positive regulation of transcription by RNA polymerase II;alpha-beta T cell differentiation;thymus development;olfactory bulb axon guidance;lymphoid lineage cell migration into thymus	nucleus;neuron projection	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;protein binding;sequence-specific DNA binding;metal ion binding	HDAC2[17245431;23752268];HDAC3[17245431];AIM2[25665578];NOTCH1[23022380];NEK4[25798074];HDAC1[17245431;23752268];TAL1[19497860];SUV39H1[17245431];HDAC6[23752268];	99641543
26211	chr14	101005248	C	T	chr14:101005248	BEGAIN	brain enriched guanylate kinase associated	SNV	0|1	0.5	54_55	110	99.0	0/0	0.0	34_0	34	99.0			rs569494209	EXONIC	YES	NM_001385085.1	Transcript	protein_coding	synonymous_variant		8/8	NM_001385085.1:c.987G>A	NP_001372014.1:p.Ala329%3D		-1.0						.	.	.		1.97096e-05	3.0	152210.0	0.0	34	0.98	PASS	afr	4.82439e-05	2.0	0.0	0.0	4.27248e-06	1.0	234056.0	0.0	40	0.84	PASS	afr	6.83527e-05	1.0	0.0	0.0	0.0000322	5						3.243	0.039067		0	0	0			BEGAIN	0.0	0.0	0.0	0.0	-2.0	-27.0	3.0	12.0						0.0838	0.89	0.000000000			.			pons;prefrontal cortex;superior cervical ganglion;atrioventricular node;trigeminal ganglion;parietal lobe;skeletal muscle;globus pallidus;cerebellum;	.	.	cytoplasm;membrane	protein binding	ZNF572[unassigned1304];ZNF250[16189514];FAM107A[16189514];GCC1[unassigned1304];HID1[16189514];AQP1[unassigned1304];CDC23[unassigned1304];ZNF648[unassigned1304];QSOX1[21988832];TRIM27[16189514];ATPAF2[unassigned1304;25910212];USP2[16189514];ATP6AP2[26496610];GEM[unassigned1304];LENG1[unassigned1304];RBL1[16189514];PRPF18[unassigned1304];FAM161A[unassigned1304];TRAF4[unassigned1304];HGS[16189514];ZNF319[unassigned1304];GFOD2[25416956];ZNF835[unassigned1304];KIFC3[unassigned1304];SAXO1[unassigned1304];KIAA0408[16189514];CATSPER1[16189514];HDAC4[unassigned1304];DDX6[unassigned1304];RASAL3[unassigned1304];SKA1[26496610];GMCL1[unassigned1304];ABLIM1[16189514];GUCD1[unassigned1304];BAHD1[16189514];ZNF587[unassigned1304];RIBC2[16189514];ENKD1[16189514];DTNB[16189514;unassigned1304];BMP7[unassigned1304];DEF6[16189514];FAM90A1[unassigned1304];MAB21L3[unassigned1304];CEP170P1[20360068;26496610];GFI1B[16713569];ZNF417[16189514];ZFP64[16189514];ZNF774[25416956;unassigned1304];PRR35[unassigned1304];	101005248
26285	chr14	103593607	CGG		chr14:103593607-103593609	TNFAIP2	TNF alpha induced protein 2	deletion	0/0	0.0	19_0	19	54.0	0/1	0.25	9_3	12	99.0			rs967106334	EXONIC	YES	NM_001371220.1	Transcript	protein_coding	inframe_deletion		3/13	NM_001371220.1:c.512_514del	NP_001358149.1:p.Ala171del		1.0						.	.	.		2.07394e-05	3.0	144652.0	0.0	33	0.93	PASS	sas	0.000211149	1.0	3.05979e-05	2.0	0.0	0.0	6.0	0.0	0	0.0	AC0				0.0	0.0								17.4	1.688033		0	0	0			TNFAIP2	0.0	0.0	0.0	0.0	5.0	2.0	4.0	1.0							0.0				.			.	.	angiogenesis;exocytosis;cell differentiation;exocyst localization	exocyst;extracellular space	SNARE binding	NEK4[25798074];ERBB2[24189400];USP2[unassigned1304];CDC5L[20467437];	103593606
26305	chr14	104575640	C	T	chr14:104575640	ASPG	asparaginase	SNV	0/1	0.49	47_46	94	99.0	0/1	0.49	49_47	96	99.0			rs201499159	EXONIC	YES	NM_001080464.3	Transcript	protein_coding	missense_variant		13/16	NM_001080464.3:c.1508C>T	NP_001073933.2:p.Thr503Met		1.0	Ankyrin repeat-containing domain&Ankyrin repeat-containing domain,.,Ankyrin repeat-containing domain&Ankyrin repeat-containing domain					.	.	.		0.000565261	86.0	152142.0	1.0	32	0.96	PASS	amr	0.00189865	29.0	0.00042632	29.0	0.000636521	154.0	241940.0	0.0	32	0.81	PASS	amr	0.00206076	70.0	0.000564756	62.0	0.0005080	79	0.004	13.0				23.4	2.920941	0.152	10	10	20	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	ASPG	0.0	0.0	0.0	0.0	13.0	-19.0	6.0	12.0						0.595	0.0	0.000000000	0.246	0.947	.			.	.	cellular amino acid biosynthetic process;lipid catabolic process	cytosol	1-alkyl-2-acetylglycerophosphocholine esterase activity;asparaginase activity;lysophospholipase activity	GSDMD[unassigned1304];RTP5[unassigned1304];SHC3[unassigned1304];TMEM115[unassigned1304];CEACAM6[unassigned1304];USP2[unassigned1304];TEKT3[unassigned1304];MYOZ3[unassigned1304];DMRT3[unassigned1304];VPS25[unassigned1304];LINC00313[unassigned1304];C20orf85[unassigned1304];	104575640
26342	chr14	105174792	G	A	chr14:105174792	INF2	inverted formin, FH2 and WH2 domain containing	SNV	0/1	0.51	52_55	108	99.0	0/0	0.0	40_0	40	99.0			rs375573206	EXONIC	YES	NM_022489.4	Transcript	protein_coding	synonymous_variant		9/23	NM_022489.4:c.1755G>A	NP_071934.3:p.Ala585%3D		1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	Focal_segmental_glomerulosclerosis_5|Charcot-Marie-Tooth_disease,_dominant_intermediate_E|not_specified|not_provided	Glomerulosclerosis, focal segmental, 5, 613237 (3); Charcot-Marie-Tooth disease, dominant intermediate E, 614455 (3), Autosomal dominant	Autosomal dominant intermediate Charcot-Marie-Tooth disease type E;Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Axonal loss;Distal lower limb amyotrophy;Steppage gait;Hyporeflexia;Distal sensory impairment;Proteinuria;Onion bulb formation;Foot dorsiflexor weakness;Hammertoe;Stage 5 chronic kidney disease;Split hand;Areflexia;Pes cavus;Focal segmental glomerulosclerosis;Autosomal dominant inheritance;Distal upper limb amyotrophy;Distal muscle weakness;Progressive;Autosomal dominant inheritance;Nephrotic syndrome;Focal segmental glomerulosclerosis		0.000203711	31.0	152176.0	0.0	33	0.98	PASS	amr	0.000981418	15.0	0.000191109	13.0	0.000303204	75.0	247358.0	1.0	73	0.99	PASS	amr	0.0016247	56.0	0.000116494	13.0	0.0002122	33	0.002	5.0	0.00202	23.0		0.925	-0.16225		0	0	0			INF2	0.07	0.0	0.0	0.0	12.0	-19.0	-7.0	-5.0						0.0417	1.0	60.327738465			cardiovascular system phenotype ; reproductive system phenotype; embryo phenotype; growth/size/body region phenotype; 			caudate nucleus;ciliary ganglion;olfactory bulb;temporal lobe;trigeminal ganglion;superior cervical ganglion;cingulate cortex;pons;subthalamic nucleus;dorsal root ganglion;atrioventricular node;spinal cord;parietal lobe;globus pallidus;medulla oblongata;	.	actin cytoskeleton organization;regulation of mitochondrial fission	perinuclear region of cytoplasm	actin binding;Rho GTPase binding	IQGAP1[26496610];TOMM20[29568061];ADD1[26496610];TOMM22[29568061];PPP1CB[26496610];LIMA1[26496610];PPP1CC[26496610];MYO18A[26496610];BDKRB2[28298427];FLNA[26496610];MYH11[26496610];SYNPO[26496610];ACTR2[26496610];CSNK2A1[22113938];MYO19[26496610];PPP1CA[25593058];GAK[26496610];ANLN[26496610];MYO1C[26496610];UBE2R2[21900206];MYO5C[26496610];CAPZA2[26496610];CANX[29568061];MYH9[26496610];CRK[26496610];CFAP97[26496610];DBN1[26496610];	105174792
26354	chr14	105268595	G	A	chr14:105268595	ZBTB42	zinc finger and BTB domain containing 42	SNV	0/1	0.45	73_59	132	99.0	0/0	0.0	43_0	43	99.0			rs375499035	EXONIC	YES	NM_001370342.1	Transcript	protein_coding	missense_variant		2/2	NM_001370342.1:c.1061G>A	NP_001357271.1:p.Arg354Gln		1.0	Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type,Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type				?Lethal congenital contracture syndrome 6, 616248 (3), Autosomal recessive	.	.	Congenital contracture;Macrocephaly;Decreased fetal movement;Polyhydramnios;Autosomal recessive inheritance		0.00016423	25.0	152226.0	0.0	32	0.98	PASS	amr	0.000851677	13.0	0.000102872	7.0	0.000313275	48.0	153220.0	1.0	59	0.58	PASS	amr	0.00170247	42.0	3.39386e-05	2.0	0.0000322	5	0.001	3.0				29.7	4.235524	0.514	11	9	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	ZBTB42	0.0	0.0	0.01	0.0	2.0	11.0	11.0	14.0								0.000000000	0.985	1.083	.			.	.	negative regulation of transcription by RNA polymerase II;cellular response to DNA damage stimulus;muscle organ development	nucleus;nucleoplasm;cytoplasm;plasma membrane	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	ZNF330[unassigned1304];TTC23[unassigned1304];CLIC3[unassigned1304];FMR1[unassigned1304];HSF2BP[unassigned1304];CCDC102B[unassigned1304];GOLGA2[unassigned1304];NCK2[unassigned1304];TRIM68[unassigned1304];UBASH3A[unassigned1304];ANKS1A[unassigned1304];MYLIP[unassigned1304];TRAPPC2L[unassigned1304];ATG9A[unassigned1304];MID2[unassigned1304];GEM[unassigned1304];KCTD9[unassigned1304];RAD51D[unassigned1304];CINP[unassigned1304];POLR1C[unassigned1304];CRY2[unassigned1304];MDFI[unassigned1304];CATSPER1[unassigned1304];BLK[unassigned1304];KANK2[unassigned1304];CTBP2[unassigned1304];USHBP1[unassigned1304];CABP5[unassigned1304];NOC4L[unassigned1304];PLA2G6[unassigned1304];KRT40[unassigned1304];OAZ3[unassigned1304];GUCD1[unassigned1304];NDOR1[unassigned1304];MAPK1[unassigned1304];C1orf109[unassigned1304];OTX1[unassigned1304];ZBTB7B[unassigned1304];HSD3B7[unassigned1304];ZBTB16[unassigned1304];OSGIN1[unassigned1304];MAGOHB[unassigned1304];CIDEC[unassigned1304];SNX18[unassigned1304];ASB6[unassigned1304];PIN1[unassigned1304];MKRN3[unassigned1304];CDR2L[unassigned1304];SPG21[unassigned1304];	105268595
26360	chr14	105415752	A	T	chr14:105415752	AHNAK2	AHNAK nucleoprotein 2	SNV	0/0	0.0	95_0	95	99.0	0|1	0.66	26_51	77	99.0			rs200936018	EXONIC	YES	NM_138420.4	Transcript	protein_coding	missense_variant		7/7	NM_138420.4:c.6036T>A	NP_612429.2:p.Asp2012Glu		-1.0						.	.	.		0.00248238	360.0	145022.0	39.0	30	0.79	PASS	amr	0.00434966	62.0	0.00406517	264.0	0.00220562	541.0	245282.0	44.0	100	0.98	PASS	nfe	0.00328652	366.0	0.00328652	366.0	0.0000064,0.0023151	1,360	0.003	9.0				0.02	-0.698981	0.024	1	16	17	MutationTaster_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	AHNAK2	0.0	0.0	0.0	0.0	-2.0	-49.0	-15.0	-27.0						0.908			0.0	-3.026	.			ciliary ganglion;pons;tongue;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;skin;atrioventricular node;skeletal muscle;globus pallidus;	.	plasma membrane repair;regulation of RNA splicing	nucleus;cytoplasm;cytosol;plasma membrane;Z disc;T-tubule;cytoplasmic vesicle membrane;sarcolemma;costamere	protein binding	CYB5B[unassigned1304];TOMM70[30021884];GABARAPL2[25416956];GABARAPL1[25416956;unassigned1304];UBIAD1[unassigned1304];CYBC1[unassigned1304];RPL3[30021884];IGFBP5[unassigned1304];TTMP[unassigned1304];HUWE1[26496610];PRAP1[unassigned1304];ASGR1[unassigned1304];TSPO2[unassigned1304];ACTR1A[30021884];MYC[21150319];FAM3C[unassigned1304];ZFPL1[unassigned1304];PPGB[unassigned1304];VAMP3[unassigned1304];	105415752
26370	chr14	105622160	G	A	chr14:105622160	JAG2	jagged 2	SNV	0/0	0.0	45_0	45	99.0	0/1	0.57	52_68	120	99.0			rs142729116	EXONIC	YES	NM_002226.5	Transcript	protein_coding	synonymous_variant		4/26	NM_002226.5:c.642C>T	NP_002217.3:p.Arg214%3D		-1.0					Muscular dystrophy, limb-girdle, autosomal recessive 27, 619566 (3), Autosomal recessive	.	.	.		0.00128075	195.0	152254.0	0.0	34	0.99	PASS	nfe	0.00205749	140.0	0.00205749	140.0	0.00101668	253.0	248850.0	0.0	100	0.92	PASS	nfe	0.00172248	193.0	0.00172248	193.0	0.0010482	163	0.002	6.0	0.00254	29.0		14.67	1.20405		0	0	0			JAG2	0.0	0.0	0.0	0.0	-34.0	30.0	2.0	-32.0						0.00958	0.99	76.774479802			hematopoietic system phenotype; mortality/aging ; reproductive system phenotype; respiratory system phenotype; embryo phenotype; skeleton phenotype; immune system phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype ; hearing/vestibular/ear phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype ; homeostasis/metabolism phenotype; craniofacial phenotype; 			pons;amygdala;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;parietal lobe;globus pallidus;medulla oblongata;	Notch signaling pathway	skeletal system development;in utero embryonic development;respiratory system process;Notch signaling pathway;spermatogenesis;auditory receptor cell fate commitment;regulation of signaling receptor activity;morphogenesis of embryonic epithelium;cell differentiation;regulation of cell adhesion;T cell differentiation;regulation of cell population proliferation;odontogenesis of dentin-containing tooth;gamma-delta T cell differentiation;thymic T cell selection;positive regulation of Notch signaling pathway;epithelial cell apoptotic process involved in palatal shelf morphogenesis	plasma membrane;integral component of plasma membrane	Notch binding;calcium ion binding;protein binding;growth factor activity	GFI1B[16713569];TMEM17[26638075];ATXN7[21078624];TMEM216[26638075];ATN1[16713569];CACNA1A[21078624];	105622160
26392	chr14	105715329	GCC		chr14:105715329-105715331	BTBD6	BTB domain containing 6	deletion	0/1	0.12	14_2	16	42.0	0|0	0.0	20_0	22	60.0				EXONIC	YES	NM_001387567.1	Transcript	protein_coding	inframe_deletion		1/4	NM_001387567.1:c.291_293del	NP_001374496.1:p.Pro98del		1.0						.	.	.		0.0	0.0	145368.0	0.0	33	0.91	AC0				0.0	0.0					0	0.0																	0	0	0			BTBD6	0.0	0.0	0.0	0.0	-36.0	1.0	-49.0	1.0						0.584	0.0				.			testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;trigeminal ganglion;testis;skeletal muscle;globus pallidus;cerebellum;	.	neurogenesis;post-translational protein modification	cytosol	.	DAXX[21988832;21573799];NME7[unassigned1304];CUL3[unassigned1304];BTBD3[unassigned1304];TCEA2[unassigned1304];NFKBIB[unassigned1304];	105715328
26403	chr15	22368862	G	A	chr15:22368862	OR4M2	olfactory receptor family 4 subfamily M member 2	SNV	1/1	0.98	0_126	128	99.0	1/1	1.0	0_135	135	99.0			rs1835183,COSV60307128	EXONIC	YES	NM_001004719.2	Transcript	protein_coding	missense_variant		1/1	NM_001004719.2:c.287G>A	NP_001004719.2:p.Gly96Glu		1.0	GPCR, rhodopsin-like, 7TM					.	.	.						0	0.0							0.634013	155768.0	245686.0	36934.0	100	1.0	InbreedingCoeff	amr	0.691306	23568.0	0.643616	72076.0	0.0445069	6921	0.229	706.0				22.9	2.695646	0.564	5	12	17	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MutationAssessor_pred	Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4M2	0.0	0.0	0.0	0.0	14.0	-36.0	-2.0	-36.0						0.789			0.033	1.037	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	22368862
26406	chr15	22368905	G	A	chr15:22368905	OR4M2	olfactory receptor family 4 subfamily M member 2	SNV	1/1	1.0	0_139	139	99.0	1/1	1.0	0_152	152	99.0			rs1835182,COSV60306467	EXONIC	YES	NM_001004719.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001004719.2:c.330G>A	NP_001004719.2:p.Ser110%3D		1.0						.	.	.		0.0	0.0	572.0	0.0	0	0.0	AC0_AS_VQSR				0.0	0.0	0.616199	150981.0	245020.0	33732.0	100	1.0	InbreedingCoeff	amr	0.670525	22822.0	0.632213	70794.0	0.0428028	6656	0.24	755.0				6.295	0.231452		0	0	0			OR4M2	0.01	0.0	0.0	0.0	20.0	-29.0	5.0	-5.0						0.789					.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	22368905
26433	chr15	23685226		G	chr15:23685225-23685226	GOLGA6L2	golgin A6 family-like 2	insertion	0/0	0.0	34_0	34	87.0	0/1	0.19	22_5	27	99.0			rs765480707	EXONIC	YES	NM_001304388.2	Transcript	protein_coding	frameshift_variant		8/8	NM_001304388.2:c.2396dup	NP_001291317.1:p.Gly800ArgfsTer113		-1.0						.	.	.		0.00678512	333.0	49078.0	8.0	4	0.19	AS_VQSR	sas	0.00801282	10.0	0.00736658	143.0	0.0702978	5080.0	72264.0	102.0	44	0.57	RF	eas	0.166811	769.0	0.0694495	1920.0	0.0021607	336						22.7	2.5767		0	0	0			GOLGA6L2	0.0	0.0	0.0	0.0	25.0	-2.0	38.0	9.0							0.0				.			.	.	.	.	.	KRT33B[unassigned1304];NUMA1[30021884];GORASP2[unassigned1304];HSPA4[30021884];NEK6[unassigned1304];KRT31[unassigned1304];SDHA[30021884];SPERT[25416956];KRT40[25416956];CDR2[27173435;unassigned1312];MAGEB4[unassigned1304];HIST2H2BE[30021884];	23685225
26508	chr15	27572153	C	T	chr15:27572153	GABRG3	gamma-aminobutyric acid type A receptor gamma3 subunit	SNV	0/1	0.37	48_28	76	99.0	0/1	0.58	27_38	65	99.0			rs376676320,COSV61520220	EXONIC	YES	NM_033223.5	Transcript	protein_coding	synonymous_variant		4/10	NM_033223.5:c.468C>T	NP_150092.2:p.Asp156%3D		1.0						.	.	.		0.000236602	36.0	152154.0	0.0	33	0.97	PASS	amr	0.00111329	17.0	0.000102896	7.0	0.000378327	94.0	248462.0	1.0	59	0.97	PASS	amr	0.00147998	51.0	0.000222317	25.0	0.0002894	45	0.002	7.0	0.00109	2.0		5.715	0.191602		0	0	0			GABRG3	0.0	0.0	0.0	0.0	-2.0	-49.0	-2.0	23.0						0.196	0.99	0.000000000			.			.	Neuroactive ligand-receptor interaction	signal transduction;gamma-aminobutyric acid signaling pathway;chemical synaptic transmission;ion transmembrane transport;regulation of membrane potential;response to drug;nervous system process;synaptic transmission, GABAergic;regulation of postsynaptic membrane potential;chloride transmembrane transport	plasma membrane;integral component of plasma membrane;cell junction;dendrite membrane;chloride channel complex;neuron projection;synapse;postsynaptic membrane;postsynapse;GABA-ergic synapse;integral component of synaptic membrane;GABA-A receptor complex	GABA-A receptor activity;extracellular ligand-gated ion channel activity;inhibitory extracellular ligand-gated ion channel activity;chloride channel activity;benzodiazepine receptor activity;GABA-gated chloride ion channel activity;transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential	.	27572153
26525	chr15	28517436	T	C	chr15:28517436	HERC2	HECT and RLD domain containing E3 ubiquitin protein ligase 2	SNV	0/1	0.4	130_98	243	99.0	0/1	0.45	116_103	230	99.0			rs75181529,COSV55308410	EXONIC	YES	NM_004667.6	Transcript	protein_coding	synonymous_variant		9/93	NM_004667.6:c.1008A>G	NP_004658.3:p.Pro336%3D		-1.0					Intellectual developmental disorder, autosomal recessive 38, 615516 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3), Autosomal recessive	Developmental delay with autism spectrum disorder and gait instability	Disease-causing germline mutation(s) (loss of function) in	Autosomal dominant inheritance;Autism;Short stature;Hypermetropia;Delayed speech and language development;Scrotal hypoplasia;Almond-shaped palpebral fissure;Decreased fetal movement;Poor fine motor coordination;Poor gross motor coordination;Syndactyly;Frontal upsweep of hair;Short palm;Delayed puberty;Seizure;Impaired pain sensation;Osteoporosis;Dolichocephaly;Hyperinsulinemia;Decreased muscle mass;Oligomenorrhea;Iris hypopigmentation;Small hand;Hypopigmentation of hair;Micropenis;Clitoral hypoplasia;Cryptorchidism;Thin upper lip vermilion;Primary amenorrhea;Infertility;Type II diabetes mellitus;Hypoplastic labia minora;Hypoventilation;Clinodactyly;Narrow nasal bridge;Short foot;Failure to thrive in infancy;Narrow forehead;Poor suck;Thin upper lip vermilion;Recurrent respiratory infections;Myopia;Global developmental delay;Upslanted palpebral fissure;Kyphosis;Psychosis;Motor delay;Radial deviation of finger;Attention deficit hyperactivity disorder;Narrow palm;Temperature instability;Esotropia;Growth hormone deficiency;Genu valgum;Specific learning disability;Downturned corners of mouth;Neonatal hypotonia;Generalized hypotonia;Sleep apnea;Hypogonadotropic hypogonadism;Cutaneous photosensitivity;Carious teeth;Scoliosis;Hip dysplasia;Polyphagia;Nasal speech;Osteopenia;Generalized hypopigmentation;Adrenal insufficiency;Sporadic;Abdominal obesity;Acromicria;Ventriculomegaly;Precocious puberty;Delayed ability to walk;Aggressive behavior;Sandal gap;Hyperactivity;Self-mutilation;Neonatal hypotonia;Echolalia;Autistic behavior;Infantile onset;Diminished ability to concentrate;Global developmental delay;Unsteady gait;Recurrent hand flapping;Febrile seizure (within the age range of 3 months to 6 years);Mandibular prognathia;Delayed speech and language development;Generalized hypotonia;Seizure;Autosomal recessive inheritance;Intellectual disability;Strabismus;Blue irides;Narrow palate;Plagiocephaly						33	0.97							0.49154	117834.0	239724.0	0.0	53	0.99	InbreedingCoeff	eas	0.499278	8985.0	0.489322	53068.0	0.0207840	3232	0.16	505.0	0.47614	878.0		0.7	-0.203807		0	0	0			HERC2	0.01	0.0	0.0	0.0	14.0	-21.0	14.0	-20.0						0.307	1.0				mortality/aging ; reproductive system phenotype; behavior/neurological phenotype ; growth/size/body region phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			pons;caudate nucleus;amygdala;prefrontal cortex;whole brain;superior cervical ganglion;trigeminal ganglion;cingulate cortex;medulla oblongata;thalamus;	Ubiquitin mediated proteolysis	double-strand break repair via nonhomologous end joining;intracellular protein transport;cellular response to DNA damage stimulus;spermatogenesis;protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process	nucleus;nucleoplasm;cytoplasm;centriole;membrane	ubiquitin-protein transferase activity;guanyl-nucleotide exchange factor activity;protein binding;zinc ion binding;ubiquitin protein ligase binding;SUMO binding	WDR48[29426014];ECI2[29426014];UBE3A[29426014];SMC3[26496610];MKI67[29426014];MAP1LC3B[20562859];PCM1[26638075;29426014];TUBB6[29426014];NUDCD2[29426014];CHCHD3[29426014];EME1[29426014];TUBB3[29426014];FTH1[29426014];BDKRB2[28298427];CEP170[29426014];GTSE1[26496610];CEP290[26638075];KRT6C[29426014];KRT6B[29426014];DBNL[17353931];USP42[19615732];MIOS[29426014];NCOA4[29426014];KRT77[29426014];OCRL[29426014];PHKA1[29426014];PHKA2[29426014];SIRT3[19343720];SELENOO[29426014];CHMP4B[26496610];KIF20A[26496610];KIFC3[26496610];PFDN4[29426014];TP53[22653443];FTL[29426014];CEP104[26638075];COPB2[29426014];COPA[29426014];USP16[19615732];SET[29426014];SEH1L[29426014];C5AR2[28298427];XPA[20304803];RNF8[26503038];DPT[29426014];WDR20[29426014];ZBTB5[29426014];WDR24[29426014];USP19[19615732];CAMSAP1[29426014];CDC42[20936779];PHKG2[29426014];LMNA[29426014];CTNNA1[29426014];CCDC180[29426014];FLNA[29426014];RPL13[30021884];DISC1[17043677];MAPK6[23602568;26972000;29426014];MARK2[26496610];GCN1[29426014];MPDU1[17353931];ZRANB1[19615732];WDR59[29426014];USP20[19615732;29426014];NEK4[25798074];PHKB[29426014];LRPPRC[29426014];CDK8[23602568];NEURL4[29426014];EIF3M[29426014];KRT17[29426014];EIF3K[29426014];EIF3L[29426014];PSMC1[26496610];EIF3I[29426014];GNAS[29426014];EIF3G[29426014];CEP162[26638075];EIF3H[29426014];EIF3E[29426014];EIF3F[29426014];EIF3C[29426014];EIF3D[29426014];EIF3A[29426014];EIF4G1[29426014];EIF3B[29426014];	28517436
26526	chr15	28517539	G	A	chr15:28517539	HERC2	HECT and RLD domain containing E3 ubiquitin protein ligase 2	SNV	0|1	0.25	76_28	110	99.0	0|1	0.27	73_29	107	99.0			rs80340439,COSV55308431	SPLICING	YES	NM_004667.6	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	8/92		NM_004667.6:c.912-7C>T			-1.0					Intellectual developmental disorder, autosomal recessive 38, 615516 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3), Autosomal recessive	Developmental delay with autism spectrum disorder and gait instability	Disease-causing germline mutation(s) (loss of function) in	Autosomal dominant inheritance;Autism;Short stature;Hypermetropia;Delayed speech and language development;Scrotal hypoplasia;Almond-shaped palpebral fissure;Decreased fetal movement;Poor fine motor coordination;Poor gross motor coordination;Syndactyly;Frontal upsweep of hair;Short palm;Delayed puberty;Seizure;Impaired pain sensation;Osteoporosis;Dolichocephaly;Hyperinsulinemia;Decreased muscle mass;Oligomenorrhea;Iris hypopigmentation;Small hand;Hypopigmentation of hair;Micropenis;Clitoral hypoplasia;Cryptorchidism;Thin upper lip vermilion;Primary amenorrhea;Infertility;Type II diabetes mellitus;Hypoplastic labia minora;Hypoventilation;Clinodactyly;Narrow nasal bridge;Short foot;Failure to thrive in infancy;Narrow forehead;Poor suck;Thin upper lip vermilion;Recurrent respiratory infections;Myopia;Global developmental delay;Upslanted palpebral fissure;Kyphosis;Psychosis;Motor delay;Radial deviation of finger;Attention deficit hyperactivity disorder;Narrow palm;Temperature instability;Esotropia;Growth hormone deficiency;Genu valgum;Specific learning disability;Downturned corners of mouth;Neonatal hypotonia;Generalized hypotonia;Sleep apnea;Hypogonadotropic hypogonadism;Cutaneous photosensitivity;Carious teeth;Scoliosis;Hip dysplasia;Polyphagia;Nasal speech;Osteopenia;Generalized hypopigmentation;Adrenal insufficiency;Sporadic;Abdominal obesity;Acromicria;Ventriculomegaly;Precocious puberty;Delayed ability to walk;Aggressive behavior;Sandal gap;Hyperactivity;Self-mutilation;Neonatal hypotonia;Echolalia;Autistic behavior;Infantile onset;Diminished ability to concentrate;Global developmental delay;Unsteady gait;Recurrent hand flapping;Febrile seizure (within the age range of 3 months to 6 years);Mandibular prognathia;Delayed speech and language development;Generalized hypotonia;Seizure;Autosomal recessive inheritance;Intellectual disability;Strabismus;Blue irides;Narrow palate;Plagiocephaly		6.57039e-06	1.0	152198.0	0.0	33	0.97	PASS	nfe	1.46985e-05	1.0	1.46985e-05	1.0	0.46538	75642.0	162538.0	0.0	34	0.87	InbreedingCoeff	afr	0.476195	4841.0	0.462888	34599.0	0.0030160	469	0.043	131.0	0.27169	501.0		9.197	0.478404		0	0	0			HERC2	0.0	0.02	0.0	0.0	11.0	-41.0	-41.0	-7.0	1.816944460928e-05	0.042	6.168	0.291	6.458	0.307	1.0				mortality/aging ; reproductive system phenotype; behavior/neurological phenotype ; growth/size/body region phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			pons;caudate nucleus;amygdala;prefrontal cortex;whole brain;superior cervical ganglion;trigeminal ganglion;cingulate cortex;medulla oblongata;thalamus;	Ubiquitin mediated proteolysis	double-strand break repair via nonhomologous end joining;intracellular protein transport;cellular response to DNA damage stimulus;spermatogenesis;protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process	nucleus;nucleoplasm;cytoplasm;centriole;membrane	ubiquitin-protein transferase activity;guanyl-nucleotide exchange factor activity;protein binding;zinc ion binding;ubiquitin protein ligase binding;SUMO binding	WDR48[29426014];ECI2[29426014];UBE3A[29426014];SMC3[26496610];MKI67[29426014];MAP1LC3B[20562859];PCM1[26638075;29426014];TUBB6[29426014];NUDCD2[29426014];CHCHD3[29426014];EME1[29426014];TUBB3[29426014];FTH1[29426014];BDKRB2[28298427];CEP170[29426014];GTSE1[26496610];CEP290[26638075];KRT6C[29426014];KRT6B[29426014];DBNL[17353931];USP42[19615732];MIOS[29426014];NCOA4[29426014];KRT77[29426014];OCRL[29426014];PHKA1[29426014];PHKA2[29426014];SIRT3[19343720];SELENOO[29426014];CHMP4B[26496610];KIF20A[26496610];KIFC3[26496610];PFDN4[29426014];TP53[22653443];FTL[29426014];CEP104[26638075];COPB2[29426014];COPA[29426014];USP16[19615732];SET[29426014];SEH1L[29426014];C5AR2[28298427];XPA[20304803];RNF8[26503038];DPT[29426014];WDR20[29426014];ZBTB5[29426014];WDR24[29426014];USP19[19615732];CAMSAP1[29426014];CDC42[20936779];PHKG2[29426014];LMNA[29426014];CTNNA1[29426014];CCDC180[29426014];FLNA[29426014];RPL13[30021884];DISC1[17043677];MAPK6[23602568;26972000;29426014];MARK2[26496610];GCN1[29426014];MPDU1[17353931];ZRANB1[19615732];WDR59[29426014];USP20[19615732;29426014];NEK4[25798074];PHKB[29426014];LRPPRC[29426014];CDK8[23602568];NEURL4[29426014];EIF3M[29426014];KRT17[29426014];EIF3K[29426014];EIF3L[29426014];PSMC1[26496610];EIF3I[29426014];GNAS[29426014];EIF3G[29426014];CEP162[26638075];EIF3H[29426014];EIF3E[29426014];EIF3F[29426014];EIF3C[29426014];EIF3D[29426014];EIF3A[29426014];EIF4G1[29426014];EIF3B[29426014];	28517539
26529	chr15	28518126	G	A	chr15:28518126	HERC2	HECT and RLD domain containing E3 ubiquitin protein ligase 2	SNV	0|0	0.06	115_7	122	52.0	0|1	0.12	83_12	96	99.0			rs748386216,COSV55307262	EXONIC	YES	NM_004667.6	Transcript	protein_coding	synonymous_variant		8/93	NM_004667.6:c.825C>T	NP_004658.3:p.Thr275%3D		-1.0					Intellectual developmental disorder, autosomal recessive 38, 615516 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3), Autosomal recessive	Developmental delay with autism spectrum disorder and gait instability	Disease-causing germline mutation(s) (loss of function) in	Autosomal dominant inheritance;Autism;Short stature;Hypermetropia;Delayed speech and language development;Scrotal hypoplasia;Almond-shaped palpebral fissure;Decreased fetal movement;Poor fine motor coordination;Poor gross motor coordination;Syndactyly;Frontal upsweep of hair;Short palm;Delayed puberty;Seizure;Impaired pain sensation;Osteoporosis;Dolichocephaly;Hyperinsulinemia;Decreased muscle mass;Oligomenorrhea;Iris hypopigmentation;Small hand;Hypopigmentation of hair;Micropenis;Clitoral hypoplasia;Cryptorchidism;Thin upper lip vermilion;Primary amenorrhea;Infertility;Type II diabetes mellitus;Hypoplastic labia minora;Hypoventilation;Clinodactyly;Narrow nasal bridge;Short foot;Failure to thrive in infancy;Narrow forehead;Poor suck;Thin upper lip vermilion;Recurrent respiratory infections;Myopia;Global developmental delay;Upslanted palpebral fissure;Kyphosis;Psychosis;Motor delay;Radial deviation of finger;Attention deficit hyperactivity disorder;Narrow palm;Temperature instability;Esotropia;Growth hormone deficiency;Genu valgum;Specific learning disability;Downturned corners of mouth;Neonatal hypotonia;Generalized hypotonia;Sleep apnea;Hypogonadotropic hypogonadism;Cutaneous photosensitivity;Carious teeth;Scoliosis;Hip dysplasia;Polyphagia;Nasal speech;Osteopenia;Generalized hypopigmentation;Adrenal insufficiency;Sporadic;Abdominal obesity;Acromicria;Ventriculomegaly;Precocious puberty;Delayed ability to walk;Aggressive behavior;Sandal gap;Hyperactivity;Self-mutilation;Neonatal hypotonia;Echolalia;Autistic behavior;Infantile onset;Diminished ability to concentrate;Global developmental delay;Unsteady gait;Recurrent hand flapping;Febrile seizure (within the age range of 3 months to 6 years);Mandibular prognathia;Delayed speech and language development;Generalized hypotonia;Seizure;Autosomal recessive inheritance;Intellectual disability;Strabismus;Blue irides;Narrow palate;Plagiocephaly						33	0.98							0.00117525	247.0	210168.0	0.0	52	0.99	PASS	amr	0.00352406	93.0	0.000654165	63.0	0.0009517	148	0.0	0.0	0.00706	13.0		11.43	0.734782		0	0	0			HERC2	0.0	0.0	0.0	0.0	-28.0	24.0	-5.0	20.0						0.307	1.0				mortality/aging ; reproductive system phenotype; behavior/neurological phenotype ; growth/size/body region phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			pons;caudate nucleus;amygdala;prefrontal cortex;whole brain;superior cervical ganglion;trigeminal ganglion;cingulate cortex;medulla oblongata;thalamus;	Ubiquitin mediated proteolysis	double-strand break repair via nonhomologous end joining;intracellular protein transport;cellular response to DNA damage stimulus;spermatogenesis;protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process	nucleus;nucleoplasm;cytoplasm;centriole;membrane	ubiquitin-protein transferase activity;guanyl-nucleotide exchange factor activity;protein binding;zinc ion binding;ubiquitin protein ligase binding;SUMO binding	WDR48[29426014];ECI2[29426014];UBE3A[29426014];SMC3[26496610];MKI67[29426014];MAP1LC3B[20562859];PCM1[26638075;29426014];TUBB6[29426014];NUDCD2[29426014];CHCHD3[29426014];EME1[29426014];TUBB3[29426014];FTH1[29426014];BDKRB2[28298427];CEP170[29426014];GTSE1[26496610];CEP290[26638075];KRT6C[29426014];KRT6B[29426014];DBNL[17353931];USP42[19615732];MIOS[29426014];NCOA4[29426014];KRT77[29426014];OCRL[29426014];PHKA1[29426014];PHKA2[29426014];SIRT3[19343720];SELENOO[29426014];CHMP4B[26496610];KIF20A[26496610];KIFC3[26496610];PFDN4[29426014];TP53[22653443];FTL[29426014];CEP104[26638075];COPB2[29426014];COPA[29426014];USP16[19615732];SET[29426014];SEH1L[29426014];C5AR2[28298427];XPA[20304803];RNF8[26503038];DPT[29426014];WDR20[29426014];ZBTB5[29426014];WDR24[29426014];USP19[19615732];CAMSAP1[29426014];CDC42[20936779];PHKG2[29426014];LMNA[29426014];CTNNA1[29426014];CCDC180[29426014];FLNA[29426014];RPL13[30021884];DISC1[17043677];MAPK6[23602568;26972000;29426014];MARK2[26496610];GCN1[29426014];MPDU1[17353931];ZRANB1[19615732];WDR59[29426014];USP20[19615732;29426014];NEK4[25798074];PHKB[29426014];LRPPRC[29426014];CDK8[23602568];NEURL4[29426014];EIF3M[29426014];KRT17[29426014];EIF3K[29426014];EIF3L[29426014];PSMC1[26496610];EIF3I[29426014];GNAS[29426014];EIF3G[29426014];CEP162[26638075];EIF3H[29426014];EIF3E[29426014];EIF3F[29426014];EIF3C[29426014];EIF3D[29426014];EIF3A[29426014];EIF4G1[29426014];EIF3B[29426014];	28518126
26530	chr15	28518135	C	T	chr15:28518135	HERC2	HECT and RLD domain containing E3 ubiquitin protein ligase 2	SNV	0|0	0.06	110_7	117	37.0	0|1	0.12	83_11	95	99.0			rs766763181,COSV55307305	EXONIC	YES	NM_004667.6	Transcript	protein_coding	synonymous_variant		8/93	NM_004667.6:c.816G>A	NP_004658.3:p.Thr272%3D		-1.0					Intellectual developmental disorder, autosomal recessive 38, 615516 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3), Autosomal recessive	Developmental delay with autism spectrum disorder and gait instability	Disease-causing germline mutation(s) (loss of function) in	Autosomal dominant inheritance;Autism;Short stature;Hypermetropia;Delayed speech and language development;Scrotal hypoplasia;Almond-shaped palpebral fissure;Decreased fetal movement;Poor fine motor coordination;Poor gross motor coordination;Syndactyly;Frontal upsweep of hair;Short palm;Delayed puberty;Seizure;Impaired pain sensation;Osteoporosis;Dolichocephaly;Hyperinsulinemia;Decreased muscle mass;Oligomenorrhea;Iris hypopigmentation;Small hand;Hypopigmentation of hair;Micropenis;Clitoral hypoplasia;Cryptorchidism;Thin upper lip vermilion;Primary amenorrhea;Infertility;Type II diabetes mellitus;Hypoplastic labia minora;Hypoventilation;Clinodactyly;Narrow nasal bridge;Short foot;Failure to thrive in infancy;Narrow forehead;Poor suck;Thin upper lip vermilion;Recurrent respiratory infections;Myopia;Global developmental delay;Upslanted palpebral fissure;Kyphosis;Psychosis;Motor delay;Radial deviation of finger;Attention deficit hyperactivity disorder;Narrow palm;Temperature instability;Esotropia;Growth hormone deficiency;Genu valgum;Specific learning disability;Downturned corners of mouth;Neonatal hypotonia;Generalized hypotonia;Sleep apnea;Hypogonadotropic hypogonadism;Cutaneous photosensitivity;Carious teeth;Scoliosis;Hip dysplasia;Polyphagia;Nasal speech;Osteopenia;Generalized hypopigmentation;Adrenal insufficiency;Sporadic;Abdominal obesity;Acromicria;Ventriculomegaly;Precocious puberty;Delayed ability to walk;Aggressive behavior;Sandal gap;Hyperactivity;Self-mutilation;Neonatal hypotonia;Echolalia;Autistic behavior;Infantile onset;Diminished ability to concentrate;Global developmental delay;Unsteady gait;Recurrent hand flapping;Febrile seizure (within the age range of 3 months to 6 years);Mandibular prognathia;Delayed speech and language development;Generalized hypotonia;Seizure;Autosomal recessive inheritance;Intellectual disability;Strabismus;Blue irides;Narrow palate;Plagiocephaly		2.62819e-05	4.0	152196.0	0.0	33	0.98	PASS	afr	4.82393e-05	2.0	2.93962e-05	2.0	0.000332283	73.0	219692.0	0.0	48	0.99	RF	afr	0.000508351	7.0	0.000272419	27.0	0.0008617	134	0.001	2.0	0.00923	17.0		1.032	-0.146045		0	0	0			HERC2	0.0	0.0	0.0	0.0	-5.0	15.0	15.0	5.0						0.307	1.0				mortality/aging ; reproductive system phenotype; behavior/neurological phenotype ; growth/size/body region phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			pons;caudate nucleus;amygdala;prefrontal cortex;whole brain;superior cervical ganglion;trigeminal ganglion;cingulate cortex;medulla oblongata;thalamus;	Ubiquitin mediated proteolysis	double-strand break repair via nonhomologous end joining;intracellular protein transport;cellular response to DNA damage stimulus;spermatogenesis;protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process	nucleus;nucleoplasm;cytoplasm;centriole;membrane	ubiquitin-protein transferase activity;guanyl-nucleotide exchange factor activity;protein binding;zinc ion binding;ubiquitin protein ligase binding;SUMO binding	WDR48[29426014];ECI2[29426014];UBE3A[29426014];SMC3[26496610];MKI67[29426014];MAP1LC3B[20562859];PCM1[26638075;29426014];TUBB6[29426014];NUDCD2[29426014];CHCHD3[29426014];EME1[29426014];TUBB3[29426014];FTH1[29426014];BDKRB2[28298427];CEP170[29426014];GTSE1[26496610];CEP290[26638075];KRT6C[29426014];KRT6B[29426014];DBNL[17353931];USP42[19615732];MIOS[29426014];NCOA4[29426014];KRT77[29426014];OCRL[29426014];PHKA1[29426014];PHKA2[29426014];SIRT3[19343720];SELENOO[29426014];CHMP4B[26496610];KIF20A[26496610];KIFC3[26496610];PFDN4[29426014];TP53[22653443];FTL[29426014];CEP104[26638075];COPB2[29426014];COPA[29426014];USP16[19615732];SET[29426014];SEH1L[29426014];C5AR2[28298427];XPA[20304803];RNF8[26503038];DPT[29426014];WDR20[29426014];ZBTB5[29426014];WDR24[29426014];USP19[19615732];CAMSAP1[29426014];CDC42[20936779];PHKG2[29426014];LMNA[29426014];CTNNA1[29426014];CCDC180[29426014];FLNA[29426014];RPL13[30021884];DISC1[17043677];MAPK6[23602568;26972000;29426014];MARK2[26496610];GCN1[29426014];MPDU1[17353931];ZRANB1[19615732];WDR59[29426014];USP20[19615732;29426014];NEK4[25798074];PHKB[29426014];LRPPRC[29426014];CDK8[23602568];NEURL4[29426014];EIF3M[29426014];KRT17[29426014];EIF3K[29426014];EIF3L[29426014];PSMC1[26496610];EIF3I[29426014];GNAS[29426014];EIF3G[29426014];CEP162[26638075];EIF3H[29426014];EIF3E[29426014];EIF3F[29426014];EIF3C[29426014];EIF3D[29426014];EIF3A[29426014];EIF4G1[29426014];EIF3B[29426014];	28518135
26531	chr15	28518136	G	A	chr15:28518136	HERC2	HECT and RLD domain containing E3 ubiquitin protein ligase 2	SNV	0|0	0.05	106_6	112	67.0	0|1	0.12	81_11	93	99.0			rs201979656,COSV55307326	EXONIC	YES	NM_004667.6	Transcript	protein_coding	missense_variant		8/93	NM_004667.6:c.815C>T	NP_004658.3:p.Thr272Met		-1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	not_specified|not_provided	Intellectual developmental disorder, autosomal recessive 38, 615516 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blond/brown hair], 227220 (3), Autosomal recessive; [Skin/hair/eye pigmentation 1, blue/nonblue eyes], 227220 (3), Autosomal recessive	Developmental delay with autism spectrum disorder and gait instability	Disease-causing germline mutation(s) (loss of function) in	Autosomal dominant inheritance;Autism;Short stature;Hypermetropia;Delayed speech and language development;Scrotal hypoplasia;Almond-shaped palpebral fissure;Decreased fetal movement;Poor fine motor coordination;Poor gross motor coordination;Syndactyly;Frontal upsweep of hair;Short palm;Delayed puberty;Seizure;Impaired pain sensation;Osteoporosis;Dolichocephaly;Hyperinsulinemia;Decreased muscle mass;Oligomenorrhea;Iris hypopigmentation;Small hand;Hypopigmentation of hair;Micropenis;Clitoral hypoplasia;Cryptorchidism;Thin upper lip vermilion;Primary amenorrhea;Infertility;Type II diabetes mellitus;Hypoplastic labia minora;Hypoventilation;Clinodactyly;Narrow nasal bridge;Short foot;Failure to thrive in infancy;Narrow forehead;Poor suck;Thin upper lip vermilion;Recurrent respiratory infections;Myopia;Global developmental delay;Upslanted palpebral fissure;Kyphosis;Psychosis;Motor delay;Radial deviation of finger;Attention deficit hyperactivity disorder;Narrow palm;Temperature instability;Esotropia;Growth hormone deficiency;Genu valgum;Specific learning disability;Downturned corners of mouth;Neonatal hypotonia;Generalized hypotonia;Sleep apnea;Hypogonadotropic hypogonadism;Cutaneous photosensitivity;Carious teeth;Scoliosis;Hip dysplasia;Polyphagia;Nasal speech;Osteopenia;Generalized hypopigmentation;Adrenal insufficiency;Sporadic;Abdominal obesity;Acromicria;Ventriculomegaly;Precocious puberty;Delayed ability to walk;Aggressive behavior;Sandal gap;Hyperactivity;Self-mutilation;Neonatal hypotonia;Echolalia;Autistic behavior;Infantile onset;Diminished ability to concentrate;Global developmental delay;Unsteady gait;Recurrent hand flapping;Febrile seizure (within the age range of 3 months to 6 years);Mandibular prognathia;Delayed speech and language development;Generalized hypotonia;Seizure;Autosomal recessive inheritance;Intellectual disability;Strabismus;Blue irides;Narrow palate;Plagiocephaly		0.000118267	18.0	152198.0	0.0	33	0.98	PASS	amr	0.000981033	15.0	0.0	0.0	0.00112234	245.0	218294.0	0.0	48	0.99	RF	amr	0.00549753	160.0	0.000305219	30.0	0.0527125	8197	0.001	2.0	0.00869	16.0		12.51	0.872212	0.061	1	17	18	fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	HERC2	0.0	0.0	0.0	0.0	-6.0	50.0	2.0	4.0						0.307	1.0		0.001	0.217	mortality/aging ; reproductive system phenotype; behavior/neurological phenotype ; growth/size/body region phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			pons;caudate nucleus;amygdala;prefrontal cortex;whole brain;superior cervical ganglion;trigeminal ganglion;cingulate cortex;medulla oblongata;thalamus;	Ubiquitin mediated proteolysis	double-strand break repair via nonhomologous end joining;intracellular protein transport;cellular response to DNA damage stimulus;spermatogenesis;protein ubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process	nucleus;nucleoplasm;cytoplasm;centriole;membrane	ubiquitin-protein transferase activity;guanyl-nucleotide exchange factor activity;protein binding;zinc ion binding;ubiquitin protein ligase binding;SUMO binding	WDR48[29426014];ECI2[29426014];UBE3A[29426014];SMC3[26496610];MKI67[29426014];MAP1LC3B[20562859];PCM1[26638075;29426014];TUBB6[29426014];NUDCD2[29426014];CHCHD3[29426014];EME1[29426014];TUBB3[29426014];FTH1[29426014];BDKRB2[28298427];CEP170[29426014];GTSE1[26496610];CEP290[26638075];KRT6C[29426014];KRT6B[29426014];DBNL[17353931];USP42[19615732];MIOS[29426014];NCOA4[29426014];KRT77[29426014];OCRL[29426014];PHKA1[29426014];PHKA2[29426014];SIRT3[19343720];SELENOO[29426014];CHMP4B[26496610];KIF20A[26496610];KIFC3[26496610];PFDN4[29426014];TP53[22653443];FTL[29426014];CEP104[26638075];COPB2[29426014];COPA[29426014];USP16[19615732];SET[29426014];SEH1L[29426014];C5AR2[28298427];XPA[20304803];RNF8[26503038];DPT[29426014];WDR20[29426014];ZBTB5[29426014];WDR24[29426014];USP19[19615732];CAMSAP1[29426014];CDC42[20936779];PHKG2[29426014];LMNA[29426014];CTNNA1[29426014];CCDC180[29426014];FLNA[29426014];RPL13[30021884];DISC1[17043677];MAPK6[23602568;26972000;29426014];MARK2[26496610];GCN1[29426014];MPDU1[17353931];ZRANB1[19615732];WDR59[29426014];USP20[19615732;29426014];NEK4[25798074];PHKB[29426014];LRPPRC[29426014];CDK8[23602568];NEURL4[29426014];EIF3M[29426014];KRT17[29426014];EIF3K[29426014];EIF3L[29426014];PSMC1[26496610];EIF3I[29426014];GNAS[29426014];EIF3G[29426014];CEP162[26638075];EIF3H[29426014];EIF3E[29426014];EIF3F[29426014];EIF3C[29426014];EIF3D[29426014];EIF3A[29426014];EIF4G1[29426014];EIF3B[29426014];	28518136
26537	chr15	29346251	G	A	chr15:29346251	APBA2	amyloid beta precursor protein binding family A member 2	SNV	0/1	0.44	107_86	194	99.0	0/1	0.52	86_94	180	99.0			rs142678624,COSV68794980	EXONIC	YES	NM_001353790.2	Transcript	protein_coding	missense_variant		4/15	NM_001353790.2:c.164G>A	NP_001340719.1:p.Ser55Asn		1.0	.,.,.,.,.,.,.,.	Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00498791	759.0	152168.0	5.0	32	0.98	PASS	amr	0.00804868	123.0	0.00761451	518.0	0.00526756	1323.0	251160.0	14.0	100	1.0	PASS	nfe	0.00740075	840.0	0.00740075	840.0	0.0053889	838	0.009	28.0	0.00954	108.0		23.0	2.747937	0.281	9	12	21	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,LRT_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	APBA2	0.0	0.0	0.0	0.0	-3.0	1.0	-3.0	37.0						0.451	0.07		0.769	1.176	growth/size/body region phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype ; mortality/aging ; normal phenotype; nervous system phenotype ; 			caudate nucleus;amygdala;temporal lobe;prefrontal cortex;cingulate cortex;cerebellum peduncles;cerebellum;pons;fetal brain;occipital lobe;subthalamic nucleus;whole brain;parietal lobe;spinal cord;globus pallidus;hypothalamus;medulla oblongata;thalamus;	.	in utero embryonic development;chemical synaptic transmission;nervous system development;locomotory behavior;regulation of gene expression;protein transport;multicellular organism growth;regulation of synaptic vesicle exocytosis	cytoplasm;plasma membrane;synaptic vesicle;dendritic spine;synapse;Schaffer collateral - CA1 synapse	amyloid-beta binding;protein binding	CAMK2D[29426014];USP20[19615732;unassigned1304];CLSTN1[17332754];MAPK6[21900206];MAGEB6[unassigned1304];BET1[29568061];	29346251
26614	chr15	34105698	G	A	chr15:34105698	RYR3	ryanodine receptor 3	SNV	0/1	0.51	38_39	77	99.0	0/0	0.0	40_0	40	99.0			rs201678035	EXONIC	YES	NM_001036.6	Transcript	protein_coding	missense_variant		74/104	NM_001036.6:c.10420G>A	NP_001027.3:p.Val3474Ile		1.0	.,.,.,.,.	Uncertain_significance	criteria_provided,_single_submitter	Epileptic_encephalopathy		.	.	.		0.000164268	25.0	152190.0	0.0	32	0.98	PASS	afr	0.000603224	25.0	0.0	0.0	8.02484e-05	20.0	249226.0	0.0	78	1.0	PASS	afr	0.000645745	10.0	7.0809e-05	8.0	0.0000579	9						24.2	3.24327	0.157	14	7	21	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	RYR3	0.0	0.0	0.0	0.0	-21.0	-30.0	-31.0	-14.0						0.0351	1.0	0.000000000	0.995	1.172	nervous system phenotype ; behavior/neurological phenotype ; muscle phenotype; 			caudate nucleus;amygdala;occipital lobe;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;	Calcium signaling pathway	calcium ion transport;ion transmembrane transport;release of sequestered calcium ion into cytosol;protein homotetramerization;negative regulation of cytosolic calcium ion concentration;calcium ion transmembrane transport;cellular response to calcium ion;cellular response to magnesium ion;cellular response to caffeine;cellular response to ATP;regulation of cardiac conduction	smooth endoplasmic reticulum;plasma membrane;integral component of membrane;sarcoplasmic reticulum;Z disc;cytoplasmic vesicle membrane;sarcoplasmic reticulum membrane;calcium channel complex;sarcolemma;perinuclear region of cytoplasm	ryanodine-sensitive calcium-release channel activity;calcium ion binding;calmodulin binding;calcium-release channel activity;calcium-induced calcium release activity	HNF1A[20195357];UGGT1[30021884];RTN4[30021884];	34105698
26638	chr15	34655653	G	A	chr15:34655653	LPCAT4	lysophosphatidylcholine acyltransferase 4	SNV	0/1	0.52	53_58	112	99.0	0/0	0.0	33_0	33	99.0			rs756316718,COSV59218156	EXONIC	YES	NM_153613.3	Transcript	protein_coding	missense_variant		7/14	NM_153613.3:c.716C>T	NP_705841.2:p.Thr239Ile		-1.0	.,.					.	.	.						32	0.97							3.97839e-06	1.0	251358.0	0.0	54	0.99	PASS	nfe	8.79554e-06	1.0	8.79554e-06	1.0	0.0000064	1						24.0	3.179109	0.697	19	2	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,DEOGEN2_pred	LPCAT4	0.03	0.0	0.03	0.0	4.0	43.0	-30.0	43.0						0.121	1.0	0.000000000	0.997	1.164	.			caudate nucleus;ciliary ganglion;amygdala;temporal lobe;prefrontal cortex;superior cervical ganglion;cingulate cortex;trigeminal ganglion;cerebellum peduncles;cerebellum;pons;occipital lobe;subthalamic nucleus;whole brain;parietal lobe;globus pallidus;medulla oblongata;hypothalamus;thalamus;	.	phospholipid metabolic process;phosphatidic acid biosynthetic process;phosphatidylglycerol acyl-chain remodeling;phosphatidylserine acyl-chain remodeling;phosphatidylcholine acyl-chain remodeling;phosphatidylethanolamine acyl-chain remodeling	endoplasmic reticulum;endoplasmic reticulum membrane;membrane;integral component of membrane	1-acylglycerol-3-phosphate O-acyltransferase activity;2-acylglycerol-3-phosphate O-acyltransferase activity;1-alkenylglycerophosphoethanolamine O-acyltransferase activity;1-acylglycerophosphocholine O-acyltransferase activity;1-alkylglycerophosphocholine O-acetyltransferase activity;lysophospholipid acyltransferase activity	.	34655653
26793	chr15	42159250	C	T	chr15:42159250	SPTBN5	spectrin beta, non-erythrocytic 5	SNV	0/1	0.49	64_61	125	99.0	0/1	0.49	48_46	94	99.0			rs61739719	EXONIC	YES	NM_016642.4	Transcript	protein_coding	synonymous_variant		36/68	NM_016642.4:c.6387G>A	NP_057726.4:p.Gln2129%3D		-1.0						.	.	.		0.000992037	151.0	152212.0	0.0	33	0.98	PASS	nfe	0.00171983	117.0	0.00171983	117.0	0.00112794	172.0	152490.0	1.0	31	0.57	PASS	amr	0.00168485	42.0	0.00149122	88.0	0.0005788	90	0.003	11.0	0.00438	50.0		0.304	-0.326922		0	0	0			SPTBN5	0.0	0.04	0.0	0.0	-19.0	-1.0	30.0	-1.0							0.0	2.866869586			.			ciliary ganglion;dorsal root ganglion;atrioventricular node;superior cervical ganglion;	.	MAPK cascade;endoplasmic reticulum to Golgi vesicle-mediated transport;Golgi organization;lysosomal transport;axon guidance;actin cytoskeleton organization;protein homooligomerization;actin filament capping	cytoplasm;microtubule organizing center;cytosol;spectrin;membrane;filamentous actin;photoreceptor connecting cilium;photoreceptor disc membrane	actin binding;Ras guanyl-nucleotide exchange factor activity;kinesin binding;spectrin binding;myosin tail binding;dynactin binding;protein self-association;dynein intermediate chain binding	FBF1[26638075];CANX[29568061];SBDS[30021884];	42159250
26798	chr15	42979064	T	G	chr15:42979064	STARD9	StAR related lipid transfer domain containing 9	SNV	0/1	0.5	67_67	135	99.0	0/1	0.52	60_64	124	99.0			rs1193793083	EXONIC	YES	NM_020759.3	Transcript	protein_coding	missense_variant		23/33	NM_020759.3:c.5288T>G	NP_065810.2:p.Ile1763Ser		1.0						.	.	.		6.57237e-06	1.0	152152.0	0.0	32	0.97	PASS	afr	2.41324e-05	1.0	0.0	0.0	1.41543e-05	2.0	141300.0	0.0	39	0.59	PASS	amr	8.14531e-05	2.0	0.0	0.0			0.0	1.0				26.8	3.886253	0.086	9	9	18	SIFT,PolyPhen,M-CAP_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,ClinPred_pred,fathmm-MKL_coding_pred	MetaLR_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-XF_coding_pred	STARD9	0.0	0.0	0.0	0.0	48.0	43.0	-44.0	16.0								0.000000000	0.998	1.138	.			ciliary ganglion;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;globus pallidus;	.	microtubule-based movement;spindle assembly	nucleus;cytoplasm;centriole	microtubule motor activity;ATP binding;microtubule binding;lipid binding	PPP1CC[21382349];NDUFA7[16169070];HNRNPA3[30021884];NEK4[25798074];HNRNPA2B1[30021884];HNRNPA1L2[30021884];CDK5RAP2[16169070];HERPUD1[16169070];	42979064
26924	chr15	43544998	C	T	chr15:43544998	TGM5	transglutaminase 5	SNV	0/1	0.45	60_49	110	99.0	0/1	0.44	78_61	139	99.0			rs116616135,COSV55011804	EXONIC	YES	NM_201631.4	Transcript	protein_coding	missense_variant		6/13	NM_201631.4:c.821G>A	NP_963925.2:p.Arg274His		-1.0	Transglutaminase-like&Transglutaminase-like,Transglutaminase-like&Transglutaminase-like,Transglutaminase-like&Transglutaminase-like,Transglutaminase-like&Transglutaminase-like,.	Uncertain_significance	criteria_provided,_single_submitter	Peeling_skin_syndrome_2	Peeling skin syndrome 2, 609796 (3), Autosomal recessive	Acral peeling skin syndrome	Disease-causing germline mutation(s) in	Eczema;Ichthyosis;Scaling skin;Excessive wrinkling of palmar skin;High hypermetropia;Skin erosion;Allergy;Abnormal blistering of the skin;Macule;Papule;Hyperpigmentation of the skin;Erythema;Scaling skin;Erythema;Abnormal blistering of the skin;Autosomal recessive inheritance		0.00024314	37.0	152176.0	0.0	32	0.97	PASS	eas	0.00423403	22.0	1.47007e-05	1.0	0.000242778	61.0	251258.0	0.0	100	1.0	PASS	amr	0.000982943	34.0	3.51853e-05	4.0	0.0001994	31	0.001	3.0	0.00237	27.0		18.55	1.845931	0.258	5	14	19	SIFT,M-CAP_pred,MutationAssessor_pred,PROVEAN_pred,DEOGEN2_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TGM5	0.0	0.0	0.0	0.0	15.0	5.0	-33.0	5.0						0.226	0.0	0.000000000	0.703	0.13	.			caudate nucleus;tongue;superior cervical ganglion;	.	cellular protein modification process;epidermis development;peptide cross-linking;cornification	cytoplasm;plasma membrane	protein-glutamine gamma-glutamyltransferase activity;metal ion binding	KANK2[unassigned1304];GRB7[unassigned1304];RBM41[unassigned1304];LARP4[unassigned1304];LGALS7[unassigned1304];	43544998
27076	chr15	50581870		A	chr15:50581869-50581870	GABPB1	GA binding protein transcription factor subunit beta 1	insertion	0/0	0.0	38_0	38	79.0	0/1	0.2	15_4	20	49.0			rs374196509	SPLICING	YES	NM_001320910.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	7/9		NM_001320910.2:c.734-5dup			-1.0						.	.	.		0.000866514	121.0	139640.0	0.0	31	0.91	PASS	sas	0.00383921	17.0	0.000563134	36.0	0.0558989	4921.0	88034.0	0.0	26	0.64	InbreedingCoeff	amr	0.0748492	794.0	0.0443872	1860.0	0.0004823,0.0000322,0.0005145,0.0000257	75,5,80,4						0.556	-0.238364		0	0	0			GABPB1	0.0	0.0	0.0	0.0	-4.0	17.0	-20.0	-34.0						0.507	0.93				behavior/neurological phenotype ; mortality/aging ; 			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;	.	regulation of transcription by RNA polymerase II;mitochondrion organization;positive regulation of transcription by RNA polymerase II	nucleus;nucleoplasm;cytoplasmic ribonucleoprotein granule	DNA-binding transcription factor activity;protein binding;transcription regulatory region DNA binding;protein heterodimerization activity	MAGEB18[16189514;19060904];GSTP1[26496610];USO1[16189514];FHL2[16624878];POGZ[25416956];SNRPB2[25416956];HIF1AN[17003112];CIC[16713569];GABPA[unassigned1304];RBM11[25416956];LMO1[21516116;25416956];LMO4[25416956;unassigned1304];LMO3[16189514];DDIT4L[unassigned1304];TDRD7[16189514;25416956];IL16[19060904;unassigned1304];TRAF2[21516116;25416956;unassigned1304];ZDHHC17[24705354];FANCG[16189514];HCFC1[10675337];FAM90A1[25416956];SNW1[unassigned1304];ADGRB2[16412436];RSPH14[25416956];RAN[24855949];SNRPA[25416956];	50581869
27214	chr15	57384062	A	G	chr15:57384062	TCF12	transcription factor 12	SNV	0/1	0.32	36_17	53	99.0	0/0	0.0	35_0	35	99.0			rs748321218	EXONIC	YES	NM_001322151.2	Transcript	protein_coding	missense_variant		5/21	NM_001322151.2:c.298A>G	NP_001309080.1:p.Thr100Ala		1.0	.,.,.,.,.,.				Craniosynostosis 3, 615314 (3), Autosomal dominant; Hypogonadotropic hypogonadism 26 with or without anosmia, 619718 (3), Autosomal recessive, Autosomal dominant	Extraskeletal myxoid chondrosarcoma;Isolated brachycephaly;Isolated plagiocephaly	Part of a fusion gene in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Increased intracranial pressure;Brachydactyly;Metacarpal synostosis;Proptosis;Hearing impairment;Broad forehead;Underdeveloped supraorbital ridges;Midface retrusion;Intellectual disability;Hypertelorism;Brachycephaly;Hallux valgus;Ptosis;Global developmental delay;Autosomal dominant inheritance;Low anterior hairline;Strabismus;Single transverse palmar crease;Brachydactyly;Autism;Craniosynostosis;Strabismus;Visual field defect;Intellectual disability;Frontal bossing;Macrocephaly;Global developmental delay;Facial asymmetry;Plagiocephaly;Midface retrusion;Hearing impairment		1.31409e-05	2.0	152196.0	0.0	32	0.97	PASS	nfe	2.93997e-05	2.0	2.93997e-05	2.0	2.38798e-05	6.0	251258.0	0.0	64	1.0	PASS	eas	0.000271828	5.0	8.80204e-06	1.0	0.0000129	2						20.6	2.092871	0.182	5	14	19	LRT_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	TCF12	0.0	0.0	0.0	0.0	1.0	-49.0	27.0	25.0						0.622	0.97	0.000000000	1.0	1.29	immune system phenotype; nervous system phenotype ; mortality/aging ; hematopoietic system phenotype; behavior/neurological phenotype ; growth/size/body region phenotype; endocrine/exocrine gland phenotype; 			ciliary ganglion;caudate nucleus;amygdala;uterus;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;spinal cord;globus pallidus;	.	regulation of transcription by RNA polymerase II;immune response;muscle organ development;positive regulation of neuron differentiation;positive regulation of transcription by RNA polymerase II;regulation of hematopoietic stem cell differentiation	nuclear chromatin;nucleus;nucleoplasm;transcription factor complex;cytoplasm;nuclear speck;intracellular membrane-bounded organelle;RNA polymerase II transcription factor complex	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;protein binding;transcription factor binding;enhancer binding;cAMP response element binding;protein homodimerization activity;bHLH transcription factor binding;transcription regulatory region DNA binding;SMAD binding;protein heterodimerization activity;E-box binding;HMG box domain binding	MAPKBP1[25416956];TRIM72[25416956;unassigned1304];CRCP[25416956];NGLY1[unassigned1304];TCF23[unassigned1304];TCF21[unassigned1304];C16orf45[25416956];PRSS23[16169070];CKS1B[unassigned1304];EDRF1[25416956];MYC[21150319];STK16[25416956];ARL16[unassigned1304];HIF1AN[26972000];ZNF688[26871637];PRKAB2[unassigned1304];EXOC8[unassigned1304];FIGLA[unassigned1304];FOXH1[21828274];MSGN1[unassigned1304];ARMC8[25416956];RHOA[unassigned1304];NCOR1[17572682];PSMA1[25416956];TAL1[9824680;21179004;19497860];TBC1D21[unassigned1304];HAND2[unassigned1304];HAND1[unassigned1304];VPS28[25416956;26871637];GRB7[unassigned1304];DDX6[unassigned1304];RNASEL[25416956];ASCL3[unassigned1304];ASCL4[25416956;unassigned1304];NOTCH1[23022380];RBM8A[unassigned1304];TWIST2[25416956;unassigned1304];CLCNKA[unassigned1304];SRI[25416956];CFAP206[25416956];MLLT6[25416956];STRN3[26496610];NEUROD1[unassigned1304];NHLH2[unassigned1304];BMF[21988832];C1orf109[25416956];TP53BP1[29656893];MSC[unassigned1304];RUNX1T1[16803958];STAT5A[25416956];TSNAX[25416956;unassigned1304];HEXIM2[21516116;25416956;unassigned1304];SMAD3[21828274];CDKN2C[25416956;unassigned1304;25910212];WTAP[unassigned1304];NEK6[unassigned1304];OSGIN1[25416956;unassigned1304];LYSMD1[25416956];HOPX[25416956];ZWINT[26496610];NUDT21[unassigned1304];NAGK[25416956];QARS[25416956];MORN4[25416956;unassigned1304];ID2[16549780;19321746];ID1[26496610;unassigned1304];MYF6[21516116];LNX1[unassigned1304];ID3[25416956;unassigned1304];PIN1[unassigned1304];TCF4[25609649];TCF3[21828274];NEUROG1[unassigned1304];TRIM33[20603019];SPG21[25416956];LAMTOR5[23414517];NEUROG3[25416956;unassigned1304;25910212];	57384062
27317	chr15	62234230	A	C	chr15:62234230	VPS13C	vacuolar protein sorting 13 homolog C	SNV	0/1	0.49	38_36	74	99.0	0/1	0.51	42_43	85	99.0			rs370438226,COSV51359006	EXONIC	YES	NM_020821.3	Transcript	protein_coding	missense_variant		46/85	NM_020821.3:c.5185T>G	NP_065872.1:p.Leu1729Val		-1.0	VPS13, repeated coiled region,.,VPS13, repeated coiled region,.,.,.	Uncertain_significance	criteria_provided,_single_submitter	not_provided	Parkinson disease 23, autosomal recessive, early onset, 616840 (3), Autosomal recessive	Young-onset Parkinson disease	Disease-causing germline mutation(s) (loss of function) in	Abnormal autonomic nervous system physiology;Male sexual dysfunction;Hallucinations;Tremor;Insomnia;Short attention span;Postural instability;Rigidity;Dyskinesia;Constipation;Impulsivity;Frontal lobe dementia;Gastroparesis;Impaired social interactions;Nausea;Anxiety;Hyposmia;Female sexual dysfunction;Dystonia;Color vision defect;Hyperreflexia;Diarrhea;Gait imbalance;Apathy;Bradykinesia;Restless legs;Diplopia;Spasticity;Muscle spasm;Agitation;Panic attack;Depressivity;Neurofibrillary tangles;Mental deterioration;Rigidity;Dementia;Progressive;Hyperreflexia;Parkinsonism;Lewy bodies;Spasticity;Limb dystonia;Akinesia;Abnormal pyramidal sign;Autosomal recessive inheritance;Abnormal autonomic nervous system physiology;Resting tremor;Cerebral cortical atrophy		9.19842e-05	14.0	152200.0	0.0	32	0.97	PASS	amr	0.00026178	4.0	5.88062e-05	4.0	0.000200343	50.0	249572.0	0.0	40	0.93	PASS	sas	0.000393546	12.0	0.00010627	12.0	0.0001608	25	0.0	1.0				16.18	1.484454	0.031	4	15	19	MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	VPS13C	0.0	0.0	0.18	0.0	36.0	39.0	1.0	-3.0						0.971	0.0	0.000000000	0.978	0.233	hematopoietic system phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; 			ciliary ganglion;pons;testis - interstitial;subthalamic nucleus;dorsal root ganglion;cingulate cortex;trigeminal ganglion;atrioventricular node;superior cervical ganglion;skeletal muscle;medulla oblongata;	.	protein targeting to vacuole;Golgi to endosome transport;mitochondrion organization;protein retention in Golgi apparatus;negative regulation of parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization	cytoplasm;mitochondrial outer membrane;cytosol;extrinsic component of membrane;extracellular exosome	.	HNRNPK[30021884];DNAJC7[26496610];NUDCD1[29021621];HNRNPA2B1[30021884];RAB9A[29568061];ESR2[25604459];HSP90B1[30021884];	62234230
27341	chr15	62360217	GGC		chr15:62360217-62360219	C2CD4A	C2 calcium dependent domain containing 4A	deletion	0/0	0.0	33_0	33	75.0	0/1	0.13	20_3	23	66.0			rs947333052	EXONIC	YES	NM_207322.3	Transcript	protein_coding	inframe_deletion		2/2	NM_207322.3:c.418_420del	NP_997205.2:p.Gly140del		1.0						.	.	.		1.33661e-05	2.0	149632.0	0.0	32	0.95	PASS	nfe	2.97318e-05	2.0	2.97318e-05	2.0	0.00175439	4.0	2280.0	0.0	0	0.0	PASS	nfe	0.00322061	4.0	0.00322061	4.0								10.47	0.618974		0	0	0			C2CD4A	0.0	0.0	0.0	0.0	20.0	3.0	-32.0	-34.0							0.09				.			.	.	regulation of vascular permeability involved in acute inflammatory response;positive regulation of acute inflammatory response;regulation of cell adhesion	nucleus	.	.	62360216
27349	chr15	63128231	G	T	chr15:63128231	TLN2	talin 2	SNV	0/0	0.0	36_0	36	99.0	0/1	0.42	46_34	80	99.0			rs78592652	EXONIC	YES	NM_015059.2	Transcript	protein_coding	missense_variant		54/56	NM_015059.2:c.7333G>T	NP_055874.2:p.Val2445Leu		1.0	I/LWEQ domain&I/LWEQ domain&I/LWEQ domain&I/LWEQ domain,I/LWEQ domain&I/LWEQ domain&I/LWEQ domain&I/LWEQ domain,I/LWEQ domain&I/LWEQ domain&I/LWEQ domain&I/LWEQ domain					.	.	.		0.00176674	269.0	152258.0	1.0	33	0.98	PASS	sas	0.00516742	25.0	0.00258664	176.0	0.00192493	475.0	246762.0	3.0	89	0.82	PASS	sas	0.0037447	113.0	0.00232037	259.0	0.0021671	337	0.002	5.0				27.6	3.9931	0.761	15	6	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LRT_pred,MetaLR_pred,FATHMM_pred,MetaRNN_pred,BayesDel_addAF_pred,ClinPred_pred	TLN2	0.0	0.0	0.0	0.01	-39.0	0.0	41.0	-1.0						0.525	1.0	0.000000000	1.0	1.176	behavior/neurological phenotype ; mortality/aging ; normal phenotype; muscle phenotype; cellular phenotype; 			ciliary ganglion;cingulate cortex;superior cervical ganglion;skin;trigeminal ganglion;pons;kidney;occipital lobe;subthalamic nucleus;dorsal root ganglion;atrioventricular node;skeletal muscle;globus pallidus;	Focal adhesion	cytoskeletal anchoring at plasma membrane;cell-cell junction assembly;cell adhesion	ruffle;cytoplasm;plasma membrane;focal adhesion;actin cytoskeleton;synapse	actin binding;structural molecule activity;structural constituent of cytoskeleton;protein binding;actin filament binding	ITGB5[25448675];SGTB[26496610];ITGB2[19234221];CDC5L[20467437];FOS[20195357];SYNCRIP[26496610];ALB[15174051];ABL1[19234221];HNRNPD[26496610];DGCR8[26496610];CHMP4B[26496610];HIF1AN[26972000];SKP1[26496610];	63128231
27391	chr15	64008649	T	C	chr15:64008649	HERC1	HECT and RLD domain containing E3 ubiquitin protein ligase family member 1	SNV	0/1	0.35	34_18	52	99.0	0/1	0.51	36_37	73	99.0			rs766264556	EXONIC	YES	NM_003922.4	Transcript	protein_coding	synonymous_variant		22/78	NM_003922.4:c.4002A>G	NP_003913.3:p.Ala1334%3D		-1.0					Macrocephaly, dysmorphic facies, and psychomotor retardation, 617011 (3), Autosomal recessive	Megalencephaly-severe kyphoscoliosis-overgrowth syndrome	Disease-causing germline mutation(s) (loss of function) in	Large hands;Low-set ears;Cerebellar atrophy;Frontal bossing;Long neck;Pes planus;Absent speech;Hydrocephalus;Intellectual disability;Malar flattening;Macrotia;Ventriculomegaly;High palate;Long face;Thick corpus callosum;Megalencephaly;Proptosis;Arachnodactyly;Mandibular prognathia;Posteriorly rotated ears;Hypertelorism;Global developmental delay;Triangular face;Downslanted palpebral fissures;Generalized hypotonia;Cerebral cortical atrophy;Kyphosis;Upslanted palpebral fissure;Long foot;Scoliosis;Congenital onset;Sparse eyebrow;Prominent nasal bridge;Prominent forehead;Seizure;Joint laxity;Autosomal recessive inheritance;Tall stature;Macrocephaly;Gait ataxia;Hyperlordosis;Drooling;Megalencephaly;Long neck;Absent speech;Arachnodactyly;Prominent forehead;Large for gestational age;Gait ataxia;Intellectual disability, severe;Low-set, posteriorly rotated ears;Mandibular prognathia;Triangular face;Global developmental delay;Downslanted palpebral fissures;High myopia;Macrocephaly;Thick corpus callosum;Shallow orbits;Neonatal hypoglycemia;Long foot;Diffuse white matter abnormalities;Broad eyebrow;Ventriculomegaly;Bilateral tonic-clonic seizure;Pes planus;Metopic synostosis;Lumbar hyperlordosis;Cerebral cortical atrophy;Kyphoscoliosis;Difficulty walking;Communicating hydrocephalus;Limitation of joint mobility;Slender build;High palate;Hypertelorism;Severe expressive language delay;Asymmetry of the thorax;Impaired social interactions;Upslanted palpebral fissure;Overgrowth;Prominent nasal bridge;Malar flattening;Facial hypotonia;Long face;Macrotia;Cerebellar hypoplasia;Disproportionate tall stature;Sparse eyebrow;Micropenis;Joint laxity		0.00011827	18.0	152194.0	0.0	32	0.96	PASS	amr	0.000327268	5.0	7.3497e-05	5.0	0.000105047	26.0	247508.0	0.0	36	0.88	PASS	amr	0.000293307	10.0	8.89648e-05	10.0	0.0000643	10	0.001	4.0				12.54	0.87661		0	0	0			HERC1	0.19	0.02	0.0	0.0	-16.0	16.0	-16.0	-2.0						0.652	1.0	70.585892658			nervous system phenotype ; behavior/neurological phenotype ; growth/size/body region phenotype; mortality/aging ; 			.	Ubiquitin mediated proteolysis	negative regulation of autophagy;protein ubiquitination;cerebellar Purkinje cell differentiation;neuron projection development;neuromuscular process controlling balance	cytoplasm;Golgi apparatus;cytosol;membrane	ubiquitin-protein transferase activity;ARF guanyl-nucleotide exchange factor activity	JUN[20195357];SCHIP1[20195357];CANX[30021884];PPEF1[28330616];HMGN2[30021884];PTBP3[22575643];	64008649
27474	chr15	66191208	G	A	chr15:66191208	MEGF11	multiple EGF like domains 11	SNV	0/0	0.0	34_0	34	99.0	0/1	0.47	51_46	97	99.0			rs149810579	EXONIC	YES	NM_001385028.1	Transcript	protein_coding	synonymous_variant		25/26	NM_001385028.1:c.3120C>T	NP_001371957.1:p.Tyr1040%3D		-1.0						.	.	.		0.000525749	80.0	152164.0	0.0	32	0.97	PASS	nfe	0.00101414	69.0	0.00101414	69.0	0.000501756	126.0	251118.0	2.0	78	1.0	PASS	nfe	0.000872693	99.0	0.000872693	99.0	0.0004116	64	0.001	2.0	0.00096	11.0		7.653	0.334804		0	0	0			MEGF11	0.0	0.0	0.0	0.0	-13.0	15.0	-6.0	48.0						0.239	0.0	66.323177249			vision/eye phenotype; nervous system phenotype ; 			ciliary ganglion;testis - seminiferous tubule;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;cerebellum peduncles;cerebellum;pons;dorsal root ganglion;whole brain;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;	.	retina layer formation;homotypic cell-cell adhesion	integral component of membrane;basolateral plasma membrane	.	NUFIP2[unassigned1304];ATN1[16713569];	66191208
27515	chr15	68120418	GGC		chr15:68120418-68120420	SKOR1	SKI family transcriptional corepressor 1	deletion	0/1	0.14	48_8	56	99.0	0/0	0.0	34_0	34	99.0			rs756238272	EXONIC	YES	NM_001365915.1	Transcript	protein_coding	inframe_deletion		2/9	NM_001365915.1:c.2263_2265del	NP_001352844.1:p.Gly755del		1.0						.	.	.		0.0	0.0	151948.0	0.0	33	0.98	AC0_AS_VQSR				0.0	0.0	0.00498879	485.0	97218.0	0.0	9	0.29	RF	afr	0.0155833	35.0	0.0047734	174.0	0.0000064	1	0.009	28.0				14.32	1.14187		0	0	0			SKOR1	0.0	0.0	0.0	0.0	-19.0	2.0	-28.0	48.0											.			dorsal root ganglion;superior cervical ganglion;skeletal muscle;	.	regulation of transcription, DNA-templated;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of BMP signaling pathway;negative regulation of cell differentiation;negative regulation of transcription, DNA-templated;neuron development	nucleus;transcription factor complex;dendrite;neuronal cell body	DNA-binding transcription factor activity, RNA polymerase II-specific;transcription corepressor activity;SMAD binding	CD247[24502978];	68120417
27722	chr15	74628335	T	C	chr15:74628335	CCDC33	coiled-coil domain containing 33	SNV	0/1	0.49	55_52	107	99.0	0/1	0.59	40_57	97	99.0				EXONIC	YES	NM_025055.5	Transcript	protein_coding	missense_variant		19/19	NM_025055.5:c.2209T>C	NP_079331.3:p.Ser737Pro		1.0						.	.	.						32	0.96											77	1.0														7.423	0.316436	0.042	0	16	16		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CCDC33	0.0	0.0	0.0	0.0	-36.0	-39.0	0.0	-36.0						0.941	0.0	66.323177249	0.034	0.32	limbs/digits/tail phenotype; skeleton phenotype; 			superior cervical ganglion;trigeminal ganglion;	.	.	.	protein binding	ZBTB8A[16189514];RHOXF2[19447967];KHDRBS3[16189514;19447967];CALCOCO2[16189514];USHBP1[16189514];EHMT2[16189514];PIK3R3[25814554];RAD54B[16189514];FXR2[16189514];FAM124A[21516116];CAPZB[30021884];CCDC85B[16189514];PPP2R3C[21516116];STK16[21516116];DVL2[16189514];ARIH2[21516116];SSSCA1[16189514];NINL[16189514];UBQLN4[16713569];TSC22D4[16189514];PRKAB2[21516116];PARP2[21812934];EAF1[21516116];TRAF2[16189514];PLSCR1[16189514];HOOK2[16189514];HGS[16189514];KXD1[16189514];TRIM37[19447967];HNRNPC[30021884];RBMX[16189514];MDFI[19447967];	74628335
27725	chr15	74709990	G	A	chr15:74709990	SEMA7A	semaphorin 7A (John Milton Hagen blood group)	SNV	0/1	0.42	62_45	107	99.0	0/0	0.0	34_0	34	99.0			rs142309393,COSV99984554	EXONIC	YES	NM_003612.5	Transcript	protein_coding	synonymous_variant		5/14	NM_003612.5:c.492C>T	NP_003603.1:p.Gly164%3D		-1.0					[Blood group, John-Milton-Hagen system], 614745 (3)	.	.	.		0.000867314	132.0	152194.0	0.0	33	0.98	PASS	nfe	0.00169053	115.0	0.00169053	115.0	0.000705337	176.0	249526.0	0.0	47	0.97	PASS	nfe	0.00124719	141.0	0.00124719	141.0	0.0008038	125			0.00063	6.0		4.281	0.101157		0	0	0			SEMA7A	0.0	0.0	0.02	0.0	27.0	26.0	27.0	-45.0						0.653	0.03	55.133174808			nervous system phenotype ; cellular phenotype; 			pons;ciliary ganglion;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	Axon guidance	osteoblast differentiation;neural crest cell migration;inflammatory response;immune response;integrin-mediated signaling pathway;olfactory lobe development;positive regulation of cell migration;positive regulation of axon extension;axon extension;negative regulation of axon extension involved in axon guidance;regulation of inflammatory response;negative chemotaxis;positive regulation of macrophage cytokine production;positive regulation of ERK1 and ERK2 cascade;semaphorin-plexin signaling pathway	extracellular space;plasma membrane;integral component of plasma membrane;external side of plasma membrane;membrane;anchored component of membrane;collagen-containing extracellular matrix	integrin binding;protein binding;semaphorin receptor binding;neuropilin binding;chemorepellent activity	SEMA7A[20727575];ABL1[17474147];FYN[17474147];GRB2[17474147];PLXNC1[20727575];PLEKHA7[28877994];NCK1[17474147];	74709990
27738	chr15	75116809	G	A	chr15:75116809	LMAN1L	lectin, mannose binding 1 like	SNV	0/1	0.49	45_44	89	99.0	0/0	0.0	45_0	45	99.0			rs146826349	EXONIC	YES	NM_021819.3	Transcript	protein_coding	missense_variant		13/14	NM_021819.3:c.1441G>A	NP_068591.2:p.Val481Met		1.0	.,.					.	.	.		0.00312048	475.0	152220.0	3.0	32	0.98	PASS	nfe	0.00454145	309.0	0.00454145	309.0	0.00306268	770.0	251414.0	2.0	59	1.0	PASS	nfe	0.00422015	480.0	0.00422015	480.0	0.0031318	487	0.001	2.0				5.82	0.198614	0.037	0	19	19		SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LMAN1L	0.0	0.0	0.0	0.01	11.0	-21.0	-19.0	10.0						0.916	0.0	0.000000000	0.408	-0.134	.			prostate;	.	endoplasmic reticulum to Golgi vesicle-mediated transport;endoplasmic reticulum organization;Golgi organization	Golgi membrane;endoplasmic reticulum membrane;endoplasmic reticulum-Golgi intermediate compartment;integral component of membrane;COPII-coated ER to Golgi transport vesicle;endoplasmic reticulum-Golgi intermediate compartment membrane;collagen-containing extracellular matrix	mannose binding	LRRK1[24947832];	75116809
27749	chr15	75341523	G	A	chr15:75341523	PPCDC	phosphopantothenoylcysteine decarboxylase	SNV	0/0	0.0	34_0	34	99.0	0/1	0.47	51_45	96	99.0			rs146346759	EXONIC	YES	NM_021823.5	Transcript	protein_coding	missense_variant		6/6	NM_021823.5:c.562G>A	NP_068595.3:p.Val188Met		1.0	Flavoprotein,Flavoprotein,Flavoprotein,Flavoprotein,Flavoprotein					.	.	.		0.000532125	81.0	152220.0	0.0	33	0.98	PASS	amr	0.00196258	30.0	0.000529163	36.0	0.000373992	94.0	251342.0	0.0	62	1.0	PASS	amr	0.000983284	34.0	0.000466393	53.0	0.0003923	61	0.002	5.0				22.5	2.466144	0.123	5	15	20	SIFT,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,fathmm-MKL_coding_pred	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	PPCDC	0.01	0.04	0.0	0.0	35.0	-49.0	-33.0	8.0						0.571	0.0	0.000000000	0.996	0.225	.			superior cervical ganglion;	Pantothenate and CoA biosynthesis	coenzyme biosynthetic process;coenzyme A biosynthetic process	cytosol	phosphopantothenoylcysteine decarboxylase activity;protein binding;identical protein binding	CENPT[16169070];ZNF232[25416956;unassigned1304];PLEKHF2[unassigned1304];UBE2I[unassigned1304];SREK1IP1[25416956];DDIT4L[unassigned1304];DBI[16169070];WDYHV1[25416956;unassigned1304];PPCDC[25416956;26514574;unassigned1304];TXN2[25416956;unassigned1304];NAA80[unassigned1304];FOXR1[25416956;unassigned1304];PSMA1[21516116];LNX1[unassigned1304];PPIG[25416956];TXNDC5[unassigned1304];	75341523
27761	chr15	75980667	A	C	chr15:75980667	CSPG4	chondroitin sulfate proteoglycan 4	SNV	0/0	0.0	82_0	82	99.0	0/1	0.44	70_54	124	99.0			rs188314342	EXONIC	YES	NM_001897.5	Transcript	protein_coding	synonymous_variant		3/10	NM_001897.5:c.2739T>G	NP_001888.2:p.Gly913%3D		-1.0						.	.	.		9.85312e-05	15.0	152236.0	0.0	33	0.98	PASS	amr	0.000588543	9.0	5.87872e-05	4.0	0.000139563	35.0	250782.0	0.0	100	1.0	PASS	amr	0.000664971	23.0	8.83392e-05	10.0	0.0001158	18	0.001	4.0				0.248	-0.356001		0	0	0			CSPG4	0.0	0.0	0.0	0.0	-48.0	46.0	5.0	2.0						0.654	0.0				hearing/vestibular/ear phenotype; nervous system phenotype ; immune system phenotype; liver/biliary system phenotype; hematopoietic system phenotype; normal phenotype; adipose tissue phenotype ; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;	.	activation of MAPK activity;angiogenesis;transmembrane receptor protein tyrosine kinase signaling pathway;cell population proliferation;glial cell migration;chondroitin sulfate biosynthetic process;chondroitin sulfate catabolic process;dermatan sulfate biosynthetic process;intracellular signal transduction;tissue remodeling;positive regulation of peptidyl-tyrosine phosphorylation	extracellular region;Golgi lumen;integral component of plasma membrane;focal adhesion;cell surface;apical plasma membrane;lamellipodium membrane;lysosomal lumen;collagen-containing extracellular matrix;extracellular exosome	protein kinase binding	ATF7IP[15231748];LAMP1[29568061];SORT1[26496610];NEDD9[22984505];ZNF644[26496610];	75980667
27763	chr15	75982085	C	T	chr15:75982085	CSPG4	chondroitin sulfate proteoglycan 4	SNV	0|1	0.13	156_24	182	99.0	0/0	0.0	41_0	41	99.0			rs79463888,COSV57890918	EXONIC	YES	NM_001897.5	Transcript	protein_coding	missense_variant		3/10	NM_001897.5:c.1321G>A	NP_001888.2:p.Glu441Lys		-1.0						.	.	.	25537509	0.00421144	602.0	142944.0	0.0	34	0.98	AS_VQSR	nfe	0.00563819	351.0	0.00563819	351.0	0.0454807	8679.0	190828.0	0.0	74	0.99	PASS	nfe	0.0617069	5096.0	0.0617069	5096.0	0.1187751	18470	0.054	163.0				25.0	3.494113	0.603	11	9	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_addAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_noAF_pred,ClinPred_pred	CSPG4	0.0	0.0	0.0	0.0	-3.0	30.0	7.0	-28.0						0.654	0.0		0.971	0.937	hearing/vestibular/ear phenotype; nervous system phenotype ; immune system phenotype; liver/biliary system phenotype; hematopoietic system phenotype; normal phenotype; adipose tissue phenotype ; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;	.	activation of MAPK activity;angiogenesis;transmembrane receptor protein tyrosine kinase signaling pathway;cell population proliferation;glial cell migration;chondroitin sulfate biosynthetic process;chondroitin sulfate catabolic process;dermatan sulfate biosynthetic process;intracellular signal transduction;tissue remodeling;positive regulation of peptidyl-tyrosine phosphorylation	extracellular region;Golgi lumen;integral component of plasma membrane;focal adhesion;cell surface;apical plasma membrane;lamellipodium membrane;lysosomal lumen;collagen-containing extracellular matrix;extracellular exosome	protein kinase binding	ATF7IP[15231748];LAMP1[29568061];SORT1[26496610];NEDD9[22984505];ZNF644[26496610];	75982085
27828	chr15	78317696	C	T	chr15:78317696	TBC1D2B	TBC1 domain family member 2B	SNV	0/1	0.54	51_60	111	99.0	0/0	0.0	34_0	34	99.0			rs145243820,COSV56042045	EXONIC	YES	NM_001387142.1	Transcript	protein_coding	missense_variant		5/14	NM_001387142.1:c.991G>A	NP_001374071.1:p.Val331Ile		-1.0	.,.,.				Neurodevelopmental disorder with seizures and gingival overgrowth, 619323 (3), Autosomal recessive	.	.	.		0.00095327	145.0	152108.0	1.0	32	0.96	PASS	nfe	0.00139644	95.0	0.00139644	95.0	0.000971446	244.0	251172.0	0.0	93	1.0	PASS	nfe	0.00136583	155.0	0.00136583	155.0	0.0008296	129	0.002	6.0				0.134	-0.443119	0.066	0	17	17		LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TBC1D2B	0.0	0.0	0.0	0.0	-39.0	40.0	39.0	-38.0						0.972	0.0	0.000000000	0.0	-0.65	homeostasis/metabolism phenotype; skeleton phenotype; 			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;globus pallidus;	.	intracellular protein transport;activation of GTPase activity;regulation of cilium assembly	cytosol	GTPase activator activity;protein binding;Rab GTPase binding	OFD1[26638075];GABARAPL2[20562859];GABARAPL1[20562859];MAP1LC3B[20562859];MAP1LC3C[20562859];MKS1[26638075];GABARAP[20562859];TRDMT1[21988832];CEP89[26638075];	78317696
27871	chr15	79067099	G	C	chr15:79067099	ADAMTS7	ADAM metallopeptidase with thrombospondin type 1 motif 7	SNV	0/0	0.0	36_0	36	99.0	0/1	0.36	90_50	140	99.0			rs142017909,COSV66305672	EXONIC	YES	NM_014272.5	Transcript	protein_coding	synonymous_variant		12/24	NM_014272.5:c.1743C>G	NP_055087.2:p.Arg581%3D		-1.0						.	.	.		0.00304462	446.0	146488.0	0.0	35	0.98	PASS	afr	0.00786435	301.0	0.00114293	76.0	0.00370914	864.0	232938.0	0.0	50	0.98	PASS	afr	0.00412552	61.0	0.00279041	292.0	0.0124691	1939	0.01	30.0				1.966	-0.047926		0	0	0			ADAMTS7	0.0	0.07	0.0	0.0	36.0	-28.0	23.0	8.0						0.623	0.0				homeostasis/metabolism phenotype; cellular phenotype; cardiovascular system phenotype ; hematopoietic system phenotype; behavior/neurological phenotype ; respiratory system phenotype; liver/biliary system phenotype; 			.	.	negative regulation of chondrocyte differentiation;proteolysis involved in cellular protein catabolic process;cellular response to interleukin-1;cellular response to tumor necrosis factor;cellular response to BMP stimulus	extracellular region;endoplasmic reticulum lumen;cell surface	metalloendopeptidase activity;protein binding;metallopeptidase activity;metal ion binding	COMP[18485748];A2M[18485748];	79067099
27895	chr15	79586693	GGT		chr15:79586693-79586695	ANKRD34C	ankyrin repeat domain 34C	deletion	0/1	0.62	52_86	138	99.0	0/1	0.45	85_70	157	99.0			rs536236949	EXONIC	YES	NM_001146341.2	Transcript	protein_coding	inframe_deletion		2/2	NM_001146341.2:c.1069_1071del	NP_001139813.1:p.Gly357del		1.0						.	.	.		0.00316759	482.0	152166.0	0.0	32	0.96	PASS	nfe	0.00583618	397.0	0.00583618	397.0	0.00244836	375.0	153164.0	0.0	32	0.58	PASS	nfe	0.00533953	315.0	0.00533953	315.0	0.0000322,0.0007009	5,109	0.002	6.0				10.1	0.57613		0	0	0			ANKRD34C	0.0	0.0	0.01	0.08	19.0	3.0	0.0	3.0								0.000000000			.			.	.	.	.	.	.	79586692
27908	chr15	80872845	G	T	chr15:80872845	ARNT2	aryl hydrocarbon receptor nuclear translocator 2	SNV	0/1	0.59	57_81	138	99.0	0/1	0.5	52_53	105	99.0			rs145379118,COSV100309729	EXONIC	YES	NM_014862.4	Transcript	protein_coding	missense_variant		16/19	NM_014862.4:c.1707G>T	NP_055677.3:p.Gln569His		1.0	.,.,.,.	Likely_benign	criteria_provided,_single_submitter	not_provided	?Webb-Dattani syndrome, 615926 (3), Autosomal recessive	Septo-optic dysplasia spectrum	Disease-causing germline mutation(s) (loss of function) in	Hip dislocation;Blindness;Spasticity;Retrognathia;Hydronephrosis;Pituitary hypothyroidism;Deeply set eye;Diabetes insipidus;Global developmental delay;Hypoplasia of the corpus callosum;Severe global developmental delay;Delayed myelination;Neurogenic bladder;Vesicoureteral reflux;Seizure;Autosomal recessive inheritance;Prominent forehead;Hypernatremia;Postnatal microcephaly;Growth hormone deficiency;Gastroesophageal reflux;Cryptorchidism;Agenesis of corpus callosum;Tracheoesophageal fistula;Intellectual disability;Global developmental delay;Aplasia/Hypoplasia of the cerebellum;Seizure;Esophageal atresia;Anosmia;Short stature;Maternal diabetes;Anterior pituitary hypoplasia;Polydipsia;Cleft palate;Autism;Dry skin;Abnormality of cardiovascular system morphology;Hypohidrosis;Visual impairment;Sleep disturbance;Septo-optic dysplasia;Obesity;Fatigue;Sensorineural hearing impairment;Hypoplasia of penis;Nystagmus;Cryptorchidism;Strabismus;Hemiplegia/hemiparesis;Diabetes insipidus;Constipation		0.00312114	475.0	152188.0	4.0	32	0.97	PASS	nfe	0.00477674	325.0	0.00477674	325.0	0.00335224	843.0	251474.0	3.0	94	1.0	PASS	nfe	0.00528314	601.0	0.00528314	601.0	0.0033375	519	0.006	20.0				24.3	3.267738	0.107	4	16	20	SIFT,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	ARNT2	0.0	0.0	0.0	0.19	45.0	-32.0	6.0	45.0						0.274	0.96	0.000000000	0.998	1.176	nervous system phenotype ; mortality/aging ; cellular phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; 			caudate nucleus;temporal lobe;amygdala;prefrontal cortex;cingulate cortex;cerebellum peduncles;cerebellum;pons;occipital lobe;fetal brain;subthalamic nucleus;whole brain;parietal lobe;spinal cord;globus pallidus;medulla oblongata;hypothalamus;thalamus;	Renal cell carcinoma	response to hypoxia;in utero embryonic development;regulation of transcription, DNA-templated;xenobiotic metabolic process;central nervous system development;brain development;positive regulation of cell population proliferation;response to estradiol;negative regulation of apoptotic process;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II	nucleus;nucleoplasm;transcription factor complex;cytoplasm	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;protein binding;aryl hydrocarbon receptor binding;protein heterodimerization activity	USP7[16713569];LMO4[unassigned1304];LMO2[unassigned1304];OSGIN1[unassigned1304];DTX2[unassigned1304];FAAP20[unassigned1304];AP3M1[unassigned1304];BCL6[16147992];CAPN7[unassigned1304];PSMB1[unassigned1304];STK16[unassigned1304];TAX1BP3[21988832];SIM1[unassigned1304];SH3GL2[21988832];AP1M1[unassigned1304];	80872845
27916	chr15	81517710	G	A	chr15:81517710	IL16	interleukin 16	SNV	0/1	0.56	25_32	57	99.0	0/0	0.0	34_0	34	99.0			rs770980958	EXONIC	YES	NM_001352686.1	Transcript	protein_coding	synonymous_variant		2/19	NM_001352686.1:c.123G>A	NP_001339615.1:p.Arg41%3D		1.0						.	.	.		3.9412e-05	6.0	152238.0	0.0	32	0.97	PASS	sas	0.000206782	1.0	1.46955e-05	1.0	2.06683e-05	5.0	241916.0	0.0	39	0.75	PASS	amr	5.88443e-05	2.0	1.81604e-05	2.0	0.0000064	1	0.0	1.0	0.00054	1.0		14.89	1.243573		0	0	0																	0.717	0.0				immune system phenotype; hematopoietic system phenotype; 			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;cerebellum;	.	immune response;regulation of signaling receptor activity;viral process;cytokine-mediated signaling pathway;leukocyte chemotaxis;induction of positive chemotaxis;regulation of calcium ion transport	extracellular region;extracellular space;cytosol;plasma membrane;nuclear speck	cytokine activity;CD4 receptor binding	ZNF572[unassigned1304];SMARCB1[unassigned1304];KDM1A[23455924];CALCOCO2[unassigned1304];SUV39H1[23455924];PRDM6[unassigned1304];FHL5[unassigned1304];GABPB1[19060904;unassigned1304];MBD3L1[unassigned1304];GOLGA2[unassigned1304];EFEMP2[16189514;unassigned1304];SPRED1[unassigned1304];PSTPIP1[unassigned1304];CYSRT1[unassigned1304];GOLGA6L9[unassigned1304];MYC[21150319];DMRTB1[19060904];ZNF526[unassigned1304];SSSCA1[16189514];OIP5[unassigned1304];TRIM27[unassigned1304];KRTAP3-1[unassigned1304];KRTAP1-1[unassigned1304];TRIM23[unassigned1304];MYOG[unassigned1304];CARD10[unassigned1304];ZNF165[unassigned1304];ZBTB39[unassigned1304];LMO3[unassigned1304];PPP1R16A[unassigned1304];LGALS14[unassigned1304];MTUS2[unassigned1304];TFIP11[21516116;unassigned1304];KRT31[unassigned1304];MID2[unassigned1304];DUSP7[unassigned1304];KCTD9[unassigned1304];KIF16B[unassigned1304];ZNF835[unassigned1304];RAPGEF2[unassigned1304];PICK1[unassigned1304];TRIB3[unassigned1304];KIFC3[unassigned1304];RBCK1[unassigned1304];PFDN5[unassigned1304];BLZF1[unassigned1304];PRR13[unassigned1304];KANK2[unassigned1304];FTO[unassigned1304];ZNF474[unassigned1304];L3MBTL3[unassigned1304];USHBP1[16189514;unassigned1304];SNU13[30021884];JAKMIP1[unassigned1304];KRT86[unassigned1304];SERTAD3[unassigned1304];FAM124A[unassigned1304];SOHLH1[unassigned1304];MIER2[unassigned1304];CEP72[unassigned1304];TRIM42[unassigned1304];CCDC184[unassigned1304];ZIM2[unassigned1304];PDLIM7[unassigned1304];WWTR1[unassigned1304];ZNF143[unassigned1304];ZRANB1[unassigned1304];ZNF581[unassigned1304];KRTAP10-8[unassigned1304];DDIT4L[unassigned1304];WDYHV1[unassigned1304];HOOK2[unassigned1304];UBXN11[unassigned1304];TRIP6[21516116];NOXA1[unassigned1304];LNX1[unassigned1304];ZNF777[unassigned1304];CAMK1[unassigned1304];ZNF774[unassigned1304];	81517710
27969	chr15	86198827	GGTCGAGAAAGTGAG		chr15:86198827-86198841	AKAP13	A-kinase anchoring protein 13	deletion	0/1	0.3	78_33	111	99.0	0/1	0.36	79_45	124	99.0			rs534473998	EXONIC	YES	NM_006738.6	Transcript	protein_coding	inframe_deletion		11/37	NM_006738.6:c.4558_4572del	NP_006729.4:p.Gly1520_Glu1524del		1.0						.	.	.		0.0001117	17.0	152194.0	0.0	32	0.97	PASS	amr	0.000327225	5.0	0.000146981	10.0	9.14709e-05	23.0	251446.0	0.0	98	1.0	PASS	amr	0.000231267	8.0	0.000123092	14.0	0.0000193	3	0.0	1.0	0.00054	1.0		19.77	2.004455		0	0	0																	0.0693	0.85				growth/size/body region phenotype; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; immune system phenotype; embryo phenotype; mortality/aging ; reproductive system phenotype; cardiovascular system phenotype ; hematopoietic system phenotype; nervous system phenotype ; 			ciliary ganglion;uterus;dorsal root ganglion;skin;atrioventricular node;superior cervical ganglion;skeletal muscle;	.	protein phosphorylation;G protein-coupled receptor signaling pathway;heart development;positive regulation of Rho protein signal transduction;positive regulation of apoptotic process;positive regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of MAP kinase activity;regulation of small GTPase mediated signal transduction;nuclear export;cardiac muscle cell differentiation;regulation of sarcomere organization;bone development;cell growth involved in cardiac muscle cell development;adrenergic receptor signaling pathway;adenylate cyclase-activating adrenergic receptor signaling pathway involved in heart process;regulation of glucocorticoid mediated signaling pathway	nucleus;cytosol;actin filament;cell cortex;membrane;cortical actin cytoskeleton;perinuclear region of cytoplasm	cAMP-dependent protein kinase activity;MAP-kinase scaffold activity;guanyl-nucleotide exchange factor activity;Rho guanyl-nucleotide exchange factor activity;protein binding;Rho GTPase binding;protein-containing complex scaffold activity;metal ion binding;protein kinase A binding	RANBP2[20936779];THRA[9627117];APC[26496610];YWHAB[15324660;17353931;15691829];ANG[28777577];BAK1[17353931];MKI67[30021884];YWHAZ[15161933];ESR1[9627117];YWHAG[15324660;17353931];TGM2[16301118];	86198826
28126	chr15	99673100	G	A	chr15:99673100	SYNM	synemin	SNV	0/1	0.54	72_83	155	99.0	0/1	0.53	60_68	128	99.0			rs144209117	EXONIC	YES	NM_145728.3	Transcript	protein_coding	missense_variant		5/5	NM_145728.3:c.4532G>A	NP_663780.2:p.Gly1511Glu		1.0	.,.,.					.	.	.		0.00175531	267.0	152110.0	0.0	32	0.96	PASS	amr	0.00444968	68.0	0.00210257	143.0	0.00173819	433.0	249110.0	0.0	100	1.0	PASS	amr	0.0032445	112.0	0.00213444	241.0	0.0015562	242	0.01	33.0	0.0071	81.0		2.651	0.001853		1	16	17	M-CAP_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SYNM	0.0	0.0	0.0	0.0	-16.0	-29.0	22.0	-29.0							0.0	0.000000000	0.005	0.156	growth/size/body region phenotype; muscle phenotype; behavior/neurological phenotype ; cardiovascular system phenotype ; 			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;prostate;spinal cord;skeletal muscle;	.	fast-twitch skeletal muscle fiber contraction;intermediate filament cytoskeleton organization	intermediate filament;adherens junction;sarcolemma;costamere;neurofilament cytoskeleton	structural constituent of cytoskeleton;protein binding;structural constituent of muscle;vinculin binding;intermediate filament binding	DTNA[11353857];CEP135[26638075];CSNK2A2[26496610];FGFR1OP[26496610];FLNC[25447537];DISC1[25447537];SKA1[26496610];TTN[25447537];	99673100
28132	chr15	99758801	T	C	chr15:99758801	TTC23	tetratricopeptide repeat domain 23	SNV	0/1	0.55	22_27	49	99.0	0/1	0.61	7_11	18	99.0			rs773190522	EXONIC	YES	NM_001288615.3	Transcript	protein_coding	synonymous_variant		8/14	NM_001288615.3:c.573A>G	NP_001275544.1:p.Ser191%3D		-1.0						.	.	.		8.5405e-05	13.0	152216.0	0.0	32	0.97	PASS	amr	0.000719801	11.0	0.0	0.0	5.17059e-05	13.0	251422.0	0.0	69	1.0	PASS	amr	0.000260206	9.0	2.63769e-05	3.0	0.0000129	2	0.0	1.0				9.777	0.540574		0	0	0			TTC23	0.0	0.0	0.03	0.0	48.0	-8.0	-8.0	-3.0						0.988	0.0	78.268432150			.			superior cervical ganglion;	.	.	.	protein binding	CREBZF[25416956;unassigned1304];ALAS1[25416956];TRIM74[unassigned1304];PRDM6[unassigned1304];EFCAB3[unassigned1304];HSF2BP[unassigned1304];IKZF3[unassigned1304];CCDC102B[unassigned1304];GOLGA2[25416956;unassigned1304];ZFYVE26[unassigned1304];CYSRT1[unassigned1304];GOLGA6L9[unassigned1304];KRT27[unassigned1304];LZTS2[25416956;unassigned1304];GPRASP2[unassigned1304];CCDC155[unassigned1304];PLEKHG4[unassigned1304];GRIPAP1[unassigned1304];PRKAB2[unassigned1304];SPAG11B[unassigned1304];PPP1R16A[unassigned1304];IQCE[unassigned1304];MTUS2[unassigned1304];KRT34[unassigned1304];LDOC1[25416956;unassigned1304];TRAF2[unassigned1304];KRT31[25416956;unassigned1304];ZDHHC17[24705354];MID2[unassigned1304];KLHL42[unassigned1304];AES[unassigned1304];RAD51D[unassigned1304];GPANK1[unassigned1304];TRAPPC6A[unassigned1304];TEX13A[unassigned1304];XRN2[unassigned1304];KRT36[unassigned1304];PIH1D2[unassigned1304];PICK1[unassigned1304];TRIB3[unassigned1304];RBCK1[unassigned1304];TRIM54[25416956;unassigned1304];TRIM10[25416956];SSX2IP[25416956];MDFI[25416956;unassigned1304];BLZF1[unassigned1304];MAGED1[25416956;unassigned1304];CCDC24[unassigned1304];TSGA10IP[unassigned1304];USHBP1[unassigned1304];HTT[23275563];ZBTB42[unassigned1304];XIAP[unassigned1304];CCNDBP1[25416956];MESD[unassigned1304];KRT40[25416956];MED12L[unassigned1304];PSORS1C2[unassigned1304];KIAA1328[unassigned1304];PNMA1[unassigned1304];NOTO[unassigned1304];ZBED1[unassigned1304];FSD2[unassigned1304];SMN1[unassigned1304];DISC1[unassigned1304];CDR2[unassigned1304];BANP[unassigned1304];SPDEF[unassigned1304];PRPH[unassigned1304];CBX8[unassigned1304];MBD3[unassigned1304];POLR2J3[unassigned1304];CDK18[unassigned1304];ZFHX3[unassigned1304];SPAG8[unassigned1304];SPAG5[25416956];ZBTB16[unassigned1304];KRTAP10-8[unassigned1304];PNMA5[25416956];POU6F2[unassigned1304];TADA2A[25416956];HOOK2[unassigned1304];UBXN11[unassigned1304];KRT16[unassigned1304];KRT15[unassigned1304];BHLHE40[25416956];TRIP6[unassigned1304];ABI1[unassigned1304];LCN2[unassigned1304];MKRN3[unassigned1304];CNTROB[25416956];TRIM32[unassigned1304];ZBTB8B[unassigned1304];	99758801
28171	chr15	101565169	C	T	chr15:101565169	LRRK1	leucine rich repeat kinase 1	SNV	0/1	0.58	27_37	64	99.0	0/0	0.0	35_0	35	99.0			rs367700715,COSV52605816	EXONIC	YES	NM_024652.6	Transcript	protein_coding	synonymous_variant		16/34	NM_024652.6:c.2229C>T	NP_078928.3:p.Ile743%3D		1.0					Osteosclerotic metaphyseal dysplasia, 615198 (3), Autosomal recessive	Osteosclerotic metaphyseal dysplasia	Disease-causing germline mutation(s) in	.		5.25762e-05	8.0	152160.0	0.0	32	0.97	PASS	nfe	8.8199e-05	6.0	8.8199e-05	6.0	9.27232e-05	23.0	248050.0	0.0	53	0.98	PASS	nfe	0.000177604	20.0	0.000177604	20.0	0.0000643	10						11.75	0.773952		0	0	0			LRRK1	0.0	0.0	0.0	0.0	-35.0	-17.0	-2.0	3.0						0.478	0.0	17.006969425			hematopoietic system phenotype; mortality/aging ; behavior/neurological phenotype ; skeleton phenotype; renal/urinary system phenotype; immune system phenotype; vision/eye phenotype; limbs/digits/tail phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; 			ciliary ganglion;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	.	protein phosphorylation;osteoclast development;bone resorption;positive regulation of peptidyl-tyrosine phosphorylation;negative regulation of peptidyl-tyrosine phosphorylation;positive regulation of canonical Wnt signaling pathway;positive regulation of intracellular signal transduction	mitochondrion;cytosol	protein serine/threonine kinase activity;protein binding;ATP binding;GTP binding;identical protein binding;metal ion binding	RET[24947832];HSP90AB1[24947832];TCF25[24947832];LRRK2[19712061;20144646];RPLP1[24947832];FLT4[24947832];LRRK1[22952686;19712061];CBLB[24947832];RIMS1[17353931];TRMT112[24947832];NEK1[24947832];SPTAN1[24947832];CHGB[24947832];CDK5RAP2[26192437];DAPK1[19712061];EPHA8[24947832];LMAN1L[24947832];TUBB[24947832];MATK[24947832];CKAP2[24947832];ACTN4[24947832];NUDT16L1[24947832];TIRAP[24947832];FOXP1[24947832];BCR[20697350];GAK[24947832];KIAA1217[24947832];VGF[24947832];Tcr-alpha[17353931];CDC42EP3[24947832];CD2BP2[24947832];S100A8[17353931];DBN1[24947832];VGLL4[24947832];GNAZ[24947832];ECHS1[24947832];SHC1[24947832];EGFR[24947832];C9orf163[17353931];SCEL[24947832];BLOC1S5[24947832];BAG5[24510904;24947832];BAG2[24947832];BAG3[24947832];BAG1[24947832];ABL1[20697350;24947832];PAK6[24947832];GPBP1L1[24947832];SNX9[24947832];SPTBN1[24947832];PAK4[17353931];CLVS1[24947832];POLR2M[24947832];HSPA8[24510904;24947832];CCL21[24947832];ODF2[24947832];TEX33[24947832];PLK1[26192437];SNX21[24947832];CWC15[24947832];LYZ[17353931];TUBB4B[24947832];ITCH[24947832];PDCD4[24947832];GRB2[19380743;24947832];STUB1[24947832];FGFR2[24947832];	101565169
28172	chr15	101592118	G	A	chr15:101592118	LRRK1	leucine rich repeat kinase 1	SNV	0/1	0.42	54_40	95	99.0	0/0	0.0	37_0	37	99.0			rs375373859,COSV99439920	EXONIC	YES	NM_024652.6	Transcript	protein_coding	synonymous_variant		24/34	NM_024652.6:c.3642G>A	NP_078928.3:p.Pro1214%3D		1.0					Osteosclerotic metaphyseal dysplasia, 615198 (3), Autosomal recessive	Osteosclerotic metaphyseal dysplasia	Disease-causing germline mutation(s) in	.		6.57013e-05	10.0	152204.0	0.0	33	0.98	PASS	eas	0.00019253	1.0	0.000102917	7.0	0.000104332	26.0	249204.0	0.0	61	0.99	PASS	nfe	0.000194584	22.0	0.000194584	22.0	0.0000643	10						3.484	0.053592		0	0	0			LRRK1	0.0	0.0	0.0	0.0	7.0	-21.0	42.0	47.0						0.478	0.0	24.151647419			hematopoietic system phenotype; mortality/aging ; behavior/neurological phenotype ; skeleton phenotype; renal/urinary system phenotype; immune system phenotype; vision/eye phenotype; limbs/digits/tail phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; 			ciliary ganglion;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	.	protein phosphorylation;osteoclast development;bone resorption;positive regulation of peptidyl-tyrosine phosphorylation;negative regulation of peptidyl-tyrosine phosphorylation;positive regulation of canonical Wnt signaling pathway;positive regulation of intracellular signal transduction	mitochondrion;cytosol	protein serine/threonine kinase activity;protein binding;ATP binding;GTP binding;identical protein binding;metal ion binding	RET[24947832];HSP90AB1[24947832];TCF25[24947832];LRRK2[19712061;20144646];RPLP1[24947832];FLT4[24947832];LRRK1[22952686;19712061];CBLB[24947832];RIMS1[17353931];TRMT112[24947832];NEK1[24947832];SPTAN1[24947832];CHGB[24947832];CDK5RAP2[26192437];DAPK1[19712061];EPHA8[24947832];LMAN1L[24947832];TUBB[24947832];MATK[24947832];CKAP2[24947832];ACTN4[24947832];NUDT16L1[24947832];TIRAP[24947832];FOXP1[24947832];BCR[20697350];GAK[24947832];KIAA1217[24947832];VGF[24947832];Tcr-alpha[17353931];CDC42EP3[24947832];CD2BP2[24947832];S100A8[17353931];DBN1[24947832];VGLL4[24947832];GNAZ[24947832];ECHS1[24947832];SHC1[24947832];EGFR[24947832];C9orf163[17353931];SCEL[24947832];BLOC1S5[24947832];BAG5[24510904;24947832];BAG2[24947832];BAG3[24947832];BAG1[24947832];ABL1[20697350;24947832];PAK6[24947832];GPBP1L1[24947832];SNX9[24947832];SPTBN1[24947832];PAK4[17353931];CLVS1[24947832];POLR2M[24947832];HSPA8[24510904;24947832];CCL21[24947832];ODF2[24947832];TEX33[24947832];PLK1[26192437];SNX21[24947832];CWC15[24947832];LYZ[17353931];TUBB4B[24947832];ITCH[24947832];PDCD4[24947832];GRB2[19380743;24947832];STUB1[24947832];FGFR2[24947832];	101592118
28196	chr15	102346082	C	T	chr15:102346082	OR4F6	olfactory receptor family 4 subfamily F member 6	SNV	0/0	0.0	36_0	36	99.0	0/1	0.39	50_32	82	99.0			rs141580524,COSV61026862	EXONIC	YES	NM_001005326.2	Transcript	protein_coding	missense_variant		2/2	NM_001005326.2:c.160C>T	NP_001005326.1:p.Arg54Cys		1.0	GPCR, rhodopsin-like, 7TM					.	.	.		0.00271425	413.0	152160.0	1.0	32	0.96	PASS	amr	0.00660995	101.0	0.00390981	266.0	0.00218707	550.0	251478.0	1.0	100	1.0	PASS	nfe	0.00356025	405.0	0.00356025	405.0	0.0019614	305	0.012	38.0				15.86	1.425911	0.167	2	17	19	SIFT,PROVEAN_pred	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR4F6	0.01	0.0	0.01	0.0	9.0	-46.0	-16.0	16.0						0.717	0.0	0.000000000	0.085	0.052	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	102346082
28208	chr16	226808	GAGGT		chr16:226808-226812	HBA1	hemoglobin subunit alpha 1	deletion	0/1	0.41	24_17	41	99.0	0/1	0.27	22_8	30	99.0			rs1181505507	SPLICING	YES	NM_000558.5	Transcript	protein_coding	splice_donor_variant,coding_sequence_variant	1/2	1/3	NM_000558.5:c.95+2_95+6del			1.0		Likely_pathogenic	criteria_provided,_multiple_submitters,_no_conflicts	alpha_Thalassemia|not_provided	Hemoglobin H disease, nondeletional, 613978 (3); Thalassemias, alpha-, 604131 (3); Heinz body anemias, alpha-, 140700 (3), Autosomal dominant; Methemoglobinemia, alpha type, 617973 (3), Autosomal dominant; Erythrocytosis 7, 617981 (3), Autosomal dominant	Hb Bart's hydrops fetalis;Hemoglobin M disease;Hemoglobin H disease;Alpha-thalassemia-intellectual disability syndrome linked to chromosome 16	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Role in the phenotype of	Splenomegaly;HbH hemoglobin;Reduced alpha/beta synthesis ratio;Hemolytic anemia;Hepatomegaly;Abnormal hemoglobin;Hydrops fetalis;Congestive heart failure;Hepatomegaly;Preeclampsia;Pallor;Splenomegaly;Pericarditis;Polyhydramnios;Anemia;Hydrocephalus;Oligohydramnios;Heinz body anemia;Abnormality of metabolism/homeostasis;Nonspherocytic hemolytic anemia;Autosomal dominant inheritance;Heinz bodies;Hypochromic microcytic anemia;Reduced alpha/beta synthesis ratio;Aplasia/Hypoplasia of the earlobes;Wide nasal bridge;Flexion contracture;Failure to thrive;Pectus carinatum;Epicanthus;Short stature;Cryptorchidism;Short neck;Underdeveloped supraorbital ridges;Malar flattening;High forehead;Short toe;High palate;Muscular hypotonia;HbH hemoglobin;Neurological speech impairment;Bruising susceptibility;Micrognathia;Downslanted palpebral fissures;Microcephaly;Broad forehead;Hypertelorism;Intellectual disability;Fatigue;Talipes equinovarus;Aplasia/Hypoplasia of the eyebrow;Low-set, posteriorly rotated ears;Hypospadias;Frontal bossing;Microcytic anemia;Retrognathia		2.75744e-05	4.0	145062.0	0.0	28	0.8	AS_VQSR	amr	6.76407e-05	1.0	4.56302e-05	3.0	6.58319e-06	1.0	151902.0	0.0	44	0.57	RF				0.0	0.0								23.7	3.056222		0	0	0																		0.51				.			.	.	receptor-mediated endocytosis;positive regulation of cell death;oxygen transport;bicarbonate transport;response to hydrogen peroxide;hydrogen peroxide catabolic process;protein heterooligomerization;cellular oxidant detoxification	extracellular region;extracellular space;cytosol;hemoglobin complex;membrane;cytosolic small ribosomal subunit;haptoglobin-hemoglobin complex;extracellular exosome;endocytic vesicle lumen;blood microparticle	peroxidase activity;oxygen carrier activity;iron ion binding;protein binding;oxygen binding;heme binding;haptoglobin binding;organic acid binding	ATF2[22304920];PTEN[16169070];HBB[16169070;1552945;9441940;9830011;9894000;10390349;10930828;11724557;15835899;6683087;unassigned1304;29997244];DLST[29128334];UBE3A[21900206];HBD[unassigned1304];MKI67[26949251];HSD17B10[29128334];KRT40[25416956];SYNCRIP[26496610];CYB5R3[23123858];AHSP[15550245;25156257];HBQ1[unassigned1304];CTSD[17112520];IQCB1[21565611];DAXX[21988832];VCAM1[22623428];HBG2[881729;unassigned1304];ATP6AP1[16169070];CCDC57[25416956];NOS3[23123858];HBE1[11159543;unassigned1304];HLA-B[17353931];APOA1[15174051];KRT34[unassigned1304];NAP1L1[16169070];TSC1[17355907];NOTCH2NLA[unassigned1304];KRT31[unassigned1304];DNAJC5[29997244];HSPA1A[25156257];	226807
28448	chr16	2025255	G	A	chr16:2025255	TBL3	transducin beta like 3	SNV	0/1	0.45	60_50	110	99.0	0/1	0.56	46_58	104	99.0			rs35265313,COSV99049611	EXONIC	YES	NM_006453.3	Transcript	protein_coding	missense_variant		8/22	NM_006453.3:c.703G>A	NP_006444.2:p.Val235Met		1.0	WD40-repeat-containing domain,WD40-repeat-containing domain					.	.	.		0.00224631	342.0	152250.0	3.0	33	0.97	PASS	amr	0.00464417	71.0	0.00307118	209.0	0.00239992	603.0	251258.0	3.0	100	1.0	PASS	amr	0.00439433	152.0	0.00306403	348.0	0.0021479	334	0.009	28.0				24.3	3.270722	0.2	11	10	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LRT_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	TBL3	0.01	0.0	0.0	0.0	-27.0	-1.0	1.0	-1.0						0.681	0.0	0.000000000	0.922	1.172	.			thyroid;testis - seminiferous tubule;liver;atrioventricular node;prostate;testis;heart;	.	maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);rRNA processing	nucleus;nucleoplasm;nucleolus;small-subunit processome;Pwp2p-containing subcomplex of 90S preribosome	RNA binding;protein binding	ITSN2[16169070];NOP56[26496610];USP36[19615732];NUDC[25036637];JUN[25609649];URM1[16169070];USP11[16169070];CEP164[26638075];RPS6[29568061];HNRNPU[26496610];RRP1B[20926688];MKI67[26949251];AURKB[16169070];FBL[29568061];EXOSC5[26496610];CACNB4[16169070];APPBP2[16189514;25416956];IFI16[25665578];SFN[16189514];MNDA[25665578];EXOSC1[26496610];	2025255
28453	chr16	2027195	C	T	chr16:2027195	TBL3	transducin beta like 3	SNV	0/1	0.58	57_78	135	99.0	0/1	0.49	59_56	115	99.0			rs148169075	EXONIC	YES	NM_006453.3	Transcript	protein_coding	synonymous_variant		15/22	NM_006453.3:c.1581C>T	NP_006444.2:p.Val527%3D		1.0						.	.	.		0.0016822	256.0	152182.0	1.0	33	0.97	PASS	amr	0.0042556	65.0	0.00211684	144.0	0.00183508	459.0	250126.0	3.0	87	0.99	PASS	amr	0.00419827	145.0	0.0019861	224.0	0.0017106	266	0.008	25.0				6.195	0.224345		0	0	0			TBL3	0.04	0.11	0.01	0.0	22.0	-25.0	-7.0	21.0						0.681	0.0	66.323177249			.			thyroid;testis - seminiferous tubule;liver;atrioventricular node;prostate;testis;heart;	.	maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);rRNA processing	nucleus;nucleoplasm;nucleolus;small-subunit processome;Pwp2p-containing subcomplex of 90S preribosome	RNA binding;protein binding	ITSN2[16169070];NOP56[26496610];USP36[19615732];NUDC[25036637];JUN[25609649];URM1[16169070];USP11[16169070];CEP164[26638075];RPS6[29568061];HNRNPU[26496610];RRP1B[20926688];MKI67[26949251];AURKB[16169070];FBL[29568061];EXOSC5[26496610];CACNB4[16169070];APPBP2[16189514;25416956];IFI16[25665578];SFN[16189514];MNDA[25665578];EXOSC1[26496610];	2027195
28460	chr16	2042766	C	G	chr16:2042766	SYNGR3	synaptogyrin 3	SNV	0/1	0.49	38_37	75	99.0	0/1	0.4	34_23	57	99.0			rs746642045,COSV50192692	EXONIC	YES	NM_004209.6	Transcript	protein_coding	missense_variant		3/4	NM_004209.6:c.467C>G	NP_004200.2:p.Ser156Cys		1.0	Marvel domain&Marvel domain					.	.	.		1.31465e-05	2.0	152132.0	0.0	33	0.99	PASS	nfe	2.9417e-05	2.0	2.9417e-05	2.0	2.85861e-05	5.0	174910.0	0.0	15	0.32	PASS	amr	0.000184966	5.0	0.0	0.0	0.0000129	2	0.001	2.0				25.7	3.676923	0.595	15	6	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	SYNGR3	0.0	0.0	0.0	0.0	1.0	-8.0	13.0	17.0							0.29	0.000000000	0.99	1.012	behavior/neurological phenotype ; nervous system phenotype ; 			caudate nucleus;temporal lobe;amygdala;prefrontal cortex;cingulate cortex;cerebellum peduncles;cerebellum;pons;fetal brain;occipital lobe;subthalamic nucleus;whole brain;placenta;parietal lobe;globus pallidus;hypothalamus;medulla oblongata;thalamus;	.	substantia nigra development;positive regulation of transporter activity;regulated exocytosis	synaptic vesicle;integral component of membrane;cell junction;synaptic vesicle membrane;neuromuscular junction	SH2 domain binding;protein N-terminus binding	SH3GLB1[unassigned1304];MPP1[unassigned1304];NDRG4[unassigned1304];MIDN[unassigned1304];PNKP[unassigned1304];GAD2[unassigned1304];ACSF2[unassigned1304];IRF3[25609649];EHHADH[unassigned1304];TTPA[unassigned1304];HSBP1L1[unassigned1304];PLIN3[unassigned1304];ARFIP1[unassigned1304];SPG21[unassigned1304];	2042766
28533	chr16	2229038	GCG		chr16:2229038-2229040	CASKIN1	CASK interacting protein 1	deletion	0/0	0.0	23_0	23	0.0	0/1	0.22	17_5	23	99.0			rs553373927	EXONIC	YES	NM_020764.4	Transcript	protein_coding	inframe_deletion		19/20	NM_020764.4:c.4062_4064del	NP_065815.1:p.Ala1355del		-1.0						.	.	.		0.00105213	154.0	146370.0	0.0	32	0.88	PASS	eas	0.00217134	11.0	0.00106028	70.0	0.0	0.0	110.0	0.0	0	0.0	AC0				0.0	0.0			0.001	2.0				10.99	0.680606		0	0	0			CASKIN1	0.0	0.0	0.0	0.0	-20.0	-32.0	-20.0	-32.0							1.0				homeostasis/metabolism phenotype; integument phenotype ; endocrine/exocrine gland phenotype; pigmentation phenotype; renal/urinary system phenotype; mortality/aging ; reproductive system phenotype; 			.	.	signal transduction	cytoplasm;membrane	protein binding;identical protein binding	CASKIN1[21763699;22153505];CASK[21763699;22153505];	2229037
28564	chr16	2287649	A	C	chr16:2287649	DNASE1L2	deoxyribonuclease 1 like 2	SNV	0/1	0.43	50_38	88	99.0	0/1	0.57	44_62	108	99.0			rs62621282,CM1314355,COSV100065821	SPLICING	YES	NM_001374.3	Transcript	protein_coding	missense_variant,splice_region_variant		5/7	NM_001374.3:c.590A>C	NP_001365.1:p.Asp197Ala		1.0	Endonuclease/exonuclease/phosphatase,.,Endonuclease/exonuclease/phosphatase,Endonuclease/exonuclease/phosphatase,.,.					.	.	.		0.00278176	423.0	152062.0	1.0	33	0.97	PASS	amr	0.00536649	82.0	0.0041033	279.0	0.00277996	657.0	236334.0	4.0	32	0.82	PASS	amr	0.00542485	184.0	0.00355488	376.0	0.0025723	400	0.009	30.0				27.6	3.984115	0.582	11	9	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,DEOGEN2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	DNASE1L2	0.0	0.0	0.0	0.1	1.0	36.0	-12.0	1.0	0.99657510705792	0.91	5.129	1.969	7.098	0.532	0.0	0.000000000	0.645	1.29	integument phenotype ; growth/size/body region phenotype; adipose tissue phenotype ; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; skeleton phenotype; renal/urinary system phenotype; behavior/neurological phenotype ; hematopoietic system phenotype; cardiovascular system phenotype ; limbs/digits/tail phenotype; nervous system phenotype ; hearing/vestibular/ear phenotype; digestive/alimentary phenotype; vision/eye phenotype; immune system phenotype; 			superior cervical ganglion;	.	DNA catabolic process, endonucleolytic;hair follicle development;corneocyte development;DNA metabolic process;DNA catabolic process	extracellular region;nucleus;cytoplasm	DNA binding;deoxyribonuclease I activity;deoxyribonuclease activity;calcium ion binding	ABL1[17474147];FYN[17474147];	2287649
28610	chr16	2818191	C	T	chr16:2818191	SRRM2	serine/arginine repetitive matrix 2	SNV	0/1	0.47	43_38	81	99.0	0/1	0.42	34_25	59	99.0			rs148768052	EXONIC	YES	NM_016333.4	Transcript	protein_coding	synonymous_variant		11/15	NM_016333.4:c.7662C>T	NP_057417.3:p.Ser2554%3D		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.000289059	44.0	152218.0	0.0	31	0.95	PASS	nfe	0.000484923	33.0	0.000484923	33.0	0.000180579	44.0	243660.0	0.0	37	0.85	PASS	nfe	0.000331303	36.0	0.000331303	36.0	0.0001929	30	0.0	1.0				0.038	-0.614817		0	0	0			SRRM2	0.0	0.0	0.0	0.0	15.0	39.0	15.0	-22.0						0.174		3.896359401			.			superior cervical ganglion;cingulate cortex;prostate;skeletal muscle;adrenal cortex;	.	mRNA splicing, via spliceosome	nucleus;nucleoplasm;Cajal body;nuclear speck;U2-type catalytic step 2 spliceosome;catalytic step 2 spliceosome	RNA binding;protein N-terminus binding;C2H2 zinc finger domain binding	YWHAB[15324660;17353931];EIF4A3[23084401];HDAC11[23752268];ILK[25852190];ARRB1[17620599];ARRB2[17620599];DDX41[25920683];OSBPL10[19615732];MAP1LC3B[20562859];MAP1LC3A[20562859];MAGOH[23084401];SNIP1[22365833];HIF1AN[29426014];YWHAG[15324660;17353931];YWHAH[26496610];USP42[19615732];CSNK2A1[22113938;25852190];PRPF4B[23602568];YWHAZ[15161933];PRPF6[22365833];MAGEB2[17353931];SRSF4[22365833];SF1[26420826];PFKFB2[26496610];HDAC2[23752268];RPL10[30021884];GABARAP[20562859];HDAC6[23752268];NUAK1[25852190];RASSF10[24366813];IFI16[25665578];EPB41L3[24366813];SFN[15778465];BAK1[17353931];TTC14[22365833];SRPK2[23602568];SRPK3[23602568];SF3A2[17332742];NEK4[25798074];PYHIN1[25665578];ESR1[21182205];CLK4[23602568];ESR2[21182203;25604459];CLK3[23602568];PLEKHA7[28877994];SRPK1[23602568;25852190];SNW1[20467437];RNPS1[17353931];PTPN4[28330616];PTPN3[28330616];	2818191
28616	chr16	2949149	A	G	chr16:2949149	FLYWCH2	FLYWCH family member 2	SNV	0/1	0.46	38_33	71	99.0	0/1	0.45	30_25	56	99.0			rs143698118	EXONIC	YES	NM_001142500.1	Transcript	protein_coding	stop_retained_variant		4/4	NM_001142500.1:c.422A>G	NP_001135972.1:p.Ter141%3D		1.0						.	.	.		0.00291225	443.0	152116.0	0.0	33	0.96	PASS	nfe	0.00521829	355.0	0.00521829	355.0	0.0027599	682.0	247110.0	3.0	26	0.79	PASS	nfe	0.00476873	532.0	0.00476873	532.0	0.0028552	444	0.003	10.0				2.293	-0.022859		0	0	0			FLYWCH2	0.0	0.0	0.0	0.0	47.0	14.0	27.0	-13.0						0.273	0.58	43.835265295			.			whole brain;	.	biological_process	cellular_component	RNA binding	OTUB1[26752685];	2949149
28661	chr16	3108904	C	T	chr16:3108904	MMP25	matrix metallopeptidase 25	SNV	0/1	0.51	65_69	134	99.0	0/1	0.39	61_40	102	99.0			rs200461438	EXONIC	YES	NM_022468.5	Transcript	protein_coding	synonymous_variant		10/10	NM_022468.5:c.1494C>T	NP_071913.1:p.Pro498%3D		1.0						Hypomaturation amelogenesis imperfecta	Disease-causing germline mutation(s) in	Amelogenesis imperfecta;Autosomal recessive inheritance;Anterior open bite		0.00348961	531.0	152166.0	2.0	31	0.94	PASS	nfe	0.00646964	440.0	0.00646964	440.0	0.00347075	541.0	155874.0	2.0	18	0.48	PASS	nfe	0.00650313	386.0	0.00650313	386.0	0.0019356	301	0.003	9.0				5.392	0.170373		0	0	0			MMP25	0.0	0.0	0.0	0.0	-29.0	4.0	-31.0	7.0						0.859	0.0	0.000000000			.			ciliary ganglion;superior cervical ganglion;cingulate cortex;atrioventricular node;whole blood;skeletal muscle;globus pallidus;thalamus;	.	proteolysis;inflammatory response;extracellular matrix organization;collagen catabolic process;neutrophil degranulation;hard palate development	extracellular space;plasma membrane;membrane;integral component of membrane;extracellular matrix;anchored component of membrane;specific granule membrane	metalloendopeptidase activity;zinc ion binding	MEOX2[unassigned1304];	3108904
28754	chr16	3808053	A	AA	chr16:3808053	CREBBP	CREB binding protein	sequence_alteration	0/1	0.1	20_8_4	39	90.0	0/2	0.19	24_5_7	36	33.0			rs75459669	SPLICING	YES	NM_004380.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	17/30		NM_004380.3:c.3370-4dup			-1.0		Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	History_of_neurodevelopmental_disorder|not_specified|not_provided	Menke-Hennekam syndrome 1, 618332 (3), Autosomal dominant; Rubinstein-Taybi syndrome 1, 180849 (3), Autosomal dominant	Acute myeloid leukemia with t(8;16)(p11;p13) translocation;Rubinstein-Taybi syndrome due to CREBBP mutations;Rubinstein-Taybi syndrome due to 16p13.3 microdeletion	Part of a fusion gene in;Disease-causing germline mutation(s) in;Role in the phenotype of	Abnormal number of teeth;Hypoplastic iliac wing;Patent ductus arteriosus;Joint laxity;Sporadic;Failure to thrive;Ventricular septal defect;Hyperactivity;Short attention span;Feeding difficulties in infancy;Unsteady gait;Abnormality of the kidney;Highly arched eyebrow;Bimanual synkinesia;Plantar crease between first and second toes;Pectus excavatum;Agoraphobia;Papillary cystadenoma of the epididymis;Intellectual disability;Frontal bossing;Hypoplasia of the maxilla;Agenesis of corpus callosum;Low posterior hairline;Avascular necrosis of the capital femoral epiphysis;Radial deviation of thumb terminal phalanx;Abnormality of refraction;Joint hypermobility;Microcephaly;Abnormality of the cervical spine;Dental crowding;Duplication of phalanx of hallux;Hyperreflexia;Polyhydramnios;Scoliosis;Low hanging columella;Syndactyly;Laryngomalacia;Clinodactyly of the 5th finger;Coloboma;Bifid uterus;Postnatal growth retardation;Variable expressivity;Muscular hypotonia;Thick eyebrow;Cryptorchidism;Long eyelashes;Tethered cord;Talon cusp;Downslanted palpebral fissures;Keloids;Seizure;Delayed skeletal maturation;Vascular ring;Flared iliac wings;Delayed cranial suture closure;Chorioretinal dystrophy;Prominent fingertip pads;Wide nasal bridge;Deviated nasal septum;Premature thelarche;Poor coordination;Self-mutilation;Capillary hemangioma;Proptosis;Deeply set eye;Glaucoma;Delayed speech and language development;Hypoplasia of dental enamel;Spina bifida occulta;Autism;High axial triradius;Single transverse palmar crease;Hypospadias;Heterogeneous;Respiratory distress;Duane anomaly;Impulsivity;Shawl scrotum;Cafe-au-lait spot;Low-set ears;Aganglionic megacolon;Hearing impairment;Hirsutism;Truncal obesity;Stereotypy;Patellar dislocation;Wide anterior fontanel;Pes planus;Ptosis;Parietal foramina;Abnormal cornea morphology;Arrhythmia;Low anterior hairline;Polydactyly;Facial grimacing;Short stature;Leukemia;Abnormality of the pinna;Generalized hypotonia;Narrow palate;Phonophobia;Large foramen magnum;Flexion contracture;Recurrent upper respiratory tract infections;Dental malocclusion;Epicanthus;High palate;Micrognathia;Constipation;Dislocated radial head;Nasolacrimal duct obstruction;Atrial septal defect;Autosomal dominant inheritance;Narrow mouth;Broad thumb;Cataract;EEG abnormality;Obstructive sleep apnea;Broad hallux;Convex nasal ridge;Retrognathia;Frontal upsweep of hair		0.00213193	304.0	142594.0	0.0	30	0.71	PASS	amr	0.00226116	32.0	0.00199277	129.0	0.152574	18780.0	123088.0	0.0	39	0.92	InbreedingCoeff	amr	0.213128	3445.0	0.164396	8108.0	0.0002379,0.0000965,0.0000064,0.0608152	37,15,1,9457			0.01882	206.0		10.77	0.654452		0	0	0			CREBBP	0.0	0.0	0.0	0.0	-3.0	-24.0	-17.0	-24.0						0.0011	1.0				homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype ; respiratory system phenotype; embryo phenotype; skeleton phenotype; immune system phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype ; neoplasm; cardiovascular system phenotype ; hematopoietic system phenotype; normal phenotype; mortality/aging ; behavior/neurological phenotype ; liver/biliary system phenotype; 			skeletal muscle;medulla oblongata;cerebellum;	Neurodegenerative Diseases;Cell cycle;Wnt signaling pathway;Notch signaling pathway;TGF-beta signaling pathway;Adherens junction;Jak-STAT signaling pathway;Long-term potentiation;Melanogenesis;Huntington's disease;Renal cell carcinoma;Prostate cancer	negative regulation of transcription by RNA polymerase II;response to hypoxia;stimulatory C-type lectin receptor signaling pathway;regulation of transcription, DNA-templated;transcription initiation from RNA polymerase II promoter;protein acetylation;signal transduction;Notch signaling pathway;positive regulation of transcription of Notch receptor target;regulation of smoothened signaling pathway;viral process;histone acetylation;N-terminal peptidyl-lysine acetylation;regulation of lipid metabolic process;positive regulation of transforming growth factor beta receptor signaling pathway;protein destabilization;positive regulation of type I interferon production;cellular response to UV;homeostatic process;embryonic digit morphogenesis;regulation of apoptotic process;regulation of myeloid cell differentiation;positive regulation of Notch signaling pathway;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;rhythmic process;regulation of transcription from RNA polymerase II promoter in response to hypoxia;protein-containing complex assembly;regulation of cellular response to heat;beta-catenin-TCF complex assembly	histone acetyltransferase complex;nuclear chromatin;nucleus;nucleoplasm;cytoplasm;nuclear body	proximal promoter sequence-specific DNA binding;RNA polymerase II transcription factor binding;RNA polymerase II activating transcription factor binding;p53 binding;chromatin binding;damaged DNA binding;transcription coactivator activity;transcription corepressor activity;histone acetyltransferase activity;protein binding;transcription factor binding;zinc ion binding;acetyltransferase activity;peptide N-acetyltransferase activity;MRF binding	CRTC2[17476304];CDKN1A[25241761];GTF2B[10196247];RORC[20203100];IKBKB[11971985;25241761];EIF4ENIF1[unassigned1312];SUMO1[23395904];MYB[16799563];RUVBL1[18087039];AKT1[23434580];EP300[25314079];IKBKG[11971985];TRIM21[11971985];SOX4[19234109];MAP3K5[20936779];NCOA1[11971985;11113179;12482968];IFNAR2[17923090];NCOA2[11971985];SREBF1[16799563];DAXX[11799127];CHUK[11971985];KSR1[27086506];NCOA6[10866662;12482968];NCOA3[11971985;26267537];ITPK1[22308441];DYRK1A[23602568];DYRK1B[23602568];SREBF2[16799563];RUNX1[16917507];NISCH[unassigned1312];KAT2B[9687513;8684459];AR[20541699];MARF1[unassigned1312];CREB1[17476304;20541704;16799563];IRF3[18309294;20581830;21903422;16154084;23746807];IRF5[18836453];SOWAHA[unassigned1312];PPARA[21775429];TP53[10823891;9194564;10196247;25314079;19234109;19805293];ATF4[25241761];PPARD[21775429];KHDRBS1[12496368];HTT[10823891;17500595];FOXO3[15126506;25609649];GATA2[18250304];HIF1A[17382325;21602890];RELA[16291753;17362989];FOXO1[15220471;25609649];MTDH[18316612];ARNTL[24737000];WRN[18203716];MKNK1[20936779];TBX21[17075044];TP53BP1[29656893];LDLR[18660751];SMAD2[15231748];STAT5A[9989503];STAT5B[9989503];UBE2I[23395904];PCGF3[unassigned1312];RPA2[17525332];NFATC2[19060202];NAP1L1[11940655];HELZ[unassigned1312];NMI[9989503];KLF1[21670263];MAPK10[20936779];PAN2[unassigned1312];MEIS1[20541704];HIST1H4A[24361270];MAFB[20581830];APC[20936779];COPS2[23441852];ERCC1[25314079];CDK2[23455922;23602568];SNAI1[25314079];CTNNB1[21751375;23273993];FGFR1[25241761];	3808052
28756	chr16	4165484	T	C	chr16:4165484	ADCY9	adenylate cyclase 9	SNV	0/1	0.58	14_19	33	99.0	0/1	0.59	16_23	39	99.0			rs370670383	SPLICING	YES	NM_001116.4	Transcript	protein_coding	splice_region_variant,5_prime_UTR_variant		2/11	NM_001116.4:c.-41A>G			-1.0						.	.	.		0.000651925	99.0	151858.0	0.0	32	0.94	PASS	nfe	0.00116337	79.0	0.00116337	79.0	0.00066355	65.0	97958.0	0.0	7	0.27	PASS	nfe	0.00136161	52.0	0.00136161	52.0	0.0001736	27	0.0	1.0	0.00115	11.0		7.254	0.303347		0	0	0			ADCY9	0.0	0.01	0.0	0.0	39.0	2.0	-18.0	40.0			10.67	-0.266	10.404	0.0303	0.97				hematopoietic system phenotype; cardiovascular system phenotype ; normal phenotype; mortality/aging ; embryo phenotype; liver/biliary system phenotype; respiratory system phenotype; immune system phenotype; skeleton phenotype; digestive/alimentary phenotype; nervous system phenotype ; hearing/vestibular/ear phenotype; craniofacial phenotype; vision/eye phenotype; homeostasis/metabolism phenotype; 			ciliary ganglion;thyroid;atrioventricular node;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Purine metabolism;Calcium signaling pathway;Gap junction;GnRH signaling pathway;Melanogenesis;Vibrio cholerae infection	renal water homeostasis;cAMP biosynthetic process;signal transduction;G protein-coupled receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway;cellular response to glucagon stimulus;adenylate cyclase-activating adrenergic receptor signaling pathway	plasma membrane;integral component of plasma membrane;integral component of membrane;axon;dendrite	adenylate cyclase activity;ATP binding;metal ion binding	TMEM17[26638075];PLGRKT[29568061];CANX[29568061];HSPB1[25277244];	4165484
28887	chr16	4953900	T	C	chr16:4953900	PPL	periplakin	SNV	0/1	0.48	45_42	87	99.0	0/1	0.58	38_52	90	99.0			rs775077606	EXONIC	YES	NM_002705.5	Transcript	protein_coding	missense_variant		3/22	NM_002705.5:c.304A>G	NP_002696.4:p.Met102Val		-1.0	.,.,.					.	.	.		5.25617e-05	8.0	152202.0	0.0	32	0.97	PASS	amr	0.000327139	5.0	2.93971e-05	2.0	8.35754e-05	21.0	251270.0	0.0	76	1.0	PASS	sas	0.000359289	11.0	1.75954e-05	2.0	0.0000257	4	0.001	3.0				23.0	2.744072	0.452	10	11	21	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	PPL	0.0	0.0	0.03	0.0	47.0	-13.0	-17.0	26.0						0.597	0.0	0.000000000	0.999	1.127	normal phenotype; 			lung;tonsil;trachea;tongue;adipose tissue;skin;placenta;	.	response to mechanical stimulus;wound healing;intermediate filament cytoskeleton organization;cornification	cornified envelope;nucleus;cytoplasm;mitochondrion;cytosol;cytoskeleton;intermediate filament;membrane;desmosome;extracellular exosome	structural molecule activity;structural constituent of cytoskeleton;protein binding;cadherin binding	AHCYL1[25416956];ALAS1[25416956;unassigned1304];INTS14[26496610];ZBTB26[unassigned1304];IKZF1[unassigned1304];FYCO1[26496610];RBM4[26496610];POF1B[unassigned1304];ZC3H7A[unassigned1304];KRT25[unassigned1304];BDKRB2[24211782];AKT1[12244133;18624398];ANXA9[22841549];TRIM27[25416956];SYNPO[26496610];TSC22D4[25416956];ZNF165[unassigned1304];USP7[16713569];RALBP1[25416956];BTN3A1[25637025];ACTR5[unassigned1304];BTN1A1[25637025];KRT8[22841549];TRAF2[25416956;unassigned1304];KNSTRN[unassigned1304];WRAP73[17353931];KRT39[unassigned1304];CEP57L1[25416956];PICK1[unassigned1304];UPRT[unassigned1304];ZNF474[unassigned1304];WHAMMP3[unassigned1304];HTT[17500595];SDCBP[unassigned1304];HECTD3[unassigned1304];KCTD21[unassigned1304];SKIL[15231748];ZSCAN16[unassigned1304];C6orf141[unassigned1304];ZNF263[unassigned1304];RAB3IP[25416956;unassigned1304];MRPL28[unassigned1304];PBX4[unassigned1304];PLEKHA7[unassigned1304;28877994];LETM1[30021884];HNRNPM[30021884];DES[unassigned1304];VIM[25416956];ZNF213[unassigned1304];ZSCAN1[25416956;unassigned1304];	4953900
28970	chr16	8949104	G	A	chr16:8949104	CARHSP1	calcium regulated heat stable protein 1	SNV	0/0	0.0	34_0	34	99.0	0/1	0.49	62_60	122	99.0			rs148643770	EXONIC	YES	NM_001042476.2	Transcript	protein_coding	synonymous_variant		4/4	NM_001042476.2:c.361C>T	NP_001035941.1:p.Leu121%3D		-1.0						.	.	.		0.00220829	336.0	152154.0	2.0	31	0.94	PASS	amr	0.00576444	88.0	0.00279305	190.0	0.0023101	578.0	250206.0	1.0	39	0.92	PASS	amr	0.00337582	116.0	0.00285917	323.0	0.0020514	319	0.004	13.0				11.7	0.768095		0	0	0			CARHSP1	0.0	0.01	0.0	0.0	-6.0	9.0	29.0	-14.0						0.134		0.000000000			.			testis - seminiferous tubule;trigeminal ganglion;placenta;testis;	.	regulation of transcription by RNA polymerase II;intracellular signal transduction;regulation of mRNA stability	cytoplasmic exosome (RNase complex);P-body;cytoplasm;cytosol;P granule	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;mRNA 3'-UTR binding;protein binding;phosphatase binding	PIAS3[21900206];TSC22D1[21900206];KRTAP10-7[25416956];DOCK8[25416956];KRTAP10-8[25416956;unassigned1304];FBF1[26638075];AKAP8L[unassigned1304];TRAF1[25416956];NOTCH2NLA[25416956;unassigned1304];MID2[unassigned1304];CYSRT1[unassigned1304];PNMA1[25416956];GORASP2[unassigned1304];PPP2R1A[unassigned1304];STC2[16169070];THEM5[25416956];PIN1[21900206];SMN1[21900206];TK1[21900206];	8949104
29000	chr16	10274091	C	T	chr16:10274091	GRIN2A	glutamate ionotropic receptor NMDA type subunit 2A	SNV	0/1	0.45	89_73	162	99.0	0/1	0.42	76_55	131	99.0			rs1276986122	EXONIC	YES	NM_001134407.3	Transcript	protein_coding	missense_variant		2/13	NM_001134407.3:c.178G>A	NP_001127879.1:p.Ala60Thr		-1.0	.,.,.				Epilepsy, focal, with speech disorder and with or without impaired intellectual development, 245570 (3), Autosomal dominant	Rolandic epilepsy-speech dyspraxia syndrome;Rolandic epilepsy;Early-onset epileptic encephalopathy and intellectual disability due to GRIN2A mutation;Continuous spikes and waves during sleep;Landau-Kleffner syndrome	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Hypoplasia of the corpus callosum;Specific learning disability;Intellectual disability, moderate;EEG with multifocal slow activity;Profound global developmental delay;Pes cavus;Behavioral abnormality;Postnatal microcephaly;Myoclonus;Small for gestational age;Infantile axial hypotonia;Congenital microcephaly;Short nose;Generalized tonic seizure;Focal seizures, afebril;Febrile seizure (within the age range of 3 months to 6 years);Abnormal involuntary eye movements;Hypertonia;Abnormal facial shape;Bilateral tonic-clonic seizure;Diffuse cerebral atrophy;Intellectual disability, severe;Short stature;Epileptic spasm;Abnormal myelination;Stereotypical hand wringing;Hyporeflexia;Poor head control;Anxiety;Drooling;Attention deficit hyperactivity disorder;Mood changes;Intellectual disability, borderline;Bilateral tonic-clonic seizure with focal onset;Focal hemifacial clonic seizure;EEG with irregular generalized spike and wave complexes;Sleep apnea;Depressivity;Specific learning disability;Dysesthesia;Focal seizures, afebril;Febrile seizure (within the age range of 3 months to 6 years);Laryngospasm;Atypical absence seizure;Migraine;EEG with centrotemporal focal spike waves;Speech articulation difficulties;Specific learning disability;Bilateral tonic-clonic seizure with focal onset;Hypoplasia of the corpus callosum;EEG with focal sharp waves;Abnormal speech prosody;Focal seizures, afebril;Dysarthria;EEG with generalized epileptiform discharges;Drooling;Intellectual disability;Delayed speech and language development;Nasal speech;Abnormally low-pitched voice;Speech apraxia;Incomprehensible speech;Short attention span;Continuous spike and waves during slow sleep;Intellectual disability;Delayed speech and language development;Speech apraxia;Dysphasia;Seizure;Variable expressivity;Global developmental delay;EEG with centrotemporal focal spike waves;Aphasia;Incomplete penetrance;Agnosia;Attention deficit hyperactivity disorder;Behavioral abnormality;Autosomal dominant inheritance						32	0.98							4.00045e-06	1.0	249972.0	0.0	100	1.0	PASS	amr	2.89168e-05	1.0	0.0	0.0					0.00018	2.0		21.9	2.278349	0.05	4	15	19	M-CAP_pred,MetaLR_pred,FATHMM_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	GRIN2A	0.0	0.0	0.0	0.0	49.0	0.0	-29.0	1.0						0.085	1.0	0.000000000	0.665	1.022	integument phenotype ; nervous system phenotype ; behavior/neurological phenotype ; 			pons;temporal lobe;occipital lobe;subthalamic nucleus;superior cervical ganglion;trigeminal ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;	Calcium signaling pathway;Neuroactive ligand-receptor interaction;Long-term potentiation	MAPK cascade;startle response;response to amphetamine;glutamate receptor signaling pathway;chemical synaptic transmission;brain development;learning or memory;memory;visual learning;response to wounding;sensory perception of pain;calcium-mediated signaling;neurogenesis;sleep;directional locomotion;ionotropic glutamate receptor signaling pathway;negative regulation of protein catabolic process;dopamine metabolic process;serotonin metabolic process;positive regulation of apoptotic process;response to ethanol;regulation of synaptic plasticity;regulation of sensory perception of pain;excitatory postsynaptic potential;long-term synaptic potentiation;activation of cysteine-type endopeptidase activity;calcium ion transmembrane import into cytosol;excitatory chemical synaptic transmission;positive regulation of long-term synaptic potentiation;protein localization to postsynaptic membrane;cellular response to amyloid-beta	endoplasmic reticulum;plasma membrane;integral component of plasma membrane;synaptic vesicle;cell surface;postsynaptic density;NMDA selective glutamate receptor complex;cell junction;presynaptic membrane;neuron projection;synaptic membrane;postsynaptic density membrane;glutamatergic synapse;integral component of postsynaptic density membrane	amyloid-beta binding;NMDA glutamate receptor activity;Ras guanyl-nucleotide exchange factor activity;protein binding;zinc ion binding;glutamate-gated calcium ion channel activity	LRP1[17360663];DLG4[11937501;17360663];AKT1[25640309];NOS1[17360663];	10274091
29058	chr16	11941518	T	A	chr16:11941518	RSL1D1	ribosomal L1 domain containing 1	SNV	0/0	0.0	6_0	6	18.0	0/1	0.71	2_5	7	28.0			rs71383294	SPLICING	YES	NM_015659.3	Transcript	protein_coding	splice_region_variant,intron_variant	3/8		NM_015659.3:c.384+7A>T			-1.0						.	.	.		0.00280471	427.0	152244.0	0.0	33	0.97	PASS	sas	0.00950806	46.0	0.00404115	275.0	0.00383221	941.0	245550.0	4.0	43	0.83	PASS	sas	0.00907845	265.0	0.0047179	530.0	0.0037298	580	0.003	10.0				2.512	-0.007489		0	0	0			RSL1D1	0.0	0.0	0.0	0.0	33.0	46.0	9.0	-5.0	0.000163515365941	0.002				0.485	0.0				.			superior cervical ganglion;	.	maturation of LSU-rRNA;osteoblast differentiation;regulation of protein localization;regulation of apoptotic process;regulation of cellular senescence	nucleolus;membrane;90S preribosome	RNA binding;mRNA 3'-UTR binding;cadherin binding;mRNA 5'-UTR binding	PHF3[30021884];RBM28[30021884];LECT2[30021884];MED19[15175163];HNRNPU[26496610];YBX1[23986595];MKI67[26949251];YY1[23531880];RPL7A[30021884];METTL14[29507755];CCDC91[30021884];CHL1[30021884];CCDC54[30021884];PLS1[30021884];CFAP44[30021884];FGB[30021884];CAST[30021884];GABARAPL2[20562859];GABARAPL1[20562859];DAXX[30021884];CSNK2A1[22113938];UTP11[30021884];APAF1[30021884];DST[30021884];RPS6[29568061];STIM1[30021884];VDAC1[29128334];NCBP3[26382858];HIST1H2BH[30021884];CYLC2[30021884];DLD[29128334];DNAH3[30021884];LRRC59[30021884];PLEKHD1[30021884];CAB39[23414517];CREBL2[30021884];GABARAP[20562859];RNF2[26496610];ADH6[21988832];TTN[30021884];NXF1[30021884];HIST1H3A[29568061];IFI16[25665578];MAPK6[26972000];LYAR[17353931];NKTR[30021884];NOP56[26496610];CBX8[26496610];SRPK3[23602568];JUN[25609649];NPM1[26496610];VCAM1[22623428];CNBP[17353931];PYHIN1[25665578];RRP1B[19710015;20926688];ESR1[21182205];SMARCA2[30021884];COQ2[29128334];MRGBP[12963728];AGO1[17932509];HDGF[21907836];MNDA[25665578];CD247[24502978];CDR2L[30021884];MAP3K14[14743216];	11941518
29096	chr16	14969010	C	T	chr16:14969010	NOMO1	NODAL modulator 1	SNV	0/1	0.44	74_58	132	99.0	0/0	0.0	33_0	33	99.0			rs781405331,COSV55061326	EXONIC	YES	NM_014287.4	Transcript	protein_coding	synonymous_variant		19/31	NM_014287.4:c.2172C>T	NP_055102.3:p.Asn724%3D		1.0						.	.	.		6.57791e-05	10.0	152024.0	0.0	30	0.93	PASS	sas	0.000207297	1.0	7.34948e-05	5.0	7.16646e-05	18.0	251170.0	0.0	100	1.0	PASS	sas	0.000326627	10.0	6.16979e-05	7.0	0.0000064	1						0.166	-0.413051		0	0	0			NOMO1	0.0	0.0	0.0	0.0	46.0	-18.0	-19.0	13.0											.			.	.	biological_process	endoplasmic reticulum membrane;membrane;integral component of membrane	molecular_function;carbohydrate binding	ATF7IP[15231748];MROH2A[30021884];TMEM120B[unassigned1312];JUN[25609649];TRIM63[18157088];SMURF2[18157088];ZNF492[30021884];STAT1[21988832];ARL15[unassigned1312];TMEM120A[unassigned1312];ATRX[30021884];UPF3B[30021884];MYO9B[30021884];HSCB[28380382];AGPAT3[unassigned1312];BAG6[16169070];TOM1L1[16169070];EXOSC10[15231747];NCLN[unassigned1312];CYTH4[30021884];SERINC1[unassigned1312];UBQLN4[16713569];METTL9[unassigned1312];EPHA2[30021884];	14969010
29193	chr16	15702141	C	A	chr16:15702141	KIAA0430		SNV	0/1	0.14	12_2	14	47.0	0/0	0.0	20_0	20	10.0			rs773556814	SPLICING	YES	NM_001184998.2	Transcript	protein_coding	splice_region_variant,intron_variant	21/26		NM_001184998.2:c.4182+7G>T			-1.0										0.00406701	436.0	107204.0	0.0	30	0.75	AS_VQSR	eas	0.00525015	17.0	0.00386757	200.0	0.0301844	1535.0	50854.0	0.0	21	0.54	RF	sas	0.0412534	183.0	0.0267396	714.0	0.0016012	249						0.05	-0.576269		0	0	0			KIAA0430	0.0	0.0	0.0	0.0	38.0	27.0	13.0	7.0	9.51298571804062e-06	0.002				0.0229	1.0													15702141
29232	chr16	16292021	C	T	chr16:16292021	ABCC6	ATP binding cassette subfamily C member 6	SNV	0/1	0.39	67_42	109	99.0	0/0	0.0	38_0	38	99.0			rs368723482	EXONIC	YES	NM_001171.6	Transcript	protein_coding	missense_variant		10/31	NM_001171.6:c.1195G>A	NP_001162.5:p.Gly399Ser		-1.0	ABC transporter type 1, transmembrane domain&ABC transporter type 1, transmembrane domain,.	Uncertain_significance	criteria_provided,_single_submitter	not_provided	Pseudoxanthoma elasticum, 264800 (3), Autosomal recessive; Arterial calcification, generalized, of infancy, 2, 614473 (3), Autosomal recessive; Pseudoxanthoma elasticum, forme fruste, 177850 (3), Autosomal dominant	Pseudoxanthoma elasticum;Generalized arterial calcification of infancy	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Angina pectoris;Arteriosclerosis;High, narrow palate;Yellow papule;Abnormality of the sternum;Reduced visual acuity;Mitral valve prolapse;Peau d'orange;Medial calcification of medium-sized arteries;Angioid streaks of the fundus;Premature occlusive vascular stenosis;Visual impairment;Autosomal dominant inheritance;High palate;Calcification of falx cerebri;Gastrointestinal hemorrhage;Kyphosis;Cerebral hemorrhage;Myopia;Blue sclerae;Macular degeneration;Retinal hemorrhage;Scoliosis;Medial calcification of large arteries;Macular degeneration;Drusen;Reduced visual acuity;Mitral stenosis;Angina pectoris;Civatte bodies;Abnormality of the mouth;Hypermelanotic macule;Congestive heart failure;Stroke;Mitral valve prolapse;Peau d'orange;Renovascular hypertension;Angioid streaks of the fundus;Hypertension;Renal insufficiency;Accelerated atherosclerosis;Retinal hemorrhage;Restrictive cardiomyopathy;Intermittent claudication;Autosomal recessive inheritance;Gastrointestinal hemorrhage;Choroidal neovascularization;Metamorphopsia;Dilatation;Blue sclerae;Pruritus;Striae distensae;Nephrocalcinosis;Abnormal thrombocyte morphology;Hemiplegia/hemiparesis;Arterial stenosis;Visual impairment;Hypertension;Restrictive cardiomyopathy;Postural instability;Bruising susceptibility;Sudden cardiac death;Abnormal endocardium morphology;Telangiectasia of the skin;Angina pectoris;Acne;Hypothyroidism;Gastrointestinal hemorrhage;Angioid streaks of the fundus;Mitral valve prolapse;Abnormality of the cerebral vasculature;Multiple lipomas;Excessive wrinkled skin;Retinopathy;Atherosclerosis;Scoliosis;Joint hyperflexibility;Subcutaneous nodule;Abnormality of the thorax;High palate;Retinal hemorrhage;Thickened nuchal skin fold;Cerebral calcification;Myopia;Skin rash;Hyperextensible skin;Autosomal recessive inheritance;Coronary artery calcification;Congestive heart failure;Myocardial infarction;Nephrocalcinosis;Hypophosphatemic rickets;Hypertension		0.000118321	18.0	152128.0	0.0	33	0.97	PASS	nfe	0.00023517	16.0	0.00023517	16.0	0.000100464	23.0	228938.0	0.0	55	0.64	PASS	sas	0.000173768	5.0	0.000137679	14.0	0.0000772	12	0.001	2.0	0.00018	2.0		12.67	0.893916	0.238	2	16	18	M-CAP_pred,FATHMM_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ABCC6	0.01	0.0	0.0	0.0	-2.0	18.0	-20.0	-11.0						0.0194	0.0	0.000000000	0.293	0.118	craniofacial phenotype; homeostasis/metabolism phenotype; integument phenotype ; growth/size/body region phenotype; vision/eye phenotype; renal/urinary system phenotype; cardiovascular system phenotype ; 			ciliary ganglion;kidney;liver;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;fetal liver;skeletal muscle;cerebellum peduncles;	ABC transporters	visual perception;response to drug;transmembrane transport;ATP hydrolysis coupled anion transmembrane transport	nucleus;vacuolar membrane;endoplasmic reticulum membrane;plasma membrane;membrane;integral component of membrane;basolateral plasma membrane;apical plasma membrane;lateral plasma membrane	transporter activity;ATP binding;ATPase activity, coupled to transmembrane movement of substances;ATPase-coupled anion transmembrane transporter activity	NR4A1[21988832];AK2[21988832];CRYL1[21988832];FURIN[21988832];A1BG[21988832];	16292021
29331	chr16	20487086	G	A	chr16:20487086	ACSM2A	acyl-CoA synthetase medium chain family member 2A	SNV	0/1	0.66	22_43	65	99.0	0/0	0.0	35_0	35	99.0			rs371399781	EXONIC	YES	NM_001308954.2	Transcript	protein_coding	synonymous_variant		9/15	NM_001308954.2:c.1089G>A	NP_001295883.1:p.Gln363%3D		1.0						.	.	.		6.56996e-06	1.0	152208.0	0.0	32	0.96	PASS	nfe	1.46972e-05	1.0	1.46972e-05	1.0	1.59213e-05	4.0	251236.0	0.0	78	0.99	PASS	nfe	3.52069e-05	4.0	3.52069e-05	4.0	0.0000257	4						7.484	0.32122		0	0	0			ACSM2A	0.0	0.0	0.0	0.02	5.0	9.0	-2.0	9.0						0.97	0.0				homeostasis/metabolism phenotype; integument phenotype ; 			.	.	fatty acid biosynthetic process;acyl-CoA metabolic process;medium-chain fatty-acyl-CoA metabolic process;glucose homeostasis;triglyceride homeostasis	mitochondrion;mitochondrial matrix	acyl-CoA ligase activity;fatty-acyl-CoA synthase activity;ATP binding;fatty acid ligase activity;metal ion binding;butyrate-CoA ligase activity	.	20487086
29346	chr16	20803558	C	T	chr16:20803558	ACSM3	acyl-CoA synthetase medium chain family member 3	SNV	0/0	0.0	36_0	36	99.0	0/1	0.35	29_16	46	99.0			rs141598766	SPLICING	YES	NM_005622.4	Transcript	protein_coding	splice_region_variant,synonymous_variant		12/14	NM_005622.4:c.1455C>T	NP_005613.2:p.Gly485%3D		1.0					{?Hypertension, essential} (1)	.	.	.		0.00134702	205.0	152188.0	1.0	32	0.97	PASS	afr	0.00475294	197.0	0.0	0.0	0.000381913	96.0	251366.0	0.0	99	1.0	PASS	afr	0.00566015	92.0	0.0	0.0	0.0004694	73						10.42	0.613002		0	0	0			ACSM3	0.0	0.05	0.0	0.0	22.0	0.0	-30.0	21.0	6.89925739660516e-05	0.038	6.863	0.171	7.033	0.959	0.0	29.227379471			normal phenotype; 			dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	.	fatty acid biosynthetic process;acyl-CoA metabolic process;regulation of blood pressure;cholesterol homeostasis	cellular_component;mitochondrial matrix	molecular_function;acyl-CoA ligase activity;fatty-acyl-CoA synthase activity;ATP binding;fatty acid ligase activity;metal ion binding;butyrate-CoA ligase activity	VCAM1[22623428];	20803558
29350	chr16	20809588	C	T	chr16:20809588	ERI2	ERI1 exoribonuclease family member 2	SNV	0/0	0.0	33_0	33	99.0	0/1	0.46	31_27	59	99.0			rs150284099	EXONIC	YES	NM_001142725.2	Transcript	protein_coding	missense_variant		9/9	NM_001142725.2:c.1534G>A	NP_001136197.1:p.Val512Ile		-1.0	.,.,.					.	.	.		0.00134061	204.0	152170.0	1.0	32	0.97	PASS	afr	0.00472927	196.0	0.0	0.0	0.00028732	45.0	156620.0	0.0	42	0.6	PASS	afr	0.00528302	42.0	0.0	0.0	0.0001801	28						6.981	0.282142	0.018	0	18	18		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	ERI2	0.05	0.0	0.0	0.0	-28.0	1.0	15.0	1.0						0.547	0.0	0.000000000	0.523	1.026	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;	.	DNA metabolic process;RNA phosphodiester bond hydrolysis, exonucleolytic	.	3'-5'-exoribonuclease activity;nucleic acid binding;zinc ion binding;single-stranded DNA 3'-5' exodeoxyribonuclease activity	CASQ2[30021884];PTBP3[22575643];	20809588
29427	chr16	20970725	G	A	chr16:20970725	DNAH3	dynein axonemal heavy chain 3	SNV	0/0	0.0	40_0	40	99.0	0/1	0.52	32_35	67	99.0			rs144226614	SPLICING	YES	NM_017539.2	Transcript	protein_coding	splice_region_variant,synonymous_variant		54/62	NM_017539.2:c.10602C>T	NP_060009.1:p.Gly3534%3D		-1.0						.	.	.		0.000755654	115.0	152186.0	1.0	31	0.96	PASS	afr	0.00260479	108.0	0.0	0.0	0.000231103	58.0	250970.0	0.0	65	1.0	PASS	afr	0.00301501	49.0	0.0	0.0	0.0003087	48						3.556	0.057896		0	0	0			DNAH3	0.0	0.02	0.0	0.0	1.0	45.0	2.0	-25.0	3.64408349585394e-05	0.002	10.092	-1.007	9.085	0.98	0.0	86.873896706			.			ciliary ganglion;testis - seminiferous tubule;tongue;skin;trigeminal ganglion;superior cervical ganglion;adrenal cortex;pons;subthalamic nucleus;testis - interstitial;dorsal root ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	cilium movement;microtubule-based movement;cilium-dependent cell motility	axonemal dynein complex;microtubule;dynein complex	microtubule motor activity;ATP binding;ATP-dependent microtubule motor activity, minus-end-directed;dynein light chain binding;dynein intermediate chain binding;dynein light intermediate chain binding	RSL1D1[30021884];HNRNPD[30021884];ARRB1[17620599];MKI67[26949251];DHRS2[30021884];PLEC[30021884];	20970725
29429	chr16	20996501	G	A	chr16:20996501	DNAH3	dynein axonemal heavy chain 3	SNV	0/0	0.0	35_0	35	99.0	0/1	0.53	65_75	141	99.0			rs73534339,COSV99765919	EXONIC	YES	NM_017539.2	Transcript	protein_coding	synonymous_variant		48/62	NM_017539.2:c.7563C>T	NP_060009.1:p.Asp2521%3D		-1.0						.	.	.		0.00205061	312.0	152150.0	2.0	31	0.96	PASS	afr	0.00680633	282.0	7.34905e-05	5.0	0.000576577	145.0	251484.0	0.0	83	1.0	PASS	afr	0.00750492	122.0	3.51624e-05	4.0	0.0007524	117						0.086	-0.50459		0	0	0			DNAH3	0.0	0.0	0.02	0.0	29.0	28.0	29.0	-49.0						0.98	0.0	47.005114841			.			ciliary ganglion;testis - seminiferous tubule;tongue;skin;trigeminal ganglion;superior cervical ganglion;adrenal cortex;pons;subthalamic nucleus;testis - interstitial;dorsal root ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	cilium movement;microtubule-based movement;cilium-dependent cell motility	axonemal dynein complex;microtubule;dynein complex	microtubule motor activity;ATP binding;ATP-dependent microtubule motor activity, minus-end-directed;dynein light chain binding;dynein intermediate chain binding;dynein light intermediate chain binding	RSL1D1[30021884];HNRNPD[30021884];ARRB1[17620599];MKI67[26949251];DHRS2[30021884];PLEC[30021884];	20996501
29464	chr16	21122973	C	T	chr16:21122973	DNAH3	dynein axonemal heavy chain 3	SNV	0/0	0.0	35_0	35	99.0	0/1	0.35	43_23	66	99.0			rs141874161,COSV54544532	EXONIC	YES	NM_017539.2	Transcript	protein_coding	synonymous_variant		14/62	NM_017539.2:c.2073G>A	NP_060009.1:p.Val691%3D		-1.0						.	.	.		0.000709994	108.0	152114.0	0.0	32	0.96	PASS	afr	0.0025355	105.0	0.0	0.0	0.000223191	56.0	250906.0	0.0	49	0.99	PASS	afr	0.00319961	52.0	0.0	0.0	0.0003344	52						11.42	0.733282		0	0	0			DNAH3	0.0	0.0	0.0	0.05	-2.0	1.0	47.0	-26.0						0.98	0.0	55.018366116			.			ciliary ganglion;testis - seminiferous tubule;tongue;skin;trigeminal ganglion;superior cervical ganglion;adrenal cortex;pons;subthalamic nucleus;testis - interstitial;dorsal root ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	cilium movement;microtubule-based movement;cilium-dependent cell motility	axonemal dynein complex;microtubule;dynein complex	microtubule motor activity;ATP binding;ATP-dependent microtubule motor activity, minus-end-directed;dynein light chain binding;dynein intermediate chain binding;dynein light intermediate chain binding	RSL1D1[30021884];HNRNPD[30021884];ARRB1[17620599];MKI67[26949251];DHRS2[30021884];PLEC[30021884];	21122973
29497	chr16	22337380	G	A	chr16:22337380	POLR3E	RNA polymerase III subunit E	SNV	0/0	0.0	36_0	36	99.0	0/1	0.46	66_56	122	99.0			rs144892562	EXONIC	YES	NM_018119.4	Transcript	protein_coding	synonymous_variant		18/21	NM_018119.4:c.1647G>A	NP_060589.1:p.Pro549%3D		1.0						.	.	.		0.000617836	94.0	152144.0	0.0	31	0.97	PASS	nfe	0.00101468	69.0	0.00101468	69.0	0.000597939	146.0	244172.0	0.0	32	0.84	PASS	nfe	0.0010334	113.0	0.0010334	113.0	0.0005016	78	0.001	2.0				0.294	-0.331488		0	0	0			POLR3E	0.0	0.0	0.0	0.0	7.0	-19.0	7.0	-15.0						0.544	0.02	0.731042203			.			trigeminal ganglion;atrioventricular node;	.	transcription by RNA polymerase III;innate immune response;defense response to virus	nucleus;nucleoplasm;RNA polymerase III complex;cytosol	RNA polymerase III activity	URI1[26496610];CRCP[26496610];RPS19BP1[26496610];CHM[19615732];KEAP1[26496610];IQGAP1[30021884];SUPT6H[26496610];RPAP3[26496610];TMEM263[26496610];WDR92[26496610];RUVBL2[26496610];POLR2E[26496610];POLR2F[26496610];POLR2H[26496610];POLR2K[26496610];BRF1[26496610];POLR3GL[26496610];PIH1D1[26496610];CDC5L[20467437];SSRP1[19214185];GPN1[26496610];PDRG1[26496610];GPN3[26496610];FMNL1[26496610];POLR3A[26496610];POLR3B[26496610];SLC25A19[26496610];POLR3C[26496610];POLR3D[26496610];POLR1C[26496610];POLR3F[26496610];POLR3G[26496610];POLR3H[26496610];PFDN2[26496610];BDP1[26496610];POLR3K[26496610];PFDN6[26496610];SLC25A6[26496610];	22337380
29502	chr16	22545618	TCCACCCTCAGC		chr16:22545618-22545629	NPIPB5	nuclear pore complex interacting protein family member B5	deletion	0/0	0.0	14_0	14	42.0	0/1	0.25	6_2	8	66.0			rs771882324	EXONIC	YES	NM_001135865.2	Transcript	protein_coding	inframe_deletion		9/9	NM_001135865.2:c.1326_1337del	NP_001129337.1:p.Pro443_Ala446del		1.0						.	.	.		0.00449891	58.0	12892.0	0.0	4	0.0	AS_VQSR	nfe	0.00318697	18.0	0.00318697	18.0	0.00199387	108.0	54166.0	0.0	2	0.24	RF	sas	0.00370508	20.0	0.00113796	26.0	0.0000129	2						2.551	-0.004826		0	0	0																						.			.	.	.	nucleoplasm;integral component of membrane	.	.	22545617
29516	chr16	23117811	A		chr16:23117811	USP31	ubiquitin specific peptidase 31	deletion	0/0	0.0	60_0	60	99.0	0/1	0.2	39_10	51	99.0			rs137886921	SPLICING	YES	NM_020718.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	2/15		NM_020718.4:c.772-3del			-1.0						.	.	.		0.00012902	19.0	147264.0	0.0	32	0.95	PASS	amr	0.000203749	3.0	0.000105327	7.0	0.0350006	4221.0	120598.0	0.0	24	0.6	RF	amr	0.0537806	707.0	0.0349503	2026.0	0.0002637	41	0.001	3.0				9.108	0.469253		0	0	0			USP31	0.0	0.01	0.0	0.0	-12.0	-2.0	31.0	-46.0						0.57	0.01				.			.	.	ubiquitin-dependent protein catabolic process;protein deubiquitination	nucleus	thiol-dependent ubiquitin-specific protease activity	.	23117810
29519	chr16	23200963	G	A	chr16:23200963	SCNN1G	sodium channel epithelial 1 gamma subunit	SNV	0/1	0.49	58_56	114	99.0	0/0	0.0	33_0	33	99.0			rs5738,CM086916,COSV100264512	EXONIC	YES	NM_001039.4	Transcript	protein_coding	missense_variant		3/13	NM_001039.4:c.589G>A	NP_001030.2:p.Glu197Lys		1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Autosomal_recessive_pseudohypoaldosteronism_type_1|Bronchiectasis_with_or_without_elevated_sweat_chloride_3|Liddle_syndrome_2|not_specified|not_provided	Bronchiectasis with or without elevated sweat chloride 3, 613071 (3), Autosomal dominant; Pseudohypoaldosteronism, type I, 264350 (3), Autosomal recessive; Liddle syndrome 2, 618114 (3), Autosomal dominant	Generalized pseudohypoaldosteronism type 1;Liddle syndrome;Idiopathic bronchiectasis	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in	Nephropathy;Renal insufficiency;Arrhythmia;Fatigue;Constipation;Muscle weakness;Hypertension;Cerebral ischemia;Hypokalemia;Hyperaldosteronism;Hyponatremia;Hypotension;Dehydration;Infantile onset;Hyperkalemia;Metabolic acidosis;Hyperactive renin-angiotensin system;Autosomal recessive inheritance;Pseudohypoaldosteronism;Vomiting;Feeding difficulties in infancy;Renal salt wasting;Recurrent respiratory infections;Diarrhea;Failure to thrive;Hyperkalemia;Failure to thrive in infancy;Weight loss;Vomiting;Glucocortocoid-insensitive primary hyperaldosteronism;Recurrent upper and lower respiratory tract infections;Increased circulating renin level;Arrhythmia;Cough;Abnormal circulating aldosterone;Cholelithiasis;Osteomyelitis;Feeding difficulties in infancy;Pustule;Hyponatremia;Atopic dermatitis;Dehydration;Proportionate short stature;Wheezing;Hypovolemic shock;Metabolic acidosis;Tonsillitis;Autosomal dominant inheritance;Bronchiectasis;Chronic bronchitis;Myocardial infarction;Emphysema;Clubbing;Fever;Recurrent lower respiratory tract infections;Chest pain;Halitosis;Hemoptysis;Cachexia;Bronchiectasis;Dyspnea;Wheezing;Reduced FEV1/FVC ratio;Productive cough;Recurrent Haemophilus influenzae infections;Crackles;Decreased pulmonary function;Acute infectious pneumonia;Hypertension;Decreased circulating renin level;Metabolic alkalosis;Autosomal dominant inheritance;Hypokalemia	25741868,18507830,25306238	0.00537451	818.0	152200.0	7.0	32	0.97	PASS	nfe	0.00868658	591.0	0.00868658	591.0	0.00502656	1264.0	251464.0	7.0	100	1.0	PASS	nfe	0.00827325	941.0	0.00827325	941.0	0.0049066	763	0.012	39.0	0.0115	131.0		14.76	1.219321	0.052	1	17	18	MutationTaster_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SCNN1G	0.0	0.0	0.0	0.0	3.0	9.0	-39.0	29.0						0.565	0.37	0.000000000	0.728	1.176	homeostasis/metabolism phenotype; integument phenotype ; growth/size/body region phenotype; renal/urinary system phenotype; digestive/alimentary phenotype; normal phenotype; mortality/aging ; respiratory system phenotype; behavior/neurological phenotype ; 			.	Taste transduction	sodium ion transport;excretion;sodium ion transmembrane transport;multicellular organismal water homeostasis;response to stimulus;sensory perception of taste;sodium ion homeostasis	nucleoplasm;plasma membrane;integral component of plasma membrane;external side of plasma membrane;apical plasma membrane;sodium channel complex;extracellular exosome	ion channel activity;sodium channel activity;protein binding;ligand-gated sodium channel activity;WW domain binding	SCNN1G[21775436];SCNN1D[16423824];NEDD4[11359767];SCNN1A[21775436;16423824];COMMD1[14645214];MRPL12[30021884];	23200963
29543	chr16	23568649	T	C	chr16:23568649	EARS2	glutamyl-tRNA synthetase 2, mitochondrial	SNV	0/1	0.56	39_50	89	99.0	0/0	0.0	36_0	36	99.0			rs113722817	EXONIC	YES	NM_001308211.1	Transcript	protein_coding	missense_variant		1/8	NM_001308211.1:c.16A>G	NP_001295140.1:p.Arg6Gly		-1.0	.,.,.,.	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Combined_oxidative_phosphorylation_deficiency_12|not_specified|not_provided	Combined oxidative phosphorylation deficiency 12, 614924 (3), Autosomal recessive	Leukoencephalopathy-thalamus and brainstem anomalies-high lactate syndrome	Disease-causing germline mutation(s) in	Visual impairment;Cholestasis;Dysplastic corpus callosum;Absent speech;Global developmental delay;Autosomal recessive inheritance;Increased serum lactate;Ragged-red muscle fibers;Ptosis;Leukoencephalopathy;Infantile onset;Decreased activity of mitochondrial complex III;Dystonia;Hypoplasia of the corpus callosum;Hepatomegaly;Decreased activity of mitochondrial complex IV;Cleft palate;Spastic tetraparesis;Ophthalmoplegia;Failure to thrive;Bradykinesia;Neonatal hypotonia;Macrovesicular hepatic steatosis;Seizure;Developmental regression;Decreased activity of mitochondrial complex I;Lactic acidosis	25741868	0.00487593	742.0	152176.0	5.0	33	0.98	PASS	nfe	0.00798295	543.0	0.00798295	543.0	0.00626509	965.0	154028.0	5.0	16	0.42	PASS	nfe	0.00840154	544.0	0.00840154	544.0	0.0046751	727	0.011	37.0	0.01429	163.0		18.69	1.864613	0.368	2	16	18	SIFT,fathmm-MKL_coding_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	EARS2	0.0	0.0	0.0	0.0	46.0	-2.0	35.0	-47.0						0.674	0.0	12.686267460,0.000000000	0.16	0.197	.			ciliary ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;globus pallidus;cerebellum;	Glutamate metabolism;Porphyrin and chlorophyll metabolism;Aminoacyl-tRNA biosynthesis	glutamyl-tRNA aminoacylation;tRNA aminoacylation for mitochondrial protein translation	mitochondrion;mitochondrial matrix	tRNA binding;glutamate-tRNA ligase activity;ATP binding;zinc ion binding;glutamate-tRNA(Gln) ligase activity	HSCB[28380382];	23568649
29652	chr16	28374068	G	C	chr16:28374068	NPIPB6	nuclear pore complex interacting protein family member B6	SNV	0/0	0.0	33_0	33	99.0	0/1	0.3	58_25	83	99.0			rs62032561	EXONIC	YES	NM_001282524.2	Transcript	protein_coding	missense_variant		3/9	NM_001282524.2:c.76C>G	NP_001269453.1:p.Gln26Glu		-1.0						.	.	.		0.00354765	537.0	151368.0	11.0	26	0.81	PASS	amr	0.00678256	103.0	0.00183932	125.0	0.00339813	751.0	221004.0	23.0	82	0.67	PASS	amr	0.00511651	166.0	0.00204576	213.0	0.0000836	13	0.009	30.0				5.78	0.195931	0.068	1	16	17	PolyPhen	SIFT,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	NPIPB6	0.0	0.0	0.0	0.0	42.0	24.0	-48.0	-44.0							0.64		0.035	-0.842	.			.	.	.	nucleoplasm	.	.	28374068
29662	chr16	28511176	CTC		chr16:28511176-28511178	IL27	interleukin 27	deletion	0/1	0.12	35_5	41	99.0	0/0	0.0	37_0	37	99.0			rs748703179	EXONIC	YES	NM_145659.3	Transcript	protein_coding	inframe_deletion		5/5	NM_145659.3:c.526_528del	NP_663634.2:p.Glu176del		-1.0						.	.	.		0.0012934	196.0	151538.0	0.0	32	0.95	PASS	afr	0.00392385	162.0	0.000250789	17.0	0.00130351	188.0	144226.0	0.0	41	0.57	PASS	afr	0.0037332	30.0	0.00134152	76.0	0.0000064	1	0.019	60.0				7.597	0.330241		0	0	0			IL27	0.0	0.0	0.0	0.0	36.0	-19.0	7.0	4.0						0.149	0.93	0.000000000			homeostasis/metabolism phenotype; immune system phenotype; hematopoietic system phenotype; mortality/aging ; 			pons;ciliary ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;	.	positive regulation of defense response to virus by host;inflammatory response;response to bacterium;regulation of signaling receptor activity;regulation of T cell proliferation;positive regulation of interferon-gamma biosynthetic process;innate immune response;regulation of T-helper 1 cell differentiation;interleukin-27-mediated signaling pathway	extracellular region;extracellular space;endoplasmic reticulum lumen;cytosol	signaling receptor binding;cytokine activity;protein binding;interleukin-27 receptor binding	EBI3[20974977];	28511175
29875	chr16	30017955	A	G	chr16:30017955	DOC2A	double C2 domain alpha	SNV	0|1	0.16	89_17	107	99.0	0|1	0.17	75_15	90	99.0			rs1203577523	EXONIC	YES	NM_001282062.1	Transcript	protein_coding	missense_variant		10/12	NM_001282062.1:c.922T>C	NP_001268991.1:p.Cys308Arg		-1.0	C2 domain&C2 domain&C2 domain,C2 domain&C2 domain&C2 domain,C2 domain&C2 domain&C2 domain,C2 domain&C2 domain&C2 domain					.	.	.		6.6462e-06	1.0	150462.0	0.0	31	0.92	PASS	nfe	1.47741e-05	1.0	1.47741e-05	1.0					100	1.0														0.168	-0.411472	0.24	1	18	19	M-CAP_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	DOC2A	0.0	0.0	0.0	0.01	18.0	-12.0	-35.0	2.0						0.601	0.02	65.976414245	0.669	1.312	nervous system phenotype ; behavior/neurological phenotype ; 			ciliary ganglion;amygdala;superior cervical ganglion;globus pallidus;	.	chemical synaptic transmission;nervous system development;synaptic vesicle exocytosis;regulation of calcium ion-dependent exocytosis	nucleus;nucleolus;lysosome;cell junction;neuron projection;extrinsic component of synaptic vesicle membrane	calcium ion binding;protein binding;calcium-dependent phospholipid binding	VDAC1[30021884];	30017955
29890	chr16	30017957		T	chr16:30017956-30017957	DOC2A	double C2 domain alpha	insertion	0|1	0.16	90_17	108	99.0	0|1	0.17	75_15	90	99.0			rs1307300945	EXONIC	YES	NM_001282062.1	Transcript	protein_coding	frameshift_variant		10/12	NM_001282062.1:c.920_921insA	NP_001268991.1:p.Cys308ValfsTer12		-1.0						.	.	.						31	0.92											100	1.0														32.0	4.470169		0	0	0			DOC2A	0.0	0.0	0.0	0.01	33.0	42.0	0.0	1.0						0.601	0.02	65.976414245,0.000000000			nervous system phenotype ; behavior/neurological phenotype ; 			ciliary ganglion;amygdala;superior cervical ganglion;globus pallidus;	.	chemical synaptic transmission;nervous system development;synaptic vesicle exocytosis;regulation of calcium ion-dependent exocytosis	nucleus;nucleolus;lysosome;cell junction;neuron projection;extrinsic component of synaptic vesicle membrane	calcium ion binding;protein binding;calcium-dependent phospholipid binding	VDAC1[30021884];	30017956
29902	chr16	30017965	C	T	chr16:30017965	DOC2A	double C2 domain alpha	SNV	0|1	0.12	89_12	102	99.0	0|1	0.17	73_15	88	99.0			rs796885773,COSV100451329	EXONIC	YES	NM_001282062.1	Transcript	protein_coding	synonymous_variant		10/12	NM_001282062.1:c.912G>A	NP_001268991.1:p.Lys304%3D		-1.0						.	.	.						31	0.92											100	1.0							0.0000064	1						10.38	0.607656		0	0	0			DOC2A	0.0	0.0	0.0	0.0	-19.0	8.0	34.0	-8.0						0.601	0.02	29.227379471			nervous system phenotype ; behavior/neurological phenotype ; 			ciliary ganglion;amygdala;superior cervical ganglion;globus pallidus;	.	chemical synaptic transmission;nervous system development;synaptic vesicle exocytosis;regulation of calcium ion-dependent exocytosis	nucleus;nucleolus;lysosome;cell junction;neuron projection;extrinsic component of synaptic vesicle membrane	calcium ion binding;protein binding;calcium-dependent phospholipid binding	VDAC1[30021884];	30017965
29913	chr16	30081261	C	T	chr16:30081261	ALDOA	aldolase, fructose-bisphosphate A	SNV	0/1	0.57	45_60	106	99.0	0/0	0.0	40_0	40	99.0			rs1393835385,CM040670	EXONIC	YES	NM_001243177.4	Transcript	protein_coding	stop_gained		9/10	NM_001243177.4:c.1072C>T	NP_001230106.1:p.Arg358Ter		1.0	.,.,.,.,.,.,.,.,.,.				Glycogen storage disease XII, 611881 (3), Autosomal recessive	Glycogen storage disease due to aldolase A deficiency	Disease-causing germline mutation(s) in	Normocytic anemia;Delayed puberty;Cholecystitis;Ptosis;Epicanthus;Nonspherocytic hemolytic anemia;Short neck;Cholelithiasis;Myopathy;Splenomegaly;Short stature;Jaundice;Low posterior hairline;Normochromic anemia;Autosomal recessive inheritance;Intellectual disability		2.62822e-05	4.0	152194.0	0.0	32	0.97	PASS	nfe	5.87993e-05	4.0	5.87993e-05	4.0	3.98676e-06	1.0	250830.0	0.0	82	0.99	PASS	nfe	8.82348e-06	1.0	8.82348e-06	1.0					9e-05	1.0		40.0	7.967478		5	1	6	LRT_pred,MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	fathmm-XF_coding_pred	ALDOA	0.0	0.0	0.0	0.0	12.0	-27.0	-3.0	-4.0						0.0383	0.02	0.000000000	0.977	1.01	.			pons;temporal lobe;tongue;subthalamic nucleus;whole brain;adipose tissue;parietal lobe;skeletal muscle;heart;medulla oblongata;thalamus;	Glycolysis / Gluconeogenesis;Pentose phosphate pathway;Fructose and mannose metabolism;Carbon fixation	platelet degranulation;fructose metabolic process;gluconeogenesis;glycolytic process;ATP biosynthetic process;striated muscle contraction;actin filament organization;binding of sperm to zona pellucida;regulation of cell shape;fructose 1,6-bisphosphate metabolic process;neutrophil degranulation;muscle cell cellular homeostasis;protein homotetramerization;canonical glycolysis	extracellular region;extracellular space;nucleus;cytosol;actin cytoskeleton;membrane;integral component of membrane;platelet alpha granule lumen;M band;I band;secretory granule lumen;sperm head;extracellular exosome;tertiary granule lumen;ficolin-1-rich granule lumen	RNA binding;actin binding;fructose-bisphosphate aldolase activity;protein binding;cytoskeletal protein binding;tubulin binding;identical protein binding;cadherin binding;fructose binding	ATF2[22304920];IFNA4[25416956];HSP90AB1[16263121];HSPB2[26465331];SLC2A1[23219802];SLC40A1[23219802];SLC4A1[23219802];ENO1[23414517];MKI67[26949251];ENO3[23414517];OSBPL10[19615732];AQP1[23219802];METTL14[29507755];FLOT1[23219802];FLOT2[23219802];DNM1L[29128334];PIAS4[21988832];IQCB1[21565611];VPS18[26496610];H2AFX[20000738];TERF1[21044950];YWHAZ[15161933];BCAM[23219802];XRN1[15231747];SOAT1[29128334];ALDOC[25416956;26496610;25910212];ALDOB[21988832];ALDOA[21988832;25416956;unassigned1304];CRYAB[26465331];GAPDH[23219802];BCAT2[21988832];OTUB1[26752685];PPP1R15A[29109149];USP15[19615732];PCNA[20849852];CACNA1A[21078624];EGFR[20029029];NCAPH[26496610];NCSTN[26496610];STOM[23219802];TFAP2A[24835590];GALNT6[21988832];JUN[25609649];VCAM1[22623428;19738201];FN1[19738201];DDIT4L[unassigned1304];MLH1[20706999];PLEKHA7[28877994];MAPK13[19135240];PPP1CA[25593058];SOD1[29128334];RAD52[19338310];CDK2AP1[26496610];DRC1[26496610];BCAR1[28007913];	30081261
29952	chr16	30666033	C	T	chr16:30666033	PRR14	proline rich 14	SNV	0/0	0.0	34_0	34	99.0	0/1	0.45	61_52	115	99.0			rs568329424,COSV99788582	EXONIC	YES	NM_024031.5	Transcript	protein_coding	missense_variant		8/12	NM_024031.5:c.742C>T	NP_076936.1:p.Pro248Ser		1.0	.,.					.	.	.		1.97197e-05	3.0	152132.0	0.0	32	0.96	PASS	amr	0.00013089	2.0	1.47029e-05	1.0	3.19933e-05	8.0	250052.0	0.0	65	0.99	PASS	amr	0.000144642	5.0	1.7768e-05	2.0	0.0000257	4	0.001	2.0				25.6	3.674528	0.428	10	11	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	PRR14	0.0	0.0	0.0	0.0	27.0	-16.0	14.0	-9.0						0.512	0.26	0.000000000	0.937	1.018	.			thyroid;subthalamic nucleus;atrioventricular node;trigeminal ganglion;whole blood;placenta;skeletal muscle;cerebellum peduncles;cerebellum;	.	muscle organ development	nuclear lamina;nucleoplasm;chromosome	protein binding	PPP2CA[19156129];PPP2CB[19156129];CBX5[16189514;20562864;27705803;unassigned1304];PPP2R1A[19156129;26496610;28330616];CBX3[27705803;unassigned1304];CBX1[27705803];SH3BP4[18654987];SH3GL2[21900206];	30666033
29955	chr16	30671164	AGG		chr16:30671164-30671166	FBRS	fibrosin	deletion	0/1	0.13	46_7	53	99.0	0/0	0.0	37_0	37	99.0			rs746156246	EXONIC	YES	NM_001105079.3	Transcript	protein_coding	inframe_deletion		1/18	NM_001105079.3:c.344_346del	NP_001098549.2:p.Glu115del		1.0						.	.	.		0.0027096	410.0	151314.0	1.0	33	0.97	PASS	afr	0.00556847	230.0	0.00121201	82.0	0.0145836	1266.0	86810.0	0.0	13	0.34	PASS	afr	0.0215774	87.0	0.0154932	485.0	0.0000450,0.0026173,0.0001865,0.0000064	7,407,29,1						19.37	1.953203		0	0	0																		0.98	0.000000000			.			ciliary ganglion;testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;superior cervical ganglion;atrioventricular node;testis;	.	regulation of signaling receptor activity;positive regulation of fibroblast proliferation	extracellular space	growth factor activity	CBX8[27705803];PCGF6[27705803];CBX4[27705803];CSNK2A1[27705803;25852190];RING1[27705803];AUTS2[25519132];PCGF5[27705803];CSNK2A2[23455922;27705803];PCGF3[27705803;unassigned1312];HELZ[unassigned1312];DCAF7[27705803];RNF2[27705803;26496610];MARF1[unassigned1312];RYBP[27705803];SOWAHA[unassigned1312];YAF2[27705803];	30671163
29966	chr16	30727746	C	G	chr16:30727746	SRCAP	Snf2 related CREBBP activator protein	SNV	0/1	0.59	43_62	105	99.0	0/0	0.0	34_0	34	99.0			rs757062198	EXONIC	YES	NM_006662.3	Transcript	protein_coding	missense_variant		18/34	NM_006662.3:c.2763C>G	NP_006653.2:p.Ile921Met		1.0	.,.				Developmental delay, hypotonia, musculoskeletal defects, and behavioral abnormalities, 619595 (3), Autosomal dominant; Floating-Harbor syndrome, 136140 (3), Autosomal dominant	Floating-Harbor syndrome	Disease-causing germline mutation(s) in	Abnormality of cardiovascular system morphology;Intrauterine growth retardation;Short clavicles;Abnormal fingernail morphology;Hypoplasia of penis;Prominent nose;Triangular face;Delayed skeletal maturation;Broad columella;Thin vermilion border;Underdeveloped nasal alae;Broad thumb;Enlarged joints;Abnormal soft palate morphology;Congenital pseudoarthrosis of the clavicle;Wide mouth;Feeding difficulties in infancy;Trigonocephaly;Deeply set eye;Short philtrum;Telecanthus;Constipation;Posteriorly rotated ears;Joint stiffness;Intellectual disability;Clinodactyly of the 5th finger;Long eyelashes;Malabsorption;High pitched voice;Joint hyperflexibility;Camptodactyly of finger;Expressive language delay;Strabismus;Recurrent otitis media;Bulbous nose;Wide nasal bridge;Generalized hirsutism;Brachydactyly;Global developmental delay;Congenital posterior urethral valve;Short neck;Short stature;Nasal speech;Neurological speech impairment;Generalized cerebral atrophy/hypoplasia;Short neck;Strabismus;Epididymal cyst;Wide mouth;Cone-shaped epiphyses of the phalanges of the hand;Triangular face;Congenital posterior urethral valve;Cognitive impairment;Long eyelashes;Conductive hearing impairment;Hirsutism;Short stature;Delayed skeletal maturation;Hydronephrosis;Thin vermilion border;Prominent nose;Expressive language delay;Persistent left superior vena cava;Varicocele;Cryptorchidism;Atrial septal defect;Joint laxity;Inguinal hernia;Celiac disease;Umbilical hernia;Recurrent otitis media;Downturned corners of mouth;Mesocardia;Clinodactyly of the 5th finger;Nephrocalcinosis;Hypospadias;Coarctation of aorta;Low posterior hairline;Deeply set eye;Autosomal dominant inheritance;Posteriorly rotated ears;Hypermetropia;Smooth philtrum						32	0.97							3.97706e-06	1.0	251442.0	0.0	73	1.0	PASS	nfe	8.79322e-06	1.0	8.79322e-06	1.0	0.0000064	1			0.00018	2.0		24.7	3.420238	0.157	13	8	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	LRT_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,ClinPred_pred,fathmm-XF_coding_pred	SRCAP	0.03	0.0	0.0	0.0	-4.0	30.0	-5.0	21.0						0.00579	1.0	0.000000000	1.0	0.125	.			ciliary ganglion;pons;appendix;atrioventricular node;superior cervical ganglion;trigeminal ganglion;cingulate cortex;parietal lobe;skeletal muscle;	.	chromatin remodeling;regulation of transcription by RNA polymerase II;viral process;gene silencing;histone acetylation;ATP-dependent chromatin remodeling;histone exchange;positive regulation of nucleic acid-templated transcription	Swr1 complex;nucleus;nucleoplasm;Golgi apparatus;nuclear body;protein-containing complex;perinuclear region of cytoplasm	DNA binding;transcription coactivator activity;helicase activity;histone acetyltransferase activity;protein binding;ATP binding;ATPase activity;histone binding	JUN[25609649];BHLHB9[unassigned1304];USHBP1[unassigned1304];ANKRD11[unassigned1304];ATG9A[16169070];ACTL6A[15647280];DIS3L[26496610];YEATS4[26496610];CCNC[unassigned1304];MIPOL1[unassigned1304];RNF168[26496610];MAU2[26496610];ZNHIT1[16230350;15647280];NCOR1[11013263];VPS72[15647280];RUVBL2[16230350];RUVBL1[16230350];NUF2[26496610];MED20[unassigned1304];CEP70[unassigned1304];TRIM54[unassigned1304];ZBTB7A[26816381];PDK1[26496610];PTPN3[unassigned1304];	30727746
29975	chr16	30939098	C	T	chr16:30939098	FBXL19	F-box and leucine rich repeat protein 19	SNV	0/1	0.49	50_49	99	99.0	0/0	0.0	43_0	43	99.0			rs367877670	EXONIC	YES	NM_001099784.3	Transcript	protein_coding	synonymous_variant		5/11	NM_001099784.3:c.501C>T	NP_001093254.2:p.Ala167%3D		1.0						.	.	.		0.000223335	34.0	152238.0	0.0	33	0.98	PASS	nfe	0.000352754	24.0	0.000352754	24.0	0.000224674	36.0	160232.0	0.0	24	0.55	PASS	nfe	0.000501159	32.0	0.000501159	32.0	0.0000900	14	0.001	2.0				11.25	0.71254		0	0	0			FBXL19	0.01	0.01	0.0	0.0	-25.0	-3.0	24.0	-26.0						0.46	0.98	90.708307284			hematopoietic system phenotype; immune system phenotype; 			ciliary ganglion;pons;subthalamic nucleus;whole brain;atrioventricular node;trigeminal ganglion;superior cervical ganglion;skeletal muscle;globus pallidus;medulla oblongata;cerebellum;	.	protein polyubiquitination;proteasome-mediated ubiquitin-dependent protein catabolic process;post-translational protein modification	cytosol;SCF ubiquitin ligase complex	DNA binding;ubiquitin-protein transferase activity;protein binding;zinc ion binding	SORT1[26496610];CUL1[22660580];GGH[30021884];HELZ[unassigned1312];CTDSPL2[26496610];DGAT2L6[unassigned1304];SORBS3[unassigned1304];DHRS2[30021884];FGD1[26496610];MARF1[unassigned1312];ABI2[unassigned1304];PSME3[unassigned1304];ABI1[unassigned1304];TMEM239[unassigned1304];NCK2[unassigned1304];EFHC2[unassigned1304];SKP1[27705803;unassigned1304];NSMAF[26496610];RPRM[unassigned1304];	30939098
29979	chr16	31088007	C	T	chr16:31088007	ZNF646	zinc finger protein 646	SNV	0/1	0.61	53_84	137	99.0	0/0	0.0	34_0	34	99.0			rs375213551	EXONIC	YES	NM_014699.4	Transcript	protein_coding	missense_variant		2/3	NM_014699.4:c.362C>T	NP_055514.3:p.Thr121Met		1.0	.,.,.					.	.	.		4.59855e-05	7.0	152222.0	0.0	32	0.97	PASS	afr	0.00012061	5.0	2.94005e-05	2.0	1.99426e-05	5.0	250720.0	0.0	61	0.98	PASS	afr	0.000123579	2.0	2.64863e-05	3.0	0.0000193	3						8.367	0.397147	0.026	0	18	18		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF646	0.0	0.0	0.0	0.0	-1.0	-7.0	-7.0	1.0						0.534	0.01	0.000000000	0.009	-0.234	.			trigeminal ganglion;atrioventricular node;superior cervical ganglion;testis;	.	regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;protein binding;metal ion binding	UBE2I[16189514];AIM2[25665578];PYHIN1[25665578];KRTAP10-9[unassigned1304];TRAF2[16189514];NINL[16189514];GAPDH[30021884];MDFI[16189514;19060904];PRKG1[25416956];EMSY[25416956];LEUTX[unassigned1304];C9orf72[29950492];	31088007
30006	chr16	31367963	C	A	chr16:31367963	ITGAX	integrin subunit alpha X	SNV	0/1	0.33	37_18	55	99.0	0/0	0.0	36_0	36	99.0				EXONIC	YES	NM_001286375.2	Transcript	protein_coding	missense_variant		3/31	NM_001286375.2:c.161C>A	NP_001273304.1:p.Pro54His		1.0	.,.,.					.	.	.						32	0.97											43	0.67														24.6	3.380283	0.579	17	3	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	FATHMM_pred,PrimateAI_pred,fathmm-XF_coding_pred	ITGAX	0.0	0.0	0.0	0.0	-17.0	-37.0	2.0	-17.0						0.441	0.0	63.484011183	0.528	1.008	hematopoietic system phenotype; normal phenotype; immune system phenotype; 			lymph node;whole blood;	Regulation of actin cytoskeleton	cell adhesion;integrin-mediated signaling pathway;animal organ morphogenesis;cytokine-mediated signaling pathway;extracellular matrix organization;heterotypic cell-cell adhesion;neutrophil degranulation;leukocyte migration	plasma membrane;integrin complex;cell surface;membrane;secretory granule membrane;tertiary granule membrane;ficolin-1-rich granule membrane	protein binding;signaling receptor activity;metal ion binding	ITGB2[20033057;20679211];	31367963
30044	chr16	32265022	G	C	chr16:32265022	TP53TG3D	TP53 target 3D	SNV	0/1	0.48	108_99	207	99.0	0/1	0.33	77_38	115	99.0			rs854250	EXONIC	YES	NM_001243722.2	Transcript	protein_coding	synonymous_variant		1/2	NM_001243722.2:c.348G>C	NP_001230651.1:p.Ala116%3D		1.0						.	.	.						18	0.32							0.366792	86466.0	235736.0	198.0	61	0.94	InbreedingCoeff	sas	0.455347	13532.0	0.357863	37426.0	0.0094467	1469	0.058	170.0				0.173	-0.407281		0	0	0			TP53TG3D	0.0	0.0	0.01	0.01	5.0	-36.0	14.0	-26.0							0.64				.			.	.	.	.	.	.	32265022
30059	chr16	46708575	A		chr16:46708575	VPS35	VPS35, retromer complex component	deletion	0/1	0.28	13_5	18	72.0	0/1	0.16	14_3	19	28.0			rs569369937	SPLICING	YES	NM_018206.6	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	8/16		NM_018206.6:c.915-3del			-1.0		Benign	criteria_provided,_single_submitter	Parkinson_disease_17|not_provided	{Parkinson disease 17}, 614203 (3), Autosomal dominant	Hereditary late-onset Parkinson disease	Disease-causing germline mutation(s) in	Chronic constipation;Rigidity;Dyskinesia;Orthostatic hypotension due to autonomic dysfunction;Impulsivity;Schizophrenia;Hypomimic face;Visual hallucinations;Muscle spasm;Resting tremor;Frequent falls;Low frustration tolerance;Depressivity;Gliosis;Bradykinesia;Lewy bodies;Weight loss;Dysphagia;Hyposmia;Dystonia;Postural instability;Parkinsonism with favorable response to dopaminergic medication;Cerebral cortical atrophy;Dementia;Sleep disturbance;Monotonic speech;Agitation;Apathy;Akinesia;Shuffling gait;Spastic/hyperactive bladder;Diplopia;Parkinsonism;Postural instability;Autosomal dominant inheritance;Rigidity;Bradykinesia;Akinesia;Resting tremor;Dyskinesia		0.00314362	419.0	133286.0	0.0	32	0.89	PASS	nfe	0.00299568	183.0	0.00299568	183.0	0.385664	39593.0	102662.0	0.0	19	0.5	InbreedingCoeff	eas	0.402594	2918.0	0.389843	16980.0	0.0003151,0.0016334,0.0000322,0.0000257	49,254,5,4			0.29254	2988.0		10.09	0.574209		0	0	0			VPS35	0.03	0.0	0.0	0.0	-7.0	-28.0	38.0	-48.0						0.406	0.99				normal phenotype; mortality/aging ; behavior/neurological phenotype ; nervous system phenotype ; digestive/alimentary phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			ciliary ganglion;amygdala;cingulate cortex;testis;pons;occipital lobe;subthalamic nucleus;dorsal root ganglion;parietal lobe;globus pallidus;medulla oblongata;hypothalamus;thalamus;	.	intracellular protein transport;lysosome organization;synapse assembly;positive regulation of gene expression;negative regulation of gene expression;regulation of mitochondrion organization;viral process;Wnt signaling pathway;regulation of macroautophagy;regulation of protein stability;protein destabilization;regulation of cellular protein metabolic process;negative regulation of protein homooligomerization;protein localization to organelle;retrograde transport, endosome to Golgi;mitochondrial fragmentation involved in apoptotic process;transcytosis;negative regulation of inflammatory response;voluntary musculoskeletal movement;positive regulation of dopamine receptor signaling pathway;negative regulation of cell death;positive regulation of Wnt protein secretion;positive regulation of mitochondrial fission;positive regulation of canonical Wnt signaling pathway;positive regulation of locomotion involved in locomotory behavior;neurotransmitter receptor transport, endosome to postsynaptic membrane;vesicle-mediated transport in synapse;mitochondrion to lysosome transport;neurotransmitter receptor transport, endosome to plasma membrane;negative regulation of neuron death;negative regulation of late endosome to lysosome transport;regulation of dendritic spine maintenance;positive regulation of dopamine biosynthetic process;positive regulation of cellular protein catabolic process;negative regulation of cellular protein localization;negative regulation of lysosomal protein catabolic process;regulation of presynapse assembly;retrograde transport, endosome to plasma membrane;regulation of terminal button organization	mitochondrion;lysosome;lysosomal membrane;endosome;early endosome;late endosome;cytosol;plasma membrane;endosome membrane;postsynaptic density;retromer complex;retromer, cargo-selective complex;neuron projection;neuronal cell body;perinuclear region of cytoplasm;extracellular exosome;tubular endosome;presynapse;glutamatergic synapse;mitochondrion-derived vesicle	protein binding;protein transporter activity;D1 dopamine receptor binding	ZNF512B[15231748];VPS29[11102511;25416956;unassigned1304;17891154;24747528];FKBP15[20923837];USP32[19615732];VPS26A[11102511;15078903;26496610;unassigned1304;16732284;17891154;24747528];ARRB2[17620599];VPS26B[26496610;unassigned1304];SNX1[11102511];SNX2[11102511];ANKFY1[22284051];RIOK2[23455922];VHL[17353931];GABARAPL2[17353931];JUN[25609649];VCAM1[22623428];USP43[19615732];H2AFX[20000738];ATG9A[24603492];HLA-B[17353931];FN1[19738201];LCA5[26638075];MCC[17353931];PRKAB1[17353931];IGF2R[15078903];VEGFA[21988832];MTNR1B[17215244;26514267];IRF4[21903422];TBC1D5[20923837];TRAF6[17353931];	46708574
30127	chr16	53674971	C	T	chr16:53674971	RPGRIP1L	RPGRIP1 like	SNV	0/0	0.0	33_0	33	99.0	0/1	0.22	40_11	51	99.0			rs367845452,COSV99030273	EXONIC	YES	NM_015272.5	Transcript	protein_coding	missense_variant		19/27	NM_015272.5:c.2932G>A	NP_056087.2:p.Val978Met		-1.0	.,.,.,.,.,.	Uncertain_significance	criteria_provided,_multiple_submitters,_no_conflicts	Agenesis_of_cerebellar_vermis|COACH_syndrome_1|Joubert_syndrome_7|Meckel_syndrome,_type_5|Meckel-Gruber_syndrome	Joubert syndrome 7, 611560 (3), Autosomal recessive; Meckel syndrome 5, 611561 (3), Autosomal recessive; ?COACH syndrome 3, 619113 (3)	Meckel syndrome;Joubert syndrome with hepatic defect;Joubert syndrome with renal defect	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Talipes;Cataract;Anophthalmia;Situs inversus totalis;Hypertelorism;Microphthalmia;Preaxial hand polydactyly;Accessory spleen;Aplasia/Hypoplasia of the corpus callosum;Hydrocephalus;Pancreatic cysts;Multicystic kidney dysplasia;Aplasia/Hypoplasia of the iris;Urethral atresia;Dandy-Walker malformation;Microcornea;Anencephaly;Optic atrophy;Furrowed tongue;Cryptorchidism;Congenital hepatic fibrosis;Cystic liver disease;Asplenia;Pancreatic fibrosis;Sclerocornea;Ureteral duplication;Microcephaly;Lobar holoprosencephaly;Postaxial hand polydactyly;True hermaphroditism;Bowing of the long bones;Encephalocele;Micrognathia;Male pseudohermaphroditism;Sloping forehead;Abnormal chorioretinal morphology;Aplasia/Hypoplasia of the tongue;Cleft palate;Oligohydramnios;Full cheeks;Postaxial foot polydactyly;Depressed nasal ridge;Low-set, posteriorly rotated ears;Renal insufficiency;Nystagmus;Agenesis of corpus callosum;Aganglionic megacolon;Iris coloboma;Apnea;Global developmental delay;Nephropathy;Long face;Oculomotor apraxia;Hydrocephalus;Low-set, posteriorly rotated ears;Seizure;Ptosis;Scoliosis;Molar tooth sign on MRI;Gait disturbance;Encephalocele;Highly arched eyebrow;Anteverted nares;Hand polydactyly;Tremor;Feeding difficulties;Muscular hypotonia;Cerebellar vermis hypoplasia;Prominent nasal bridge;Biparietal narrowing;Abnormality of cardiovascular system morphology;Strabismus;Polymicrogyria;Abnormality of the hypothalamus-pituitary axis;Cleft palate;Intellectual disability;Ataxia;Postaxial foot polydactyly;Occipital encephalocele;Cleft palate;Heterogeneous;Microphthalmia;Postaxial hand polydactyly;Bowing of the long bones;Cleft upper lip;Abnormality of the urinary system;Autosomal recessive inheritance;Bile duct proliferation;Anencephaly;Macrocephaly;Oral cleft;Elevated hepatic transaminase;Abnormality of neuronal migration;Neoplasm of the liver;Long face;Chorioretinal coloboma;Inguinal hernia;Nephropathy;Hydrocephalus;Optic nerve coloboma;Apnea;Aplasia/Hypoplasia of the corpus callosum;Seizure;Anteverted nares;Oculomotor apraxia;Intrahepatic biliary atresia;Intellectual disability, moderate;Low-set ears;Postaxial hand polydactyly;Congenital hepatic fibrosis;Renal insufficiency;Cerebellar vermis hypoplasia;Highly arched eyebrow;Feeding difficulties in infancy;Abnormality of the hypothalamus-pituitary axis;Hepatomegaly;Visual impairment;Ptosis;Prominent nasal bridge;Tremor;Ataxia;Multicystic kidney dysplasia;Hyperreflexia;Aplasia/Hypoplasia of the cerebellum;Strabismus;Gait disturbance;Cirrhosis;Occipital encephalocele;Biparietal narrowing;Nystagmus;Scoliosis;Muscular hypotonia;Portal hypertension;Iris coloboma;Splenomegaly;Chronic hepatic failure;Heterogeneous;Ptosis;Nystagmus;Brainstem dysplasia;Scoliosis;Encephalocele;Generalized hypotonia;Nephronophthisis;Intellectual disability;Neonatal breathing dysregulation;Autosomal recessive inheritance;Episodic tachypnea;Abnormal corpus callosum morphology;Oculomotor apraxia;Hypoplasia of the brainstem;Renal cyst;Postaxial hand polydactyly;Molar tooth sign on MRI;Retinal dystrophy;Ataxia;Global developmental delay;Central apnea;Ptosis;Dilatation;Hyperreflexia;Seizure;Postaxial hand polydactyly;Growth delay;Oculomotor apraxia;Hypertension;Portal hypertension;Cerebellar vermis hypoplasia;Spasticity;Intellectual disability, moderate;Hepatic fibrosis;Coloboma;Generalized hypotonia;Heterogeneous;Muscular hypotonia;Abnormality of abdomen morphology;Infantile onset;Nephronophthisis;Aplasia/Hypoplasia of the cerebellar vermis;Splenomegaly;Occipital encephalocele;Hepatomegaly;Renal insufficiency;Elevated hepatic transaminase;Multiple small medullary renal cysts;Wide mouth;Molar tooth sign on MRI;Hypertelorism;Round face;Ataxia;Anteverted nares;Autosomal recessive inheritance;Nystagmus;Global developmental delay;Cirrhosis		8.54656e-05	13.0	152108.0	0.0	32	0.96	PASS	nfe	0.000146998	10.0	0.000146998	10.0	5.9822e-05	15.0	250744.0	0.0	69	1.0	PASS	nfe	8.83845e-05	10.0	8.83845e-05	10.0	0.0000514	8	0.0	1.0	0.00035	4.0		21.2	2.172199	0.052	2	17	19	M-CAP_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	RPGRIP1L	0.0	0.0	0.01	0.02	-26.0	17.0	10.0	-26.0						0.145	0.0	0.000000000	0.937	-0.239	vision/eye phenotype; nervous system phenotype ; hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; digestive/alimentary phenotype; renal/urinary system phenotype; skeleton phenotype; immune system phenotype; respiratory system phenotype; liver/biliary system phenotype; embryo phenotype; mortality/aging ; reproductive system phenotype; growth/size/body region phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; craniofacial phenotype; muscle phenotype; homeostasis/metabolism phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			superior cervical ganglion;testis;skeletal muscle;	.	in utero embryonic development;establishment of planar polarity;kidney development;liver development;establishment or maintenance of cell polarity;determination of left/right symmetry;regulation of smoothened signaling pathway;neural tube patterning;cerebellum development;lateral ventricle development;olfactory bulb development;corpus callosum development;embryonic forelimb morphogenesis;embryonic hindlimb morphogenesis;camera-type eye development;nose development;negative regulation of G protein-coupled receptor signaling pathway;pericardium development;cochlea development;ciliary basal body-plasma membrane docking;non-motile cilium assembly	nucleoplasm;cytoplasm;centrosome;cytosol;axonemal microtubule;plasma membrane;cell-cell junction;bicellular tight junction;cilium;axoneme;photoreceptor connecting cilium;ciliary rootlet;ciliary transition zone;ciliary basal body	protein binding;thromboxane A2 receptor binding	TFRC[26638075];KDM1A[26638075];CCP110[26638075];GPATCH1[26638075];WDR83[26638075];PLOD1[26638075];C21orf2[unassigned1312];SMC3[26638075];IPO7[26638075];WASHC2A[26638075];CEP128[26638075];EIF4ENIF1[26638075];IPO8[26638075];PSMD7[26638075];IPO9[26638075];MPRIP[26638075;27173435;unassigned1312];CSPP1[26638075];LONP1[26638075];NEK1[unassigned1312];TRIM27[26638075];CEP97[26638075];LZTS2[26638075];CDK5RAP2[26638075];SEC63[26638075];ACOT9[26638075];ECH1[26638075];CEP131[26638075];SPICE1[26638075];RPGRIP1L[17558407];ESCO2[26638075];SDHA[26638075];RPP25L[27173435;unassigned1312];CD2AP[26638075];TMEM256[26638075];MSH2[unassigned1312];ILVBL[26638075];ZNF318[26638075];PKP2[26638075];SRSF2[26638075];KCTD12[26638075];RAF1[unassigned1312];TP53[26638075];RAI14[26638075;27173435;unassigned1312];RAB5B[26638075];SNU13[26638075];HACD2[26638075];SPATA7[27173435;unassigned1312];RACGAP1[26638075];PDCD11[26638075];NPHP1[26638075;27173435;unassigned1312];DVL2[26638075];TP53BP2[26638075];NPHP4[17558407;26638075;27173435;unassigned1312;16339905];CEP192[26638075];ECT2[26638075;27173435;unassigned1312];RAB6A[26638075];N4BP2[26638075];ANKRD28[26638075];CHTOP[26638075];NEK4[26638075;27173435;unassigned1312;25798074];NUP155[26638075];CCDC138[26638075];CEP350[26638075];ERLIN1[26638075];ERLIN2[26638075];ACADSB[26638075];MOB4[26638075];IBTK[26638075];LAS1L[30021884];GKAP1[26638075;27173435;unassigned1312];TRIP6[26638075];SPATS2L[26638075];CCSER2[26638075];CEP85[26638075];SH3KBP1[26638075];DDX47[26638075];KIAA1671[26638075];KIF14[26638075];PYGL[26638075];SIPA1L2[26638075];SIPA1L3[26638075];RPGR[26638075;27173435;unassigned1312];TCHP[26638075];PCM1[26638075];SIPA1L1[26638075];CAPZB[26638075];NNT[26638075];DBT[26638075];CNTRL[26638075];CEP170B[26638075];IDH3B[26638075];ELOA[26638075];CEP170[26638075];NINL[26638075];YWHAH[26638075];CTSB[26638075];OFD1[26638075];ANKDD1A[26638075];UPF1[26638075];HSDL2[26638075];PLEKHG1[26638075];CLUH[26638075;27173435;unassigned1312];PPP1R12A[26638075];RBM15[26638075];GPX1[26638075];NUP133[unassigned1312];DDX56[26638075];DDX54[26638075];HAUS3[26638075];CTPS1[26638075];KIF23[26638075];HAUS6[26638075];DYNLL1[unassigned1312];DYNLL2[unassigned1312];SIRT2[26638075];RCN1[26638075];KIF2A[26638075];NME7[26638075];GARS[26638075];MYZAP[26638075];PTMA[26638075];SSX2IP[26638075];FH[26638075];LUZP1[26638075];NDUFB4[26638075];NOC4L[26638075];ABRACL[26638075];TTK[26638075];TYMS[26638075];SELENOH[26638075];NXF1[26638075];IFT74[26638075];GANAB[26638075];WDCP[26638075];HECTD1[26638075];HAUS8[26638075];CCDC85C[26638075];KIAA0753[26638075];EMC3[26638075];ENTR1[26638075];PCNT[26638075];ABCF1[27173435;unassigned1312];TEFM[27173435;unassigned1312];DYNC1H1[26638075];TRIM41[26638075];SPAG5[26638075];CEP152[26638075];LCA5[26638075];ATP2B1[26638075];ASS1[26638075];PPP1CA[19389623];TJP1[26638075];RAD50[26638075];MPHOSPH9[26638075];APC[26638075];CAPZA1[26638075];CAPZA2[26638075];CEP162[26638075];TRIM37[26638075];EPPK1[26638075];TNRC6A[26638075];TNRC6B[26638075];	53674971
30149	chr16	55844871	T	C	chr16:55844871	CES1	carboxylesterase 1	SNV	0/0	0.0	35_0	35	99.0	0/1	0.44	60_47	107	99.0			rs140704082	EXONIC	YES	NM_001025195.2	Transcript	protein_coding	missense_variant		10/14	NM_001025195.2:c.1138A>G	NP_001020366.1:p.Met380Val		-1.0	.,.,Carboxylesterase, type B				Drug metabolism, altered, CES1-related, 618057 (3), Autosomal dominant	.	.	.		0.000914835	139.0	151940.0	0.0	34	0.95	PASS	amr	0.00209644	32.0	0.00132302	90.0	0.00103065	259.0	251298.0	1.0	94	0.98	PASS	amr	0.00251561	87.0	0.00115252	131.0	0.0009067	141	0.005	17.0	0.00691	78.0		0.26	-0.349395	0.025	1	18	19	LIST-S2_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CES1	0.08	0.0	0.07	0.0	48.0	-38.0	-32.0	-1.0						0.954	0.0		0.058	-0.789	.			.	Alkaloid biosynthesis II;Drug metabolism - other enzymes	cholesterol biosynthetic process;xenobiotic metabolic process;response to toxic substance;lipid catabolic process;epithelial cell differentiation;medium-chain fatty acid metabolic process;cholesterol ester hydrolysis involved in cholesterol transport	extracellular space;endoplasmic reticulum;endoplasmic reticulum lumen;cytosol	sterol esterase activity;triglyceride lipase activity;methylumbelliferyl-acetate deacetylase activity;carboxylic ester hydrolase activity	KPRP[unassigned1304];CREB3[21516116];CYSRT1[unassigned1304];SAR1A[unassigned1304];GORAB[unassigned1304];PLSCR4[unassigned1304];PDZK1IP1[unassigned1304];VENTX[unassigned1304];	55844871
30475	chr16	57188382	C	G	chr16:57188382	FAM192A	family with sequence similarity 192 member A	SNV	0/1	0.48	42_38	80	99.0	0/0	0.0	41_0	41	99.0			rs759216991	EXONIC	YES	NM_001354098.2	Transcript	protein_coding	synonymous_variant		7/7	NM_001354098.2:c.663G>C	NP_001341027.1:p.Leu221%3D		-1.0						.	.	.		2.63006e-05	4.0	152088.0	0.0	32	0.96	PASS	amr	6.54793e-05	1.0	4.41138e-05	3.0	1.21633e-05	3.0	246644.0	0.0	33	0.94	PASS	nfe	2.69731e-05	3.0	2.69731e-05	3.0	0.0000129	2						11.33	0.722251		0	0	0			FAM192A	0.0	0.0	0.0	0.0	37.0	-35.0	-33.0	-37.0						0.196	0.94	72.648288731			.			caudate nucleus;amygdala;prefrontal cortex;superior cervical ganglion;cingulate cortex;cerebellum;pons;occipital lobe;whole brain;spinal cord;medulla oblongata;hypothalamus;thalamus;	.	negative regulation of protein binding;negative regulation of proteasomal protein catabolic process	nucleus	protein binding	BLM[26496610];KSR1[27086506];LRRK2[29513927];FZD7[28298427];PRKCD[26496610];HSFX1[25036637];TRAF2[25416956];SOD2[20195357];CLCN2[26496610];MFHAS1[29513927];SLX4[19596235];CREB1[25609649];KIF3A[26496610];MTNR1B[26514267];ATP13A2[22645275];KIFAP3[26496610];YWHAH[26496610];	57188382
30529	chr16	57562541	C	T	chr16:57562541	CCDC102A	coiled-coil domain containing 102A	SNV	0/1	0.47	33_29	62	99.0	0/1	0.53	23_26	49	99.0			rs146791662,COSV99264739	EXONIC	YES	NM_033212.4	Transcript	protein_coding	synonymous_variant		2/9	NM_033212.4:c.549G>A	NP_149989.2:p.Val183%3D		-1.0						.	.	.		0.0043965	659.0	149892.0	2.0	33	0.94	PASS	nfe	0.00704581	475.0	0.00704581	475.0	0.00527023	251.0	47626.0	1.0	5	0.01	PASS	nfe	0.00751239	194.0	0.00751239	194.0	0.0022893	356	0.003	11.0			1.0	11.0	0.682388		0	0	0			CCDC102A	0.0	0.0	0.41	0.02	3.0	1.0	3.0	-36.0							0.0				.			superior cervical ganglion;trigeminal ganglion;	.	.	myosin complex	motor activity	DSN1[26496610];ODF2[26638075];MYH9[26496610];VPS26B[26496610];CEP128[26638075];	57562541
30855	chr16	61687613	A	C	chr16:61687613	CDH8	cadherin 8	SNV	0/1	0.51	49_50	99	99.0	0/1	0.5	64_64	128	99.0			rs201100815	EXONIC	YES	NM_001796.5	Transcript	protein_coding	missense_variant		12/12	NM_001796.5:c.2299T>G	NP_001787.2:p.Ser767Ala		-1.0	Cadherin, cytoplasmic domain					.	.	.		0.000164327	25.0	152136.0	0.0	32	0.97	PASS	amr	0.000261849	4.0	0.000249949	17.0	0.000163075	41.0	251418.0	0.0	63	1.0	PASS	nfe	0.000316534	36.0	0.000316534	36.0	0.0001736	27	0.0	1.0	0.00054	1.0		22.5	2.469315	0.304	4	14	18	M-CAP_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	CDH8	0.0	0.0	0.0	0.0	-1.0	41.0	-48.0	41.0						0.194	1.0		1.0	1.312	integument phenotype ; vision/eye phenotype; nervous system phenotype ; behavior/neurological phenotype ; 			appendix;trigeminal ganglion;atrioventricular node;superior cervical ganglion;skeletal muscle;globus pallidus;	.	cell morphogenesis;cell-cell junction assembly;cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;response to cold;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;adherens junction organization;synaptic transmission, glutamatergic;cell-cell adhesion mediated by cadherin;regulation of synapse organization;cell-cell adhesion	plasma membrane;cell-cell adherens junction;cell surface;integral component of membrane;catenin complex;synaptic cleft;axon terminus;synaptic membrane;glutamatergic synapse	calcium ion binding;cytoskeletal protein binding;protein homodimerization activity;cadherin binding	.	61687613
30888	chr16	66855469		A	chr16:66855468-66855469	NAE1	NEDD8 activating enzyme E1 subunit 1	insertion	0/1	0.21	27_8	39	99.0	0/0	0.0	35_0	35	63.0			rs762477396	SPLICING	YES	NM_001286500.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	6/19		NM_001286500.2:c.411-7dup			-1.0						.	.	.		0.000420939	61.0	144914.0	0.0	32	0.94	PASS	eas	0.000595238	3.0	0.00056387	37.0	0.0304799	2664.0	87402.0	0.0	18	0.43	RF	sas	0.0432277	360.0	0.0251459	1120.0	0.0000707,0.0001865,0.0099483	11,29,1547						1.874	-0.055539		0	0	0			NAE1	0.0	0.0	0.0	0.0	-23.0	-6.0	-6.0	-19.0						0.931	0.0				muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; mortality/aging ; cardiovascular system phenotype ; hematopoietic system phenotype; 			testis - seminiferous tubule;testis - interstitial;testis;	Alzheimer's disease	signal transduction;protein modification by small protein conjugation;mitotic DNA replication checkpoint;regulation of apoptotic process;regulation of neuron apoptotic process;post-translational protein modification;protein neddylation;neuron apoptotic process	cytoplasm;cytosol;plasma membrane	protein binding;NEDD8 activating enzyme activity;ubiquitin protein ligase binding;protein heterodimerization activity	ALG8[21988832];UIMC1[19615732];UBA3[unassigned1304];NEDD8[14690597;18274552];UBQLN4[16169070];FBXO11[17098746];SREBF2[21988832];UBE2M[17353931];	66855468
30904	chr16	66949271	G	A	chr16:66949271	CDH16	cadherin 16	SNV	0/1	0.53	44_52	98	99.0	0/0	0.0	36_0	36	99.0			rs774222467,COSV100233624	EXONIC	YES	NM_004062.4	Transcript	protein_coding	synonymous_variant		6/18	NM_004062.4:c.435C>T	NP_004053.1:p.Phe145%3D		-1.0						.	.	.						32	0.97							7.96756e-06	2.0	251018.0	0.0	41	0.96	PASS	nfe	1.76159e-05	2.0	1.76159e-05	2.0	0.0000129	2						13.37	0.990789		0	0	0			CDH16	0.35	0.23	0.0	0.0	-20.0	33.0	33.0	-13.0						0.949	0.0	65.963391326			.			ciliary ganglion;kidney;thyroid;	.	cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	integral component of plasma membrane;basolateral plasma membrane;extracellular exosome	calcium ion binding	G6PC[21988832];RPL14[30021884];	66949271
30934	chr16	67229794	GCA		chr16:67229794-67229796	E2F4	E2F transcription factor 4	deletion	0/1	0.14	73_12	87	99.0	0/1	0.14	48_8	59	99.0			rs3830472	EXONIC	YES	NM_001950.4	Transcript	protein_coding	inframe_deletion		7/10	NM_001950.4:c.956_958del	NP_001941.2:p.Ser319del		1.0						.	.	.		0.00364136	546.0	149944.0	2.0	32	0.87	PASS	amr	0.00431779	65.0	0.00406155	274.0					100	1.0							0.0029774,0.1770630	463,27534			0.12335	1175.0		15.4	1.340797		0	0	0			E2F4	0.06	0.13	0.0	0.0	10.0	4.0	13.0	44.0						0.126	0.32	0.000000000			behavior/neurological phenotype ; respiratory system phenotype; embryo phenotype; neoplasm; cardiovascular system phenotype ; hematopoietic system phenotype; mortality/aging ; normal phenotype; reproductive system phenotype; digestive/alimentary phenotype; hearing/vestibular/ear phenotype; skeleton phenotype; homeostasis/metabolism phenotype; immune system phenotype; cellular phenotype; taste/olfaction phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype ; craniofacial phenotype; 			.	TGF-beta signaling pathway	regulation of transcription involved in G1/S transition of mitotic cell cycle;negative regulation of transcription by RNA polymerase II;epithelial cell development;cell volume homeostasis;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;blood circulation;animal organ morphogenesis;regulation of cell population proliferation;motile cilium assembly;positive regulation of transcription by RNA polymerase II;regulation of cell cycle;centriole assembly;multi-ciliated epithelial cell differentiation	nuclear chromatin;nucleus;nucleoplasm;RNA polymerase II transcription factor complex	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;protein binding;transcription factor binding;protein domain specific binding;sequence-specific DNA binding;protein dimerization activity;promoter-specific chromatin binding	RB1[16360038];LIN54[17531812];L3MBTL3[17517653];LIN37[17531812];TRRAP[11418595];LRRK2[29513927];LIN9[17159899;17531812];PML[22002537];RBL2[17531812;22002537;20133863];MFHAS1[29513927];PCM1[21988832];TFDP1[16360038;27705803;unassigned1304];RBL1[16360038];TFDP2[10090723;16360038;unassigned1304];KAT5[unassigned1304];CDK4[27173435;unassigned1312];CDK2[25852190];CHMP2A[21988832];POLR1D[21988832];PIN1[unassigned1304];MYBL2[17159899];AP3S2[21988832];	67229793
30975	chr16	68025998	A	C	chr16:68025998	DPEP2	dipeptidase 2	SNV	0/1	0.45	32_26	58	99.0	0/1	0.64	28_50	78	99.0			rs144339907	EXONIC	YES	NM_001369657.1	Transcript	protein_coding	stop_gained		3/10	NM_001369657.1:c.489T>G	NP_001356586.1:p.Tyr163Ter		-1.0	.,.,.					.	.	.		0.00164283	250.0	152176.0	1.0	32	0.97	PASS	nfe	0.00286596	195.0	0.00286596	195.0	0.00178573	449.0	251438.0	1.0	89	1.0	PASS	nfe	0.00315682	359.0	0.00315682	359.0	0.0019035	296	0.001	3.0				32.0	4.628976		3	4	7	LRT_pred,MutationTaster_pred,BayesDel_noAF_pred	BayesDel_addAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	DPEP2	0.04	0.0	0.0	0.01	-1.0	-7.0	-1.0	-35.0							0.0	0.000000000	0.953	-0.089	.			white blood cells;whole blood;skeletal muscle;	.	proteolysis	anchored component of membrane	metalloexopeptidase activity;dipeptidyl-peptidase activity;dipeptidase activity;metal ion binding	NLGN3[25464930];	68025998
31043	chr16	68679319	TCT		chr16:68679319-68679321	CDH3	cadherin 3	deletion	0/1	0.49	48_47	95	99.0	0/1	0.47	52_47	99	99.0				EXONIC	YES	NM_001793.6	Transcript	protein_coding	inframe_deletion		1/16	NM_001793.6:c.39_41del	NP_001784.2:p.Leu14del		1.0					Hypotrichosis, congenital, with juvenile macular dystrophy, 601553 (3), Autosomal recessive; Ectodermal dysplasia, ectrodactyly, and macular dystrophy, 225280 (3), Autosomal recessive	Hypotrichosis with juvenile macular degeneration;EEM syndrome	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Blindness;Macular dystrophy;Autosomal recessive inheritance;Reduced terminal:vellus ratio;Pili torti;Sparse hair;Macular dystrophy;Retinopathy;Absent eyebrow;Sparse scalp hair;Ectrodactyly;Strabismus;Carious teeth;Selective tooth agenesis;Finger syndactyly;Widely spaced teeth;Sparse body hair;Abnormality of vision;Microdontia;Abnormality of retinal pigmentation;Abnormality of limb bone morphology;Fine hair;Hyperkeratosis;Immunologic hypersensitivity;Sparse scalp hair;Pili torti;Freckling;Melanocytic nevus;Macular degeneration;Short stature;Blindness;Abnormality of macular pigmentation;Brittle hair;Skeletal dysplasia;Nystagmus;Macular dystrophy;Joint contracture of the hand;Sparse scalp hair;Camptodactyly;Sparse and thin eyebrow;Split hand;Sparse eyelashes;Selective tooth agenesis;Ectodermal dysplasia;Autosomal recessive inheritance;Microdontia;Syndactyly;Widely spaced teeth						33	0.98											96	0.96											9e-05	1.0					0	0	0			CDH3	0.0	0.01	0.0	0.01	-40.0	-37.0	10.0	9.0						0.729	0.0	59.984957943			integument phenotype ; endocrine/exocrine gland phenotype; 			lung;thymus;	Cell adhesion molecules (CAMs)	cell morphogenesis;retina homeostasis;cell-cell junction assembly;cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;visual perception;positive regulation of gene expression;positive regulation of keratinocyte proliferation;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;hair cycle process;keratinization;positive regulation of monophenol monooxygenase activity;negative regulation of transforming growth factor beta2 production;adherens junction organization;wound healing;response to drug;positive regulation of insulin-like growth factor receptor signaling pathway;cell-cell adhesion mediated by cadherin;positive regulation of melanin biosynthetic process;negative regulation of timing of catagen;regulation of hair cycle by canonical Wnt signaling pathway;positive regulation of canonical Wnt signaling pathway;cell-cell adhesion;positive regulation of melanosome transport	cytoplasm;plasma membrane;cell-cell adherens junction;cell surface;integral component of membrane;catenin complex	molecular_function;calcium ion binding;cytoskeletal protein binding;protein homodimerization activity;cadherin binding	YAP1[21376238];AP2M1[24189400];IGF1R[21317933];	68679318
31059	chr16	69390938	C	T	chr16:69390938	TERF2	telomeric repeat binding factor 2	SNV	0/1	0.37	37_22	59	99.0	0/1	0.45	36_30	66	99.0			rs150757154	EXONIC	YES	NM_005652.5	Transcript	protein_coding	missense_variant		10/10	NM_005652.5:c.1492G>A	NP_005643.2:p.Glu498Lys		-1.0	SANT/Myb domain&Myb domain&SANT/Myb domain					.	.	.		0.00152435	232.0	152196.0	0.0	32	0.97	PASS	amr	0.00314301	48.0	0.00230794	157.0	0.00133203	330.0	247742.0	0.0	39	0.82	PASS	nfe	0.00215709	243.0	0.00215709	243.0	0.0014019	218	0.003	8.0				28.4	4.077995	0.382	5	12	17	SIFT,MutationTaster_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,fathmm-XF_coding_pred	TERF2	0.01	0.0	0.0	0.0	18.0	21.0	-1.0	-17.0						0.346	0.93	0.000000000	0.999	1.022	liver/biliary system phenotype; mortality/aging ; cellular phenotype; 			amygdala;prefrontal cortex;trigeminal ganglion;cingulate cortex;superior cervical ganglion;cerebellum peduncles;cerebellum;pons;occipital lobe;subthalamic nucleus;whole brain;parietal lobe;skeletal muscle;globus pallidus;	.	telomere maintenance;RNA-dependent DNA biosynthetic process;regulation of transcription by RNA polymerase II;cell cycle;positive regulation of gene expression;negative regulation of gene expression;telomere capping;telomeric loop formation;protection from non-homologous end joining at telomere;regulation of telomere maintenance;negative regulation of telomere maintenance;negative regulation of telomere maintenance via recombination;regulation of telomere maintenance via telomerase;negative regulation of telomere maintenance via telomerase;negative regulation of telomere maintenance via semi-conservative replication;positive regulation of nitric-oxide synthase activity;telomeric D-loop disassembly;protein localization to chromosome, telomeric region;cellular senescence;anterograde axonal transport of messenger ribonucleoprotein complex;negative regulation of beta-galactosidase activity;negative regulation of telomere single strand break repair;negative regulation of telomere capping;negative regulation of telomere maintenance via telomere lengthening;negative regulation of t-circle formation;negative regulation of exonuclease activity;negative regulation of telomeric D-loop disassembly;negative regulation of cellular senescence	chromosome, telomeric region;nuclear telomere cap complex;nuclear chromosome, telomeric region;nucleus;nucleoplasm;nuclear body;Mre11 complex;shelterin complex;axon cytoplasm	DNA-binding transcription factor activity, RNA polymerase II-specific;double-stranded telomeric DNA binding;telomerase activity;protein binding;protein C-terminus binding;enzyme binding;telomeric DNA binding;protein homodimerization activity;protein-containing complex binding;G-rich strand telomeric DNA binding	DCLRE1B[16730175;26496610;20479256;21217703];MDC1[29656893];FEN1[21044950];MRE11[19287395];NUMA1[21044950];PPP1R10[19287395];WDR4[21044950];HMGB1[21044950];BRCA1[29656893];MKI67[26949251];HMGN4[21044950];NBN[19287395];HMGN2[21044950];HMGN3[21044950];TMSB10[21044950];HMGN1[21044950];TINF2[15383534;26496610;21044950;16880378;19287395];TOP3A[18418389];H2AFX[21824286;22157895;21044950];ANXA5[21044950];TALDO1[21044950];TERF2[21044950];PTBP3[22575643];PIAS1[26450775];DDX39A[21044950];NCL[21044950];NUMB[25814554];LANCL2[21044950];TERF2IP[15383534;19651898;21829167;26496610;21044950;27214791;16880378;19287395;21217703];POT1[15383534;19651898;26496610;16880378;19287395];HIST1H2BH[30021884];SRSF6[21044950];HDGFL2[21044950];PTMA[21044950];MCPH1[19287395];BLM[12181313;15229185];SP100[21044950];SET[21044950];DDX24[21044950];CTBP1[21044950];NAIF1[21044950];PIK3R3[25814554];DDX21[21044950];TOR1AIP1[21044950];PPM1G[21044950];WRN[12181313];RNF113A[21044950];SLX4[19596235;19596236];ORC1[16799465];TERT[24550003];ORC2[16799465];ZC3H18[21044950];RPL13[21044950];RPRD1B[21044950];TP53BP1[21824286;29656893];LYAR[21044950];NXNL1[21044950];ATG5[20562859];BANP[21044950];HEXIM1[21044950];HEXIM2[21044950];ACD[15231715;15383534;16880378];STN1[19648609];JUN[25609649];XRCC6[26496610;21044950];AFAP1L2[21044950];CCDC137[21044950];MAGOHB[21044950];PML[18418389];ASS1[21044950];GNMT[21044950];RAD50[19287395];NASP[21044950];APEX1[21044950];ATM[15314656];OCM2[21044950];	69390938
31328	chr16	75674253	AAA		chr16:75674253-75674255	KARS	lysyl-tRNA synthetase	sequence_alteration	0/2	0.0	13_0_6	19	83.0	0/1	0.11	16_3_3	27	35.0			rs370077957	SPLICING	YES	NM_001130089.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	3/14		NM_001130089.2:c.307-8_307-6del			-1.0		Benign	criteria_provided,_single_submitter	not_provided		Autosomal recessive intermediate Charcot-Marie-Tooth disease type B;Autosomal recessive non-syndromic sensorineural deafness type DFNB	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Steppage gait;Autosomal recessive inheritance;Pes cavus;Foot dorsiflexor weakness;Global developmental delay;Distal sensory impairment;Areflexia;Vestibular Schwannoma;Hyporeflexia;Hearing impairment;Autosomal recessive inheritance		5.54877e-05	7.0	126154.0	0.0	30	0.81	PASS	amr	7.82595e-05	1.0	6.99986e-05	4.0	0.00390566	721.0	184604.0	0.0	72	0.99	InbreedingCoeff	nfe	0.00496549	423.0	0.00496549	423.0	0.0000193,0.0000836,0.0071638	3,13,1114			0.02294	260.0		10.06	0.571329		0	0	0			KARS	0.0	0.0	0.0	0.0	-5.0	-25.0	-16.0	-46.0						0.342	0.09				craniofacial phenotype; mortality/aging ; skeleton phenotype; 			ciliary ganglion;white blood cells;testis - seminiferous tubule;testis - interstitial;tumor;trigeminal ganglion;superior cervical ganglion;atrioventricular node;testis;skeletal muscle;	Lysine biosynthesis;Aminoacyl-tRNA biosynthesis;Amyotrophic lateral sclerosis (ALS)	activation of MAPK activity;basophil activation involved in immune response;positive regulation of cytokine secretion involved in immune response;tRNA aminoacylation for protein translation;lysyl-tRNA aminoacylation;tRNA processing;negative regulation of cell population proliferation;response to X-ray;positive regulation of macrophage chemotaxis;diadenosine tetraphosphate biosynthetic process;viral process;tumor necrosis factor-mediated signaling pathway;positive regulation of macrophage activation;positive regulation of transcription, DNA-templated;ERK1 and ERK2 cascade;positive regulation of ERK1 and ERK2 cascade;positive regulation of cytokine production involved in inflammatory response;positive regulation of p38MAPK cascade;positive regulation of metallopeptidase activity	extracellular space;nucleus;mitochondrion;mitochondrial matrix;cytosol;plasma membrane;aminoacyl-tRNA synthetase multienzyme complex	tRNA binding;ATP adenylyltransferase activity;lysine-tRNA ligase activity;protein binding;ATP binding;amino acid binding;identical protein binding;protein homodimerization activity	SMARCB1[30108113];PLGRKT[29568061];COX4I1[29568061];DYSF[23414517];PIK3R3[21900206];NEDD8[18274552];MRPL58[20186120];EPRS[22386318;21220307];TANK[14743216];HSD17B10[29128334];TOMM22[29568061];TGOLN2[29568061];MYC[21150319];STK38L[30108113];CD37[22624718];COX14[29568061];IKBKE[17353931];PDK1[29568061];OFD1[unassigned1312];GABARAPL2[20562859];GABARAPL1[20562859];JUN[25609649];FN1[19738201];RPSA[24983501;24212136];LAMB1[24983501];FRS3[16169070];RAB11A[29568061];EEF1G[16169070];AIMP1[17443684];AIMP2[16189514;21988832;21900206;25416956;unassigned1304;21536907;24212136;29997244];KARS[18272479;21536907;24212136];RAB9A[29568061];PKN2[26496610];SFXN1[29568061];VIM[21900206];AURKAIP1[29568061];EZR[29568061];GAPDH[21900206];RAB5A[29568061];PAFAH1B1[16169070];SLC25A6[16169070];OTUB1[26752685];BET1[29568061];	75674252
31386	chr16	82673008	C	T	chr16:82673008	CDH13	cadherin 13	SNV	0/0	0.0	35_0	35	99.0	0/1	0.37	56_33	89	99.0			rs576859115	EXONIC	YES	NM_001220488.2	Transcript	protein_coding	missense_variant		2/15	NM_001220488.2:c.124C>T	NP_001207417.1:p.His42Tyr		1.0						.	.	.		0.000394296	60.0	152170.0	0.0	32	0.94	PASS	amr	0.00130873	20.0	0.00032332	22.0	0.000560756	72.0	128398.0	0.0	33	0.56	PASS	amr	0.00184775	45.0	0.000377644	18.0	0.0000579	9	0.002	6.0	0.00184	21.0		4.538	0.116667	0.028	0	16	16		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CDH13	0.0	0.09	0.0	0.0	-2.0	-43.0	-2.0	-43.0						0.493	0.22	0.000000000	0.0	-1.829	endocrine/exocrine gland phenotype; integument phenotype ; homeostasis/metabolism phenotype; neoplasm; cardiovascular system phenotype ; vision/eye phenotype; 			ciliary ganglion;pons;occipital lobe;dorsal root ganglion;trigeminal ganglion;skin;superior cervical ganglion;atrioventricular node;heart;	.	mitotic cell cycle;cell morphogenesis;positive regulation of endothelial cell proliferation;positive regulation of cell-matrix adhesion;sprouting angiogenesis;cell-cell junction assembly;homophilic cell adhesion via plasma membrane adhesion molecules;negative regulation of cell adhesion;Rho protein signal transduction;negative regulation of cell population proliferation;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;Rac protein signal transduction;lamellipodium assembly;regulation of endocytosis;positive regulation of cell migration;adherens junction organization;regulation of epidermal growth factor receptor signaling pathway;endothelial cell migration;keratinocyte proliferation;cell-cell adhesion mediated by cadherin;positive regulation of transcription by RNA polymerase II;positive regulation of smooth muscle cell proliferation;positive regulation of calcium-mediated signaling;positive regulation of positive chemotaxis;localization within membrane;low-density lipoprotein particle mediated signaling;cell-cell adhesion	extracellular region;extracellular space;cytoplasm;plasma membrane;caveola;cell-cell adherens junction;focal adhesion;external side of plasma membrane;cell surface;catenin complex;anchored component of membrane;neuron projection;perinuclear region of cytoplasm;collagen-containing extracellular matrix;extracellular exosome;GABA-ergic synapse	calcium ion binding;cytoskeletal protein binding;low-density lipoprotein particle binding;protein homodimerization activity;cadherin binding;adiponectin binding;lipoprotein particle binding	PTPN1[25640309];MDC1[29656893];CASP8[25640309];RAD51[25640309];CCND1[25640309];MTNR1B[26514267];CHEK2[25640309];HMMR[25640309];MAPK6[21900206];AURKA[25640309];	82673008
31418	chr16	84227804	G	A	chr16:84227804	ADAD2	adenosine deaminase domain containing 2	SNV	0/1	0.44	48_38	86	99.0	0/0	0.0	44_0	44	99.0			rs374657943,COSV51892547	EXONIC	YES	NM_139174.4	Transcript	protein_coding	missense_variant		2/11	NM_139174.4:c.611G>A	NP_631913.3:p.Arg204His		1.0						.	.	.		5.91327e-05	9.0	152200.0	0.0	33	0.97	PASS	amr	0.000130907	2.0	5.87976e-05	4.0	0.000115298	21.0	182136.0	0.0	75	0.59	PASS	nfe	0.000201998	15.0	0.000201998	15.0	0.0000965	15	0.0	1.0				1.194	-0.124513	0.015	0	17	17		SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ADAD2	0.0	0.0	0.0	0.02	2.0	-4.0	-6.0	23.0						0.114	0.0	0.000000000	0.0	-2.069	behavior/neurological phenotype ; 			ciliary ganglion;testis - seminiferous tubule;atrioventricular node;superior cervical ganglion;testis;skeletal muscle;globus pallidus;	.	adenosine to inosine editing;RNA processing	nucleus;nucleolus;cytoplasm	double-stranded RNA binding;double-stranded RNA adenosine deaminase activity;tRNA-specific adenosine deaminase activity	.	84227804
31430	chr16	84256411	G	A	chr16:84256411	KCNG4	potassium voltage-gated channel modifier subfamily G member 4	SNV	0/0	0.0	169_0	169	99.0	0|1	0.53	66_73	139	99.0			rs147997404,COSV100377093,COSV100377214	EXONIC	YES	NM_172347.3	Transcript	protein_coding	synonymous_variant		3/3	NM_172347.3:c.972C>T	NP_758857.1:p.Ser324%3D		-1.0						.	.	.		0.0014324	218.0	152192.0	1.0	33	0.97	PASS	amr	0.00196232	30.0	0.00177899	121.0	0.00151581	375.0	247392.0	1.0	33	0.87	PASS	nfe	0.00210619	235.0	0.00210619	235.0	0.0015305	238	0.003	10.0				0.174	-0.406491		0	0	0			KCNG4	0.0	0.0	0.0	0.0	26.0	17.0	2.0	-21.0						0.147	0.0	46.777098537			nervous system phenotype ; vision/eye phenotype; 			testis - seminiferous tubule;testis - interstitial;atrioventricular node;superior cervical ganglion;parietal lobe;	.	regulation of ion transmembrane transport;protein homooligomerization;potassium ion transmembrane transport	plasma membrane;voltage-gated potassium channel complex;integral component of membrane	voltage-gated potassium channel activity;delayed rectifier potassium channel activity;ion channel binding	.	84256411
31500	chr16	84778635	CAG		chr16:84778635-84778637	USP10	ubiquitin specific peptidase 10	deletion	0/1	0.52	44_47	91	99.0	0/0	0.0	34_0	34	99.0			rs749035076	EXONIC	YES	NM_001272075.2	Transcript	protein_coding	inframe_deletion		5/15	NM_001272075.2:c.563_565del	NP_001259004.1:p.Ala188del		1.0						.	.	.		1.31372e-05	2.0	152240.0	0.0	32	0.96	PASS	amr	6.54022e-05	1.0	0.0	0.0	2.00913e-05	5.0	248864.0	0.0	100	0.99	PASS	amr	0.000115888	4.0	8.87516e-06	1.0	0.0000129	2						11.19	0.705193		0	0	0			USP10	0.0	0.0	0.0	0.0	7.0	4.0	-19.0	17.0						0.523	0.99				cellular phenotype; mortality/aging ; 			white blood cells;testis - interstitial;cingulate cortex;whole blood;placenta;	.	ubiquitin-dependent protein catabolic process;autophagy;cellular response to DNA damage stimulus;regulation of autophagy;protein deubiquitination;translesion synthesis;DNA damage response, signal transduction by p53 class mediator;negative regulation of I-kappaB kinase/NF-kappaB signaling;cellular response to interleukin-1	nucleus;nucleoplasm;cytoplasm;early endosome;cytosol;protein-containing complex	p53 binding;RNA binding;cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;protein binding;thiol-dependent ubiquitinyl hydrolase activity;ion channel binding	BECN1[20562859];RPL10[26496610];CELF1[19615732];YBX1[23986595;25497084];IFI16[25665578];PPP6R1[24255178];MYC[21150319];G3BP1[19615732;unassigned1304;21455491];ZC3H12A[24270572];G3BP2[19615732;25416956;unassigned1304];GAR1[19615732];RACK1[unassigned1304];IKBKG[24270572];ANKRD28[24255178];NOP56[26496610];JUN[25609649];NPM1[26496610];CDC5L[20467437];EIF4G1 variant protein[19615732];IBTK[26496610];RAD51[25640309];ULK1[20562859];EIF4G3[19615732];BCAR1[28007913];CFTR[21455491];	84778634
31509	chr16	84900645	G	A	chr16:84900645	CRISPLD2	cysteine rich secretory protein LCCL domain containing 2	SNV	0/1	0.39	45_29	75	99.0	0/0	0.0	33_0	33	99.0			rs149615348,CM174026	SPLICING	YES	NM_031476.4	Transcript	protein_coding	missense_variant,splice_region_variant		7/15	NM_031476.4:c.852G>A	NP_113664.1:p.Met284Ile		1.0	LCCL domain,LCCL domain,.,LCCL domain					.	.	.	29875488	0.00495154	753.0	152074.0	2.0	32	0.94	PASS	nfe	0.00655651	446.0	0.00655651	446.0	0.00534366	1343.0	251326.0	11.0	52	1.0	PASS	nfe	0.00697634	793.0	0.00697634	793.0	0.0049709	773	0.007	23.0				24.5	3.342202	0.181	11	8	19	SIFT,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred	CRISPLD2	0.0	0.0	0.0	0.0	-48.0	1.0	1.0	-48.0	0.870719002803744	0.372	6.434	0.081	6.514	0.235	0.0	0.000000000	0.997	1.176	skeleton phenotype; immune system phenotype; embryo phenotype; growth/size/body region phenotype; mortality/aging ; homeostasis/metabolism phenotype; 			ciliary ganglion;adipose tissue;placenta;	.	extracellular matrix organization;lung development;neutrophil degranulation;face morphogenesis	extracellular region;extracellular space;transport vesicle;extracellular matrix;secretory granule lumen;extracellular exosome;ficolin-1-rich granule lumen	glycosaminoglycan binding;heparin binding	IQCB1[21565611];	84900645
31518	chr16	84940201	A	T	chr16:84940201	CRISPLD2	cysteine rich secretory protein LCCL domain containing 2	SNV	0/0	0.0	34_0	34	99.0	0/1	0.43	51_39	90	99.0			rs151315770	EXONIC	YES	NM_031476.4	Transcript	protein_coding	missense_variant		15/15	NM_031476.4:c.1447A>T	NP_113664.1:p.Thr483Ser		1.0	LCCL domain,LCCL domain					.	.	.		3.30662e-05	5.0	151212.0	0.0	32	0.95	PASS	nfe	7.36941e-05	5.0	7.36941e-05	5.0	6.76671e-05	17.0	251230.0	0.0	76	1.0	PASS	afr	0.00018546	3.0	0.000123207	14.0	0.0000579	9						9.246	0.483463	0.101	1	18	19	FATHMM_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CRISPLD2	0.0	0.04	0.0	0.0	18.0	-7.0	-38.0	35.0						0.235	0.0	0.000000000	0.008	1.31	skeleton phenotype; immune system phenotype; embryo phenotype; growth/size/body region phenotype; mortality/aging ; homeostasis/metabolism phenotype; 			ciliary ganglion;adipose tissue;placenta;	.	extracellular matrix organization;lung development;neutrophil degranulation;face morphogenesis	extracellular region;extracellular space;transport vesicle;extracellular matrix;secretory granule lumen;extracellular exosome;ficolin-1-rich granule lumen	glycosaminoglycan binding;heparin binding	IQCB1[21565611];	84940201
31569	chr16	87445672	G	T	chr16:87445672	ZCCHC14	zinc finger CCHC-type containing 14	SNV	0/1	0.46	46_41	89	99.0	0/0	0.0	61_0	61	99.0			rs139009476	EXONIC	YES	NM_015144.3	Transcript	protein_coding	synonymous_variant		12/13	NM_015144.3:c.2655C>A	NP_055959.2:p.Gly885%3D		-1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00151127	230.0	152190.0	0.0	33	0.97	PASS	amr	0.00419177	64.0	0.00189622	129.0	0.00118356	293.0	247558.0	0.0	97	0.99	PASS	nfe	0.00204583	230.0	0.00204583	230.0	0.0011575	180	0.003	10.0				0.024	-0.671523		0	0	0			ZCCHC14	0.0	0.0	0.0	0.0	-2.0	-17.0	-1.0	-17.0						0.146	0.95	48.043046710			hearing/vestibular/ear phenotype; 			ciliary ganglion;testis - seminiferous tubule;cingulate cortex;superior cervical ganglion;trigeminal ganglion;testis;pons;occipital lobe;testis - interstitial;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;	.	.	.	nucleic acid binding;zinc ion binding;phosphatidylinositol binding	MYOG[unassigned1304];PLEKHG4[unassigned1304];SMAD3[21988832];CYSRT1[unassigned1304];USP54[unassigned1304];NFIC[16189514];FHL3[unassigned1304];HIF1AN[26972000];PRR20D[unassigned1304];TNS2[unassigned1304];	87445672
31572	chr16	87525653	G	A	chr16:87525653	ZCCHC14	zinc finger CCHC-type containing 14	SNV	0/0	0.0	25_0	25	75.0	0/1	0.53	15_17	32	99.0			rs543077895	EXONIC	YES	NM_015144.3	Transcript	protein_coding	synonymous_variant		1/13	NM_015144.3:c.192C>T	NP_055959.2:p.Ile64%3D		-1.0						.	.	.		0.00262286	399.0	152124.0	0.0	32	0.96	PASS	amr	0.00765506	117.0	0.00325124	221.0					0	0.0							0.0015922	42	0.001	4.0				17.71	1.733213		0	0	0																	0.146	0.95				hearing/vestibular/ear phenotype; 			ciliary ganglion;testis - seminiferous tubule;cingulate cortex;superior cervical ganglion;trigeminal ganglion;testis;pons;occipital lobe;testis - interstitial;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;	.	.	.	nucleic acid binding;zinc ion binding;phosphatidylinositol binding	MYOG[unassigned1304];PLEKHG4[unassigned1304];SMAD3[21988832];CYSRT1[unassigned1304];USP54[unassigned1304];NFIC[16189514];FHL3[unassigned1304];HIF1AN[26972000];PRR20D[unassigned1304];TNS2[unassigned1304];	87525653
31580	chr16	87742977	A	G	chr16:87742977	KLHDC4	kelch domain containing 4	SNV	0/0	0.0	45_0	45	99.0	0/1	0.46	71_61	133	99.0			rs141807379	EXONIC	YES	NM_017566.4	Transcript	protein_coding	synonymous_variant		10/12	NM_017566.4:c.1341T>C	NP_060036.2:p.Tyr447%3D		-1.0						.	.	.		0.0051005	776.0	152142.0	6.0	33	0.99	PASS	nfe	0.00948418	645.0	0.00948418	645.0	0.00506069	1270.0	250954.0	3.0	100	1.0	PASS	nfe	0.00942614	1069.0	0.00942614	1069.0	0.0050224	781	0.005	16.0				1.025	-0.147083		0	0	0			KLHDC4	0.0	0.0	0.0	0.0	20.0	-16.0	-30.0	-2.0						0.957	0.0	0.000000000			.			.	.	.	.	protein binding	SUV39H2[23455924];MFHAS1[29513927];KDM1A[23455924];HSPA5[30021884];SUV39H1[23455924];NCL[30021884];TERF1[21044950];CEP76[25416956];	87742977
31612	chr16	88498350	C	T	chr16:88498350	ZNF469	zinc finger protein 469	SNV	0/0	0.0	129_0	129	99.0	0/1	0.44	80_64	145	99.0			rs375045076,COSV71258398	EXONIC	YES	NM_001367624.2	Transcript	protein_coding	missense_variant		3/3	NM_001367624.2:c.4472C>T	NP_001354553.1:p.Thr1491Met		1.0	.,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Brittle_cornea_syndrome_1|not_specified|not_provided	Brittle cornea syndrome 1, 229200 (3), Autosomal recessive	Brittle cornea syndrome	Disease-causing germline mutation(s) in	Visual loss;Myalgia;Scoliosis;Hyperextensible skin;Mitral valve prolapse;Sensorineural hearing impairment;Blue sclerae;Joint hyperflexibility;High myopia;Hernia;Abnormality of hair pigmentation;Corneal scarring;Glaucoma;Retinal detachment;Bruising susceptibility;Hallux valgus;Corneal erosion;Neonatal hypotonia;Conductive hearing impairment;Corneal dystrophy;Abnormality of epiphysis morphology;Pulmonic stenosis;Arachnodactyly;Hip dysplasia;Keratoglobus;Cleft palate;Soft skin;Camptodactyly;Osteoporosis;Gait disturbance;Increased susceptibility to fractures;Abnormality of the dentition;Pes planus;Dentinogenesis imperfecta;Keratoglobus;Decreased corneal thickness;Autosomal recessive inheritance;Blue sclerae;Keratoconus;Spondylolisthesis;Disproportionate tall stature;Scoliosis;Congenital hip dislocation;Red hair;Myopia;Molluscoid pseudotumors;Mitral valve prolapse;Epicanthus;Visual loss;Atypical scarring of skin;Palmoplantar cutis laxa;Joint laxity;Hearing impairment;Macrocephaly	25741868	0.00246467	375.0	152150.0	1.0	33	0.96	PASS	nfe	0.00440982	300.0	0.00440982	300.0	0.00190683	292.0	153134.0	1.0	100	0.59	PASS	nfe	0.00393026	234.0	0.00393026	234.0	0.0008553	133	0.006	18.0	0.00447	51.0		12.52	0.873522	0.071	2	15	17	SIFT,M-CAP_pred	PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF469	0.0	0.0	0.0	0.0	-44.0	12.0	46.0	1.0								0.000000000	0.001	0.125	.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	HIST1H2BL[30021884];RIPK4[26972000];HIST1H2BH[30021884];	88498350
31642	chr16	88782074	T	C	chr16:88782074	PIEZO1	piezo type mechanosensitive ion channel component 1	SNV	0/0	0.0	33_0	33	99.0	0/1	0.42	48_35	83	99.0			rs34830861	EXONIC	YES	NM_001142864.4	Transcript	protein_coding	missense_variant		51/51	NM_001142864.4:c.7505A>G	NP_001136336.2:p.Lys2502Arg		-1.0	Piezo non-specific cation channel, R-Ras-binding domain	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_specified|not_provided	Lymphatic malformation 6, 616843 (3), Autosomal recessive; Dehydrated hereditary stomatocytosis with or without pseudohyperkalemia and/or perinatal edema, 194380 (3), Autosomal dominant	Dehydrated hereditary stomatocytosis	Disease-causing germline mutation(s) (gain of function) in	Pulmonary venous hypertension;Neonatal hyperbilirubinemia;Increased mean corpuscular hemoglobin concentration;Edema;Schistocytosis;Nonspherocytic hemolytic anemia;Portal vein thrombosis;Episodic fatigue;Reticulocytosis;Macrocytic anemia;Polycythemia;Increased lactate dehydrogenase level;Increased red cell osmotic fragility;Abdominal pain;Congenital hemolytic anemia;Thromboembolism;Intermittent jaundice;Increased serum ferritin;Cholelithiasis;Increased mean corpuscular volume;Splenomegaly;Increased total bilirubin;Abnormal blood potassium concentration;Increased hemoglobin concentration;Prune belly;Hypothyroidism;Short stature;Varicose veins;Chylothorax;Scoliosis;Periorbital edema;Cellulitis;Autosomal recessive inheritance;Hearing impairment;Generalized edema;Epicanthus;Gastroesophageal reflux;Webbed neck;Facial edema;Nonimmune hydrops fetalis;Ascites;Global developmental delay;Cupped ear;Atrial septal defect;Micrognathia;Pectus excavatum;Hydrocele testis;Splenomegaly;Genital edema;Polyhydramnios;Deep venous thrombosis;Lymphedema;Intestinal lymphangiectasia;Autosomal dominant inheritance;Increased mean corpuscular hemoglobin concentration;Exercise-induced hemolysis;Increased serum ferritin;Conjunctival icterus;Hepatomegaly;Cholelithiasis;Hemoglobinuria;Jaundice;Reticulocytosis;Increased red cell hemolysis by shear stress;Splenomegaly;Pallor;Hepatitis		0.00566345	862.0	152204.0	2.0	33	0.97	PASS	nfe	0.00598265	407.0	0.00598265	407.0	0.00608446	946.0	155478.0	14.0	100	0.59	PASS	nfe	0.00502311	300.0	0.00502311	300.0	0.0013569	211	0.003	9.0				25.4	3.619718	0.544	12	8	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	PIEZO1	0.0	0.0	0.0	0.0	-1.0	-29.0	47.0	9.0							0.54	0.000000000	0.994	1.02	homeostasis/metabolism phenotype; growth/size/body region phenotype; embryo phenotype; immune system phenotype; mortality/aging ; hematopoietic system phenotype; cardiovascular system phenotype ; 			white blood cells;tumor;prostate;	.	cation transport;positive regulation of integrin activation;positive regulation of cell-cell adhesion mediated by integrin;regulation of membrane potential;detection of mechanical stimulus;cellular response to mechanical stimulus;cation transmembrane transport	endoplasmic reticulum;endoplasmic reticulum membrane;plasma membrane;integral component of membrane;lamellipodium membrane;endoplasmic reticulum-Golgi intermediate compartment membrane	cation channel activity;mechanosensitive ion channel activity	GJB2[26496610];RAB5C[26496610];VAPA[26496610];GOLT1B[26496610];RAB7A[26496610];	88782074
31939	chr17	691225	C	A	chr17:691225	MRM3	mitochondrial rRNA methyltransferase 3	SNV	0/1	0.42	29_21	50	99.0	0/1	0.24	34_11	45	99.0			rs752656104,COSV58680382	EXONIC	YES	NM_018146.4	Transcript	protein_coding	missense_variant		3/4	NM_018146.4:c.580C>A	NP_060616.1:p.His194Asn		1.0	RNA 2-O ribose methyltransferase, substrate binding					.	.	.		1.31391e-05	2.0	152218.0	0.0	33	0.97	PASS	nfe	2.93962e-05	2.0	2.93962e-05	2.0	2.38624e-05	6.0	251442.0	0.0	86	1.0	PASS	nfe	5.275e-05	6.0	5.275e-05	6.0	0.0000129	2						14.59	1.189181	0.041	1	17	18	fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	RNMTL1	0.0	0.0	0.0	0.0	-20.0	-6.0	2.0	-47.0								0.000000000	0.996	1.022	mortality/aging ; immune system phenotype; 			.	.	rRNA 2'-O-methylation	mitochondrion;mitochondrial matrix	RNA binding;protein binding;rRNA (guanosine-2'-O-)-methyltransferase activity	UBIAD1[unassigned1304];RPL10[26496610];RTCA[17353931];MGST3[29568061];CUL2[17353931];NUDT1[17353931];FHL3[25416956;unassigned1304];MRPL58[20186120];USP39[19615732];TNF[unassigned1304];MRM3[unassigned1304];HSPD1[29568061];PUF60[17353931];ORC1[26496610];NTHL1[17353931];OSTCL[unassigned1304];TNFRSF14[17353931];ZFPL1[unassigned1304];SMNDC1[17353931];PDK1[29568061];JAGN1[unassigned1304];C4orf3[unassigned1304];BTN2A2[unassigned1304];KSR1[27086506];GALNT2[unassigned1304];GAD2[unassigned1304];MCC[17353931];AIG1[unassigned1304];PRKAB1[17353931];ATG12[17353931];HNRNPM[30021884];MIP[unassigned1304];TRIP6[17353931];POLR1E[17353931];AURKAIP1[29568061];TRMT61B[29568061];	691225
32003	chr17	1372861	T	G	chr17:1372861	MYO1C	myosin IC	SNV	0/1	0.46	49_43	93	99.0	0/1	0.39	50_33	84	99.0			rs61753652,CM090123	EXONIC	YES	NM_001080779.2	Transcript	protein_coding	missense_variant		25/32	NM_001080779.2:c.2574A>C	NP_001074248.1:p.Lys858Asn		-1.0	.,.,.,.,.,.,.,.,.	Benign	criteria_provided,_multiple_submitters,_no_conflicts	not_specified|not_provided		Autosomal dominant non-syndromic sensorineural deafness type DFNA	Disease-causing germline mutation(s) in	.		0.00610389	929.0	152198.0	7.0	33	0.96	PASS	nfe	0.00951079	647.0	0.00951079	647.0	0.00642767	1604.0	249546.0	7.0	100	0.89	PASS	nfe	0.00982531	1108.0	0.00982531	1108.0	0.0069130	1075	0.006	19.0	0.00561	64.0		21.4	2.193796	0.162	8	12	20	SIFT,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MYO1C	0.0	0.0	0.0	0.0	47.0	40.0	-36.0	9.0						0.0331	0.0	0.000000000	0.994	-0.718	skeleton phenotype; hearing/vestibular/ear phenotype; nervous system phenotype ; hematopoietic system phenotype; 			ciliary ganglion;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	.	protein targeting;protein targeting to membrane;vesicle transport along actin filament;positive regulation of cell migration;positive regulation of actin filament polymerization;positive regulation of cell migration by vascular endothelial growth factor signaling pathway;Fc-gamma receptor signaling pathway involved in phagocytosis;positive regulation of gene expression, epigenetic;mRNA transport;cellular response to interferon-gamma;positive regulation of protein targeting to membrane;positive regulation of cellular response to insulin stimulus;positive regulation of vascular endothelial growth factor signaling pathway;regulation of bicellular tight junction assembly	stress fiber;nuclear pore;nucleoplasm;nucleolus;cytoplasm;cytosol;plasma membrane;microvillus;brush border;basal plasma membrane;membrane;lateral plasma membrane;unconventional myosin complex;nuclear body;cytoplasmic vesicle membrane;filamentous actin;ruffle membrane;membrane raft;phagocytic vesicle;stereocilium membrane;extracellular exosome	microfilament motor activity;signaling receptor binding;protein binding;calmodulin binding;ATP binding;protein C-terminus binding;Ral GTPase binding;actin-dependent ATPase activity;actin filament binding	EIF4A2[17353931];TRIR[26496610];DIXDC1[26496610];CCAR1[26496610];ACTG1[26496610];PYCARD[24407287];PPP1CB[26496610];GOLGA2[29568061];FBL[16514417];CHCHD3[26496610];MPRIP[26496610];BASP1[26496610];TUBB3[27291054];CFL2[26496610];CFL1[26496610];BAP18[26496610];SYNPO[26496610];PHLDA3[17353931];TMOD1[26496610];CARD10[26496610];PDGFRA[26496610];PPTC7[28330616];TMOD3[26496610];AFAP1[26496610];OCRL[25107275];ACTN4[26496610];GTF2F1[26496610];CDC25C[28330616];DDX39B[26496610];PPP1R3C[28330616];KCTD10[26496610];SRSF2[26496610];ZSCAN26[26496610];PTPRCAP[28330616];PHLDB2[26496610];HDGFL2[26496610];VCL[26496610];RAI14[26496610];SHC1[19380743];COX15[29128334];FLII[26496610];TWF2[26496610];TWF1[26496610];FBXO46[26496610];IQGAP1[26496610];CIAO1[17353931];CORO1C[26496610];ARHGAP21[26496610];SAFB2[26496610];PNPO[26496610];SPTBN1[26496610];RBM10[26496610];SPTBN2[26496610];SPECC1[26496610];UVRAG[26496610];ITPRID2[26496610];JUN[25609649];NEK6[17353931];DSTN[26496610];MYO5A[26496610];CORO2A[26496610];LARP4[26496610];ESR1[21182205];ESR2[21182203];FBXO30[26496610];SSH1[26496610];CHERP[26496610];ANLN[26496610];ARPC3[26496610];GIPC1[17353931];JMY[26496610];TADA3[26496610];CDK2[26496610];GRB2[12577067];CALM1[26496610];ARHGAP11A[26496610];MCM7[23764002];CCDC127[26496610];WDR1[26496610];LRRK2[24725412];ARPC1B[26496610];DOCK7[26496610];HMGB2[26496610];ARRB1[17620599];ARRB2[17620599];KIF11[26496610];MED16[26496610];SIPA1L3[26496610];MED15[26496610];TRIOBP[26496610];MED12[26496610];TUBA1A[27291054];MYO18A[26496610];IKBKG[14743216];SPTAN1[26496610];RBM5[26496610];RBM33[26496610];TPRN[26496610];ILKAP[28330616];IQCB1[21565611];PLEKHG3[26496610];UNC45A[26496610];SUN2[22555292];RBM17[26496610];PPP1R12A[26496610];TIMM29[26496610];RIPK3[14743216];KSR1[27086506];SPHK1[25216046];COBL[26496610];DUSP7[28330616];GAK[26496610];WRAP73[17353931];PTP4A3[17353931];INF2[26496610];DUSP21[28330616];PSMA1[29568061];PALLD[26496610];POLR1B[16514417];POLR1E[16514417];MYH9[26496610];NCBP3[26496610];NSRP1[26496610];DBN1[26496610];PPP1R15A[29109149];RALA[26496610];SF3B2[26496610];TIMM13[26496610];NEXN[26496610];CSTF2T[26496610];DLST[29128334];CRIP2[26496610];MRM1[26496610];ADD1[26496610];MRPL55[26496610];PCNP[26496610];AP3M1[26496610];LIMA1[26496610];SCAF8[26496610];ABLIM1[26496610];SLX4[19596235];FLNA[26496610];E2F3[22157815];SF3B1[26496610];MISP[26496610];PDLIM7[26496610];CLASP1[26496610];TIMM8B[26496610];MAP3K3[14743216];SVIL[26496610];FARP1[26496610];USP20[19615732];CDKN2A[26496610];RIOK3[26496610];SQOR[26496610];SORBS2[26496610];RRP1B[20926688];OXR1[26496610];MYO19[26496610];U2SURP[26496610];PPP1CA[26496610];TJP1[26496610];MYO1B[26496610];IMPDH1[26496610];IMPDH2[26496610];EIF3I[26496610];CAPZA2[26496610];AGGF1[26496610];CEP162[26496610];SIPA1[26496610];BCAR1[28007913];PTPN2[28330616];EIF3B[26496610];TJP2[26496610];	1372861
32095	chr17	1960405	GGC		chr17:1960405-1960407	HIC1	HIC ZBTB transcriptional repressor 1	deletion	0/1	0.15	23_4	27	99.0	0/0	0.0	35_0	35	99.0			rs762248690	EXONIC	YES	NM_001098202.1	Transcript	protein_coding	inframe_deletion		2/2	NM_001098202.1:c.499_501del	NP_001091672.1:p.Gly167del		1.0						Miller-Dieker syndrome	Candidate gene tested in	Nephropathy;Lissencephaly;Ataxia;Abnormality of upper lip;Growth delay;High forehead;Short nose;Epicanthus;Abnormality of the cardiovascular system;Seizure;Sacral dimple;Polyhydramnios;Hypoplasia of the corpus callosum;Omphalocele;Anteverted nares;Clinodactyly of the 5th finger;EEG abnormality;Cerebral cortical atrophy		0.000277125	42.0	151556.0	0.0	33	0.97	PASS	nfe	0.000501416	34.0	0.000501416	34.0	0.00296177	22.0	7428.0	0.0	2	0.0	PASS	amr	0.00898204	3.0	0.0022309	8.0	0.0000193,0.0000514,0.0006109	3,8,95						21.2	2.167772		0	0	0			HIC1	0.0	0.0	0.0	0.0	-38.0	-20.0	-16.0	-20.0											growth/size/body region phenotype; integument phenotype ; craniofacial phenotype; skeleton phenotype; immune system phenotype; embryo phenotype; neoplasm; mortality/aging ; normal phenotype; digestive/alimentary phenotype; nervous system phenotype ; hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; 			ciliary ganglion;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	.	negative regulation of transcription by RNA polymerase II;regulation of transcription, DNA-templated;cellular response to DNA damage stimulus;multicellular organism development;intrinsic apoptotic signaling pathway in response to DNA damage;Wnt signaling pathway;negative regulation of Wnt signaling pathway;positive regulation of DNA damage response, signal transduction by p53 class mediator	chromatin;nucleus;nucleoplasm;cytosol	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;protein binding;histone deacetylase binding;sequence-specific DNA binding;metal ion binding	TCF7L2[16724116];HIC2[11554746];CTBP2[19486893];CTBP1[19486893;16762039];CTNNB1[16724116];ARID1A[19486893];SIRT1[16269335];HIC1[12052894];	1960404
32119	chr17	2246847	A	G	chr17:2246847	SGSM2	small G protein signaling modulator 2	SNV	0/1	0.44	48_37	85	99.0	0/1	0.49	46_45	91	99.0			rs138672949	EXONIC	YES	NM_014853.3	Transcript	protein_coding	synonymous_variant		2/24	NM_014853.3:c.66A>G	NP_055668.2:p.Gln22%3D		1.0						.	.	.		0.000945999	144.0	152220.0	0.0	32	0.97	PASS	amr	0.00242052	37.0	0.00117574	80.0	0.000906633	228.0	251480.0	0.0	77	1.0	PASS	amr	0.0017056	59.0	0.00119556	136.0	0.0007717	120	0.004	14.0				11.92	0.796188		0	0	0			SGSM2	0.01	0.0	0.0	0.0	1.0	-31.0	26.0	-9.0						0.76	0.0	0.000000000			.			caudate nucleus;pons;amygdala;temporal lobe;subthalamic nucleus;prefrontal cortex;trigeminal ganglion;atrioventricular node;cingulate cortex;superior cervical ganglion;globus pallidus;medulla oblongata;	.	intracellular protein transport;late endosome to Golgi transport;positive regulation of GTPase activity;activation of GTPase activity	cytoplasm;melanosome	GTPase activator activity;Rab GTPase binding	MPP1[16169070];CA12[16169070];KHDRBS3[16169070];PNO1[16169070];GDPD2[16169070];PTN[16169070];CHD3[16169070];AFP[16169070];FNBP1L[16169070];ILF2[16169070];EGFR[16169070];CELSR3[16169070];RGMA[16169070];RPS25[16169070];	2246847
32200	chr17	3916826	C	T	chr17:3916826	ZZEF1	zinc finger ZZ-type and EF-hand domain containing 1	SNV	0/0	0.0	33_0	33	99.0	0/1	0.37	66_39	106	99.0			rs145180691	EXONIC	YES	NM_015113.4	Transcript	protein_coding	synonymous_variant		52/55	NM_015113.4:c.8496G>A	NP_055928.3:p.Val2832%3D		-1.0						.	.	.		0.00137278	209.0	152246.0	0.0	32	0.97	PASS	amr	0.0028777	44.0	0.00191058	130.0	0.00153937	387.0	251402.0	0.0	69	0.97	PASS	amr	0.00269004	93.0	0.00184648	210.0	0.0012154	189	0.005	15.0				8.061	0.369503		0	0	0			ZZEF1	0.0	0.0	0.0	0.0	-2.0	-19.0	3.0	45.0						0.55	1.0	6.586176324			homeostasis/metabolism phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype ; behavior/neurological phenotype ; skeleton phenotype; hematopoietic system phenotype; 			.	.	.	.	calcium ion binding;zinc ion binding	PDGFRB[26496610];XRCC5[26496610];MYC[21150319];TGS1[26496610];THOC1[26496610];HSPB3[16169070];PTPN4[16169070];SKIL[15231748];PHYHIP[16169070];	3916826
32251	chr17	4542794	C	G	chr17:4542794	ALOX15	arachidonate 15-lipoxygenase	SNV	0/0	0.0	35_0	35	99.0	0/1	0.46	62_53	115	99.0			rs11568142	EXONIC	YES	NM_001140.5	Transcript	protein_coding	missense_variant		2/14	NM_001140.5:c.268G>C	NP_001131.3:p.Asp90His		-1.0	PLAT/LH2 domain&PLAT/LH2 domain&PLAT/LH2 domain,PLAT/LH2 domain&PLAT/LH2 domain&PLAT/LH2 domain,.,PLAT/LH2 domain&PLAT/LH2 domain&PLAT/LH2 domain	Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.	31114288	0.00477542	727.0	152238.0	1.0	29	0.94	PASS	amr	0.00817528	125.0	0.00699527	476.0	0.00588221	1477.0	251096.0	6.0	100	1.0	PASS	nfe	0.00835669	948.0	0.00835669	948.0	0.0056076	872	0.015	49.0	0.01517	173.0		21.1	2.15393	0.108	3	15	18	SIFT,PolyPhen,MutationAssessor_pred	Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ALOX15	0.0	0.02	0.1	0.0	-6.0	15.0	-5.0	1.0						0.935	0.0		0.004	0.946	cellular phenotype; homeostasis/metabolism phenotype; integument phenotype ; endocrine/exocrine gland phenotype; neoplasm; immune system phenotype; mortality/aging ; cardiovascular system phenotype ; hematopoietic system phenotype; 			pons;ciliary ganglion;appendix;trachea;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Arachidonic acid metabolism;Linoleic acid metabolism	ossification;negative regulation of adaptive immune response;phosphatidylethanolamine biosynthetic process;leukotriene metabolic process;inflammatory response;positive regulation of cell-substrate adhesion;cytokine-mediated signaling pathway;arachidonic acid metabolic process;lipoxygenase pathway;bone mineralization;positive regulation of actin filament polymerization;positive regulation of heterotypic cell-cell adhesion;response to endoplasmic reticulum stress;regulation of peroxisome proliferator activated receptor signaling pathway;cellular response to interleukin-13;wound healing;long-chain fatty acid biosynthetic process;apoptotic cell clearance;hepoxilin biosynthetic process;oxidation-reduction process;positive regulation of ERK1 and ERK2 cascade;cellular response to calcium ion;regulation of engulfment of apoptotic cell;lipoxin A4 biosynthetic process	lipid droplet;cytosol;plasma membrane;membrane;extrinsic component of cytoplasmic side of plasma membrane	arachidonate 12-lipoxygenase activity;iron ion binding;protein binding;phosphatidylinositol-4,5-bisphosphate binding;hepoxilin-epoxide hydrolase activity;arachidonate 15-lipoxygenase activity;hepoxilin A3 synthase activity;eoxin A4 synthase activity	KSR1[27086506];PEBP1[21831839];	4542794
32315	chr17	5036834	G	A	chr17:5036834	USP6	ubiquitin specific peptidase 6	SNV	0/0	0.0	16_0	16	34.0	0|1	0.12	14_2	16	42.0			rs200027130,COSV51473281	EXONIC	YES	NM_001304284.2	Transcript	protein_coding	missense_variant		14/38	NM_001304284.2:c.373G>A	NP_001291213.1:p.Gly125Arg		1.0	Rab-GTPase-TBC domain&Rab-GTPase-TBC domain&Rab-GTPase-TBC domain,Rab-GTPase-TBC domain&Rab-GTPase-TBC domain&Rab-GTPase-TBC domain					Nodular fasciitis	Part of a fusion gene in	.						32	0.93							4.81649e-05	12.0	249144.0	0.0	100	1.0	PASS	afr	0.000191034	3.0	7.12581e-05	8.0	0.0051831	806						0.28	-0.338827	0.113	1	18	19	MutationTaster_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	USP6	0.0	0.0	0.0	0.0	2.0	-21.0	-44.0	11.0						0.996	0.0		0.014	-1.301	.			amygdala;testis - seminiferous tubule;fetal brain;subthalamic nucleus;testis - interstitial;prefrontal cortex;atrioventricular node;testis;parietal lobe;	.	cellular protein modification process;ubiquitin-dependent protein catabolic process;intracellular protein transport;protein deubiquitination;regulation of vesicle-mediated transport;activation of GTPase activity	cytoplasm;lysosome;plasma membrane;recycling endosome	nucleic acid binding;cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;GTPase activator activity;protein binding;calmodulin binding;Rab GTPase binding	USP32[19615732];MYL2[16555005];ANKRD44[16555005];ATXN7L3[16713569];MDFI[19060904];	5036834
32316	chr17	5036838	G	A	chr17:5036838	USP6	ubiquitin specific peptidase 6	SNV	0/0	0.0	15_0	15	31.0	0|1	0.15	11_2	13	51.0			rs200666860,COSV51473306	EXONIC	YES	NM_001304284.2	Transcript	protein_coding	missense_variant		14/38	NM_001304284.2:c.377G>A	NP_001291213.1:p.Arg126Lys		1.0	Rab-GTPase-TBC domain&Rab-GTPase-TBC domain&Rab-GTPase-TBC domain,Rab-GTPase-TBC domain&Rab-GTPase-TBC domain&Rab-GTPase-TBC domain					Nodular fasciitis	Part of a fusion gene in	.		6.61489e-06	1.0	151174.0	0.0	31	0.93	PASS	nfe	1.47462e-05	1.0	1.47462e-05	1.0	3.21136e-05	8.0	249116.0	0.0	100	1.0	PASS	afr	0.000191131	3.0	3.56411e-05	4.0	0.0051767	805						0.014	-0.745863	0.083	1	18	19	MutationTaster_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	USP6	0.0	0.0	0.0	0.0	8.0	-25.0	7.0	10.0						0.996	0.0		0.006	-1.301	.			amygdala;testis - seminiferous tubule;fetal brain;subthalamic nucleus;testis - interstitial;prefrontal cortex;atrioventricular node;testis;parietal lobe;	.	cellular protein modification process;ubiquitin-dependent protein catabolic process;intracellular protein transport;protein deubiquitination;regulation of vesicle-mediated transport;activation of GTPase activity	cytoplasm;lysosome;plasma membrane;recycling endosome	nucleic acid binding;cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;GTPase activator activity;protein binding;calmodulin binding;Rab GTPase binding	USP32[19615732];MYL2[16555005];ANKRD44[16555005];ATXN7L3[16713569];MDFI[19060904];	5036838
32318	chr17	5036843	C	A	chr17:5036843	USP6	ubiquitin specific peptidase 6	SNV	0/0	0.0	14_0	14	39.0	0|1	0.15	11_2	13	51.0			rs201820402,COSV51473324	SPLICING	YES	NM_001304284.2	Transcript	protein_coding	missense_variant,splice_region_variant		14/38	NM_001304284.2:c.382C>A	NP_001291213.1:p.Gln128Lys		1.0	Rab-GTPase-TBC domain&Rab-GTPase-TBC domain&Rab-GTPase-TBC domain,Rab-GTPase-TBC domain&Rab-GTPase-TBC domain&Rab-GTPase-TBC domain					Nodular fasciitis	Part of a fusion gene in	.						32	0.93							3.61379e-05	9.0	249046.0	0.0	100	1.0	PASS	afr	0.000127926	2.0	5.34769e-05	6.0	0.0050352	783						0.003	-0.969546	0.05	1	18	19	MutationTaster_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	USP6	0.0	0.0	0.0	0.0	-47.0	-30.0	2.0	4.0	2.23011001264645e-05	0.012	9.549	-0.18	9.369	0.996	0.0		0.003	-1.581	.			amygdala;testis - seminiferous tubule;fetal brain;subthalamic nucleus;testis - interstitial;prefrontal cortex;atrioventricular node;testis;parietal lobe;	.	cellular protein modification process;ubiquitin-dependent protein catabolic process;intracellular protein transport;protein deubiquitination;regulation of vesicle-mediated transport;activation of GTPase activity	cytoplasm;lysosome;plasma membrane;recycling endosome	nucleic acid binding;cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;GTPase activator activity;protein binding;calmodulin binding;Rab GTPase binding	USP32[19615732];MYL2[16555005];ANKRD44[16555005];ATXN7L3[16713569];MDFI[19060904];	5036843
32342	chr17	5342377	C	A	chr17:5342377	C1QBP	complement C1q binding protein	SNV	0/1	0.36	23_13	36	99.0	0/1	0.47	32_28	60	99.0			rs56242428	EXONIC	YES	NM_001212.4	Transcript	protein_coding	missense_variant		1/6	NM_001212.4:c.17G>T	NP_001203.1:p.Arg6Leu		-1.0					Combined oxidative phosphorylation deficiency 33, 617713 (3), Autosomal recessive	.	.	Nephrotic syndrome;Cardiomegaly;Adult onset;Left ventricular hypertrophy;Oligohydramnios;Hepatomegaly;Ptosis;Hypothyroidism;Elevated hepatic transaminase;Autosomal recessive inheritance;Exercise intolerance;Fatigue;Progressive external ophthalmoplegia;Amblyopia;Cardiomyopathy;Metabolic acidosis;Myopathy;Astigmatism;Increased serum lactate;Elevated serum creatine kinase;Sensorineural hearing impairment		0.000886758	135.0	152240.0	0.0	33	0.99	PASS	amr	0.00398954	61.0	0.000867264	59.0	0.000710838	91.0	128018.0	0.0	10	0.38	PASS	amr	0.00188695	45.0	0.000881302	38.0	0.0001608	25	0.002	7.0				19.8	2.008811	0.095	4	14	18	SIFT,M-CAP_pred,PrimateAI_pred,fathmm-MKL_coding_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	C1QBP	0.0	0.0	0.0	0.0	-21.0	27.0	36.0	5.0						0.273	0.07	0.000000000	0.069	1.023	cellular phenotype; growth/size/body region phenotype; mortality/aging ; hematopoietic system phenotype; embryo phenotype; 			lung;amygdala;tumor;whole brain;	.	negative regulation of transcription by RNA polymerase II;mRNA processing;apoptotic process;immune response;complement activation, classical pathway;blood coagulation, intrinsic pathway;RNA splicing;phosphatidylinositol 3-kinase signaling;viral process;regulation of complement activation;negative regulation of interferon-gamma production;negative regulation of interleukin-12 production;negative regulation of MDA-5 signaling pathway;negative regulation of RIG-I signaling pathway;mature ribosome assembly;positive regulation of apoptotic process;innate immune response;positive regulation of cell adhesion;negative regulation of mRNA splicing, via spliceosome;negative regulation of defense response to virus;positive regulation of protein kinase B signaling;positive regulation of mitochondrial translation;positive regulation of neutrophil chemotaxis;positive regulation of substrate adhesion-dependent cell spreading;positive regulation of trophoblast cell migration;positive regulation of dendritic cell chemotaxis	extracellular space;nucleus;nucleolus;cytoplasm;mitochondrion;mitochondrial matrix;cytosol;plasma membrane;cell surface;membrane;presynaptic active zone;glutamatergic synapse;GABA-ergic synapse	complement component C1q binding;transcription corepressor activity;mRNA binding;protein kinase C binding;protein binding;hyaluronic acid binding;transcription factor binding;translation activator activity;kininogen binding;adrenergic receptor binding;mitochondrial ribosome binding	GOLT1B[26496610];BUB1B[30021884];SAT2[30021884];SPATA20[27499296];DUX4[26816005];CISD3[27499296];FBL[29568061];LACTB[27499296];CHCHD2[27499296];RASSF2[24255178];ABHD11[27499296];CDH1[16212417];PPP2R1A[26496610];MYC[17314511];HABP4[19523114];GABARAPL2[20562859];GABARAPL1[20562859];PPTC7[27499296];PRKCD[10831594];RPS6[29568061];METTL3[29507755];BOLA1[27499296];PRKCA[10831594];COX6B1[27499296];PPIF[20950273];PRKD1[10831594];AURKAIP1[29568061];PHYHIPL[27499296];PRKCZ[10831594;25852190];GABARAP[20562859];KNG1[8710908];VTN[8900153];HIST1H3A[29568061];PTPMT1[27499296];DVL2[26496610];C6orf203[27499296];JUN[25609649];PRELID1[27499296];APOOL[27499296];PYHIN1[25665578];FN1[19738201];XRCC1[26496610];COQ9[27499296];FBXO33[16797541];COQ7[27499296];PRRC2A[14667819];COQ4[27499296];COQ3[27499296];MAVS[19164550];NDUFAF8[27499296];COQ2[27499296];ADCK2[27499296];FMC1[27499296];ADCK1[27499296];NDUFAF4[27499296];HNRNPF[30021884];AGO2[17932509];NDUFAF5[27499296];REL[14743216];HNRNPD[15231747];RSRP1[26496610];ADCK5[27499296];TAB2[14743216];NFKBIE[14743216;21988832];CDK13[16721827];NIT1[27499296];MAP3K14[14743216];RETREG1[26040720];HRK[15031724];YWHAB[15324660];MAST3[25852190];TRADD[14743216];ARRB2[17620599];YBX1[22118625;23986595;25497084];MAIP1[27499296];IKBKB[14743216];COIL[16713569];MAP1LC3B[20562859];METTL14[29507755];MAP1LC3A[20562859];TCTN3[26638075];TCTN2[26638075];OPA3[27499296];ACP6[27499296];YWHAG[15324660];YWHAH[17979178];BRD1[27142060];RIPK3[14743216];KSR1[27086506];NME4[27499296];TRAF1[14743216];TNFRSF1B[14743216];F2[8900153];COQ10A[27499296];TNFRSF1A[14743216];MMP14[12220632];SDHAF3[27499296];IVD[27499296];DUX4L9[26816005];SDHAF4[27499296];C1QB[28018340];CEBPA[21988832];C1QA[28018340];FOXC1[18676636];SERPINC1[8900153];MRPL58[20186120];PPM1K[27499296];RELB[14743216];IFI16[25665578];C21orf33[27499296];OXCT1[27499296];MIC13[27499296];LMNA[29568061];DGLUCY[27499296];ETFRF1[27499296];OXCT2[27499296];PAK5[27499296];MAP3K3[14743216];SPRYD4[27499296];CDKN2A[17486078];NDUFA4[27499296];F12[8710908];CCDC58[27499296];PRSS35[27499296];RRP1B[19710015;20926688];PLEKHA7[28877994];KLF1[unassigned1304];DHRS4[27499296];LYRM1[27499296];NEURL4[29426014];LYRM2[27499296];GPAM[27499296];LYRM4[27499296];PPP2R2B[19156129];LYRM7[27499296];OCIAD1[27499296];C1QC[28018340];	5342377
32454	chr17	7369490	C	T	chr17:7369490	ZBTB4	zinc finger and BTB domain containing 4	SNV	0/0	0.0	36_0	36	99.0	0/1	0.58	39_53	92	99.0				EXONIC	YES	NM_020899.4	Transcript	protein_coding	missense_variant		3/4	NM_020899.4:c.631G>A	NP_065950.2:p.Gly211Arg		-1.0	.,.					.	.	.						32	0.98											57	0.97									0.0	1.0				13.7	1.040277	0.186	0	18	18		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZBTB4	0.0	0.0	0.0	0.0	-48.0	-33.0	4.0	8.0						0.22	1.0	0.000000000	0.687	1.026	behavior/neurological phenotype ; vision/eye phenotype; 			atrioventricular node;skin;skeletal muscle;	.	negative regulation of transcription by RNA polymerase II;regulation of transcription, DNA-templated;cellular response to DNA damage stimulus;negative regulation of transcription, DNA-templated	nucleus;nucleoplasm;chromosome;cytosol;nuclear body	RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;protein binding;methyl-CpG binding;methyl-CpNpG binding;protein kinase binding;protein homodimerization activity;sequence-specific DNA binding;metal ion binding	CCDC57[unassigned1304];CALCOCO2[unassigned1304];POU6F2[unassigned1304];PDE4DIP[unassigned1304];KLHL12[unassigned1304];GOLGA2[unassigned1304];CYSRT1[unassigned1304];CEP70[unassigned1304];TP53BP2[unassigned1304];HOMER3[unassigned1304];CEP76[unassigned1304];PIBF1[unassigned1304];TP63[20085233];BANP[unassigned1304];TRIM23[unassigned1304];	7369490
32457	chr17	7370097	C	T	chr17:7370097	ZBTB4	zinc finger and BTB domain containing 4	SNV	0/1	0.46	39_34	74	99.0	0/1	0.54	34_40	74	99.0			rs147041318	EXONIC	YES	NM_020899.4	Transcript	protein_coding	synonymous_variant		3/4	NM_020899.4:c.24G>A	NP_065950.2:p.Thr8%3D		-1.0						.	.	.		0.000184492	28.0	151768.0	0.0	32	0.96	PASS	nfe	0.000338723	23.0	0.000338723	23.0	0.00016617	30.0	180538.0	0.0	19	0.5	PASS	nfe	0.000299666	23.0	0.000299666	23.0	0.0001286	20	0.001	2.0				11.22	0.708101		0	0	0			ZBTB4	0.03	0.04	0.0	0.0	-34.0	7.0	6.0	-48.0						0.22	1.0	89.175055721			behavior/neurological phenotype ; vision/eye phenotype; 			atrioventricular node;skin;skeletal muscle;	.	negative regulation of transcription by RNA polymerase II;regulation of transcription, DNA-templated;cellular response to DNA damage stimulus;negative regulation of transcription, DNA-templated	nucleus;nucleoplasm;chromosome;cytosol;nuclear body	RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;protein binding;methyl-CpG binding;methyl-CpNpG binding;protein kinase binding;protein homodimerization activity;sequence-specific DNA binding;metal ion binding	CCDC57[unassigned1304];CALCOCO2[unassigned1304];POU6F2[unassigned1304];PDE4DIP[unassigned1304];KLHL12[unassigned1304];GOLGA2[unassigned1304];CYSRT1[unassigned1304];CEP70[unassigned1304];TP53BP2[unassigned1304];HOMER3[unassigned1304];CEP76[unassigned1304];PIBF1[unassigned1304];TP63[20085233];BANP[unassigned1304];TRIM23[unassigned1304];	7370097
32524	chr17	7750262	A	G	chr17:7750262	KDM6B	lysine demethylase 6B	SNV	0/1	0.53	41_47	89	99.0	0|1	0.4	46_31	78	99.0			rs146637535	EXONIC	YES	NM_001080424.2	Transcript	protein_coding	synonymous_variant		9/22	NM_001080424.2:c.837A>G	NP_001073893.1:p.Pro279%3D		1.0					Neurodevelopmental disorder with coarse facies and mild distal skeletal abnormalities, 618505 (3), Autosomal dominant	.	.	Cryptorchidism;Abnormality of the dentition;Autistic behavior;Wide nasal bridge;Hypoplastic nipples;Exotropia;Hemangioma;Autosomal dominant inheritance;Pectus excavatum;Speech apraxia;Full cheeks;Global developmental delay;Mandibular prognathia;Thick vermilion border;Round face;Seizure;Joint hypermobility;Generalized hypotonia;Dolichocephaly;Wide mouth;Hyperactivity;Macrotia;Depressed nasal bridge;Telecanthus;Cafe-au-lait spot;Esotropia;Hypermelanotic macule;Prominent forehead;Epicanthus;Clinodactyly of the 5th finger		0.000953825	122.0	127906.0	1.0	32	0.85	PASS	sas	0.00345929	13.0	0.000762389	48.0	0.00121803	304.0	249584.0	0.0	100	0.99	PASS	sas	0.00258102	79.0	0.000779699	88.0	0.0010932	170	0.0	1.0	0.00035	4.0		11.48	0.740487		0	0	0			KDM6B	0.0	0.0	0.0	0.0	-11.0	2.0	49.0	2.0						0.2	1.0	64.435363487			skeleton phenotype; immune system phenotype; limbs/digits/tail phenotype; nervous system phenotype ; reproductive system phenotype; mortality/aging ; hematopoietic system phenotype; respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; 			pons;ciliary ganglion;subthalamic nucleus;dorsal root ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;skin;whole blood;testis;parietal lobe;skeletal muscle;	.	inflammatory response to antigenic stimulus;chromatin remodeling;response to activity;hippocampus development;cell fate commitment;endothelial cell differentiation;positive regulation of transcription by RNA polymerase II;mesodermal cell differentiation;cardiac muscle cell differentiation;oxidation-reduction process;response to fungicide;cellular response to hydrogen peroxide;histone H3-K27 demethylation;positive regulation of cold-induced thermogenesis	nucleus;nucleoplasm;MLL3/4 complex	RNA polymerase II proximal promoter sequence-specific DNA binding;chromatin binding;protein binding;beta-catenin binding;chromatin DNA binding;histone demethylase activity;sequence-specific DNA binding;metal ion binding;dioxygenase activity;histone demethylase activity (H3-K27 specific)	SOX2[22801502];CSNK2B[21900206];TK1[21900206];KLF4[22801502];ESR1[21841772];HIST1H1C[30021884];	7750262
32583	chr17	7788344	GCC		chr17:7788344-7788346	CHD3	chromodomain helicase DNA binding protein 3	deletion	0/0	0.0	35_0	35	99.0	0/1	0.12	21_3	24	63.0			rs759738955	EXONIC	YES	NM_001005271.3	Transcript	protein_coding	inframe_deletion		1/40	NM_001005271.3:c.240_242del	NP_001005271.2:p.Pro82del		1.0					Snijders Blok-Campeau syndrome, 618205 (3), Autosomal dominant	.	.	Abnormality of the foot;High, narrow palate;Prominent forehead;Wide nasal bridge;Epicanthus;Global developmental delay;Macrocephaly;Speech apraxia;Stuttering;Delayed speech and language development;Broad-based gait;Astigmatism;Stereotypy;Ventriculomegaly;Autosomal dominant inheritance;Dysarthria;Cerebral visual impairment;Prominent nose;Unsteady gait;Hypertelorism;Abnormality of the dentition;Scoliosis;Infantile onset;Midface retrusion;Hypermetropia;Strabismus;Low-set ears;Frontal bossing;Delayed ability to walk;Generalized hypotonia		0.000230489	33.0	143174.0	0.0	28	0.83	PASS	afr	0.000625845	25.0	9.27873e-05	6.0	0.0090525	30.0	3314.0	0.0	0	0.0	PASS	sas	0.0207373	9.0	0.0042735	5.0					0.00316	30.0		13.41	0.997765		0	0	0			CHD3	0.0	0.0	0.0	0.0	-21.0	4.0	-15.0	2.0						0.0137	1.0				.			caudate nucleus;amygdala;occipital lobe;fetal brain;prefrontal cortex;dorsal root ganglion;cingulate cortex;prostate;parietal lobe;globus pallidus;thalamus;	.	chromatin assembly or disassembly;regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II;spindle organization;centrosome cycle;histone deacetylation;DNA duplex unwinding	nucleus;nucleoplasm;nucleolus;cytoplasm;centrosome;microtubule organizing center;NuRD complex	DNA binding;RNA binding;ATP-dependent DNA helicase activity;helicase activity;histone deacetylase activity;protein binding;ATP binding;zinc ion binding	TCERG1[15383276];KDM1A[19703393];MKI67[26949251];SAT1[16169070];ATP5IF1[16169070];PCMT1[16169070];RGS2[21900206];TRIM28[16169070;21642969];UROD[21900206];HABP4[12505151;16169070];PIAS4[15383276];IK[16169070];ZGPAT[19644445];TALDO1[15383276];THOC7[16169070];PSME1[16169070];CHMP4B[16730941];LRIF1[15383276];RPL29[16169070];AURKAIP1[29568061];KPNB1[15383276];DDX5[20676135];TXNDC9[16169070];PSMD14[26496610];CTBP1[21900206];CSTF2[16169070];ADH5[16169070];HSPH1[16169070];HIST1H3A[29568061];MAN2A2[16169070];ZNF827[25150861];TSPAN6[16169070];TNFRSF14[16169070];SKIL[15231748];ZBTB7A[26816381];SERF2[16169070];BARD1[15383276];IVNS1ABP[16169070];PLK4[21900206];JUN[25609649];CBX5[28977666];XRCC4[16169070];CBX3[21888893;28977666];GADD45A[21900206];CBX1[21888893;28977666];PRG2[16169070];SMARCA5[28977666];PAICS[16169070];NFKB1[25609649];SMARCA4[28977666];SETX[24244371];AIMP2[21900206];NR4A1[21900206];SNW1[20467437];SP1[20195357];FUBP1[16169070];MAFG[16169070];BHLHE40[16169070];UBA3[16169070];CPE[16169070];RETREG2[16169070];GSK3B[21900206];PTPRS[16169070];CHD4[28977666];CHD3[15383276];KIF15[16169070];CASP8[16169070];ACTR1B[16169070];SUMO1[21642969];CASP6[16169070];SUMO2[15383276;16169070;21900206];NEFL[15383276];GIT1[15383276];TSC22D1[21900206];PRPF40A[15383276];SIRT6[16169070;21900206];SAFB[16169070];ZHX1[15383276];SIRT1[18235501];ZEB2[26028330];CREB1[16169070];TNNT1[21900206];TAL1[19497860];YAE1[16169070;21900206];LUC7L2[16169070];FBP2[16169070];SLC25A6[16169070];HDAC2[23752268;28977666];RPL10[26496610];HDAC1[23752268;26496610;28977666];EMS1[16169070];SRRT[16169070];CRCT1[16169070];HTT[15383276];GPS2[16169070];PTN[15383276;16169070];HSD17B10[21900206];TTR[16169070;21900206];MTA1[28977666];PUF60[16169070];RBBP4[27705803;28977666];C4orf17[16169070];ENTR1[16169070];RBBP7[27705803;28977666];MTA2[19703393;28977666];MTA3[28977666];MBD3[25123934;28977666];NR1H2[21900206];MBD2[28977666];IMMT[15383276;16169070];EPOP[27705803];GATAD2B[28977666];GATAD2A[28977666];RAD51[16169070];FABP4[21900206];SERBP1[12505151];SGSM2[16169070];CDK2AP1[25123934;26496610;28977666];VIM[15383276];DKFZp434D1428[16169070];	7788343
32710	chr17	8093240	C	T	chr17:8093240	BORCS6	BLOC-1 related complex subunit 6	SNV	0/1	0.43	70_52	122	99.0	0/1	0.63	44_76	120	99.0			rs183207665	EXONIC	YES	NM_017622.3	Transcript	protein_coding	synonymous_variant		1/1	NM_017622.3:c.219G>A	NP_060092.2:p.Pro73%3D		-1.0						.	.	.		0.00367966	560.0	152188.0	2.0	32	0.98	PASS	nfe	0.0049406	336.0	0.0049406	336.0	0.00305251	444.0	145454.0	4.0	29	0.56	PASS	nfe	0.00424213	230.0	0.00424213	230.0	0.0007074	110	0.002	5.0				5.624	0.185605		0	0	0			BORCS6	0.0	0.0	0.0	0.0	-2.0	-10.0	4.0	-5.0								69.474072606			.			.	.	lysosome localization	lysosomal membrane;BORC complex	protein binding	KANK2[unassigned1304];BEX2[unassigned1304];DCTN2[unassigned1304];USHBP1[unassigned1304];FBXO44[25416956;unassigned1304];C19orf25[unassigned1304];EPS8[25416956];TGOLN2[29568061];EXOSC5[unassigned1304];VPS52[unassigned1304];C1orf109[unassigned1304];PKNOX1[unassigned1304];CCHCR1[unassigned1304];RIBC1[unassigned1304];DISC1[unassigned1304];BORCS6[unassigned1304];NDEL1[unassigned1304];SHPRH[25416956];EXOC8[unassigned1304];WTAP[29507755];PLA2G4A[18330356];WDYHV1[unassigned1304];INSYN1[unassigned1304];HAUS1[unassigned1304];MOS[25416956];FCHSD2[unassigned1304];ABI2[unassigned1304];HGS[unassigned1304];LNX1[unassigned1304];KXD1[unassigned1304];RAB9A[29568061];LAMTOR2[unassigned1304];FAM161B[unassigned1304];TACC2[unassigned1304];ZNF655[unassigned1304];RCOR3[unassigned1304];C1orf216[unassigned1304];SPG21[unassigned1304];GAS8[unassigned1304];GLYR1[unassigned1304];	8093240
32723	chr17	8110921	C	T	chr17:8110921	AURKB	aurora kinase B	SNV	0/1	0.51	52_54	106	99.0	0/1	0.52	48_51	99	99.0			rs74385486	EXONIC	YES	NM_001284526.2	Transcript	protein_coding	missense_variant		4/9	NM_001284526.2:c.174G>A	NP_001271455.1:p.Met58Ile		-1.0	.,.,.,.,.,.,.,.					.	.	.		0.000151171	23.0	152146.0	0.0	31	0.95	PASS	afr	0.000193218	8.0	0.000102878	7.0	9.94534e-05	25.0	251374.0	0.0	55	1.0	PASS	eas	0.000163097	3.0	7.91473e-05	9.0	0.0001029	16	0.0	1.0				15.2	1.302319	0.046	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	AURKB	0.0	0.0	0.0	0.0	8.0	22.0	-36.0	6.0						0.635	0.01	0.000000000	0.089	-0.411	cardiovascular system phenotype ; mortality/aging ; reproductive system phenotype; neoplasm; embryo phenotype; growth/size/body region phenotype; integument phenotype ; homeostasis/metabolism phenotype; cellular phenotype; 			ciliary ganglion;tumor;dorsal root ganglion;superior cervical ganglion;	.	negative regulation of transcription by RNA polymerase II;negative regulation of B cell apoptotic process;protein phosphorylation;spindle organization;mitotic spindle organization;mitotic spindle assembly checkpoint;aging;cell population proliferation;attachment of spindle microtubules to kinetochore;abscission;histone modification;anaphase-promoting complex-dependent catabolic process;negative regulation of protein binding;positive regulation of telomere maintenance via telomerase;regulation of cytokinesis;negative regulation of cytokinesis;positive regulation of cytokinesis;protein localization to kinetochore;cellular response to UV;cleavage furrow formation;histone H3-S28 phosphorylation;mitotic cytokinesis checkpoint;protein autophosphorylation;mitotic spindle midzone assembly;positive regulation of telomerase activity;regulation of chromosome segregation;regulation of signal transduction by p53 class mediator;positive regulation of telomere capping	kinetochore;condensed chromosome, centromeric region;condensed nuclear chromosome, centromeric region;nucleus;nucleoplasm;spindle;cytosol;spindle microtubule;chromocenter;midbody;spindle pole centrosome;chromosome passenger complex;spindle midzone;mitotic spindle midzone	protein serine/threonine kinase activity;protein serine/threonine/tyrosine kinase activity;protein binding;ATP binding;kinase binding;histone serine kinase activity;metal ion binding	RBM28[29568061];HSP90AB1[22939624;25036637;29568061];RIF1[29568061];LRRK2[29513927];NAT10[29568061];CIB1[21988832];MIA3[29568061];TFG[26496610];KAT5[26829474];ZFP30[29568061];PPP2R1A[26829474];POGZ[20562864];CNTRL[26638075];RACK1[21988832];RRP12[29568061];OFD1[26638075;29568061];DDX18[29568061];GAS2L3[24571573];HSP90AA1[29568061];RIPK4[26972000];CEP131[29568061];LANCL1[29568061];SEPT1[16179162;21988832];DDX54[29568061];VRK1[29340707];GTPBP4[29568061];FTSJ3[29568061];DPM1[29568061];PSMA3[21988832];INCENP[16239925;17956729;20562864;21051298;27332895;21346195;19357306;20739936;29568061];CDC37[25036637;29568061];BIRC5[16291752;17099693;17681274;21051298;24571573;27332895;19357306;29568061];BIRC6[18329369];HAGH[29568061];MICU1[unassigned1312];MAPRE1[18477699];TP53[29340707];FKBP5[25036637];NIM1K[29568061];NUP205[29568061];GTF3C3[29568061];HDAC3[16980585];DDX24[29568061];DCTN1[26638075];AKAP8[16980585];CDCA8[17956729;18243099;21051298;20739936;29568061];STK4[24255178];AURKC[27332895];NCAPH[21633354];CENPC[20562864];STK3[24255178];BCL2L11[21988832];SPAST[24571573];RACGAP1[18201571];GRPEL1[29568061];DHX37[29568061];MYH14[29568061];SURF6[29568061];CEP192[29568061];MAPK6[26972000;29426014];LYAR[29568061];ANKZF1[16169070];NPM1[24857377];JUN[25609649];CBX5[20562864];CDKN2A[29568061];CEP152[29568061];SEC16A[29568061];CDC5L[20467437];PPP1CA[17274640];MFHAS1[29513927];TBL3[16169070];SNW1[20467437];MYBBP1A[29568061];HIST3H3[29340707];CDK1[17681274];TACC1[15064709];HYOU1[29568061];SUGP2[29568061];AARS[unassigned1312];	8110921
32809	chr17	8638873	G	A	chr17:8638873	CCDC42	coiled-coil domain containing 42	SNV	0/1	0.52	57_64	122	99.0	0/0	0.0	41_0	41	99.0			rs147370742	EXONIC	YES	NM_144681.3	Transcript	protein_coding	synonymous_variant		5/7	NM_144681.3:c.549C>T	NP_653282.2:p.His183%3D		-1.0						.	.	.		0.000144524	22.0	152224.0	0.0	32	0.98	PASS	sas	0.000207039	1.0	0.000146959	10.0	0.000119487	30.0	251074.0	0.0	66	1.0	PASS	sas	0.000195989	6.0	0.00016746	19.0	0.0001158	18						4.864	0.136739		0	0	0			CCDC42	0.05	0.0	0.0	0.0	-13.0	50.0	39.0	15.0						0.916	0.0	16.428434049			endocrine/exocrine gland phenotype; cellular phenotype; reproductive system phenotype; 			.	.	spermatid development	.	protein binding	TSC22D4[16189514];KRT18[30021884];USHBP1[unassigned1304];MYH9[30021884];TFIP11[25416956;27107012];MID2[25416956;unassigned1304];	8638873
32834	chr17	9615412	T	G	chr17:9615412	USP43	ubiquitin specific peptidase 43	SNV	0/1	0.53	40_45	85	99.0	0/0	0.0	33_0	33	99.0			rs201010220	EXONIC	YES	NM_153210.5	Transcript	protein_coding	synonymous_variant		14/15	NM_153210.5:c.2298T>G	NP_694942.3:p.Ser766%3D		1.0						.	.	.		9.20241e-05	14.0	152134.0	0.0	32	0.96	PASS	sas	0.0010352	5.0	0.000117637	8.0	0.000197591	48.0	242926.0	0.0	26	0.7	PASS	sas	0.00100556	30.0	0.000135781	15.0	0.0001929	30						1.378	-0.103041		0	0	0			USP43	0.0	0.0	0.0	0.0	-11.0	18.0	37.0	-12.0						0.688	0.01	90.761025643			.			ciliary ganglion;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	.	ubiquitin-dependent protein catabolic process;protein deubiquitination;translesion synthesis	nucleoplasm	ISG15-specific protease activity;thiol-dependent ubiquitinyl hydrolase activity	YWHAE[19615732];CEP57[26496610];YWHAB[19615732];WDR3[19615732];MRPS12[26496610];TMEM165[26496610];STX10[26496610];POLD1[26496610];NHS[26496610];USP1[26496610];SFN[15778465];VPS35[19615732];DKFZP586J0619[26496610];TXNL4A[26496610];YWHAH[19615732];CDK5RAP2[26496610];MAGI3[19615732];DDX11[26496610];SSR3[26496610];NCOA4[26496610];FN3KRP[19615732];HAUS5[26496610];FTSJ1[26496610];PSMA2[26496610];PSME3[19615732];TRMT6[26496610];CSNK2B[26496610];LCOR[26496610];PDCD2[19615732];ATG4A[26496610];MAPT[26496610];TRIM56[26496610];	9615412
33058	chr17	16068340	C	T	chr17:16068340	NCOR1	nuclear receptor corepressor 1	SNV	0|1	0.35	52_29	84	99.0	0|1	0.37	50_30	82	99.0			rs76780359,COSV51959636	EXONIC	YES	NM_006311.4	Transcript	protein_coding	missense_variant		5/46	NM_006311.4:c.571G>A	NP_006302.2:p.Glu191Lys		-1.0	N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain,.,.,N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain					.	.	.		0.0	0.0	151178.0	0.0	31	0.94	AC0_AS_VQSR				0.0	0.0	0.259957	28144.0	108264.0	0.0	35	0.64	InbreedingCoeff	sas	0.330115	4753.0	0.265616	12663.0	0.0002058	32	0.013	39.0				25.9	3.738267	0.615	15	5	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,ClinPred_pred	NCOR1	0.0	0.0	0.03	0.0	-47.0	5.0	21.0	-47.0						0.467	1.0		1.0	1.026	embryo phenotype; liver/biliary system phenotype; behavior/neurological phenotype ; cardiovascular system phenotype ; hematopoietic system phenotype; mortality/aging ; nervous system phenotype ; immune system phenotype; growth/size/body region phenotype; integument phenotype ; endocrine/exocrine gland phenotype; adipose tissue phenotype ; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			ciliary ganglion;caudate nucleus;testis - seminiferous tubule;prefrontal cortex;skin;superior cervical ganglion;trigeminal ganglion;pons;testis - interstitial;subthalamic nucleus;dorsal root ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;	Huntington's disease	negative regulation of transcription by RNA polymerase II;chromatin organization;transcription by RNA polymerase II;circadian rhythm;regulation of lipid metabolic process;negative regulation of transcription, DNA-templated;negative regulation of JNK cascade;spindle assembly;negative regulation of androgen receptor signaling pathway;regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter;regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter;negative regulation of production of miRNAs involved in gene silencing by miRNA;regulation of fatty acid transport	histone deacetylase complex;nuclear chromatin;nucleus;nucleoplasm;cytosol;membrane;Sin3 complex;transcriptional repressor complex;mitotic spindle	DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II regulatory region DNA binding;RNA polymerase II activating transcription factor binding;chromatin binding;transcription corepressor activity;protein binding;nuclear hormone receptor binding;histone deacetylase binding;sequence-specific DNA binding;transcription regulatory region DNA binding;thyroid hormone receptor binding	YWHAE[17630505];LIN54[17531812];KDM5C[17468742];SMARCB1[11013263];THRB[20956942];ENO1[23414517];HSCB[24606901];HK1[26120082];GOLGA2[29568061];DACH1[14525983];TRIM28[11013263];MYC[21150319];KIF5B[26496610];MYB[20195357];NINL[26638075];NELFE[14667819];KPNA1[26496610];SREBF1[26120082];SMARCC1[11013263];SMARCC2[11013263];TCF12[17572682];UGT2B17[26175416];SIRT1[15175761];PTBP3[22575643];NCOR2[11013263];SGO1[26496610];AR[23518348];TBL1XR1[21258344];RARA[21988832;16606617;25303530;27107012;20543827];PPARG[22078880;21775429];ZMYND11[10734313];PPARA[19955185;21775429];PPARD[21775429];HDAC4[23752268;17956988];HDAC5[23752268];PFKFB1[26120082];HDAC3[11013263;21258344;23752268;16980585];SF3B3[11013263];SRCAP[11013263];AKAP8[16980585];TULP3[23414517];HTT[17500595];FOXK2[25609649];FOXK1[25609649];HDAC9[12590135];HDAC7[23752268];ATXN1[16713569];BAG1[19595997];SKIL[15231748];EXOSC1[26496610];RUNX1T1[17572682;18952841];SF3A1[11013263];EGLN3[26972000];SIAH2[23518348];NR1H2[26120082];CDC5L[20467437];NR1H3[26120082];NBEAL2[29187380];NR1D1[20581824];ESR1[21182203];SMARCA4[11013263];SKI[14525983;10049357;19032343];KIF18A[26496610];REST[17468742];SNW1[20467437];FGFR1OP[26638075];RAB5A[26496610];	16068340
33059	chr17	16068343	G	A	chr17:16068343	NCOR1	nuclear receptor corepressor 1	SNV	0|1	0.35	52_30	85	99.0	0|1	0.37	50_30	82	99.0			rs78230791,COSV51959653	EXONIC	YES	NM_006311.4	Transcript	protein_coding	stop_gained		5/46	NM_006311.4:c.568C>T	NP_006302.2:p.Arg190Ter		-1.0	N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain,.,.,N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain					.	.	.						32	0.95							0.25638	27689.0	108000.0	0.0	37	0.66	InbreedingCoeff_RF	sas	0.320295	4520.0	0.262251	12319.0	0.0000707	11	0.012	36.0				33.0	5.348793		5	1	6	LRT_pred,MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	fathmm-XF_coding_pred	NCOR1	0.0	0.0	0.07	0.04	-50.0	33.0	18.0	-50.0						0.467	1.0		1.0	1.176	embryo phenotype; liver/biliary system phenotype; behavior/neurological phenotype ; cardiovascular system phenotype ; hematopoietic system phenotype; mortality/aging ; nervous system phenotype ; immune system phenotype; growth/size/body region phenotype; integument phenotype ; endocrine/exocrine gland phenotype; adipose tissue phenotype ; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			ciliary ganglion;caudate nucleus;testis - seminiferous tubule;prefrontal cortex;skin;superior cervical ganglion;trigeminal ganglion;pons;testis - interstitial;subthalamic nucleus;dorsal root ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;	Huntington's disease	negative regulation of transcription by RNA polymerase II;chromatin organization;transcription by RNA polymerase II;circadian rhythm;regulation of lipid metabolic process;negative regulation of transcription, DNA-templated;negative regulation of JNK cascade;spindle assembly;negative regulation of androgen receptor signaling pathway;regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter;regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter;negative regulation of production of miRNAs involved in gene silencing by miRNA;regulation of fatty acid transport	histone deacetylase complex;nuclear chromatin;nucleus;nucleoplasm;cytosol;membrane;Sin3 complex;transcriptional repressor complex;mitotic spindle	DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II regulatory region DNA binding;RNA polymerase II activating transcription factor binding;chromatin binding;transcription corepressor activity;protein binding;nuclear hormone receptor binding;histone deacetylase binding;sequence-specific DNA binding;transcription regulatory region DNA binding;thyroid hormone receptor binding	YWHAE[17630505];LIN54[17531812];KDM5C[17468742];SMARCB1[11013263];THRB[20956942];ENO1[23414517];HSCB[24606901];HK1[26120082];GOLGA2[29568061];DACH1[14525983];TRIM28[11013263];MYC[21150319];KIF5B[26496610];MYB[20195357];NINL[26638075];NELFE[14667819];KPNA1[26496610];SREBF1[26120082];SMARCC1[11013263];SMARCC2[11013263];TCF12[17572682];UGT2B17[26175416];SIRT1[15175761];PTBP3[22575643];NCOR2[11013263];SGO1[26496610];AR[23518348];TBL1XR1[21258344];RARA[21988832;16606617;25303530;27107012;20543827];PPARG[22078880;21775429];ZMYND11[10734313];PPARA[19955185;21775429];PPARD[21775429];HDAC4[23752268;17956988];HDAC5[23752268];PFKFB1[26120082];HDAC3[11013263;21258344;23752268;16980585];SF3B3[11013263];SRCAP[11013263];AKAP8[16980585];TULP3[23414517];HTT[17500595];FOXK2[25609649];FOXK1[25609649];HDAC9[12590135];HDAC7[23752268];ATXN1[16713569];BAG1[19595997];SKIL[15231748];EXOSC1[26496610];RUNX1T1[17572682;18952841];SF3A1[11013263];EGLN3[26972000];SIAH2[23518348];NR1H2[26120082];CDC5L[20467437];NR1H3[26120082];NBEAL2[29187380];NR1D1[20581824];ESR1[21182203];SMARCA4[11013263];SKI[14525983;10049357;19032343];KIF18A[26496610];REST[17468742];SNW1[20467437];FGFR1OP[26638075];RAB5A[26496610];	16068343
33062	chr17	16068362	C	T	chr17:16068362	NCOR1	nuclear receptor corepressor 1	SNV	0/1	0.42	57_44	104	99.0	0/1	0.42	60_44	106	99.0			rs76375524,COSV51960926	EXONIC	YES	NM_006311.4	Transcript	protein_coding	synonymous_variant		5/46	NM_006311.4:c.549G>A	NP_006302.2:p.Gln183%3D		-1.0						.	.	.						32	0.96							0.274906	32595.0	118568.0	0.0	47	0.76	InbreedingCoeff_RF	sas	0.308404	4565.0	0.281997	14480.0	0.0001029	16	0.006	19.0				12.05	0.812933		0	0	0			NCOR1	0.0	0.0	0.13	0.0	-3.0	-1.0	-1.0	-33.0						0.467	1.0				embryo phenotype; liver/biliary system phenotype; behavior/neurological phenotype ; cardiovascular system phenotype ; hematopoietic system phenotype; mortality/aging ; nervous system phenotype ; immune system phenotype; growth/size/body region phenotype; integument phenotype ; endocrine/exocrine gland phenotype; adipose tissue phenotype ; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			ciliary ganglion;caudate nucleus;testis - seminiferous tubule;prefrontal cortex;skin;superior cervical ganglion;trigeminal ganglion;pons;testis - interstitial;subthalamic nucleus;dorsal root ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;	Huntington's disease	negative regulation of transcription by RNA polymerase II;chromatin organization;transcription by RNA polymerase II;circadian rhythm;regulation of lipid metabolic process;negative regulation of transcription, DNA-templated;negative regulation of JNK cascade;spindle assembly;negative regulation of androgen receptor signaling pathway;regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter;regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter;negative regulation of production of miRNAs involved in gene silencing by miRNA;regulation of fatty acid transport	histone deacetylase complex;nuclear chromatin;nucleus;nucleoplasm;cytosol;membrane;Sin3 complex;transcriptional repressor complex;mitotic spindle	DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II regulatory region DNA binding;RNA polymerase II activating transcription factor binding;chromatin binding;transcription corepressor activity;protein binding;nuclear hormone receptor binding;histone deacetylase binding;sequence-specific DNA binding;transcription regulatory region DNA binding;thyroid hormone receptor binding	YWHAE[17630505];LIN54[17531812];KDM5C[17468742];SMARCB1[11013263];THRB[20956942];ENO1[23414517];HSCB[24606901];HK1[26120082];GOLGA2[29568061];DACH1[14525983];TRIM28[11013263];MYC[21150319];KIF5B[26496610];MYB[20195357];NINL[26638075];NELFE[14667819];KPNA1[26496610];SREBF1[26120082];SMARCC1[11013263];SMARCC2[11013263];TCF12[17572682];UGT2B17[26175416];SIRT1[15175761];PTBP3[22575643];NCOR2[11013263];SGO1[26496610];AR[23518348];TBL1XR1[21258344];RARA[21988832;16606617;25303530;27107012;20543827];PPARG[22078880;21775429];ZMYND11[10734313];PPARA[19955185;21775429];PPARD[21775429];HDAC4[23752268;17956988];HDAC5[23752268];PFKFB1[26120082];HDAC3[11013263;21258344;23752268;16980585];SF3B3[11013263];SRCAP[11013263];AKAP8[16980585];TULP3[23414517];HTT[17500595];FOXK2[25609649];FOXK1[25609649];HDAC9[12590135];HDAC7[23752268];ATXN1[16713569];BAG1[19595997];SKIL[15231748];EXOSC1[26496610];RUNX1T1[17572682;18952841];SF3A1[11013263];EGLN3[26972000];SIAH2[23518348];NR1H2[26120082];CDC5L[20467437];NR1H3[26120082];NBEAL2[29187380];NR1D1[20581824];ESR1[21182203];SMARCA4[11013263];SKI[14525983;10049357;19032343];KIF18A[26496610];REST[17468742];SNW1[20467437];FGFR1OP[26638075];RAB5A[26496610];	16068362
33065	chr17	16068377	C	G	chr17:16068377	NCOR1	nuclear receptor corepressor 1	SNV	0|1	0.45	63_55	121	99.0	0|1	0.46	64_58	126	99.0			rs200020868,COSV51959222	EXONIC	YES	NM_006311.4	Transcript	protein_coding	missense_variant		5/46	NM_006311.4:c.534G>C	NP_006302.2:p.Lys178Asn		-1.0	N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain,.,.,N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain					.	.	.						32	0.96							0.190681	18993.0	99606.0	0.0	53	0.86	InbreedingCoeff	nfe	0.198097	8038.0	0.198097	8038.0	0.0000836	13	0.006	18.0				23.5	2.96789	0.611	12	8	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	NCOR1	0.0	0.0	0.0	0.01	-16.0	-1.0	-48.0	-16.0						0.467	1.0		0.997	-0.23	embryo phenotype; liver/biliary system phenotype; behavior/neurological phenotype ; cardiovascular system phenotype ; hematopoietic system phenotype; mortality/aging ; nervous system phenotype ; immune system phenotype; growth/size/body region phenotype; integument phenotype ; endocrine/exocrine gland phenotype; adipose tissue phenotype ; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			ciliary ganglion;caudate nucleus;testis - seminiferous tubule;prefrontal cortex;skin;superior cervical ganglion;trigeminal ganglion;pons;testis - interstitial;subthalamic nucleus;dorsal root ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;	Huntington's disease	negative regulation of transcription by RNA polymerase II;chromatin organization;transcription by RNA polymerase II;circadian rhythm;regulation of lipid metabolic process;negative regulation of transcription, DNA-templated;negative regulation of JNK cascade;spindle assembly;negative regulation of androgen receptor signaling pathway;regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter;regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter;negative regulation of production of miRNAs involved in gene silencing by miRNA;regulation of fatty acid transport	histone deacetylase complex;nuclear chromatin;nucleus;nucleoplasm;cytosol;membrane;Sin3 complex;transcriptional repressor complex;mitotic spindle	DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II regulatory region DNA binding;RNA polymerase II activating transcription factor binding;chromatin binding;transcription corepressor activity;protein binding;nuclear hormone receptor binding;histone deacetylase binding;sequence-specific DNA binding;transcription regulatory region DNA binding;thyroid hormone receptor binding	YWHAE[17630505];LIN54[17531812];KDM5C[17468742];SMARCB1[11013263];THRB[20956942];ENO1[23414517];HSCB[24606901];HK1[26120082];GOLGA2[29568061];DACH1[14525983];TRIM28[11013263];MYC[21150319];KIF5B[26496610];MYB[20195357];NINL[26638075];NELFE[14667819];KPNA1[26496610];SREBF1[26120082];SMARCC1[11013263];SMARCC2[11013263];TCF12[17572682];UGT2B17[26175416];SIRT1[15175761];PTBP3[22575643];NCOR2[11013263];SGO1[26496610];AR[23518348];TBL1XR1[21258344];RARA[21988832;16606617;25303530;27107012;20543827];PPARG[22078880;21775429];ZMYND11[10734313];PPARA[19955185;21775429];PPARD[21775429];HDAC4[23752268;17956988];HDAC5[23752268];PFKFB1[26120082];HDAC3[11013263;21258344;23752268;16980585];SF3B3[11013263];SRCAP[11013263];AKAP8[16980585];TULP3[23414517];HTT[17500595];FOXK2[25609649];FOXK1[25609649];HDAC9[12590135];HDAC7[23752268];ATXN1[16713569];BAG1[19595997];SKIL[15231748];EXOSC1[26496610];RUNX1T1[17572682;18952841];SF3A1[11013263];EGLN3[26972000];SIAH2[23518348];NR1H2[26120082];CDC5L[20467437];NR1H3[26120082];NBEAL2[29187380];NR1D1[20581824];ESR1[21182203];SMARCA4[11013263];SKI[14525983;10049357;19032343];KIF18A[26496610];REST[17468742];SNW1[20467437];FGFR1OP[26638075];RAB5A[26496610];	16068377
33069	chr17	16068383	G	A	chr17:16068383	NCOR1	nuclear receptor corepressor 1	SNV	0|1	0.47	66_61	130	99.0	0|1	0.47	66_63	133	99.0			rs199892481,COSV51969699	EXONIC	YES	NM_006311.4	Transcript	protein_coding	synonymous_variant		5/46	NM_006311.4:c.528C>T	NP_006302.2:p.Leu176%3D		-1.0						.	.	.						32	0.96							0.207173	21703.0	104758.0	0.0	55	0.86	InbreedingCoeff_RF	nfe	0.224195	9635.0	0.224195	9635.0	0.0000772	12	0.008	26.0				10.17	0.584406		0	0	0			NCOR1	0.0	0.0	0.0	0.01	-7.0	6.0	-24.0	-22.0						0.467	1.0				embryo phenotype; liver/biliary system phenotype; behavior/neurological phenotype ; cardiovascular system phenotype ; hematopoietic system phenotype; mortality/aging ; nervous system phenotype ; immune system phenotype; growth/size/body region phenotype; integument phenotype ; endocrine/exocrine gland phenotype; adipose tissue phenotype ; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			ciliary ganglion;caudate nucleus;testis - seminiferous tubule;prefrontal cortex;skin;superior cervical ganglion;trigeminal ganglion;pons;testis - interstitial;subthalamic nucleus;dorsal root ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;	Huntington's disease	negative regulation of transcription by RNA polymerase II;chromatin organization;transcription by RNA polymerase II;circadian rhythm;regulation of lipid metabolic process;negative regulation of transcription, DNA-templated;negative regulation of JNK cascade;spindle assembly;negative regulation of androgen receptor signaling pathway;regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter;regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter;negative regulation of production of miRNAs involved in gene silencing by miRNA;regulation of fatty acid transport	histone deacetylase complex;nuclear chromatin;nucleus;nucleoplasm;cytosol;membrane;Sin3 complex;transcriptional repressor complex;mitotic spindle	DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II regulatory region DNA binding;RNA polymerase II activating transcription factor binding;chromatin binding;transcription corepressor activity;protein binding;nuclear hormone receptor binding;histone deacetylase binding;sequence-specific DNA binding;transcription regulatory region DNA binding;thyroid hormone receptor binding	YWHAE[17630505];LIN54[17531812];KDM5C[17468742];SMARCB1[11013263];THRB[20956942];ENO1[23414517];HSCB[24606901];HK1[26120082];GOLGA2[29568061];DACH1[14525983];TRIM28[11013263];MYC[21150319];KIF5B[26496610];MYB[20195357];NINL[26638075];NELFE[14667819];KPNA1[26496610];SREBF1[26120082];SMARCC1[11013263];SMARCC2[11013263];TCF12[17572682];UGT2B17[26175416];SIRT1[15175761];PTBP3[22575643];NCOR2[11013263];SGO1[26496610];AR[23518348];TBL1XR1[21258344];RARA[21988832;16606617;25303530;27107012;20543827];PPARG[22078880;21775429];ZMYND11[10734313];PPARA[19955185;21775429];PPARD[21775429];HDAC4[23752268;17956988];HDAC5[23752268];PFKFB1[26120082];HDAC3[11013263;21258344;23752268;16980585];SF3B3[11013263];SRCAP[11013263];AKAP8[16980585];TULP3[23414517];HTT[17500595];FOXK2[25609649];FOXK1[25609649];HDAC9[12590135];HDAC7[23752268];ATXN1[16713569];BAG1[19595997];SKIL[15231748];EXOSC1[26496610];RUNX1T1[17572682;18952841];SF3A1[11013263];EGLN3[26972000];SIAH2[23518348];NR1H2[26120082];CDC5L[20467437];NR1H3[26120082];NBEAL2[29187380];NR1D1[20581824];ESR1[21182203];SMARCA4[11013263];SKI[14525983;10049357;19032343];KIF18A[26496610];REST[17468742];SNW1[20467437];FGFR1OP[26638075];RAB5A[26496610];	16068383
33073	chr17	16068396	G	A	chr17:16068396	NCOR1	nuclear receptor corepressor 1	SNV	0/1	0.51	70_75	148	99.0	0/1	0.51	80_89	173	99.0			rs150910818,COSV51959131	EXONIC	YES	NM_006311.4	Transcript	protein_coding	missense_variant		5/46	NM_006311.4:c.515C>T	NP_006302.2:p.Ser172Leu		-1.0	N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain,.,.,N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain,N-CoR, GPS2-interacting domain					.	.	.						32	0.96							0.365091	57220.0	156728.0	0.0	65	0.85	InbreedingCoeff_RF	nfe	0.393955	28115.0	0.393955	28115.0	0.0050159	780	0.015	48.0				22.9	2.66933	0.125	8	12	20	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationTaster_pred,PrimateAI_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	NCOR1	0.0	0.0	0.0	0.01	-20.0	-35.0	-24.0	-35.0						0.467	1.0		1.0	1.176	embryo phenotype; liver/biliary system phenotype; behavior/neurological phenotype ; cardiovascular system phenotype ; hematopoietic system phenotype; mortality/aging ; nervous system phenotype ; immune system phenotype; growth/size/body region phenotype; integument phenotype ; endocrine/exocrine gland phenotype; adipose tissue phenotype ; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			ciliary ganglion;caudate nucleus;testis - seminiferous tubule;prefrontal cortex;skin;superior cervical ganglion;trigeminal ganglion;pons;testis - interstitial;subthalamic nucleus;dorsal root ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;	Huntington's disease	negative regulation of transcription by RNA polymerase II;chromatin organization;transcription by RNA polymerase II;circadian rhythm;regulation of lipid metabolic process;negative regulation of transcription, DNA-templated;negative regulation of JNK cascade;spindle assembly;negative regulation of androgen receptor signaling pathway;regulation of glycolytic process by negative regulation of transcription from RNA polymerase II promoter;regulation of lipid transport by negative regulation of transcription from RNA polymerase II promoter;negative regulation of production of miRNAs involved in gene silencing by miRNA;regulation of fatty acid transport	histone deacetylase complex;nuclear chromatin;nucleus;nucleoplasm;cytosol;membrane;Sin3 complex;transcriptional repressor complex;mitotic spindle	DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II regulatory region DNA binding;RNA polymerase II activating transcription factor binding;chromatin binding;transcription corepressor activity;protein binding;nuclear hormone receptor binding;histone deacetylase binding;sequence-specific DNA binding;transcription regulatory region DNA binding;thyroid hormone receptor binding	YWHAE[17630505];LIN54[17531812];KDM5C[17468742];SMARCB1[11013263];THRB[20956942];ENO1[23414517];HSCB[24606901];HK1[26120082];GOLGA2[29568061];DACH1[14525983];TRIM28[11013263];MYC[21150319];KIF5B[26496610];MYB[20195357];NINL[26638075];NELFE[14667819];KPNA1[26496610];SREBF1[26120082];SMARCC1[11013263];SMARCC2[11013263];TCF12[17572682];UGT2B17[26175416];SIRT1[15175761];PTBP3[22575643];NCOR2[11013263];SGO1[26496610];AR[23518348];TBL1XR1[21258344];RARA[21988832;16606617;25303530;27107012;20543827];PPARG[22078880;21775429];ZMYND11[10734313];PPARA[19955185;21775429];PPARD[21775429];HDAC4[23752268;17956988];HDAC5[23752268];PFKFB1[26120082];HDAC3[11013263;21258344;23752268;16980585];SF3B3[11013263];SRCAP[11013263];AKAP8[16980585];TULP3[23414517];HTT[17500595];FOXK2[25609649];FOXK1[25609649];HDAC9[12590135];HDAC7[23752268];ATXN1[16713569];BAG1[19595997];SKIL[15231748];EXOSC1[26496610];RUNX1T1[17572682;18952841];SF3A1[11013263];EGLN3[26972000];SIAH2[23518348];NR1H2[26120082];CDC5L[20467437];NR1H3[26120082];NBEAL2[29187380];NR1D1[20581824];ESR1[21182203];SMARCA4[11013263];SKI[14525983;10049357;19032343];KIF18A[26496610];REST[17468742];SNW1[20467437];FGFR1OP[26638075];RAB5A[26496610];	16068396
33104	chr17	17412821	C	T	chr17:17412821	PEMT	phosphatidylethanolamine N-methyltransferase	SNV	0/0	0.0	33_0	33	99.0	0/1	0.44	70_55	126	99.0			rs551149216,COSV55130169	EXONIC	YES	NM_148172.3	Transcript	protein_coding	missense_variant		5/7	NM_148172.3:c.505G>A	NP_680477.1:p.Val169Met		-1.0	.,.,.,.,.					.	.	.		0.000170796	26.0	152228.0	1.0	33	0.99	PASS	sas	0.00310302	15.0	0.000117585	8.0	0.00048558	122.0	251246.0	2.0	77	0.97	PASS	sas	0.00353033	108.0	7.91835e-05	9.0	0.0004437	69						12.73	0.901143	0.081	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PEMT	0.0	0.0	0.0	0.0	-44.0	38.0	39.0	-31.0						0.457	0.37	0.000000000	0.739	-1.281	growth/size/body region phenotype; homeostasis/metabolism phenotype; digestive/alimentary phenotype; nervous system phenotype ; mortality/aging ; behavior/neurological phenotype ; liver/biliary system phenotype; 			ciliary ganglion;thyroid;liver;testis - interstitial;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;testis;skeletal muscle;	Glycine, serine and threonine metabolism;Glycerophospholipid metabolism	blastocyst hatching;lipid metabolic process;phosphatidylcholine biosynthetic process;sphingomyelin biosynthetic process;cell population proliferation;negative regulation of cell population proliferation;methylation;response to vitamin;response to amino acid;response to ethanol;S-adenosylhomocysteine metabolic process;S-adenosylmethionine metabolic process;positive regulation of lipoprotein metabolic process;positive regulation of cold-induced thermogenesis	endoplasmic reticulum membrane;integral component of membrane;brush border membrane;mitochondrial membrane;sarcolemma	phosphatidyl-N-methylethanolamine N-methyltransferase activity;phosphatidylethanolamine N-methyltransferase activity;phosphatidylethanolamine binding;phosphatidyl-N-dimethylethanolamine N-methyltransferase activity	AQP6[unassigned1304];STOM[unassigned1304];	17412821
33117	chr17	18034132	GTGTGTGTGTGT		chr17:18034132-18034143	MYO15A	myosin XVA	sequence_alteration	1/2	0.27	1_8_14_1_1	30	99.0	3/4	0.1	1_2_2_5_3	20	99.0			rs59214589	SPLICING	YES	NM_016239.4	Transcript	protein_coding	splice_region_variant,intron_variant	8/65		NM_016239.4:c.4038+8_4038+19del			1.0		Likely_benign	criteria_provided,_single_submitter	not_provided	Deafness, autosomal recessive 3, 600316 (3), Autosomal recessive	Autosomal recessive non-syndromic sensorineural deafness type DFNB	Disease-causing germline mutation(s) in	Autosomal recessive inheritance;Profound sensorineural hearing impairment		0.000383865	37.0	96388.0	0.0	26	0.73	PASS	eas	0.00147667	5.0	0.000245459	12.0					58	0.99											0.0027	20.0		7.176	0.297253		0	0	0																	0.0478					vision/eye phenotype; hearing/vestibular/ear phenotype; nervous system phenotype ; behavior/neurological phenotype ; growth/size/body region phenotype; adipose tissue phenotype ; 			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	sensory perception of sound;locomotory behavior;inner ear morphogenesis	cytoplasm;myosin complex;stereocilium;extracellular exosome	motor activity;actin binding;calmodulin binding;ATP binding	EPS8[16169070];USP13[16169070];HSF4[25036637];FASLG[19807924];	18034131
33143	chr17	18661804	T	C	chr17:18661804	FBXW10	F-box and WD repeat domain containing 10	SNV	0/1	0.41	36_25	61	99.0	0/1	0.64	12_21	33	99.0			rs138093156	EXONIC	YES	NM_001267585.2	Transcript	protein_coding	synonymous_variant		7/14	NM_001267585.2:c.1419T>C	NP_001254514.1:p.Tyr473%3D		1.0						.	.	.		1.31825e-05	2.0	151716.0	0.0	27	0.79	PASS	amr	6.60851e-05	1.0	0.0	0.0	1.59317e-05	4.0	251072.0	0.0	61	0.99	PASS	nfe	2.64546e-05	3.0	2.64546e-05	3.0	0.0000064	1						9.049	0.463216		0	0	0			FBXW10	0.0	0.0	0.05	0.0	-29.0	14.0	14.0	-35.0											.			.	.	protein polyubiquitination;post-translational protein modification	cytosol	ubiquitin-protein transferase activity	.	18661804
33217	chr17	19702893	A		chr17:19702893	ULK2	unc-51 like autophagy activating kinase 2	sequence_alteration	1/2	0.25	1_6_13	24	99.0	1/2	0.12	3_2_5	17	8.0			rs11456096	SPLICING	YES	NM_014683.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	16/26		NM_014683.4:c.1442-5del			-1.0						.	.	.		0.000132061	16.0	121156.0	0.0	0	0.02	PASS	eas	0.000512033	2.0	6.62339e-05	4.0					11	0.23							0.0017877,0.0000064	278,1						0.983	-0.153233		0	0	0			ULK2	0.0	0.0	0.0	0.0	-4.0	4.0	-2.0	6.0						0.822	0.0				mortality/aging ; normal phenotype; behavior/neurological phenotype ; homeostasis/metabolism phenotype; 			pons;superior cervical ganglion;trigeminal ganglion;parietal lobe;testis;globus pallidus;	Regulation of autophagy;mTOR signaling pathway	autophagosome assembly;autophagy;signal transduction;regulation of autophagy;response to starvation;protein autophosphorylation;negative regulation of collateral sprouting;axon extension;autophagy of host cells involved in interaction with symbiont	phagophore assembly site;cytosol;membrane;cytoplasmic vesicle membrane;phagophore assembly site membrane	protein serine/threonine kinase activity;protein binding;ATP binding	YWHAE[20562859];HBS1L[20562859];GLDC[20562859];PRKAG1[20562859];DIXDC1[21988832];PRKAG2[20562859];KIF11[20562859];EEF1B2[16169070];MAP1LC3B[20562859];IPO9[20562859];PPP2R1B[20562859];RB1CC1[20562859];WDR6[20562859];YWHAH[20562859];GABARAPL2[20562859];GABARAPL1[20562859];PRKAB2[20562859];GLRX3[20562859];CSNK1D[20562859];WIPI2[20562859];PRKAB1[20562859];ATG13[20562859];CKAP4[20562859];CREB1[20562859];IRF1[17353931];CDC37[20562859];CLNS1A[20562859];ULK2[20562859];OBSL1[20562859];LUC7L2[16169070];DBN1[20562859];PRKAA1[20562859];WDR26[20562859];PRKAA2[20562859];GABARAP[20562859];ATG101[20562859];FLNA[20562859];MTA2[20562859];AASDHPPT[20562859];MAPK3[20562859];CBX6[21282530];SETDB1[16169070];PLK1[20562859];ZNF32[21988832];PYCR3[20562859];POLA2[16169070];PPP5C[20562859];SNW1[20562859];NASP[16169070];HNRNPA2B1[20562859];PPP2R2D[20562859];LNX1[21988832];SSBP3[20562859];	19702892
33245	chr17	20769862	T	A	chr17:20769862	CCDC144NL	coiled-coil domain containing 144 family, N-terminal like	SNV	0|1	0.66	36_69	105	99.0	0|1	0.61	55_85	140	99.0			rs79433424,COSV60001282	SPLICING	YES	NR_164128.1	Transcript	transcribed_pseudogene	splice_region_variant,non_coding_transcript_exon_variant		3/4	NR_164128.1:n.713A>T			-1.0						.	.	.						32	0.96							0.0501401	5011.0	99940.0	0.0	44	0.6	PASS	nfe	0.0599007	2607.0	0.0599007	2607.0	0.0001994	31	0.119	350.0				6.245	0.227886		0	0	0			CCDC144NL	0.0	0.0	0.11	0.3	-17.0	-1.0	27.0	-1.0	0.0885380822532824	0.282	4.708	3.528	8.235	0.94	0.0				.			.	.	.	.	.	.	20769862
33630	chr17	21208413	C	T	chr17:21208413	MAP2K3	mitogen-activated protein kinase kinase 3	SNV	0/1	0.29	144_58	203	99.0	0/1	0.28	148_57	206	99.0			rs1657695,COSV57570678	EXONIC	YES	NM_145109.3	Transcript	protein_coding	synonymous_variant		9/12	NM_145109.3:c.747C>T	NP_659731.1:p.Ser249%3D		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00124896	190.0	152126.0	0.0	45	1.0	PASS	afr	0.00166578	69.0	0.00150084	102.0	0.49987	115671.0	231402.0	0.0	100	1.0	InbreedingCoeff_RF	afr	0.5	7442.0	0.499924	52408.0	0.0352917	5488	0.183	596.0	0.2909	3318.0		5.864	0.201594		0	0	0			MAP2K3	0.0	0.0	0.0	0.0	27.0	-50.0	39.0	27.0						0.736	0.0	87.157101722			cellular phenotype; immune system phenotype; hematopoietic system phenotype; mortality/aging ; 			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;whole blood;fetal liver;skeletal muscle;bone marrow;	MAPK signaling pathway;Toll-like receptor signaling pathway;Fc epsilon RI signaling pathway;GnRH signaling pathway	activation of MAPK activity;inflammatory response;signal transduction;peptidyl-tyrosine phosphorylation;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;cellular response to vascular endothelial growth factor stimulus;p38MAPK cascade;regulation of cytokine biosynthetic process;positive regulation of blood vessel endothelial cell migration;positive regulation of protein kinase activity;positive regulation of transcription, DNA-templated;cardiac muscle contraction	nucleoplasm;cytoplasm;cytosol;membrane	protein serine/threonine kinase activity;MAP kinase kinase activity;protein tyrosine kinase activity;protein binding;ATP binding;protein kinase binding	LRRK2[20067578;20173330];TINF2[21044950];DYRK1B[11980910];FOXL1[25609649];HSCB[28380382];MAPK14[17255949;23602568];MAD2L2[29656893];FOXS1[25609649];SNW1[20467437];TAOK2[25241761];RPL13[21900206];ALDOC[21988832];PKN1[12761180];MAP3K4[25241761];FOXA3[25609649];MYH6[26496610];MAP3K5[21771788;19805025];MAP2K6[25241761];	21208413
33660	chr17	21215446	C	T	chr17:21215446	MAP2K3	mitogen-activated protein kinase kinase 3	SNV	0/1	0.43	65_50	115	99.0	0/1	0.44	63_49	112	99.0			rs62055363	SPLICING	YES	NM_145109.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	9/11		NM_145109.3:c.775-8C>T			1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		1.31413e-05	2.0	152192.0	0.0	32	0.97	PASS	afr	2.41173e-05	1.0	0.0	0.0	0.499523	118239.0	236704.0	5.0	30	0.67	InbreedingCoeff	nfe	0.49964	54178.0	0.49964	54178.0	0.0323979	5038	0.128	372.0	0.46914	4469.0		0.725	-0.198554		0	0	0			MAP2K3	0.0	0.0	0.0	0.0	-43.0	8.0	8.0	26.0	2.25802545323353e-05	0.002	9.963	-0.406	9.557	0.736	0.0				cellular phenotype; immune system phenotype; hematopoietic system phenotype; mortality/aging ; 			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;whole blood;fetal liver;skeletal muscle;bone marrow;	MAPK signaling pathway;Toll-like receptor signaling pathway;Fc epsilon RI signaling pathway;GnRH signaling pathway	activation of MAPK activity;inflammatory response;signal transduction;peptidyl-tyrosine phosphorylation;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;cellular response to vascular endothelial growth factor stimulus;p38MAPK cascade;regulation of cytokine biosynthetic process;positive regulation of blood vessel endothelial cell migration;positive regulation of protein kinase activity;positive regulation of transcription, DNA-templated;cardiac muscle contraction	nucleoplasm;cytoplasm;cytosol;membrane	protein serine/threonine kinase activity;MAP kinase kinase activity;protein tyrosine kinase activity;protein binding;ATP binding;protein kinase binding	LRRK2[20067578;20173330];TINF2[21044950];DYRK1B[11980910];FOXL1[25609649];HSCB[28380382];MAPK14[17255949;23602568];MAD2L2[29656893];FOXS1[25609649];SNW1[20467437];TAOK2[25241761];RPL13[21900206];ALDOC[21988832];PKN1[12761180];MAP3K4[25241761];FOXA3[25609649];MYH6[26496610];MAP3K5[21771788;19805025];MAP2K6[25241761];	21215446
33668	chr17	21215537	C	A	chr17:21215537	MAP2K3	mitogen-activated protein kinase kinase 3	SNV	0/1	0.46	88_76	164	99.0	0/1	0.5	98_100	199	99.0			rs55736474,COSV57570716	EXONIC	YES	NM_145109.3	Transcript	protein_coding	synonymous_variant		10/12	NM_145109.3:c.858C>A	NP_659731.1:p.Ser286%3D		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00179383	273.0	152188.0	3.0	32	0.97	PASS	afr	0.00632026	262.0	2.93988e-05	2.0	0.499891	123690.0	247434.0	3.0	41	0.91	InbreedingCoeff	afr	0.499937	7979.0	0.499866	55936.0	0.0219737	3417	0.213	669.0	0.47103	4487.0		9.665	0.528205		0	0	0			MAP2K3	0.0	0.0	0.0	0.0	-29.0	7.0	32.0	-18.0						0.736	0.0	34.893533698			cellular phenotype; immune system phenotype; hematopoietic system phenotype; mortality/aging ; 			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;whole blood;fetal liver;skeletal muscle;bone marrow;	MAPK signaling pathway;Toll-like receptor signaling pathway;Fc epsilon RI signaling pathway;GnRH signaling pathway	activation of MAPK activity;inflammatory response;signal transduction;peptidyl-tyrosine phosphorylation;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;cellular response to vascular endothelial growth factor stimulus;p38MAPK cascade;regulation of cytokine biosynthetic process;positive regulation of blood vessel endothelial cell migration;positive regulation of protein kinase activity;positive regulation of transcription, DNA-templated;cardiac muscle contraction	nucleoplasm;cytoplasm;cytosol;membrane	protein serine/threonine kinase activity;MAP kinase kinase activity;protein tyrosine kinase activity;protein binding;ATP binding;protein kinase binding	LRRK2[20067578;20173330];TINF2[21044950];DYRK1B[11980910];FOXL1[25609649];HSCB[28380382];MAPK14[17255949;23602568];MAD2L2[29656893];FOXS1[25609649];SNW1[20467437];TAOK2[25241761];RPL13[21900206];ALDOC[21988832];PKN1[12761180];MAP3K4[25241761];FOXA3[25609649];MYH6[26496610];MAP3K5[21771788;19805025];MAP2K6[25241761];	21215537
33670	chr17	21215552	C	T	chr17:21215552	MAP2K3	mitogen-activated protein kinase kinase 3	SNV	0|1	0.46	83_70	153	99.0	0|1	0.51	92_96	189	99.0			rs56369732,COSV57569597	EXONIC	YES	NM_145109.3	Transcript	protein_coding	synonymous_variant		10/12	NM_145109.3:c.873C>T	NP_659731.1:p.Ala291%3D		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		3.28563e-05	5.0	152178.0	0.0	32	0.97	PASS	sas	0.000206954	1.0	4.40982e-05	3.0	0.499935	123601.0	247234.0	0.0	41	0.89	InbreedingCoeff	eas	0.499944	8971.0	0.499937	55907.0	0.0219930	3420	0.214	672.0	0.47502	4525.0		6.502	0.246293		0	0	0			MAP2K3	0.0	0.0	0.0	0.0	19.0	-44.0	38.0	41.0						0.736	0.0	60.327738465			cellular phenotype; immune system phenotype; hematopoietic system phenotype; mortality/aging ; 			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;whole blood;fetal liver;skeletal muscle;bone marrow;	MAPK signaling pathway;Toll-like receptor signaling pathway;Fc epsilon RI signaling pathway;GnRH signaling pathway	activation of MAPK activity;inflammatory response;signal transduction;peptidyl-tyrosine phosphorylation;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;cellular response to vascular endothelial growth factor stimulus;p38MAPK cascade;regulation of cytokine biosynthetic process;positive regulation of blood vessel endothelial cell migration;positive regulation of protein kinase activity;positive regulation of transcription, DNA-templated;cardiac muscle contraction	nucleoplasm;cytoplasm;cytosol;membrane	protein serine/threonine kinase activity;MAP kinase kinase activity;protein tyrosine kinase activity;protein binding;ATP binding;protein kinase binding	LRRK2[20067578;20173330];TINF2[21044950];DYRK1B[11980910];FOXL1[25609649];HSCB[28380382];MAPK14[17255949;23602568];MAD2L2[29656893];FOXS1[25609649];SNW1[20467437];TAOK2[25241761];RPL13[21900206];ALDOC[21988832];PKN1[12761180];MAP3K4[25241761];FOXA3[25609649];MYH6[26496610];MAP3K5[21771788;19805025];MAP2K6[25241761];	21215552
33674	chr17	21215557	G	A	chr17:21215557	MAP2K3	mitogen-activated protein kinase kinase 3	SNV	0|1	0.46	79_67	146	99.0	0|1	0.51	92_98	191	99.0			rs35206134,COSV57561435	EXONIC	YES	NM_145109.3	Transcript	protein_coding	missense_variant		10/12	NM_145109.3:c.878G>A	NP_659731.1:p.Arg293His		1.0	Protein kinase domain&Protein kinase domain&Protein kinase domain,.,.,.,.	Benign	criteria_provided,_single_submitter	not_provided		.	.	.		4.59945e-05	7.0	152192.0	0.0	32	0.97	PASS	amr	0.00013089	2.0	5.87924e-05	4.0	0.499903	123584.0	247216.0	0.0	40	0.89	InbreedingCoeff	sas	0.499934	15043.0	0.499884	55920.0	0.0220123	3423	0.213	671.0	0.4747	4522.0		18.92	1.895575	0.047	2	18	20	PolyPhen,Polyphen2_HDIV_pred	SIFT,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MAP2K3	0.0	0.0	0.0	0.0	-25.0	-49.0	33.0	12.0						0.736	0.0	95.750275165	0.749	-0.595	cellular phenotype; immune system phenotype; hematopoietic system phenotype; mortality/aging ; 			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;whole blood;fetal liver;skeletal muscle;bone marrow;	MAPK signaling pathway;Toll-like receptor signaling pathway;Fc epsilon RI signaling pathway;GnRH signaling pathway	activation of MAPK activity;inflammatory response;signal transduction;peptidyl-tyrosine phosphorylation;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;cellular response to vascular endothelial growth factor stimulus;p38MAPK cascade;regulation of cytokine biosynthetic process;positive regulation of blood vessel endothelial cell migration;positive regulation of protein kinase activity;positive regulation of transcription, DNA-templated;cardiac muscle contraction	nucleoplasm;cytoplasm;cytosol;membrane	protein serine/threonine kinase activity;MAP kinase kinase activity;protein tyrosine kinase activity;protein binding;ATP binding;protein kinase binding	LRRK2[20067578;20173330];TINF2[21044950];DYRK1B[11980910];FOXL1[25609649];HSCB[28380382];MAPK14[17255949;23602568];MAD2L2[29656893];FOXS1[25609649];SNW1[20467437];TAOK2[25241761];RPL13[21900206];ALDOC[21988832];PKN1[12761180];MAP3K4[25241761];FOXA3[25609649];MYH6[26496610];MAP3K5[21771788;19805025];MAP2K6[25241761];	21215557
33721	chr17	21216846	G	C	chr17:21216846	MAP2K3	mitogen-activated protein kinase kinase 3	SNV	0/1	0.47	58_53	113	99.0	0/1	0.44	79_61	140	99.0			rs1657688,COSV57561194	EXONIC	YES	NM_145109.3	Transcript	protein_coding	synonymous_variant		11/12	NM_145109.3:c.957G>C	NP_659731.1:p.Leu319%3D		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.000964538	141.0	146184.0	0.0	32	0.93	AS_VQSR	sas	0.00325885	14.0	0.00128755	84.0	0.499899	123861.0	247772.0	1.0	90	0.99	InbreedingCoeff	amr	0.499971	17180.0	0.499938	56067.0	0.0364235	5664	0.125	380.0	0.47265	5391.0		12.25	0.837926		0	0	0			MAP2K3	0.0	0.0	0.0	0.0	-32.0	-42.0	-5.0	7.0						0.736	0.0	54.938639654			cellular phenotype; immune system phenotype; hematopoietic system phenotype; mortality/aging ; 			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;whole blood;fetal liver;skeletal muscle;bone marrow;	MAPK signaling pathway;Toll-like receptor signaling pathway;Fc epsilon RI signaling pathway;GnRH signaling pathway	activation of MAPK activity;inflammatory response;signal transduction;peptidyl-tyrosine phosphorylation;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;cellular response to vascular endothelial growth factor stimulus;p38MAPK cascade;regulation of cytokine biosynthetic process;positive regulation of blood vessel endothelial cell migration;positive regulation of protein kinase activity;positive regulation of transcription, DNA-templated;cardiac muscle contraction	nucleoplasm;cytoplasm;cytosol;membrane	protein serine/threonine kinase activity;MAP kinase kinase activity;protein tyrosine kinase activity;protein binding;ATP binding;protein kinase binding	LRRK2[20067578;20173330];TINF2[21044950];DYRK1B[11980910];FOXL1[25609649];HSCB[28380382];MAPK14[17255949;23602568];MAD2L2[29656893];FOXS1[25609649];SNW1[20467437];TAOK2[25241761];RPL13[21900206];ALDOC[21988832];PKN1[12761180];MAP3K4[25241761];FOXA3[25609649];MYH6[26496610];MAP3K5[21771788;19805025];MAP2K6[25241761];	21216846
33765	chr17	21217513	G	A	chr17:21217513	MAP2K3	mitogen-activated protein kinase kinase 3	SNV	0/1	0.42	121_88	210	99.0	0/1	0.43	109_83	193	99.0			rs2363198,COSV57561451	EXONIC	YES	NM_145109.3	Transcript	protein_coding	missense_variant		12/12	NM_145109.3:c.1015G>A	NP_659731.1:p.Val339Met		1.0	.,.,.,.	Benign	criteria_provided,_single_submitter	not_provided		.	.	.		2.62923e-05	4.0	152136.0	0.0	32	0.97	PASS	nfe	5.88149e-05	4.0	5.88149e-05	4.0	0.499996	125623.0	251248.0	0.0	100	1.0	InbreedingCoeff	nfe	0.5	56842.0	0.5	56842.0	0.0357869	5565	0.182	542.0	0.47054	5367.0		23.7	3.066878	0.404	9	11	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	MAP2K3	0.0	0.0	0.0	0.0	-21.0	-18.0	14.0	-1.0						0.736	0.0	0.096954234	0.997	0.161	cellular phenotype; immune system phenotype; hematopoietic system phenotype; mortality/aging ; 			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;whole blood;fetal liver;skeletal muscle;bone marrow;	MAPK signaling pathway;Toll-like receptor signaling pathway;Fc epsilon RI signaling pathway;GnRH signaling pathway	activation of MAPK activity;inflammatory response;signal transduction;peptidyl-tyrosine phosphorylation;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;cellular response to vascular endothelial growth factor stimulus;p38MAPK cascade;regulation of cytokine biosynthetic process;positive regulation of blood vessel endothelial cell migration;positive regulation of protein kinase activity;positive regulation of transcription, DNA-templated;cardiac muscle contraction	nucleoplasm;cytoplasm;cytosol;membrane	protein serine/threonine kinase activity;MAP kinase kinase activity;protein tyrosine kinase activity;protein binding;ATP binding;protein kinase binding	LRRK2[20067578;20173330];TINF2[21044950];DYRK1B[11980910];FOXL1[25609649];HSCB[28380382];MAPK14[17255949;23602568];MAD2L2[29656893];FOXS1[25609649];SNW1[20467437];TAOK2[25241761];RPL13[21900206];ALDOC[21988832];PKN1[12761180];MAP3K4[25241761];FOXA3[25609649];MYH6[26496610];MAP3K5[21771788;19805025];MAP2K6[25241761];	21217513
33829	chr17	21318595	G	C	chr17:21318595	KCNJ12	potassium voltage-gated channel subfamily J member 12	SNV	0/1	0.44	60_48	109	99.0	0/1	0.4	55_37	92	99.0			rs58780973,COSV59168601	SPLICING	YES	NM_021012.5	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	2/2		NM_021012.5:c.-56-4G>C			1.0						.	.	.						64	1.0											0	0.0							0.1701039	4487	0.069	179.0	0.49181	4685.0		6.709	0.261468		0	0	0			KCNJ12	0.0	0.01	0.0	0.0	7.0	4.0	7.0	-1.0	6.79726635997955e-05	0.214	10.444	-0.253	10.191	0.0599	0.0				.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];	21318595
33833	chr17	21318698	C	T	chr17:21318698	KCNJ12	potassium voltage-gated channel subfamily J member 12	SNV	0/1	0.36	253_143	397	99.0	0/1	0.33	222_111	333	99.0			rs1657738,COSV59162518	EXONIC	YES	NM_021012.5	Transcript	protein_coding	missense_variant		3/3	NM_021012.5:c.44C>T	NP_066292.2:p.Ser15Leu		1.0	Potassium channel, inwardly rectifying, Kir, N-terminal,Potassium channel, inwardly rectifying, Kir, N-terminal					.	.	.		6.56659e-05	10.0	152286.0	0.0	68	1.0	PASS	sas	0.000206697	1.0	7.34711e-05	5.0	0.499594	121776.0	243750.0	1.0	100	1.0	InbreedingCoeff	amr	0.499853	17018.0	0.499719	55097.0	0.0317162	4932	0.153	444.0	0.49507	4716.0		23.1	2.799047	0.206	5	14	19	SIFT,LRT_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	KCNJ12	0.0	0.0	0.0	0.0	5.0	-11.0	-6.0	22.0						0.0599	0.0	74.840780568	0.359	1.021	.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];	21318698
33834	chr17	21318770	G	A	chr17:21318770	KCNJ12	potassium voltage-gated channel subfamily J member 12	SNV	0|1	0.33	314_153	467	99.0	0|1	0.38	254_158	412	99.0			rs3752033,COSV59162676	EXONIC	YES	NM_021012.5	Transcript	protein_coding	missense_variant		3/3	NM_021012.5:c.116G>A	NP_066292.2:p.Arg39Gln		1.0	Potassium channel, inwardly rectifying, Kir, N-terminal,Potassium channel, inwardly rectifying, Kir, N-terminal					.	.	.		0.000132317	20.0	151152.0	0.0	50	0.98	PASS,PASS	afr,eas	0.00033859	14.0	2.96402e-05	2.0	0.293368	48452.0	165158.0	0.0	100	1.0	InbreedingCoeff	eas	0.478866	6911.0	0.26834	19555.0	0.0247582	3850	0.108	321.0	0.34086	3247.0		23.8	3.112377	0.338	4	14	18	MutationAssessor_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	KCNJ12	0.0	0.0	0.0	0.0	2.0	7.0	6.0	-11.0						0.0599	0.0	6.586176324	0.972	1.17	.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];	21318770
33835	chr17	21318773	G	A	chr17:21318773	KCNJ12	potassium voltage-gated channel subfamily J member 12	SNV	0|1	0.33	310_151	461	99.0	0|1	0.38	259_156	415	99.0			rs3752034,COSV59162687	EXONIC	YES	NM_021012.5	Transcript	protein_coding	missense_variant		3/3	NM_021012.5:c.119G>A	NP_066292.2:p.Arg40His		1.0	Potassium channel, inwardly rectifying, Kir, N-terminal,Potassium channel, inwardly rectifying, Kir, N-terminal					.	.	.		7.9385e-05	12.0	151162.0	0.0	50	0.97	PASS,PASS	sas,eas	0.000209996	1.0	2.96454e-05	2.0	0.293869	48968.0	166632.0	0.0	100	1.0	InbreedingCoeff_RF	eas	0.483084	7111.0	0.268857	19783.0	0.0257485	4004	0.094	280.0	0.33918	3231.0		23.3	2.883065	0.269	4	14	18	MutationAssessor_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	KCNJ12	0.0	0.0	0.0	0.0	4.0	-13.0	3.0	-19.0						0.0599	0.0	40.547457460	0.976	1.17	.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];	21318773
33837	chr17	21318897	G	C	chr17:21318897	KCNJ12	potassium voltage-gated channel subfamily J member 12	SNV	0/1	0.43	211_160	373	99.0	0/1	0.37	242_145	387	99.0			rs1657739,COSV59166881	EXONIC	YES	NM_021012.5	Transcript	protein_coding	synonymous_variant		3/3	NM_021012.5:c.243G>C	NP_066292.2:p.Arg81%3D		1.0						.	.	.		5.25472e-05	8.0	152244.0	0.0	68	1.0	PASS	eas	0.000384172	2.0	2.93902e-05	2.0	0.49992	124803.0	249646.0	0.0	100	1.0	InbreedingCoeff_RF	afr	0.5	8052.0	0.499947	56460.0	0.0286424	4454	0.137	402.0	0.49916	4755.0		11.19	0.704788		0	0	0			KCNJ12	0.0	0.0	0.0	0.0	4.0	-1.0	3.0	-1.0						0.0599	0.0	6.586176324			.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];	21318897
33845	chr17	21319007	G	A	chr17:21319007	KCNJ12	potassium voltage-gated channel subfamily J member 12	SNV	0/1	0.4	223_151	376	99.0	0/1	0.33	260_128	389	99.0			rs1657740,COSV59162539	EXONIC	YES	NM_021012.5	Transcript	protein_coding	missense_variant		3/3	NM_021012.5:c.353G>A	NP_066292.2:p.Arg118Gln		1.0	.,.					.	.	.		3.94021e-05	6.0	152276.0	0.0	54	1.0	PASS	amr	6.53851e-05	1.0	5.87769e-05	4.0	0.499828	124644.0	249374.0	0.0	100	1.0	InbreedingCoeff	sas	0.499967	15237.0	0.499858	56434.0	0.0302436	4703	0.158	460.0	0.49927	4756.0		11.93	0.796593	0.088	1	17	18	FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	KCNJ12	0.0	0.0	0.0	0.0	2.0	26.0	2.0	-25.0						0.0599	0.0	0.235039220	0.73	1.169	.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];	21319007
33851	chr17	21319121	C	T	chr17:21319121	KCNJ12	potassium voltage-gated channel subfamily J member 12	SNV	0/1	0.38	262_162	425	99.0	0/1	0.4	223_149	373	99.0			rs1714864,COSV59162867	EXONIC	YES	NM_021012.5	Transcript	protein_coding	missense_variant		3/3	NM_021012.5:c.467C>T	NP_066292.2:p.Pro156Leu		1.0	.,.					.	.	.		0.0	0.0	152296.0	0.0	57	1.0	AC0				0.0	0.0	0.499868	124541.0	249148.0	0.0	100	1.0	InbreedingCoeff	eas	0.5	9177.0	0.499965	56577.0	0.0290153	4512	0.185	563.0	0.49937	4757.0		28.8	4.119805	0.632	14	6	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,MetaRNN_pred,DEOGEN2_pred,ClinPred_pred,LIST-S2_pred	KCNJ12	0.0	0.0	0.0	0.0	-43.0	-4.0	-17.0	1.0						0.0599	0.0	26.103281974	0.951	1.021	.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];	21319121
33854	chr17	21319230	G	C	chr17:21319230	KCNJ12	potassium voltage-gated channel subfamily J member 12	SNV	0/1	0.36	334_187	521	99.0	0/1	0.45	204_165	369	99.0			rs1657742,COSV59162549	EXONIC	YES	NM_021012.5	Transcript	protein_coding	missense_variant		3/3	NM_021012.5:c.576G>C	NP_066292.2:p.Gln192His		1.0	.,.					.	.	.		1.9734e-05	3.0	152022.0	0.0	44	0.99	PASS,InbreedingCoeff	amr,amr	6.54536e-05	1.0	1.46968e-05	1.0	0.499264	120747.0	241850.0	0.0	100	1.0	InbreedingCoeff	eas	0.49989	9127.0	0.499163	54253.0	0.0268160	4170	0.115	324.0	0.49822	4746.0		23.1	2.802329	0.262	11	7	18	SIFT,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,LRT_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,ClinPred_pred,LIST-S2_pred	KCNJ12	0.0	0.0	0.0	0.0	15.0	-26.0	-24.0	43.0						0.0599	0.0	93.824270006	1.0	1.17	.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];	21319230
33863	chr17	21319302	T	C	chr17:21319302	KCNJ12	potassium voltage-gated channel subfamily J member 12	SNV	0/1	0.62	191_309	500	99.0	0/1	0.7	109_258	367	99.0			rs1657743,COSV59168745	EXONIC	YES	NM_021012.5	Transcript	protein_coding	synonymous_variant		3/3	NM_021012.5:c.648T>C	NP_066292.2:p.Gly216%3D		1.0						.	.	.		0.000193372	26.0	134456.0	0.0	37	0.96	AS_VQSR	eas	0.00167304	7.0	9.93049e-05	6.0	0.500004	125645.0	251288.0	1.0	100	1.0	InbreedingCoeff	nfe	0.500009	56813.0	0.500009	56813.0	0.0300185	4668	0.146	432.0	0.5	4763.0		11.92	0.795386		0	0	0			KCNJ12	0.0	0.0	0.0	0.0	46.0	-1.0	33.0	-6.0						0.0599	0.0	11.487689946			.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];	21319302
33866	chr17	21319311	C	T	chr17:21319311	KCNJ12	potassium voltage-gated channel subfamily J member 12	SNV	0/1	0.31	351_155	506	99.0	0/1	0.3	263_115	378	99.0			rs72846668,COSV59163274	EXONIC	YES	NM_021012.5	Transcript	protein_coding	synonymous_variant		3/3	NM_021012.5:c.657C>T	NP_066292.2:p.Arg219%3D		1.0						.	.	.		0.000638308	78.0	122198.0	0.0	43	0.95	AS_VQSR,InbreedingCoeff	eas,nfe	0.00391032	15.0	0.000506476	28.0	0.483777	54900.0	113482.0	0.0	100	1.0	InbreedingCoeff	sas	0.48746	6103.0	0.483951	26415.0	0.0077104	1199	0.123	355.0	0.34075	3246.0		11.58	0.753438		0	0	0			KCNJ12	0.0	0.0	0.0	0.0	-10.0	37.0	-2.0	-38.0						0.0599	0.0	29.139785081			.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];	21319311
33872	chr17	21319399	A	G	chr17:21319399	KCNJ12	potassium voltage-gated channel subfamily J member 12	SNV	0/1	0.32	306_147	454	99.0	0/1	0.34	248_126	374	99.0			rs4985866,COSV59162501	EXONIC	YES	NM_021012.5	Transcript	protein_coding	missense_variant		3/3	NM_021012.5:c.745A>G	NP_066292.2:p.Ile249Val		1.0	.,.					.	.	.		3.94032e-05	6.0	152272.0	0.0	44	0.98	PASS,InbreedingCoeff	eas,eas	0.000192308	1.0	7.34732e-05	5.0	0.321072	56187.0	174998.0	0.0	100	1.0	InbreedingCoeff_RF	eas	0.484698	7697.0	0.279553	21473.0	0.0137296	2135	0.063	192.0	0.34117	3250.0		17.61	1.718702	0.115	5	13	18	LRT_pred,FATHMM_pred,PrimateAI_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	KCNJ12	0.0	0.0	0.0	0.0	0.0	27.0	-1.0	11.0						0.0599	0.0	62.390150711	0.998	1.311	.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];	21319399
33889	chr17	21319473	G	A	chr17:21319473	KCNJ12	potassium voltage-gated channel subfamily J member 12	SNV	0/1	0.4	242_165	408	99.0	0/1	0.39	225_146	371	99.0			rs1657744,COSV59168799	EXONIC	YES	NM_021012.5	Transcript	protein_coding	synonymous_variant		3/3	NM_021012.5:c.819G>A	NP_066292.2:p.Glu273%3D		1.0						.	.	.		1.31351e-05	2.0	152264.0	0.0	60	1.0	PASS	afr	4.82556e-05	2.0	0.0	0.0	0.499868	125299.0	250664.0	0.0	100	1.0	InbreedingCoeff	sas	0.499967	15298.0	0.499965	56805.0	0.0336519	5233	0.167	527.0	0.49979	4761.0		12.29	0.843956		0	0	0			KCNJ12	0.0	0.0	0.0	0.0	15.0	1.0	-27.0	1.0						0.0599	0.0				.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];	21319473
33908	chr17	21319767	C	T	chr17:21319767	KCNJ12	potassium voltage-gated channel subfamily J member 12	SNV	0/1	0.36	169_158	433	99.0	0/1	0.4	120_134	335	99.0			rs1612176,COSV59162626,COSV59163167	EXONIC	YES	NM_021012.5	Transcript	protein_coding	synonymous_variant		3/3	NM_021012.5:c.1113C>T	NP_066292.2:p.Ser371%3D		1.0						.	.	.		1.31313e-05	2.0	152308.0	0.0	68	1.0	PASS	sas	0.000206697	1.0	0.0	0.0	0.471801	116179.0	246246.0	0.0	100	1.0	InbreedingCoeff	amr	0.486025	16624.0	0.475152	53256.0	0.2347464	36504	0.075	225.0	0.479	4563.0		7.46	0.319315		0	0	0			KCNJ12	0.0	0.0	0.0	0.0	22.0	-39.0	-27.0	-39.0						0.0599	0.0				.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];	21319767
33909	chr17	21319785	C	T	chr17:21319785	KCNJ12	potassium voltage-gated channel subfamily J member 12	SNV	0/1	0.34	258_131	389	99.0	0/1	0.38	207_130	338	99.0			rs1657745,COSV59168851	EXONIC	YES	NM_021012.5	Transcript	protein_coding	synonymous_variant		3/3	NM_021012.5:c.1131C>T	NP_066292.2:p.Tyr377%3D		1.0						.	.	.		0.000111631	17.0	152288.0	0.0	73	1.0	PASS	afr	0.000265278	11.0	4.40813e-05	3.0	0.499992	125441.0	250886.0	0.0	100	1.0	InbreedingCoeff	nfe	0.5	56746.0	0.5	56746.0	0.0336454	5232	0.146	438.0	0.49685	4733.0		3.68	0.065319		0	0	0			KCNJ12	0.0	0.0	0.0	0.0	24.0	4.0	-45.0	8.0						0.0599	0.0				.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];	21319785
33915	chr17	21319943	A	G	chr17:21319943	KCNJ12	potassium voltage-gated channel subfamily J member 12	SNV	0/1	0.35	140_76	216	99.0	0/1	0.33	143_70	214	99.0			rs5021699,COSV59162965	EXONIC	YES	NM_021012.5	Transcript	protein_coding	missense_variant		3/3	NM_021012.5:c.1289A>G	NP_066292.2:p.Glu430Gly		1.0	.,.					.	.	.		1.31309e-05	2.0	152312.0	0.0	66	1.0	PASS	nfe	2.93867e-05	2.0	2.93867e-05	2.0	0.498178	116764.0	234382.0	1.0	37	0.92	InbreedingCoeff	amr	0.49931	16638.0	0.49808	52152.0	0.0301986	4696	0.09	233.0	0.48887	4657.0		27.1	3.928835	0.314	12	8	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LRT_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,ClinPred_pred,LIST-S2_pred	KCNJ12	0.0	0.0	0.0	0.0	0.0	-47.0	0.0	-4.0						0.0599	0.0		0.99	1.201	.			occipital lobe;skeletal muscle;cerebellum peduncles;cerebellum;	.	potassium ion transport;muscle contraction;regulation of heart contraction;regulation of ion transmembrane transport;protein homotetramerization;potassium ion import across plasma membrane	plasma membrane;integral component of membrane;intrinsic component of membrane	inward rectifier potassium channel activity;protein binding;G-protein activated inward rectifier potassium channel activity	DLG1[24550280];SCRIB[24550280;30126976];EMD[unassigned1304];	21319943
33956	chr17	26925625	C	T	chr17:26925625	SPAG5	sperm associated antigen 5	SNV	0/1	0.55	36_45	82	99.0	0/0	0.0	33_0	33	99.0			rs149715782	EXONIC	YES	NM_006461.4	Transcript	protein_coding	missense_variant		2/24	NM_006461.4:c.80G>A	NP_006452.3:p.Arg27His		-1.0	.,.					.	.	.		0.000269606	41.0	152074.0	0.0	32	0.96	PASS	amr	0.00170469	26.0	0.000132314	9.0	0.000386651	96.0	248286.0	0.0	39	0.85	PASS	amr	0.00190012	64.0	0.00017767	20.0	0.0004051	63	0.007	21.0				23.7	3.042709	0.096	4	16	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,LIST-S2_pred	Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SPAG5	0.01	0.0	0.0	0.0	-17.0	28.0	-4.0	1.0						0.246	0.0	0.000000000	0.931	1.023	normal phenotype; 			testis - seminiferous tubule;tumor;testis - interstitial;superior cervical ganglion;testis;	.	mitotic sister chromatid segregation;spindle organization;chromosome segregation;positive regulation of intracellular transport;cell division;regulation of attachment of spindle microtubules to kinetochore;protein localization to centrosome;regulation of metaphase plate congression;positive regulation of spindle assembly	kinetochore;condensed chromosome kinetochore;cytoplasm;midbody;centriolar satellite;microtubule plus-end;mitotic spindle;mitotic spindle pole	protein binding;microtubule binding	ZNF572[unassigned1304];GSK3B[29568061];TTC23[25416956];SH2D4A[25416956];FBXO28[25416956];ATN1[16713569];SLC9C1[27173435;unassigned1312];RPTOR[23953116];ZFYVE26[21516116];PCM1[26297806];CHCHD3[25416956];ZNF385C[21516116];CEP170[26638075];ZNF688[26871637];CCHCR1[25416956;unassigned1304];CDK5RAP2[26297806];OFD1[26638075];MED1[27173435;unassigned1312];ZGPAT[21516116];KRT3[unassigned1304];SPICE1[26638075];LGALS14[25416956;unassigned1304];RPGRIP1L[26638075];DYNLL1[26496610];PIMREG[26871637];KRT75[unassigned1304];IGFN1[unassigned1304];GEM[unassigned1304];HAUS1[25416956];CDC20B[25416956];ZC2HC1C[25416956];ADAM15[10531379];GOLGA8F[25416956];KATNAL2[26929214];DCX[25416956];EIF4E2[25416956];MAPRE1[26496610];NLGN3[25464930];SNAP47[25416956];POM121[unassigned1304];TSHZ3[25416956];CEBPD[20805509];DCTN1[26638075];AURKA[18361916];ORC6[25416956];TUBA3C[unassigned1312];ZMAT2[25416956];G3BP1[23953116];CEP72[26297806];C1orf109[25416956];CLASP1[20852589];ENKD1[21516116];POLR2L[25416956];BARD1[25416956];SMARCE1[25416956];PLK4[unassigned1304];LINGO1[25416956];SNAPIN[16169070];NEBL[unassigned1304];PLK1[27173435;unassigned1312];OGA[16169070];ZFC3H1[25416956];GOLGA8DP[25416956];NEURL4[27173435;unassigned1312];KANSL1[25416956];CENPH[unassigned1304];RBM41[25416956];AMOTL2[25416956];PKN1[unassigned1304];CEP44[26638075];	26925625
33991	chr17	27445462	G	A	chr17:27445462	MYO18A	myosin XVIIIA	SNV	0/1	0.34	42_22	64	99.0	0/0	0.0	34_0	34	99.0				SPLICING	YES	NM_001346765.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	9/42		NM_001346765.2:c.1866-4C>T			-1.0						.	.	.						32	0.99											37	0.83														15.21	1.30339		0	0	0			MYO18A	0.0	0.09	0.0	0.0	27.0	-9.0	-33.0	-40.0	0.0037280600122297	0.076	9.77	0.777	10.547	0.118	1.0				vision/eye phenotype; limbs/digits/tail phenotype; liver/biliary system phenotype; embryo phenotype; cardiovascular system phenotype ; growth/size/body region phenotype; mortality/aging ; integument phenotype ; 			.	.	DNA metabolic process;Golgi organization;cell migration;actomyosin structure organization;regulation of macrophage activation;negative regulation of apoptotic process;Golgi vesicle budding;positive regulation of protein secretion;Golgi ribbon formation;asymmetric Golgi ribbon formation;positive regulation of opsonization	Golgi membrane;endoplasmic reticulum-Golgi intermediate compartment;trans-Golgi network;cell surface;membrane;myosin complex;actomyosin	DNA binding;RNA binding;protein binding;ATP binding;ATPase activity;ADP binding;actin filament binding	TES[26496610];ARAF[20936779];ARPC5L[26496610];ACTB[26496610];ACTG1[26496610];PPP1CB[26496610];LACTB[30021884];MPRIP[26496610];BASP1[26496610];MYC[21150319];CFL2[26496610];CFL1[26496610];SYNPO[26496610];LZTS2[26496610];AP2M1[26496610];TMOD1[26496610];TPM4[26496610];LIMCH1[26496610];TPM3[26496610];TMOD3[26496610];TPM2[26496610];DAPK3[26496610];TPM1[26496610];AFAP1[26496610];LMO7[26496610];ACTN4[26496610];MYL6[26496610];KCTD10[26496610];SPECC1L[26496610];PHLDB2[26496610];RAI14[26496610];FLII[26496610];TWF1[26496610];FBXO46[26496610];IQGAP1[26496610];MYL12A[26496610];CORO1B[26496610];CORO1C[26496610];ARHGAP21[26496610];ATXN1[16713569];MYO6[26496610];MARK4[14676191];SPTBN1[26496610];SPTBN2[26496610];SMAD2[20195357];SPECC1[26496610];ITPRID2[26496610];VCAM1[22623428];SEC16A[26496610];PLK2[26496610];MICAL3[26496610];CYBRD1[26496610];DSTN[26496610];MYO5A[26496610];ARPC4[26496610];CGN[26496610];SSH2[26496610];CORO2A[26496610];ANLN[26496610];DAB2[26496610];ARPC3[26496610];MYO5B[26496610];MYO5C[26496610];CDK2[26496610];RNPS1[17353931];GRB2[20936779];CALM1[26496610];PICALM[26496610];ARHGAP11A[26496610];WDR1[26496610];ARPC1B[26496610];CLTC[26496610];HMGB2[26496610];CLTB[26496610];CLTA[26496610];MYL6B[26496610];AP2A1[26496610];TNFAIP1[26496610];STON2[26496610];PIK3C2A[26496610];CLINT1[26496610];SIPA1L3[26496610];PPP1R18[26496610];TRIOBP[26496610];CAPZB[26496610];MYO18A[18854160];EFHD2[26496610];LRRFIP2[26496610];SPTAN1[26496610];TPRN[26496610];PLEKHG3[26496610];ACTR3[26496610];ACTR2[26496610];PPP1R12A[26496610];DST[26496610];ANXA2[26496610];ARHGEF17[26496610];COBL[26496610];DDX51[26496610];RANGAP1[26496610];INF2[26496610];CTTN[26496610];BMP2K[26496610];MYH9[26496610];DSG2[26496610];PPP1R12B[26496610];DBN1[26496610];PLEC[26496610];DCTN2[26496610];LUZP1[26496610];NEXN[26496610];DLST[29128334];KIAA1211[26496610];AKAP2[26496610];LIMA1[26496610];ABLIM1[26496610];NOCT[26496610];FLNA[26496610];FLNB[26496610];FYN[26496610];MISP[26496610];SVIL[26496610];GSN[26496610];CSNK1A1[26496610];SORBS2[26496610];CDC42BPB[18854160;26496610];CDC42BPA[18854160];MYO19[26496610];PLEKHA7[28877994];PPP1CA[26496610];MYO1E[26496610];GOLPH3[19837035;24485452];MYO1B[26496610];MYO1C[26496610];ACTC1[26496610];ST5[26496610];CAPZA1[26496610];CAPZA2[26496610];CEP162[26496610];BCAR1[28007913];TJP2[26496610];	27445462
33992	chr17	27445462	G	A	chr17:27445462	MYO18A	myosin XVIIIA	SNV	0/1	0.34	42_22	64	99.0	0/0	0.0	34_0	34	99.0				SPLICING	YES	NM_001346765.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	9/42		NM_001346765.2:c.1866-4C>T			-1.0						.	.	.						32	0.99											37	0.83														15.21	1.30339		0	0	0			MYO18A	0.0	0.09	0.0	0.0	27.0	-9.0	-33.0	-40.0	0.0037280600122297	0.076	9.77	0.777	10.547	0.118	1.0				vision/eye phenotype; limbs/digits/tail phenotype; liver/biliary system phenotype; embryo phenotype; cardiovascular system phenotype ; growth/size/body region phenotype; mortality/aging ; integument phenotype ; 			.	.	DNA metabolic process;Golgi organization;cell migration;actomyosin structure organization;regulation of macrophage activation;negative regulation of apoptotic process;Golgi vesicle budding;positive regulation of protein secretion;Golgi ribbon formation;asymmetric Golgi ribbon formation;positive regulation of opsonization	Golgi membrane;endoplasmic reticulum-Golgi intermediate compartment;trans-Golgi network;cell surface;membrane;myosin complex;actomyosin	DNA binding;RNA binding;protein binding;ATP binding;ATPase activity;ADP binding;actin filament binding	TES[26496610];ARAF[20936779];ARPC5L[26496610];ACTB[26496610];ACTG1[26496610];PPP1CB[26496610];LACTB[30021884];MPRIP[26496610];BASP1[26496610];MYC[21150319];CFL2[26496610];CFL1[26496610];SYNPO[26496610];LZTS2[26496610];AP2M1[26496610];TMOD1[26496610];TPM4[26496610];LIMCH1[26496610];TPM3[26496610];TMOD3[26496610];TPM2[26496610];DAPK3[26496610];TPM1[26496610];AFAP1[26496610];LMO7[26496610];ACTN4[26496610];MYL6[26496610];KCTD10[26496610];SPECC1L[26496610];PHLDB2[26496610];RAI14[26496610];FLII[26496610];TWF1[26496610];FBXO46[26496610];IQGAP1[26496610];MYL12A[26496610];CORO1B[26496610];CORO1C[26496610];ARHGAP21[26496610];ATXN1[16713569];MYO6[26496610];MARK4[14676191];SPTBN1[26496610];SPTBN2[26496610];SMAD2[20195357];SPECC1[26496610];ITPRID2[26496610];VCAM1[22623428];SEC16A[26496610];PLK2[26496610];MICAL3[26496610];CYBRD1[26496610];DSTN[26496610];MYO5A[26496610];ARPC4[26496610];CGN[26496610];SSH2[26496610];CORO2A[26496610];ANLN[26496610];DAB2[26496610];ARPC3[26496610];MYO5B[26496610];MYO5C[26496610];CDK2[26496610];RNPS1[17353931];GRB2[20936779];CALM1[26496610];PICALM[26496610];ARHGAP11A[26496610];WDR1[26496610];ARPC1B[26496610];CLTC[26496610];HMGB2[26496610];CLTB[26496610];CLTA[26496610];MYL6B[26496610];AP2A1[26496610];TNFAIP1[26496610];STON2[26496610];PIK3C2A[26496610];CLINT1[26496610];SIPA1L3[26496610];PPP1R18[26496610];TRIOBP[26496610];CAPZB[26496610];MYO18A[18854160];EFHD2[26496610];LRRFIP2[26496610];SPTAN1[26496610];TPRN[26496610];PLEKHG3[26496610];ACTR3[26496610];ACTR2[26496610];PPP1R12A[26496610];DST[26496610];ANXA2[26496610];ARHGEF17[26496610];COBL[26496610];DDX51[26496610];RANGAP1[26496610];INF2[26496610];CTTN[26496610];BMP2K[26496610];MYH9[26496610];DSG2[26496610];PPP1R12B[26496610];DBN1[26496610];PLEC[26496610];DCTN2[26496610];LUZP1[26496610];NEXN[26496610];DLST[29128334];KIAA1211[26496610];AKAP2[26496610];LIMA1[26496610];ABLIM1[26496610];NOCT[26496610];FLNA[26496610];FLNB[26496610];FYN[26496610];MISP[26496610];SVIL[26496610];GSN[26496610];CSNK1A1[26496610];SORBS2[26496610];CDC42BPB[18854160;26496610];CDC42BPA[18854160];MYO19[26496610];PLEKHA7[28877994];PPP1CA[26496610];MYO1E[26496610];GOLPH3[19837035;24485452];MYO1B[26496610];MYO1C[26496610];ACTC1[26496610];ST5[26496610];CAPZA1[26496610];CAPZA2[26496610];CEP162[26496610];BCAR1[28007913];TJP2[26496610];	27445462
34011	chr17	27446394	G	A	chr17:27446394	MYO18A	myosin XVIIIA	SNV	0/1	0.55	41_51	93	99.0	0/0	0.0	34_0	34	99.0			rs114765291	EXONIC	YES	NM_001346765.2	Transcript	protein_coding	synonymous_variant		9/43	NM_001346765.2:c.1824C>T	NP_001333694.1:p.Asn608%3D		-1.0						.	.	.		0.000466632	71.0	152154.0	0.0	32	0.96	PASS	amr	0.00229208	35.0	0.000338096	23.0	0.000514249	127.0	246962.0	0.0	35	0.92	PASS	amr	0.00203856	70.0	0.000410282	46.0	0.0004437	69	0.007	21.0				9.814	0.544691		0	0	0			MYO18A	0.0	0.0	0.0	0.0	41.0	44.0	-50.0	-41.0						0.118	1.0	32.003957900			vision/eye phenotype; limbs/digits/tail phenotype; liver/biliary system phenotype; embryo phenotype; cardiovascular system phenotype ; growth/size/body region phenotype; mortality/aging ; integument phenotype ; 			.	.	DNA metabolic process;Golgi organization;cell migration;actomyosin structure organization;regulation of macrophage activation;negative regulation of apoptotic process;Golgi vesicle budding;positive regulation of protein secretion;Golgi ribbon formation;asymmetric Golgi ribbon formation;positive regulation of opsonization	Golgi membrane;endoplasmic reticulum-Golgi intermediate compartment;trans-Golgi network;cell surface;membrane;myosin complex;actomyosin	DNA binding;RNA binding;protein binding;ATP binding;ATPase activity;ADP binding;actin filament binding	TES[26496610];ARAF[20936779];ARPC5L[26496610];ACTB[26496610];ACTG1[26496610];PPP1CB[26496610];LACTB[30021884];MPRIP[26496610];BASP1[26496610];MYC[21150319];CFL2[26496610];CFL1[26496610];SYNPO[26496610];LZTS2[26496610];AP2M1[26496610];TMOD1[26496610];TPM4[26496610];LIMCH1[26496610];TPM3[26496610];TMOD3[26496610];TPM2[26496610];DAPK3[26496610];TPM1[26496610];AFAP1[26496610];LMO7[26496610];ACTN4[26496610];MYL6[26496610];KCTD10[26496610];SPECC1L[26496610];PHLDB2[26496610];RAI14[26496610];FLII[26496610];TWF1[26496610];FBXO46[26496610];IQGAP1[26496610];MYL12A[26496610];CORO1B[26496610];CORO1C[26496610];ARHGAP21[26496610];ATXN1[16713569];MYO6[26496610];MARK4[14676191];SPTBN1[26496610];SPTBN2[26496610];SMAD2[20195357];SPECC1[26496610];ITPRID2[26496610];VCAM1[22623428];SEC16A[26496610];PLK2[26496610];MICAL3[26496610];CYBRD1[26496610];DSTN[26496610];MYO5A[26496610];ARPC4[26496610];CGN[26496610];SSH2[26496610];CORO2A[26496610];ANLN[26496610];DAB2[26496610];ARPC3[26496610];MYO5B[26496610];MYO5C[26496610];CDK2[26496610];RNPS1[17353931];GRB2[20936779];CALM1[26496610];PICALM[26496610];ARHGAP11A[26496610];WDR1[26496610];ARPC1B[26496610];CLTC[26496610];HMGB2[26496610];CLTB[26496610];CLTA[26496610];MYL6B[26496610];AP2A1[26496610];TNFAIP1[26496610];STON2[26496610];PIK3C2A[26496610];CLINT1[26496610];SIPA1L3[26496610];PPP1R18[26496610];TRIOBP[26496610];CAPZB[26496610];MYO18A[18854160];EFHD2[26496610];LRRFIP2[26496610];SPTAN1[26496610];TPRN[26496610];PLEKHG3[26496610];ACTR3[26496610];ACTR2[26496610];PPP1R12A[26496610];DST[26496610];ANXA2[26496610];ARHGEF17[26496610];COBL[26496610];DDX51[26496610];RANGAP1[26496610];INF2[26496610];CTTN[26496610];BMP2K[26496610];MYH9[26496610];DSG2[26496610];PPP1R12B[26496610];DBN1[26496610];PLEC[26496610];DCTN2[26496610];LUZP1[26496610];NEXN[26496610];DLST[29128334];KIAA1211[26496610];AKAP2[26496610];LIMA1[26496610];ABLIM1[26496610];NOCT[26496610];FLNA[26496610];FLNB[26496610];FYN[26496610];MISP[26496610];SVIL[26496610];GSN[26496610];CSNK1A1[26496610];SORBS2[26496610];CDC42BPB[18854160;26496610];CDC42BPA[18854160];MYO19[26496610];PLEKHA7[28877994];PPP1CA[26496610];MYO1E[26496610];GOLPH3[19837035;24485452];MYO1B[26496610];MYO1C[26496610];ACTC1[26496610];ST5[26496610];CAPZA1[26496610];CAPZA2[26496610];CEP162[26496610];BCAR1[28007913];TJP2[26496610];	27446394
34012	chr17	27446394	G	A	chr17:27446394	MYO18A	myosin XVIIIA	SNV	0/1	0.55	41_51	93	99.0	0/0	0.0	34_0	34	99.0			rs114765291	EXONIC	YES	NM_001346765.2	Transcript	protein_coding	synonymous_variant		9/43	NM_001346765.2:c.1824C>T	NP_001333694.1:p.Asn608%3D		-1.0						.	.	.		0.000466632	71.0	152154.0	0.0	32	0.96	PASS	amr	0.00229208	35.0	0.000338096	23.0	0.000514249	127.0	246962.0	0.0	35	0.92	PASS	amr	0.00203856	70.0	0.000410282	46.0	0.0004437	69	0.007	21.0				9.814	0.544691		0	0	0			MYO18A	0.0	0.0	0.0	0.0	41.0	44.0	-50.0	-41.0						0.118	1.0	32.003957900			vision/eye phenotype; limbs/digits/tail phenotype; liver/biliary system phenotype; embryo phenotype; cardiovascular system phenotype ; growth/size/body region phenotype; mortality/aging ; integument phenotype ; 			.	.	DNA metabolic process;Golgi organization;cell migration;actomyosin structure organization;regulation of macrophage activation;negative regulation of apoptotic process;Golgi vesicle budding;positive regulation of protein secretion;Golgi ribbon formation;asymmetric Golgi ribbon formation;positive regulation of opsonization	Golgi membrane;endoplasmic reticulum-Golgi intermediate compartment;trans-Golgi network;cell surface;membrane;myosin complex;actomyosin	DNA binding;RNA binding;protein binding;ATP binding;ATPase activity;ADP binding;actin filament binding	TES[26496610];ARAF[20936779];ARPC5L[26496610];ACTB[26496610];ACTG1[26496610];PPP1CB[26496610];LACTB[30021884];MPRIP[26496610];BASP1[26496610];MYC[21150319];CFL2[26496610];CFL1[26496610];SYNPO[26496610];LZTS2[26496610];AP2M1[26496610];TMOD1[26496610];TPM4[26496610];LIMCH1[26496610];TPM3[26496610];TMOD3[26496610];TPM2[26496610];DAPK3[26496610];TPM1[26496610];AFAP1[26496610];LMO7[26496610];ACTN4[26496610];MYL6[26496610];KCTD10[26496610];SPECC1L[26496610];PHLDB2[26496610];RAI14[26496610];FLII[26496610];TWF1[26496610];FBXO46[26496610];IQGAP1[26496610];MYL12A[26496610];CORO1B[26496610];CORO1C[26496610];ARHGAP21[26496610];ATXN1[16713569];MYO6[26496610];MARK4[14676191];SPTBN1[26496610];SPTBN2[26496610];SMAD2[20195357];SPECC1[26496610];ITPRID2[26496610];VCAM1[22623428];SEC16A[26496610];PLK2[26496610];MICAL3[26496610];CYBRD1[26496610];DSTN[26496610];MYO5A[26496610];ARPC4[26496610];CGN[26496610];SSH2[26496610];CORO2A[26496610];ANLN[26496610];DAB2[26496610];ARPC3[26496610];MYO5B[26496610];MYO5C[26496610];CDK2[26496610];RNPS1[17353931];GRB2[20936779];CALM1[26496610];PICALM[26496610];ARHGAP11A[26496610];WDR1[26496610];ARPC1B[26496610];CLTC[26496610];HMGB2[26496610];CLTB[26496610];CLTA[26496610];MYL6B[26496610];AP2A1[26496610];TNFAIP1[26496610];STON2[26496610];PIK3C2A[26496610];CLINT1[26496610];SIPA1L3[26496610];PPP1R18[26496610];TRIOBP[26496610];CAPZB[26496610];MYO18A[18854160];EFHD2[26496610];LRRFIP2[26496610];SPTAN1[26496610];TPRN[26496610];PLEKHG3[26496610];ACTR3[26496610];ACTR2[26496610];PPP1R12A[26496610];DST[26496610];ANXA2[26496610];ARHGEF17[26496610];COBL[26496610];DDX51[26496610];RANGAP1[26496610];INF2[26496610];CTTN[26496610];BMP2K[26496610];MYH9[26496610];DSG2[26496610];PPP1R12B[26496610];DBN1[26496610];PLEC[26496610];DCTN2[26496610];LUZP1[26496610];NEXN[26496610];DLST[29128334];KIAA1211[26496610];AKAP2[26496610];LIMA1[26496610];ABLIM1[26496610];NOCT[26496610];FLNA[26496610];FLNB[26496610];FYN[26496610];MISP[26496610];SVIL[26496610];GSN[26496610];CSNK1A1[26496610];SORBS2[26496610];CDC42BPB[18854160;26496610];CDC42BPA[18854160];MYO19[26496610];PLEKHA7[28877994];PPP1CA[26496610];MYO1E[26496610];GOLPH3[19837035;24485452];MYO1B[26496610];MYO1C[26496610];ACTC1[26496610];ST5[26496610];CAPZA1[26496610];CAPZA2[26496610];CEP162[26496610];BCAR1[28007913];TJP2[26496610];	27446394
34166	chr17	33884567	A	G	chr17:33884567	SLFN14	schlafen family member 14	SNV	0/1	0.51	63_67	131	99.0	0/0	0.0	40_0	40	99.0			rs139678049,COSV99066554	EXONIC	YES	NM_001129820.2	Transcript	protein_coding	missense_variant		3/6	NM_001129820.2:c.515T>C	NP_001123292.1:p.Val172Ala		-1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	not_specified|not_provided	Bleeding disorder, platelet-type, 20, 616913 (3), Autosomal dominant	Autosomal dominant thrombocytopenia with platelet secretion defect	Disease-causing germline mutation(s) in	Autosomal dominant inheritance;Menorrhagia;Bruising susceptibility;Thrombocytopenia;Epistaxis		0.00360109	548.0	152176.0	6.0	32	0.97	PASS	sas	0.00683513	33.0	0.00460091	313.0	0.00428167	659.0	153912.0	2.0	41	0.58	PASS	sas	0.00737683	168.0	0.00509999	304.0	0.0014276	222	0.003	9.0				0.012	-0.76241	0.127	0	17	17		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SLFN14	0.0	0.0	0.0	0.0	-44.0	1.0	26.0	2.0								0.000000000	0.014	1.312	.			.	.	mRNA catabolic process;rRNA catabolic process;platelet maturation;cellular response to magnesium ion;cellular response to manganese ion;RNA phosphodiester bond hydrolysis, endonucleolytic	nucleus;cytoplasm	endoribonuclease activity;ATP binding;ribosome binding	S100A10[30021884];	33884567
34292	chr17	35988719	A		chr17:35988719	DDX52	DExD-box helicase 52	deletion	0/0	0.0	38_0	38	99.0	0/1	0.39	8_7	18	99.0			rs748612808	SPLICING	YES	NM_007010.5	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	5/14		NM_007010.5:c.748-3del			-1.0						.	.	.		0.000842337	121.0	143648.0	0.0	31	0.93	PASS	nfe	0.000735903	48.0	0.000735903	48.0	0.244745	20866.0	85256.0	0.0	34	0.71	InbreedingCoeff_RF	sas	0.320222	2768.0	0.228721	9593.0	0.0001222	19						13.06	0.946486		0	0	0			DDX52	0.0	0.0	0.0	0.0	-10.0	1.0	-10.0	-12.0						0.96	0.0				growth/size/body region phenotype; immune system phenotype; skeleton phenotype; hematopoietic system phenotype; 			pons;ciliary ganglion;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;parietal lobe;skeletal muscle;globus pallidus;	Starch and sucrose metabolism;Folate biosynthesis	rRNA processing	nucleoplasm;nucleolus;membrane	RNA binding;helicase activity;ATP binding	PPP1R15A[29109149];MED19[15175163];FOXM1[25609649];AP4M1[21988832];GOLGA2[29568061];FBL[29568061];HIST1H3A[29568061];HLCS[21988832];MYC[17314511];HMGN2[30021884];JUN[25609649];RPS6[29568061];MED9[15175163];FOXL2[25609649];EDF1[30021884];FOXL1[25609649];RRP1B[20926688];MED29[15175163];HIST2H2BE[30021884];MTNR1A[26514267];CDK7[29568061];H1F0[30021884];PMP22[21988832];MNDA[25665578];AURKAIP1[29568061];RAB5A[29568061];HIST1H2BD[30021884];BET1[29568061];	35988718
34366	chr17	37360844	G	A	chr17:37360844	RPL19	ribosomal protein L19	SNV	0|1	0.27	56_21	77	99.0	0|1	0.31	47_21	68	99.0			rs72823350,COSV56634704	EXONIC	YES	NM_000981.4	Transcript	protein_coding	synonymous_variant		6/6	NM_000981.4:c.534G>A	NP_000972.1:p.Gln178%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.						32	0.97							0.00198326	419.0	211268.0	0.0	79	1.0	RF	amr	0.0036415	98.0	0.00162699	161.0	0.0172279	2679	0.028	89.0				11.06	0.688946		0	0	0			RPL19	0.0	0.0	0.0	0.0	7.0	-45.0	-46.0	0.0							0.97				.			.	Ribosome	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;cytoplasmic translation;translation;translational initiation;SRP-dependent cotranslational protein targeting to membrane;liver regeneration	cytosol;focal adhesion;membrane;cytosolic large ribosomal subunit;polysomal ribosome;synapse	RNA binding;structural constituent of ribosome;protein binding;large ribosomal subunit rRNA binding;5.8S rRNA binding	FKBP2[30021884];RPL10[26496610];LRRK2[24725412];EIF4A3[23084401];HNRNPU[26496610];ARRB2[17620599];MKI67[26949251];DUX4[26816005];GABARAP[20562859];UBE2L3[19549727];FBL[29568061];METTL14[29507755];HIST1H3A[29568061];MAGOH[23084401];COX11[21988832];ZC3H18[29298432];GABARAPL2[20562859];TMEM132C[30021884];GABARAPL1[20562859];JUN[25609649];NPM1[26496610];VCAM1[22623428];RPS6[29568061];RRP1B[20926688];TEX15[30021884];TERF1[21044950];YWHAZ[15161933];ESR1[21182205];IGF2R[30021884];HIST2H2BE[30021884];NISCH[30021884];FMNL3[30021884];SNW1[20467437];PPP2R2B[19156129];AGO1[17932509];HDGF[21907836];	37360844
34369	chr17	37360846	C	T	chr17:37360846	RPL19	ribosomal protein L19	SNV	0|1	0.27	57_21	78	99.0	0|1	0.31	47_21	68	99.0			rs113832291,COSV56634747	EXONIC	YES	NM_000981.4	Transcript	protein_coding	missense_variant		6/6	NM_000981.4:c.536C>T	NP_000972.1:p.Ala179Val		1.0	.,.,.,.	Benign	criteria_provided,_single_submitter	not_provided		.	.	.						32	0.97							0.00198538	421.0	212050.0	0.0	78	1.0	RF	amr	0.00376996	102.0	0.00166146	165.0	0.0172343	2680	0.027	86.0				23.8	3.089496	0.41	6	11	17	LRT_pred,MutationTaster_pred,PrimateAI_pred,BayesDel_addAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	RPL19	0.0	0.0	0.0	0.0	-2.0	23.0	-2.0	-48.0							0.97		1.0	1.026	.			.	Ribosome	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;cytoplasmic translation;translation;translational initiation;SRP-dependent cotranslational protein targeting to membrane;liver regeneration	cytosol;focal adhesion;membrane;cytosolic large ribosomal subunit;polysomal ribosome;synapse	RNA binding;structural constituent of ribosome;protein binding;large ribosomal subunit rRNA binding;5.8S rRNA binding	FKBP2[30021884];RPL10[26496610];LRRK2[24725412];EIF4A3[23084401];HNRNPU[26496610];ARRB2[17620599];MKI67[26949251];DUX4[26816005];GABARAP[20562859];UBE2L3[19549727];FBL[29568061];METTL14[29507755];HIST1H3A[29568061];MAGOH[23084401];COX11[21988832];ZC3H18[29298432];GABARAPL2[20562859];TMEM132C[30021884];GABARAPL1[20562859];JUN[25609649];NPM1[26496610];VCAM1[22623428];RPS6[29568061];RRP1B[20926688];TEX15[30021884];TERF1[21044950];YWHAZ[15161933];ESR1[21182205];IGF2R[30021884];HIST2H2BE[30021884];NISCH[30021884];FMNL3[30021884];SNW1[20467437];PPP2R2B[19156129];AGO1[17932509];HDGF[21907836];	37360846
34370	chr17	37360863	A	T	chr17:37360863	RPL19	ribosomal protein L19	SNV	0|1	0.26	55_19	74	99.0	0|1	0.31	47_21	68	99.0			rs149983979,COSV56634757	EXONIC	YES	NM_000981.4	Transcript	protein_coding	missense_variant		6/6	NM_000981.4:c.553A>T	NP_000972.1:p.Ile185Phe		1.0	.,.,.,.	Benign	criteria_provided,_single_submitter	not_provided		.	.	.						32	0.97							0.000287457	67.0	233078.0	0.0	70	1.0	PASS	afr	0.00047259	7.0	0.000346163	37.0	0.0059677	928	0.01	31.0				23.9	3.128008	0.409	8	9	17	SIFT,LRT_pred,MutationTaster_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,ClinPred_pred,LIST-S2_pred	RPL19	0.0	0.0	0.0	0.0	6.0	18.0	-4.0	34.0							0.97		1.0	1.312	.			.	Ribosome	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;cytoplasmic translation;translation;translational initiation;SRP-dependent cotranslational protein targeting to membrane;liver regeneration	cytosol;focal adhesion;membrane;cytosolic large ribosomal subunit;polysomal ribosome;synapse	RNA binding;structural constituent of ribosome;protein binding;large ribosomal subunit rRNA binding;5.8S rRNA binding	FKBP2[30021884];RPL10[26496610];LRRK2[24725412];EIF4A3[23084401];HNRNPU[26496610];ARRB2[17620599];MKI67[26949251];DUX4[26816005];GABARAP[20562859];UBE2L3[19549727];FBL[29568061];METTL14[29507755];HIST1H3A[29568061];MAGOH[23084401];COX11[21988832];ZC3H18[29298432];GABARAPL2[20562859];TMEM132C[30021884];GABARAPL1[20562859];JUN[25609649];NPM1[26496610];VCAM1[22623428];RPS6[29568061];RRP1B[20926688];TEX15[30021884];TERF1[21044950];YWHAZ[15161933];ESR1[21182205];IGF2R[30021884];HIST2H2BE[30021884];NISCH[30021884];FMNL3[30021884];SNW1[20467437];PPP2R2B[19156129];AGO1[17932509];HDGF[21907836];	37360863
34372	chr17	37360874	A	G	chr17:37360874	RPL19	ribosomal protein L19	SNV	0|1	0.23	51_15	66	99.0	0|1	0.31	43_19	62	99.0			rs758902267,COSV56635874	EXONIC	YES	NM_000981.4	Transcript	protein_coding	synonymous_variant		6/6	NM_000981.4:c.564A>G	NP_000972.1:p.Leu188%3D		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.						32	0.97							0.000121447	29.0	238788.0	0.0	65	1.0	RF	afr	0.000541199	8.0	0.000119308	13.0	0.0000193	3						11.04	0.686526		0	0	0			RPL19	0.0	0.0	0.0	0.0	-29.0	7.0	44.0	-3.0							0.97				.			.	Ribosome	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;cytoplasmic translation;translation;translational initiation;SRP-dependent cotranslational protein targeting to membrane;liver regeneration	cytosol;focal adhesion;membrane;cytosolic large ribosomal subunit;polysomal ribosome;synapse	RNA binding;structural constituent of ribosome;protein binding;large ribosomal subunit rRNA binding;5.8S rRNA binding	FKBP2[30021884];RPL10[26496610];LRRK2[24725412];EIF4A3[23084401];HNRNPU[26496610];ARRB2[17620599];MKI67[26949251];DUX4[26816005];GABARAP[20562859];UBE2L3[19549727];FBL[29568061];METTL14[29507755];HIST1H3A[29568061];MAGOH[23084401];COX11[21988832];ZC3H18[29298432];GABARAPL2[20562859];TMEM132C[30021884];GABARAPL1[20562859];JUN[25609649];NPM1[26496610];VCAM1[22623428];RPS6[29568061];RRP1B[20926688];TEX15[30021884];TERF1[21044950];YWHAZ[15161933];ESR1[21182205];IGF2R[30021884];HIST2H2BE[30021884];NISCH[30021884];FMNL3[30021884];SNW1[20467437];PPP2R2B[19156129];AGO1[17932509];HDGF[21907836];	37360874
34374	chr17	37360889	G	T	chr17:37360889	RPL19	ribosomal protein L19	SNV	0|1	0.19	48_11	59	99.0	0|1	0.29	42_17	59	99.0			rs753150645,COSV56634896,COSV99841486	EXONIC	YES	NM_000981.4	Transcript	protein_coding	missense_variant		6/6	NM_000981.4:c.579G>T	NP_000972.1:p.Glu193Asp		1.0	.,.,.,.					.	.	.						32	0.97							0.000103778	25.0	240900.0	0.0	56	0.99	PASS	afr	0.00108651	16.0	5.449e-05	6.0	0.0000064	1						24.9	3.470184	0.144	7	11	18	SIFT,PolyPhen,LRT_pred,MutationTaster_pred,PrimateAI_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	RPL19	0.0	0.0	0.0	0.0	-8.0	23.0	-2.0	29.0							0.97		1.0	0.226	.			.	Ribosome	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;cytoplasmic translation;translation;translational initiation;SRP-dependent cotranslational protein targeting to membrane;liver regeneration	cytosol;focal adhesion;membrane;cytosolic large ribosomal subunit;polysomal ribosome;synapse	RNA binding;structural constituent of ribosome;protein binding;large ribosomal subunit rRNA binding;5.8S rRNA binding	FKBP2[30021884];RPL10[26496610];LRRK2[24725412];EIF4A3[23084401];HNRNPU[26496610];ARRB2[17620599];MKI67[26949251];DUX4[26816005];GABARAP[20562859];UBE2L3[19549727];FBL[29568061];METTL14[29507755];HIST1H3A[29568061];MAGOH[23084401];COX11[21988832];ZC3H18[29298432];GABARAPL2[20562859];TMEM132C[30021884];GABARAPL1[20562859];JUN[25609649];NPM1[26496610];VCAM1[22623428];RPS6[29568061];RRP1B[20926688];TEX15[30021884];TERF1[21044950];YWHAZ[15161933];ESR1[21182205];IGF2R[30021884];HIST2H2BE[30021884];NISCH[30021884];FMNL3[30021884];SNW1[20467437];PPP2R2B[19156129];AGO1[17932509];HDGF[21907836];	37360889
34377	chr17	37360895	G	A	chr17:37360895	RPL19	ribosomal protein L19	SNV	0|1	0.19	39_9	48	99.0	0|1	0.27	43_16	59	99.0			rs751845105	EXONIC	YES	NM_000981.4	Transcript	protein_coding	synonymous_variant		6/6	NM_000981.4:c.585G>A	NP_000972.1:p.Lys195%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.						32	0.97							9.23524e-05	22.0	238218.0	0.0	53	0.98	RF	afr	0.000751058	11.0	2.74675e-05	3.0	0.0035047	545						12.88	0.922273		0	0	0			RPL19	0.0	0.0	0.0	0.0	-26.0	23.0	2.0	23.0							0.97				.			.	Ribosome	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;cytoplasmic translation;translation;translational initiation;SRP-dependent cotranslational protein targeting to membrane;liver regeneration	cytosol;focal adhesion;membrane;cytosolic large ribosomal subunit;polysomal ribosome;synapse	RNA binding;structural constituent of ribosome;protein binding;large ribosomal subunit rRNA binding;5.8S rRNA binding	FKBP2[30021884];RPL10[26496610];LRRK2[24725412];EIF4A3[23084401];HNRNPU[26496610];ARRB2[17620599];MKI67[26949251];DUX4[26816005];GABARAP[20562859];UBE2L3[19549727];FBL[29568061];METTL14[29507755];HIST1H3A[29568061];MAGOH[23084401];COX11[21988832];ZC3H18[29298432];GABARAPL2[20562859];TMEM132C[30021884];GABARAPL1[20562859];JUN[25609649];NPM1[26496610];VCAM1[22623428];RPS6[29568061];RRP1B[20926688];TEX15[30021884];TERF1[21044950];YWHAZ[15161933];ESR1[21182205];IGF2R[30021884];HIST2H2BE[30021884];NISCH[30021884];FMNL3[30021884];SNW1[20467437];PPP2R2B[19156129];AGO1[17932509];HDGF[21907836];	37360895
34537	chr17	39118795	A	G	chr17:39118795	KRT39	keratin 39	SNV	0/1	0.38	43_27	71	99.0	0/1	0.44	43_35	79	99.0			rs202225236	EXONIC	YES	NM_213656.4	Transcript	protein_coding	synonymous_variant		4/7	NM_213656.4:c.729T>C	NP_998821.3:p.Cys243%3D		-1.0						.	.	.		7.22828e-05	11.0	152180.0	0.0	32	0.97	PASS	sas	0.000206868	1.0	0.000117581	8.0	9.18142e-05	23.0	250506.0	0.0	55	0.94	PASS	amr	0.00020337	7.0	9.71834e-05	11.0	0.0000965	15	0.001	2.0				9.365	0.49591		0	0	0			KRT39	0.0	0.0	0.0	0.0	37.0	2.0	-27.0	2.0						0.221	0.0	16.534934111			.			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;globus pallidus;	Cell Communication	keratinization;cornification	cytosol;intermediate filament	structural molecule activity	KRT81[unassigned1304];BEX2[unassigned1304];SHC3[unassigned1304];KDM1A[unassigned1304];KLHL38[unassigned1304];CLCNKA[unassigned1304];KRT86[unassigned1304];PPL[unassigned1304];KRT85[unassigned1304];KRT83[unassigned1304];FAM110A[unassigned1304];ANKRD36BP1[unassigned1304];TGM7[unassigned1304];UBASH3A[unassigned1304];ANKS1A[unassigned1304];KRT6B[unassigned1304];TXNDC5[unassigned1304];SMARCE1[unassigned1304];VPS9D1[unassigned1304];LMO4[unassigned1304];KRT3[unassigned1304];KRT1[unassigned1304];KRT78[unassigned1304];ARMC7[unassigned1304];KRT76[unassigned1304];IGFN1[unassigned1304];KRT74[unassigned1304];GFAP[unassigned1304];SCNM1[unassigned1304];PRPF18[unassigned1304];TXLNB[unassigned1304];HGS[unassigned1304];ZNF417[unassigned1304];CCDC196[unassigned1304];C1orf216[unassigned1304];GAPDH[30021884];	39118795
34539	chr17	39140373	C	T	chr17:39140373	KRT40	keratin 40	SNV	0/1	0.54	79_91	170	99.0	0/1	0.37	96_56	152	99.0			rs142639581	EXONIC	YES	NM_001385217.1	Transcript	protein_coding	synonymous_variant		3/9	NM_001385217.1:c.153G>A	NP_001372146.1:p.Arg51%3D		-1.0						.	.	.		0.00345222	525.0	152076.0	5.0	31	0.92	PASS	nfe	0.00393955	268.0	0.00393955	268.0	0.00441829	1102.0	249418.0	4.0	100	1.0	PASS	nfe	0.00449009	508.0	0.00449009	508.0	0.0040578	631	0.002	7.0				6.215	0.22574		0	0	0			KRT40	0.0	0.0	0.0	0.01	-17.0	0.0	26.0	1.0						0.176	0.0	45.493016930			.			.	Cell Communication	keratinization;cornification	cytosol;intermediate filament	structural molecule activity;protein binding	MAPKBP1[25416956];POP5[25416956];CNTF[25416956];SCOC[25416956];CHIC2[25416956];TTLL10[25416956];SLC23A1[unassigned1304];AQP5[25416956];AQP1[25416956];UXT[25416956];ZFYVE26[25416956;unassigned1304];C2orf68[unassigned1304];KAT5[25416956];RASSF5[25416956];DHX57[unassigned1304];SPATA24[25416956];C6orf226[25416956];ZNF844[25416956;unassigned1304];HOXA1[25416956];UBASH3A[25416956];SMCO4[25416956];TBC1D22B[25416956];EXOC3-AS1[25416956];ZNF17[unassigned1304];ZNF165[25416956];PRKAB2[25416956;unassigned1304];KRT4[25416956;unassigned1304];ZFP1[unassigned1304];KRT2[25416956;unassigned1304;25910212];ZFP2[25416956;unassigned1304];KRT8[25416956;unassigned1304];MED8[25416956];ZFYVE21[25416956];ARMC7[25416956;unassigned1304];KRT5[25416956;unassigned1304];PIMREG[25416956;26871637];ZC2HC1C[25416956];HOXB9[unassigned1304];DAAM2[25416956];CEP57L1[25416956];THAP7[25416956];NINJ1[25416956];ZSCAN21[25416956];TYRO3[25416956];COL8A1[25416956];C1orf216[25416956];GNE[unassigned1304];RWDD2B[25416956;unassigned1304];BEX2[25416956];TSHZ3[25416956];USHBP1[25416956];C10orf62[25416956];FBF1[25416956];CWF19L2[25416956];ZNF20[25416956];AKAP17A[25416956];GATA2[25416956];ZNF26[25416956];MRPL11[25416956];GMCL2[unassigned1304];GUCD1[25416956];FAM124B[25416956];RNF213[25416956];PTPMT1[25416956];INPP5D[25416956];NPBWR2[25416956];ARSI[25416956];HOXC8[unassigned1304];ZNF266[25416956];BARD1[25416956];CDK18[25416956];DTNB[25416956];ZFAB[25416956];RAB3IP[25416956];NR1D2[25416956];SFRS2[25416956];MAGOHB[25416956];HSPA12B[25416956];C19orf57[25416956];SNW1[25416956];ZNF702P[25416956];SNAI1[25416956];LINC00303[unassigned1304];FNDC11[25416956];ZNF138[25416956];RCOR3[25416956];CEP57[25416956];PIGS[25416956];C2CD6[25416956];SETD5[25416956];CCDC120[25416956];ZNF250[25416956;unassigned1304];SPEF1[25416956];ZNF490[25416956];PHF1[unassigned1304];WT1-AS[25416956];CTSZ[25416956];SPATC1L[unassigned1304];KRT20[25416956];PPP1R18[25416956];FARS2[25416956;unassigned1304];ING5[25416956];CATIP[25416956];ADAMTSL3[25416956];TMSB4X[25416956];ELOA[25416956];RAC1[25416956];CCHCR1[25416956;unassigned1304];ZNF488[25416956];DLGAP2[25416956];FEZF1[unassigned1304];CD33[25416956];ZNF124[25416956];UTP14C[25416956];NDEL1[25416956];ATPAF2[25416956;25910212];CCDC112[25416956];TEAD4[26871637;unassigned1304];HBZ[25416956];TSC22D4[25416956];CCDC116[unassigned1304];RAB3IL1[25416956];AEN[25416956];TYK2[25416956];HBA1[25416956];JOSD1[25416956;unassigned1304];AES[25416956;unassigned1304];C11orf87[25416956];CDC20B[25416956];HCK[25416956;unassigned1304];PRPF18[unassigned1304];PSMA1[25416956];TNNT1[25416956];ZNF833P[unassigned1304];FRG1[25416956];KIFC3[25416956];SLU7[25416956];MRRF[unassigned1304];AVPI1[25416956];KANK2[unassigned1304];WDR25[25416956];ZNF230[25416956];LIN37[25416956];RPL11[25416956];PTGER3[25416956];C5orf60[25416956];COX5A[25416956];FAM214A[25416956];PRAM1[25416956];GNAI2[25416956];RXRB[26871637];PSMB1[unassigned1304];ANKRD36BP1[25416956];HSF4[unassigned1304];C18orf45[25416956];SCAND1[unassigned1304];ZNF587[25416956;unassigned1304];ZNF101[25416956];FOXB1[25416956];ZNF581[25416956;unassigned1304];ZNF580[unassigned1304];GAD1[26871637];CARD9[25416956];ZNF76[unassigned1304];DMRT3[25416956;unassigned1304];RYDEN[25416956;unassigned1304];TTC9C[unassigned1304];LCE3E[25416956];BYSL[25416956;unassigned1304];GATAD2A[25416956];MOS[25416956];PSMC5[25416956];WT1[25416956];CCNG1[25416956];FKBP1B[25416956];TCEA2[25416956];MSRB3[unassigned1304];PRPF31[25416956;25910212];ZNF337[25416956];ZNF697[25416956];LIMS2[25416956];ZNF575[unassigned1304];CDK5R1[25416956];KDM1A[unassigned1304];ZBTB24[25416956];KLHL38[25416956];TACO1[unassigned1304];FAM107A[25416956];CCER1[25416956];COMT[25416956];CLEC18A[25416956];TXN2[25416956];NPPB[25416956];FADS2[unassigned1304];CHCHD2[25416956];CHCHD3[25416956];ZNF329[25416956];ZNF569[25416956];OIP5[unassigned1304];ZNF446[25416956;unassigned1304];ZNF688[26871637];SSX2[25416956];KPNA2[25416956];RGS8[unassigned1304];ZNF202[25416956;unassigned1304];KRT6C[25416956;unassigned1304];PHLDA1[unassigned1304];LINC01588[25416956];ZNF564[25416956];KRT6B[unassigned1304];KRT6A[25416956;26871637;unassigned1304;25910212];LMO1[25416956];KRT71[25416956;unassigned1304];ZGPAT[25416956;26871637];FBXW5[25416956];LMO4[25416956];USP2[25416956;unassigned1304];LMO2[25416956];ARID5A[25416956];GOLGA6L2[25416956];ZFP69B[25416956];KRT76[unassigned1304];KRT75[unassigned1304];GEM[25416956];MID2[unassigned1304];KRT72[25416956];LENG1[25416956;unassigned1304];MOB3C[25416956];KCTD9[25416956];TXLNA[25416956;unassigned1304];HGS[25416956;26871637];TBC1D21[unassigned1304];ZNF319[unassigned1304];ZNF439[25416956;unassigned1304];ZNF317[25416956];ZNF438[unassigned1304];ISCU[25416956];SNRPB[25416956];DDX6[25416956];ZNF792[25416956];INO80B[unassigned1304];SHC3[25416956;unassigned1304];TROAP[25416956];CCDC146[25416956];CCDC26[25416956];UTP23[25416956];FLJ23584[25416956];GPATCH2L[25416956];PHF21A[25416956];C8orf48[25416956];MGC13033[25416956];ZMAT2[25416956];MOBP[26871637];ALDH3B1[25416956];MARK4[25416956];FAM71C[25416956];TXNDC5[25416956;unassigned1304];AP1M1[25416956;unassigned1304];ENKD1[unassigned1304];CBX8[25416956;unassigned1304];ZFHX3[25416956];MYPOP[unassigned1304];ZBTB16[25416956;26871637;unassigned1304];NEK6[25416956;unassigned1304];TCEANC[unassigned1304];FBXO34[25416956];ACSF3[unassigned1304];SYT6[25416956];GGN[25416956];FAM90A1[25416956;unassigned1304];TMEM231[25416956];ZNF417[25416956;unassigned1304];RSPH14[25416956];CYCS[25416956;25910212];PIN1[25416956];ZNF655[25416956];LHX4[26871637];LRCH4[25416956];NFKBID[25416956];ZNF410[unassigned1304];TTC25[25416956];RTP5[25416956];TTC23[25416956];ITGB5[25416956];SH2D4A[25416956;unassigned1304];ITGB4[unassigned1304];DOCK8[25416956];FASLG[25416956];PKD2[25416956];HAPLN2[unassigned1304];TCHP[25416956];FAM74A4[25416956;unassigned1304];ZNF408[unassigned1304];ADAMTS1[unassigned1304];NAPRT[25416956];IQUB[25416956];CA6[25416956];POLL[25416956];BCAS2[25416956];METTL17[25416956;26871637];C19orf73[25416956];CCDC198[25416956];ELA2B[25416956];AXIN1[26871637];ASMTL[25416956];VEZF1[unassigned1304];HAUS1[25416956];TRAF4[25416956;unassigned1304];GFOD1[25416956];FAM27E3[25416956];CRY2[unassigned1304];DCX[25416956];SLC25A10[25416956];EIF4E2[25416956];DOCK2[25416956;unassigned1304];AGXT[unassigned1304];C4orf45[unassigned1304];SSX2IP[25416956];CREB5[25416956;unassigned1304];HDAC4[25416956;unassigned1304];OTUB2[25416956];KRT82[unassigned1304];KRT81[25416956;unassigned1304];PRKAA1[25416956];GTF3C5[25416956];TSGA10IP[25416956];POLDIP3[25416956];ZBTB42[unassigned1304];RNF6[26871637];CFAP206[25416956;unassigned1304];SPG7[25416956];KRT86[unassigned1304];LAGE3[25416956;unassigned1304];UACA[25416956];KRT85[unassigned1304];LMF2[25416956];HSPD1[25416956];KRT83[unassigned1304];NXF1[25416956];MTA1[25416956];CYTH4[25416956];GNG5[25416956];BAHD1[25416956];DCDC2B[25416956];MXI1[25416956;26871637];ZNF625[25416956];C1orf109[25416956];TRIM42[25416956];CCDC185[25416956;unassigned1304];PDLIM5[25416956];CNNM3[unassigned1304];OPCML[25416956];ZNF286A[25416956];SMARCE1[25416956;unassigned1304];GADD45GIP1[unassigned1304];HSD3B7[unassigned1304];USP21[25416956];HEL-S-90n[25416956];TIE1[25416956];SEMA4C[25416956];FBXL18[25416956];SUOX[unassigned1304];MFAP1[25416956];TNIP3[25416956];MAB21L2[25416956];RBM41[25416956];SLIRP[25416956];RECK[25416956];	39140373
34560	chr17	39211193		A	chr17:39211192-39211193	KRTAP2-2	keratin associated protein 2-2	insertion	0/0	0.0	4_0	4	9.0	0|1	0.75	2_6	8	66.0			rs1312840649	EXONIC	YES	NM_033032.3	Transcript	protein_coding	frameshift_variant		1/1	NM_033032.3:c.271_272insT	NP_149021.2:p.Pro91LeufsTer111		-1.0						.	.	.		0.00674388	559.0	82890.0	0.0	8	0.15	PASS	amr	0.00859317	70.0	0.00828771	333.0	1.91516e-05	2.0	104430.0	0.0	6	0.38	PASS	amr	4.45157e-05	1.0	2.68284e-05	1.0								33.0	4.85601		0	0	0			KRTAP2-2	0.05	0.0	0.0	0.0	2.0	-19.0	-33.0	11.0											.			.	.	keratinization	cytosol;keratin filament	.	.	39211192
34564	chr17	39211194		GT	chr17:39211193-39211194	KRTAP2-2	keratin associated protein 2-2	insertion	0/0	0.0	4_0	4	0.0	0|1	0.75	2_6	8	66.0			rs1373958086	EXONIC	YES	NM_033032.3	Transcript	protein_coding	frameshift_variant		1/1	NM_033032.3:c.270_271insAC	NP_149021.2:p.Pro91ThrfsTer96		-1.0						.	.	.		0.00735741	387.0	52600.0	0.0	6	0.14	PASS	nfe	0.00967378	223.0	0.00967378	223.0	9.93641e-06	1.0	100640.0	0.0	6	0.39	RF	amr	4.62535e-05	1.0	0.0	0.0								33.0	4.808556		0	0	0																						.			.	.	keratinization	cytosol;keratin filament	.	.	39211193
34581	chr17	39274449	C	T	chr17:39274449	KRTAP4-11	keratin associated protein 4-11	SNV	0|1	0.12	161_22	183	99.0	0|0	0.06	144_9	153	56.0			rs1160698604	EXONIC	YES	NM_033059.4	Transcript	protein_coding	missense_variant		1/1	NM_033059.4:c.119G>A	NP_149048.2:p.Cys40Tyr		-1.0						.	.	.		0.00386681	419.0	108358.0	0.0	33	0.9	AS_VQSR	afr	0.00676877	198.0	0.00213799	103.0	0.0	0.0	250230.0	0.0	86	1.0	AC0_RF				0.0	0.0								12.81	0.912131	0.257	2	16	18	MutationAssessor_pred,PROVEAN_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	KRTAP4-11	0.01	0.0	0.0	0.0	-10.0	11.0	31.0	-14.0							0.1		0.004	0.006	.			.	.	keratinization	cytosol;keratin filament	protein binding	SLC23A1[unassigned1304];KLHL38[unassigned1304];MEOX2[25416956;unassigned1304];LCE1A[unassigned1304];LCE1B[unassigned1304];CYSRT1[unassigned1304];LCE5A[unassigned1304];ADAMTSL4[25416956;unassigned1304];GRAP2[27107012];HOXA1[25416956;unassigned1304];KRTAP3-3[unassigned1304];LINC00574[unassigned1304];KRTAP3-1[unassigned1304];KRTAP11-1[unassigned1304];KRTAP5-9[25416956;unassigned1304];GLRX3[25416956;unassigned1304];KRTAP9-2[unassigned1304];KRTAP15-1[unassigned1304];KRTAP17-1[unassigned1304];EPDR1[unassigned1304];LCE1E[unassigned1304];LCE1F[unassigned1304];LCE1C[unassigned1304];KRTAP9-8[unassigned1304];LCE1D[unassigned1304];LCE2C[unassigned1304];PLSCR1[25416956];ZNF837[unassigned1304];EHHADH[unassigned1304];FAM76B[unassigned1304];ZNF552[unassigned1304];GNE[unassigned1304];VGLL3[unassigned1304];CATSPER1[25416956;unassigned1304];RGS17[unassigned1304];NUFIP2[25416956;unassigned1304];CRCT1[unassigned1304];GATA1[unassigned1304];LCE3C[unassigned1304];FAM221A[unassigned1304];LCE3A[unassigned1304];BAG4[unassigned1304];LCE3B[unassigned1304];TSPAN4[unassigned1304];KRTAP6-2[unassigned1304];OTX1[25416956;unassigned1304];LELP1[unassigned1304];KRTAP2-3[unassigned1304];TXNDC5[unassigned1304];LINC01600[unassigned1304];ENKD1[unassigned1304];SMCP[25416956;unassigned1304];TGFB1[unassigned1304];POTEB3[unassigned1304];KRTAP10-9[25416956;unassigned1304];KRTAP10-8[25416956;unassigned1304];RYDEN[unassigned1304];NOTCH2NLA[25416956;unassigned1304];DHRS1[unassigned1304];VASN[unassigned1304];LCE3E[unassigned1304];POU4F2[unassigned1304];NR4A3[unassigned1304];LCE4A[unassigned1304];ZNF417[unassigned1304];SPRY2[25416956];PRPF31[unassigned1304];P4HB[unassigned1304];	39274449
34590	chr17	39324347	G	T	chr17:39324347	KRTAP4-3	keratin associated protein 4-3	SNV	0/0	0.0	89_0	89	0.0	0|1	0.21	86_23	109	99.0			rs775293129,COSV66940405	EXONIC	YES	NM_033187.2	Transcript	protein_coding	synonymous_variant		1/1	NM_033187.2:c.78C>A	NP_149443.1:p.Arg26%3D		-1.0						.	.	.		0.00266277	284.0	106656.0	0.0	31	0.77	AS_VQSR	afr	0.00519526	120.0	0.00185035	96.0	0.000290133	63.0	217142.0	0.0	75	0.99	PASS	afr	0.00120863	13.0	0.000366991	37.0	0.0001415	22						0.517	-0.249113		0	0	0			KRTAP4-3	0.0	0.0	0.0	0.0	38.0	-30.0	-33.0	26.0						0.839	0.0	0.000000000			.			.	.	aging;keratinization;hair cycle	cytosol;keratin filament	.	.	39324347
34591	chr17	39324348	C	T	chr17:39324348	KRTAP4-3	keratin associated protein 4-3	SNV	0/0	0.0	89_0	89	0.0	0|1	0.21	86_23	109	99.0			rs201948308,COSV66940557	EXONIC	YES	NM_033187.2	Transcript	protein_coding	missense_variant		1/1	NM_033187.2:c.77G>A	NP_149443.1:p.Arg26His		-1.0						.	.	.		0.00246168	247.0	100338.0	0.0	31	0.73	AS_VQSR	eas	0.00489237	15.0	0.00180975	89.0	0.000265628	57.0	214586.0	0.0	73	0.99	PASS	afr	0.00113529	12.0	0.000320622	32.0	0.0001479	23						2.134	-0.03465	0.06	1	16	17	MutationAssessor_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	KRTAP4-3	0.0	0.0	0.0	0.0	24.0	-31.0	25.0	-34.0						0.839	0.0	0.000000000	0.005	-1.031	.			.	.	aging;keratinization;hair cycle	cytosol;keratin filament	.	.	39324348
34592	chr17	39324349	G	T	chr17:39324349	KRTAP4-3	keratin associated protein 4-3	SNV	0/0	0.0	89_0	89	0.0	0|1	0.13	86_13	99	99.0			rs773968723,COSV66940612,COSV66940732	EXONIC	YES	NM_033187.2	Transcript	protein_coding	missense_variant		1/1	NM_033187.2:c.76C>A	NP_149443.1:p.Arg26Ser		-1.0						.	.	.		0.00206055	214.0	103856.0	0.0	31	0.75	AS_VQSR	afr	0.00399383	88.0	0.00153127	78.0	0.00024351	53.0	217650.0	0.0	73	0.99	PASS	afr	0.0010127	11.0	0.000306627	31.0	0.0001479	23						0.045	-0.591365	0.041	1	16	17	MutationAssessor_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	KRTAP4-3	0.0	0.0	0.0	0.0	36.0	-32.0	24.0	-8.0						0.839	0.0	1.955342103	0.041	-1.002	.			.	.	aging;keratinization;hair cycle	cytosol;keratin filament	.	.	39324349
34600	chr17	39383224	C	T	chr17:39383224	KRTAP9-2	keratin associated protein 9-2	SNV	0/1	0.46	86_75	162	99.0	0/1	0.34	85_44	130	99.0			rs150952626	EXONIC	YES	NM_031961.3	Transcript	protein_coding	synonymous_variant		1/1	NM_031961.3:c.318C>T	NP_114167.2:p.Gly106%3D		1.0						.	.	.		0.00130419	198.0	151818.0	1.0	32	0.95	PASS	afr	0.00435899	180.0	8.82846e-05	6.0	0.000450659	113.0	250744.0	0.0	100	0.99	PASS	afr	0.00439864	70.0	0.000123442	14.0	0.0000193	3						1.428	-0.097642		0	0	0			KRTAP9-2	0.01	0.0	0.01	0.0	33.0	-36.0	-2.0	23.0						0.841	0.24	1.955342103			.			.	.	keratinization	cytosol;keratin filament	protein binding;identical protein binding	MAPKBP1[25416956];CERK[unassigned1304];KLHL38[unassigned1304];ZDHHC1[unassigned1304];AQP1[25416956];CCDC28A[25416956];CDC20[17353931];LCE1A[unassigned1304];LCE1B[25416956;unassigned1304];CYSRT1[unassigned1304];HOXA1[25416956;unassigned1304];KRTAP3-2[25416956];SLC39A7[unassigned1304];LOC401296[unassigned1304];TMSB10[25416956];PHLDA1[unassigned1304];CARD10[unassigned1304];PRKAB2[25416956;unassigned1304];KRTAP13-2[unassigned1304];KRTAP13-3[unassigned1304];ATG9A[unassigned1304];P3H3[unassigned1304];C22orf39[unassigned1304];LCE1E[unassigned1304];LCE1F[unassigned1304];LCE1D[unassigned1304];LCE2B[unassigned1304];LCE2C[unassigned1304];LCE2A[25416956;unassigned1304];KRTAP4-12[25416956;unassigned1304];KRTAP4-11[unassigned1304];ADAM12[unassigned1304];TYRO3[unassigned1304];GEMIN4[unassigned1304];COL8A1[25416956];FAM76B[25416956;unassigned1304];PDE9A[25416956];GNE[25416956;unassigned1304];KRTAP10-11[25416956;unassigned1304];SDC3[unassigned1304];CHRD[25416956];ZNF20[unassigned1304];SPATA3[unassigned1304];GATA1[25416956];SPATA8[25416956];GUCD1[unassigned1304];PTPMT1[25416956;unassigned1304];KRTAP5-11[unassigned1304];TSPAN4[unassigned1304];KRTAP4-4[unassigned1304];KRTAP4-2[25416956;unassigned1304];OTX1[25416956;unassigned1304];LELP1[unassigned1304];TXNDC5[unassigned1304];KRTAP12-1[unassigned1304];SMCP[25416956;unassigned1304];KRTAP12-3[unassigned1304];TFAP2D[unassigned1304];KRTAP4-7[25416956];TMEM190[unassigned1304];DDIT4L[unassigned1304];WDYHV1[25416956;unassigned1304];NR1D2[unassigned1304];NOTCH2NLA[25416956;unassigned1304];GNG13[unassigned1304];NR4A3[unassigned1304];CTRC[unassigned1304];PIGS[unassigned1304];ITGB4[unassigned1304];KRTAP26-1[25416956;unassigned1304];WT1-AS[unassigned1304];PRKAG1[unassigned1304];MEOX2[25416956;unassigned1304];HAPLN2[unassigned1304];LCE5A[unassigned1304];ADAMTSL4[25416956;unassigned1304];KRTAP5-3[unassigned1304];KRTAP5-2[unassigned1304];KRTAP1-5[unassigned1304];KRTAP1-1[unassigned1304];KRTAP11-1[unassigned1304];KRTAP5-9[25416956;unassigned1304];KRTAP9-4[25416956];GLRX3[25416956;unassigned1304];KRTAP9-3[unassigned1304];KRTAP5-7[unassigned1304];KRTAP5-6[25416956;unassigned1304];KRTAP9-2[25416956;unassigned1304];PLLP[unassigned1304];KRTAP15-1[unassigned1304];LMNTD2[unassigned1304];KRTAP5-4[unassigned1304];AXIN2[unassigned1304];JOSD1[25416956;unassigned1304];KRT31[unassigned1304];ZDHHC17[24705354];ARFGAP1[25416956];KRTAP19-7[unassigned1304];KRTAP9-8[unassigned1304];PLSCR1[25416956];CYP21A2[unassigned1304];DOCK2[25416956];AGXT[unassigned1304];CREB5[25416956;unassigned1304];VGLL3[unassigned1304];CATSPER1[25416956;unassigned1304];RNF31[25416956];NUFIP2[25416956;unassigned1304];CRCT1[unassigned1304];RNF8[unassigned1304];RCHY1[25416956];LCE3C[unassigned1304];LCE3D[unassigned1304];P2RY6[unassigned1304];LCE3A[unassigned1304];LCE3B[unassigned1304];KRTAP2-3[unassigned1304];SUMO1P1[25416956];SLC13A5[unassigned1304];CNNM3[unassigned1304];LINC01600[unassigned1304];LINGO1[unassigned1304];KRTAP10-5[25416956];KRTAP10-7[25416956;unassigned1304];KRTAP10-9[25416956;unassigned1304];KRTAP10-8[25416956;unassigned1304];DMRT3[unassigned1304];RYDEN[25416956;unassigned1304];LBX1[unassigned1304];LYVE1[unassigned1304];LCE3E[25416956;unassigned1304];POU4F2[unassigned1304];LCE4A[25416956;unassigned1304];LNX1[25416956];SPRY2[25416956];SPRY1[unassigned1304];ZNF575[unassigned1304];ZNF696[unassigned1304];	39383224
34613	chr17	39766695	G	A	chr17:39766695	KRT16	keratin 16	SNV	0/1	0.56	43_54	97	99.0	0/1	0.48	43_40	83	99.0			rs141569849,COSV56968276	EXONIC	YES	NM_005557.4	Transcript	protein_coding	missense_variant		6/8	NM_005557.4:c.1168C>T	NP_005548.2:p.Arg390Cys		-1.0	Intermediate filament, rod domain&Intermediate filament, rod domain&Intermediate filament, rod domain,Intermediate filament, rod domain&Intermediate filament, rod domain&Intermediate filament, rod domain	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_provided	Palmoplantar keratoderma, nonepidermolytic, focal, 613000 (3), Autosomal dominant; Pachyonychia congenita 1, 167200 (3), Autosomal dominant	Epidermolytic palmoplantar keratoderma;Pachyonychia congenita;Isolated focal non-epidermolytic palmoplantar keratoderma	Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Localized epidermolytic hyperkeratosis;Verrucae;Hyperhidrosis;Abnormal fingernail morphology;Eczema;Palmoplantar keratoderma;Erythema;Autosomal dominant inheritance;Keratosis pilaris;Palmoplantar keratoderma;Abnormal blistering of the skin;Cognitive impairment;Palmoplantar keratoderma;Nail dystrophy;Epidermoid cyst;Laryngomalacia;Hepatomegaly;Corneal dystrophy;Abnormal fingernail morphology;Abnormality of nail color;Alopecia;Oral leukoplakia;Anonychia;Hyperhidrosis;Ichthyosis;Carious teeth;Onychogryposis;Skin plaque;Cataract;Respiratory insufficiency;Follicular hyperkeratosis;Palmoplantar hyperkeratosis;Heterogeneous;Autosomal dominant inheritance;Oral leukoplakia;Onychogryposis		0.00216809	330.0	152208.0	1.0	33	0.97	PASS	sas	0.00393375	19.0	0.00320428	218.0	0.00271237	681.0	251072.0	0.0	100	1.0	PASS	nfe	0.00351069	398.0	0.00351069	398.0	0.0027781	432	0.002	8.0	0.00159	18.0		24.5	3.364485	0.828	14	6	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	LRT_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,ClinPred_pred,fathmm-XF_coding_pred	KRT16	0.0	0.0	0.0	0.0	18.0	12.0	-3.0	-28.0						0.12	0.0		0.583	1.176	behavior/neurological phenotype ; mortality/aging ; digestive/alimentary phenotype; integument phenotype ; growth/size/body region phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			tongue;skin;skeletal muscle;	Cell Communication	morphogenesis of an epithelium;inflammatory response;cytoskeleton organization;aging;cell population proliferation;epidermis development;keratinocyte differentiation;negative regulation of cell migration;keratinization;hair cycle;innate immune response;intermediate filament cytoskeleton organization;keratinocyte migration;establishment of skin barrier;cornification	nucleus;cytosol;cytoskeleton;intermediate filament;extracellular exosome	structural constituent of cytoskeleton;protein binding	TTC23[unassigned1304];PUS10[unassigned1304];EIF4A3[23084401];CCNC[unassigned1304];SGF29[unassigned1304];PPP1R18[unassigned1304];AMOT[unassigned1304];TCHP[unassigned1304];EPM2AIP1[unassigned1304];IGHG1[15174051];MAP1LC3B[20562859];METTL14[29507755];ARFIP2[unassigned1304];POLL[unassigned1304];CCHCR1[unassigned1304];KRT6C[unassigned1304];KRT6A[unassigned1304];LMO1[unassigned1304];KRT71[unassigned1304];GABARAPL2[20562859];GABARAPL1[20562859];KRT4[unassigned1304];KRT3[unassigned1304];KRT2[unassigned1304];KRT1[unassigned1304];METTL3[29507755];KRT8[unassigned1304];KRT79[unassigned1304];APOA1[15174051];KRT78[unassigned1304];KRT5[unassigned1304];KRT76[unassigned1304];KRT74[unassigned1304];KRT73[unassigned1304];KRT72[unassigned1304];TXLNB[unassigned1304];HGS[unassigned1304];KIFC3[unassigned1304];C1orf216[unassigned1304];GAS8[unassigned1304];WHAMMP3[unassigned1304];SMARCD1[unassigned1304];KRT81[unassigned1304];KRT80[unassigned1304];TSG101[unassigned1304];PRKAA2[unassigned1304];USHBP1[unassigned1304];CCDC146[unassigned1304];KRT86[unassigned1304];TANK[14743216];KRT85[unassigned1304];GABARAP[20562859];KRT83[unassigned1304];KLC4[unassigned1304];GNG10[unassigned1304];CYTH4[unassigned1304];C1orf109[unassigned1304];MAPK6[26972000];PRPH[unassigned1304];MBD3[unassigned1304];SMARCE1[unassigned1304];CDK18[unassigned1304];CCDC17[unassigned1304];VCAM1[22623428];SNAPIN[unassigned1304];WTAP[29507755];CARD9[unassigned1304];SEMA4C[unassigned1304];PPP2R2B[19156129];ALB[15174051];LNX1[unassigned1304];PKN1[unassigned1304];	39766695
34615	chr17	39780443	C	T	chr17:39780443	KRT17	keratin 17	SNV	0/1	0.47	49_43	92	99.0	0/1	0.53	44_50	94	99.0			rs150004075,COSV60861738	EXONIC	YES	NM_000422.3	Transcript	protein_coding	missense_variant		1/8	NM_000422.3:c.319G>A	NP_000413.1:p.Glu107Lys		-1.0	Intermediate filament, rod domain&Intermediate filament, rod domain&Intermediate filament, rod domain,Intermediate filament, rod domain&Intermediate filament, rod domain&Intermediate filament, rod domain,Intermediate filament, rod domain&Intermediate filament, rod domain&Intermediate filament, rod domain	Benign	criteria_provided,_single_submitter	not_provided	Steatocystoma multiplex, 184500 (3), Autosomal dominant; Pachyonychia congenita 2, 167210 (3), Autosomal dominant	Pachyonychia congenita;Sebocystomatosis	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Nephrolithiasis;Adenoma sebaceum;Steatocystoma multiplex;Folliculitis;Hoarse voice;Epidermoid cyst;Nail dystrophy;Palmoplantar hyperkeratosis;Dry hair;Steatocystoma multiplex;Subungual hyperkeratosis;Heterogeneous;Natal tooth;Nail dysplasia;Sparse scalp hair;Autosomal dominant inheritance;Sparse and thin eyebrow;Palmoplantar hyperhidrosis;Abnormal blistering of the skin;Cognitive impairment;Palmoplantar keratoderma;Nail dystrophy;Epidermoid cyst;Laryngomalacia;Hepatomegaly;Corneal dystrophy;Abnormal fingernail morphology;Abnormality of nail color;Alopecia;Oral leukoplakia;Anonychia;Hyperhidrosis;Ichthyosis;Carious teeth;Onychogryposis;Skin plaque;Cataract;Respiratory insufficiency;Steatocystoma multiplex;Autosomal dominant inheritance		0.00143909	219.0	152180.0	1.0	33	0.98	PASS	nfe	0.00207262	141.0	0.00207262	141.0	0.00164237	413.0	251466.0	0.0	100	1.0	PASS	nfe	0.00220667	251.0	0.00220667	251.0	0.0016463	256	0.002	7.0	0.00064	7.0		22.5	2.477371	0.81	8	11	19	LRT_pred,M-CAP_pred,MetaLR_pred,MutationTaster_pred,FATHMM_pred,DEOGEN2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	KRT17	0.0	0.0	0.0	0.0	15.0	0.0	16.0	-10.0						0.191	0.0		0.997	1.026	digestive/alimentary phenotype; pigmentation phenotype; mortality/aging ; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype ; 			lung;trachea;tongue;superior cervical ganglion;skin;prostate;skeletal muscle;globus pallidus;	Cell Communication	cytoskeleton organization;signal transduction;epidermis development;hair follicle morphogenesis;keratinization;cornification	cytosol;intermediate filament;intermediate filament cytoskeleton;extracellular exosome	structural constituent of cytoskeleton;protein binding;MHC class II receptor activity;MHC class II protein binding	KDM1A[23455924];AGAP2[30021884];EGFR[15657067];UCHL1[19615732];TUBA1A[27291054];HERC2[29426014];CCDC85B[16189514];USP1[19615732];TRIM69[25416956];KRT6A[16189514];GABARAPL1[20562859];SNAPIN[23414517];WTAP[29507755];ECH1[29426014];AXIN1[26496610];KRT8[30021884];ARAP2[30021884];KRT77[30021884];NETO2[26496610];YWHAZ[20618440];ZDHHC17[24705354];EEF1G[17906640];APC[20936779;26496610];MYH9[26496610];GRB2[12577067];CFTR[22038833];	39780443
34643	chr17	40253855	C	T	chr17:40253855	DHX58	DExH-box helicase 58	SNV	0/1	0.52	67_74	142	99.0	0/1	0.55	59_72	131	99.0			rs117253612,COSV52428211	EXONIC	YES	NM_024119.3	Transcript	protein_coding	missense_variant		14/14	NM_024119.3:c.1961G>A	NP_077024.2:p.Arg654His		-1.0	RIG-I-like receptor, C-terminal regulatory domain&RIG-I-like receptor, C-terminal regulatory domain					.	.	.		0.00390861	595.0	152228.0	3.0	32	0.98	PASS	nfe	0.00531962	362.0	0.00531962	362.0	0.00394189	991.0	251402.0	4.0	84	1.0	PASS	nfe	0.00482038	548.0	0.00482038	548.0	0.0039613	616	0.003	10.0				19.23	1.935714	0.019	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	DHX58	0.0	0.0	0.0	0.0	-38.0	28.0	-1.0	9.0						0.933	0.0	0.000000000	0.321	-0.29	cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; mortality/aging ; reproductive system phenotype; hematopoietic system phenotype; 			ciliary ganglion;superior cervical ganglion;skeletal muscle;	Starch and sucrose metabolism;Folate biosynthesis	response to virus;response to bacterium;viral process;negative regulation of type I interferon production;positive regulation of type I interferon production;negative regulation of MDA-5 signaling pathway;negative regulation of RIG-I signaling pathway;innate immune response;regulation of innate immune response;negative regulation of innate immune response;defense response to virus;positive regulation of MDA-5 signaling pathway;positive regulation of RIG-I signaling pathway	cytoplasm	DNA binding;double-stranded RNA binding;single-stranded RNA binding;helicase activity;protein binding;ATP binding;zinc ion binding	STAU1[21903422];STAU2[21903422];DDX58[17190814];EIF2AK2[21903422];AP2B1[16189514];DICER1[21903422];CDKN2AIP[21903422];IFIH1[17190814];DHX30[21903422];EIF6[21903422];NKRF[21903422];MYC[21150319];AGO2[21903422];XRN2[21903422];	40253855
34652	chr17	40312349	G	A	chr17:40312349	KCNH4	potassium voltage-gated channel subfamily H member 4	SNV	0/1	0.46	76_66	142	99.0	0/1	0.44	69_54	124	99.0			rs138917401,COSV52919156	EXONIC	YES	NM_012285.3	Transcript	protein_coding	synonymous_variant		16/17	NM_012285.3:c.2763C>T	NP_036417.1:p.Ser921%3D		-1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00456906	695.0	152110.0	4.0	31	0.97	PASS	nfe	0.00664628	452.0	0.00664628	452.0	0.00441752	1110.0	251272.0	5.0	63	1.0	PASS	nfe	0.00634672	721.0	0.00634672	721.0	0.0045787	712	0.004	14.0				0.012	-0.768657		0	0	0			KCNH4	0.0	0.0	0.0	0.0	-31.0	35.0	5.0	-35.0						0.00241	1.0	54.855545267			immune system phenotype; hematopoietic system phenotype; 			pons;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	.	potassium ion transport;regulation of ion transmembrane transport;regulation of membrane potential;potassium ion transmembrane transport	plasma membrane;integral component of plasma membrane;voltage-gated potassium channel complex	voltage-gated potassium channel activity	.	40312349
34760	chr17	41243509	T	C	chr17:41243509	BRCA1	BRCA1, DNA repair associated	SNV	0/1	0.39	44_28	72	99.0	0/1	0.39	63_41	105	99.0			rs28897689,CD1111481,CM960181,COSV100524757	EXONIC	YES	NM_007300.4	Transcript	protein_coding	missense_variant		10/24	NM_007300.4:c.4039A>G	NP_009231.2:p.Arg1347Gly		-1.0	.,.,.,.	Benign	reviewed_by_expert_panel	Hereditary_breast_and_ovarian_cancer_syndrome|Breast-ovarian_cancer,_familial_1|Hereditary_cancer-predisposing_syndrome|Familial_cancer_of_breast|not_specified|Breast_and/or_ovarian_cancer|not_provided	Fanconi anemia, complementation group S, 617883 (3), Autosomal recessive; {Breast-ovarian cancer, familial, 1}, 604370 (3), Autosomal dominant, Multifactorial; {Pancreatic cancer, susceptibility to, 4}, 614320 (3)	Primary peritoneal carcinoma;Fanconi anemia;Familial prostate cancer;Hereditary site-specific ovarian cancer syndrome;Hereditary breast and ovarian cancer syndrome;Hereditary breast cancer;Familial pancreatic carcinoma	Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in;Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in;Major susceptibility factor in;Major susceptibility factor in	Somatic mutation;Autosomal dominant inheritance;Heterogeneous;Breast carcinoma;Low anterior hairline;Microphthalmia;Epicanthus;Macrodontia;Proximal placement of thumb;Failure to thrive;Sparse hair;Upslanted palpebral fissure;Short stature;Autosomal recessive inheritance;Delayed speech and language development;Clinodactyly;Prominent nasal bridge;Narrow palate;Coarse facial features;Breast carcinoma;Anemia;Hypertelorism;Global developmental delay;Ovarian neoplasm;Anteverted nares;Long eyelashes;Chromosome breakage;Blepharophimosis;Microcephaly;Intellectual disability;Dental malocclusion;Thick upper lip vermilion;Elevated hepatic transaminase;Breast carcinoma;Weight loss;Melanoma;Poor appetite;Ovarian carcinoma;Colon cancer;Nausea and vomiting;Back pain;Hepatosplenomegaly;Functional intestinal obstruction;Peritoneal abscess;Diabetes mellitus;Exocrine pancreatic insufficiency;Pancreatic adenocarcinoma;Anorexia;Intermittent diarrhea;Extrahepatic cholestasis;Neoplasm of the liver;Intestinal pseudo-obstruction;Abdominal pain;Lymphadenopathy;Jaundice;Chronic fatigue;Constipation;Neoplasm;Abdominal pain;Nausea and vomiting;Abdominal distention;Peritonitis;Multifactorial inheritance;Breast carcinoma;Autosomal dominant inheritance;Ovarian neoplasm;Primary peritoneal carcinoma;Melanoma;Neoplasm of the pancreas;Prostate cancer;Breast carcinoma;Ovarian neoplasm;Abnormal fallopian tube morphology;Hydroureter;Hypopigmented skin patches;Cranial nerve paralysis;Umbilical hernia;Epicanthus;Weight loss;Choanal atresia;Myelodysplasia;Hypogonadism;Scoliosis;Hip dislocation;Recurrent urinary tract infections;Abnormality of the hypothalamus-pituitary axis;Short palpebral fissure;Hypertrophic cardiomyopathy;High palate;Aplasia/Hypoplasia of the iris;Decreased fertility in males;Aplasia/Hypoplasia of fingers;Toe syndactyly;Irregular hyperpigmentation;Almond-shaped palpebral fissure;Tetralogy of Fallot;Astigmatism;Pyridoxine-responsive sideroblastic anemia;Meckel diverticulum;Hypertelorism;Sloping forehead;Ptosis;Anal atresia;Cryptorchidism;Intellectual disability;Facial asymmetry;Visual impairment;Upslanted palpebral fissure;Duodenal stenosis;Abnormality of the liver;Aplasia/Hypoplasia of the uvula;Abnormal carotid artery morphology;Hypospadias;Nystagmus;Multiple cafe-au-lait spots;Renal insufficiency;Clinodactyly of the 5th finger;Bicornuate uterus;Abnormality of chromosome stability;Strabismus;Micrognathia;Hypoplasia of the ulna;Proptosis;Atrial septal defect;Abnormal aortic valve morphology;Abnormality of femur morphology;Cataract;Microphthalmia;Hydrocephalus;Ventriculomegaly;Aganglionic megacolon;Absent testis;Hearing impairment;Arteriovenous malformation;Azoospermia;Renal hypoplasia/aplasia;Thrombocytopenia;Finger syndactyly;Oligohydramnios;External ear malformation;Global developmental delay;Aplasia/Hypoplasia of the radius;Reduced bone mineral density;Clubbing of toes;Microcephaly;Abnormal aortic morphology;Frontal bossing;Dolichocephaly;Spina bifida;Leukopenia;Tracheoesophageal fistula;Patent ductus arteriosus;Abnormality of the preputium;Hyperreflexia;Short stature;Abnormal localization of kidney;Cleft palate;Triphalangeal thumb;Intrauterine growth retardation;Pes planus	25741868,24033266,22703879,24728327,22995991,20104584,21702907,21990134,21965345,15235020,21520273,18694767,17719744,16014699,8776600,12215251,28497333,25948282,26092435	0.00407236	620.0	152246.0	4.0	32	0.98	PASS	nfe	0.0064372	438.0	0.0064372	438.0	0.00382339	960.0	251086.0	8.0	94	0.99	PASS	nfe	0.00684956	778.0	0.00684956	778.0	0.0041414	644	0.002	8.0	0.00298	34.0		21.4	2.196668	0.014	7	12	19	PolyPhen,M-CAP_pred,MutationAssessor_pred,FATHMM_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,fathmm-XF_coding_pred	BRCA1	0.01	0.0	0.0	0.0	11.0	-2.0	11.0	4.0						0.00207	0.0	0.000000000	0.663	1.138	mortality/aging ; normal phenotype; reproductive system phenotype; cardiovascular system phenotype ; hematopoietic system phenotype; neoplasm; pigmentation phenotype; embryo phenotype; behavior/neurological phenotype ; respiratory system phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; nervous system phenotype ; limbs/digits/tail phenotype; digestive/alimentary phenotype; integument phenotype ; growth/size/body region phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; 			pons;ciliary ganglion;appendix;tumor;dorsal root ganglion;atrioventricular node;superior cervical ganglion;testis;skeletal muscle;	Ubiquitin mediated proteolysis	double-strand break repair via homologous recombination;DNA double-strand break processing;DNA replication;postreplication repair;double-strand break repair;double-strand break repair via nonhomologous end joining;regulation of gene expression by genetic imprinting;regulation of transcription by RNA polymerase II;regulation of transcription by RNA polymerase III;fatty acid biosynthetic process;apoptotic process;cellular response to DNA damage stimulus;DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator;chromosome segregation;centrosome cycle;intrinsic apoptotic signaling pathway in response to DNA damage;dosage compensation by inactivation of X chromosome;response to ionizing radiation;positive regulation of vascular endothelial growth factor production;positive regulation of gene expression;protein ubiquitination;protein deubiquitination;androgen receptor signaling pathway;positive regulation of protein ubiquitination;negative regulation of intracellular estrogen receptor signaling pathway;positive regulation of histone acetylation;negative regulation of histone acetylation;regulation of cell population proliferation;regulation of apoptotic process;chordate embryonic development;response to estrogen;regulation of DNA methylation;mitotic G2/M transition checkpoint;negative regulation of fatty acid biosynthetic process;positive regulation of DNA repair;positive regulation of angiogenesis;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;negative regulation of centriole replication;positive regulation of histone H3-K4 methylation;negative regulation of histone H3-K4 methylation;negative regulation of histone H3-K9 methylation;positive regulation of histone H3-K9 methylation;protein autoubiquitination;negative regulation of G0 to G1 transition;positive regulation of histone H4-K20 methylation;positive regulation of cell cycle arrest;cellular response to tumor necrosis factor;cellular response to indole-3-methanol;signal transduction involved in G2 DNA damage checkpoint;protein K6-linked ubiquitination;negative regulation of extrinsic apoptotic signaling pathway via death domain receptors;negative regulation of reactive oxygen species metabolic process;positive regulation of histone H3-K9 acetylation;positive regulation of histone H4-K16 acetylation	ubiquitin ligase complex;lateral element;nucleus;nucleoplasm;chromosome;cytoplasm;plasma membrane;gamma-tubulin ring complex;BRCA1-BARD1 complex;protein-containing complex;BRCA1-A complex;ribonucleoprotein complex	DNA binding;damaged DNA binding;transcription coactivator activity;RNA binding;ubiquitin-protein transferase activity;protein binding;zinc ion binding;tubulin binding;enzyme binding;ubiquitin protein ligase binding;identical protein binding;transcription regulatory region DNA binding;androgen receptor binding;RNA polymerase binding	MDC1[12607005;17525332;29656893];TONSL[29656893];SMC5[29656893];SMC6[29656893];TRIM28[29656893];CHEK2[17525332];CHEK1[11836499];TRIM24[21988832];AKT1[21242970];TRIM27[29656893];FAAP100[29656893];NSMCE3[29656893];TINF2[29656893];NSMCE2[29656893];NSMCE1[29656893];RECQL[29656893];HUS1[29656893];AARSD1[25036637];KNL1[29656893];EWSR1[29656893];KIF20B[29656893];TP53[9926942];RHNO1[29656893];EXD2[26807646];CTBP2[29656893];CSTF2[10477523];ZBTB1[29656893];PIK3R1[17474147];BRCC3[19202061;29656893];UBE2J1[19690564];BRIP1[14576432;17525340;17581638;21240188;19369211;22792074;29656893];ZNF827[29656893];HIVEP1[21988832];DHX38[29656893];TP53BP1[17525332;18001824;22884692;29656893];ATRIP[29656893];BARD1[11573085;10477523;8944023;23680151;17873885;19369211;22110403;29656893];BRAP[9497340];CTC1[29656893];JUN[25609649];ACD[29656893];EGR3[29656893];JUP[21988832];PLK1[29656893];NR2F2[29656893];FOSL2[29656893];SETX[29656893];TPX2[22110403;29656893];FAM111A[29656893];ANLN[29656893];HIST1H4A[16628214];STAG1[29656893];SMTN[29656893];FUBP1[29656893];ATM[29656893];BAP1[9528852];RAD18[29656893];EZH2[23624935];ATR[29656893];TOP2A[15965487];WDR48[19615732];NCAPG2[29656893];BRCA1[8944023;29656893];BRCA2[22193777;19369211;29656893];BABAM1[29656893];MED12[29656893];BABAM2[29656893];EPM2AIP1[29656893];UIMC1[17525340;19615732;17643121;29656893];NELFB[11739404];JAK2[11163768];JAK1[11163768];RMI2[29656893];RMI1[29656893];TOP3A[29656893];KIF23[29656893];TERF1[29656893];ZHX1[29656893];TERF2[29656893];MLF1[25036637];RNF168[29656893];RAD51B[29656893];RNF169[29656893];KIF2A[29656893];SAGE1[29656893];KIFC1[29656893];POT1[29656893];KIF2C[29656893];ZNF350[11090615];FAAP24[29656893];RECQL4[29656893];WRN[29656893];RECQL5[29656893];SLX4[29656893];LMNA[22193777];RPL13[16452482];PRAME[29656893];SUZ12[23624935];CENPU[29656893];EGLN3[26972000];SLF1[29656893];SLF2[29656893];RPA1[21240188;19369211;29656893];RPA2[29656893];MLH1[21240188;29656893];PPP1CA[17511879];ETAA1[29656893];GFI1B[16713569];CENPI[29656893];RPA3[29656893];NFIC[29656893];HNRNPA2B1[29656893];RAD1[29656893];NCAPD3[29656893];DCLRE1B[29656893];DCLRE1A[29656893];MRE11[29656893];RIF1[29656893];PPP1CB[17511879];PPP1CC[17511879];SMCHD1[29656893];CCND1[17334399];EME1[29656893];KHSRP[29656893];ZNF207[29656893];NBN[29656893];KPNA2[9497340];KPNA1[8955125];GTF2I[21407215];MORC3[29656893];SLX4IP[29656893];WRNIP1[29656893];EMSY[29656893];PIAS1[29656893];MORF4L1[22193777];SGO2[29656893];MAU2[29656893];FANCD2[11239454;29656893];CCNE1[17525332];PMS2P3[29656893];RAD54L2[29656893];ZCCHC8[17525332];BLM[29656893];CT45A3[29656893];HMMR[22110403];ACACA[16326698;29899443];FAM83H[29656893];HMBOX1[29656893];ORC3[17525332];ABL1[17352427];LONRF1[22493164];FANCI[29656893];CPSF6[29656893];VCAM1[29656893];FANCM[29656893];FUS[29656893];FANCL[29656893];FANCA[12354784;21240188;29656893];FANCC[29656893];FANCB[29656893];FANCE[29656893];ESR1[11244506;15674350];PALB2[22193777;19369211;26649820;29656893];FANCG[29656893];ESR2[21951318];FANCF[29656893];KIF18A[29656893];KIF4A[29656893];BCL2[21444675];MNAT1[22493164];RAD9A[29656893];MUS81[29656893];TRIM74[22493164];FHL2[14550570;21988832];DDX42[29656893];MCM10[29656893];CABIN1[29656893];SUMO1[20016594];SUMO2[20016594;20016603];TOPBP1[29656893];POLE[29656893];NCK1[17474147];H2AFX[12419185;18001824;18001825;22193777];CIP2A[29656893];SMC1A[11877377];ARID1A[29656893];RAD23B[16712842];POMGNT1[21988832];ETV6[29656893];MMS22L[29656893];CREB1[9926942];NSMCE4A[29656893];PEX5[21988832];TERF2IP[29656893];MCPH1[29656893];CHMP5[29656893];LUZP1[29656893];ABRAXAS1[17525340;17643121;29656893];BRAT1[16452482];ZBTB48[29656893];RNF8[18001825];RNF6[29656893];HSPD1[21988832];AURKA[22110403];IFI16[14654789];POLD1[29656893];RBBP8[17525340;9811458;11739404;19369211;29656893];TRIM46[22493164];HNRNPA1[29656893];STN1[29656893];HNRNPAB[29656893];PML[29656893];RAD52[29656893];RAD50[29656893];RAD51[22193777;19369211;29656893];ERCC4[29656893];PRC1[29656893];ERCC1[29656893];RBM45[29656893];TRIM33[29656893];	41243509
34991	chr17	43367980	G	A	chr17:43367980	MAP3K14	mitogen-activated protein kinase kinase kinase 14	SNV	0/1	0.57	53_70	123	99.0	0/1	0.5	74_74	148	99.0			rs55740287	EXONIC	YES	NM_003954.5	Transcript	protein_coding	synonymous_variant		2/17	NM_003954.5:c.132C>T	NP_003945.2:p.Ala44%3D		-1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	NIK_deficiency|not_provided		NIK deficiency	Disease-causing germline mutation(s) (loss of function) in	.		0.00393156	597.0	151848.0	5.0	31	0.92	PASS	nfe	0.00501456	341.0	0.00501456	341.0	0.00454465	1133.0	249304.0	5.0	100	1.0	PASS	nfe	0.00504228	570.0	0.00504228	570.0	0.0039227	610	0.005	17.0	0.00682	65.0		7.325	0.30881		0	0	0			MAP3K14	0.0	0.0	0.0	0.01	-31.0	8.0	0.0	-48.0											mortality/aging ; hematopoietic system phenotype; liver/biliary system phenotype; respiratory system phenotype; immune system phenotype; renal/urinary system phenotype; digestive/alimentary phenotype; vision/eye phenotype; integument phenotype ; adipose tissue phenotype ; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; 			.	MAPK signaling pathway;Apoptosis;T cell receptor signaling pathway;Epithelial cell signaling in Helicobacter pylori infection	MAPK cascade;activation of MAPKK activity;immune response;I-kappaB kinase/NF-kappaB signaling;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;tumor necrosis factor-mediated signaling pathway;NIK/NF-kappaB signaling;positive regulation of I-kappaB kinase/NF-kappaB signaling;defense response to virus;cellular response to mechanical stimulus	fibrillar center;nucleus;cytoplasm;cytosol;intracellular membrane-bounded organelle	protein kinase activity;protein serine/threonine kinase activity;NF-kappaB-inducing kinase activity;MAP kinase kinase kinase activity;protein binding;ATP binding;kinase activity	RPL4[14743216];RPL5[14743216];RPLP0P6[14743216];RPL30[14743216];RPL3[14743216];RPL32[14743216];RPL10L[14743216];HNRNPU[14743216];EPRS[14743216];RPL10A[14743216];RPL8[14743216];RPL9[14743216];RPL6[14743216];ACTG1[14743216];RPL7[14743216];FBL[14743216];RPS17[14743216];RPS16[14743216];TBK1[23023393];RPS18[14743216];RUVBL2[14743216];RUVBL1[14743216];RPL35[14743216];RPS11[14743216];MAP3K7[10094049];RPS10[14743216];RPS13[14743216];RPS12[14743216];RPS9[14743216];RPS8[14743216];IL1R1[16286467];RPS5[14743216];RPL23[14743216];RPS6[14743216];RPL22[14743216];ILF2[14743216];EDAR[11035039];EEF1A1[21900206];GRWD1[14743216];NCL[14743216];CDC37[14743216;25036637];RPL24[14743216];RPL27[14743216];DDX5[14743216];DHX9[14743216];TIMM50[14743216];RAP1B[14743216];BAG2[14743216];HSPA9[14743216];HSPA8[14743216];HSPA5[14743216];HSPA6[14743216];NFKB2[14743216];GLUD1[14743216];HNRNPM[14743216];QARS[14743216];RPL27A[14743216];ALPL[15208311];RPS20[14743216];IARS[14743216];CALM1[14743216];RPS24[14743216];RPS23[14743216];HSP70-1[14743216];DDX3X[14743216];HSP90AB1[14743216;22939624];YBX1[14743216];ARRB2[17620599];YBX3[14743216];RPS4X[14743216];IKBKB[14743216;9520446;10733566];RPL7A[14743216];CASP8[12884866];CASP10[12884866];RARS[14743216];C1QBP[14743216];CASP3[25241761];RPLP2[14743216];HIST1H1E[14743216];RRP12[14743216];IKBKG[14743216];HSP90AA1[14743216];CHUK[10094049;14743216;16498412;16286467;9520446;25241761];TUBB[14743216];CAD[14743216];RPS3A[14743216];TRAF2[25416956;9020361];TUBB2B[14743216];SFPQ[14743216];TRAF3[14743216;unassigned1304];TRAF6[16286467;25241761];PABPC1[14743216];GAPDH[14743216];BIRC2[18022362];STAU1[14743216];RPL10[14743216];PELI3[12874243];RPL11[14743216];DDX21[14743216];ATP5F1A[14743216];TUBA3C[14743216];EXOSC10[14743216];RPS15A[14743216];RPS3[14743216];RPL14[14743216];RPL13[14743216];RPL18[14743216];HNRNPA1[14743216];NPM1[14743216];SSB[14743216];HSPA1L[14743216];TUBB4A[14743216];BYSL[14743216];DNAJA1[14743216];RSL1D1[14743216];MYBBP1A[14743216];TSR1[14743216];STUB1[14743216];FAU[14743216];	43367980
35032	chr17	45234303	G	C	chr17:45234303	CDC27	cell division cycle 27	SNV	0/1	0.44	31_24	55	99.0	0/1	0.53	20_23	43	99.0			rs200611688,COSV50364331	EXONIC	YES	NM_001114091.4	Transcript	protein_coding	missense_variant		7/19	NM_001114091.4:c.818C>G	NP_001107563.1:p.Ala273Gly		-1.0	.,.,.,.					.	.	.						32	0.98							0.489517	102125.0	208624.0	2.0	39	0.96	InbreedingCoeff	sas	0.498964	13972.0	0.485146	43473.0	0.0050288	782	0.09	280.0				23.2	2.855066	0.316	6	13	19	LRT_pred,MutationAssessor_pred,MutationTaster_pred,BayesDel_addAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	CDC27	0.01	0.0	0.0	0.01	46.0	-3.0	47.0	-24.0						0.684	0.49	98.285118952	0.999	1.167	.			ciliary ganglion;prefrontal cortex;testis - interstitial;dorsal root ganglion;trigeminal ganglion;skin;superior cervical ganglion;atrioventricular node;fetal liver;testis;	Cell cycle;Ubiquitin mediated proteolysis	metaphase/anaphase transition of mitotic cell cycle;cell population proliferation;anaphase-promoting complex-dependent catabolic process;protein K11-linked ubiquitination;regulation of mitotic cell cycle phase transition	nucleus;nucleoplasm;anaphase-promoting complex;cytoplasm;centrosome;spindle;cytosol;spindle microtubule	protein binding;protein phosphatase binding	FOXE1[25609649];CHD8[26496610];CCDC125[30021884];PTEN[21241890];BUB1B[11030144;20360068;20951947;25852190;20212161;21300909];COMT[25416956];RBPJ[25609649];CDC20[20360068;20951947;22014574;24781523;17443180;17443186;20212161];FOXQ1[25609649];CDC23[16648845;20360068;26496610;27173435;unassigned1312];CCND1[20439707];PTTG1[21186364];CDH1[20951947;20802534];CDC26[20360068];ZNF526[26496610];NEK2[16648845];FBXO5[17719540;18662541;23708001];HIST1H1A[30021884];TEAD2[25609649];NCK1[17474147];ANAPC7[21241890;unassigned1312];GKN1[21988832];FOXP3[25609649];SIRT2[22014574];ANAPC4[20360068;21241890;26496610;25383541;26083744];ANAPC5[20360068;21241890];ADNP[21988832];CFAP97[26496610];ANAPC1[20360068];ANAPC2[16648845;20360068;17443186;25043029;26083744;27120157];ANAPC13[20360068];ANAPC15[26496610];NOTCH1[23022380];ANAPC16[20360068];USP11[19615732];CDCA5[21186364];PIK3R1[17474147];FOXO3[25609649];ANAPC10[26496610;27509861];FZR1[18662541;21241890;22014574;21186364];HIST1H3A[29568061];ABL1[17474147];FYN[17474147];DCPS[21988832];CDC5L[20467437];MAD2L2[17719540];CDK7[29568061];SNW1[20467437];CDC16[16648845;20360068;26496610;unassigned1312;21186364];GRB2[17474147];MAD2L1[20951947;21772247;26496610;17443180;17443186;20212161];	45234303
35049	chr17	45234407	A		chr17:45234407	CDC27	cell division cycle 27	deletion	0|1	0.51	19_21	41	99.0	0|1	0.5	22_22	44	99.0			rs112848754,COSV50364069	EXONIC	YES	NM_001114091.4	Transcript	protein_coding	frameshift_variant		7/19	NM_001114091.4:c.714del	NP_001107563.1:p.Val239Ter		-1.0						.	.	.						32	0.97							0.498268	119681.0	240194.0	1.0	25	0.74	InbreedingCoeff	eas	0.499832	8944.0	0.497865	53395.0	0.0000450,0.0131958	7,2052						29.4	4.198786		0	0	0			CDC27	0.0	0.01	0.0	0.0	-34.0	2.0	2.0	1.0						0.684	0.49	92.752832727			.			ciliary ganglion;prefrontal cortex;testis - interstitial;dorsal root ganglion;trigeminal ganglion;skin;superior cervical ganglion;atrioventricular node;fetal liver;testis;	Cell cycle;Ubiquitin mediated proteolysis	metaphase/anaphase transition of mitotic cell cycle;cell population proliferation;anaphase-promoting complex-dependent catabolic process;protein K11-linked ubiquitination;regulation of mitotic cell cycle phase transition	nucleus;nucleoplasm;anaphase-promoting complex;cytoplasm;centrosome;spindle;cytosol;spindle microtubule	protein binding;protein phosphatase binding	FOXE1[25609649];CHD8[26496610];CCDC125[30021884];PTEN[21241890];BUB1B[11030144;20360068;20951947;25852190;20212161;21300909];COMT[25416956];RBPJ[25609649];CDC20[20360068;20951947;22014574;24781523;17443180;17443186;20212161];FOXQ1[25609649];CDC23[16648845;20360068;26496610;27173435;unassigned1312];CCND1[20439707];PTTG1[21186364];CDH1[20951947;20802534];CDC26[20360068];ZNF526[26496610];NEK2[16648845];FBXO5[17719540;18662541;23708001];HIST1H1A[30021884];TEAD2[25609649];NCK1[17474147];ANAPC7[21241890;unassigned1312];GKN1[21988832];FOXP3[25609649];SIRT2[22014574];ANAPC4[20360068;21241890;26496610;25383541;26083744];ANAPC5[20360068;21241890];ADNP[21988832];CFAP97[26496610];ANAPC1[20360068];ANAPC2[16648845;20360068;17443186;25043029;26083744;27120157];ANAPC13[20360068];ANAPC15[26496610];NOTCH1[23022380];ANAPC16[20360068];USP11[19615732];CDCA5[21186364];PIK3R1[17474147];FOXO3[25609649];ANAPC10[26496610;27509861];FZR1[18662541;21241890;22014574;21186364];HIST1H3A[29568061];ABL1[17474147];FYN[17474147];DCPS[21988832];CDC5L[20467437];MAD2L2[17719540];CDK7[29568061];SNW1[20467437];CDC16[16648845;20360068;26496610;unassigned1312;21186364];GRB2[17474147];MAD2L1[20951947;21772247;26496610;17443180;17443186;20212161];	45234406
35058	chr17	45234417	A	G	chr17:45234417	CDC27	cell division cycle 27	SNV	0/1	0.39	18_12	31	99.0	0|1	0.48	22_20	42	99.0			rs193061947,COSV50364052	EXONIC	YES	NM_001114091.4	Transcript	protein_coding	missense_variant		7/19	NM_001114091.4:c.704T>C	NP_001107563.1:p.Ile235Thr		-1.0	.,.,.					.	.	.						32	0.97							0.495447	110345.0	222718.0	1.0	41	0.98	InbreedingCoeff	sas	0.499289	14048.0	0.494178	48294.0	0.0003280	51	0.101	318.0				22.7	2.58091	0.332	8	10	18	LRT_pred,MutationTaster_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,ClinPred_pred	CDC27	0.01	0.01	0.0	0.0	18.0	-9.0	-10.0	36.0						0.684	0.49	92.752832727	1.0	1.302	.			ciliary ganglion;prefrontal cortex;testis - interstitial;dorsal root ganglion;trigeminal ganglion;skin;superior cervical ganglion;atrioventricular node;fetal liver;testis;	Cell cycle;Ubiquitin mediated proteolysis	metaphase/anaphase transition of mitotic cell cycle;cell population proliferation;anaphase-promoting complex-dependent catabolic process;protein K11-linked ubiquitination;regulation of mitotic cell cycle phase transition	nucleus;nucleoplasm;anaphase-promoting complex;cytoplasm;centrosome;spindle;cytosol;spindle microtubule	protein binding;protein phosphatase binding	FOXE1[25609649];CHD8[26496610];CCDC125[30021884];PTEN[21241890];BUB1B[11030144;20360068;20951947;25852190;20212161;21300909];COMT[25416956];RBPJ[25609649];CDC20[20360068;20951947;22014574;24781523;17443180;17443186;20212161];FOXQ1[25609649];CDC23[16648845;20360068;26496610;27173435;unassigned1312];CCND1[20439707];PTTG1[21186364];CDH1[20951947;20802534];CDC26[20360068];ZNF526[26496610];NEK2[16648845];FBXO5[17719540;18662541;23708001];HIST1H1A[30021884];TEAD2[25609649];NCK1[17474147];ANAPC7[21241890;unassigned1312];GKN1[21988832];FOXP3[25609649];SIRT2[22014574];ANAPC4[20360068;21241890;26496610;25383541;26083744];ANAPC5[20360068;21241890];ADNP[21988832];CFAP97[26496610];ANAPC1[20360068];ANAPC2[16648845;20360068;17443186;25043029;26083744;27120157];ANAPC13[20360068];ANAPC15[26496610];NOTCH1[23022380];ANAPC16[20360068];USP11[19615732];CDCA5[21186364];PIK3R1[17474147];FOXO3[25609649];ANAPC10[26496610;27509861];FZR1[18662541;21241890;22014574;21186364];HIST1H3A[29568061];ABL1[17474147];FYN[17474147];DCPS[21988832];CDC5L[20467437];MAD2L2[17719540];CDK7[29568061];SNW1[20467437];CDC16[16648845;20360068;26496610;unassigned1312;21186364];GRB2[17474147];MAD2L1[20951947;21772247;26496610;17443180;17443186;20212161];	45234417
35072	chr17	45234420	T	G	chr17:45234420	CDC27	cell division cycle 27	SNV	0|1	0.44	17_14	32	99.0	0|1	0.45	22_18	40	99.0			rs78493795,COSV50364086	EXONIC	YES	NM_001114091.4	Transcript	protein_coding	missense_variant		7/19	NM_001114091.4:c.701A>C	NP_001107563.1:p.Tyr234Ser		-1.0	.,.,.					.	.	.		0.0	0.0	151802.0	0.0	32	0.97	AC0_AS_VQSR				0.0	0.0	0.496267	111801.0	225284.0	2.0	40	0.97	InbreedingCoeff	sas	0.499824	14179.0	0.495333	49032.0	0.0004566	71	0.094	296.0				22.8	2.649739	0.376	6	12	18	LRT_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,ClinPred_pred,LIST-S2_pred	CDC27	0.02	0.0	0.0	0.0	-12.0	-48.0	-13.0	33.0						0.684	0.49	92.752832727	0.998	1.13	.			ciliary ganglion;prefrontal cortex;testis - interstitial;dorsal root ganglion;trigeminal ganglion;skin;superior cervical ganglion;atrioventricular node;fetal liver;testis;	Cell cycle;Ubiquitin mediated proteolysis	metaphase/anaphase transition of mitotic cell cycle;cell population proliferation;anaphase-promoting complex-dependent catabolic process;protein K11-linked ubiquitination;regulation of mitotic cell cycle phase transition	nucleus;nucleoplasm;anaphase-promoting complex;cytoplasm;centrosome;spindle;cytosol;spindle microtubule	protein binding;protein phosphatase binding	FOXE1[25609649];CHD8[26496610];CCDC125[30021884];PTEN[21241890];BUB1B[11030144;20360068;20951947;25852190;20212161;21300909];COMT[25416956];RBPJ[25609649];CDC20[20360068;20951947;22014574;24781523;17443180;17443186;20212161];FOXQ1[25609649];CDC23[16648845;20360068;26496610;27173435;unassigned1312];CCND1[20439707];PTTG1[21186364];CDH1[20951947;20802534];CDC26[20360068];ZNF526[26496610];NEK2[16648845];FBXO5[17719540;18662541;23708001];HIST1H1A[30021884];TEAD2[25609649];NCK1[17474147];ANAPC7[21241890;unassigned1312];GKN1[21988832];FOXP3[25609649];SIRT2[22014574];ANAPC4[20360068;21241890;26496610;25383541;26083744];ANAPC5[20360068;21241890];ADNP[21988832];CFAP97[26496610];ANAPC1[20360068];ANAPC2[16648845;20360068;17443186;25043029;26083744;27120157];ANAPC13[20360068];ANAPC15[26496610];NOTCH1[23022380];ANAPC16[20360068];USP11[19615732];CDCA5[21186364];PIK3R1[17474147];FOXO3[25609649];ANAPC10[26496610;27509861];FZR1[18662541;21241890;22014574;21186364];HIST1H3A[29568061];ABL1[17474147];FYN[17474147];DCPS[21988832];CDC5L[20467437];MAD2L2[17719540];CDK7[29568061];SNW1[20467437];CDC16[16648845;20360068;26496610;unassigned1312;21186364];GRB2[17474147];MAD2L1[20951947;21772247;26496610;17443180;17443186;20212161];	45234420
35085	chr17	45669359	T	G	chr17:45669359	NPEPPS	aminopeptidase puromycin sensitive	SNV	0/1	0.2	60_15	75	99.0	0/1	0.23	63_19	83	99.0			rs200616431,COSV59100571	EXONIC	YES	NM_006310.4	Transcript	protein_coding	missense_variant		11/23	NM_006310.4:c.1298T>G	NP_006301.3:p.Phe433Cys		1.0	Peptidase M1, membrane alanine aminopeptidase, N-terminal,Peptidase M1, membrane alanine aminopeptidase, N-terminal,Peptidase M1, membrane alanine aminopeptidase, N-terminal,Peptidase M1, membrane alanine aminopeptidase, N-terminal					.	.	.						29	0.87							0.132488	21014.0	158610.0	0.0	60	1.0	InbreedingCoeff_RF	nfe	0.204639	13534.0	0.204639	13534.0	0.0007267	113	0.051	155.0				30.0	4.280729	0.977	14	6	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,ClinPred_pred	NPEPPS	0.0	0.02	0.0	0.0	-49.0	19.0	23.0	-38.0						0.374	1.0		1.0	1.104	integument phenotype ; growth/size/body region phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; reproductive system phenotype; mortality/aging ; behavior/neurological phenotype ; 			ciliary ganglion;caudate nucleus;testis - seminiferous tubule;superior cervical ganglion;cingulate cortex;pons;occipital lobe;subthalamic nucleus;dorsal root ganglion;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;thalamus;	.	protein polyubiquitination;proteolysis;peptide catabolic process;cellular response to hypoxia;positive regulation of protein targeting to mitochondrion	nucleus;cytoplasm;cytosol;extracellular exosome	aminopeptidase activity;zinc ion binding;peptide binding;metalloaminopeptidase activity	OTUD4[19615732];JUN[25609649];HLA-B[17353931];HSCB[28380382];MCC[17353931];PRKAB1[17353931];NFKB1[25609649];NIPSNAP2[20562859];GH1[17353931];CLN3[20562859];EIF6[17353931];TRAF6[17353931];DMWD[19615732];PHKG2[23455922];TIMP2[17353931];ARF6[17353931];	45669359
35086	chr17	45669429		AAAA	chr17:45669428-45669429	NPEPPS	aminopeptidase puromycin sensitive	insertion	0/0	0.0	38_0	38	84.0	0/1	0.17	20_4	24	80.0			rs59875832	SPLICING	YES	NM_006310.4	Transcript	protein_coding	splice_region_variant,intron_variant	11/22		NM_006310.4:c.1365+8_1365+11dup			1.0						.	.	.		0.0	0.0	150626.0	0.0	14	0.53	AC0				0.0	0.0					25	0.72							0.0000257	4	0.002	7.0				16.14	1.477321		0	0	0																	0.374	1.0				integument phenotype ; growth/size/body region phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; reproductive system phenotype; mortality/aging ; behavior/neurological phenotype ; 			ciliary ganglion;caudate nucleus;testis - seminiferous tubule;superior cervical ganglion;cingulate cortex;pons;occipital lobe;subthalamic nucleus;dorsal root ganglion;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;thalamus;	.	protein polyubiquitination;proteolysis;peptide catabolic process;cellular response to hypoxia;positive regulation of protein targeting to mitochondrion	nucleus;cytoplasm;cytosol;extracellular exosome	aminopeptidase activity;zinc ion binding;peptide binding;metalloaminopeptidase activity	OTUD4[19615732];JUN[25609649];HLA-B[17353931];HSCB[28380382];MCC[17353931];PRKAB1[17353931];NFKB1[25609649];NIPSNAP2[20562859];GH1[17353931];CLN3[20562859];EIF6[17353931];TRAF6[17353931];DMWD[19615732];PHKG2[23455922];TIMP2[17353931];ARF6[17353931];	45669428
35092	chr17	45699163	A	C	chr17:45699163	NPEPPS	aminopeptidase puromycin sensitive	SNV	0/1	0.32	56_26	82	99.0	0/1	0.62	20_36	58	99.0			rs755904149	EXONIC	YES	NM_006310.4	Transcript	protein_coding	synonymous_variant		23/23	NM_006310.4:c.2637A>C	NP_006301.3:p.Ser879%3D		1.0						.	.	.						32	0.97							1.60693e-05	4.0	248922.0	0.0	41	0.96	PASS	amr	8.70423e-05	3.0	8.86666e-06	1.0	0.0000129	2						11.08	0.691062		0	0	0			NPEPPS	0.0	0.0	0.0	0.0	-17.0	2.0	7.0	2.0						0.374	1.0	54.855545267			integument phenotype ; growth/size/body region phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; reproductive system phenotype; mortality/aging ; behavior/neurological phenotype ; 			ciliary ganglion;caudate nucleus;testis - seminiferous tubule;superior cervical ganglion;cingulate cortex;pons;occipital lobe;subthalamic nucleus;dorsal root ganglion;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;thalamus;	.	protein polyubiquitination;proteolysis;peptide catabolic process;cellular response to hypoxia;positive regulation of protein targeting to mitochondrion	nucleus;cytoplasm;cytosol;extracellular exosome	aminopeptidase activity;zinc ion binding;peptide binding;metalloaminopeptidase activity	OTUD4[19615732];JUN[25609649];HLA-B[17353931];HSCB[28380382];MCC[17353931];PRKAB1[17353931];NFKB1[25609649];NIPSNAP2[20562859];GH1[17353931];CLN3[20562859];EIF6[17353931];TRAF6[17353931];DMWD[19615732];PHKG2[23455922];TIMP2[17353931];ARF6[17353931];	45699163
35236	chr17	48245751	C	T	chr17:48245751	SGCA	sarcoglycan alpha	SNV	0/1	0.47	44_39	83	99.0	0/1	0.36	63_35	98	99.0			rs780264754,CM105561	EXONIC	YES	NM_000023.4	Transcript	protein_coding	synonymous_variant		5/10	NM_000023.4:c.402C>T	NP_000014.1:p.Tyr134%3D		1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Autosomal_recessive_limb-girdle_muscular_dystrophy_type_2D|not_provided	Muscular dystrophy, limb-girdle, autosomal recessive 3, 608099 (3), Autosomal recessive	Autosomal recessive limb-girdle muscular dystrophy type 2D	Disease-causing germline mutation(s) in	Waddling gait;Achilles tendon contracture;Gowers sign;Frequent falls;Limited shoulder movement;Elevated serum creatine kinase;Thoracic scoliosis;Muscular dystrophy;Toe walking;Hyperlordosis;Difficulty climbing stairs;Scapular winging;Calf muscle pseudohypertrophy;Flexion contracture;Autosomal recessive inheritance;Progressive;Cardiomyopathy;Calf muscle hypertrophy;Variable expressivity;Scoliosis;Limb-girdle muscle atrophy;Juvenile onset;EMG: myopathic abnormalities;Limb-girdle muscular dystrophy;Limb-girdle muscle weakness;Unsteady gait;Elevated serum creatine kinase	11475588	1.97176e-05	3.0	152148.0	0.0	32	0.97	PASS	nfe	2.94083e-05	2.0	2.94083e-05	2.0	1.99992e-05	4.0	200008.0	0.0	77	0.58	PASS	amr	6.86672e-05	2.0	2.30776e-05	2.0	0.0000064	1			9e-05	1.0		6.515	0.247247		0	0	0			SGCA	0.0	0.02	0.0	0.0	5.0	24.0	15.0	-38.0						0.0528	0.19	90.620357098			homeostasis/metabolism phenotype; muscle phenotype; immune system phenotype; cardiovascular system phenotype ; 			ciliary ganglion;superior cervical ganglion;trigeminal ganglion;skeletal muscle;heart;	.	muscle contraction;muscle organ development	cytoplasm;cytoskeleton;cell-cell junction;dystrophin-associated glycoprotein complex;sarcoglycan complex;integral component of membrane;sarcolemma;membrane raft	calcium ion binding;protein binding	SGTB[unassigned1304];SGTA[21516116;25416956;26871637;unassigned1304;25910212];FN1[23414517];ITGB1BP2[23414517];FSTL1[23414517];TAF1[23414517];	48245751
35385	chr17	48733187	C	T	chr17:48733187	ABCC3	ATP binding cassette subfamily C member 3	SNV	0/1	0.47	43_38	81	99.0	0/0	0.0	35_0	35	99.0			rs62059746	SPLICING	YES	NM_003786.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/30		NM_003786.4:c.46-6C>T			1.0						.	.	.		0.00482476	734.0	152132.0	2.0	31	0.94	PASS	nfe	0.00662865	451.0	0.00662865	451.0	0.0051932	1301.0	250520.0	5.0	37	0.98	PASS	nfe	0.00752618	851.0	0.00752618	851.0	0.0052925	823	0.005	18.0	0.00668	75.0		13.23	0.971356		0	0	0			ABCC3	0.0	0.0	0.0	0.0	31.0	-20.0	16.0	31.0	0.0002853921394229	0.07	10.759	1.697	12.456	0.0379	0.0				homeostasis/metabolism phenotype; integument phenotype ; behavior/neurological phenotype ; 			liver;pancreas;superior cervical ganglion;trigeminal ganglion;adrenal gland;adrenal cortex;skeletal muscle;	ABC transporters	bile acid and bile salt transport;canalicular bile acid transport;transmembrane transport;ATP hydrolysis coupled anion transmembrane transport	vacuolar membrane;plasma membrane;integral component of plasma membrane;membrane	ATP binding;organic anion transmembrane transporter activity;bile acid-exporting ATPase activity;ATPase activity, coupled to transmembrane movement of substances;ATPase-coupled anion transmembrane transporter activity	MLH1[20706999];	48733187
35452	chr17	56270849	T	C	chr17:56270849	EPX	eosinophil peroxidase	SNV	0/0	0.0	44_0	44	99.0	0/1	0.42	62_45	107	99.0			rs35979397	EXONIC	YES	NM_000502.6	Transcript	protein_coding	synonymous_variant		3/13	NM_000502.6:c.288T>C	NP_000493.1:p.Ala96%3D		1.0					[Eosinophil peroxidase deficiency], 261500 (3), Autosomal recessive	Autosomal dominant secondary polycythemia	Disease-causing germline mutation(s) (gain of function) in	Autosomal recessive inheritance;Infantile onset;Anemia;Increased hematocrit;Autosomal dominant inheritance;Increased hemoglobin		0.0022339	340.0	152200.0	2.0	32	0.97	PASS	afr	0.00692434	287.0	0.00027928	19.0	0.00126083	317.0	251422.0	3.0	100	1.0	PASS	afr	0.00750492	122.0	0.000413325	47.0	0.0012476	194	0.003	10.0	0.00228	26.0		10.96	0.676665		0	0	0			EPX	0.0	0.0	0.01	0.0	-46.0	17.0	35.0	-6.0						0.861	0.0	49.947708191			immune system phenotype; hematopoietic system phenotype; 			bone marrow;	Asthma	defense response to nematode;response to oxidative stress;negative regulation of interleukin-10 production;negative regulation of interleukin-5 production;positive regulation of interleukin-4 production;defense response to bacterium;hydrogen peroxide catabolic process;neutrophil degranulation;oxidation-reduction process;eosinophil migration;cellular oxidant detoxification	extracellular region;extracellular space;cytoplasm;secretory granule lumen;extracellular exosome	peroxidase activity;heme binding;metal ion binding	PIK3R1[17474147];PLCG1[17474147];NCK1[17474147];	56270849
35476	chr17	56383739	T	C	chr17:56383739	TSPOAP1	TSPO associated protein 1	SNV	0/0	0.0	41_0	41	99.0	0/1	0.46	43_39	84	99.0			rs201775210	EXONIC	YES	NM_004758.4	Transcript	protein_coding	missense_variant		26/32	NM_004758.4:c.5188A>G	NP_004749.2:p.Thr1730Ala		-1.0	.,.,.					.	.	.		0.00036169	55.0	152064.0	0.0	32	0.96	PASS	amr	0.00190039	29.0	0.000279338	19.0	0.000737491	119.0	161358.0	2.0	32	0.58	PASS	amr	0.00320894	81.0	0.000378322	24.0	0.0003601	56	0.002	7.0				0.006	-0.852467	0.009	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	BZRAP1	0.01	0.01	0.01	0.0	-1.0	35.0	-36.0	30.0								0.000000000	0.021	-1.34	nervous system phenotype ; normal phenotype; 			.	.	C21-steroid hormone biosynthetic process;neuromuscular synaptic transmission;biological_process;regulation of presynaptic cytosolic calcium ion concentration	cytoplasm;mitochondrion;cytosol;calyx of Held;glutamatergic synapse	protein binding;benzodiazepine receptor binding;voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels	CACNA1A[21078624];HIST1H2BD[30021884];HIST1H1C[30021884];	56383739
35571	chr17	57290852	T	C	chr17:57290852	SMG8	SMG8, nonsense mediated mRNA decay factor	SNV	0/0	0.0	44_0	44	99.0	0/1	0.44	60_47	107	99.0			rs137980220	EXONIC	YES	NM_018149.7	Transcript	protein_coding	missense_variant		3/4	NM_018149.7:c.2668T>C	NP_060619.4:p.Tyr890His		1.0	.,.				Alzahrani-Kuwahara syndrome, 619268 (3), Autosomal recessive	.	.	.		0.000584772	89.0	152196.0	0.0	32	0.96	PASS	amr	0.00333813	51.0	0.000308678	21.0	0.000362192	91.0	251248.0	0.0	100	1.0	PASS	amr	0.00115634	40.0	0.000387529	44.0	0.0002894	45	0.003	8.0				28.2	4.059869	0.689	13	8	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	SMG8	0.0	0.03	0.0	0.0	1.0	22.0	21.0	22.0							0.02	0.000000000	0.997	1.138	.			pons;ciliary ganglion;appendix;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;parietal lobe;skeletal muscle;globus pallidus;	.	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;regulation of protein kinase activity	cellular_component;cytosol	protein binding	UPF1[19417104];SMG1[20371770;19417104;20817927];RBM8A[19417104];SMG9[19417104;20817927;26496610];	57290852
35790	chr17	62080248	C	T	chr17:62080248	ICAM2	intercellular adhesion molecule 2	SNV	0/1	0.41	76_53	130	99.0	0/0	0.0	42_0	42	99.0			rs141394372	EXONIC	YES	NM_001099786.2	Transcript	protein_coding	synonymous_variant		6/6	NM_001099786.2:c.687G>A	NP_001093256.1:p.Thr229%3D		-1.0						.	.	.		0.00214248	326.0	152160.0	0.0	32	0.98	PASS	nfe	0.00324885	221.0	0.00324885	221.0	0.0015906	395.0	248334.0	0.0	49	0.98	PASS	nfe	0.00251664	279.0	0.00251664	279.0	0.0013762	214	0.004	13.0				0.123	-0.455053		0	0	0			ICAM2	0.0	0.01	0.0	0.0	-2.0	37.0	-5.0	0.0						0.764	0.02				hematopoietic system phenotype; respiratory system phenotype; immune system phenotype; 			.	Cell adhesion molecules (CAMs);Natural killer cell mediated cytotoxicity	stimulatory C-type lectin receptor signaling pathway;cell adhesion;extracellular matrix organization;regulation of immune response;cell-cell adhesion	uropod;plasma membrane;integral component of plasma membrane;microvillus;membrane;cleavage furrow	integrin binding	F2RL1[28298427];ATP13A2[22645275];	62080248
35834	chr17	65822267	GGA		chr17:65822267-65822269	BPTF	bromodomain PHD finger transcription factor	deletion	0/1	0.15	52_9	61	99.0	0/0	0.06	47_3	54	27.0			rs751039972	EXONIC	YES	NM_182641.4	Transcript	protein_coding	inframe_deletion		1/28	NM_182641.4:c.444_446del	NP_872579.2:p.Glu148del		1.0					Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies, 617755 (3), Autosomal dominant	.	.	Vesicoureteral reflux;Failure to thrive in infancy;Abnormality of the wrist;Otosclerosis;Secondary amenorrhea;Recurrent otitis media;Thick eyebrow;Broad neck;Aggressive behavior;Upper limb undergrowth;Abnormality of the ankles;Short neck;Pineal cyst;Hypertelorism;Wide nasal bridge;Synophrys;Delayed speech and language development;Pulmonic stenosis;Scoliosis;Hemihypotrophy of lower limb;Misalignment of teeth;Patent ductus arteriosus after birth at term;Broad thumb;Mood swings;Prolonged QT interval;Triangular face;Midface retrusion;Hallucinations;Anxiety;Generalized neonatal hypotonia;Myopia;Intellectual disability, mild;Progressive conductive hearing impairment;Impaired visuospatial constructive cognition;Micrognathia;Ptosis;Seizure;Short philtrum;Cubitus valgus;Thin upper lip vermilion;Truncal obesity;Deeply set eye;Downslanted palpebral fissures;Microtia;Feeding difficulties;Slender finger;Microcephaly;Prominent nose;Overlapping toe;Strabismus;Thin upper lip vermilion;Intellectual disability;Broad hallux;Micrognathia;Upslanted palpebral fissure;Global developmental delay;Pes planus;Short palpebral fissure;Short stature;Autosomal dominant inheritance;Sandal gap;Epicanthus;Hypertelorism;Abnormality of the cerebral white matter;Broad nasal tip;Clinodactyly;Delayed speech and language development;Small hand;Generalized hypotonia;Narrow mouth		0.000205499	31.0	150852.0	0.0	30	0.93	PASS	sas	0.000416667	2.0	0.00022217	15.0	0.00334234	638.0	190884.0	0.0	35	0.84	PASS	eas	0.00480553	64.0	0.00373507	322.0	0.0000386	6	0.038	120.0				17.57	1.713664		0	0	0			BPTF	0.0	0.0	0.0	0.0	10.0	4.0	-6.0	3.0						0.278	1.0				cellular phenotype; growth/size/body region phenotype; mortality/aging ; embryo phenotype; 			occipital lobe;superior cervical ganglion;	.	negative regulation of transcription by RNA polymerase II;embryonic placenta development;chromatin remodeling;regulation of transcription by RNA polymerase II;brain development;endoderm development;anterior/posterior pattern specification;positive regulation of transcription by RNA polymerase II	nuclear chromatin;nucleus;nucleoplasm;cytoplasm;NURF complex;Set1C/COMPASS complex;extracellular exosome	protein binding;DNA-dependent ATPase activity;transcription factor binding;methylated histone binding;sequence-specific DNA binding;metal ion binding	CBX6[21282530];H3F3A[20953165];TIMM13[26496610];EN2[14609955];SMARCA5[22729083];FOXK2[25609649];EN1[14609955];DPY30[23995757;25456412];DLST[29128334];SMC1A[26496610];RNASEK-C17orf49[26496610];SMARCA1[15640247;14609955];RPS4X[30021884];HIST1H4A[21596426];HIST1H3A[29568061];RBBP4[27705803;14609955];NUDCD1[29021621];MYC[21150319];HIST1H2BH[30021884];RBBP7[14609955];HIST2H3D[21596426];AURKAIP1[29568061];SQSTM1[21900206];LLGL2[26496610];	65822266
35836	chr17	65850232	C	G	chr17:65850232	BPTF	bromodomain PHD finger transcription factor	SNV	0/0	0.0	35_0	35	99.0	0/1	0.44	73_57	130	99.0			rs201658052	EXONIC	YES	NM_182641.4	Transcript	protein_coding	missense_variant		2/28	NM_182641.4:c.790C>G	NP_872579.2:p.Pro264Ala		1.0	DDT domain&DDT domain&DDT domain,DDT domain&DDT domain&DDT domain,.,DDT domain&DDT domain&DDT domain,DDT domain&DDT domain&DDT domain,DDT domain&DDT domain&DDT domain,DDT domain&DDT domain&DDT domain				Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies, 617755 (3), Autosomal dominant	.	.	Vesicoureteral reflux;Failure to thrive in infancy;Abnormality of the wrist;Otosclerosis;Secondary amenorrhea;Recurrent otitis media;Thick eyebrow;Broad neck;Aggressive behavior;Upper limb undergrowth;Abnormality of the ankles;Short neck;Pineal cyst;Hypertelorism;Wide nasal bridge;Synophrys;Delayed speech and language development;Pulmonic stenosis;Scoliosis;Hemihypotrophy of lower limb;Misalignment of teeth;Patent ductus arteriosus after birth at term;Broad thumb;Mood swings;Prolonged QT interval;Triangular face;Midface retrusion;Hallucinations;Anxiety;Generalized neonatal hypotonia;Myopia;Intellectual disability, mild;Progressive conductive hearing impairment;Impaired visuospatial constructive cognition;Micrognathia;Ptosis;Seizure;Short philtrum;Cubitus valgus;Thin upper lip vermilion;Truncal obesity;Deeply set eye;Downslanted palpebral fissures;Microtia;Feeding difficulties;Slender finger;Microcephaly;Prominent nose;Overlapping toe;Strabismus;Thin upper lip vermilion;Intellectual disability;Broad hallux;Micrognathia;Upslanted palpebral fissure;Global developmental delay;Pes planus;Short palpebral fissure;Short stature;Autosomal dominant inheritance;Sandal gap;Epicanthus;Hypertelorism;Abnormality of the cerebral white matter;Broad nasal tip;Clinodactyly;Delayed speech and language development;Small hand;Generalized hypotonia;Narrow mouth		1.31408e-05	2.0	152198.0	0.0	32	0.97	PASS	amr	0.00013101	2.0	0.0	0.0	3.97668e-06	1.0	251466.0	0.0	100	1.0	PASS	amr	2.89084e-05	1.0	0.0	0.0	0.0000193	3						24.2	3.262977	0.281	19	1	20	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT	BPTF	0.0	0.0	0.0	0.0	-36.0	15.0	32.0	-37.0						0.278	1.0	0.000000000	0.983	1.008	cellular phenotype; growth/size/body region phenotype; mortality/aging ; embryo phenotype; 			occipital lobe;superior cervical ganglion;	.	negative regulation of transcription by RNA polymerase II;embryonic placenta development;chromatin remodeling;regulation of transcription by RNA polymerase II;brain development;endoderm development;anterior/posterior pattern specification;positive regulation of transcription by RNA polymerase II	nuclear chromatin;nucleus;nucleoplasm;cytoplasm;NURF complex;Set1C/COMPASS complex;extracellular exosome	protein binding;DNA-dependent ATPase activity;transcription factor binding;methylated histone binding;sequence-specific DNA binding;metal ion binding	CBX6[21282530];H3F3A[20953165];TIMM13[26496610];EN2[14609955];SMARCA5[22729083];FOXK2[25609649];EN1[14609955];DPY30[23995757;25456412];DLST[29128334];SMC1A[26496610];RNASEK-C17orf49[26496610];SMARCA1[15640247;14609955];RPS4X[30021884];HIST1H4A[21596426];HIST1H3A[29568061];RBBP4[27705803;14609955];NUDCD1[29021621];MYC[21150319];HIST1H2BH[30021884];RBBP7[14609955];HIST2H3D[21596426];AURKAIP1[29568061];SQSTM1[21900206];LLGL2[26496610];	65850232
35838	chr17	65908885	TAC		chr17:65908885-65908887	BPTF	bromodomain PHD finger transcription factor	deletion	0/1	0.37	65_38	103	99.0	0/0	0.0	37_0	37	99.0			rs764167122	EXONIC	YES	NM_182641.4	Transcript	protein_coding	inframe_deletion		11/28	NM_182641.4:c.4887_4889del	NP_872579.2:p.Thr1631del		1.0					Neurodevelopmental disorder with dysmorphic facies and distal limb anomalies, 617755 (3), Autosomal dominant	.	.	Vesicoureteral reflux;Failure to thrive in infancy;Abnormality of the wrist;Otosclerosis;Secondary amenorrhea;Recurrent otitis media;Thick eyebrow;Broad neck;Aggressive behavior;Upper limb undergrowth;Abnormality of the ankles;Short neck;Pineal cyst;Hypertelorism;Wide nasal bridge;Synophrys;Delayed speech and language development;Pulmonic stenosis;Scoliosis;Hemihypotrophy of lower limb;Misalignment of teeth;Patent ductus arteriosus after birth at term;Broad thumb;Mood swings;Prolonged QT interval;Triangular face;Midface retrusion;Hallucinations;Anxiety;Generalized neonatal hypotonia;Myopia;Intellectual disability, mild;Progressive conductive hearing impairment;Impaired visuospatial constructive cognition;Micrognathia;Ptosis;Seizure;Short philtrum;Cubitus valgus;Thin upper lip vermilion;Truncal obesity;Deeply set eye;Downslanted palpebral fissures;Microtia;Feeding difficulties;Slender finger;Microcephaly;Prominent nose;Overlapping toe;Strabismus;Thin upper lip vermilion;Intellectual disability;Broad hallux;Micrognathia;Upslanted palpebral fissure;Global developmental delay;Pes planus;Short palpebral fissure;Short stature;Autosomal dominant inheritance;Sandal gap;Epicanthus;Hypertelorism;Abnormality of the cerebral white matter;Broad nasal tip;Clinodactyly;Delayed speech and language development;Small hand;Generalized hypotonia;Narrow mouth		0.000151157	23.0	152160.0	0.0	32	0.97	PASS	nfe	0.000264581	18.0	0.000264581	18.0	0.000123755	31.0	250494.0	0.0	54	1.0	PASS	nfe	0.000203367	23.0	0.000203367	23.0	0.0001029	16	0.0	1.0				18.0	1.773299		0	0	0			BPTF	0.01	0.0	0.0	0.0	38.0	-31.0	-48.0	-31.0						0.278	1.0	0.000000000			cellular phenotype; growth/size/body region phenotype; mortality/aging ; embryo phenotype; 			occipital lobe;superior cervical ganglion;	.	negative regulation of transcription by RNA polymerase II;embryonic placenta development;chromatin remodeling;regulation of transcription by RNA polymerase II;brain development;endoderm development;anterior/posterior pattern specification;positive regulation of transcription by RNA polymerase II	nuclear chromatin;nucleus;nucleoplasm;cytoplasm;NURF complex;Set1C/COMPASS complex;extracellular exosome	protein binding;DNA-dependent ATPase activity;transcription factor binding;methylated histone binding;sequence-specific DNA binding;metal ion binding	CBX6[21282530];H3F3A[20953165];TIMM13[26496610];EN2[14609955];SMARCA5[22729083];FOXK2[25609649];EN1[14609955];DPY30[23995757;25456412];DLST[29128334];SMC1A[26496610];RNASEK-C17orf49[26496610];SMARCA1[15640247;14609955];RPS4X[30021884];HIST1H4A[21596426];HIST1H3A[29568061];RBBP4[27705803;14609955];NUDCD1[29021621];MYC[21150319];HIST1H2BH[30021884];RBBP7[14609955];HIST2H3D[21596426];AURKAIP1[29568061];SQSTM1[21900206];LLGL2[26496610];	65908884
35869	chr17	67092949	A		chr17:67092949	ABCA6	ATP binding cassette subfamily A member 6	deletion	0/1	0.31	9_4	13	75.0	0/0	0.0	28_0	28	81.0			rs752703431	SPLICING	YES	NM_080284.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	23/38		NM_080284.3:c.3121-7del			-1.0						.	.	.		0.000591983	84.0	141896.0	0.0	32	0.93	AS_VQSR	nfe	0.000524513	34.0	0.000524513	34.0	0.0384581	3445.0	89578.0	0.0	16	0.43	RF	amr	0.050772	342.0	0.0394319	1813.0	0.0000064,0.0447448	1,6958						0.62	-0.222135		0	0	0			ABCA6	0.02	0.01	0.0	0.0	-6.0	-37.0	-36.0	-6.0						0.0858	0.0				hematopoietic system phenotype; nervous system phenotype ; homeostasis/metabolism phenotype; 			atrioventricular node;superior cervical ganglion;trigeminal ganglion;skin;skeletal muscle;	ABC transporters	lipid transport;transmembrane transport	nucleoplasm;integral component of membrane;intracellular membrane-bounded organelle	lipid transporter activity;ATP binding;ATPase activity, coupled to transmembrane movement of substances	APOA1[15174051];	67092948
35883	chr17	70845950	A		chr17:70845950	SLC39A11	solute carrier family 39 member 11	deletion	0/1	0.24	19_12	50	99.0	0/1	0.3	26_16	53	99.0			rs34998299	SPLICING	YES	NM_001352692.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	5/9		NM_001352692.2:c.452-7del			-1.0						.	.	.		0.00203205	266.0	130902.0	0.0	0	0.25	PASS	eas	0.00252738	12.0	0.00207311	120.0	0.0662436	3539.0	53424.0	2.0	9	0.25	PASS	amr	0.0730216	406.0	0.0704849	2038.0	0.0002251,0.0001929,0.0002894,0.0003730,0.0001672,0.0164948	35,30,45,58,26,2565						4.425	0.109828		0	0	0			SLC39A11	0.01	0.0	0.0	0.0	-11.0	-10.0	-11.0	-20.0						0.86	0.0				.			kidney;trigeminal ganglion;	.	zinc ion transmembrane transport	fungal-type vacuole membrane;nucleus;cytoplasm;Golgi apparatus;plasma membrane;integral component of membrane	zinc ion transmembrane transporter activity	.	70845949
35931	chr17	72889677		GGCTCCGTAGGTTCCATGGGCTCCGTAGGTTCCATGGGCTCCGTAGGTTCCATC	chr17:72889676-72889677	FADS6	fatty acid desaturase 6	insertion	0/1	0.62	71_118	189	99.0	0/1	0.59	53_79	134	99.0			rs1598567899,rs1598567993	EXONIC	YES	NM_178128.6	Transcript	protein_coding	inframe_insertion		1/6	NM_178128.6:c.71_72insGATGGAACCTACGGAGCCCATGGAACCTACGGAGCCCATGGAACCTACGGAGCC	NP_835229.3:p.Thr16_Glu33insThrGluProMetGluProThrGluProMetGluProThrGluProMetGluPro		-1.0						.	.	.						34	0.88											18	0.47							0.0024823	386						13.14	0.957974		0	0	0																	0.595	0.0	18.481425805			.			.	.	fatty acid biosynthetic process;oxidation-reduction process	integral component of membrane	oxidoreductase activity	MTERF3[unassigned1304];KRTAP10-7[unassigned1304];DIABLO[unassigned1304];PNKP[unassigned1304];KRTAP10-8[unassigned1304];PBX3[unassigned1304];FHL3[unassigned1304];GAD2[unassigned1304];RCHY1[21988832];CYSRT1[unassigned1304];TTPA[unassigned1304];ARFIP2[unassigned1304];INPP5K[unassigned1304];KRTAP3-3[unassigned1304];KRTAP5-1[unassigned1304];UBASH3A[unassigned1304];TRIM32[unassigned1304];MDFI[unassigned1304];TMEM14B[unassigned1304];	72889676
35938	chr17	72938066	C	T	chr17:72938066	OTOP3	otopetrin 3	SNV	0/1	0.5	55_56	112	99.0	0/1	0.35	72_40	113	99.0				EXONIC	YES	NM_178233.2	Transcript	protein_coding	synonymous_variant		3/7	NM_178233.2:c.561C>T	NP_839947.1:p.His187%3D		1.0						.	.	.						32	0.94											39	0.97														3.767	0.070499		0	0	0			OTOP3	0.0	0.0	0.0	0.0	46.0	-48.0	-9.0	36.0						0.781	0.0	58.777530019			cellular phenotype; vision/eye phenotype; nervous system phenotype ; behavior/neurological phenotype ; 			.	.	proton transmembrane transport	plasma membrane;integral component of membrane	nucleic acid binding;proton channel activity	FAM210B[unassigned1304];EBP[unassigned1304];SLC13A4[unassigned1304];ZFYVE27[unassigned1304];TMEM237[unassigned1304];	72938066
35948	chr17	73235919	C	T	chr17:73235919	GGA3	golgi associated, gamma adaptin ear containing, ARF binding protein 3	SNV	0/1	0.45	50_43	95	99.0	0/1	0.4	52_35	87	99.0			rs141316552	EXONIC	YES	NM_138619.4	Transcript	protein_coding	missense_variant		13/17	NM_138619.4:c.1534G>A	NP_619525.1:p.Ala512Thr		-1.0	.,.,.,.,.					.	.	.		0.000584718	89.0	152210.0	0.0	32	0.97	PASS	amr	0.000261746	4.0	0.000235183	16.0	0.000815211	204.0	250242.0	2.0	82	0.99	PASS	amr	0.000318066	11.0	0.00010636	12.0	0.0005788	90						0.04	-0.606817	0.034	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	GGA3	0.0	0.0	0.01	0.0	35.0	-49.0	-49.0	-44.0							0.51	0.000000000	0.0	-0.646	reproductive system phenotype; mortality/aging ; homeostasis/metabolism phenotype; growth/size/body region phenotype; 			pons;ciliary ganglion;dorsal root ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;parietal lobe;skeletal muscle;globus pallidus;cerebellum;	.	intracellular protein transport;regulation of protein stability;protein destabilization;endocytic recycling;protein localization to cell surface;Golgi to plasma membrane protein transport;cellular protein metabolic process;positive regulation of protein catabolic process;protein localization to lysosome;negative regulation of amyloid-beta formation	Golgi apparatus;trans-Golgi network;endosome membrane;early endosome membrane;recycling endosome membrane	protein binding;ADP-ribosylation factor binding;ubiquitin binding	DAZAP2[unassigned1304];RNF11[15231748];MON2[18418388];TSG101[15039775];PLEKHB2[unassigned1304];M6PR[11387475];LITAF[unassigned1304];IGF2R[11387475;16977309];TGOLN2[16977309;29568061];TRAPPC6A[unassigned1304];RABEP1[12505986];TMEM17[26638075];UBB[15039775];HGS[15611048];PACS1[16977309];P4HA3[unassigned1304];UPRT[unassigned1304];UBASH3A[unassigned1304];ZNF497[unassigned1304];TRIM23[unassigned1304];ARF6[23143332];BET1[29568061];	73235919
35996	chr17	73568125	G	A	chr17:73568125	LLGL2	LLGL2, scribble cell polarity complex component	SNV	0/1	0.4	50_34	85	99.0	0/1	0.41	52_37	90	99.0			rs34545262	EXONIC	YES	NM_001031803.2	Transcript	protein_coding	missense_variant		19/26	NM_001031803.2:c.2440G>A	NP_001026973.1:p.Val814Ile		1.0	.,.,.					.	.	.		0.000111698	17.0	152196.0	0.0	32	0.96	PASS	amr	0.000327225	5.0	8.81938e-05	6.0	0.000169638	42.0	247586.0	0.0	59	0.94	PASS	amr	0.000318915	11.0	0.000196446	22.0	0.0001801	28						16.85	1.599318	0.057	2	17	19	MutationAssessor_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	LLGL2	0.0	0.0	0.0	0.0	20.0	-36.0	13.0	20.0						0.637	0.0	0.000000000	0.47	1.172	embryo phenotype; mortality/aging ; growth/size/body region phenotype; cardiovascular system phenotype ; 			kidney;	Tight junction	exocytosis;regulation of Notch signaling pathway;cortical actin cytoskeleton organization;regulation of establishment or maintenance of cell polarity;positive regulation of GTPase activity;establishment of spindle orientation;cell division	cytoplasm;cytosol;plasma membrane;cortical actin cytoskeleton;intracellular membrane-bounded organelle	GTPase activator activity;protein binding;Rab GTPase binding;PDZ domain binding	ATF2[26496610];RBM26[26496610];ZC3H3[26496610];BHLHE41[26496610];FMN1[26496610];CASC3[26496610];GCC1[26496610];ECSIT[26496610];LYST[26496610];DCAF1[26496610];EPB41L4B[26496610];EXO1[26496610];DNM1L[26496610];PHACTR4[26496610];PRKCI[14676191;20360068;26496610];PLEKHG1[26496610];IMP3[26496610];DAPK2[26496610];SPHK1[25216046];IMPACT[26496610];PALLD[26496610];BIRC6[26496610];LLGL1[24366813];LLGL2[20360068];SF1[26496610];ATP5S[26496610];NKAPD1[26496610];TAF9[26496610];PARD6G[14676191];NOLC1[26496610];CD99L2[26496610];PRKCZ[25852190];PHF21A[26496610];IWS1[26496610];KIAA0556[26496610];BAG6[26496610];PARD6B[14676191;20360068;26496610];CCNB1[26496610];PARD6A[14676191;20360068;26496610];HMGXB4[26496610];ZNF707[26496610];FIP1L1[26496610];ZNHIT3[26496610];MKNK1[26496610];ZNF668[26496610];RBBP6[26496610];LNPK[26496610];BPTF[26496610];RNF20[26496610];SVIL[26496610];MAP3K1[26496610];ABCA7[26496610];MTOR[26496610];ST5[26496610];ALDH18A1[26496610];	73568125
36030	chr17	73916453	G	T	chr17:73916453	FBF1	Fas binding factor 1	SNV	0|1	0.48	42_38	80	99.0	0|1	0.29	64_26	90	99.0			rs756218697	EXONIC	YES	NM_001319193.1	Transcript	protein_coding	missense_variant		17/29	NM_001319193.1:c.1732C>A	NP_001306122.1:p.Gln578Lys		-1.0	.,.,.					Congenital analbuminemia	Disease-causing germline mutation(s) in	Osteoporosis;Hypoalbuminemia;Autosomal recessive inheritance;Lipodystrophy;Hyperlipidemia;Hypotension;Fatigue;Mild global developmental delay;Hypoproteinemia;Obesity;Hyperlipidemia;Pedal edema;Oligohydramnios;Lipodystrophy;Increased alpha-globulin;Hypercholesterolemia;Low pulse pressure;Facial edema;Fatigue;Premature birth;Small for gestational age;Spontaneous abortion;Recurrent lower respiratory tract infections;Hypoalbuminemia;Increased circulating antibody level		1.3138e-05	2.0	152230.0	0.0	32	0.97	PASS	afr	2.41161e-05	1.0	1.4699e-05	1.0	2.16666e-05	5.0	230770.0	0.0	35	0.66	PASS	amr	6.12895e-05	2.0	1.92256e-05	2.0	0.0000064	1						18.54	1.844716	0.054	1	17	18	MutationAssessor_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred															0.992	0.0	0.000000000	0.981	1.079	homeostasis/metabolism phenotype; skeleton phenotype; immune system phenotype; limbs/digits/tail phenotype; hematopoietic system phenotype; 			ciliary ganglion;dorsal root ganglion;	.	apical junction assembly;cilium assembly;establishment of epithelial cell polarity;ciliary basal body-plasma membrane docking	spindle pole;centrosome;centriole;cytosol;apical junction complex;keratin filament;ciliary transition fiber	protein binding	ITSN2[26638075];GPATCH1[26638075];WDR83[26638075];DEUP1[25416956];GCC1[26638075];IKZF3[25416956];YARS2[26638075];CCDC102B[25416956];CEP128[26638075];WASHC2A[26638075];GOLGA2[25416956];EIF4ENIF1[26638075];PSMD7[26638075];CSPP1[26638075];TRIM26[26638075];TRIM27[25416956];LZTS2[25416956;26638075];PRKACA[26638075];TRIM23[25416956];MAP3K5[30021884];PDIA3[26638075];RAB2A[26638075];CEP131[26638075];SDHC[26638075];SCRIB[26638075];MID2[25416956];TMEM256[26638075];CARHSP1[26638075];TXLNA[26638075];IFT81[26638075];SRSF2[26638075];TTLL12[26638075];STAM2[26638075];BLZF1[25416956];VCL[26638075];SPTBN5[26638075];CTBP1[26638075];USHBP1[25416956];MGST3[26638075];GATA1[25416956];KRT40[25416956];CCNB1[26638075];SCFD1[26638075];TIMM23B[26638075];TP53BP2[26638075];SNX9[26638075];CEP192[26638075];NRBF2[26638075];ANKRD28[24255178];RBPMS[25416956];PLK1[26638075];STAM[26638075];ACADSB[26638075];TSGA10[25416956];TADA2A[25416956];DNMBP[26638075];NMT1[26638075];TMCC2[25416956];MYCBPAP[26638075];HYOU1[26638075];GRB2[26638075];TUBGCP4[19060904];CEP85[26638075];STT3B[26638075];CC2D1A[26638075];FKBP15[26638075];CALCOCO2[25416956];CLTC[26638075];FAM208B[25416956];MEOX2[25416956];HK1[26638075];PCM1[26638075];LASP1[26638075];SUMO1[25416956];NNT[26638075];PEA15[26638075];FLOT1[26638075];CEP170[26638075];ERC1[26638075];CEP55[25416956];CTSB[26638075];UNC45A[26638075];OFD1[26638075];TSFM[26638075];BCAS3[26638075];ADSL[26638075];RBM14[26638075];TTC32[25416956];TEX11[25416956];HAUS3[26638075];HAUS6[26638075];TRAF1[25416956];VPS37B[25416956];KRT31[25416956];SIRT2[26638075];AES[25416956];DNM2[26638075];CINP[25416956];GARS[26638075];CEP63[25416956];TRIM54[25416956];SSX2IP[25416956;26638075];RAB7A[26638075];TXLNG[26638075];CBL[26638075];NT5C2[26638075];MIPOL1[25416956];IFT74[26638075];ABLIM1[26638075];PNMA1[25416956];HAUS8[26638075];CCDC85C[26638075];ENTR1[26638075];IGF2BP2[26638075];SEC24B[26638075];AGK[26638075];KRT13[25416956];SCLT1[26638075];SORBS1[26638075];TJP1[26638075];NEDD1[26638075];TNIP1[26638075];ABI3[25416956];PRKRA[26638075];TCEA2[16169070];CPVL[26638075];TNRC6B[26638075];TJP2[26638075];	73916453
36032	chr17	73916454	C	T	chr17:73916454	FBF1	Fas binding factor 1	SNV	0|1	0.48	42_38	80	99.0	0|1	0.29	64_26	90	99.0			rs777879778	EXONIC	YES	NM_001319193.1	Transcript	protein_coding	synonymous_variant		17/29	NM_001319193.1:c.1731G>A	NP_001306122.1:p.Lys577%3D		-1.0						Congenital analbuminemia	Disease-causing germline mutation(s) in	Osteoporosis;Hypoalbuminemia;Autosomal recessive inheritance;Lipodystrophy;Hyperlipidemia;Hypotension;Fatigue;Mild global developmental delay;Hypoproteinemia;Obesity;Hyperlipidemia;Pedal edema;Oligohydramnios;Lipodystrophy;Increased alpha-globulin;Hypercholesterolemia;Low pulse pressure;Facial edema;Fatigue;Premature birth;Small for gestational age;Spontaneous abortion;Recurrent lower respiratory tract infections;Hypoalbuminemia;Increased circulating antibody level		1.3138e-05	2.0	152230.0	0.0	32	0.97	PASS	afr	2.4115e-05	1.0	1.46977e-05	1.0	2.16398e-05	5.0	231056.0	0.0	35	0.66	PASS	amr	6.12145e-05	2.0	1.92016e-05	2.0	0.0000064	1						14.97	1.258869		0	0	0																	0.992	0.0	42.822651501			homeostasis/metabolism phenotype; skeleton phenotype; immune system phenotype; limbs/digits/tail phenotype; hematopoietic system phenotype; 			ciliary ganglion;dorsal root ganglion;	.	apical junction assembly;cilium assembly;establishment of epithelial cell polarity;ciliary basal body-plasma membrane docking	spindle pole;centrosome;centriole;cytosol;apical junction complex;keratin filament;ciliary transition fiber	protein binding	ITSN2[26638075];GPATCH1[26638075];WDR83[26638075];DEUP1[25416956];GCC1[26638075];IKZF3[25416956];YARS2[26638075];CCDC102B[25416956];CEP128[26638075];WASHC2A[26638075];GOLGA2[25416956];EIF4ENIF1[26638075];PSMD7[26638075];CSPP1[26638075];TRIM26[26638075];TRIM27[25416956];LZTS2[25416956;26638075];PRKACA[26638075];TRIM23[25416956];MAP3K5[30021884];PDIA3[26638075];RAB2A[26638075];CEP131[26638075];SDHC[26638075];SCRIB[26638075];MID2[25416956];TMEM256[26638075];CARHSP1[26638075];TXLNA[26638075];IFT81[26638075];SRSF2[26638075];TTLL12[26638075];STAM2[26638075];BLZF1[25416956];VCL[26638075];SPTBN5[26638075];CTBP1[26638075];USHBP1[25416956];MGST3[26638075];GATA1[25416956];KRT40[25416956];CCNB1[26638075];SCFD1[26638075];TIMM23B[26638075];TP53BP2[26638075];SNX9[26638075];CEP192[26638075];NRBF2[26638075];ANKRD28[24255178];RBPMS[25416956];PLK1[26638075];STAM[26638075];ACADSB[26638075];TSGA10[25416956];TADA2A[25416956];DNMBP[26638075];NMT1[26638075];TMCC2[25416956];MYCBPAP[26638075];HYOU1[26638075];GRB2[26638075];TUBGCP4[19060904];CEP85[26638075];STT3B[26638075];CC2D1A[26638075];FKBP15[26638075];CALCOCO2[25416956];CLTC[26638075];FAM208B[25416956];MEOX2[25416956];HK1[26638075];PCM1[26638075];LASP1[26638075];SUMO1[25416956];NNT[26638075];PEA15[26638075];FLOT1[26638075];CEP170[26638075];ERC1[26638075];CEP55[25416956];CTSB[26638075];UNC45A[26638075];OFD1[26638075];TSFM[26638075];BCAS3[26638075];ADSL[26638075];RBM14[26638075];TTC32[25416956];TEX11[25416956];HAUS3[26638075];HAUS6[26638075];TRAF1[25416956];VPS37B[25416956];KRT31[25416956];SIRT2[26638075];AES[25416956];DNM2[26638075];CINP[25416956];GARS[26638075];CEP63[25416956];TRIM54[25416956];SSX2IP[25416956;26638075];RAB7A[26638075];TXLNG[26638075];CBL[26638075];NT5C2[26638075];MIPOL1[25416956];IFT74[26638075];ABLIM1[26638075];PNMA1[25416956];HAUS8[26638075];CCDC85C[26638075];ENTR1[26638075];IGF2BP2[26638075];SEC24B[26638075];AGK[26638075];KRT13[25416956];SCLT1[26638075];SORBS1[26638075];TJP1[26638075];NEDD1[26638075];TNIP1[26638075];ABI3[25416956];PRKRA[26638075];TCEA2[16169070];CPVL[26638075];TNRC6B[26638075];TJP2[26638075];	73916454
36037	chr17	74017554	G	T	chr17:74017554	EVPL	envoplakin	SNV	0/0	0.0	93_0	93	46.0	0|1	0.19	64_15	79	99.0			rs74955334,COSV56907016	EXONIC	YES	NM_001320747.2	Transcript	protein_coding	missense_variant		9/22	NM_001320747.2:c.1006C>A	NP_001307676.1:p.Arg336Ser		-1.0	.,.					.	.	.		0.000256376	38.0	148220.0	0.0	31	0.93	PASS	nfe	0.00042156	28.0	0.00042156	28.0	0.0503555	7223.0	143440.0	0.0	42	0.71	PASS	nfe	0.05659	3495.0	0.05659	3495.0	0.0787247	12242	0.034	108.0				22.1	2.316067	0.168	2	16	18	MutationAssessor_pred,PROVEAN_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	EVPL	0.0	0.01	0.0	0.0	21.0	30.0	-5.0	-17.0						0.859	0.0		0.676	1.176	integument phenotype ; 			tongue;	.	epidermis development;peptide cross-linking;keratinocyte differentiation;wound healing;intermediate filament cytoskeleton organization;cornification	cornified envelope;cytoplasm;cytosol;intermediate filament;membrane;desmosome;intermediate filament cytoskeleton;extracellular exosome	structural molecule activity;intermediate filament binding;protein binding, bridging;cadherin binding	TSNAX[26496610];PLEKHA5[20936779];CORO1C[30021884];	74017554
36039	chr17	74017573	C	G	chr17:74017573	EVPL	envoplakin	SNV	0/0	0.0	76_0	76	99.0	0|1	0.18	70_15	85	99.0			rs78569674,COSV56908126	EXONIC	YES	NM_001320747.2	Transcript	protein_coding	synonymous_variant		9/22	NM_001320747.2:c.987G>C	NP_001307676.1:p.Leu329%3D		-1.0						.	.	.		0.000133994	20.0	149260.0	0.0	31	0.93	PASS	nfe	0.000164883	11.0	0.000164883	11.0	0.0229496	3725.0	162312.0	0.0	51	0.76	RF	nfe	0.0289336	2061.0	0.0289336	2061.0	0.0614454	9555	0.078	247.0				11.98	0.803576		0	0	0			EVPL	0.01	0.03	0.0	0.0	8.0	11.0	-2.0	-24.0						0.859	0.0				integument phenotype ; 			tongue;	.	epidermis development;peptide cross-linking;keratinocyte differentiation;wound healing;intermediate filament cytoskeleton organization;cornification	cornified envelope;cytoplasm;cytosol;intermediate filament;membrane;desmosome;intermediate filament cytoskeleton;extracellular exosome	structural molecule activity;intermediate filament binding;protein binding, bridging;cadherin binding	TSNAX[26496610];PLEKHA5[20936779];CORO1C[30021884];	74017573
36042	chr17	74017594	A	G	chr17:74017594	EVPL	envoplakin	SNV	0/0	0.0	76_0	76	99.0	0|1	0.17	72_15	87	99.0			rs193119748,COSV56906864	EXONIC	YES	NM_001320747.2	Transcript	protein_coding	synonymous_variant		9/22	NM_001320747.2:c.966T>C	NP_001307676.1:p.Cys322%3D		-1.0						.	.	.		6.03015e-05	9.0	149250.0	0.0	31	0.93	PASS	afr	9.87849e-05	4.0	5.97639e-05	4.0	0.00951678	1986.0	208684.0	0.0	51	0.77	RF	nfe	0.0121293	1141.0	0.0121293	1141.0	0.0191699	2981	0.035	111.0				11.94	0.798479		0	0	0			EVPL	0.0	0.29	0.0	0.0	41.0	-10.0	-45.0	2.0						0.859	0.0				integument phenotype ; 			tongue;	.	epidermis development;peptide cross-linking;keratinocyte differentiation;wound healing;intermediate filament cytoskeleton organization;cornification	cornified envelope;cytoplasm;cytosol;intermediate filament;membrane;desmosome;intermediate filament cytoskeleton;extracellular exosome	structural molecule activity;intermediate filament binding;protein binding, bridging;cadherin binding	TSNAX[26496610];PLEKHA5[20936779];CORO1C[30021884];	74017594
36287	chr17	77926526	C	T	chr17:77926526	TBC1D16	TBC1 domain family member 16	SNV	0/0	0.0	33_0	33	99.0	0/1	0.39	73_47	121	99.0			rs150604803	EXONIC	YES	NM_019020.4	Transcript	protein_coding	missense_variant		4/12	NM_019020.4:c.871G>A	NP_061893.2:p.Ala291Thr		-1.0						.	.	.		0.00480182	731.0	152234.0	7.0	33	0.98	PASS	nfe	0.00621638	423.0	0.00621638	423.0	0.00573849	1421.0	247626.0	8.0	43	0.97	PASS	nfe	0.00727797	808.0	0.00727797	808.0	0.0054532	848	0.004	13.0				16.58	1.554547	0.031	4	15	19	Polyphen2_HDIV_pred,MutationAssessor_pred,MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	TBC1D16	0.0	0.0	0.0	0.0	49.0	33.0	7.0	5.0						0.684	0.01	0.000000000	0.318	0.129	.			ciliary ganglion;superior cervical ganglion;	.	regulation of receptor recycling;intracellular protein transport;activation of GTPase activity;regulation of cilium assembly	early endosome;cytosol	GTPase activator activity;protein binding;Rab GTPase binding	TTLL6[26496610];TIMELESS[26496610];HDAC6[26496610];SYNE2[26496610];CTSC[26496610];	77926526
36289	chr17	77983989	C	T	chr17:77983989	TBC1D16	TBC1 domain family member 16	SNV	0/1	0.41	67_47	115	99.0	0/1	0.47	57_50	107	99.0			rs760338893	EXONIC	YES	NM_019020.4	Transcript	protein_coding	missense_variant		3/12	NM_019020.4:c.749G>A	NP_061893.2:p.Arg250His		-1.0						.	.	.		0.000137984	21.0	152192.0	0.0	33	0.98	PASS	amr	0.000523286	8.0	2.9404e-05	2.0	3.66315e-05	9.0	245690.0	0.0	28	0.79	PASS	afr	0.000382458	6.0	1.80923e-05	2.0	0.0000322	5						17.07	1.635524	0.045	2	17	19	fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	TBC1D16	0.0	0.0	0.0	0.0	-22.0	20.0	-26.0	-30.0						0.684	0.01	0.000000000	0.019	-0.262	.			ciliary ganglion;superior cervical ganglion;	.	regulation of receptor recycling;intracellular protein transport;activation of GTPase activity;regulation of cilium assembly	early endosome;cytosol	GTPase activator activity;protein binding;Rab GTPase binding	TTLL6[26496610];TIMELESS[26496610];HDAC6[26496610];SYNE2[26496610];CTSC[26496610];	77983989
36431	chr17	79256084	T	C	chr17:79256084	SLC38A10	solute carrier family 38 member 10	SNV	0/1	0.5	64_63	127	99.0	0/0	0.0	42_0	42	99.0			rs146598954,COSV55849807	EXONIC	YES	NM_001037984.3	Transcript	protein_coding	missense_variant		5/16	NM_001037984.3:c.406A>G	NP_001033073.1:p.Ile136Val		-1.0	Amino acid transporter, transmembrane domain,.,Amino acid transporter, transmembrane domain					.	.	.		0.00539486	821.0	152182.0	3.0	33	0.97	PASS	nfe	0.00723359	492.0	0.00723359	492.0	0.00617674	1545.0	250132.0	6.0	74	0.99	PASS	nfe	0.00769149	867.0	0.00769149	867.0	0.0057169	889	0.003	11.0				17.12	1.64375	0.038	4	14	18	SIFT,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	SLC38A10	0.0	0.01	0.0	0.0	48.0	-17.0	5.0	-2.0						0.802	0.0	0.000000000	0.272	0.15	immune system phenotype; skeleton phenotype; vision/eye phenotype; cardiovascular system phenotype ; hematopoietic system phenotype; liver/biliary system phenotype; behavior/neurological phenotype ; homeostasis/metabolism phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype ; adipose tissue phenotype ; 			thyroid;liver;	.	amino acid transmembrane transport;sodium ion transport;bone development	Golgi apparatus;integral component of membrane	amino acid transmembrane transporter activity	KIF5B[26496610];PPIB[30021884];NCAPH[26496610];	79256084
36455	chr17	79495707	C	G	chr17:79495707	FSCN2	fascin actin-bundling protein 2, retinal	SNV	0/1	0.42	89_64	153	99.0	0/0	0.0	38_0	38	99.0			rs184519759,COSV100603341	EXONIC	YES	NM_001077182.3	Transcript	protein_coding	synonymous_variant		1/5	NM_001077182.3:c.150C>G	NP_001070650.1:p.Pro50%3D		1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Retinitis_pigmentosa_30|not_specified|not_provided	Retinitis pigmentosa 30, 607921 (3)	Retinitis pigmentosa	Disease-causing germline mutation(s) in	Autosomal dominant inheritance;Rod-cone dystrophy;Visual impairment;Nyctalopia;Bone spicule pigmentation of the retina;Attenuation of retinal blood vessels;Chorioretinal atrophy;Optic atrophy;Hyperinsulinemia;Optic atrophy;Nystagmus;Abnormal retinal vascular morphology;Obesity;Hypoplasia of penis;Cataract;Abnormality of retinal pigmentation;Keratoconus;Progressive night blindness;Ophthalmoplegia;Abnormal testis morphology;Atypical scarring of skin;Hyperreflexia;Sensorineural hearing impairment;Blindness;Type II diabetes mellitus;Conductive hearing impairment;Photophobia;Intellectual disability;Anteverted nares;Abnormal electroretinogram;Wide nasal bridge;Hypogonadism;Glaucoma		0.00401377	611.0	152226.0	5.0	34	0.99	PASS	sas	0.00950806	46.0	0.00358623	244.0	0.00435902	972.0	222986.0	10.0	100	0.64	PASS	sas	0.00657049	184.0	0.00315352	311.0	0.0033568	522	0.004	13.0	0.00412	47.0		0.436	-0.274306		0	0	0			FSCN2	0.0	0.0	0.0	0.0	36.0	8.0	13.0	-12.0							0.0				nervous system phenotype ; hearing/vestibular/ear phenotype; vision/eye phenotype; 			pons;appendix;testis - interstitial;trigeminal ganglion;skeletal muscle;	.	establishment or maintenance of cell polarity;visual perception;anatomical structure morphogenesis;cell migration;actin cytoskeleton organization;eye photoreceptor cell development;actin filament bundle assembly	cytoplasm;actin cytoskeleton;stereocilium	actin binding;protein binding, bridging;actin filament binding	.	79495707
36614	chr17	80847540	G	A	chr17:80847540	TBCD	tubulin folding cofactor D	SNV	0/0	0.0	35_0	35	99.0	0/1	0.5	59_60	120	99.0			rs116536514	SPLICING	YES	NM_005993.5	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	15/38		NM_005993.5:c.1534-4G>A			1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_provided	Encephalopathy, progressive, early-onset, with brain atrophy and thin corpus callosum, 617193 (3), Autosomal recessive	Early-onset progressive diffuse brain atrophy-microcephaly-muscle weakness-optic atrophy syndrome	Disease-causing germline mutation(s) (loss of function) in	Respiratory failure;Widely spaced teeth;Muscle weakness;Fasciculations;Arthrogryposis multiplex congenita;Infantile muscular hypotonia;Intellectual disability, profound;Postnatal microcephaly;Pectus excavatum;Cerebellar atrophy;Urinary incontinence;Macrotia;Progressive spasticity;Dysphagia;Cerebral hypomyelination;Cerebral cortical atrophy;Plagiocephaly;Skeletal muscle atrophy;Tetraplegia;Hirsutism;Respiratory failure requiring assisted ventilation;Dystonia;Growth delay;Congenital microcephaly;Congenital hip dislocation;Hypertelorism;Absent smooth pursuit;Feeding difficulties;Chronic constipation;Stereotypy;Generalized tonic seizure;Absent speech;Micrognathia;Recurrent pneumonia;Motor axonal neuropathy;Upslanted palpebral fissure;Neurogenic bladder;Developmental regression;Pectus carinatum;Poor speech;Scoliosis;Bowel incontinence;Optic atrophy;Hypoplasia of the corpus callosum;Polyhydramnios;Febrile seizure (within the age range of 3 months to 6 years);Intellectual disability, moderate;Elevated serum creatine kinase;Bilateral tonic-clonic seizure;Ataxia;Sparse eyebrow;Global developmental delay;Areflexia;Fractures of the long bones;Cataplexy;Postnatal microcephaly;Seizure;CNS hypomyelination;Intellectual disability;Global developmental delay;Tongue fasciculations;Neuronal loss in central nervous system;Feeding difficulties;Optic atrophy;Cerebellar atrophy;Developmental regression;Muscle weakness;Arthrogryposis multiplex congenita;Respiratory insufficiency;Facial hypotonia;Severe muscular hypotonia;Constipation;Upslanted palpebral fissure;Widely spaced teeth;Ventriculomegaly;Diffuse cerebral atrophy;Skeletal muscle atrophy;Hypertelorism;Sparse eyebrow;Atrophy/Degeneration affecting the brainstem;Encephalopathy;Absent speech;Scoliosis;Gliosis;Autosomal recessive inheritance;Spastic tetraplegia;Variable expressivity;Hypoplasia of the corpus callosum;Micrognathia		0.00112354	171.0	152198.0	1.0	33	0.98	PASS	afr	0.00359504	149.0	0.000102893	7.0	0.000341555	85.0	248862.0	0.0	42	0.96	PASS	afr	0.00401139	62.0	0.000106319	12.0	0.0003794	59	0.001	2.0				8.878	0.44601		0	0	0			TBCD	0.01	0.0	0.02	0.0	4.0	16.0	33.0	39.0	4.36300606558606e-05	0.002	10.769	0.06	10.829	0.799	0.0				.			caudate nucleus;thymus;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	.	microtubule cytoskeleton organization;mitotic cell cycle;protein folding;tubulin complex assembly;post-chaperonin tubulin folding pathway;negative regulation of cell-substrate adhesion;negative regulation of microtubule polymerization;adherens junction assembly;positive regulation of GTPase activity;cell morphogenesis involved in neuron differentiation;bicellular tight junction assembly	cytoplasm;centrosome;microtubule;adherens junction;bicellular tight junction;lateral plasma membrane	GTPase activator activity;protein binding;beta-tubulin binding;chaperone binding	XRCC6[16169070];ACD[21044950];ARL3[18588884];SMAD9[15231748];ARL2[18588884];TERF1[21044950];DEXI[16169070];HIST1H4A[30021884];MTNR1B[26514267];ZNF836[unassigned1312];TCP11L1[unassigned1312];POT1[21044950];IKBKG[14743216];POLR2I[21988832];ZNF146[unassigned1312];	80847540
36672	chr18	6239821	C	T	chr18:6239821	L3MBTL4	L3MBTL4, histone methyl-lysine binding protein	SNV	0/0	0.0	34_0	34	99.0	0/1	0.47	41_37	78	99.0			rs147344740	EXONIC	YES	NM_173464.4	Transcript	protein_coding	synonymous_variant		9/20	NM_173464.4:c.603G>A	NP_775735.2:p.Val201%3D		-1.0						.	.	.		0.0015772	240.0	152168.0	0.0	32	0.97	PASS	nfe	0.00257232	175.0	0.00257232	175.0	0.0015469	389.0	251470.0	1.0	74	1.0	PASS	nfe	0.00254044	289.0	0.00254044	289.0	0.0014855	231	0.004	13.0				3.044	0.026868		0	0	0			L3MBTL4	0.0	0.14	0.0	0.01	-41.0	31.0	24.0	-21.0						0.745	0.0	16.428434049			.			ciliary ganglion;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	.	chromatin organization;regulation of transcription, DNA-templated	nucleus	DNA-binding transcription factor activity;protein binding;zinc ion binding	PSMA5[27705803];PSMB6[27705803];L3MBTL3[27705803];PSMB5[27705803];PSMC1[27705803];PDGFC[27705803];HSF2BP[unassigned1304];RPL39[27705803];NINL[25416956];KPNA3[unassigned1304];PSMA7[27705803];	6239821
36753	chr18	10705456	G	A	chr18:10705456	PIEZO2	piezo type mechanosensitive ion channel component 2	SNV	0/1	0.49	58_56	114	99.0	0/0	0.0	34_0	34	99.0			rs539810112	EXONIC	YES	NM_001378183.1	Transcript	protein_coding	synonymous_variant		41/56	NM_001378183.1:c.5877C>T	NP_001365112.1:p.Asp1959%3D		-1.0		Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_specified|not_provided	Arthrogryposis, distal, type 5, 108145 (3), Autosomal dominant; Arthrogryposis, distal, with impaired proprioception and touch, 617146 (3), Autosomal recessive; Arthrogryposis, distal, type 3, 114300 (3), Autosomal dominant; ?Marden-Walker syndrome, 248700 (3), Autosomal dominant	Arthrogryposis-oculomotor limitation-electroretinal anomalies syndrome;Gordon syndrome;Marden-Walker syndrome	Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Visual impairment;Ophthalmoplegia;Optic atrophy;Congenital finger flexion contractures;Ptosis;Macrotia;Dimple chin;Triangular face;Abnormal electroretinogram;Pectus excavatum;Inguinal hernia;Absent palmar crease;Deeply set eye;Deviation of finger;Bilateral talipes equinovarus;Arachnodactyly;Joint stiffness;Ophthalmoplegia;High palate;Astigmatism;Deeply set eye;Ptosis;Keratoconus;Restrictive ventilatory defect;Firm muscles;Clinodactyly;Distal arthrogryposis;Bilateral talipes equinovarus;Limited wrist extension;Abnormality of the rib cage;Arachnodactyly;Abnormality of retinal pigmentation;Duane anomaly;Congenital finger flexion contractures;Pectus excavatum;Autosomal dominant inheritance;Arthrogryposis multiplex congenita;Abnormal electroretinogram;Triangular face;Epicanthus;Short stature;Absent phalangeal crease;Blepharophimosis;Hypermetropia;Scoliosis;Decreased facial expression;Keratoglobus;Decreased muscle mass;Decreased palmar creases;Protruding ear;Dysarthria;Sensory axonal neuropathy;Talipes equinovarus;Pes planus;Inability to walk;Sensory ataxia;Hip dysplasia;Respiratory insufficiency;Scoliosis;Flexion contracture;Areflexia;Feeding difficulties in infancy;High palate;Neonatal hypotonia;Poor head control;Short stature;Generalized hypotonia;Gastroesophageal reflux;Elevated serum creatine kinase;Thin upper lip vermilion;Global developmental delay;Upper limb muscle weakness;Delayed ability to walk;Autosomal recessive inheritance;Wide nasal bridge;Poor fine motor coordination;Long nose;Sandal gap;Broad-based gait;Progressive;Myopathic facies;Lower limb muscle weakness;Camptodactyly;Arachnodactyly;Motor delay;Strabismus;Postnatal growth retardation;Autosomal recessive inheritance;Blepharophimosis;Micrognathia;Zollinger-Ellison syndrome;Low-set ears;Ptosis;Kyphosis;Hypoplasia of the brainstem;Talipes equinovarus;Scoliosis;Arachnodactyly;Pulmonary hypoplasia;Long philtrum;Wide anterior fontanel;Decreased muscle mass;Joint contracture of the hand;Seizure;Inferior vermis hypoplasia;Narrow mouth;Cryptorchidism;Intellectual disability;Epicanthus;Dandy-Walker malformation;Micropenis;Renal hypoplasia;High palate;Inguinal hernia;Intrauterine growth retardation;Congenital contracture;Dextrocardia;Radioulnar synostosis;Microcephaly;Short neck;Agenesis of corpus callosum;Cerebellar hypoplasia;Muscular hypotonia;High, narrow palate;Abnormality of the sternum;Cleft palate;Anteverted nares;Microphthalmia;Hypospadias;Primitive reflex;Fixed facial expression;Camptodactyly;Autosomal dominant inheritance;Generalized hypotonia;Pyloric stenosis;Hypertelorism;Absent septum pellucidum;Specific learning disability;Multicystic kidney dysplasia;Hydronephrosis;Ptosis;Pyloric stenosis;Joint stiffness;Arthrogryposis multiplex congenita;Radioulnar synostosis;Pectus carinatum;Intrauterine growth retardation;Retrognathia;Cerebellar hypoplasia;Muscular hypotonia;Abnormality of the cerebellar vermis;Short palpebral fissure;Feeding difficulties;Mask-like facies;Blepharophimosis;Agenesis of corpus callosum;Hypospadias;Camptodactyly of finger;Posteriorly rotated ears;Situs inversus totalis;Low-set ears;Scoliosis;Narrow mouth;Bifid uvula;Skeletal muscle atrophy;Muscular dystrophy;Talipes;Metatarsus adductus;Failure to thrive;Aplasia/Hypoplasia involving the skeletal musculature;Intellectual disability;Microcephaly;Renal dysplasia;Hydrocephalus;Abnormal form of the vertebral bodies;Renal agenesis;Attention deficit hyperactivity disorder;Severe short stature;Pectus excavatum;Kyphosis;Epispadias;Hydroureter;Submucous cleft hard palate;Arachnodactyly;Global developmental delay;Micrognathia;Ventricular septal defect;Thoracolumbar scoliosis;Camptodactyly of finger;Bifid uvula;High palate;Micrognathia;Cutaneous finger syndactyly;Ulnar deviation of the hand or of fingers of the hand;Talipes equinovarus;Facial asymmetry;Short neck;Ophthalmoplegia;Epicanthus;Abnormality of the rib cage;Kyphoscoliosis;Short phalanx of finger;Camptodactyly of toe;Overlapping toe;Congenital hip dislocation;Down-sloping shoulders;Knee flexion contracture;Submucous cleft hard palate;Intellectual disability, mild;Single transverse palmar crease;Global developmental delay;Arthrogryposis multiplex congenita;Autosomal dominant inheritance;Pectus excavatum;Distal arthrogryposis;Decreased hip abduction;Short stature;Decreased muscle mass;Cryptorchidism;Ptosis;Lumbar hyperlordosis;Limitation of joint mobility;Short stature;Hearing impairment;Camptodactyly of finger;Decreased muscle mass;High palate;Scoliosis;Facial asymmetry;Clinodactyly of the 5th finger;Cleft palate;Cryptorchidism;Talipes;Pectus excavatum;Finger syndactyly	25741868	0.000223399	34.0	152194.0	0.0	32	0.97	PASS	sas	0.000828844	4.0	0.000220504	15.0	0.00023968	34.0	141856.0	0.0	65	0.58	PASS	sas	0.000879894	20.0	0.000120097	7.0	0.0000707	11	0.0	1.0				1.846	-0.057912		0	0	0			PIEZO2	0.0	0.0	0.0	0.0	-11.0	2.0	36.0	-10.0							0.6	13.760195306			behavior/neurological phenotype ; nervous system phenotype ; integument phenotype ; 			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;medulla oblongata;	.	cation transport;response to mechanical stimulus;regulation of membrane potential;detection of mechanical stimulus involved in sensory perception;detection of mechanical stimulus;cellular response to mechanical stimulus;cation transmembrane transport	plasma membrane;integral component of membrane	cation channel activity;mechanosensitive ion channel activity	.	10705456
36785	chr18	13100377	T	C	chr18:13100377	CEP192	centrosomal protein 192	SNV	0/0	0.0	34_0	34	99.0	0/1	0.52	37_40	77	99.0			rs117901677,COSV58068236	EXONIC	YES	NM_032142.4	Transcript	protein_coding	missense_variant		38/45	NM_032142.4:c.6737T>C	NP_115518.3:p.Phe2246Ser		1.0	.,.					.	.	.		0.00534773	814.0	152214.0	2.0	32	0.98	PASS	nfe	0.00840608	572.0	0.00840608	572.0	0.00500362	1258.0	251418.0	3.0	86	1.0	PASS	nfe	0.00768608	874.0	0.00768608	874.0	0.0049709	773	0.007	21.0				13.75	1.049193	0.019	0	18	18		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CEP192	0.0	0.15	0.0	0.0	0.0	18.0	31.0	18.0						0.85	0.0	0.000000000	0.024	0.199	.			thyroid;tumor;fetal liver;testis;	.	G2/M transition of mitotic cell cycle;response to bacterium;regulation of G2/M transition of mitotic cell cycle;negative regulation of phosphatase activity;centrosome duplication;protein localization to centrosome;centrosome-templated microtubule nucleation;mitotic spindle assembly;ciliary basal body-plasma membrane docking	pericentriolar material;centrosome;centriole;cytosol	protein binding;phosphatase binding	KDM1B[26496610];CEP19[26638075];CEP120[26638075];FBF1[26638075];AURKB[29568061];AURKA[20360068];CEP128[26638075];PCM1[26638075];POLD1[26496610];CNTRL[26638075];NINL[26638075];ANKRD28[24255178];OFD1[26638075];PLK4[24997597;26188084];CEP135[26638075];ODF2[26638075];UBE2E3[19549727];CEP152[26638075];PCDHB15[26496610];RPGRIP1L[26638075];PPP1CA[19389623];RNF41[26496610];LATS1[24255178];CYLD[19615732];DIAPH1[26496610];NIN[26638075];KIF2A[26496610];POC5[26638075];SLMAP[24255178];CENPJ[26638075];SASS6[26638075];CNTROB[26638075];CEP63[26638075];KPNB1[26496610];EZH2[26496610];CEP89[26638075];	13100377
36801	chr18	14542867	C	T	chr18:14542867	POTEC	POTE ankyrin domain family member C	SNV	0|1	0.23	142_42	186	99.0	0|1	0.27	137_50	187	99.0			rs200779556,COSV62801324	EXONIC	YES	NM_001137671.2	Transcript	protein_coding	synonymous_variant		1/11	NM_001137671.2:c.279G>A	NP_001131143.1:p.Thr93%3D		-1.0						.	.	.		0.000139823	21.0	150190.0	0.0	30	0.91	PASS	amr	0.00132031	20.0	0.0	0.0	0.428978	66157.0	154220.0	0.0	100	1.0	InbreedingCoeff_RF	eas	0.48365	6508.0	0.442949	31934.0	0.0003537	55	0.004	14.0				0.037	-0.61938		0	0	0			POTEC	0.0	0.0	0.0	0.0	-6.0	25.0	42.0	-16.0							0.16				.			.	.	.	.	.	.	14542867
36802	chr18	14542909	G	A	chr18:14542909	POTEC	POTE ankyrin domain family member C	SNV	0|1	0.32	183_85	269	99.0	0|1	0.35	160_88	248	99.0			rs370268513,COSV62800580	EXONIC	YES	NM_001137671.2	Transcript	protein_coding	synonymous_variant		1/11	NM_001137671.2:c.237C>T	NP_001131143.1:p.Asn79%3D		-1.0						.	.	.		6.59152e-06	1.0	151710.0	0.0	30	0.91	PASS	nfe	1.47158e-05	1.0	1.47158e-05	1.0	0.480797	104509.0	217366.0	0.0	100	1.0	InbreedingCoeff	eas	0.497462	8625.0	0.482632	48130.0	0.0029903	465	0.047	141.0				0.254	-0.352904		0	0	0			POTEC	0.0	0.0	0.0	0.0	18.0	-2.0	0.0	18.0							0.16				.			.	.	.	.	.	.	14542909
36804	chr18	14542979	A	G	chr18:14542979	POTEC	POTE ankyrin domain family member C	SNV	0/1	0.37	158_94	253	99.0	0/1	0.37	129_75	204	99.0			rs200806970,COSV62800439	EXONIC	YES	NM_001137671.2	Transcript	protein_coding	missense_variant		1/11	NM_001137671.2:c.167T>C	NP_001131143.1:p.Met56Thr		-1.0	.,.					.	.	.						31	0.9							0.486041	116821.0	240352.0	0.0	100	1.0	InbreedingCoeff_RF	eas	0.497938	8933.0	0.487421	53433.0	0.0100062	1556	0.089	270.0				0.001	-1.403316	0.011	0	17	17		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	POTEC	0.0	0.0	0.0	0.0	-7.0	1.0	-17.0	2.0							0.16		0.008	-1.098	.			.	.	.	.	.	.	14542979
36906	chr18	24436328	T	C	chr18:24436328	AQP4	aquaporin 4	SNV	0/1	0.48	65_63	131	99.0	0/1	0.47	69_62	133	99.0			rs72557972	EXONIC	YES	NM_001317384.3	Transcript	protein_coding	synonymous_variant		5/5	NM_001317384.3:c.819A>G	NP_001304313.1:p.Thr273%3D		-1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00338916	516.0	152250.0	0.0	33	0.97	PASS	sas	0.00848159	41.0	0.00529085	360.0	0.00332822	837.0	251486.0	4.0	100	1.0	PASS	sas	0.00901489	276.0	0.00409634	466.0	0.0033633	523	0.002	8.0	0.00289	33.0		9.535	0.514146		0	0	0			AQP4	0.0	0.0	0.02	0.0	28.0	-5.0	-39.0	25.0						0.139	0.02	76.261293521			immune system phenotype; renal/urinary system phenotype; hearing/vestibular/ear phenotype; nervous system phenotype ; vision/eye phenotype; mortality/aging ; cardiovascular system phenotype ; hematopoietic system phenotype; respiratory system phenotype; behavior/neurological phenotype ; homeostasis/metabolism phenotype; growth/size/body region phenotype; 			.	.	renal water homeostasis;water transport;multicellular organismal water homeostasis;transmembrane transport;cellular response to interferon-gamma	cytoplasm;plasma membrane;external side of plasma membrane;integral component of membrane;basolateral plasma membrane	water transmembrane transporter activity;protein binding;water channel activity	CREB3[25910212];AQP4[19383790];GJA8[unassigned1304];HPCAL4[unassigned1304];	24436328
37030	chr18	33793426	T	C	chr18:33793426	MOCOS	molybdenum cofactor sulfurase	SNV	0/1	0.34	50_26	77	99.0	0/1	0.57	34_46	80	99.0			rs144644128	EXONIC	YES	NM_017947.4	Transcript	protein_coding	missense_variant		7/15	NM_017947.4:c.1316T>C	NP_060417.4:p.Met439Thr		1.0	Aminotransferase class V domain	Likely_benign	criteria_provided,_single_submitter	Xanthinuria_type_II	Xanthinuria, type II, 603592 (3), Autosomal recessive	Xanthinuria type II	Disease-causing germline mutation(s) in	Autosomal recessive inheritance;Nephrolithiasis;Renal insufficiency;Hypouricemia		0.000315652	48.0	152066.0	0.0	32	0.97	PASS	sas	0.00248756	12.0	0.000249949	17.0	0.000700258	176.0	251336.0	0.0	100	1.0	PASS	sas	0.0028745	88.0	0.000501593	57.0	0.0006945	108	0.001	3.0	0.00105	12.0		16.35	1.513977	0.049	1	18	19	fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	MOCOS	0.0	0.0	0.01	0.0	-25.0	19.0	19.0	1.0						0.337	0.0	0.000000000	0.835	1.138	.			liver;trigeminal ganglion;atrioventricular node;superior cervical ganglion;	MAPK signaling pathway;Regulation of actin cytoskeleton	Mo-molybdopterin cofactor biosynthetic process;molybdopterin cofactor biosynthetic process;molybdopterin cofactor metabolic process	cellular_component;cytosol	protein binding;Mo-molybdopterin cofactor sulfurase activity;lyase activity;molybdenum ion binding;pyridoxal phosphate binding;molybdenum cofactor sulfurtransferase activity	MRPL50[26496610];NUDCD1[29021621];APOA1[15174051];PARVA[21516116;25416956];CNTROB[26496610];PLEKHA7[28877994];	33793426
37033	chr18	34232735	C	T	chr18:34232735	FHOD3	formin homology 2 domain containing 3	SNV	0/1	0.49	69_66	135	99.0	0/1	0.51	70_74	144	99.0			rs191109699	EXONIC	YES	NM_001281740.3	Transcript	protein_coding	missense_variant		12/29	NM_001281740.3:c.1489C>T	NP_001268669.1:p.Arg497Trp		1.0					Cardiomyopathy, familial hypertrophic, 28, 619402 (3), Autosomal dominant	.	.	.		0.000710125	108.0	152086.0	0.0	32	0.95	PASS	afr	0.0024866	103.0	1.47046e-05	1.0	0.000178582	24.0	134392.0	0.0	94	0.57	PASS	afr	0.00294027	19.0	0.0	0.0	0.0000643	10						6.634	0.255891		1	11	12	SIFT	PolyPhen,M-CAP_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FHOD3	0.16	0.09	0.0	0.0	22.0	-5.0	22.0	32.0						0.569	1.0	0.000000000	0.092	0.901	homeostasis/metabolism phenotype; muscle phenotype; growth/size/body region phenotype; embryo phenotype; cardiovascular system phenotype ; mortality/aging ; 			.	.	actin filament organization;negative regulation of actin filament polymerization;sarcomere organization;cardiac myofibril assembly	striated muscle thin filament;Z disc	actin binding;protein binding	IKBIP[30021884];CSNK2A1[21149568];SQSTM1[21149568];	34232735
37054	chr18	43417847	G	A	chr18:43417847	SIGLEC15	sialic acid binding Ig like lectin 15	SNV	0/1	0.48	44_40	84	99.0	0/0	0.0	42_0	42	99.0			rs759975797	EXONIC	YES	NM_213602.3	Transcript	protein_coding	missense_variant		3/6	NM_213602.3:c.482G>A	NP_998767.1:p.Arg161Gln		1.0	Immunoglobulin V-set domain&Immunoglobulin subtype					.	.	.		1.31365e-05	2.0	152248.0	0.0	33	0.99	PASS	amr	0.000130787	2.0	0.0	0.0	1.55671e-05	2.0	128476.0	0.0	10	0.28	PASS	sas	4.63564e-05	1.0	0.0	0.0	0.0000129	2						23.4	2.929729	0.07	3	17	20	M-CAP_pred,MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	SIGLEC15	0.0	0.0	0.01	0.01	2.0	-46.0	3.0	14.0							0.0	0.000000000	0.997	1.088	immune system phenotype; renal/urinary system phenotype; skeleton phenotype; hematopoietic system phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			.	.	regulation of actin cytoskeleton organization;innate immune response;regulation of bone resorption;regulation of osteoclast development	plasma membrane;integral component of membrane;protein-containing complex	.	.	43417847
37225	chr18	47363917	A	G	chr18:47363917	MYO5B	myosin VB	SNV	0|1	0.13	65_10	76	99.0	0|1	0.17	82_17	100	99.0			rs138128932,COSV53210117	EXONIC	YES	NM_001080467.3	Transcript	protein_coding	missense_variant		37/40	NM_001080467.3:c.5108T>C	NP_001073936.1:p.Val1703Ala		-1.0	Dilute domain&Dilute domain&Dilute domain&Myosin 5b, cargo-binding domain,Dilute domain&Dilute domain&Dilute domain&Myosin 5b, cargo-binding domain,.				Diarrhea 2, with microvillus atrophy, 251850 (3), Autosomal recessive	Microvillus inclusion disease;MYO5B-related progressive familial intrahepatic cholestasis;Progressive familial intrahepatic cholestasis type 1	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Diarrhea;Dehydration;Hypovolemia;Metabolic acidosis;Abdominal distention;Abnormal renal physiology;Global developmental delay;Pruritus;Nephrocalcinosis;Villous atrophy;Malnutrition;Dehydration;Growth delay;Protracted diarrhea;Villous atrophy;Autosomal recessive inheritance;Death in infancy	27826991	2.64326e-05	4.0	151328.0	0.0	33	0.98	AS_VQSR	sas	0.00020903	1.0	1.47619e-05	1.0	0.00038969	86.0	220688.0	0.0	100	1.0	RF	afr	0.00100792	14.0	0.000573625	57.0	0.0582429	9057	0.077	249.0	0.03953	405.0		22.6	2.519207	0.123	4	14	18	SIFT,MutationTaster_pred,FATHMM_pred,fathmm-MKL_coding_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	MYO5B	0.0	0.0	0.0	0.0	4.0	33.0	-17.0	-30.0						0.0862	0.0	58.664435614	0.986	0.324	homeostasis/metabolism phenotype; integument phenotype ; mortality/aging ; growth/size/body region phenotype; digestive/alimentary phenotype; 			ciliary ganglion;pons;kidney;testis - interstitial;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;testis;skeletal muscle;globus pallidus;	.	renal water homeostasis;protein transport;vesicle-mediated transport;endosomal transport	myosin complex;cytoplasmic vesicle membrane;protein-containing complex;apical cortex;recycling endosome;extracellular exosome	microfilament motor activity;protein binding;calmodulin binding;ATP binding;Rab GTPase binding;actin filament binding	IQGAP1[26496610];SKA3[26496610];MEOX2[unassigned1304];FAM214B[unassigned1304];COIL[16713569];PPP1CB[26496610];LIMA1[26496610];KIAA1549[12421765];ZNHIT1[unassigned1304];PDF[unassigned1312];RAB25[unassigned1304];TRIM3[unassigned1304];MYO18A[26496610];BNIP2[25416956;unassigned1304];RAC1[unassigned1312];SYNPO[26496610];CD164[17673908];MYO19[26496610];RAB11A[unassigned1304];RAB11B[unassigned1304];ANLN[26496610];NEURL4[29426014];CCDC8[unassigned1312];POLR1C[21988832];CAPZA2[26496610];MYH9[26496610];TCF4[25416956;unassigned1304];AMOTL2[25416956;unassigned1304];EFHC2[unassigned1304];TRIM54[25416956;unassigned1304];DBN1[26496610];	47363917
37227	chr18	47363930	A	G	chr18:47363930	MYO5B	myosin VB	SNV	0|1	0.14	73_12	86	99.0	0|1	0.19	87_21	109	99.0			rs79271359,COSV53210125	EXONIC	YES	NM_001080467.3	Transcript	protein_coding	synonymous_variant		37/40	NM_001080467.3:c.5095T>C	NP_001073936.1:p.Leu1699%3D		-1.0					Diarrhea 2, with microvillus atrophy, 251850 (3), Autosomal recessive	Microvillus inclusion disease;MYO5B-related progressive familial intrahepatic cholestasis;Progressive familial intrahepatic cholestasis type 1	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Diarrhea;Dehydration;Hypovolemia;Metabolic acidosis;Abdominal distention;Abnormal renal physiology;Global developmental delay;Pruritus;Nephrocalcinosis;Villous atrophy;Malnutrition;Dehydration;Growth delay;Protracted diarrhea;Villous atrophy;Autosomal recessive inheritance;Death in infancy		7.29588e-05	11.0	150770.0	0.0	33	0.97	AS_VQSR	sas	0.000209644	1.0	4.44326e-05	3.0	0.00349627	636.0	181908.0	0.0	100	1.0	RF	afr	0.00955463	124.0	0.00487556	402.0	0.0605515	9416	0.078	252.0	0.04519	463.0		12.29	0.843868		0	0	0			MYO5B	0.0	0.0	0.0	0.0	20.0	-9.0	-43.0	-36.0						0.0862	0.0	89.052035434			homeostasis/metabolism phenotype; integument phenotype ; mortality/aging ; growth/size/body region phenotype; digestive/alimentary phenotype; 			ciliary ganglion;pons;kidney;testis - interstitial;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;testis;skeletal muscle;globus pallidus;	.	renal water homeostasis;protein transport;vesicle-mediated transport;endosomal transport	myosin complex;cytoplasmic vesicle membrane;protein-containing complex;apical cortex;recycling endosome;extracellular exosome	microfilament motor activity;protein binding;calmodulin binding;ATP binding;Rab GTPase binding;actin filament binding	IQGAP1[26496610];SKA3[26496610];MEOX2[unassigned1304];FAM214B[unassigned1304];COIL[16713569];PPP1CB[26496610];LIMA1[26496610];KIAA1549[12421765];ZNHIT1[unassigned1304];PDF[unassigned1312];RAB25[unassigned1304];TRIM3[unassigned1304];MYO18A[26496610];BNIP2[25416956;unassigned1304];RAC1[unassigned1312];SYNPO[26496610];CD164[17673908];MYO19[26496610];RAB11A[unassigned1304];RAB11B[unassigned1304];ANLN[26496610];NEURL4[29426014];CCDC8[unassigned1312];POLR1C[21988832];CAPZA2[26496610];MYH9[26496610];TCF4[25416956;unassigned1304];AMOTL2[25416956;unassigned1304];EFHC2[unassigned1304];TRIM54[25416956;unassigned1304];DBN1[26496610];	47363930
37229	chr18	47363931	G	C	chr18:47363931	MYO5B	myosin VB	SNV	0|1	0.14	73_12	86	99.0	0|1	0.19	87_21	109	99.0			rs77840018,COSV53210139	EXONIC	YES	NM_001080467.3	Transcript	protein_coding	synonymous_variant		37/40	NM_001080467.3:c.5094C>G	NP_001073936.1:p.Leu1698%3D		-1.0					Diarrhea 2, with microvillus atrophy, 251850 (3), Autosomal recessive	Microvillus inclusion disease;MYO5B-related progressive familial intrahepatic cholestasis;Progressive familial intrahepatic cholestasis type 1	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Diarrhea;Dehydration;Hypovolemia;Metabolic acidosis;Abdominal distention;Abnormal renal physiology;Global developmental delay;Pruritus;Nephrocalcinosis;Villous atrophy;Malnutrition;Dehydration;Growth delay;Protracted diarrhea;Villous atrophy;Autosomal recessive inheritance;Death in infancy		6.6342e-05	10.0	150734.0	0.0	33	0.97	AS_VQSR	sas	0.000209908	1.0	4.44339e-05	3.0	0.00402393	729.0	181166.0	0.0	100	1.0	PASS	afr	0.0102893	133.0	0.00550376	451.0	0.0608666	9465	0.077	249.0	0.04597	471.0		10.21	0.588938		0	0	0			MYO5B	0.0	0.0	0.0	0.0	19.0	-10.0	-44.0	-12.0						0.0862	0.0	89.052035434			homeostasis/metabolism phenotype; integument phenotype ; mortality/aging ; growth/size/body region phenotype; digestive/alimentary phenotype; 			ciliary ganglion;pons;kidney;testis - interstitial;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;testis;skeletal muscle;globus pallidus;	.	renal water homeostasis;protein transport;vesicle-mediated transport;endosomal transport	myosin complex;cytoplasmic vesicle membrane;protein-containing complex;apical cortex;recycling endosome;extracellular exosome	microfilament motor activity;protein binding;calmodulin binding;ATP binding;Rab GTPase binding;actin filament binding	IQGAP1[26496610];SKA3[26496610];MEOX2[unassigned1304];FAM214B[unassigned1304];COIL[16713569];PPP1CB[26496610];LIMA1[26496610];KIAA1549[12421765];ZNHIT1[unassigned1304];PDF[unassigned1312];RAB25[unassigned1304];TRIM3[unassigned1304];MYO18A[26496610];BNIP2[25416956;unassigned1304];RAC1[unassigned1312];SYNPO[26496610];CD164[17673908];MYO19[26496610];RAB11A[unassigned1304];RAB11B[unassigned1304];ANLN[26496610];NEURL4[29426014];CCDC8[unassigned1312];POLR1C[21988832];CAPZA2[26496610];MYH9[26496610];TCF4[25416956;unassigned1304];AMOTL2[25416956;unassigned1304];EFHC2[unassigned1304];TRIM54[25416956;unassigned1304];DBN1[26496610];	47363931
37231	chr18	47364009	G	A	chr18:47364009	MYO5B	myosin VB	SNV	0/0	0.09	83_8	92	55.0	0/1	0.22	86_24	110	99.0			rs149010847,COSV53210237	EXONIC	YES	NM_001080467.3	Transcript	protein_coding	synonymous_variant		37/40	NM_001080467.3:c.5016C>T	NP_001073936.1:p.Gly1672%3D		-1.0					Diarrhea 2, with microvillus atrophy, 251850 (3), Autosomal recessive	Microvillus inclusion disease;MYO5B-related progressive familial intrahepatic cholestasis;Progressive familial intrahepatic cholestasis type 1	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Diarrhea;Dehydration;Hypovolemia;Metabolic acidosis;Abdominal distention;Abnormal renal physiology;Global developmental delay;Pruritus;Nephrocalcinosis;Villous atrophy;Malnutrition;Dehydration;Growth delay;Protracted diarrhea;Villous atrophy;Autosomal recessive inheritance;Death in infancy		0.000125985	19.0	150812.0	0.0	33	0.97	PASS	sas	0.000210084	1.0	0.000118371	8.0	0.00239022	548.0	229268.0	0.0	100	1.0	PASS	afr	0.00800884	116.0	0.00342084	356.0	0.0201024	3126	0.016	49.0	0.00068	7.0		11.29	0.716618		0	0	0			MYO5B	0.0	0.0	0.0	0.02	-25.0	16.0	2.0	-24.0						0.0862	0.0	6.586176324			homeostasis/metabolism phenotype; integument phenotype ; mortality/aging ; growth/size/body region phenotype; digestive/alimentary phenotype; 			ciliary ganglion;pons;kidney;testis - interstitial;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;testis;skeletal muscle;globus pallidus;	.	renal water homeostasis;protein transport;vesicle-mediated transport;endosomal transport	myosin complex;cytoplasmic vesicle membrane;protein-containing complex;apical cortex;recycling endosome;extracellular exosome	microfilament motor activity;protein binding;calmodulin binding;ATP binding;Rab GTPase binding;actin filament binding	IQGAP1[26496610];SKA3[26496610];MEOX2[unassigned1304];FAM214B[unassigned1304];COIL[16713569];PPP1CB[26496610];LIMA1[26496610];KIAA1549[12421765];ZNHIT1[unassigned1304];PDF[unassigned1312];RAB25[unassigned1304];TRIM3[unassigned1304];MYO18A[26496610];BNIP2[25416956;unassigned1304];RAC1[unassigned1312];SYNPO[26496610];CD164[17673908];MYO19[26496610];RAB11A[unassigned1304];RAB11B[unassigned1304];ANLN[26496610];NEURL4[29426014];CCDC8[unassigned1312];POLR1C[21988832];CAPZA2[26496610];MYH9[26496610];TCF4[25416956;unassigned1304];AMOTL2[25416956;unassigned1304];EFHC2[unassigned1304];TRIM54[25416956;unassigned1304];DBN1[26496610];	47364009
37240	chr18	48255893	A	C	chr18:48255893	MAPK4	mitogen-activated protein kinase 4	SNV	0/1	0.47	48_43	91	99.0	0/1	0.56	37_47	84	99.0			rs1463072484	EXONIC	YES	NM_002747.4	Transcript	protein_coding	missense_variant		6/6	NM_002747.4:c.1433A>C	NP_002738.2:p.Asp478Ala		1.0	.,.					.	.	.		3.29381e-05	5.0	151800.0	0.0	33	0.98	PASS	afr	2.41955e-05	1.0	0.0	0.0	3.46176e-05	2.0	57774.0	0.0	3	0.12	PASS	eas	0.000137325	1.0	0.0	0.0								9.727	0.535068	0.039	1	18	19	M-CAP_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MAPK4	0.0	0.0	0.0	0.0	-40.0	-37.0	17.0	-1.0						0.27	0.32		0.003	0.278	growth/size/body region phenotype; normal phenotype; mortality/aging ; respiratory system phenotype; 			.	.	MAPK cascade;protein phosphorylation;cell cycle;regulation of gene expression;intracellular signal transduction;cellular response to organic substance	nucleus;nucleoplasm;cytoplasm;cytosol	protein serine/threonine kinase activity;MAP kinase activity;protein binding;ATP binding;protein kinase binding;protein homodimerization activity;protein heterodimerization activity	HSP90AB1[22939624];FAM57A[23602568];TECR[23602568];FASTKD5[23602568];CALML3[21988832];MAPKAPK5[23602568];ATP1A1[23602568];ERC1[23602568];CRK[21988832];PSMA7[23602568];PFKP[23602568];	48255893
37253	chr18	51057011	C	G	chr18:51057011	DCC	DCC netrin 1 receptor	SNV	0/1	0.34	43_24	70	99.0	0/1	0.46	44_38	82	99.0			rs1372588537	EXONIC	YES	NM_005215.4	Transcript	protein_coding	synonymous_variant		29/29	NM_005215.4:c.4332C>G	NP_005206.2:p.Gly1444%3D		1.0					Mirror movements 1 and/or agenesis of the corpus callosum, 157600 (3), Autosomal dominant; Esophageal carcinoma, somatic, 133239 (3); Colorectal cancer, somatic, 114500 (3); Gaze palsy, familial horizontal, with progressive scoliosis, 2, 617542 (3), Autosomal recessive	Kallmann syndrome;Familial congenital mirror movements	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Global developmental delay;Bimanual synkinesia;Autosomal recessive inheritance;Generalized hypotonia;Intellectual disability;Scoliosis;Agenesis of corpus callosum;Hyperreflexia;Bimanual synkinesia;Autosomal dominant inheritance;Incomplete penetrance;Intellectual disability, mild;Agenesis of corpus callosum;Somatic mutation;Autosomal dominant inheritance;Squamous cell carcinoma;Cerebral palsy;Clumsiness;Fused cervical vertebrae;Myalgia;Hypogonadotropic hypogonadism;Morphological abnormality of the corticospinal tract;Dysgenesis of the hippocampus;Specific learning disability;Agenesis of corpus callosum;Easy fatigability;Intellectual disability, mild;Bimanual synkinesia;Poor fine motor coordination;Color vision defect;Micropenis;Hypothalamic gonadotropin-releasing hormone deficiency;Abnormality of the voice;Reduced number of teeth;Hypogonadotropic hypogonadism;Decreased fertility;Pes cavus;Reduced bone mineral density;Gynecomastia;Bimanual synkinesia;Recurrent fractures;Dyspareunia;Decreased testicular size;Muscular hypotonia;Paraplegia;Sensorineural hearing impairment;Tremor;Abnormal morphology of female internal genitalia;Delayed puberty;Ataxia;Cleft palate;Erectile dysfunction;Visual impairment;Anosmia;Breast hypoplasia;Skeletal dysplasia;Gait disturbance;Ichthyosis;Primary amenorrhea;Cryptorchidism;Abnormality of cardiovascular system morphology;Pes planus;Delayed skeletal maturation;Ptosis;Dysarthria;Muscle weakness;Hyposmia;Anterior hypopituitarism;Seizure;Obesity;Renal agenesis;Nystagmus;Sensorineural hearing impairment;Kyphosis;Cognitive impairment;Horizontal supranuclear gaze palsy;Short neck;Nystagmus;Seizure;Scoliosis						32	0.97											100	1.0											9e-05	1.0		10.42	0.613043		0	0	0			DCC	0.0	0.0	0.41	0.02	-1.0	35.0	-1.0	34.0						0.313	1.0	92.223971235			behavior/neurological phenotype ; respiratory system phenotype; hematopoietic system phenotype; mortality/aging ; pigmentation phenotype; neoplasm; digestive/alimentary phenotype; nervous system phenotype ; vision/eye phenotype; immune system phenotype; cellular phenotype; 			atrioventricular node;superior cervical ganglion;	Axon guidance;Colorectal cancer	neuron migration;apoptotic process;axonogenesis;axon guidance;negative regulation of neuron projection development;spinal cord ventral commissure morphogenesis;dorsal/ventral axon guidance;anterior/posterior axon guidance;netrin-activated signaling pathway;negative regulation of collateral sprouting;extrinsic apoptotic signaling pathway in absence of ligand;postsynaptic modulation of chemical synaptic transmission;regulation of neuron death;negative regulation of netrin-activated signaling pathway;negative regulation of dendrite development	cytosol;plasma membrane;axon;Schaffer collateral - CA1 synapse;integral component of postsynaptic density membrane	transmembrane signaling receptor activity;netrin receptor activity;protein binding	HEMGN[24412244];RPL5[20434207];EIF4E3[20434207];ITGB5[21642953];MAZ[11527412];EIF5A2[20434207];TRMO[24412244];NTN4[19721007];RRBP1[30021884];CTSV[24412244];RPL10A[20434207];NTN1[20434207;26190107;19721007];CASP9[16537496;19721007];MAPK1[20434207];RPL13[20434207];RPL38[20434207];EIF2B1[20434207];RPS10[20434207];RPS13[20434207];TMOD1[24412244];EIF2B4[20434207];EIF2B2[20434207];MYO10[21642953];TSTD2[24412244];RPL23[20434207];RPS6[20434207];TDRD7[24412244];EIF2S2[20434207];CORO2A[24412244];EIF2S1[20434207];PTK2[20434207];TBC1D2[24412244];EIF2S3[20434207];SFRP2[24412244];MAPKAPK3[24412244];RASA1[24412244];ALB[15174051];EIF3E[20434207];ALDOB[24412244];ANP32B[24412244];EZR[20434207];RPL28[20434207];FBP1[24412244];RPS24[20434207];RPS23[20434207];	51057011
37453	chr18	56586714	G	A	chr18:56586714	ZNF532	zinc finger protein 532	SNV	0/1	0.5	66_65	131	99.0	0/0	0.0	45_0	45	99.0			rs755855361	EXONIC	YES	NM_001375912.1	Transcript	protein_coding	missense_variant		3/10	NM_001375912.1:c.1195G>A	NP_001362841.1:p.Val399Met		1.0	.,.,.,.,.					.	.	.		6.57091e-06	1.0	152186.0	0.0	32	0.97	PASS	nfe	1.46972e-05	1.0	1.46972e-05	1.0	1.19487e-05	3.0	251074.0	0.0	60	1.0	PASS	sas	3.26691e-05	1.0	1.76342e-05	2.0	0.0000064	1						13.75	1.048692	0.014	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF532	0.0	0.0	0.0	0.0	2.0	37.0	45.0	-5.0						0.247	0.91		0.978	1.146	.			pons;temporal lobe;occipital lobe;subthalamic nucleus;atrioventricular node;superior cervical ganglion;	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	MBD3[25123934];KDM5C[26496610];ZMYND8[26496610];MAPT[26402096];	56586714
37478	chr18	56964146	A	T	chr18:56964146	CPLX4	complexin 4	SNV	0/0	0.0	48_0	48	99.0	0/1	0.55	18_23	42	99.0			rs185848311	EXONIC	YES	NM_181654.4	Transcript	protein_coding	missense_variant		3/3	NM_181654.4:c.267T>A	NP_857637.1:p.Asp89Glu		-1.0						.	.	.		0.000427502	65.0	152046.0	0.0	31	0.95	PASS	nfe	0.000646964	44.0	0.000646964	44.0	0.000303361	75.0	247230.0	0.0	43	0.88	PASS	nfe	0.000496868	56.0	0.000496868	56.0	0.0003344	52	0.001	2.0				21.6	2.228781	0.569	12	8	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,ClinPred_pred,fathmm-XF_coding_pred	CPLX4	0.0	0.01	0.0	0.0	-2.0	9.0	11.0	2.0						0.47	0.0	0.000000000	0.976	-0.088	vision/eye phenotype; nervous system phenotype ; 			superior cervical ganglion;	.	synaptic vesicle exocytosis;regulation of neurotransmitter secretion	cell junction;SNARE complex;terminal bouton	SNARE binding;syntaxin binding	PNLIPRP1[unassigned1304];SLC35B4[unassigned1304];TTMP[unassigned1304];PGAP2[unassigned1304];CD81[unassigned1304];CCL4L1[unassigned1304];GIMAP1[unassigned1304];AQP9[unassigned1304];NRM[unassigned1304];TMEM97[unassigned1304];WFDC2[unassigned1304];ASGR1[unassigned1304];AQP1[unassigned1304];TMEM267[unassigned1304];SLC39A9[unassigned1304];SMCO4[unassigned1304];TMEM14A[unassigned1304];TMEM14B[unassigned1304];VKORC1[unassigned1304];SLC30A8[unassigned1304];SLC30A2[unassigned1304];STX8[unassigned1304];SFTPC[unassigned1304];ADIPOQ[unassigned1304];AGTRAP[unassigned1304];TMEM254[unassigned1304];NINJ2[unassigned1304];MALL[unassigned1304];TMEM79[unassigned1304];CTXN3[unassigned1304];VAMP4[unassigned1304];SEC22B[unassigned1304];ATP6V0C[unassigned1304];VAMP5[unassigned1304];CLEC4G[unassigned1304];CLDND2[unassigned1304];HACD1[unassigned1304];NRAC[unassigned1304];INSIG2[unassigned1304];LPAR3[unassigned1304];CLN6[unassigned1304];TMEM243[unassigned1304];C5[unassigned1304];TMEM201[unassigned1304];SLC38A7[unassigned1304];HMOX1[unassigned1304];BNIP2[unassigned1304];APOD[unassigned1304];STX3[unassigned1304];CACNG1[unassigned1304];CDIPT[unassigned1304];CYB5B[unassigned1304];AOC3[unassigned1304];HHATL[unassigned1304];SLC35A1[unassigned1304];SLC35A4[unassigned1304];MGAM[unassigned1304];CMTM5[unassigned1304];ORMDL1[unassigned1304];GAD2[unassigned1304];SYNJ2BP[unassigned1304];AIG1[unassigned1304];TF[unassigned1304];TSPO2[unassigned1304];CNIH1[unassigned1304];MAN2B2[unassigned1304];PTPN9[unassigned1304];PLP2[unassigned1304];CDS2[unassigned1304];TMEM229B[unassigned1304];	56964146
37664	chr19	694832	G	A	chr19:694832	PRSS57	serine protease 57	SNV	0/1	0.47	52_46	98	99.0	0/0	0.0	40_0	40	99.0			rs377737528,COSV104535995	EXONIC	YES	NM_214710.5	Transcript	protein_coding	missense_variant		2/5	NM_214710.5:c.218C>T	NP_999875.2:p.Ala73Val		-1.0	Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain					.	.	.						31	0.94							4.25764e-06	1.0	234872.0	0.0	21	0.55	PASS				0.0	0.0	0.0000064	1						26.4	3.818145	0.426	18	3	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LRT_pred,PrimateAI_pred,LIST-S2_pred	PRSS57	0.0	0.0	0.0	0.0	-13.0	-18.0	-18.0	-30.0							0.0	0.168998750	0.593	1.175	.			.	.	proteolysis	extracellular space;azurophil granule lumen	serine-type endopeptidase activity;heparin binding;serine-type peptidase activity	.	694832
37726	chr19	1000600	C	T	chr19:1000600	GRIN3B	glutamate ionotropic receptor NMDA type subunit 3B	SNV	0/0	0.0	22_0	22	60.0	0/1	0.43	8_6	14	99.0			rs998053758	EXONIC	YES	NM_138690.3	Transcript	protein_coding	missense_variant		1/9	NM_138690.3:c.164C>T	NP_619635.1:p.Ala55Val		1.0						.	.	.		0.000380621	56.0	147128.0	0.0	33	0.92	PASS	nfe	0.000756132	50.0	0.000756132	50.0	0.0	0.0	126.0	0.0	0	0.0	AC0				0.0	0.0	0.0000129	2						15.22	1.305233	0.068	1	18	19	PrimateAI_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	GRIN3B	0.0	0.0	0.0	0.0	18.0	9.0	-2.0	0.0							0.0		0.003	0.046	growth/size/body region phenotype; behavior/neurological phenotype ; 			.	Neuroactive ligand-receptor interaction	ionotropic glutamate receptor signaling pathway;protein insertion into membrane;regulation of calcium ion transport;calcium ion transmembrane transport	plasma membrane;NMDA selective glutamate receptor complex;cell junction;neuronal cell body;postsynaptic membrane	ionotropic glutamate receptor activity;cation channel activity;calcium channel activity;glycine binding;neurotransmitter receptor activity;neurotransmitter binding	.	1000600
37856	chr19	1881395	T	C	chr19:1881395	ABHD17A	abhydrolase domain containing 17A	SNV	0|1	0.11	103_13	116	99.0	0|1	0.21	91_24	115	99.0			rs199929215,COSV51749725	EXONIC	YES	NM_031213.4	Transcript	protein_coding	synonymous_variant		2/6	NM_031213.4:c.171A>G	NP_112490.3:p.Arg57%3D		-1.0						.	.	.		0.000283178	40.0	141254.0	0.0	34	0.96	AS_VQSR	eas	0.000411353	2.0	0.000202316	13.0	0.000961144	206.0	214328.0	0.0	36	0.85	RF	afr	0.00102145	12.0	0.000821308	79.0	0.0000836	13	0.01	33.0				4.558	0.117885		0	0	0			ABHD17A	0.0	0.0	0.0	0.0	0.0	-31.0	35.0	-31.0							0.05				homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype; 			.	.	protein depalmitoylation;protein palmitoylation;protein localization to membrane;regulation of postsynapse organization;negative regulation of protein localization to microtubule;positive regulation of protein localization to endosome	plasma membrane;endosome membrane;membrane;cell junction;dendritic spine;recycling endosome membrane;glutamatergic synapse;anchored component of postsynaptic density membrane;anchored component of postsynaptic recycling endosome membrane	protein binding;palmitoyl-(protein) hydrolase activity	GOLGA2[21516116];KRTAP5-9[21516116];HPGDS[25416956];TNIP1[21516116];PNMA1[21516116];EHMT2[21516116];RGS20[21516116];TRAF1[21516116];GPC4[21516116];TRIM27[21516116];BIRC2[21516116];MDFI[21516116];	1881395
37858	chr19	1881397	T	G	chr19:1881397	ABHD17A	abhydrolase domain containing 17A	SNV	0|1	0.11	103_13	116	99.0	0|1	0.21	91_24	115	99.0			rs200867680,COSV51750309	EXONIC	YES	NM_031213.4	Transcript	protein_coding	synonymous_variant		2/6	NM_031213.4:c.169A>C	NP_112490.3:p.Arg57%3D		-1.0						.	.	.		0.000376217	54.0	143534.0	0.0	34	0.97	AS_VQSR	afr	0.000469876	18.0	0.000276141	18.0	0.00113879	241.0	211628.0	0.0	37	0.86	RF	afr	0.00156904	18.0	0.000971345	92.0	0.0000772	12	0.01	33.0				7.551	0.326528		0	0	0			ABHD17A	0.0	0.0	0.0	0.0	-4.0	-33.0	-43.0	33.0							0.05				homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype; 			.	.	protein depalmitoylation;protein palmitoylation;protein localization to membrane;regulation of postsynapse organization;negative regulation of protein localization to microtubule;positive regulation of protein localization to endosome	plasma membrane;endosome membrane;membrane;cell junction;dendritic spine;recycling endosome membrane;glutamatergic synapse;anchored component of postsynaptic density membrane;anchored component of postsynaptic recycling endosome membrane	protein binding;palmitoyl-(protein) hydrolase activity	GOLGA2[21516116];KRTAP5-9[21516116];HPGDS[25416956];TNIP1[21516116];PNMA1[21516116];EHMT2[21516116];RGS20[21516116];TRAF1[21516116];GPC4[21516116];TRIM27[21516116];BIRC2[21516116];MDFI[21516116];	1881397
37862	chr19	1881408	A	G	chr19:1881408	ABHD17A	abhydrolase domain containing 17A	SNV	0/1	0.15	105_19	124	99.0	0/1	0.23	97_29	126	99.0			rs199712154,COSV51750010	EXONIC	YES	NM_031213.4	Transcript	protein_coding	missense_variant		2/6	NM_031213.4:c.158T>C	NP_112490.3:p.Leu53Ser		-1.0	.,.,.					.	.	.						34	0.99							0.000880788	193.0	219122.0	0.0	38	0.89	RF	eas	0.00160851	26.0	0.000683632	67.0	0.0000514	8						2.256	-0.025529	0.018	0	18	18		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ABHD17A	0.0	0.0	0.0	0.0	37.0	-44.0	-38.0	47.0							0.05		0.001	0.159	homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype; 			.	.	protein depalmitoylation;protein palmitoylation;protein localization to membrane;regulation of postsynapse organization;negative regulation of protein localization to microtubule;positive regulation of protein localization to endosome	plasma membrane;endosome membrane;membrane;cell junction;dendritic spine;recycling endosome membrane;glutamatergic synapse;anchored component of postsynaptic density membrane;anchored component of postsynaptic recycling endosome membrane	protein binding;palmitoyl-(protein) hydrolase activity	GOLGA2[21516116];KRTAP5-9[21516116];HPGDS[25416956];TNIP1[21516116];PNMA1[21516116];EHMT2[21516116];RGS20[21516116];TRAF1[21516116];GPC4[21516116];TRIM27[21516116];BIRC2[21516116];MDFI[21516116];	1881408
37864	chr19	1881527	G		chr19:1881527	ABHD17A	abhydrolase domain containing 17A	deletion	0|1	0.26	65_23	88	99.0	0|1	0.25	71_24	97	99.0			rs762199778,COSV51749296	EXONIC	YES	NM_031213.4	Transcript	protein_coding	frameshift_variant		2/6	NM_031213.4:c.39del	NP_112490.3:p.Cys14AlafsTer43		-1.0						.	.	.						34	0.99							8.79245e-06	2.0	227468.0	0.0	37	0.86	RF	nfe	9.87615e-06	1.0	9.87615e-06	1.0			0.001	2.0				29.5	4.208976		0	0	0			ABHD17A	0.03	0.0	0.0	0.0	-36.0	-19.0	21.0	-34.0							0.05				homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype; 			.	.	protein depalmitoylation;protein palmitoylation;protein localization to membrane;regulation of postsynapse organization;negative regulation of protein localization to microtubule;positive regulation of protein localization to endosome	plasma membrane;endosome membrane;membrane;cell junction;dendritic spine;recycling endosome membrane;glutamatergic synapse;anchored component of postsynaptic density membrane;anchored component of postsynaptic recycling endosome membrane	protein binding;palmitoyl-(protein) hydrolase activity	GOLGA2[21516116];KRTAP5-9[21516116];HPGDS[25416956];TNIP1[21516116];PNMA1[21516116];EHMT2[21516116];RGS20[21516116];TRAF1[21516116];GPC4[21516116];TRIM27[21516116];BIRC2[21516116];MDFI[21516116];	1881526
37868	chr19	1881529	AG		chr19:1881529-1881530	ABHD17A	abhydrolase domain containing 17A	deletion	0|1	0.26	65_23	88	99.0	0|1	0.24	72_24	98	99.0			rs768141721	EXONIC	YES	NM_031213.4	Transcript	protein_coding	frameshift_variant		2/6	NM_031213.4:c.36_37del	NP_112490.3:p.Phe13LeufsTer27		-1.0						.	.	.						34	0.99							8.80747e-06	2.0	227080.0	0.0	37	0.86	RF	nfe	9.89844e-06	1.0	9.89844e-06	1.0	0.0000064	1	0.001	2.0				28.4	4.07594		0	0	0			ABHD17A	0.0	0.02	0.0	0.0	13.0	-38.0	19.0	-38.0							0.05				homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype; 			.	.	protein depalmitoylation;protein palmitoylation;protein localization to membrane;regulation of postsynapse organization;negative regulation of protein localization to microtubule;positive regulation of protein localization to endosome	plasma membrane;endosome membrane;membrane;cell junction;dendritic spine;recycling endosome membrane;glutamatergic synapse;anchored component of postsynaptic density membrane;anchored component of postsynaptic recycling endosome membrane	protein binding;palmitoyl-(protein) hydrolase activity	GOLGA2[21516116];KRTAP5-9[21516116];HPGDS[25416956];TNIP1[21516116];PNMA1[21516116];EHMT2[21516116];RGS20[21516116];TRAF1[21516116];GPC4[21516116];TRIM27[21516116];BIRC2[21516116];MDFI[21516116];	1881528
37891	chr19	2291501	T	A	chr19:2291501	LINGO3	leucine rich repeat and Ig domain containing 3	SNV	0/1	0.37	54_32	86	99.0	0/1	0.42	54_39	93	99.0			rs201142184	EXONIC	YES	NM_001101391.2	Transcript	protein_coding	missense_variant		2/2	NM_001101391.2:c.275A>T	NP_001094861.1:p.His92Leu		-1.0						.	.	.		0.00510882	777.0	152090.0	4.0	33	0.99	PASS	nfe	0.00851621	579.0	0.00851621	579.0	0.00487156	1172.0	240580.0	3.0	43	0.9	PASS	nfe	0.00819504	881.0	0.00819504	881.0	0.0049002	762	0.006	19.0				20.2	2.051339	0.265	2	15	17	M-CAP_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	LINGO3	0.0	0.0	0.0	0.0	-8.0	-2.0	11.0	3.0								0.000000000	1.0	1.056	.			.	.	.	extracellular space;integral component of membrane;extracellular matrix	.	.	2291501
37969	chr19	3770956	A	G	chr19:3770956	RAX2	retina and anterior neural fold homeobox 2	SNV	0/1	0.42	32_23	55	99.0	0/1	0.58	14_19	33	99.0			rs772356880	SPLICING	YES	NM_001319074.4	Transcript	protein_coding	missense_variant,splice_region_variant		3/3	NM_001319074.4:c.218T>C	NP_001306003.2:p.Val73Ala		-1.0	Homeobox domain&Homeobox, conserved site&Homeobox domain&Homeobox domain&Homeobox domain,Homeobox domain&Homeobox, conserved site&Homeobox domain&Homeobox domain&Homeobox domain	Uncertain_significance	criteria_provided,_single_submitter	not_provided	Cone-rod dystrophy 11, 610381 (3), Autosomal dominant; ?Macular degeneration, age-related, 6, 613757 (3)	Cone rod dystrophy	Disease-causing germline mutation(s) in	Macular atrophy;Autosomal dominant inheritance;Macular degeneration;Photophobia;Cone/cone-rod dystrophy;Pallor;Slow decrease in visual acuity;Bull's eye maculopathy;Macular degeneration;Photophobia;Visual impairment;Color vision defect;Abnormality of retinal pigmentation;Nyctalopia						33	0.98							1.85676e-05	3.0	161572.0	0.0	29	0.56	PASS	amr	0.000111251	3.0	0.0	0.0	0.0000064	1			0.00018	2.0		25.3	3.599307	0.381	16	4	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,LRT_pred,PrimateAI_pred,LIST-S2_pred	RAX2	0.0	0.0	0.0	0.0	30.0	-11.0	-48.0	2.0	0.0056676143228099	0.192	9.794	1.535	11.329		0.51	0.000000000	0.974	1.01	.			.	.	visual perception;positive regulation of transcription by RNA polymerase II;response to stimulus	nucleus	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific	CRX[15028672];	3770956
38036	chr19	4511674	C	T	chr19:4511674	PLIN4	perilipin 4	SNV	0|1	0.29	47_19	66	99.0	0/0	0.0	55_0	55	99.0			rs775085816,COSV56686007	EXONIC	YES	NM_001367868.2	Transcript	protein_coding	synonymous_variant		5/8	NM_001367868.2:c.2298G>A	NP_001354797.1:p.Val766%3D		-1.0						.	.	.		0.00153976	84.0	54554.0	0.0	0	0.28	PASS	eas	0.00337079	3.0	0.000543774	12.0	0.000755668	87.0	115130.0	0.0	100	1.0	PASS	afr	0.00201014	23.0	0.000211223	12.0	0.0000836	13	0.001	3.0				0.07	-0.532286		0	0	0			PLIN4	0.0	0.0	0.0	0.0	-17.0	-6.0	3.0	31.0						0.888	0.0	0.000000000			homeostasis/metabolism phenotype; cardiovascular system phenotype ; 			.	.	.	lipid droplet;cytosol;plasma membrane;intracellular membrane-bounded organelle	.	CASP8[21988832];PPP1CA[25593058];	4511674
38037	chr19	4511679	C	T	chr19:4511679	PLIN4	perilipin 4	SNV	0|1	0.31	45_21	67	99.0	0/0	0.0	55_0	55	99.0			rs200355083,COSV56686383	EXONIC	YES	NM_001367868.2	Transcript	protein_coding	missense_variant		5/8	NM_001367868.2:c.2293G>A	NP_001354797.1:p.Ala765Thr		-1.0	.,.					.	.	.		0.00180999	86.0	47514.0	0.0	0	0.25	PASS	eas	0.00403226	3.0	0.000699526	13.0	0.00220221	223.0	101262.0	1.0	100	1.0	PASS	eas	0.00666009	27.0	0.00119433	59.0	0.0000129	2	0.001	4.0				0.001	-1.405004	0.08	0	17	17		LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PLIN4	0.0	0.0	0.0	0.0	-22.0	2.0	26.0	-13.0						0.888	0.0	0.000000000	0.0	-7.04	homeostasis/metabolism phenotype; cardiovascular system phenotype ; 			.	.	.	lipid droplet;cytosol;plasma membrane;intracellular membrane-bounded organelle	.	CASP8[21988832];PPP1CA[25593058];	4511679
38038	chr19	4511680	A	G	chr19:4511680	PLIN4	perilipin 4	SNV	0|1	0.14	44_21	153	99.0	0/0	0.0	57_0	57	67.0			rs759223445,COSV56686051	EXONIC	YES	NM_001367868.2	Transcript	protein_coding	synonymous_variant		5/8	NM_001367868.2:c.2292T>C	NP_001354797.1:p.Asp764%3D		-1.0						.	.	.		0.00231357	95.0	41062.0	0.0	0	0.22	PASS	eas	0.00727273	4.0	0.00105341	17.0	0.00309983	264.0	85166.0	1.0	100	1.0	PASS	eas	0.00998004	30.0	0.00180602	74.0	0.0001093	17	0.001	3.0				0.052	-0.57104		0	0	0			PLIN4	0.0	0.0	0.0	0.0	43.0	-23.0	-3.0	25.0						0.888	0.0	0.000000000			homeostasis/metabolism phenotype; cardiovascular system phenotype ; 			.	.	.	lipid droplet;cytosol;plasma membrane;intracellular membrane-bounded organelle	.	CASP8[21988832];PPP1CA[25593058];	4511680
38048	chr19	4817657	C	T	chr19:4817657	TICAM1	toll like receptor adaptor molecule 1	SNV	0/1	0.57	41_56	98	99.0	0/1	0.45	65_54	119	99.0			rs151272128,COSV99941356	EXONIC	YES	NM_182919.4	Transcript	protein_coding	missense_variant		2/2	NM_182919.4:c.733G>A	NP_891549.1:p.Gly245Ser		-1.0	.,.	Likely_benign	criteria_provided,_single_submitter	Herpes_simplex_encephalitis,_susceptibility_to,_4|not_provided	{Encephalopathy, acute, infection-induced (herpes-specific), susceptibility to, 6}, 614850 (3), Autosomal recessive, Autosomal dominant	Herpes simplex virus encephalitis	Major susceptibility factor in	Herpes simplex encephalitis;Incomplete penetrance;Autosomal recessive inheritance;Autosomal dominant inheritance;Cerebral edema;Focal impaired awareness seizure;Excessive daytime somnolence;Nuchal rigidity;Immunodeficiency;Alcoholism;Hyperreflexia;Elevated C-reactive protein level;Increased CSF protein;Headache;EEG abnormality;Hyponatremia;Loss of consciousness;Leukocytosis;Status epilepticus;Hypoglycorrhachia;Coma;Fever;Neutrophilia;Fatigue;CSF lymphocytic pleiocytosis;Nausea and vomiting;Functional motor deficit;Respiratory failure requiring assisted ventilation;Neurological speech impairment;Focal aware seizure;Chills		0.00272211	414.0	152088.0	2.0	32	0.97	PASS	afr	0.0065691	272.0	0.000602835	41.0	0.00110167	245.0	222390.0	2.0	37	0.7	PASS	afr	0.00716221	111.0	0.000505651	51.0	0.0009710	151	0.005	13.0	0.00351	40.0		3.215	0.037357	0.029	0	18	18		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TICAM1	0.0	0.0	0.0	0.0	-2.0	-12.0	-2.0	0.0						0.35	0.85	0.000000000	0.0	-0.942	growth/size/body region phenotype; homeostasis/metabolism phenotype; cellular phenotype; liver/biliary system phenotype; cardiovascular system phenotype ; hematopoietic system phenotype; mortality/aging ; neoplasm; digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype ; vision/eye phenotype; immune system phenotype; 			.	Toll-like receptor signaling pathway	macrophage activation involved in immune response;positive regulation of myeloid dendritic cell cytokine production;MyD88-independent toll-like receptor signaling pathway;inflammatory response;I-kappaB kinase/NF-kappaB signaling;positive regulation of autophagy;positive regulation of gene expression;positive regulation of B cell proliferation;positive regulation of protein ubiquitination;lipopolysaccharide-mediated signaling pathway;positive regulation of protein binding;positive regulation of interleukin-6 production;positive regulation of tumor necrosis factor production;positive regulation of natural killer cell activation;negative regulation of MyD88-independent toll-like receptor signaling pathway;toll-like receptor 3 signaling pathway;TRIF-dependent toll-like receptor signaling pathway;positive regulation of I-kappaB kinase/NF-kappaB signaling;response to exogenous dsRNA;regulation of protein homodimerization activity;positive regulation of chemokine biosynthetic process;innate immune response;positive regulation of interferon-beta biosynthetic process;positive regulation of nitric oxide biosynthetic process;positive regulation of NF-kappaB transcription factor activity;defense response to virus;necroptotic process;cellular response to lipopolysaccharide;apoptotic signaling pathway;cellular response to oxidised low-density lipoprotein particle stimulus;positive regulation of cytokine production involved in inflammatory response	mitochondrion;autophagosome;cytosol;endosome membrane;ripoptosome	protein binding;protein kinase binding	PIAS4[15251447];CEP170P1[26496610];TICAM2[12721283];TBK1[15841462;21903422;19416887];CDCA5[26496610];MKNK2[26496610];SARM1[26592460];TNFAIP3[15474016];SRSF4[21988832];KIF21B[26496610];TANK[21903422];	4817657
38068	chr19	5207960	G	C	chr19:5207960	PTPRS	protein tyrosine phosphatase, receptor type S	SNV	0/1	0.36	65_37	102	99.0	0/1	0.52	40_44	84	99.0			rs141597386	EXONIC	YES	NM_002850.4	Transcript	protein_coding	synonymous_variant		37/38	NM_002850.4:c.5751C>G	NP_002841.3:p.Thr1917%3D		-1.0						.	.	.		0.000512403	78.0	152224.0	0.0	33	0.98	PASS	amr	0.00130839	20.0	0.000161679	11.0	0.000413878	104.0	251282.0	0.0	66	1.0	PASS	afr	0.000492187	8.0	0.000237463	27.0	0.0001929	30	0.001	2.0				5.968	0.208644		0	0	0			PTPRS	0.0	0.0	0.0	0.0	20.0	18.0	-15.0	18.0						0.317	0.76	51.597781923			nervous system phenotype ; digestive/alimentary phenotype; vision/eye phenotype; skeleton phenotype; renal/urinary system phenotype; behavior/neurological phenotype ; respiratory system phenotype; mortality/aging ; reproductive system phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; taste/olfaction phenotype; muscle phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; integument phenotype ; growth/size/body region phenotype; 			pons;superior cervical ganglion;	.	protein dephosphorylation;negative regulation of neuron projection development;spinal cord development;cerebellum development;hippocampus development;cerebral cortex development;corpus callosum development;negative regulation of axon extension;negative regulation of interferon-alpha production;negative regulation of interferon-beta production;negative regulation of toll-like receptor 9 signaling pathway;peptidyl-tyrosine dephosphorylation;negative regulation of collateral sprouting;negative regulation of axon regeneration;modulation of chemical synaptic transmission;negative regulation of dendritic spine development;establishment of endothelial intestinal barrier;regulation of postsynaptic density assembly;synaptic membrane adhesion	plasma membrane;integral component of plasma membrane;cell junction;integral component of synaptic vesicle membrane;axon;perikaryon;extracellular exosome;Schaffer collateral - CA1 synapse;glutamatergic synapse;integral component of presynaptic membrane;integral component of postsynaptic density membrane	phosphoprotein phosphatase activity;protein tyrosine phosphatase activity;protein binding;heparin binding;chondroitin sulfate binding;heparan sulfate proteoglycan binding	EIF4A2[17353931];CEP126[16169070];PTPRS[15978577];SETDB1[16169070];PTPRN[16273344];CCDC47[30021884];RRBP1[30021884];PTN[16169070];UBR1[16169070];CHD3[16169070];EEF1G[16169070];MOB4[16169070];TUBB2A[16169070];KAT5[16169070];FEZ1[16169070];SUMO2[16169070];RAB35[16169070];UNC119[16169070];UTP14A[16169070];PFN2[16169070];	5207960
38074	chr19	5262979	G	C	chr19:5262979	PTPRS	protein tyrosine phosphatase, receptor type S	SNV	0/1	0.4	34_23	58	99.0	0/1	0.46	36_31	68	99.0			rs118081237,COSV99511502	EXONIC	YES	NM_002850.4	Transcript	protein_coding	synonymous_variant		6/38	NM_002850.4:c.573C>G	NP_002841.3:p.Thr191%3D		-1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00468842	697.0	148664.0	2.0	31	0.89	PASS	nfe	0.00715093	481.0	0.00715093	481.0	0.00493875	1074.0	217464.0	7.0	37	0.61	PASS	nfe	0.00726586	708.0	0.00726586	708.0	0.0043279	673	0.005	15.0				11.43	0.734085		0	0	0			PTPRS	0.0	0.01	0.0	0.0	1.0	4.0	-4.0	-2.0						0.317	0.76	0.515571727			nervous system phenotype ; digestive/alimentary phenotype; vision/eye phenotype; skeleton phenotype; renal/urinary system phenotype; behavior/neurological phenotype ; respiratory system phenotype; mortality/aging ; reproductive system phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; taste/olfaction phenotype; muscle phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; integument phenotype ; growth/size/body region phenotype; 			pons;superior cervical ganglion;	.	protein dephosphorylation;negative regulation of neuron projection development;spinal cord development;cerebellum development;hippocampus development;cerebral cortex development;corpus callosum development;negative regulation of axon extension;negative regulation of interferon-alpha production;negative regulation of interferon-beta production;negative regulation of toll-like receptor 9 signaling pathway;peptidyl-tyrosine dephosphorylation;negative regulation of collateral sprouting;negative regulation of axon regeneration;modulation of chemical synaptic transmission;negative regulation of dendritic spine development;establishment of endothelial intestinal barrier;regulation of postsynaptic density assembly;synaptic membrane adhesion	plasma membrane;integral component of plasma membrane;cell junction;integral component of synaptic vesicle membrane;axon;perikaryon;extracellular exosome;Schaffer collateral - CA1 synapse;glutamatergic synapse;integral component of presynaptic membrane;integral component of postsynaptic density membrane	phosphoprotein phosphatase activity;protein tyrosine phosphatase activity;protein binding;heparin binding;chondroitin sulfate binding;heparan sulfate proteoglycan binding	EIF4A2[17353931];CEP126[16169070];PTPRS[15978577];SETDB1[16169070];PTPRN[16273344];CCDC47[30021884];RRBP1[30021884];PTN[16169070];UBR1[16169070];CHD3[16169070];EEF1G[16169070];MOB4[16169070];TUBB2A[16169070];KAT5[16169070];FEZ1[16169070];SUMO2[16169070];RAB35[16169070];UNC119[16169070];UTP14A[16169070];PFN2[16169070];	5262979
38104	chr19	6013053	C	T	chr19:6013053	RFX2	regulatory factor X2	SNV	0/1	0.36	57_32	90	99.0	0/1	0.41	59_41	100	99.0				EXONIC	YES	NM_000635.4	Transcript	protein_coding	synonymous_variant		8/18	NM_000635.4:c.843G>A	NP_000626.2:p.Leu281%3D		-1.0						.	.	.						32	0.97											26	0.63											9e-05	1.0		10.76	0.652737		0	0	0			RFX2	0.0	0.0	0.0	0.0	-4.0	23.0	3.0	-14.0						0.177	0.99	63.547278066			reproductive system phenotype; cellular phenotype; endocrine/exocrine gland phenotype; 			ciliary ganglion;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;testis;	.	acrosome assembly;regulation of transcription by RNA polymerase II;spermatid development;positive regulation of transcription by RNA polymerase II;cilium assembly;cellular response to leukemia inhibitory factor	nucleus;cytoplasm	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;protein binding	RFX6[16189514;unassigned1304];EYA2[unassigned1304];FOXJ2[25609649];FOXJ1[25609649;unassigned1304];FOXN4[unassigned1304];TP53BP1[29656893];NFKBID[unassigned1304];MDFI[16189514];PIAS2[unassigned1304];	6013053
38179	chr19	7593048	C	T	chr19:7593048	MCOLN1	mucolipin 1	SNV	0/1	0.47	42_38	81	99.0	0/1	0.37	57_33	90	99.0			rs73003348	EXONIC	YES	NM_020533.3	Transcript	protein_coding	missense_variant		7/14	NM_020533.3:c.782C>T	NP_065394.1:p.Thr261Met		1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Mucolipidosis_type_IV|not_specified|not_provided	Mucolipidosis IV, 252650 (3), Autosomal recessive	Mucolipidosis type IV	Disease-causing germline mutation(s) (loss of function) in	Intellectual disability;Generalized hypotonia;Achlorhydria;Cerebral dysmyelination;Global developmental delay;Hyperreflexia;Infantile onset;Babinski sign;Cerebellar atrophy;Strabismus;Spastic tetraplegia;Dystonia;Abnormality of abdomen morphology;Visual impairment;Decreased light- and dark-adapted electroretinogram amplitude;Hypergastrinemia;Retinal degeneration;Dysplastic corpus callosum;Photophobia;Muscular hypotonia;Progressive neurologic deterioration;Autosomal recessive inheritance;Opacification of the corneal stroma;Microcephaly;Developmental stagnation;Optic atrophy;Absent speech;Ganglioside accumulation;Abnormality of mucopolysaccharide metabolism;Intellectual disability;Abnormality of mucopolysaccharide metabolism;Developmental stagnation;Gait disturbance;Strabismus;Genu recurvatum;Biparietal narrowing;Coarse facial features;Muscular hypotonia;EEG abnormality;Abnormality of retinal pigmentation;Corneal opacity;Absent speech;Microdontia;Ganglioside accumulation;Aplasia/Hypoplasia of the abdominal wall musculature;Everted lower lip vermilion;Retinopathy;Ataxia;Nystagmus;Microcephaly;Abnormal electroretinogram;Photophobia;Abnormal nasal morphology;Hyperreflexia;Palmoplantar keratoderma	25933391	0.0031416	478.0	152152.0	2.0	32	0.96	PASS	amr	0.0094858	145.0	0.00385203	262.0	0.00309084	777.0	251388.0	4.0	100	1.0	PASS	amr	0.00543604	188.0	0.00381767	434.0	0.0030803	479	0.014	47.0	0.01298	148.0		14.72	1.212148	0.041	3	16	19	M-CAP_pred,MutationTaster_pred,FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MCOLN1	0.01	0.0	0.0	0.0	15.0	-4.0	15.0	0.0						0.27	0.04	0.000000000	0.616	-0.239	mortality/aging ; hematopoietic system phenotype; cardiovascular system phenotype ; behavior/neurological phenotype ; immune system phenotype; renal/urinary system phenotype; nervous system phenotype ; digestive/alimentary phenotype; vision/eye phenotype; integument phenotype ; growth/size/body region phenotype; adipose tissue phenotype ; homeostasis/metabolism phenotype; muscle phenotype; 			whole brain;placenta;	.	adaptive immune response;cation transport;calcium-mediated signaling;transferrin transport;iron ion transmembrane transport;release of sequestered calcium ion into cytosol;protein homotetramerization;calcium ion transmembrane transport;cellular response to calcium ion;cellular response to pH;autophagosome maturation	phagocytic cup;lysosome;lysosomal membrane;late endosome;cytosol;plasma membrane;integral component of plasma membrane;endosome membrane;integral component of membrane;phagocytic vesicle membrane;late endosome membrane;cell projection;receptor complex	cation channel activity;calcium channel activity;iron ion transmembrane transporter activity;protein binding;lipid binding;NAADP-sensitive calcium-release channel activity;intracellular phosphatidylinositol-3,5-bisphosphate-sensitive cation channel activity;ligand-gated calcium channel activity	APPBP2[unassigned1304];SLC35E1[16169070];GPR35[28298427];TRIM27[16169070];SEC22A[unassigned1304];	7593048
38260	chr19	8322805	G	A	chr19:8322805	CERS4	ceramide synthase 4	SNV	0/1	0.45	57_47	104	99.0	0/1	0.61	43_70	115	99.0			rs149089779	EXONIC	YES	NM_024552.3	Transcript	protein_coding	missense_variant		10/12	NM_024552.3:c.784G>A	NP_078828.2:p.Asp262Asn		1.0	TRAM/LAG1/CLN8 homology domain&TRAM/LAG1/CLN8 homology domain&TRAM/LAG1/CLN8 homology domain,TRAM/LAG1/CLN8 homology domain&TRAM/LAG1/CLN8 homology domain&TRAM/LAG1/CLN8 homology domain,TRAM/LAG1/CLN8 homology domain&TRAM/LAG1/CLN8 homology domain&TRAM/LAG1/CLN8 homology domain					.	.	.		0.000269464	41.0	152154.0	0.0	33	0.96	PASS	amr	0.000785855	12.0	0.000338086	23.0	0.000302324	76.0	251386.0	0.0	85	1.0	PASS	amr	0.000520352	18.0	0.000351648	40.0	0.0002765	43	0.001	2.0				8.622	0.421118	0.058	1	18	19	FATHMM_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CERS4	0.0	0.01	0.0	0.0	-33.0	-42.0	-7.0	-5.0							0.0	0.000000000	0.003	0.051	integument phenotype ; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; 			thyroid;liver;trigeminal ganglion;prostate;	.	sphingolipid biosynthetic process;ceramide biosynthetic process	endoplasmic reticulum;endoplasmic reticulum membrane;integral component of membrane;nuclear membrane	DNA binding;sphingosine N-acyltransferase activity	SLC35F6[unassigned1304];ITGAM[unassigned1304];CCL4L1[unassigned1304];TMEM72[unassigned1304];IER3IP1[unassigned1304];SLC7A1[unassigned1304];SCAMP5[unassigned1304];SERP2[unassigned1304];SMIM11A[unassigned1304];GPR151[unassigned1304];UPK1B[unassigned1304];CLEC1A[unassigned1304];CYB5R3[unassigned1304];NEU1[unassigned1304];SLC35A1[unassigned1304];JAGN1[unassigned1304];SLC13A4[unassigned1304];IGFBP5[unassigned1304];STX8[unassigned1304];TMEM176A[unassigned1304];STX7[unassigned1304];LHFPL5[unassigned1304];TMEM254[unassigned1304];NAT8[unassigned1304];SCD[unassigned1304];PTPN9[unassigned1304];COL4A5[unassigned1304];FXYD6[unassigned1304];PLP2[unassigned1304];FATE1[unassigned1304];MS4A1[unassigned1304];TOMM6[unassigned1304];	8322805
38262	chr19	8491580	C	T	chr19:8491580	MARCH2	membrane associated ring-CH-type finger 2	SNV	0/1	0.4	64_43	107	99.0	0/1	0.44	70_56	128	99.0			rs149320465	EXONIC	YES	NM_001369776.1	Transcript	protein_coding	synonymous_variant		4/6	NM_001369776.1:c.264C>T	NP_001356705.1:p.Ala88%3D		1.0						.	.	.		4.60133e-05	7.0	152130.0	0.0	31	0.95	PASS	amr	0.000196489	3.0	1.4702e-05	1.0	9.1492e-05	23.0	251388.0	0.0	72	1.0	PASS	amr	0.000375896	13.0	8.79585e-06	1.0	0.0000772	12	0.001	2.0				9.38	0.497563		0	0	0			MARCH2	0.0	0.0	0.0	0.0	48.0	-4.0	-5.0	13.0						0.454	0.25	1.772665448			.			.	.	endocytosis;protein ubiquitination	lysosomal membrane;endoplasmic reticulum;endoplasmic reticulum membrane;endosome membrane;integral component of membrane;cytoplasmic vesicle	ubiquitin-protein transferase activity;protein binding;zinc ion binding	CCDC155[25416956];TMEM86B[unassigned1304];PLPPR2[unassigned1304];TMEM52B[unassigned1304];TMEM179B[unassigned1304];LDLRAD1[25416956;unassigned1304];GPX8[unassigned1304];AQP6[unassigned1304];FAM209A[unassigned1304];SSMEM1[unassigned1304];SYNE4[25416956];F11R[unassigned1304];PEX12[unassigned1304];TSPAN12[unassigned1304];CD79A[unassigned1304];TSPO2[unassigned1304];CREB3L1[unassigned1304];CCL4[unassigned1304];TMEM106C[unassigned1304];GJA8[unassigned1304];FATE1[25416956;unassigned1304];ERGIC3[unassigned1304];LGR4[unassigned1304];	8491580
38315	chr19	8668691	C	T	chr19:8668691	ADAMTS10	ADAM metallopeptidase with thrombospondin type 1 motif 10	SNV	0/1	0.53	66_74	140	99.0	0/1	0.44	61_48	109	99.0			rs144993590	EXONIC	YES	NM_030957.4	Transcript	protein_coding	synonymous_variant		5/26	NM_030957.4:c.513G>A	NP_112219.3:p.Pro171%3D		-1.0		Likely_benign	criteria_provided,_single_submitter	not_provided	Weill-Marchesani syndrome 1, recessive, 277600 (3), Autosomal recessive	Weill-Marchesani syndrome	Disease-causing germline mutation(s) in	Lumbar hyperlordosis;Thin bony cortex;Glaucoma;Shallow anterior chamber;Broad phalanges of the hand;Joint stiffness;Broad metatarsal;Depressed nasal bridge;Shallow orbits;Cataract;Microspherophakia;Patent ductus arteriosus;Abnormality of dental morphology;Proportionate short stature;Narrow palate;Blindness;Brachydactyly;Aortic valve stenosis;Mitral regurgitation;Autosomal recessive inheritance;Broad palm;Intellectual disability, mild;Spinal canal stenosis;Ectopia lentis;Thickened skin;Pulmonic stenosis;Brachycephaly;Hypoplasia of the maxilla;Broad metacarpals;Broad ribs;Misalignment of teeth;Broad skull;Short stature;High myopia;Ventricular septal defect;Scoliosis;Brachydactyly;Limitation of joint mobility;Ventricular septal defect;Ectopia lentis;Visual loss;Pulmonic stenosis;Mitral regurgitation;High myopia;Short stature;Short thumb;Glaucoma;Intellectual disability, mild;Aortic valve stenosis;Thickened skin;Cataract		0.000151184	23.0	152132.0	0.0	32	0.95	PASS	afr	0.000313843	13.0	8.82042e-05	6.0	0.000119325	30.0	251414.0	0.0	61	1.0	PASS	amr	0.000462668	16.0	7.91445e-05	9.0	0.0000900	14	0.001	2.0	0.00053	6.0		3.191	0.035912		0	0	0			ADAMTS10	0.0	0.0	0.0	0.0	-2.0	14.0	26.0	-21.0						0.476	0.98	1.772665448			.			ciliary ganglion;pons;subthalamic nucleus;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	.	proteolysis;biological_process	microfibril;collagen-containing extracellular matrix	molecular_function;metalloendopeptidase activity;protein binding;metal ion binding	HMGCL[21900206];CDKN1A[21900206];PCYT2[21900206];YTHDC1[30021884];HIST2H2BC[30021884];ANXA7[21900206];SMN1[21900206];TK1[21900206];LAMTOR3[21900206];	8668691
38321	chr19	8993031	G	A	chr19:8993031	MUC16	mucin 16, cell surface associated	SNV	0|1	0.13	27_4	31	87.0	0/0	0.0	34_0	34	93.0			rs778256098,COSV66695927	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		67/84	NM_024690.2:c.41728C>T	NP_078966.2:p.Arg13910Trp		-1.0						.	.	.		1.36633e-05	2.0	146378.0	0.0	33	0.94	PASS	afr	2.5015e-05	1.0	1.52472e-05	1.0	0.0	0.0	248758.0	0.0	51	0.93	AC0				0.0	0.0	0.0000064	1						15.22	1.305246	0.06	1	15	16	PolyPhen	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.0	0.07	0.0	0.08	-24.0	11.0	11.0	-24.0						0.998		11.065761130	0.001	-0.583	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];	8993031
38322	chr19	8993035	G	A	chr19:8993035	MUC16	mucin 16, cell surface associated	SNV	0|1	0.13	27_4	31	87.0	0/0	0.0	34_0	34	84.0			rs1484220210	EXONIC	YES	NM_024690.2	Transcript	protein_coding	synonymous_variant		67/84	NM_024690.2:c.41724C>T	NP_078966.2:p.Thr13908%3D		-1.0						.	.	.		0.0	0.0	149278.0	0.0	33	0.96	AC0_AS_VQSR				0.0	0.0					50	0.93														0.065	-0.542892		0	0	0			MUC16	0.0	0.01	0.0	0.01	-27.0	7.0	-32.0	-28.0						0.998		40.085683608			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];	8993035
38346	chr19	8999429	G	T	chr19:8999429	MUC16	mucin 16, cell surface associated	SNV	0/1	0.15	73_13	86	99.0	0/1	0.09	53_5	58	10.0			rs563734214,COSV66695345	EXONIC	YES	NM_024690.2	Transcript	protein_coding	synonymous_variant		56/84	NM_024690.2:c.40746C>A	NP_078966.2:p.Gly13582%3D		-1.0						.	.	.		0.00550666	667.0	121126.0	0.0	44	0.96	PASS	sas	0.00758765	29.0	0.00397409	216.0	0.00128002	280.0	218746.0	0.0	40	0.89	PASS	sas	0.00219789	57.0	0.00138074	137.0	0.0000579	9	0.001	4.0				0.001	-1.223054		0	0	0			MUC16	0.0	0.0	0.0	0.0	47.0	-18.0	-37.0	-34.0						0.998		1.772665448			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];	8999429
38402	chr19	9021069	C	T	chr19:9021069	MUC16	mucin 16, cell surface associated	SNV	0/0	0.0	33_0	33	49.0	0|1	0.14	24_4	28	96.0			rs758491152,COSV67452605	EXONIC	YES	NM_024690.2	Transcript	protein_coding	synonymous_variant		19/84	NM_024690.2:c.37254G>A	NP_078966.2:p.Arg12418%3D		-1.0						.	.	.		0.000867676	111.0	127928.0	0.0	33	0.89	AS_VQSR	sas	0.00302725	12.0	0.000556328	32.0	0.0	0.0	248492.0	0.0	60	0.99	AC0				0.0	0.0	0.0000064	1						0.002	-1.140268		0	0	0			MUC16	0.0	0.0	0.02	0.0	21.0	-10.0	-15.0	0.0						0.998		1.772665448			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];	9021069
38403	chr19	9021075	T	C	chr19:9021075	MUC16	mucin 16, cell surface associated	SNV	0/0	0.0	33_0	33	49.0	0|1	0.14	25_4	29	93.0			rs76949269,COSV67475917	EXONIC	YES	NM_024690.2	Transcript	protein_coding	synonymous_variant		19/84	NM_024690.2:c.37248A>G	NP_078966.2:p.Thr12416%3D		-1.0						.	.	.		0.00095057	101.0	106252.0	0.0	31	0.75	PASS	sas	0.00259217	9.0	0.000645911	30.0	0.0	0.0	248576.0	0.0	63	0.99	AC0				0.0	0.0	0.0001672	26						0.001	-1.308165		0	0	0			MUC16	0.0	0.0	0.03	0.0	47.0	-16.0	-21.0	-6.0						0.998		6.169915974			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];	9021075
38404	chr19	9021096	G	A	chr19:9021096	MUC16	mucin 16, cell surface associated	SNV	0/0	0.0	36_0	36	58.0	0/1	0.12	29_4	33	81.0			rs79920615,COSV67472175	EXONIC	YES	NM_024690.2	Transcript	protein_coding	synonymous_variant		19/84	NM_024690.2:c.37227C>T	NP_078966.2:p.Gly12409%3D		-1.0						.	.	.		0.000909477	90.0	98958.0	0.0	30	0.72	AS_VQSR	amr	0.00147088	15.0	0.00075315	33.0	4.01442e-06	1.0	249102.0	0.0	67	1.0	PASS	nfe	8.85708e-06	1.0	8.85708e-06	1.0	0.0000900	14						0.02	-0.697841		0	0	0			MUC16	0.0	0.0	0.0	0.0	-6.0	26.0	-37.0	-42.0						0.998		6.169915974			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];	9021096
38405	chr19	9021118	C	T	chr19:9021118	MUC16	mucin 16, cell surface associated	SNV	0/0	0.0	32_0	32	46.0	0/1	0.13	27_4	31	87.0			rs79498466,COSV67442557	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		19/84	NM_024690.2:c.37205G>A	NP_078966.2:p.Gly12402Glu		-1.0	SEA domain&SEA domain&SEA domain					.	.	.		0.00421352	329.0	78082.0	0.0	26	0.59	PASS	sas	0.00711893	17.0	0.0039858	137.0					73	1.0							0.0002186	34						0.084	-0.506534	0.11	0	16	16		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.0	0.0	0.0	0.0	4.0	-45.0	6.0	44.0						0.998		6.169915974	0.0	-1.104	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];	9021118
38406	chr19	9021138	G	A	chr19:9021138	MUC16	mucin 16, cell surface associated	SNV	0/0	0.0	30_0	30	40.0	0/1	0.15	22_4	26	99.0			rs1422356441,COSV67475918	EXONIC	YES	NM_024690.2	Transcript	protein_coding	synonymous_variant		19/84	NM_024690.2:c.37185C>T	NP_078966.2:p.Thr12395%3D		-1.0						.	.	.		0.0	0.0	150120.0	0.0	36	0.97	AC0_AS_VQSR				0.0	0.0					71	1.0							0.0000322	5						0.097	-0.487093		0	0	0			MUC16	0.0	0.03	0.0	0.0	-16.0	46.0	24.0	-14.0						0.998		6.169915974			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];	9021138
38407	chr19	9021159	T	C	chr19:9021159	MUC16	mucin 16, cell surface associated	SNV	0/0	0.0	24_0	24	22.0	0/1	0.24	13_4	17	99.0			rs200978134,COSV67476537	EXONIC	YES	NM_024690.2	Transcript	protein_coding	synonymous_variant		19/84	NM_024690.2:c.37164A>G	NP_078966.2:p.Val12388%3D		-1.0						.	.	.		0.0	0.0	137700.0	0.0	35	0.91	AC0_AS_VQSR				0.0	0.0	0.0	0.0	248860.0	0.0	66	1.0	AC0_RF				0.0	0.0	0.0023794,0.0000257	370,4	0.0	1.0				0.006	-0.850011		0	0	0			MUC16	0.0	0.0	0.0	0.0	25.0	44.0	-35.0	3.0						0.998		34.145841890			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];	9021159
38410	chr19	9021179	CCATAA		chr19:9021179-9021184	MUC16	mucin 16, cell surface associated	deletion	0/0	0.0	17_0	17	51.0	0|1	0.22	7_2	9	63.0				SPLICING	YES	NM_024690.2	Transcript	protein_coding	inframe_deletion,splice_region_variant		19/84	NM_024690.2:c.37139_37144del	NP_078966.2:p.Ile12380_Ala12382delinsThr		-1.0						.	.	.		0.0	0.0	146052.0	0.0	32	0.83	AC0_AS_VQSR				0.0	0.0					50	0.99																	0	0	0																	0.998		0.000000000,1.772665448,0.000000000,45.211109758			reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];	9021178
38411	chr19	9021188	G	C	chr19:9021188	MUC16	mucin 16, cell surface associated	SNV	0/0	0.0	17_0	17	42.0	0|1	0.25	6_2	8	66.0				SPLICING	YES	NM_024690.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	18/83		NM_024690.2:c.37139-4C>G			-1.0						.	.	.						36	0.97											47	0.98														0.087	-0.502076		0	0	0			MUC16	0.01	0.02	0.0	0.0	-4.0	15.0	-26.0	-4.0	1.51965981708353e-05	0.0	9.561	-0.36	9.201	0.998					reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];	9021188
38412	chr19	9021190	A	G	chr19:9021190	MUC16	mucin 16, cell surface associated	SNV	0/0	0.0	16_0	16	13.0	0|1	0.25	6_2	8	66.0			rs75840402	SPLICING	YES	NM_024690.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	18/83		NM_024690.2:c.37139-6T>C			-1.0						.	.	.		0.0	0.0	86252.0	0.0	25	0.58	AC0_AS_VQSR				0.0	0.0	0.0	0.0	248612.0	0.0	47	0.98	AC0_RF				0.0	0.0	0.0002315	36						0.2	-0.386806		0	0	0			MUC16	0.07	0.05	0.0	0.0	13.0	-6.0	-6.0	-28.0	8.9799691605922e-05	0.066	7.719	1.482	9.201	0.998					reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];	9021190
38418	chr19	9025584	T	G	chr19:9025584	MUC16	mucin 16, cell surface associated	SNV	0/1	0.52	26_28	54	99.0	0/1	0.36	27_15	42	99.0			rs77811999,COSV67446378	SPLICING	YES	NM_024690.2	Transcript	protein_coding	splice_region_variant,intron_variant	15/83		NM_024690.2:c.36863+7A>C			-1.0						.	.	.		0.00196621	246.0	125114.0	0.0	31	0.85	AS_VQSR	sas	0.00301054	12.0	0.00170673	96.0	0.00259158	503.0	194090.0	0.0	70	1.0	RF	nfe	0.00394753	331.0	0.00394753	331.0	0.0645064	10031	0.001	3.0				0.112	-0.467762		0	0	0			MUC16	0.0	0.0	0.0	0.01	7.0	21.0	-30.0	7.0	2.18395384611236e-05	0.01				0.998					reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];	9025584
38420	chr19	9025654	T	G	chr19:9025654	MUC16	mucin 16, cell surface associated	SNV	0/1	0.19	51_12	63	99.0	0/1	0.22	35_10	45	99.0			rs201931630,COSV67447147	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		15/84	NM_024690.2:c.36800A>C	NP_078966.2:p.Lys12267Thr		-1.0	SEA domain&SEA domain&SEA domain					.	.	.		0.000862671	126.0	146058.0	0.0	34	0.96	AS_VQSR	amr	0.00151997	22.0	0.000799975	52.0	8.59156e-05	21.0	244426.0	0.0	83	1.0	RF	nfe	0.000117816	13.0	0.000117816	13.0	0.0000193	3	0.002	5.0				0.219	-0.373526	0.121	0	16	16		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.0	0.02	0.0	0.0	38.0	4.0	4.0	-33.0						0.998		22.908947238	0.0	-1.546	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];	9025654
38437	chr19	9067935	G	T	chr19:9067935	MUC16	mucin 16, cell surface associated	SNV	0/1	0.5	42_42	84	99.0	0/1	0.44	51_41	93	99.0			rs200919021,COSV67495982	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		3/84	NM_024690.2:c.19511C>A	NP_078966.2:p.Ser6504Tyr		-1.0						.	.	.		0.00335932	511.0	152114.0	1.0	32	0.97	PASS	sas	0.00580191	28.0	0.00511885	348.0	0.00375704	934.0	248600.0	3.0	51	0.98	PASS	sas	0.00670241	205.0	0.00499956	563.0	0.0038391	597	0.001	4.0				12.69	0.89653	0.049	2	14	16	SIFT,PolyPhen	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.0	0.0	0.0	0.0	-45.0	-16.0	-45.0	35.0						0.998		0.000000000	0.007	0.044	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];	9067935
38442	chr19	9084401	C	T	chr19:9084401	MUC16	mucin 16, cell surface associated	SNV	0/1	0.51	71_74	145	99.0	0/1	0.49	66_64	130	99.0			rs142278154,COSV99064015	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		1/84	NM_024690.2:c.7414G>A	NP_078966.2:p.Val2472Ile		-1.0						.	.	.		0.00551934	840.0	152192.0	4.0	32	0.97	PASS	nfe	0.00943618	642.0	0.00943618	642.0	0.00531675	1323.0	248836.0	5.0	57	0.98	PASS	nfe	0.00859131	968.0	0.00859131	968.0	0.0051574	802	0.009	29.0				9.668	0.52855	0.077	2	15	17	SIFT,PolyPhen	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.0	0.0	0.0	0.0	-14.0	28.0	-20.0	1.0						0.998		0.000000000	0.008	0.38	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];	9084401
38443	chr19	9085414	G	A	chr19:9085414	MUC16	mucin 16, cell surface associated	SNV	0/1	0.55	64_79	144	99.0	0/1	0.51	65_67	132	99.0			rs183496438,COSV99064161	EXONIC	YES	NM_024690.2	Transcript	protein_coding	missense_variant		1/84	NM_024690.2:c.6401C>T	NP_078966.2:p.Thr2134Ile		-1.0						.	.	.		0.00405441	617.0	152180.0	3.0	32	0.97	PASS	nfe	0.00696813	474.0	0.00696813	474.0	0.00348184	867.0	249006.0	2.0	100	1.0	PASS	nfe	0.00556649	628.0	0.00556649	628.0	0.0033568	522	0.005	15.0				11.6	0.755834	0.095	2	15	17	SIFT,PolyPhen	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC16	0.0	0.0	0.0	0.0	-4.0	12.0	13.0	-10.0						0.998		0.000000000	0.071	0.43	reproductive system phenotype; 			.	.	stimulatory C-type lectin receptor signaling pathway;cell adhesion;O-glycan processing	Golgi lumen;plasma membrane;integral component of membrane;extrinsic component of membrane;vesicle;extracellular exosome	protein binding	CEP170P1[26496610];RAD21[26496610];	9085414
38504	chr19	9868686	T	A	chr19:9868686	ZNF846	zinc finger protein 846	SNV	0/1	0.45	23_19	42	99.0	0/1	0.33	29_14	43	99.0			rs79195449,COSV101194287	EXONIC	YES	NM_001077624.2	Transcript	protein_coding	missense_variant		6/6	NM_001077624.2:c.1067A>T	NP_001071092.1:p.His356Leu		-1.0	Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type					.	.	.		0.00484311	735.0	151762.0	7.0	33	0.96	PASS	nfe	0.00840756	572.0	0.00840756	572.0	0.00430038	1075.0	249978.0	7.0	52	0.99	PASS	nfe	0.00771908	874.0	0.00771908	874.0	0.0045851	713	0.009	28.0				23.1	2.800561	0.654	11	9	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,BayesDel_noAF_pred	M-CAP_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF846	0.0	0.0	0.0	0.0	49.0	30.0	49.0	-1.0						0.748	0.0	0.000000000	0.952	0.74	.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;metal ion binding	KRTAP10-7[25416956];	9868686
38551	chr19	10428422	C	T	chr19:10428422	RAVER1	ribonucleoprotein, PTB binding 1	SNV	0/1	0.43	60_46	106	99.0	0/1	0.56	50_63	113	99.0			rs377043925	EXONIC	YES	NM_133452.3	Transcript	protein_coding	missense_variant		12/13	NM_133452.3:c.2017G>A	NP_597709.3:p.Gly673Arg		-1.0	.,.,.,.					.	.	.		0.000249681	38.0	152194.0	0.0	32	0.98	PASS	amr	0.00189741	29.0	5.88045e-05	4.0	0.00019257	42.0	218102.0	0.0	30	0.6	PASS	amr	0.000780908	25.0	0.000134137	13.0	0.0000772	12	0.0	0.0				20.3	2.058587	0.056	3	17	20	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	RAVER1	0.0	0.0	0.0	0.0	-2.0	27.0	-36.0	5.0							0.98	0.000000000	0.263	-0.214	nervous system phenotype ; 			ciliary ganglion;superior cervical ganglion;	.	.	nucleus;cytoplasm	RNA binding	BAG6[26496610];VCAM1[22623428];CNOT1[26496610];GORASP2[unassigned1312];GRAP2[unassigned1304];CDC5L[20467437];UBAP2[unassigned1312];HIF1AN[26972000];B9D2[26638075];TOB1[18377426];NINL[26638075];VCL[19523901];	10428422
38558	chr19	10444074	G	A	chr19:10444074	RAVER1	ribonucleoprotein, PTB binding 1	SNV	0/1	0.53	70_78	148	99.0	0/1	0.48	70_64	134	99.0			rs34642407	EXONIC	YES	NM_133452.3	Transcript	protein_coding	missense_variant		1/13	NM_133452.3:c.110C>T	NP_597709.3:p.Pro37Leu		-1.0	.,.,.,.					.	.	.		0.00197073	300.0	152228.0	2.0	32	0.98	PASS	nfe	0.00267498	182.0	0.00267498	182.0	0.00213223	530.0	248566.0	0.0	90	1.0	PASS	nfe	0.00278252	313.0	0.00278252	313.0	0.0016720	260	0.002	7.0				19.23	1.935243	0.048	3	16	19	SIFT,MutationTaster_pred,fathmm-MKL_coding_pred	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	RAVER1	0.0	0.0	0.0	0.0	-9.0	6.0	-9.0	-8.0							0.98	0.000000000	0.071	0.176	nervous system phenotype ; 			ciliary ganglion;superior cervical ganglion;	.	.	nucleus;cytoplasm	RNA binding	BAG6[26496610];VCAM1[22623428];CNOT1[26496610];GORASP2[unassigned1312];GRAP2[unassigned1304];CDC5L[20467437];UBAP2[unassigned1312];HIF1AN[26972000];B9D2[26638075];TOB1[18377426];NINL[26638075];VCL[19523901];	10444074
38597	chr19	10692277	C	G	chr19:10692277	AP1M2	adaptor related protein complex 1 subunit mu 2	SNV	0/1	0.47	57_50	107	99.0	0/1	0.48	53_49	102	99.0			rs375773149	EXONIC	YES	NM_001300887.2	Transcript	protein_coding	synonymous_variant		5/12	NM_001300887.2:c.432G>C	NP_001287816.1:p.Thr144%3D		-1.0						.	.	.		0.000184094	28.0	152096.0	0.0	31	0.95	PASS	amr	0.00183655	28.0	0.0	0.0	0.000104383	26.0	249082.0	0.0	44	0.95	PASS	amr	0.0006965	24.0	8.86713e-06	1.0	0.0000193	3						3.493	0.054124		0	0	0			AP1M2	0.01	0.0	0.0	0.0	17.0	33.0	-1.0	34.0						0.755	0.0	1.862811053			mortality/aging ; digestive/alimentary phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			fetal thyroid;kidney;thyroid;superior cervical ganglion;placenta;	.	protein targeting;vesicle targeting;antigen processing and presentation of exogenous peptide antigen via MHC class II;regulation of defense response to virus by virus	Golgi membrane;lysosomal membrane;cytosol;clathrin adaptor complex;cytoplasmic vesicle membrane;clathrin-coated vesicle membrane;trans-Golgi network membrane;intracellular membrane-bounded organelle	protein binding	APP[21163940];ERBB3[24189400];MAST1[21163940];AP2B1[16189514;25416956];ECSIT[21163940];NDRG1[17220478];PLEKHA7[28877994];	10692277
38758	chr19	11527628	C	T	chr19:11527628	RGL3	ral guanine nucleotide dissociation stimulator like 3	SNV	0/1	0.5	69_70	139	99.0	0/1	0.54	52_62	114	99.0			rs143235367	EXONIC	YES	NM_001161616.3	Transcript	protein_coding	missense_variant		3/19	NM_001161616.3:c.253G>A	NP_001155088.2:p.Asp85Asn		-1.0	Ras-like guanine nucleotide exchange factor, N-terminal&Ras-like guanine nucleotide exchange factor, N-terminal&Ras-like guanine nucleotide exchange factor, N-terminal&Ras-like guanine nucleotide exchange factor, N-terminal,.,Ras-like guanine nucleotide exchange factor, N-terminal&Ras-like guanine nucleotide exchange factor, N-terminal&Ras-like guanine nucleotide exchange factor, N-terminal&Ras-like guanine nucleotide exchange factor, N-terminal,Ras-like guanine nucleotide exchange factor, N-terminal&Ras-like guanine nucleotide exchange factor, N-terminal					.	.	.		0.00382628	582.0	152106.0	2.0	30	0.94	PASS	nfe	0.00632111	430.0	0.00632111	430.0	0.00408685	1027.0	251294.0	1.0	69	1.0	PASS	nfe	0.00664519	755.0	0.00664519	755.0	0.0042636	663	0.004	14.0				19.96	2.028169	0.029	4	14	18	PolyPhen,LRT_pred,M-CAP_pred,PrimateAI_pred	SIFT,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	RGL3	0.0	0.0	0.01	0.0	-12.0	-1.0	-3.0	8.0						0.983	0.0	0.000000000	0.797	0.907	.			.	.	small GTPase mediated signal transduction;positive regulation of GTPase activity	.	Ral guanyl-nucleotide exchange factor activity	NRAS[unassigned1304];FAM200A[unassigned1304];RIT1[unassigned1304];CHCHD3[30021884];KLHL12[unassigned1304];	11527628
38791	chr19	12014450	T	G	chr19:12014450	ZNF69	zinc finger protein 69	SNV	0/1	0.46	19_16	35	99.0	0/1	0.39	25_16	41	99.0			rs749203543	EXONIC	YES	NM_001364730.1	Transcript	protein_coding	missense_variant		2/4	NM_001364730.1:c.126T>G	NP_001351659.1:p.Asp42Glu		1.0	Krueppel-associated box&Krueppel-associated box&Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box&Krueppel-associated box&Krueppel-associated box,.					.	.	.		0.000164303	25.0	152158.0	0.0	32	0.96	PASS	amr	0.00157089	24.0	1.47011e-05	1.0	7.15888e-05	18.0	251436.0	0.0	68	0.99	PASS	amr	0.000433852	15.0	2.63759e-05	3.0	0.0000257	4						18.9	1.892708	0.288	6	14	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationAssessor_pred,PROVEAN_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF69	0.09	0.0	0.0	0.0	-20.0	10.0	-17.0	-20.0						0.756	0.0		0.334	0.848	.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;metal ion binding	SMARCD1[unassigned1304];FAM124B[unassigned1304];KATNAL1[25416956;unassigned1304];LMO3[unassigned1304];ZNF417[unassigned1304];P4HB[unassigned1304];KRT31[25416956;unassigned1304];MEOX2[unassigned1304];FRS3[unassigned1304];ZNF69[unassigned1304];GTPBP3[unassigned1304];	12014450
38795	chr19	12060587	A	G	chr19:12060587	ZNF700	zinc finger protein 700	SNV	0/1	0.5	5_5	10	99.0	0/1	0.73	4_11	15	74.0			rs181074027	EXONIC	YES	NM_001271848.2	Transcript	protein_coding	missense_variant		4/4	NM_001271848.2:c.1757A>G	NP_001258777.1:p.Glu586Gly		1.0	Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type,Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type,Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type					.	.	.		0.000555475	84.0	151222.0	0.0	32	0.96	PASS	sas	0.00274725	13.0	0.000767369	52.0	0.000692152	174.0	251390.0	0.0	100	1.0	PASS	sas	0.00228698	70.0	0.000738812	84.0	0.0006431	100						0.25	-0.355159	0.194	1	17	18	PROVEAN_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF700	0.0	0.0	0.0	0.0	-33.0	3.0	32.0	31.0						0.921	0.0	0.000000000	0.001	-0.853	.			pons;ciliary ganglion;dorsal root ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	.	12060587
38803	chr19	12461178	G	A	chr19:12461178	ZNF442	zinc finger protein 442	SNV	0/1	0.5	16_16	32	99.0	0/1	0.67	6_12	18	99.0			rs759273034	EXONIC	YES	NM_030824.3	Transcript	protein_coding	synonymous_variant		6/6	NM_030824.3:c.1221C>T	NP_110451.1:p.Cys407%3D		-1.0						.	.	.		0.000164519	25.0	151958.0	0.0	32	0.97	PASS	amr	0.00157274	24.0	1.47046e-05	1.0	7.15859e-05	18.0	251446.0	0.0	100	1.0	PASS	amr	0.000433626	15.0	2.63764e-05	3.0	0.0000257	4						5.237	0.160349		0	0	0			ZNF442	0.0	0.0	0.0	0.0	-44.0	-33.0	-3.0	38.0						0.95	0.0	16.326696793			.			ciliary ganglion;superior cervical ganglion;skeletal muscle;	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	HNRNPU[30021884];	12461178
38810	chr19	12768906	G	A	chr19:12768906	MAN2B1	mannosidase alpha class 2B member 1	SNV	0/1	0.54	49_58	107	99.0	0/1	0.48	42_38	80	99.0			COSV55474741	EXONIC	YES	NM_000528.4	Transcript	protein_coding	missense_variant		10/24	NM_000528.4:c.1280C>T	NP_000519.2:p.Pro427Leu		-1.0	Glycoside hydrolase family 38, central domain&Glycoside hydrolase family 38, central domain,.				Mannosidosis, alpha-, types I and II, 248500 (3), Autosomal recessive	Alpha-mannosidosis, infantile form;Alpha-mannosidosis, adult form	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Mandibular prognathia;Spasticity;Vacuolated lymphocytes;Epicanthus;Dysostosis multiplex;Inguinal hernia;Midface retrusion;Generalized hypotonia;Depressed nasal ridge;Gait ataxia;Malar flattening;Widely spaced teeth;Dysarthria;Frontal bossing;Flat occiput;Abnormality of the rib cage;Delayed myelination;Cerebellar atrophy;Retinal degeneration;Growth delay;Macrocephaly;Hypertrichosis;Thick eyebrow;Increased vertebral height;Intellectual disability;Muscular hypotonia;Nystagmus;Hepatomegaly;Hyperreflexia;Babinski sign;Autosomal recessive inheritance;Coarse facial features;Cerebral atrophy;Decreased circulating antibody level;Impaired smooth pursuit;Macrotia;Thickened calvaria;Broad forehead;Thoracolumbar kyphosis;Femoral bowing;Spondylolisthesis;Recurrent bacterial infections;Splenomegaly;Macroglossia;Pectus carinatum;Sensorineural hearing impairment;Gliosis;Spinocerebellar tract disease in lower limbs;Low anterior hairline;Global developmental delay;Limb ataxia;Gingival overgrowth;Umbilical hernia;Cataract;Mitral regurgitation;Abnormality of the sella turcica;Abnormal enzyme/coenzyme activity;Strabismus;Delayed speech and language development;Subcortical cerebral atrophy;Optic disc pallor;Craniosynostosis;Clumsiness;Pectus carinatum;Depressed nasal bridge;Prominent forehead;Short attention span;Pancytopenia;Immunodeficiency;Aortic regurgitation;Astigmatism;Widely spaced teeth;Joint stiffness;Joint laxity;Myopathy;Cortical thickening of long bone diaphyses;Mandibular prognathia;Highly arched eyebrow;Osteopenia;Hypertelorism;Talipes valgus;Corneal opacity;Dysostosis multiplex;Cerebral cortical atrophy;Facial hypotonia;Specific learning disability;Bilateral talipes equinovarus;Short neck;Ataxia;Genu valgum;Otitis media;Pectus excavatum;Hypoplastic inferior ilia;Soft skin;Thickened ribs;Oligosacchariduria;Platyspondyly;Avascular necrosis;Confusion;Loss of speech;Disproportionate tall stature;Flat face;Cranial hyperostosis;Abnormality of the sphenoid sinus;Hallucinations;Recurrent urinary tract infections;Bilateral coxa valga;Arnold-Chiari malformation;Proptosis;Intellectual disability, mild;Drowsiness;Cerebellar atrophy;Coarse facial features;Communicating hydrocephalus;Recurrent gastroenteritis;Hypermetropia;Pneumonia;Osteolysis;Depressivity;Mixed hearing impairment;Broad forehead;Thickened calvaria;Anxiety;Facial shape deformation;Macroglossia;Motor delay;Asthenia;Macrocephaly;Hepatosplenomegaly;Brachycephaly;Infantile axial hypotonia;Delusions;Spastic paraplegia;Myopia;Subcortical cerebral atrophy;Hepatosplenomegaly;Delusions;Oligosacchariduria;Clumsiness;Osteopenia;Cataract;Immunodeficiency;Optic disc pallor;Myopia;Anxiety;Asthenia;Macroglossia;Pancytopenia;Intellectual disability, mild;Aortic regurgitation;Hallucinations;Confusion;Ataxia;Mixed hearing impairment;Cerebral cortical atrophy;Depressivity;Cerebellar atrophy;Drowsiness;Pneumonia;Corneal opacity;Recurrent gastroenteritis;Delayed speech and language development						32	0.95											78	0.98											0.00018	2.0		26.4	3.820274	0.85	17	4	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LRT_pred,PrimateAI_pred,BayesDel_noAF_pred,LIST-S2_pred	MAN2B1	0.0	0.0	0.0	0.0	37.0	50.0	-29.0	-33.0						0.19	0.0	11.207145309	1.0	1.08	vision/eye phenotype; hearing/vestibular/ear phenotype; nervous system phenotype ; digestive/alimentary phenotype; skeleton phenotype; renal/urinary system phenotype; immune system phenotype; liver/biliary system phenotype; behavior/neurological phenotype ; cardiovascular system phenotype ; hematopoietic system phenotype; growth/size/body region phenotype; muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; 			white blood cells;superior cervical ganglion;whole blood;	N-Glycan degradation;Glycan structures - degradation	mannose metabolic process;cellular protein modification process;protein deglycosylation;oligosaccharide catabolic process;neutrophil degranulation	extracellular region;extracellular space;vacuolar membrane;azurophil granule lumen;lysosomal lumen;extracellular exosome	alpha-mannosidase activity;carbohydrate binding;metal ion binding	.	12768906
38814	chr19	12939525	C	T	chr19:12939525	RTBDN	retbindin	SNV	0/1	0.55	55_67	122	99.0	0/1	0.52	43_47	90	99.0			rs147174126	EXONIC	YES	NM_031429.3	Transcript	protein_coding	missense_variant		5/7	NM_031429.3:c.407G>A	NP_113617.1:p.Arg136Gln		-1.0	Folate receptor-like,.,Folate receptor-like,.,Folate receptor-like,Folate receptor-like,Folate receptor-like,Folate receptor-like,Folate receptor-like,Folate receptor-like,Folate receptor-like					.	.	.		0.000978744	149.0	152236.0	0.0	32	0.98	PASS	amr	0.00261643	40.0	0.00105801	72.0	0.00144851	364.0	251292.0	2.0	58	1.0	PASS	sas	0.00202508	62.0	0.0015491	176.0	0.0012090	188	0.001	2.0				11.88	0.79084	0.044	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	RTBDN	0.01	0.0	0.08	0.0	14.0	-10.0	-10.0	-49.0						0.895	0.0	0.000000000	0.002	-0.308	vision/eye phenotype; hematopoietic system phenotype; pigmentation phenotype; 			pons;pancreas;superior cervical ganglion;atrioventricular node;	.	riboflavin transport	anchored component of external side of plasma membrane;interphotoreceptor matrix	riboflavin transmembrane transporter activity;signaling receptor activity;riboflavin binding	.	12939525
38839	chr19	13227202	C	T	chr19:13227202	TRMT1	tRNA methyltransferase 1	SNV	0/1	0.58	42_58	100	99.0	0/1	0.46	45_39	84	99.0			rs764963059	EXONIC	YES	NM_017722.5	Transcript	protein_coding	synonymous_variant		1/16	NM_017722.5:c.12G>A	NP_060192.1:p.Ser4%3D		-1.0					Intellectual developmental disorder, autosomal recessive 68, 618302 (3), Autosomal recessive	.	.	Generalized hypotonia;Global developmental delay;Infantile onset;Autosomal recessive inheritance;Pes planus;Wide nasal bridge;Delayed ability to walk;Narrow palpebral fissure;Delayed speech and language development;Cerebellar atrophy;Abnormal facial shape;Periventricular leukomalacia;Small for gestational age;Synophrys;Seizure;Broad eyebrow;Microcephaly		0.000177431	27.0	152172.0	0.0	32	0.97	PASS	amr	0.00170135	26.0	1.46977e-05	1.0	6.63465e-05	16.0	241158.0	0.0	52	0.97	PASS	amr	0.000435793	15.0	9.06766e-06	1.0	0.0000193	3						6.927	0.277953		0	0	0			TRMT1	0.0	0.0	0.0	0.0	-48.0	4.0	-48.0	43.0						0.0725	0.0	37.220952837			mortality/aging ; behavior/neurological phenotype ; 			pons;white blood cells;testis - seminiferous tubule;prefrontal cortex;	.	tRNA N2-guanine methylation;tRNA modification	nucleus;nucleoplasm	tRNA binding;RNA binding;tRNA (guanine-N2-)-methyltransferase activity;protein binding;metal ion binding	MAGEA11[16189514;21516116;25416956;unassigned1304];TERF1[21044950];CISD3[27499296];HSPD1[29568061];	13227202
38871	chr19	13988559	GAG		chr19:13988559-13988561	NANOS3	nanos C2HC-type zinc finger 3	deletion	0/1	0.13	85_13	98	99.0	0/0	0.0	44_0	44	99.0			rs148122339	EXONIC	YES	NM_001098622.3	Transcript	protein_coding	inframe_deletion		1/2	NM_001098622.3:c.512_514del	NP_001092092.1:p.Gly171del		1.0						.	.	Autosomal dominant inheritance;Proteinuria;Hypertension;Edema;Thrombocytopenia;Maternal hypertension;Eclampsia;Seizure;Intrauterine growth retardation;Elevated hepatic transaminase;Preeclampsia;Stroke;Elevated mean arterial pressure;Multifactorial inheritance;Elevated systolic blood pressure;Elevated diastolic blood pressure;Autosomal dominant inheritance;Neurofibrillary tangles;Long-tract signs;Decreased level of GABA in serum;Dementia;Heterogeneous;Parkinsonism;Alzheimer disease		2.63439e-05	4.0	151838.0	0.0	32	0.95	PASS	nfe	2.9449e-05	2.0	2.9449e-05	2.0	0.00243473	401.0	164700.0	0.0	28	0.56	PASS	sas	0.0030614	71.0	0.00256417	182.0	0.0000579,0.0006366,0.0023022	9,99,358						15.34	1.327819		0	0	0			NANOS3	0.0	0.0	0.01	0.01	-45.0	-15.0	21.0	33.0						0.47	0.01	0.000000000			reproductive system phenotype; endocrine/exocrine gland phenotype; 			ciliary ganglion;pons;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;	Arginine and proline metabolism;Calcium signaling pathway;VEGF signaling pathway;Long-term depression;Small cell lung cancer	regulation of translation;multicellular organism development;germ cell development;spermatogenesis;negative regulation of translation;oogenesis;regulation of cell cycle;positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;negative regulation of apoptotic signaling pathway	P-body;nucleus;cytoplasm;cytoplasmic stress granule;perinuclear region of cytoplasm	RNA binding;protein binding;zinc ion binding	IMP3[unassigned1304];PSMB1[unassigned1304];TEKT4[unassigned1304];MLH1[unassigned1304];	13988558
38879	chr19	14165383	C	T	chr19:14165383	PALM3	paralemmin 3	SNV	0/1	0.53	66_74	140	99.0	0/1	0.52	64_68	132	99.0			rs780643841	EXONIC	YES	NM_001145028.2	Transcript	protein_coding	synonymous_variant		7/7	NM_001145028.2:c.1101G>A	NP_001138500.2:p.Glu367%3D		-1.0						.	.	.		0.000144609	22.0	152134.0	0.0	32	0.95	PASS	amr	0.000589623	9.0	0.000102908	7.0	0.000120462	19.0	157726.0	0.0	39	0.59	PASS	amr	0.000283355	7.0	0.000179527	11.0	0.0000386	6	0.002	5.0				0.397	-0.288084		0	0	0			PALM3	0.0	0.0	0.0	0.0	-47.0	1.0	-23.0	1.0								42.319439619			.			.	.	negative regulation of cytokine-mediated signaling pathway;Toll signaling pathway;response to lipopolysaccharide	cytoplasm;plasma membrane	protein binding;ATP binding	HSPB1[25277244];PLEKHA7[28877994];	14165383
38916	chr19	14805888	C	G	chr19:14805888	ZNF333	zinc finger protein 333	SNV	0/1	0.51	50_53	103	99.0	0/1	0.51	44_46	90	99.0			rs61995698,COSV104392986,COSV52884682	EXONIC	YES	NM_032433.4	Transcript	protein_coding	missense_variant		3/12	NM_032433.4:c.70C>G	NP_115809.1:p.Arg24Gly		1.0	.,Krueppel-associated box&Krueppel-associated box&Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box&Krueppel-associated box&Krueppel-associated box					.	.	.		0.00374665	570.0	152136.0	2.0	33	0.96	PASS	sas	0.00559238	27.0	0.00551244	375.0	0.00494829	1244.0	251400.0	8.0	74	1.0	PASS	nfe	0.00611333	695.0	0.00611333	695.0	0.0049131	764	0.005	16.0				5.214	0.158901	0.011	0	17	17		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF333	0.0	0.0	0.0	0.0	-48.0	-24.0	-23.0	34.0						0.922	0.0	0.000000000	0.009	0.031	.			ciliary ganglion;pons;subthalamic nucleus;atrioventricular node;uterus corpus;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	KDM1A[23455924];ZDHHC17[24705354];	14805888
38947	chr19	15491034	CCT		chr19:15491034-15491036	AKAP8L	A-kinase anchoring protein 8 like	deletion	0/0	0.0	34_0	34	99.0	0/1	0.12	53_7	60	99.0			rs759306827	EXONIC	YES	NM_014371.4	Transcript	protein_coding	inframe_deletion		14/14	NM_014371.4:c.1838_1840del	NP_055186.3:p.Glu613del		-1.0						.	.	.		1.31744e-05	2.0	151810.0	0.0	32	0.98	AS_VQSR	amr	6.56168e-05	1.0	1.47336e-05	1.0	0.00818223	685.0	83718.0	0.0	6	0.28	PASS	afr	0.011782	16.0	0.00825341	253.0	0.0000193,0.0018328	3,285	0.021	65.0				19.95	2.027034		0	0	0			AKAP8L	0.0	0.0	0.0	0.0	-38.0	15.0	4.0	42.0						0.227	0.54				.			.	.	mRNA processing;mitotic chromosome condensation;RNA splicing;regulation of mRNA export from nucleus;positive regulation of histone deacetylation;regulation of histone phosphorylation;cell cycle G2/M phase transition;positive regulation of transcription by RNA polymerase II;nuclear envelope disassembly	chromatin;nucleus;cytoplasm;nuclear matrix;PML body;nuclear speck;ribonucleoprotein complex	DNA binding;RNA binding;protein binding;lamin binding;DEAD/H-box RNA helicase binding;protein kinase A regulatory subunit binding;histone deacetylase binding;metal ion binding	RTP5[unassigned1304];RAMAC[unassigned1304];CCDC120[unassigned1304];HDAC11[23752268];IRS4[25036637];ILK[23455922];HSCB[28380382];DUSP16[28330616];TIAL1[unassigned1304];TUBA1A[29568061];NUDCD1[29021621];AIFM1[29568061];RUSC1[unassigned1304];MYC[17314511];TMSB4X[unassigned1304];TEKT4[unassigned1304];PLEKHN1[unassigned1304];TEKT5[unassigned1304];DGCR6[unassigned1304];MYOZ1[unassigned1304];PITX1[unassigned1304];ZNF366[unassigned1304];ATPAF2[unassigned1304];FOXD4[unassigned1304];RNF43[18313049];HEMK1[unassigned1304];RPS6[29568061];METTL3[29507755];PRPF40A[16391387];TENT5B[unassigned1304];AES[unassigned1304];CARHSP1[unassigned1304];GPANK1[unassigned1304];HGS[unassigned1304];MATR3[26496610];TRIB3[unassigned1304];SAXO1[unassigned1304];SNRPC[unassigned1304];CREB5[unassigned1304];L3MBTL1[27705803];PPP1R15A[29109149];CATSPER1[unassigned1304];KPRP[unassigned1304];WDR25[unassigned1304];HDAC3[16980585];PRKAA2[unassigned1304];MAGED1[17353931];PEF1[unassigned1304];CCDC24[unassigned1304];TSGA10IP[unassigned1304];PPP1R32[unassigned1304];CSTF2[unassigned1304];AKAP8[16980585];HTT[16391387];GPS2[unassigned1304];CSTF2T[unassigned1304];FAM214B[unassigned1304];LAGE3[unassigned1304];RELA[14743216];CIAO1[17353931];LMNA[29568061];HSF4[unassigned1304];TP53BP1[29656893];PATZ1[unassigned1304];CNNM3[unassigned1304];ENKD1[unassigned1304];SMAD2[20195357];ANKRD28[24255178];MAP3K3[14743216];MYPOP[unassigned1304];TFAP2D[unassigned1304];NEK4[25798074];SEC16A[26496610];INCA1[unassigned1304];SAMD4A[unassigned1304];PCDHB14[unassigned1304];DMRT3[unassigned1304];NBEAL2[29187380];SH3RF2[unassigned1304];ABI2[unassigned1304];IFT27[27173435];ZNF211[27705803];BET1[29568061];	15491033
38954	chr19	15540782	G	A	chr19:15540782	WIZ	widely interspaced zinc finger motifs	SNV	0/1	0.52	75_81	157	99.0	0/1	0.49	80_78	158	99.0			rs189657005,COSV54614604	EXONIC	YES	NM_001371589.1	Transcript	protein_coding	synonymous_variant		7/13	NM_001371589.1:c.3030C>T	NP_001358518.1:p.Gly1010%3D		-1.0						.	.	.		0.000867314	132.0	152194.0	0.0	33	0.98	PASS	amr	0.00255069	39.0	0.00117592	80.0	0.0011087	149.0	134392.0	0.0	45	0.57	PASS	amr	0.00220895	54.0	0.00157459	83.0	0.0002058	32	0.006	17.0				17.62	1.720698		0	0	0			WIZ	0.0	0.0	0.0	0.0	-37.0	3.0	2.0	-40.0						0.065	1.0	96.538111201			cellular phenotype; mortality/aging ; 			caudate nucleus;ciliary ganglion;amygdala;testis - seminiferous tubule;superior cervical ganglion;trigeminal ganglion;testis;pons;testis - interstitial;dorsal root ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;	.	regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II;positive regulation of nuclear cell cycle DNA replication;protein stabilization;protein heterotrimerization	nucleus;nucleoplasm;midbody;extracellular exosome	DNA-binding transcription factor activity, RNA polymerase II-specific;nucleic acid binding;DNA-binding transcription factor activity;protein binding;metal ion binding;SET domain binding	SUV39H2[23455924];HDAC2[21258344];CDKN1A[21900206];NOTCH1[23022380];FOXE1[25609649];MAX[25609649];EHMT2[21258344;27705803;26028330;26496610];SUV39H1[23455924];FOXG1[25609649];RPP30[26496610];EHMT1[26496610];UACA[26496610];OSGEP[21900206];IFIH1[29251827];HIST1H3A[29568061];MIER3[26496610];MIER1[26496610];RCC1[21900206];SMN1[21900206];TK1[21900206];ZNF644[26496610];RPP14[21900206];RPS10[21900206];ZNF462[27705803];RPS9[17461779];CBX5[20562864];TSC22D1[21900206];CBX4[26496610];CBX3[27705803];CBX1[27705803];USP45[26496610];CDYL[26496610];KSR2[27086506];C8orf33[21900206];TUBG1[26496610];CDYL2[26496610];WDR77[26496610];COPRS[26496610];CDK8[29568061];SNW1[20467437];APC[26496610];DOK5[25814554];NCL[30021884];PIN1[21900206];POLR1E[26496610];	15540782
39023	chr19	17036130	C	T	chr19:17036130	CPAMD8	C3 and PZP like, alpha-2-macroglobulin domain containing 8	SNV	0/1	0.38	79_49	128	99.0	0/1	0.49	59_56	115	99.0			rs377275521,COSV71596958	EXONIC	YES	NM_015692.5	Transcript	protein_coding	synonymous_variant		26/42	NM_015692.5:c.3423G>A	NP_056507.3:p.Pro1141%3D		-1.0					Anterior segment dysgenesis 8, 617319 (3), Autosomal recessive	.	.	Cataract;Optic nerve dysplasia;Ectopia pupillae;Iridodonesis;Ectopia lentis;Hypoplasia of the iris;Microphakia;Autosomal recessive inheritance;Iris transillumination defect;Persistent pupillary membrane;Uveal ectropion		0.000177368	27.0	152226.0	0.0	32	0.97	PASS	amr	0.000523286	8.0	0.000191075	13.0	0.00019635	49.0	249554.0	0.0	80	1.0	PASS	amr	0.000463392	16.0	0.00019424	22.0	0.0001994	31	0.003	8.0				9.856	0.5494		0	0	0			CPAMD8	0.0	0.0	0.0	0.0	2.0	-19.0	-7.0	1.0						0.912	0.0	83.108364874			immune system phenotype; cardiovascular system phenotype ; normal phenotype; mortality/aging ; reproductive system phenotype; behavior/neurological phenotype ; respiratory system phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; 			.	.	eye development;negative regulation of endopeptidase activity	extracellular space;plasma membrane	serine-type endopeptidase inhibitor activity	HIST1H2AJ[30021884];HIST2H2BC[30021884];	17036130
39207	chr19	18547486	G	A	chr19:18547486	ISYNA1	inositol-3-phosphate synthase 1	SNV	0/1	0.49	37_35	72	99.0	0/0	0.0	39_0	39	99.0			rs144717477	SPLICING	YES	NM_016368.5	Transcript	protein_coding	splice_region_variant,intron_variant	5/10		NM_016368.5:c.609+8C>T			-1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.0029108	443.0	152192.0	0.0	33	0.98	PASS	nfe	0.00452768	308.0	0.00452768	308.0	0.00297372	544.0	182936.0	0.0	18	0.47	PASS	nfe	0.00473495	368.0	0.00473495	368.0	0.0021800	339	0.002	8.0	0.00434	8.0		8.374	0.397759		0	0	0			ISYNA1	0.0	0.0	0.0	0.0	7.0	4.0	8.0	19.0	0.0007966503521128	0.046				0.115	0.0				.			testis - seminiferous tubule;testis - interstitial;placenta;testis;	Streptomycin biosynthesis;Inositol phosphate metabolism	inositol biosynthetic process;phospholipid biosynthetic process;inositol phosphate metabolic process	cytoplasm;cytosol	inositol-3-phosphate synthase activity;protein binding	PPP2CA[16169070];HSPA8[29568061];TRAF4[25416956;25910212];NME2[17353931];POT1[21044950];EZR[29568061];IKBKE[17353931];USE1[19369418];DUSP14[21988832];	18547486
39242	chr19	18779548	G	A	chr19:18779548	KLHL26	kelch like family member 26	SNV	0/1	0.51	57_60	117	99.0	0/1	0.46	75_63	138	99.0				EXONIC	YES	NM_001345981.2	Transcript	protein_coding	synonymous_variant		3/3	NM_001345981.2:c.1428G>A	NP_001332910.1:p.Lys476%3D		1.0						.	.	.						33	0.99											26	0.64														10.75	0.651277		0	0	0			KLHL26	0.0	0.0	0.0	0.0	35.0	1.0	-46.0	24.0						0.523	0.0	36.154217717			.			pons;amygdala;prefrontal cortex;whole brain;superior cervical ganglion;cingulate cortex;cerebellum;	.	.	.	.	NUDC[25036637];HSP90AB1[22939624];INCA1[unassigned1304];FOXH1[unassigned1304];AQP1[unassigned1304];NUDT22[unassigned1304];KCTD9[unassigned1304];NUDCD3[25036637];NUDCD2[25036637];POGZ[unassigned1304];ZIC1[unassigned1304];ACIN1[16169070];OTX1[unassigned1304];ANKS1A[unassigned1304];UBQLN4[16713569];PITX1[unassigned1304];PRR35[unassigned1304];ENKD1[unassigned1304];	18779548
39254	chr19	18967730	G	A	chr19:18967730	UPF1	UPF1, RNA helicase and ATPase	SNV	0/0	0.0	33_0	33	99.0	0/1	0.56	50_64	114	99.0			rs146805409,COSV53197757	EXONIC	YES	NM_001297549.2	Transcript	protein_coding	synonymous_variant		14/24	NM_001297549.2:c.1902G>A	NP_001284478.1:p.Pro634%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00261019	397.0	152096.0	0.0	33	0.97	PASS	amr	0.00418903	64.0	0.00386776	263.0	0.00282468	709.0	251002.0	3.0	60	0.99	PASS	nfe	0.00432942	491.0	0.00432942	491.0	0.0028810	448	0.006	17.0				0.102	-0.47981		0	0	0			UPF1	0.01	0.0	0.0	0.0	-37.0	-44.0	2.0	-20.0						0.0218	1.0	40.393402115			cellular phenotype; mortality/aging ; reproductive system phenotype; embryo phenotype; 			testis - seminiferous tubule;testis - interstitial;trigeminal ganglion;superior cervical ganglion;testis;skeletal muscle;cerebellum peduncles;cerebellum;	.	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;nuclear-transcribed mRNA catabolic process, endonucleolytic cleavage-dependent decay;nuclear-transcribed mRNA catabolic process;DNA replication;DNA repair;mRNA export from nucleus;regulation of translational termination;dosage compensation by inactivation of X chromosome;viral process;telomere maintenance via semi-conservative replication;regulation of telomere maintenance;cell cycle phase transition;positive regulation of mRNA catabolic process;3'-UTR-mediated mRNA destabilization;histone mRNA catabolic process;cellular response to lipopolysaccharide;cellular response to interleukin-1	nuclear chromosome, telomeric region;chromatin;P-body;nucleus;nucleoplasm;cytoplasm;cytosol;exon-exon junction complex;supraspliceosomal complex	chromatin binding;RNA binding;ATP-dependent RNA helicase activity;helicase activity;protein binding;ATP binding;zinc ion binding;telomeric DNA binding	PLEKHB2[15231747];CEP19[26638075];EIF4A3[18423202;21145460;16452507;18066079];CASC3[18066079;19478851;22522823];NADSYN1[15231747];EDC3[16364915];EDC4[16364915];FBL[29568061];TUBB3[27291054];MAGOH[18066079];EIF2A[18423202];RPS6[19417104];RPGRIP1L[26638075];DICER1[21858095];SRRM1[11546874];XRN1[18423202;21145460];CDC37[25036637];CSNK2B[21900206];DXO[15231747];DDX6[19150429];CEP104[26638075];SLBP[16086026];RBM8A[11546874;16452507;19417104;18066079];NDRG1[17220478];GSPT2[18447585];OAZ1[26496610];GSPT1[18256688;18423202];TERT[21829167];ACD[21829167];JUN[25609649];STIL[26638075];VCAM1[22623428];ALYREF[11546874];UPF3B[15680326;12417715;21145460;11163187;16601204;19417104;26496610;18066079;19478851;22522823];UPF3A[12417715;11163187;16601204];NBEAL2[29187380];EIF2S2[18423202];EEF2[19417104];ESR1[21182205];LSM8[15231747];GNPTG[15231747];TF[15174051];SNW1[20467437];AGO1[17932509];CNOT2[26496610];AGO2[17932509];RNPS1[11546874];INTS6[17469741];DCP1A[16364915;12417715;18423202;19150429];RHOXF2[15231747];SMG1[18256688;18423202;16452507;20371770;19417104];SMG9[19417104];ADAR[18362360];YBX1[25497084];SMG7[21145460;16452507;23348841];SMG8[19417104];SMG5[21145460;23348841];SMG6[21145460];TRMT112[15231747];RPL7A[19417104];TUBA1A[27291054];ABHD16A[15231747];CNTRL[26638075];CEP170[26638075];L1RE1[24267889];UPF2[15680326;12417715;17469741;18256688;19556969;21145460;11163187;16452507;19150429;19417104;16086026;18066079;19478851;19503078];UPF1[12417715];NCBP1[19417104;23665581];NCBP2[19417104];YWHAZ[15161933];PTBP3[22575643];AIM2[25665578];ETF1[18256688];PABPC1[21145460;19417104;23665581];DCP2[16364915;12417715];ACSS2[15231747];STAU1[15680326;23722113];DCTN1[26638075];URM1[21209336];RPL11[19417104];HIRA[15231747];NXF1[11546874];IFI16[25665578];PABPN1[23665581];RPS3[19417104];SAMD1[26496610];EXOSC2[18423202];EIF4E[23665581];KDM4A[23871696];SORT1[26496610];SCLT1[26638075];CDC5L[20467437];RPRD2[15231747];DEK[11546874];PNRC1[19150429];PNRC2[19150429];NIN[26638075];CEP162[26638075];MNDA[25665578];EIF3F[18423202];EIF3A[18423202];BCAR1[28007913];EIF3B[18423202];	18967730
39283	chr19	19144303	G	A	chr19:19144303	SUGP2	SURP and G-patch domain containing 2	SNV	0/0	0.0	16_0	16	48.0	0/1	0.61	14_22	36	99.0			rs1395890101	EXONIC	YES	NM_001321699.1	Transcript	protein_coding	missense_variant		1/11	NM_001321699.1:c.26C>T	NP_001308628.1:p.Ala9Val		-1.0						.	.	.		6.61183e-06	1.0	151244.0	0.0	32	0.95	PASS	sas	0.000207297	1.0	0.0	0.0	3.11556e-05	2.0	64194.0	0.0	1	0.09	PASS	amr	8.77193e-05	1.0	0.0	0.0								17.76	1.740652		2	9	11	SIFT,MutationTaster_pred	PolyPhen,M-CAP_pred,FATHMM_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SUGP2	0.0	0.0	0.0	0.0	-5.0	4.0	-5.0	-1.0							1.0		0.709	-0.832	.			caudate nucleus;amygdala;testis - seminiferous tubule;prefrontal cortex;trigeminal ganglion;testis;cerebellum;occipital lobe;fetal brain;whole brain;skeletal muscle;globus pallidus;thalamus;temporal lobe;superior cervical ganglion;cingulate cortex;cerebellum peduncles;pons;testis - interstitial;subthalamic nucleus;dorsal root ganglion;atrioventricular node;parietal lobe;hypothalamus;medulla oblongata;	.	mRNA processing;RNA splicing	nucleoplasm;nuclear body	RNA binding	NBEAL2[29187380];DDX41[25920683];TUBG1[29568061];AURKB[29568061];PTBP3[22575643];NR4A2[20195357];GOLGA2[unassigned1304];CDK8[29568061];CDK7[29568061];ATXN1[16713569];AIM2[25665578];COL5A1[30021884];PPP2R2B[19156129];MATR3[26496610];B9D2[26638075];BCOR[27505670];HNRNPA1[26496610];HMGN1[30021884];	19144303
39367	chr19	19656134	T	C	chr19:19656134	CILP2	cartilage intermediate layer protein 2	SNV	0/1	0.51	79_83	162	99.0	0/0	0.0	99_0	99	99.0				EXONIC	YES	NM_153221.2	Transcript	protein_coding	missense_variant		8/8	NM_153221.2:c.2780T>C	NP_694953.2:p.Leu927Pro		1.0	.,.					.	.	.						33	0.99											52	0.88														26.6	3.851683	0.858	18	3	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred	CILP2	0.0	0.0	0.0	0.0	2.0	23.0	46.0	-2.0						0.643	0.0	0.000000000	0.958	0.976	.			ciliary ganglion;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skin;testis;	.	dephosphorylation	extracellular exosome	alkaline phosphatase activity;nucleotide diphosphatase activity	.	19656134
39412	chr19	22270783	G	C	chr19:22270783	ZNF257	zinc finger protein 257	SNV	0/0	0.0	4_0	4	12.0	0|1	0.15	11_2	13	51.0			rs1238706882,COSV71307936	EXONIC	YES	NM_033468.4	Transcript	protein_coding	missense_variant		4/4	NM_033468.4:c.231G>C	NP_258429.2:p.Met77Ile		1.0	.,.					.	.	.		0.00156381	176.0	112546.0	0.0	32	0.83	AS_VQSR	sas	0.00277932	10.0	0.000779362	40.0	5.54385e-06	1.0	180380.0	0.0	26	0.59	PASS	nfe	1.13361e-05	1.0	1.13361e-05	1.0	0.0000064	1						0.384	-0.2928	0.031	1	16	17	LIST-S2_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF257	0.01	0.0	0.0	0.0	-4.0	-35.0	20.0	-4.0						0.731	0.0	0.000000000	0.0	-3.113	.			.	.	regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;zinc ion binding	SSRP1[30021884];	22270783
39414	chr19	22270793	A	T	chr19:22270793	ZNF257	zinc finger protein 257	SNV	0/0	0.0	4_0	4	12.0	0|1	0.14	12_2	14	48.0			rs751823819	EXONIC	YES	NM_033468.4	Transcript	protein_coding	missense_variant		4/4	NM_033468.4:c.241A>T	NP_258429.2:p.Ile81Phe		1.0	.,.					.	.	.		0.00289828	314.0	108340.0	0.0	32	0.81	AS_VQSR	amr	0.00476561	49.0	0.00170683	84.0					29	0.62							0.0000064	1						0.002	-1.049174	0.013	0	17	17		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF257	0.0	0.0	0.0	0.0	10.0	-14.0	10.0	34.0						0.731	0.0	0.000000000	0.001	-1.038	.			.	.	regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;zinc ion binding	SSRP1[30021884];	22270793
39419	chr19	22270798	T	C	chr19:22270798	ZNF257	zinc finger protein 257	SNV	0/0	0.0	4_0	4	12.0	0|1	0.14	12_2	14	48.0			rs1271362900	EXONIC	YES	NM_033468.4	Transcript	protein_coding	synonymous_variant		4/4	NM_033468.4:c.246T>C	NP_258429.2:p.Ala82%3D		1.0						.	.	.		0.00395698	418.0	105636.0	0.0	32	0.82	AS_VQSR	amr	0.00662055	67.0	0.00236174	113.0					31	0.64							0.0000965	15						0.961	-0.156649		0	0	0			ZNF257	0.0	0.0	0.0	0.0	-19.0	5.0	17.0	2.0						0.731	0.0	12.558015364			.			.	.	regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;zinc ion binding	SSRP1[30021884];	22270798
39424	chr19	22270799	G	A	chr19:22270799	ZNF257	zinc finger protein 257	SNV	0/0	0.0	4_0	4	12.0	0|1	0.14	12_2	14	48.0			rs570207024	EXONIC	YES	NM_033468.4	Transcript	protein_coding	missense_variant		4/4	NM_033468.4:c.247G>A	NP_258429.2:p.Glu83Lys		1.0	.,.					.	.	.		0.00422278	439.0	103960.0	0.0	32	0.82	AS_VQSR	amr	0.00735294	73.0	0.00252654	119.0	1.03357e-05	2.0	193504.0	0.0	30	0.64	PASS	sas	0.000107342	2.0	0.0	0.0	0.0001286	20						10.2	0.587632	0.035	0	17	17		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF257	0.0	0.3	0.0	0.0	46.0	-20.0	-20.0	28.0						0.731	0.0	0.000000000	0.001	-1.226	.			.	.	regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;zinc ion binding	SSRP1[30021884];	22270799
39426	chr19	22270807	T	C	chr19:22270807	ZNF257	zinc finger protein 257	SNV	0/0	0.0	6_0	6	15.0	0|1	0.13	13_2	15	45.0			rs1204698400	EXONIC	YES	NM_033468.4	Transcript	protein_coding	synonymous_variant		4/4	NM_033468.4:c.255T>C	NP_258429.2:p.Leu85%3D		1.0						.	.	.		0.00588581	601.0	102110.0	0.0	32	0.81	AS_VQSR	amr	0.00983204	96.0	0.0036392	168.0					33	0.66							0.0000900	14						0.663	-0.211946		0	0	0			ZNF257	0.02	0.0	0.0	0.0	-28.0	32.0	8.0	-28.0						0.731	0.0	36.040626007			.			.	.	regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;zinc ion binding	SSRP1[30021884];	22270807
39523	chr19	33490616	A	T	chr19:33490616	RHPN2	rhophilin Rho GTPase binding protein 2	SNV	0/1	0.26	77_28	106	99.0	0/1	0.34	50_26	76	99.0			rs199764566,COSV54276982	SPLICING	YES	NM_033103.5	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	9/14		NM_033103.5:c.1106-5T>A			-1.0						.	.	.		0.000363666	53.0	145738.0	0.0	32	0.94	AS_VQSR	sas	0.000882223	4.0	0.000338149	22.0	0.0509713	9372.0	183868.0	0.0	100	1.0	RF	nfe	0.0624407	4999.0	0.0624407	4999.0	0.1190580	18514	0.016	52.0	0.05947	609.0		21.4	2.202148		0	0	0			RHPN2	0.99	0.07	0.0	0.0	-2.0	-10.0	47.0	-38.0	0.998919067902049	0.758	6.927	3.622	10.549	0.744	0.0				normal phenotype; 			.	.	signal transduction	cytosol;perinuclear region of cytoplasm	.	RARG[21988832];TRAF6[17353931];HLA-C[17353931];SFN[15778465];VHL[17353931];HNF1A[17353931];FTSJ1[17353931];TNFRSF10D[17353931];ATG5[17353931];	33490616
39533	chr19	34180194	G	A	chr19:34180194	CHST8	carbohydrate sulfotransferase 8	SNV	0/1	0.48	34_31	65	99.0	0/0	0.0	34_0	34	99.0			rs62103464,COSV52858922	EXONIC	YES	NM_022467.3	Transcript	protein_coding	synonymous_variant		2/4	NM_022467.3:c.27G>A	NP_071912.2:p.Arg9%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided	?Peeling skin syndrome 3, 616265 (3), Autosomal recessive	Peeling skin syndrome type A	Disease-causing germline mutation(s) (loss of function) in	White scaling skin;Autosomal recessive inheritance		0.006099	928.0	152156.0	3.0	33	0.98	PASS	nfe	0.00882016	600.0	0.00882016	600.0	0.00744208	1806.0	242674.0	14.0	27	0.69	PASS	nfe	0.00956168	1058.0	0.00956168	1058.0	0.0069516	1081	0.009	30.0	0.00894	102.0		11.41	0.732115		0	0	0			CHST8	0.0	0.0	0.0	0.0	44.0	-50.0	29.0	-49.0						0.629	0.0	47.585109787			integument phenotype ; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype ; reproductive system phenotype; vision/eye phenotype; 			pons;cingulate cortex;trigeminal ganglion;thalamus;	.	sulfur compound metabolic process;central nervous system development;carbohydrate biosynthetic process;proteoglycan biosynthetic process;hormone biosynthetic process	Golgi membrane;integral component of membrane	N-acetylgalactosamine 4-O-sulfotransferase activity	.	34180194
39561	chr19	35173717	T	A	chr19:35173717	ZNF302	zinc finger protein 302	SNV	0/0	0.0	41_0	41	24.0	0/1	0.23	41_12	53	99.0			rs199664059,COSV71063302	EXONIC	YES	NM_001289181.2	Transcript	protein_coding	missense_variant		4/6	NM_001289181.2:c.177T>A	NP_001276110.1:p.His59Gln		1.0	Krueppel-associated box&Krueppel-associated box&Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box&Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box&Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box&Krueppel-associated box&Krueppel-associated box,.,Krueppel-associated box&Krueppel-associated box&Krueppel-associated box&Krueppel-associated box,.,.,Krueppel-associated box&Krueppel-associated box&Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box&Krueppel-associated box&Krueppel-associated box,Krueppel-associated box&Krueppel-associated box&Krueppel-associated box&Krueppel-associated box					.	.	.		0.000119408	18.0	150744.0	0.0	32	0.97	PASS	afr	0.000221893	9.0	5.90423e-05	4.0	0.00361017	834.0	231014.0	0.0	52	0.94	PASS	afr	0.016941	212.0	0.00298009	314.0	0.0000322	5	0.0	1.0				15.57	1.372779	0.035	0	18	18		SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF302	0.0	0.0	0.0	0.0	-35.0	20.0	48.0	-36.0						0.709	0.01		0.753	-0.829	.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;metal ion binding	CBX5[20562864];NUP210[30021884];KRTAP10-6[unassigned1304];CEP70[25416956];CLIC1[21988832];OPTN[23414517];	35173717
39704	chr19	36604446	G	A	chr19:36604446	OVOL3	ovo like zinc finger 3	SNV	0/1	0.47	58_51	109	99.0	0/1	0.44	49_39	88	99.0			rs117966240	EXONIC	YES	NM_001302757.1	Transcript	protein_coding	synonymous_variant		4/4	NM_001302757.1:c.456G>A	NP_001289686.1:p.Pro152%3D		1.0						.	.	.		0.00319978	487.0	152198.0	1.0	33	0.98	PASS	amr	0.00543052	83.0	0.00498295	339.0	0.0027878	380.0	136308.0	1.0	100	0.57	PASS	nfe	0.00490251	264.0	0.00490251	264.0	0.0008489	132	0.006	18.0				5.814	0.19823		0	0	0			OVOL3	0.01	0.03	0.0	0.0	2.0	-2.0	16.0	0.0								0.343152490			.			superior cervical ganglion;	.	negative regulation of transcription by RNA polymerase II;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;sequence-specific DNA binding;metal ion binding	.	36604446
39762	chr19	38377225	G	A	chr19:38377225	WDR87	WD repeat domain 87	SNV	0/1	0.42	39_28	67	99.0	0/1	0.37	51_30	82	99.0			rs548162056,COSV100382453	EXONIC	YES	NM_001291088.2	Transcript	protein_coding	synonymous_variant		6/6	NM_001291088.2:c.7086C>T	NP_001278017.1:p.Asp2362%3D		-1.0						.	.	.		0.00122246	185.0	151334.0	0.0	31	0.95	PASS	amr	0.00414747	63.0	0.00109071	74.0	0.00126514	163.0	128840.0	0.0	9	0.18	PASS	amr	0.00247925	46.0	0.00117082	60.0	0.0001543,0.0001608	24,25	0.001	2.0				0.02	-0.698869		0	0	0			WDR87	0.0	0.0	0.0	0.0	-38.0	-39.0	29.0	-39.0								0.000000000			.			.	.	.	.	.	HSPA8[30021884];NCL[30021884];HIST1H1E[30021884];MAPT[26402096];HIST1H1B[30021884];	38377225
39764	chr19	38573053	C	T	chr19:38573053	SIPA1L3	signal induced proliferation associated 1 like 3	SNV	0/1	0.48	65_60	125	99.0	0/1	0.48	55_51	106	99.0			rs141958728,COSV55908460	EXONIC	YES	NM_015073.3	Transcript	protein_coding	missense_variant		3/22	NM_015073.3:c.848C>T	NP_055888.1:p.Ala283Val		1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_provided	?Cataract 45, 616851 (3), Autosomal recessive	Total early-onset cataract	Disease-causing germline mutation(s) in	Developmental cataract;Autosomal recessive inheritance		0.00766107	1166.0	152198.0	7.0	33	0.99	PASS	nfe	0.00856874	583.0	0.00856874	583.0	0.00687679	1464.0	212890.0	7.0	22	0.59	PASS	nfe	0.00830142	789.0	0.00830142	789.0	0.0059034	918	0.004	14.0				13.6	1.025958	0.005	0	18	18		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIPA1L3	0.0	0.0	0.0	0.0	-2.0	-22.0	-2.0	-22.0						0.132	1.0	0.000000000	0.97	-0.283	vision/eye phenotype; 			superior cervical ganglion;cerebellum;	.	eye development;hematopoietic progenitor cell differentiation;epithelial cell morphogenesis;cytoskeleton organization;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction;establishment of epithelial cell polarity	stress fiber;extracellular space;apical plasma membrane;apical part of cell;tricellular tight junction	GTPase activator activity	EGLN3[26972000];CEP135[26496610;26638075];YWHAB[24255178];ODF2[26638075];CEP152[26638075];DYRK1B[23602568];IQGAP1[26496610];RPGRIP1L[26638075];YWHAZ[15161933];MYO19[26496610];PLEKHA7[28877994];PPP1CB[26496610];MYO1C[26496610];MYC[21150319];CAPZA2[26496610];MYO18A[26496610];MYH9[26496610];SFN[15778465];SYNPO[26496610];NINL[26638075];	38573053
39771	chr19	38899502	AAG		chr19:38899502-38899504	FAM98C	family with sequence similarity 98 member C	deletion	0/1	0.12	43_6	49	99.0	0/0	0.0	41_0	41	99.0			rs59917662	EXONIC	YES	NM_174905.3	Transcript	protein_coding	inframe_deletion		8/8	NM_174905.3:c.1045_1047del	NP_777565.3:p.Lys349del		1.0						.	.	.		0.000260737	39.0	149576.0	0.0	31	0.9	PASS	sas	0.00147493	7.0	0.000252315	17.0	0.033244	4936.0	148478.0	0.0	22	0.54	RF	sas	0.0664063	986.0	0.0290461	2098.0	0.0000643,0.0010032,0.0332339	10,156,5168						17.69	1.730537		0	0	0			FAM98C	0.0	0.0	0.01	0.0	17.0	-11.0	17.0	-11.0						0.784	0.0	25.444033613			.			ciliary ganglion;subthalamic nucleus;atrioventricular node;superior cervical ganglion;globus pallidus;	.	.	tRNA-splicing ligase complex	.	.	38899501
39792	chr19	38903330	G	A	chr19:38903330	RASGRP4	RAS guanyl releasing protein 4	SNV	0/1	0.41	57_40	97	99.0	0/1	0.45	55_45	100	99.0			rs117892748	EXONIC	YES	NM_170604.3	Transcript	protein_coding	synonymous_variant		13/17	NM_170604.3:c.1662C>T	NP_733749.1:p.Cys554%3D		-1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00617049	939.0	152176.0	3.0	32	0.97	PASS	nfe	0.00937794	638.0	0.00937794	638.0	0.0056592	1402.0	247738.0	3.0	32	0.88	PASS	nfe	0.00839416	943.0	0.00839416	943.0	0.0058712	913	0.008	25.0				12.54	0.87591		0	0	0			RASGRP4	0.0	0.0	0.05	0.09	-6.0	11.0	27.0	-18.0						0.668	0.05	2.987031381			hematopoietic system phenotype; pigmentation phenotype; digestive/alimentary phenotype; vision/eye phenotype; immune system phenotype; skeleton phenotype; cellular phenotype; 			.	MAPK signaling pathway	MAPK cascade;transmembrane receptor protein tyrosine kinase signaling pathway;activation of phospholipase C activity;small GTPase mediated signal transduction;regulation of G protein-coupled receptor signaling pathway;cell population proliferation;response to extracellular stimulus;myeloid cell differentiation;positive regulation of Ras protein signal transduction	cytosol;plasma membrane;membrane	Ras guanyl-nucleotide exchange factor activity;calcium ion binding;diacylglycerol binding;GTP-dependent protein binding	RAP1A[25241761];TMPRSS4[unassigned1304];BNIP2[unassigned1304];DYNLL1[unassigned1304];SEC22A[unassigned1304];HSP90B1[30021884];	38903330
39813	chr19	38935300	G	C	chr19:38935300	RYR1	ryanodine receptor 1	SNV	0/1	0.59	35_50	85	99.0	0/1	0.53	31_35	66	99.0			rs201834803	EXONIC	YES	NM_000540.3	Transcript	protein_coding	missense_variant		7/106	NM_000540.3:c.614G>C	NP_000531.2:p.Cys205Ser		1.0	.,Inositol 1,4,5-trisphosphate/ryanodine receptor	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	RYR1-Related_Disorders|not_provided	Neuromuscular disease, congenital, with uniform type 1 fiber, 117000 (3), Autosomal recessive, Autosomal dominant; Central core disease, 117000 (3), Autosomal recessive, Autosomal dominant; King-Denborough syndrome, 619542 (3), Autosomal dominant; {Malignant hyperthermia susceptibility 1}, 145600 (3), Autosomal dominant; Minicore myopathy with external ophthalmoplegia, 255320 (3), Autosomal recessive	Central core disease;Autosomal recessive centronuclear myopathy;Autosomal dominant centronuclear myopathy;Malignant hyperthermia of anesthesia;Moderate multiminicore disease with hand involvement;Benign Samaritan congenital myopathy;Exercise-induced malignant hyperthermia;Congenital myopathy with myasthenic-like onset;Lethal multiple pterygium syndrome;King-Denborough syndrome;Congenital multicore myopathy with external ophthalmoplegia	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Candidate gene tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Joint hyperflexibility;Talipes equinovarus;Intrinsic hand muscle atrophy;Knee dislocation;Distal upper limb muscle weakness;Facial palsy;Type 1 muscle fiber predominance;Axial muscle weakness;Generalized muscle weakness;Difficulty running;Hyporeflexia of upper limbs;Delayed gross motor development;Recurrent patellar dislocation;Neonatal hypotonia;EMG: myopathic abnormalities;Polyhydramnios;Peripheral axonal neuropathy;Centrally nucleated skeletal muscle fibers;Mildly elevated creatine kinase;Respiratory insufficiency due to muscle weakness;Exercise-induced myalgia;Delayed gross motor development;Spontaneous abortion;Pyloric stenosis;Abnormality of the foot musculature;Difficulty walking;Areflexia of lower limbs;Proximal muscle weakness in lower limbs;Thin ribs;Cavernous hemangioma;Muscle fibrillation;Malignant hyperthermia;External ophthalmoplegia;Large for gestational age;Neonatal asphyxia;Calf muscle hypertrophy;Type 1 muscle fiber predominance;Ptosis;Decreased fetal movement;Macrocephaly at birth;Generalized hypotonia;Urinary incontinence;Proximal muscle weakness in upper limbs;Cryptorchidism;High palate;Dysphagia;Generalized muscle weakness;Ophthalmoplegia;Neonatal hypotonia;Dilated cardiomyopathy;Limb joint contracture;Autosomal recessive inheritance;Congenital hip dislocation;Scoliosis;Weak cry;Type 1 fibers relatively smaller than type 2 fibers;Respiratory insufficiency due to muscle weakness;Respiratory insufficiency;Lumbar hyperlordosis;Autosomal dominant inheritance;Narrow face;Congenital onset;Feeding difficulties;Ptosis;Variable expressivity;Heterogeneous;Facial palsy;Failure to thrive;Proximal muscle weakness;Centrally nucleated skeletal muscle fibers;Reduced forced vital capacity;Decreased fetal movement;Bulbar palsy;Long face;Elevated serum creatine kinase;Malignant hyperthermia;Myoglobinuria;Rigidity;Hypotension;Hyperphosphatemia;Autosomal dominant inheritance;Tachycardia;Mixed respiratory and metabolic acidosis;Fever;Abnormality of the coagulation cascade;Hyperkalemia;Rhabdomyolysis;High palate;Pulmonary hypoplasia;Increased variability in muscle fiber diameter;Nemaline bodies;Type 1 and type 2 muscle fiber minicore regions;Exercise-induced myalgia;Ptosis;Polyhydramnios;Areflexia;Muscular hypotonia;Scoliosis;Decreased fetal movement;Muscular dystrophy;Difficulty running;Neonatal onset;Proximal muscle weakness;Hydrops fetalis;Facial palsy;Recurrent respiratory infections;External ophthalmoplegia;Axial muscle weakness;Autosomal recessive inheritance;Joint laxity;Neonatal hypotonia;Feeding difficulties in infancy;Motor delay;Skeletal muscle atrophy;Increased connective tissue;Myopathic facies;Respiratory insufficiency;Generalized muscle weakness;High palate;Decreased fetal movement;Polyhydramnios;Scoliosis;Generalized hypotonia;Shoulder girdle muscle weakness;Micropenis;Tented upper lip vermilion;Ptosis;Cryptorchidism;Flexion contracture;Scrotal hypoplasia;Myopathic facies;Proximal muscle weakness;Feeding difficulties;Increased variability in muscle fiber diameter;Facial diplegia;Nemaline bodies;Recurrent respiratory infections;Muscle fiber hypertrophy;Frog-leg posture;External ophthalmoplegia;Pneumonia;Sternocleidomastoid amyotrophy;Severe postnatal growth retardation;Narrow face;Axial muscle weakness;Respiratory failure;Internally nucleated skeletal muscle fibers;Rectus femoris muscle atrophy;Muscular dystrophy;Type 1 muscle fiber predominance;Difficulty running;Tibialis atrophy;Edema;Increased connective tissue;Motor delay;Joint laxity;Type 1 muscle fiber atrophy;Pes planus;Multiple joint contractures;Myopathy;Type 1 muscle fiber predominance;Bulbar signs;Muscular hypotonia;Easy fatigability;Mitral valve prolapse;Motor delay;Congenital hip dislocation;Muscle stiffness;Malignant hyperthermia;Pelvic girdle muscle weakness;Fetal akinesia sequence;Ophthalmoplegia;Respiratory insufficiency due to muscle weakness;Kyphoscoliosis;Neonatal respiratory distress;Talipes equinovarus;Joint laxity;Nemaline bodies;Elevated serum creatine kinase;Central core regions in muscle fibers;Waddling gait;Dysphonia;Talipes equinovarus;Difficulty climbing stairs;Pes cavus;Generalized amyotrophy;Intellectual disability, mild;Motor delay;Narrow mouth;Dysarthria;Scapular winging;Protruding ear;Facial diplegia;Type 1 muscle fiber predominance;Ophthalmoplegia;Areflexia;Bifid uvula;Delayed speech and language development;Respiratory insufficiency;Hyperlordosis;Generalized hypotonia;Difficulty running;Retrognathia;Gowers sign;EMG: decremental response of compound muscle action potential to repetitive nerve stimulation;Long face;Centrally nucleated skeletal muscle fibers;Abnormal heart valve morphology;Left ventricular hypertrophy;Progressive muscle weakness;Long fingers;High palate;Hip contracture;Autosomal dominant inheritance;Autosomal recessive inheritance;Slow progression;Neonatal hypotonia;Kyphoscoliosis;Pes planus;Congenital hip dislocation;Fever;Malignant hyperthermia;Nemaline bodies;Motor delay;Type 1 muscle fiber predominance;Skeletal muscle atrophy;Nonprogressive;Flexion contracture;Infantile onset;Generalized muscle weakness;Areflexia;Failure to thrive;Motor delay;EMG: myopathic abnormalities;Ophthalmoplegia;Recurrent respiratory infections;Proximal muscle weakness;Fatigable weakness;Scoliosis;Gait disturbance;Respiratory insufficiency due to muscle weakness;Myopathic facies;Malignant hyperthermia;Type 1 muscle fiber predominance;Multiple joint contractures;Ptosis;Minicore myopathy;Feeding difficulties;Easy fatigability;Scapular winging;Infantile axial hypotonia;Lethargy;Centrally nucleated skeletal muscle fibers;Wide nasal bridge;Internally nucleated skeletal muscle fibers;Epicanthus;Prominent forehead;Functional respiratory abnormality;Thickened skin;Generalized hypotonia;Weak cry;Narrow mouth;Hypertelorism;Myopathic facies;Hyporeflexia;Motor delay;Narrow forehead;Dolichocephaly;Frog-leg posture;Fasciculations;Elevated creatine kinase after exercise;High-output congestive heart failure;Ventricular tachycardia;Ventricular extrasystoles;Hyperphosphatemia;Metabolic acidosis;Tachypnea;Abnormality of the coagulation cascade;Acute rhabdomyolysis;Acute kidney injury;Muscle stiffness;Acute hepatic failure;Necrotizing myopathy;Fever;Abnormality of masseter muscle;Hyperkalemia;Exercise-induced rhabdomyolysis;Hypercapnia;Supraventricular tachycardia;Cardiomyocyte mitochondrial proliferation;Malignant hyperthermia;Myoglobinuria;Intermittent painful muscle spasms		0.000374822	57.0	152072.0	0.0	31	0.94	PASS	amr	0.00340537	52.0	4.40995e-05	3.0	0.00028771	72.0	250252.0	0.0	84	0.9	PASS	amr	0.00179773	62.0	6.18746e-05	7.0	0.0002186	34	0.003	9.0	0.00368	42.0		17.45	1.694827	0.396	8	10	18	M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	RYR1	0.0	0.02	0.0	0.01	17.0	-25.0	-47.0	17.0						0.00248	0.0	0.000000000	1.0	1.176	muscle phenotype; craniofacial phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; integument phenotype ; adipose tissue phenotype ; digestive/alimentary phenotype; limbs/digits/tail phenotype; skeleton phenotype; respiratory system phenotype; behavior/neurological phenotype ; cardiovascular system phenotype ; mortality/aging ; 			tongue;skeletal muscle;	Calcium signaling pathway;Long-term depression	response to hypoxia;outflow tract morphogenesis;calcium ion transport;muscle contraction;release of sequestered calcium ion into cytosol by sarcoplasmic reticulum;response to caffeine;ion transmembrane transport;skin development;ossification involved in bone maturation;skeletal muscle fiber development;release of sequestered calcium ion into cytosol;protein homotetramerization;regulation of cytosolic calcium ion concentration;cellular response to calcium ion;cellular response to caffeine;regulation of cardiac conduction	cytoplasm;smooth endoplasmic reticulum;plasma membrane;integral component of plasma membrane;cell cortex;junctional sarcoplasmic reticulum membrane;terminal cisterna;sarcoplasmic reticulum;Z disc;junctional membrane complex;T-tubule;cytoplasmic vesicle membrane;integral component of organelle membrane;I band;sarcoplasmic reticulum membrane;calcium channel complex;sarcolemma;extracellular exosome;ryanodine receptor complex	protease binding;ryanodine-sensitive calcium-release channel activity;voltage-gated calcium channel activity;calcium channel activity;calcium ion binding;protein binding;calmodulin binding;ATP binding;calcium-release channel activity;calcium-induced calcium release activity	PDE4D[18268335];METTL3[29507755];TULP3[23414517];MYOM2[23414517];PPP1CA[18755143];TTN[23414517];PPP2CA[18755143];FKBP1A[18268335];TF[15174051];PDLIM3[23414517];GRB2[17474147];PLCG1[17474147];NCK1[17474147];	38935300
39843	chr19	39401288	C	T	chr19:39401288	CCER2	coiled-coil glutamate rich protein 2	SNV	0/1	0.59	38_54	92	99.0	0/1	0.37	61_36	97	99.0			rs181740944	EXONIC	YES	NM_001243212.2	Transcript	protein_coding	missense_variant		4/5	NM_001243212.2:c.626G>A	NP_001230141.1:p.Arg209His		-1.0	.,.					.	.	.		0.00224781	342.0	152148.0	3.0	32	0.97	PASS	nfe	0.00376371	256.0	0.00376371	256.0	0.00198989	248.0	124630.0	1.0	15	0.44	PASS	nfe	0.00334997	153.0	0.00334997	153.0	0.0005852	91	0.005	15.0				0.031	-0.641356		0	11	11		SIFT,PolyPhen,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CCER2	0.0	0.0	0.0	0.0	-38.0	9.0	3.0	-43.0									0.014	-0.602	.			.	.	.	extracellular region	.	.	39401288
39861	chr19	39760635	T	C	chr19:39760635	IFNL2	interferon lambda 2	SNV	0/1	0.21	89_23	112	99.0	0/1	0.26	62_22	84	99.0			rs372089263,COSV59593175	EXONIC	YES	NM_172138.2	Transcript	protein_coding	synonymous_variant		6/6	NM_172138.2:c.585T>C	NP_742150.1:p.Ser195%3D		1.0						.	.	.		0.000191356	29.0	151550.0	0.0	32	0.97	PASS	sas	0.00083091	4.0	0.000132747	9.0	0.0056333	1260.0	223670.0	0.0	47	0.63	PASS	amr	0.0224948	673.0	0.00336026	337.0	0.0064757	1007	0.013	41.0				0.032	-0.638136		0	0	0			IFNL2	0.0	0.0	0.0	0.0	0.0	-2.0	8.0	-2.0							0.0				hematopoietic system phenotype; immune system phenotype; 			.	Cytokine-cytokine receptor interaction;Jak-STAT signaling pathway	mucosal immune response;JAK-STAT cascade;regulation of signaling receptor activity;cytokine-mediated signaling pathway;innate immune response;positive regulation of immune response;defense response to virus	extracellular region;extracellular space	signaling receptor binding;cytokine activity	.	39760635
39889	chr19	40720965	C	A	chr19:40720965	MAP3K10	mitogen-activated protein kinase kinase kinase 10	SNV	0/1	0.56	35_44	79	99.0	0/1	0.51	41_43	84	99.0			rs200029351	EXONIC	YES	NM_002446.4	Transcript	protein_coding	synonymous_variant		10/10	NM_002446.4:c.2631C>A	NP_002437.2:p.Arg877%3D		1.0						.	.	.		0.001409	211.0	149752.0	2.0	29	0.89	PASS	afr	0.00370755	150.0	0.000281866	19.0	0.000691021	164.0	237330.0	0.0	60	0.9	PASS	afr	0.0034154	48.0	0.000448653	47.0	0.0006624	103	0.003	8.0				10.06	0.570899		0	0	0			MAP3K10	0.04	0.0	0.0	0.0	-44.0	45.0	-5.0	-13.0						0.176	0.79	13.482084632			skeleton phenotype; immune system phenotype; normal phenotype; homeostasis/metabolism phenotype; 			caudate nucleus;pons;temporal lobe;subthalamic nucleus;superior cervical ganglion;trigeminal ganglion;parietal lobe;skeletal muscle;globus pallidus;cerebellum;	MAPK signaling pathway	MAPK cascade;apoptotic process;signal transduction;smoothened signaling pathway;JNK cascade;activation of JNKK activity;activation of JUN kinase activity;peptidyl-serine phosphorylation;peptidyl-threonine phosphorylation;positive regulation of apoptotic process;negative regulation of DNA-binding transcription factor activity;positive regulation of JUN kinase activity;negative regulation of transcription, DNA-templated;positive regulation of JNK cascade;protein autophosphorylation	cytoplasm	transcription corepressor activity;protein kinase activity;protein serine/threonine kinase activity;JUN kinase kinase kinase activity;ATP binding;protein homodimerization activity;bHLH transcription factor binding	ABL2[20936779];MAP3K21[20936779];GARS[21988832];	40720965
39919	chr19	41600317	C	T	chr19:41600317	CYP2A13	cytochrome P450 family 2 subfamily A member 13	SNV	0/1	0.65	23_43	66	99.0	0/1	0.35	39_22	62	99.0			rs147797134,COSV57837841	EXONIC	YES	NM_000766.5	Transcript	protein_coding	missense_variant		7/9	NM_000766.5:c.1141C>T	NP_000757.2:p.Arg381Trp		1.0						.	.	.		0.00080203	122.0	152114.0	0.0	31	0.95	PASS	nfe	0.00139665	95.0	0.00139665	95.0	0.000767548	193.0	251450.0	0.0	73	1.0	PASS	nfe	0.0013801	157.0	0.0013801	157.0	0.0008231	128	0.003	9.0	0.00225	23.0		23.7	3.064933	0.718	8	13	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,PROVEAN_pred,LIST-S2_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CYP2A13	0.01	0.0	0.03	0.02	21.0	-22.0	-36.0	-5.0						0.785	0.0		0.018	0.116	homeostasis/metabolism phenotype; 			pons;superior cervical ganglion;trigeminal ganglion;cingulate cortex;	Caffeine metabolism;Retinol metabolism;Drug metabolism - cytochrome P450;Drug metabolism - other enzymes	organic acid metabolic process;xenobiotic metabolic process;coumarin metabolic process;epoxygenase P450 pathway;exogenous drug catabolic process;oxidation-reduction process	cytoplasm;endoplasmic reticulum membrane;organelle membrane;intracellular membrane-bounded organelle	monooxygenase activity;iron ion binding;coumarin 7-hydroxylase activity;arachidonic acid epoxygenase activity;steroid hydroxylase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;heme binding;aromatase activity	.	41600317
39946	chr19	42265242	G	A	chr19:42265242	CEACAM6	carcinoembryonic antigen related cell adhesion molecule 6	SNV	0/1	0.49	30_29	59	99.0	0/1	0.46	33_28	61	99.0			rs782511112	EXONIC	YES	NM_002483.7	Transcript	protein_coding	synonymous_variant		3/6	NM_002483.7:c.510G>A	NP_002474.4:p.Glu170%3D		1.0						.	.	.		6.57134e-06	1.0	152176.0	0.0	32	0.97	PASS	nfe	1.47003e-05	1.0	1.47003e-05	1.0	7.95248e-06	2.0	251494.0	0.0	100	1.0	PASS	amr	2.89084e-05	1.0	8.78982e-06	1.0	0.0000064	1	0.001	2.0				0.016	-0.724551		0	0	0			CEACAM6	0.0	0.0	0.02	0.01	2.0	40.0	23.0	0.0						0.618	0.19	28.854279525			.			lung;trachea;tongue;superior cervical ganglion;trigeminal ganglion;skeletal muscle;bone marrow;	.	apoptotic process;homophilic cell adhesion via plasma membrane adhesion molecules;heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules;signal transduction;positive regulation of cell population proliferation;positive regulation of cell migration;positive regulation of heterotypic cell-cell adhesion;neutrophil degranulation;leukocyte migration;positive regulation of endothelial cell-matrix adhesion via fibronectin;negative regulation of anoikis	extracellular space;plasma membrane;cell surface;apical plasma membrane;anchored component of membrane;azurophil granule membrane	protein binding;identical protein binding;protein heterodimerization activity	KANK2[unassigned1304];GCM2[unassigned1304];SMARCD1[unassigned1304];EXOC3L1[unassigned1304];RHOXF2[unassigned1304];POM121[unassigned1304];SHC3[unassigned1304];TNXB[unassigned1304];ZMYND19[unassigned1304];CSTF2[unassigned1304];CIB1[unassigned1304];MYOZ1[unassigned1304];PITX1[unassigned1304];UBQLN2[unassigned1304];TXNDC5[unassigned1304];VENTX[unassigned1304];WWOX[unassigned1304];DSCR10[unassigned1304];FOXH1[unassigned1304];ZNF76[unassigned1304];VEZF1[unassigned1304];CARTPT[21982860];HPCAL4[unassigned1304];MSS51[unassigned1304];CEACAM1[21982860];GPANK1[unassigned1304];CEACAM7[21982860];TLX3[unassigned1304];CEACAM6[21982860;unassigned1304];HGS[unassigned1304];CEACAM5[21982860];ASPG[unassigned1304];QRICH1[unassigned1304];CEACAM8[21982860];	42265242
40002	chr19	42793211	T	C	chr19:42793211	CIC	capicua transcriptional repressor	SNV	0/1	0.45	42_35	77	99.0	0/1	0.55	41_50	91	99.0			rs773764871,COSV50661975	EXONIC	YES	NM_001386298.1	Transcript	protein_coding	missense_variant		8/21	NM_001386298.1:c.3830T>C	NP_001373227.1:p.Val1277Ala		1.0	.,.,.				Mental retardation, autosomal dominant 45, 617600 (3), Autosomal dominant	Autosomal dominant non-syndromic intellectual disability	Disease-causing germline mutation(s) (loss of function) in	Generalized hypotonia;Poor speech;Variable expressivity;Attention deficit hyperactivity disorder;Seizure;Global developmental delay;Intellectual disability;Autosomal dominant inheritance;Developmental regression		5.91576e-05	9.0	152136.0	0.0	32	0.98	PASS	amr	0.000392773	6.0	4.41163e-05	3.0	5.22357e-05	13.0	248872.0	0.0	100	0.98	PASS	amr	0.000289436	10.0	1.7854e-05	2.0	0.0000129	2	0.0	1.0	0.00061	7.0		14.77	1.221916	0.048	3	15	18	M-CAP_pred,FATHMM_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	CIC	0.01	0.0	0.05	0.03	-29.0	32.0	38.0	-26.0						0.0161	1.0	0.000000000	0.977	0.197	respiratory system phenotype; mortality/aging ; nervous system phenotype ; growth/size/body region phenotype; 			superior cervical ganglion;skeletal muscle;	.	negative regulation of transcription by RNA polymerase II;brain development;learning;memory;social behavior;negative regulation of transcription, DNA-templated;lung alveolus development	nucleus;nucleoplasm;protein-containing complex;intracellular membrane-bounded organelle	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;chromatin binding;protein binding	SETD2[16713569];NFYC[20936779];PLK1[21900206];FOXK2[25609649];PYCR2[16713569];GABPB1[16713569];YWHAZ[15161933];GTPBP3[16713569];GOLGA2[unassigned1304;29568061];RAD50[30021884];ZNRD1[16713569];ATXN1[16713569;18337722];CENPJ[16713569];CSNK2B[21900206];PICK1[16713569];SEC62[16713569];TRIM22[16713569];	42793211
40008	chr19	42814708	C	T	chr19:42814708	PRR19	proline rich 19	SNV	0/1	0.38	72_44	117	99.0	0/1	0.53	54_61	116	99.0			rs138700619	EXONIC	YES	NM_199285.3	Transcript	protein_coding	missense_variant		3/3	NM_199285.3:c.887C>T	NP_954979.2:p.Pro296Leu		1.0	.,.					.	.	.		0.00523701	797.0	152186.0	9.0	32	0.98	PASS	nfe	0.0054097	368.0	0.0054097	368.0	0.0059924	1501.0	250484.0	12.0	100	1.0	PASS	nfe	0.00655072	739.0	0.00655072	739.0	0.0053889	838	0.008	25.0				23.2	2.834664	0.531	6	13	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationTaster_pred,PROVEAN_pred	LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRR19	0.0	0.0	0.0	0.0	35.0	-14.0	19.0	-14.0						0.141	0.2	0.000000000	0.804	0.128	.			ciliary ganglion;pons;subthalamic nucleus;atrioventricular node;skin;superior cervical ganglion;testis;skeletal muscle;	.	.	.	protein binding	CYSRT1[unassigned1304];ADAMTSL4[unassigned1304];PDCD6[unassigned1304];KRTAP10-8[unassigned1304];KRT34[unassigned1304];TRIB3[unassigned1304];KRT31[25416956;unassigned1304];MEOX2[25416956];	42814708
40043	chr19	43965594	C	T	chr19:43965594	LYPD3	LY6/PLAUR domain containing 3	SNV	0/1	0.49	49_47	96	99.0	0/1	0.44	43_34	77	99.0			rs149095976	EXONIC	YES	NM_014400.3	Transcript	protein_coding	missense_variant		5/5	NM_014400.3:c.950G>A	NP_055215.2:p.Gly317Glu		-1.0						.	.	.		0.00116953	178.0	152198.0	0.0	32	0.97	PASS	nfe	0.0020137	137.0	0.0020137	137.0	0.00104262	262.0	251290.0	0.0	68	1.0	PASS	nfe	0.00168089	191.0	0.00168089	191.0	0.0010289	160	0.003	9.0				7.755	0.34325	0.022	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LYPD3	0.0	0.0	0.0	0.0	37.0	-42.0	4.0	22.0						0.796	0.0	0.000000000	0.001	-0.281	homeostasis/metabolism phenotype; adipose tissue phenotype ; integument phenotype ; mortality/aging ; growth/size/body region phenotype; hematopoietic system phenotype; immune system phenotype; behavior/neurological phenotype ; neoplasm; 			tonsil;tongue;dorsal root ganglion;superior cervical ganglion;skin;placenta;prostate;	.	cell-matrix adhesion	extracellular region;extracellular space;plasma membrane;integral component of membrane;anchored component of plasma membrane	laminin binding	SMAD4[25640309];PCGF5[27705803];PTPRJ[25640309];LSP1[25640309];PPM1D[25640309];PALB2[25640309];AURKA[25640309];IGF1R[25640309];BAG4[25640309];STK11[25640309];BRMS1[25640309];CASP8[25640309];CHEK2[25640309];RB1CC1[25640309];ERBB2[25640309];	43965594
40061	chr19	44611525	A	C	chr19:44611525	ZNF224	zinc finger protein 224	SNV	0/1	0.38	24_15	39	99.0	0/1	0.49	38_36	74	99.0			rs3208207	EXONIC	YES	NM_001321645.3	Transcript	protein_coding	missense_variant		6/6	NM_001321645.3:c.1212A>C	NP_001308574.1:p.Glu404Asp		1.0	Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type					.	.	.		2.67108e-05	4.0	149752.0	0.0	32	0.96	PASS	amr	6.62515e-05	1.0	4.45898e-05	3.0	3.38656e-05	8.0	236228.0	0.0	55	0.72	PASS	amr	0.000221449	7.0	0.0	0.0	0.0000129	2	0.0	1.0				17.96	1.767729	0.154	1	19	20	PolyPhen	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF224	0.0	0.0	0.0	0.0	-38.0	46.0	-21.0	1.0						0.93	0.0	0.000000000	0.356	-0.771	.			testis - seminiferous tubule;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;	.	negative regulation of transcription by RNA polymerase II;negative regulation of transcription, DNA-templated	nucleus;transcriptional repressor complex;nuclear membrane	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;protein binding;sequence-specific DNA binding;metal ion binding	MAGEA8[unassigned1304];	44611525
40065	chr19	44612322	A	G	chr19:44612322	ZNF224	zinc finger protein 224	SNV	0/1	0.52	41_44	85	99.0	0/1	0.54	31_36	67	99.0			rs775922392	EXONIC	YES	NM_001321645.3	Transcript	protein_coding	missense_variant		6/6	NM_001321645.3:c.2009A>G	NP_001308574.1:p.His670Arg		1.0	Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type					.	.	.						33	0.97							7.95551e-06	2.0	251398.0	0.0	95	1.0	PASS	nfe	1.75908e-05	2.0	1.75908e-05	2.0	0.0000064	1						18.85	1.886024	0.478	15	5	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred	MutationTaster_pred,PrimateAI_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-XF_coding_pred	ZNF224	0.0	0.0	0.0	0.0	-20.0	5.0	-49.0	-7.0						0.93	0.0	0.000000000	0.032	1.292	.			testis - seminiferous tubule;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;	.	negative regulation of transcription by RNA polymerase II;negative regulation of transcription, DNA-templated	nucleus;transcriptional repressor complex;nuclear membrane	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;protein binding;sequence-specific DNA binding;metal ion binding	MAGEA8[unassigned1304];	44612322
40137	chr19	45261649	C	T	chr19:45261649	BCL3	B cell CLL/lymphoma 3	SNV	0/1	0.46	58_50	108	99.0	0/1	0.59	42_61	103	99.0			rs745806788	EXONIC	YES	NM_005178.5	Transcript	protein_coding	synonymous_variant		7/9	NM_005178.5:c.1038C>T	NP_005169.2:p.Leu346%3D		1.0					Leukemia/lymphoma, B-cell, 3, 109560 (2)	.	.	.		6.5684e-06	1.0	152244.0	0.0	32	0.98	PASS	nfe	1.46981e-05	1.0	1.46981e-05	1.0	6.98714e-06	1.0	143120.0	0.0	17	0.47	PASS	nfe	1.84407e-05	1.0	1.84407e-05	1.0	0.0000064	1						10.58	0.632064		0	0	0			BCL3	0.0	0.0	0.0	0.0	21.0	-45.0	3.0	21.0							0.86	92.620088715			mortality/aging ; hematopoietic system phenotype; immune system phenotype; homeostasis/metabolism phenotype; 			ciliary ganglion;superior cervical ganglion;trigeminal ganglion;whole blood;skeletal muscle;	.	obsolete protein import into nucleus, translocation;follicular dendritic cell differentiation;marginal zone B cell differentiation;humoral immune response mediated by circulating immunoglobulin;germinal center formation;transcription, DNA-templated;cellular response to DNA damage stimulus;I-kappaB kinase/NF-kappaB signaling;response to virus;response to UV-C;antimicrobial humoral response;extracellular matrix organization;DNA damage response, signal transduction by p53 class mediator;positive regulation of interferon-gamma production;T-helper 1 type immune response;negative regulation of tumor necrosis factor biosynthetic process;defense response to bacterium;intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator;defense response to protozoan;regulation of apoptotic process;negative regulation of apoptotic process;T-helper 2 cell differentiation;positive regulation of interleukin-10 biosynthetic process;negative regulation of interleukin-8 biosynthetic process;positive regulation of translation;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;negative regulation of JAK-STAT cascade;spleen development;regulation of DNA binding;maintenance of protein location in nucleus;regulation of NIK/NF-kappaB signaling	nucleus;nucleoplasm;cytoplasm;cytosol;plasma membrane;midbody;protein-containing complex;Bcl3-Bcl10 complex;Bcl3/NF-kappaB2 complex;intracellular membrane-bounded organelle;perinuclear region of cytoplasm	DNA binding;DNA-binding transcription factor activity;protein binding;transcription factor binding;protein binding, bridging	ANKRD28[23414517];CTBP2[21988832];LCK[16099425];PIR[25680527];FYN[16099425];BCL10[16280327];	45261649
40165	chr19	45774933	C	T	chr19:45774933	MARK4	microtubule affinity regulating kinase 4	SNV	0/1	0.5	70_69	139	99.0	0/1	0.48	59_55	115	99.0			rs757881996,COSV53463491	EXONIC	YES	NM_001199867.2	Transcript	protein_coding	synonymous_variant		8/17	NM_001199867.2:c.753C>T	NP_001186796.1:p.Ser251%3D		1.0						.	.	.						32	0.97							2.3945e-05	6.0	250574.0	0.0	74	1.0	PASS	nfe	4.42729e-05	5.0	4.42729e-05	5.0	0.0000257	4						13.19	0.965014		0	0	0			MARK4	0.0	0.0	0.0	0.0	-6.0	0.0	-6.0	33.0						0.0914	1.0	60.289312567			behavior/neurological phenotype ; adipose tissue phenotype ; homeostasis/metabolism phenotype; growth/size/body region phenotype; 			caudate nucleus;amygdala;temporal lobe;testis - seminiferous tubule;prefrontal cortex;cingulate cortex;superior cervical ganglion;testis;cerebellum;pons;fetal brain;occipital lobe;subthalamic nucleus;testis - interstitial;whole brain;parietal lobe;globus pallidus;medulla oblongata;thalamus;	.	microtubule cytoskeleton organization;microtubule bundle formation;protein phosphorylation;cell cycle;nervous system development;establishment of cell polarity;intracellular signal transduction;positive regulation of programmed cell death;cilium organization;positive regulation of cilium assembly;regulation of centrosome cycle;cell division;ciliary basal body-plasma membrane docking;positive regulation of protein localization to centrosome	gamma-tubulin complex;cytoplasm;centrosome;microtubule organizing center;cytosol;microtubule cytoskeleton;dendrite;midbody;ciliary basal body;neuron projection	protein serine/threonine kinase activity;protein binding;ATP binding;microtubule binding;gamma-tubulin binding;ubiquitin binding;tau protein binding;tau-protein kinase activity	YWHAE[16306228];CYFIP1[14676191];KHDRBS3[25416956];MTCL1[14676191];DOCK7[14676191];PARD6G[14676191];SOGA1[14676191];KRT40[25416956];CDC42[14676191];PPP2CB[14676191];STK11[14676191];TUBA1A[14594945];PNMA1[14676191];KCTD20[14676191];PPP2R1A[14676191];MYO18A[14676191];YWHAH[14676191;16959763];PRNP[18482256];PRKCI[14676191];USP7[14676191];USP9X[14676191];TUBB[14594945];MTUS2[25416956];HPS6[16169070];PNMA2[14676191];TUBG1[14676191;14594945];KRT31[25416956];NOTCH2NLA[25416956];YWHAZ[16306228];SMARCA4[14676191];RNF41[14676191];HNRNPK[25416956];MYBBP1A[14676191];APLNR[28298427];ARHGEF2[14676191];MAPT[23666762];	45774933
40246	chr19	46264988	C	G	chr19:46264988	BHMG1	basic helix-loop-helix and HMG-box containing 1	SNV	0/1	0.54	45_52	97	99.0	0/1	0.53	50_57	107	99.0			rs536926335,COSV58222783	EXONIC	YES	NM_001310124.2	Transcript	protein_coding	missense_variant		12/15	NM_001310124.2:c.1297C>G	NP_001297053.1:p.Arg433Gly		1.0						.	.	.		0.00144609	220.0	152134.0	0.0	30	0.91	PASS	nfe	0.00263127	179.0	0.00263127	179.0	0.00148	203.0	137162.0	0.0	24	0.55	PASS	nfe	0.002239	121.0	0.002239	121.0	0.0004437	69	0.001	2.0				6.613	0.254398		1	10	11	FATHMM_pred	SIFT,PolyPhen,M-CAP_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	BHMG1	0.0	0.02	0.0	0.0	-7.0	10.0	-44.0	-7.0								0.000000000	0.018	-0.01	.			.	.	.	nucleus	DNA binding;protein dimerization activity	.	46264988
40281	chr19	46997246	C	T	chr19:46997246	PNMAL2		SNV	0/1	0.56	57_74	131	99.0	0/1	0.49	87_84	171	99.0			rs1393371733,COSV66535873	EXONIC	YES	NM_020709.3	Transcript	protein_coding	missense_variant		1/1	NM_020709.3:c.1477G>A	NP_065760.1:p.Ala493Thr		-1.0										6.57013e-06	1.0	152204.0	0.0	32	0.97	PASS	nfe	1.46994e-05	1.0	1.46994e-05	1.0					68	1.0														22.9	2.687659		3	10	13	SIFT,PolyPhen,M-CAP_pred	Polyphen2_HDIV_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PNMAL2	0.0	0.0	0.0	0.0	32.0	-9.0	33.0	19.0								43.514487481	0.01	-0.024										46997246
40379	chr19	48946911	CGC		chr19:48946911-48946913	GRIN2D	glutamate ionotropic receptor NMDA type subunit 2D	deletion	0/0	0.0	17_0	17	48.0	0/1	0.14	12_2	14	48.0			rs770358301	EXONIC	YES	NM_000836.4	Transcript	protein_coding	inframe_deletion		14/14	NM_000836.4:c.3738_3740del	NP_000827.2:p.Ala1247del		1.0					Developmental and epileptic encephalopathy 46, 617162 (3), Autosomal dominant	Undetermined early-onset epileptic encephalopathy	Disease-causing germline mutation(s) (gain of function) in	Tremor;Retinal degeneration;Ataxia;High forehead;Spasticity;Global developmental delay;Cerebral atrophy;Microcephaly;Encephalopathy;Decreased fetal movement;Delayed speech and language development;Generalized hypotonia;Developmental regression;Short stature;Downslanted palpebral fissures;Abnormal myelination;Intellectual disability;Failure to thrive;Dyskinesia;Feeding difficulties;Autism;Unsteady gait;EEG with multifocal slow activity;Abnormal corpus callosum morphology;Hyporeflexia;Impulsivity;Abnormality of vision;Status epilepticus;Difficulty walking;Rigidity;Myoclonus;Hypsarrhythmia;Optic atrophy;Gastroesophageal reflux;Ptosis;Mental deterioration;Attention deficit hyperactivity disorder;Nystagmus;Poor head control;Limb hypertonia;Hypodontia;Seizure;Autosomal dominant inheritance;Epileptic encephalopathy;Microcephaly;Infantile onset;Pes planus;Hypertonia;Failure to thrive;Feeding difficulties;Global developmental delay;Dysphagia;Absent speech;Cerebral atrophy;Phenotypic variability;Hypsarrhythmia;Muscular hypotonia of the trunk;Cerebral visual impairment		6.85533e-06	1.0	145872.0	0.0	32	0.91	PASS				0.0	0.0	0.00056243	4.0	7112.0	0.0	0	0.0	PASS	sas	0.00198939	3.0	0.000424088	1.0	0.0000064	1						15.94	1.441917		0	0	0			GRIN2D	0.0	0.0	0.0	0.0	29.0	-1.0	28.0	-16.0							1.0				skeleton phenotype; behavior/neurological phenotype ; integument phenotype ; growth/size/body region phenotype; cardiovascular system phenotype ; homeostasis/metabolism phenotype; adipose tissue phenotype ; 			pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Calcium signaling pathway;Neuroactive ligand-receptor interaction;Long-term potentiation	startle response;brain development;adult locomotory behavior;calcium-mediated signaling;ionotropic glutamate receptor signaling pathway;regulation of synaptic plasticity;regulation of sensory perception of pain;excitatory postsynaptic potential;long-term synaptic potentiation;calcium ion transmembrane import into cytosol;excitatory chemical synaptic transmission	plasma membrane;integral component of plasma membrane;NMDA selective glutamate receptor complex;cell junction;postsynaptic density membrane	ionotropic glutamate receptor activity;NMDA glutamate receptor activity;protein binding;glutamate-gated calcium ion channel activity	DLG1[30126976];DLG4[11937501];CRK[17474147];	48946910
40385	chr19	49002059	G	GG	chr19:49002059	LMTK3	lemur tyrosine kinase 3	sequence_alteration	0/1	0.0	9_4_0	26	93.0	0/2	0.19	9_2_4	21	50.0			rs757900513	EXONIC	YES	NM_001080434.1	Transcript	protein_coding	frameshift_variant		12/16	NM_001080434.1:c.2354dup	NP_001073903.1:p.Pro786AlafsTer783		-1.0						.	.	.		0.00273473	24.0	8776.0	0.0	25	0.72	PASS	sas	0.00396825	1.0	0.00175968	7.0					1	0.0																	0	0	0			LMTK3	0.0	0.0	0.0	0.0	14.0	38.0	39.0	40.0											growth/size/body region phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype ; reproductive system phenotype; nervous system phenotype ; 			ciliary ganglion;liver;skin;cingulate cortex;superior cervical ganglion;trigeminal ganglion;bone marrow;fetal brain;subthalamic nucleus;dorsal root ganglion;atrioventricular node;skeletal muscle;globus pallidus;medulla oblongata;	.	protein phosphorylation;negative regulation of phosphatase activity	Golgi membrane;cellular_component;integral component of membrane;axon;dendrite	molecular_function;protein serine/threonine kinase activity;protein binding;ATP binding;metal ion binding	ZBTB16[16169070];ESR1[21602804];PPP1CA[19389623];	49002058
40403	chr19	49165157	A	C	chr19:49165157	NTN5	netrin 5	SNV	0/1	0.41	35_24	59	99.0	0/1	0.35	34_18	52	99.0			rs549539292,COSV54307301	EXONIC	YES	NM_145807.4	Transcript	protein_coding	missense_variant		7/7	NM_145807.4:c.1247T>G	NP_665806.1:p.Leu416Arg		-1.0	Netrin module, non-TIMP type&Netrin domain&Netrin module, non-TIMP type					.	.	.		0.00538546	813.0	150962.0	3.0	32	0.96	PASS	nfe	0.00847884	573.0	0.00847884	573.0	0.00408982	106.0	25918.0	0.0	2	0.01	PASS	amr	0.00722983	19.0	0.0063987	71.0	0.0011189	174	0.005	15.0				25.6	3.66258	0.923	11	9	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	NTN5	0.0	0.09	0.0	0.0	25.0	-26.0	-9.0	-29.0							0.0		0.895	1.298	nervous system phenotype ; 			pons;testis - interstitial;trigeminal ganglion;superior cervical ganglion;atrioventricular node;parietal lobe;skeletal muscle;	.	neurogenesis	extracellular region	.	.	49165157
40465	chr19	49685951	G	C	chr19:49685951	TRPM4	transient receptor potential cation channel subfamily M member 4	SNV	0/1	0.44	67_53	120	99.0	0/1	0.46	55_46	101	99.0			rs145755269	EXONIC	YES	NM_017636.4	Transcript	protein_coding	synonymous_variant		11/25	NM_017636.4:c.1380G>C	NP_060106.2:p.Leu460%3D		1.0		Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Progressive_familial_heart_block_type_IB|not_provided	Progressive familial heart block, type IB, 604559 (3), Autosomal dominant; Erythrokeratodermia variabilis et progressiva 6, 618531 (3), Autosomal dominant	Familial progressive cardiac conduction defect;Brugada syndrome;Brugada syndrome	Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in;Major susceptibility factor in	Shortened PR interval;Bradycardia;Prolonged QT interval;Left anterior fascicular block;Autosomal dominant inheritance;Right bundle branch block;Atrioventricular block;Syncope;Trifascicular block;Supraventricular tachycardia;Right bundle branch block;ST segment elevation;Syncope;Paroxysmal ventricular tachycardia;First degree atrioventricular block;Ventricular fibrillation;Cardiac arrest;Sick sinus syndrome;Trifascicular block;Supraventricular tachycardia;Right bundle branch block;ST segment elevation;Syncope;Paroxysmal ventricular tachycardia;First degree atrioventricular block;Ventricular fibrillation;Cardiac arrest;Sick sinus syndrome;Erythema;Palmoplantar keratoderma;Skin plaque;Abdominal pain;Dyspnea;Arrhythmia;Vertigo;Bundle branch block;Congestive heart failure;Syncope		0.000361409	55.0	152182.0	0.0	32	0.98	PASS	amr	0.00130907	20.0	0.000441112	30.0	0.000250958	63.0	251038.0	0.0	81	1.0	PASS	amr	0.000780618	27.0	0.000291072	33.0	0.0002572	40	0.001	3.0	0.00167	19.0		8.289	0.389936		0	0	0			TRPM4	0.06	0.0	0.0	0.0	15.0	-30.0	15.0	0.0						0.752	0.0	45.316768849			hematopoietic system phenotype; cardiovascular system phenotype ; immune system phenotype; homeostasis/metabolism phenotype; 			ciliary ganglion;dorsal root ganglion;prostate;skeletal muscle;	.	adaptive immune response;dendritic cell chemotaxis;regulation of T cell cytokine production;positive regulation of cytosolic calcium ion concentration;positive regulation of cell population proliferation;positive regulation of heart rate;protein sumoylation;calcium-mediated signaling;negative regulation of bone mineralization;positive regulation of insulin secretion involved in cellular response to glucose stimulus;vasoconstriction;positive regulation of fat cell differentiation;negative regulation of osteoblast differentiation;positive regulation of vasoconstriction;protein homotetramerization;calcium ion transmembrane transport;cellular response to ATP;membrane depolarization during AV node cell action potential;membrane depolarization during Purkinje myocyte cell action potential;membrane depolarization during bundle of His cell action potential;regulation of heart rate by cardiac conduction;positive regulation of canonical Wnt signaling pathway;inorganic cation transmembrane transport;sodium ion import across plasma membrane;regulation of ventricular cardiac muscle cell action potential;positive regulation of atrial cardiac muscle cell action potential;positive regulation of adipose tissue development;positive regulation of regulation of vascular smooth muscle cell membrane depolarization	nucleoplasm;endoplasmic reticulum;Golgi apparatus;cytosol;plasma membrane;sodium channel complex;neuronal cell body;spanning component of plasma membrane;spanning component of membrane	calcium activated cation channel activity;calcium channel activity;sodium channel activity;calcium ion binding;calmodulin binding;ATP binding	CCR9[28298427];TRPM4[29217581];	49685951
40512	chr19	50097772	C	T	chr19:50097772	PRR12	proline rich 12	SNV	0/1	0.52	44_47	91	99.0	0/1	0.4	66_44	111	99.0			rs371896951	EXONIC	YES	NM_020719.3	Transcript	protein_coding	synonymous_variant		3/14	NM_020719.3:c.261C>T	NP_065770.1:p.Ser87%3D		1.0					Neuroocular syndrome, 619539 (3), Autosomal dominant	.	.	.		0.000302329	46.0	152152.0	0.0	32	0.95	PASS	nfe	0.000544022	37.0	0.000544022	37.0	0.000305941	76.0	248414.0	0.0	74	0.98	PASS	nfe	0.00063967	72.0	0.00063967	72.0	0.0003087	48						12.4	0.858253		0	0	0			PRR12	0.0	0.0	0.0	0.0	-13.0	2.0	0.0	-5.0							1.0	22.908947238			.			atrioventricular node;superior cervical ganglion;trigeminal ganglion;globus pallidus;	.	.	nucleus;postsynaptic density;cell junction;neuron projection;postsynaptic membrane	.	NEK4[25798074];NCBP2[26382858];FASN[21988832];NCBP3[26382858];TP53BP1[29656893];PUM1[21988832];HIST2H2BE[30021884];SOD1[26496610];	50097772
40515	chr19	50097850	C	A	chr19:50097850	PRR12	proline rich 12	SNV	0/1	0.51	41_43	84	99.0	0/1	0.49	54_52	107	99.0				EXONIC	YES	NM_020719.3	Transcript	protein_coding	missense_variant		3/14	NM_020719.3:c.339C>A	NP_065770.1:p.Phe113Leu		1.0					Neuroocular syndrome, 619539 (3), Autosomal dominant	.	.	.						32	0.95											52	0.95														25.1	3.524738	0.287	10	8	18	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-XF_coding_pred	PRR12	0.0	0.0	0.0	0.01	23.0	-2.0	-4.0	22.0							1.0	34.145841890	1.0	1.026	.			atrioventricular node;superior cervical ganglion;trigeminal ganglion;globus pallidus;	.	.	nucleus;postsynaptic density;cell junction;neuron projection;postsynaptic membrane	.	NEK4[25798074];NCBP2[26382858];FASN[21988832];NCBP3[26382858];TP53BP1[29656893];PUM1[21988832];HIST2H2BE[30021884];SOD1[26496610];	50097850
40524	chr19	50154190	G	A	chr19:50154190	SCAF1	SR-related CTD associated factor 1	SNV	0/1	0.5	42_43	86	99.0	0/1	0.4	30_21	52	99.0			rs151252460	EXONIC	YES	NM_021228.3	Transcript	protein_coding	missense_variant		7/11	NM_021228.3:c.544G>A	NP_067051.2:p.Gly182Arg		1.0	.,.					.	.	.		0.00378388	574.0	151696.0	3.0	32	0.94	PASS	nfe	0.00592588	402.0	0.00592588	402.0	0.00377456	872.0	231020.0	5.0	22	0.6	PASS	nfe	0.00580433	589.0	0.00580433	589.0	0.0035305	549	0.006	20.0				23.2	2.807438	0.171	3	16	19	SIFT,PrimateAI_pred,fathmm-MKL_coding_pred	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	SCAF1	0.0	0.0	0.0	0.0	-40.0	-7.0	-41.0	-12.0							1.0	0.000000000	0.227	0.209	.			.	.	transcription by RNA polymerase II;mRNA processing;RNA splicing	nucleus	RNA binding;protein domain specific binding;RNA polymerase II C-terminal domain binding	NPM1[26496610];RPL10[26496610];GSTP1[21988832];BUD31[28298427];EIF4A3[23084401];THOC1[26496610];MTSS1L[unassigned1304];CIB1[unassigned1304];MEOX2[unassigned1304];THOC7[26496610];DMBX1[unassigned1304];CEP170P1[26496610];IGHG1[15174051];GOLGA4[30021884];ALB[15174051];MAGOH[23084401];GSC2[unassigned1304];RTN4IP1[unassigned1304];UBQLN4[16713569];	50154190
40525	chr19	50156901	C	G	chr19:50156901	SCAF1	SR-related CTD associated factor 1	SNV	0|1	0.59	32_46	78	99.0	0|1	0.6	25_39	65	99.0			rs201476531,COSV100862025	EXONIC	YES	NM_021228.3	Transcript	protein_coding	synonymous_variant		7/11	NM_021228.3:c.3255C>G	NP_067051.2:p.Pro1085%3D		1.0						.	.	.		0.00162918	248.0	152224.0	0.0	32	0.97	PASS	amr	0.00320555	49.0	0.00239558	163.0	0.0016742	340.0	203082.0	2.0	18	0.46	PASS	amr	0.00278543	87.0	0.00239486	214.0	0.0013890	216	0.003	9.0				10.77	0.653687		0	0	0			SCAF1	0.0	0.0	0.0	0.0	-14.0	26.0	28.0	-24.0							1.0	67.551192786			.			.	.	transcription by RNA polymerase II;mRNA processing;RNA splicing	nucleus	RNA binding;protein domain specific binding;RNA polymerase II C-terminal domain binding	NPM1[26496610];RPL10[26496610];GSTP1[21988832];BUD31[28298427];EIF4A3[23084401];THOC1[26496610];MTSS1L[unassigned1304];CIB1[unassigned1304];MEOX2[unassigned1304];THOC7[26496610];DMBX1[unassigned1304];CEP170P1[26496610];IGHG1[15174051];GOLGA4[30021884];ALB[15174051];MAGOH[23084401];GSC2[unassigned1304];RTN4IP1[unassigned1304];UBQLN4[16713569];	50156901
40653	chr19	50548282	C	T	chr19:50548282	ZNF473	zinc finger protein 473	SNV	0/1	0.54	56_66	122	99.0	0/1	0.48	52_49	102	99.0			rs377312436,COSV54521939	EXONIC	YES	NM_015428.4	Transcript	protein_coding	synonymous_variant		5/5	NM_015428.4:c.582C>T	NP_056243.1:p.Ser194%3D		1.0						.	.	.		0.000170886	26.0	152148.0	0.0	32	0.97	PASS	eas	0.00115473	6.0	8.81964e-05	6.0	0.000127273	32.0	251428.0	0.0	76	1.0	PASS	eas	0.000924214	17.0	3.51716e-05	4.0	0.0001222	19						0.195	-0.390168		0	0	0			ZNF473	0.0	0.0	0.01	0.0	9.0	-40.0	-20.0	49.0						0.513	0.77	71.305694962			.			ciliary ganglion;pons;testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;superior cervical ganglion;testis;	.	regulation of transcription, DNA-templated;termination of RNA polymerase II transcription;mRNA 3'-end processing by stem-loop binding and cleavage;histone mRNA metabolic process	nucleus;nucleoplasm;Cajal body	DNA binding;protein binding;metal ion binding	SLBP[11782445];ZNF792[25416956];TRIM41[16189514;unassigned1304];ZNF250[25416956];KRTAP10-10[unassigned1304];KRTAP10-9[25416956];KRTAP10-8[25416956;unassigned1304];AEN[25416956];GPATCH2L[25416956];CLK3[unassigned1304];CLK2[25416956];ZNF837[unassigned1304];ZNF408[unassigned1304];DHX57[25416956];ZSCAN12[25416956];RNPS1[25416956];PRPF31[25910212];ZNF202[16189514];RBM10[26871637];ZNF497[unassigned1304];	50548282
40665	chr19	51159547	C	T	chr19:51159547	C19orf81	chromosome 19 open reading frame 81	SNV	0/1	0.36	47_26	73	99.0	0/1	0.51	23_24	47	99.0			rs144243088	EXONIC	YES	NM_001195076.2	Transcript	protein_coding	missense_variant		3/5	NM_001195076.2:c.205C>T	NP_001182005.1:p.Arg69Trp		1.0	.,.					.	.	.		0.000840966	128.0	152206.0	1.0	33	0.96	PASS	amr	0.00333682	51.0	0.000661434	45.0	0.00106388	146.0	137234.0	1.0	41	0.58	PASS	amr	0.00302386	74.0	0.000873476	47.0	0.0002122	33	0.004	14.0				23.7	3.052976	0.585	8	8	16	SIFT,PolyPhen,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_noAF_pred,LIST-S2_pred	MetaLR_pred,MetaSVM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	C19orf81	0.0	0.0	0.0	0.0	-35.0	6.0	-35.0	-8.0								0.000000000	0.764	0.098	integument phenotype ; 			.	.	.	.	.	.	51159547
40669	chr19	51274851	A	C	chr19:51274851	GPR32	G protein-coupled receptor 32	SNV	0/1	0.27	113_41	154	99.0	0/1	0.22	97_28	125	99.0			rs201404376,COSV54513662	EXONIC	YES	NM_001506.2	Transcript	protein_coding	missense_variant		1/1	NM_001506.2:c.994A>C	NP_001497.1:p.Thr332Pro		1.0						.	.	.		0.00359346	501.0	139420.0	0.0	31	0.93	PASS	sas	0.0069511	29.0	0.0039075	245.0	0.0725205	14431.0	198992.0	0.0	78	1.0	RF	nfe	0.10519	8955.0	0.10519	8955.0	0.0020835	324	0.045	135.0				0.935	-0.16065	0.057	0	17	17		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	GPR32	0.0	0.0	0.0	0.0	17.0	-29.0	-17.0	-36.0						0.673	0.0		0.708	-0.401	.			atrioventricular node;superior cervical ganglion;skeletal muscle;	.	complement receptor mediated signaling pathway;inflammatory response;G protein-coupled receptor signaling pathway;phospholipase C-activating G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration	plasma membrane;integral component of plasma membrane	G protein-coupled receptor activity;N-formyl peptide receptor activity	.	51274851
40674	chr19	51844722		C	chr19:51844721-51844722	VSIG10L	V-set and immunoglobulin domain containing 10 like	insertion	0|1	0.32	30_14	44	99.0	0|1	0.23	48_15	64	99.0			rs771045882	EXONIC	YES	NM_001163922.3	Transcript	protein_coding	frameshift_variant		2/10	NM_001163922.3:c.580_581insG	NP_001157394.1:p.Gln194ArgfsTer65		-1.0						.	.	.		0.00020369	31.0	152192.0	0.0	32	0.97	PASS	amr	0.00124329	19.0	8.82042e-05	6.0	0.000166898	25.0	149792.0	0.0	16	0.43	PASS	amr	0.000835981	20.0	5.17348e-05	3.0	0.0000129	2						21.5	2.208608		0	0	0			VSIG10L	0.0	0.0	0.0	0.04	-26.0	-2.0	-19.0	-1.0								0.000000000,0.000000000			.			kidney;dorsal root ganglion;parietal lobe;	.	.	nucleus;nucleoplasm;integral component of membrane	.	.	51844721
40675	chr19	51844722	G	T	chr19:51844722	VSIG10L	V-set and immunoglobulin domain containing 10 like	SNV	0|1	0.33	30_15	45	99.0	0|1	0.23	48_15	64	99.0			rs758667475	EXONIC	YES	NM_001163922.3	Transcript	protein_coding	missense_variant		2/10	NM_001163922.3:c.580C>A	NP_001157394.1:p.Gln194Lys		-1.0						.	.	.		0.000203618	31.0	152246.0	0.0	32	0.97	PASS	amr	0.00124264	19.0	8.81782e-05	6.0	0.000186956	28.0	149768.0	0.0	16	0.44	PASS	amr	0.00096178	23.0	5.17688e-05	3.0	0.0000129	2						17.16	1.650719	0.019	2	18	20	SIFT,PolyPhen	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	VSIG10L	0.0	0.0	0.0	0.02	29.0	-3.0	-26.0	-2.0								0.000000000	0.349	1.176	.			kidney;dorsal root ganglion;parietal lobe;	.	.	nucleus;nucleoplasm;integral component of membrane	.	.	51844722
40678	chr19	51844727		T	chr19:51844726-51844727	VSIG10L	V-set and immunoglobulin domain containing 10 like	insertion	0|1	0.31	36_16	52	99.0	0|1	0.23	50_15	65	99.0			rs776719186	EXONIC	YES	NM_001163922.3	Transcript	protein_coding	frameshift_variant		2/10	NM_001163922.3:c.575_576insA	NP_001157394.1:p.Gln193ProfsTer66		-1.0						.	.	.		0.000203677	31.0	152202.0	0.0	32	0.97	PASS	amr	0.00124378	19.0	8.81782e-05	6.0	0.000179264	27.0	150616.0	0.0	17	0.45	PASS	amr	0.000915827	22.0	5.14544e-05	3.0	0.0000129	2						23.3	2.898025		0	0	0			VSIG10L	0.0	0.0	0.1	0.0	25.0	-7.0	-6.0	-30.0								0.000000000,9.198065977			.			kidney;dorsal root ganglion;parietal lobe;	.	.	nucleus;nucleoplasm;integral component of membrane	.	.	51844726
40681	chr19	51844729	AAA		chr19:51844729-51844731	VSIG10L	V-set and immunoglobulin domain containing 10 like	deletion	0|1	0.32	36_17	53	99.0	0|1	0.23	50_15	65	99.0			rs759476878	EXONIC	YES	NM_001163922.3	Transcript	protein_coding	inframe_deletion		2/10	NM_001163922.3:c.571_573del	NP_001157394.1:p.Phe191del		-1.0						.	.	.		0.000203637	31.0	152232.0	0.0	32	0.97	PASS	amr	0.00124297	19.0	8.81964e-05	6.0	0.000192165	29.0	150912.0	0.0	17	0.45	PASS	amr	0.000956739	23.0	5.13347e-05	3.0	0.0000129	2						12.5	0.870731		0	0	0			VSIG10L	0.0	0.0	0.04	0.0	23.0	-9.0	-8.0	-4.0								9.198065977			.			kidney;dorsal root ganglion;parietal lobe;	.	.	nucleus;nucleoplasm;integral component of membrane	.	.	51844728
40684	chr19	51844732	G	T	chr19:51844732	VSIG10L	V-set and immunoglobulin domain containing 10 like	SNV	0|1	0.32	36_17	53	99.0	0|1	0.23	51_15	66	99.0			rs780495593	EXONIC	YES	NM_001163922.3	Transcript	protein_coding	missense_variant		2/10	NM_001163922.3:c.570C>A	NP_001157394.1:p.Ser190Arg		-1.0						.	.	.		0.000203629	31.0	152238.0	0.0	32	0.97	PASS	amr	0.00124329	19.0	8.81782e-05	6.0	0.000197926	30.0	151572.0	0.0	18	0.47	PASS	amr	0.000993049	24.0	5.10777e-05	3.0	0.0000129	2						18.65	1.859386	0.052	3	16	19	SIFT,M-CAP_pred,fathmm-MKL_coding_pred	PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	VSIG10L	0.0	0.0	0.02	0.0	19.0	-13.0	-12.0	6.0								0.000000000	0.112	1.176	.			kidney;dorsal root ganglion;parietal lobe;	.	.	nucleus;nucleoplasm;integral component of membrane	.	.	51844732
40687	chr19	51844735	T	G	chr19:51844735	VSIG10L	V-set and immunoglobulin domain containing 10 like	SNV	0|1	0.31	37_17	54	99.0	0|1	0.24	52_16	68	99.0			rs751680054	EXONIC	YES	NM_001163922.3	Transcript	protein_coding	synonymous_variant		2/10	NM_001163922.3:c.567A>C	NP_001157394.1:p.Ala189%3D		-1.0						.	.	.		0.000203744	31.0	152152.0	0.0	32	0.97	PASS	amr	0.00124346	19.0	8.82197e-05	6.0	0.000210737	32.0	151848.0	0.0	18	0.48	PASS	amr	0.00107474	26.0	5.0984e-05	3.0	0.0000129	2						2.417	-0.01403		0	0	0			VSIG10L	0.0	0.0	0.01	0.0	16.0	-16.0	-15.0	3.0								25.636341002			.			kidney;dorsal root ganglion;parietal lobe;	.	.	nucleus;nucleoplasm;integral component of membrane	.	.	51844735
40690	chr19	51844738	A	G	chr19:51844738	VSIG10L	V-set and immunoglobulin domain containing 10 like	SNV	0|1	0.35	36_19	55	99.0	0|1	0.27	51_19	70	99.0			rs755030044	EXONIC	YES	NM_001163922.3	Transcript	protein_coding	synonymous_variant		2/10	NM_001163922.3:c.564T>C	NP_001157394.1:p.Ala188%3D		-1.0						.	.	.		0.000210244	32.0	152204.0	0.0	32	0.97	PASS	amr	0.00124346	19.0	0.000102899	7.0	0.000210288	32.0	152172.0	0.0	19	0.49	PASS	amr	0.0010727	26.0	5.08751e-05	3.0	0.0000129	2						0.825	-0.179316		0	0	0			VSIG10L	0.0	0.0	0.0	0.0	13.0	-19.0	-18.0	-14.0								25.636341002			.			kidney;dorsal root ganglion;parietal lobe;	.	.	nucleus;nucleoplasm;integral component of membrane	.	.	51844738
40693	chr19	51844740		TGGGT	chr19:51844739-51844740	VSIG10L	V-set and immunoglobulin domain containing 10 like	insertion	0|1	0.35	36_19	55	99.0	0|1	0.28	51_20	71	99.0			rs769660332	EXONIC	YES	NM_001163922.3	Transcript	protein_coding	frameshift_variant		2/10	NM_001163922.3:c.562_563insACCCA	NP_001157394.1:p.Ala188AspfsTer26		-1.0						.	.	.		0.000203621	31.0	152244.0	0.0	32	0.97	PASS	amr	0.00124313	19.0	8.81912e-05	6.0	0.000210114	32.0	152298.0	0.0	20	0.5	RF	amr	0.00107031	26.0	5.08233e-05	3.0	0.0000129	2						20.2	2.047143		0	0	0																			25.636341002			.			kidney;dorsal root ganglion;parietal lobe;	.	.	nucleus;nucleoplasm;integral component of membrane	.	.	51844739
40698	chr19	51844743		GT	chr19:51844742-51844743	VSIG10L	V-set and immunoglobulin domain containing 10 like	insertion	0|1	0.38	34_21	55	99.0	0|1	0.29	50_21	72	99.0			rs775128588	EXONIC	YES	NM_001163922.3	Transcript	protein_coding	frameshift_variant		2/10	NM_001163922.3:c.559_560insAC	NP_001157394.1:p.Ser187TyrfsTer26		-1.0						.	.	.		0.000203634	31.0	152234.0	0.0	32	0.97	PASS	amr	0.00124264	19.0	8.81938e-05	6.0	0.000281347	43.0	152836.0	0.0	20	0.5	PASS	amr	0.00151292	37.0	5.06551e-05	3.0	0.0000129	2						19.43	1.961214		0	0	0																			0.000000000,0.000000000			.			kidney;dorsal root ganglion;parietal lobe;	.	.	nucleus;nucleoplasm;integral component of membrane	.	.	51844742
40699	chr19	51844743	A	G	chr19:51844743	VSIG10L	V-set and immunoglobulin domain containing 10 like	SNV	0|1	0.38	34_21	55	99.0	0|1	0.29	50_21	72	99.0			rs748068902	EXONIC	YES	NM_001163922.3	Transcript	protein_coding	missense_variant		2/10	NM_001163922.3:c.559T>C	NP_001157394.1:p.Ser187Pro		-1.0						.	.	.		0.000203714	31.0	152174.0	0.0	32	0.97	PASS	amr	0.00124329	19.0	8.82068e-05	6.0	0.000281362	43.0	152828.0	0.0	20	0.5	PASS	amr	0.00151267	37.0	5.06534e-05	3.0	0.0000129	2						1.238	-0.119104	0.027	0	18	18		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	VSIG10L	0.0	0.0	0.0	0.0	8.0	-24.0	-23.0	-19.0								0.000000000	0.002	-0.147	.			kidney;dorsal root ganglion;parietal lobe;	.	.	nucleus;nucleoplasm;integral component of membrane	.	.	51844743
40771	chr19	52618471	C	T	chr19:52618471	ZNF616	zinc finger protein 616	SNV	0/1	0.44	20_16	36	99.0	0/1	0.52	15_17	33	99.0			rs45622033,COSV57513508	EXONIC	YES	NM_178523.5	Transcript	protein_coding	missense_variant		4/4	NM_178523.5:c.1946G>A	NP_848618.2:p.Arg649Lys		-1.0	Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type					.	.	.		0.00421869	642.0	152180.0	3.0	33	0.97	PASS	nfe	0.00651049	443.0	0.00651049	443.0	0.0047928	1204.0	251210.0	7.0	100	1.0	PASS	sas	0.00676161	207.0	0.00644843	732.0	0.0046623	725	0.012	37.0				0.038	-0.614647	0.05	0	16	16		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF616	0.0	0.0	0.0	0.0	-11.0	-1.0	19.0	34.0						0.825	0.0	0.000000000	0.0	-0.249	.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	ZSCAN5A[26496610];	52618471
40848	chr19	53678701	G		chr19:53678701	ZNF665	zinc finger protein 665	deletion	0/0	0.0	21_0	21	63.0	0/1	0.2	8_2	10	41.0				EXONIC	YES	NM_001353458.2	Transcript	protein_coding	frameshift_variant		4/5	NM_001353458.2:c.223del	NP_001340387.1:p.Leu75TrpfsTer8		-1.0						.	.	.						32	0.96											52	0.83																	0	0	0			ZNF665	0.0	0.0	0.0	0.01	-2.0	-31.0	8.0	-2.0						0.828	0.0	36.372186846			.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	NEK4[25798074];KAT6B[unassigned1304];	53678700
40909	chr19	54662043	T	T	chr19:54662043	LENG1	leukocyte receptor cluster member 1	SNV	0/1	0.47	36_32	68	99.0	0/1	0.52	29_32	61	99.0			rs35089861,rs753553936,COSV55369152	EXONIC	YES	NM_024316.3	Transcript	protein_coding	synonymous_variant		2/4	NM_024316.3:c.289G>A	NP_077292.2:p.Lys97%3D		-1.0						.	.	.						0	0.0							0.0380745	9572.0	251402.0	247.0	59	0.99	PASS	nfe	0.0570328	6486.0	0.0570328	6486.0	0.0381148	5927	0.055	174.0				27.8	4.016935		0	0	0			LENG1	0.0	0.0	0.0	0.01	-23.0	5.0	-20.0	5.0						0.88	0.0	0.000000000			.			.	.	biological_process	cellular_component	molecular_function;protein binding	ISY1[unassigned1304];CALCOCO2[25416956];NAB2[25416956;unassigned1304];IKZF3[unassigned1304];CCDC102B[25416956];GOLGA2[25416956;27107012;unassigned1304];UBL5[unassigned1304];GOLGA6L9[unassigned1304];OIP5[unassigned1304];TRIM27[25416956];CCHCR1[unassigned1304];LZTS1[unassigned1304];SCYL1[unassigned1304];TRIM23[unassigned1304];KLF10[21900206];CCDC155[25416956];CARD10[unassigned1304];NCBP2[26496610];KRT35[unassigned1304];MTUS2[25416956;unassigned1304];LDOC1[25416956;unassigned1304];TFIP11[25416956];TRAF2[unassigned1304];TSC1[unassigned1304];KRT31[25416956;unassigned1304];MID2[25416956;unassigned1304];PTBP3[22575643];RABEP1[unassigned1304];PRKAR1B[unassigned1304];CEP57L1[25416956];TRIB3[unassigned1304];KIFC3[25416956;unassigned1304];TRIM54[25416956;unassigned1304];ZMYND12[unassigned1304];ROPN1[25416956;unassigned1304];MAD1L1[unassigned1304];NECAB2[25416956];KANK2[unassigned1304];USHBP1[25416956];SPATA2[unassigned1304];ASB12[unassigned1304];OSGEP[21900206];STX11[25416956];KRT40[25416956;unassigned1304];BEGAIN[unassigned1304];MIPOL1[unassigned1304];PNMA1[16169070];CEP70[25416956;unassigned1304];PSMB1[unassigned1304];FSD2[25416956;unassigned1304];C14orf119[unassigned1304];DISC1[unassigned1304];EVI5[unassigned1304];CDR2[25416956;unassigned1304];PAK5[25416956];BANP[25416956];PRPH[unassigned1304];ZRANB1[unassigned1304];CCDC57[25416956;unassigned1304];CCDC136[25416956];PLK2[26496610];CARD9[25416956;unassigned1304];KRTAP10-8[unassigned1304];PDE4DIP[25416956];MRPL28[unassigned1304];DDIT4L[unassigned1304];WDYHV1[unassigned1304];MEIS3[unassigned1304];LRP2BP[unassigned1304];GFAP[unassigned1304];KRT19[unassigned1304];NAGK[21900206];DES[unassigned1304];HOOK2[unassigned1304];ABI2[unassigned1304];UBXN11[unassigned1304];TMEM239[25416956];REL[unassigned1304];TCF4[25416956];CDR2L[unassigned1304];SPERT[25416956];	54662043
41097	chr19	54722515	G	T	chr19:54722515	LILRB3	leukocyte immunoglobulin like receptor B3	SNV	0/0	0.0	36_0	36	99.0	0/1	0.53	36_41	77	99.0				SPLICING	YES	NM_001320960.2	Transcript	protein_coding	splice_region_variant,synonymous_variant		11/14	NM_001320960.2:c.1590C>A	NP_001307889.1:p.Leu530%3D		-1.0						.	.	.						32	0.96											95	1.0														0.791	-0.185512		0	0	0			LILRB3	0.02	0.0	0.06	0.01	36.0	-9.0	-1.0	-29.0	0.0001738836604482	0.17	3.535	0.549	4.084	0.928	0.03	45.316768849,45.316768849			cellular phenotype; immune system phenotype; nervous system phenotype ; hematopoietic system phenotype; 			whole blood;	B cell receptor signaling pathway	adaptive immune response;defense response;cell surface receptor signaling pathway;neutrophil degranulation;negative regulation of osteoclast differentiation	plasma membrane;integral component of plasma membrane;secretory granule membrane	amyloid-beta binding;transmembrane signaling receptor activity;protein binding;signaling receptor activity	FDPS[26769854];KRT19[26769854];KRT18[26769854];KRT8[26769854];PTPN6[18802077];ACTB[26769854];	54722515
41138	chr19	54744710	C	T	chr19:54744710	LILRB3	leukocyte immunoglobulin like receptor B3	SNV	0|1	0.22	161_45	206	99.0	0|1	0.1	120_13	133	99.0			rs1132600,COSV54428407	EXONIC	YES	NM_001320960.2	Transcript	protein_coding	missense_variant		5/14	NM_001320960.2:c.952G>A	NP_001307889.1:p.Ala318Thr		-1.0	.,.					.	.	.		6.59083e-05	10.0	151726.0	0.0	47	0.98	AS_VQSR	afr	0.000170782	7.0	1.46985e-05	1.0	0.0162698	3653.0	224526.0	0.0	70	0.97	PASS	afr	0.0462158	585.0	0.014872	1506.0	0.0040321	627	0.003	10.0				0.003	-1.009809	0.126	0	14	14		LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred															0.928	0.03		0.0	-3.089	cellular phenotype; immune system phenotype; nervous system phenotype ; hematopoietic system phenotype; 			whole blood;	B cell receptor signaling pathway	adaptive immune response;defense response;cell surface receptor signaling pathway;neutrophil degranulation;negative regulation of osteoclast differentiation	plasma membrane;integral component of plasma membrane;secretory granule membrane	amyloid-beta binding;transmembrane signaling receptor activity;protein binding;signaling receptor activity	FDPS[26769854];KRT19[26769854];KRT18[26769854];KRT8[26769854];PTPN6[18802077];ACTB[26769854];	54744710
41142	chr19	54744711	C	G	chr19:54744711	LILRB3	leukocyte immunoglobulin like receptor B3	SNV	0|1	0.22	163_45	208	99.0	0|1	0.1	120_13	133	99.0			rs1132599,COSV54428418	EXONIC	YES	NM_001320960.2	Transcript	protein_coding	missense_variant		5/14	NM_001320960.2:c.951G>C	NP_001307889.1:p.Met317Ile		-1.0	.,.					.	.	.		0.000547421	83.0	151620.0	0.0	46	0.98	PASS	afr	0.00183132	75.0	0.0	0.0	0.0166539	3729.0	223912.0	0.0	72	0.97	RF	afr	0.0502173	624.0	0.0149189	1510.0	0.0044115	686	0.074	235.0				0.007	-0.847257	0.052	0	14	14		LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred															0.928	0.03		0.001	-0.281	cellular phenotype; immune system phenotype; nervous system phenotype ; hematopoietic system phenotype; 			whole blood;	B cell receptor signaling pathway	adaptive immune response;defense response;cell surface receptor signaling pathway;neutrophil degranulation;negative regulation of osteoclast differentiation	plasma membrane;integral component of plasma membrane;secretory granule membrane	amyloid-beta binding;transmembrane signaling receptor activity;protein binding;signaling receptor activity	FDPS[26769854];KRT19[26769854];KRT18[26769854];KRT8[26769854];PTPN6[18802077];ACTB[26769854];	54744711
41146	chr19	54744722	T	C	chr19:54744722	LILRB3	leukocyte immunoglobulin like receptor B3	SNV	0|1	0.23	190_58	248	99.0	0|1	0.1	139_15	154	99.0			rs1132597,COSV54428432	EXONIC	YES	NM_001320960.2	Transcript	protein_coding	missense_variant		5/14	NM_001320960.2:c.940A>G	NP_001307889.1:p.Asn314Asp		-1.0	Immunoglobulin-like domain&Immunoglobulin subtype,Immunoglobulin-like domain&Immunoglobulin subtype					.	.	.		0.000395273	60.0	151794.0	0.0	47	0.98	PASS	afr	0.000705322	29.0	0.000102893	7.0	0.0259386	5186.0	199934.0	1.0	90	0.98	RF	afr	0.0877225	956.0	0.0215318	1955.0	0.0008424	131	0.08	246.0				7.388	0.313702	0.068	1	13	14	MutationTaster_pred	LRT_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred															0.928	0.03		0.0	-0.381	cellular phenotype; immune system phenotype; nervous system phenotype ; hematopoietic system phenotype; 			whole blood;	B cell receptor signaling pathway	adaptive immune response;defense response;cell surface receptor signaling pathway;neutrophil degranulation;negative regulation of osteoclast differentiation	plasma membrane;integral component of plasma membrane;secretory granule membrane	amyloid-beta binding;transmembrane signaling receptor activity;protein binding;signaling receptor activity	FDPS[26769854];KRT19[26769854];KRT18[26769854];KRT8[26769854];PTPN6[18802077];ACTB[26769854];	54744722
41161	chr19	54745550	G	T	chr19:54745550	LILRB3	leukocyte immunoglobulin like receptor B3	SNV	0/1	0.34	74_38	112	99.0	0/0	0.0	38_0	38	99.0			rs1414100330,rs61734499,COSV54428497,COSV54443617	EXONIC	YES	NM_001320960.2	Transcript	protein_coding	missense_variant		4/14	NM_001320960.2:c.560C>A	NP_001307889.1:p.Thr187Asn		-1.0						.	.	.						0	0.0							0.185952	31118.0	167344.0	2810.0	37	0.77	RF	eas	0.392413	4417.0	0.162392	12321.0	0.0058069	903	0.001	4.0				13.17	0.962366		0	0	0																	0.928	0.03				cellular phenotype; immune system phenotype; nervous system phenotype ; hematopoietic system phenotype; 			whole blood;	B cell receptor signaling pathway	adaptive immune response;defense response;cell surface receptor signaling pathway;neutrophil degranulation;negative regulation of osteoclast differentiation	plasma membrane;integral component of plasma membrane;secretory granule membrane	amyloid-beta binding;transmembrane signaling receptor activity;protein binding;signaling receptor activity	FDPS[26769854];KRT19[26769854];KRT18[26769854];KRT8[26769854];PTPN6[18802077];ACTB[26769854];	54745550
41175	chr19	54746051	A	C	chr19:54746051	LILRB3	leukocyte immunoglobulin like receptor B3	SNV	0/1	0.53	131_145	276	99.0	0/1	0.32	128_59	187	99.0			rs620207,COSV54428540	EXONIC	YES	NM_001320960.2	Transcript	protein_coding	missense_variant		3/14	NM_001320960.2:c.206T>G	NP_001307889.1:p.Leu69Trp		-1.0						.	.	.						0	0.0							0.470106	105960.0	225396.0	11067.0	100	1.0	InbreedingCoeff	sas	0.535472	15020.0	0.443873	45347.0	0.0180703	2810	0.149	464.0				0.179	-0.402292		0	0	0																	0.928	0.03				cellular phenotype; immune system phenotype; nervous system phenotype ; hematopoietic system phenotype; 			whole blood;	B cell receptor signaling pathway	adaptive immune response;defense response;cell surface receptor signaling pathway;neutrophil degranulation;negative regulation of osteoclast differentiation	plasma membrane;integral component of plasma membrane;secretory granule membrane	amyloid-beta binding;transmembrane signaling receptor activity;protein binding;signaling receptor activity	FDPS[26769854];KRT19[26769854];KRT18[26769854];KRT8[26769854];PTPN6[18802077];ACTB[26769854];	54746051
41297	chr19	54962467	G	A	chr19:54962467	LENG8	leukocyte receptor cluster member 8	SNV	1/1	1.0	0_85	85	99.0	1/1	1.0	0_49	49	99.0			rs1035451,rs936193582,COSV58729331	SPLICING	YES	NM_001375638.1	Transcript	protein_coding	splice_region_variant,5_prime_UTR_variant		2/15	NM_001375638.1:c.-55G>A			1.0						.	.	.						0	0.0											0	0.0							0.1285176	19985	0.328	1022.0				12.55	0.878039		0	0	0			LENG8	0.01	0.15	0.0	0.0	4.0	0.0	4.0	48.0	0.0002549548128494	0.13	7.835	0.924	8.759	0.319	1.0				.			.	.	.	nucleus	protein binding	"INTS11[unassigned1304];RHOXF2[16189514;unassigned1304];KDM1A[23455924];SUV39H1[23455924];ATN1[16713569;unassigned1304];MIA3[unassigned1304];MKI67[26949251];KIAA1107[26496610];FAM166B[unassigned1304];LASP1[unassigned1304];CYSRT1[unassigned1304];TFG[unassigned1304];DMRTB1[19060904];MYOZ3[unassigned1304];IKBKG[unassigned1304];MAPK1IP1L[19060904;unassigned1304];PRMT6[23455924];PRMT5[23455924];PCID2[unassigned1304];MSX2[unassigned1304];ARID5A[unassigned1304];HIST2H2BE[30021884];AES[unassigned1304];PYGO1[20936779];CLUHP3[unassigned1304];TRAF4[unassigned1304];NCBP3[unassigned1304;26382858];CFAP53[unassigned1304];SNRPA[25416956;unassigned1304];HIST1H2BD[30021884];VGLL3[unassigned1304];TSG101[unassigned1304];MAGED1[unassigned1304];CAMK2A[unassigned1304];OAZ1[26496610];SKA1[26496610];HMGXB4[unassigned1304];BAG3[unassigned1304];CEP70[25416956];SMYD1[23455924];DVL3[unassigned1304];GSE1[unassigned1304];SMN1[16189514;unassigned1304];C10orf55[unassigned1304];SOCS7[unassigned1304];CPSF7[unassigned1304];INCA1[unassigned1304];ZFC3H1[26496610];""Em[unassigned1304];RRP1B[20926688];ZWINT[26496610];ANKHD1[unassigned1304];PER2[unassigned1304];HNRNPM[unassigned1304];TNIP1[unassigned1304];MNDA[25665578];FAM22F[unassigned1304];"	54962467
41366	chr19	55086249	C	C	chr19:55086249	LILRA2	leukocyte immunoglobulin like receptor A2	SNV	0/1	0.56	50_65	117	99.0	0/1	0.5	56_56	113	99.0			rs45523736	EXONIC	YES	NM_001290271.2	Transcript	protein_coding	synonymous_variant		5/9	NM_001290271.2:c.404T>C	NP_001277200.1:p.Ser135%3D		1.0						.	.	.						0	0.0							0.032222	8099.0	251350.0	200.0	100	1.0	PASS	sas	0.0580489	1772.0	0.0404132	4597.0	0.0325779	5066	0.03	93.0				0.308	-0.325071		0	0	0			LILRA2	0.0	0.02	0.03	0.0	-41.0	35.0	34.0	-41.0						0.899	0.0				.			ciliary ganglion;subthalamic nucleus;superior cervical ganglion;whole blood;bone marrow;	.	innate immune response activating cell surface receptor signaling pathway;neutrophil activation involved in immune response;defense response;signal transduction;negative regulation of lipopolysaccharide-mediated signaling pathway;granulocyte macrophage colony-stimulating factor production;interleukin-6 production;interleukin-8 production;negative regulation of toll-like receptor 4 signaling pathway;innate immune response;positive regulation of interleukin-1 beta secretion;positive regulation of cell activation;positive regulation of calcium ion transport;granulocyte colony-stimulating factor production;positive regulation of tumor necrosis factor secretion;positive regulation of interleukin-6 secretion	extracellular region;integral component of plasma membrane	IgM binding;antigen binding;signaling receptor activity	.	55086249
41386	chr19	55143576	C	T	chr19:55143576	LILRB1	leukocyte immunoglobulin like receptor B1	SNV	0/0	0.0	46_0	46	99.0	0/1	0.51	93_95	188	99.0			rs189680206,COSV61116169	EXONIC	YES	NM_001081637.2	Transcript	protein_coding	synonymous_variant		5/15	NM_001081637.2:c.549C>T	NP_001075106.2:p.Ser183%3D		1.0						.	.	.		9.85196e-05	15.0	152254.0	0.0	38	0.99	PASS	eas	0.00134823	7.0	7.34819e-05	5.0	0.00017496	44.0	251486.0	1.0	100	1.0	PASS	eas	0.00125041	23.0	7.9107e-05	9.0	0.0001608	25	0.0	1.0				0.388	-0.29145		0	0	0			LILRB1	0.0	0.0	0.01	0.04	27.0	-35.0	-26.0	38.0						0.869	0.0				.			white blood cells;whole blood;	.	negative regulation of T cell mediated cytotoxicity;positive regulation of defense response to virus by host;adaptive immune response;T cell proliferation involved in immune response;negative regulation of cytokine secretion involved in immune response;immune response-inhibiting cell surface receptor signaling pathway;Fc receptor mediated inhibitory signaling pathway;signal transduction;response to virus;positive regulation of gene expression;negative regulation of serotonin secretion;receptor internalization;interferon-gamma production;negative regulation of interferon-gamma production;negative regulation of mononuclear cell proliferation;negative regulation of interferon-beta secretion;negative regulation of T cell proliferation;negative regulation of tumor necrosis factor biosynthetic process;positive regulation of apoptotic process;negative regulation of interferon-gamma biosynthetic process;negative regulation of cell cycle;negative regulation of endocytosis;positive regulation of cytolysis;positive regulation of transcription by RNA polymerase II;negative regulation of natural killer cell mediated cytotoxicity;negative regulation of alpha-beta T cell activation;regulation of immune response;defense response to virus;negative regulation of calcium ion transport;positive regulation of macrophage cytokine production;cellular response to lipopolysaccharide;interferon-gamma secretion;dendritic cell differentiation;negative regulation of dendritic cell apoptotic process;negative regulation of interleukin-10 secretion;negative regulation of interleukin-12 secretion;negative regulation of CD8-positive, alpha-beta T cell activation;negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;positive regulation of gamma-delta T cell activation involved in immune response;negative regulation of dendritic cell differentiation;negative regulation of transforming growth factor-beta secretion;negative regulation of osteoclast development	extracellular region;cytoplasm;plasma membrane;external side of plasma membrane;integral component of membrane	amyloid-beta binding;protein binding;protein phosphatase 1 binding;HLA-A specific inhibitory MHC class I receptor activity;HLA-B specific inhibitory MHC class I receptor activity;MHC class I receptor activity;MHC class Ib receptor activity;SH2 domain binding;MHC class I protein binding;protein homodimerization activity	EBI3[24018270];H2AFX[16455647];HLA-B[27649529;12853576];CSK[15474475];PTPN6[18802077];HLA-A[12897781];KPNA2[24018270];HLA-G[19583775;16455647];B2M[27649529;12853576;16455647];INS[24018270];	55143576
41391	chr19	55144147	C	T	chr19:55144147	LILRB1	leukocyte immunoglobulin like receptor B1	SNV	0|1	0.1	193_22	217	99.0	0|1	0.13	143_22	166	99.0			rs74906426,COSV61116377	EXONIC	YES	NM_001081637.2	Transcript	protein_coding	synonymous_variant		6/15	NM_001081637.2:c.894C>T	NP_001075106.2:p.Tyr298%3D		1.0						.	.	.		0.000177396	27.0	152202.0	0.0	33	0.97	PASS	eas	0.000385654	2.0	0.000205792	14.0	0.00078314	191.0	243890.0	0.0	87	1.0	PASS	afr	0.00114694	18.0	0.000386649	43.0	0.0000064	1	0.001	2.0				0.002	-1.02824		0	0	0			LILRB1	0.0	0.0	0.0	0.0	39.0	-6.0	-36.0	-4.0						0.869	0.0				.			white blood cells;whole blood;	.	negative regulation of T cell mediated cytotoxicity;positive regulation of defense response to virus by host;adaptive immune response;T cell proliferation involved in immune response;negative regulation of cytokine secretion involved in immune response;immune response-inhibiting cell surface receptor signaling pathway;Fc receptor mediated inhibitory signaling pathway;signal transduction;response to virus;positive regulation of gene expression;negative regulation of serotonin secretion;receptor internalization;interferon-gamma production;negative regulation of interferon-gamma production;negative regulation of mononuclear cell proliferation;negative regulation of interferon-beta secretion;negative regulation of T cell proliferation;negative regulation of tumor necrosis factor biosynthetic process;positive regulation of apoptotic process;negative regulation of interferon-gamma biosynthetic process;negative regulation of cell cycle;negative regulation of endocytosis;positive regulation of cytolysis;positive regulation of transcription by RNA polymerase II;negative regulation of natural killer cell mediated cytotoxicity;negative regulation of alpha-beta T cell activation;regulation of immune response;defense response to virus;negative regulation of calcium ion transport;positive regulation of macrophage cytokine production;cellular response to lipopolysaccharide;interferon-gamma secretion;dendritic cell differentiation;negative regulation of dendritic cell apoptotic process;negative regulation of interleukin-10 secretion;negative regulation of interleukin-12 secretion;negative regulation of CD8-positive, alpha-beta T cell activation;negative regulation of T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell;positive regulation of gamma-delta T cell activation involved in immune response;negative regulation of dendritic cell differentiation;negative regulation of transforming growth factor-beta secretion;negative regulation of osteoclast development	extracellular region;cytoplasm;plasma membrane;external side of plasma membrane;integral component of membrane	amyloid-beta binding;protein binding;protein phosphatase 1 binding;HLA-A specific inhibitory MHC class I receptor activity;HLA-B specific inhibitory MHC class I receptor activity;MHC class I receptor activity;MHC class Ib receptor activity;SH2 domain binding;MHC class I protein binding;protein homodimerization activity	EBI3[24018270];H2AFX[16455647];HLA-B[27649529;12853576];CSK[15474475];PTPN6[18802077];HLA-A[12897781];KPNA2[24018270];HLA-G[19583775;16455647];B2M[27649529;12853576;16455647];INS[24018270];	55144147
41458	chr19	55445856	C	T	chr19:55445856	NLRP7	NLR family pyrin domain containing 7	SNV	0/0	0.0	33_0	33	99.0	0/1	0.4	29_20	50	99.0			rs104895505,CS061310,COSV60178708,COSV60178990	SPLICING	YES	NM_001127255.1	Transcript	protein_coding	splice_donor_variant	7/10		NM_001127255.1:c.2471+1G>A			-1.0		Pathogenic	no_assertion_criteria_provided	Hydatidiform_mole,_recurrent,_1	Hydatidiform mole, recurrent, 1, 231090 (3), Autosomal recessive	Partial hydatidiform mole;Complete hydatidiform mole	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Autosomal recessive inheritance;Abnormality of the genitourinary system;Hydatidiform mole	16462743	5.91576e-05	9.0	152136.0	0.0	32	0.97	PASS	afr	0.00012068	5.0	5.87993e-05	4.0	5.16915e-05	13.0	251492.0	0.0	100	1.0	PASS	afr	0.000123031	2.0	5.27389e-05	6.0	0.0000322	5			0.00044	5.0		28.7	4.111284		0	0	0			NLRP7	0.0	0.0	0.05	0.99	-25.0	38.0	46.0	1.0	0.999958003653399	0.802	1.719	8.182	9.901	0.9	0.0				.			.	.	negative regulation of endopeptidase activity;negative regulation of protein processing;negative regulation of interleukin-1 beta secretion;positive regulation of interleukin-1 beta secretion;cellular response to lipopolysaccharide;cellular response to interleukin-1;negative regulation of cytokine production involved in inflammatory response;negative regulation of aspartic-type peptidase activity	cellular_component	ATP binding;aspartic-type endopeptidase inhibitor activity;interleukin-1 binding;caspase binding	.	55445856
41521	chr19	55743305	G	A	chr19:55743305	PPP6R1	protein phosphatase 6 regulatory subunit 1	SNV	0/0	0.0	48_0	48	99.0	0/1	0.5	76_75	151	99.0			rs373792893	EXONIC	YES	NM_014931.4	Transcript	protein_coding	missense_variant		19/24	NM_014931.4:c.2171C>T	NP_055746.3:p.Pro724Leu		-1.0	.,.					.	.	.		0.000138036	21.0	152134.0	0.0	32	0.98	PASS	sas	0.001657	8.0	0.000147024	10.0	0.000235018	52.0	221260.0	0.0	18	0.43	PASS	sas	0.00113895	30.0	0.000189943	19.0	0.0002379	37	0.0	1.0				1.378	-0.103104	0.146	2	17	19	M-CAP_pred,PROVEAN_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PPP6R1	0.0	0.01	0.0	0.0	38.0	6.0	17.0	24.0							1.0	0.000000000	0.0	-0.578	.			.	.	regulation of phosphoprotein phosphatase activity;COPII vesicle coating	Golgi membrane;cytosol	protein binding;Rho GTPase binding;protein phosphatase binding	GSK3B[29568061];C2CD5[24255178];GTF3C4[24255178];NOTCH1[23022380];USP10[24255178];HDAC11[23752268];TTF2[24255178];PPP6C[16769727;18186651;21187329;24255178;28330616];SGPL1[24255178];PPP6R2[24255178];PPP6R3[18186651];KNTC1[24255178];ANKRD52[18186651;24255178];HIF1AN[26972000];ACAD11[24255178];SH3GL2[21900206];ANKRD28[18186651;24255178];HSPA8[29568061];USP49[19615732];HSPA4[24255178];ANKRD44[18186651;24255178];RIPK4[26972000];ELP1[24255178];CNOT10[24255178];ACSL3[24255178];ESR1[25604459];MOB1B[24255178];ALDH3A2[24255178];HADHB[24255178];HADHA[24255178];MOB1A[24255178];ILVBL[24255178];CNOT1[24255178];MTNR1B[26514267];SRPRA[24255178];SRPRB[24255178];PDCD2[24255178];PFDN2[24255178];ARHGEF2[24255178];NFKBIE[14743216;16769727];PFDN5[24255178];PFDN6[24255178];CEP44[26638075];	55743305
41546	chr19	55944677	G	C	chr19:55944677	SHISA7	shisa family member 7	SNV	0/0	0.0	39_0	39	99.0	0/1	0.42	35_25	60	99.0			rs940393004	EXONIC	YES	NM_001145176.1	Transcript	protein_coding	missense_variant		4/4	NM_001145176.1:c.1463C>G	NP_001138648.1:p.Pro488Arg		-1.0						.	.	.		0.000170918	26.0	152120.0	0.0	32	0.98	PASS	amr	0.00163591	25.0	0.0	0.0	0.000272244	22.0	80810.0	0.0	5	0.16	PASS	amr	0.00114716	21.0	0.0	0.0			0.001	3.0				18.39	1.82483	0.129	3	15	18	Polyphen2_HDIV_pred,M-CAP_pred,PrimateAI_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SHISA7	0.0	0.0	0.0	0.0	-1.0	1.0	1.0	-9.0									0.912	0.951	nervous system phenotype ; behavior/neurological phenotype ; 			.	.	memory;regulation of short-term neuronal synaptic plasticity;regulation of postsynaptic neurotransmitter receptor activity;positive regulation of long-term synaptic potentiation;regulation of AMPA glutamate receptor clustering;regulation of AMPA receptor activity	postsynaptic density;cell junction;AMPA glutamate receptor complex;dendritic spine membrane;synapse;postsynaptic membrane;asymmetric, glutamatergic, excitatory synapse;integral component of postsynaptic specialization membrane	ionotropic glutamate receptor binding	.	55944677
41570	chr19	56029632	C	T	chr19:56029632	SSC5D	scavenger receptor cysteine rich family member with 5 domains	SNV	0/1	0.41	70_48	118	99.0	0/0	0.0	89_0	89	99.0			rs568193889	EXONIC	YES	NM_001144950.2	Transcript	protein_coding	missense_variant		14/14	NM_001144950.2:c.3989C>T	NP_001138422.1:p.Pro1330Leu		1.0						.	.	.		0.000313376	40.0	127642.0	0.0	27	0.76	PASS	amr	0.00251623	31.0	7.8338e-05	5.0	0.000421628	66.0	156536.0	1.0	56	0.6	PASS	amr	0.00231012	57.0	4.95409e-05	3.0	0.0001029	16	0.003	9.0				7.272	0.304688	0.034	1	17	18	M-CAP_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SSC5D	0.0	0.0	0.0	0.0	9.0	-3.0	-7.0	-12.0							0.35	0.000000000	0.001	0.067	.			.	.	receptor-mediated endocytosis;multicellular organism development;detection of bacterial lipoprotein;innate immune response;defense response to Gram-negative bacterium;defense response to Gram-positive bacterium;negative regulation of interleukin-8 secretion	extracellular space;cytoplasm;external side of plasma membrane;collagen-containing extracellular matrix	fibronectin binding;scavenger receptor activity;protein binding;laminin binding;extracellular matrix binding	NECAB2[25416956;unassigned1304];EXOC7[25416956;unassigned1304];DTNBP1[25416956];TRAF1[25416956];MED29[unassigned1304];SKA1[unassigned1304];HAUS1[unassigned1304];CEP170P1[25416956;unassigned1304];SDCBP[unassigned1304];MED11[unassigned1304];SEC23IP[25416956;unassigned1304];KRT27[unassigned1304];MED21[25416956;unassigned1304];BLOC1S2[unassigned1304];NUP62[25416956;unassigned1304];TCEA2[unassigned1304];PIN1[unassigned1304];	56029632
41641	chr19	57795933	C	T	chr19:57795933	ZNF460	zinc finger protein 460	SNV	0|1	0.47	20_18	38	99.0	0/1	0.42	11_8	19	99.0			rs145610334,COSV64416310	EXONIC	YES	NM_006635.4	Transcript	protein_coding	synonymous_variant		2/3	NM_006635.4:c.45C>T	NP_006626.3:p.Phe15%3D		1.0						.	.	.		0.00115051	175.0	152106.0	2.0	31	0.94	PASS	amr	0.00419507	64.0	0.00119058	81.0	0.000963915	241.0	250022.0	1.0	33	0.8	PASS	amr	0.00187441	64.0	0.00125366	142.0	0.0008939	139	0.003	11.0				4.746	0.129448		0	0	0			ZNF460	0.0	0.01	0.0	0.0	28.0	-14.0	-14.0	4.0						0.14	0.65	48.274358164			.			ciliary ganglion;kidney;subthalamic nucleus;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skin;skeletal muscle;globus pallidus;	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;metal ion binding	LMO1[unassigned1304];ZNF330[unassigned1304];CDK11A[23602568];MTNR1A[26514267];CBX5[20562864];TRIM41[unassigned1304];ZNF250[25416956];CBX3[21888893];DEUP1[25416956];FGF12[25416956];ZNF211[27705803];	57795933
41657	chr19	58385762	C	G	chr19:58385762	ZNF814	zinc finger protein 814	SNV	0|1	0.15	11_2	13	51.0	0/0	0.0	19_0	19	8.0			rs199732634,COSV101457224,COSV71381725,COSV71382323	EXONIC	YES	NM_001144989.2	Transcript	protein_coding	synonymous_variant		3/3	NM_001144989.2:c.996G>C	NP_001138461.1:p.Ser332%3D		-1.0						.	.	.		0.00695897	479.0	68832.0	0.0	14	0.25	PASS	afr	0.00905907	150.0	0.0069148	230.0	0.0535738	2442.0	45582.0	0.0	36	0.6	PASS	sas	0.0569878	168.0	0.0545847	1087.0	0.0005273	82	0.026	82.0				0.114	-0.464734		0	0	0			ZNF814	0.0	0.0	0.0	0.0	-13.0	-18.0	11.0	-48.0							0.0				.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	.	58385762
41932	chr2	11774311	C	T	chr2:11774311	GREB1	growth regulating estrogen receptor binding 1	SNV	0|1	0.47	68_61	129	99.0	0/0	0.0	34_0	34	99.0			rs373456450,COSV99302686	EXONIC	YES	NM_014668.4	Transcript	protein_coding	synonymous_variant		29/33	NM_014668.4:c.5046C>T	NP_055483.2:p.Ile1682%3D		1.0						.	.	.		0.000183937	28.0	152226.0	0.0	32	0.97	PASS	eas	0.00077101	4.0	0.000249846	17.0	0.000128548	32.0	248934.0	0.0	100	1.0	PASS	amr	0.000289637	10.0	0.000133165	15.0	0.0001158	18	0.001	3.0				3.715	0.067355		0	0	0			GREB1	0.0	0.0	0.0	0.0	-17.0	-33.0	-33.0	-5.0						0.471	0.03	11.065761130			cardiovascular system phenotype ; skeleton phenotype; limbs/digits/tail phenotype; growth/size/body region phenotype; adipose tissue phenotype ; 			pons;ciliary ganglion;ovary;amygdala;uterus;trigeminal ganglion;cingulate cortex;superior cervical ganglion;uterus corpus;prostate;testis;skeletal muscle;	.	.	nucleoplasm;integral component of membrane;extracellular exosome	.	BCAR3[25640309];FOXA1[25303530];HSPA9[30021884];MED1[25303530];SMAD4[25640309];RARG[25303530];TFAP2C[25303530];JUN[25303530];CDKN2C[25640309];TGFB1[25640309];PRKDC[25303530];STAT1[25303530];XRCC3[25640309];HMMR[25640309];LSP1[25640309];FOS[25303530];GATA3[25303530];PALB2[25640309];ESR1[25303530];CASP8[25640309];RB1CC1[25640309];RARA[25303530];EP300[25303530];HRAS[25640309];	11774311
41971	chr2	16082844	G	T	chr2:16082844	MYCN	MYCN proto-oncogene, bHLH transcription factor	SNV	0/0	0.0	40_0	40	99.0	0/1	0.56	22_28	50	99.0			rs745414155,COSV55259819	EXONIC	YES	NM_001293228.2	Transcript	protein_coding	missense_variant		2/3	NM_001293228.2:c.658G>T	NP_001280157.1:p.Ala220Ser		1.0	Transcription regulator Myc, N-terminal	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	not_specified|not_provided	Feingold syndrome 1, 164280 (3), Autosomal dominant	Neuroblastoma;Non-hereditary retinoblastoma;Hereditary retinoblastoma;Feingold syndrome type 1;Feingold syndrome type 1	Biomarker tested in;Candidate gene tested in;Candidate gene tested in;Disease-causing germline mutation(s) in;Role in the phenotype of	Elevated urinary catecholamines;Neoplasm of the nervous system;Hearing impairment;Esophageal atresia;Prominent occiput;Aplasia/Hypoplasia of the middle phalanx of the 5th finger;Short palpebral fissure;Small anterior fontanelle;Aplasia/Hypoplasia of the middle phalanx of the 2nd finger;Annular pancreas;2-3 toe syndactyly;Micrognathia;Depressed nasal tip;Microcephaly;Low-set ears;Upslanted palpebral fissure;4-5 toe syndactyly;Polyhydramnios;Polysplenia;Thick vermilion border;Epicanthus;Narrow palpebral fissure;Blepharophimosis;Patent ductus arteriosus;Posteriorly rotated ears;Tracheoesophageal fistula;Accessory spleen;High palate;Triangular face;Everted lower lip vermilion;Facial asymmetry;Specific learning disability;Wide nasal bridge;Intellectual disability;Short toe;Asplenia;Duodenal atresia;Anteverted nares;Vocal cord paralysis;Decreased fetal movement;Autosomal dominant inheritance		0.000364862	55.0	150742.0	0.0	32	0.96	PASS	nfe	0.000355208	24.0	0.000355208	24.0	0.00087108	7.0	8036.0	0.0	1	0.0	PASS	nfe	0.00126103	6.0	0.00126103	6.0	0.0001350	21			0.00082	8.0		4.8	0.132759	0.009	1	17	18	M-CAP_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MYCN	0.0	0.0	0.0	0.0	28.0	1.0	-4.0	12.0						0.0238	0.91		0.032	-0.283	muscle phenotype; craniofacial phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype ; vision/eye phenotype; skeleton phenotype; renal/urinary system phenotype; embryo phenotype; behavior/neurological phenotype ; liver/biliary system phenotype; respiratory system phenotype; cardiovascular system phenotype ; hematopoietic system phenotype; normal phenotype; mortality/aging ; 			fetal brain;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;placenta;parietal lobe;skeletal muscle;heart;	.	regulation of transcription by RNA polymerase II;positive regulation of gene expression;negative regulation of gene expression;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of production of miRNAs involved in gene silencing by miRNA	chromatin;nucleus;nucleolus	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;protein binding;kinase binding;protein dimerization activity	SUZ12[27728805];GSK3B[17353931];ZBTB17[26766587];HDAC2[20697349];MAX[10597290;23792191;25175806;27728805;18003922];CDKN2A[17289033];FBXW7[19111882];HDAC1[18003922];NMI[10597290];SIRT1[21698133];AURKA[19111882;23792191;25175806;27728805];FOXR1[25609649];AR[27728805];CDH5[27728805];KAT5[18003922];SP1[20697349;18003922];MYC[25609649];PMAIP1[26859456];EZH2[27728805];	16082844
42014	chr2	20647604	T	G	chr2:20647604	RHOB	ras homolog family member B	SNV	0/1	0.41	77_53	130	99.0	0/0	0.0	37_0	37	99.0			rs137856773	EXONIC	YES	NM_004040.4	Transcript	protein_coding	missense_variant		1/1	NM_004040.4:c.378T>G	NP_004031.1:p.His126Gln		1.0	Small GTP-binding protein domain					.	.	.		0.000532537	81.0	152102.0	0.0	33	0.98	PASS	nfe	0.000970417	66.0	0.000970417	66.0	0.000529602	133.0	251132.0	0.0	100	1.0	PASS	nfe	0.00103095	117.0	0.00103095	117.0	0.0005145	80	0.0	1.0				10.61	0.635403	0.052	4	14	18	MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	RHOB	0.0	0.0	0.05	0.0	-19.0	11.0	0.0	-18.0						0.285	0.25	0.000000000	0.998	-0.21	nervous system phenotype ; vision/eye phenotype; cardiovascular system phenotype ; neoplasm; cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; 			adrenal gland;	.	mitotic cytokinesis;angiogenesis;intracellular protein transport;apoptotic process;actin filament organization;cell adhesion;G protein-coupled receptor signaling pathway;Rho protein signal transduction;endosome to lysosome transport;regulation of cell shape;positive regulation of endothelial cell migration;cell migration;cell differentiation;regulation of cell migration;negative regulation of cell migration;establishment or maintenance of actin cytoskeleton polarity;regulation of actin cytoskeleton organization;positive regulation of apoptotic process;positive regulation of angiogenesis;negative regulation of cell cycle;actin filament bundle assembly;regulation of small GTPase mediated signal transduction;endothelial tube morphogenesis;cellular response to hydrogen peroxide;cellular response to ionizing radiation	nucleus;cytoplasm;early endosome;cytosol;plasma membrane;focal adhesion;cell cortex;endosome membrane;late endosome membrane;cell division site;cleavage furrow;intracellular membrane-bounded organelle;extracellular exosome	GTPase activity;protein binding;GTP binding;GDP binding;protein kinase binding	PTPN1[14722096];NQO2[19637314];DUT[19637314];SMURF1[25249323];CD81[30024968];INSR[14722096];PRAF2[19637314];NME2[19637314];TNFAIP1[19637314];FBXO42[19637314];DIAPH1[18218625];SERTAD1[19637314];DAAM1[18218625];KCTD10[19637314];ARHGDIA[19637314];MAP1A[19637314];NEK2[19637314];PHGDH[19637314];ARHGEF1[19637314];PPIG[19637314];EIF1B[19637314];NGEF[19637314];FBN1[19637314];	20647604
42034	chr2	24262346	T	G	chr2:24262346	WDCP	WD repeat and coiled coil containing	SNV	0/1	0.5	50_51	101	99.0	0/0	0.0	45_0	45	99.0			rs139596495	EXONIC	YES	NM_025203.3	Transcript	protein_coding	missense_variant		2/4	NM_025203.3:c.19A>C	NP_079479.1:p.Lys7Gln		-1.0	.,.,.					.	.	.		0.000394068	60.0	152258.0	0.0	33	0.98	PASS	afr	0.000771679	32.0	0.000146964	10.0	0.000156334	39.0	249466.0	0.0	52	0.98	PASS	afr	0.000554529	9.0	0.000142824	16.0	0.0002379	37	0.003	11.0				19.64	1.988433	0.286	6	12	18	SIFT,LRT_pred,M-CAP_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	C2orf44	0.0	0.0	0.0	0.0	36.0	-40.0	-21.0	37.0								0.000000000	0.82	0.168	.			.	.	protein complex oligomerization	.	kinase binding	CEP120[26638075];NLK[23602568];MAPK8[26496610];NUDCD1[29021621];RUVBL2[17353931];MED31[16169070];RUVBL1[17353931];GAR1[26496610];CD14[26496610];DYNC1I1[21900206];HSPA8[29568061];ANXA1[23754495];PDPK1[21900206];SCAF11[26496610];ZNF281[26496610];PLK1[19596235];CSNK1E[21900206];KIF22[26496610];RPGRIP1L[26638075];TCTE1[26638075];SGO1[26496610];HCK[12029088];RPS27[21900206];KIF2A[26496610];PRKAR1A[21900206];TNNT1[21900206];RAB35[16169070];TAB1[21900206];YPEL5[27173435;unassigned1312];CSNK1G2[21900206];CSNK1G1[21900206];	24262346
42119	chr2	25467089	G	A	chr2:25467089	DNMT3A	DNA methyltransferase 3 alpha	SNV	0/1	0.5	55_54	109	99.0	0/0	0.0	34_0	34	99.0				EXONIC	YES	NM_022552.5	Transcript	protein_coding	missense_variant		15/23	NM_022552.5:c.1786C>T	NP_072046.2:p.Arg596Trp		-1.0	ADD domain,.,ADD domain,ADD domain				Tatton-Brown-Rahman syndrome, 615879 (3), Autosomal dominant; Acute myeloid leukemia, somatic, 601626 (3); Heyn-Sproul-Jackson syndrome, 618724 (3), Autosomal dominant	Tall stature-intellectual disability-facial dysmorphism syndrome	Disease-causing germline mutation(s) in	Mitral regurgitation;Schizophrenia;Short columella;Narrow palpebral fissure;Neuroendocrine neoplasm;Arnold-Chiari malformation;Intellectual disability, severe;Cryptorchidism;Tricuspid regurgitation;Short toe;Infantile muscular hypotonia;Umbilical hernia;Aortic root aneurysm;Intellectual disability, mild;Thick eyebrow;Kyphoscoliosis;Myeloid leukemia;Macrocephaly;Widely-spaced maxillary central incisors;Patent ductus arteriosus;Proportionate tall stature;Anxiety;Proportionate short stature;Deep philtrum;Ventriculomegaly;Developmental regression;Bipolar affective disorder;Seizure;Supraventricular tachycardia with an accessory connection mediated pathway;Widely spaced toes;Aggressive behavior;Atrial septal defect;Obesity;Round face;Joint hypermobility;Intellectual disability, moderate;Hypertelorism;Mandibular prognathia;Coarse facial features;Acute myeloid leukemia;Autosomal dominant inheritance;Somatic mutation;Tall stature;Intellectual disability;Atrial septal defect;Encephalomalacia;Generalized hypotonia;Scoliosis;Blepharophimosis;Narrow palpebral fissure;Autosomal dominant inheritance;Optic nerve hypoplasia;Seizure;Umbilical hernia;Macrocephaly;Arnold-Chiari type I malformation;Round face		6.57056e-06	1.0	152194.0	0.0	32	0.97	PASS	afr	2.41208e-05	1.0	0.0	0.0					80	0.99											9e-05	1.0		25.1	3.528023	0.907	11	8	19	SIFT,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,PrimateAI_pred,BayesDel_noAF_pred	DNMT3A	0.0	0.0	0.0	0.0	18.0	-33.0	18.0	-34.0						0.15	0.0	6.169915974	1.0	1.172	behavior/neurological phenotype ; embryo phenotype; hematopoietic system phenotype; mortality/aging ; reproductive system phenotype; nervous system phenotype ; homeostasis/metabolism phenotype; immune system phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; growth/size/body region phenotype; 			superior cervical ganglion;skeletal muscle;	Methionine metabolism	negative regulation of transcription by RNA polymerase II;mitotic cell cycle;DNA methylation;methylation-dependent chromatin silencing;regulation of gene expression by genetic imprinting;spermatogenesis;aging;response to ionizing radiation;response to lead ion;positive regulation of cell death;neuron differentiation;response to estradiol;response to vitamin A;response to cocaine;DNA methylation involved in embryo development;DNA methylation involved in gamete generation;negative regulation of gene expression, epigenetic;cellular response to amino acid stimulus;cellular response to ethanol;cellular response to hypoxia;C-5 methylation of cytosine;hepatocyte apoptotic process	chromosome, centromeric region;euchromatin;XY body;nucleus;nucleoplasm;nuclear heterochromatin;cytoplasm;nuclear matrix	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;chromatin binding;transcription corepressor activity;DNA (cytosine-5-)-methyltransferase activity;protein binding;transcription factor binding;DNA-methyltransferase activity;identical protein binding;metal ion binding	PRMT5[19234465];SP100[25416956];CBX5[19834512];SETDB1[16682412];EED[16357870];UHRF1[19798101];H3F3A[19834512];DNMT3A[24656771];CREM[21976679];MEOX2[unassigned1304];TCL1A[25416956;unassigned1304];DNMT3L[25383530];NRIP1[17972916];TERF2IP[21044950];ZNF513[unassigned1304];MDFI[unassigned1304];EZH2[16357870;24074865];	25467089
42160	chr2	25656835	G	A	chr2:25656835	DTNB	dystrobrevin beta	SNV	0/0	0.0	34_0	34	99.0	0/1	0.41	44_31	75	99.0			rs201598651	EXONIC	YES	NM_021907.5	Transcript	protein_coding	synonymous_variant		13/21	NM_021907.5:c.1287C>T	NP_068707.1:p.Asn429%3D		-1.0						.	.	.		0.00106639	162.0	151914.0	1.0	31	0.94	PASS	sas	0.00518242	25.0	0.00135314	92.0	0.00200629	500.0	249216.0	4.0	89	1.0	PASS	sas	0.00803869	246.0	0.00138087	156.0	0.0019485	303	0.002	6.0				11.8	0.780618		0	0	0			DTNB	0.0	0.12	0.0	0.0	-24.0	29.0	29.0	-50.0							0.0	68.736759511			nervous system phenotype ; normal phenotype; behavior/neurological phenotype ; 			caudate nucleus;temporal lobe;amygdala;prefrontal cortex;whole brain;skin;cingulate cortex;superior cervical ganglion;spinal cord;skeletal muscle;hypothalamus;	.	.	cytoplasm	protein binding;zinc ion binding	HEL-S-70[25416956];PPP1R13B[unassigned1304];DEUP1[unassigned1304];CEP128[26638075];SPZ1[25416956;unassigned1304];ZMYM1[25852190];KRT27[unassigned1304];NUP62[16189514;25416956;unassigned1304];PPFIA1[25416956];DAG1[unassigned1793];HMG20A[16189514;25416956;unassigned1304];TRIM27[unassigned1304];CCHCR1[unassigned1304];MB21D2[unassigned1304];CEP55[25416956;unassigned1304];TNS2[28330616];NDEL1[25416956];COG6[unassigned1304];KRT35[unassigned1304];MTUS2[25416956;unassigned1304];TRAF2[16189514;25416956;unassigned1304];TFIP11[unassigned1304];INSYN1[unassigned1304];KRT31[25416956;unassigned1304];TXLNA[25416956;unassigned1304];PRKAR1B[unassigned1304];KRT38[unassigned1304];PICK1[unassigned1304];CEP63[21516116;25416956;unassigned1304];UTRN[10545507];CCDC196[unassigned1304];TRIM54[unassigned1304];PRTFDC1[16189514];VCP[unassigned1304];TSACC[16189514];CTBP2[unassigned1304];USHBP1[25416956;unassigned1304];KRT40[25416956];BEGAIN[16189514;unassigned1304];KRT33B[unassigned1304];GGA1[25416956;unassigned1304];SNTG2[25416956;unassigned1304];CCDC85B[16189514];VPS52[unassigned1304];DMD[9395493;10545507;25416956;unassigned1304];FSD2[unassigned1304];LURAP1[unassigned1304];ABCA1[16192269];ZRANB1[unassigned1304];DTNB[25416956];DTNBP1[25416956];POU6F2[unassigned1304];ZBTB9[25416956];CCDC88B[unassigned1304];FAM167A[unassigned1304];PPFIBP2[16189514];ABI2[25416956;unassigned1304];ABI3[25416956];KRT15[unassigned1304];ABI1[unassigned1304];TRIM37[unassigned1304];AMOTL2[unassigned1304];SSBP3[unassigned1304];SPERT[unassigned1304];	25656835
42276	chr2	27360578	T	C	chr2:27360578	PRR30	proline rich 30	SNV	0/1	0.59	62_90	152	99.0	0/0	0.0	40_0	40	99.0			rs142231081	EXONIC	YES	NM_178553.4	Transcript	protein_coding	missense_variant		3/3	NM_178553.4:c.620A>G	NP_848648.2:p.Asp207Gly		-1.0						.	.	.		0.00277289	422.0	152188.0	0.0	32	0.98	PASS	nfe	0.00521859	355.0	0.00521859	355.0	0.00233073	579.0	248420.0	2.0	66	0.99	PASS	nfe	0.00429763	478.0	0.00429763	478.0	0.0025851	402	0.0	1.0				22.8	2.640207	0.196	3	15	18	SIFT,PROVEAN_pred,fathmm-MKL_coding_pred	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	PRR30	0.0	0.0	0.0	0.0	2.0	-6.0	1.0	9.0								0.000000000	0.875	0.879	.			.	.	.	.	.	CYSRT1[unassigned1304];KRTAP6-2[unassigned1304];TEX37[unassigned1304];	27360578
42432	chr2	27884248	C	T	chr2:27884248	SUPT7L	SPT7 like, STAGA complex gamma subunit	SNV	0/1	0.33	44_22	66	99.0	0/0	0.0	36_0	36	99.0			rs1302941143	EXONIC	YES	NM_001282729.2	Transcript	protein_coding	missense_variant		3/6	NM_001282729.2:c.22G>A	NP_001269658.1:p.Gly8Arg		-1.0	.,.,.,.					.	.	.		1.31567e-05	2.0	152014.0	0.0	32	0.96	PASS	amr	0.000130993	2.0	0.0	0.0					57	0.99														27.9	4.029209	0.813	16	4	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PrimateAI_pred	SUPT7L	0.13	0.01	0.0	0.0	7.0	0.0	13.0	19.0							0.83	54.323687816	1.0	1.026	homeostasis/metabolism phenotype; adipose tissue phenotype ; growth/size/body region phenotype; integument phenotype ; 			ciliary ganglion;occipital lobe;prefrontal cortex;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;parietal lobe;	.	histone H3 acetylation;maintenance of protein location in nucleus;positive regulation of nucleic acid-templated transcription	nucleus;nucleoplasm;STAGA complex	transcription coactivator activity;histone acetyltransferase activity;protein binding;protein heterodimerization activity	CDK8[26496610];TRRAP[26496610];USP22[19615732];PTN[16169070];SGF29[26496610];	27884248
42464	chr2	29287898	G	A	chr2:29287898	C2orf71		SNV	0/1	0.43	66_49	115	99.0	0/0	0.0	65_0	65	99.0			rs201933656,CM1410567	EXONIC	YES	NM_001029883.3	Transcript	protein_coding	missense_variant		2/2	NM_001029883.3:c.3704C>T	NP_001025054.1:p.Pro1235Leu		-1.0		Uncertain_significance	criteria_provided,_single_submitter	not_provided						0.000336265	51.0	151666.0	0.0	33	0.98	PASS	eas	0.00117096	6.0	2.94291e-05	2.0	0.000303296	47.0	154964.0	0.0	100	0.58	PASS	eas	0.00198951	22.0	8.40788e-05	5.0	0.0001801	28			9e-05	1.0		19.07	1.914602	0.206	3	16	19	PolyPhen,Polyphen2_HDIV_pred,PROVEAN_pred	SIFT,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	C2orf71	0.0	0.03	0.0	0.0	-32.0	32.0	32.0	-44.0						0.86	0.0	0.000000000	0.004	1.176										29287898
42471	chr2	31483371	G	A	chr2:31483371	EHD3	EH domain containing 3	SNV	0/1	0.66	16_31	47	99.0	0/0	0.0	37_0	37	99.0			rs200027155,COSV100434599	SPLICING	YES	NM_014600.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	3/5		NM_014600.3:c.503-5G>A			1.0						.	.	.		0.000302437	46.0	152098.0	0.0	33	0.97	PASS	nfe	0.000514494	35.0	0.000514494	35.0	0.000335779	80.0	238252.0	0.0	36	0.77	PASS	nfe	0.00062942	68.0	0.00062942	68.0	0.0003151	49	0.0	1.0				17.91	1.760935		0	0	0			EHD3	0.87	0.11	0.0	0.0	2.0	5.0	5.0	1.0	0.976697793281944	0.594	6.671	1.671	8.341	0.139	0.09				homeostasis/metabolism phenotype; cellular phenotype; cardiovascular system phenotype ; growth/size/body region phenotype; mortality/aging ; normal phenotype; renal/urinary system phenotype; 			temporal lobe;amygdala;prefrontal cortex;cingulate cortex;cerebellum peduncles;cerebellum;pons;occipital lobe;subthalamic nucleus;whole brain;parietal lobe;globus pallidus;medulla oblongata;hypothalamus;thalamus;	.	receptor recycling;blood coagulation;protein transport;endocytic recycling;early endosome to Golgi transport;protein homooligomerization;regulation of cardiac muscle contraction;cilium assembly;protein localization to plasma membrane;regulation of cardiac muscle cell membrane potential;Golgi to lysosome transport;positive regulation of voltage-gated calcium channel activity;regulation of Golgi organization;regulation of cardiac conduction	nucleus;cytoplasm;cytosol;focal adhesion;endosome membrane;ciliary pocket membrane;endocytic vesicle;myelin sheath;perinuclear region of cytoplasm;recycling endosome membrane	nucleic acid binding;calcium ion binding;protein binding;ATP binding;GTP binding	EHD1[26226295;unassigned1304];INTU[27173435;unassigned1312];ARL6IP1[unassigned1304];NUDCD1[29021621];MICALL1[27189942;19864458];ANKFY1[27189942];ANK2[20489164];RBSN[15020713];	31483371
42593	chr2	37505108	C	T	chr2:37505108	PRKD3	protein kinase D3	SNV	0/0	0.0	22_0	22	60.0	0|1	0.5	19_19	38	99.0			rs116096831	EXONIC	YES	NM_005813.6	Transcript	protein_coding	synonymous_variant		9/19	NM_005813.6:c.1197G>A	NP_005804.1:p.Pro399%3D		-1.0						.	.	.		0.00427868	650.0	151916.0	3.0	32	0.96	PASS	nfe	0.00576403	392.0	0.00576403	392.0	0.00502985	1252.0	248914.0	8.0	55	0.81	PASS	nfe	0.0067935	767.0	0.0067935	767.0	0.0049967	777	0.002	6.0	0.00381	7.0		8.993	0.457492		0	0	0			PRKD3	0.0	0.06	0.0	0.0	-28.0	24.0	24.0	-9.0						0.342	0.01	85.986413712			endocrine/exocrine gland phenotype; immune system phenotype; skeleton phenotype; limbs/digits/tail phenotype; hematopoietic system phenotype; 			ciliary ganglion;tonsil;white blood cells;testis - seminiferous tubule;testis - interstitial;prefrontal cortex;trigeminal ganglion;superior cervical ganglion;testis;adrenal cortex;	.	protein phosphorylation;protein kinase C-activating G protein-coupled receptor signaling pathway;sphingolipid biosynthetic process;protein kinase D signaling	nucleoplasm;cytosol;membrane	protein serine/threonine kinase activity;protein kinase C activity;protein binding;ATP binding;kinase activity;metal ion binding	MYH3[23414517];PKM[24606918];CHM[19615732];PRKD2[26496610];POLL[unassigned1304];DLAT[21988832];IKBKG[20098747];VAMP2[17196367];NUDT3[21900206];SKA2[21988832];TAF1[23414517];	37505108
42641	chr2	39042718	T	G	chr2:39042718	DHX57	DExH-box helicase 57	SNV	0/0	0.0	43_0	43	99.0	0/1	0.44	55_44	100	99.0			rs150735204,COSV54884198	EXONIC	YES	NM_198963.3	Transcript	protein_coding	missense_variant		20/24	NM_198963.3:c.3551A>C	NP_945314.1:p.Glu1184Ala		-1.0						.	.	.		0.00445806	678.0	152084.0	4.0	32	0.95	PASS	nfe	0.00717267	488.0	0.00717267	488.0	0.00425488	1070.0	251476.0	0.0	97	1.0	PASS	nfe	0.00695348	791.0	0.00695348	791.0	0.0043793	681	0.003	10.0				22.5	2.496871	0.232	4	13	17	MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	DHX57	0.0	0.0	0.0	0.0	37.0	30.0	2.0	30.0						0.839	0.0	0.000000000	0.997	1.138	.			testis - seminiferous tubule;	.	.	.	RNA binding;protein binding;ATP binding;ATP-dependent 3'-5' RNA helicase activity;metal ion binding	ZNF473[25416956];RPL10[26496610];GABARAP[20562859];KRT40[unassigned1304];DMBX1[unassigned1304];PLAGL2[unassigned1304];KRTAP2-3[unassigned1304];LYAR[17353931];ZNF587[unassigned1304];RSPO4[unassigned1304];NOP56[26496610];RBMY1A1[unassigned1304];CARD10[unassigned1304];KRTAP10-5[25416956];NPM1[26496610];KRTAP12-3[unassigned1304];KRTAP9-4[25416956];KRTAP10-7[25416956;unassigned1304];NAA10[unassigned1304];KRTAP10-6[unassigned1304];KRTAP10-9[25416956;unassigned1304];CBX2[25416956;unassigned1304];NONO[30021884];DDX56[17353931];KRTAP10-8[25416956;unassigned1304];DICER1[21858095];MEX3C[22863774];ZNF837[unassigned1304];MNDA[25665578];CEP44[25416956];FKBP5[25036637];	39042718
42746	chr2	44566505	AG		chr2:44566505-44566506	PREPL	prolyl endopeptidase like	deletion	0/0	0.0	27_0	27	54.0	0/1	0.15	22_4	26	73.0			rs750292662	SPLICING	YES	NM_006036.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	5/13		NM_006036.4:c.753-4_753-3del			-1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	Myasthenic_syndrome,_congenital,_22	Myasthenic syndrome, congenital, 22, 616224 (3), Autosomal recessive	2p21 microdeletion syndrome;Hypotonia-cystinuria syndrome;Atypical hypotonia-cystinuria syndrome;2p21 microdeletion syndrome without cystinuria	Role in the phenotype of;Role in the phenotype of;Role in the phenotype of;Role in the phenotype of	Frontal bossing;Long eyelashes;Muscular hypotonia;Intellectual disability, moderate;Cystinuria;Growth delay;Global developmental delay;Lactic acidosis;Nasal speech;Nephrolithiasis;Failure to thrive;Mitochondrial respiratory chain defects;Hypoglycemia;Depressed nasal bridge;Decreased fetal movement;Hypogonadism;Seizure;Hypocalcemia;Low-set, posteriorly rotated ears;Waddling gait;Motor delay;Autosomal recessive inheritance;Muscle weakness;Ptosis;Congenital onset;Tented upper lip vermilion;Feeding difficulties;Short stature;Growth hormone deficiency;Generalized hypotonia;Ptosis;Frontal bossing;Nasal speech;Cystinuria;Muscular hypotonia;Growth delay;Retrognathia;Dolichocephaly;Epicanthus;Fatigue;Decreased fetal movement;Failure to thrive;Nephrolithiasis;Polyphagia		0.000200997	30.0	149256.0	0.0	32	0.96	PASS	amr	0.000200642	3.0	0.000164042	11.0	0.0396061	5020.0	126748.0	0.0	46	0.9	RF	sas	0.0606155	780.0	0.0413676	2513.0	0.0001029,0.0005273,0.0563201	16,82,8758			0.12232	1392.0		8.098	0.37276		0	0	0			PREPL	0.06	0.02	0.0	0.0	-31.0	-2.0	-31.0	-25.0						0.0602	0.0				behavior/neurological phenotype ; muscle phenotype; growth/size/body region phenotype; 			caudate nucleus;temporal lobe;amygdala;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;cingulate cortex;cerebellum peduncles;cerebellum;pons;occipital lobe;subthalamic nucleus;whole brain;parietal lobe;globus pallidus;hypothalamus;medulla oblongata;thalamus;	.	proteolysis;regulation of synaptic vesicle exocytosis	Golgi apparatus;cytosol;cytoskeleton	serine-type endopeptidase activity;protein binding;serine-type exopeptidase activity	PRELID1[27499296];STARD7[27499296];USP22[19615732];MGST3[29568061];PRSS35[27499296];TRIAP1[27499296];ESR2[21182203;25604459];HSPD1[29568061];COIL[16713569];NR4A1[20195357];ADCK1[27499296];CAPN3[23414517];TRMT61B[29568061];PDK1[29568061];HIST1H1C[30021884];	44566504
42776	chr2	47233090	G	T	chr2:47233090	TTC7A	tetratricopeptide repeat domain 7A	SNV	0/1	0.52	54_58	112	99.0	0/0	0.0	36_0	36	99.0			rs113844968	EXONIC	YES	NM_001288951.2	Transcript	protein_coding	synonymous_variant		9/21	NM_001288951.2:c.1095G>T	NP_001275880.1:p.Val365%3D		1.0		Benign	criteria_provided,_single_submitter	Multiple_gastrointestinal_atresias|not_provided	Gastrointestinal defects and immunodeficiency syndrome, 243150 (3), Autosomal recessive	Multiple intestinal atresia;Combined immunodeficiency-enteropathy spectrum	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in	Hashimoto thyroiditis;Psoriasiform dermatitis;Intestinal atresia;Nail dystrophy;Recurrent abscess formation;Ventricular septal defect;Absent eyebrow;Bloody diarrhea;Severe combined immunodeficiency;Hypoplasia of the thymus;Peritoneal abscess;Intrauterine growth retardation;Omphalocele;Intestinal malrotation;Congenital cystic adenomatoid malformation of the lung;Alopecia of scalp;Polyhydramnios;Abnormality of the ductus choledochus;Autoimmune hemolytic anemia;Type I diabetes mellitus;Abdominal distention;Jejunoileal ulceration;Hepatitis;Thickened skin;Sparse hair;Rectal abscess;Ectopic calcification;Polyhydramnios;Gastrointestinal atresia;Duodenal stenosis;Abnormality of abdomen morphology;Intestinal malrotation;Prominent forehead;Hematochezia;Psoriasiform dermatitis;Intrauterine growth retardation;Hypoplasia of the thymus;Ventricular septal defect;Omphalocele;Hypertelorism;Autosomal recessive inheritance;Autoimmune hemolytic anemia;Intestinal atresia;Interface hepatitis;Polyhydramnios;Severe combined immunodeficiency;Hypoplasia of dental enamel		0.00283288	431.0	152142.0	3.0	32	0.95	PASS	amr	0.00831152	127.0	0.00341056	232.0	0.00266067	669.0	251440.0	1.0	75	1.0	PASS	amr	0.00453888	157.0	0.00344658	392.0	0.0026559	413	0.012	37.0				0.144	-0.432388		0	0	0			TTC7A	0.0	0.0	0.0	0.0	10.0	-29.0	10.0	-3.0						0.832	0.0	6.169915974			immune system phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; digestive/alimentary phenotype; mortality/aging ; hematopoietic system phenotype; cardiovascular system phenotype ; neoplasm; pigmentation phenotype; liver/biliary system phenotype; homeostasis/metabolism phenotype; integument phenotype ; growth/size/body region phenotype; endocrine/exocrine gland phenotype; 			ciliary ganglion;atrioventricular node;testis;	.	cellular iron ion homeostasis;hemopoiesis;phosphatidylinositol phosphorylation;protein localization to plasma membrane	cytoplasm;plasma membrane	.	MCM7[23764002];CHMP4B[26496610];	47233090
42991	chr2	65245352	G	A	chr2:65245352	SLC1A4	solute carrier family 1 member 4	SNV	0/1	0.58	32_44	76	99.0	0/0	0.0	33_0	33	99.0			rs34416635,COSV99308938	EXONIC	YES	NM_003038.5	Transcript	protein_coding	synonymous_variant		6/8	NM_003038.5:c.1182G>A	NP_003029.2:p.Ala394%3D		1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	not_provided	Spastic tetraplegia, thin corpus callosum, and progressive microcephaly, 616657 (3), Autosomal recessive	Spastic tetraplegia-thin corpus callosum-progressive postnatal microcephaly syndrome	Disease-causing germline mutation(s) in	Protruding ear;Motor delay;Gastroesophageal reflux;Hypsarrhythmia;Hypertelorism;Muscular hypotonia;Recurrent respiratory infections;Irritability;Brain atrophy;Congenital microcephaly;Urinary incontinence;Depressed nasal bridge;Hyperactivity;Dysphagia;Wide nasal bridge;Myoclonic spasms;Hypoplasia of the corpus callosum;Infantile spasms;Delayed speech and language development;Bilateral tonic-clonic seizure;Stereotypy;Clonus;Gastrostomy tube feeding in infancy;Hair-pulling;Synophrys;Low-set ears;Intellectual disability;Multiple joint contractures;Postnatal microcephaly;Cerebral hypomyelination;Abnormal facial shape;Lower limb spasticity;Hyperactivity;Hypoplasia of the corpus callosum;Babinski sign;Intellectual disability;Spastic tetraplegia;Global developmental delay;Seizure;Cerebral atrophy;Inability to walk;Progressive microcephaly;Generalized hypotonia;Absent speech;Autosomal recessive inheritance;Irritability;Hyperreflexia;Congenital onset		0.00290652	442.0	152072.0	2.0	32	0.97	PASS	sas	0.00747819	36.0	0.00455815	310.0	0.00277616	698.0	251426.0	2.0	73	1.0	PASS	sas	0.00633656	194.0	0.00352645	401.0	0.0028552	444	0.003	11.0				4.286	0.10142		0	0	0			SLC1A4	0.0	0.0	0.0	0.0	17.0	-34.0	-25.0	12.0						0.519	0.24	40.085683608			.			ciliary ganglion;caudate nucleus;amygdala;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skeletal muscle;globus pallidus;	.	amino acid transport;glutamine transport;L-alanine transport;L-cystine transport;proline transport;L-serine transport;threonine transport;hydroxyproline transport;synaptic transmission, glutamatergic;proline transmembrane transport;cognition;chloride transmembrane transport	centrosome;microtubule organizing center;intermediate filament;plasma membrane;integral component of plasma membrane;cell surface;membrane;integral component of membrane;dendrite;melanosome;neuronal cell body;extracellular exosome	chloride channel activity;amino acid transmembrane transporter activity;L-alanine transmembrane transporter activity;L-cystine transmembrane transporter activity;L-glutamine transmembrane transporter activity;L-proline transmembrane transporter activity;L-serine transmembrane transporter activity;L-threonine transmembrane transporter activity;symporter activity;L-hydroxyproline transmembrane transporter activity	TMEM17[26638075];NEK4[25798074];F2RL1[28298427];	65245352
43029	chr2	70456453		A	chr2:70456452-70456453	TIA1	TIA1 cytotoxic granule associated RNA binding protein	insertion	0/1	0.43	4_3	7	58.0	0/0	0.0	4_0	4	9.0			rs750862626	SPLICING	YES	NM_022173.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	3/12		NM_022173.4:c.223-3dup			-1.0					Welander distal myopathy, 604454 (3), Autosomal recessive, Autosomal dominant; Amyotrophic lateral sclerosis 26 with or without frontotemporal dementia, 619133 (3), Autosomal dominant	Distal myopathy, Welander type	Disease-causing germline mutation(s) (gain of function) in	Difficulty walking;Clumsiness;Weakness of long finger extensor muscles;Intrinsic hand muscle atrophy;EMG: myopathic abnormalities;Distal upper limb muscle weakness;Steppage gait;Rimmed vacuoles;Foot dorsiflexor weakness;Mildly elevated creatine kinase;Difficulty walking;Clumsiness;Weakness of long finger extensor muscles;Intrinsic hand muscle atrophy;EMG: myopathic abnormalities;Distal upper limb muscle weakness;Steppage gait;Rimmed vacuoles;Foot dorsiflexor weakness;Mildly elevated creatine kinase;Slow progression;Autosomal dominant inheritance;Steppage gait;Adult onset;Distal muscle weakness;Mildly elevated creatine kinase;Rimmed vacuoles;Autosomal recessive inheritance;Distal amyotrophy		0.000378955	55.0	145136.0	0.0	30	0.92	PASS	afr	0.000680306	27.0	0.000152226	10.0	0.0422291	4242.0	100452.0	0.0	51	0.83	RF	amr	0.0611822	679.0	0.0347382	1726.0	0.0002251,0.0001543,0.0207197	35,24,3222						12.93	0.929054		0	0	0			TIA1	0.0	0.03	0.0	0.0	-2.0	-6.0	-47.0	-49.0						0.354	0.83				immune system phenotype; skeleton phenotype; hematopoietic system phenotype; mortality/aging ; growth/size/body region phenotype; 			.	.	apoptotic process;fibroblast growth factor receptor signaling pathway;negative regulation of translation;negative regulation of cytokine biosynthetic process;regulation of mRNA splicing, via spliceosome;protein localization to cytoplasmic stress granule;positive regulation of epithelial cell apoptotic process	nucleoplasm;cytoplasm;cytosol;cytoplasmic stress granule;nuclear stress granule	RNA binding;protein binding;poly(A) binding;AU-rich element binding	DDX3X[18596238];AK1[26496610];WBP4[28838205];YBX1[24965446];HSCB[28380382];MKI67[26949251];TOB1[18377426];CXXC4[26496610];GABARAP[20562859];MAP1LC3B[20562859];MAP1LC3A[20562859];HABP4[21771594];POLK[26496610];GABARAPL2[20562859];RPS9[17461779];GABARAPL1[20562859];VCAM1[22623428];NETO2[26496610];ELL2[26496610];RC3H2[20412057];SND1[20643132];PTBP3[22575643];SERBP1[24205981];ANG[28777577];DCP1A[20412057;24965446];SF1[26420826];	70456452
43397	chr2	86074998	G	A	chr2:86074998	ST3GAL5	ST3 beta-galactoside alpha-2,3-sialyltransferase 5	SNV	0/1	0.58	21_29	50	99.0	0/1	0.62	26_42	68	99.0			rs149309844	EXONIC	YES	NM_003896.4	Transcript	protein_coding	synonymous_variant		4/7	NM_003896.4:c.648C>T	NP_003887.3:p.Phe216%3D		-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	GM3_synthase_deficiency|not_specified|not_provided	Salt and pepper developmental regression syndrome, 609056 (3), Autosomal recessive	Amish infantile epilepsy syndrome;Salt-and-pepper syndrome	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in	Progressive neurologic deterioration;Hypermelanotic macule;Status epilepticus;Gastrostomy tube feeding in infancy;Cerebral visual impairment;Sensorineural hearing impairment;Poor eye contact;Abnormality of the cerebral white matter;Irritability;Gastrointestinal dysmotility;Failure to thrive;Inability to walk;Microcephaly;Bilateral tonic-clonic seizure;Developmental stagnation;Stereotypy;Developmental regression;Tetraparesis;Increased serum lactate;Optic atrophy;Bilateral ptosis;Intellectual disability, profound;Nystagmus;Myoclonus;Profound global developmental delay;Cerebral cortical atrophy;Paroxysmal choreoathetosis;Depigmentation/hyperpigmentation of skin;Absent speech;Infantile muscular hypotonia;Irritability;Vomiting;Microcephaly;Ataxia;Cerebral visual impairment;Incoordination;Choreoathetosis;Slow decrease in visual acuity;Bilateral tonic-clonic seizure;Hyperintensity of cerebral white matter on MRI;Generalized hypotonia;Tremor;Myoclonic spasms;Hyporeflexia of upper limbs;Global brain atrophy;Status epilepticus;Optic atrophy;Feeding difficulties;Increased serum lactate;Tetraparesis;Hyperpigmented/hypopigmented macules;Sensorineural hearing impairment;Dyskinesia;Developmental regression;Absent speech;Failure to thrive;Intellectual disability, severe;Cerebral palsy;Functional motor deficit;Poor eye contact;Global developmental delay;Lower limb hyperreflexia;Macular hyperpigmented dermopathy;Visual loss;Myoclonus;Status epilepticus;Developmental regression;Bilateral tonic-clonic seizure;Failure to thrive;Developmental stagnation at onset of seizures;Hearing impairment;Vomiting;Lower limb hyperreflexia;Global brain atrophy;Hypermelanotic macule;Muscular hypotonia;Absent speech;Optic atrophy;Generalized hypotonia;Feeding difficulties in infancy;Autosomal recessive inheritance;Irritability;Microcephaly;Choreoathetosis;Cerebral visual impairment;Hyporeflexia of upper limbs;Global developmental delay;Multifocal epileptiform discharges		0.00365088	555.0	152018.0	2.0	32	0.96	PASS	amr	0.00969602	148.0	0.00499956	340.0	0.00257036	642.0	249770.0	0.0	92	0.99	PASS	nfe	0.00410077	461.0	0.00410077	461.0	0.0023665	368	0.005	18.0	0.00746	80.0		0.515	-0.249686		0	0	0			ST3GAL5	0.0	0.0	0.0	0.0	-14.0	2.0	-6.0	-14.0						0.713	0.03	52.560661187			mortality/aging ; nervous system phenotype ; homeostasis/metabolism phenotype; 			pons;caudate nucleus;amygdala;prefrontal cortex;whole brain;cingulate cortex;superior cervical ganglion;adrenal gland;parietal lobe;skeletal muscle;medulla oblongata;thalamus;	Glycosphingolipid biosynthesis - ganglioseries;Glycan structures - biosynthesis 2	ganglioside biosynthetic process;carbohydrate metabolic process;protein glycosylation;glycosphingolipid biosynthetic process;sialylation	Golgi membrane;integral component of plasma membrane;integral component of membrane	beta-galactoside (CMP) alpha-2,3-sialyltransferase activity;neolactotetraosylceramide alpha-2,3-sialyltransferase activity;sialyltransferase activity;lactosylceramide alpha-2,3-sialyltransferase activity	.	86074998
43407	chr2	86832132	T	C	chr2:86832132	RNF103	ring finger protein 103	SNV	0/1	0.52	24_26	50	99.0	0/1	0.4	35_23	58	99.0			rs61760875	EXONIC	YES	NM_005667.4	Transcript	protein_coding	missense_variant		4/4	NM_005667.4:c.892A>G	NP_005658.1:p.Arg298Gly		-1.0						.	.	.		0.000736009	112.0	152172.0	0.0	32	0.97	PASS	nfe	0.00110245	75.0	0.00110245	75.0	0.000787834	198.0	251322.0	1.0	68	1.0	PASS	nfe	0.00122295	139.0	0.00122295	139.0	0.0007910	123	0.001	4.0				18.42	1.829117	0.248	4	15	19	LRT_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	RNF103	0.0	0.0	0.0	0.0	-39.0	-2.0	19.0	-1.0						0.249	0.83	0.000000000	0.999	0.177	nervous system phenotype ; behavior/neurological phenotype ; 			.	.	central nervous system development;protein ubiquitination;ubiquitin-dependent ERAD pathway;endoplasmic reticulum mannose trimming	endoplasmic reticulum;endoplasmic reticulum membrane;integral component of membrane;endoplasmic reticulum quality control compartment	ubiquitin-protein transferase activity;protein binding;metal ion binding;ubiquitin protein ligase activity	UBE2W[19690564];UBE2H[19690564];UBE2D4[19690564];UBE2D2[19690564];UBE2D3[19690564];UBE2N[19690564];UBE2D1[19690564];UBE2Z[19690564];	86832132
43423	chr2	95691596	C	T	chr2:95691596	MAL	mal, T cell differentiation protein	SNV	0/1	0.52	38_42	80	99.0	0/1	0.49	56_54	110	99.0			rs145146615	EXONIC	YES	NM_002371.4	Transcript	protein_coding	missense_variant		1/4	NM_002371.4:c.59C>T	NP_002362.1:p.Thr20Ile		1.0	Marvel domain,.,.,.					.	.	.		0.00698997	1064.0	152218.0	16.0	32	0.98	PASS	nfe	0.00946641	644.0	0.00946641	644.0	0.00738056	1446.0	195920.0	15.0	15	0.39	PASS	nfe	0.00935943	808.0	0.00935943	808.0	0.0051060	794	0.009	27.0				14.54	1.17927	0.079	0	18	18		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MAL	0.0	0.0	0.0	0.0	32.0	34.0	30.0	38.0							0.79	0.000000000	0.987	0.874	vision/eye phenotype; nervous system phenotype ; 			caudate nucleus;kidney;olfactory bulb;tongue;dorsal root ganglion;spinal cord;parietal lobe;	.	membrane raft polarization;protein localization to paranode region of axon;apoptotic process;central nervous system development;cell differentiation;myelination;apical protein localization;protein insertion into plasma membrane;positive regulation of extrinsic apoptotic signaling pathway via death domain receptors	endoplasmic reticulum;integral component of membrane;apical plasma membrane;plasma membrane raft;membrane raft;hinge region between urothelial plaques of apical plasma membrane	protein binding;lipid binding;peptidase activator activity involved in apoptotic process;structural constituent of myelin sheath	EDA[25416956;unassigned1304];DAGLA[unassigned1304];AMHR2[unassigned1304];HIBADH[unassigned1304];CLSTN3[unassigned1304];PTPRN[25416956];LDLRAD1[25416956;unassigned1304];AQP6[unassigned1304];CD3G[unassigned1304];MS4A4A[unassigned1304];MC4R[28298427];SGCB[unassigned1304];CREB3L1[unassigned1304];GJA8[unassigned1304];CALN1[unassigned1304];CD53[unassigned1304];USP7[21988832];CXADR[unassigned1304];SYK[22366891];TMEM52B[unassigned1304];SLC35C2[unassigned1304];FIBCD1[25416956;unassigned1304];EMP1[unassigned1304];OPRM1[unassigned1304];FNDC9[unassigned1304];TMEM174[unassigned1304];CLEC4C[unassigned1304];SPINT1[unassigned1304];JAML[unassigned1304];CLDN14[unassigned1304];CLDN9[unassigned1304];CLDN7[unassigned1304];PLA2G10[unassigned1304];BTK[22366891];TMEM106C[unassigned1304];KCNA10[unassigned1304];STX1A[unassigned1304];SMIM3[25416956;unassigned1304];GRAMD1A[unassigned1304];SDC4[unassigned1304];LMAN2L[unassigned1304];SRC[22366891];LSMEM1[25416956];KCNA1[unassigned1304];LRTM1[unassigned1304];IL20RB[unassigned1304];PIK3R1[22366891];GPR152[unassigned1304];BCL2L13[unassigned1304];NKAIN4[unassigned1304];TMEM248[unassigned1304];PERP[unassigned1304];TMEM207[unassigned1304];SYNDIG1[unassigned1304];KCNMB4[unassigned1304];GSG1L[unassigned1304];KLRC1[25416956;unassigned1304];TIGIT[unassigned1304];LYN[22366891];NPDC1[unassigned1304];PRRT1[unassigned1304];LRRC25[unassigned1304];TM4SF18[unassigned1304];LY49L[unassigned1304];TMEM30A[unassigned1304];TNFSF14[unassigned1304];BTN2A1[unassigned1304];SLC10A1[unassigned1304];FAM209A[unassigned1304];PTK2[22366891];TSPO2[unassigned1304];GJB1[unassigned1304];EVI2A[unassigned1304];CD69[unassigned1304];MYD88[21988832];	95691596
43441	chr2	95954294	G	A	chr2:95954294	PROM2	prominin 2	SNV	0/1	0.47	71_63	134	99.0	0/1	0.37	52_31	83	99.0			rs200062940,COSV58297587	EXONIC	YES	NM_001165978.3	Transcript	protein_coding	missense_variant		22/24	NM_001165978.3:c.2398G>A	NP_001159450.1:p.Val800Ile		1.0	.,.,.					.	.	.		0.000315321	48.0	152226.0	0.0	32	0.98	PASS	amr	0.00176655	27.0	8.8186e-05	6.0	0.000206829	52.0	251416.0	0.0	70	1.0	PASS	amr	0.000549578	19.0	0.000114304	13.0	0.0001093	17	0.002	5.0				17.95	1.766953	0.031	2	17	19	MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	PROM2	0.0	0.04	0.0	0.0	6.0	-13.0	-38.0	43.0						0.824	0.0	0.000000000	0.998	1.176	immune system phenotype; vision/eye phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; pigmentation phenotype; behavior/neurological phenotype ; homeostasis/metabolism phenotype; integument phenotype ; 			ciliary ganglion;skeletal muscle;	.	positive regulation of protein phosphorylation;positive regulation of cell projection organization;regulation of GTPase activity;negative regulation of pinocytosis;regulation of clathrin-dependent endocytosis;negative regulation of caveolin-mediated endocytosis	integral component of plasma membrane;microvillus;cilium;cell surface;basolateral plasma membrane;apical plasma membrane;cytoplasmic vesicle;microvillus membrane;cell projection;microspike;membrane raft;ciliary membrane;extracellular exosome;prominosome	cholesterol binding	GPR152[unassigned1304];AMIGO1[unassigned1304];	95954294
43461	chr2	96780987		TCCTCCTCT	chr2:96780986-96780987	ADRA2B	adrenoceptor alpha 2B	insertion	0/1	0.47	68_60	128	99.0	0/1	0.33	67_35	105	99.0			rs1204257059,rs4066772	EXONIC	YES	NM_000682.7	Transcript	protein_coding	inframe_insertion		1/1	NM_000682.7:c.903_911dup	NP_000673.2:p.Glu304_Glu306dup		-1.0						Benign adult familial myoclonic epilepsy	Disease-causing germline mutation(s) (gain of function) in	EEG abnormality;Amaurosis fugax;Hand tremor;Focal-onset seizure;Intellectual disability;Headache;Generalized-onset seizure;Myoclonus	20051907					28	0.73											18	0.49							0.0209448,0.5142826	3257,79973			0.68086	7740.0		16.79	1.590496		0	0	0																	0.761	0.0	43.832499795			respiratory system phenotype; embryo phenotype; mortality/aging ; reproductive system phenotype; cardiovascular system phenotype ; cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; muscle phenotype; 			.	Neuroactive ligand-receptor interaction	activation of MAPK activity;regulation of vascular smooth muscle contraction;G protein-coupled receptor signaling pathway;adenylate cyclase-modulating G protein-coupled receptor signaling pathway;cell-cell signaling;female pregnancy;negative regulation of norepinephrine secretion;platelet activation;activation of protein kinase B activity;negative regulation of epinephrine secretion;receptor transactivation;positive regulation of MAPK cascade;positive regulation of neuron differentiation;positive regulation of blood pressure;positive regulation of uterine smooth muscle contraction;adrenergic receptor signaling pathway;adenylate cyclase-activating adrenergic receptor signaling pathway	plasma membrane;integral component of plasma membrane;cell surface	adrenergic receptor activity;alpha2-adrenergic receptor activity;protein binding;epinephrine binding	RAB26[23105096];SH3GL2[25517094];SH3GL1[25517094];	96780986
43466	chr2	96949750	GAGG		chr2:96949750-96949753	SNRNP200	small nuclear ribonucleoprotein U5 subunit 200	deletion	0|1	0.25	12_4	16	99.0	0/0	0.0	38_0	38	0.0			rs752499482	SPLICING	YES	NM_014014.5	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	31/44		NM_014014.5:c.4393-11_4393-8del			-1.0					Retinitis pigmentosa 33, 610359 (3), Autosomal dominant	Retinitis pigmentosa	Disease-causing germline mutation(s) in	Optic disc pallor;Autosomal dominant inheritance;Attenuation of retinal blood vessels;Rod-cone dystrophy;Retinal pigment epithelial atrophy;Bone spicule pigmentation of the retina;Visual impairment;Nyctalopia;Hyperinsulinemia;Optic atrophy;Nystagmus;Abnormal retinal vascular morphology;Obesity;Hypoplasia of penis;Cataract;Abnormality of retinal pigmentation;Keratoconus;Progressive night blindness;Ophthalmoplegia;Abnormal testis morphology;Atypical scarring of skin;Hyperreflexia;Sensorineural hearing impairment;Blindness;Type II diabetes mellitus;Conductive hearing impairment;Photophobia;Intellectual disability;Anteverted nares;Abnormal electroretinogram;Wide nasal bridge;Hypogonadism;Glaucoma		1.39026e-05	2.0	143858.0	0.0	32	0.95	AS_VQSR	afr	4.98679e-05	2.0	0.0	0.0	8.28149e-05	16.0	193202.0	0.0	97	0.58	RF	nfe	0.000143414	12.0	0.000143414	12.0	0.0000064	1			0.01391	155.0		5.935	0.20639		0	0	0			SNRNP200	0.03	0.0	0.0	0.0	20.0	-7.0	-42.0	-18.0						0.112	1.0				limbs/digits/tail phenotype; mortality/aging ; cardiovascular system phenotype ; 			ciliary ganglion;testis - interstitial;placenta;testis;globus pallidus;	Starch and sucrose metabolism;Folate biosynthesis	cis assembly of pre-catalytic spliceosome;spliceosome conformational change to release U4 (or U4atac) and U1 (or U11);mRNA splicing, via spliceosome;osteoblast differentiation	nucleus;nucleoplasm;spliceosomal complex;U5 snRNP;membrane;U4/U6 x U5 tri-snRNP complex;catalytic step 2 spliceosome;post-mRNA release spliceosomal complex	RNA binding;ATP-dependent RNA helicase activity;protein binding;ATP binding;ATP-dependent helicase activity;identical protein binding	MEGF10[12421765];YWHAB[15324660;17353931];EIF4A3[23084401];HSPB1[25277244];YBX1[23986595];DDX41[25920683];USP39[19615732];FOXM1[25609649];MKI67[26949251];DUX4[26816005];DUSP16[28330616];FOXQ1[25609649];EFTUD2[unassigned1312];METTL14[29507755];MAP1LC3A[20562859];NUDCD1[29021621];MYC[17353931;17314511];CHMP1B[16730941];CASP4[17353931];MAGOH[23084401];RIOK1[unassigned1312];IKBKE[17353931];YWHAG[15324660;17353931];RBM5[22569250];PPP1R16B[30021884];GABARAPL2[20562859];GABARAPL1[20562859];HSP90AA1[19875381];METTL3[29507755];PRPF4B[23602568];PRKAB1[17353931];TIRAP[21903422];PRPF4[26496610];PRPF6[27173435;unassigned1312];CD2BP2[17353931;unassigned1312];TOP1[15848144];SNRNP200[22365833];SNRPB[17353931];SF3B2[22365833];EPB41[17353931];FOXG1[25609649];WBP4[28838205];FOXK2[25609649];STK4[23386615];PRPF8[9774689;unassigned1312;23704370];GABARAP[20562859];CIAO1[17353931];RNF113A[22365833];IRAK2[21903422];VHL[17353931];SNCA[26496610];SMAD2[20195357];JUN[25609649];SF3A2[17332742];VCAM1[22623428];RAB4B[26496610];NEK4[25798074];ADRM1[24811749];CDC5L[20467437];RRP1B[20926688];MCC[17353931];MEX3C[22863774];GNMT[unassigned1304];SMU1[unassigned1312];LSM8[22365833];SNRNP40[9774689;17353931];PPP5C[28330616];SNW1[20467437;12840015];AGO1[17932509];RNPS1[17353931];GRB2[18624398];CD247[24502978];FERMT3[26496610];	96949749
43522	chr2	97866079	C	T	chr2:97866079	ANKRD36	ankyrin repeat domain 36	SNV	0/1	0.43	4_3	7	63.0	0/0	0.0	7_0	7	21.0			rs746699789,COSV101347559,COSV70739221	EXONIC	YES	NM_001354587.1	Transcript	protein_coding	missense_variant		45/76	NM_001354587.1:c.2764C>T	NP_001341516.1:p.Arg922Trp		1.0	.,.					.	.	.		5.26975e-05	8.0	151810.0	0.0	44	0.98	PASS	sas	0.000209732	1.0	1.47271e-05	1.0	0.000126661	31.0	244748.0	0.0	76	0.98	PASS	amr	0.000583363	20.0	1.78859e-05	2.0	0.0001286	20	0.0	1.0				20.2	2.041499	0.125	5	15	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LIST-S2_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKRD36	0.0	0.08	0.0	0.05	49.0	-8.0	-41.0	20.0							0.0		0.0	-1.778	.			.	.	.	.	.	GOLGA2[unassigned1304];HMBOX1[unassigned1304];STAC3[unassigned1304];EVI5L[unassigned1304];IKZF1[unassigned1304];CEP76[unassigned1304];	97866079
43524	chr2	98129707	G	T	chr2:98129707	ANKRD36B	ankyrin repeat domain 36B	SNV	0/0	0.0	7_0	7	21.0	0|1	0.29	5_2	7	69.0			rs79527710	EXONIC	YES	NM_025190.4	Transcript	protein_coding	missense_variant		38/44	NM_025190.4:c.2741C>A	NP_079466.3:p.Pro914Gln		-1.0	.,.,.					.	.	.						19	0.49							5.89887e-05	5.0	84762.0	0.0	5	0.19	RF	afr	0.00109987	5.0	0.0	0.0	0.0000064	1	0.001	2.0				0.317	-0.320727		0	10	10		SIFT,PolyPhen,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	ANKRD36B	0.0	0.0	0.0	0.0	-24.0	-27.0	11.0	-28.0									0.004	-0.518	.			.	.	.	.	protein binding	FAM9B[25416956];ZCCHC10[unassigned1304];NDUFB7[unassigned1304];EXOC8[unassigned1304];DDIT4L[unassigned1304];WDYHV1[unassigned1304];AKAP17A[unassigned1304];GEM[unassigned1304];TXN2[unassigned1304];GLIS2[unassigned1304];TXNRD3NB[unassigned1304];MAB21L3[unassigned1304];SDCBP[unassigned1304];PER3[26496610];EHHADH[unassigned1304];TADA3[unassigned1304];TNFAIP8L1[unassigned1304];DVL3[unassigned1304];GAPDH[26496610];ANKRD36B[unassigned1304];	98129707
43525	chr2	98129716	A	G	chr2:98129716	ANKRD36B	ankyrin repeat domain 36B	SNV	0/0	0.0	7_0	7	21.0	0|1	0.29	5_2	7	69.0			rs80295552	EXONIC	YES	NM_025190.4	Transcript	protein_coding	missense_variant		38/44	NM_025190.4:c.2732T>C	NP_079466.3:p.Val911Ala		-1.0	.,.,.					.	.	.						19	0.49							3.58663e-05	6.0	167288.0	0.0	13	0.29	PASS	afr	0.000855432	6.0	0.0	0.0	0.0000064	1						4.635	0.122616		0	10	10		SIFT,PolyPhen,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	ANKRD36B	0.0	0.01	0.0	0.0	14.0	-36.0	-37.0	2.0									0.0	-1.089	.			.	.	.	.	protein binding	FAM9B[25416956];ZCCHC10[unassigned1304];NDUFB7[unassigned1304];EXOC8[unassigned1304];DDIT4L[unassigned1304];WDYHV1[unassigned1304];AKAP17A[unassigned1304];GEM[unassigned1304];TXN2[unassigned1304];GLIS2[unassigned1304];TXNRD3NB[unassigned1304];MAB21L3[unassigned1304];SDCBP[unassigned1304];PER3[26496610];EHHADH[unassigned1304];TADA3[unassigned1304];TNFAIP8L1[unassigned1304];DVL3[unassigned1304];GAPDH[26496610];ANKRD36B[unassigned1304];	98129716
43526	chr2	98129717	C	T	chr2:98129717	ANKRD36B	ankyrin repeat domain 36B	SNV	0/0	0.0	7_0	7	21.0	0|1	0.29	5_2	7	69.0			rs74341509	EXONIC	YES	NM_025190.4	Transcript	protein_coding	missense_variant		38/44	NM_025190.4:c.2731G>A	NP_079466.3:p.Val911Met		-1.0	.,.,.					.	.	.		8.25603e-05	11.0	133236.0	1.0	19	0.49	PASS	nfe	0.000165978	11.0	0.000165978	11.0	7.89818e-05	14.0	177256.0	0.0	14	0.32	PASS	afr	0.000678426	5.0	0.000101258	8.0	0.0000129	2						4.229	0.098016		0	10	10		SIFT,PolyPhen,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	ANKRD36B	0.0	0.0	0.0	0.0	-34.0	13.0	41.0	1.0									0.001	-0.251	.			.	.	.	.	protein binding	FAM9B[25416956];ZCCHC10[unassigned1304];NDUFB7[unassigned1304];EXOC8[unassigned1304];DDIT4L[unassigned1304];WDYHV1[unassigned1304];AKAP17A[unassigned1304];GEM[unassigned1304];TXN2[unassigned1304];GLIS2[unassigned1304];TXNRD3NB[unassigned1304];MAB21L3[unassigned1304];SDCBP[unassigned1304];PER3[26496610];EHHADH[unassigned1304];TADA3[unassigned1304];TNFAIP8L1[unassigned1304];DVL3[unassigned1304];GAPDH[26496610];ANKRD36B[unassigned1304];	98129717
43527	chr2	98129731	C	T	chr2:98129731	ANKRD36B	ankyrin repeat domain 36B	SNV	0/0	0.0	9_0	9	27.0	0|1	0.2	8_2	10	60.0			rs144131603	EXONIC	YES	NM_025190.4	Transcript	protein_coding	missense_variant		38/44	NM_025190.4:c.2717G>A	NP_079466.3:p.Arg906Lys		-1.0	.,.,.					.	.	.						19	0.49							0.00808308	1447.0	179016.0	5.0	24	0.64	PASS	afr	0.028429	211.0	0.00805188	637.0	0.0001350	21	0.035	99.0				5.87	0.201984		1	9	10	SIFT	PolyPhen,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	ANKRD36B	0.0	0.0	0.0	0.0	-2.0	-1.0	-13.0	38.0									0.0	-1.385	.			.	.	.	.	protein binding	FAM9B[25416956];ZCCHC10[unassigned1304];NDUFB7[unassigned1304];EXOC8[unassigned1304];DDIT4L[unassigned1304];WDYHV1[unassigned1304];AKAP17A[unassigned1304];GEM[unassigned1304];TXN2[unassigned1304];GLIS2[unassigned1304];TXNRD3NB[unassigned1304];MAB21L3[unassigned1304];SDCBP[unassigned1304];PER3[26496610];EHHADH[unassigned1304];TADA3[unassigned1304];TNFAIP8L1[unassigned1304];DVL3[unassigned1304];GAPDH[26496610];ANKRD36B[unassigned1304];	98129731
43528	chr2	98129733	A	C	chr2:98129733	ANKRD36B	ankyrin repeat domain 36B	SNV	0/0	0.0	9_0	9	27.0	0|1	0.2	8_2	10	60.0			rs879468063	EXONIC	YES	NM_025190.4	Transcript	protein_coding	stop_gained		38/44	NM_025190.4:c.2715T>G	NP_079466.3:p.Tyr905Ter		-1.0	.,.,.					.	.	.						19	0.49							0.00979901	1683.0	171752.0	9.0	25	0.67	RF	afr	0.0336207	234.0	0.0097312	732.0	0.0001479	23	0.026	72.0				6.124	0.219396		0	3	3		BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	ANKRD36B	0.0	0.0	0.0	0.0	34.0	-3.0	-15.0	36.0									0.002	0.03	.			.	.	.	.	protein binding	FAM9B[25416956];ZCCHC10[unassigned1304];NDUFB7[unassigned1304];EXOC8[unassigned1304];DDIT4L[unassigned1304];WDYHV1[unassigned1304];AKAP17A[unassigned1304];GEM[unassigned1304];TXN2[unassigned1304];GLIS2[unassigned1304];TXNRD3NB[unassigned1304];MAB21L3[unassigned1304];SDCBP[unassigned1304];PER3[26496610];EHHADH[unassigned1304];TADA3[unassigned1304];TNFAIP8L1[unassigned1304];DVL3[unassigned1304];GAPDH[26496610];ANKRD36B[unassigned1304];	98129733
43529	chr2	98129734	T	C	chr2:98129734	ANKRD36B	ankyrin repeat domain 36B	SNV	0/0	0.0	9_0	9	27.0	0|1	0.2	8_2	10	60.0			rs146893214	EXONIC	YES	NM_025190.4	Transcript	protein_coding	missense_variant		38/44	NM_025190.4:c.2714A>G	NP_079466.3:p.Tyr905Cys		-1.0	.,.,.					.	.	.						19	0.49							0.0306598	4594.0	149838.0	35.0	27	0.71	PASS	afr	0.0848603	565.0	0.0343148	2163.0	0.0001608	25	0.014	37.0				7.616	0.331799		1	9	10	PrimateAI_pred	SIFT,PolyPhen,MutationAssessor_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	ANKRD36B	0.0	0.0	0.0	0.0	9.0	-4.0	1.0	35.0									0.003	0.774	.			.	.	.	.	protein binding	FAM9B[25416956];ZCCHC10[unassigned1304];NDUFB7[unassigned1304];EXOC8[unassigned1304];DDIT4L[unassigned1304];WDYHV1[unassigned1304];AKAP17A[unassigned1304];GEM[unassigned1304];TXN2[unassigned1304];GLIS2[unassigned1304];TXNRD3NB[unassigned1304];MAB21L3[unassigned1304];SDCBP[unassigned1304];PER3[26496610];EHHADH[unassigned1304];TADA3[unassigned1304];TNFAIP8L1[unassigned1304];DVL3[unassigned1304];GAPDH[26496610];ANKRD36B[unassigned1304];	98129734
43530	chr2	98129744	C	T	chr2:98129744	ANKRD36B	ankyrin repeat domain 36B	SNV	0/0	0.0	8_0	8	24.0	0|1	0.22	7_2	9	63.0			rs5011473	EXONIC	YES	NM_025190.4	Transcript	protein_coding	missense_variant		38/44	NM_025190.4:c.2704G>A	NP_079466.3:p.Glu902Lys		-1.0	.,.,.					.	.	.		0.0	0.0	134358.0	0.0	19	0.49	AC0_AS_VQSR				0.0	0.0	0.312164	44411.0	142268.0	941.0	38	0.89	InbreedingCoeff_RF	afr	0.405859	3505.0	0.324883	21940.0	0.0018070	281	0.085	265.0				11.25	0.712211		4	8	12	PolyPhen,Polyphen2_HDIV_pred,BayesDel_addAF_pred,fathmm-MKL_coding_pred	SIFT,Polyphen2_HVAR_pred,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_noAF_pred,LIST-S2_pred	ANKRD36B	0.0	0.0	0.0	0.0	-14.0	-1.0	25.0	-26.0									0.006	-0.083	.			.	.	.	.	protein binding	FAM9B[25416956];ZCCHC10[unassigned1304];NDUFB7[unassigned1304];EXOC8[unassigned1304];DDIT4L[unassigned1304];WDYHV1[unassigned1304];AKAP17A[unassigned1304];GEM[unassigned1304];TXN2[unassigned1304];GLIS2[unassigned1304];TXNRD3NB[unassigned1304];MAB21L3[unassigned1304];SDCBP[unassigned1304];PER3[26496610];EHHADH[unassigned1304];TADA3[unassigned1304];TNFAIP8L1[unassigned1304];DVL3[unassigned1304];GAPDH[26496610];ANKRD36B[unassigned1304];	98129744
43538	chr2	98920215	G	A	chr2:98920215	VWA3B	von Willebrand factor A domain containing 3B	SNV	0/1	0.39	27_17	44	99.0	0/1	0.27	51_19	70	99.0			rs146673560,COSV71373887	EXONIC	YES	NM_144992.5	Transcript	protein_coding	synonymous_variant		26/28	NM_144992.5:c.3471G>A	NP_659429.4:p.Ala1157%3D		1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	not_provided	?Spinocerebellar ataxia, autosomal recessive 22, 616948 (3), Autosomal recessive	.	.	Lower limb spasticity;Autosomal recessive inheritance;Nystagmus;Dysmetria;Hypoplasia of the corpus callosum;Cerebellar atrophy;Intention tremor;Dysarthria;Unsteady gait;Hyperreflexia;Truncal ataxia;Slow progression;Intellectual disability;Abnormal pyramidal sign		0.00036814	56.0	152116.0	0.0	32	0.97	PASS	amr	0.00202986	31.0	0.000117606	8.0	0.000268496	67.0	249538.0	0.0	71	1.0	PASS	amr	0.00086886	30.0	0.000141275	16.0	0.0002379	37	0.002	5.0				1.118	-0.134215		0	0	0			VWA3B	0.0	0.11	0.0	0.13	22.0	-50.0	-7.0	50.0						0.959	0.0	54.264395328			.			.	.	.	cytoplasm	.	.	98920215
43542	chr2	98999847	G	A	chr2:98999847	CNGA3	cyclic nucleotide gated channel alpha 3	SNV	0/1	0.49	38_36	74	99.0	0/1	0.37	73_43	116	99.0			rs114951127	SPLICING	YES	NM_001298.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	4/7		NM_001298.3:c.396-4G>A			1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Achromatopsia_2|not_provided	Achromatopsia 2, 216900 (3), Autosomal recessive	Cone rod dystrophy;Achromatopsia	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Blindness;Photophobia;Achromatopsia;Nystagmus;Hemeralopia;Autosomal recessive inheritance;Dyschromatopsia;Attenuation of retinal blood vessels;Hypoplasia of the fovea;Abnormal electroretinogram;Exotropia;Hypermetropia;Granular macular appearance;Retinal pigment epithelial atrophy;Blue cone monochromacy;Central scotoma;Photophobia;Pendular nystagmus;Photophobia;Visual impairment;Color vision defect;Abnormality of retinal pigmentation;Nyctalopia		0.00340686	518.0	152046.0	1.0	32	0.97	PASS	afr	0.009036	374.0	0.000514615	35.0	0.00170695	429.0	251326.0	1.0	98	1.0	PASS	afr	0.010116	164.0	0.000589291	67.0	0.0017106	266	0.005	15.0	0.00474	54.0		4.49	0.113794		0	0	0			CNGA3	0.04	0.0	0.0	0.0	4.0	-45.0	28.0	4.0	5.02323345786381e-05	0.0	11.153	0.196	11.349	0.0506	0.0				vision/eye phenotype; nervous system phenotype ; behavior/neurological phenotype ; taste/olfaction phenotype; 			pituitary;ciliary ganglion;appendix;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;spinal cord;skeletal muscle;globus pallidus;	Olfactory transduction	cation transport;signal transduction;visual perception;response to corticosteroid;response to magnesium ion;response to cAMP;inorganic cation import across plasma membrane	cytoplasm;plasma membrane;dendrite;axon initial segment;perikaryon;glial cell projection;transmembrane transporter complex	intracellular cAMP-activated cation channel activity;intracellular cGMP-activated cation channel activity;protein C-terminus binding;ligand-gated ion channel activity;cGMP binding	MIS18A[unassigned1304];HNRNPU[30021884];ARRB1[17620599];	98999847
43573	chr2	99936266	A		chr2:99936266	TXNDC9	thioredoxin domain containing 9	deletion	0/1	0.43	8_6	14	99.0	0/1	0.33	4_3	9	62.0			rs751602309	SPLICING	YES	NM_005783.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	4/4		NM_005783.4:c.564-4del			-1.0						.	.	.		0.00527768	727.0	137750.0	1.0	32	0.89	PASS	eas	0.00640761	31.0	0.00478287	302.0	0.395651	47691.0	120538.0	1.0	17	0.41	InbreedingCoeff	sas	0.439577	6562.0	0.38531	21723.0	0.0001929,0.0007588,0.1928375	30,118,29987						10.51	0.623083		0	0	0			TXNDC9	0.02	0.02	0.0	0.0	-31.0	-3.0	-14.0	-2.0						0.471	0.22				.			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;	.	biological_process;cell redox homeostasis	cellular_component;nucleus;centrosome;cytosol;midbody	protein binding;cadherin binding	C1orf94[25416956];CEP126[16169070];CHD3[16169070];PTN[16169070];MRPL12[unassigned1304];TUBA1C[26496610];TUBA1A[27291054;29568061];PNMA1[25416956];C3orf62[25416956];EXOSC8[25416956;unassigned1304];POC1A[26638075];CEP170[26638075];COX14[29568061];TRIM27[25416956];MAGEA6[21516116;25416956];CEP76[25416956];LZTS1[unassigned1304];GIT1[16169070];MYOG[25416956];KLF11[25416956];STIL[26638075];SETDB1[16169070];COG4[unassigned1304];ELP1[16169070];IMMT[16169070];PBX4[unassigned1304];TUBG1[29568061];MED22[unassigned1304];TEX9[unassigned1304];FEZ1[16169070];PICK1[unassigned1304];DYDC1[25416956];B9D1[26638075];ZNF655[unassigned1304];CCDC172[25416956];	99936265
43798	chr2	113943522	C	A	chr2:113943522	PSD4	pleckstrin and Sec7 domain containing 4	SNV	0/0	0.0	43_0	43	99.0	0/1	0.54	61_73	134	99.0			rs546428381	EXONIC	YES	NM_012455.3	Transcript	protein_coding	missense_variant		5/17	NM_012455.3:c.1318C>A	NP_036587.2:p.Pro440Thr		1.0						.	.	.		3.9414e-05	6.0	152230.0	0.0	33	0.98	PASS	amr	0.000196258	3.0	2.93979e-05	2.0	5.59333e-05	14.0	250298.0	0.0	42	0.95	PASS	amr	0.000202722	7.0	6.19579e-05	7.0	0.0000707	11	0.001	2.0				18.4	1.826338	0.038	2	17	19	SIFT,MutationTaster_pred	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PSD4	0.01	0.0	0.0	0.0	4.0	-4.0	4.0	-25.0						0.553	0.81	0.000000000	0.05	-0.371	.			thymus;white blood cells;liver;superior cervical ganglion;	.	regulation of ARF protein signal transduction	membrane;cleavage furrow;ruffle membrane	ARF guanyl-nucleotide exchange factor activity;phospholipid binding	ARL14[21458045];PPP2R2B[19156129];LDLRAP1[unassigned1304;25910212];ARF6[21458045];	113943522
43869	chr2	118575304	G	A	chr2:118575304	DDX18	DEAD-box helicase 18	SNV	0/1	0.45	12_10	22	99.0	0/0	0.0	29_0	29	69.0			rs200312980	SPLICING	YES	NM_006773.4	Transcript	protein_coding	missense_variant,splice_region_variant		2/14	NM_006773.4:c.370G>A	NP_006764.3:p.Asp124Asn		1.0						.	.	.		0.000236599	36.0	152156.0	0.0	33	0.97	PASS	sas	0.00331813	16.0	0.000176393	12.0	0.000670768	152.0	226606.0	0.0	40	0.78	PASS	sas	0.00339287	87.0	0.000424472	45.0	0.0006624	103						29.2	4.167818	0.672	5	15	20	MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	DDX18	0.0	0.0	0.64	0.02	-19.0	-36.0	4.0	0.0	0.999902444543283	1.0	4.336	4.032	8.368	0.588	0.84	0.000000000	0.207	0.221	.			pons;ciliary ganglion;white blood cells;testis - seminiferous tubule;subthalamic nucleus;trigeminal ganglion;atrioventricular node;superior cervical ganglion;cingulate cortex;skeletal muscle;globus pallidus;	Starch and sucrose metabolism;Folate biosynthesis	cellular response to estradiol stimulus	chromosome;nucleolus;membrane	RNA binding;ATP-dependent RNA helicase activity;protein binding;ATP binding	PATJ[16169070];RPL10[26496610];PINX1[17353931];CRMP1[16169070];HNRNPU[26496610];YBX1[25497084];HSCB[28380382];AURKB[29568061];TGOLN2[29568061];FBL[29568061];MTA1[16169070];HIST1H3A[29568061];IFI16[25665578];NOP56[26496610];JUN[25609649];VCAM1[22623428];RPS6[29568061];FN1[19738201];RRP1B[20926688];ESR1[21182205];RAB11A[29568061];GNL3[30021884];AGO1[17932509];CANX[29568061];RAB9A[29568061];MNDA[25665578];CD247[24502978];AURKAIP1[29568061];EZR[29568061];RPL29[30021884];BET1[29568061];	118575304
43870	chr2	118577312	A	C	chr2:118577312	DDX18	DEAD-box helicase 18	SNV	0/0	0.0	37_0	37	99.0	0/1	0.39	27_17	44	99.0			rs143106122	EXONIC	YES	NM_006773.4	Transcript	protein_coding	missense_variant		3/14	NM_006773.4:c.458A>C	NP_006764.3:p.Lys153Thr		1.0						.	.	.		0.000716182	109.0	152196.0	1.0	33	0.97	PASS	amr	0.00497578	76.0	0.000323349	22.0	0.000584578	145.0	248042.0	0.0	37	0.77	PASS	amr	0.00318339	107.0	0.000265774	30.0	0.0004952	77	0.006	20.0				10.71	0.646713	0.054	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	DDX18	0.0	0.0	0.0	0.0	6.0	2.0	28.0	-8.0						0.588	0.84	0.000000000	0.274	1.312	.			pons;ciliary ganglion;white blood cells;testis - seminiferous tubule;subthalamic nucleus;trigeminal ganglion;atrioventricular node;superior cervical ganglion;cingulate cortex;skeletal muscle;globus pallidus;	Starch and sucrose metabolism;Folate biosynthesis	cellular response to estradiol stimulus	chromosome;nucleolus;membrane	RNA binding;ATP-dependent RNA helicase activity;protein binding;ATP binding	PATJ[16169070];RPL10[26496610];PINX1[17353931];CRMP1[16169070];HNRNPU[26496610];YBX1[25497084];HSCB[28380382];AURKB[29568061];TGOLN2[29568061];FBL[29568061];MTA1[16169070];HIST1H3A[29568061];IFI16[25665578];NOP56[26496610];JUN[25609649];VCAM1[22623428];RPS6[29568061];FN1[19738201];RRP1B[20926688];ESR1[21182205];RAB11A[29568061];GNL3[30021884];AGO1[17932509];CANX[29568061];RAB9A[29568061];MNDA[25665578];CD247[24502978];AURKAIP1[29568061];EZR[29568061];RPL29[30021884];BET1[29568061];	118577312
43879	chr2	119604141	C	G	chr2:119604141	EN1	engrailed homeobox 1	SNV	0/0	0.0	39_0	39	99.0	0|1	0.55	9_11	20	99.0			rs931210130,COSV54632719,COSV99727232	EXONIC	YES	NM_001426.4	Transcript	protein_coding	synonymous_variant		1/2	NM_001426.4:c.603G>C	NP_001417.3:p.Ala201%3D		-1.0					?ENDOVE syndrome, limb-brain type, 619218 (3), Autosomal recessive	.	.	.		0.00403632	601.0	148898.0	2.0	32	0.94	PASS	amr	0.00781041	117.0	0.00535885	359.0	0.00568586	16.0	2814.0	0.0	0	0.0	PASS	amr	0.0166667	1.0	0.00888325	14.0	0.0001994	31	0.001	2.0				10.75	0.651239		0	0	0			EN1	0.0	0.0	0.0	0.0	-47.0	50.0	32.0	0.0							0.75				integument phenotype ; growth/size/body region phenotype; endocrine/exocrine gland phenotype; muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; skeleton phenotype; embryo phenotype; behavior/neurological phenotype ; reproductive system phenotype; mortality/aging ; normal phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; pigmentation phenotype; nervous system phenotype ; limbs/digits/tail phenotype; immune system phenotype; 			superior cervical ganglion;	.	negative regulation of transcription by RNA polymerase II;skeletal system development;adult locomotory behavior;anatomical structure morphogenesis;dorsal/ventral pattern formation;proximal/distal pattern formation;cerebellum development;midbrain development;midbrain-hindbrain boundary development;embryonic forelimb morphogenesis;social behavior;multicellular organism growth;drinking behavior;pigmentation;negative regulation of neuron apoptotic process;positive regulation of transcription by RNA polymerase II;neuron development;motor learning;dopaminergic neuron differentiation;embryonic brain development	nucleus	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific	SMARCA1[14609955];BPTF[14609955];	119604141
43892	chr2	120204460	G	A	chr2:120204460	SCTR	secretin receptor	SNV	0/0	0.0	35_0	35	99.0	0/1	0.51	26_28	55	99.0			rs143434396	SPLICING	YES	NM_002980.3	Transcript	protein_coding	missense_variant,splice_region_variant		11/13	NM_002980.3:c.1015C>T	NP_002971.2:p.Arg339Cys		-1.0	GPCR, family 2-like					.	.	.		0.00145219	221.0	152184.0	0.0	32	0.96	PASS	amr	0.00517016	79.0	0.00158721	108.0	0.00129146	248.0	192030.0	2.0	17	0.46	PASS	amr	0.00429965	97.0	0.00131696	121.0	0.0010675	166	0.011	34.0				30.0	4.280324	0.68	14	7	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,ClinPred_pred	SCTR	0.05	0.0	0.0	0.0	1.0	-1.0	2.0	-10.0	0.700169386722566	0.608	10.67	-1.148	9.522	0.864	0.0	0.000000000	0.992	1.176	immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype ; hematopoietic system phenotype; nervous system phenotype ; renal/urinary system phenotype; 			atrioventricular node;trigeminal ganglion;superior cervical ganglion;	Neuroactive ligand-receptor interaction	cell surface receptor signaling pathway;G protein-coupled receptor signaling pathway;brain development	cytoplasmic microtubule;plasma membrane;integral component of membrane	G protein-coupled peptide receptor activity;secretin receptor activity;peptide hormone binding	CYFIP1[21988832];CALM1[15670850];DNAL4[21988832];	120204460
43922	chr2	121999927	C	T	chr2:121999927	TFCP2L1	transcription factor CP2 like 1	SNV	0/0	0.0	42_0	42	99.0	0/1	0.5	19_19	38	99.0			rs142941586,COSV99748972	SPLICING	YES	NM_014553.3	Transcript	protein_coding	splice_region_variant,intron_variant	7/14		NM_014553.3:c.768+8G>A			-1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00260875	397.0	152180.0	3.0	32	0.96	PASS	amr	0.0041225	63.0	0.00220497	150.0	0.00357265	898.0	251354.0	10.0	72	1.0	PASS	sas	0.00339692	104.0	0.00272705	310.0	0.0028681	446	0.006	20.0				7.64	0.333713		0	0	0			TFCP2L1	0.0	0.0	0.0	0.0	-2.0	9.0	-5.0	8.0	0.0002655732910241	0.01				0.0581	1.0				endocrine/exocrine gland phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; digestive/alimentary phenotype; mortality/aging ; respiratory system phenotype; renal/urinary system phenotype; 			ciliary ganglion;kidney;atrioventricular node;superior cervical ganglion;	.	negative regulation of transcription by RNA polymerase II;cell morphogenesis;epithelial cell maturation;regulation of transcription by RNA polymerase II;steroid biosynthetic process;cytoplasm organization;salivary gland development;female pregnancy;determination of adult lifespan;positive regulation of growth	fibrillar center;nucleus;mitochondrion;membrane	RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;transcription corepressor activity;sequence-specific DNA binding	CFAP20[21988832];	121999927
43989	chr2	128393336	C	T	chr2:128393336	MYO7B	myosin VIIB	SNV	0/1	0.43	67_50	117	99.0	0/0	0.0	33_0	33	99.0			rs200149655	EXONIC	YES	NM_001080527.2	Transcript	protein_coding	missense_variant		43/47	NM_001080527.2:c.5782C>T	NP_001073996.1:p.Arg1928Trp		1.0	FERM central domain&FERM domain&Band 4.1 domain&FERM central domain,FERM central domain&FERM domain&Band 4.1 domain&FERM central domain,FERM central domain&FERM domain&Band 4.1 domain&FERM central domain					.	.	.		0.000906666	138.0	152206.0	0.0	33	0.97	PASS	nfe	0.00149951	102.0	0.00149951	102.0	0.00121392	278.0	229010.0	1.0	39	0.65	PASS	nfe	0.00184448	190.0	0.00184448	190.0	0.0013183	205	0.004	12.0	0.00202	23.0		23.3	2.868287	0.361	10	11	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MutationAssessor_pred,PROVEAN_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,LRT_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred	MYO7B	0.0	0.03	0.0	0.0	-43.0	-36.0	-6.0	43.0						0.203	0.0	0.000000000	0.586	0.929	homeostasis/metabolism phenotype; 			pons;ciliary ganglion;subthalamic nucleus;testis - interstitial;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;medulla oblongata;	.	cell differentiation;brush border assembly	microvillus;brush border;myosin complex;apical cytoplasm	motor activity;protein binding;ATP binding;actin filament binding	HADHA[30021884];CDHR2[24725409];USH1C[24725409];CDHR5[24725409];	128393336
44040	chr2	129026227	G	T	chr2:129026227	HS6ST1	heparan sulfate 6-O-sulfotransferase 1	SNV	0/1	0.26	57_20	77	99.0	0/1	0.3	42_18	60	99.0			rs3958533,COSV52126236	EXONIC	YES	NM_004807.3	Transcript	protein_coding	missense_variant		2/2	NM_004807.3:c.745C>A	NP_004798.3:p.Arg249Ser		-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Hypogonadotropic_hypogonadism_7_with_or_without_anosmia|Hypogonadotropic_hypogonadism_15_with_or_without_anosmia|not_provided	{Hypogonadotropic hypogonadism 15 with or without anosmia}, 614880 (3), Autosomal dominant	Kallmann syndrome;Normosmic congenital hypogonadotropic hypogonadism	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Decreased testicular size;Decreased serum testosterone level;Congenital sensorineural hearing impairment;Osteopenia;Abnormality of body height;Delayed skeletal maturation;Cleft palate;Camptodactyly;Depressivity;Abnormality of the voice;Eunuchoid habitus;Secondary amenorrhea;Anxiety;Primary amenorrhea;Delayed puberty;Breast hypoplasia;Male hypogonadism;Gynecomastia;Hypogonadotropic hypogonadism;Female hypogonadism;Hypertelorism;Absence of secondary sex characteristics;Hypoplasia of the uterus;Abnormality of the dentition;Cryptorchidism;Impotence;Depressed nasal bridge;Generalized joint laxity;Micropenis;Sparse body hair;Absence of pubertal development;Non-obstructive azoospermia;Increased female libido;Wide intermamillary distance;Hypoplasia of the ovary;Osteoporosis;Decreased testicular size;Small pituitary gland;Cryptorchidism;Micropenis;Genu valgum;Cleft palate;Autosomal dominant inheritance;Primary amenorrhea;Color vision defect;Micropenis;Hypothalamic gonadotropin-releasing hormone deficiency;Abnormality of the voice;Reduced number of teeth;Hypogonadotropic hypogonadism;Decreased fertility;Pes cavus;Reduced bone mineral density;Gynecomastia;Bimanual synkinesia;Recurrent fractures;Dyspareunia;Decreased testicular size;Muscular hypotonia;Paraplegia;Sensorineural hearing impairment;Tremor;Abnormal morphology of female internal genitalia;Delayed puberty;Ataxia;Cleft palate;Erectile dysfunction;Visual impairment;Anosmia;Breast hypoplasia;Skeletal dysplasia;Gait disturbance;Ichthyosis;Primary amenorrhea;Cryptorchidism;Abnormality of cardiovascular system morphology;Pes planus;Delayed skeletal maturation;Ptosis;Dysarthria;Muscle weakness;Hyposmia;Anterior hypopituitarism;Seizure;Obesity;Renal agenesis;Nystagmus		0.00589105	733.0	124426.0	0.0	33	0.92	PASS	sas	0.00848765	33.0	0.0071345	378.0	0.140684	18444.0	131102.0	0.0	74	0.95	InbreedingCoeff	nfe	0.191198	10088.0	0.191198	10088.0	0.0029838	464	0.002	7.0	0.00118	2.0		28.3	4.071927	0.83	15	5	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,ClinPred_pred	HS6ST1	0.0	0.0	0.0	0.0	-2.0	-6.0	-5.0	-32.0							0.91		1.0	1.172	mortality/aging ; cardiovascular system phenotype ; respiratory system phenotype; embryo phenotype; skeleton phenotype; vision/eye phenotype; limbs/digits/tail phenotype; growth/size/body region phenotype; cellular phenotype; 			.	Heparan sulfate biosynthesis;Glycan structures - biosynthesis 1	angiogenesis;glycosaminoglycan biosynthetic process;heparan sulfate proteoglycan biosynthetic process, enzymatic modification;lung alveolus development;neuron development;labyrinthine layer blood vessel development	Golgi membrane;integral component of plasma membrane	sulfotransferase activity;heparan sulfate 6-O-sulfotransferase activity	KRTAP10-8[unassigned1304];OPRM1[28298427];KRT31[unassigned1304];	129026227
44050	chr2	130872791	A	G	chr2:130872791	POTEF	POTE ankyrin domain family member F	SNV	0/1	0.29	15_6	21	93.0	0/1	0.31	20_9	29	99.0			rs200596208,COSV62539510	EXONIC	YES	NM_001099771.2	Transcript	protein_coding	missense_variant		4/17	NM_001099771.2:c.632T>C	NP_001093241.1:p.Ile211Thr		-1.0	Ankyrin repeat-containing domain&Ankyrin repeat-containing domain&Ankyrin repeat-containing domain,Ankyrin repeat-containing domain&Ankyrin repeat-containing domain&Ankyrin repeat-containing domain					.	.	.		0.000147724	22.0	148926.0	0.0	31	0.93	PASS	sas	0.00043122	2.0	0.00014979	10.0	1.62893e-05	4.0	245560.0	0.0	38	0.92	RF	sas	3.29924e-05	1.0	2.70334e-05	3.0	0.0000064	1	0.003	11.0				8.489	0.408526	0.119	1	18	19	PrimateAI_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	POTEF	0.0	0.0	0.06	0.0	6.0	-13.0	-34.0	-4.0									0.004	-0.539	.			.	.	retina homeostasis	extracellular space;cell cortex;extracellular exosome;blood microparticle	.	TFAP2A[24835590];NEK4[25798074];TUBB3[27291054];UBE3A[29426014];	130872791
44055	chr2	130902494	G	C	chr2:130902494	CCDC74B	coiled-coil domain containing 74B	SNV	0/0	0.0	39_0	39	99.0	0/1	0.47	43_38	81	99.0			rs573987925,COSV60100762	EXONIC	YES	NM_207310.4	Transcript	protein_coding	missense_variant		1/8	NM_207310.4:c.76C>G	NP_997193.1:p.Arg26Gly		-1.0	.,.,.,.,.,.					.	.	.		0.000375722	57.0	151708.0	0.0	30	0.9	PASS	amr	0.000852124	13.0	0.000368178	25.0	0.000689491	116.0	168240.0	0.0	15	0.35	PASS	nfe	0.000711781	54.0	0.000711781	54.0	0.0000450	7						23.4	2.923525	0.178	8	12	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred	MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CCDC74B	0.0	0.0	0.0	0.0	0.0	-21.0	0.0	-8.0						0.973	0.0		0.11	0.955	.			.	.	.	.	.	SCNM1[unassigned1304];KDM1A[23455924];ABI2[unassigned1304];BANP[unassigned1304];	130902494
44158	chr2	135884187	G	T	chr2:135884187	RAB3GAP1	RAB3 GTPase activating protein catalytic subunit 1	SNV	0/1	0.36	23_13	36	99.0	0/1	0.3	29_13	43	99.0				EXONIC	YES	NM_001172435.2	Transcript	protein_coding	missense_variant		11/25	NM_001172435.2:c.934G>T	NP_001165906.1:p.Val312Phe		1.0	.,.,.				Martsolf syndrome 2, 619420 (3), Autosomal recessive; Warburg micro syndrome 1, 600118 (3), Autosomal recessive	Cataract-intellectual disability-hypogonadism syndrome;Micro syndrome	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Overlapping toe;Kyphoscoliosis;Hypoplasia of the corpus callosum;Facial hypertrichosis;Macrotia;Generalized hypotonia;Cerebellar hypoplasia;Cryptorchidism;Micrognathia;Cerebral atrophy;Microcephaly;Joint hypermobility;Developmental cataract;Microcornea;Ptosis;Osteoporosis;Optic atrophy;Intellectual disability;Agenesis of corpus callosum;Autosomal recessive inheritance;Short stature;Microphthalmia;Spastic diplegia;Failure to thrive;External genital hypoplasia;Deeply set eye;Muscular hypotonia;Hyperreflexia;Macrotia;Retinal coloboma;Anteverted nares;Intrauterine growth retardation;Hypoplasia of penis;Microcephaly;Global developmental delay;Cerebellar vermis hypoplasia;Wide nasal bridge;Microphthalmia;Cryptorchidism;Microcornea;Abnormality of retinal pigmentation;Low-set, posteriorly rotated ears;Abnormality of visual evoked potentials;Spasticity;Short stature;Aplasia/Hypoplasia of the corpus callosum;Muscular hypotonia;Micrognathia;Scoliosis;Seizure;Cerebral visual impairment;Intellectual disability, severe;Pachygyria;Hypoplastic labia minora;Optic atrophy;Hydronephrosis;Short philtrum;High palate;Short nose;Abnormal localization of kidney;Cataract;Cerebral cortical atrophy;Delayed puberty;Joint stiffness;Clitoral hypoplasia;Peripheral neuropathy;Kyphosis;Generalized hirsutism;Microcephaly;Low-set, posteriorly rotated ears;Prematurely aged appearance;Feeding difficulties in infancy;Furrowed tongue;Micrognathia;Short stature;Midface retrusion;Malar flattening;Abnormal dermatoglyphics;Low posterior hairline;Scoliosis;Abnormal toenail morphology;Cataract;Depressed nasal bridge;Cryptorchidism;Hypogonadotropic hypogonadism;Abnormal distal phalanx morphology of finger;Everted lower lip vermilion;Hypotelorism;Abnormality of the antihelix;High palate;Brachycephaly;Intellectual disability;Short philtrum;Misalignment of teeth;Ulnar deviation of finger;Cerebral cortical atrophy;Hyperlordosis						32	0.97											100	1.0											9e-05	1.0		29.3	4.181759	0.538	17	4	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,PrimateAI_pred	RAB3GAP1	0.06	0.12	0.0	0.13	5.0	-34.0	5.0	39.0						0.941	0.0	0.000000000	1.0	1.106	nervous system phenotype ; 			caudate nucleus;amygdala;temporal lobe;prefrontal cortex;cingulate cortex;superior cervical ganglion;pons;occipital lobe;subthalamic nucleus;dorsal root ganglion;placenta;parietal lobe;skeletal muscle;globus pallidus;hypothalamus;medulla oblongata;	.	brain development;positive regulation of gene expression;hypothalamus development;lipid droplet organization;camera-type eye development;regulation of GTPase activity;positive regulation of GTPase activity;regulation of short-term neuronal synaptic plasticity;excitatory postsynaptic potential;face morphogenesis;positive regulation of glutamate neurotransmitter secretion in response to membrane depolarization;establishment of protein localization to endoplasmic reticulum membrane;positive regulation of protein lipidation;regulation of calcium ion-dependent exocytosis of neurotransmitter;positive regulation of endoplasmic reticulum tubular network organization;positive regulation of autophagosome assembly	endoplasmic reticulum membrane;Golgi apparatus;lipid droplet;cytosol;protein-containing complex;extracellular exosome;endoplasmic reticulum tubular network;postsynapse	guanyl-nucleotide exchange factor activity;GTPase activator activity;protein binding;Rab guanyl-nucleotide exchange factor activity;Rab GTPase binding	RXRB[20195357];GSTK1[17353931];PTP4A3[17353931];MAP1LC3A[20562859];NPHP1[26638075];CANX[29568061];AP2B1[30021884];MAGEA6[17353931];	135884187
44174	chr2	136107663	T	C	chr2:136107663	ZRANB3	zinc finger RANBP2-type containing 3	SNV	0/1	0.47	46_40	86	99.0	0/0	0.0	35_0	35	99.0			rs183525970	EXONIC	YES	NM_032143.4	Transcript	protein_coding	missense_variant		5/21	NM_032143.4:c.482A>G	NP_115519.2:p.Tyr161Cys		-1.0	.,SNF2-related, N-terminal domain&Helicase superfamily 1/2, ATP-binding domain&Helicase superfamily 1/2, ATP-binding domain					.	.	.		0.0016883	257.0	152224.0	0.0	32	0.96	PASS	amr	0.00327139	50.0	0.00266059	181.0	0.00154187	384.0	249048.0	0.0	71	1.0	PASS	nfe	0.00239082	270.0	0.00239082	270.0	0.0013440	209	0.003	10.0				26.8	3.882945	0.822	17	4	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,ClinPred_pred	ZRANB3	0.0	0.0	0.0	0.0	-48.0	-13.0	21.0	26.0							0.0	0.000000000	1.0	1.138	.			.	.	DNA strand renaturation;DNA repair;cellular response to DNA damage stimulus;response to UV;replication fork processing;DNA duplex unwinding;DNA rewinding;negative regulation of DNA recombination;replication fork protection;nucleic acid phosphodiester bond hydrolysis	nucleus;nuclear replication fork	DNA helicase activity;endodeoxyribonuclease activity;protein binding;ATP binding;annealing helicase activity;metal ion binding;K63-linked polyubiquitin modification-dependent protein binding	PCNA[22759634];MCM7[22759634];MCM3[22759634];MCM4[22759634];HIST2H3D[30021884];	136107663
44187	chr2	136418868	A	G	chr2:136418868	R3HDM1	R3H domain containing 1	SNV	0/0	0.0	33_0	33	99.0	0/1	0.56	30_38	68	99.0			rs139502420,COSV99041669	EXONIC	YES	NM_001378107.1	Transcript	protein_coding	missense_variant		19/27	NM_001378107.1:c.2057A>G	NP_001365036.1:p.His686Arg		1.0	.,.,.,.,.					.	.	.		0.00172187	262.0	152160.0	0.0	32	0.97	PASS	amr	0.00274977	42.0	0.00264612	180.0	0.00166231	418.0	251458.0	0.0	86	1.0	PASS	nfe	0.00257601	293.0	0.00257601	293.0	0.0015241	237	0.006	19.0				22.4	2.433549	0.211	4	13	17	LRT_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	R3HDM1	0.01	0.0	0.0	0.0	-28.0	-35.0	21.0	-36.0						0.594	0.01	0.000000000	1.0	1.312	reproductive system phenotype; endocrine/exocrine gland phenotype; 			amygdala;temporal lobe;prefrontal cortex;trigeminal ganglion;cingulate cortex;superior cervical ganglion;pons;occipital lobe;fetal brain;subthalamic nucleus;whole brain;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;	.	.	.	RNA binding	EGLN3[26972000];ATXN1[16713569];YWHAB[24255178];VPS50[26496610];F2RL1[28298427];ZNF24[20195357];	136418868
44191	chr2	136519456	G	C	chr2:136519456	UBXN4	UBX domain protein 4	SNV	0/1	0.47	34_30	64	99.0	0/0	0.0	35_0	35	99.0			rs201063365	EXONIC	YES	NM_014607.4	Transcript	protein_coding	missense_variant		6/13	NM_014607.4:c.577G>C	NP_055422.1:p.Glu193Gln		1.0						.	.	.		0.00105769	161.0	152218.0	0.0	33	0.98	PASS	amr	0.00274869	42.0	0.00155782	106.0	0.00105592	263.0	249072.0	0.0	37	0.93	PASS	amr	0.00198216	68.0	0.00156418	177.0	0.0009968	155	0.003	11.0				23.7	3.077012	0.036	6	15	21	PolyPhen,Polyphen2_HDIV_pred,MutationAssessor_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	UBXN4	0.0	0.0	0.0	0.03	3.0	-33.0	11.0	25.0						0.344	0.97	0.000000000	0.969	1.176	.			testis - seminiferous tubule;dorsal root ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;parietal lobe;	.	response to unfolded protein;ubiquitin-dependent ERAD pathway	nuclear envelope;endoplasmic reticulum;endoplasmic reticulum membrane;cytosol	protein binding	EVC2[26638075];VCP[18775313;29997244];PLGRKT[29568061];MGST3[29568061];ZNF24[20195357];TOMM20[29568061];TOMM22[29568061];TOM1L1[16169070];GNGT1[unassigned1304];TMEM17[26638075];TCTN3[26638075];TMEM67[26638075];TCTN2[26638075];TMEM216[26638075];CANX[29568061];UBQLN1[25416956;unassigned1304];	136519456
44212	chr2	141294286		AA	chr2:141294285-141294286	LRP1B	LDL receptor related protein 1B	insertion	0/0	0.0	28_0	28	49.0	0/1	0.15	19_4	27	70.0			rs748331070	SPLICING	YES	NM_018557.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	45/90		NM_018557.3:c.7514-9_7514-8dup			-1.0						.	.	.		0.000271119	34.0	125406.0	0.0	28	0.81	PASS	amr	0.00147929	18.0	0.000222885	13.0	0.00188936	208.0	110090.0	0.0	24	0.61	InbreedingCoeff	amr	0.00272155	32.0	0.00192923	105.0	0.0000257,0.0000064	4,1						0.547	-0.240705		0	0	0																	0.00916	1.0				normal phenotype; mortality/aging ; 			.	.	receptor-mediated endocytosis;protein transport	integral component of membrane;receptor complex	calcium ion binding	HNRNPCL2[30021884];HSPA5[30021884];MYC[21150319];ARRB1[17620599];PCBD1[20195357];	141294285
44215	chr2	141625835	AA		chr2:141625835-141625836	LRP1B	LDL receptor related protein 1B	sequence_alteration	0/1	0.38	6_5_0	13	99.0	0/2	0.0	4_0_10	14	42.0			rs34488899	SPLICING	YES	NM_018557.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	25/90		NM_018557.3:c.4170-4_4170-3del			-1.0						.	.	.		0.000362218	39.0	107670.0	0.0	22	0.55	PASS	amr	0.00058548	6.0	0.000388969	20.0	0.0828053	4626.0	55866.0	0.0	20	0.49	PASS	nfe	0.0979883	2416.0	0.0979883	2416.0	0.0000064	1						10.77	0.654579		0	0	0			LRP1B	0.0	0.03	0.0	0.0	-19.0	-2.0	-19.0	-2.0						0.00916	1.0				normal phenotype; mortality/aging ; 			.	.	receptor-mediated endocytosis;protein transport	integral component of membrane;receptor complex	calcium ion binding	HNRNPCL2[30021884];HSPA5[30021884];MYC[21150319];ARRB1[17620599];PCBD1[20195357];	141625834
44219	chr2	143743586	C	T	chr2:143743586	KYNU	kynureninase	SNV	0/1	0.46	31_26	57	99.0	0/1	0.39	36_23	59	99.0			COSV99933824	EXONIC	YES	NM_001199241.2	Transcript	protein_coding	missense_variant		11/15	NM_001199241.2:c.898C>T	NP_001186170.1:p.Pro300Ser		1.0	Aminotransferase class V domain,.,Aminotransferase class V domain				?Hydroxykynureninuria, 236800 (3), Autosomal recessive; Vertebral, cardiac, renal, and limb defects syndrome 2, 617661 (3), Autosomal recessive	Hydroxykynureninuria;Congenital vertebral-cardiac-renal anomalies syndrome	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Coma;Intellectual disability;Tachycardia;Hearing impairment;Abnormality of the respiratory system;Abnormality of the musculature;Nonprogressive encephalopathy;Psychomotor retardation;Aminoaciduria;Global developmental delay;Hypotension;Autosomal recessive inheritance;Renal tubular dysfunction;Metabolic acidosis;Hypertonia;Frontal bossing;Rhizomelia;Delayed speech and language development;Patent ductus arteriosus;Microcephaly;Depressed nasal bridge;Hypoplastic left heart;Talipes;Renal hypoplasia;Narrow chest;Chronic kidney disease;Autosomal recessive inheritance;Low-set ears;Hemivertebrae;Stomatitis;Dry skin;Intellectual disability;Hypotension;Abnormal circulating tryptophan concentration;Breathing dysregulation;Stereotypy;Hypertonia;Congenital sensorineural hearing impairment;Headache;Tachycardia;Metabolic acidosis;Renal tubular acidosis;Global developmental delay;Encephalopathy;Coma						32	0.96											44	0.98											0.00018	2.0		24.9	3.467086	0.511	19	2	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,PrimateAI_pred	KYNU	0.0	0.0	0.0	0.01	4.0	-50.0	3.0	32.0						0.539	0.0	45.211109758	0.906	1.026	.			dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;placenta;testis;skeletal muscle;	Tryptophan metabolism	tryptophan catabolic process;aging;NAD biosynthetic process;tryptophan catabolic process to kynurenine;tryptophan catabolic process to acetyl-CoA;quinolinate biosynthetic process;response to interferon-gamma;'de novo' NAD biosynthetic process from tryptophan;response to vitamin B6;anthranilate metabolic process;L-kynurenine catabolic process	nucleoplasm;mitochondrion;cytosol	pyridoxal phosphate binding;kynureninase activity;protein homodimerization activity;3-hydroxykynureninase activity	RET[26496610];RASSF3[unassigned1304];CTBP2[unassigned1304];LMO4[unassigned1304];MCCD1[unassigned1304];FAM86C1[unassigned1304];PIP4K2B[unassigned1304];MYOZ3[unassigned1304];	143743586
44336	chr2	157352735	T		chr2:157352735	GPD2	glycerol-3-phosphate dehydrogenase 2	deletion	0/0	0.06	28_2	32	40.0	0/1	0.29	16_8	28	99.0			rs55843224	SPLICING	YES	NM_001083112.3	Transcript	protein_coding	splice_region_variant,intron_variant	3/16		NM_001083112.3:c.274+19del			1.0					{Type 2 diabetes mellitus, susceptibility to}, 125853 (3), Autosomal dominant	.	.	Type II diabetes mellitus;Increased waist to hip ratio;Insulin resistance;Autosomal dominant inheritance;Late onset		0.00246118	356.0	144646.0	0.0	32	0.92	PASS	afr	0.00355325	141.0	0.00120869	79.0	0.344163	35846.0	104154.0	1.0	34	0.84	InbreedingCoeff_RF	sas	0.409358	5013.0	0.329934	16434.0	0.0000450,0.0000193,0.1785292	7,3,27762			0.29225	3320.0		6.093	0.217202		0	0	0			GPD2	0.0	0.0	0.0	0.0	-39.0	-48.0	-7.0	-10.0						0.356	0.0				vision/eye phenotype; nervous system phenotype ; reproductive system phenotype; mortality/aging ; liver/biliary system phenotype; behavior/neurological phenotype ; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype ; growth/size/body region phenotype; 			superior cervical ganglion;atrioventricular node;skeletal muscle;	Glycerophospholipid metabolism	gluconeogenesis;glycerophosphate shuttle;glycerol catabolic process;multicellular organism growth;camera-type eye development;glycerol-3-phosphate catabolic process	mitochondrion;mitochondrial inner membrane;glycerol-3-phosphate dehydrogenase complex	glycerol-3-phosphate dehydrogenase [NAD+] activity;glycerol-3-phosphate dehydrogenase (quinone) activity;calcium ion binding;sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity	E2F3[22157815];	157352734
44499	chr2	163361057	C	A	chr2:163361057	KCNH7	potassium voltage-gated channel subfamily H member 7	SNV	0/0	0.0	37_0	37	99.0	0/1	0.43	39_30	69	99.0			rs151139318	EXONIC	YES	NM_033272.4	Transcript	protein_coding	missense_variant		6/16	NM_033272.4:c.1024G>T	NP_150375.2:p.Val342Phe		-1.0	.,.,.,.					.	.	.		5.26801e-05	8.0	151860.0	0.0	32	0.96	PASS	amr	0.000262881	4.0	0.0	0.0	8.75845e-05	22.0	251186.0	0.0	96	1.0	PASS	amr	0.000492126	17.0	3.52175e-05	4.0	0.0000707	11	0.001	2.0				18.53	1.84284	0.106	1	18	19	fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	KCNH7	0.01	0.0	0.0	0.0	2.0	0.0	2.0	1.0						0.0506	0.98	0.000000000	0.999	1.026	.			ciliary ganglion;pons;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	regulation of ion transmembrane transport;regulation of membrane potential;potassium ion transmembrane transport	plasma membrane;integral component of plasma membrane	voltage-gated potassium channel activity	NEK4[25798074];GRB2[17474147];	163361057
44615	chr2	169103866	GCC		chr2:169103866-169103868	STK39	serine/threonine kinase 39	deletion	0/0	0.0	27_0	27	81.0	0/1	0.17	20_4	24	88.0			rs549892329	EXONIC	YES	NM_013233.3	Transcript	protein_coding	inframe_deletion		1/18	NM_013233.3:c.78_80del	NP_037365.2:p.Ala27del		-1.0						.	.	.		1.36674e-05	2.0	146334.0	0.0	32	0.9	PASS	amr	0.000135465	2.0	0.0	0.0	0.00528169	6.0	1136.0	0.0	1	0.0	PASS	sas	0.0333333	1.0	0.0049505	4.0	0.0000064,0.0000450	1,7			0.00012	1.0		14.29	1.136484		0	0	0			STK39	0.0	0.0	0.0	0.0	-35.0	44.0	24.0	3.0						0.341	1.0				reproductive system phenotype; cardiovascular system phenotype ; renal/urinary system phenotype; nervous system phenotype ; muscle phenotype; homeostasis/metabolism phenotype; 			pons;amygdala;occipital lobe;subthalamic nucleus;cingulate cortex;spinal cord;parietal lobe;medulla oblongata;hypothalamus;thalamus;	.	activation of MAPK activity;protein phosphorylation;regulation of blood pressure;positive regulation of T cell chemotaxis;peptidyl-serine phosphorylation;peptidyl-threonine phosphorylation;signal transduction by protein phosphorylation;signal transduction by trans-phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;positive regulation of ion transmembrane transporter activity;intracellular signal transduction;maintenance of lens transparency;chemokine (C-X-C motif) ligand 12 signaling pathway;positive regulation of potassium ion transport;protein autophosphorylation;regulation of inflammatory response;ion homeostasis;cellular hypotonic response;negative regulation of pancreatic juice secretion;negative regulation of potassium ion transmembrane transporter activity;negative regulation of potassium ion transmembrane transport;negative regulation of creatine transmembrane transporter activity;cellular response to chemokine;negative regulation of sodium ion transmembrane transporter activity	nucleoplasm;cytoplasm;cytosol;cytoskeleton;basolateral plasma membrane;apical plasma membrane;extrinsic component of membrane;intracellular membrane-bounded organelle	protein serine/threonine kinase activity;protein binding;ATP binding;kinase activity;protein kinase binding	CAB39[21423148];ARX[26496610];ATL2[26496610];CTNNB1[20195357];HSCB[28380382];CD46[20694009];SLC12A6[24655550];C2orf49[30021884];RHOA[26496610];	169103865
44748	chr2	176804340	C	T	chr2:176804340	LNPK	lunapark, ER junction formation factor	SNV	0/0	0.0	34_0	34	99.0	0/1	0.5	33_33	66	99.0			rs1170644434	EXONIC	YES	NM_001305008.1	Transcript	protein_coding	missense_variant		10/13	NM_001305008.1:c.950G>A	NP_001291937.1:p.Arg317Gln		-1.0	.,.,.				Neurodevelopmental disorder with epilepsy and hypoplasia of the corpus callosum, 618090 (3), Autosomal recessive	.	.	Generalized myoclonic seizure;Absent speech;Hyperactivity;Generalized hypotonia;Dysmetria;Rigidity;Cerebellar atrophy;Inability to walk;Hypoplasia of the corpus callosum;Global developmental delay;Tremor;Autosomal recessive inheritance		1.32032e-05	2.0	151478.0	0.0	31	0.94	PASS	nfe	2.94499e-05	2.0	2.94499e-05	2.0	8.005e-06	2.0	249844.0	0.0	36	0.86	PASS	sas	3.29012e-05	1.0	8.84377e-06	1.0								23.5	2.950026	0.373	10	9	19	PolyPhen,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred	KIAA1715	0.0	0.01	0.0	0.0	-3.0	30.0	30.0	-8.0								0.000000000	1.0	1.026	skeleton phenotype; limbs/digits/tail phenotype; reproductive system phenotype; mortality/aging ; homeostasis/metabolism phenotype; 			.	.	blood coagulation;regulation of chondrocyte differentiation;embryonic forelimb morphogenesis;embryonic digit morphogenesis;limb development;endoplasmic reticulum tubular network organization;endoplasmic reticulum tubular network maintenance;positive regulation of endoplasmic reticulum tubular network organization	nucleoplasm;endoplasmic reticulum;endoplasmic reticulum membrane;integral component of membrane;integral component of endoplasmic reticulum membrane;endoplasmic reticulum tubular network;endoplasmic reticulum tubular network membrane	identical protein binding;metal ion binding	ANXA1[unassigned1304];GOLT1B[26496610];LMO3[unassigned1304];KLHL12[unassigned1304];NOC4L[unassigned1304];PAX6[unassigned1304];SYP[unassigned1304];YIF1A[unassigned1304];TMEM17[26638075];TTC30B[unassigned1312];TCTN3[26638075];TMEM67[26638075];TCTN2[26638075];TMEM216[26638075];CHMP1A[17353931];PLIN3[unassigned1304];LLGL2[26496610];	176804340
44757	chr2	176995146	CGG		chr2:176995146-176995148	HOXD8	homeobox D8	deletion	0/1	0.19	48_11	59	99.0	0/0	0.0	34_0	34	99.0			rs560225489	EXONIC	YES	NM_019558.4	Transcript	protein_coding	inframe_deletion		1/2	NM_019558.4:c.68_70del	NP_062458.1:p.Ala23del		1.0						.	.	.		0.000148653	22.0	147996.0	0.0	32	0.93	PASS	sas	0.000213584	1.0	5.99826e-05	4.0	0.0319162	2063.0	64638.0	0.0	3	0.16	PASS	eas	0.0633908	169.0	0.0288285	689.0	0.0045787,0.0000129	712,2					1.0	16.74	1.58088		0	0	0			HOXD8	0.0	0.0	0.0	0.0	-38.0	-14.0	-47.0	-8.0							0.62				skeleton phenotype; 			ciliary ganglion;caudate nucleus;testis - seminiferous tubule;subthalamic nucleus;testis - interstitial;superior cervical ganglion;testis;	.	negative regulation of transcription by RNA polymerase II;anterior/posterior axis specification, embryo;positive regulation of transcription by RNA polymerase II;skeletal system morphogenesis	nucleus	RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific	CDKN1A[21900206];NCK2[unassigned1304];ANXA7[21900206];PFDN1[21900206];RCC1[21900206];LDLRAP1[unassigned1304];BAIAP2[unassigned1304];	176995145
44809	chr2	179414206	A	C	chr2:179414206	TTN	titin	SNV	0/1	0.45	46_37	83	99.0	0/0	0.0	36_0	36	99.0				SPLICING	YES	NM_001267550.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	338/362		NM_001267550.2:c.92153-6T>G			-1.0					Muscular dystrophy, limb-girdle, autosomal recessive 10, 608807 (3), Autosomal recessive; Cardiomyopathy, familial hypertrophic, 9, 613765 (3), Autosomal dominant; Tibial muscular dystrophy, tardive, 600334 (3), Autosomal dominant; Salih myopathy, 611705 (3), Autosomal recessive; Cardiomyopathy, dilated, 1G, 604145 (3); Myopathy, myofibrillar, 9, with early respiratory failure, 603689 (3), Autosomal dominant	Autosomal recessive centronuclear myopathy;Familial isolated dilated cardiomyopathy;Hereditary myopathy with early respiratory failure;Autosomal recessive limb-girdle muscular dystrophy type 2J;Classic multiminicore myopathy;Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;Early-onset myopathy with fatal cardiomyopathy;Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome;Tibial muscular dystrophy	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Centrally nucleated skeletal muscle fibers;Arrhythmia;Ptosis;Myopathy;Infantile onset;Elevated serum creatine kinase;Congenital onset;Autosomal recessive inheritance;Sudden death;Scoliosis;Calf muscle hypertrophy;Generalized muscle weakness;Facial palsy;Motor delay;Dilated cardiomyopathy;Flexion contracture;Mitochondrial depletion;Elevated serum creatine kinase;Skeletal muscle atrophy;Distal muscle weakness;Elevated serum creatine kinase;Childhood onset;Proximal muscle weakness;Muscular dystrophy;Progressive;Autosomal recessive inheritance;EMG: myopathic abnormalities;Variable expressivity;Tibialis muscle weakness;Internally nucleated skeletal muscle fibers;EMG: myopathic abnormalities;Skeletal muscle atrophy;Elevated serum creatine kinase;Neck flexor weakness;Type 1 muscle fiber predominance;Limited hip movement;Increased variability in muscle fiber diameter;Orthopnea;Rimmed vacuoles;Restrictive ventilatory defect;Falls;Muscle fiber splitting;Reduced vital capacity;Respiratory insufficiency due to muscle weakness;Calf muscle hypertrophy;Foot dorsiflexor weakness;Muscle fiber hypertrophy;Proximal muscle weakness;Necrotizing myopathy;Autosomal dominant inheritance;Adult onset;EMG: myopathic abnormalities;Steppage gait;Slow progression;Incomplete penetrance;Rimmed vacuoles;Muscular dystrophy;Palmoplantar keratoderma;EMG abnormality;Lipoatrophy;Dilated cardiomyopathy;Elevated serum creatine kinase;Abnormality of neutrophils;Sensorineural hearing impairment;Myopathy;Waddling gait;Dysphonia;Talipes equinovarus;Difficulty climbing stairs;Pes cavus;Generalized amyotrophy;Intellectual disability, mild;Motor delay;Narrow mouth;Dysarthria;Scapular winging;Protruding ear;Facial diplegia;Type 1 muscle fiber predominance;Ophthalmoplegia;Areflexia;Bifid uvula;Delayed speech and language development;Respiratory insufficiency;Hyperlordosis;Generalized hypotonia;Difficulty running;Retrognathia;Gowers sign;EMG: decremental response of compound muscle action potential to repetitive nerve stimulation;Long face;Centrally nucleated skeletal muscle fibers;Abnormal heart valve morphology;Left ventricular hypertrophy;Progressive muscle weakness;Long fingers;High palate;Hip contracture;Limited neck flexion;Intermittent episodes of respiratory insufficiency due to muscle weakness;Pes planus;Muscle fiber atrophy;Generalized hypotonia;Poor head control;High palate;Spinal rigidity;Mandibular prognathia;Delayed gross motor development;Right ventricular hypertrophy;Hip dysplasia;Increased muscle lipid content;Right ventricular failure;Congenital muscular dystrophy;Microretrognathia;Multiple joint contractures;Weakness of facial musculature;Scoliosis;Failure to thrive;High pitched voice;Generalized amyotrophy;Nocturnal hypoventilation;Congestive heart failure;Restrictive ventilatory defect;Axial muscle weakness;Short stature;Mitral valve prolapse;Dilated cardiomyopathy;Autosomal dominant inheritance;Hypertrophic cardiomyopathy;Increased variability in muscle fiber diameter;Neck flexor weakness;Frequent falls;Shoulder girdle muscle weakness;Proximal muscle weakness;Variable expressivity;Reduced vital capacity;Elevated serum creatine kinase;Autosomal dominant inheritance;Rimmed vacuoles;Diaphragmatic weakness;Pelvic girdle muscle weakness;Difficulty walking;Foot dorsiflexor weakness;Nocturnal hypoventilation;Adult onset;Respiratory failure;Slow progression;Calf muscle hypertrophy;Muscle fiber splitting;Myofibrillar myopathy;Quadriceps muscle weakness;Rimmed vacuoles;Increased muscle lipid content;Mildly elevated creatine kinase;Ankle weakness;Increased variability in muscle fiber diameter;Foot dorsiflexor weakness;Peroneal muscle atrophy;Steppage gait;Distal upper limb muscle weakness;Centrally nucleated skeletal muscle fibers;EMG: myopathic abnormalities;Clumsiness;Quadriceps muscle weakness;Difficulty walking;Atrioventricular block;Reduced ejection fraction;Atrial fibrillation;Dilated cardiomyopathy;Autosomal dominant inheritance;Ventricular tachycardia;Congestive heart failure;Premature atrial contractions						33	0.98											46	0.83											9e-05	1.0		12.64	0.889123		0	0	0			TTN	0.0	0.01	0.0	0.0	-33.0	-6.0	-6.0	-50.0	0.001506709693101	0.324	7.926	3.149	11.076	0.971	0.0				growth/size/body region phenotype; muscle phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; skeleton phenotype; embryo phenotype; behavior/neurological phenotype ; normal phenotype; mortality/aging ; cardiovascular system phenotype ; vision/eye phenotype; immune system phenotype; 			pons;fetal thyroid;thyroid;tongue;trigeminal ganglion;atrioventricular node;superior cervical ganglion;testis;skeletal muscle;globus pallidus;	.	platelet degranulation;cardiac muscle hypertrophy;muscle contraction;striated muscle contraction;mitotic chromosome condensation;positive regulation of gene expression;protein kinase A signaling;peptidyl-tyrosine phosphorylation;muscle filament sliding;skeletal muscle thin filament assembly;skeletal muscle myosin thick filament assembly;detection of muscle stretch;sarcomere organization;regulation of protein kinase activity;cardiac muscle fiber development;sarcomerogenesis;positive regulation of protein secretion;regulation of catalytic activity;response to calcium ion;cardiac myofibril assembly;cardiac muscle tissue morphogenesis;cardiac muscle contraction;striated muscle myosin thick filament assembly	condensed nuclear chromosome;extracellular region;cytosol;striated muscle thin filament;sarcomere;Z disc;M band;I band;extracellular exosome	protease binding;protein serine/threonine kinase activity;protein tyrosine kinase activity;calcium ion binding;protein binding;calmodulin binding;ATP binding;structural constituent of muscle;enzyme binding;protein kinase binding;telethonin binding;identical protein binding;actinin binding;protein self-association;actin filament binding;muscle alpha-actinin binding;structural molecule activity conferring elasticity	ENO1[23414517];ENO3[23414517];AMOT[23414517];IGHG1[15174051];MYC[21150319];HIST1H2AE[30021884];CAPN3[20860623;23414517];SH3GLB1[23414517];ACTN3[23414517];ACTN2[9501083;16902413;23414517;11101506;11846417];HIST1H2AH[30021884];ACTN1[11101506];FNDC3B[23414517];KRT8[30021884];ACTN4[23414517];OBSCN[11448995;20489725;23414517;20133654];SCO1[29568061];PARD3[23414517];CLIP4[23414517];ERP29[30021884];VDAC1[17353931];HIST1H2BH[30021884];OBSL1[20489725;20133654];OPTN[23414517];ASF1B[17353931];SF1[23414517];MYCBP2[23414517];PIK3R4[30021884];GABARAP[23414517];HNRNPDL[30021884];STK38L[30108113];ANKRD28[23414517];SRPK2[23602568];NEK9[23414517];UBE2I[23414517];SMURF2[18157088];FN1[23414517];HMGA1[30021884];NEB[16902413;12482578];H2BFS[30021884];ESR1[25604459];ESR2[25604459];CCT6A[23414517];HNRNPF[30021884];ALB[15174051];CALU[30021884];TAB2[23414517];STT3B[30021884];CALM1[7607248];HNRNPA1L2[30021884];RYR1[23414517];MYOM1[23414517];SYNM[25447537];DYRK2[23602568];ITGB5[23414517];MAST2[23414517];FHL1[23414517];DYSF[23414517];HSPB2[26465331];MED19[15175163];ARRB1[17620599];ASH2L[23414517];PYGM[23414517];CHD4[23414517];C1QTNF9[23414517];KRI1[30021884];JPH1[23414517];MYOM2[23414517];HK1[29568061];MAP1LC3B[20562859];MED10[15175163];ANKRD1[23414517];PHGDH[23414517];NEO1[23414517];SGCG[23414517];HIST1H1B[30021884];HIST1H1C[30021884];SUN2[22555292];DFFA[17353931];MYBPC1[23414517];TRIM63[18157088;23414517];MYBPC2[23414517];DDX56[17353931];MED26[15175163];YWHAZ[20618440];HIST2H2BF[30021884];MED29[15175163];HIST2H2BE[30021884];VAV2[18654987;23414517];ACTA2[9501083];RNF167[23414517];PKM[24606918];ITGB1BP2[23414517];RPL12[23414517];POMP[23414517];FSTL1[20860622];TTN[9804419;23414517;16407954;16962974];ABLIM1[23414517];ABLIM2[23414517];EXOSC10[23414517];UGP2[23414517];ATP5F1B[30021884];PUF60[17353931];DNAJB6[23414517];DNAJB5[23414517];FLNA[16902413];EBLN1[30021884];NPM1[30021884];MCRS1[17353931];MYBPH[23414517];HSPE1[30021884];ATP5F1D[23414517];KTN1[30021884];RSL1D1[30021884];TTC3[23414517];HNRNPA2B1[30021884];TCAP[16962094;23414517;15582318;11846417;16407954;19622741];TARDBP[30021884];LIMS1[23414517];HSPA1A[23414517];	179414206
44819	chr2	179417691	G	A	chr2:179417691	TTN	titin	SNV	0/0	0.0	37_0	37	99.0	0/1	0.35	60_33	94	99.0			rs779619858	EXONIC	YES	NM_001267550.2	Transcript	protein_coding	missense_variant		335/363	NM_001267550.2:c.89936C>T	NP_001254479.2:p.Thr29979Ile		-1.0	.,.,Fibronectin type III&Fibronectin type III&Fibronectin type III&Fibronectin type III,Fibronectin type III&Fibronectin type III&Fibronectin type III&Fibronectin type III,.,Fibronectin type III&Fibronectin type III&Fibronectin type III&Fibronectin type III,Fibronectin type III&Fibronectin type III&Fibronectin type III&Fibronectin type III	Uncertain_significance	criteria_provided,_single_submitter	Dilated_cardiomyopathy_1G|Limb-girdle_muscular_dystrophy,_type_2J	Muscular dystrophy, limb-girdle, autosomal recessive 10, 608807 (3), Autosomal recessive; Cardiomyopathy, familial hypertrophic, 9, 613765 (3), Autosomal dominant; Tibial muscular dystrophy, tardive, 600334 (3), Autosomal dominant; Salih myopathy, 611705 (3), Autosomal recessive; Cardiomyopathy, dilated, 1G, 604145 (3); Myopathy, myofibrillar, 9, with early respiratory failure, 603689 (3), Autosomal dominant	Autosomal recessive centronuclear myopathy;Familial isolated dilated cardiomyopathy;Hereditary myopathy with early respiratory failure;Autosomal recessive limb-girdle muscular dystrophy type 2J;Classic multiminicore myopathy;Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;Early-onset myopathy with fatal cardiomyopathy;Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome;Tibial muscular dystrophy	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Centrally nucleated skeletal muscle fibers;Arrhythmia;Ptosis;Myopathy;Infantile onset;Elevated serum creatine kinase;Congenital onset;Autosomal recessive inheritance;Sudden death;Scoliosis;Calf muscle hypertrophy;Generalized muscle weakness;Facial palsy;Motor delay;Dilated cardiomyopathy;Flexion contracture;Mitochondrial depletion;Elevated serum creatine kinase;Skeletal muscle atrophy;Distal muscle weakness;Elevated serum creatine kinase;Childhood onset;Proximal muscle weakness;Muscular dystrophy;Progressive;Autosomal recessive inheritance;EMG: myopathic abnormalities;Variable expressivity;Tibialis muscle weakness;Internally nucleated skeletal muscle fibers;EMG: myopathic abnormalities;Skeletal muscle atrophy;Elevated serum creatine kinase;Neck flexor weakness;Type 1 muscle fiber predominance;Limited hip movement;Increased variability in muscle fiber diameter;Orthopnea;Rimmed vacuoles;Restrictive ventilatory defect;Falls;Muscle fiber splitting;Reduced vital capacity;Respiratory insufficiency due to muscle weakness;Calf muscle hypertrophy;Foot dorsiflexor weakness;Muscle fiber hypertrophy;Proximal muscle weakness;Necrotizing myopathy;Autosomal dominant inheritance;Adult onset;EMG: myopathic abnormalities;Steppage gait;Slow progression;Incomplete penetrance;Rimmed vacuoles;Muscular dystrophy;Palmoplantar keratoderma;EMG abnormality;Lipoatrophy;Dilated cardiomyopathy;Elevated serum creatine kinase;Abnormality of neutrophils;Sensorineural hearing impairment;Myopathy;Waddling gait;Dysphonia;Talipes equinovarus;Difficulty climbing stairs;Pes cavus;Generalized amyotrophy;Intellectual disability, mild;Motor delay;Narrow mouth;Dysarthria;Scapular winging;Protruding ear;Facial diplegia;Type 1 muscle fiber predominance;Ophthalmoplegia;Areflexia;Bifid uvula;Delayed speech and language development;Respiratory insufficiency;Hyperlordosis;Generalized hypotonia;Difficulty running;Retrognathia;Gowers sign;EMG: decremental response of compound muscle action potential to repetitive nerve stimulation;Long face;Centrally nucleated skeletal muscle fibers;Abnormal heart valve morphology;Left ventricular hypertrophy;Progressive muscle weakness;Long fingers;High palate;Hip contracture;Limited neck flexion;Intermittent episodes of respiratory insufficiency due to muscle weakness;Pes planus;Muscle fiber atrophy;Generalized hypotonia;Poor head control;High palate;Spinal rigidity;Mandibular prognathia;Delayed gross motor development;Right ventricular hypertrophy;Hip dysplasia;Increased muscle lipid content;Right ventricular failure;Congenital muscular dystrophy;Microretrognathia;Multiple joint contractures;Weakness of facial musculature;Scoliosis;Failure to thrive;High pitched voice;Generalized amyotrophy;Nocturnal hypoventilation;Congestive heart failure;Restrictive ventilatory defect;Axial muscle weakness;Short stature;Mitral valve prolapse;Dilated cardiomyopathy;Autosomal dominant inheritance;Hypertrophic cardiomyopathy;Increased variability in muscle fiber diameter;Neck flexor weakness;Frequent falls;Shoulder girdle muscle weakness;Proximal muscle weakness;Variable expressivity;Reduced vital capacity;Elevated serum creatine kinase;Autosomal dominant inheritance;Rimmed vacuoles;Diaphragmatic weakness;Pelvic girdle muscle weakness;Difficulty walking;Foot dorsiflexor weakness;Nocturnal hypoventilation;Adult onset;Respiratory failure;Slow progression;Calf muscle hypertrophy;Muscle fiber splitting;Myofibrillar myopathy;Quadriceps muscle weakness;Rimmed vacuoles;Increased muscle lipid content;Mildly elevated creatine kinase;Ankle weakness;Increased variability in muscle fiber diameter;Foot dorsiflexor weakness;Peroneal muscle atrophy;Steppage gait;Distal upper limb muscle weakness;Centrally nucleated skeletal muscle fibers;EMG: myopathic abnormalities;Clumsiness;Quadriceps muscle weakness;Difficulty walking;Atrioventricular block;Reduced ejection fraction;Atrial fibrillation;Dilated cardiomyopathy;Autosomal dominant inheritance;Ventricular tachycardia;Congestive heart failure;Premature atrial contractions		0.000170864	26.0	152168.0	0.0	33	0.98	PASS	amr	0.00150622	23.0	1.4699e-05	1.0	9.68e-05	24.0	247934.0	0.0	65	0.99	PASS	amr	0.000521921	18.0	1.7811e-05	2.0	0.0000322	5	0.001	2.0	0.0014	16.0		23.6	2.994992	0.081	5	12	17	M-CAP_pred,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	TTN	0.0	0.0	0.0	0.0	-44.0	19.0	2.0	-3.0						0.971	0.0	0.000000000	1.0	1.176	growth/size/body region phenotype; muscle phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; skeleton phenotype; embryo phenotype; behavior/neurological phenotype ; normal phenotype; mortality/aging ; cardiovascular system phenotype ; vision/eye phenotype; immune system phenotype; 			pons;fetal thyroid;thyroid;tongue;trigeminal ganglion;atrioventricular node;superior cervical ganglion;testis;skeletal muscle;globus pallidus;	.	platelet degranulation;cardiac muscle hypertrophy;muscle contraction;striated muscle contraction;mitotic chromosome condensation;positive regulation of gene expression;protein kinase A signaling;peptidyl-tyrosine phosphorylation;muscle filament sliding;skeletal muscle thin filament assembly;skeletal muscle myosin thick filament assembly;detection of muscle stretch;sarcomere organization;regulation of protein kinase activity;cardiac muscle fiber development;sarcomerogenesis;positive regulation of protein secretion;regulation of catalytic activity;response to calcium ion;cardiac myofibril assembly;cardiac muscle tissue morphogenesis;cardiac muscle contraction;striated muscle myosin thick filament assembly	condensed nuclear chromosome;extracellular region;cytosol;striated muscle thin filament;sarcomere;Z disc;M band;I band;extracellular exosome	protease binding;protein serine/threonine kinase activity;protein tyrosine kinase activity;calcium ion binding;protein binding;calmodulin binding;ATP binding;structural constituent of muscle;enzyme binding;protein kinase binding;telethonin binding;identical protein binding;actinin binding;protein self-association;actin filament binding;muscle alpha-actinin binding;structural molecule activity conferring elasticity	ENO1[23414517];ENO3[23414517];AMOT[23414517];IGHG1[15174051];MYC[21150319];HIST1H2AE[30021884];CAPN3[20860623;23414517];SH3GLB1[23414517];ACTN3[23414517];ACTN2[9501083;16902413;23414517;11101506;11846417];HIST1H2AH[30021884];ACTN1[11101506];FNDC3B[23414517];KRT8[30021884];ACTN4[23414517];OBSCN[11448995;20489725;23414517;20133654];SCO1[29568061];PARD3[23414517];CLIP4[23414517];ERP29[30021884];VDAC1[17353931];HIST1H2BH[30021884];OBSL1[20489725;20133654];OPTN[23414517];ASF1B[17353931];SF1[23414517];MYCBP2[23414517];PIK3R4[30021884];GABARAP[23414517];HNRNPDL[30021884];STK38L[30108113];ANKRD28[23414517];SRPK2[23602568];NEK9[23414517];UBE2I[23414517];SMURF2[18157088];FN1[23414517];HMGA1[30021884];NEB[16902413;12482578];H2BFS[30021884];ESR1[25604459];ESR2[25604459];CCT6A[23414517];HNRNPF[30021884];ALB[15174051];CALU[30021884];TAB2[23414517];STT3B[30021884];CALM1[7607248];HNRNPA1L2[30021884];RYR1[23414517];MYOM1[23414517];SYNM[25447537];DYRK2[23602568];ITGB5[23414517];MAST2[23414517];FHL1[23414517];DYSF[23414517];HSPB2[26465331];MED19[15175163];ARRB1[17620599];ASH2L[23414517];PYGM[23414517];CHD4[23414517];C1QTNF9[23414517];KRI1[30021884];JPH1[23414517];MYOM2[23414517];HK1[29568061];MAP1LC3B[20562859];MED10[15175163];ANKRD1[23414517];PHGDH[23414517];NEO1[23414517];SGCG[23414517];HIST1H1B[30021884];HIST1H1C[30021884];SUN2[22555292];DFFA[17353931];MYBPC1[23414517];TRIM63[18157088;23414517];MYBPC2[23414517];DDX56[17353931];MED26[15175163];YWHAZ[20618440];HIST2H2BF[30021884];MED29[15175163];HIST2H2BE[30021884];VAV2[18654987;23414517];ACTA2[9501083];RNF167[23414517];PKM[24606918];ITGB1BP2[23414517];RPL12[23414517];POMP[23414517];FSTL1[20860622];TTN[9804419;23414517;16407954;16962974];ABLIM1[23414517];ABLIM2[23414517];EXOSC10[23414517];UGP2[23414517];ATP5F1B[30021884];PUF60[17353931];DNAJB6[23414517];DNAJB5[23414517];FLNA[16902413];EBLN1[30021884];NPM1[30021884];MCRS1[17353931];MYBPH[23414517];HSPE1[30021884];ATP5F1D[23414517];KTN1[30021884];RSL1D1[30021884];TTC3[23414517];HNRNPA2B1[30021884];TCAP[16962094;23414517;15582318;11846417;16407954;19622741];TARDBP[30021884];LIMS1[23414517];HSPA1A[23414517];	179417691
44876	chr2	179563644	AA		chr2:179563644-179563645	TTN	titin	sequence_alteration	0/2	0.0	9_0_7	17	99.0	0/1	0.15	17_3_0	20	49.0			rs368277751	SPLICING	YES	NM_001267550.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	111/362		NM_001267550.2:c.30683-4_30683-3del			-1.0		Benign	criteria_provided,_single_submitter	not_provided	Muscular dystrophy, limb-girdle, autosomal recessive 10, 608807 (3), Autosomal recessive; Cardiomyopathy, familial hypertrophic, 9, 613765 (3), Autosomal dominant; Tibial muscular dystrophy, tardive, 600334 (3), Autosomal dominant; Salih myopathy, 611705 (3), Autosomal recessive; Cardiomyopathy, dilated, 1G, 604145 (3); Myopathy, myofibrillar, 9, with early respiratory failure, 603689 (3), Autosomal dominant	Autosomal recessive centronuclear myopathy;Familial isolated dilated cardiomyopathy;Hereditary myopathy with early respiratory failure;Autosomal recessive limb-girdle muscular dystrophy type 2J;Classic multiminicore myopathy;Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;Early-onset myopathy with fatal cardiomyopathy;Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome;Tibial muscular dystrophy	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Centrally nucleated skeletal muscle fibers;Arrhythmia;Ptosis;Myopathy;Infantile onset;Elevated serum creatine kinase;Congenital onset;Autosomal recessive inheritance;Sudden death;Scoliosis;Calf muscle hypertrophy;Generalized muscle weakness;Facial palsy;Motor delay;Dilated cardiomyopathy;Flexion contracture;Mitochondrial depletion;Elevated serum creatine kinase;Skeletal muscle atrophy;Distal muscle weakness;Elevated serum creatine kinase;Childhood onset;Proximal muscle weakness;Muscular dystrophy;Progressive;Autosomal recessive inheritance;EMG: myopathic abnormalities;Variable expressivity;Tibialis muscle weakness;Internally nucleated skeletal muscle fibers;EMG: myopathic abnormalities;Skeletal muscle atrophy;Elevated serum creatine kinase;Neck flexor weakness;Type 1 muscle fiber predominance;Limited hip movement;Increased variability in muscle fiber diameter;Orthopnea;Rimmed vacuoles;Restrictive ventilatory defect;Falls;Muscle fiber splitting;Reduced vital capacity;Respiratory insufficiency due to muscle weakness;Calf muscle hypertrophy;Foot dorsiflexor weakness;Muscle fiber hypertrophy;Proximal muscle weakness;Necrotizing myopathy;Autosomal dominant inheritance;Adult onset;EMG: myopathic abnormalities;Steppage gait;Slow progression;Incomplete penetrance;Rimmed vacuoles;Muscular dystrophy;Palmoplantar keratoderma;EMG abnormality;Lipoatrophy;Dilated cardiomyopathy;Elevated serum creatine kinase;Abnormality of neutrophils;Sensorineural hearing impairment;Myopathy;Waddling gait;Dysphonia;Talipes equinovarus;Difficulty climbing stairs;Pes cavus;Generalized amyotrophy;Intellectual disability, mild;Motor delay;Narrow mouth;Dysarthria;Scapular winging;Protruding ear;Facial diplegia;Type 1 muscle fiber predominance;Ophthalmoplegia;Areflexia;Bifid uvula;Delayed speech and language development;Respiratory insufficiency;Hyperlordosis;Generalized hypotonia;Difficulty running;Retrognathia;Gowers sign;EMG: decremental response of compound muscle action potential to repetitive nerve stimulation;Long face;Centrally nucleated skeletal muscle fibers;Abnormal heart valve morphology;Left ventricular hypertrophy;Progressive muscle weakness;Long fingers;High palate;Hip contracture;Limited neck flexion;Intermittent episodes of respiratory insufficiency due to muscle weakness;Pes planus;Muscle fiber atrophy;Generalized hypotonia;Poor head control;High palate;Spinal rigidity;Mandibular prognathia;Delayed gross motor development;Right ventricular hypertrophy;Hip dysplasia;Increased muscle lipid content;Right ventricular failure;Congenital muscular dystrophy;Microretrognathia;Multiple joint contractures;Weakness of facial musculature;Scoliosis;Failure to thrive;High pitched voice;Generalized amyotrophy;Nocturnal hypoventilation;Congestive heart failure;Restrictive ventilatory defect;Axial muscle weakness;Short stature;Mitral valve prolapse;Dilated cardiomyopathy;Autosomal dominant inheritance;Hypertrophic cardiomyopathy;Increased variability in muscle fiber diameter;Neck flexor weakness;Frequent falls;Shoulder girdle muscle weakness;Proximal muscle weakness;Variable expressivity;Reduced vital capacity;Elevated serum creatine kinase;Autosomal dominant inheritance;Rimmed vacuoles;Diaphragmatic weakness;Pelvic girdle muscle weakness;Difficulty walking;Foot dorsiflexor weakness;Nocturnal hypoventilation;Adult onset;Respiratory failure;Slow progression;Calf muscle hypertrophy;Muscle fiber splitting;Myofibrillar myopathy;Quadriceps muscle weakness;Rimmed vacuoles;Increased muscle lipid content;Mildly elevated creatine kinase;Ankle weakness;Increased variability in muscle fiber diameter;Foot dorsiflexor weakness;Peroneal muscle atrophy;Steppage gait;Distal upper limb muscle weakness;Centrally nucleated skeletal muscle fibers;EMG: myopathic abnormalities;Clumsiness;Quadriceps muscle weakness;Difficulty walking;Atrioventricular block;Reduced ejection fraction;Atrial fibrillation;Dilated cardiomyopathy;Autosomal dominant inheritance;Ventricular tachycardia;Congestive heart failure;Premature atrial contractions		0.00031746	27.0	85050.0	0.0	30	0.86	PASS	amr	0.000378119	3.0	0.000362669	15.0	0.0344183	2265.0	65808.0	0.0	6	0.27	PASS	amr	0.0481375	367.0	0.0292605	865.0	0.0000064	1			0.04408	497.0		11.63	0.759535		0	0	0			TTN	0.0	0.0	0.0	0.0	-13.0	37.0	-15.0	-13.0						0.971	0.0				growth/size/body region phenotype; muscle phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; skeleton phenotype; embryo phenotype; behavior/neurological phenotype ; normal phenotype; mortality/aging ; cardiovascular system phenotype ; vision/eye phenotype; immune system phenotype; 			pons;fetal thyroid;thyroid;tongue;trigeminal ganglion;atrioventricular node;superior cervical ganglion;testis;skeletal muscle;globus pallidus;	.	platelet degranulation;cardiac muscle hypertrophy;muscle contraction;striated muscle contraction;mitotic chromosome condensation;positive regulation of gene expression;protein kinase A signaling;peptidyl-tyrosine phosphorylation;muscle filament sliding;skeletal muscle thin filament assembly;skeletal muscle myosin thick filament assembly;detection of muscle stretch;sarcomere organization;regulation of protein kinase activity;cardiac muscle fiber development;sarcomerogenesis;positive regulation of protein secretion;regulation of catalytic activity;response to calcium ion;cardiac myofibril assembly;cardiac muscle tissue morphogenesis;cardiac muscle contraction;striated muscle myosin thick filament assembly	condensed nuclear chromosome;extracellular region;cytosol;striated muscle thin filament;sarcomere;Z disc;M band;I band;extracellular exosome	protease binding;protein serine/threonine kinase activity;protein tyrosine kinase activity;calcium ion binding;protein binding;calmodulin binding;ATP binding;structural constituent of muscle;enzyme binding;protein kinase binding;telethonin binding;identical protein binding;actinin binding;protein self-association;actin filament binding;muscle alpha-actinin binding;structural molecule activity conferring elasticity	ENO1[23414517];ENO3[23414517];AMOT[23414517];IGHG1[15174051];MYC[21150319];HIST1H2AE[30021884];CAPN3[20860623;23414517];SH3GLB1[23414517];ACTN3[23414517];ACTN2[9501083;16902413;23414517;11101506;11846417];HIST1H2AH[30021884];ACTN1[11101506];FNDC3B[23414517];KRT8[30021884];ACTN4[23414517];OBSCN[11448995;20489725;23414517;20133654];SCO1[29568061];PARD3[23414517];CLIP4[23414517];ERP29[30021884];VDAC1[17353931];HIST1H2BH[30021884];OBSL1[20489725;20133654];OPTN[23414517];ASF1B[17353931];SF1[23414517];MYCBP2[23414517];PIK3R4[30021884];GABARAP[23414517];HNRNPDL[30021884];STK38L[30108113];ANKRD28[23414517];SRPK2[23602568];NEK9[23414517];UBE2I[23414517];SMURF2[18157088];FN1[23414517];HMGA1[30021884];NEB[16902413;12482578];H2BFS[30021884];ESR1[25604459];ESR2[25604459];CCT6A[23414517];HNRNPF[30021884];ALB[15174051];CALU[30021884];TAB2[23414517];STT3B[30021884];CALM1[7607248];HNRNPA1L2[30021884];RYR1[23414517];MYOM1[23414517];SYNM[25447537];DYRK2[23602568];ITGB5[23414517];MAST2[23414517];FHL1[23414517];DYSF[23414517];HSPB2[26465331];MED19[15175163];ARRB1[17620599];ASH2L[23414517];PYGM[23414517];CHD4[23414517];C1QTNF9[23414517];KRI1[30021884];JPH1[23414517];MYOM2[23414517];HK1[29568061];MAP1LC3B[20562859];MED10[15175163];ANKRD1[23414517];PHGDH[23414517];NEO1[23414517];SGCG[23414517];HIST1H1B[30021884];HIST1H1C[30021884];SUN2[22555292];DFFA[17353931];MYBPC1[23414517];TRIM63[18157088;23414517];MYBPC2[23414517];DDX56[17353931];MED26[15175163];YWHAZ[20618440];HIST2H2BF[30021884];MED29[15175163];HIST2H2BE[30021884];VAV2[18654987;23414517];ACTA2[9501083];RNF167[23414517];PKM[24606918];ITGB1BP2[23414517];RPL12[23414517];POMP[23414517];FSTL1[20860622];TTN[9804419;23414517;16407954;16962974];ABLIM1[23414517];ABLIM2[23414517];EXOSC10[23414517];UGP2[23414517];ATP5F1B[30021884];PUF60[17353931];DNAJB6[23414517];DNAJB5[23414517];FLNA[16902413];EBLN1[30021884];NPM1[30021884];MCRS1[17353931];MYBPH[23414517];HSPE1[30021884];ATP5F1D[23414517];KTN1[30021884];RSL1D1[30021884];TTC3[23414517];HNRNPA2B1[30021884];TCAP[16962094;23414517;15582318;11846417;16407954;19622741];TARDBP[30021884];LIMS1[23414517];HSPA1A[23414517];	179563643
44885	chr2	179593503	G	T	chr2:179593503	TTN	titin	SNV	0/1	0.56	32_40	72	99.0	0/1	0.45	35_29	64	99.0			rs72648953,COSV60063043	SPLICING	YES	NM_001267550.2	Transcript	protein_coding	missense_variant,splice_region_variant		66/363	NM_001267550.2:c.19150C>A	NP_001254479.2:p.Pro6384Thr		-1.0	.,Immunoglobulin-like domain,Immunoglobulin-like domain,Immunoglobulin-like domain	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Cardiomyopathy|Tibial_muscular_dystrophy|Myopathy,_myofibrillar,_9,_with_early_respiratory_failure|Dilated_cardiomyopathy_1G|Limb-girdle_muscular_dystrophy,_type_2J|Myopathy,_early-onset,_with_fatal_cardiomyopathy|not_specified|not_provided	Muscular dystrophy, limb-girdle, autosomal recessive 10, 608807 (3), Autosomal recessive; Cardiomyopathy, familial hypertrophic, 9, 613765 (3), Autosomal dominant; Tibial muscular dystrophy, tardive, 600334 (3), Autosomal dominant; Salih myopathy, 611705 (3), Autosomal recessive; Cardiomyopathy, dilated, 1G, 604145 (3); Myopathy, myofibrillar, 9, with early respiratory failure, 603689 (3), Autosomal dominant	Autosomal recessive centronuclear myopathy;Familial isolated dilated cardiomyopathy;Hereditary myopathy with early respiratory failure;Autosomal recessive limb-girdle muscular dystrophy type 2J;Classic multiminicore myopathy;Familial isolated arrhythmogenic ventricular dysplasia, right dominant form;Familial isolated arrhythmogenic ventricular dysplasia, biventricular form;Familial isolated arrhythmogenic ventricular dysplasia, left dominant form;Early-onset myopathy with fatal cardiomyopathy;Childhood-onset progressive contractures-limb-girdle weakness-muscle dystrophy syndrome;Tibial muscular dystrophy	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Centrally nucleated skeletal muscle fibers;Arrhythmia;Ptosis;Myopathy;Infantile onset;Elevated serum creatine kinase;Congenital onset;Autosomal recessive inheritance;Sudden death;Scoliosis;Calf muscle hypertrophy;Generalized muscle weakness;Facial palsy;Motor delay;Dilated cardiomyopathy;Flexion contracture;Mitochondrial depletion;Elevated serum creatine kinase;Skeletal muscle atrophy;Distal muscle weakness;Elevated serum creatine kinase;Childhood onset;Proximal muscle weakness;Muscular dystrophy;Progressive;Autosomal recessive inheritance;EMG: myopathic abnormalities;Variable expressivity;Tibialis muscle weakness;Internally nucleated skeletal muscle fibers;EMG: myopathic abnormalities;Skeletal muscle atrophy;Elevated serum creatine kinase;Neck flexor weakness;Type 1 muscle fiber predominance;Limited hip movement;Increased variability in muscle fiber diameter;Orthopnea;Rimmed vacuoles;Restrictive ventilatory defect;Falls;Muscle fiber splitting;Reduced vital capacity;Respiratory insufficiency due to muscle weakness;Calf muscle hypertrophy;Foot dorsiflexor weakness;Muscle fiber hypertrophy;Proximal muscle weakness;Necrotizing myopathy;Autosomal dominant inheritance;Adult onset;EMG: myopathic abnormalities;Steppage gait;Slow progression;Incomplete penetrance;Rimmed vacuoles;Muscular dystrophy;Palmoplantar keratoderma;EMG abnormality;Lipoatrophy;Dilated cardiomyopathy;Elevated serum creatine kinase;Abnormality of neutrophils;Sensorineural hearing impairment;Myopathy;Waddling gait;Dysphonia;Talipes equinovarus;Difficulty climbing stairs;Pes cavus;Generalized amyotrophy;Intellectual disability, mild;Motor delay;Narrow mouth;Dysarthria;Scapular winging;Protruding ear;Facial diplegia;Type 1 muscle fiber predominance;Ophthalmoplegia;Areflexia;Bifid uvula;Delayed speech and language development;Respiratory insufficiency;Hyperlordosis;Generalized hypotonia;Difficulty running;Retrognathia;Gowers sign;EMG: decremental response of compound muscle action potential to repetitive nerve stimulation;Long face;Centrally nucleated skeletal muscle fibers;Abnormal heart valve morphology;Left ventricular hypertrophy;Progressive muscle weakness;Long fingers;High palate;Hip contracture;Limited neck flexion;Intermittent episodes of respiratory insufficiency due to muscle weakness;Pes planus;Muscle fiber atrophy;Generalized hypotonia;Poor head control;High palate;Spinal rigidity;Mandibular prognathia;Delayed gross motor development;Right ventricular hypertrophy;Hip dysplasia;Increased muscle lipid content;Right ventricular failure;Congenital muscular dystrophy;Microretrognathia;Multiple joint contractures;Weakness of facial musculature;Scoliosis;Failure to thrive;High pitched voice;Generalized amyotrophy;Nocturnal hypoventilation;Congestive heart failure;Restrictive ventilatory defect;Axial muscle weakness;Short stature;Mitral valve prolapse;Dilated cardiomyopathy;Autosomal dominant inheritance;Hypertrophic cardiomyopathy;Increased variability in muscle fiber diameter;Neck flexor weakness;Frequent falls;Shoulder girdle muscle weakness;Proximal muscle weakness;Variable expressivity;Reduced vital capacity;Elevated serum creatine kinase;Autosomal dominant inheritance;Rimmed vacuoles;Diaphragmatic weakness;Pelvic girdle muscle weakness;Difficulty walking;Foot dorsiflexor weakness;Nocturnal hypoventilation;Adult onset;Respiratory failure;Slow progression;Calf muscle hypertrophy;Muscle fiber splitting;Myofibrillar myopathy;Quadriceps muscle weakness;Rimmed vacuoles;Increased muscle lipid content;Mildly elevated creatine kinase;Ankle weakness;Increased variability in muscle fiber diameter;Foot dorsiflexor weakness;Peroneal muscle atrophy;Steppage gait;Distal upper limb muscle weakness;Centrally nucleated skeletal muscle fibers;EMG: myopathic abnormalities;Clumsiness;Quadriceps muscle weakness;Difficulty walking;Atrioventricular block;Reduced ejection fraction;Atrial fibrillation;Dilated cardiomyopathy;Autosomal dominant inheritance;Ventricular tachycardia;Congestive heart failure;Premature atrial contractions	24033266,23861362	0.00225489	343.0	152114.0	1.0	33	0.98	PASS	eas	0.00502124	26.0	0.00282245	192.0	0.003043	738.0	242524.0	2.0	42	0.87	PASS	eas	0.00751542	134.0	0.0028312	313.0	0.0027459	427	0.002	5.0	0.00114	13.0		20.4	2.065598	0.086	7	10	17	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	TTN	0.04	0.01	0.0	0.0	-4.0	2.0	-4.0	-11.0			6.845	0.325	7.17	0.971	0.0	0.000000000	0.999	1.176	growth/size/body region phenotype; muscle phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; skeleton phenotype; embryo phenotype; behavior/neurological phenotype ; normal phenotype; mortality/aging ; cardiovascular system phenotype ; vision/eye phenotype; immune system phenotype; 			pons;fetal thyroid;thyroid;tongue;trigeminal ganglion;atrioventricular node;superior cervical ganglion;testis;skeletal muscle;globus pallidus;	.	platelet degranulation;cardiac muscle hypertrophy;muscle contraction;striated muscle contraction;mitotic chromosome condensation;positive regulation of gene expression;protein kinase A signaling;peptidyl-tyrosine phosphorylation;muscle filament sliding;skeletal muscle thin filament assembly;skeletal muscle myosin thick filament assembly;detection of muscle stretch;sarcomere organization;regulation of protein kinase activity;cardiac muscle fiber development;sarcomerogenesis;positive regulation of protein secretion;regulation of catalytic activity;response to calcium ion;cardiac myofibril assembly;cardiac muscle tissue morphogenesis;cardiac muscle contraction;striated muscle myosin thick filament assembly	condensed nuclear chromosome;extracellular region;cytosol;striated muscle thin filament;sarcomere;Z disc;M band;I band;extracellular exosome	protease binding;protein serine/threonine kinase activity;protein tyrosine kinase activity;calcium ion binding;protein binding;calmodulin binding;ATP binding;structural constituent of muscle;enzyme binding;protein kinase binding;telethonin binding;identical protein binding;actinin binding;protein self-association;actin filament binding;muscle alpha-actinin binding;structural molecule activity conferring elasticity	ENO1[23414517];ENO3[23414517];AMOT[23414517];IGHG1[15174051];MYC[21150319];HIST1H2AE[30021884];CAPN3[20860623;23414517];SH3GLB1[23414517];ACTN3[23414517];ACTN2[9501083;16902413;23414517;11101506;11846417];HIST1H2AH[30021884];ACTN1[11101506];FNDC3B[23414517];KRT8[30021884];ACTN4[23414517];OBSCN[11448995;20489725;23414517;20133654];SCO1[29568061];PARD3[23414517];CLIP4[23414517];ERP29[30021884];VDAC1[17353931];HIST1H2BH[30021884];OBSL1[20489725;20133654];OPTN[23414517];ASF1B[17353931];SF1[23414517];MYCBP2[23414517];PIK3R4[30021884];GABARAP[23414517];HNRNPDL[30021884];STK38L[30108113];ANKRD28[23414517];SRPK2[23602568];NEK9[23414517];UBE2I[23414517];SMURF2[18157088];FN1[23414517];HMGA1[30021884];NEB[16902413;12482578];H2BFS[30021884];ESR1[25604459];ESR2[25604459];CCT6A[23414517];HNRNPF[30021884];ALB[15174051];CALU[30021884];TAB2[23414517];STT3B[30021884];CALM1[7607248];HNRNPA1L2[30021884];RYR1[23414517];MYOM1[23414517];SYNM[25447537];DYRK2[23602568];ITGB5[23414517];MAST2[23414517];FHL1[23414517];DYSF[23414517];HSPB2[26465331];MED19[15175163];ARRB1[17620599];ASH2L[23414517];PYGM[23414517];CHD4[23414517];C1QTNF9[23414517];KRI1[30021884];JPH1[23414517];MYOM2[23414517];HK1[29568061];MAP1LC3B[20562859];MED10[15175163];ANKRD1[23414517];PHGDH[23414517];NEO1[23414517];SGCG[23414517];HIST1H1B[30021884];HIST1H1C[30021884];SUN2[22555292];DFFA[17353931];MYBPC1[23414517];TRIM63[18157088;23414517];MYBPC2[23414517];DDX56[17353931];MED26[15175163];YWHAZ[20618440];HIST2H2BF[30021884];MED29[15175163];HIST2H2BE[30021884];VAV2[18654987;23414517];ACTA2[9501083];RNF167[23414517];PKM[24606918];ITGB1BP2[23414517];RPL12[23414517];POMP[23414517];FSTL1[20860622];TTN[9804419;23414517;16407954;16962974];ABLIM1[23414517];ABLIM2[23414517];EXOSC10[23414517];UGP2[23414517];ATP5F1B[30021884];PUF60[17353931];DNAJB6[23414517];DNAJB5[23414517];FLNA[16902413];EBLN1[30021884];NPM1[30021884];MCRS1[17353931];MYBPH[23414517];HSPE1[30021884];ATP5F1D[23414517];KTN1[30021884];RSL1D1[30021884];TTC3[23414517];HNRNPA2B1[30021884];TCAP[16962094;23414517;15582318;11846417;16407954;19622741];TARDBP[30021884];LIMS1[23414517];HSPA1A[23414517];	179593503
44906	chr2	179751485	T	G	chr2:179751485	CCDC141	coiled-coil domain containing 141	SNV	0/1	0.3	14_6	20	79.0	0/0	0.0	19_0	19	54.0			rs114129666	EXONIC	YES	NM_173648.4	Transcript	protein_coding	missense_variant		10/24	NM_173648.4:c.1521A>C	NP_775919.3:p.Gln507His		-1.0	.,.,.	Likely_benign	criteria_provided,_single_submitter	not_provided		Kallmann syndrome;Kallmann syndrome	Disease-causing germline mutation(s) in;Major susceptibility factor in	Gynecomastia;Micropenis;Decreased testicular size;Autosomal recessive inheritance;Cryptorchidism;Autosomal dominant inheritance;Hypogonadotropic hypogonadism;Sparse pubic hair;Primary amenorrhea;Infertility;Sparse axillary hair;Color vision defect;Micropenis;Hypothalamic gonadotropin-releasing hormone deficiency;Abnormality of the voice;Reduced number of teeth;Hypogonadotropic hypogonadism;Decreased fertility;Pes cavus;Reduced bone mineral density;Gynecomastia;Bimanual synkinesia;Recurrent fractures;Dyspareunia;Decreased testicular size;Muscular hypotonia;Paraplegia;Sensorineural hearing impairment;Tremor;Abnormal morphology of female internal genitalia;Delayed puberty;Ataxia;Cleft palate;Erectile dysfunction;Visual impairment;Anosmia;Breast hypoplasia;Skeletal dysplasia;Gait disturbance;Ichthyosis;Primary amenorrhea;Cryptorchidism;Abnormality of cardiovascular system morphology;Pes planus;Delayed skeletal maturation;Ptosis;Dysarthria;Muscle weakness;Hyposmia;Anterior hypopituitarism;Seizure;Obesity;Renal agenesis;Nystagmus;Color vision defect;Micropenis;Hypothalamic gonadotropin-releasing hormone deficiency;Abnormality of the voice;Reduced number of teeth;Hypogonadotropic hypogonadism;Decreased fertility;Pes cavus;Reduced bone mineral density;Gynecomastia;Bimanual synkinesia;Recurrent fractures;Dyspareunia;Decreased testicular size;Muscular hypotonia;Paraplegia;Sensorineural hearing impairment;Tremor;Abnormal morphology of female internal genitalia;Delayed puberty;Ataxia;Cleft palate;Erectile dysfunction;Visual impairment;Anosmia;Breast hypoplasia;Skeletal dysplasia;Gait disturbance;Ichthyosis;Primary amenorrhea;Cryptorchidism;Abnormality of cardiovascular system morphology;Pes planus;Delayed skeletal maturation;Ptosis;Dysarthria;Muscle weakness;Hyposmia;Anterior hypopituitarism;Seizure;Obesity;Renal agenesis;Nystagmus		0.00452694	689.0	152200.0	2.0	32	0.97	PASS	nfe	0.00774567	527.0	0.00774567	527.0	0.00348387	353.0	101324.0	0.0	6	0.09	PASS	nfe	0.00571487	224.0	0.00571487	224.0	0.0009196,0.0000514	143,8	0.006	20.0				19.67	1.991564	0.219	7	12	19	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	CCDC141	0.0	0.0	0.0	0.0	37.0	-2.0	-6.0	0.0							0.0		1.0	1.138	cellular phenotype; integument phenotype ; nervous system phenotype ; behavior/neurological phenotype ; 			.	.	.	cytoplasm;microtubule organizing center	protein binding	RRAD[23414517];HOMER3[unassigned1304];DISC1[12812986];DHRS2[30021884];	179751485
45087	chr2	190617412		A	chr2:190617411-190617412	OSGEPL1	O-sialoglycoprotein endopeptidase like 1	insertion	0/1	0.36	37_21	58	99.0	0/0	0.0	35_0	35	99.0			rs568165204	EXONIC	YES	NM_001376082.1	Transcript	protein_coding	frameshift_variant		7/9	NM_001376082.1:c.1133dup	NP_001363011.1:p.Leu378PhefsTer3		-1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00257488	392.0	152240.0	2.0	31	0.97	PASS	nfe	0.00440865	300.0	0.00440865	300.0	0.00286657	714.0	249078.0	0.0	65	1.0	PASS	nfe	0.00483605	546.0	0.00483605	546.0	0.0000322,0.0028424	5,442	0.002	7.0				32.0	4.579812		0	0	0			OSGEPL1	0.03	0.0	0.0	0.04	39.0	24.0	35.0	-39.0						0.743	0.0	0.000000000,34.039754228			.			occipital lobe;superior cervical ganglion;globus pallidus;	.	tRNA threonylcarbamoyladenosine modification;proteolysis	EKC/KEOPS complex;mitochondrion	metalloendopeptidase activity;metal ion binding;N(6)-L-threonylcarbamoyladenine synthase activity	API5[30021884];	190617411
45139	chr2	191850391	A	G	chr2:191850391	STAT1	signal transducer and activator of transcription 1	SNV	0/1	0.4	30_20	50	99.0	0/0	0.0	33_0	33	99.0			rs191364028	SPLICING	YES	NM_001384891.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	14/24		NM_001384891.1:c.1258-5T>C			-1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Mycobacterial_and_viral_infections,_susceptibility_to,_autosomal_recessive|Immunodeficiency_31C|Immunodeficiency_31a|not_specified|not_provided	Immunodeficiency 31C, chronic mucocutaneous candidiasis, autosomal dominant, 614162 (3), Autosomal dominant; Immunodeficiency 31A, mycobacteriosis, autosomal dominant, 614892 (3), Autosomal dominant; Immunodeficiency 31B, mycobacterial and viral infections, autosomal recessive, 613796 (3), Autosomal recessive	Mendelian susceptibility to mycobacterial diseases due to partial STAT1 deficiency;Autoimmune enteropathy and endocrinopathy-susceptibility to chronic infections syndrome;Susceptibility to viral and mycobacterial infections	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in	Herpes simplex encephalitis;Autosomal recessive inheritance;Recurrent viral infections;Recurrent mycobacterial infections;Herpes simplex encephalitis;Incomplete penetrance;Autosomal dominant inheritance;Immunodeficiency;Delayed puberty;Lymphopenia;Short stature;Autoimmune hemolytic anemia;Recurrent respiratory infections;Immunodeficiency;Eczema;Osteopenia;Chronic mucocutaneous candidiasis;Autosomal dominant inheritance;Hypothyroidism;Diabetes mellitus;Diarrhea;Villous atrophy;Immune dysregulation;Functional abnormality of the bladder;Autoimmune hemolytic anemia;Hepatitis;Immunodeficiency;B lymphocytopenia;Oropharyngeal squamous cell carcinoma;Chronic mucocutaneous candidiasis;Immune dysregulation;Abnormal serum interferon-gamma level;Thyroiditis;Primary hypothyroidism;Recurrent upper respiratory tract infections;Encephalitis;Medial calcification of large arteries;Patent foramen ovale;Type I diabetes mellitus;Enterocolitis;Congestive heart failure;Generalized osteoporosis;Hepatosplenomegaly;Neutropenia in presence of anti-neutropil antibodies;Autoimmune thrombocytopenia;Recurrent herpes;Pulmonary arterial hypertension;Esophageal carcinoma;Delayed puberty;Diarrhea;Eczema;Short stature;Renal artery stenosis;Recurrent Aspergillus infections;Carotid artery dilatation;Bronchiectasis;Dilatation of the cerebral artery;Osteopenia;Delayed skeletal maturation;Villous atrophy;Antiphospholipid antibody positivity;Renovascular hypertension		0.00133347	203.0	152234.0	0.0	33	0.98	PASS	nfe	0.00202804	138.0	0.00202804	138.0	0.0018107	455.0	251284.0	4.0	84	0.99	PASS	nfe	0.0027899	317.0	0.0027899	317.0	0.0019485	303	0.004	12.0	0.00491	56.0		15.24	1.310399		0	0	0			STAT1	0.0	0.32	0.0	0.32	50.0	-5.0	-5.0	-46.0	0.0044122387172052	0.174	5.101	1.094	6.195	0.151	1.0				neoplasm; normal phenotype; mortality/aging ; cardiovascular system phenotype ; hematopoietic system phenotype; behavior/neurological phenotype ; liver/biliary system phenotype; skeleton phenotype; immune system phenotype; vision/eye phenotype; limbs/digits/tail phenotype; nervous system phenotype ; muscle phenotype; digestive/alimentary phenotype; endocrine/exocrine gland phenotype; integument phenotype ; growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			ciliary ganglion;pons;white blood cells;lymph node;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skin;whole blood;	Toll-like receptor signaling pathway;Jak-STAT signaling pathway;Pancreatic cancer	negative regulation of transcription by RNA polymerase II;negative regulation of endothelial cell proliferation;positive regulation of mesenchymal cell proliferation;positive regulation of defense response to virus by host;negative regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis;transcription by RNA polymerase II;positive regulation of transcription of Notch receptor target;JAK-STAT cascade;response to nutrient;blood circulation;response to mechanical stimulus;macrophage derived foam cell differentiation;viral process;negative regulation of angiogenesis;cytokine-mediated signaling pathway;positive regulation of interferon-alpha production;cellular response to insulin stimulus;tumor necrosis factor-mediated signaling pathway;response to cytokine;response to interferon-beta;cellular response to interferon-beta;interleukin-9-mediated signaling pathway;interleukin-21-mediated signaling pathway;response to hydrogen peroxide;regulation of apoptotic process;negative regulation of I-kappaB kinase/NF-kappaB signaling;response to peptide hormone;endothelial cell migration;positive regulation of erythrocyte differentiation;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;negative regulation by virus of viral protein levels in host cell;positive regulation of smooth muscle cell proliferation;response to cAMP;defense response to virus;positive regulation of nitric-oxide synthase biosynthetic process;interferon-gamma-mediated signaling pathway;regulation of interferon-gamma-mediated signaling pathway;type I interferon signaling pathway;renal tubule development;interleukin-6-mediated signaling pathway;interleukin-27-mediated signaling pathway;interleukin-35-mediated signaling pathway;cellular response to interferon-gamma;cellular response to organic cyclic compound;metanephric mesenchymal cell proliferation involved in metanephros development;metanephric mesenchymal cell differentiation;negative regulation of metanephric nephron tubule epithelial cell differentiation	nuclear chromatin;nucleus;nucleoplasm;nucleolus;cytoplasm;cytosol;axon;dendrite;protein-containing complex;perinuclear region of cytoplasm	RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II core promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;double-stranded DNA binding;DNA-binding transcription factor activity;tumor necrosis factor receptor binding;protein binding;RNA polymerase II general transcription initiation factor activity;enzyme binding;CCR5 chemokine receptor binding;histone acetyltransferase binding;nuclear hormone receptor binding;histone binding;identical protein binding;protein homodimerization activity;ubiquitin-like protein ligase binding;cadherin binding;protein phosphatase 2A binding;repressing transcription factor binding;promoter-specific chromatin binding	OTUD4[25416956];MT-ND4L[21988832];HSP90AB1[20936779];TNFAIP3[unassigned1774];ARRB2[17620599];HSCB[28380382];PYGL[26966684];ETFB[26966684];TNFSF13B[23271704];ACTG1[26966684];UCHL1[26966684];CHCHD3[26966684];NUDCD1[29021621];STMN1[26966684];KPNA6[26966684];HADH[21988832];JAK2[24255956];SPTAN1[20936779;26966684];NOMO1[21988832];NOMO2[21988832];KPNA1[26966684];IFNAR2[9121453];PDGFRB[23397142];GSTK1[17353931];PDGFRA[25241761];IFNGR1[15780933;8156998;8662591];DDX58[24360797];LMO2[16189514];HLA-B[21988832];ACTN4[20936779];FOS[25241761;12788789];PGD[26966684];SPTB[25814554];PTBP2[26966684];PIAS1[25241761];DDB1[21988832];PTP4A3[17353931];POR[21988832];KIT[25241761];CANX[26966684];RARA[25303530];UQCRC1[26966684];NDUFS3[26966684];PABPC3[26966684];IL6ST[8662591];INA[26966684];IRF9[17923090;24065129];IFNAR1[9121453];SHANK1[20936779];PLEC[26966684];KDM3A[25535969];DCTN1[20936779];GLO1[26966684];HSD17B4[26966684];GATA3[25303530];STK4[23386615];EGFR[12070153;24658140];RELA[25241761];EIF1AD[16189514;25416956];LDHB[26966684];RXRA[21988832];ERBB2[16273093;25241761];E2F1[20195357];SPTBN1[20936779];UBE2F[17353931];STAT5A[25241761];STAT1[8605877;9630226;18591661];STAT2[17923090;8605877;24065129;15825084;26966684];STAT3[8662591;25241761;25609649;26966684];GREB1[25303530];NMI[9989503];TBCA[26966684];RRP1B[20926688];ESR1[25303530];MTOR[25241761];PTK2[25241761];GFAP[20936779];ERP44[26966684];MAVS[21903422];PFKL[26966684];CNOT7[23386060];DES[26966684];BPIFB3[17353931];DNAJA3[21106534];CAPRIN1[26966684];FOXA3[25609649];FARSB[26966684];UBE2M[26966684];	191850391
45433	chr2	210806000	G	A	chr2:210806000	UNC80	unc-80 homolog, NALCN channel complex subunit	SNV	0/1	0.58	54_74	128	99.0	0/0	0.0	34_0	34	99.0			rs139008923	EXONIC	YES	NM_001371986.1	Transcript	protein_coding	synonymous_variant		44/65	NM_001371986.1:c.6702G>A	NP_001358915.1:p.Leu2234%3D		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided	Hypotonia, infantile, with psychomotor retardation and characteristic facies 2, 616801 (3), Autosomal recessive	Hypotonia-speech impairment-severe cognitive delay syndrome	Disease-causing germline mutation(s) (loss of function) in	Low-set, posteriorly rotated ears;Tented upper lip vermilion;Cachexia;Self-injurious behavior;Thin upper lip vermilion;Nasogastric tube feeding in infancy;Muscular hypotonia of the trunk;Tapered distal phalanges of finger;Spastic tetraplegia;Enlarged naris;Intellectual disability, severe;Motor delay;Small hand;Short stature;Smooth philtrum;Wide nasal bridge;Elbow flexion contracture;Esotropia;Nystagmus;Dyskinesia;Micrognathia;Conspicuously happy disposition;Triangular face;Plagiocephaly;Frontal bossing;Microcephaly;Constipation;Talipes equinovarus;Short neck;Severe failure to thrive;Hypoplasia of the corpus callosum;Seizure;Knee flexion contracture;Obstructive sleep apnea;Anteverted nares;EEG abnormality;Hip contracture;Global developmental delay;Intrauterine growth retardation;Downslanted palpebral fissures;Neonatal hypotonia;Hyperesthesia;EMG: myopathic abnormalities;Infantile muscular hypotonia;Short philtrum;Prominent nasal bridge;Absent speech;Scoliosis;Arachnodactyly;Central hypotonia;Ptosis;Broad forehead;Osteopenia;Short neck;Intrauterine growth retardation;Microcephaly;Low-set ears;Frontal bossing;Triangular face;Generalized hypotonia;Brachycephaly;Autosomal recessive inheritance;Short philtrum;Prominent forehead;Profound static encephalopathy;Hypoplasia of the corpus callosum;Profound global developmental delay;Seizure;Prominent nasal bridge;Dyskinesia;Epicanthus;Thin upper lip vermilion;Tapered finger;Nystagmus;Prominent nose;Esotropia;Intellectual disability, profound;Cerebral atrophy;Hip contracture;Absent speech;Anteverted nares;Severe global developmental delay;Inability to walk;Feeding difficulties;Appendicular hypotonia;Global brain atrophy;Cachexia;Plagiocephaly;High forehead;Scoliosis;Downslanted palpebral fissures;Poor speech;Bulbous nose;Smooth philtrum;Open mouth;Failure to thrive in infancy;Constipation;Spasticity;Posteriorly rotated ears;Facial hypotonia		0.000243079	37.0	152214.0	0.0	32	0.96	PASS	nfe	0.000396837	27.0	0.000396837	27.0	0.000269992	42.0	155560.0	1.0	23	0.55	PASS	nfe	0.000415904	25.0	0.000415904	25.0	0.0000965	15	0.001	2.0	9e-05	1.0		8.613	0.420218		0	0	0			UNC80	0.0	0.0	0.0	0.0	-47.0	-20.0	6.0	28.0						0.64	0.14	85.287469911			.			ciliary ganglion;amygdala;tongue;dorsal root ganglion;superior cervical ganglion;skin;cingulate cortex;atrioventricular node;trigeminal ganglion;globus pallidus;	.	ion transmembrane transport	plasma membrane;integral component of membrane	.	GABARAPL2[20562859];TIMMDC1[24344204];GABARAP[20562859];	210806000
45564	chr2	219529924	T	G	chr2:219529924	RNF25	ring finger protein 25	SNV	0/1	0.43	67_50	117	99.0	0/1	0.44	58_45	103	99.0			rs112523387	EXONIC	YES	NM_022453.3	Transcript	protein_coding	missense_variant		8/10	NM_022453.3:c.620A>C	NP_071898.2:p.Tyr207Ser		-1.0						.	.	.		0.00365352	556.0	152182.0	2.0	32	0.97	PASS	nfe	0.00589359	401.0	0.00589359	401.0	0.00341608	859.0	251458.0	2.0	58	1.0	PASS	nfe	0.00567043	645.0	0.00567043	645.0	0.0037169	578	0.005	17.0				25.2	3.571805	0.312	12	9	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	RNF25	0.0	0.05	0.0	0.01	-24.0	43.0	43.0	-46.0						0.798	0.83	0.000000000	0.944	1.138	homeostasis/metabolism phenotype; behavior/neurological phenotype ; 			pons;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	.	protein ubiquitination;positive regulation of NF-kappaB transcription factor activity	nucleus;cytosol	ubiquitin-protein transferase activity;protein binding;metal ion binding;NF-kappaB binding;ubiquitin protein ligase activity	UBE2D4[19690564;19549727];UBE2D2[19690564;19549727];UBE2E3[19690564;19549727];UBE2D3[19690564;19549727;unassigned1304;16462746];UBE2E1[19690564;19549727];UBE2D1[19690564;19549727;unassigned1304];UBE2E2[19549727];UBE2L6[19690564];MEOX2[unassigned1304];NKD2[18757723];KCTD21[unassigned1304];UBE2U[19690564];TRIM27[22493164];MAPT[26402096];	219529924
45566	chr2	219564014	G	A	chr2:219564014	STK36	serine/threonine kinase 36	SNV	0/1	0.45	75_62	137	99.0	0/1	0.47	62_54	116	99.0			rs148113887	EXONIC	YES	NM_015690.5	Transcript	protein_coding	synonymous_variant		26/27	NM_015690.5:c.3747G>A	NP_056505.2:p.Val1249%3D		1.0					?Ciliary dyskinesia, primary, 46, 619436 (3), Autosomal recessive	Primary ciliary dyskinesia	Disease-causing germline mutation(s) (loss of function) in	Hydrocephalus;Pectus excavatum;Chronic otitis media;Tachypnea;Impaired nasal mucociliary clearance;Delayed speech and language development;Asthma;Atelectasis;Headache;Ectopic pregnancy;Nasal polyposis;Clubbing of fingers;Pulmonary obstruction;Asplenia;Scoliosis;Reduced sperm motility;Respiratory distress;Immotile cilia;Chronic sinusitis;Infertility;Chronic bronchitis;Corneal dystrophy;Glue ear;Pneumonia;Spontaneous abortion;Conductive hearing impairment;Recurrent respiratory infections;Situs inversus totalis;Cough;Bronchiectasis;Ventriculomegaly;Rhinitis;Halitosis		0.000394296	60.0	152170.0	0.0	31	0.95	PASS	nfe	0.000602746	41.0	0.000602746	41.0	0.000287327	72.0	250586.0	0.0	85	0.99	PASS	nfe	0.000459786	52.0	0.000459786	52.0	0.0003087	48	0.002	5.0	0.00084	8.0		10.9	0.669667		0	0	0			STK36	0.0	0.0	0.01	0.0	40.0	-41.0	-3.0	46.0						0.886	0.0	40.085683608			nervous system phenotype ; hearing/vestibular/ear phenotype; renal/urinary system phenotype; skeleton phenotype; immune system phenotype; behavior/neurological phenotype ; respiratory system phenotype; mortality/aging ; reproductive system phenotype; growth/size/body region phenotype; hematopoietic system phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; 			ciliary ganglion;testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;cingulate cortex;testis;skeletal muscle;	Hedgehog signaling pathway;Basal cell carcinoma	epithelial cilium movement;protein phosphorylation;positive regulation of hh target transcription factor activity;brain development;post-embryonic development;positive regulation of smoothened signaling pathway;regulation of DNA-binding transcription factor activity;cilium assembly	nucleus;cytoplasm;cytosol	protein serine/threonine kinase activity;protein binding;ATP binding;transcription factor binding;metal ion binding	FRMPD4[12421765];ARMC6[17353931];MAST2[12421765];SUFU[10806483;25241761];CLNK[25814554];GLI1[10806483;25241761];GLI3[10806483;25241761];CDK5RAP2[12421765];	219564014
45575	chr2	219846565	T	C	chr2:219846565	FEV	FEV, ETS transcription factor	SNV	0/1	0.58	13_18	31	99.0	0/0	0.0	19_0	19	54.0			rs1052936032	EXONIC	YES	NM_017521.3	Transcript	protein_coding	missense_variant		3/3	NM_017521.3:c.541A>G	NP_059991.1:p.Met181Val		-1.0						.	.	.		3.36832e-05	5.0	148442.0	0.0	33	0.96	PASS	amr	0.000132926	2.0	2.98606e-05	2.0	0.0	0.0	2908.0	0.0	0	0.0	AC0				0.0	0.0								17.1	1.640799	0.068	3	15	18	M-CAP_pred,PrimateAI_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	FEV	0.0	0.0	0.0	0.0	-7.0	-2.0	1.0	34.0									0.996	0.967	cellular phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype ; mortality/aging ; nervous system phenotype ; 			ciliary ganglion;pons;subthalamic nucleus;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;prostate;skeletal muscle;globus pallidus;	.	regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;positive regulation of gene expression;cell differentiation;neuron maturation;neuron fate specification;negative regulation of nucleic acid-templated transcription	nucleus;nuclear speck	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;transcription corepressor activity;sequence-specific DNA binding	.	219846565
45620	chr2	220113139	A	T	chr2:220113139	STK16	serine/threonine kinase 16	SNV	0/1	0.56	40_51	91	99.0	0/1	0.54	49_57	106	99.0				SPLICING	YES	NM_001330213.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	7/7		NM_001330213.2:c.780-4A>T			1.0						.	.	.						32	0.96											63	0.97														3.092	0.029824		0	0	0			STK16	0.01	0.01	0.0	0.0	-32.0	4.0	3.0	-1.0	6.53129245704839e-05	0.02	9.124	1.676	10.8	0.714	0.0				behavior/neurological phenotype ; hematopoietic system phenotype; adipose tissue phenotype ; 			.	.	peptidyl-tyrosine phosphorylation;positive regulation of transcription by RNA polymerase II;protein autophosphorylation;cellular response to transforming growth factor beta stimulus	Golgi-associated vesicle;cytosol;membrane;perinuclear region of cytoplasm	protein serine/threonine kinase activity;non-membrane spanning protein tyrosine kinase activity;protein binding;ATP binding	ZNF330[unassigned1304];CNTF[17353931];TRAF3IP2[25416956];CALCOCO2[25416956];KRTAP26-1[25416956];PRDM6[unassigned1304];ICA1[17353931];TNFAIP1[25416956];PTH1R[unassigned1304];MEOX2[25416956];PCSK5[25416956];IKZF3[25416956];NAA80[unassigned1304];EFEMP2[25416956;unassigned1304];CYSRT1[unassigned1304];ADAMTSL4[16189514;19060904;unassigned1304];CSKMT[unassigned1304];HNF4A[17353931];TRIM27[25416956];LINC00574[unassigned1304];IKBKE[17353931];GABPA[unassigned1304];KRTAP1-1[unassigned1304];RSPO4[unassigned1304];PKNOX2[unassigned1304];TGIF1[17353931];KRTAP11-1[unassigned1304];MKKS[17353931];KRTAP13-2[unassigned1304];SNRPN[17353931];TCF12[25416956];MTUS2[25416956];PASK[17353931];KRT31[unassigned1304];FRS3[unassigned1304];AES[25416956];PLSCR1[25416956];NIF3L1[25416956];MELK[17353931];RFX6[25416956];PLSCR3[25416956;unassigned1304];PRKAR1B[unassigned1304];CSNK2B[21900206];LPAL2[unassigned1304];PLA2G10[unassigned1304];KCTD14[25416956;unassigned1304];EFHC2[25416956];KCTD17[16189514;25416956;unassigned1304];SAXO1[25416956;unassigned1304];KPRP[unassigned1304];ROCK2[17353931];ATP23[unassigned1304];USP54[unassigned1304];CRX[25416956];CFP[unassigned1304];FXR1[unassigned1304];MIER3[unassigned1304];EBLN2[17353931];AGR2[unassigned1304];VHL[17353931];CCDC33[21516116];TRIM42[25416956;unassigned1304];SKIL[25416956];ZNF343[unassigned1304];BHLHA9[unassigned1304];ARNT2[unassigned1304];KRTAP10-5[25416956];KRTAP10-7[25416956];CBX3[unassigned1304];KRTAP10-9[25416956];KRTAP10-8[25416956;unassigned1304];INCA1[25416956;unassigned1304];MIIP[25416956];DDIT4L[unassigned1304];NOTCH2NLA[25416956;unassigned1304];KLHL20[unassigned1304];RPIA[16189514;25416956];EXT2[17353931];SNRK[17353931];ALS2CR12[25416956];DNAJA3[25416956];TRIP6[25416956];REL[25416956;unassigned1304];DRG1[25416956];SPRY2[25416956];TCF4[25416956];ZNF774[unassigned1304];	220113139
45635	chr2	220353552	G	A	chr2:220353552	SPEG	striated muscle enriched protein kinase	SNV	0/1	0.56	51_65	116	99.0	0/0	0.0	49_0	49	99.0			rs200286305,COSV100403833	EXONIC	YES	NM_005876.5	Transcript	protein_coding	synonymous_variant		34/41	NM_005876.5:c.8079G>A	NP_005867.3:p.Thr2693%3D		1.0					Centronuclear myopathy 5, 615959 (3), Autosomal recessive	Autosomal recessive centronuclear myopathy	Disease-causing germline mutation(s) in	Axial muscle weakness;Retrognathia;Infantile onset;Ophthalmoplegia;Motor delay;Generalized hypotonia;Areflexia;High palate;Autosomal recessive inheritance;Facial palsy;Respiratory insufficiency;Severe muscular hypotonia;Hip contracture;Narrow mouth;Dilated cardiomyopathy;Micrognathia;Waddling gait;Dysphonia;Talipes equinovarus;Difficulty climbing stairs;Pes cavus;Generalized amyotrophy;Intellectual disability, mild;Motor delay;Narrow mouth;Dysarthria;Scapular winging;Protruding ear;Facial diplegia;Type 1 muscle fiber predominance;Ophthalmoplegia;Areflexia;Bifid uvula;Delayed speech and language development;Respiratory insufficiency;Hyperlordosis;Generalized hypotonia;Difficulty running;Retrognathia;Gowers sign;EMG: decremental response of compound muscle action potential to repetitive nerve stimulation;Long face;Centrally nucleated skeletal muscle fibers;Abnormal heart valve morphology;Left ventricular hypertrophy;Progressive muscle weakness;Long fingers;High palate;Hip contracture		0.000124896	19.0	152126.0	0.0	32	0.97	PASS	amr	0.000523697	8.0	8.82301e-05	6.0	0.000178293	38.0	213132.0	0.0	62	0.61	PASS	sas	0.000433808	12.0	0.000128639	12.0	0.0001222	19						5.984	0.209748		0	0	0			SPEG	0.0	0.0	0.0	0.0	-49.0	-25.0	6.0	-24.0						0.507	1.0	25.366878582			cardiovascular system phenotype ; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; immune system phenotype; muscle phenotype; 			ciliary ganglion;testis - seminiferous tubule;dorsal root ganglion;atrioventricular node;cingulate cortex;superior cervical ganglion;skeletal muscle;globus pallidus;cerebellum;	.	protein phosphorylation;muscle organ development;negative regulation of cell population proliferation;muscle cell differentiation;cardiovascular system development	nucleus	protein kinase activity;protein serine/threonine kinase activity;protein binding;ATP binding	PRMT1[25416956;unassigned1304];MYC[21150319];PICK1[unassigned1304];DDIT4L[unassigned1304];HSF2BP[unassigned1304];MEOX2[unassigned1304];	220353552
45649	chr2	220428241	C	T	chr2:220428241	OBSL1	obscurin like 1	SNV	0/0	0.0	34_0	34	99.0	0/1	0.41	89_61	150	99.0			rs371714401,COSV99216452	EXONIC	YES	NM_015311.3	Transcript	protein_coding	missense_variant		7/21	NM_015311.3:c.2516G>A	NP_056126.1:p.Arg839His		-1.0	Immunoglobulin-like domain&Immunoglobulin subtype 2&Immunoglobulin subtype,Immunoglobulin-like domain&Immunoglobulin subtype 2&Immunoglobulin subtype,.,.,Immunoglobulin-like domain&Immunoglobulin subtype 2&Immunoglobulin subtype	Uncertain_significance	criteria_provided,_multiple_submitters,_no_conflicts	not_provided	3-M syndrome 2, 612921 (3), Autosomal recessive	3M syndrome	Disease-causing germline mutation(s) in	Slender long bone;Short 5th finger;Abnormality of the sternum;Pointed chin;Short neck;Short thorax;Delayed eruption of teeth;High palate;Thin ribs;Depressed nasal bridge;Protruding ear;Anteverted nares;Small for gestational age;Triangular face;Prominent nasal tip;Malar flattening;Hyperlordosis;Long philtrum;Short stature;Autosomal recessive inheritance;Thick vermilion border;Relative macrocephaly;Dental malocclusion;Midface retrusion;Prominent calcaneus;Frontal bossing;Delayed skeletal maturation;Scapular winging;Dolichocephaly;Decreased fertility;Scapular winging;Short thorax;Increased vertebral height;Abnormality of dental enamel;Thick eyebrow;Long philtrum;Horizontal ribs;Short stature;Hypoplastic ischia;Pointed chin;Joint hyperflexibility;Rocker bottom foot;Bulbous nose;Clinodactyly of the 5th finger;Enlarged thorax;Hypoplastic pelvis;Congenital hip dislocation;Triangular face;Anteverted nares;Abnormality of the elbow;Kyphosis;Hypospadias;Delayed eruption of teeth;Midface retrusion;Everted lower lip vermilion;Short neck;Slender long bone;Intrauterine growth retardation;Hypoplasia of the ulna;Abnormality of the metaphysis;Delayed skeletal maturation;Hyperlordosis;Broad forehead;Micromelia;Frontal bossing;Hypoplastic pubic bone;Thin ribs;Scoliosis;Protruding ear;Abnormality of the cerebral vasculature;Dolichocephaly		5.25769e-05	8.0	152158.0	0.0	32	0.95	PASS	amr	0.000196309	3.0	0.0	0.0	2.4074e-05	6.0	249232.0	0.0	72	1.0	PASS	afr	0.000129016	2.0	1.77019e-05	2.0	0.0000386	6			0.00026	3.0		6.288	0.230923	0.072	1	17	18	M-CAP_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OBSL1	0.0	0.0	0.01	0.01	25.0	15.0	-3.0	5.0						0.861	0.0	0.000000000	0.021	-1.227	.			thyroid;testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;atrioventricular node;superior cervical ganglion;uterus corpus;testis;	.	microtubule cytoskeleton organization;muscle contraction;cytoskeleton organization;Golgi organization;regulation of mitotic nuclear division;skeletal muscle thin filament assembly;skeletal muscle myosin thick filament assembly;protein localization to Golgi apparatus;post-translational protein modification;sarcomere organization;cardiac muscle fiber development;positive regulation of dendrite morphogenesis;cardiac myofibril assembly;cardiac muscle tissue morphogenesis;striated muscle myosin thick filament assembly	cytoplasm;Golgi apparatus;centrosome;cytosol;striated muscle thin filament;intercalated disc;sarcomere;Z disc;M band;perinuclear region of cytoplasm;3M complex	protein binding;cytoskeletal adaptor activity;structural constituent of muscle;actin filament binding;muscle alpha-actinin binding	CUL7[21572988];SEPT12[25775403];KSR1[27086506];FBXW8[21572988];DNAAF1[27173435;unassigned1312];HSPB1[25277244];MAPK14[23455922;23602568];TANK[unassigned1774];TTN[20489725;20133654];CAMKK2[20562859];MAPK11[23602568];LTB4R2[28298427];ALB[15174051];ULK2[20562859];TBKBP1[21903422];KBTBD7[20562859];TP53[22653443;25609649];	220428241
45692	chr2	227661537	C	T	chr2:227661537	IRS1	insulin receptor substrate 1	SNV	0/1	0.48	77_71	148	99.0	0/1	0.51	81_87	169	99.0			rs777987963,COSV59333725	EXONIC	YES	NM_005544.3	Transcript	protein_coding	missense_variant		1/2	NM_005544.3:c.1918G>A	NP_005535.1:p.Val640Ile		-1.0					{Type 2 diabetes mellitus, susceptibility to}, 125853 (3), Autosomal dominant; {Coronary artery disease, susceptibility to} (3)	.	.	Type II diabetes mellitus;Increased waist to hip ratio;Insulin resistance;Autosomal dominant inheritance;Late onset						33	0.98							2.34306e-05	5.0	213396.0	0.0	61	0.74	PASS	amr	6.39795e-05	2.0	1.02583e-05	1.0	0.0000064	1	0.0	1.0	0.00018	2.0		26.9	3.901657	0.127	11	10	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	IRS1	0.0	0.0	0.0	0.0	-35.0	-18.0	3.0	1.0						0.354	0.22	0.000000000	0.992	0.947	skeleton phenotype; immune system phenotype; hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; mortality/aging ; cardiovascular system phenotype ; hematopoietic system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; growth/size/body region phenotype; 			thyroid;superior cervical ganglion;	Insulin signaling pathway;Adipocytokine signaling pathway;Type II diabetes mellitus	MAPK cascade;signal transduction;positive regulation of cell population proliferation;insulin receptor signaling pathway;positive regulation of glucose metabolic process;phosphatidylinositol 3-kinase signaling;positive regulation of fatty acid beta-oxidation;response to insulin;cellular response to insulin stimulus;phosphatidylinositol-3-phosphate biosynthetic process;interleukin-7-mediated signaling pathway;glucose homeostasis;response to peptide hormone;positive regulation of phosphatidylinositol 3-kinase activity;positive regulation of glycogen biosynthetic process;positive regulation of glucose import;negative regulation of insulin receptor signaling pathway;positive regulation of insulin receptor signaling pathway;negative regulation of insulin secretion;phosphatidylinositol phosphorylation;insulin-like growth factor receptor signaling pathway;phosphatidylinositol-mediated signaling;positive regulation of protein kinase B signaling	nucleus;cytoplasm;cytosol;plasma membrane;insulin receptor complex;caveola;intracellular membrane-bounded organelle	phosphotyrosine residue binding;transmembrane receptor protein tyrosine kinase adaptor activity;SH3/SH2 adaptor activity;protein kinase C binding;Ras guanyl-nucleotide exchange factor activity;insulin receptor binding;insulin-like growth factor receptor binding;protein binding;1-phosphatidylinositol-3-kinase activity;SH2 domain binding;phosphatidylinositol 3-kinase binding;phosphatidylinositol-4,5-bisphosphate 3-kinase activity	YWHAE[9312143;9111084];DDR1[17721511];BCAR3[25814554];LRRK2[24947832];PIK3R3[25814554];PIK3R1[16150444;14632132;16230374;11403293;11416002;7680095;7680644;8382612;23643389;25814554];EGFR[16273093];IGF1R[7541045];CYTH3[17167487];CYTH2[17167487];ERBB2[16273093];SFN[15778465];EIF4E[23770097];PTPN1[11579209];EGLN3[26972000];SMAD3[18729074];INSR[8662806;7935368;16582879;17167487];PTPN11[7513703];SIRT1[21241768];PTPRD[22305495];PIK3CA[16150444;23643389];NUMB[25814554];PELI1[25814554];GRB2[21706016];PABPC1[23770097];	227661537
45843	chr2	233243529	CTG		chr2:233243529-233243531	ALPP	alkaline phosphatase, placental	deletion	0/0	0.0	33_0	33	99.0	0/1	0.14	57_9	66	99.0			rs377162921	EXONIC	YES	NM_001632.5	Transcript	protein_coding	inframe_deletion		1/11	NM_001632.5:c.37_39del	NP_001623.3:p.Leu13del		1.0						.	.	.		7.9091e-05	12.0	151724.0	0.0	32	0.95	PASS	nfe	0.000117848	8.0	0.000117848	8.0	0.0025959	512.0	197234.0	2.0	61	0.99	PASS	sas	0.004699	106.0	0.00283939	255.0	0.0000386,0.0018649,0.0336583	6,290,5234	0.05	157.0				12.7	0.897316		0	0	0			ALPP	0.0	0.0	0.0	0.0	5.0	-17.0	48.0	50.0						0.174	0.0				.			.	gamma-Hexachlorocyclohexane degradation;Folate biosynthesis	dephosphorylation	plasma membrane;cell surface;integral component of membrane;anchored component of membrane	magnesium ion binding;alkaline phosphatase activity;protein binding;zinc ion binding	NLGN3[25464930];RGS19[unassigned1304];GPAA1[12616539];CRCT1[unassigned1304];MEOX2[unassigned1304];CXCL5[unassigned1304];LCE3C[unassigned1304];TGM1[unassigned1304];LCE3D[unassigned1304];LCE3A[unassigned1304];CYSRT1[unassigned1304];LCE3B[unassigned1304];SUMO1[17000644];LCE5A[unassigned1304];ADAMTSL4[unassigned1304];SUMO3[17000644];RGS20[unassigned1304];HOXA1[unassigned1304];GSC2[unassigned1304];IGFBP6[unassigned1304];OTX1[unassigned1304];LELP1[unassigned1304];A2M[17174955];KRTAP1-1[unassigned1304];SMCP[unassigned1304];KRTAP5-9[25416956;unassigned1304];KRTAP10-8[unassigned1304];FBXO34[unassigned1304];NOTCH2NLA[unassigned1304];LCE1E[unassigned1304];LCE1F[unassigned1304];LCE3E[unassigned1304];POU4F2[unassigned1304];LCE1D[unassigned1304];LCE2C[unassigned1304];NR4A3[unassigned1304];KRTAP4-12[25416956];PIGK[12616539];GEMIN4[unassigned1304];CREB5[unassigned1304];GLYR1[unassigned1304];	233243528
45849	chr2	233246221	C	T	chr2:233246221	ALPP	alkaline phosphatase, placental	SNV	0/1	0.42	79_58	137	99.0	0/0	0.0	44_0	44	99.0			rs142493383	EXONIC	YES	NM_001632.5	Transcript	protein_coding	missense_variant		11/11	NM_001632.5:c.1324C>T	NP_001623.3:p.Arg442Trp		1.0						.	.	.		0.00251042	382.0	152166.0	1.0	32	0.98	PASS	amr	0.00575766	88.0	0.00304313	207.0	0.00246305	611.0	248066.0	9.0	45	0.95	PASS	amr	0.00487748	168.0	0.00265114	296.0	0.0000064,0.0023472	1,365	0.008	26.0				23.0	2.743815	0.125	11	10	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,LIST-S2_pred	Polyphen2_HVAR_pred,LRT_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ALPP	0.01	0.01	0.0	0.0	-10.0	-14.0	-25.0	42.0						0.174	0.0		0.026	-0.068	.			.	gamma-Hexachlorocyclohexane degradation;Folate biosynthesis	dephosphorylation	plasma membrane;cell surface;integral component of membrane;anchored component of membrane	magnesium ion binding;alkaline phosphatase activity;protein binding;zinc ion binding	NLGN3[25464930];RGS19[unassigned1304];GPAA1[12616539];CRCT1[unassigned1304];MEOX2[unassigned1304];CXCL5[unassigned1304];LCE3C[unassigned1304];TGM1[unassigned1304];LCE3D[unassigned1304];LCE3A[unassigned1304];CYSRT1[unassigned1304];LCE3B[unassigned1304];SUMO1[17000644];LCE5A[unassigned1304];ADAMTSL4[unassigned1304];SUMO3[17000644];RGS20[unassigned1304];HOXA1[unassigned1304];GSC2[unassigned1304];IGFBP6[unassigned1304];OTX1[unassigned1304];LELP1[unassigned1304];A2M[17174955];KRTAP1-1[unassigned1304];SMCP[unassigned1304];KRTAP5-9[25416956;unassigned1304];KRTAP10-8[unassigned1304];FBXO34[unassigned1304];NOTCH2NLA[unassigned1304];LCE1E[unassigned1304];LCE1F[unassigned1304];LCE3E[unassigned1304];POU4F2[unassigned1304];LCE1D[unassigned1304];LCE2C[unassigned1304];NR4A3[unassigned1304];KRTAP4-12[25416956];PIGK[12616539];GEMIN4[unassigned1304];CREB5[unassigned1304];GLYR1[unassigned1304];	233246221
45932	chr2	233990575	G	A	chr2:233990575	INPP5D	inositol polyphosphate-5-phosphatase D	SNV	0/0	0.0	39_0	39	99.0	0/1	0.57	53_70	123	99.0			rs200834931	EXONIC	YES	NM_001017915.3	Transcript	protein_coding	missense_variant		4/28	NM_001017915.3:c.470G>A	NP_001017915.1:p.Arg157Gln		1.0	.,.					.	.	.		0.00133446	203.0	152122.0	0.0	32	0.97	PASS	nfe	0.00213223	145.0	0.00213223	145.0	0.00147042	365.0	248228.0	0.0	42	0.95	PASS	nfe	0.00226808	255.0	0.00226808	255.0	0.0014340	223	0.004	13.0	0.00189	18.0		20.2	2.049851		2	14	16	M-CAP_pred,MetaLR_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaSVM_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	INPP5D	0.0	0.0	0.0	0.0	-25.0	-2.0	-44.0	50.0							0.17	0.000000000	0.767	1.083	immune system phenotype; skeleton phenotype; limbs/digits/tail phenotype; digestive/alimentary phenotype; mortality/aging ; hematopoietic system phenotype; cardiovascular system phenotype ; neoplasm; behavior/neurological phenotype ; respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; integument phenotype ; growth/size/body region phenotype; endocrine/exocrine gland phenotype; 			ciliary ganglion;tonsil;white blood cells;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;whole blood;skeletal muscle;bone marrow;	Phosphatidylinositol signaling system;B cell receptor signaling pathway;Fc epsilon RI signaling pathway;Insulin signaling pathway	phosphatidylinositol biosynthetic process;phosphate-containing compound metabolic process;apoptotic process;signal transduction;determination of adult lifespan;negative regulation of signal transduction;immunoglobulin mediated immune response;cytokine-mediated signaling pathway;negative regulation of B cell proliferation;intracellular signal transduction;positive regulation of apoptotic process;inositol phosphate metabolic process;negative regulation of interleukin-6 biosynthetic process;positive regulation of B cell differentiation;positive regulation of erythrocyte differentiation;negative regulation of monocyte differentiation;negative regulation of neutrophil differentiation;negative regulation of osteoclast differentiation;negative regulation of bone resorption;phosphatidylinositol dephosphorylation;negative regulation of immune response;T cell receptor signaling pathway;leukocyte migration	cytosol;cytoskeleton;plasma membrane;membrane raft	inositol-polyphosphate 5-phosphatase activity;protein binding;phosphatidylinositol-3,4,5-trisphosphate 3-phosphatase activity;SH3 domain binding;phosphatidylinositol-3,4,5-trisphosphate 5-phosphatase activity;inositol-1,3,4,5-tetrakisphosphate 5-phosphatase activity	IL4R[11714803];KHDRBS3[25416956;unassigned1304];MME[17342744];KRTAP10-7[25416956];SHC1[10704825];SH3KBP1[15090612];KRTAP10-9[25416956];SH2D1B[23322602];HMGA1[30021884];KRT31[25416956];NOTCH2NLA[25416956];ZDHHC17[24705354];LY9[26221972];EPOR[15644415;10660611];KRT40[25416956];TNFRSF1A[11786908];HCK[12029088];DOK3[17290227];CYSRT1[unassigned1304];FAS[11786908];SIRPA[24642916];FCGR2B[9148918;10382761;24642916];CD244[26221972;24642916];SLAMF1[11313386];	233990575
45949	chr2	234368935	G	A	chr2:234368935	DGKD	diacylglycerol kinase delta	SNV	0/1	0.56	45_58	103	99.0	0/1	0.45	62_51	113	99.0			rs147134923	EXONIC	YES	NM_152879.3	Transcript	protein_coding	synonymous_variant		24/30	NM_152879.3:c.2925G>A	NP_690618.2:p.Glu975%3D		1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	not_provided		.	.	.		0.0059588	906.0	152044.0	8.0	31	0.95	PASS	nfe	0.00969032	659.0	0.00969032	659.0	0.00553279	1388.0	250868.0	12.0	63	1.0	PASS	nfe	0.00899573	1019.0	0.00899573	1019.0	0.0058134	904	0.009	29.0	0.01008	115.0		9.6	0.52117		0	0	0			DGKD	0.0	0.0	0.0	0.0	2.0	1.0	29.0	18.0						0.202	0.98	28.755760600			growth/size/body region phenotype; integument phenotype ; homeostasis/metabolism phenotype; vision/eye phenotype; mortality/aging ; neoplasm; respiratory system phenotype; behavior/neurological phenotype ; nervous system phenotype ; 			white blood cells;fetal brain;testis - seminiferous tubule;testis - interstitial;testis;skeletal muscle;cerebellum peduncles;cerebellum;	Glycerolipid metabolism;Glycerophospholipid metabolism;Phosphatidylinositol signaling system	endocytosis;signal transduction;epidermal growth factor receptor signaling pathway;protein kinase C-activating G protein-coupled receptor signaling pathway;multicellular organism development;response to organic substance;protein transport;second-messenger-mediated signaling;platelet activation;intracellular signal transduction;diacylglycerol metabolic process;glycerolipid metabolic process;lipid phosphorylation;protein homooligomerization	nucleus;cytoplasm;cytosol;plasma membrane	NAD+ kinase activity;diacylglycerol kinase activity;protein binding;ATP binding;diacylglycerol binding;protein homodimerization activity;metal ion binding;protein heterodimerization activity	IGSF21[16169070];NEURL4[29426014];HAX1[16169070];DGKD[18334213];NEK4[25798074];DYSF[23414517];MOK[30021884];TNFRSF14[21900206];HIST1H2BH[30021884];	234368935
45981	chr2	238287313	A	G	chr2:238287313	COL6A3	collagen type VI alpha 3 chain	SNV	0/1	0.51	59_62	121	99.0	0/0	0.0	34_0	34	99.0			rs115387170,COSV55090080	EXONIC	YES	NM_004369.4	Transcript	protein_coding	synonymous_variant		6/44	NM_004369.4:c.2463T>C	NP_004360.2:p.Ser821%3D		-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Bethlem_myopathy_1|Collagen_VI-related_myopathy|not_specified|not_provided	Ullrich congenital muscular dystrophy 1, 254090 (3), Autosomal recessive, Autosomal dominant; Dystonia 27, 616411 (3), Autosomal recessive; Bethlem myopathy 1, 158810 (3), Autosomal recessive, Autosomal dominant	Bethlem myopathy;Primary dystonia, DYT27 type;Congenital muscular dystrophy, Ullrich type	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Multiple joint contractures;Neonatal hypotonia;Camptodactyly of finger;Progressive proximal muscle weakness;Torticollis;Proximal amyotrophy;EMG abnormality;Cachexia;Ankle flexion contracture;Follicular hyperkeratosis;Joint stiffness;Muscular dystrophy;Joint laxity;Scoliosis;Generalized hypotonia;Pes valgus;Hyperextensibility at wrists;Elevated serum creatine kinase;Generalized amyotrophy;Diaphragmatic weakness;Micrognathia;Increased endomysial connective tissue;Increased variability in muscle fiber diameter;Adducted thumb;Spinal rigidity;Knee flexion contracture;Increased laxity of fingers;Decreased fetal movement;Esotropia;Generalized muscle weakness;Frequent falls;Torticollis;Abnormal palate morphology;Hip dislocation;Kyphosis;Elbow flexion contracture;Short neck;Slender finger;EMG: myopathic abnormalities;Respiratory failure;Long toe;Upper limb postural tremor;Axial dystonia;Limb dystonia;Laryngeal dystonia;Writer's cramp;Oromandibular dystonia;Autosomal recessive inheritance;Limb-girdle muscle weakness;Elbow flexion contracture;Variable expressivity;Decreased fetal movement;Ankle flexion contracture;Neonatal hypotonia;Respiratory insufficiency due to muscle weakness;Distal muscle weakness;Elevated serum creatine kinase;Slow progression;Autosomal dominant inheritance;Myopathy;Skeletal muscle atrophy;Motor delay;Camptodactyly of finger;Congenital muscular torticollis;Torticollis;Abnormality of the cardiovascular system;Proximal muscle weakness;Postural tremor;Autosomal recessive inheritance;Writer's cramp;Laryngeal dystonia;Oromandibular dystonia;Feeding difficulties in infancy;Autosomal dominant inheritance;Generalized amyotrophy;Torticollis;Flexion contracture;Hip dislocation;Follicular hyperkeratosis;Round face;Motor delay;Respiratory insufficiency due to muscle weakness;Kyphosis;Facial palsy;High palate;Increased laxity of fingers;Protruding ear;Proximal muscle weakness;Failure to thrive;Congenital muscular dystrophy;Increased laxity of ankles;Type 1 muscle fiber predominance;Hyperextensibility at wrists;Neonatal hypotonia;Talipes equinovarus;Recurrent lower respiratory tract infections;Variable expressivity;Increased variability in muscle fiber diameter;Spinal rigidity;Autosomal recessive inheritance;Scoliosis;Mildly elevated creatine kinase;Distal joint laxity;Hyperhidrosis;Infantile onset;Distal joint laxity;Nocturnal hypoventilation;Progressive;Muscle fiber necrosis;Slender build;Reduced muscle collagen VI	25741868	0.00270636	412.0	152234.0	2.0	33	0.98	PASS	nfe	0.00393909	268.0	0.00393909	268.0	0.0023783	598.0	251440.0	4.0	100	1.0	PASS	nfe	0.00364033	414.0	0.00364033	414.0	0.0023987	373	0.005	15.0	0.0043	49.0		9.812	0.544496		0	0	0			COL6A3	0.0	0.0	0.11	0.0	43.0	-34.0	-34.0	6.0						0.00372	0.0	80.055462835			skeleton phenotype; muscle phenotype; cellular phenotype; growth/size/body region phenotype; 			fetal thyroid;uterus;appendix;uterus corpus;adipose tissue;atrioventricular node;smooth muscle;placenta;fetal lung;testis;heart;	Cell Communication;Focal adhesion;ECM-receptor interaction	growth plate cartilage chondrocyte morphogenesis;cell adhesion;muscle organ development;negative regulation of endopeptidase activity;extracellular matrix organization	extracellular region;collagen type VI trimer;extracellular space;endoplasmic reticulum lumen;extracellular matrix;sarcolemma;collagen-containing extracellular matrix;extracellular exosome;extracellular vesicle	serine-type endopeptidase inhibitor activity;extracellular matrix structural constituent conferring tensile strength	PDIA3[17170699];COL5A1[20979576];NEK4[25798074];DYSF[23414517];	238287313
46041	chr2	239072556	C	A	chr2:239072556	ERFE	erythroferrone	SNV	0/1	0.48	29_29	60	99.0	0/0	0.0	33_0	33	99.0			rs546333844	EXONIC	YES	NM_001291832.2	Transcript	protein_coding	synonymous_variant		4/8	NM_001291832.2:c.603C>A	NP_001278761.1:p.Arg201%3D		1.0						.	.	.		0.00586788	887.0	151162.0	1.0	33	0.97	PASS	nfe	0.00744329	504.0	0.00744329	504.0	0.0123239	91.0	7384.0	2.0	0	0.0	PASS	nfe	0.0134541	49.0	0.0134541	49.0	0.0010096	157	0.007	21.0				11.29	0.717114		0	0	0			FAM132B	0.0	0.0	0.0	0.0	2.0	7.0	-4.0	-45.0											liver/biliary system phenotype; hematopoietic system phenotype; homeostasis/metabolism phenotype; 			.	.	cellular iron ion homeostasis;regulation of signaling receptor activity;regulation of fatty acid metabolic process;positive regulation of fatty acid transport	extracellular region;extracellular space;cell	hormone activity;protein homodimerization activity	.	239072556
46180	chr2	241817048	C	T	chr2:241817048	AGXT	alanine--glyoxylate and serine--pyruvate aminotransferase	SNV	0/1	0.39	44_28	72	99.0	0/0	0.0	33_0	33	99.0			rs138582006,COSV100280251	SPLICING	YES	NM_000030.3	Transcript	protein_coding	missense_variant,splice_region_variant		9/11	NM_000030.3:c.941C>T	NP_000021.1:p.Pro314Leu		1.0	Aminotransferase class V domain				Hyperoxaluria, primary, type 1, 259900 (3), Autosomal recessive	Primary hyperoxaluria type 1	Disease-causing germline mutation(s) in	Nephrolithiasis;Recurrent urinary tract infections;Nephrocalcinosis;Decreased glomerular filtration rate;Atherosclerosis;Abnormality of the skeletal system;Failure to thrive;Hematuria;Stage 5 chronic kidney disease;Hyperoxaluria;Abnormality of the dentition;Calcinosis;Dysuria;Stroke;Metabolic acidosis;Abnormality of circulating enzyme level;Anemia;Enuresis;Hyperoxaluria;Peripheral arterial stenosis;Arterial occlusion;Calcinosis cutis;Metabolic acidosis;Atrioventricular block;Autosomal recessive inheritance;Nephrocalcinosis;Pathologic fracture;Retinal crystals;Gangrene;Intermittent claudication;Retinopathy;Hematuria;Optic atrophy;Choroidal neovascularization;Increased bone mineral density;Raynaud phenomenon;Acrocyanosis;Bone pain;Optic neuropathy;Cutis marmorata;Peripheral neuropathy;Renal insufficiency;Calcium oxalate nephrolithiasis		0.000177354	27.0	152238.0	0.0	34	0.98	PASS	nfe	0.000279264	19.0	0.000279264	19.0	0.000211817	32.0	151074.0	0.0	41	0.57	PASS	nfe	0.000392143	22.0	0.000392143	22.0	0.0000193	3	0.001	3.0	0.00053	6.0		23.0	2.752043	0.601	10	9	19	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-XF_coding_pred	PolyPhen,LRT_pred,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred	AGXT	0.0	0.0	0.0	0.0	28.0	-31.0	1.0	-4.0	0.0051840099536028	0.062	9.675	0.52	10.195	0.0556	0.0	0.000000000	0.043	1.026	homeostasis/metabolism phenotype; renal/urinary system phenotype; 			pons;kidney;liver;atrioventricular node;superior cervical ganglion;trigeminal ganglion;fetal lung;fetal liver;skeletal muscle;	Alanine and aspartate metabolism;Glycine, serine and threonine metabolism	protein targeting to peroxisome;Notch signaling pathway;glyoxylate catabolic process;glycine biosynthetic process, by transamination of glyoxylate;L-cysteine catabolic process;cellular nitrogen compound metabolic process;L-alanine catabolic process;pyruvate biosynthetic process;glyoxylate metabolic process;oxalic acid secretion;response to glucocorticoid;response to cAMP	mitochondrial matrix;peroxisome;peroxisomal matrix;cytosol;intracellular membrane-bounded organelle	serine-pyruvate transaminase activity;signaling receptor binding;protein binding;alanine-glyoxylate transaminase activity;transaminase activity;amino acid binding;pyridoxal phosphate binding;identical protein binding;protein homodimerization activity;protein self-association	CHIC2[unassigned1304];PRDM6[unassigned1304];FHL5[unassigned1304];LOC151121[unassigned1304];KRT40[unassigned1304];ACAT1[21988832];FAM168B[unassigned1304];CYSRT1[unassigned1304];EFS[unassigned1304];FNTB[unassigned1304];ATXN1L[unassigned1304];LPXN[unassigned1304];OIP5[unassigned1304];HOXA1[unassigned1304];KRTAP3-1[unassigned1304];KRTAP1-1[unassigned1304];LINC01600[unassigned1304];BATF3[unassigned1304];C19orf54[unassigned1304];KRTAP12-3[unassigned1304];C7orf43[unassigned1304];KRTAP9-2[unassigned1304];SPRYD7[unassigned1304];KRTAP8-1[unassigned1304];KRT34[unassigned1304];H1FX-AS1[unassigned1304];SNCAIP[16169070];NOTCH2NLA[unassigned1304];KRT31[unassigned1304];TTC19[unassigned1304];RFX6[unassigned1304];MORN5[unassigned1304];KRT37[unassigned1304];PLA2G10[unassigned1304];PEX5[22529745];FOSB[unassigned1304];AGXT[unassigned1304;22529745];MDFI[unassigned1304];C12orf74[unassigned1304];	241817048
46228	chr2	242157692	C	A	chr2:242157692	ANO7	anoctamin 7	SNV	0/1	0.51	25_26	51	99.0	0/0	0.0	33_0	33	99.0			rs199499943	EXONIC	YES	NM_001370694.2	Transcript	protein_coding	synonymous_variant		21/25	NM_001370694.2:c.2217C>A	NP_001357623.1:p.Arg739%3D		1.0						.	.	.		0.00226274	343.0	151586.0	0.0	30	0.9	PASS	nfe	0.00338943	230.0	0.00338943	230.0	0.00210248	355.0	168848.0	4.0	15	0.4	PASS	nfe	0.00340189	263.0	0.00340189	263.0	0.0018006	280	0.004	12.0	0.00513	57.0		11.99	0.805029		0	0	0			ANO7	0.08	0.0	0.0	0.0	2.0	-38.0	-4.0	11.0						0.987	0.0	77.307546149			.			ciliary ganglion;occipital lobe;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;fetal liver;prostate;skeletal muscle;globus pallidus;	.	chloride transport;ion transmembrane transport;calcium activated phosphatidylserine scrambling;calcium activated phosphatidylcholine scrambling;calcium activated galactosylceramide scrambling	endoplasmic reticulum;cytosol;plasma membrane;integral component of membrane;cell junction	intracellular calcium activated chloride channel activity;phospholipid scramblase activity;protein dimerization activity	.	242157692
46306	chr20	257685	C	A	chr20:257685	C20orf96	chromosome 20 open reading frame 96	SNV	0/1	0.45	29_24	53	99.0	0/0	0.0	47_0	47	99.0			rs143466555,COSV64403932,COSV64404183	SPLICING	YES	NM_153269.3	Transcript	protein_coding	splice_region_variant,synonymous_variant		8/11	NM_153269.3:c.825G>T	NP_695001.2:p.Ala275%3D		-1.0						.	.	.		7.8854e-05	12.0	152180.0	0.0	33	0.96	PASS	sas	0.000207039	1.0	2.93962e-05	2.0	0.000207928	52.0	250086.0	0.0	91	0.94	PASS	amr	0.000173772	6.0	0.000106165	12.0	0.0001093	17	0.0	1.0				12.02	0.808517		0	0	0			C20orf96	0.0	0.0	0.0	0.0	-38.0	12.0	-37.0	0.0	0.765875399682748	0.716	7.389	3.105	10.494	0.922	0.0	22.509097950			.			dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum;	.	.	.	.	.	257685
46392	chr20	1301000	G	A	chr20:1301000	FKBP1A-SDCBP2	FKBP1A-SDCBP2 readthrough (NMD candidate)	SNV	0/1	0.5	44_44	88	99.0	0/0	0.0	33_0	33	99.0			rs138479611	SPLICING	YES	NR_037661.1	Transcript	lncRNA	splice_region_variant,intron_variant,non_coding_transcript_variant	3/9		NR_037661.1:n.332+7C>T			-1.0						.	.	.		0.00331901	505.0	152154.0	3.0	32	0.98	PASS	amr	0.00752519	115.0	0.00433721	295.0	0.00371057	925.0	249288.0	4.0	47	0.97	PASS	nfe	0.00480931	544.0	0.00480931	544.0	0.0035948	559	0.005	17.0				0.402	-0.286111		0	0	0			RP11-314N13.10	0.0	0.0	0.0	0.0	14.0	35.0	3.0	7.0	4.19653283409031e-05	0.008									.			.	.	.	.	.	.	1301000
46393	chr20	1301000	G	A	chr20:1301000	SDCBP2	syndecan binding protein 2	SNV	0/1	0.5	44_44	88	99.0	0/0	0.0	33_0	33	99.0			rs138479611	SPLICING	YES	NM_080489.5	Transcript	protein_coding	splice_region_variant,intron_variant	2/8		NM_080489.5:c.54+7C>T			-1.0						.	.	.		0.00331901	505.0	152154.0	3.0	32	0.98	PASS	amr	0.00752519	115.0	0.00433721	295.0	0.00371057	925.0	249288.0	4.0	47	0.97	PASS	nfe	0.00480931	544.0	0.00480931	544.0	0.0035948	559	0.005	17.0				0.402	-0.286111		0	0	0			SDCBP2	0.0	0.0	0.0	0.0	14.0	35.0	3.0	7.0	4.19653283409031e-05	0.008				0.732	0.41				.			.	.	nervous system development;cell population proliferation;intracellular signal transduction;intracellular transport	nucleolus;cytoplasm;plasma membrane;nuclear speck;extracellular exosome	protein binding;phosphatidylinositol-4,5-bisphosphate binding;protein C-terminus binding;identical protein binding;protein homodimerization activity;protein heterodimerization activity	ARF4[25416956];ZCCHC10[25416956];FAM13C[25416956];FBXO28[25416956;unassigned1304];ZCCHC17[16189514;21516116;25416956;unassigned1304];NFU1[unassigned1304];LGALS2[25416956;unassigned1304];TDO2[25416956];NUF2[21988832];TCP11L1[unassigned1304];CHCHD1[unassigned1304];CT45A10[unassigned1304];PRM2[unassigned1304];HSBP1[unassigned1304];RPL22[27107012;unassigned1304];LGALS14[25416956];PRPF40A[21516116;25416956;unassigned1304];TRAF1[27107012];MED4[27107012];SDCBP2[25416956;27107012];TM4SF1[11102519];FAM133A[25416956;27107012;unassigned1304];THAP6[21988832];TNNT1[unassigned1304];DPPA2[16189514];CRY2[unassigned1304];DMC1[unassigned1304];PAFAH1B3[16189514;unassigned1304];VPS25[unassigned1304];PRR13[16189514;25416956;unassigned1304];NKAPD1[25416956;unassigned1304];SEC23A[21988832];YTHDC1[25416956;unassigned1304];CRCT1[unassigned1304];CT45A3[21516116;25416956;unassigned1304];CT45A5[21516116;25416956];AKAP17A[unassigned1304];TANK[unassigned1774];CT45A1[unassigned1304];MMTAG2[16189514;unassigned1304];EIF1AD[21516116;25416956;unassigned1304];TIFA[16189514;25416956;27107012];BEND7[16189514];LYAR[25416956;unassigned1304];AP1M1[unassigned1304];NOP56[unassigned1304];ZRSR2[25416956;unassigned1304];FAM9B[25416956];RPL41[unassigned1304];NPM2[25416956];PRPF38A[25416956;unassigned1304];ZNF581[25416956];PHC1[unassigned1304];JAG1[11102519];GABRA3[21988832];SREK1IP1[25416956;unassigned1304];ADAP1[25416956];VAX1[unassigned1304];SYT17[unassigned1304];CTH[21988832];RNPS1[25416956;unassigned1304];RPL22L1[unassigned1304];TNP1[25416956];LINC00467[unassigned1304];	1301000
46492	chr20	2797146	C	G	chr20:2797146	TMEM239	transmembrane protein 239	SNV	0/0	0.0	27_0	27	72.0	0/1	0.67	16_33	49	99.0			rs535751196	SPLICING	YES	NM_001318207.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/1		NM_001318207.1:c.82-7C>G			1.0						.	.	.		0.00321507	477.0	148364.0	8.0	30	0.89	PASS	afr	0.00923321	361.0	0.0010211	69.0	0.00256478	330.0	128666.0	1.0	25	0.54	PASS	afr	0.0106762	66.0	0.00173181	88.0	0.0008553	133	0.001	2.0				5.673	0.188829		0	0	0			TMEM239	0.01	0.12	0.0	0.0	44.0	7.0	7.0	43.0	5.5872545787408e-05	0.006	5.832	2.927	8.76						.			ciliary ganglion;testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;trigeminal ganglion;atrioventricular node;skin;superior cervical ganglion;testis;skeletal muscle;globus pallidus;	.	.	integral component of membrane	protein binding	MS4A3[unassigned1304];RETREG3[unassigned1304];CREB3L3[unassigned1304];CREB3L1[unassigned1304];FAM174A[unassigned1304];POLI[25416956];FFAR2[unassigned1304];UBASH3A[unassigned1304];SLC18A1[unassigned1304];SLC34A2[unassigned1304];USP5[25416956;unassigned1304];SLC35C2[unassigned1304];EMP1[unassigned1304];PDCD1LG2[unassigned1304];SSMEM1[unassigned1304];SENP2[25416956;unassigned1304];MTURN[unassigned1304];TRHR[unassigned1304];LENG1[25416956];FKBP7[unassigned1304];ATF7[25416956];C12orf10[25416956];CLRN1[unassigned1304];PNKP[unassigned1304];DCUN1D1[unassigned1304];MIEF2[unassigned1304];MTIF3[unassigned1304];FTHL17[unassigned1304];FGD2[25416956];TBRG4[unassigned1304];SDCBP[25416956;unassigned1304];CD79A[unassigned1304];GPR151[unassigned1304];SNX1[unassigned1304];EBP[unassigned1304];SNX2[unassigned1304];TMEM248[unassigned1304];SCAND1[unassigned1304];MPP1[unassigned1304];SLC10A6[unassigned1304];TIMMDC1[unassigned1304];SLC10A1[unassigned1304];FBXL19[unassigned1304];ODF4[unassigned1304];SYT16[unassigned1304];WDYHV1[25416956];S100B[26871637];MFSD14B[unassigned1304];OTULIN[unassigned1304];OCIAD1[unassigned1304];LNX1[unassigned1304];FXYD6[unassigned1304];COQ8A[25416956;25910212];GPR101[unassigned1304];SPG21[unassigned1304];	2797146
46514	chr20	3026764	G	A	chr20:3026764	MRPS26	mitochondrial ribosomal protein S26	SNV	0/0	0.0	38_0	38	99.0	0/1	0.37	32_19	51	99.0			rs370605157	EXONIC	YES	NM_030811.4	Transcript	protein_coding	missense_variant		1/4	NM_030811.4:c.50G>A	NP_110438.1:p.Arg17Gln		1.0						.	.	.		0.000177454	27.0	152152.0	0.0	33	0.97	PASS	nfe	0.000308905	21.0	0.000308905	21.0	0.000157954	31.0	196260.0	0.0	27	0.59	PASS	nfe	0.000307531	27.0	0.000307531	27.0	0.0000707	11	0.0	1.0				13.66	1.034826	0.067	1	18	19	M-CAP_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MRPS26	0.0	0.0	0.0	0.0	21.0	-5.0	21.0	-5.0							0.19	0.000000000	0.0	-1.797	.			.	.	DNA damage response, detection of DNA damage;mitochondrial translational elongation;mitochondrial translational termination	nucleoplasm;mitochondrion;mitochondrial inner membrane;mitochondrial small ribosomal subunit	RNA binding	MPP1[26496610];JUN[25609649];USP42[19615732];MGST3[29568061];RPS6[29568061];MRPL58[20186120];HSPD1[29568061];PPP2CA[16169070];FBL[29568061];HIST1H3A[29568061];ERBB3[24189400];DLG3[26496610];AIFM1[29568061];AURKAIP1[29568061];TRMT61B[29568061];PDK1[29568061];	3026764
46584	chr20	3651791	G	T	chr20:3651791	ADAM33	ADAM metallopeptidase domain 33	SNV	0/1	0.4	41_27	68	99.0	0/0	0.0	35_0	35	99.0			rs148007711	EXONIC	YES	NM_025220.5	Transcript	protein_coding	missense_variant		19/22	NM_025220.5:c.2102C>A	NP_079496.1:p.Thr701Asn		-1.0	.,.,.,.	Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00235164	358.0	152234.0	1.0	34	0.98	PASS	afr	0.00692133	287.0	0.000161698	11.0	0.000813159	201.0	247184.0	0.0	42	0.83	PASS	afr	0.00738543	117.0	0.000161562	18.0	0.0010161	158	0.003	10.0	0.00202	23.0		16.31	1.507245	0.07	2	17	19	fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	ADAM33	0.02	0.04	0.0	0.0	9.0	-48.0	-25.0	9.0						0.95	0.0	0.000000000	0.011	0.166	normal phenotype; 			pons;ciliary ganglion;subthalamic nucleus;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;globus pallidus;	.	proteolysis	integral component of membrane	metalloendopeptidase activity;zinc ion binding	STOML3[unassigned1304];HIBADH[unassigned1304];AQP9[unassigned1304];SLC4A1[unassigned1304];CLDN2[unassigned1304];CD3E[unassigned1304];ASGR2[unassigned1304];MUC1[unassigned1304];ATXN7[21078624];CLEC7A[25416956;unassigned1304];SGCB[unassigned1304];CREB3L1[unassigned1304];UBQLN4[16713569];LOC728138[unassigned1304];TMEM14B[unassigned1304];BTNL9[unassigned1304];GGT6[unassigned1304];SLC35E2[unassigned1304];TNFSF14[unassigned1304];SLC30A2[25416956;unassigned1304];OPRM1[unassigned1304];NCR1[unassigned1304];SLC22A23[unassigned1304];EPGN[unassigned1304];FCGR2A[unassigned1304];SPINT1[unassigned1304];TMEM237[unassigned1304];VMA21[unassigned1304];TMEM106C[unassigned1304];PLEKHO1[unassigned1304];	3651791
46601	chr20	3675136	G	A	chr20:3675136	SIGLEC1	sialic acid binding Ig like lectin 1	SNV	0/1	0.44	65_52	118	99.0	0/0	0.0	36_0	36	99.0			rs709020	EXONIC	YES	NM_023068.4	Transcript	protein_coding	synonymous_variant		13/22	NM_023068.4:c.2988C>T	NP_075556.1:p.Gly996%3D		-1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00739806	1126.0	152202.0	1.0	33	0.97	PASS	amr	0.00948953	145.0	0.00806973	549.0	0.00678301	1484.0	218782.0	3.0	21	0.54	PASS	nfe	0.00916661	885.0	0.00916661	885.0	0.0064436	1002	0.009	26.0				13.57	1.020298		0	0	0			SIGLEC1	0.35	0.15	0.0	0.0	1.0	43.0	2.0	-37.0						0.916	0.0	67.155435144			immune system phenotype; homeostasis/metabolism phenotype; hematopoietic system phenotype; 			pons;lymph node;superior cervical ganglion;placenta;	Cell adhesion molecules (CAMs)	endocytosis;inflammatory response;cell-matrix adhesion;cell-cell adhesion	extracellular region;plasma membrane;integral component of membrane	carbohydrate binding	.	3675136
46711	chr20	7886834	A	G	chr20:7886834	HAO1	hydroxyacid oxidase 1	SNV	0/1	0.58	24_35	60	99.0	0/0	0.0	33_0	33	99.0			rs146825169	EXONIC	YES	NM_017545.3	Transcript	protein_coding	missense_variant		4/8	NM_017545.3:c.688T>C	NP_060015.1:p.Ser230Pro		-1.0	FMN-dependent dehydrogenase&FMN hydroxy acid dehydrogenase domain					.	.	.		0.00206297	314.0	152208.0	0.0	32	0.97	PASS	nfe	0.00335127	228.0	0.00335127	228.0	0.0019694	494.0	250838.0	1.0	96	0.98	PASS	amr	0.00367711	127.0	0.00264831	300.0	0.0017813	277	0.008	26.0				9.278	0.486777	0.082	1	18	19	LIST-S2_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HAO1	0.0	0.0	0.0	0.0	-21.0	34.0	-34.0	-33.0						0.818	0.0	0.000000000	0.001	-0.145	.			.	Glyoxylate and dicarboxylate metabolism	fatty acid alpha-oxidation;protein targeting to peroxisome;response to oxidative stress;cellular nitrogen compound metabolic process;glycolate catabolic process	peroxisome;peroxisomal matrix;cytosol	(S)-2-hydroxy-acid oxidase activity;signaling receptor binding;glycolate oxidase activity;FMN binding;glyoxylate oxidase activity;very-long-chain-(S)-2-hydroxy-acid oxidase activity;long-chain-(S)-2-hydroxy-long-chain-acid oxidase activity;medium-chain-(S)-2-hydroxy-acid oxidase activity	.	7886834
46749	chr20	10625893	ACTG		chr20:10625893-10625896	JAG1	jagged 1	deletion	0/0	0.0	35_0	35	99.0	0/1	0.56	40_52	93	99.0			rs727504412	EXONIC	YES	NM_000214.3	Transcript	protein_coding	frameshift_variant		17/26	NM_000214.3:c.2122_2125del	NP_000205.1:p.Gln708ValfsTer34		-1.0		Pathogenic	criteria_provided,_multiple_submitters,_no_conflicts	Heart,_malformation_of|Tetralogy_of_Fallot|Arteriohepatic_dysplasia|Alagille_syndrome_1|not_provided	?Deafness, congenital heart defects, and posterior embryotoxon, 617992 (3), Autosomal dominant; Charcot-Marie-Tooth disease, axonal, type 2HH, 619574 (3), Autosomal dominant; Alagille syndrome 1, 118450 (3), Autosomal dominant; Tetralogy of Fallot, 187500 (3), Autosomal dominant	Tetralogy of Fallot;Alagille syndrome due to 20p12 microdeletion;Alagille syndrome due to a JAG1 point mutation	Disease-causing germline mutation(s) in;Role in the phenotype of;Disease-causing germline mutation(s) in	Cryptorchidism;Preauricular pit;Intrauterine growth retardation;Abnormal nasal morphology;Thin vermilion border;Clinodactyly of the 5th finger;Broad forehead;Tetralogy of Fallot;Brachydactyly;Dolichocephaly;Proptosis;Underdeveloped supraorbital ridges;Chorioretinal atrophy;Deeply set eye;Renal dysplasia;Myopia;Areflexia;Hypoplasia of the ulna;Butterfly vertebral arch;Hemivertebrae;Exocrine pancreatic insufficiency;Posterior embryotoxon;Triangular face;Renal tubular acidosis;Hepatocellular carcinoma;Incomplete penetrance;Vesicoureteral reflux;Prolonged neonatal jaundice;Multiple small medullary renal cysts;Autosomal dominant inheritance;Depressed nasal bridge;Coarctation of aorta;Stage 5 chronic kidney disease;Long nose;Broad forehead;Hypertriglyceridemia;Failure to thrive;Infantile onset;Specific learning disability;Focal segmental glomerulosclerosis;Tetralogy of Fallot;Hypercholesterolemia;Atrial septal defect;Cataract;Abnormal anterior chamber morphology;Renal artery stenosis;Abnormality of the ribs;Renal hypoplasia;Band keratopathy;Ventricular septal defect;Short distal phalanx of finger;Peripheral pulmonary artery stenosis;Stroke;Reduced number of intrahepatic bile ducts;Pigmentary retinopathy;Cirrhosis;Cholestasis;Papillary thyroid carcinoma;Strabismus;Hepatic failure;Duplicated collecting system;Upslanted palpebral fissure;Macrotia;Microcornea;Elevated hepatic transaminase;Hypertelorism;Intellectual disability, mild;Axenfeld anomaly;Autosomal dominant inheritance;Broad forehead;Tetralogy of Fallot;Preauricular pit;Proptosis;Clinodactyly of the 5th finger	24033266,10220506,9207788,12442286,15712272					33	0.97											100	1.0							0.0000064	1						34.0	5.633633		0	0	0			JAG1	0.0	0.01	0.0	0.0	-8.0	1.0	5.0	1.0						0.00627	1.0	92.212165298			growth/size/body region phenotype; integument phenotype ; endocrine/exocrine gland phenotype; muscle phenotype; craniofacial phenotype; homeostasis/metabolism phenotype; cellular phenotype; skeleton phenotype; renal/urinary system phenotype; embryo phenotype; behavior/neurological phenotype ; liver/biliary system phenotype; cardiovascular system phenotype ; mortality/aging ; normal phenotype; digestive/alimentary phenotype; nervous system phenotype ; hearing/vestibular/ear phenotype; vision/eye phenotype; 			ciliary ganglion;uterus;dorsal root ganglion;trigeminal ganglion;skin;atrioventricular node;cingulate cortex;superior cervical ganglion;placenta;	Notch signaling pathway	angiogenesis;cell fate determination;negative regulation of cell-matrix adhesion;blood vessel remodeling;morphogenesis of an epithelial sheet;T cell mediated immunity;aortic valve morphogenesis;pulmonary valve morphogenesis;cardiac right ventricle morphogenesis;Notch signaling pathway;nervous system development;regulation of signaling receptor activity;negative regulation of cell-cell adhesion;hemopoiesis;keratinocyte differentiation;negative regulation of cell migration;response to muramyl dipeptide;aorta morphogenesis;regulation of cell population proliferation;inner ear auditory receptor cell differentiation;myoblast differentiation;endothelial cell differentiation;negative regulation of fat cell differentiation;negative regulation of endothelial cell differentiation;positive regulation of myeloid cell differentiation;negative regulation of neuron differentiation;positive regulation of osteoblast differentiation;positive regulation of Notch signaling pathway;positive regulation of transcription by RNA polymerase II;cardiac septum morphogenesis;ciliary body morphogenesis;pulmonary artery morphogenesis;cardiac neural crest cell development involved in outflow tract morphogenesis;Notch signaling involved in heart development;endocardial cushion cell development;positive regulation of cardiac epithelial to mesenchymal transition;nephron development;glomerular visceral epithelial cell development;distal tubule development;loop of Henle development;neuronal stem cell population maintenance;negative regulation of stem cell differentiation	extracellular region;plasma membrane;integral component of plasma membrane;adherens junction;membrane;apical plasma membrane	Notch binding;structural molecule activity;calcium ion binding;protein binding;phospholipid binding;growth factor activity	NOTCH3[22487239];ADAM17[23375636];NOTCH1[23086448;18660822];CANX[22487239];CALR[22487239];CD46[23086448];SDCBP2[11102519];	10625892
46900	chr20	23729759	C	A	chr20:23729759	CST1	cystatin SN	SNV	0/0	0.0	43_0	43	99.0	0/1	0.43	30_23	53	99.0			rs112232806,COSV59054960,COSV99063075,COSV99063079	EXONIC	YES	NM_001898.3	Transcript	protein_coding	missense_variant		2/3	NM_001898.3:c.236G>T	NP_001889.2:p.Gly79Val		-1.0	Cystatin domain&Proteinase inhibitor I25, cystatin, conserved site&Cystatin domain&Cystatin domain,Cystatin domain&Proteinase inhibitor I25, cystatin, conserved site&Cystatin domain&Cystatin domain					.	.	.		0.00116968	178.0	152178.0	0.0	31	0.95	PASS	afr	0.00347474	144.0	0.000146972	10.0	0.000469282	118.0	251448.0	0.0	100	1.0	PASS	afr	0.00356791	58.0	0.000131884	15.0	0.0004244	66	0.001	2.0				0.923	-0.16261	0.122	1	17	18	SIFT	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CST1	0.0	0.0	0.0	0.0	7.0	-27.0	-28.0	16.0						0.87	0.0		0.0	-8.954	.			salivary gland;thyroid;skeletal muscle;	.	detection of chemical stimulus involved in sensory perception of bitter taste;negative regulation of endopeptidase activity	extracellular space	cysteine-type endopeptidase inhibitor activity;protein binding	ASPH[unassigned1304];SGTA[25416956];SOD2[17353931];IER3IP1[unassigned1304];UBQLN2[unassigned1304];	23729759
46974	chr20	25597083	A	G	chr20:25597083	NANP	N-acetylneuraminic acid phosphatase	SNV	0/1	0.43	27_20	47	99.0	0/0	0.0	35_0	35	99.0			rs1177109844	EXONIC	YES	NM_152667.3	Transcript	protein_coding	synonymous_variant		2/2	NM_152667.3:c.225T>C	NP_689880.1:p.His75%3D		-1.0						.	.	.		0.000144556	22.0	152190.0	0.0	32	0.97	PASS	amr	0.00144092	22.0	0.0	0.0	6.3885e-05	16.0	250450.0	0.0	59	0.99	PASS	amr	0.000463017	16.0	0.0	0.0								4.984	0.144244		0	0	0			NANP	0.0	0.0	0.0	0.0	9.0	-11.0	-28.0	32.0						0.514	0.03				.			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;medulla oblongata;cerebellum;	Aminosugars metabolism	carbohydrate metabolic process;N-acetylglucosamine biosynthetic process;dephosphorylation;N-acetylneuraminate biosynthetic process	cellular_component;cytosol	N-acylneuraminate-9-phosphatase activity	VAPA[26496610];PCDHB15[26496610];DDIT4L[unassigned1304];MLH1[26496610];PML[26496610];	25597083
47000	chr20	30522545	C	T	chr20:30522545	TTLL9	tubulin tyrosine ligase like 9	SNV	0/0	0.0	37_0	37	99.0	0/1	0.48	54_49	103	99.0			rs148917180	EXONIC	YES	NM_001008409.5	Transcript	protein_coding	synonymous_variant		12/15	NM_001008409.5:c.858C>T	NP_001008409.1:p.His286%3D		1.0						.	.	.		0.00269361	410.0	152212.0	0.0	32	0.98	PASS	nfe	0.00413065	281.0	0.00413065	281.0	0.00270999	675.0	249078.0	3.0	53	1.0	PASS	nfe	0.00421702	476.0	0.00421702	476.0	0.0025015	389	0.007	21.0				0.106	-0.474745		0	0	0			TTLL9	0.0	0.0	0.0	0.0	14.0	-50.0	9.0	-19.0						0.82	0.0	0.000000000			.			ciliary ganglion;testis - interstitial;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;	.	cellular protein modification process	cytoplasm;microtubule;cilium	ATP binding;ligase activity	.	30522545
47023	chr20	31611174	C	T	chr20:31611174	BPIFB2	BPI fold containing family B member 2	SNV	0/0	0.0	34_0	34	99.0	0/1	0.48	48_44	92	99.0			rs146905219	EXONIC	YES	NM_025227.3	Transcript	protein_coding	synonymous_variant		16/16	NM_025227.3:c.1362C>T	NP_079503.1:p.Leu454%3D		1.0						.	.	.		0.00235883	359.0	152194.0	3.0	32	0.97	PASS	nfe	0.00274871	187.0	0.00274871	187.0	0.00235539	592.0	251338.0	3.0	63	1.0	PASS	nfe	0.00216397	246.0	0.00216397	246.0	0.0020450	318						0.186	-0.397123		0	0	0			BPIFB2	0.0	0.01	0.0	0.0	10.0	-26.0	16.0	41.0							0.0	61.907554744			.			ciliary ganglion;trachea;superior cervical ganglion;atrioventricular node;	.	antimicrobial humoral response;post-translational protein modification;cellular protein metabolic process	extracellular region;endoplasmic reticulum lumen;extracellular exosome	lipid binding	HIST2H2BE[30021884];	31611174
47041	chr20	31954820	A	AA	chr20:31954820	CDK5RAP1	CDK5 regulatory subunit associated protein 1	sequence_alteration	0/1	0.19	17_5_0	26	66.0	0/2	0.0	25_0_7	32	88.0			rs368904466	SPLICING	YES	NM_001365728.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	12/14		NM_001365728.1:c.1435-6dup			-1.0						.	.	.		0.00353935	491.0	138726.0	3.0	30	0.86	PASS	nfe	0.00478213	304.0	0.00478213	304.0	0.0298732	4197.0	140494.0	0.0	25	0.63	InbreedingCoeff	afr	0.0372845	346.0	0.0299864	1946.0	0.0001158,0.0001543,0.0001994	18,24,31						1.454	-0.094981		0	0	0			CDK5RAP1	0.05	0.01	0.0	0.0	-8.0	-5.0	-49.0	4.0						0.271	0.0				behavior/neurological phenotype ; cardiovascular system phenotype ; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			ciliary ganglion;trigeminal ganglion;parietal lobe;	.	brain development;tRNA methylthiolation;regulation of neuron differentiation;negative regulation of cyclin-dependent protein serine/threonine kinase activity;positive regulation of translational fidelity;positive regulation of mitochondrial translation;mitochondrial tRNA modification	cellular_component;mitochondrion	protein kinase binding;N6-isopentenyladenosine methylthiotransferase activity;protein-containing complex binding;metal ion binding;4 iron, 4 sulfur cluster binding	EXOSC5[15231747];NEURL4[29426014];MGST3[29568061];RIPK4[26972000];EXOSC3[15231747];TRMT61B[29568061];	31954819
47046	chr20	31954820	A		chr20:31954820	CDK5RAP1	CDK5 regulatory subunit associated protein 1	sequence_alteration	0/1	0.0	17_5_0	26	66.0	0/2	0.22	25_0_7	32	88.0			rs368904466	SPLICING	YES	NM_001365728.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	12/14		NM_001365728.1:c.1435-6del			-1.0						.	.	.		0.009332	1290.0	138234.0	1.0	30	0.86	PASS	nfe	0.00968037	613.0	0.00968037	613.0	0.420175	59032.0	140494.0	2.0	25	0.63	InbreedingCoeff	sas	0.446622	7589.0	0.412028	26739.0	0.0000257,0.0008681	4,135						0.102	-0.479811		0	0	0			CDK5RAP1	0.01	0.0	0.02	0.0	-5.0	-25.0	-49.0	-8.0						0.271	0.0				behavior/neurological phenotype ; cardiovascular system phenotype ; muscle phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			ciliary ganglion;trigeminal ganglion;parietal lobe;	.	brain development;tRNA methylthiolation;regulation of neuron differentiation;negative regulation of cyclin-dependent protein serine/threonine kinase activity;positive regulation of translational fidelity;positive regulation of mitochondrial translation;mitochondrial tRNA modification	cellular_component;mitochondrion	protein kinase binding;N6-isopentenyladenosine methylthiotransferase activity;protein-containing complex binding;metal ion binding;4 iron, 4 sulfur cluster binding	EXOSC5[15231747];NEURL4[29426014];MGST3[29568061];RIPK4[26972000];EXOSC3[15231747];TRMT61B[29568061];	31954819
47094	chr20	33442648	T	C	chr20:33442648	GGT7	gamma-glutamyltransferase 7	SNV	0/0	0.0	44_0	44	99.0	0/1	0.63	27_46	73	99.0			rs141899095,COSV60541447	EXONIC	YES	NM_178026.3	Transcript	protein_coding	missense_variant		9/15	NM_178026.3:c.1181A>G	NP_821158.2:p.Asn394Ser		-1.0						.	.	.		0.00108427	165.0	152176.0	0.0	32	0.97	PASS	nfe	0.00177878	121.0	0.00177878	121.0	0.00091873	231.0	251434.0	0.0	69	1.0	PASS	nfe	0.00150361	171.0	0.00150361	171.0	0.0010611	165	0.002	5.0				25.5	3.633921	0.436	9	12	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	GGT7	0.0	0.0	0.0	0.0	-1.0	-10.0	-1.0	-49.0						0.201	1.0	0.000000000	1.0	1.138	.			ciliary ganglion;trigeminal ganglion;skeletal muscle;	Taurine and hypotaurine metabolism;Selenoamino acid metabolism;Cyanoamino acid metabolism;Glutathione metabolism;Arachidonic acid metabolism	translation;proteolysis;cellular amino acid metabolic process;glutamate metabolic process;glutathione metabolic process;glutathione biosynthetic process;glutathione catabolic process;cysteine biosynthetic process;leukotriene D4 biosynthetic process;negative regulation of response to oxidative stress	plasma membrane;integral component of membrane	peptidyltransferase activity;protein binding;glutathione hydrolase activity;hypoglycin A gamma-glutamyl transpeptidase activity;leukotriene C4 gamma-glutamyl transferase activity	CMTM7[unassigned1304];GPR25[25416956;unassigned1304];SLC35A4[unassigned1304];MAX[20195357];LHFPL5[25416956;unassigned1304;25910212];LNPEP[unassigned1304];HTR4[28298427];TMEM242[25416956;unassigned1304];PTP4A3[17353931];TSPO2[unassigned1304];MTNR1B[26514267];MALL[25416956;unassigned1304];CLDN19[unassigned1304];IFT27[27173435];CYB561[unassigned1304];	33442648
47106	chr20	33711831	T	C	chr20:33711831	EDEM2	ER degradation enhancing alpha-mannosidase like protein 2	SNV	0/0	0.0	36_0	36	99.0	0/1	0.55	30_36	66	99.0			rs149260082	EXONIC	YES	NM_018217.3	Transcript	protein_coding	missense_variant		9/11	NM_018217.3:c.976A>G	NP_060687.2:p.Ile326Val		-1.0	.,.					.	.	.		0.00107764	164.0	152184.0	0.0	32	0.96	PASS	nfe	0.00176362	120.0	0.00176362	120.0	0.00090121	226.0	250774.0	0.0	46	0.99	PASS	nfe	0.00147519	167.0	0.00147519	167.0	0.0010289	160	0.001	4.0				20.2	2.04574	0.073	4	15	19	LRT_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	EDEM2	0.0	0.0	0.0	0.0	6.0	4.0	-47.0	4.0						0.888	0.0	0.000000000	0.987	1.138	.			.	.	response to unfolded protein;trimming of terminal mannose on B branch;trimming of terminal mannose on C branch;trimming of first mannose on A branch;trimming of second mannose on A branch;ubiquitin-dependent glycoprotein ERAD pathway;positive regulation of retrograde protein transport, ER to cytosol;mannose trimming involved in glycoprotein ERAD pathway	endoplasmic reticulum;endoplasmic reticulum lumen;membrane;endoplasmic reticulum quality control compartment	mannosyl-oligosaccharide 1,2-alpha-mannosidase activity;calcium ion binding	RPS3A[16169070];	33711831
47107	chr20	33711831	T	C	chr20:33711831	MMP24-AS1-EDEM2		SNV	0/0	0.0	36_0	36	99.0	0/1	0.55	30_36	66	99.0			rs149260082	EXONIC	YES	NM_001355008.2	Transcript	protein_coding	missense_variant		13/15	NM_001355008.2:c.853A>G	NP_001341937.1:p.Ile285Val		-1.0	.,.									0.00107764	164.0	152184.0	0.0	32	0.96	PASS	nfe	0.00176362	120.0	0.00176362	120.0	0.00090121	226.0	250774.0	0.0	46	0.99	PASS	nfe	0.00147519	167.0	0.00147519	167.0	0.0010289	160	0.001	4.0				20.2	2.04574	0.073	4	13	17	LRT_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	EDEM2	0.0	0.0	0.0	0.0	6.0	4.0	-47.0	4.0								0.000000000	0.987	1.138										33711831
47173	chr20	34806861	A	G	chr20:34806861	EPB41L1	erythrocyte membrane protein band 4.1 like 1	SNV	0/0	0.0	33_0	33	99.0	0/1	0.45	56_45	101	99.0			rs199993775	EXONIC	YES	NM_012156.2	Transcript	protein_coding	missense_variant		18/22	NM_012156.2:c.2332A>G	NP_036288.2:p.Thr778Ala		1.0	.,.,.,.,.,.,.,.	Likely_benign	criteria_provided,_single_submitter	not_specified	?Intellectual developmental disorder, autosomal dominant 11, 614257 (3), Autosomal dominant	Autosomal dominant non-syndromic intellectual disability	Disease-causing germline mutation(s) in	Intellectual disability;Intellectual disability, severe;Autosomal dominant inheritance	25741868	0.000643797	98.0	152222.0	0.0	32	0.98	PASS	nfe	0.000823118	56.0	0.000823118	56.0	0.000661207	166.0	251056.0	1.0	100	0.98	PASS	nfe	0.000431528	49.0	0.000431528	49.0	0.0004823	75	0.0	1.0	0.00044	5.0		17.71	1.733685	0.034	6	14	20	Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MutationTaster_pred,FATHMM_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	EPB41L1	0.0	0.0	0.0	0.0	-9.0	29.0	23.0	27.0						0.0449	0.65	0.000000000	1.0	1.312	nervous system phenotype ; normal phenotype; 			caudate nucleus;ciliary ganglion;temporal lobe;amygdala;prefrontal cortex;trigeminal ganglion;cingulate cortex;cerebellum peduncles;cerebellum;pons;occipital lobe;subthalamic nucleus;dorsal root ganglion;whole brain;adrenal gland;spinal cord;parietal lobe;globus pallidus;hypothalamus;medulla oblongata;thalamus;	Tight junction	cortical actin cytoskeleton organization;actomyosin structure organization	cytosol;cytoskeleton;plasma membrane	actin binding;structural molecule activity;protein binding	SRPK2[23602568];BRD2[26496610];STARD13[14697242];CHRM5[28298427];HSPB1[25277244];TERF1[21044950];PLEKHA7[28877994];PPP1CA[26575790];PPP1CB[26575790];PPP1CC[26575790];TMEM17[26638075];LAMP1[29568061];EPB41L3[24366813];POT1[21044950];EZR[29568061];	34806861
47248	chr20	36024614	C	T	chr20:36024614	SRC	SRC proto-oncogene, non-receptor tyrosine kinase	SNV	0/0	0.0	36_0	36	99.0	0/1	0.55	38_47	85	99.0			rs769476998	EXONIC	YES	NM_005417.5	Transcript	protein_coding	synonymous_variant		8/14	NM_005417.5:c.603C>T	NP_005408.1:p.Asn201%3D		1.0					?Thrombocytopenia 6, 616937 (3), Autosomal dominant; Colon cancer, advanced, somatic, 114500 (3)	Hereditary thrombocytopenia with early-onset myelofibrosis	Disease-causing germline mutation(s) (gain of function) in	Osteoporosis;Thrombocytopenia;Autosomal dominant inheritance;Myelofibrosis;Bone marrow hypercellularity;Large forehead;Hypotelorism;Deeply set eye;Spontaneous, recurrent epistaxis		1.31415e-05	2.0	152190.0	0.0	33	0.98	PASS	amr	0.000130804	2.0	0.0	0.0	1.19473e-05	3.0	251102.0	0.0	81	1.0	PASS	amr	5.7867e-05	2.0	8.80592e-06	1.0	0.0000064	1	0.001	2.0	0.00018	2.0		11.79	0.778979		0	0	0			SRC	0.0	0.01	0.0	0.0	7.0	-31.0	0.0	15.0						0.0217	0.99	33.815882131			skeleton phenotype; immune system phenotype; vision/eye phenotype; limbs/digits/tail phenotype; neoplasm; pigmentation phenotype; reproductive system phenotype; mortality/aging ; hematopoietic system phenotype; respiratory system phenotype; behavior/neurological phenotype ; embryo phenotype; cellular phenotype; craniofacial phenotype; endocrine/exocrine gland phenotype; integument phenotype ; growth/size/body region phenotype; 			ciliary ganglion;subthalamic nucleus;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;testis;skeletal muscle;	ErbB signaling pathway;VEGF signaling pathway;Focal adhesion;Adherens junction;Tight junction;Gap junction;GnRH signaling pathway;Epithelial cell signaling in Helicobacter pylori infection	primary ovarian follicle growth;stimulatory C-type lectin receptor signaling pathway;cell cycle;signal transduction;transmembrane receptor protein tyrosine kinase signaling pathway;signal complex assembly;epidermal growth factor receptor signaling pathway;transforming growth factor beta receptor signaling pathway;integrin-mediated signaling pathway;axon guidance;cell population proliferation;response to mechanical stimulus;response to virus;response to acidic pH;regulation of epithelial cell migration;positive regulation of epithelial cell migration;positive regulation of platelet-derived growth factor receptor signaling pathway;positive regulation of glucose metabolic process;positive regulation of protein processing;positive regulation of phosphatidylinositol 3-kinase signaling;positive regulation of smooth muscle cell migration;viral process;macroautophagy;peptidyl-serine phosphorylation;peptidyl-tyrosine phosphorylation;regulation of cell-cell adhesion;cell differentiation;platelet activation;forebrain development;T cell costimulation;protein destabilization;response to nutrient levels;positive regulation of protein autophosphorylation;activation of protein kinase B activity;negative regulation of telomere maintenance via telomerase;negative regulation of protein homooligomerization;cellular response to insulin stimulus;regulation of intracellular estrogen receptor signaling pathway;positive regulation of integrin activation;adherens junction organization;substrate adhesion-dependent cell spreading;cellular response to reactive oxygen species;intracellular signal transduction;entry of bacterium into host cell;osteoclast development;cellular response to platelet-derived growth factor stimulus;peptidyl-tyrosine autophosphorylation;Fc-gamma receptor signaling pathway involved in phagocytosis;response to hydrogen peroxide;positive regulation of apoptotic process;negative regulation of apoptotic process;regulation of vascular permeability;stress fiber assembly;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;regulation of protein binding;positive regulation of MAP kinase activity;positive regulation of phosphatidylinositol 3-kinase activity;transcytosis;regulation of bone resorption;bone resorption;positive regulation of cyclin-dependent protein serine/threonine kinase activity;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;positive regulation of insulin receptor signaling pathway;protein autophosphorylation;phosphatidylinositol phosphorylation;vascular endothelial growth factor receptor signaling pathway;neurotrophin TRK receptor signaling pathway;ephrin receptor signaling pathway;oogenesis;positive regulation of cytokine secretion;positive regulation of peptidyl-tyrosine phosphorylation;progesterone receptor signaling pathway;leukocyte migration;positive regulation of small GTPase mediated signal transduction;response to mineralocorticoid;response to electrical stimulus;negative regulation of focal adhesion assembly;positive regulation of protein kinase B signaling;negative regulation of mitochondrial depolarization;negative regulation of telomerase activity;uterus development;branching involved in mammary gland duct morphogenesis;regulation of cell projection assembly;positive regulation of ERK1 and ERK2 cascade;response to interleukin-1;cellular response to lipopolysaccharide;cellular response to peptide hormone stimulus;cellular response to progesterone stimulus;cellular response to fatty acid;cellular response to hypoxia;cellular response to fluid shear stress;positive regulation of podosome assembly;positive regulation of protein serine/threonine kinase activity;angiotensin-activated signaling pathway involved in heart process;positive regulation of canonical Wnt signaling pathway;cell-cell adhesion;regulation of postsynaptic neurotransmitter receptor activity;positive regulation of protein localization to nucleus;positive regulation of non-membrane spanning protein tyrosine kinase activity;positive regulation of ovarian follicle development;positive regulation of lamellipodium morphogenesis;positive regulation of DNA biosynthetic process;regulation of early endosome to late endosome transport;negative regulation of anoikis;negative regulation of extrinsic apoptotic signaling pathway;negative regulation of intrinsic apoptotic signaling pathway;regulation of caveolin-mediated endocytosis	podosome;nucleus;cytoplasm;mitochondrion;mitochondrial inner membrane;lysosome;late endosome;cytosol;actin filament;plasma membrane;caveola;postsynaptic density;extrinsic component of cytoplasmic side of plasma membrane;ruffle membrane;neuron projection;perinuclear region of cytoplasm;extracellular exosome;glutamatergic synapse;postsynaptic specialization, intracellular component	protein kinase activity;protein tyrosine kinase activity;non-membrane spanning protein tyrosine kinase activity;SH3/SH2 adaptor activity;protein kinase C binding;signaling receptor binding;insulin receptor binding;integrin binding;protein binding;ATP binding;protein C-terminus binding;kinase activity;enzyme binding;kinase binding;heme binding;estrogen receptor binding;ubiquitin protein ligase binding;SH2 domain binding;ion channel binding;cadherin binding;ephrin receptor binding;phosphatidylinositol-4,5-bisphosphate 3-kinase activity;phosphoprotein binding;growth factor receptor binding;connexin binding;scaffold protein binding	CBLB[17094785];MKI67[17474147];ACTB[19903481];GJA1[11035005];EDNRA[19202075];DAG1[17474147];KDR[18377662;18662404;12509223];AKT1[25241761];TNS3[19732724];CSNK2A1[21075308];ACTN1[16291744];PRKCD[15851033];JMJD6[24498420];AR[24728074];TXNIP[26919541];RIN3[17474147];CBLL1[21685945];AIRE[17474147];XPA[24412244];PIK3R3[22402981;25814554];PIK3R2[22402981];PIK3R1[19903481;25241761;23397142;23065768;24498420];GNS[17474147];SNX3[17474147];RRAS[17474147];EPB41L3[17474147];NKX2-1[17474147];SPRR2A[18155796];HOXC8[17474147];PAG1[18070987];LYN[18070987;22581261];CYP4F2[17474147];PTK2[16291744;16966330;17525734;21034468;22402981;25241761;23065768;25814554];ALS2CR12[17474147];HNRNPK[17178840];ID4[17474147];CDKN1B[17254967];FBH1[23954233];TRMO[24412244];CTSV[24412244];IKBKB[15749833];DLGAP1[17474147];IKBKG[15749833];DLGAP3[17474147];JAK2[21075308];NANS[24412244];HRAS[12695509];DLGAP2[17474147];DLGAP4[17474147];MAP4K1[17474147];GAB1[24728074];PAX3[17474147];BAAT[24412244];MED28[16899217;16964398];CDCP1[15851033;21725358;21233420];PAX7[17474147];KIT[24728074];RAPGEF1[17474147];MAPT[16115884];ALDOB[24412244];TLR3[16858407];DDR2[11884411];PTGER4[16432186];CD63[18211905];RPL10[16741966];STX17[24412244];PRICKLE3[17474147];AKAP6[17474147];AKAP2[17474147];EGFR[17284441;20624308;21278788;20935677;24658140];APOL5[17474147];PPP2CB[24412244];RPL13[17474147];FLNA[20936779];PAK2[16374509];EXTL3[17474147];CENPV[19930468];STAT3[18070987;19372587];KRT10[17868192];PLEKHA7[28877994];SNX17[17474147];AXL[22327215];ABI1[20598684];FAS[18328427;20696918];CTNNB1[22056988];F2RL2[17474147];GALNT12[24412244];DGKA[17700527];CELSR2[17474147];ETS1[25117710];CDH5[16909109];CDH1[21685945];RPP38[17474147];TGM2[20080707];CAST[17474147];CD97[17474147];PDGFRB[7685273];PDIA2[17474147];MAP2K1[24412244];LIG3[17474147];OCRL[25107275];SRCIN1[17525734];SELENON[17474147];ADAM17[16641105];RALGAPB[17474147];ACAP1[17474147];ADAM15[16374509;11741929];MAPKAPK3[24412244];MAL[22366891];ROR1[22439932];PGR[12612073];CUL9[17474147];KHDRBS1[16169070;7537265];DDX4[17868192];DLX4[17474147];NXPH3[17474147];SHC1[26551075];PXN[14665621];ISG20L2[17474147];ADRB2[17170700];RTN4[17474147];SDCBP[18832467];UBC[17936276];ABL1[17318191;17474147];ABL2[17474147];ZNF658B[17868192];CAV1[8621645];FANCA[17474147];FANCC[24412244];ESR1[17284441;14963108;20935677;23065768;17043237;17921256;24498420];AFDN[17491594];SP1[17474147];PTPRA[10698938;11923305];OGN[17474147];DOCK3[17474147];DOCK8[22581261];PTPN21[15143158];FASLG[19807924];ARRB1[16432186;19202075];PTPN23[18835089];ARRB2[19122674;19202075];DUSP15[17474147];HK1[28054552];PHACTR2[17474147];HSP90AA1[16844778];PDCD6IP[15557335];CHUK[15749833];SHROOM2[17474147];MEPE[17474147];CKAP5[17474147];DNM1[15834155];DNM2[15834155];PALLD[17537434];PECAM1[10801826;9162084];LCP2[15929943];LCT[17053785];SOS1[17474147];SHANK3[17474147];SOS2[17474147];DOCK1[17474147];ZP2[17474147];MET[20624308;24034250;24728074];CRK[23397142];SHANK2[17474147];FBP2[24412244];HEMGN[24412244];SRC[17170700];TULP4[17474147];CRMP1[21900206];ASAP1[17474147;16636290];PBXIP1[17043237];ASAP2[17474147];ATP1A1[21278788];CBL[17141222;18273061;17094785;16636290];BICRA[17474147];ASB16[17474147];MUC1[11483589;11152665;21798038];EFS[17474147];ERBB3[16273093];POLD1[17474147];ERBB2[11940572;21075308;19372587];PTK2B[10521452;11149930;8849729];CCDC180[24412244];FYN[16966330];CSK[17525734];ZNF189[24412244];PTPN1[9600099;15866871;16537444;12857726;17092689;11007774;17974954;16115959];PTPN11[20308328];LNX1[17936276];FCGR2B[17474147];FCGR2C[17474147];EIF3D[17474147];HCN2[17474147];BCAR1[17038317;10542110;21034468];	36024614
47315	chr20	42252537	G	C	chr20:42252537	IFT52	intraflagellar transport 52	SNV	0/0	0.0	34_0	34	99.0	0/1	0.4	35_23	58	99.0			rs149821266	EXONIC	YES	NM_016004.5	Transcript	protein_coding	missense_variant		10/14	NM_016004.5:c.775G>C	NP_057088.2:p.Asp259His		1.0	.,.	Likely_benign	criteria_provided,_single_submitter	not_provided	Short-rib thoracic dysplasia 16 with or without polydactyly, 617102 (3), Autosomal recessive	Cranioectodermal dysplasia	Disease-causing germline mutation(s) in	Telecanthus;Cone-shaped epiphyses of the phalanges of the hand;Full cheeks;Brachydactyly;Widely spaced teeth;Protuberant abdomen;Short metacarpal;Depressed nasal bridge;Respiratory distress;Motor delay;Sandal gap;Short distal phalanx of finger;Autosomal recessive inheritance;Flat acetabular roof;High forehead;Narrow chest;Limb undergrowth;Postaxial polydactyly;Carious teeth;Short stature;Short thorax;Midface retrusion;Dolichocephaly;Hypermetropia;Hypoplasia of the corpus callosum;Wide nasal bridge;Short metatarsal;Low-set ears;Microdontia;Abnormal toenail morphology;Craniosynostosis;Abnormal diaphysis morphology;Hypodontia;Abnormal fingernail morphology;Sparse hair;Myopia;Abnormality of the metaphysis;Frontal bossing;Dolichocephaly;Epicanthus;Taurodontia;Pectus excavatum;Joint hyperflexibility;High hypermetropia;Prominent occiput;Clinodactyly of the 5th finger;Short distal phalanx of finger;Abnormality of dental enamel;Osteoporosis;Rhizomelia;Hypotelorism;Nystagmus;Everted lower lip vermilion;Brachydactyly;Finger syndactyly;Narrow chest;Anteverted nares	31042281	0.000295776	45.0	152142.0	0.0	32	0.96	PASS	amr	0.000851343	13.0	0.000205846	14.0	0.000447263	112.0	250412.0	1.0	38	0.93	PASS	amr	0.00180013	62.0	0.000247612	28.0	0.0004244	66	0.001	4.0				30.0	4.275021	0.905	15	5	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,ClinPred_pred	IFT52	0.0	0.05	0.0	0.0	-13.0	25.0	-6.0	25.0						0.262	0.0	0.000000000	0.999	1.176	mortality/aging ; 			.	.	neural tube formation;heart looping;smoothened signaling pathway;dorsal/ventral pattern formation;intraciliary anterograde transport;intraciliary transport involved in cilium assembly;intraciliary transport;embryonic digit morphogenesis;negative regulation of epithelial cell proliferation;cilium assembly;regulation of protein processing;non-motile cilium assembly	centrosome;centriole;cilium;intraciliary transport particle B;motile cilium;photoreceptor connecting cilium;dendrite terminus;ciliary tip;ciliary base	protein C-terminus binding	TTC26[27173435;unassigned1312];SLC35E1[27173435;unassigned1312];IFT172[27173435;unassigned1312];IFT80[27173435;unassigned1312];HSPB11[27173435;unassigned1312];IFT20[27173435;unassigned1312];IFT74[27173435;unassigned1312];FAM210A[27173435;unassigned1312];IFT22[27173435;unassigned1312];IFT88[27173435;unassigned1312];TTC30B[27173435;unassigned1312];IFT81[27173435;unassigned1312];TTC30A[27173435;unassigned1312];IFT27[27173435;unassigned1312];IFT46[27173435;unassigned1312];MAPRE1[27173435;unassigned1312];	42252537
47380	chr20	44236770	A	G	chr20:44236770	WFDC9	WAP four-disulfide core domain 9	SNV	0/1	0.53	43_48	91	99.0	0/0	0.0	38_0	38	99.0			rs1040248804,COSV58097258	EXONIC	YES	NM_147198.4	Transcript	protein_coding	synonymous_variant		5/5	NM_147198.4:c.249T>C	NP_671731.1:p.Leu83%3D		-1.0						.	.	.						32	0.96							8.02987e-06	2.0	249070.0	0.0	85	0.88	PASS	amr	2.94516e-05	1.0	8.86211e-06	1.0			0.0	1.0				0.143	-0.433348		0	0	0			WFDC9	0.23	0.0	0.0	0.0	9.0	-22.0	7.0	-22.0						0.672	0.01	37.854947814			.			.	.	.	extracellular region	protein binding	MEOX2[25416956];	44236770
47384	chr20	44333227	G	A	chr20:44333227	WFDC13	WAP four-disulfide core domain 13	SNV	0/0	0.0	34_0	34	99.0	0/1	0.52	26_28	54	99.0			rs142436120	EXONIC	YES	NM_172005.2	Transcript	protein_coding	missense_variant		2/4	NM_172005.2:c.233G>A	NP_742002.1:p.Arg78His		1.0						.	.	.		0.00263785	401.0	152018.0	1.0	31	0.95	PASS	afr	0.006745	279.0	0.00154389	105.0	0.00126705	318.0	250976.0	1.0	56	0.99	PASS	afr	0.00744615	121.0	0.00132249	150.0	0.0012218	190	0.001	3.0				0.142	-0.434748	0.102	0	17	17		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	WFDC13	0.0	0.0	0.0	0.0	29.0	-27.0	6.0	28.0						0.694	0.25	0.000000000	0.0	-2.265	.			.	.	negative regulation of endopeptidase activity	extracellular region	serine-type endopeptidase inhibitor activity	SGTA[unassigned1304];MEOX2[unassigned1304];	44333227
47402	chr20	44520238	CTGCTG	CTGCTGCTG	chr20:44520238-44520243	CTSA	cathepsin A	sequence_alteration	1/2	0.0	0_3_26_0	29	39.0	2/3	0.41	0_0_16_11	27	99.0				EXONIC	YES	NM_001167594.2	Transcript	protein_coding	inframe_insertion		2/14	NM_001167594.2:c.90_91insCTG	NP_001161066.1:p.Leu37dup		1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	Combined_deficiency_of_sialidase_AND_beta_galactosidase|not_specified	Galactosialidosis, 256540 (3), Autosomal recessive	Galactosialidosis	Disease-causing germline mutation(s) in	Hearing impairment;Corneal opacity;Abnormal vertebral morphology;Coarse facial features;Intellectual disability;Cherry red spot of the macula;Skeletal dysplasia;Seizure;Intellectual disability;Coarse facial features;Severe short stature;Visceromegaly;Opacification of the corneal stroma;Dysostosis multiplex;Conjunctival telangiectasia;Hemangioma;Autosomal recessive inheritance;Cherry red spot of the macula;Nonimmune hydrops fetalis;Decreased beta-galactosidase activity;Hepatosplenomegaly;Seizure;Hearing impairment		0.00464644	696.0	149792.0	1.0	11	0.39	PASS	nfe	0.00776705	526.0	0.00776705	526.0	0.00573076	1167.0	203638.0	5.0	62	0.81	PASS	nfe	0.00907818	830.0	0.00907818	830.0	0.0002830,0.0001093,0.0040706	44,17,633			0.00589	67.0		13.27	0.976632		0	0	0																	0.069	0.0	0.000000000			immune system phenotype; renal/urinary system phenotype; mortality/aging ; hematopoietic system phenotype; cardiovascular system phenotype ; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype ; cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; integument phenotype ; growth/size/body region phenotype; 			kidney;placenta;adrenal gland;	Renin-angiotensin system	proteolysis;glycosphingolipid metabolic process;intracellular protein transport;regulation of protein stability;positive regulation of catalytic activity;neutrophil degranulation;proteolysis involved in cellular protein catabolic process;regulation of chaperone-mediated autophagy;negative regulation of chaperone-mediated autophagy	extracellular region;nucleoplasm;lysosome;endoplasmic reticulum;membrane;azurophil granule lumen;lysosomal lumen;intracellular membrane-bounded organelle;extracellular exosome;lumenal side of lysosomal membrane	carboxypeptidase activity;serine-type carboxypeptidase activity;exo-alpha-sialidase activity;enzyme activator activity	GABARAPL2[20562859];GABARAPL1[20562859];VAPA[26496610];LTB4R2[28298427];GLB1[unassigned1312];CTNNBIP1[17353931];VIM[27173435;unassigned1312];YPEL5[27173435;unassigned1312];GABARAP[20562859];	44520237
47405	chr20	44520238	CTGCTG		chr20:44520238-44520243	CTSA	cathepsin A	sequence_alteration	1/2	0.1	0_3_26_0	29	39.0	2/3	0.0	0_0_16_11	27	99.0				EXONIC	YES	NM_001167594.2	Transcript	protein_coding	inframe_deletion		2/14	NM_001167594.2:c.85_90del	NP_001161066.1:p.Leu36_Leu37del		1.0		Benign	criteria_provided,_single_submitter	Combined_deficiency_of_sialidase_AND_beta_galactosidase	Galactosialidosis, 256540 (3), Autosomal recessive	Galactosialidosis	Disease-causing germline mutation(s) in	Hearing impairment;Corneal opacity;Abnormal vertebral morphology;Coarse facial features;Intellectual disability;Cherry red spot of the macula;Skeletal dysplasia;Seizure;Intellectual disability;Coarse facial features;Severe short stature;Visceromegaly;Opacification of the corneal stroma;Dysostosis multiplex;Conjunctival telangiectasia;Hemangioma;Autosomal recessive inheritance;Cherry red spot of the macula;Nonimmune hydrops fetalis;Decreased beta-galactosidase activity;Hepatosplenomegaly;Seizure;Hearing impairment		1.33584e-05	2.0	149718.0	0.0	11	0.39	PASS	nfe	1.47724e-05	1.0	1.47724e-05	1.0	0.000417407	85.0	203638.0	0.0	62	0.81	PASS	nfe	0.000371877	34.0	0.000371877	34.0	0.0000129,0.0117875	2,1833			0.02259	257.0		13.35	0.988632		0	0	0																	0.069	0.0	0.000000000			immune system phenotype; renal/urinary system phenotype; mortality/aging ; hematopoietic system phenotype; cardiovascular system phenotype ; liver/biliary system phenotype; respiratory system phenotype; behavior/neurological phenotype ; cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; integument phenotype ; growth/size/body region phenotype; 			kidney;placenta;adrenal gland;	Renin-angiotensin system	proteolysis;glycosphingolipid metabolic process;intracellular protein transport;regulation of protein stability;positive regulation of catalytic activity;neutrophil degranulation;proteolysis involved in cellular protein catabolic process;regulation of chaperone-mediated autophagy;negative regulation of chaperone-mediated autophagy	extracellular region;nucleoplasm;lysosome;endoplasmic reticulum;membrane;azurophil granule lumen;lysosomal lumen;intracellular membrane-bounded organelle;extracellular exosome;lumenal side of lysosomal membrane	carboxypeptidase activity;serine-type carboxypeptidase activity;exo-alpha-sialidase activity;enzyme activator activity	GABARAPL2[20562859];GABARAPL1[20562859];VAPA[26496610];LTB4R2[28298427];GLB1[unassigned1312];CTNNBIP1[17353931];VIM[27173435;unassigned1312];YPEL5[27173435;unassigned1312];GABARAP[20562859];	44520237
47439	chr20	44879855		GCA	chr20:44879854-44879855	CDH22	cadherin 22	insertion	0/0	0.0	34_0	34	99.0	0/1	0.42	19_15	36	99.0			rs747181004	EXONIC	YES	NM_021248.3	Transcript	protein_coding	inframe_insertion		2/12	NM_021248.3:c.77_79dup	NP_067071.1:p.Leu26dup		-1.0						.	.	.		6.58293e-05	10.0	151908.0	0.0	32	0.98	PASS	afr	0.000193227	8.0	2.94386e-05	2.0	6.91061e-05	4.0	57882.0	0.0	2	0.12	PASS	sas	0.000187126	2.0	9.29454e-05	2.0	0.0000064	1									0	0	0																	0.226					.			.	.	cell morphogenesis;cell-cell junction assembly;homophilic cell adhesion via plasma membrane adhesion molecules;brain development;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;adherens junction organization;cell-cell adhesion mediated by cadherin;cell-cell adhesion	plasma membrane;cell-cell adherens junction;cell surface;integral component of membrane;catenin complex	calcium ion binding;cytoskeletal protein binding;protein homodimerization activity;cadherin binding	.	44879854
47688	chr20	51871502	G	A	chr20:51871502	TSHZ2	teashirt zinc finger homeobox 2	SNV	0/1	0.45	61_50	111	99.0	0/0	0.0	42_0	42	99.0			rs45479792	EXONIC	YES	NM_173485.6	Transcript	protein_coding	missense_variant		2/3	NM_173485.6:c.1505G>A	NP_775756.3:p.Arg502Lys		1.0	.,.,.					.	.	.		0.00597193	909.0	152212.0	1.0	32	0.98	PASS	nfe	0.0093186	634.0	0.0093186	634.0	0.00615589	1547.0	251304.0	13.0	77	0.99	PASS	nfe	0.00993051	1129.0	0.00993051	1129.0	0.0065979	1026	0.01	33.0				23.5	2.984149	0.3	9	11	20	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	TSHZ2	0.0	0.0	0.0	0.0	2.0	1.0	29.0	0.0						0.135	0.41	0.000000000	0.999	1.176	mortality/aging ; embryo phenotype; 			.	.	negative regulation of transcription by RNA polymerase II;regulation of transcription by RNA polymerase II;multicellular organism development	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;chromatin binding;protein binding;metal ion binding	GRIPAP1[unassigned1304];CCDC57[unassigned1304];TFIP11[unassigned1304];TRAF2[unassigned1304];TRAF1[unassigned1304];MCC[unassigned1304];BACH2[unassigned1304];PYCARD[24407287];GOLGA2[unassigned1304];CCDC88B[unassigned1304];SPTA1[unassigned1304];RINT1[unassigned1304];GIGYF1[unassigned1304];RABEP1[unassigned1304];CRACR2B[unassigned1304];PNMA1[unassigned1304];CNTROB[unassigned1304];PIBF1[unassigned1304];	51871502
47740	chr20	56140633	G	A	chr20:56140633	PCK1	phosphoenolpyruvate carboxykinase 1	SNV	0/1	0.44	65_52	118	99.0	0/1	0.53	82_93	175	99.0			rs148684857	EXONIC	YES	NM_002591.4	Transcript	protein_coding	missense_variant		10/10	NM_002591.4:c.1642G>A	NP_002582.3:p.Ala548Thr		1.0	Phosphoenolpyruvate carboxykinase, GTP-utilising, C-terminal	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Phosphoenolpyruvate_carboxykinase_deficiency,_cytosolic|not_provided	?Phosphoenolpyruvate carboxykinase deficiency, cytosolic, 261680 (3), Autosomal recessive	Phosphoenolpyruvate carboxykinase deficiency	Disease-causing germline mutation(s) in	Apnea;Renal steatosis;Infantile onset;Autosomal recessive inheritance;Global developmental delay;Fasting hypoglycemia;Cerebral atrophy;Lactic acidosis;Hepatic steatosis;Ketonuria;Cyanosis;Hepatomegaly;Seizure;Hepatic failure;Low plasma citrulline;EEG abnormality;Impaired gluconeogenesis;Optic atrophy;Hepatic encephalopathy		0.00137965	210.0	152212.0	0.0	32	0.97	PASS	nfe	0.00249853	170.0	0.00249853	170.0	0.00146425	368.0	251324.0	1.0	100	1.0	PASS	nfe	0.00277225	315.0	0.00277225	315.0	0.0014469	225	0.004	12.0	0.00272	5.0		15.13	1.28901	0.093	4	15	19	MutationAssessor_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	PCK1	0.0	0.0	0.0	0.0	25.0	1.0	20.0	-1.0						0.718	0.0	0.000000000	0.011	1.176	behavior/neurological phenotype ; liver/biliary system phenotype; normal phenotype; mortality/aging ; growth/size/body region phenotype; integument phenotype ; adipose tissue phenotype ; homeostasis/metabolism phenotype; 			pituitary;ciliary ganglion;kidney;liver;adipose tissue;superior cervical ganglion;fetal lung;	Citrate cycle (TCA cycle);Pyruvate metabolism;PPAR signaling pathway;Insulin signaling pathway;Adipocytokine signaling pathway	glucose metabolic process;pyruvate metabolic process;gluconeogenesis;oxaloacetate metabolic process;internal protein amino acid acetylation;aging;response to activity;propionate catabolic process;response to lipopolysaccharide;response to insulin;cellular response to insulin stimulus;response to lipid;glucose homeostasis;response to starvation;glycerol biosynthetic process from pyruvate;cellular response to potassium ion starvation;positive regulation of transcription from RNA polymerase II promoter in response to acidic pH;hepatocyte differentiation;response to interleukin-6;cellular response to retinoic acid;cellular response to cAMP;cellular response to fructose stimulus;cellular response to glucose stimulus;cellular response to interleukin-1;cellular response to tumor necrosis factor;cellular response to glucagon stimulus;cellular response to hypoxia;cellular response to dexamethasone stimulus;response to methionine	cytoplasm;mitochondrion;cytosol;extracellular exosome	magnesium ion binding;phosphoenolpyruvate carboxykinase (GTP) activity;GTP binding;GDP binding;manganese ion binding;carboxylic acid binding	NDUFA11[24344204];C1R[21988832];	56140633
47778	chr20	57273761	G	A	chr20:57273761	NPEPL1	aminopeptidase like 1	SNV	0/1	0.45	74_62	137	99.0	0/0	0.0	39_0	39	99.0			rs201904128	EXONIC	YES	NM_024663.4	Transcript	protein_coding	missense_variant		4/12	NM_024663.4:c.529G>A	NP_078939.3:p.Gly177Ser		1.0	.,.,.					.	.	.		0.000354782	54.0	152206.0	0.0	33	0.97	PASS	amr	0.00156986	24.0	0.000382128	26.0	0.000350931	87.0	247912.0	0.0	52	0.99	PASS	amr	0.00110177	38.0	0.000373042	42.0	0.0003408	53	0.003	10.0				21.9	2.278701	0.333	9	10	19	LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred	NPEPL1	0.0	0.01	0.0	0.0	-42.0	-14.0	2.0	-2.0						0.764	0.0	0.000000000	0.676	1.176	.			ciliary ganglion;subthalamic nucleus;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;testis;globus pallidus;	.	proteolysis	nucleus;cytoplasm	aminopeptidase activity;metalloexopeptidase activity;manganese ion binding	TFCP2[25416956];TFRC[30021884];MDFI[unassigned1304];	57273761
47847	chr20	60791185	C	T	chr20:60791185	HRH3	histamine receptor H3	SNV	0/1	0.42	76_56	132	99.0	0/1	0.47	64_57	121	99.0			rs2067476	EXONIC	YES	NM_007232.3	Transcript	protein_coding	synonymous_variant		3/3	NM_007232.3:c.1215G>A	NP_009163.2:p.Ser405%3D		-1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00473931	721.0	152132.0	6.0	33	0.98	PASS	amr	0.00850897	130.0	0.0065714	447.0	0.00478313	1187.0	248164.0	6.0	100	0.94	PASS	amr	0.00711465	245.0	0.00689495	770.0	0.0045465	707	0.016	51.0	0.01194	22.0		8.689	0.427529		0	0	0			HRH3	0.04	0.0	0.02	0.0	-39.0	-1.0	37.0	38.0						0.163	0.37	97.525301800			nervous system phenotype ; immune system phenotype; behavior/neurological phenotype ; growth/size/body region phenotype; cardiovascular system phenotype ; homeostasis/metabolism phenotype; adipose tissue phenotype ; 			ciliary ganglion;pons;caudate nucleus;atrioventricular node;superior cervical ganglion;trigeminal ganglion;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;	Neuroactive ligand-receptor interaction	G protein-coupled receptor signaling pathway;G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;adenylate cyclase-inhibiting G protein-coupled acetylcholine receptor signaling pathway;chemical synaptic transmission;neurotransmitter secretion;negative regulation of glutamate secretion;regulation of norepinephrine secretion;negative regulation of serotonin secretion;cognition;G protein-coupled serotonin receptor signaling pathway	plasma membrane;integral component of plasma membrane;dendrite;presynapse	G protein-coupled receptor activity;histamine receptor activity;G protein-coupled serotonin receptor activity;G protein-coupled acetylcholine receptor activity;neurotransmitter receptor activity	SH3GL2[25517094];SH3GL1[25517094];	60791185
47913	chr20	60888510	G	A	chr20:60888510	LAMA5	laminin subunit alpha 5	SNV	0/1	0.53	40_46	87	99.0	0/1	0.44	44_36	81	99.0			rs138708242	EXONIC	YES	NM_005560.6	Transcript	protein_coding	missense_variant		64/80	NM_005560.6:c.8665C>T	NP_005551.3:p.Pro2889Ser		-1.0	Laminin G domain&Laminin G domain&Laminin G domain	Likely_benign	criteria_provided,_single_submitter	not_provided		LAMA5-related multisystemic syndrome	Disease-causing germline mutation(s) in	.		0.0042104	641.0	152242.0	7.0	32	0.98	PASS	amr	0.00941915	144.0	0.00565794	385.0	0.00404812	957.0	236406.0	2.0	24	0.65	PASS	amr	0.00766853	258.0	0.00562527	598.0	0.0036333	565	0.016	48.0	0.01088	20.0		1.716	-0.069461	0.0	0	18	18		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LAMA5	0.01	0.0	0.0	0.0	-39.0	20.0	-19.0	35.0						0.482	0.94	0.000000000	0.004	0.028	vision/eye phenotype; digestive/alimentary phenotype; hearing/vestibular/ear phenotype; nervous system phenotype ; limbs/digits/tail phenotype; skeleton phenotype; renal/urinary system phenotype; immune system phenotype; respiratory system phenotype; behavior/neurological phenotype ; embryo phenotype; cardiovascular system phenotype ; hematopoietic system phenotype; growth/size/body region phenotype; mortality/aging ; craniofacial phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; 			.	Cell Communication;Focal adhesion;ECM-receptor interaction;Small cell lung cancer	angiogenesis;branching involved in ureteric bud morphogenesis;morphogenesis of a polarized epithelium;neural crest cell migration;hair follicle development;cytoskeleton organization;integrin-mediated signaling pathway;muscle organ development;cell recognition;cell population proliferation;morphogenesis of embryonic epithelium;cell migration;cytokine-mediated signaling pathway;cell differentiation;regulation of cell adhesion;extracellular matrix organization;lung development;regulation of cell migration;substrate adhesion-dependent cell spreading;regulation of cell population proliferation;odontogenesis of dentin-containing tooth;endothelial cell differentiation;regulation of embryonic development;focal adhesion assembly;cilium assembly;branching involved in salivary gland morphogenesis;protein localization to plasma membrane	extracellular region;basement membrane;laminin-5 complex;extracellular space;nucleus;neuromuscular junction;synaptic cleft;laminin-10 complex;laminin-11 complex;collagen-containing extracellular matrix;extracellular exosome	integrin binding;extracellular matrix structural constituent	SMAD2[15231748];ATF7IP[15231748];TFAP2A[24835590];TFAP2C[24835590];RNASEH2A[26496610];NUDCD1[29021621];MUC7[16203048];DAG1[unassigned1793];LAMC1[25241761];BTBD10[16169070];CRKL[18654987];PLEC[30021884];	60888510
47951	chr20	61492985	G	C	chr20:61492985	TCFL5	transcription factor like 5	SNV	0/1	0.6	4_6	10	89.0	0/0	0.0	14_0	14	39.0			rs1011891001	EXONIC	YES	NM_006602.4	Transcript	protein_coding	missense_variant		1/6	NM_006602.4:c.38C>G	NP_006593.2:p.Ala13Gly		-1.0						.	.	.		0.000102655	15.0	146120.0	0.0	31	0.9	PASS	nfe	0.000182326	12.0	0.000182326	12.0					0	0.0														12.21	0.832736	0.043	0	19	19		SIFT,PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TCFL5	0.0	0.0	0.0	0.0	-12.0	-3.0	36.0	2.0							0.96		0.452	0.683	.			amygdala;testis - seminiferous tubule;testis - interstitial;prefrontal cortex;whole brain;cingulate cortex;spinal cord;testis;medulla oblongata;	.	negative regulation of transcription by RNA polymerase II;regulation of transcription, DNA-templated;transcription by RNA polymerase II;multicellular organism development;spermatogenesis;cell differentiation;regulation of cell population proliferation;regulation of cell differentiation	male germ cell nucleus;nucleus	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;protein dimerization activity	.	61492985
47958	chr20	61637831	CGC		chr20:61637831-61637833	BHLHE23	basic helix-loop-helix family member e23	deletion	0/0	0.0	25_0	25	72.0	0/1	0.15	11_2	13	51.0			rs1019982118	EXONIC	YES	NM_080606.4	Transcript	protein_coding	inframe_deletion		1/1	NM_080606.4:c.294_296del	NP_542173.2:p.Arg99del		-1.0						.	.	.						33	0.97							0.000650026	5.0	7692.0	0.0	1	0.0	PASS	eas	0.025	1.0	0.000276243	1.0								18.08	1.784573		0	0	0			BHLHE23	0.0	0.01	0.0	0.0	-8.0	14.0	-8.0	14.0							0.06				cellular phenotype; nervous system phenotype ; vision/eye phenotype; 			.	.	regulation of transcription by RNA polymerase II;cell development	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein dimerization activity	KRT34[unassigned1304];	61637830
48218	chr20	62597996	T	C	chr20:62597996	ZNF512B	zinc finger protein 512B	SNV	0/0	0.0	34_0	34	99.0	0/1	0.44	75_59	134	99.0			rs150966051	EXONIC	YES	NM_020713.3	Transcript	protein_coding	missense_variant		5/17	NM_020713.3:c.532A>G	NP_065764.1:p.Arg178Gly		-1.0						.	.	.		0.00465773	709.0	152220.0	3.0	33	0.98	PASS	nfe	0.00836322	569.0	0.00836322	569.0	0.00460341	1154.0	250684.0	3.0	90	0.99	PASS	nfe	0.00793104	898.0	0.00793104	898.0	0.0051639	803	0.001	2.0				19.31	1.946629	0.099	2	18	20	SIFT,MutationAssessor_pred	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF512B	0.0	0.0	0.01	0.0	15.0	-2.0	-29.0	-1.0						0.136	1.0		0.996	0.203	.			superior cervical ganglion;	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;metal ion binding	CREBZF[15231748];INVS[15231748];ANKLE2[15231748];DDX3X[15231748];FHL3[25416956;unassigned1304];MEOX2[unassigned1304];PTPRF[15231748];GOLGA2[unassigned1304];ZMYM2[15231748];AP1G1[15231748];PEG10[15231748];TOM1[15231748];SDF4[15231748];HIST1H1E[30021884];VPS35[15231748];LZTS2[15231748];TGM2[15231748];PIAS4[15231748];KLF10[15231748];BRD1[15231748];PBRM1[15231748];KDM2A[15231748];VWF[15231748];GLRX3[15231748];APLP2[15231748];ATRX[15231748];MTUS2[unassigned1304];TRAF1[25416956;unassigned1304];TOX4[15231748];RABEP1[unassigned1304];TRAF4[15231748];RAPGEF2[26496610];AJUBA[unassigned1304];MDFI[unassigned1304];PAPPA2[15231748];PPP1R15A[15231748];CDC123[15231748];KDM3B[15231748];ANAPC15[26496610];CTBP2[15231748];DCTN1[15231748];HDAC1[23752268];UBA5[26496610];KMT2B[15231748];XPC[15231748];HTATSF1[15231748];FAM129B[15231748];HIST1H3A[29568061];TNKS2[15231748];OS9[15231748];RBBP4[27705803];BTBD2[15231748];NACC1[unassigned1304];PLCG2[15231748];SMYD2[17353931];DROSHA[15231748];DVL3[15231748];IL36RN[15231748];VHL[15231748];RPS27A[15231748];MYH10[15231748];SPTBN1[15231748];BANP[unassigned1304];ANKRD28[15231748];MBD3[25123934];SMAD1[15231748];ZNF143[unassigned1304];XRCC6[15231748];YES1[15231748];LAMB2[15231748];SIAH1[25416956];PDE4DIP[15231748];UBE2A[26496610];SUPT5H[15231748];ESR1[21182205];ESR2[21182203];HEYL[15231748];VPS41[15231748];ZYX[unassigned1304];L1TD1[15231748];PTPN3[15231748];	62597996
48325	chr21	28210535	C	T	chr21:28210535	ADAMTS1	ADAM metallopeptidase with thrombospondin type 1 motif 1	SNV	0/0	0.0	34_0	34	99.0	0/1	0.49	51_50	102	99.0			rs139455257,COSV99034675	EXONIC	YES	NM_006988.5	Transcript	protein_coding	missense_variant		9/9	NM_006988.5:c.2267G>A	NP_008919.3:p.Arg756Gln		-1.0	ADAM-TS Spacer 1	Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00242671	369.0	152058.0	1.0	32	0.96	PASS	sas	0.00560166	27.0	0.00398354	271.0	0.0027623	693.0	250878.0	3.0	50	0.99	PASS	sas	0.00676692	207.0	0.00368698	418.0	0.0029710	462	0.002	5.0	0.00294	28.0		30.0	4.280885	0.26	10	10	20	SIFT,PolyPhen,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	ADAMTS1	0.0	0.0	0.0	0.0	-2.0	-19.0	11.0	28.0						0.398	0.59	0.000000000	0.925	1.026	endocrine/exocrine gland phenotype; adipose tissue phenotype ; growth/size/body region phenotype; homeostasis/metabolism phenotype; reproductive system phenotype; mortality/aging ; renal/urinary system phenotype; 			ciliary ganglion;ovary;superior cervical ganglion;atrioventricular node;uterus corpus;trigeminal ganglion;placenta;adrenal cortex;	.	ovulation from ovarian follicle;kidney development;proteolysis;integrin-mediated signaling pathway;negative regulation of cell population proliferation;heart trabecula formation;positive regulation of G1/S transition of mitotic cell cycle;positive regulation of vascular smooth muscle cell proliferation;positive regulation of vascular associated smooth muscle cell migration	basement membrane;cytoplasmic vesicle;collagen-containing extracellular matrix	metalloendopeptidase activity;heparin binding;metallopeptidase activity;zinc ion binding	KRTAP10-8[unassigned1304];KRT40[unassigned1304];USP17L24[19615732];	28210535
48343	chr21	31802815	C	T	chr21:31802815	KRTAP13-4	keratin associated protein 13-4	SNV	0/1	0.53	55_63	119	99.0	0/0	0.0	43_0	43	99.0			rs148405082,COSV61880109	EXONIC	YES	NM_181600.2	Transcript	protein_coding	synonymous_variant		1/1	NM_181600.2:c.222C>T	NP_853631.1:p.Cys74%3D		1.0						.	.	.		0.00036786	56.0	152232.0	0.0	33	0.96	PASS	nfe	0.000587907	40.0	0.000587907	40.0	0.000361967	91.0	251404.0	0.0	74	1.0	PASS	nfe	0.000501275	57.0	0.000501275	57.0	0.0002894	45	0.001	3.0				1.392	-0.101501		0	0	0			KRTAP13-4	0.03	0.0	0.03	0.0	13.0	-15.0	7.0	41.0						0.617	0.01	39.608978480			.			.	.	keratinization	cytosol;intermediate filament	.	RHOXF2[unassigned1304];CYSRT1[unassigned1304];FCHO1[unassigned1304];GEMIN4[unassigned1304];HOXA1[unassigned1304];CDR2L[unassigned1304];NOTCH2NLA[unassigned1304];	31802815
48370	chr21	33044257	GCT		chr21:33044257-33044259	SCAF4	SR-related CTD associated factor 4	deletion	0/1	0.12	52_7	59	99.0	0/0	0.0	35_0	35	99.0			rs578023456	EXONIC	YES	NM_020706.2	Transcript	protein_coding	inframe_deletion		20/20	NM_020706.2:c.2897_2899del	NP_065757.1:p.Gln966del		-1.0						.	.	.		0.00340675	516.0	151464.0	3.0	32	0.96	PASS	amr	0.00420555	64.0	0.00404416	274.0	0.00363817	843.0	231710.0	1.0	96	1.0	PASS	nfe	0.00455138	482.0	0.00455138	482.0	0.0000514,0.0080963,0.0009775	8,1259,152	0.001	2.0				17.29	1.671474		0	0	0			SCAF4	0.0	0.0	0.0	0.0	37.0	43.0	41.0	-45.0							1.0				.			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;globus pallidus;	.	.	nucleoplasm	RNA binding	CCNB2[26496610];WBP4[16055720];LARP7[18281698];PPP4R3A[26496610];	33044256
48378	chr21	33720037	C	T	chr21:33720037	URB1	URB1 ribosome biogenesis homolog	SNV	0/0	0.0	35_0	35	99.0	0/1	0.5	59_58	117	99.0			rs773718546	EXONIC	YES	NM_014825.3	Transcript	protein_coding	synonymous_variant		22/39	NM_014825.3:c.3096G>A	NP_055640.2:p.Pro1032%3D		-1.0						.	.	.						33	0.98							1.33586e-05	2.0	149716.0	0.0	44	0.57	PASS	sas	4.39522e-05	1.0	1.77186e-05	1.0	0.0000193	3						0.335	-0.312659		0	0	0			URB1	0.0	0.0	0.0	0.0	-15.0	8.0	35.0	-49.0								2.819156620			.			.	.	maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);maturation of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);biological_process	fibrillar center;nucleolus	RNA binding	NOP56[26496610];SORT1[26496610];RPS6[29568061];KIF14[26496610];RRP1B[20926688];BAG6[26496610];FBL[29568061];CDC23[26496610];TFG[26496610];NLRP3[26496610];MNDA[25665578];TAB1[21900206];MAPK6[21900206];AURKAIP1[29568061];NCK1[17474147];	33720037
48486	chr21	37618805	C	T	chr21:37618805	DOPEY2		SNV	0/1	0.45	77_62	139	99.0	0/0	0.0	48_0	48	99.0			rs117952108	EXONIC	YES	NM_001320714.2	Transcript	protein_coding	synonymous_variant		19/37	NM_001320714.2:c.4527C>T	NP_001307643.1:p.Pro1509%3D		1.0										0.00424548	646.0	152162.0	2.0	32	0.97	PASS	nfe	0.00740915	504.0	0.00740915	504.0	0.00389837	974.0	249848.0	8.0	70	1.0	PASS	nfe	0.00730025	819.0	0.00730025	819.0	0.0042250	657	0.004	14.0				4.054	0.087574		0	0	0			DOPEY2	0.0	0.0	0.0	0.0	26.0	-38.0	7.0	30.0						0.83	0.0	31.897692340												37618805
48649	chr21	43176892	G	A	chr21:43176892	RIPK4	receptor interacting serine/threonine kinase 4	SNV	0/0	0.0	35_0	35	99.0	0/1	0.55	59_71	130	99.0			rs55798804	EXONIC	YES	NM_020639.3	Transcript	protein_coding	synonymous_variant		2/8	NM_020639.3:c.267C>T	NP_065690.2:p.Arg89%3D		-1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Bartsocas-Papas_syndrome|not_provided	CHAND syndrome, 214350 (3), Autosomal recessive; Popliteal pterygium syndrome, Bartsocas-Papas type 1, 263650 (3), Autosomal recessive	Bartsocas-Papas syndrome	Disease-causing germline mutation(s) (loss of function) in	Dry skin;Commissural lip pit;Imperforate hymen;Agenesis of maxillary incisor;Cleft palate;Ankyloblepharon;Abnormal oral frenulum morphology;Hypohidrosis;Agenesis of permanent teeth;Atelectasis;Hydroureter;Curly hair;Bifid tongue;Short fifth metatarsal;Hypertelorism;Nail dysplasia;Depressed nasal bridge;Ataxia;Synostosis of joints;Abnormality of cardiovascular system morphology;Microcephaly;Ambiguous genitalia;Underdeveloped nasal alae;Hypoplastic toenails;Alopecia totalis;Toe syndactyly;Corneal opacity;Aplasia/Hypoplasia of the distal phalanges of the toes;Finger syndactyly;Intellectual disability;Hypoplastic male external genitalia;Short nose;Micrognathia;Aplasia/Hypoplasia of the eyebrow;Median cleft lip;Eyelid coloboma;Renal hypoplasia/aplasia;Ankyloblepharon;Cleft palate;Narrow mouth;Sparse or absent eyelashes;Popliteal pterygium;Absent thumb;Talipes;Micrognathia;Alopecia totalis;Hypoplastic male external genitalia;Hypertelorism;Microphthalmia;Absent eyebrow;Ambiguous genitalia;Hypoplasia of the maxilla;Absent thumb;Intrauterine growth retardation;Cleft upper lip;Hypoplastic labia majora;Cleft palate;Axillary pterygium;Absent eyelashes;Hypoplastic scapulae;Facial cleft;Cupped ear;Anonychia;Short nose;Opacification of the corneal stroma;Anal stenosis;Ankyloblepharon;Syndactyly;Wide intermamillary distance;Skin tags;Inferiorly positioned umbilicus;Low-set ears;Bilateral cryptorchidism;Small nail;Popliteal pterygium;Autosomal recessive inheritance;Short phalanx of finger;Autosomal recessive inheritance;Ankyloblepharon;Nail dysplasia;Commissural lip pit;Curly hair		0.00128077	195.0	152252.0	2.0	33	0.98	PASS	amr	0.00712791	109.0	0.00111676	76.0	0.0010222	257.0	251418.0	0.0	90	1.0	PASS	amr	0.00292026	101.0	0.00127495	145.0	0.0010096	157	0.009	30.0	0.00482	55.0		0.14	-0.436037		0	0	0			RIPK4	0.0	0.0	0.0	0.0	-11.0	35.0	16.0	37.0						0.382	0.0	1.597133001			integument phenotype ; growth/size/body region phenotype; cellular phenotype; craniofacial phenotype; limbs/digits/tail phenotype; digestive/alimentary phenotype; mortality/aging ; respiratory system phenotype; 			kidney;trachea;thyroid;liver;tongue;skin;prostate;	.	morphogenesis of an epithelium;protein phosphorylation;positive regulation of NF-kappaB transcription factor activity	cytoplasm;membrane	protein serine/threonine kinase activity;protein binding;ATP binding	RPLP0P6[26972000];HSP90AA4P[26972000];CLPB[26972000];ECI2[26972000];ARAF[26972000];SMC3[26972000];PPP2R1A[26972000];CDK5RAP1[26972000];RCC1[26972000];BTRC[26972000];CIAO2B[26972000];PELO[26972000];SKP1[26972000];PRKCI[26972000];PRKCH[26972000];PRKCB[23371553];ZNF281[26972000];PRKCD[26972000;23371553];GTPBP6[26972000];PTOV1[26972000];CSNK1D[26972000];CSNK1E[26972000];ALG1[26972000];PISD[26972000];AFG3L2[26972000];ARMC5[26972000];MTHFD1[26972000];SCO1[26972000];SCO2[26972000];KATNAL2[26972000];CDC37[26972000];YME1L1[26972000];MT-CO2[26972000];FAR1[26972000];UQCRC2[26972000];RTEL1[26972000];SDC4[26972000];PRKDC[26972000];MAGED1[26972000];SDC2[26972000];MAPKAP1[26972000];FLII[26972000];HSPA4L[26972000];PIK3R4[26972000];PIK3R3[26972000];PIK3R1[26972000];IQGAP3[26972000];GLG1[26972000];RPAP3[26972000];PRDX3[26972000];RHOT2[26972000];SCFD1[26972000];SPATA5L1[26972000];CEP78[26972000];EDEM3[26972000];SLC35E1[26972000];IQSEC1[26972000];LRBA[26972000];CDC7[26972000];ERAL1[26972000];SMTN[26972000];PPP5C[26972000];TBL2[26972000];RPS27[26972000];HNRNPK[26972000];PAF1[26972000];SFXN4[26972000];SFXN2[26972000];CALM1[26972000];FARSA[26972000];WDR48[26972000];TCF25[26972000];RPLP1[26972000];TECR[26972000];FAF2[26972000];LPCAT1[26972000];MIA3[26972000];TFB1M[26972000];SMG7[26972000];SERPINA7[26972000];JPH1[26972000];PFAS[26972000];AKAP12[26972000];TUBA1B[26972000];AIFM1[26972000];SDF4[26972000];RPLP2[26972000];IKBKG[26972000];SEC61B[26972000];GPRASP2[26972000];EMD[26972000];TOMM70[26972000];CCT3[26972000];CCT2[26972000];CLUH[26972000];SSR4[26972000];TUBB[26972000];RIPK4[26972000];TYK2[26972000];MRPL48[26972000];UCHL5[26972000];LRRC41[26972000];MLF2[26972000];VWA8[26972000];HADHB[26972000];HADHA[26972000];TUBB2B[26972000];TUBB2A[26972000];AGPS[26972000];CDC42EP1[26972000];GART[26972000];EXOC2[26972000];KANK2[26972000];GBA[26972000];XIAP[21931591];RPS27L[26972000];PURB[26972000];PSMB2[26972000];PRR14L[26972000];MTHFD1L[26972000];RNF138[26972000];MIC13[26972000];GPC3[26972000];ZNF469[26972000];RICTOR[26972000];GPC4[26972000];CCT8[26972000];UBL4A[26972000];FARP2[26972000];FARP1[26972000];SLC16A1[26972000];CSNK1A1[26972000];AGK[26972000];PTGES3[26972000];CKMT1A[26972000];GBF1[26972000];HUWE1[26972000];ERBIN[26972000];TUBB4B[26972000];ATP5F1C[26972000];TUBB4A[26972000];XPOT[26972000];NCAPD3[26972000];COQ8A[26972000];HSPA1A[26972000];NDUFA10[26972000];IRS4[26972000];UBE2D1[21931591];IPO4[26972000];TUBB6[26972000];TUBB3[26972000];CHP1[26972000];MTPAP[26972000];GTF2I[26972000];RADX[26972000];FBXW11[26972000];DNAJB12[26972000];TRAFD1[26972000];TSC2[26972000];SARS[26972000];DNAJB14[26972000];CDKAL1[26972000];LEMD3[26972000];ATAD3B[26972000];ATAD3A[26972000];RBX1[26972000];DPM1[26972000];ACLY[26972000];MAP7D3[26972000];ARMCX5[26972000];MADD[26972000];DNAJB11[26972000];FKBP8[26972000];PHLDB3[26972000];RAF1[26972000];SQSTM1[26972000];FKBP5[26972000];SLC27A4[26972000];LRRC59[26972000];FECH[26972000];NDUFB10[26972000];CNP[26972000];TUBGCP2[26972000];COPB1[26972000];CUL1[26972000];TARS[26972000];NTPCR[26972000];SPATA5[26972000];KLC1[26972000];HIGD1A[26972000];ESS2[26972000];STK3[26972000];TIMM50[26972000];BAG6[26972000];STIP1[26972000];BAG5[26972000];BAG2[26972000];IRAK1[26972000];DHRS7B[26972000];DVL2[23371553];ECT2[26972000];MDN1[26972000];GCN1[26972000];OSBPL8[26972000];HSPA8[26972000];CCDC138[26972000];HSPA4[26972000];SEC16A[26972000];HSPA6[26972000];ECD[26972000];NFXL1[26972000];MARCH7[26972000];HIGD2A[26972000];P4HA1[26972000];SRPRA[26972000];TUBGCP6[26972000];UBA1[26972000];NF2[26972000];COX20[26972000];YWHAE[26972000];SLC25A1[26972000];SLC25A3[26972000];ABCD3[26972000];YWHAB[26972000];CCDC47[26972000];ILK[26972000];MAIP1[26972000];PPP6C[26972000];YWHAQ[26972000];NOB1[26972000];PPP6R1[26972000];TIMM17A[26972000];VWC2L[unassigned1304];WDR6[26972000];HIF1AN[26972000];POLE[26972000];HIST1H1A[30021884];GPSM3[unassigned1304];YWHAH[26972000];RFC5[26972000];JAGN1[26972000];HSP90AA1[26972000];KSR1[26972000];CAD[26972000];DDX54[26972000];SMC1A[26972000];YWHAZ[26972000];PJA2[26972000];SENP1[26972000];HAX1[26972000];DNAJC7[26972000];SLC25A5[26972000];SLC25A12[26972000];BIRC2[21931591];BIRC3[21931591];SLC25A6[26972000];SLC25A13[26972000];GTF3C3[26972000];NDUFB4[26972000];VPS4A[26972000];AMBRA1[26972000];SAMHD1[26972000];CLN6[26972000];AURKB[26972000];HSPD1[26972000];LRP6[23371553];PRTG[26972000];DNAJB1[26972000];TMEM201[26972000];CAND1[26972000];DNAJB6[26972000];ZNF507[26972000];POLR2B[26972000];C1orf109[26972000];SLC25A21[26972000];CDIPT[26972000];SLC25A22[26972000];NDUFA9[26972000];NDUFA8[26972000];SPAG8[unassigned1304];NDUFA4[26972000];NAP1L1[26972000];DNAJA1[26972000];PNKD[26972000];POLR3B[26972000];DNAJA4[26972000];DNAJA3[26972000];DNAJA2[26972000];NAA16[26972000];STUB1[26972000];ABCE1[26972000];GLA[26972000];PFKM[26972000];METAP2[26972000];	43176892
48821	chr21	44483185		TGATCTGCAGAGGGCGCGGCTTCAGGGCTCAAGCCCAGCAAAAGCCCCACCTGGATGATCCACCCCAG	chr21:44483184-44483185	CBS	cystathionine-beta-synthase	insertion	0/1	0.56	36_46	82	99.0	0/0	0.0	36_0	36	99.0				EXONIC	YES	NM_001320298.2	Transcript	protein_coding	stop_gained,frameshift_variant		11/18	NM_001320298.2:c.832_833insCTGGGGTGGATCATCCAGGTGGGGCTTTTGCTGGGCTTGAGCCCTGAAGCCGCGCCCTCTGCAGATCA	NP_001307227.1:p.Ile278ThrfsTer16		-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Classic_homocystinuria|not_specified|not_provided	Thrombosis, hyperhomocysteinemic, 236200 (3), Autosomal recessive; Homocystinuria, B6-responsive and nonresponsive types, 236200 (3), Autosomal recessive	Classic homocystinuria	Disease-causing germline mutation(s) in	Myopia;Pulmonary embolism;Retinal detachment;Gastrointestinal hemorrhage;High palate;Urticaria;Joint stiffness;Anorexia;Genu valgum;Osteoporosis;Intellectual disability;Intracranial hemorrhage;Hypertension;Hernia;Ectopia lentis;Arteriovenous malformation;Seizure;Subcutaneous hemorrhage;Amblyopia;Sparse scalp hair;Disproportionate tall stature;Abnormality of retinal pigmentation;Pectus excavatum;Hepatomegaly;Pectus carinatum;Psychosis;Elevated hepatic transaminase;Kyphosis;Scoliosis;Dental crowding;Venous thrombosis;Cerebral ischemia;Hemiplegia/hemiparesis;Arterial thrombosis;Recurrent fractures;Optic atrophy;Arachnodactyly;Cataract;Esophageal varix;Glaucoma;Abnormality of amino acid metabolism;Autosomal recessive inheritance;Inguinal hernia;Behavioral abnormality;Intellectual disability;Global developmental delay;Methioninuria;Myopia;Lens subluxation;Biconcave vertebral bodies;Depressivity;Osteoporosis;Limitation of joint mobility;Arachnodactyly;Brittle hair;Mitral valve prolapse;Hypermethioninemia;Cutis marmorata;Hyperhomocystinemia;Stroke;Hypopigmentation of the skin;Tall stature;Pectus excavatum;Failure to thrive;Myocardial infarction;Pancreatitis;Kyphoscoliosis;Thromboembolism;Hepatic steatosis;High palate;Homocystinuria;Glaucoma;Generalized osteoporosis;Seizure;Disproportionate tall stature;Dental crowding;Pectus carinatum;Personality disorder;Visual impairment;Scoliosis			0.0	0.0	0.0	0	0.0	AC0					0.0					82	1.0							0.0003537	55	0.004	14.0	0.0868	990.0		26.5	3.834434		0	0	0																	0.0305	0.01	45.018806413			muscle phenotype; craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; integument phenotype ; growth/size/body region phenotype; endocrine/exocrine gland phenotype; nervous system phenotype ; limbs/digits/tail phenotype; vision/eye phenotype; immune system phenotype; renal/urinary system phenotype; embryo phenotype; respiratory system phenotype; liver/biliary system phenotype; reproductive system phenotype; mortality/aging ; hematopoietic system phenotype; cardiovascular system phenotype ; 			liver;superior cervical ganglion;	Glycine, serine and threonine metabolism;Methionine metabolism;Selenoamino acid metabolism;Huntington's disease	cysteine biosynthetic process from serine;L-serine metabolic process;L-serine catabolic process;cysteine biosynthetic process via cystathionine;cysteine biosynthetic process;transsulfuration;L-cysteine catabolic process;DNA protection;homocysteine catabolic process;homocysteine metabolic process;oxidation-reduction process;hydrogen sulfide biosynthetic process	nucleus;cytoplasm;cytosol	cystathionine beta-synthase activity;cysteine synthase activity;protein binding;oxygen binding;enzyme binding;heme binding;pyridoxal phosphate binding;ubiquitin protein ligase binding;identical protein binding;protein homodimerization activity;metal ion binding;nitrite reductase (NO-forming) activity;carbon monoxide binding;nitric oxide binding;modified amino acid binding;S-adenosyl-L-methionine binding	HSP90AB1[25910212];PRKAG1[25416956];GABARAP[20562859];HID1[16189514];COL4A3BP[19447967];FXR2[16189514];UGP2[21988832];CBS[16189514;19447967;21900206;25416956];UBASH3A[25416956];TRAP1[unassigned1312];HSPA8[25910212];DAXX[21988832];UBE2I[25416956];VTA1[16189514];NEK7[unassigned1312];TPM1[30021884];WDYHV1[27107012];PA2G4[unassigned1312];ZDHHC17[24705354];PSMA1[25416956];PRKAR1A[21900206];EHHADH[25416956];UBE2N[unassigned1312];PIN1[25416956];OTUB1[26752685];EIF3B[30021884];	44483184
48881	chr21	44840138	G	A	chr21:44840138	SIK1	salt inducible kinase 1	SNV	0/0	0.0	33_0	33	99.0	0/1	0.48	64_58	122	99.0			rs17004546,COSV54257824	EXONIC	YES	NM_173354.5	Transcript	protein_coding	synonymous_variant		8/14	NM_173354.5:c.948C>T	NP_775490.2:p.Gly316%3D		-1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	Seizure|Epileptic_encephalopathy,_early_infantile,_30|not_provided	Developmental and epileptic encephalopathy 30, 616341 (3), Autosomal dominant	Early infantile epileptic encephalopathy;Early myoclonic encephalopathy;West syndrome	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Lethargy;Generalized myoclonic seizure;Global developmental delay;Epileptic encephalopathy;Hypsarrhythmia;Dysphagia;Hyperreflexia;Focal tonic seizure;Infantile spasms;Myoclonus;Muscular hypotonia;Recurrent respiratory infections;Poor suck;Eyelid myoclonias;Renal dysplasia;Ureterocele;Strabismus;Micropenis;Hypsarrhythmia;Depressed nasal bridge;Autistic behavior;Generalized tonic seizure;Focal seizures, afebril;Generalized non-motor (absence) seizure;Precocious puberty;Absent thumbnail;EEG with burst suppression;Cerebellar atrophy;Uni- and bilateral multifocal epileptiform discharges;Myoclonus;Developmental regression;Spasticity;Umbilical hernia;EEG with spike-wave complexes;Broad finger;Microcephaly;Self-injurious behavior;Bilateral tonic-clonic seizure;Febrile seizure (within the age range of 3 months to 6 years);Broad phalanx of the toes;Sloping forehead;Diffuse cerebral atrophy;Pachygyria;Generalized clonic seizure;Infantile spasms;Sleep disturbance;Intellectual disability;Atonic seizure;Diffuse white matter abnormalities;Dystonia;Hypoplasia of the corpus callosum;Infantile muscular hypotonia;Short finger;Hyperactivity;Ventricular septal defect;Episodic ataxia;Poor head control;Failure to thrive;Anteverted nares;Cleft palate;Dyskinesia;Delayed myelination;Global developmental delay;Choreoathetosis;Tremor;Autosomal dominant inheritance;Bilateral tonic-clonic seizure;Global developmental delay;Encephalopathy;Feeding difficulties;Generalized myoclonic seizure;Epileptic encephalopathy;Death in infancy;Absent speech;Hypsarrhythmia;Stereotypy;Respiratory distress;Myoclonus;Infantile spasms;Developmental regression;Hypsarrhythmia;Abnormality of skin morphology		0.0	0.0	50.0	0.0	0	0.0	AC0_AS_VQSR				0.0	0.0	0.0482274	12009.0	249008.0	396.0	46	0.98	PASS	sas	0.0874885	2674.0	0.0496422	5550.0	0.0458831	7135	0.04	119.0				3.278	0.041161		0	0	0			SIK1	0.0	0.0	0.0	0.0	2.0	26.0	2.0	-24.0						0.325	0.99	20.568521354			skeleton phenotype; mortality/aging ; cardiovascular system phenotype ; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; adipose tissue phenotype ; growth/size/body region phenotype; 			superior cervical ganglion;skin;adrenal cortex;	.	regulation of sodium ion transport;protein phosphorylation;cell cycle;regulation of mitotic cell cycle;regulation of myotube differentiation;negative regulation of triglyceride biosynthetic process;negative regulation of TOR signaling;negative regulation of CREB transcription factor activity;intracellular signal transduction;cellular response to glucose starvation;entrainment of circadian clock by photoperiod;regulation of cell differentiation;negative regulation of gluconeogenesis;protein autophosphorylation;rhythmic process;cardiac muscle cell differentiation;positive regulation of anoikis	nucleus;cytoplasm;nucleotide-activated protein kinase complex	magnesium ion binding;protein serine/threonine kinase activity;protein binding;ATP binding;cAMP response element binding protein binding;protein kinase binding;14-3-3 protein binding	YWHAE[16306228];CRTC2[16306228];RPL3[21988832];NMNAT1[21988832];CD247[24502978];TIMM10[unassigned1304];SUPT5H[21988832];YWHAZ[16306228];MESD[unassigned1304];PITX1[unassigned1304];PRTFDC1[unassigned1304];LHX8[unassigned1304];	44840138
48900	chr21	45534637	C	T	chr21:45534637	PWP2	PWP2, small subunit processome component	SNV	0/0	0.0	35_0	35	99.0	0/1	0.45	46_37	83	99.0			rs144440735	EXONIC	YES	NM_005049.3	Transcript	protein_coding	missense_variant		5/21	NM_005049.3:c.458C>T	NP_005040.2:p.Thr153Met		1.0	WD40-repeat-containing domain					.	.	.		0.0	0.0	45056.0	0.0	3	0.01	AC0_AS_VQSR,AC0_AS_VQSR				0.0	0.0	1.59238e-05	4.0	251196.0	0.0	93	1.0	PASS	eas	5.43656e-05	1.0	8.79616e-06	1.0	0.0000129	2						24.3	3.300701	0.63	14	7	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	PWP2	0.0	0.0	0.0	0.0	13.0	-43.0	9.0	12.0						0.456	0.88	0.000000000	0.622	0.103	.			amygdala;	.	ribosomal small subunit assembly;maturation of SSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA);rRNA processing	nucleoplasm;small-subunit processome;Pwp2p-containing subcomplex of 90S preribosome	RNA binding	USP36[19615732];JUN[25609649];CEP19[26638075];RPS6[29568061];DDX41[25920683];HSCB[28380382];RRP1B[20926688];UTP18[30021884];TOM1L1[16169070];BAG6[26496610];FBL[29568061];RNF169[21252943];IFI16[25665578];CNTRL[26638075];HDGF[21907836];CD247[24502978];B9D2[26638075];	45534637
48997	chr21	45856978	G	A	chr21:45856978	TRPM2	transient receptor potential cation channel subfamily M member 2	SNV	0|1	0.44	53_41	94	99.0	0/0	0.0	38_0	38	99.0			rs775827047	EXONIC	YES	NM_001320350.1	Transcript	protein_coding	synonymous_variant		30/33	NM_001320350.1:c.4245G>A	NP_001307279.1:p.Arg1415%3D		1.0						.	.	.		0.000151121	23.0	152196.0	0.0	33	0.98	PASS	amr	0.000654108	10.0	0.000191058	13.0	0.000294679	46.0	156102.0	0.0	54	0.59	PASS	amr	0.000889608	22.0	0.000347349	21.0	0.0000514	8	0.002	6.0	0.0021	24.0		9.907	0.555059		0	0	0			TRPM2	0.0	0.0	0.0	0.0	-30.0	-27.0	-34.0	33.0						0.797	0.0	59.606630230			cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; behavior/neurological phenotype ; liver/biliary system phenotype; immune system phenotype; nervous system phenotype ; mortality/aging ; normal phenotype; cardiovascular system phenotype ; hematopoietic system phenotype; 			superior cervical ganglion;	.	temperature homeostasis;dendritic cell chemotaxis;calcium ion transport;response to purine-containing compound;calcium-mediated signaling using intracellular calcium source;sodium ion transmembrane transport;neutrophil degranulation;release of sequestered calcium ion into cytosol;regulation of filopodium assembly;cellular response to hydrogen peroxide;calcium ion transmembrane transport;cellular response to calcium ion;cellular response to purine-containing compound;cellular response to temperature stimulus;zinc ion transmembrane transport;dendritic cell differentiation;calcium ion transmembrane import into cytosol;calcium ion import across plasma membrane;regulation of actin cytoskeleton reorganization	lysosome;lysosomal membrane;plasma membrane;integral component of plasma membrane;cytoplasmic vesicle membrane;specific granule membrane;cell projection;perikaryon;tertiary granule membrane;ficolin-1-rich granule membrane	cation channel activity;calcium channel activity;sodium channel activity;calcium ion binding;calcium-release channel activity;hydrolase activity;ligand-gated calcium channel activity	PPP1R12A[28330616];	45856978
49001	chr21	45856979	A	G	chr21:45856979	TRPM2	transient receptor potential cation channel subfamily M member 2	SNV	0|1	0.44	53_41	94	99.0	0/0	0.0	38_0	38	99.0			rs763303047	EXONIC	YES	NM_001320350.1	Transcript	protein_coding	missense_variant		30/33	NM_001320350.1:c.4246A>G	NP_001307279.1:p.Lys1416Glu		1.0	NUDIX hydrolase domain,NUDIX hydrolase domain,NUDIX hydrolase domain,.,NUDIX hydrolase domain					.	.	.		0.000151123	23.0	152194.0	0.0	33	0.98	PASS	amr	0.000654193	10.0	0.000191098	13.0	0.000294679	46.0	156102.0	0.0	54	0.59	PASS	amr	0.000889608	22.0	0.000347406	21.0	0.0000514	8	0.002	6.0	0.0021	24.0		17.6	1.717964	0.032	2	17	19	MutationAssessor_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	TRPM2	0.0	0.0	0.0	0.0	-1.0	-34.0	-1.0	32.0						0.797	0.0	0.000000000	0.999	1.134	cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; behavior/neurological phenotype ; liver/biliary system phenotype; immune system phenotype; nervous system phenotype ; mortality/aging ; normal phenotype; cardiovascular system phenotype ; hematopoietic system phenotype; 			superior cervical ganglion;	.	temperature homeostasis;dendritic cell chemotaxis;calcium ion transport;response to purine-containing compound;calcium-mediated signaling using intracellular calcium source;sodium ion transmembrane transport;neutrophil degranulation;release of sequestered calcium ion into cytosol;regulation of filopodium assembly;cellular response to hydrogen peroxide;calcium ion transmembrane transport;cellular response to calcium ion;cellular response to purine-containing compound;cellular response to temperature stimulus;zinc ion transmembrane transport;dendritic cell differentiation;calcium ion transmembrane import into cytosol;calcium ion import across plasma membrane;regulation of actin cytoskeleton reorganization	lysosome;lysosomal membrane;plasma membrane;integral component of plasma membrane;cytoplasmic vesicle membrane;specific granule membrane;cell projection;perikaryon;tertiary granule membrane;ficolin-1-rich granule membrane	cation channel activity;calcium channel activity;sodium channel activity;calcium ion binding;calcium-release channel activity;hydrolase activity;ligand-gated calcium channel activity	PPP1R12A[28330616];	45856979
49015	chr21	46011745	T	T	chr21:46011745	KRTAP10-6	keratin associated protein 10-6	SNV	0|1	0.91	15_160	175	99.0	1|1	1.0	0_142	142	99.0			rs1555926683,rs1569206313,rs1569206319,rs1569206335,rs233304,COSV59967523	EXONIC	YES	NM_198688.3	Transcript	protein_coding	synonymous_variant		1/1	NM_198688.3:c.621G>A	NP_941961.3:p.Ser207%3D		-1.0						.	.	.						0	0.0											100	1.0							0.0000064,0.0000129,0.0000129,0.6991138,0.0002251,0.0000064	1,2,2,108715,35,1	0.593	1716.0				0.006	-0.851982		0	0	0			KRTAP10-6	0.01	0.01	0.0	0.0	-10.0	25.0	50.0	1.0						0.918	0.0				.			.	.	keratinization	cytosol;keratin filament	.	ZBTB24[unassigned1304];ZNF490[unassigned1304];HHEX[unassigned1304];FAM74A4[unassigned1304];DHX57[unassigned1304];ADAMTSL3[unassigned1304];MFSD3[unassigned1304];ZNF280C[unassigned1304];RSPO2[unassigned1304];SNIP1[unassigned1304];KRTAP5-2[unassigned1304];ZNF600[unassigned1304];ZNF169[unassigned1304];ZNF563[unassigned1304];FOXD4[unassigned1304];ZNF440[unassigned1304];KRTAP5-9[unassigned1304];LCE1E[unassigned1304];LCE1F[unassigned1304];DKK2[unassigned1304];LCE2C[unassigned1304];KIF9[unassigned1304];ZNF319[unassigned1304];HAND1[unassigned1304];ZNF679[unassigned1304];ZNF239[unassigned1304];ZNF479[unassigned1304];MT1B[unassigned1304];ZNF114[unassigned1304];AVPI1[unassigned1304];HOXB5[unassigned1304];ZNF595[unassigned1304];ZNF155[unassigned1304];ZNF672[unassigned1304];ZNF792[unassigned1304];YTHDC1[unassigned1304];PBXIP1[unassigned1304];SPATA3[unassigned1304];ZC3HAV1[unassigned1304];KIAA0040[unassigned1304];LCE2D[unassigned1304];NKD1[unassigned1304];ZNHIT1[unassigned1304];LCE3B[unassigned1304];MOBP[unassigned1304];KRTAP5-11[unassigned1304];ZNF669[unassigned1304];KRTAP4-4[unassigned1304];KRTAP4-2[unassigned1304];ZNF302[unassigned1304];ZNF543[unassigned1304];ZIM2[unassigned1304];STRA6[unassigned1304];NPDC1[unassigned1304];ZNF221[unassigned1304];ZNF264[unassigned1304];KRTAP10-5[unassigned1304];NAA10[unassigned1304];KRTAP4-5[unassigned1304];CLK4[unassigned1304];VASN[unassigned1304];LCE3E[unassigned1304];CLK1[unassigned1304];WT1[unassigned1304];LCE4A[unassigned1304];ZNF418[unassigned1304];NMU[unassigned1304];PIN1[unassigned1304];NAXD[unassigned1304];ZNF138[unassigned1304];ZNF776[unassigned1304];NOL12[unassigned1304];ZNF774[unassigned1304];ZNF696[unassigned1304];	46011745
49020	chr21	46011751	T	T	chr21:46011751	KRTAP10-6	keratin associated protein 10-6	SNV	0|1	0.91	15_155	170	99.0	1|1	1.0	0_140	140	99.0			rs233305,rs782466433,COSV59954350	EXONIC	YES	NM_198688.3	Transcript	protein_coding	synonymous_variant		1/1	NM_198688.3:c.615G>A	NP_941961.3:p.Thr205%3D		-1.0						.	.	.						0	0.0											100	1.0							0.6881302,0.0000322	107007,5	0.558	1621.0				0.105	-0.476636		0	0	0			KRTAP10-6	0.01	0.01	0.0	0.0	-16.0	19.0	44.0	48.0						0.918	0.0				.			.	.	keratinization	cytosol;keratin filament	.	ZBTB24[unassigned1304];ZNF490[unassigned1304];HHEX[unassigned1304];FAM74A4[unassigned1304];DHX57[unassigned1304];ADAMTSL3[unassigned1304];MFSD3[unassigned1304];ZNF280C[unassigned1304];RSPO2[unassigned1304];SNIP1[unassigned1304];KRTAP5-2[unassigned1304];ZNF600[unassigned1304];ZNF169[unassigned1304];ZNF563[unassigned1304];FOXD4[unassigned1304];ZNF440[unassigned1304];KRTAP5-9[unassigned1304];LCE1E[unassigned1304];LCE1F[unassigned1304];DKK2[unassigned1304];LCE2C[unassigned1304];KIF9[unassigned1304];ZNF319[unassigned1304];HAND1[unassigned1304];ZNF679[unassigned1304];ZNF239[unassigned1304];ZNF479[unassigned1304];MT1B[unassigned1304];ZNF114[unassigned1304];AVPI1[unassigned1304];HOXB5[unassigned1304];ZNF595[unassigned1304];ZNF155[unassigned1304];ZNF672[unassigned1304];ZNF792[unassigned1304];YTHDC1[unassigned1304];PBXIP1[unassigned1304];SPATA3[unassigned1304];ZC3HAV1[unassigned1304];KIAA0040[unassigned1304];LCE2D[unassigned1304];NKD1[unassigned1304];ZNHIT1[unassigned1304];LCE3B[unassigned1304];MOBP[unassigned1304];KRTAP5-11[unassigned1304];ZNF669[unassigned1304];KRTAP4-4[unassigned1304];KRTAP4-2[unassigned1304];ZNF302[unassigned1304];ZNF543[unassigned1304];ZIM2[unassigned1304];STRA6[unassigned1304];NPDC1[unassigned1304];ZNF221[unassigned1304];ZNF264[unassigned1304];KRTAP10-5[unassigned1304];NAA10[unassigned1304];KRTAP4-5[unassigned1304];CLK4[unassigned1304];VASN[unassigned1304];LCE3E[unassigned1304];CLK1[unassigned1304];WT1[unassigned1304];LCE4A[unassigned1304];ZNF418[unassigned1304];NMU[unassigned1304];PIN1[unassigned1304];NAXD[unassigned1304];ZNF138[unassigned1304];ZNF776[unassigned1304];NOL12[unassigned1304];ZNF774[unassigned1304];ZNF696[unassigned1304];	46011751
49025	chr21	46021179	A	A	chr21:46021179	KRTAP10-7	keratin associated protein 10-7	SNV	1/1	0.99	0_160	161	99.0	1/1	0.99	1_100	101	99.0			rs363877,COSV59109234	EXONIC	YES	NM_198689.3	Transcript	protein_coding	synonymous_variant		1/1	NM_198689.3:c.643C>A	NP_941962.1:p.Lys215%3D		1.0						.	.	.						0	0.0											100	1.0							0.0000064,0.0000064,0.0000064,0.7339490,0.0000193,0.0000386,0.0000064	1,1,1,114132,3,6,1	0.603	1869.0				16.87	1.603439		0	0	0			KRTAP10-7	0.0	0.01	0.0	0.0	-37.0	33.0	50.0	35.0							0.01				.			.	.	keratinization	cytosol;keratin filament	protein binding;identical protein binding	MAPKBP1[25416956;unassigned1304];CHIC2[25416956];ZNF175[25416956];SLC23A1[25416956];AQP1[25416956];NUBP2[25416956];UXT[25416956];LCE1A[unassigned1304];LCE1B[25416956;unassigned1304];ZFYVE26[25416956;unassigned1304];RPL36AL[25416956];DHX57[25416956;unassigned1304];ZNF846[25416956];SPATA24[unassigned1304];ZNF844[unassigned1304];HOXA1[unassigned1304];SMCO4[25416956];PTGDS[25416956];ZNF169[25416956];TNS2[25416956];TMEM8A[25416956];GABARAPL2[25416956;unassigned1304];ZNF165[25416956];PRKAB2[25416956;unassigned1304];GABARAPL1[25416956];HPCAL1[25416956];LCE1F[unassigned1304];THAP1[25416956];LCE1D[unassigned1304];LCE2B[unassigned1304];LCE2C[unassigned1304];THAP6[25416956];CARHSP1[25416956];LCE2A[25416956];ZNF837[unassigned1304];ZSCAN21[unassigned1304];TYRO3[25416956];COL8A1[25416956];ZSCAN26[25416956;unassigned1304];FAM76B[25416956];PRR13[25416956];GNE[25416956;unassigned1304];ZNF155[25416956];IGSF8[25416956;unassigned1304];RWDD2B[25416956];ZNF20[25416956];SLC6A20[25416956];ZNF26[25416956];GUCD1[25416956];FAM124B[25416956];ZNHIT1[25416956];ZNF707[25416956];PTPMT1[25416956;unassigned1304];INPP5D[25416956];TTPA[unassigned1304];NPBWR2[25416956];KRTAP5-11[unassigned1304];ZSCAN10[unassigned1304];HOXC8[unassigned1304];ZNF266[25416956];VTI1B[25416956];SMCP[25416956;unassigned1304];ZNF264[unassigned1304];ZNF260[unassigned1304];TREX1[25416956;25910212];ZNF32[25416956];WDYHV1[25416956];NOTCH2NLA[25416956];TYMSOS[unassigned1304];VASN[unassigned1304];C19orf57[25416956];ZBTB9[25416956;unassigned1304];RPS28[25416956];ZNF138[unassigned1304];NOL12[25416956];CTRC[25416956];ZNF256[unassigned1304];PRR35[unassigned1304];ZNF133[25416956];ZNF250[25416956];ZNF491[unassigned1304];SUV39H1[25416956;unassigned1304];ZNF490[25416956;unassigned1304];KRTAP26-1[unassigned1304];KRT20[25416956];PCSK5[25416956];FARS2[25416956;unassigned1304];ING5[25416956];CATIP[25416956];LCE5A[unassigned1304];ZNF41[25416956];RSPO2[25416956;unassigned1304];LINC00612[unassigned1304];ZNF124[25416956];HBZ[25416956];KRTAP9-3[unassigned1304];HSBP1[25416956];KRTAP9-2[25416956;unassigned1304];AEN[25416956];AES[25416956;unassigned1304];KRTAP9-8[unassigned1304];HCK[unassigned1304];SCNM1[25416956];RPUSD3[25416956];PPARD[25416956];AVPI1[25416956];VGLL3[unassigned1304];GRN[25416956];GSTP1[25416956;unassigned1304];RPL11[25416956];PTGER3[25416956];CRCT1[25416956;unassigned1304];DERL2[25416956];ZNF2[25416956];NKD1[unassigned1304];LCE3C[unassigned1304];LCE3D[unassigned1304];LCE3A[unassigned1304];LCE3B[unassigned1304];CHRNG[25416956;25910212];LMNA[25416956];UCP2[25416956];ANKRD36BP1[25416956];ZNF587[25416956;unassigned1304];ZNF223[25416956];ZIM2[unassigned1304];ZNF101[25416956;unassigned1304];NPDC1[25416956;unassigned1304];ZNF581[25416956;unassigned1304];ZNF580[unassigned1304];MCRS1[unassigned1304];STAT3[25814554];DMRT3[25416956];RYDEN[25416956;unassigned1304];LCE3E[25416956;unassigned1304];BYSL[25416956];LCE4A[25416956;unassigned1304];WT1[unassigned1304];CCNG1[25416956];TCEA2[25416956];ZNF337[25416956];ZNF578[25416956;unassigned1304];ZNF697[25416956];LIMS2[25416956];ZNF575[unassigned1304];ZNF696[unassigned1304];ZNF572[25416956];ZBTB24[25416956];KLHL38[25416956;unassigned1304];PVR[25416956];SLC25A48[25416956];CYSRT1[unassigned1304];FADS6[unassigned1304];STK16[25416956];ZNF329[25416956];ZNF444[unassigned1304];PHLDA1[unassigned1304];ZNF564[25416956;unassigned1304];ZNF320[25416956];ZNF440[unassigned1304];PRM2[25416956;unassigned1304];LMO2[25416956];CTNNBIP1[25416956];GEM[25416956;unassigned1304];PDIA5[25416956];FAM161A[25416956];ZFP41[unassigned1304];ZNF439[25416956];ZNF555[25416956];ZNF433[25416956];CSNK1G2[25416956];PDE9A[unassigned1304];CSNK1G1[25416956];ZNF792[25416956];TEDC2[25416956];ZNF670[25416956];CCDC26[25416956];CHRD[25416956;unassigned1304];SPATA8[25416956];RPF1[25416956];SDCBP[25416956];MOBP[25416956;unassigned1304];ALDH3B1[25416956];E4F1[25416956];ZNF425[25416956];KRTAP4-2[25416956];ZNF667[unassigned1304];OTX1[unassigned1304];RNF175[25416956];ZNF786[unassigned1304];ZNF543[25416956];ZNF542[unassigned1304];TXNDC5[25416956;unassigned1304];AP1M1[25416956;unassigned1304];ZNF420[unassigned1304];KRTAP12-1[25416956;unassigned1304];KRTAP12-3[unassigned1304];TOR1A[25416956;25910212];MYPOP[unassigned1304];TFAP2D[unassigned1304];CBX2[25416956];TCEANC[25416956];KRTAP4-5[unassigned1304];C8orf33[25416956];BMP7[25416956];CLK4[25416956;unassigned1304];CLK1[25416956;unassigned1304];MRGBP[25416956;unassigned1304];ZNF419[25416956];ZNF418[25416956];ZNF417[25416956;unassigned1304];PIN1[25416956;unassigned1304];ZNF778[25416956];ZNF414[unassigned1304];LRCH4[25416956];ZNF774[unassigned1304];MXD3[25416956];GLP1R[25416956];ITGB5[unassigned1304];ITGB4[unassigned1304];CDCA7L[25416956];HHEX[25416956];FAM74A4[25416956];ZNF408[unassigned1304];IQUB[25416956];KRTAP5-2[unassigned1304];POLL[25416956];ZNF524[unassigned1304];ZNF764[unassigned1304];KRTAP5-9[25416956];KRTAP5-6[25416956;unassigned1304];BUD31[25416956;unassigned1304];RTN4RL1[25416956];EHHADH[25416956];FAM27E3[25416956];CRY2[unassigned1304];MCM5[25416956];DOCK2[unassigned1304];B4GALT7[25416956];SSX2IP[25416956];CREB5[25416956];SPACA9[25416956];LINC00242[25416956];NUFIP2[25416956;unassigned1304];ZBTB48[unassigned1304];TULP3[25416956];SPG7[25416956];TMA16[25416956];KRT83[25416956];P2RY6[25416956];WNT11[25416956];BAHD1[25416956];PCED1A[25416956];MXI1[25416956];ZNF625[25416956];TRIM42[25416956];CCDC185[25416956];PDLIM5[25416956];E2F6[25416956];CNNM3[unassigned1304];HSD3B7[25416956];KRTAP10-5[25416956];NAA10[25416956];KRTAP10-7[25416956];KRTAP10-9[25416956;unassigned1304];KRTAP10-8[25416956;unassigned1304];ZNF180[25416956];GOLGA8DP[25416956];PFKL[25416956];BCL6B[25416956];SPRY1[25416956;unassigned1304];TNP2[25416956];NAXD[25416956;unassigned1304];NECTIN3[25416956];NECTIN2[25416956];R3HDM2[unassigned1304];	46021179
49029	chr21	46021205	T	T	chr21:46021205	KRTAP10-7	keratin associated protein 10-7	SNV	1/1	0.96	2_168	175	99.0	1/1	1.0	0_108	108	99.0			rs1569213000,rs389167,COSV59111661	EXONIC	YES	NM_198689.3	Transcript	protein_coding	synonymous_variant		1/1	NM_198689.3:c.669C>T	NP_941962.1:p.Pro223%3D		1.0						.	.	.						0	0.0											100	1.0							0.0000064,0.0000064,0.0000064,0.7734013,0.0000064,0.0000129,0.0000064	1,1,1,120267,1,2,1	0.209	654.0				12.87	0.921349		0	0	0			KRTAP10-7	0.11	0.0	0.0	0.0	7.0	-35.0	9.0	46.0							0.01				.			.	.	keratinization	cytosol;keratin filament	protein binding;identical protein binding	MAPKBP1[25416956;unassigned1304];CHIC2[25416956];ZNF175[25416956];SLC23A1[25416956];AQP1[25416956];NUBP2[25416956];UXT[25416956];LCE1A[unassigned1304];LCE1B[25416956;unassigned1304];ZFYVE26[25416956;unassigned1304];RPL36AL[25416956];DHX57[25416956;unassigned1304];ZNF846[25416956];SPATA24[unassigned1304];ZNF844[unassigned1304];HOXA1[unassigned1304];SMCO4[25416956];PTGDS[25416956];ZNF169[25416956];TNS2[25416956];TMEM8A[25416956];GABARAPL2[25416956;unassigned1304];ZNF165[25416956];PRKAB2[25416956;unassigned1304];GABARAPL1[25416956];HPCAL1[25416956];LCE1F[unassigned1304];THAP1[25416956];LCE1D[unassigned1304];LCE2B[unassigned1304];LCE2C[unassigned1304];THAP6[25416956];CARHSP1[25416956];LCE2A[25416956];ZNF837[unassigned1304];ZSCAN21[unassigned1304];TYRO3[25416956];COL8A1[25416956];ZSCAN26[25416956;unassigned1304];FAM76B[25416956];PRR13[25416956];GNE[25416956;unassigned1304];ZNF155[25416956];IGSF8[25416956;unassigned1304];RWDD2B[25416956];ZNF20[25416956];SLC6A20[25416956];ZNF26[25416956];GUCD1[25416956];FAM124B[25416956];ZNHIT1[25416956];ZNF707[25416956];PTPMT1[25416956;unassigned1304];INPP5D[25416956];TTPA[unassigned1304];NPBWR2[25416956];KRTAP5-11[unassigned1304];ZSCAN10[unassigned1304];HOXC8[unassigned1304];ZNF266[25416956];VTI1B[25416956];SMCP[25416956;unassigned1304];ZNF264[unassigned1304];ZNF260[unassigned1304];TREX1[25416956;25910212];ZNF32[25416956];WDYHV1[25416956];NOTCH2NLA[25416956];TYMSOS[unassigned1304];VASN[unassigned1304];C19orf57[25416956];ZBTB9[25416956;unassigned1304];RPS28[25416956];ZNF138[unassigned1304];NOL12[25416956];CTRC[25416956];ZNF256[unassigned1304];PRR35[unassigned1304];ZNF133[25416956];ZNF250[25416956];ZNF491[unassigned1304];SUV39H1[25416956;unassigned1304];ZNF490[25416956;unassigned1304];KRTAP26-1[unassigned1304];KRT20[25416956];PCSK5[25416956];FARS2[25416956;unassigned1304];ING5[25416956];CATIP[25416956];LCE5A[unassigned1304];ZNF41[25416956];RSPO2[25416956;unassigned1304];LINC00612[unassigned1304];ZNF124[25416956];HBZ[25416956];KRTAP9-3[unassigned1304];HSBP1[25416956];KRTAP9-2[25416956;unassigned1304];AEN[25416956];AES[25416956;unassigned1304];KRTAP9-8[unassigned1304];HCK[unassigned1304];SCNM1[25416956];RPUSD3[25416956];PPARD[25416956];AVPI1[25416956];VGLL3[unassigned1304];GRN[25416956];GSTP1[25416956;unassigned1304];RPL11[25416956];PTGER3[25416956];CRCT1[25416956;unassigned1304];DERL2[25416956];ZNF2[25416956];NKD1[unassigned1304];LCE3C[unassigned1304];LCE3D[unassigned1304];LCE3A[unassigned1304];LCE3B[unassigned1304];CHRNG[25416956;25910212];LMNA[25416956];UCP2[25416956];ANKRD36BP1[25416956];ZNF587[25416956;unassigned1304];ZNF223[25416956];ZIM2[unassigned1304];ZNF101[25416956;unassigned1304];NPDC1[25416956;unassigned1304];ZNF581[25416956;unassigned1304];ZNF580[unassigned1304];MCRS1[unassigned1304];STAT3[25814554];DMRT3[25416956];RYDEN[25416956;unassigned1304];LCE3E[25416956;unassigned1304];BYSL[25416956];LCE4A[25416956;unassigned1304];WT1[unassigned1304];CCNG1[25416956];TCEA2[25416956];ZNF337[25416956];ZNF578[25416956;unassigned1304];ZNF697[25416956];LIMS2[25416956];ZNF575[unassigned1304];ZNF696[unassigned1304];ZNF572[25416956];ZBTB24[25416956];KLHL38[25416956;unassigned1304];PVR[25416956];SLC25A48[25416956];CYSRT1[unassigned1304];FADS6[unassigned1304];STK16[25416956];ZNF329[25416956];ZNF444[unassigned1304];PHLDA1[unassigned1304];ZNF564[25416956;unassigned1304];ZNF320[25416956];ZNF440[unassigned1304];PRM2[25416956;unassigned1304];LMO2[25416956];CTNNBIP1[25416956];GEM[25416956;unassigned1304];PDIA5[25416956];FAM161A[25416956];ZFP41[unassigned1304];ZNF439[25416956];ZNF555[25416956];ZNF433[25416956];CSNK1G2[25416956];PDE9A[unassigned1304];CSNK1G1[25416956];ZNF792[25416956];TEDC2[25416956];ZNF670[25416956];CCDC26[25416956];CHRD[25416956;unassigned1304];SPATA8[25416956];RPF1[25416956];SDCBP[25416956];MOBP[25416956;unassigned1304];ALDH3B1[25416956];E4F1[25416956];ZNF425[25416956];KRTAP4-2[25416956];ZNF667[unassigned1304];OTX1[unassigned1304];RNF175[25416956];ZNF786[unassigned1304];ZNF543[25416956];ZNF542[unassigned1304];TXNDC5[25416956;unassigned1304];AP1M1[25416956;unassigned1304];ZNF420[unassigned1304];KRTAP12-1[25416956;unassigned1304];KRTAP12-3[unassigned1304];TOR1A[25416956;25910212];MYPOP[unassigned1304];TFAP2D[unassigned1304];CBX2[25416956];TCEANC[25416956];KRTAP4-5[unassigned1304];C8orf33[25416956];BMP7[25416956];CLK4[25416956;unassigned1304];CLK1[25416956;unassigned1304];MRGBP[25416956;unassigned1304];ZNF419[25416956];ZNF418[25416956];ZNF417[25416956;unassigned1304];PIN1[25416956;unassigned1304];ZNF778[25416956];ZNF414[unassigned1304];LRCH4[25416956];ZNF774[unassigned1304];MXD3[25416956];GLP1R[25416956];ITGB5[unassigned1304];ITGB4[unassigned1304];CDCA7L[25416956];HHEX[25416956];FAM74A4[25416956];ZNF408[unassigned1304];IQUB[25416956];KRTAP5-2[unassigned1304];POLL[25416956];ZNF524[unassigned1304];ZNF764[unassigned1304];KRTAP5-9[25416956];KRTAP5-6[25416956;unassigned1304];BUD31[25416956;unassigned1304];RTN4RL1[25416956];EHHADH[25416956];FAM27E3[25416956];CRY2[unassigned1304];MCM5[25416956];DOCK2[unassigned1304];B4GALT7[25416956];SSX2IP[25416956];CREB5[25416956];SPACA9[25416956];LINC00242[25416956];NUFIP2[25416956;unassigned1304];ZBTB48[unassigned1304];TULP3[25416956];SPG7[25416956];TMA16[25416956];KRT83[25416956];P2RY6[25416956];WNT11[25416956];BAHD1[25416956];PCED1A[25416956];MXI1[25416956];ZNF625[25416956];TRIM42[25416956];CCDC185[25416956];PDLIM5[25416956];E2F6[25416956];CNNM3[unassigned1304];HSD3B7[25416956];KRTAP10-5[25416956];NAA10[25416956];KRTAP10-7[25416956];KRTAP10-9[25416956;unassigned1304];KRTAP10-8[25416956;unassigned1304];ZNF180[25416956];GOLGA8DP[25416956];PFKL[25416956];BCL6B[25416956];SPRY1[25416956;unassigned1304];TNP2[25416956];NAXD[25416956;unassigned1304];NECTIN3[25416956];NECTIN2[25416956];R3HDM2[unassigned1304];	46021205
49032	chr21	46032674	T	C	chr21:46032674	KRTAP10-8	keratin associated protein 10-8	SNV	0/0	0.0	43_0	43	99.0	0|1	0.43	73_55	129	99.0			rs782009803	EXONIC	YES	NM_198695.2	Transcript	protein_coding	synonymous_variant		1/1	NM_198695.2:c.657T>C	NP_941968.2:p.Pro219%3D		1.0						.	.	.		1.32149e-05	2.0	151344.0	0.0	32	0.97	PASS	nfe	2.95107e-05	2.0	2.95107e-05	2.0	3.1837e-05	8.0	251280.0	0.0	100	1.0	PASS	sas	9.79944e-05	3.0	8.80297e-06	1.0	0.0000129	2						0.25	-0.355001		0	0	0			KRTAP10-8	0.0	0.0	0.0	0.01	-12.0	-45.0	-12.0	9.0						0.643	0.0				.			.	.	keratinization	cytosol;keratin filament	protein binding;identical protein binding	MAPKBP1[25416956;unassigned1304];CHIC2[25416956;unassigned1304];SLC23A1[25416956;unassigned1304];FZD10[unassigned1304];ZDHHC1[unassigned1304];LOC151121[unassigned1304];HS6ST1[unassigned1304];C19orf25[unassigned1304];AQP1[unassigned1304];ICAM1[unassigned1304];UXT[25416956;unassigned1304];FAM110A[unassigned1304];LCE1A[unassigned1304];LCE1B[25416956;unassigned1304];C2orf68[unassigned1304];DHX57[25416956;unassigned1304];SPATA24[unassigned1304];HOXA1[25416956;unassigned1304];LOC401296[unassigned1304];ANKS1A[unassigned1304];TNS2[25416956];TMEM8A[unassigned1304];ZNF165[unassigned1304];PRKAB2[25416956;unassigned1304];KRTAP17-1[unassigned1304];HPCAL1[25416956;unassigned1304];ZFYVE21[25416956];C22orf39[unassigned1304];LCE1E[unassigned1304];FRS3[unassigned1304];LCE1F[unassigned1304];LCE1C[unassigned1304];LCE1D[unassigned1304];LCE2B[unassigned1304];LCE2C[unassigned1304];CARHSP1[25416956;unassigned1304];LCE2A[25416956;unassigned1304];HOXB9[unassigned1304];KRTAP4-12[25416956;unassigned1304];THAP7[25416956;unassigned1304];PRR19[unassigned1304];ZNF837[unassigned1304];KRTAP4-11[25416956;unassigned1304];ZSCAN21[25416956;unassigned1304];TYRO3[25416956];COL8A1[25416956;unassigned1304];FAM76B[25416956;unassigned1304];PRR13[25416956;unassigned1304];GNE[25416956;unassigned1304];RHNO1[unassigned1304];HOXB5[unassigned1304];KPRP[unassigned1304];IGSF8[25416956;unassigned1304];BEX2[25416956;unassigned1304];KRTAP10-10[unassigned1304];KRTAP10-11[unassigned1304];C10orf62[unassigned1304];ZNF20[25416956];TAPBPL[unassigned1304];ZNF23[unassigned1304];SLC6A20[25416956;unassigned1304];KLK8[unassigned1304];C3[unassigned1304];FAM221B[unassigned1304];GUCD1[unassigned1304];PTPMT1[25416956;unassigned1304];KRTAP5-11[unassigned1304];VPS11[25416956;unassigned1304];TSPAN4[unassigned1304];ZSCAN12[unassigned1304];RALGDS[unassigned1304];HOXC8[unassigned1304];RHBDL1[unassigned1304];ZNF266[unassigned1304];SMCP[25416956;unassigned1304];ZNF264[unassigned1304];ZFAB[25416956;unassigned1304];ZNF32[25416956];AMMECR1[26871637];NR1D2[unassigned1304];NOTCH2NLA[25416956;unassigned1304];HSPA12B[unassigned1304];TYMSOS[25416956;unassigned1304];THAP10[25416956];VASN[unassigned1304];C19orf57[unassigned1304];RPS28[25416956];PTK7[unassigned1304];CYP2S1[unassigned1304];INTS5[unassigned1304];ZNF138[25416956;unassigned1304];CTRC[unassigned1304];RGL2[unassigned1304];CCNJL[25416956];ZNF497[unassigned1304];PIGS[25416956];ACY3[25416956];ZNF250[unassigned1304];ZNF491[unassigned1304];SUV39H1[unassigned1304];ZNF490[unassigned1304];WT1-AS[25416956;unassigned1304];QPRT[unassigned1304];SMG9[unassigned1304];KRT20[25416956;unassigned1304];MEOX2[25416956;unassigned1304];PTPRH[25416956];PCSK5[25416956;unassigned1304];AREG[unassigned1304];FARS2[unassigned1304];UBL5[unassigned1304];JPH3[unassigned1304];LCE5A[unassigned1304];ADAMTSL4[25416956;unassigned1304];ADAMTSL3[25416956;unassigned1304];LINC00612[unassigned1304];C17orf50[unassigned1304];FEZF1[unassigned1304];ZNF124[25416956;unassigned1304];KRTAP1-1[unassigned1304];VENTX[unassigned1304];IL10[unassigned1304];ZNF121[unassigned1304];ApoL6[25416956];TMEM150A[25416956];KRTAP9-4[25416956];KRTAP9-3[unassigned1304];KRTAP9-2[25416956;unassigned1304];KRTAP15-1[unassigned1304];AEN[25416956];IL16[unassigned1304];PAX5[unassigned1304];JOSD1[25416956;unassigned1304];AES[25416956;unassigned1304];KRTAP9-8[unassigned1304];SLC22A23[25416956];C11orf87[25416956;unassigned1304];HCK[unassigned1304];SCNM1[25416956;unassigned1304];AEBP2[unassigned1304];PLSCR4[unassigned1304];MATN3[25416956];AVPI1[unassigned1304];VGLL3[unassigned1304];ZNF473[25416956;unassigned1304];GRN[unassigned1304];PTGER3[25416956];CRCT1[25416956;unassigned1304];DERL2[25416956];LCE2D[25416956;unassigned1304];NKD1[unassigned1304];GNAI2[25416956];LCE3C[25416956;unassigned1304];LCE3D[unassigned1304];LCE3A[unassigned1304];APOL6[unassigned1304];LCE3B[unassigned1304];CHRNG[25416956;unassigned1304;25910212];WIF1[25416956;unassigned1304];ZNF107[unassigned1304];SUSD6[25416956;unassigned1304];ZNF587[25416956;unassigned1304];ZNF101[unassigned1304];NPDC1[unassigned1304];FOXB1[25416956];ZNF581[unassigned1304];ZNF580[unassigned1304];YIPF3[25416956];SUSD2[unassigned1304];DMRT3[25416956;unassigned1304];RYDEN[25416956;unassigned1304];FAH[25416956];DHRS1[25416956;unassigned1304];ZNF79[unassigned1304];LYVE1[25416956];ATP5F1D[unassigned1304];LCE3E[25416956;unassigned1304];POU4F2[unassigned1304];WT1[25416956];LCE4A[25416956;unassigned1304];SMOC1[25416956];TCEA2[unassigned1304];VWC2[unassigned1304];PRPF31[25416956;unassigned1304;25910212];ZNF578[25416956;unassigned1304];ZNF697[25416956];ZNF575[unassigned1304];ZNF696[unassigned1304];GPHB5[unassigned1304];ZNF572[25416956;unassigned1304];ZNF330[unassigned1304];RAB3A[unassigned1304];CSF1[unassigned1304];ZBTB25[unassigned1304];ZBTB24[25416956;unassigned1304];KLHL38[25416956;unassigned1304];NAB2[25416956];TMEM140[unassigned1304];PVR[25416956;unassigned1304];YY1[unassigned1304];EFEMP2[unassigned1304];CYSRT1[unassigned1304];FADS6[unassigned1304];STK16[25416956;unassigned1304];KRTAP3-2[unassigned1304];SLC25A42[unassigned1304];KRTAP3-1[unassigned1304];PHLDA1[unassigned1304];ZNF444[unassigned1304];SH3GLB2[unassigned1304];ZNF440[unassigned1304];CARD10[unassigned1304];FBXW5[25416956;unassigned1304];ATG9A[25416956;unassigned1304];ARID5A[unassigned1304];EPDR1[unassigned1304];MUL1[unassigned1304];GEM[unassigned1304];LENG1[unassigned1304];GPANK1[unassigned1304];CLUHP3[unassigned1304];FAM161A[unassigned1304];ZNF319[unassigned1304];ZNF439[25416956;unassigned1304];ADAM12[unassigned1304];ZNF559[unassigned1304];TBC1D23[25416956];PDE9A[25416956;unassigned1304];DDX6[25416956;unassigned1304];INO80B[unassigned1304];ZNF792[unassigned1304];RPS19BP1[unassigned1304];CCDC26[25416956;unassigned1304];UTP23[25416956;unassigned1304];COX17[unassigned1304];CHRD[25416956;unassigned1304];TACSTD2[unassigned1304];AK3[unassigned1304];SPATA3[unassigned1304];GLYAT[25416956];MOBP[26871637];ALDH3B1[25416956;unassigned1304];ZNF669[unassigned1304];KRTAP4-4[unassigned1304];KRTAP4-2[25416956;unassigned1304];OTX1[25416956;unassigned1304];IGFBP6[unassigned1304];LELP1[unassigned1304];FAM71C[unassigned1304];ZNF786[unassigned1304];IP6K3[unassigned1304];TXNDC5[25416956;unassigned1304];AP1M1[unassigned1304];ENKD1[unassigned1304];KRTAP12-1[25416956;unassigned1304];TCAF1[unassigned1304];KRTAP12-3[unassigned1304];KRTAP12-2[25416956];TGFB1[unassigned1304];MYPOP[unassigned1304];TFAP2D[unassigned1304];KRTAP4-7[25416956];NEK6[unassigned1304];TCEANC[unassigned1304];KRTAP4-5[unassigned1304];ASPSCR1[25416956];BMP7[25416956;unassigned1304];CLK4[25416956];FAM90A1[unassigned1304];LRFN4[unassigned1304];NR4A3[unassigned1304];ALPP[unassigned1304];ZNF417[25416956;unassigned1304];PIN1[unassigned1304];ALPI[25416956];ZNF414[unassigned1304];MELTF[unassigned1304];LRCH4[25416956];ZNF775[unassigned1304];GLP1R[25416956];TTC23[unassigned1304];ITGB5[25416956;unassigned1304];ITGB4[unassigned1304];LOC200261[25416956];ITGB2[unassigned1304];DDX43[unassigned1304];ECE1[unassigned1304];PKD2[25416956];HAPLN2[unassigned1304];HHEX[25416956;unassigned1304];LASP1[unassigned1304];FAM74A4[25416956;unassigned1304];ZNF408[unassigned1304];ADAMTS1[unassigned1304];ZIC1[unassigned1304];ZNF648[unassigned1304];VWC2L[unassigned1304];KRTAP5-3[unassigned1304];KRTAP5-2[unassigned1304];ZNF524[unassigned1304];SCARF1[unassigned1304];TNPO3[unassigned1304];KRTAP11-1[unassigned1304];KRTAP5-9[25416956;unassigned1304];POU1F1[unassigned1304];GLRX3[25416956;unassigned1304];H2AFY[unassigned1304];OLIG3[unassigned1304];KRTAP5-6[25416956;unassigned1304];DDX55[25416956];KRTAP5-4[unassigned1304];VEZF1[unassigned1304];AXIN2[unassigned1304];GFOD1[25416956];RTN4RL1[25416956];FAM27E3[25416956;unassigned1304];CRY2[unassigned1304];DCX[25416956];CRH[unassigned1304];SLC25A10[25416956];EIF4E2[25416956];DOCK2[25416956;unassigned1304];CREB5[25416956;unassigned1304];SPACA9[25416956];CATSPER1[25416956;unassigned1304];LUZP4[25416956];NUFIP2[25416956;unassigned1304];SEMA3B[unassigned1304];RNF38[unassigned1304];NTN4[unassigned1304];RNF8[unassigned1304];IL2RG[unassigned1304];FTHL17[unassigned1304];LAGE3[unassigned1304];LMF2[unassigned1304];HSPD1[25416956];KRT83[25416956];MLLT6[25416956];P2RY6[unassigned1304];MTA1[25416956];RASD1[unassigned1304];WNT11[unassigned1304];PCED1A[25416956];BAHD1[unassigned1304];MXI1[25416956;unassigned1304];ZNF625[unassigned1304];SLIT1[unassigned1304];TRIM42[unassigned1304];SLC13A5[unassigned1304];CNNM3[25416956;unassigned1304];OPCML[unassigned1304];SMARCE1[unassigned1304];HSD3B7[25416956;unassigned1304];KRTAP10-5[unassigned1304];SPAG8[unassigned1304];TRIM41[unassigned1304];KRTAP10-7[25416956;unassigned1304];HEL-S-90n[25416956];KRTAP10-9[25416956;unassigned1304];TIE1[unassigned1304];KRTAP10-8[25416956;unassigned1304];MEIS2[unassigned1304];P2RX7[25416956];GOLGA8DP[25416956;unassigned1304];TNIP3[25416956];BCL6B[unassigned1304];LNX1[unassigned1304];SPRY2[25416956];RAB19[unassigned1304];SPRY1[25416956;unassigned1304];TNP2[25416956;unassigned1304];NAXD[25416956;unassigned1304];SLC25A31[unassigned1304];NECTIN3[25416956;unassigned1304];RECK[unassigned1304];NECTIN2[unassigned1304];R3HDM2[25416956;unassigned1304];	46032674
49035	chr21	46032683	T	C	chr21:46032683	KRTAP10-8	keratin associated protein 10-8	SNV	0/0	0.0	43_0	43	99.0	0|1	0.42	70_52	123	99.0			rs1480784239	EXONIC	YES	NM_198695.2	Transcript	protein_coding	synonymous_variant		1/1	NM_198695.2:c.666T>C	NP_941968.2:p.Cys222%3D		1.0						.	.	.						32	0.97											100	1.0														0.135	-0.44201		0	0	0			KRTAP10-8	0.0	0.02	0.0	0.01	8.0	48.0	-42.0	0.0						0.643	0.0				.			.	.	keratinization	cytosol;keratin filament	protein binding;identical protein binding	MAPKBP1[25416956;unassigned1304];CHIC2[25416956;unassigned1304];SLC23A1[25416956;unassigned1304];FZD10[unassigned1304];ZDHHC1[unassigned1304];LOC151121[unassigned1304];HS6ST1[unassigned1304];C19orf25[unassigned1304];AQP1[unassigned1304];ICAM1[unassigned1304];UXT[25416956;unassigned1304];FAM110A[unassigned1304];LCE1A[unassigned1304];LCE1B[25416956;unassigned1304];C2orf68[unassigned1304];DHX57[25416956;unassigned1304];SPATA24[unassigned1304];HOXA1[25416956;unassigned1304];LOC401296[unassigned1304];ANKS1A[unassigned1304];TNS2[25416956];TMEM8A[unassigned1304];ZNF165[unassigned1304];PRKAB2[25416956;unassigned1304];KRTAP17-1[unassigned1304];HPCAL1[25416956;unassigned1304];ZFYVE21[25416956];C22orf39[unassigned1304];LCE1E[unassigned1304];FRS3[unassigned1304];LCE1F[unassigned1304];LCE1C[unassigned1304];LCE1D[unassigned1304];LCE2B[unassigned1304];LCE2C[unassigned1304];CARHSP1[25416956;unassigned1304];LCE2A[25416956;unassigned1304];HOXB9[unassigned1304];KRTAP4-12[25416956;unassigned1304];THAP7[25416956;unassigned1304];PRR19[unassigned1304];ZNF837[unassigned1304];KRTAP4-11[25416956;unassigned1304];ZSCAN21[25416956;unassigned1304];TYRO3[25416956];COL8A1[25416956;unassigned1304];FAM76B[25416956;unassigned1304];PRR13[25416956;unassigned1304];GNE[25416956;unassigned1304];RHNO1[unassigned1304];HOXB5[unassigned1304];KPRP[unassigned1304];IGSF8[25416956;unassigned1304];BEX2[25416956;unassigned1304];KRTAP10-10[unassigned1304];KRTAP10-11[unassigned1304];C10orf62[unassigned1304];ZNF20[25416956];TAPBPL[unassigned1304];ZNF23[unassigned1304];SLC6A20[25416956;unassigned1304];KLK8[unassigned1304];C3[unassigned1304];FAM221B[unassigned1304];GUCD1[unassigned1304];PTPMT1[25416956;unassigned1304];KRTAP5-11[unassigned1304];VPS11[25416956;unassigned1304];TSPAN4[unassigned1304];ZSCAN12[unassigned1304];RALGDS[unassigned1304];HOXC8[unassigned1304];RHBDL1[unassigned1304];ZNF266[unassigned1304];SMCP[25416956;unassigned1304];ZNF264[unassigned1304];ZFAB[25416956;unassigned1304];ZNF32[25416956];AMMECR1[26871637];NR1D2[unassigned1304];NOTCH2NLA[25416956;unassigned1304];HSPA12B[unassigned1304];TYMSOS[25416956;unassigned1304];THAP10[25416956];VASN[unassigned1304];C19orf57[unassigned1304];RPS28[25416956];PTK7[unassigned1304];CYP2S1[unassigned1304];INTS5[unassigned1304];ZNF138[25416956;unassigned1304];CTRC[unassigned1304];RGL2[unassigned1304];CCNJL[25416956];ZNF497[unassigned1304];PIGS[25416956];ACY3[25416956];ZNF250[unassigned1304];ZNF491[unassigned1304];SUV39H1[unassigned1304];ZNF490[unassigned1304];WT1-AS[25416956;unassigned1304];QPRT[unassigned1304];SMG9[unassigned1304];KRT20[25416956;unassigned1304];MEOX2[25416956;unassigned1304];PTPRH[25416956];PCSK5[25416956;unassigned1304];AREG[unassigned1304];FARS2[unassigned1304];UBL5[unassigned1304];JPH3[unassigned1304];LCE5A[unassigned1304];ADAMTSL4[25416956;unassigned1304];ADAMTSL3[25416956;unassigned1304];LINC00612[unassigned1304];C17orf50[unassigned1304];FEZF1[unassigned1304];ZNF124[25416956;unassigned1304];KRTAP1-1[unassigned1304];VENTX[unassigned1304];IL10[unassigned1304];ZNF121[unassigned1304];ApoL6[25416956];TMEM150A[25416956];KRTAP9-4[25416956];KRTAP9-3[unassigned1304];KRTAP9-2[25416956;unassigned1304];KRTAP15-1[unassigned1304];AEN[25416956];IL16[unassigned1304];PAX5[unassigned1304];JOSD1[25416956;unassigned1304];AES[25416956;unassigned1304];KRTAP9-8[unassigned1304];SLC22A23[25416956];C11orf87[25416956;unassigned1304];HCK[unassigned1304];SCNM1[25416956;unassigned1304];AEBP2[unassigned1304];PLSCR4[unassigned1304];MATN3[25416956];AVPI1[unassigned1304];VGLL3[unassigned1304];ZNF473[25416956;unassigned1304];GRN[unassigned1304];PTGER3[25416956];CRCT1[25416956;unassigned1304];DERL2[25416956];LCE2D[25416956;unassigned1304];NKD1[unassigned1304];GNAI2[25416956];LCE3C[25416956;unassigned1304];LCE3D[unassigned1304];LCE3A[unassigned1304];APOL6[unassigned1304];LCE3B[unassigned1304];CHRNG[25416956;unassigned1304;25910212];WIF1[25416956;unassigned1304];ZNF107[unassigned1304];SUSD6[25416956;unassigned1304];ZNF587[25416956;unassigned1304];ZNF101[unassigned1304];NPDC1[unassigned1304];FOXB1[25416956];ZNF581[unassigned1304];ZNF580[unassigned1304];YIPF3[25416956];SUSD2[unassigned1304];DMRT3[25416956;unassigned1304];RYDEN[25416956;unassigned1304];FAH[25416956];DHRS1[25416956;unassigned1304];ZNF79[unassigned1304];LYVE1[25416956];ATP5F1D[unassigned1304];LCE3E[25416956;unassigned1304];POU4F2[unassigned1304];WT1[25416956];LCE4A[25416956;unassigned1304];SMOC1[25416956];TCEA2[unassigned1304];VWC2[unassigned1304];PRPF31[25416956;unassigned1304;25910212];ZNF578[25416956;unassigned1304];ZNF697[25416956];ZNF575[unassigned1304];ZNF696[unassigned1304];GPHB5[unassigned1304];ZNF572[25416956;unassigned1304];ZNF330[unassigned1304];RAB3A[unassigned1304];CSF1[unassigned1304];ZBTB25[unassigned1304];ZBTB24[25416956;unassigned1304];KLHL38[25416956;unassigned1304];NAB2[25416956];TMEM140[unassigned1304];PVR[25416956;unassigned1304];YY1[unassigned1304];EFEMP2[unassigned1304];CYSRT1[unassigned1304];FADS6[unassigned1304];STK16[25416956;unassigned1304];KRTAP3-2[unassigned1304];SLC25A42[unassigned1304];KRTAP3-1[unassigned1304];PHLDA1[unassigned1304];ZNF444[unassigned1304];SH3GLB2[unassigned1304];ZNF440[unassigned1304];CARD10[unassigned1304];FBXW5[25416956;unassigned1304];ATG9A[25416956;unassigned1304];ARID5A[unassigned1304];EPDR1[unassigned1304];MUL1[unassigned1304];GEM[unassigned1304];LENG1[unassigned1304];GPANK1[unassigned1304];CLUHP3[unassigned1304];FAM161A[unassigned1304];ZNF319[unassigned1304];ZNF439[25416956;unassigned1304];ADAM12[unassigned1304];ZNF559[unassigned1304];TBC1D23[25416956];PDE9A[25416956;unassigned1304];DDX6[25416956;unassigned1304];INO80B[unassigned1304];ZNF792[unassigned1304];RPS19BP1[unassigned1304];CCDC26[25416956;unassigned1304];UTP23[25416956;unassigned1304];COX17[unassigned1304];CHRD[25416956;unassigned1304];TACSTD2[unassigned1304];AK3[unassigned1304];SPATA3[unassigned1304];GLYAT[25416956];MOBP[26871637];ALDH3B1[25416956;unassigned1304];ZNF669[unassigned1304];KRTAP4-4[unassigned1304];KRTAP4-2[25416956;unassigned1304];OTX1[25416956;unassigned1304];IGFBP6[unassigned1304];LELP1[unassigned1304];FAM71C[unassigned1304];ZNF786[unassigned1304];IP6K3[unassigned1304];TXNDC5[25416956;unassigned1304];AP1M1[unassigned1304];ENKD1[unassigned1304];KRTAP12-1[25416956;unassigned1304];TCAF1[unassigned1304];KRTAP12-3[unassigned1304];KRTAP12-2[25416956];TGFB1[unassigned1304];MYPOP[unassigned1304];TFAP2D[unassigned1304];KRTAP4-7[25416956];NEK6[unassigned1304];TCEANC[unassigned1304];KRTAP4-5[unassigned1304];ASPSCR1[25416956];BMP7[25416956;unassigned1304];CLK4[25416956];FAM90A1[unassigned1304];LRFN4[unassigned1304];NR4A3[unassigned1304];ALPP[unassigned1304];ZNF417[25416956;unassigned1304];PIN1[unassigned1304];ALPI[25416956];ZNF414[unassigned1304];MELTF[unassigned1304];LRCH4[25416956];ZNF775[unassigned1304];GLP1R[25416956];TTC23[unassigned1304];ITGB5[25416956;unassigned1304];ITGB4[unassigned1304];LOC200261[25416956];ITGB2[unassigned1304];DDX43[unassigned1304];ECE1[unassigned1304];PKD2[25416956];HAPLN2[unassigned1304];HHEX[25416956;unassigned1304];LASP1[unassigned1304];FAM74A4[25416956;unassigned1304];ZNF408[unassigned1304];ADAMTS1[unassigned1304];ZIC1[unassigned1304];ZNF648[unassigned1304];VWC2L[unassigned1304];KRTAP5-3[unassigned1304];KRTAP5-2[unassigned1304];ZNF524[unassigned1304];SCARF1[unassigned1304];TNPO3[unassigned1304];KRTAP11-1[unassigned1304];KRTAP5-9[25416956;unassigned1304];POU1F1[unassigned1304];GLRX3[25416956;unassigned1304];H2AFY[unassigned1304];OLIG3[unassigned1304];KRTAP5-6[25416956;unassigned1304];DDX55[25416956];KRTAP5-4[unassigned1304];VEZF1[unassigned1304];AXIN2[unassigned1304];GFOD1[25416956];RTN4RL1[25416956];FAM27E3[25416956;unassigned1304];CRY2[unassigned1304];DCX[25416956];CRH[unassigned1304];SLC25A10[25416956];EIF4E2[25416956];DOCK2[25416956;unassigned1304];CREB5[25416956;unassigned1304];SPACA9[25416956];CATSPER1[25416956;unassigned1304];LUZP4[25416956];NUFIP2[25416956;unassigned1304];SEMA3B[unassigned1304];RNF38[unassigned1304];NTN4[unassigned1304];RNF8[unassigned1304];IL2RG[unassigned1304];FTHL17[unassigned1304];LAGE3[unassigned1304];LMF2[unassigned1304];HSPD1[25416956];KRT83[25416956];MLLT6[25416956];P2RY6[unassigned1304];MTA1[25416956];RASD1[unassigned1304];WNT11[unassigned1304];PCED1A[25416956];BAHD1[unassigned1304];MXI1[25416956;unassigned1304];ZNF625[unassigned1304];SLIT1[unassigned1304];TRIM42[unassigned1304];SLC13A5[unassigned1304];CNNM3[25416956;unassigned1304];OPCML[unassigned1304];SMARCE1[unassigned1304];HSD3B7[25416956;unassigned1304];KRTAP10-5[unassigned1304];SPAG8[unassigned1304];TRIM41[unassigned1304];KRTAP10-7[25416956;unassigned1304];HEL-S-90n[25416956];KRTAP10-9[25416956;unassigned1304];TIE1[unassigned1304];KRTAP10-8[25416956;unassigned1304];MEIS2[unassigned1304];P2RX7[25416956];GOLGA8DP[25416956;unassigned1304];TNIP3[25416956];BCL6B[unassigned1304];LNX1[unassigned1304];SPRY2[25416956];RAB19[unassigned1304];SPRY1[25416956;unassigned1304];TNP2[25416956;unassigned1304];NAXD[25416956;unassigned1304];SLC25A31[unassigned1304];NECTIN3[25416956;unassigned1304];RECK[unassigned1304];NECTIN2[unassigned1304];R3HDM2[25416956;unassigned1304];	46032683
49102	chr21	46876658	C	T	chr21:46876658	COL18A1	collagen type XVIII alpha 1 chain	SNV	0/1	0.56	57_74	132	99.0	0/0	0.0	45_0	45	99.0			rs549345311	EXONIC	YES	NM_130444.3	Transcript	protein_coding	missense_variant		1/41	NM_130444.3:c.1214C>T	NP_569711.2:p.Pro405Leu		1.0	Frizzled domain&Frizzled domain&Frizzled domain&Collagen alpha-1(XVIII) chain, frizzled domain				Knobloch syndrome, type 1, 267750 (3), Autosomal recessive; Glaucoma, primary closed-angle, 618880 (3), Autosomal dominant	Knobloch syndrome	Disease-causing germline mutation(s) in	Mental deterioration;Cerebellar atrophy;Autosomal recessive inheritance;Nystagmus;Cerebral atrophy;Macular hypoplasia;Visual loss;Occipital encephalocele;High myopia;Alopecia;Retinal detachment;Polymicrogyria;Band keratopathy;Vitreoretinopathy;Peripapillary atrophy;Phthisis bulbi;Developmental cataract;Ventriculomegaly;Seizure;Ataxia;Nystagmus;Epicanthus;Lymphangioma;Strabismus;Myopia;Cataract;Patent ductus arteriosus;Abnormal hair morphology;Macular degeneration;Ectopia lentis;Midface retrusion;Occipital encephalocele;Calvarial skull defect;Dextrocardia;Joint hyperflexibility;Seizure;Pyloric stenosis;Depressed nasal bridge;Vitreoretinopathy;Hydrocephalus;Progressive visual loss;Retinal detachment;Vesicoureteral reflux;Bifid ureter		0.00103811	158.0	152200.0	0.0	33	0.98	PASS	amr	0.00228908	35.0	0.00158777	108.0	0.000902048	119.0	131922.0	0.0	18	0.48	PASS	nfe	0.00147257	70.0	0.00147257	70.0	0.0001801	28	0.002	6.0	0.00381	32.0		7.221	0.300779	0.038	2	15	17	M-CAP_pred,MutationTaster_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	COL18A1	0.0	0.0	0.0	0.0	17.0	35.0	-17.0	-35.0						0.155	0.0	0.000000000	0.0	0.052	homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; vision/eye phenotype; cardiovascular system phenotype ; pigmentation phenotype; behavior/neurological phenotype ; renal/urinary system phenotype; skeleton phenotype; nervous system phenotype ; 			liver;trigeminal ganglion;	.	angiogenesis;endothelial cell morphogenesis;cell adhesion;visual perception;positive regulation of cell population proliferation;negative regulation of cell population proliferation;animal organ morphogenesis;extracellular matrix organization;positive regulation of cell migration;response to drug;response to hydrostatic pressure;positive regulation of endothelial cell apoptotic process	extracellular region;collagen trimer;basement membrane;extracellular space;endoplasmic reticulum lumen;extracellular matrix;collagen-containing extracellular matrix;extracellular exosome	extracellular matrix structural constituent;extracellular matrix structural constituent conferring tensile strength;metal ion binding	ITGB1[17615292];COL18A1[16269408;11956183];APP[19542224;28106549];MMP2[17615292];PYHIN1[25665578];TPM1[17615292];PCOLCE[24117177];HSCB[28380382];THBS1[19542224];AHI1[22623184];NCL[19877579;17615292];ITGA5[17615292];TECPR1[20562859];TGM2[19542224];	46876658
49168	chr21	47410727	C	T	chr21:47410727	COL6A1	collagen type VI alpha 1 chain	SNV	0/1	0.54	56_65	121	99.0	0/0	0.0	46_0	46	99.0			rs142882745,COSV62614769	EXONIC	YES	NM_001848.3	Transcript	protein_coding	missense_variant		14/35	NM_001848.3:c.1043C>T	NP_001839.2:p.Ser348Leu		1.0	.,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Bethlem_myopathy_1|Collagen_VI-related_myopathy|not_specified|not_provided	Bethlem myopathy 1, 158810 (3), Autosomal recessive, Autosomal dominant; Ullrich congenital muscular dystrophy 1, 254090 (3), Autosomal recessive, Autosomal dominant	Bethlem myopathy;Congenital muscular dystrophy, Ullrich type	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Multiple joint contractures;Neonatal hypotonia;Camptodactyly of finger;Progressive proximal muscle weakness;Torticollis;Proximal amyotrophy;EMG abnormality;Cachexia;Ankle flexion contracture;Follicular hyperkeratosis;Joint stiffness;Muscular dystrophy;Joint laxity;Scoliosis;Generalized hypotonia;Pes valgus;Hyperextensibility at wrists;Elevated serum creatine kinase;Generalized amyotrophy;Diaphragmatic weakness;Micrognathia;Increased endomysial connective tissue;Increased variability in muscle fiber diameter;Adducted thumb;Spinal rigidity;Knee flexion contracture;Increased laxity of fingers;Decreased fetal movement;Esotropia;Generalized muscle weakness;Frequent falls;Torticollis;Abnormal palate morphology;Hip dislocation;Kyphosis;Elbow flexion contracture;Short neck;Slender finger;EMG: myopathic abnormalities;Respiratory failure;Long toe;Autosomal recessive inheritance;Limb-girdle muscle weakness;Elbow flexion contracture;Variable expressivity;Decreased fetal movement;Ankle flexion contracture;Neonatal hypotonia;Respiratory insufficiency due to muscle weakness;Distal muscle weakness;Elevated serum creatine kinase;Slow progression;Autosomal dominant inheritance;Myopathy;Skeletal muscle atrophy;Motor delay;Camptodactyly of finger;Congenital muscular torticollis;Torticollis;Abnormality of the cardiovascular system;Proximal muscle weakness;Feeding difficulties in infancy;Autosomal dominant inheritance;Generalized amyotrophy;Torticollis;Flexion contracture;Hip dislocation;Follicular hyperkeratosis;Round face;Motor delay;Respiratory insufficiency due to muscle weakness;Kyphosis;Facial palsy;High palate;Increased laxity of fingers;Protruding ear;Proximal muscle weakness;Failure to thrive;Congenital muscular dystrophy;Increased laxity of ankles;Type 1 muscle fiber predominance;Hyperextensibility at wrists;Neonatal hypotonia;Talipes equinovarus;Recurrent lower respiratory tract infections;Variable expressivity;Increased variability in muscle fiber diameter;Spinal rigidity;Autosomal recessive inheritance;Scoliosis;Mildly elevated creatine kinase;Distal joint laxity;Hyperhidrosis;Infantile onset;Distal joint laxity;Nocturnal hypoventilation;Progressive;Muscle fiber necrosis;Slender build;Reduced muscle collagen VI		0.00063752	97.0	152152.0	0.0	33	0.97	PASS	nfe	0.00108792	74.0	0.00108792	74.0	0.000633501	159.0	250986.0	1.0	100	1.0	PASS	nfe	0.000996473	113.0	0.000996473	113.0	0.0006109	95	0.001	3.0	0.00044	5.0		23.9	3.13998	0.761	13	7	20	SIFT,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,Polyphen2_HDIV_pred,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,ClinPred_pred	COL6A1	0.05	0.01	0.0	0.06	50.0	-40.0	6.0	13.0						0.0443	1.0	0.000000000	0.592	0.935	muscle phenotype; 			ciliary ganglion;appendix;cingulate cortex;trigeminal ganglion;superior cervical ganglion;smooth muscle;adipose tissue;fetal lung;heart;pons;uterus;thyroid;subthalamic nucleus;atrioventricular node;placenta;globus pallidus;	Cell Communication;Focal adhesion;ECM-receptor interaction	osteoblast differentiation;growth plate cartilage chondrocyte morphogenesis;cell adhesion;extracellular matrix organization;endodermal cell differentiation;protein heterotrimerization;cellular response to amino acid stimulus	extracellular region;collagen type VI trimer;extracellular space;lysosomal membrane;endoplasmic reticulum lumen;membrane;extracellular matrix;protein-containing complex;sarcolemma;collagen-containing extracellular matrix;extracellular exosome	extracellular matrix structural constituent conferring tensile strength;platelet-derived growth factor binding	APP[28106549];COL5A1[20979576];LOX[30082873];DNAJB11[21900206];HSD17B4[30021884];KLF17[30021884];	47410727
49224	chr21	47664746	C	T	chr21:47664746	MCM3AP	minichromosome maintenance complex component 3 associated protein	SNV	0/1	0.36	58_32	90	99.0	0/0	0.0	45_0	45	99.0			rs17183255	EXONIC	YES	NM_003906.5	Transcript	protein_coding	synonymous_variant		23/28	NM_003906.5:c.5013G>A	NP_003897.2:p.Pro1671%3D		-1.0					Peripheral neuropathy, autosomal recessive, with or without impaired intellectual development, 618124 (3), Autosomal recessive	.	.	Delayed speech and language development;Strabismus;Scoliosis;Areflexia;Obesity;Premature ovarian insufficiency;Foot dorsiflexor weakness;Generalized hypotonia;Motor delay;Abnormality of the foot;Unsteady gait;Distal sensory impairment;Slow progression;Ophthalmoplegia;Autosomal recessive inheritance;Hyporeflexia;High, narrow palate;Short stature;Peripheral axonal neuropathy		0.00229285	349.0	152212.0	0.0	33	0.98	PASS	nfe	0.00365993	249.0	0.00365993	249.0	0.00249242	623.0	249958.0	2.0	43	0.97	PASS	nfe	0.00393135	443.0	0.00393135	443.0	0.0023601	367	0.005	15.0	0.0076	14.0		4.593	0.120061		0	0	0			MCM3AP	0.0	0.0	0.0	0.0	-17.0	5.0	24.0	-25.0						0.685	0.84	15.709032015			mortality/aging ; hematopoietic system phenotype; immune system phenotype; 			prefrontal cortex;dorsal root ganglion;whole brain;trigeminal ganglion;atrioventricular node;superior cervical ganglion;skeletal muscle;cerebellum peduncles;	.	immune system process;mRNA export from nucleus;protein transport;poly(A)+ mRNA export from nucleus;mRNA transport	nucleus;nuclear pore;nucleoplasm;cytoplasm;cytosol;nuclear membrane;transcription export complex 2	nucleic acid binding;transferase activity, transferring acyl groups	SUV39H2[21900206];ENY2[16169070];BLM[26496610];CLSTN1[12421765];CRMP1[16169070];NUDT5[16169070];CELSR3[unassigned5];CDC73[21900206];CDC42[20936779];KLC4[26496610];TAF1D[21900206];EP300[21988832];POLR2G[21988832];RAC1[20936779];PCID2[22343721];SMAD3[15231748];TSC22D1[21900206];SMAD9[15231748];CDC25A[21988832];FAM118B[21900206];SEM1[22343721];APC[20936779];TMEM216[16169070];KIFC3[26496610];MYH6[26496610];PLEC[30021884];	47664746
49338	chr22	17669265	C	T	chr22:17669265	CECR1		SNV	0/0	0.0	61_0	61	99.0	0/1	0.47	62_55	118	99.0			rs74317375	EXONIC	YES	NM_001282225.2	Transcript	protein_coding	missense_variant		7/10	NM_001282225.2:c.1045G>A	NP_001269154.1:p.Val349Ile		-1.0	Adenosine/AMP deaminase domain,Adenosine/AMP deaminase domain,Adenosine/AMP deaminase domain,.,Adenosine/AMP deaminase domain,Adenosine/AMP deaminase domain,Adenosine/AMP deaminase domain,Adenosine/AMP deaminase domain	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Behcet_disease|Polyarteritis_nodosa,_childhoood-onset|not_specified|not_provided						0.00222704	339.0	152220.0	1.0	34	0.97	PASS	nfe	0.00388018	264.0	0.00388018	264.0	0.0021089	530.0	251316.0	3.0	55	0.99	PASS	nfe	0.00347509	395.0	0.00347509	395.0	0.0021350	332	0.003	10.0				0.133	-0.444008	0.058	3	15	18	M-CAP_pred,MetaLR_pred,FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CECR1	0.0	0.0	0.0	0.0	-37.0	30.0	-37.0	-36.0						0.161	0.0	0.000000000	0.0	-0.534										17669265
49389	chr22	18652695	C	A	chr22:18652695	USP18	ubiquitin specific peptidase 18	SNV	0/0	0.0	35_0	35	99.0	0/1	0.44	37_29	66	99.0				EXONIC	YES	NM_017414.4	Transcript	protein_coding	missense_variant		7/11	NM_017414.4:c.712C>A	NP_059110.2:p.Arg238Ser		1.0	Peptidase C19, ubiquitin carboxyl-terminal hydrolase&Ubiquitin specific protease domain				Pseudo-TORCH syndrome 2, 617397 (3), Autosomal recessive	USP18 deficiency	Disease-causing germline mutation(s) (loss of function) in	Congenital onset;Autosomal recessive inheritance;Polymicrogyria;Elevated hepatic transaminase;Microcephaly;Cerebellar hypoplasia;Ventriculomegaly;Lactic acidosis;Bradycardia;Thrombocytopenia;Gray matter heterotopia;Lethargy;Generalized hypotonia;Cerebral hemorrhage;Cerebral calcification;Petechiae;Ascites;Seizure;Respiratory insufficiency;Patent ductus arteriosus;Hepatomegaly;Decreased liver function						30	0.91											54	0.63														8.841	0.442346	0.068	0	18	18		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	USP18	0.0	0.0	0.0	0.05	2.0	11.0	-36.0	11.0						0.519	0.39		0.003	0.102	homeostasis/metabolism phenotype; cellular phenotype; nervous system phenotype ; hematopoietic system phenotype; cardiovascular system phenotype ; mortality/aging ; behavior/neurological phenotype ; immune system phenotype; 			.	.	ubiquitin-dependent protein catabolic process;protein deubiquitination;regulation of protein stability;regulation of inflammatory response;regulation of type I interferon-mediated signaling pathway	nucleus;cytosol	cysteine-type endopeptidase activity;thiol-dependent ubiquitin-specific protease activity;protein binding;ISG15-specific protease activity;thiol-dependent ubiquitinyl hydrolase activity	IFNAR2[16710296];KDM3B[19615732];HSP90AB1[25036637];FKBPL[25036637];SGTA[25036637];TTC1[25036637];ISG15[16189514;25416956;unassigned1304;25307056];CACYBP[25036637];AARSD1[25036637];ZDHHC17[24705354];MLF1[25036637];NME1[19615732];STIP1[25036637];MYL6[19615732];NUDCD3[25036637];PPP5C[25036637];IKBKG[14743216];USP41[19615732];SKP2[25307056];TMEM14A[21516116];C10orf111[unassigned1304];FKBP5[25036637];	18652695
49535	chr22	20024596	C	G	chr22:20024596	TANGO2	transport and golgi organization 2 homolog	SNV	0/1	0.49	42_40	82	99.0	0/1	0.38	56_34	90	99.0			rs186875212,CS171053	EXONIC	YES	NM_001322141.2	Transcript	protein_coding	stop_gained		2/9	NM_001322141.2:c.158C>G	NP_001309070.1:p.Ser53Ter		1.0	.,.,.	Likely_benign	criteria_provided,_single_submitter	not_provided	Metabolic encephalomyopathic crises, recurrent, with rhabdomyolysis, cardiac arrhythmias, and neurodegeneration, 616878 (3), Autosomal recessive	Recurrent metabolic encephalomyopathic crises-rhabdomyolysis-cardiac arrhythmia-intellectual disability syndrome	Disease-causing germline mutation(s) (loss of function) in	Delayed ability to walk;Global brain atrophy;EMG: myopathic abnormalities;Nystagmus;Delayed speech and language development;Moderate global developmental delay;Optic atrophy;Intellectual disability;Sensorineural hearing impairment;Increased serum lactate;Babinski sign;Gastrointestinal dysmotility;Cerebral visual impairment;Infantile spasms;Focal impaired awareness seizure;Compensated hypothyroidism;Incoordination;Developmental regression;Stroke;Clonus;Hypertonia;Elevated serum creatine kinase;Amblyopia;Ataxia;Dysphagia;Abnormality of extrapyramidal motor function;Microcephaly;Supranuclear gaze palsy;Severe global developmental delay;Elevated hepatic transaminase;Lactic acidosis;Multifocal seizures;Dystonia;Elevated plasma acylcarnitine levels;Bilateral tonic-clonic seizure;Hypoglycemic seizures;Generalized myoclonic seizure;Arrhythmia;Prolonged QT interval;Ketonuria;Generalized tonic seizure;Acute rhabdomyolysis;Feeding difficulties in infancy;Mild global developmental delay;Hyperammonemia;Cardiac arrest;Increased serum lactate;Ventricular tachycardia;Lactic acidosis;Elevated plasma acylcarnitine levels;Drooling;Autosomal recessive inheritance;Muscle weakness;Spastic tetraplegia;Hypothyroidism;Acute rhabdomyolysis;Ventricular fibrillation;Clonus;Hypertrophic cardiomyopathy;Hyperammonemia;Seizure;Neurodegeneration;Premature thelarche;Microcephaly;Poor coordination;Dystonia;Absent speech;Elevated hepatic transaminase;Premature pubarche;Dysarthria;Elevated serum creatine kinase;Sensorineural hearing impairment;Hypoglycemia;Myoglobinuria;Optic atrophy;Ketonuria;Myopathic facies;Oral-pharyngeal dysphagia;Intellectual disability;Ataxia;Cerebral atrophy;Gait ataxia;Prolonged QTc interval;Spastic diplegia;Gait disturbance;Hyperactive deep tendon reflexes;Metabolic acidosis;Torsade de pointes;Global developmental delay;Generalized hypotonia		0.00582129	886.0	152200.0	5.0	32	0.97	PASS	nfe	0.0099512	677.0	0.0099512	677.0	0.00637732	1137.0	178288.0	6.0	45	0.64	PASS	nfe	0.0107336	894.0	0.0107336	894.0	0.0062571	973	0.002	7.0				7.077	0.289562		1	4	5	MutationTaster_pred	BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TANGO2	0.0	0.0	0.0	0.01	21.0	-24.0	24.0	21.0							0.0	0.000000000	0.006	-0.044	.			.	.	Golgi organization;protein secretion	Golgi apparatus	.	.	20024596
49761	chr22	22890552	G	A	chr22:22890552	PRAME	preferentially expressed antigen in melanoma	SNV	0/0	0.0	35_0	35	99.0	0/1	0.44	79_62	141	99.0			rs61730840,COSV104432992	EXONIC	YES	NM_206953.3	Transcript	protein_coding	synonymous_variant		5/5	NM_206953.3:c.1467C>T	NP_996836.1:p.His489%3D		-1.0						.	.	.		0.0051602	784.0	151932.0	5.0	32	0.95	PASS	nfe	0.00770475	524.0	0.00770475	524.0	0.00530461	1331.0	250914.0	7.0	83	1.0	PASS	nfe	0.00763392	865.0	0.00763392	865.0	0.0051060	794	0.013	42.0				0.413	-0.282135		0	0	0			PRAME	0.0	0.0	0.0	0.0	-12.0	-31.0	49.0	-38.0						0.769	0.0	61.768774340			.			.	.	apoptotic process;positive regulation of cell population proliferation;cell differentiation;regulation of growth;negative regulation of apoptotic process;negative regulation of cell differentiation;negative regulation of transcription, DNA-templated;negative regulation of retinoic acid receptor signaling pathway	nucleus;cytoplasm;plasma membrane	protein binding;retinoic acid receptor binding	UBE2F[19549727];HSP90AB1[25036637];CUL2[21822215];METTL3[29507755];STK19[14667819];NEDD8[21822215];AARSD1[25036637];BRCA1[29656893];CCDC28B[unassigned1312];RBX1[21822215];NUDCD3[25036637];PPP5C[25036637];METTL14[29507755];PSMD2[25036637];ELOB[21822215];ELOC[21822215];TP53BP1[29656893];	22890552
49827	chr22	23653976		CCGG	chr22:23653975-23653976	BCR	BCR, RhoGEF and GTPase activating protein	insertion	0/1	0.17	71_15	86	99.0	0/0	0.0	38_0	38	99.0			rs372013175	EXONIC	YES	NM_004327.4	Transcript	protein_coding	frameshift_variant		19/23	NM_004327.4:c.3275_3278dup	NP_004318.3:p.Val1094ArgfsTer17		1.0		Uncertain_significance	criteria_provided,_single_submitter	Chronic_myelogenous_leukemia,_BCR-ABL1_positive|not_provided	Leukemia, chronic myeloid, Philadelphia chromosome positive, somatic, 608232 (4); Leukemia, acute lymphocytic, Philadelphia chromosome positive, somatic, 613065 (4)	Distal 22q11.2 microdeletion syndrome;Chronic myeloid leukemia;Precursor B-cell acute lymphoblastic leukemia;Precursor T-cell acute lymphoblastic leukemia	Role in the phenotype of;Part of a fusion gene in;Part of a fusion gene in;Part of a fusion gene in	Poor appetite;Splenomegaly;Leukocytosis;Thrombocytosis;Fatigue;Thrombocytopenia;Abnormal basophil morphology;Myeloproliferative disorder;Fever;Ph-positive acute lymphoblastic leukemia;Chronic myelogenous leukemia;Somatic mutation;Reduced leukocyte alkaline phosphatase;Acute lymphoblastic leukemia;Polygenic inheritance;Malar flattening;Long face;Microcephaly;Recurrent respiratory infections;Camptodactyly of finger;Oculomotor apraxia;Toe syndactyly;Absent fingernail;Underdeveloped nasal alae;Seizure;Bowing of the long bones;Short distal phalanx of finger;Choanal atresia;Pes planus;Bowel incontinence;Branchial fistula;Narrow mouth;Short palm;Global developmental delay;Obsessive-compulsive behavior;Pointed chin;Ventricular septal defect;Attention deficit hyperactivity disorder;Cleft palate;Short stature;Abnormality of earlobe;Thin upper lip vermilion;Aortic regurgitation;Clinodactyly of the 5th finger;Prominent nasal bridge;Blepharophimosis;Ulnar deviation of finger;Smooth philtrum;Premature birth;Sandal gap;Atrial septal defect;Pyloric stenosis;Coxa valga;Depressivity;Tics;Language impairment;Aortic aneurysm;Facial asymmetry;Intellectual disability;Ankyloglossia;Joint hyperflexibility;Immunodeficiency;Inguinal hernia;Sensorineural hearing impairment;Recurrent urinary tract infections;Absent toenail;Deeply set eye;Truncus arteriosus;Highly arched eyebrow;Arachnodactyly;High, narrow palate;Intrauterine growth retardation;Hyperlordosis;Neoplasm						32	0.97							8.02002e-06	2.0	249376.0	0.0	60	0.99	RF	sas	3.30011e-05	1.0	0.0	0.0	0.0000064	1			0.21823	2236.0		33.0	5.421252		0	0	0																	0.144	1.0				nervous system phenotype ; hearing/vestibular/ear phenotype; digestive/alimentary phenotype; immune system phenotype; renal/urinary system phenotype; behavior/neurological phenotype ; liver/biliary system phenotype; normal phenotype; mortality/aging ; hematopoietic system phenotype; cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; 			caudate nucleus;ciliary ganglion;pons;amygdala;superior cervical ganglion;atrioventricular node;placenta;globus pallidus;medulla oblongata;	Chronic myeloid leukemia	negative regulation of cellular extravasation;renal system process;protein phosphorylation;signal transduction;brain development;peptidyl-tyrosine phosphorylation;actin cytoskeleton organization;regulation of Rho protein signal transduction;intracellular signal transduction;inner ear morphogenesis;regulation of vascular permeability;negative regulation of neutrophil degranulation;positive regulation of GTPase activity;protein autophosphorylation;platelet-derived growth factor receptor signaling pathway;homeostasis of number of cells;negative regulation of inflammatory response;positive regulation of phagocytosis;modulation of chemical synaptic transmission;neuromuscular process controlling balance;regulation of small GTPase mediated signal transduction;regulation of nitrogen compound metabolic process;regulation of cell cycle;definitive hemopoiesis;negative regulation of respiratory burst;negative regulation of blood vessel remodeling;intracellular protein transmembrane transport;cellular response to lipopolysaccharide;negative regulation of reactive oxygen species metabolic process	cytosol;postsynaptic density;membrane;cell junction;protein-containing complex;postsynaptic membrane;extracellular exosome;Schaffer collateral - CA1 synapse;glutamatergic synapse;postsynaptic density, intracellular component	protein serine/threonine kinase activity;protein tyrosine kinase activity;Rho guanyl-nucleotide exchange factor activity;GTPase activator activity;protein binding;ATP binding;kinase activity	USP15[unassigned1312];WDR48[19615732];COPB1[15494376];CLTC[15494376];TCF7[16442529];LRRK1[20697350];HSCB[28380382];PIK3CG[25241761];CEP128[26638075];IGSF21[16169070];TNKS2[22153077];MYC[17314511];STK38L[30108113];NINL[26638075];SH2D5[25331951];AP2M1[24189400];SPAG9[unassigned1312];PTPN1[9566916];CSNK1A1[unassigned1312];CSNK2A2[23455922];PDZK1[15494376];ATP2B1[15494376];AFDN[17491594];WEE1[unassigned1312];GIPC1[15494376];KIT[25241761];UNC119[16169070];MCM4[unassigned1312];GRB2[11726515;10887132;8112292;9174058;9178913;8955135;8995379;21706016];RGS12[15494376];GRAP[8995379];MCM6[unassigned1312];APBA3[15494376];EZR[29568061];TP53[16169070;25241761];CFTR[15494376;17110338];TJP2[15494376];MCM2[unassigned1312];	23653975
49828	chr22	23956322	G	A	chr22:23956322	DRICH1	aspartate rich 1	SNV	0/1	0.64	14_25	39	99.0	0/0	0.0	35_0	35	99.0			rs74953418,COSV99048507	SPLICING	YES	NM_016449.4	Transcript	protein_coding	splice_region_variant,synonymous_variant		9/12	NM_016449.4:c.621C>T	NP_057533.2:p.His207%3D		-1.0						.	.	.		0.00552621	841.0	152184.0	2.0	32	0.98	PASS	nfe	0.00890967	606.0	0.00890967	606.0	0.00581498	1450.0	249356.0	6.0	41	0.96	PASS	nfe	0.00862313	976.0	0.00862313	976.0	0.0054339	845	0.006	18.0				0.008	-0.822799		0	0	0			DRICH1	0.0	0.0	0.0	0.0	-31.0	-1.0	2.0	0.0	0.0009027378540892	0.538	5.582	1.865	7.447			0.000000000			.			.	.	.	.	protein binding	CSNK1G3[unassigned1304];CSNK1D[unassigned1304];RYDEN[25416956;unassigned1304];MYOZ2[25416956];	23956322
49989	chr22	29075622	C	T	chr22:29075622	TTC28	tetratricopeptide repeat domain 28	SNV	0|1	0.22	43_12	55	99.0	0|1	0.22	41_12	54	99.0			rs76130400,COSV67423659	EXONIC	YES	NM_001145418.1	Transcript	protein_coding	synonymous_variant		1/23	NM_001145418.1:c.90G>A	NP_001138890.1:p.Pro30%3D		-1.0						.	.	.		0.000912631	135.0	147924.0	0.0	33	0.94	AS_VQSR	afr	0.000742023	30.0	0.000709006	47.0	0.00511101	279.0	54588.0	0.0	2	0.07	PASS	afr	0.00788644	5.0	0.00450759	92.0	0.0015369	239						14.8	1.227853		0	0	0			TTC28	0.0	0.0	0.0	0.02	-2.0	33.0	-12.0	-16.0											craniofacial phenotype; homeostasis/metabolism phenotype; adipose tissue phenotype ; hematopoietic system phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; skeleton phenotype; 			.	.	cell cycle;regulation of mitotic cell cycle;cell division	spindle pole;cytoplasm;microtubule organizing center;midbody;mitotic spindle	kinase binding	TOMM70[30021884];BABAM2[19615732];NIN[26638075];NEK4[25798074];PDCD11[30021884];YWHAB[24255178];CEP152[26638075];CEP120[26638075];SASS6[26638075];ZNF862[12421765];NINL[26638075];	29075622
49991	chr22	29075634	T	G	chr22:29075634	TTC28	tetratricopeptide repeat domain 28	SNV	0|1	0.18	47_10	57	99.0	0|1	0.22	42_12	55	99.0			rs1288874226,COSV101194742	EXONIC	YES	NM_001145418.1	Transcript	protein_coding	synonymous_variant		1/23	NM_001145418.1:c.78A>C	NP_001138890.1:p.Pro26%3D		-1.0						.	.	.		0.0012096	170.0	140542.0	0.0	33	0.92	AS_VQSR	sas	0.00114469	5.0	0.000914625	58.0	0.000579456	33.0	56950.0	0.0	2	0.05	PASS	eas	0.00255754	2.0	0.000412768	9.0	0.0000064	1						12.97	0.934808		0	0	0			TTC28	0.0	0.0	0.0	0.0	2.0	-2.0	-32.0	-28.0											craniofacial phenotype; homeostasis/metabolism phenotype; adipose tissue phenotype ; hematopoietic system phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; skeleton phenotype; 			.	.	cell cycle;regulation of mitotic cell cycle;cell division	spindle pole;cytoplasm;microtubule organizing center;midbody;mitotic spindle	kinase binding	TOMM70[30021884];BABAM2[19615732];NIN[26638075];NEK4[25798074];PDCD11[30021884];YWHAB[24255178];CEP152[26638075];CEP120[26638075];SASS6[26638075];ZNF862[12421765];NINL[26638075];	29075634
49993	chr22	29075636	G	T	chr22:29075636	TTC28	tetratricopeptide repeat domain 28	SNV	0|1	0.17	48_10	58	99.0	0|1	0.22	42_12	55	99.0			rs748336223,COSV67413216	EXONIC	YES	NM_001145418.1	Transcript	protein_coding	missense_variant		1/23	NM_001145418.1:c.76C>A	NP_001138890.1:p.Pro26Thr		-1.0						.	.	.		0.000757412	112.0	147872.0	0.0	33	0.94	AS_VQSR	afr	0.000618689	25.0	0.000557783	37.0	0.000590275	32.0	54212.0	0.0	1	0.05	PASS	eas	0.0042735	3.0	0.000384357	8.0	0.0000064	1						16.32	1.509891	0.027	2	16	18	M-CAP_pred,FATHMM_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TTC28	0.0	0.0	0.0	0.0	-4.0	19.0	-30.0	-34.0									0.988	1.167	craniofacial phenotype; homeostasis/metabolism phenotype; adipose tissue phenotype ; hematopoietic system phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; skeleton phenotype; 	RFPL1S	Adipose_Subcutaneous	.	.	cell cycle;regulation of mitotic cell cycle;cell division	spindle pole;cytoplasm;microtubule organizing center;midbody;mitotic spindle	kinase binding	TOMM70[30021884];BABAM2[19615732];NIN[26638075];NEK4[25798074];PDCD11[30021884];YWHAB[24255178];CEP152[26638075];CEP120[26638075];SASS6[26638075];ZNF862[12421765];NINL[26638075];	29075636
50116	chr22	30742328	CTG		chr22:30742328-30742330	SF3A1	splicing factor 3a subunit 1	deletion	0/0	0.0	32_0	32	96.0	0/1	0.12	37_5	42	99.0			rs753907540	EXONIC	YES	NM_005877.6	Transcript	protein_coding	inframe_deletion		3/16	NM_005877.6:c.364_366del	NP_005868.1:p.Gln122del		-1.0						.	.	.		1.97381e-05	3.0	151990.0	0.0	32	0.95	PASS	nfe	4.41319e-05	3.0	4.41319e-05	3.0	6.56588e-05	16.0	243684.0	0.0	65	1.0	RF	nfe	9.02723e-05	10.0	9.02723e-05	10.0	0.0000193,0.0000193	3,3						20.9	2.134791		0	0	0			SF3A1	0.0	0.0	0.0	0.01	22.0	21.0	-27.0	22.0						0.21	0.99	0.000000000			mortality/aging ; 			ciliary ganglion;testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skin;testis;skeletal muscle;globus pallidus;cerebellum;	.	mRNA 3'-splice site recognition;mRNA splicing, via spliceosome;mRNA processing	nucleoplasm;spliceosomal complex;U2-type spliceosomal complex;U2 snRNP;nuclear speck;U2-type prespliceosome;catalytic step 2 spliceosome	RNA binding;protein binding	GSK3B[17353931];EIF4A3[23084401];HDAC11[23752268];DDX42[22365833];ILK[17353931];CHM[19615732];DDX41[25920683];FOXQ1[25609649];TEPSIN[26496610];MAP1LC3A[20562859];PPP4R2[28330616];ZNF607[30021884];MAP1LC3C[20562859];MAGOH[23084401];DHX15[24304693;29021621];USP30[19615732];IKBKE[17353931];GABARAPL1[20562859];RBFOX2[22365833];CSNK2A1[22113938];ANXA5[unassigned1312];PRPF40A[22365833];PRKAB1[17353931];ATG12[17353931];SND1[unassigned1312];PTBP3[22575643];WDR77[22365833];NCOR1[11013263];MCM4[unassigned1312];PPIE[25599396];VDAC1[17353931];MCM6[unassigned1312];GAS7[16055720];ARF6[17353931];SF1[22365833;26420826];MCM2[unassigned1312];WBP4[16055720;28838205];GABARAP[20562859];HDAC6[23752268];TCOF1[30021884];EMC2[26496610];SMYD2[17353931];SNRPB2[unassigned1312];TNNI3[30021884];VHL[17353931];RBM10[22365833];SF3A3[22365833;17098193;30021884];WWOX[16055720];TRAP1[unassigned1312];JUN[25609649];SF3A2[17332742;22365833;30021884];XRCC3[26496610];CDC5L[20467437];PA2G4[unassigned1312];ESR2[21182203];TNFRSF10D[17353931];MRPL22[30021884];FAM111A[30021884];SNW1[20467437];SP1[10976766];UBE2N[unassigned1312];	30742327
50918	chr22	36872873	C	T	chr22:36872873	TXN2	thioredoxin 2	SNV	0/0	0.0	41_0	41	99.0	0/1	0.4	39_27	67	99.0			rs150502647	EXONIC	YES	NM_012473.4	Transcript	protein_coding	synonymous_variant		3/4	NM_012473.4:c.294G>A	NP_036605.2:p.Pro98%3D		-1.0		Benign	criteria_provided,_single_submitter	not_provided	?Combined oxidative phosphorylation deficiency 29, 616811 (3), Autosomal recessive	Combined oxidative phosphorylation defect type 29	Disease-causing germline mutation(s) (loss of function) in	Neurodegeneration;Bilateral tonic-clonic seizure;Global brain atrophy;Subependymal cysts;Abnormal autonomic nervous system physiology;Optic neuropathy;Severe global developmental delay;Retinopathy;Increased CSF lactate;Decreased activity of mitochondrial complex III;Congenital microcephaly;Increased CSF protein;Decreased activity of mitochondrial complex I;Myoclonic spasms;Diffuse cerebellar atrophy;Abnormal muscle tone;Delayed myelination;Gastrojejunal tube feeding in infancy;Increased serum lactate;Poor coordination;Gastrointestinal dysmotility;Axonal degeneration;Optic atrophy;Increased CSF protein;Dystonia;Feeding difficulties;Peripheral neuropathy;Decreased activity of mitochondrial complex I;Delayed CNS myelination;Decreased activity of mitochondrial complex III;Global developmental delay;Subependymal cysts;Generalized hypotonia;Cerebellar atrophy;Autosomal recessive inheritance;Retinopathy;Axonal degeneration;Optic neuropathy;Severe global developmental delay;Increased serum lactate;Infantile onset;Seizure;Microcephaly;Increased CSF lactate;Congenital onset;Progressive;Global brain atrophy;Spasticity		0.00586233	892.0	152158.0	7.0	32	0.96	PASS	nfe	0.0090102	613.0	0.0090102	613.0	0.00635025	1597.0	251486.0	9.0	82	1.0	PASS	nfe	0.0087727	998.0	0.0087727	998.0	0.0063664	990	0.012	39.0	0.01412	26.0		3.585	0.059645		0	0	0			TXN2	0.0	0.0	0.0	0.0	-3.0	30.0	-2.0	-36.0						0.605	0.01	44.884760513			mortality/aging ; embryo phenotype; nervous system phenotype ; growth/size/body region phenotype; cellular phenotype; 			liver;trigeminal ganglion;adrenal gland;skeletal muscle;globus pallidus;heart;	.	sulfur amino acid catabolic process;response to hypoxia;glycerol ether metabolic process;response to oxidative stress;response to hormone;response to glucose;response to organic cyclic compound;cellular response to nutrient levels;response to drug;cell redox homeostasis;response to axon injury;oxidation-reduction process	nucleolus;mitochondrion;mitochondrial matrix;dendrite;neuronal cell body	protein binding;peptide-methionine (S)-S-oxide reductase activity;protein disulfide oxidoreductase activity;peptide-methionine (R)-S-oxide reductase activity;protein-containing complex binding	SCYL3[25416956;unassigned1304];MRFAP1L1[25416956;unassigned1304];CIB4[unassigned1304];MRFAP1[unassigned1304];C11orf49[unassigned1304];FHL5[unassigned1304];MEOX2[unassigned1304];SAT1[unassigned1304];PPCDC[25416956;unassigned1304];DMBX1[unassigned1304];RABGEF1[25416956];GOLGA6L9[unassigned1304];KRT27[unassigned1304];CHMP1A[unassigned1304];GPRASP2[21988832;unassigned1304];TRIM21[25416956;unassigned1304];BCAS2[unassigned1304];MAGEA4[unassigned1304];PPP1R16B[unassigned1304];CCDC197[unassigned1304];TTC32[unassigned1304];TMOD4[unassigned1304];CCDC114[25416956];MTUS2[25416956;unassigned1304];AGTRAP[25416956;unassigned1304];KAZN[unassigned1304];TFIP11[unassigned1304];RPS3A[30021884];GTPBP2[unassigned1304];THAP1[21988832];HAUS1[unassigned1304];DCTD[25416956];PSME3[25416956];DDIT3[unassigned1304];ETHE1[unassigned1304];MAGEB2[unassigned1304];MAPRE3[25416956;unassigned1304];ALDOB[21988832];MAPRE2[25416956;unassigned1304];ZMYND12[unassigned1304];MYL9[unassigned1304];MDFI[unassigned1304];CGGBP1[unassigned1304];ANKRD36B[unassigned1304];BHLHB9[unassigned1304];CDCA4[unassigned1304];SSNA1[25416956;unassigned1304];KRT40[25416956];MIPOL1[unassigned1304];SPTA1[unassigned1304];SYCE1[unassigned1304];GUCD1[unassigned1304];SHARPIN[21988832];CRACR2B[unassigned1304];HAUS8[unassigned1304];VPS52[25416956;unassigned1304];TIFA[25416956];CEP70[unassigned1304];RABAC1[21988832];MAGEA11[25416956];FAM9B[25416956];STN1[unassigned1304];PEX19[unassigned1304];ZBTB14[25416956];UQCC2[unassigned1304];AP2B1[25416956;unassigned1304];MLH1[20706999];RPIA[25416956;unassigned1304];POMC[unassigned1304];KRT18[21988832];ABI3[unassigned1304];TRIP6[25416956];LCN2[unassigned1304];STUB1[25416956];VIM[21988832];REEP6[25416956;unassigned1304];RBM45[25416956;unassigned1304];	36872873
50944	chr22	37499275	C	T	chr22:37499275	TMPRSS6	transmembrane serine protease 6	SNV	0/0	0.0	34_0	34	99.0	0/1	0.49	47_45	92	99.0			rs150521260	EXONIC	YES	NM_001289000.2	Transcript	protein_coding	synonymous_variant		2/19	NM_001289000.2:c.183G>A	NP_001275929.1:p.Val61%3D		-1.0		Uncertain_significance	criteria_provided,_single_submitter	Microcytic_anemia	Iron-refractory iron deficiency anemia, 206200 (3), Autosomal recessive	IRIDA syndrome	Disease-causing germline mutation(s) (loss of function) in	Pallor;Intellectual disability;Ichthyosis;Decreased circulating copper concentration;Abnormal intestine morphology;Peripheral neuropathy;Intrahepatic cholestasis;Hyperkeratosis;Poikilocytosis;Elevated hepcidin level;Anisocytosis;Autosomal recessive inheritance;Hypochromic microcytic anemia		0.000834406	127.0	152204.0	0.0	32	0.97	PASS	nfe	0.00116132	79.0	0.00116132	79.0	0.000838076	210.0	250574.0	0.0	100	0.99	PASS	amr	0.00115727	40.0	0.000955871	108.0	0.0006173	96	0.003	11.0	0.00395	45.0		8.608	0.41972		0	0	0			TMPRSS6	0.0	0.0	0.1	0.01	-20.0	-8.0	3.0	-19.0						0.134	0.0	81.574401721			homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; mortality/aging ; integument phenotype ; reproductive system phenotype; growth/size/body region phenotype; cardiovascular system phenotype ; hematopoietic system phenotype; digestive/alimentary phenotype; immune system phenotype; liver/biliary system phenotype; 			liver;trigeminal ganglion;superior cervical ganglion;atrioventricular node;testis;skeletal muscle;	.	negative regulation of transcription by RNA polymerase II;angiogenesis;proteolysis;cellular iron ion homeostasis;extracellular matrix disassembly;extracellular matrix organization;negative regulation of BMP signaling pathway;collagen catabolic process;membrane protein proteolysis;intracellular signal transduction;fibrinolysis;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;iron ion homeostasis;self proteolysis	extracellular space;plasma membrane;integral component of membrane	metalloendopeptidase activity;serine-type endopeptidase activity;protein binding	HJV[18976966;20704562;19357398];	37499275
50965	chr22	37962693	T	G	chr22:37962693	CDC42EP1	CDC42 effector protein 1	SNV	0/0	0.0	36_0	36	99.0	0/1	0.49	62_60	122	99.0			rs768436129	EXONIC	YES	NM_152243.3	Transcript	protein_coding	missense_variant		2/3	NM_152243.3:c.337T>G	NP_689449.1:p.Ser113Ala		1.0						.	.	.						32	0.97							4.05173e-06	1.0	246808.0	0.0	33	0.81	PASS	eas	5.57289e-05	1.0	0.0	0.0	0.0000064	1						23.4	2.930192	0.077	6	14	20	SIFT,LRT_pred,MutationTaster_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred	CDC42EP1	0.0	0.02	0.0	0.0	1.0	36.0	4.0	-5.0						0.725	0.0	0.000000000	0.989	1.127	.			.	.	Rho protein signal transduction;regulation of cell shape;positive regulation of actin filament polymerization;positive regulation of pseudopodium assembly;cell-cell adhesion	cytoplasm;cytoskeleton;plasma membrane;cell-cell adherens junction;focal adhesion;endomembrane system	protein binding;GTP-Rho binding;cadherin binding involved in cell-cell adhesion	UVRAG[20562859];PRKAA2[unassigned1304];RBPMS[16189514];YWHAB[24255178];MAPKAP1[16189514];RIPK4[26972000];FHL3[16189514];ARMC7[unassigned1304];NBEAL2[29187380];SAT1[unassigned1304];DEF6[25416956];PTBP3[22575643];CDC42[16189514;20936779;21988832;25416956;unassigned1304];MAD2L2[29656893];PLSCR1[16189514];LAMP1[29568061];KRTAP4-12[16189514];MYC[21150319];RHOJ[25416956];MDFI[19060904];	37962693
50973	chr22	38120797	G	A	chr22:38120797	TRIOBP	TRIO and F-actin binding protein	SNV	0/1	0.56	46_59	105	99.0	0/0	0.0	83_0	83	99.0			rs150690007,COSV100731248	EXONIC	YES	NM_001039141.3	Transcript	protein_coding	missense_variant		7/24	NM_001039141.3:c.2234G>A	NP_001034230.1:p.Arg745Lys		1.0	.,.	Likely_benign	criteria_provided,_single_submitter	not_provided	Deafness, autosomal recessive 28, 609823 (3), Autosomal recessive	Autosomal recessive non-syndromic sensorineural deafness type DFNB	Disease-causing germline mutation(s) in	Infantile onset;Severe sensorineural hearing impairment;Autosomal recessive inheritance		0.00637404	941.0	147630.0	4.0	30	0.91	PASS	nfe	0.00949253	633.0	0.00949253	633.0	0.00672004	1677.0	249552.0	11.0	100	1.0	PASS	nfe	0.0102502	1161.0	0.0102502	1161.0	0.0068937	1072	0.009	31.0	0.00835	95.0		8.512	0.410638	0.016	0	17	17		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	RP1-37E16.12	0.0	0.0	0.0	0.0	17.0	-23.0	8.0	1.0						0.171	0.0		0.043	1.147	mortality/aging ; nervous system phenotype ; hearing/vestibular/ear phenotype; 			.	.	cell cycle;sensory perception of sound;actin modification;barbed-end actin filament capping;cell division;auditory receptor cell stereocilium organization;positive regulation of substrate adhesion-dependent cell spreading	nucleus;cytoplasm;microtubule organizing center;focal adhesion;actin cytoskeleton;midbody	GTP-Rho binding;ubiquitin protein ligase binding;myosin II binding;actin filament binding	IQGAP1[26496610];TRIOBP[17629495];PPP1CB[26496610;28330616];BAG6[26496610];SYNCRIP[26496610];LAMP1[29568061];MYO18A[26496610];POLR2F[26496610];IKBKG[21988832];PPP1R12A[28330616];SORT1[26496610];TMEM132A[26496610];GTF2H1[21988832];TERF1[17629495];HAUS2[26496610];PLEKHA7[28877994];ANLN[26496610];MYO1C[26496610];KIF2A[26496610];POLR1C[21988832];CAPZA2[26496610];MYH9[26496610];L1TD1[26496610];VIM[16169070];EZR[29568061];BCAR1[28007913];	38120797
51074	chr22	39909847	G	A	chr22:39909847	MIEF1	mitochondrial elongation factor 1	SNV	0/1	0.5	69_68	137	99.0	0/1	0.41	69_50	121	99.0			rs141041315	EXONIC	YES	NM_001304564.2	Transcript	protein_coding	missense_variant		6/7	NM_001304564.2:c.911G>A	NP_001291493.1:p.Arg304His		1.0	Mab-21 domain&Mab-21 domain,Mab-21 domain&Mab-21 domain,Mab-21 domain&Mab-21 domain	Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00439686	669.0	152154.0	2.0	32	0.97	PASS	nfe	0.00546882	372.0	0.00546882	372.0	0.00522458	1313.0	251312.0	10.0	100	1.0	PASS	nfe	0.00553609	629.0	0.00553609	629.0	0.0045465	707	0.004	13.0				18.83	1.883135	0.035	2	17	19	LRT_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	MIEF1	0.0	0.0	0.0	0.0	23.0	36.0	-14.0	44.0							0.06	0.000000000	0.981	0.225	.			.	.	mitochondrial fission;mitochondrial fusion;positive regulation of mitochondrial fission;positive regulation of protein targeting to membrane	mitochondrion;mitochondrial outer membrane;peroxisome;integral component of membrane	protein binding;GDP binding;identical protein binding;ADP binding	FIS1[21701560];ATP5PF[unassigned1304];FAM25C[unassigned1304];PRAF2[unassigned1304];CMTM5[unassigned1304];CMTM6[unassigned1304];TIMM23[21701560];AGTRAP[25416956;unassigned1304];MIEF1[21701560];SYP[unassigned1304];ABHD5[unassigned1304];TOMM20[21701560];TNFRSF10D[unassigned1304];CDC42[26496610];ZNFX1[26496610];PSMA1[unassigned1304];MAGEA1[16189514;25416956;unassigned1304];UBQLN1[25416956];ARFIP2[unassigned1304];PLIN3[unassigned1304];DNM1L[21701560];YWHAG[15324660];HTATIP2[unassigned1304];UBQLN2[unassigned1304];	39909847
51194	chr22	40816857	G	A	chr22:40816857	MKL1		SNV	0/1	0.46	31_26	57	99.0	0/0	0.0	33_0	33	99.0			rs937876523	EXONIC	YES	NM_020831.6	Transcript	protein_coding	missense_variant		10/15	NM_020831.6:c.1175C>T	NP_065882.2:p.Pro392Leu		-1.0	.,.,.,.,.,.,.													33	0.98											53	0.99											0.00026	3.0		25.3	3.582261	0.904	13	7	20	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,MetaLR_pred,MetaSVM_pred,FATHMM_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	MKL1	0.0	0.0	0.0	0.0	8.0	40.0	-6.0	17.0						0.218	0.54	82.654091026	0.994	1.176										40816857
51211	chr22	41075722	T	C	chr22:41075722	MCHR1	melanin concentrating hormone receptor 1	SNV	0/1	0.43	55_42	98	99.0	0/0	0.0	42_0	42	99.0			rs138921026	EXONIC	YES	NM_005297.4	Transcript	protein_coding	synonymous_variant		1/2	NM_005297.4:c.66T>C	NP_005288.4:p.Asp22%3D		1.0						.	.	.		0.00036149	55.0	152148.0	0.0	31	0.94	PASS	amr	0.00091671	14.0	0.000249868	17.0	0.000526413	131.0	248854.0	0.0	100	1.0	PASS	amr	0.00124313	43.0	0.000377358	42.0	0.0003601	56	0.002	8.0	0.00373	42.0		2.954	0.021252		0	0	0			MCHR1	0.0	0.0	0.0	0.0	-21.0	17.0	16.0	-2.0						0.699	0.0	52.511747412			homeostasis/metabolism phenotype; growth/size/body region phenotype; adipose tissue phenotype ; nervous system phenotype ; skeleton phenotype; behavior/neurological phenotype ; cardiovascular system phenotype ; 			pons;dorsal root ganglion;superior cervical ganglion;	Neuroactive ligand-receptor interaction	generation of precursor metabolites and energy;cell surface receptor signaling pathway;G protein-coupled receptor signaling pathway;adenylate cyclase-inhibiting G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;neuropeptide signaling pathway;feeding behavior;positive regulation of calcium ion transport	plasma membrane;integral component of plasma membrane;ciliary membrane;non-motile cilium	G protein-coupled receptor activity;signaling receptor binding;protein C-terminus binding;neuropeptide receptor activity;melanin-concentrating hormone receptor activity;peptide binding;hormone binding;neuropeptide binding	.	41075722
51235	chr22	41721853	C	T	chr22:41721853	ZC3H7B	zinc finger CCCH-type containing 7B	SNV	0/0	0.0	37_0	37	99.0	0/1	0.47	71_62	133	99.0			rs151077891	EXONIC	YES	NM_017590.6	Transcript	protein_coding	synonymous_variant		4/23	NM_017590.6:c.216C>T	NP_060060.3:p.Asp72%3D		1.0						.	.	.		0.00423701	645.0	152230.0	4.0	32	0.97	PASS	amr	0.00536579	82.0	0.00487934	332.0	0.00494085	1232.0	249350.0	10.0	82	0.88	PASS	nfe	0.00544259	614.0	0.00544259	614.0	0.0043279	673	0.006	18.0				10.8	0.657617		0	0	0			ZC3H7B	0.01	0.0	0.0	0.0	4.0	-41.0	3.0	39.0						0.292	0.99	22.509097950			.			pons;ciliary ganglion;dorsal root ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;globus pallidus;	.	posttranscriptional regulation of gene expression;viral process;production of miRNAs involved in gene silencing by miRNA	nucleus	RNA binding;protein binding;miRNA binding;metal ion binding	JUN[25609649];ATXN1[16713569];HSP90AB1[22939624];MYC[21150319];ZNF638[30021884];DDX21[30021884];AARSD1[25036637];MLF1[25036637];EIF4G1[15047801];	41721853
51238	chr22	41903852	C	T	chr22:41903852	ACO2	aconitase 2	SNV	0/1	0.53	44_50	94	99.0	0/0	0.0	33_0	33	99.0			rs150593227	EXONIC	YES	NM_001098.3	Transcript	protein_coding	synonymous_variant		3/18	NM_001098.3:c.231C>T	NP_001089.1:p.Pro77%3D		1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	not_specified|not_provided	?Optic atrophy 9, 616289 (3), Autosomal recessive; Infantile cerebellar-retinal degeneration, 614559 (3), Autosomal recessive	Infantile cerebellar-retinal degeneration;Autosomal recessive isolated optic atrophy	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Red-green dyschromatopsia;Optic atrophy;Reduced visual acuity;Paracentral scotoma;Autosomal recessive inheritance;Pallor;Ataxia;Progressive microcephaly;Infantile onset;Sensorineural hearing impairment;Severe global developmental delay;Strabismus;Retinal dystrophy;Areflexia;Hyporeflexia;Failure to thrive;Nystagmus;Intellectual disability, severe;Athetosis;Autosomal recessive inheritance;Cerebral cortical atrophy;Optic atrophy;Seizure;Cerebellar atrophy;Generalized hypotonia;Hypoplasia of the corpus callosum;Demyelinating peripheral neuropathy		0.00292974	446.0	152232.0	3.0	32	0.98	PASS	afr	0.0098635	409.0	0.000191047	13.0	0.000848714	213.0	250968.0	1.0	61	0.98	PASS	afr	0.00950735	154.0	0.000237999	27.0	0.0009003	140	0.003	9.0	0.00175	20.0		0.108	-0.472712		0	0	0			ACO2	0.0	0.0	0.0	0.0	-22.0	6.0	-22.0	22.0						0.428	0.45	5.737620576			.			caudate nucleus;amygdala;prefrontal cortex;cingulate cortex;heart;kidney;occipital lobe;subthalamic nucleus;whole brain;parietal lobe;skeletal muscle;hypothalamus;thalamus;	Citrate cycle (TCA cycle);Glyoxylate and dicarboxylate metabolism;Reductive carboxylate cycle (CO2 fixation)	liver development;generation of precursor metabolites and energy;tricarboxylic acid cycle;citrate metabolic process;isocitrate metabolic process;response to isolation stress	mitochondrion;mitochondrial matrix;cytosol;myelin sheath	aconitate hydratase activity;iron ion binding;3 iron, 4 sulfur cluster binding;4 iron, 4 sulfur cluster binding	VCAM1[22623428;19738201];TCIM[30021884];CLPP[26058080];C5AR2[28298427];HSCB[28380382];MLH1[20706999];PPP1CA[25593058];PDK1[29568061];SOD1[29128334];	41903852
51283	chr22	42524795	A	G	chr22:42524795	CYP2D6	cytochrome P450 family 2 subfamily D member 6	SNV	0/1	0.27	96_35	131	99.0	0/1	0.26	89_31	121	99.0			rs28371713,COSV62242916	EXONIC	YES	NM_000106.6	Transcript	protein_coding	synonymous_variant		4/9	NM_000106.6:c.657T>C	NP_000097.3:p.Phe219%3D		-1.0					{Codeine sensitivity}, 608902 (3), Autosomal recessive; {Debrisoquine sensitivity}, 608902 (3), Autosomal recessive	Codeine toxicity;Resistance to tamoxifene;Antidepressant or antipsychotic toxicity or dose selection	Biomarker tested in;Biomarker tested in;Biomarker tested in	Neoplasm;Abnormality of metabolism/homeostasis;Autosomal recessive inheritance	26858644	0.00420823	626.0	148756.0	21.0	32	0.92	PASS	afr	0.00851815	338.0	0.00209024	140.0	0.287005	54124.0	188582.0	112.0	100	0.84	InbreedingCoeff_RF	amr	0.381637	9976.0	0.295157	24648.0	0.0098261	1528	0.075	230.0	0.14656	627.0		0.532	-0.244841		0	0	0			CYP2D6	0.02	0.0	0.0	0.0	45.0	-10.0	-11.0	-9.0							0.0				.			.	Drug metabolism - cytochrome P450;Parkinson's disease	organic acid metabolic process;xenobiotic metabolic process;steroid metabolic process;coumarin metabolic process;alkaloid metabolic process;alkaloid catabolic process;monoterpenoid metabolic process;drug metabolic process;arachidonic acid metabolic process;isoquinoline alkaloid metabolic process;drug catabolic process;exogenous drug catabolic process;long-chain fatty acid biosynthetic process;heterocycle metabolic process;negative regulation of binding;oxidation-reduction process;oxidative demethylation;negative regulation of cellular organofluorine metabolic process	cytoplasm;mitochondrion;endoplasmic reticulum;endoplasmic reticulum membrane;organelle membrane;intracellular membrane-bounded organelle	monooxygenase activity;iron ion binding;drug binding;steroid hydroxylase activity;oxidoreductase activity;oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen;heme binding;aromatase activity	.	42524795
51299	chr22	42606905	T	C	chr22:42606905	TCF20	transcription factor 20	SNV	0/1	0.57	83_110	193	99.0	0/1	0.41	112_77	189	99.0			rs140619869,COSV100166475	EXONIC	YES	NM_001378418.1	Transcript	protein_coding	synonymous_variant		2/6	NM_001378418.1:c.4407A>G	NP_001365347.1:p.Ser1469%3D		-1.0		Benign	criteria_provided,_single_submitter	not_provided	Developmental delay with variable intellectual impairment and behavioral abnormalities, 618430 (3), Autosomal dominant	.	.	Strabismus;Tapered finger;Ataxia;Posteriorly rotated ears;Constipation;Clinodactyly of the 5th finger;Generalized hypotonia;Spasticity;Macrocephaly;Autosomal dominant inheritance;Global developmental delay;Thin upper lip vermilion;Bulbous nose;Frontal bossing;Scoliosis;Depressed nasal bridge;Hyperactivity;Inverted nipples;Brachycephaly;Downturned corners of mouth;Open mouth;Plagiocephaly;Tented upper lip vermilion;Anxiety;Poor coordination;Delayed ability to walk;Seizure;Tall stature;Aggressive behavior;Abnormality of the foot;Short nose;Delayed speech and language development;Midface retrusion;Obsessive-compulsive behavior;Sleep disturbance;Feeding difficulties;Long face;Epicanthus;Deeply set eye;High forehead;Low-set ears;Myopia;Autistic behavior;Obesity		0.00299161	455.0	152092.0	6.0	32	0.97	PASS	sas	0.006628	32.0	0.00414511	282.0	0.00347634	874.0	251414.0	6.0	100	1.0	PASS	sas	0.0078717	241.0	0.00383445	436.0	0.0034147	531	0.006	19.0				11.03	0.685506		0	0	0			TCF20	0.0	0.0	0.0	0.0	46.0	-4.0	-10.0	-9.0						0.0597	1.0	39.608978480			.			ciliary ganglion;testis - seminiferous tubule;prefrontal cortex;atrioventricular node;superior cervical ganglion;globus pallidus;	.	regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II	nucleus;nucleoplasm;nuclear body	DNA binding;DNA-binding transcription factor activity;transcription coactivator activity;RNA binding;protein binding;transcription regulatory region DNA binding;metal ion binding	MDC1[29656893];HDAC1[26496610];COPB1[26496610];CLTB[26496610];ADARB1[26496610];NOP9[26496610];RAI1[26496610];SIN3A[26496610];HMG20A[26496610];RBBP7[26496610];TRIM27[26496610];TOPBP1[17913746];MTA2[26496610];MTA3[26496610];USP7[26496610];BRF1[26496610];RPS7[30021884];PYHIN1[25665578];SLC39A10[26496610];MAPK14[20936779];ACTL8[26496610];GATAD2B[26496610];NIPSNAP1[26496610];PTBP3[22575643];GATAD2A[26496610];AIM2[25665578];PHF14[26496610];CDK2AP1[26496610];	42606905
51324	chr22	43870725	T	A	chr22:43870725	MPPED1	metallophosphoesterase domain containing 1	SNV	0/1	0.51	78_82	160	99.0	0/0	0.0	33_0	33	99.0			rs200502126	EXONIC	YES	NM_001362786.2	Transcript	protein_coding	synonymous_variant		4/7	NM_001362786.2:c.516T>A	NP_001349715.1:p.Ser172%3D		1.0						.	.	.		0.000781825	119.0	152208.0	1.0	31	0.96	PASS	afr	0.00231593	96.0	5.87889e-05	4.0	0.000409201	102.0	249266.0	0.0	100	1.0	PASS	afr	0.00284201	44.0	7.96347e-05	9.0	0.0003473	54						7.063	0.288489		0	0	0			MPPED1	0.02	0.0	0.0	0.0	2.0	10.0	2.0	16.0						0.212	0.28	97.237786809			.			ciliary ganglion;pons;trigeminal ganglion;cingulate cortex;atrioventricular node;superior cervical ganglion;skeletal muscle;globus pallidus;	.	biological_process	cellular_component	molecular_function;hydrolase activity	ZRANB1[unassigned1304];C16orf70[unassigned1304];ANXA7[21900206];TK1[21900206];DISC1[17043677];	43870725
51347	chr22	44681464	C	T	chr22:44681464	KIAA1644		SNV	0/0	0.0	37_0	37	99.0	0/1	0.45	79_64	143	99.0			rs574698559,COSV66988505	EXONIC	YES	NM_001099294.2	Transcript	protein_coding	missense_variant		4/5	NM_001099294.2:c.443G>A	NP_001092764.1:p.Arg148Gln		-1.0										0.000459897	70.0	152208.0	0.0	33	0.98	PASS	sas	0.00455675	22.0	0.000308705	21.0	0.000787338	195.0	247670.0	2.0	77	0.99	PASS	sas	0.00431373	132.0	0.000358719	40.0	0.0006109	95	0.001	2.0				22.4	2.446976	0.186	2	14	16	LRT_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	KIAA1644	0.0	0.0	0.0	0.01	-2.0	2.0	-32.0	42.0						0.065	0.68	0.000000000	0.998	1.023										44681464
51395	chr22	45821917	C	T	chr22:45821917	RIBC2	RIB43A domain with coiled-coils 2	SNV	0|1	0.37	71_42	113	99.0	0|1	0.41	66_45	111	99.0			rs142579982	EXONIC	YES	NM_015653.5	Transcript	protein_coding	synonymous_variant		6/8	NM_015653.5:c.762C>T	NP_056468.3:p.Asp254%3D		1.0						.	.	.		0.00406013	618.0	152212.0	3.0	34	0.97	PASS	nfe	0.00565877	385.0	0.00565877	385.0	0.00448255	1124.0	250750.0	5.0	100	0.99	PASS	nfe	0.00599633	679.0	0.00599633	679.0	0.0043793	681	0.008	24.0				7.039	0.286656		0	0	0			RIBC2	0.0	0.0	0.0	0.0	13.0	29.0	-2.0	24.0							0.0	15.682779978			.			testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;testis;skeletal muscle;	.	.	nucleus	protein binding	USHBP1[16189514];YBX1[22118625];BEGAIN[16189514];RAD54B[16189514];EFEMP2[16189514];RPL18A[16169070];CCDC85B[16189514];SARAF[16169070];ATRIP[16189514];NINL[16189514];TRIM23[16189514];JUP[16189514];TEX11[16189514];MTUS2[16189514];TRAF2[16189514];AP2B1[16189514];NRBP1[16189514];PJA1[16169070];GTPBP3[16189514];GFAP[16189514];HOOK2[16189514];KRT15[16189514];TRIM37[16189514];SNRPA1[30021884];VIM[16189514];	45821917
51433	chr22	50170710	G	A	chr22:50170710	BRD1	bromodomain containing 1	SNV	0/0	0.0	40_0	40	99.0	0/1	0.47	48_43	91	99.0			rs751163081	EXONIC	YES	NM_001304808.3	Transcript	protein_coding	synonymous_variant		10/13	NM_001304808.3:c.3093C>T	NP_001291737.1:p.Asn1031%3D		-1.0						.	.	.		6.56685e-05	10.0	152280.0	0.0	33	0.99	PASS	amr	0.000261677	4.0	8.81653e-05	6.0	5.57902e-05	14.0	250940.0	0.0	88	1.0	PASS	nfe	0.000123544	14.0	0.000123544	14.0	0.0000514	8			0.00026	3.0		10.02	0.566771		0	0	0			BRD1	0.0	0.0	0.0	0.0	-18.0	30.0	32.0	-28.0						0.35	0.99	33.720104447			cellular phenotype; hematopoietic system phenotype; growth/size/body region phenotype; integument phenotype ; mortality/aging ; vision/eye phenotype; nervous system phenotype ; liver/biliary system phenotype; embryo phenotype; 			ciliary ganglion;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;trigeminal ganglion;testis;skeletal muscle;cerebellum;	.	response to immobilization stress;histone H3 acetylation;response to electrical stimulus	nucleus;nuclear speck;dendrite;perikaryon;MOZ/MORF histone acetyltransferase complex	histone binding;metal ion binding	ZNF512B[15231748];YWHAE[27142060];CEP126[16169070];MRPS14[27142060];YWHAB[27142060];CLTC[27142060];PHB2[27142060];ING4[26496610;27142060];ING5[27142060];CASP8[unassigned1304];C1QBP[27142060];WDR7[27142060];KMT5B[27142060];KAT7[27142060];KPNA2[27142060];YWHAG[27142060];TMPO[26496610];KPNA1[27142060];YWHAH[27142060];RUBCN[unassigned1304];PBRM1[27142060];NSUN2[27142060];TFIP11[unassigned1304];YWHAZ[27142060];DIEXF[27142060];PICK1[unassigned1304];S100A4[26496610];MYH6[26496610];DNMT1[27142060];RPL10[26496610];MEAF6[27142060];HMBOX1[unassigned1304];PSMB2[27142060];CEP70[unassigned1304];ZNF226[27142060];MAGEA11[unassigned1304];DISC1[unassigned1304];LYAR[27142060];ZC3H15[27142060];QSER1[27142060];NPM1[27142060];ZRANB1[unassigned1304];ATP5PD[30021884];MCC[unassigned1304];NAP1L4[27142060];EIF3I[27142060];DRG1[27142060];RPL22L1[27142060];VIM[16169070];CNTROB[26496610];	50170710
51524	chr22	50616632	T	A	chr22:50616632	PANX2	pannexin 2	SNV	0|1	0.2	31_9	46	99.0	0/0	0.0	29_0	29	0.0			COSV50294194	EXONIC	YES	NM_052839.4	Transcript	protein_coding	synonymous_variant		2/3	NM_052839.4:c.1491T>A	NP_443071.2:p.Pro497%3D		1.0						.	.	.		9.75523e-05	11.0	112760.0	0.0	32	0.81	AS_VQSR	eas	0.000563063	2.0	9.74431e-05	5.0					5	0.12														0.335	-0.312618		0	0	0			PANX2	0.0	0.0	0.0	0.0	2.0	31.0	45.0	-35.0							0.01				homeostasis/metabolism phenotype; skeleton phenotype; limbs/digits/tail phenotype; nervous system phenotype ; 			ciliary ganglion;testis - seminiferous tubule;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;cerebellum peduncles;globus pallidus;	.	response to ischemia;cation transport;cell-cell signaling;protein hexamerization;positive regulation of interleukin-1 secretion;transmembrane transport	cytoplasm;plasma membrane;gap junction;integral component of membrane	wide pore channel activity;gap junction hemi-channel activity	RPN1[30021884];HMGA1[30021884];GRB2[17474147];NRF1[unassigned1304];BANP[unassigned1304];	50616632
51528	chr22	50616639	G	C	chr22:50616639	PANX2	pannexin 2	SNV	0|1	0.2	29_9	44	99.0	0/0	0.0	29_0	29	0.0			rs1009000991	EXONIC	YES	NM_052839.4	Transcript	protein_coding	missense_variant		2/3	NM_052839.4:c.1498G>C	NP_443071.2:p.Ala500Pro		1.0	.,.					.	.	.		8.92524e-05	11.0	123246.0	0.0	33	0.86	AS_VQSR	eas	0.000265957	1.0	8.83423e-05	5.0	0.0128881	269.0	20872.0	0.0	5	0.11	PASS	sas	0.0188042	39.0	0.00932951	91.0								12.1	0.819055	0.03	2	16	18	M-CAP_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	PANX2	0.0	0.0	0.0	0.0	24.0	30.0	-43.0	50.0							0.01		0.001	-0.191	homeostasis/metabolism phenotype; skeleton phenotype; limbs/digits/tail phenotype; nervous system phenotype ; 			ciliary ganglion;testis - seminiferous tubule;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;cerebellum peduncles;globus pallidus;	.	response to ischemia;cation transport;cell-cell signaling;protein hexamerization;positive regulation of interleukin-1 secretion;transmembrane transport	cytoplasm;plasma membrane;gap junction;integral component of membrane	wide pore channel activity;gap junction hemi-channel activity	RPN1[30021884];HMGA1[30021884];GRB2[17474147];NRF1[unassigned1304];BANP[unassigned1304];	50616639
51531	chr22	50616644	G	C	chr22:50616644	PANX2	pannexin 2	SNV	0|1	0.17	34_8	48	99.0	0/0	0.0	37_0	37	0.0			rs1407950563	EXONIC	YES	NM_052839.4	Transcript	protein_coding	synonymous_variant		2/3	NM_052839.4:c.1503G>C	NP_443071.2:p.Pro501%3D		1.0						.	.	.		2.64751e-05	3.0	113314.0	0.0	32	0.81	AS_VQSR	afr	3.30753e-05	1.0	1.90709e-05	1.0	0.00686176	151.0	22006.0	0.0	5	0.1	PASS	afr	0.00919118	5.0	0.00427266	43.0								0.153	-0.423697		0	0	0			PANX2	0.0	0.0	0.0	0.0	19.0	25.0	-48.0	45.0							0.01				homeostasis/metabolism phenotype; skeleton phenotype; limbs/digits/tail phenotype; nervous system phenotype ; 			ciliary ganglion;testis - seminiferous tubule;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;cerebellum peduncles;globus pallidus;	.	response to ischemia;cation transport;cell-cell signaling;protein hexamerization;positive regulation of interleukin-1 secretion;transmembrane transport	cytoplasm;plasma membrane;gap junction;integral component of membrane	wide pore channel activity;gap junction hemi-channel activity	RPN1[30021884];HMGA1[30021884];GRB2[17474147];NRF1[unassigned1304];BANP[unassigned1304];	50616644
51536	chr22	50616647	G	C	chr22:50616647	PANX2	pannexin 2	SNV	0|1	0.15	35_7	48	99.0	0/0	0.0	38_0	38	0.0			rs756342745	EXONIC	YES	NM_052839.4	Transcript	protein_coding	synonymous_variant		2/3	NM_052839.4:c.1506G>C	NP_443071.2:p.Pro502%3D		1.0						.	.	.		2.33202e-05	3.0	128644.0	0.0	33	0.88	AS_VQSR	nfe	3.36033e-05	2.0	3.36033e-05	2.0	0.00341201	109.0	31946.0	0.0	5	0.1	PASS	afr	0.00573066	4.0	0.00194607	28.0								0.221	-0.372498		0	0	0			PANX2	0.0	0.0	0.0	0.0	16.0	22.0	-50.0	42.0							0.01				homeostasis/metabolism phenotype; skeleton phenotype; limbs/digits/tail phenotype; nervous system phenotype ; 			ciliary ganglion;testis - seminiferous tubule;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;cerebellum peduncles;globus pallidus;	.	response to ischemia;cation transport;cell-cell signaling;protein hexamerization;positive regulation of interleukin-1 secretion;transmembrane transport	cytoplasm;plasma membrane;gap junction;integral component of membrane	wide pore channel activity;gap junction hemi-channel activity	RPN1[30021884];HMGA1[30021884];GRB2[17474147];NRF1[unassigned1304];BANP[unassigned1304];	50616647
51540	chr22	50616651	G	C	chr22:50616651	PANX2	pannexin 2	SNV	0|1	0.12	37_6	50	99.0	0/0	0.0	39_0	39	0.0			rs746980968	EXONIC	YES	NM_052839.4	Transcript	protein_coding	missense_variant		2/3	NM_052839.4:c.1510G>C	NP_443071.2:p.Ala504Pro		1.0	.,.					.	.	.		7.98952e-06	1.0	125164.0	0.0	33	0.86	AS_VQSR	nfe	1.72765e-05	1.0	1.72765e-05	1.0	0.00249182	96.0	38526.0	0.0	5	0.12	PASS	afr	0.00520833	4.0	0.00132611	23.0								4.745	0.129409	0.086	1	18	19	M-CAP_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PANX2	0.0	0.0	0.0	0.0	15.0	12.0	6.0	38.0							0.01		0.019	1.008	homeostasis/metabolism phenotype; skeleton phenotype; limbs/digits/tail phenotype; nervous system phenotype ; 			ciliary ganglion;testis - seminiferous tubule;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;cerebellum peduncles;globus pallidus;	.	response to ischemia;cation transport;cell-cell signaling;protein hexamerization;positive regulation of interleukin-1 secretion;transmembrane transport	cytoplasm;plasma membrane;gap junction;integral component of membrane	wide pore channel activity;gap junction hemi-channel activity	RPN1[30021884];HMGA1[30021884];GRB2[17474147];NRF1[unassigned1304];BANP[unassigned1304];	50616651
51543	chr22	50617355	G	A	chr22:50617355	PANX2	pannexin 2	SNV	0/0	0.0	33_0	33	99.0	0/1	0.47	30_28	59	99.0			rs181953058	SPLICING	YES	NM_052839.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	2/2		NM_052839.4:c.1691-8G>A			1.0						.	.	.		0.000519027	79.0	152208.0	0.0	33	0.98	PASS	nfe	0.000867417	59.0	0.000867417	59.0	0.000488017	101.0	206960.0	0.0	24	0.61	PASS	nfe	0.000856421	80.0	0.000856421	80.0	0.0004630	72						7.974	0.361899		0	0	0			PANX2	0.01	0.0	0.0	0.0	8.0	47.0	-17.0	-1.0	0.0002208314996162	0.018	8.286	0.892	9.178		0.01				homeostasis/metabolism phenotype; skeleton phenotype; limbs/digits/tail phenotype; nervous system phenotype ; 			ciliary ganglion;testis - seminiferous tubule;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;cerebellum peduncles;globus pallidus;	.	response to ischemia;cation transport;cell-cell signaling;protein hexamerization;positive regulation of interleukin-1 secretion;transmembrane transport	cytoplasm;plasma membrane;gap junction;integral component of membrane	wide pore channel activity;gap junction hemi-channel activity	RPN1[30021884];HMGA1[30021884];GRB2[17474147];NRF1[unassigned1304];BANP[unassigned1304];	50617355
51643	chr22	50885871	G	A	chr22:50885871	SBF1	SET binding factor 1	SNV	0/0	0.0	65_0	65	99.0	0/1	0.51	31_32	63	99.0			rs144773853,COSV53295307	EXONIC	YES	NM_002972.4	Transcript	protein_coding	synonymous_variant		40/41	NM_002972.4:c.5463C>T	NP_002963.2:p.Tyr1821%3D		-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_specified|not_provided	Charcot-Marie-Tooth disease, type 4B3, 615284 (3), Autosomal recessive	Charcot-Marie-Tooth disease type 4B3	Disease-causing germline mutation(s) in	Decreased nerve conduction velocity;Ophthalmoplegia;Urinary incontinence;Scoliosis;Distal sensory impairment;Syndactyly;Microcephaly;Areflexia;Onion bulb formation;Gait disturbance;Strabismus;Intellectual disability;Progressive;Brain atrophy;Limb muscle weakness;Autosomal recessive inheritance;Pes planus		0.00152399	231.0	151576.0	0.0	33	0.96	PASS	sas	0.00684363	33.0	0.00205985	140.0	0.0018365	458.0	249388.0	3.0	83	1.0	PASS	sas	0.00490196	150.0	0.00194511	220.0	0.0018199	283	0.002	5.0				0.291	-0.33321		0	0	0			SBF1	0.2	0.0	0.0	0.0	-20.0	-7.0	-22.0	-48.0						0.0648	0.69	33.720104447			cellular phenotype; endocrine/exocrine gland phenotype; reproductive system phenotype; mortality/aging ; 			caudate nucleus;amygdala;testis - seminiferous tubule;prefrontal cortex;trigeminal ganglion;cingulate cortex;superior cervical ganglion;testis;cerebellum;pons;testis - interstitial;subthalamic nucleus;whole brain;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;	.	protein dephosphorylation;phosphatidylinositol biosynthetic process;spermatogenesis;regulation of GTPase activity	cytoplasm;endoplasmic reticulum membrane;cytosol;integral component of membrane;nuclear body	protein tyrosine/serine/threonine phosphatase activity;phosphatase activity;Rab guanyl-nucleotide exchange factor activity;phosphatase regulator activity	LAMP1[29568061];PDPK1[21900206];TNFSF11[21900206];HSPB1[25277244];SIRT3[19343720];	50885871
51785	chr3	3084045	A	T	chr3:3084045	CNTN4	contactin 4	SNV	0/1	0.49	39_37	76	99.0	0/1	0.45	34_28	62	99.0			rs146888168	EXONIC	YES	NM_001350095.2	Transcript	protein_coding	missense_variant		21/25	NM_001350095.2:c.2450A>T	NP_001337024.1:p.Asp817Val		1.0	Fibronectin type III&Fibronectin type III&Fibronectin type III&Fibronectin type III,Fibronectin type III&Fibronectin type III&Fibronectin type III&Fibronectin type III,Fibronectin type III&Fibronectin type III&Fibronectin type III&Fibronectin type III,.	Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00147847	225.0	152184.0	0.0	33	0.97	PASS	nfe	0.00246928	168.0	0.00246928	168.0	0.00147977	372.0	251390.0	2.0	98	1.0	PASS	nfe	0.00240131	273.0	0.00240131	273.0	0.0013762	214	0.002	5.0	0.00123	14.0		24.4	3.325493	0.501	7	12	19	SIFT,LRT_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	CNTN4	0.0	0.0	0.0	0.0	35.0	0.0	-2.0	-1.0						0.558	1.0	0.000000000	1.0	1.312	nervous system phenotype ; 			ciliary ganglion;appendix;subthalamic nucleus;testis - interstitial;dorsal root ganglion;trigeminal ganglion;skin;atrioventricular node;	.	homophilic cell adhesion via plasma membrane adhesion molecules;neuron cell-cell adhesion;nervous system development;axonogenesis;axon guidance;axonal fasciculation;brain development;neuron projection development;negative regulation of neuron differentiation;regulation of synaptic plasticity;dendrite self-avoidance	extracellular region;plasma membrane;axon;anchored component of membrane	cell-cell adhesion mediator activity	APP[18272596];APLP1[18272596];PLEKHA7[28877994];	3084045
51792	chr3	3216933	C	T	chr3:3216933	CRBN	cereblon	SNV	0/0	0.0	31_0	31	81.0	0/1	0.5	11_12	24	99.0			rs78564552	EXONIC	YES	NM_016302.4	Transcript	protein_coding	missense_variant		2/11	NM_016302.4:c.88G>A	NP_057386.2:p.Glu30Lys		-1.0	.,.,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	not_specified|not_provided	Mental retardation, autosomal recessive 2, 607417 (3), Autosomal recessive	Autosomal recessive non-syndromic intellectual disability	Disease-causing germline mutation(s) in	Autosomal recessive inheritance;Intellectual disability, severe;Attention deficit hyperactivity disorder;Global developmental delay;Seizure;Intellectual disability, mild;Dystonia;Cerebral atrophy;Cerebral visual impairment;Autistic behavior;Intellectual disability, mild;Generalized hypotonia;Hypoplasia of the corpus callosum;Poor speech;Multifocal epileptiform discharges;Large basal ganglia;Stereotypy;Hypsarrhythmia;Microcephaly;Motor delay;Hyperactivity;Absent septum pellucidum;Delayed speech and language development;Intellectual disability, moderate;Chorea;Nasogastric tube feeding;Impulsivity;Sleep disturbance;Epileptic spasm;Short attention span;Global developmental delay;Depressivity;Intellectual disability, severe;Cortical dysplasia;Polymicrogyria;Abnormal facial shape;Generalized-onset seizure;Dyskinesia;Focal-onset seizure;Spasticity	25741868	0.00260766	396.0	151860.0	0.0	33	0.96	PASS	nfe	0.00470879	320.0	0.00470879	320.0	0.00259944	653.0	251208.0	3.0	79	0.99	PASS	nfe	0.00483173	549.0	0.00483173	549.0	0.0027716	431	0.001	4.0	0.00237	27.0		23.5	2.968006	0.369	6	12	18	LRT_pred,MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	CRBN	0.0	0.03	0.0	0.0	28.0	17.0	15.0	-21.0						0.219	0.04	0.000000000	1.0	1.026	liver/biliary system phenotype; behavior/neurological phenotype ; cardiovascular system phenotype ; reproductive system phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype ; growth/size/body region phenotype; 			amygdala;white blood cells;occipital lobe;testis - seminiferous tubule;prefrontal cortex;subthalamic nucleus;dorsal root ganglion;cingulate cortex;parietal lobe;	.	protein ubiquitination;negative regulation of protein homooligomerization;negative regulation of ion transmembrane transport;proteasome-mediated ubiquitin-dependent protein catabolic process;positive regulation of protein homodimerization activity	nucleus;nucleolus;cytoplasm;membrane;Cul4A-RING E3 ubiquitin ligase complex	protein binding;metal ion binding	KDM1A[23455924];SUV39H1[23455924];GPS1[27029275];PIK3R3[25814554];COPS7A[27029275];NEDD8[27029275];IKZF1[26183205;24292623];IKZF3[24292623];NUDCD1[29021621];MISP[unassigned1304];APPL2[25814554];PAK5[25416956];RBPMS[25416956];CSNK1A1[26131937;26909574];GTF2F2[20195357];RBX1[27029275];DDB1[24292623;26131937;26909574];CUL4A[24292623;27029275];COPS4[27029275];COPS3[27029275];COPS6[19615732;27029275];COPS5[27029275];COPS2[27029275];GRB2[25814554];COPS8[27029275];	3216933
51984	chr3	10018740	AA		chr3:10018740-10018741	EMC3	ER membrane protein complex subunit 3	sequence_alteration	0/2	0.13	6_2_4	15	42.0	0/1	0.55	3_6_2	11	31.0			rs76003899	SPLICING	YES	NM_018447.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	3/8		NM_018447.4:c.214-7_214-6del			-1.0						.	.	.		1.48573e-05	2.0	134614.0	0.0	31	0.88	PASS				0.0	0.0	0.00439755	496.0	112790.0	0.0	42	0.77	InbreedingCoeff	amr	0.00592688	83.0	0.00377787	203.0	0.0000064	1						3.732	0.068413		0	0	0			EMC3	0.01	0.0	0.0	0.0	-42.0	-5.0	-21.0	-23.0							0.8				.			.	.	biological_process;protein folding in endoplasmic reticulum	integral component of membrane;ER membrane protein complex	molecular_function	OFD1[26638075];MMGT1[26496610];DCTN1[26638075];RPGRIP1L[26638075];MTAP[unassigned1304];TMEM17[26638075];TCTN3[26638075];TMEM237[26638075];TCTN2[26638075];TMEM216[26638075];TMEM67[26638075];EMC2[26496610];TCTN1[26638075];CANX[29568061];IKBKE[17353931];	10018739
52110	chr3	10106408	C	T	chr3:10106408	FANCD2	FA complementation group D2	SNV	0/1	0.2	35_9	44	99.0	0/0	0.0	33_0	33	99.0			rs4019784,COSV55031929	SPLICING	YES	NM_033084.6	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	22/42		NM_033084.6:c.2022-5C>T			1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Fanconi_anemia,_complementation_group_D2|Fanconi_anemia,_complementation_group_A|Fanconi_anemia|not_specified|not_provided	Fanconi anemia, complementation group D2, 227646 (3), Autosomal recessive	Fanconi anemia	Disease-causing germline mutation(s) in	Hydroureter;Hypopigmented skin patches;Cranial nerve paralysis;Umbilical hernia;Epicanthus;Weight loss;Choanal atresia;Myelodysplasia;Hypogonadism;Scoliosis;Hip dislocation;Recurrent urinary tract infections;Abnormality of the hypothalamus-pituitary axis;Short palpebral fissure;Hypertrophic cardiomyopathy;High palate;Aplasia/Hypoplasia of the iris;Decreased fertility in males;Aplasia/Hypoplasia of fingers;Toe syndactyly;Irregular hyperpigmentation;Almond-shaped palpebral fissure;Tetralogy of Fallot;Astigmatism;Pyridoxine-responsive sideroblastic anemia;Meckel diverticulum;Hypertelorism;Sloping forehead;Ptosis;Anal atresia;Cryptorchidism;Intellectual disability;Facial asymmetry;Visual impairment;Upslanted palpebral fissure;Duodenal stenosis;Abnormality of the liver;Aplasia/Hypoplasia of the uvula;Abnormal carotid artery morphology;Hypospadias;Nystagmus;Multiple cafe-au-lait spots;Renal insufficiency;Clinodactyly of the 5th finger;Bicornuate uterus;Abnormality of chromosome stability;Strabismus;Micrognathia;Hypoplasia of the ulna;Proptosis;Atrial septal defect;Abnormal aortic valve morphology;Abnormality of femur morphology;Cataract;Microphthalmia;Hydrocephalus;Ventriculomegaly;Aganglionic megacolon;Absent testis;Hearing impairment;Arteriovenous malformation;Azoospermia;Renal hypoplasia/aplasia;Thrombocytopenia;Finger syndactyly;Oligohydramnios;External ear malformation;Global developmental delay;Aplasia/Hypoplasia of the radius;Reduced bone mineral density;Clubbing of toes;Microcephaly;Abnormal aortic morphology;Frontal bossing;Dolichocephaly;Spina bifida;Leukopenia;Tracheoesophageal fistula;Patent ductus arteriosus;Abnormality of the preputium;Hyperreflexia;Short stature;Abnormal localization of kidney;Cleft palate;Triphalangeal thumb;Intrauterine growth retardation;Pes planus;Complete duplication of thumb phalanx;Abnormal heart morphology;Intellectual disability;Cafe-au-lait spot;Bruising susceptibility;Small for gestational age;Anemia;Neutropenia;Ectopic kidney;Abnormality of cardiovascular system morphology;Duplicated collecting system;Prolonged G2 phase of cell cycle;Chromosomal breakage induced by crosslinking agents;Microphthalmia;Autosomal recessive inheritance;Short stature;Hearing impairment;Leukemia;Renal agenesis;Thrombocytopenia;Deficient excision of UV-induced pyrimidine dimers in DNA;Anemic pallor;Horseshoe kidney;Absent thumb;Cryptorchidism;Reticulocytopenia;Hypergonadotropic hypogonadism;Absent radius;Short thumb;Strabismus;Pancytopenia;Abnormality of skin pigmentation;Microcephaly		0.00211527	274.0	129534.0	0.0	32	0.91	AS_VQSR	afr	0.0034582	113.0	0.00121122	73.0	0.000277051	68.0	245442.0	0.0	100	1.0	PASS	eas	0.000337458	6.0	0.00013412	15.0	0.0002508	39	0.0	1.0	0.01996	204.0		9.378	0.497311		0	0	0			FANCD2	0.0	0.0	0.0	0.0	28.0	-15.0	28.0	31.0	1.37218908427361e-05	0.002	8.436	0.989	9.424	0.989	0.0				neoplasm; mortality/aging ; reproductive system phenotype; hematopoietic system phenotype; behavior/neurological phenotype ; immune system phenotype; vision/eye phenotype; nervous system phenotype ; limbs/digits/tail phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			dorsal root ganglion;trigeminal ganglion;atrioventricular node;	Homologous recombination;Pancreatic cancer	DNA repair;synapsis;gamete generation;response to gamma radiation;cellular response to oxidative stress;interstrand cross-link repair;regulation of regulatory T cell differentiation;brain morphogenesis;regulation of inflammatory response;regulation of DNA-binding transcription factor activity;neuronal stem cell population maintenance;regulation of CD40 signaling pathway	condensed chromosome;nucleus;nucleoplasm;nucleolus;cytosol;nuclear body	protein binding;DNA polymerase binding	PIGS[26496610];MDC1[12607005;29656893];MRE11[19609304];CEBPD[20805509];YEATS4[26496610];TPTE[28330616];BRCA1[11239454;29656893];JRKL[26496610];BRCA2[15115758;18212739];FAAP20[22266823];IPO4[20805509];CDC42[26496610];BAG6[26496610];MYC[17314511];EMC2[26496610];CDK20[23602568];NBN[19609304];MEN1[12874027];FANCI[20603015;17460694];HELQ[24005329];H2AFX[19609304];CDC5L[20467437];FANCE[12093742;12649160];TNFRSF1B[14743216];FANCG[18212739];TNFRSF1A[14743216];RAD50[19609304];TRAF6[14743216];FSCN1[20603015];HNRNPD[26496610];CNTROB[26496610];ITGB3BP[26496610];EPHA2[26496610];	10106408
52125	chr3	10291082	G	C	chr3:10291082	TATDN2	TatD DNase domain containing 2	SNV	0/0	0.0	42_0	42	99.0	0|1	0.44	75_59	134	99.0			rs752667287,COSV55052822	EXONIC	YES	NM_014760.4	Transcript	protein_coding	synonymous_variant		2/8	NM_014760.4:c.198G>C	NP_055575.3:p.Ser66%3D		1.0						.	.	.		0.000315325	48.0	152224.0	0.0	33	0.98	PASS	nfe	0.000602658	41.0	0.000602658	41.0	0.000356223	88.0	247036.0	0.0	38	0.91	PASS	nfe	0.000604584	67.0	0.000604584	67.0	0.0002315	36	0.001	3.0				9.217	0.48045		0	0	0			TATDN2	0.0	0.0	0.02	0.0	33.0	1.0	5.0	-12.0						0.747	0.0	0.020793813			.			pons;trigeminal ganglion;atrioventricular node;cingulate cortex;superior cervical ganglion;parietal lobe;skeletal muscle;cerebellum;	.	DNA metabolic process;IRE1-mediated unfolded protein response;nucleic acid phosphodiester bond hydrolysis	nucleus;nucleoplasm;cytosol;nuclear speck	endodeoxyribonuclease activity, producing 5'-phosphomonoesters;metal ion binding	.	10291082
52128	chr3	10291083	C	T	chr3:10291083	TATDN2	TatD DNase domain containing 2	SNV	0/0	0.0	42_0	42	99.0	0|1	0.44	75_59	134	99.0			rs144351497	EXONIC	YES	NM_014760.4	Transcript	protein_coding	missense_variant		2/8	NM_014760.4:c.199C>T	NP_055575.3:p.Arg67Trp		1.0	.,.					.	.	.		0.000315325	48.0	152224.0	0.0	32	0.98	PASS	nfe	0.000602551	41.0	0.000602551	41.0	0.000356223	88.0	247036.0	0.0	38	0.91	PASS	nfe	0.00060477	67.0	0.00060477	67.0	0.0002379	37	0.001	2.0				23.3	2.860903	0.072	2	17	19	SIFT,Polyphen2_HDIV_pred	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TATDN2	0.0	0.0	0.04	0.0	5.0	6.0	4.0	33.0						0.747	0.0	0.000000000	0.003	1.011	.			pons;trigeminal ganglion;atrioventricular node;cingulate cortex;superior cervical ganglion;parietal lobe;skeletal muscle;cerebellum;	.	DNA metabolic process;IRE1-mediated unfolded protein response;nucleic acid phosphodiester bond hydrolysis	nucleus;nucleoplasm;cytosol;nuclear speck	endodeoxyribonuclease activity, producing 5'-phosphomonoesters;metal ion binding	.	10291083
52201	chr3	12046236	TAAGA		chr3:12046236-12046240	SYN2	synapsin II	deletion	1|1	1.0	0_34	34	99.0	1|1	1.0	0_15	15	45.0			rs782195645	SPLICING	YES	NM_133625.6	Transcript	protein_coding	splice_donor_variant,splice_donor_5th_base_variant,intron_variant	1/13		NM_133625.6:c.210+1_210+5del			1.0					{Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant	.	.	Autosomal dominant inheritance;Social and occupational deterioration;Hallucinations;Heterogeneous;Schizophrenia;Delusions;Negativism;EEG abnormality						33	0.92								0.0	0.0	0.0	0	0.0	AC0					0.0	0.0019935	310	0.001	2.0	0.79881	4705.0		10.2	0.587418		0	0	0																						behavior/neurological phenotype ; nervous system phenotype ; 			.	.	chemical synaptic transmission;neurotransmitter secretion;synaptic vesicle clustering	plasma membrane;postsynaptic density;cell junction;synaptic vesicle membrane;SNARE complex;myelin sheath;synapse;Schaffer collateral - CA1 synapse;glutamatergic synapse	ATP binding	IQCB1[21565611];CHRM4[28298427];	12046235
52203	chr3	12046242	GCGCCGA		chr3:12046242-12046248	SYN2	synapsin II	deletion	1|1	1.0	0_32	32	96.0	1|1	1.0	0_15	15	45.0				SPLICING	YES	NM_133625.6	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/13		NM_133625.6:c.210+7_210+13del			1.0					{Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant	.	.	Autosomal dominant inheritance;Social and occupational deterioration;Hallucinations;Heterogeneous;Schizophrenia;Delusions;Negativism;EEG abnormality						31	0.88								0.0	0.0	0.0	0	0.0	AC0					0.0					0.79306	4752.0		10.15	0.58138		0	0	0																						behavior/neurological phenotype ; nervous system phenotype ; 			.	.	chemical synaptic transmission;neurotransmitter secretion;synaptic vesicle clustering	plasma membrane;postsynaptic density;cell junction;synaptic vesicle membrane;SNARE complex;myelin sheath;synapse;Schaffer collateral - CA1 synapse;glutamatergic synapse	ATP binding	IQCB1[21565611];CHRM4[28298427];	12046241
52210	chr3	12046257	CCCCCCCCC		chr3:12046257-12046265	SYN2	synapsin II	deletion	1|1	1.0	0_35	35	99.0	1|1	1.0	0_16	16	48.0				SPLICING	YES	NM_133625.6	Transcript	protein_coding	splice_acceptor_variant,splice_polypyrimidine_tract_variant,coding_sequence_variant,intron_variant	1/13	2/14	NM_133625.6:c.211-3_216del			1.0					{Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant	.	.	Autosomal dominant inheritance;Social and occupational deterioration;Hallucinations;Heterogeneous;Schizophrenia;Delusions;Negativism;EEG abnormality						0	0.0								0.0	0.0	0.0	0	0.0	AC0					0.0	0.0026559	413			0.93957	6701.0		9.921	0.55661		0	0	0																						behavior/neurological phenotype ; nervous system phenotype ; 			.	.	chemical synaptic transmission;neurotransmitter secretion;synaptic vesicle clustering	plasma membrane;postsynaptic density;cell junction;synaptic vesicle membrane;SNARE complex;myelin sheath;synapse;Schaffer collateral - CA1 synapse;glutamatergic synapse	ATP binding	IQCB1[21565611];CHRM4[28298427];	12046256
52213	chr3	12046269	CGCCG		chr3:12046269-12046273	SYN2	synapsin II	deletion	1|1	1.0	0_35	35	99.0	1|1	1.0	0_16	16	48.0			rs782162668	EXONIC	YES	NM_133625.6	Transcript	protein_coding	frameshift_variant		2/14	NM_133625.6:c.218_222del	NP_598328.1:p.Ala73AspfsTer66		1.0					{Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant	.	.	Autosomal dominant inheritance;Social and occupational deterioration;Hallucinations;Heterogeneous;Schizophrenia;Delusions;Negativism;EEG abnormality						0	0.0							0.0	0.0	10.0	0.0	0	0.0	AC0				0.0	0.0	0.0026494	412	0.002	6.0	0.9172	6613.0		9.898	0.554059		0	0	0																						behavior/neurological phenotype ; nervous system phenotype ; 			.	.	chemical synaptic transmission;neurotransmitter secretion;synaptic vesicle clustering	plasma membrane;postsynaptic density;cell junction;synaptic vesicle membrane;SNARE complex;myelin sheath;synapse;Schaffer collateral - CA1 synapse;glutamatergic synapse	ATP binding	IQCB1[21565611];CHRM4[28298427];	12046268
52216	chr3	12046276	G	G	chr3:12046276	SYN2	synapsin II	SNV	1|1	1.0	0_46	46	99.0	1|1	1.0	0_28	28	84.0			rs71624922	EXONIC	YES	NM_133625.6	Transcript	protein_coding	synonymous_variant		2/14	NM_133625.6:c.225A>G	NP_598328.1:p.Thr75%3D		1.0					{Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant	.	.	Autosomal dominant inheritance;Social and occupational deterioration;Hallucinations;Heterogeneous;Schizophrenia;Delusions;Negativism;EEG abnormality						0	0.0								0.0	0.0	0.0	0	0.0	AC0					0.0	0.0054790,0.0000064	852,1	0.002	6.0	0.98754	5546.0		12.48	0.868257		0	0	0			SYN2	0.0	0.0	0.0	0.0	41.0	-25.0	-42.0	42.0											behavior/neurological phenotype ; nervous system phenotype ; 			.	.	chemical synaptic transmission;neurotransmitter secretion;synaptic vesicle clustering	plasma membrane;postsynaptic density;cell junction;synaptic vesicle membrane;SNARE complex;myelin sheath;synapse;Schaffer collateral - CA1 synapse;glutamatergic synapse	ATP binding	IQCB1[21565611];CHRM4[28298427];	12046276
52219	chr3	12046297	C	C	chr3:12046297	SYN2	synapsin II	SNV	1|1	1.0	0_64	64	99.0	1|1	1.0	0_40	40	99.0			rs71624923	EXONIC	YES	NM_133625.6	Transcript	protein_coding	synonymous_variant		2/14	NM_133625.6:c.246A>C	NP_598328.1:p.Phe82%3D		1.0					{Schizophrenia, susceptibility to}, 181500 (3), Autosomal dominant	.	.	Autosomal dominant inheritance;Social and occupational deterioration;Hallucinations;Heterogeneous;Schizophrenia;Delusions;Negativism;EEG abnormality						0	0.0								0.0	0.0	0.0	0	0.0	AC0					0.0	0.0000064,0.0000064,0.0000322,0.0001479,0.0000322,0.0000322,0.0000193,0.0000386,0.0663070,0.0001029,0.0001736,0.0000643,0.0001029,0.0000257,0.0000193,0.0000514	1,1,5,23,5,5,3,6,10311,16,27,10,16,4,3,8	0.006	18.0	0.73618	6870.0		15.17	1.29558		0	0	0			SYN2	0.0	0.0	0.0	0.0	-6.0	20.0	21.0	-19.0											behavior/neurological phenotype ; nervous system phenotype ; 			.	.	chemical synaptic transmission;neurotransmitter secretion;synaptic vesicle clustering	plasma membrane;postsynaptic density;cell junction;synaptic vesicle membrane;SNARE complex;myelin sheath;synapse;Schaffer collateral - CA1 synapse;glutamatergic synapse	ATP binding	IQCB1[21565611];CHRM4[28298427];	12046297
52294	chr3	14444244	T		chr3:14444244	SLC6A6	solute carrier family 6 member 6	deletion	1|1	1.0	0_121	121	99.0	1|1	0.99	0_96	97	99.0			rs67046817,COSV62647327	SPLICING	YES	NM_001134367.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,coding_sequence_variant	1/21		NM_001134367.3:c.150+1del			1.0					Hypotaurinemic retinal degeneration and cardiomyopathy, 145350 (3), Autosomal recessive	.	.	.						0	0.0											0	0.0							0.0001137,0.0001516,0.0457957,0.0001137,0.0001137,0.7709834	3,4,1208,3,3,20337	0.001	2.0	1.0	8398.0		11.71	0.769889		0	0	0			SLC6A6	0.0	0.0	0.0	0.03	-26.0	42.0	-4.0	20.0						0.301	0.98				cardiovascular system phenotype ; reproductive system phenotype; behavior/neurological phenotype ; vision/eye phenotype; muscle phenotype; nervous system phenotype ; growth/size/body region phenotype; homeostasis/metabolism phenotype; 			pons;ciliary ganglion;tongue;subthalamic nucleus;atrioventricular node;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;	.	amino acid transmembrane transport;cellular amino acid metabolic process;neurotransmitter transport;amino acid transport;taurine transport	plasma membrane;integral component of plasma membrane;integral component of membrane	neurotransmitter:sodium symporter activity;taurine:sodium symporter activity;amino acid transmembrane transporter activity	TMEM17[26638075];HSPA5[30021884];TMEM216[26638075];	14444243
52296	chr3	14444250	T		chr3:14444250	SLC6A6	solute carrier family 6 member 6	deletion	1|1	1.0	0_121	121	99.0	1|1	1.0	0_96	96	99.0			rs66528743,COSV62647330	SPLICING	YES	NM_001134367.3	Transcript	protein_coding	splice_region_variant,coding_sequence_variant	2/21		NM_001134367.3:c.155+1del			1.0					Hypotaurinemic retinal degeneration and cardiomyopathy, 145350 (3), Autosomal recessive	.	.	.						0	0.0											0	0.0							0.0455683,0.0003033,0.0001896,0.0001137,0.4830541	1202,8,5,3,12742			1.0	8398.0		11.88	0.790884		0	0	0			SLC6A6	0.0	0.0	0.0	0.01	-32.0	1.0	-13.0	14.0						0.301	0.98				cardiovascular system phenotype ; reproductive system phenotype; behavior/neurological phenotype ; vision/eye phenotype; muscle phenotype; nervous system phenotype ; growth/size/body region phenotype; homeostasis/metabolism phenotype; 			pons;ciliary ganglion;tongue;subthalamic nucleus;atrioventricular node;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;	.	amino acid transmembrane transport;cellular amino acid metabolic process;neurotransmitter transport;amino acid transport;taurine transport	plasma membrane;integral component of plasma membrane;integral component of membrane	neurotransmitter:sodium symporter activity;taurine:sodium symporter activity;amino acid transmembrane transporter activity	TMEM17[26638075];HSPA5[30021884];TMEM216[26638075];	14444249
52303	chr3	14444277	C		chr3:14444277	SLC6A6	solute carrier family 6 member 6	deletion	1|1	1.0	0_92	92	99.0	1|1	1.0	0_83	83	99.0			rs1574897616	SPLICING	YES	NM_001134367.3	Transcript	protein_coding	splice_acceptor_variant,frameshift_variant		3/22	NM_001134367.3:c.182+1del			1.0					Hypotaurinemic retinal degeneration and cardiomyopathy, 145350 (3), Autosomal recessive	.	.	.						32	0.97											0	0.0							0.0002275,0.0001516,0.0001137,0.0004549,0.0003791,0.0000379,0.0001516,0.0000379,0.0330199,0.4781636,0.0001896	6,4,3,12,10,1,4,1,871,12613,5			1.0	8398.0		9.585	0.519468		0	0	0			SLC6A6	0.0	0.0	0.01	0.0	41.0	4.0	-13.0	-37.0						0.301	0.98				cardiovascular system phenotype ; reproductive system phenotype; behavior/neurological phenotype ; vision/eye phenotype; muscle phenotype; nervous system phenotype ; growth/size/body region phenotype; homeostasis/metabolism phenotype; 			pons;ciliary ganglion;tongue;subthalamic nucleus;atrioventricular node;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;	.	amino acid transmembrane transport;cellular amino acid metabolic process;neurotransmitter transport;amino acid transport;taurine transport	plasma membrane;integral component of plasma membrane;integral component of membrane	neurotransmitter:sodium symporter activity;taurine:sodium symporter activity;amino acid transmembrane transporter activity	TMEM17[26638075];HSPA5[30021884];TMEM216[26638075];	14444276
52309	chr3	14444286	C		chr3:14444286	SLC6A6	solute carrier family 6 member 6	deletion	1|1	1.0	0_89	89	99.0	1|1	1.0	0_76	76	99.0				SPLICING	YES	NM_001134367.3	Transcript	protein_coding	splice_acceptor_variant,frameshift_variant		4/22	NM_001134367.3:c.190+1del			1.0					Hypotaurinemic retinal degeneration and cardiomyopathy, 145350 (3), Autosomal recessive	.	.	.						0	0.0											0	0.0							0.0001516,0.0001896,0.0345743,0.4783153,0.0007582,0.0000379	4,5,912,12617,20,1			1.0	8398.0		9.513	0.511754		0	0	0			SLC6A6	0.0	0.0	0.0	0.01	32.0	-1.0	-49.0	-22.0						0.301	0.98				cardiovascular system phenotype ; reproductive system phenotype; behavior/neurological phenotype ; vision/eye phenotype; muscle phenotype; nervous system phenotype ; growth/size/body region phenotype; homeostasis/metabolism phenotype; 			pons;ciliary ganglion;tongue;subthalamic nucleus;atrioventricular node;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;	.	amino acid transmembrane transport;cellular amino acid metabolic process;neurotransmitter transport;amino acid transport;taurine transport	plasma membrane;integral component of plasma membrane;integral component of membrane	neurotransmitter:sodium symporter activity;taurine:sodium symporter activity;amino acid transmembrane transporter activity	TMEM17[26638075];HSPA5[30021884];TMEM216[26638075];	14444285
52312	chr3	14444309	T		chr3:14444309	SLC6A6	solute carrier family 6 member 6	deletion	1|1	1.0	0_67	67	99.0	1|1	1.0	0_58	58	99.0			rs68047955,COSV62647343	EXONIC	YES	NM_001134367.3	Transcript	protein_coding	coding_sequence_variant	5/21		NM_001134367.3:c.211+1del			1.0					Hypotaurinemic retinal degeneration and cardiomyopathy, 145350 (3), Autosomal recessive	.	.	.						0	0.0											0	0.0							0.0000379,0.0000379,0.0312761,0.0001516,0.0001516,0.4743726	1,1,825,4,4,12513			1.0	8398.0		7.338	0.309791		0	0	0			SLC6A6	0.0	0.0	0.0	0.03	18.0	9.0	-24.0	-45.0						0.301	0.98				cardiovascular system phenotype ; reproductive system phenotype; behavior/neurological phenotype ; vision/eye phenotype; muscle phenotype; nervous system phenotype ; growth/size/body region phenotype; homeostasis/metabolism phenotype; 			pons;ciliary ganglion;tongue;subthalamic nucleus;atrioventricular node;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;	.	amino acid transmembrane transport;cellular amino acid metabolic process;neurotransmitter transport;amino acid transport;taurine transport	plasma membrane;integral component of plasma membrane;integral component of membrane	neurotransmitter:sodium symporter activity;taurine:sodium symporter activity;amino acid transmembrane transporter activity	TMEM17[26638075];HSPA5[30021884];TMEM216[26638075];	14444308
52317	chr3	14444319	T		chr3:14444319	SLC6A6	solute carrier family 6 member 6	deletion	1|1	1.0	0_63	63	99.0	1|1	1.0	0_49	49	99.0			rs67637606,COSV62650056	EXONIC	YES	NM_001134367.3	Transcript	protein_coding	coding_sequence_variant	6/21		NM_001134367.3:c.220+1del			1.0					Hypotaurinemic retinal degeneration and cardiomyopathy, 145350 (3), Autosomal recessive	.	.	.						0	0.0											0	0.0							0.0002654,0.0310107,0.4724771	7,818,12463			1.0	8398.0		8.554	0.414607		0	0	0			SLC6A6	0.0	0.0	0.0	0.0	8.0	-1.0	37.0	38.0						0.301	0.98				cardiovascular system phenotype ; reproductive system phenotype; behavior/neurological phenotype ; vision/eye phenotype; muscle phenotype; nervous system phenotype ; growth/size/body region phenotype; homeostasis/metabolism phenotype; 			pons;ciliary ganglion;tongue;subthalamic nucleus;atrioventricular node;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;	.	amino acid transmembrane transport;cellular amino acid metabolic process;neurotransmitter transport;amino acid transport;taurine transport	plasma membrane;integral component of plasma membrane;integral component of membrane	neurotransmitter:sodium symporter activity;taurine:sodium symporter activity;amino acid transmembrane transporter activity	TMEM17[26638075];HSPA5[30021884];TMEM216[26638075];	14444318
52324	chr3	14444327	T		chr3:14444327	SLC6A6	solute carrier family 6 member 6	deletion	1|1	1.0	0_59	59	99.0	1|1	1.0	0_46	46	99.0			rs66654032,COSV62651580	SPLICING	YES	NM_001134367.3	Transcript	protein_coding	frameshift_variant,splice_region_variant,splice_polypyrimidine_tract_variant		7/22	NM_001134367.3:c.228del	NP_001127839.2:p.Asp76GlufsTer19		1.0					Hypotaurinemic retinal degeneration and cardiomyopathy, 145350 (3), Autosomal recessive	.	.	.						0	0.0											0	0.0							0.0308970,0.1894382	815,4997			1.0	8398.0		9.344	0.4937		0	0	0			SLC6A6	0.0	0.0	0.0	0.0	3.0	-9.0	-42.0	29.0						0.301	0.98				cardiovascular system phenotype ; reproductive system phenotype; behavior/neurological phenotype ; vision/eye phenotype; muscle phenotype; nervous system phenotype ; growth/size/body region phenotype; homeostasis/metabolism phenotype; 			pons;ciliary ganglion;tongue;subthalamic nucleus;atrioventricular node;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;	.	amino acid transmembrane transport;cellular amino acid metabolic process;neurotransmitter transport;amino acid transport;taurine transport	plasma membrane;integral component of plasma membrane;integral component of membrane	neurotransmitter:sodium symporter activity;taurine:sodium symporter activity;amino acid transmembrane transporter activity	TMEM17[26638075];HSPA5[30021884];TMEM216[26638075];	14444326
52327	chr3	14444330	T		chr3:14444330	SLC6A6	solute carrier family 6 member 6	deletion	1|1	1.0	0_58	58	99.0	1|1	1.0	0_46	46	99.0			rs67559364,COSV62651585	EXONIC	YES	NM_001134367.3	Transcript	protein_coding	coding_sequence_variant	7/21		NM_001134367.3:c.230-1del			1.0					Hypotaurinemic retinal degeneration and cardiomyopathy, 145350 (3), Autosomal recessive	.	.	.						0	0.0											0	0.0							0.0301767,0.0001896,0.0001516,0.0001137,0.1122526	796,5,4,3,2961			1.0	8398.0		8.86	0.444212		0	0	0			SLC6A6	0.0	0.0	0.0	0.0	27.0	49.0	-4.0	26.0						0.301	0.98				cardiovascular system phenotype ; reproductive system phenotype; behavior/neurological phenotype ; vision/eye phenotype; muscle phenotype; nervous system phenotype ; growth/size/body region phenotype; homeostasis/metabolism phenotype; 			pons;ciliary ganglion;tongue;subthalamic nucleus;atrioventricular node;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;	.	amino acid transmembrane transport;cellular amino acid metabolic process;neurotransmitter transport;amino acid transport;taurine transport	plasma membrane;integral component of plasma membrane;integral component of membrane	neurotransmitter:sodium symporter activity;taurine:sodium symporter activity;amino acid transmembrane transporter activity	TMEM17[26638075];HSPA5[30021884];TMEM216[26638075];	14444329
52406	chr3	16358506	A	G	chr3:16358506	RFTN1	raftlin, lipid raft linker 1	SNV	0/1	0.44	65_51	116	99.0	0/0	0.0	33_0	33	99.0			rs71310334,COSV100490029	EXONIC	YES	NM_015150.2	Transcript	protein_coding	synonymous_variant		10/10	NM_015150.2:c.1566T>C	NP_055965.1:p.Pro522%3D		-1.0						.	.	.		0.00640292	973.0	151962.0	5.0	32	0.94	PASS	nfe	0.00881297	599.0	0.00881297	599.0	0.00673656	1690.0	250870.0	6.0	95	1.0	PASS	nfe	0.00988341	1119.0	0.00988341	1119.0	0.0068744	1069	0.01	31.0				0.089	-0.498614		0	0	0			RFTN1	0.0	0.0	0.0	0.0	8.0	-46.0	-18.0	13.0						0.882	0.0	61.768774340			hematopoietic system phenotype; immune system phenotype; 			superior cervical ganglion;	.	membrane raft assembly;T cell antigen processing and presentation;protein transport into membrane raft;interleukin-17 production;dsRNA transport;toll-like receptor 3 signaling pathway;positive regulation of growth rate;response to exogenous dsRNA;T cell receptor signaling pathway;B cell receptor signaling pathway;protein localization to membrane raft	cytoplasm;endosome;early endosome;plasma membrane;protein-containing complex;membrane raft;extracellular exosome	double-stranded RNA binding	LAMP1[29568061];BTK[19214191];	16358506
52414	chr3	16926540	T		chr3:16926540	PLCL2	phospholipase C like 2	deletion	1|1	1.0	0_7	7	21.0	1|1	1.0	0_9	9	27.0			rs587725102,COSV67620418	EXONIC	YES	NM_001144382.2	Transcript	protein_coding	coding_sequence_variant	1/8		NM_001144382.2:c.5+1del			1.0						.	.	.						0	0.0								0.0	0.0	0.0	0	0.0	AC0					0.0	0.0000064,0.0043279,0.0498444	1,673,7751	0.029	90.0				15.42	1.344508		0	0	0																		1.0				homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype; 			ciliary ganglion;amygdala;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;skin;cingulate cortex;cerebellum;occipital lobe;fetal brain;dorsal root ganglion;atrioventricular node;skeletal muscle;globus pallidus;medulla oblongata;	.	B cell proliferation involved in immune response;B-1a B cell differentiation;lipid metabolic process;gamma-aminobutyric acid signaling pathway;regulation of synaptic transmission, GABAergic;inositol trisphosphate biosynthetic process;regulation of peptidyl-serine phosphorylation;intracellular signal transduction;negative regulation of B cell receptor signaling pathway;negative regulation of cold-induced thermogenesis;positive regulation of receptor binding	cytoplasm	phosphatidylinositol phospholipase C activity;GABA receptor binding;inositol 1,4,5 trisphosphate binding	SLC35F5[unassigned1312];SHOC2[unassigned1312];DSCAML1[12421765];PPP1CA[15231748];	16926539
52416	chr3	16926544	T	G	chr3:16926544	PLCL2	phospholipase C like 2	SNV	1|1	1.0	0_10	10	30.0	1|1	1.0	0_10	10	30.0			rs368284573,COSV67620674	EXONIC	YES	NM_001144382.2	Transcript	protein_coding	splice_donor_5th_base_variant,missense_variant		2/9	NM_001144382.2:c.9T>G	NP_001137854.1:p.Asp3Glu		1.0						.	.	.						0	0.0								0.0	0.0	0.0	0	0.0	AC0					0.0	0.0222502,0.0000257	3460,4						16.58	1.554116		0	2	2		SIFT,PolyPhen																1.0				homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype; 			ciliary ganglion;amygdala;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;skin;cingulate cortex;cerebellum;occipital lobe;fetal brain;dorsal root ganglion;atrioventricular node;skeletal muscle;globus pallidus;medulla oblongata;	.	B cell proliferation involved in immune response;B-1a B cell differentiation;lipid metabolic process;gamma-aminobutyric acid signaling pathway;regulation of synaptic transmission, GABAergic;inositol trisphosphate biosynthetic process;regulation of peptidyl-serine phosphorylation;intracellular signal transduction;negative regulation of B cell receptor signaling pathway;negative regulation of cold-induced thermogenesis;positive regulation of receptor binding	cytoplasm	phosphatidylinositol phospholipase C activity;GABA receptor binding;inositol 1,4,5 trisphosphate binding	SLC35F5[unassigned1312];SHOC2[unassigned1312];DSCAML1[12421765];PPP1CA[15231748];	16926544
52418	chr3	16926549	T		chr3:16926549	PLCL2	phospholipase C like 2	deletion	1|1	1.0	0_10	10	30.0	1|1	1.0	0_11	11	33.0			rs587740988	SPLICING	YES	NM_001144382.2	Transcript	protein_coding	frameshift_variant,splice_region_variant,splice_polypyrimidine_tract_variant		2/9	NM_001144382.2:c.14del	NP_001137854.1:p.Val5GlyfsTer24		1.0						.	.	.						0	0.0								0.0	0.0	0.0	0	0.0	AC0					0.0	0.0000450,0.0033890,0.0469506	7,527,7301	0.051	160.0				15.83	1.4217		0	0	0																		1.0				homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype; 			ciliary ganglion;amygdala;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;skin;cingulate cortex;cerebellum;occipital lobe;fetal brain;dorsal root ganglion;atrioventricular node;skeletal muscle;globus pallidus;medulla oblongata;	.	B cell proliferation involved in immune response;B-1a B cell differentiation;lipid metabolic process;gamma-aminobutyric acid signaling pathway;regulation of synaptic transmission, GABAergic;inositol trisphosphate biosynthetic process;regulation of peptidyl-serine phosphorylation;intracellular signal transduction;negative regulation of B cell receptor signaling pathway;negative regulation of cold-induced thermogenesis;positive regulation of receptor binding	cytoplasm	phosphatidylinositol phospholipase C activity;GABA receptor binding;inositol 1,4,5 trisphosphate binding	SLC35F5[unassigned1312];SHOC2[unassigned1312];DSCAML1[12421765];PPP1CA[15231748];	16926548
52420	chr3	16926552	G		chr3:16926552	PLCL2	phospholipase C like 2	deletion	1|1	1.0	0_11	11	33.0	1|1	1.0	0_11	11	33.0			rs587730619	EXONIC	YES	NM_001144382.2	Transcript	protein_coding	coding_sequence_variant	2/8		NM_001144382.2:c.16+1del			1.0						.	.	.						0	0.0								0.0	0.0	0.0	0	0.0	AC0					0.0	0.0357097	5553						16.62	1.561375		0	0	0																		1.0				homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype; 			ciliary ganglion;amygdala;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;skin;cingulate cortex;cerebellum;occipital lobe;fetal brain;dorsal root ganglion;atrioventricular node;skeletal muscle;globus pallidus;medulla oblongata;	.	B cell proliferation involved in immune response;B-1a B cell differentiation;lipid metabolic process;gamma-aminobutyric acid signaling pathway;regulation of synaptic transmission, GABAergic;inositol trisphosphate biosynthetic process;regulation of peptidyl-serine phosphorylation;intracellular signal transduction;negative regulation of B cell receptor signaling pathway;negative regulation of cold-induced thermogenesis;positive regulation of receptor binding	cytoplasm	phosphatidylinositol phospholipase C activity;GABA receptor binding;inositol 1,4,5 trisphosphate binding	SLC35F5[unassigned1312];SHOC2[unassigned1312];DSCAML1[12421765];PPP1CA[15231748];	16926551
52422	chr3	16926553	T	C	chr3:16926553	PLCL2	phospholipase C like 2	SNV	1|1	1.0	0_11	11	33.0	1|1	1.0	0_12	12	36.0			rs549925423	EXONIC	YES	NM_001144382.2	Transcript	protein_coding	coding_sequence_variant	2/8		NM_001144382.2:c.17-1T>C			1.0						.	.	.						0	0.0								0.0	0.0	0.0	0	0.0	AC0					0.0	0.0357740	5563						16.22	1.49122		0	0	0														-7.837	7.754	-0.083		1.0				homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype; 			ciliary ganglion;amygdala;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;skin;cingulate cortex;cerebellum;occipital lobe;fetal brain;dorsal root ganglion;atrioventricular node;skeletal muscle;globus pallidus;medulla oblongata;	.	B cell proliferation involved in immune response;B-1a B cell differentiation;lipid metabolic process;gamma-aminobutyric acid signaling pathway;regulation of synaptic transmission, GABAergic;inositol trisphosphate biosynthetic process;regulation of peptidyl-serine phosphorylation;intracellular signal transduction;negative regulation of B cell receptor signaling pathway;negative regulation of cold-induced thermogenesis;positive regulation of receptor binding	cytoplasm	phosphatidylinositol phospholipase C activity;GABA receptor binding;inositol 1,4,5 trisphosphate binding	SLC35F5[unassigned1312];SHOC2[unassigned1312];DSCAML1[12421765];PPP1CA[15231748];	16926553
52424	chr3	16926557	T	G	chr3:16926557	PLCL2	phospholipase C like 2	SNV	1|1	1.0	0_11	11	33.0	1|1	1.0	0_13	13	39.0			rs372006934	EXONIC	YES	NM_001144382.2	Transcript	protein_coding	missense_variant,splice_donor_region_variant		3/9	NM_001144382.2:c.20T>G	NP_001137854.1:p.Val7Gly		1.0						.	.	.						0	0.0								0.0	0.0	0.0	0	0.0	AC0					0.0	0.0000322,0.0000064,0.0000064,0.0510726,0.0002058	5,1,1,7942,32						15.42	1.344473		0	2	2		SIFT,PolyPhen																1.0				homeostasis/metabolism phenotype; hematopoietic system phenotype; immune system phenotype; 			ciliary ganglion;amygdala;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;skin;cingulate cortex;cerebellum;occipital lobe;fetal brain;dorsal root ganglion;atrioventricular node;skeletal muscle;globus pallidus;medulla oblongata;	.	B cell proliferation involved in immune response;B-1a B cell differentiation;lipid metabolic process;gamma-aminobutyric acid signaling pathway;regulation of synaptic transmission, GABAergic;inositol trisphosphate biosynthetic process;regulation of peptidyl-serine phosphorylation;intracellular signal transduction;negative regulation of B cell receptor signaling pathway;negative regulation of cold-induced thermogenesis;positive regulation of receptor binding	cytoplasm	phosphatidylinositol phospholipase C activity;GABA receptor binding;inositol 1,4,5 trisphosphate binding	SLC35F5[unassigned1312];SHOC2[unassigned1312];DSCAML1[12421765];PPP1CA[15231748];	16926557
52429	chr3	17300086	A		chr3:17300086	TBC1D5	TBC1 domain family member 5	deletion	0/1	0.21	15_4	19	63.0	0/0	0.0	44_0	44	75.0			rs546735695	SPLICING	YES	NM_001349075.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	15/22		NM_001349075.2:c.1246-3del			-1.0						.	.	.		0.000112642	17.0	150920.0	0.0	32	0.95	PASS	eas	0.00135135	7.0	4.43656e-05	3.0	0.000579908	131.0	225898.0	0.0	55	0.87	RF	eas	0.00176991	28.0	0.000351765	37.0	0.0004823,0.0000193	75,3						14.21	1.122875		0	0	0			TBC1D5	0.07	0.1	0.0	0.0	-45.0	-4.0	-2.0	-4.0						0.962	0.0				.			pons;prefrontal cortex;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;spinal cord;medulla oblongata;	.	positive regulation of receptor internalization;intracellular protein transport;autophagy;macroautophagy;retrograde transport, endosome to Golgi;response to starvation;activation of GTPase activity;regulation of cilium assembly	autophagosome;Golgi apparatus;cytosol;endosome membrane;AP-2 adaptor complex;retromer complex;intracellular membrane-bounded organelle;Atg1/ULK1 kinase complex	GTPase activator activity;protein binding;Rab GTPase binding;AP-2 adaptor complex binding;retromer complex binding	GABARAPL2[16189514;25416956;unassigned1304];VPS29[24603492;20923837;25416956];WASHC5[20923837];GABARAPL1[25416956;unassigned1304];CHIA[unassigned1304];ZBTB25[unassigned1304];YWHAB[24255178];ATG9A[24603492];AP2A1[24603492];VPS26A[20923837;26496610];VPS26B[20923837;26496610];ATG13[24603492];ZFYVE1[24603492];CCAR1[30021884];TGOLN2[29568061];EIF1AD[25416956];ATXN1[16713569];TMEM17[26638075];RAB9A[29568061];ULK1[24603492];VPS35[20923837];AP2M1[16189514;24603492];FBXL7[unassigned1304];	17300085
52582	chr3	25639964	G	A	chr3:25639964	TOP2B	DNA topoisomerase II beta	SNV	0/1	0.5	19_19	38	99.0	0/1	0.58	25_35	60	99.0			rs62638670	EXONIC	YES	NM_001330700.2	Transcript	protein_coding	missense_variant		36/36	NM_001330700.2:c.4715C>T	NP_001317629.1:p.Pro1572Leu		-1.0	DTHCT,.	Benign	criteria_provided,_single_submitter	not_provided	B-cell immunodeficiency, distal limb anomalies, and urogenital malformations, 609296 (3), Autosomal dominant	.	.	.		0.00138702	179.0	129054.0	0.0	33	0.94	PASS	amr	0.00228868	30.0	0.00176922	108.0	0.00197787	365.0	184542.0	1.0	18	0.45	PASS	amr	0.00526527	105.0	0.00191627	169.0	0.0013376	208	0.001	3.0				22.6	2.518091	0.073	2	17	19	MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	TOP2B	0.54	0.04	0.0	0.0	-23.0	4.0	-23.0	6.0						0.82	1.0	0.000000000	0.998	0.227	normal phenotype; mortality/aging ; embryo phenotype; respiratory system phenotype; behavior/neurological phenotype ; skeleton phenotype; nervous system phenotype ; growth/size/body region phenotype; cellular phenotype; 			caudate nucleus;amygdala;thyroid;fetal brain;occipital lobe;prefrontal cortex;subthalamic nucleus;cingulate cortex;parietal lobe;globus pallidus;hypothalamus;medulla oblongata;	.	resolution of meiotic recombination intermediates;sister chromatid segregation;neuron migration;DNA topological change;axonogenesis;forebrain development;mitotic DNA integrity checkpoint;positive regulation of single stranded viral RNA replication via double stranded DNA intermediate	heterochromatin;nucleus;nucleoplasm;nucleolus;cytosol;viral integration complex;ribonucleoprotein complex	DNA binding;chromatin binding;DNA topoisomerase type II (ATP-hydrolyzing) activity;protein kinase C binding;ATP binding;protein C-terminus binding;enzyme binding;histone deacetylase binding;metal ion binding;protein heterodimerization activity	UVRAG[20562859];FOXD3[25609649];JUN[25609649];DAXX[26496610];NOTCH1[23022380];RPL10[26496610];COX15[29128334];PRKCD[16611985];CEP164[26638075];SPICE1[26638075];DLST[29128334];ESR1[21182205];USF1[19303849];VAMP4[30021884];	25639964
52841	chr3	38793979	T	C	chr3:38793979	SCN10A	sodium voltage-gated channel alpha subunit 10	SNV	0|1	0.61	45_69	114	99.0	0/0	0.0	34_0	34	99.0			rs755100226	EXONIC	YES	NM_006514.4	Transcript	protein_coding	missense_variant		12/28	NM_006514.4:c.1486A>G	NP_006505.4:p.Lys496Glu		-1.0	.,.,.,.	Uncertain_significance	criteria_provided,_single_submitter	Brugada_syndrome	Episodic pain syndrome, familial, 2, 615551 (3), Autosomal dominant	Sodium channelopathy-related small fiber neuropathy;Brugada syndrome;Paroxysmal extreme pain disorder;Primary erythromelalgia;Channelopathy-associated congenital insensitivity to pain;Romano-Ward syndrome	Disease-causing germline mutation(s) (gain of function) in;Major susceptibility factor in;Candidate gene tested in;Candidate gene tested in;Candidate gene tested in;Disease-causing germline mutation(s) (loss of function) in	Autosomal dominant inheritance;Hyperalgesia;Adult onset;Recurrent respiratory infections;Abnormal thrombocyte morphology;Hypothermia;Pruritus;Vasculitis;Leukemia;Peripheral neuropathy;Erythema;Seizure;Constipation;Trifascicular block;Supraventricular tachycardia;Right bundle branch block;ST segment elevation;Syncope;Paroxysmal ventricular tachycardia;First degree atrioventricular block;Ventricular fibrillation;Cardiac arrest;Sick sinus syndrome;Abnormality of prenatal development or birth;Syncope;Torsade de pointes;Abnormal cardiac exercise stress test;Hypokalemia;Abnormal T-wave;Sudden cardiac death;Sinus bradycardia;Prolonged QTc interval;Abnormal autonomic nervous system physiology;Seizure		6.5722e-06	1.0	152156.0	0.0	32	0.96	PASS	amr	6.54365e-05	1.0	0.0	0.0	2.53985e-05	6.0	236234.0	0.0	22	0.58	PASS	amr	0.000124525	4.0	1.86047e-05	2.0	0.0000257	4	0.001	3.0	0.00114	13.0		16.58	1.554792	0.12	4	15	19	M-CAP_pred,MetaLR_pred,FATHMM_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	SCN10A	0.06	0.0	0.0	0.0	14.0	-14.0	24.0	14.0						0.0382	0.0	0.000000000	0.997	1.138	nervous system phenotype ; respiratory system phenotype; behavior/neurological phenotype ; cardiovascular system phenotype ; homeostasis/metabolism phenotype; integument phenotype ; 			.	.	regulation of heart rate;sensory perception;neuronal action potential;sensory perception of pain;regulation of ion transmembrane transport;sodium ion transmembrane transport;odontogenesis of dentin-containing tooth;regulation of cardiac muscle contraction;regulation of atrial cardiac muscle cell membrane depolarization;membrane depolarization during action potential;AV node cell action potential;bundle of His cell action potential	voltage-gated sodium channel complex;plasma membrane;axon;extracellular exosome;clathrin complex;glutamatergic synapse;integral component of presynaptic membrane	voltage-gated ion channel activity;voltage-gated sodium channel activity;ion channel binding	.	38793979
52925	chr3	42700697	G	A	chr3:42700697	ZBTB47	zinc finger and BTB domain containing 47	SNV	0/0	0.0	33_0	33	99.0	0/1	0.57	23_36	63	99.0			rs138358868,COSV51763342	EXONIC	YES	NM_145166.4	Transcript	protein_coding	missense_variant		2/6	NM_145166.4:c.850G>A	NP_660149.2:p.Glu284Lys		1.0						.	.	.		0.0030303	460.0	151800.0	0.0	31	0.93	PASS	nfe	0.00485952	330.0	0.00485952	330.0	0.00348412	427.0	122556.0	0.0	13	0.38	PASS	nfe	0.0060282	301.0	0.0060282	301.0	0.0000257,0.0015369	4,239	0.001	2.0				15.31	1.322386	0.142	4	14	18	M-CAP_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	ZBTB47	0.0	0.0	0.0	0.0	3.0	33.0	33.0	23.0						0.202	0.97	0.000000000	0.002	0.96	.			trigeminal ganglion;globus pallidus;	.	regulation of transcription by RNA polymerase II;cellular response to DNA damage stimulus	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	ZRANB1[unassigned1304];ZNF394[unassigned1304];MTUS2[unassigned1304];PNMA3[unassigned1304];CBFA2T3[20116376];REXO1L1P[unassigned1304];ZNF16[unassigned1304];AES[unassigned1304];NCKIPSD[unassigned1304];HOOK2[unassigned1304];HOOK1[unassigned1304];CEP70[unassigned1304];DVL3[unassigned1304];	42700697
52950	chr3	43607225	AAA		chr3:43607225-43607227	ANO10	anoctamin 10	sequence_alteration	0/1	0.21	10_3_0	14	54.0	0/2	0.0	5_0_4	12	58.0			rs367784953	SPLICING	YES	NM_001346467.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	7/13		NM_001346467.2:c.1219-8_1219-6del			-1.0					Spinocerebellar ataxia, autosomal recessive 10, 613728 (3), Autosomal recessive	Adult-onset autosomal recessive cerebellar ataxia	Disease-causing germline mutation(s) in	Truncal ataxia;EMG abnormality;Ptosis;Leg muscle stiffness;Ankle clonus;Intention tremor;Horizontal nystagmus;Saccadic smooth pursuit;Intellectual disability, mild;Cataract;Brisk reflexes;Tortuosity of conjunctival vessels;Downbeat nystagmus;Dysmetria;Progressive cerebellar ataxia;Fasciculations;Dysmetric saccades;Dysarthria;Pes cavus;Generalized-onset seizure;Slurred speech;Diplopia;Limb ataxia;Cerebellar atrophy;Progressive gait ataxia;Macular degeneration;Abnormal enzyme/coenzyme activity;Cerebellar atrophy;Intention tremor;Hypermetric saccades;Intellectual disability;Pes cavus;Fasciculations;Limb ataxia;Autosomal recessive inheritance;Gait ataxia;Dysarthria;Hyperreflexia;Nystagmus;Truncal ataxia;Dysmetria		1.55371e-05	1.0	64362.0	0.0	30	0.85	PASS				0.0	0.0					23	0.52											0.00686	77.0		6.641	0.256414		0	0	0			ANO10	0.0	0.0	0.0	0.0	-5.0	-2.0	48.0	-5.0						0.872	0.0				hematopoietic system phenotype; digestive/alimentary phenotype; immune system phenotype; homeostasis/metabolism phenotype; 			kidney;testis - interstitial;whole brain;superior cervical ganglion;	.	cation transport;chloride transport;ion transmembrane transport	plasma membrane;membrane;integral component of membrane	calcium activated cation channel activity;intracellular calcium activated chloride channel activity	TCTN2[26638075];TMEM216[26638075];HTR4[28298427];	43607224
52978	chr3	44856527	C	T	chr3:44856527	KIF15	kinesin family member 15	SNV	0/0	0.0	35_0	35	99.0	0/1	0.37	19_11	30	99.0			rs141676463,COSV100392771	EXONIC	YES	NM_020242.3	Transcript	protein_coding	synonymous_variant		20/35	NM_020242.3:c.2508C>T	NP_064627.1:p.Ser836%3D		1.0						21q22.11q22.12 microdeletion syndrome	Disease-causing germline mutation(s) (loss of function) in	Hypoplastic nipples;Nail dystrophy;Midface retrusion;Dental crowding;Atrial septal defect;Severe global developmental delay;Anemia;Cone-shaped epiphyses of the phalanges of the hand;Sacral dimple;Downslanted palpebral fissures;Postnatal growth retardation;Thrombocytopenia;Dry skin;Sleep-wake cycle disturbance;Short stature;Microcephaly;Clinodactyly;Feeding difficulties in infancy;Downturned corners of mouth;Infantile muscular hypotonia;Tongue thrusting;Thin upper lip vermilion;Stereotypical body rocking;Short palpebral fissure;Coarse facial features;Low-set ears;Anteverted nares;Strabismus;Delayed skeletal maturation;Acromesomelia;Brachydactyly;Bulbous nose;Self-injurious behavior;Microtia;Short proximal phalanx of the 2nd finger;Small nail;Short proximal phalanx of the 5th finger;Absent speech;Almond-shaped palpebral fissure;Hypertelorism;Thick lower lip vermilion;Failure to thrive in infancy;Round face;Camptodactyly;Bruxism;Smooth philtrum;Hyperactivity;Drooling;Seizure;Intellectual disability;Agenesis of corpus callosum;Inappropriate crying;Periorbital hyperpigmentation;Recurrent otitis media;Poor speech;Scaphocephaly		0.00174848	266.0	152132.0	0.0	32	0.98	PASS	afr	0.00584202	242.0	2.94014e-05	2.0	0.00047752	118.0	247110.0	0.0	31	0.75	PASS	afr	0.00608696	98.0	4.44286e-05	5.0	0.0005016	78						0.08	-0.513074		0	0	0			KIF15	0.0	0.0	0.0	0.01	22.0	-23.0	-49.0	41.0						0.936	0.0	37.420133545			.			superior cervical ganglion;	.	mitotic cell cycle;retrograde vesicle-mediated transport, Golgi to endoplasmic reticulum;microtubule-based movement;cell population proliferation;antigen processing and presentation of exogenous peptide antigen via MHC class II	centrosome;spindle;cytosol;kinesin complex;plus-end kinesin complex;microtubule;membrane	DNA binding;motor activity;microtubule motor activity;protein binding;ATP binding;microtubule binding;ATPase activity	UPF2[26496610];CEP126[16169070];NEK4[25798074];KIAA1143[26496610];MRI1[26496610];CHD3[16169070];DEK[30021884];MKI67[10878014];FANCG[26496610];MED6[26496610];PISD[26496610];CD2AP[26496610];MRPL44[26496610];HSP90B1[30021884];MAP1LC3A[16169070];KIF1BP[26496610];CANX[30021884];DGCR8[26496610];ELMO3[26496610];DMD[26496610];VIM[16169070];CUL4B[26496610];	44856527
53359	chr3	49167825	C	A	chr3:49167825	LAMB2	laminin subunit beta 2	SNV	0/0	0.0	34_0	34	99.0	0/1	0.55	39_47	86	99.0				EXONIC	YES	NM_002292.4	Transcript	protein_coding	missense_variant		9/32	NM_002292.4:c.1064G>T	NP_002283.3:p.Ser355Ile		-1.0	Laminin EGF domain&Laminin EGF domain&Laminin EGF domain,Laminin EGF domain&Laminin EGF domain&Laminin EGF domain				Nephrotic syndrome, type 5, with or without ocular abnormalities, 614199 (3); Pierson syndrome, 609049 (3), Autosomal recessive	Pierson syndrome;LAMB2-related infantile-onset nephrotic syndrome;Synaptic congenital myasthenic syndromes	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Decreased size of nerve terminals;Impaired mastication;Facial palsy;Unfavorable response of muscle weakness to acetylcholine esterase inhibitors;Hand muscle weakness;Limited extraocular movements;Slow pupillary light response;Recurrent lower respiratory tract infections;Skeletal muscle atrophy;Poor suck;Neck muscle weakness;Prolonged miniature endplate currents;Weak cry;Abnormality of the knee;Axial muscle weakness;High palate;Generalized muscle weakness;Talipes equinovarus;Hypoventilation;Abnormal facial shape;Abnormal enzyme/coenzyme activity;Proximal muscle weakness;Ophthalmoparesis;Dysphagia;Myopathy;Type 1 muscle fiber predominance;Triangular mouth;Type 2 muscle fiber atrophy;Sleep apnea;Respiratory distress;Areflexia;Poor head control;Distal muscle weakness;Pulmonary arterial hypertension;Scoliosis;Intellectual disability;Mandibular prognathia;Hyporeflexia;Bilateral ptosis;Frequent falls;EMG: decremental response of compound muscle action potential to repetitive nerve stimulation;Easy fatigability;Global developmental delay;Exertional dyspnea;Limited wrist extension;Muscular hypotonia;Scapular winging;Right ventricular hypertrophy;Neonatal respiratory distress;Waddling gait;Proteinuria;Strabismus;Nystagmus;Stage 5 chronic kidney disease;Nephrotic syndrome;Myopia;Autosomal recessive inheritance;Edema;Posterior lenticonus;Psychomotor retardation;Diffuse mesangial sclerosis;Neonatal onset;Proteinuria;Muscular hypotonia;Areflexia;Hypoplasia of the iris;Microcoria;Blindness;Hypoproteinemia;Stage 5 chronic kidney disease;Generalized hypotonia;Autosomal recessive inheritance;Nephrotic syndrome;Hypoplasia of the ciliary body						33	0.98											100	1.0											9e-05	1.0		21.6	2.231895	0.101	5	14	19	M-CAP_pred,PROVEAN_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-XF_coding_pred	LAMB2	0.04	0.08	0.03	0.0	27.0	-1.0	-50.0	27.0						0.84	0.0	80.670790685	0.992	1.026	growth/size/body region phenotype; cellular phenotype; immune system phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype ; mortality/aging ; vision/eye phenotype; nervous system phenotype ; renal/urinary system phenotype; 			superior cervical ganglion;	Cell Communication;Focal adhesion;ECM-receptor interaction;Prion disease;Small cell lung cancer	cell adhesion;axon guidance;neuromuscular junction development;visual perception;astrocyte development;Schwann cell development;extracellular matrix organization;post-translational protein modification;cellular protein metabolic process;axon extension involved in regeneration;retina development in camera-type eye;metanephric glomerular visceral epithelial cell development;metanephric glomerular basement membrane development	extracellular region;basement membrane;laminin-3 complex;endoplasmic reticulum lumen;neuromuscular junction;synaptic cleft;laminin-11 complex;collagen-containing extracellular matrix;extracellular exosome	integrin binding;structural molecule activity;extracellular matrix structural constituent	ZNF512B[15231748];ORC5[21988832];RBL1[21988832];NUDCD1[29021621];ATXN7[21078624];STAT3[21988832];PLEKHA5[20936779];TSR2[unassigned1304];PIK3R2[21988832];KPNA2[21988832];	49167825
53362	chr3	49215220		T	chr3:49215219-49215220	C3orf84	chromosome 3 open reading frame 84	insertion	0/1	0.53	61_70	131	99.0	0/1	0.47	75_66	141	99.0			rs761201707	EXONIC	YES	NM_001080528.3	Transcript	protein_coding	stop_gained,frameshift_variant		4/4	NM_001080528.3:c.464dup	NP_001073997.2:p.Tyr155Ter		-1.0						.	.	.		1.97148e-05	3.0	152170.0	0.0	32	0.98	PASS	nfe	2.941e-05	2.0	2.941e-05	2.0	6.1669e-05	15.0	243234.0	0.0	48	0.78	PASS	nfe	0.00010897	12.0	0.00010897	12.0	0.0000772	12						23.0	2.746157		0	0	0			C3orf84	0.0	0.01	0.0	0.0	-25.0	11.0	-12.0	48.0							0.0	0.000000000,47.737725778			.			.	.	.	.	.	.	49215219
53411	chr3	49947649	C	G	chr3:49947649	MON1A	MON1 homolog A, secretory trafficking associated	SNV	0/0	0.0	36_0	36	99.0	0/1	0.48	73_68	141	99.0			rs973815662	EXONIC	YES	NM_032355.3	Transcript	protein_coding	missense_variant		4/6	NM_032355.3:c.1573G>C	NP_115731.2:p.Glu525Gln		-1.0	.,.,.,.,.					.	.	.		6.56892e-06	1.0	152232.0	0.0	32	0.98	PASS	nfe	1.46981e-05	1.0	1.46981e-05	1.0					77	1.0														23.8	3.091656	0.359	11	7	18	PolyPhen,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_noAF_pred	MON1A	0.0	0.0	0.0	0.0	39.0	-1.0	-2.0	-35.0						0.118	0.01	39.608978480	0.381	1.026	.			thyroid;	.	protein secretion	cytosol;Mon1-Ccz1 complex	guanyl-nucleotide exchange factor activity;protein binding	GFI1B[16713569];RGS2[21900206];VPS33A[20434987];TAB1[21900206];MAPK6[21900206];MON1B[20434987];	49947649
53441	chr3	50155888	GA		chr3:50155888-50155889	RBM5	RNA binding motif protein 5	deletion	0/1	0.18	50_11	61	99.0	0/1	0.19	33_9	48	99.0			rs112672304	EXONIC	YES	NM_005778.4	Transcript	protein_coding	frameshift_variant,stop_lost		25/25	NM_005778.4:c.*19_*20del			1.0						.	.	.		0.00116076	169.0	145594.0	0.0	32	0.92	PASS	nfe	0.0013099	86.0	0.0013099	86.0	0.370082	54129.0	146262.0	0.0	38	0.84	InbreedingCoeff	sas	0.439943	7743.0	0.403293	25889.0	0.0010868,0.0112859,0.0006238	169,1755,97	0.006	18.0				33.0	4.94833		0	0	0			RBM5	0.0	0.0	0.0	0.0	-44.0	-29.0	-2.0	40.0						0.287	1.0	32.369157572			reproductive system phenotype; cellular phenotype; endocrine/exocrine gland phenotype; 			pons;subthalamic nucleus;parietal lobe;testis;	.	spliceosomal complex assembly;regulation of alternative mRNA splicing, via spliceosome;mRNA splicing, via spliceosome;RNA processing;apoptotic process;negative regulation of cell population proliferation;positive regulation of apoptotic process	nucleus;nucleoplasm;spliceosomal complex	DNA binding;RNA binding;mRNA binding;protein binding;metal ion binding	RIF1[16169070];POMP[23414517];PRPF19[22569250;22365833];MEOX2[26871637];PRPF8[22569250];MEOX1[26871637];HSPD1[30021884];U2AF2[22569250];EMC2[26496610];DHX15[22569250;22365833;24304693];MLYCD[unassigned1304];TP53BP1[29656893];SF3A2[17332742];KSR1[27086506];MMGT1[26496610];XRCC3[26496610];HIST2H2BC[30021884];WBP11[22365833];ZDHHC17[24705354];U2SURP[22365833];WDR77[22365833];LSM8[22365833];ILF3[22365833];MYO1C[26496610];FGFR1OP[26496610];HIST1H2BH[30021884];SNRNP200[22569250];GAPDH[21900206];BCL2L1[21900206];SF1[26420826];	50155887
53506	chr3	50413108	T	C	chr3:50413108	CACNA2D2	calcium voltage-gated channel auxiliary subunit alpha2delta 2	SNV	0/0	0.0	34_0	34	99.0	0/1	0.55	59_73	133	99.0			rs780181502,COSV99817446	EXONIC	YES	NM_001174051.3	Transcript	protein_coding	missense_variant		21/39	NM_001174051.3:c.1874A>G	NP_001167522.1:p.Tyr625Cys		-1.0	.,.,.,.,.,.	Uncertain_significance	criteria_provided,_single_submitter	Early_infantile_epileptic_encephalopathy_with_suppression_bursts	Cerebellar atrophy with seizures and variable developmental delay, 618501 (3), Autosomal recessive	.	.	Strabismus;Chorea;Poor eye contact;Global developmental delay;Muscular hypotonia of the trunk;Abnormal facial shape;Cerebellar vermis atrophy;Variable expressivity;Epileptic encephalopathy;Dysarthria;Nystagmus;Infantile onset;Dysmetria;Inability to walk;Autosomal recessive inheritance;Gait ataxia		6.57505e-06	1.0	152090.0	0.0	33	0.98	PASS	nfe	1.47072e-05	1.0	1.47072e-05	1.0	7.97175e-06	2.0	250886.0	0.0	76	1.0	PASS	sas	3.26627e-05	1.0	8.82566e-06	1.0	0.0000064	1			0.0001	1.0		27.7	4.003978	0.979	21	0	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred		CACNA2D2	0.03	0.01	0.0	0.0	26.0	41.0	26.0	-33.0						0.56	1.0	0.000000000	1.0	1.138	respiratory system phenotype; behavior/neurological phenotype ; reproductive system phenotype; normal phenotype; mortality/aging ; cardiovascular system phenotype ; hematopoietic system phenotype; nervous system phenotype ; skeleton phenotype; homeostasis/metabolism phenotype; immune system phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; muscle phenotype; 			.	MAPK signaling pathway	neuromuscular junction development;regulation of ion transmembrane transport;regulation of multicellular organism growth;positive regulation of organ growth;muscle fiber development;regulation of insulin secretion;rhythmic synaptic transmission;calcium ion transmembrane transport	plasma membrane;voltage-gated calcium channel complex	voltage-gated calcium channel activity;metal ion binding	TNIP1[unassigned1774];IGHA1[15174051];TANK[unassigned1774];	50413108
53566	chr3	51989835	T	C	chr3:51989835	GPR62	G protein-coupled receptor 62	SNV	0/0	0.0	34_0	34	99.0	0/1	0.33	32_16	48	99.0				EXONIC	YES	NM_080865.4	Transcript	protein_coding	missense_variant		1/1	NM_080865.4:c.167T>C	NP_543141.3:p.Val56Ala		1.0	GPCR, rhodopsin-like, 7TM					.	.	.						33	0.98											14	0.39														21.1	2.162743	0.196	0	18	18		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	GPR62	0.0	0.0	0.0	0.01	3.0	-7.0	1.0	-6.0							0.23	36.715137180	1.0	1.113	.			.	.	G protein-coupled receptor signaling pathway;positive regulation of cAMP-mediated signaling;inositol phosphate-mediated signaling	endosome;plasma membrane;endosome membrane;integral component of membrane;receptor complex	G protein-coupled receptor activity;protein binding;identical protein binding;arrestin family protein binding	.	51989835
53611	chr3	52441269	C	T	chr3:52441269	BAP1	BRCA1 associated protein 1	SNV	0/0	0.0	35_0	35	99.0	0/1	0.57	49_64	113	99.0			rs148631953	EXONIC	YES	NM_004656.4	Transcript	protein_coding	synonymous_variant		7/17	NM_004656.4:c.501G>A	NP_004647.1:p.Ala167%3D		-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Tumor_susceptibility_linked_to_germline_BAP1_mutations|Hereditary_cancer-predisposing_syndrome|not_specified	Tumor predisposition syndrome, 614327 (3), Autosomal dominant; Kury-Isidor syndrome, 619762 (3), Autosomal dominant	Familial melanoma;BAP1-related tumor predisposition syndrome;Uveal melanoma;Uveal melanoma	Major susceptibility factor in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in	Mydriasis;Ocular pain;Abnormal visual accommodation;Abnormality of refraction;Choroidal melanoma;Retinal detachment;Iris melanoma;Visual loss;Ocular hypertension;Vitreous hemorrhage;Zonular cataract;Ciliary body melanoma;Metamorphopsia;Inflammatory abnormality of the eye;Inferior lens subluxation;Photopsia;Mydriasis;Ocular pain;Abnormal visual accommodation;Abnormality of refraction;Choroidal melanoma;Retinal detachment;Iris melanoma;Visual loss;Ocular hypertension;Vitreous hemorrhage;Zonular cataract;Ciliary body melanoma;Metamorphopsia;Inflammatory abnormality of the eye;Inferior lens subluxation;Photopsia;Retinopathy;Neoplasm of the stomach;Abnormality of the lymphatic system;Neoplasm of the breast;Freckling;Neoplasm of the pancreas;Abnormality of extrapyramidal motor function;Dry skin;Melanoma;Nevus;Abnormal hair morphology;Meningioma;Cutaneous melanoma;Renal cell carcinoma;Uveal melanoma;Lung adenocarcinoma;Autosomal dominant inheritance		0.000538836	82.0	152180.0	0.0	33	0.98	PASS	sas	0.00124121	6.0	0.000529178	36.0	0.00069202	174.0	251438.0	1.0	100	1.0	PASS	afr	0.000799803	13.0	0.00074745	85.0	0.0005659	88	0.001	3.0	0.00061	7.0		7.846	0.350902		0	0	0			BAP1	0.0	0.0	0.0	0.0	-32.0	5.0	3.0	-18.0						0.364	0.39	93.370841172			cardiovascular system phenotype ; hematopoietic system phenotype; reproductive system phenotype; mortality/aging ; neoplasm; embryo phenotype; respiratory system phenotype; immune system phenotype; digestive/alimentary phenotype; growth/size/body region phenotype; integument phenotype ; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; 			amygdala;temporal lobe;testis - seminiferous tubule;testis - interstitial;prefrontal cortex;whole brain;superior cervical ganglion;testis;parietal lobe;medulla oblongata;	.	regulation of cell growth;cellular protein modification process;ubiquitin-dependent protein catabolic process;negative regulation of cell population proliferation;response to inorganic substance;protein deubiquitination;monoubiquitinated protein deubiquitination;monoubiquitinated histone H2A deubiquitination;regulation of cell cycle;macrophage homeostasis;protein K48-linked deubiquitination;regulation of cytokine production involved in inflammatory response;positive regulation of protein targeting to mitochondrion	nucleus;nucleoplasm;cytoplasm;cytosol;PR-DUB complex	chromatin binding;thiol-dependent ubiquitin-specific protease activity;protein binding;peptidase activity;thiol-dependent ubiquitinyl hydrolase activity	BCAR3[25640309];AHCYL2[19615732];KDM1B[19615732;27705803;26496610];CBLC[27107012];PTPRJ[25640309];BRCA1[9528852];IPO4[19615732];IPO5[19615732];IGF1R[25640309];PSMD8[27705803];KIAA1107[26496610];TEPSIN[26496610];TUBA1C[27705803];PSMD7[27705803];CASP8[25640309];PSMD4[27705803];PSMD2[27705803];RB1CC1[25640309];PSMD3[27705803];NBN[25640309];ANAPC7[19615732];SSR4[27705803];HCFC2[27705803];HCFC1[19615732;24211834;27705803];PSME3[19615732];HAT1[19615732];SMS[26496610];PGAM5[27705803];UBE2V1[25260751];ANKRD17[19615732];PSMD11[27705803];FOXK2[19615732;27705803;25609649];FOXK1[19615732;27705803;25609649];ITPR3[28614305];HACD3[27705803];PPM1G[19615732];BAG4[25640309];MTA1[26028330];RBBP7[19615732];TSNAX[26496610];MBD6[27705803];CBX5[27107012];CBX3[19615732];CBX1[19615732];XRCC3[25640309];ESR1[25640309];ANKHD1[19615732];ASXL1[19615732;22897849;27705803;20436459];PSMC5[27705803];PSMC6[27705803];PSMC4[27705803];ASXL2[19615732;27705803];PSMC2[27705803];UBE2N[25260751];UBE2O[19615732;27705803];UBA1[25260751];OGT[19615732;27705803];	52441269
53690	chr3	53338230	T	C	chr3:53338230	DCP1A	decapping mRNA 1A	SNV	0/0	0.0	34_0	34	99.0	0/1	0.44	35_27	62	99.0				EXONIC	YES	NM_018403.7	Transcript	protein_coding	missense_variant		6/10	NM_018403.7:c.601A>G	NP_060873.4:p.Met201Val		-1.0	.,.					.	.	.						32	0.96											60	0.98														12.24	0.837424		1	11	12	M-CAP_pred	SIFT,PolyPhen,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	DCP1A	0.0	0.0	0.04	0.0	48.0	-23.0	-23.0	2.0							0.94	39.194772040	0.553	1.138	.			superior cervical ganglion;	.	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;deadenylation-dependent decapping of nuclear-transcribed mRNA;deadenylation-independent decapping of nuclear-transcribed mRNA;positive regulation of catalytic activity;regulation of mRNA stability;exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay;protein localization to cytoplasmic stress granule	P-body;nucleus;cytoplasm;cytosol;membrane;cytoplasmic ribonucleoprotein granule	protein binding;enzyme activator activity;hydrolase activity;kinesin binding;identical protein binding	PPP1R37[26496610];DDX6[16364915;25036637;26496610;19966221];GSK3B[29568061];PPP1R35[26496610];CLTC[26496610];FHL2[25416956;unassigned1304];CBY1[unassigned1312];ZBTB21[unassigned1312];TTF2[12927788];ZC3HAV1[21876179];EDC3[16364915;25036637;26496610;27107012;unassigned1304;19966221];CRKL[26496610];EDC4[16364915;25036637;26496610;19966221];ZFP36[16364915];BAG4[25036637;26496610];KIF13B[unassigned1312];DDX17[21876179];UPF1[16364915;12417715;18423202;19150429];SMAD4[15231748;25609649;27107012];TIA1[20412057;24965446];MAP2K1[26496610];USP4[19615732];RITA1[25416956];KCTD3[unassigned1312];YWHAZ[15161933];TBX3[26496610];PNRC1[26496610];PATL1[26496610];PLEKHA7[28877994];PNRC2[19150429;25416956;unassigned1304;23085078];RAD52[unassigned1304];LSM8[15231747];MARF1[26496610];HAX1[23164465];XRN1[16364915];TRMT6[26496610];ALDH18A1[26496610];DCP1A[16364915;19966221];DCP2[15231747;16364915;12417715;25036637;26496610;19966221;23085078];DCP1B[16364915;25036637;19966221];NSMAF[26133670];	53338230
53808	chr3	57232788	T	G	chr3:57232788	HESX1	HESX homeobox 1	SNV	0/0	0.0	34_0	34	99.0	0/1	0.49	22_22	45	99.0			rs765353265,CM078514	EXONIC	YES	NM_001376061.1	Transcript	protein_coding	missense_variant		4/6	NM_001376061.1:c.350A>C	NP_001362990.1:p.Gln117Pro		-1.0	Homeobox domain&Homeobox domain&Homeobox domain&Homeobox domain,Homeobox domain&Homeobox domain&Homeobox domain&Homeobox domain,Homeobox domain	Uncertain_significance	criteria_provided,_single_submitter	Septo-optic_dysplasia_sequence|Growth_hormone_deficiency_with_pituitary_anomalies	Pituitary hormone deficiency, combined, 5, 182230 (3), Autosomal recessive, Autosomal dominant; Septooptic dysplasia, 182230 (3), Autosomal recessive, Autosomal dominant; Growth hormone deficiency with pituitary anomalies, 182230 (3), Autosomal recessive, Autosomal dominant	Septo-optic dysplasia spectrum;Kallmann syndrome;Hypothyroidism due to deficient transcription factors involved in pituitary development or function;Pituitary stalk interruption syndrome;Combined pituitary hormone deficiencies, genetic forms	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Hypothyroidism;Short stature;Adrenal hypoplasia;Septo-optic dysplasia;Intellectual disability;Ectopic posterior pituitary;Global developmental delay;Diabetes insipidus;Cryptorchidism;Failure to thrive;Delayed puberty;Death in infancy;Hypoglycemia;Hypoplasia of penis;Seizure;Primary amenorrhea;Autosomal recessive inheritance;Autosomal dominant inheritance;Global developmental delay;Anterior pituitary hypoplasia;Growth hormone deficiency;Psychomotor retardation;Diabetes insipidus;Absent septum pellucidum;Short finger;Agenesis of corpus callosum;Polydactyly;Optic disc hypoplasia;Short stature;Optic nerve hypoplasia;Intellectual disability;Global developmental delay;Jaundice;Large fontanelles;Muscular hypotonia;Septo-optic dysplasia;Sleep disturbance;Coarse facial features;Oral cleft;Umbilical hernia;Central hypothyroidism;Constipation;Fatigue;Short stature;Abnormality of the hypothalamus-pituitary axis;Abdominal distention;Feeding difficulties;Agenesis of corpus callosum;Tracheoesophageal fistula;Intellectual disability;Global developmental delay;Aplasia/Hypoplasia of the cerebellum;Seizure;Esophageal atresia;Anosmia;Short stature;Maternal diabetes;Anterior pituitary hypoplasia;Polydipsia;Cleft palate;Autism;Dry skin;Abnormality of cardiovascular system morphology;Hypohidrosis;Visual impairment;Sleep disturbance;Septo-optic dysplasia;Obesity;Fatigue;Sensorineural hearing impairment;Hypoplasia of penis;Nystagmus;Cryptorchidism;Strabismus;Hemiplegia/hemiparesis;Diabetes insipidus;Constipation;Color vision defect;Micropenis;Hypothalamic gonadotropin-releasing hormone deficiency;Abnormality of the voice;Reduced number of teeth;Hypogonadotropic hypogonadism;Decreased fertility;Pes cavus;Reduced bone mineral density;Gynecomastia;Bimanual synkinesia;Recurrent fractures;Dyspareunia;Decreased testicular size;Muscular hypotonia;Paraplegia;Sensorineural hearing impairment;Tremor;Abnormal morphology of female internal genitalia;Delayed puberty;Ataxia;Cleft palate;Erectile dysfunction;Visual impairment;Anosmia;Breast hypoplasia;Skeletal dysplasia;Gait disturbance;Ichthyosis;Primary amenorrhea;Cryptorchidism;Abnormality of cardiovascular system morphology;Pes planus;Delayed skeletal maturation;Ptosis;Dysarthria;Muscle weakness;Hyposmia;Anterior hypopituitarism;Seizure;Obesity;Renal agenesis;Nystagmus;Aplasia/Hypoplasia of the breasts;Abnormal prolactin level;Hypoglycemia;Abnormality of secondary sexual hair;Pituitary dwarfism;Anterior pituitary agenesis;Pituitary hypothyroidism;Septo-optic dysplasia;Osteopenia;Decreased circulating ACTH level;Anterior pituitary hypoplasia;Holoprosencephaly;Amenorrhea;Fatigue;Ectopic anterior pituitary gland;Agenesis of corpus callosum;Polydactyly;Severe global developmental delay;Ectopic posterior pituitary;Delayed skeletal maturation;Delayed puberty;Decreased cervical spine mobility;Osteoporosis of vertebrae;Constipation;Absence of secondary sex characteristics;Median cleft lip and palate;Hypogonadotropic hypogonadism;Infertility;Decreased testicular size;Hypotension;Depressed nasal ridge;Seizure		3.28481e-05	5.0	152216.0	0.0	32	0.97	PASS	amr	0.000196335	3.0	2.93962e-05	2.0	6.37049e-05	16.0	251158.0	0.0	100	1.0	PASS	amr	0.000318029	11.0	4.4056e-05	5.0	0.0000643	10	0.0	1.0	0.00142	16.0		22.4	2.442444	0.222	12	7	19	LRT_pred,M-CAP_pred,MetaLR_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaSVM_pred,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred	HESX1	0.0	0.0	0.03	0.0	-8.0	-7.0	-7.0	40.0						0.47	0.01	0.000000000	1.0	1.138	mortality/aging ; normal phenotype; respiratory system phenotype; embryo phenotype; vision/eye phenotype; hearing/vestibular/ear phenotype; nervous system phenotype ; taste/olfaction phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; craniofacial phenotype; 			pons;appendix;testis - seminiferous tubule;testis - interstitial;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	.	regulation of transcription by RNA polymerase II;brain development;pituitary gland development	nucleus	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding	PRMT6[23455924];UBL5[unassigned1304];GUCD1[unassigned1304];CATIP[unassigned1304];KDM1A[23455924];STAT3[25814554];C1orf109[unassigned1304];HOXC8[unassigned1304];	57232788
53914	chr3	62358505	C	G	chr3:62358505	FEZF2	FEZ family zinc finger 2	SNV	0/0	0.0	41_0	41	99.0	0/1	0.51	45_48	94	99.0			rs192509891	EXONIC	YES	NM_018008.4	Transcript	protein_coding	synonymous_variant		2/5	NM_018008.4:c.39G>C	NP_060478.3:p.Pro13%3D		-1.0						.	.	.		0.00261711	398.0	152076.0	0.0	32	0.97	PASS	nfe	0.00430806	293.0	0.00430806	293.0	0.00289219	397.0	137266.0	3.0	11	0.12	PASS	nfe	0.00446875	250.0	0.00446875	250.0	0.0020128	313	0.002	7.0	0.00509	58.0		12.19	0.830554		0	0	0			FEZF2	0.0	0.0	0.0	0.0	-40.0	-2.0	36.0	0.0							0.9	97.345645362			behavior/neurological phenotype ; respiratory system phenotype; mortality/aging ; nervous system phenotype ; growth/size/body region phenotype; taste/olfaction phenotype; craniofacial phenotype; cellular phenotype; 			ciliary ganglion;amygdala;superior cervical ganglion;skeletal muscle;	.	negative regulation of transcription by RNA polymerase II;axon guidance;axonal fasciculation;locomotory behavior;negative regulation of cell population proliferation;dendrite development;dentate gyrus development;forebrain anterior/posterior pattern specification;cerebral cortex GABAergic interneuron migration;commitment of neuronal cell to specific neuron type in forebrain;cell dedifferentiation;negative regulation of neuron differentiation;positive regulation of neuron differentiation;positive regulation of transcription by RNA polymerase II;neuron fate determination;regulation of axon guidance	nucleus	RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;chromatin DNA binding;sequence-specific DNA binding;metal ion binding	.	62358505
53924	chr3	62739202	G	T	chr3:62739202	CADPS	calcium dependent secretion activator	SNV	0/1	0.42	76_54	130	99.0	0/0	0.0	33_0	33	99.0			rs746724636,COSV99338111	EXONIC	YES	NM_003716.4	Transcript	protein_coding	missense_variant		3/30	NM_003716.4:c.802C>A	NP_003707.2:p.Leu268Met		-1.0	.,.,.,.,.					.	.	.						32	0.95							1.19384e-05	3.0	251290.0	0.0	84	1.0	PASS	amr	2.89118e-05	1.0	1.76097e-05	2.0	0.0000129	2						24.1	3.202944	0.126	18	3	21	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PROVEAN_pred,DEOGEN2_pred	CADPS	0.0	0.0	0.0	0.0	39.0	-33.0	3.0	-25.0						0.384	0.05	0.000000000	1.0	1.176	nervous system phenotype ; respiratory system phenotype; mortality/aging ; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; 			.	.	exocytosis;protein transport;synaptic vesicle exocytosis;dense core granule exocytosis	cytosol;cell junction;cytoplasmic vesicle membrane;presynapse	protein binding;lipid binding;protein kinase binding;metal ion binding	KANK2[unassigned1304];HDAC4[unassigned1304];ZNF572[25416956];SEC23A[unassigned1304];CCDC120[unassigned1304];SH2D4A[unassigned1304];TTLL10[25416956];CABP5[unassigned1304];TSEN2[unassigned1304];AURKC[unassigned1304];SDCBP[25416956];KIAA1549[12421765];TCL1A[25416956;unassigned1304];PIP5K1A[16169070];GSE1[unassigned1304];ZNF688[26871637];TENT2[unassigned1304];CCDC185[unassigned1304];ANKS1A[unassigned1304];HOXC8[unassigned1304];GADD45GIP1[unassigned1304];FAM9B[25416956];FOXD2[unassigned1304];OLIG3[unassigned1304];ACTN3[unassigned1304];NEK4[25798074];FANCL[unassigned1304];USP2[unassigned1304];ZFC3H1[unassigned1304];PNMA5[unassigned1304];RYDEN[25416956];FAM90A1[unassigned1304];GPANK1[unassigned1304];PRPF18[unassigned1304];FAM161A[25416956;unassigned1304];DNAJC5[29997244];C17orf67[25416956];LNX1[unassigned1304];LUC7L2[16169070];HOXB5[unassigned1304];	62739202
53944	chr3	64589767	TGGGTGT		chr3:64589767-64589773	ADAMTS9	ADAM metallopeptidase with thrombospondin type 1 motif 9	deletion	0/0	0.0	38_0	38	99.0	0/1	0.51	36_38	74	99.0			rs757494136	SPLICING	YES	NM_182920.2	Transcript	protein_coding	splice_acceptor_variant,splice_polypyrimidine_tract_variant,intron_variant	24/39		NM_182920.2:c.3580-8_3580-2del			-1.0						.	.	.		3.94337e-05	6.0	152154.0	0.0	32	0.95	PASS	nfe	7.34883e-05	5.0	7.34883e-05	5.0	3.98874e-05	10.0	250706.0	0.0	43	0.99	PASS	nfe	7.94814e-05	9.0	7.94814e-05	9.0	0.0000322	5						24.4	3.305096		0	0	0																	0.651	0.0				embryo phenotype; pigmentation phenotype; mortality/aging ; normal phenotype; reproductive system phenotype; cardiovascular system phenotype ; vision/eye phenotype; nervous system phenotype ; limbs/digits/tail phenotype; digestive/alimentary phenotype; cellular phenotype; immune system phenotype; endocrine/exocrine gland phenotype; integument phenotype ; growth/size/body region phenotype; craniofacial phenotype; 			ciliary ganglion;pons;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skeletal muscle;globus pallidus;	.	heart valve morphogenesis;ventricular cardiac muscle tissue development;proteolysis;glycoprotein catabolic process;multicellular organism development;response to bacterium;negative regulation of endothelial cell migration;protein transport;vesicle-mediated transport;extracellular matrix organization;aorta morphogenesis;positive regulation of melanocyte differentiation;endothelial cell-matrix adhesion;negative regulation of sprouting angiogenesis	extracellular space;endoplasmic reticulum;cell surface;extracellular matrix;intracellular membrane-bounded organelle;collagen-containing extracellular matrix	metalloendopeptidase activity;metallopeptidase activity;zinc ion binding	LIMS1[23414517];	64589766
53981	chr3	69111069	G		chr3:69111069	UBA3	ubiquitin like modifier activating enzyme 3	deletion	0/0	0.0	18_0	18	51.0	0/1	0.17	10_2	12	39.0				EXONIC	YES	NM_003968.4	Transcript	protein_coding	frameshift_variant		11/18	NM_003968.4:c.806del	NP_003959.3:p.Pro269HisfsTer2		-1.0						.	.	.						32	0.93											40	0.78																	0	0	0			UBA3	0.0	0.11	0.0	0.0	-2.0	7.0	6.0	10.0						0.552	0.97	72.102013482			cellular phenotype; embryo phenotype; mortality/aging ; 			amygdala;occipital lobe;	Ubiquitin mediated proteolysis	cellular protein modification process;proteolysis;endomitotic cell cycle;protein modification by small protein conjugation;post-translational protein modification;protein neddylation;negative regulation of transcription, DNA-templated;regulation of cell cycle	nucleus;cytoplasm;cytosol	protein binding;ATP binding;acid-amino acid ligase activity;nuclear receptor binding;NEDD8 activating enzyme activity;NEDD8 transferase activity;identical protein binding;protein heterodimerization activity	UBE2F[19549727];CUL5[18805092];KDM1A[23455924];CUL1[18805092];RAD23A[16712842];NEDD8[14690597];CHD3[16169070];RAD23B[16712842];FBXO11[17098746];DUSP23[unassigned1304];IMPA2[25416956;unassigned1304];UIMC1[19615732];UBA3[25416956;unassigned1304];CPNE2[25416956;unassigned1304];NAE1[unassigned1304];UBE2M[15694336;17353931;19549727];	69111068
53983	chr3	69247917	T	C	chr3:69247917	FRMD4B	FERM domain containing 4B	SNV	0/0	0.0	34_0	34	99.0	0/1	0.64	18_32	50	99.0			rs189397393	EXONIC	YES	NM_015123.3	Transcript	protein_coding	synonymous_variant		12/23	NM_015123.3:c.885A>G	NP_055938.2:p.Gln295%3D		-1.0						.	.	.		0.00214838	327.0	152208.0	0.0	33	0.97	PASS	nfe	0.00376271	256.0	0.00376271	256.0	0.00214944	396.0	184234.0	0.0	26	0.57	PASS	nfe	0.00398557	305.0	0.00398557	305.0	0.0017620	274	0.004	12.0				8.599	0.41893		0	0	0			FRMD4B	0.03	0.0	0.0	0.0	-1.0	-10.0	-28.0	-10.0						0.114	0.81	90.821179317			behavior/neurological phenotype ; integument phenotype ; 			.	.	establishment of epithelial cell polarity	ruffle;extracellular space;cytoplasm;cytoskeleton;adherens junction;bicellular tight junction	.	.	69247917
54040	chr3	75986663	C	A	chr3:75986663	ROBO2	roundabout guidance receptor 2	SNV	0/1	0.56	57_72	129	99.0	0/1	0.32	71_33	104	99.0			rs12171318,COSV72217800	EXONIC	YES	NM_001378191.1	Transcript	protein_coding	missense_variant		2/30	NM_001378191.1:c.19C>A	NP_001365120.1:p.Arg7Ser		1.0	.,.	Benign	criteria_provided,_single_submitter	Vesicoureteral_reflux_2	Vesicoureteral reflux 2, 610878 (3), Autosomal dominant	Familial vesicoureteral reflux	Disease-causing germline mutation(s) in	Vesicoureteral reflux;Renal hypoplasia;Autosomal dominant inheritance						32	0.94							0.500026	113387.0	226762.0	22.0	35	0.9	InbreedingCoeff	eas	0.500287	8723.0	0.500048	52562.0	0.0139932	2176	0.104	323.0	0.18993	1595.0		2.746	0.008044		0	11	11		MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred															0.324	1.0		0.005	-0.085	muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; nervous system phenotype ; digestive/alimentary phenotype; renal/urinary system phenotype; respiratory system phenotype; behavior/neurological phenotype ; reproductive system phenotype; normal phenotype; mortality/aging ; cardiovascular system phenotype ; 			fetal brain;cingulate cortex;trigeminal ganglion;	Axon guidance	metanephros development;ureteric bud development;outflow tract septum morphogenesis;aortic valve morphogenesis;pulmonary valve morphogenesis;endocardial cushion formation;homophilic cell adhesion via plasma membrane adhesion molecules;axon guidance;central nervous system development;brain development;axon midline choice point recognition;spinal cord development;olfactory bulb interneuron development;retinal ganglion cell axon guidance;cellular response to hormone stimulus;Roundabout signaling pathway;positive regulation of Notch signaling pathway involved in heart induction;aorta development;positive regulation of axonogenesis;negative regulation of negative chemotaxis;negative regulation of synapse assembly;ventricular septum morphogenesis;apoptotic process involved in luteolysis	plasma membrane;cell surface;integral component of membrane;axolemma;extracellular exosome	protein binding;axon guidance receptor activity;identical protein binding	ROBO2[12504588];ROBO1[12504588];GPR152[unassigned1304];PARD6B[26496610];RPS6KA5[21900206];RDH11[21900206];TMEM248[26496610];MYC[21150319];KIF1C[26496610];FADD[unassigned1774];UBQLN4[16713569];BNIP3L[21900206];CENPU[21900206];OR1D4[unassigned1304];NR1H2[21900206];METTL3[26496610];SSRP1[16169070];KCNRG[21900206];NR4A1[21900206];OLFM2[16169070];KIF2A[26496610];VAPA[26496610];TMEM237[unassigned1304];PPP1R1B[16169070];HLA-DPB1[21900206];CPE[16169070];	75986663
54047	chr3	75986686	A	G	chr3:75986686	ROBO2	roundabout guidance receptor 2	SNV	0/1	0.62	76_126	202	99.0	0/1	0.44	87_69	156	99.0			rs62269817,COSV72212998	EXONIC	YES	NM_001378191.1	Transcript	protein_coding	synonymous_variant		2/30	NM_001378191.1:c.42A>G	NP_001365120.1:p.Thr14%3D		1.0					Vesicoureteral reflux 2, 610878 (3), Autosomal dominant	Familial vesicoureteral reflux	Disease-causing germline mutation(s) in	Vesicoureteral reflux;Renal hypoplasia;Autosomal dominant inheritance						31	0.93							0.500026	113787.0	227562.0	16.0	38	0.92	InbreedingCoeff	eas	0.500343	8746.0	0.500009	52701.0	0.0123277	1917	0.083	243.0	0.14099	1184.0		6.244	0.227814		0	0	0																	0.324	1.0				muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; nervous system phenotype ; digestive/alimentary phenotype; renal/urinary system phenotype; respiratory system phenotype; behavior/neurological phenotype ; reproductive system phenotype; normal phenotype; mortality/aging ; cardiovascular system phenotype ; 			fetal brain;cingulate cortex;trigeminal ganglion;	Axon guidance	metanephros development;ureteric bud development;outflow tract septum morphogenesis;aortic valve morphogenesis;pulmonary valve morphogenesis;endocardial cushion formation;homophilic cell adhesion via plasma membrane adhesion molecules;axon guidance;central nervous system development;brain development;axon midline choice point recognition;spinal cord development;olfactory bulb interneuron development;retinal ganglion cell axon guidance;cellular response to hormone stimulus;Roundabout signaling pathway;positive regulation of Notch signaling pathway involved in heart induction;aorta development;positive regulation of axonogenesis;negative regulation of negative chemotaxis;negative regulation of synapse assembly;ventricular septum morphogenesis;apoptotic process involved in luteolysis	plasma membrane;cell surface;integral component of membrane;axolemma;extracellular exosome	protein binding;axon guidance receptor activity;identical protein binding	ROBO2[12504588];ROBO1[12504588];GPR152[unassigned1304];PARD6B[26496610];RPS6KA5[21900206];RDH11[21900206];TMEM248[26496610];MYC[21150319];KIF1C[26496610];FADD[unassigned1774];UBQLN4[16713569];BNIP3L[21900206];CENPU[21900206];OR1D4[unassigned1304];NR1H2[21900206];METTL3[26496610];SSRP1[16169070];KCNRG[21900206];NR4A1[21900206];OLFM2[16169070];KIF2A[26496610];VAPA[26496610];TMEM237[unassigned1304];PPP1R1B[16169070];HLA-DPB1[21900206];CPE[16169070];	75986686
54055	chr3	75986695	G	A	chr3:75986695	ROBO2	roundabout guidance receptor 2	SNV	0/1	0.22	172_49	221	99.0	0/1	0.17	135_27	162	99.0			rs79015247,COSV72212161	EXONIC	YES	NM_001378191.1	Transcript	protein_coding	synonymous_variant		2/30	NM_001378191.1:c.51G>A	NP_001365120.1:p.Pro17%3D		1.0					Vesicoureteral reflux 2, 610878 (3), Autosomal dominant	Familial vesicoureteral reflux	Disease-causing germline mutation(s) in	Vesicoureteral reflux;Renal hypoplasia;Autosomal dominant inheritance						32	0.93							0.234248	26016.0	111062.0	0.0	41	0.94	InbreedingCoeff	nfe	0.25694	13255.0	0.25694	13255.0	0.0004373	68	0.003	8.0	0.05144	432.0		0.372	-0.297604		0	0	0																	0.324	1.0				muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; nervous system phenotype ; digestive/alimentary phenotype; renal/urinary system phenotype; respiratory system phenotype; behavior/neurological phenotype ; reproductive system phenotype; normal phenotype; mortality/aging ; cardiovascular system phenotype ; 			fetal brain;cingulate cortex;trigeminal ganglion;	Axon guidance	metanephros development;ureteric bud development;outflow tract septum morphogenesis;aortic valve morphogenesis;pulmonary valve morphogenesis;endocardial cushion formation;homophilic cell adhesion via plasma membrane adhesion molecules;axon guidance;central nervous system development;brain development;axon midline choice point recognition;spinal cord development;olfactory bulb interneuron development;retinal ganglion cell axon guidance;cellular response to hormone stimulus;Roundabout signaling pathway;positive regulation of Notch signaling pathway involved in heart induction;aorta development;positive regulation of axonogenesis;negative regulation of negative chemotaxis;negative regulation of synapse assembly;ventricular septum morphogenesis;apoptotic process involved in luteolysis	plasma membrane;cell surface;integral component of membrane;axolemma;extracellular exosome	protein binding;axon guidance receptor activity;identical protein binding	ROBO2[12504588];ROBO1[12504588];GPR152[unassigned1304];PARD6B[26496610];RPS6KA5[21900206];RDH11[21900206];TMEM248[26496610];MYC[21150319];KIF1C[26496610];FADD[unassigned1774];UBQLN4[16713569];BNIP3L[21900206];CENPU[21900206];OR1D4[unassigned1304];NR1H2[21900206];METTL3[26496610];SSRP1[16169070];KCNRG[21900206];NR4A1[21900206];OLFM2[16169070];KIF2A[26496610];VAPA[26496610];TMEM237[unassigned1304];PPP1R1B[16169070];HLA-DPB1[21900206];CPE[16169070];	75986695
54061	chr3	75986719	G	C	chr3:75986719	ROBO2	roundabout guidance receptor 2	SNV	0/1	0.67	72_143	215	99.0	0/1	0.48	86_80	166	99.0			rs62269818	EXONIC	YES	NM_001378191.1	Transcript	protein_coding	synonymous_variant		2/30	NM_001378191.1:c.75G>C	NP_001365120.1:p.Val25%3D		1.0					Vesicoureteral reflux 2, 610878 (3), Autosomal dominant	Familial vesicoureteral reflux	Disease-causing germline mutation(s) in	Vesicoureteral reflux;Renal hypoplasia;Autosomal dominant inheritance		0.0	0.0	151970.0	0.0	31	0.93	AC0				0.0	0.0	0.500153	114325.0	228580.0	40.0	39	0.93	InbreedingCoeff	eas	0.500513	8778.0	0.500151	52906.0	0.0146684	2281	0.051	142.0	0.14158	1189.0		0.293	-0.332024		0	0	0																	0.324	1.0				muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; nervous system phenotype ; digestive/alimentary phenotype; renal/urinary system phenotype; respiratory system phenotype; behavior/neurological phenotype ; reproductive system phenotype; normal phenotype; mortality/aging ; cardiovascular system phenotype ; 			fetal brain;cingulate cortex;trigeminal ganglion;	Axon guidance	metanephros development;ureteric bud development;outflow tract septum morphogenesis;aortic valve morphogenesis;pulmonary valve morphogenesis;endocardial cushion formation;homophilic cell adhesion via plasma membrane adhesion molecules;axon guidance;central nervous system development;brain development;axon midline choice point recognition;spinal cord development;olfactory bulb interneuron development;retinal ganglion cell axon guidance;cellular response to hormone stimulus;Roundabout signaling pathway;positive regulation of Notch signaling pathway involved in heart induction;aorta development;positive regulation of axonogenesis;negative regulation of negative chemotaxis;negative regulation of synapse assembly;ventricular septum morphogenesis;apoptotic process involved in luteolysis	plasma membrane;cell surface;integral component of membrane;axolemma;extracellular exosome	protein binding;axon guidance receptor activity;identical protein binding	ROBO2[12504588];ROBO1[12504588];GPR152[unassigned1304];PARD6B[26496610];RPS6KA5[21900206];RDH11[21900206];TMEM248[26496610];MYC[21150319];KIF1C[26496610];FADD[unassigned1774];UBQLN4[16713569];BNIP3L[21900206];CENPU[21900206];OR1D4[unassigned1304];NR1H2[21900206];METTL3[26496610];SSRP1[16169070];KCNRG[21900206];NR4A1[21900206];OLFM2[16169070];KIF2A[26496610];VAPA[26496610];TMEM237[unassigned1304];PPP1R1B[16169070];HLA-DPB1[21900206];CPE[16169070];	75986719
54127	chr3	77693928	T	G	chr3:77693928	ROBO2	roundabout guidance receptor 2	SNV	0/1	0.46	65_56	122	99.0	0/0	0.0	39_0	39	99.0			rs758687620	EXONIC	YES	NM_001378191.1	Transcript	protein_coding	synonymous_variant		29/30	NM_001378191.1:c.4467T>G	NP_001365120.1:p.Ser1489%3D		1.0		Likely_benign	criteria_provided,_single_submitter	not_specified	Vesicoureteral reflux 2, 610878 (3), Autosomal dominant	Familial vesicoureteral reflux	Disease-causing germline mutation(s) in	Vesicoureteral reflux;Renal hypoplasia;Autosomal dominant inheritance		3.28774e-05	5.0	152080.0	0.0	32	0.95	PASS	amr	0.000131062	2.0	4.41021e-05	3.0	2.4045e-05	6.0	249532.0	0.0	81	1.0	PASS	afr	6.45911e-05	1.0	4.41423e-05	5.0	0.0000193	3			0.00035	4.0		5.539	0.180011		0	0	0			ROBO2	0.01	0.0	0.0	0.0	-28.0	7.0	33.0	-29.0						0.324	1.0	10.613500760			muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; nervous system phenotype ; digestive/alimentary phenotype; renal/urinary system phenotype; respiratory system phenotype; behavior/neurological phenotype ; reproductive system phenotype; normal phenotype; mortality/aging ; cardiovascular system phenotype ; 			fetal brain;cingulate cortex;trigeminal ganglion;	Axon guidance	metanephros development;ureteric bud development;outflow tract septum morphogenesis;aortic valve morphogenesis;pulmonary valve morphogenesis;endocardial cushion formation;homophilic cell adhesion via plasma membrane adhesion molecules;axon guidance;central nervous system development;brain development;axon midline choice point recognition;spinal cord development;olfactory bulb interneuron development;retinal ganglion cell axon guidance;cellular response to hormone stimulus;Roundabout signaling pathway;positive regulation of Notch signaling pathway involved in heart induction;aorta development;positive regulation of axonogenesis;negative regulation of negative chemotaxis;negative regulation of synapse assembly;ventricular septum morphogenesis;apoptotic process involved in luteolysis	plasma membrane;cell surface;integral component of membrane;axolemma;extracellular exosome	protein binding;axon guidance receptor activity;identical protein binding	ROBO2[12504588];ROBO1[12504588];GPR152[unassigned1304];PARD6B[26496610];RPS6KA5[21900206];RDH11[21900206];TMEM248[26496610];MYC[21150319];KIF1C[26496610];FADD[unassigned1774];UBQLN4[16713569];BNIP3L[21900206];CENPU[21900206];OR1D4[unassigned1304];NR1H2[21900206];METTL3[26496610];SSRP1[16169070];KCNRG[21900206];NR4A1[21900206];OLFM2[16169070];KIF2A[26496610];VAPA[26496610];TMEM237[unassigned1304];PPP1R1B[16169070];HLA-DPB1[21900206];CPE[16169070];	77693928
54149	chr3	78766945	C	T	chr3:78766945	ROBO1	roundabout guidance receptor 1	SNV	0/0	0.0	34_0	34	99.0	0/1	0.52	28_30	58	99.0			rs745910529,COSV101458721	EXONIC	YES	NM_002941.4	Transcript	protein_coding	missense_variant		6/31	NM_002941.4:c.746G>A	NP_002932.1:p.Arg249His		-1.0	Immunoglobulin I-set&Immunoglobulin-like domain&Immunoglobulin subtype,Immunoglobulin I-set&Immunoglobulin-like domain&Immunoglobulin subtype,Immunoglobulin I-set&Immunoglobulin-like domain&Immunoglobulin subtype,Immunoglobulin I-set&Immunoglobulin-like domain&Immunoglobulin subtype,.,.					Pituitary stalk interruption syndrome	Disease-causing germline mutation(s) (loss of function) in	Hypothyroidism;Short stature;Adrenal hypoplasia;Septo-optic dysplasia;Intellectual disability;Ectopic posterior pituitary;Global developmental delay;Diabetes insipidus;Cryptorchidism;Failure to thrive;Delayed puberty;Death in infancy;Hypoglycemia;Hypoplasia of penis;Seizure;Primary amenorrhea						32	0.96											41	0.96														29.2	4.164468	0.842	16	5	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,BayesDel_noAF_pred	ROBO1	0.0	0.0	0.0	0.0	-15.0	47.0	26.0	-32.0						0.687	0.0	0.000000000	0.988	1.026	skeleton phenotype; renal/urinary system phenotype; nervous system phenotype ; digestive/alimentary phenotype; mortality/aging ; normal phenotype; reproductive system phenotype; cardiovascular system phenotype ; neoplasm; behavior/neurological phenotype ; respiratory system phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; integument phenotype ; growth/size/body region phenotype; endocrine/exocrine gland phenotype; 			.	Axon guidance	cell migration involved in sprouting angiogenesis;outflow tract septum morphogenesis;aortic valve morphogenesis;pulmonary valve morphogenesis;endocardial cushion formation;activation of cysteine-type endopeptidase activity involved in apoptotic process;cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;nervous system development;axon guidance;positive regulation of gene expression;negative regulation of gene expression;axon midline choice point recognition;chemorepulsion involved in postnatal olfactory bulb interneuron migration;negative regulation of cell migration;negative regulation of mammary gland epithelial cell proliferation;positive regulation of Rho protein signal transduction;Roundabout signaling pathway;positive regulation of Notch signaling pathway involved in heart induction;aorta development;positive regulation of MAP kinase activity;positive regulation of axonogenesis;negative regulation of negative chemotaxis;ventricular septum morphogenesis;negative regulation of chemokine-mediated signaling pathway;positive regulation of vascular endothelial growth factor signaling pathway	cytoplasm;plasma membrane;integral component of plasma membrane;cell surface;axon;endoplasmic reticulum-Golgi intermediate compartment membrane	protein binding;axon guidance receptor activity;LRR domain binding;identical protein binding	ROBO2[12504588];ROBO4[18948384];USP33[19706539];HMGA1[30021884];BRK1[24439376];MAPK14[20936779];TUBB4A[16169070];ROBO1[12504588];ARHGAP4[26365803];PARD6B[26496610];CDK2[26496610];SLIT2[17848514];MAGEB6[unassigned1304];SRGAP2[26365803];	78766945
54153	chr3	86114834	G	C	chr3:86114834	CADM2	cell adhesion molecule 2	SNV	0/1	0.46	40_34	74	99.0	0/1	0.37	52_31	83	99.0			rs36050101,COSV67358938	EXONIC	YES	NM_001375960.1	Transcript	protein_coding	synonymous_variant		10/11	NM_001375960.1:c.1170G>C	NP_001362889.1:p.Thr390%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00553971	843.0	152174.0	5.0	32	0.98	PASS	nfe	0.008496	578.0	0.008496	578.0	0.00570218	1432.0	251132.0	6.0	42	0.98	PASS	nfe	0.00752999	855.0	0.00752999	855.0	0.0056462	878	0.011	36.0				6.813	0.269325		0	0	0			CADM2	0.0	0.0	0.0	0.0	39.0	-31.0	46.0	-12.0						0.201	0.98	39.194772040			.			.	.	cell adhesion;adherens junction organization	plasma membrane;integral component of membrane;cell junction;axon;synapse	.	MYO1B[30021884];	86114834
54184	chr3	93769712	C	G	chr3:93769712	ARL13B	ADP ribosylation factor like GTPase 13B	SNV	0/1	0.25	27_9	36	99.0	0/1	0.43	29_22	51	99.0			rs11554412	EXONIC	YES	NM_001174150.2	Transcript	protein_coding	missense_variant		9/10	NM_001174150.2:c.1186C>G	NP_001167621.1:p.Pro396Ala		1.0	.,.,.,.	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Joubert_syndrome_1|Joubert_syndrome_8|not_specified|not_provided	Joubert syndrome 8, 612291 (3), Autosomal recessive	Joubert syndrome	Disease-causing germline mutation(s) in	Intellectual disability;Generalized hypotonia;Muscular hypotonia;Oculomotor apraxia;Pigmentary retinopathy;Ataxia;Obesity;Occipital encephalocele;Molar tooth sign on MRI;Global developmental delay;Autosomal recessive inheritance;Optic disc pallor;Abnormality of the hypothalamus-pituitary axis;Aganglionic megacolon;Apnea;Anteverted nares;Polymicrogyria;Cerebellar vermis hypoplasia;Intellectual disability;Global developmental delay;Biparietal narrowing;Encephalocele;Feeding difficulties in infancy;Oral cleft;Low-set ears;Hand polydactyly;Foot polydactyly;Highly arched eyebrow;Tremor;Iris coloboma;Ataxia;Abnormal form of the vertebral bodies;Hydrocephalus;Muscular hypotonia;Prominent nasal bridge;Nystagmus;Situs inversus totalis;Aplasia/Hypoplasia of the corpus callosum;Episodic tachypnea;Seizure;Gait disturbance;Strabismus;Oculomotor apraxia;Scoliosis;Long face;Ptosis	25741868	0.00522107	794.0	152076.0	8.0	32	0.97	PASS	nfe	0.00822035	559.0	0.00822035	559.0	0.0060494	1518.0	250934.0	7.0	58	1.0	PASS	nfe	0.0091714	1042.0	0.0091714	1042.0	0.0066172	1029	0.014	45.0	0.015	171.0		24.6	3.396915	0.241	7	14	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred	Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	ARL13B	0.0	0.03	0.0	0.02	24.0	-44.0	-1.0	24.0						0.934	0.0	0.000000000	0.998	-0.287	nervous system phenotype ; renal/urinary system phenotype; embryo phenotype; respiratory system phenotype; mortality/aging ; growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			.	.	heart looping;smoothened signaling pathway;dorsal/ventral pattern formation;response to lithium ion;neural tube patterning;interneuron migration from the subpallium to the cortex;formation of radial glial scaffolds;cilium assembly;left/right axis specification;receptor localization to non-motile cilium;non-motile cilium assembly	cilium;axoneme;motile cilium;ciliary membrane;non-motile cilium	protein binding;GTP binding	CCDC167[unassigned1304];TUSC5[unassigned1304];TFRC[unassigned1304];PGAP2[unassigned1304];THSD7B[unassigned1304];CCL4L1[unassigned1304];SLC35B1[unassigned1304];GIMAP1[unassigned1304];NRM[unassigned1304];GIMAP5[unassigned1304];TMEM97[unassigned1304];LAMP1[29568061];VSTM1[unassigned1304];HOMER3[unassigned1304];THSD7A[unassigned1304];BRICD5[unassigned1304];TMEM14C[unassigned1304];S100A2[unassigned1304];ENTPD3[unassigned1304];ANKRD46[unassigned1304];MUCL1[unassigned1304];SACM1L[unassigned1304];STX7[unassigned1304];ALG3[unassigned1304];GPR37L1[unassigned1304];TMEM254[unassigned1304];CLDN4[unassigned1304];PLPP4[unassigned1304];NINJ2[unassigned1304];CLDN8[unassigned1304];MALL[unassigned1304];TMEM79[unassigned1304];FKBP8[unassigned1304];COL8A2[unassigned1304];STX1A[unassigned1304];CLEC4G[unassigned1304];TEX264[unassigned1304];FAXDC2[unassigned1304];LPAR3[unassigned1304];TMEM121[unassigned1304];TGOLN2[29568061];CLEC7A[unassigned1304];TMEM128[unassigned1304];SLC38A7[unassigned1304];HMOX1[unassigned1304];B4GALNT2[unassigned1304];HMOX2[unassigned1304];FDFT1[unassigned1304];TMEM86B[unassigned1304];ICMT[unassigned1304];TMEM190[unassigned1304];TNFRSF10C[unassigned1304];NKG7[unassigned1304];ACSF2[unassigned1304];GJB2[unassigned1304];TMEM17[26638075];NAT8[unassigned1304];TMEM11[unassigned1304];PAEP[unassigned1304];FXYD6[unassigned1304];C2CD2L[unassigned1304];RTP2[unassigned1304];BMP10[unassigned1304];ITGAM[unassigned1304];AQP10[unassigned1304];TECR[unassigned1304];SLC2A5[unassigned1304];WFDC2[unassigned1304];TMEM187[unassigned1304];CYB561D2[unassigned1304];SPN[unassigned1304];FUNDC2[unassigned1304];TMEM43[unassigned1304];PRB1[unassigned1304];MYADML2[unassigned1304];CD53[unassigned1304];SLC13A3[unassigned1304];JAGN1[unassigned1304];MMD[unassigned1304];EMP1[unassigned1304];ZDHHC15[unassigned1304];TNMD[unassigned1304];DWORF[unassigned1304];TMEM218[unassigned1304];VAMP1[unassigned1304];CD302[unassigned1304];VAMP4[unassigned1304];VAMP2[unassigned1304];VAMP3[unassigned1304];PLPPR2[unassigned1304];GOSR2[unassigned1304];CLN6[unassigned1304];TMEM65[unassigned1304];LEPROTL1[unassigned1304];ORMDL3[unassigned1304];CCL4[unassigned1304];CDIPT[unassigned1304];KCNJ2[unassigned1304];KLRG1[unassigned1304];AOC3[unassigned1304];SLC35A1[unassigned1304];C4orf3[unassigned1304];CMTM3[unassigned1304];SMAGP[unassigned1304];BNIP3[unassigned1304];ORMDL1[unassigned1304];GAD2[unassigned1304];SEMA4G[unassigned1304];PDZK1IP1[unassigned1304];AIG1[unassigned1304];TMUB2[unassigned1304];TM6SF2[unassigned1304];TSPO2[unassigned1304];TMEM54[unassigned1304];YIPF6[unassigned1304];PLP1[unassigned1304];PMP22[unassigned1304];PTPN9[unassigned1304];CFHR5[unassigned1304];RAB9A[29568061];PPGB[unassigned1304];TMEM229B[unassigned1304];	93769712
54192	chr3	97868588	A	G	chr3:97868588	OR5H14	olfactory receptor family 5 subfamily H member 14	SNV	0/1	0.24	19_6	25	73.0	0/0	0.0	33_0	33	99.0			rs759740532,COSV71194367	EXONIC	YES	NM_001005514.2	Transcript	protein_coding	missense_variant		2/2	NM_001005514.2:c.359A>G	NP_001005514.1:p.Tyr120Cys		1.0	GPCR, rhodopsin-like, 7TM,GPCR, rhodopsin-like, 7TM					.	.	.		0.000100336	15.0	149498.0	0.0	32	0.92	AS_VQSR	eas	0.00019305	1.0	8.92857e-05	6.0	4.3955e-05	11.0	250256.0	0.0	100	1.0	PASS	afr	0.000495479	8.0	1.76938e-05	2.0	0.0000064	1						18.18	1.797376	0.488	6	13	19	SIFT,LRT_pred,MutationAssessor_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	OR5H14	0.0	0.0	0.0	0.0	42.0	7.0	-5.0	-38.0						0.856	0.0		0.991	1.141	.			.	.	G protein-coupled receptor signaling pathway;sensory perception of smell;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity;odorant binding	.	97868588
54196	chr3	99643257	G	A	chr3:99643257	FILIP1L	filamin A interacting protein 1 like	SNV	1/1	1.0	0_18	18	54.0	0/1	0.48	16_15	31	99.0			rs191193772	SPLICING	YES	NM_001387850.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	3/5		NM_001387850.1:c.427-5C>T			-1.0						.	.	.		0.00141278	215.0	152182.0	0.0	33	0.98	PASS	nfe	0.00276332	188.0	0.00276332	188.0	0.00129762	323.0	248918.0	3.0	79	0.95	PASS	nfe	0.00207678	235.0	0.00207678	235.0	0.0014019	218	0.0	1.0				5.565	0.181706		0	0	0			FILIP1L	0.01	0.0	0.0	0.0	-5.0	-43.0	26.0	-5.0	3.79260434703775e-05	0.016	8.105	-0.854	7.251	0.901	0.0				.			ciliary ganglion;uterus;testis - interstitial;superior cervical ganglion;trigeminal ganglion;atrioventricular node;testis;skeletal muscle;	.	biological_process	nucleus;cytoplasm;membrane	molecular_function	PDIA3[30021884];SMTN[unassigned1304];PLEC[30021884];	99643257
54279	chr3	101370530	AAA		chr3:101370530-101370532	ZBTB11	zinc finger and BTB domain containing 11	sequence_alteration	0/2	0.17	4_4_12	24	7.0	1/2	0.26	3_7_7	27	40.0			rs56200814	SPLICING	YES	NM_014415.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	10/10		NM_014415.4:c.2645-5_2645-3del			-1.0					Intellectual developmental disorder, autosomal recessive 69, 618383 (3), Autosomal recessive	.	.	Microcephaly;Global developmental delay;Hyperplasia of the maxilla;Autosomal recessive inheritance;Dysarthria;Cerebellar hypoplasia;Ventriculomegaly;Ataxia;Drooling;Facial hypotonia		0.000179147	23.0	128386.0	0.0	10	0.5	PASS	afr	0.000501297	17.0	4.94315e-05	3.0	0.0188	1467.0	78032.0	0.0	19	0.48	PASS	afr	0.0586081	416.0	0.0150588	615.0	0.0101412	1577						5.06	0.149055		0	0	0			ZBTB11	0.0	0.0	0.0	0.0	-10.0	-2.0	-10.0	-14.0						0.641	0.27				.			amygdala;trigeminal ganglion;superior cervical ganglion;parietal lobe;medulla oblongata;	.	regulation of transcription by RNA polymerase II;biological_process	nucleoplasm	DNA-binding transcription factor activity, RNA polymerase II-specific;molecular_function;DNA binding;metal ion binding	ATP6AP2[26496610];RRP1B[20926688];SMAD7[15231748];PPP1CA[22321011];	101370529
54290	chr3	107097137	G	A	chr3:107097137	CCDC54	coiled-coil domain containing 54	SNV	0/0	0.0	36_0	36	99.0	0/1	0.38	50_30	80	99.0			rs116383550,COSV53759734	EXONIC	YES	NM_032600.3	Transcript	protein_coding	missense_variant		1/1	NM_032600.3:c.703G>A	NP_115989.1:p.Ala235Thr		1.0						.	.	.		0.000269453	41.0	152160.0	0.0	32	0.98	PASS	nfe	0.000529241	36.0	0.000529241	36.0	0.000263147	66.0	250810.0	0.0	91	0.99	PASS	nfe	0.000520264	59.0	0.000520264	59.0	0.0003215	50	0.001	2.0				1.454	-0.094905	0.025	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CCDC54	0.02	0.0	0.0	0.01	28.0	1.0	-36.0	-1.0						0.843	0.0	0.000000000	0.016	-0.122	.			.	.	.	.	.	RSL1D1[30021884];	107097137
54297	chr3	108189647	C	T	chr3:108189647	MYH15	myosin heavy chain 15	SNV	1/1	1.0	0_33	33	98.0	0/1	0.48	40_37	77	99.0			rs142178990	EXONIC	YES	NM_014981.2	Transcript	protein_coding	missense_variant		14/42	NM_014981.2:c.1341G>A	NP_055796.1:p.Met447Ile		-1.0	Myosin head, motor domain&Myosin head, motor domain&Myosin head, motor domain					.	.	.		4.59963e-05	7.0	152186.0	0.0	31	0.94	PASS	amr	0.000196489	3.0	4.41021e-05	3.0	4.81657e-05	12.0	249140.0	0.0	50	1.0	PASS	amr	0.000261051	9.0	2.65468e-05	3.0	0.0000579	9						22.5	2.464392	0.14	7	11	18	SIFT,MetaLR_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,LIST-S2_pred,fathmm-MKL_coding_pred	PolyPhen,M-CAP_pred,MetaSVM_pred,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	MYH15	0.0	0.0	0.0	0.0	-30.0	47.0	48.0	1.0						0.196	0.0	0.000000000	0.986	1.026	.			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;	Tight junction	extraocular skeletal muscle development	myofibril;myosin filament	motor activity;calmodulin binding;ATP binding;actin filament binding	H2AFZ[30021884];FLOT1[30021884];RRBP1[30021884];PDIA4[30021884];	108189647
54300	chr3	108229438		AA	chr3:108229437-108229438	MYH15	myosin heavy chain 15	insertion	1/2	0.12	1_11_2	16	6.0	1/2	0.22	4_17_6	27	46.0			rs150536264	SPLICING	YES	NM_014981.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/41		NM_014981.2:c.4-5_4-4dup			-1.0						.	.	.		0.000242388	36.0	148522.0	1.0	14	0.6	PASS	eas	0.000789578	4.0	0.000297814	20.0	0.00868216	1405.0	161826.0	0.0	36	0.8	RF	eas	0.0134035	158.0	0.0078151	610.0	0.0000836,0.0000450,0.0102956	13,7,1601			0.00109	2.0		6.65	0.257094		0	0	0																	0.196	0.0				.			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;	Tight junction	extraocular skeletal muscle development	myofibril;myosin filament	motor activity;calmodulin binding;ATP binding;actin filament binding	H2AFZ[30021884];FLOT1[30021884];RRBP1[30021884];PDIA4[30021884];	108229437
54304	chr3	109027087	G	C	chr3:109027087	DPPA2	developmental pluripotency associated 2	SNV	0/0	0.0	34_0	34	99.0	0/1	0.43	49_37	86	99.0				EXONIC	YES	NM_138815.4	Transcript	protein_coding	synonymous_variant		6/9	NM_138815.4:c.450C>G	NP_620170.3:p.Arg150%3D		-1.0						.	.	.						32	0.97											69	1.0														0.117	-0.461875		0	0	0			DPPA2	0.0	0.0	0.0	0.0	31.0	24.0	-34.0	-3.0						0.762	0.0	33.720104447			mortality/aging ; normal phenotype; respiratory system phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			.	.	.	nucleus	chromatin binding	MOAP1[16189514];SETD5[16189514];ZCCHC10[16189514];UBE2I[unassigned1304];ZNF250[16189514];VTA1[16189514];PLOD3[16189514];PBXIP1[16189514];MCM10[16189514];SDCBP2[16189514];FXR2[16189514];DPPA4[16189514];U2AF2[16189514];DPPA2[16189514];DVL2[16189514];SPOP[16189514];DVL3[16189514];AP2M1[16189514];	109027087
54413	chr3	119378773	A	C	chr3:119378773	POPDC2	popeye domain containing 2	SNV	0/1	0.39	44_28	72	99.0	0/0	0.0	40_0	40	99.0				SPLICING	YES	NM_001369919.2	Transcript	protein_coding	splice_region_variant,intron_variant	1/3		NM_001369919.2:c.491+7T>G			-1.0						.	.	.						32	0.97											60	0.73														11.68	0.765508		0	0	0			POPDC2	0.0	0.0	0.0	0.01	7.0	1.0	-1.0	50.0	0.0002107126351127	0.084				0.663	0.0				cardiovascular system phenotype ; homeostasis/metabolism phenotype; growth/size/body region phenotype; 			skeletal muscle;heart;	.	regulation of heart rate;heart development;skeletal muscle tissue development;biological_process;regulation of membrane potential;striated muscle cell differentiation	membrane;integral component of membrane;sarcolemma	molecular_function;cAMP binding	BTG2[18337750];	119378773
54419	chr3	119452252	C	T	chr3:119452252	MAATS1	MYCBP associated and testis expressed 1	SNV	0/0	0.0	36_0	36	99.0	0/1	0.48	32_30	62	99.0			rs192654936	EXONIC	YES	NM_033364.4	Transcript	protein_coding	stop_gained		10/18	NM_033364.4:c.1243C>T	NP_203528.3:p.Gln415Ter		1.0	.,.					.	.	.		2.62771e-05	4.0	152224.0	0.0	32	0.97	PASS	amr	0.000130907	2.0	1.46981e-05	1.0	8.35522e-05	21.0	251340.0	0.0	54	0.99	PASS	amr	0.000520863	18.0	1.75929e-05	2.0	0.0000579	9	0.001	3.0				36.0	6.92031		5	1	6	LRT_pred,MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	fathmm-XF_coding_pred	MAATS1	0.0	0.16	0.0	0.0	14.0	-41.0	-2.0	-41.0							0.0	0.000000000	0.945	1.026	.			.	.	cilium movement	radial spoke stalk;mitochondrion;axoneme;motile cilium	protein binding	MYCBP[12223483];MYC[21150319];DPY30[unassigned1304];CEP97[27173435;unassigned1312];AKAP1[12223483];	119452252
54548	chr3	123359207	C	T	chr3:123359207	MYLK	myosin light chain kinase	SNV	0/0	0.0	34_0	34	99.0	0/1	0.49	82_78	160	99.0			rs56056823	EXONIC	YES	NM_053025.4	Transcript	protein_coding	synonymous_variant		28/34	NM_053025.4:c.4764G>A	NP_444253.3:p.Pro1588%3D		-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Aortic_aneurysm,_familial_thoracic_7|Familial_thoracic_aortic_aneurysm_and_aortic_dissection|not_specified|Cardiovascular_phenotype|not_provided	Megacystis-microcolon-intestinal hypoperistalsis syndrome 1, 249210 (3), Autosomal recessive; Aortic aneurysm, familial thoracic 7, 613780 (3), Autosomal dominant	Megacystis-microcolon-intestinal hypoperistalsis syndrome;Familial thoracic aortic aneurysm and aortic dissection	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Hydroureter;Sepsis;Nausea and vomiting;Intestinal malrotation;Hypoperistalsis;Umbilical hernia;Microcolon;Omphalocele;Multicystic kidney dysplasia;Polyhydramnios;Death in infancy;Abdominal distention;Cryptorchidism;Megacystis;Neoplasm of the heart;Autosomal dominant inheritance;Aortic aneurysm;Aortic dissection;Arachnodactyly;Bicuspid aortic valve;Hypovolemia;Pneumothorax;Dilatation of the cerebral artery;Retrognathia;Descending aortic dissection;Paroxysmal dyspnea;Scoliosis;Abnormality iris morphology;Patent ductus arteriosus;Exertional dyspnea;Subarachnoid hemorrhage;Ascending aortic dissection;Hypertension;Dural ectasia;Chest pain;Tall stature;Mucoid extracellular matrix accumulation;Transient ischemic attack;Left ventricular dysfunction;Ischemic stroke;Aortic root aneurysm;Pes planus;Cardiomegaly;Prenatal maternal abnormality;Hemoptysis;Inguinal hernia;Aortic regurgitation;Peripheral arterial stenosis;Descending thoracic aorta aneurysm;Abdominal aortic aneurysm;Carotid artery dilatation;Abnormality of the sternum;Hypertelorism;High, narrow palate;Cutis marmorata;Bruising susceptibility;Coronary artery atherosclerosis	25741868,26017485	0.00488919	743.0	151968.0	7.0	31	0.93	PASS	nfe	0.00844068	574.0	0.00844068	574.0	0.0044776	1126.0	251474.0	6.0	100	1.0	PASS	nfe	0.00772747	879.0	0.00772747	879.0	0.0048873	760	0.01	34.0	0.00824	94.0		9.083	0.466645		0	0	0			MYLK	0.0	0.0	0.0	0.0	-2.0	26.0	43.0	-11.0						0.734	0.0	88.263289694			mortality/aging ; normal phenotype; cardiovascular system phenotype ; behavior/neurological phenotype ; renal/urinary system phenotype; skeleton phenotype; immune system phenotype; digestive/alimentary phenotype; muscle phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; 			uterus;appendix;testis - interstitial;uterus corpus;prostate;testis;	Calcium signaling pathway;Focal adhesion;Regulation of actin cytoskeleton	protein phosphorylation;muscle contraction;smooth muscle contraction;tonic smooth muscle contraction;positive regulation of cell migration;bleb assembly;positive regulation of calcium ion transport;aorta smooth muscle tissue morphogenesis;cellular hypotonic response;cardiovascular system development;positive regulation of wound healing	stress fiber;cytoplasm;cytosol;plasma membrane;actin cytoskeleton;lamellipodium;cleavage furrow	actin binding;protein kinase activity;myosin light chain kinase activity;protein binding;calmodulin binding;ATP binding;metal ion binding	JUN[25609649];CAMK2D[29426014];SDR42E2[30021884];HSPB1[25277244];PIK3R1[17474147];MYO19[26496610];HNRNPAB[30021884];MYL12A[21457715];PPP1CB[26496610];ANLN[26496610];CTTN[25241761];APPBP2[unassigned1304];MYH9[26496610];GRB2[17474147];GOPC[25416956;unassigned1304];NCK1[17474147];	123359207
54591	chr3	124457057	T	C	chr3:124457057	UMPS	uridine monophosphate synthetase	SNV	0/1	0.49	36_35	71	99.0	0/1	0.54	32_37	69	99.0			rs375535366,COSV51737705	EXONIC	YES	NM_000373.4	Transcript	protein_coding	missense_variant		3/6	NM_000373.4:c.953T>C	NP_000364.1:p.Ile318Thr		1.0	Orotidine 5'-phosphate decarboxylase domain&Orotidine 5'-phosphate decarboxylase domain	Uncertain_significance	criteria_provided,_single_submitter	Oroticaciduria	Orotic aciduria, 258900 (3), Autosomal recessive	Hereditary orotic aciduria	Disease-causing germline mutation(s) (loss of function) in	Hypochromia;Oroticaciduria;Reduced orotidine 5-prime phosphate decarboxylase level;Failure to thrive;Pyrimidine-responsive megaloblastic anemia;Poikilocytosis;Impaired T cell function;Global developmental delay;Orotic acid crystalluria;Atrial septal defect;Hematuria;Folate-unresponsive megaloblastic anemia;Autosomal recessive inheritance;Ventricular septal defect;Anisocytosis;Impaired T cell function;Low-set, posteriorly rotated ears;Aminoaciduria;Wide nasal bridge;Global developmental delay;Patent ductus arteriosus;Hypertelorism;Hip dysplasia;Recurrent respiratory infections;Abnormality of the ureter;Abnormal toenail morphology;Downslanted palpebral fissures;Orotic acid crystalluria;Oroticaciduria;Splenomegaly;Anemia		0.000118265	18.0	152200.0	0.0	33	0.98	PASS	amr	0.000458115	7.0	1.46972e-05	1.0	6.41689e-05	16.0	249342.0	0.0	55	1.0	PASS	afr	0.000129618	2.0	8.87485e-05	10.0	0.0000900	14			0.0007	8.0		26.5	3.845258	0.717	19	2	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FATHMM_pred,PrimateAI_pred	UMPS	0.0	0.0	0.01	0.0	-18.0	47.0	29.0	-36.0						0.579	0.0	0.000000000	1.0	1.138	.			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;testis;	Pyrimidine metabolism;Drug metabolism - other enzymes	'de novo' pyrimidine nucleobase biosynthetic process;UMP biosynthetic process;female pregnancy;lactation;cellular response to drug;'de novo' UMP biosynthetic process;pyrimidine nucleoside biosynthetic process	nucleus;cytoplasm;cytosol	orotate phosphoribosyltransferase activity;orotidine-5'-phosphate decarboxylase activity	PLA2G12A[21988832];JUN[25609649];PAXIP1[21163940];NOS3[21163940];DLST[16169070];CDC5L[20467437];PSEN1[21163940];HSCB[28380382];KLC4[26496610];CASP8[25640309];RAD51[25640309];PIK3CA[25640309];RPS29[21988832];RB1CC1[25640309];CDC42EP3[16169070];CASP4[17353931];CALU[21988832];USP50[19615732];ZNF227[21988832];ANG[28777577];A2M[21163940];UMPS[18184586];MYH6[26496610];	124457057
54632	chr3	126201221	G	A	chr3:126201221	UROC1	urocanate hydratase 1	SNV	0/0	0.0	33_0	33	99.0	0/1	0.44	60_47	107	99.0			rs199712731,COSV52036757,COSV99332650	EXONIC	YES	NM_001165974.2	Transcript	protein_coding	synonymous_variant		21/21	NM_001165974.2:c.2178C>T	NP_001159446.1:p.Asp726%3D		-1.0					?Urocanase deficiency, 276880 (3), Autosomal recessive	Urocanic aciduria	Disease-causing germline mutation(s) in	Recurrent infections;Action tremor;Hyperactive deep tendon reflexes;Gaze-evoked horizontal nystagmus;Urocanic aciduria;Broad-based gait;Gait ataxia;Truncal ataxia;Abnormal circulating histidine concentration;Dysarthria;Ataxia;Tremor;Intellectual disability, severe;Urocanic aciduria;Aggressive behavior;Nystagmus;Short stature;Fair hair;Blue irides;Intellectual disability, progressive;Autosomal recessive inheritance		0.000440245	67.0	152188.0	0.0	32	0.97	PASS	nfe	0.000617411	42.0	0.000617411	42.0	0.000309784	77.0	248560.0	0.0	70	0.96	PASS	nfe	0.000492038	55.0	0.000492038	55.0	0.0003151	49	0.001	2.0	0.00044	5.0		0.019	-0.705338		0	0	0			UROC1	0.0	0.0	0.0	0.0	9.0	8.0	9.0	-6.0						0.81	0.0	0.000000000			.			ciliary ganglion;liver;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;globus pallidus;	Histidine metabolism	histidine catabolic process;histidine catabolic process to glutamate and formamide;histidine catabolic process to glutamate and formate	cytosol	urocanate hydratase activity	ALX1[unassigned1304];	126201221
54635	chr3	126228500	G	A	chr3:126228500	UROC1	urocanate hydratase 1	SNV	0/1	0.39	60_38	98	99.0	0/0	0.0	44_0	44	99.0			rs993499114	EXONIC	YES	NM_001165974.2	Transcript	protein_coding	synonymous_variant		3/21	NM_001165974.2:c.279C>T	NP_001159446.1:p.Tyr93%3D		-1.0					?Urocanase deficiency, 276880 (3), Autosomal recessive	Urocanic aciduria	Disease-causing germline mutation(s) in	Recurrent infections;Action tremor;Hyperactive deep tendon reflexes;Gaze-evoked horizontal nystagmus;Urocanic aciduria;Broad-based gait;Gait ataxia;Truncal ataxia;Abnormal circulating histidine concentration;Dysarthria;Ataxia;Tremor;Intellectual disability, severe;Urocanic aciduria;Aggressive behavior;Nystagmus;Short stature;Fair hair;Blue irides;Intellectual disability, progressive;Autosomal recessive inheritance		6.5684e-06	1.0	152244.0	0.0	33	0.98	PASS	amr	6.54108e-05	1.0	0.0	0.0	1.27395e-05	2.0	156992.0	0.0	100	0.59	PASS	amr	8.06387e-05	2.0	0.0	0.0					0.00053	6.0		6.559	0.250464		0	0	0			UROC1	0.01	0.0	0.0	0.0	2.0	21.0	2.0	-11.0						0.81	0.0	66.890484856			.			ciliary ganglion;liver;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;globus pallidus;	Histidine metabolism	histidine catabolic process;histidine catabolic process to glutamate and formamide;histidine catabolic process to glutamate and formate	cytosol	urocanate hydratase activity	ALX1[unassigned1304];	126228500
54720	chr3	129183592	G	A	chr3:129183592	IFT122	intraflagellar transport 122	SNV	0/0	0.0	45_0	45	99.0	0/1	0.58	35_48	83	99.0			rs150496357	EXONIC	YES	NM_052985.4	Transcript	protein_coding	synonymous_variant		8/31	NM_052985.4:c.684G>A	NP_443711.2:p.Ser228%3D		1.0		Likely_benign	criteria_provided,_single_submitter	Cranioectodermal_dysplasia_1	Cranioectodermal dysplasia 1, 218330 (3), Autosomal recessive	Cranioectodermal dysplasia;Short rib-polydactyly syndrome, Beemer-Langer type	Disease-causing germline mutation(s) in;Candidate gene tested in	Microdontia;Abnormal toenail morphology;Craniosynostosis;Abnormal diaphysis morphology;Hypodontia;Abnormal fingernail morphology;Sparse hair;Myopia;Abnormality of the metaphysis;Frontal bossing;Dolichocephaly;Epicanthus;Taurodontia;Pectus excavatum;Joint hyperflexibility;High hypermetropia;Prominent occiput;Clinodactyly of the 5th finger;Short distal phalanx of finger;Abnormality of dental enamel;Osteoporosis;Rhizomelia;Hypotelorism;Nystagmus;Everted lower lip vermilion;Brachydactyly;Finger syndactyly;Narrow chest;Anteverted nares;Renal magnesium wasting;Osteoporosis;Anodontia;Nystagmus;Hepatic failure;Bicuspid aortic valve;Thin nail;Hepatic cysts;Sparse hair;Ectodermal dysplasia;Short ribs;Epicanthus;Dolichocephaly;Single transverse palmar crease;Frontal bossing;Hepatomegaly;Clinodactyly;Protuberant abdomen;High, narrow palate;Short toe;Hypoplasia of dental enamel;Everted lower lip vermilion;Tubulointerstitial nephritis;Hypocalcemia;Broad toe;Short distal phalanx of finger;Abnormality of the abdominal wall;Chronic kidney disease;Joint laxity;Telecanthus;Sagittal craniosynostosis;Wide nasal bridge;Fine hair;Autosomal recessive inheritance;Radial deviation of finger;Hepatic fibrosis;Short humerus;Widely spaced teeth;Slow-growing hair;Malformation of the hepatic ductal plate;Flattened epiphysis;Triphalangeal hallux;Full cheeks;Broad distal phalanges of all fingers;Myopia;Rhizomelia;High palate;Anteverted nares;Microdontia;Hypotelorism;Short nail;Brachydactyly;Fibular hypoplasia;Retinal dystrophy;Pectus excavatum;Hypodontia;Scaphocephaly;Narrow chest		0.000217025	33.0	152056.0	0.0	32	0.96	PASS	amr	0.000523903	8.0	0.000279371	19.0	0.000278368	70.0	251466.0	0.0	100	1.0	PASS	amr	0.000607077	21.0	0.000334066	38.0	0.0002701	42	0.002	8.0	0.00123	14.0		7.79	0.346167		0	0	0			IFT122	0.0	0.0	0.0	0.02	32.0	-38.0	-33.0	32.0						0.945	0.0	15.593912002			craniofacial phenotype; cellular phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; nervous system phenotype ; limbs/digits/tail phenotype; digestive/alimentary phenotype; vision/eye phenotype; embryo phenotype; mortality/aging ; cardiovascular system phenotype ; 			ciliary ganglion;testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;atrioventricular node;testis;	.	neural tube closure;signal transduction downstream of smoothened;embryonic body morphogenesis;negative regulation of smoothened signaling pathway involved in ventral spinal cord patterning;embryonic heart tube development;embryonic forelimb morphogenesis;intraciliary anterograde transport;intraciliary retrograde transport;intraciliary transport involved in cilium assembly;embryonic digit morphogenesis;negative regulation of smoothened signaling pathway;camera-type eye morphogenesis;negative regulation of epithelial cell proliferation;limb development;cilium assembly;ciliary receptor clustering involved in smoothened signaling pathway;smoothened signaling pathway involved in dorsal/ventral neural tube patterning;embryonic heart tube left/right pattern formation;protein localization to cilium;establishment of protein localization to organelle;non-motile cilium assembly	nucleoplasm;cytosol;cilium;membrane;intraciliary transport particle A;photoreceptor connecting cilium;ciliary basal body;ciliary tip;ciliary base	protein binding	NUDC[25036637];IFT140[27173435;unassigned1312];WDR19[27173435;unassigned1312];NEK7[unassigned1312];TULP3[27173435;unassigned1312];CDC7[27173435;unassigned1312];WDR35[27173435;unassigned1312];NUDCD3[25036637];IFT43[27173435;unassigned1312];DNAJC7[26496610];TTC21B[27173435;unassigned1312];NDUFAF3[27173435;unassigned1312];PFKP[27173435;unassigned1312];CCDC40[27173435;unassigned1312];	129183592
54735	chr3	130282153	C	T	chr3:130282153	COL6A6	collagen type VI alpha 6 chain	SNV	0/1	0.45	73_62	137	99.0	0/0	0.0	34_0	34	99.0			rs768634748,COSV62019781,COSV62022133	EXONIC	YES	NM_001102608.2	Transcript	protein_coding	synonymous_variant		2/36	NM_001102608.2:c.306C>T	NP_001096078.1:p.Gly102%3D		1.0						.	.	.		3.94296e-05	6.0	152170.0	0.0	33	0.97	PASS	sas	0.000207297	1.0	2.93971e-05	2.0	3.21528e-05	8.0	248812.0	0.0	54	0.99	PASS	eas	0.000167075	3.0	1.77396e-05	2.0	0.0000129	2	0.002	5.0				1.142	-0.13107		0	0	0			COL6A6	0.0	0.0	0.39	0.0	13.0	-49.0	-2.0	2.0						0.155	0.0	1.548951032			.			.	Cell Communication;Focal adhesion;ECM-receptor interaction	cell adhesion	extracellular region;collagen trimer;extracellular matrix;collagen-containing extracellular matrix	extracellular matrix structural constituent conferring tensile strength	ALDH1B1[30021884];SSR3[30021884];	130282153
54820	chr3	133969488		C	chr3:133969487-133969488	RYK	receptor-like tyrosine kinase	insertion	1/1	1.0	0_6	6	18.0	1/1	1.0	0_6	6	18.0			rs587744425	SPLICING	YES	NM_001005861.3	Transcript	protein_coding	frameshift_variant,splice_region_variant,intron_variant			NM_001005861.3:c.8-1dup	NP_001005861.1:p.Ala3GlyfsTer76		-1.0						.	.	.						31	0.9								0.0	0.0	0.0	0	0.0	AC0					0.0	0.0000322,0.0000257,0.0000129,0.0000193,0.0000064,0.0000064,0.0040128,0.0000193,0.0690979	5,4,2,3,1,1,624,3,10745	0.001	2.0	0.99093	8302.0		21.8	2.252677		0	0	0			RYK	0.0	0.0	0.0	0.0	-25.0	-7.0	10.0	6.0											behavior/neurological phenotype ; mortality/aging ; limbs/digits/tail phenotype; digestive/alimentary phenotype; vision/eye phenotype; skeleton phenotype; growth/size/body region phenotype; craniofacial phenotype; homeostasis/metabolism phenotype; 			ciliary ganglion;testis - seminiferous tubule;dorsal root ganglion;atrioventricular node;superior cervical ganglion;testis;globus pallidus;	.	protein phosphorylation;signal transduction;transmembrane receptor protein tyrosine kinase signaling pathway;nervous system development;axonogenesis;axon guidance;synapse assembly;Wnt signaling pathway;peptidyl-tyrosine phosphorylation;neurogenesis;corpus callosum development;neuron differentiation;neuron projection development;cell proliferation in midbrain;non-canonical Wnt signaling pathway;chemorepulsion of dopaminergic neuron axon;positive regulation of MAPK cascade;skeletal system morphogenesis;negative regulation of axon extension involved in axon guidance;canonical Wnt signaling pathway;commissural neuron axon guidance;planar cell polarity pathway involved in axon guidance;midbrain dopaminergic neuron differentiation;Wnt signaling pathway involved in midbrain dopaminergic neuron differentiation	nucleus;cytoplasm;plasma membrane;integral component of plasma membrane;membrane;integral component of membrane;receptor complex	protein tyrosine kinase activity;transmembrane receptor protein tyrosine kinase activity;transmembrane signaling receptor activity;frizzled binding;protein binding;ATP binding;Wnt-protein binding;Wnt-activated receptor activity;coreceptor activity involved in Wnt signaling pathway, planar cell polarity pathway	CFTR[17110338];	133969487
54903	chr3	140407211	A	T	chr3:140407211	TRIM42	tripartite motif containing 42	SNV	0/1	0.48	57_53	110	99.0	0/0	0.0	119_0	119	99.0			rs138660520,COSV53880701	EXONIC	YES	NM_152616.5	Transcript	protein_coding	missense_variant		3/5	NM_152616.5:c.1687A>T	NP_689829.3:p.Thr563Ser		1.0						.	.	.		0.00551674	837.0	151720.0	4.0	32	0.95	PASS	nfe	0.00815779	553.0	0.00815779	553.0	0.00547914	1356.0	247484.0	6.0	79	1.0	PASS	nfe	0.00776313	860.0	0.00776313	860.0	0.0041028	638	0.011	36.0				0.001	-1.447635	0.041	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TRIM42	0.01	0.0	0.0	0.0	19.0	-42.0	-37.0	39.0						0.931	0.0	0.000000000	0.011	-1.028	.			testis - interstitial;atrioventricular node;testis;	.	.	.	protein binding;zinc ion binding	MAPKBP1[unassigned1304];RAMAC[25416956];CERK[unassigned1304];KLHL38[25416956;unassigned1304];IKZF3[25416956];BACH2[unassigned1304];AQP1[unassigned1304];GOLGA2[25416956];YY1[unassigned1304];LCE1A[unassigned1304];PSMD9[25416956];LCE1B[unassigned1304];EFEMP2[unassigned1304];CHCHD2[unassigned1304];CYSRT1[unassigned1304];STK16[25416956;unassigned1304];HOXA1[25416956;unassigned1304];TRIM27[25416956];KRTAP3-2[25416956];LZTS2[25416956];PHLDA1[unassigned1304];TRIM23[25416956];PRKAB2[unassigned1304];SMARCC1[unassigned1304];ARRDC3[25416956];ATG9A[unassigned1304];FNDC3B[unassigned1304];MTUS2[25416956];ARMC7[25416956];LCE1E[unassigned1304];LCE1F[unassigned1304];MID2[25416956];LCE1C[unassigned1304];LCE1D[unassigned1304];LCE2B[unassigned1304];KCTD9[25416956;unassigned1304];LCE2C[unassigned1304];LCE2A[unassigned1304];GNE[unassigned1304];KPRP[unassigned1304];BEX2[25416956];L3MBTL2[25416956];CCDC24[unassigned1304];ZBTB1[25416956];CHRD[unassigned1304];FBLN1[unassigned1304];KRT40[25416956];FAM124B[unassigned1304];GUCD1[unassigned1304];CEP70[25416956];KRTAP5-11[unassigned1304];KRTAP4-4[unassigned1304];KRTAP4-2[25416956];OTX1[unassigned1304];LONRF1[25416956;unassigned1304];HOXC8[unassigned1304];TXNDC5[25416956;unassigned1304];TRAPPC2[25416956];NEK8[unassigned1304];SMCP[unassigned1304];TCAF1[unassigned1304];TFAP2D[unassigned1304];KRTAP12-2[unassigned1304];KRTAP4-5[unassigned1304];NOTCH2NLA[25416956;unassigned1304];MAGOHB[25416956];FAM90A1[unassigned1304];TLX3[unassigned1304];RCOR3[25416956];SPERT[25416956];KRTAP26-1[25416956];CDCA7L[25416956];FAM208B[25416956];GLI1[25416956];MEOX2[25416956;unassigned1304];PCSK5[unassigned1304];YWHAQ[25416956];LCE5A[unassigned1304];ADAMTSL4[25416956];IQUB[25416956];VWC2L[unassigned1304];EMD[25416956;25910212];PROP1[unassigned1304];GLRX3[25416956];KRTAP5-7[unassigned1304];CCDC36[25416956];AXIN1[26871637];KRT34[unassigned1304];TRAF2[25416956];VPS37A[25416956];IL16[unassigned1304];TRAF1[25416956];PLSCR1[25416956];SCNM1[25416956];PSMA1[25416956];PLSCR4[unassigned1304];EFHC2[25416956];SSX2IP[25416956];CREB5[unassigned1304];VGLL3[unassigned1304];PTGER3[25416956];LCE2D[unassigned1304];LCE3C[unassigned1304];LCE3D[unassigned1304];LCE3A[unassigned1304];PNMA1[25416956];FCHO1[unassigned1304];SLIT1[unassigned1304];C1orf109[25416956];KRTAP2-3[unassigned1304];TRIM42[25416956];RUNX1T1[25416956];HSD3B7[unassigned1304];KRTAP10-5[unassigned1304];SPAG8[unassigned1304];KRTAP10-7[25416956];YIPF3[unassigned1304];KRTAP10-9[25416956];GLYCTK[25416956];CARD9[25416956];KRTAP10-8[unassigned1304];KRT13[25416956];RYDEN[unassigned1304];MEIS2[unassigned1304];LCE3E[unassigned1304];POU4F2[unassigned1304];PPP1CA[19389623];MFAP1[25416956];LCE4A[unassigned1304];KRT15[25416956];LNX1[unassigned1304];R3HDM2[unassigned1304];	140407211
54953	chr3	148896396	C	G	chr3:148896396	CP	ceruloplasmin	SNV	0/0	0.0	33_0	33	99.0	0/1	0.44	24_20	45	99.0			rs139633388,CM066769	EXONIC	YES	NM_000096.4	Transcript	protein_coding	missense_variant		16/19	NM_000096.4:c.2684G>C	NP_000087.2:p.Gly895Ala		-1.0	.,.,Multicopper oxidase, type 3	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Deficiency_of_ferroxidase|Hypoceruloplasminemia|not_specified|not_provided	Cerebellar ataxia, 604290 (3), Autosomal recessive; [Hypoceruloplasminemia, hereditary], 604290 (3), Autosomal recessive; Hemosiderosis, systemic, due to aceruloplasminemia, 604290 (3), Autosomal recessive	Aceruloplasminemia	Disease-causing germline mutation(s) (loss of function) in	Anemia;Adult onset;Autosomal recessive inheritance;Diabetes mellitus;Torticollis;Retinal degeneration;Aceruloplasminemia;Dementia;Cogwheel rigidity;Blepharospasm;Abnormality of extrapyramidal motor function;Scanning speech;Decreased serum iron;Dysarthria;Increased serum ferritin;Chorea;Ataxia;Memory impairment;Torticollis;Tremor;Congestive heart failure;Chorea;Hypothyroidism;Blepharospasm;Refractory anemia;Ataxia;Decreased serum ceruloplasmin;Dementia;Depressivity;Retinal degeneration;Increased serum ferritin;Dysarthria;Delayed speech and language development;Diabetes mellitus;Hypertonia;Parkinsonism;Elevated hepatic iron concentration	18414213,25741868,20301666	0.00156145	237.0	151782.0	0.0	32	0.96	PASS	amr	0.0030848	47.0	0.00219343	149.0	0.00151965	380.0	250058.0	0.0	45	0.94	PASS	amr	0.00243704	84.0	0.00203266	230.0	0.0015884	247	0.005	18.0	0.00576	59.0	1.0	26.3	3.799888	0.962	15	3	18	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaRNN_pred,PrimateAI_pred,ClinPred_pred	CP	0.0	0.01	0.0	0.0	-22.0	22.0	22.0	-34.0						0.0942	0.0	0.000000000	0.997	1.026	immune system phenotype; nervous system phenotype ; vision/eye phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; pigmentation phenotype; liver/biliary system phenotype; behavior/neurological phenotype ; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; 			ciliary ganglion;appendix;trigeminal ganglion;atrioventricular node;fetal liver;	Porphyrin and chlorophyll metabolism	copper ion transport;iron ion transport;cellular iron ion homeostasis;post-translational protein modification;cellular protein metabolic process;iron ion homeostasis;oxidation-reduction process	extracellular region;extracellular space;lysosomal membrane;endoplasmic reticulum lumen;plasma membrane;extracellular exosome;blood microparticle	ferroxidase activity;copper ion binding;oxidoreductase activity;chaperone binding	IGHG1[15174051];SLC40A1[20817278];APOA1[15174051];MAPT[26402096];BTRC[21988832];	148896396
54964	chr3	148901396	A		chr3:148901396	CP	ceruloplasmin	deletion	0/1	0.22	14_4	18	59.0	0/0	0.0	19_0	19	42.0			rs561633350	SPLICING	YES	NM_000096.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	12/18		NM_000096.4:c.2286-4del			-1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	Deficiency_of_ferroxidase|not_provided	Cerebellar ataxia, 604290 (3), Autosomal recessive; [Hypoceruloplasminemia, hereditary], 604290 (3), Autosomal recessive; Hemosiderosis, systemic, due to aceruloplasminemia, 604290 (3), Autosomal recessive	Aceruloplasminemia	Disease-causing germline mutation(s) (loss of function) in	Anemia;Adult onset;Autosomal recessive inheritance;Diabetes mellitus;Torticollis;Retinal degeneration;Aceruloplasminemia;Dementia;Cogwheel rigidity;Blepharospasm;Abnormality of extrapyramidal motor function;Scanning speech;Decreased serum iron;Dysarthria;Increased serum ferritin;Chorea;Ataxia;Memory impairment;Torticollis;Tremor;Congestive heart failure;Chorea;Hypothyroidism;Blepharospasm;Refractory anemia;Ataxia;Decreased serum ceruloplasmin;Dementia;Depressivity;Retinal degeneration;Increased serum ferritin;Dysarthria;Delayed speech and language development;Diabetes mellitus;Hypertonia;Parkinsonism;Elevated hepatic iron concentration		0.00102917	133.0	129230.0	0.0	31	0.87	PASS	afr	0.00154569	48.0	0.000790488	48.0	0.0422124	4248.0	100634.0	0.0	27	0.72	PASS	eas	0.0701647	460.0	0.0428501	2088.0	0.0000386,0.0014019,0.0689114	6,218,10716			0.00918	94.0		4.454	0.111567		0	0	0			CP	0.0	0.01	0.0	0.0	-44.0	-3.0	4.0	3.0						0.0942	0.0				immune system phenotype; nervous system phenotype ; vision/eye phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; pigmentation phenotype; liver/biliary system phenotype; behavior/neurological phenotype ; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; 			ciliary ganglion;appendix;trigeminal ganglion;atrioventricular node;fetal liver;	Porphyrin and chlorophyll metabolism	copper ion transport;iron ion transport;cellular iron ion homeostasis;post-translational protein modification;cellular protein metabolic process;iron ion homeostasis;oxidation-reduction process	extracellular region;extracellular space;lysosomal membrane;endoplasmic reticulum lumen;plasma membrane;extracellular exosome;blood microparticle	ferroxidase activity;copper ion binding;oxidoreductase activity;chaperone binding	IGHG1[15174051];SLC40A1[20817278];APOA1[15174051];MAPT[26402096];BTRC[21988832];	148901395
55009	chr3	150480449	CCG		chr3:150480449-150480451	SIAH2	siah E3 ubiquitin protein ligase 2	deletion	0/0	0.0	38_0	38	99.0	0|1	0.17	29_6	35	99.0			rs539462897	EXONIC	YES	NM_005067.7	Transcript	protein_coding	inframe_deletion		1/2	NM_005067.7:c.186_188del	NP_005058.3:p.Gly63del		-1.0						.	.	.		1.33547e-05	2.0	149760.0	0.0	31	0.92	PASS	eas	0.00019516	1.0	0.0	0.0	0.00185628	197.0	106126.0	0.0	9	0.21	RF	amr	0.00451104	56.0	0.00146804	66.0	0.0000064	1						18.34	1.818962		0	0	0			SIAH2	0.0	0.0	0.0	0.0	-22.0	-49.0	30.0	48.0						0.0751	0.36	0.036169832			skeleton phenotype; mortality/aging ; 			white blood cells;whole brain;placenta;adrenal gland;fetal liver;adrenal cortex;bone marrow;	.	protein polyubiquitination;ubiquitin-dependent protein catabolic process;apoptotic process;cell cycle;small GTPase mediated signal transduction;multicellular organism development;protein deubiquitination;regulation of protein ubiquitination;regulation of circadian rhythm;negative regulation of apoptotic process;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;proteasome-mediated ubiquitin-dependent protein catabolic process;cellular protein catabolic process;cellular protein metabolic process;negative regulation of canonical Wnt signaling pathway;negative regulation of netrin-activated signaling pathway;negative regulation of nucleic acid-templated transcription;negative regulation of extrinsic apoptotic signaling pathway	nucleoplasm;cytoplasm;early endosome;cytosol;neuron projection;neuronal cell body;intracellular membrane-bounded organelle	transcription corepressor activity;ubiquitin-protein transferase activity;protein binding;zinc ion binding;ubiquitin conjugating enzyme binding;ubiquitin protein ligase activity	CCBE1[21988832];SETD2[21988832];UBE2I[21988832];STAT3[21988832];ATN1[16713569];OPRK1[23840749];CACYBP[11389839];OGDHL[25438054];OPRM1[23840749];HIPK3[15231748];SH3RF1[21586138;25438054];SH3RF3[25438054];LATS1[25438054];AR[23518348];NCOR1[23518348];LATS2[25438054];EEF1D[21988832];OGDH[25438054];MYD88[21988832];	150480448
55136	chr3	153840207	G	T	chr3:153840207	ARHGEF26	Rho guanine nucleotide exchange factor 26	SNV	0/1	0.49	53_53	108	99.0	0/0	0.0	88_0	88	99.0			rs766252685	EXONIC	YES	NM_001251962.2	Transcript	protein_coding	synonymous_variant		2/15	NM_001251962.2:c.426G>T	NP_001238891.1:p.Pro142%3D		1.0						.	.	.		7.88509e-05	12.0	152186.0	0.0	33	0.97	PASS	amr	0.000261712	4.0	7.35078e-05	5.0	0.00016784	40.0	238322.0	0.0	45	0.92	PASS	amr	0.000438982	15.0	0.000207995	22.0	0.0001222	19	0.0	1.0				5.902	0.204155		0	0	0			ARHGEF26	0.0	0.0	0.0	0.0	-20.0	-40.0	-2.0	0.0							0.0	31.184354999			cardiovascular system phenotype ; 			superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	endothelial cell morphogenesis;G protein-coupled receptor signaling pathway;regulation of Rho protein signal transduction;positive regulation of apoptotic process;regulation of small GTPase mediated signal transduction;ruffle assembly	ruffle;cytosol	guanyl-nucleotide exchange factor activity;Rho guanyl-nucleotide exchange factor activity	ZMYM1[25852190];KSR1[27086506];	153840207
55139	chr3	153909120	G	A	chr3:153909120	ARHGEF26	Rho guanine nucleotide exchange factor 26	SNV	0/0	0.0	34_0	34	99.0	0/1	0.39	43_28	71	99.0			rs537286871	EXONIC	YES	NM_001251962.2	Transcript	protein_coding	synonymous_variant		8/15	NM_001251962.2:c.1683G>A	NP_001238891.1:p.Glu561%3D		1.0						.	.	.		1.31451e-05	2.0	152148.0	0.0	32	0.97	PASS	afr	2.41429e-05	1.0	1.4699e-05	1.0	4.02787e-06	1.0	248270.0	0.0	38	0.91	PASS	nfe	8.88226e-06	1.0	8.88226e-06	1.0	0.0000129	2	0.0	1.0				11.33	0.722591		0	0	0			ARHGEF26	0.1	0.0	0.01	0.0	-42.0	13.0	13.0	-5.0							0.0	33.720104447			cardiovascular system phenotype ; 			superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	endothelial cell morphogenesis;G protein-coupled receptor signaling pathway;regulation of Rho protein signal transduction;positive regulation of apoptotic process;regulation of small GTPase mediated signal transduction;ruffle assembly	ruffle;cytosol	guanyl-nucleotide exchange factor activity;Rho guanyl-nucleotide exchange factor activity	ZMYM1[25852190];KSR1[27086506];	153909120
55154	chr3	155200461	G	A	chr3:155200461	PLCH1	phospholipase C eta 1	SNV	0/1	0.48	53_49	103	99.0	0/0	0.0	35_0	35	99.0			rs142805530,COSV58192211	EXONIC	YES	NM_001130960.2	Transcript	protein_coding	synonymous_variant		23/23	NM_001130960.2:c.3378C>T	NP_001124432.1:p.Ser1126%3D		-1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00488321	743.0	152154.0	2.0	32	0.97	PASS	nfe	0.00774749	527.0	0.00774749	527.0	0.00499085	1255.0	251460.0	6.0	85	1.0	PASS	nfe	0.00719134	818.0	0.00719134	818.0	0.0047973	746	0.014	45.0				0.096	-0.488431		0	0	0			PLCH1	0.0	0.0	0.0	0.0	-15.0	-40.0	47.0	-49.0						0.678	0.43	33.720104447			.			atrioventricular node;superior cervical ganglion;parietal lobe;skeletal muscle;	.	lipid catabolic process;inositol trisphosphate biosynthetic process;inositol phosphate metabolic process;phosphatidylinositol-mediated signaling;release of sequestered calcium ion into cytosol	cytoplasm;cytosol;plasma membrane;intracellular membrane-bounded organelle	phosphatidylinositol phospholipase C activity;calcium ion binding;calcium-dependent phospholipase C activity	HIF1AN[26972000];MTA3[26028330];EGFR[20029029];	155200461
55246	chr3	164700043	G	A	chr3:164700043	SI	sucrase-isomaltase	SNV	0/1	0.33	16_8	24	99.0	0/0	0.0	35_0	35	99.0			rs146830505	EXONIC	YES	NM_001041.4	Transcript	protein_coding	synonymous_variant		47/48	NM_001041.4:c.5403C>T	NP_001032.2:p.Asp1801%3D		-1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Sucrase-isomaltase_deficiency|not_provided	Sucrase-isomaltase deficiency, congenital, 222900 (3), Autosomal recessive	Congenital sucrase-isomaltase deficiency with starch intolerance;Congenital sucrase-isomaltase deficiency without starch intolerance;Congenital sucrase-isomaltase deficiency with minimal starch tolerance;Congenital sucrase-isomaltase deficiency with starch and lactose intolerance;Congenital sucrase-isomaltase deficiency without sucrose intolerance	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Autosomal recessive inheritance;Malabsorption;Nephrolithiasis;Diarrhea;Abnormality of metabolism/homeostasis		0.000709994	108.0	152114.0	1.0	32	0.96	PASS	amr	0.00255704	39.0	0.000867596	59.0	0.000539473	135.0	250244.0	1.0	44	0.97	PASS	amr	0.000814711	28.0	0.00074331	84.0	0.0006045	94	0.001	4.0	0.00097	11.0		0.004	-0.908845		0	0	0			SI	0.0	0.0	0.0	0.0	1.0	49.0	-44.0	-12.0						0.0899	0.0	54.088511129			.			trigeminal ganglion;superior cervical ganglion;testis;	Starch and sucrose metabolism	carbohydrate metabolic process;polysaccharide digestion	Golgi apparatus;plasma membrane;brush border;integral component of membrane;apical plasma membrane;extracellular exosome	alpha-1,4-glucosidase activity;oligo-1,6-glucosidase activity;sucrose alpha-glucosidase activity;carbohydrate binding	ADRB2[28298427];DHRS2[30021884];	164700043
55262	chr3	167248971	T	C	chr3:167248971	WDR49	WD repeat domain 49	SNV	0/1	0.59	34_49	83	99.0	0/0	0.0	35_0	35	99.0			rs201984726	EXONIC	YES	NM_001366157.1	Transcript	protein_coding	missense_variant		13/19	NM_001366157.1:c.2150A>G	NP_001353086.1:p.Asp717Gly		-1.0	WD40-repeat-containing domain,.,.					.	.	.		0.000532404	81.0	152140.0	0.0	32	0.96	PASS	amr	0.0018339	28.0	0.000308814	21.0	0.000470273	118.0	250918.0	0.0	69	0.99	PASS	amr	0.00133387	46.0	0.000405601	46.0	0.0003344	52	0.002	5.0				16.39	1.521631	0.136	1	16	17	PROVEAN_pred	LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	WDR49	0.0	0.0	0.0	0.0	36.0	-13.0	20.0	-8.0						0.974	0.0		0.143	1.138	.			dorsal root ganglion;trigeminal ganglion;atrioventricular node;	.	.	.	.	HMGN2[30021884];	167248971
55311	chr3	169555273	G	T	chr3:169555273	LRRIQ4	leucine rich repeats and IQ motif containing 4	SNV	0/1	0.32	26_12	38	99.0	0/0	0.0	31_0	31	90.0			rs200900869,COSV52981726	EXONIC	YES	NM_001080460.2	Transcript	protein_coding	missense_variant		5/5	NM_001080460.2:c.1537G>T	NP_001073929.1:p.Ala513Ser		1.0	IQ motif, EF-hand binding site					.	.	.		0.000755903	115.0	152136.0	0.0	32	0.97	PASS	afr	0.00188315	78.0	0.000293953	20.0	0.000419424	100.0	238422.0	0.0	21	0.56	PASS	afr	0.00167135	25.0	0.000337511	37.0	0.0004116	64	0.002	7.0				15.9	1.433205	0.119	2	17	19	MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	LRRIQ4	0.01	0.05	0.0	0.0	-6.0	0.0	4.0	20.0						0.887	0.0	0.000000000	0.939	1.176	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;skeletal muscle;globus pallidus;cerebellum;	.	.	.	.	HMGN2[30021884];NFKB1[25609649];	169555273
55341	chr3	169940518	G	A	chr3:169940518	PRKCI	protein kinase C iota	SNV	0/1	0.54	34_44	82	99.0	0/0	0.0	33_0	33	99.0			rs572493199,COSV55518148	EXONIC	YES	NM_002740.6	Transcript	protein_coding	missense_variant		1/18	NM_002740.6:c.61G>A	NP_002731.4:p.Asp21Asn		1.0						.	.	.		0.000105345	16.0	151882.0	0.0	30	0.93	PASS	amr	0.000852012	13.0	2.94273e-05	2.0	7.07649e-05	17.0	240232.0	0.0	30	0.78	PASS	amr	0.000410509	14.0	9.35034e-06	1.0	0.0000386	6						15.91	1.436049	0.026	2	16	18	MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	PRKCI	0.0	0.0	0.01	0.0	-14.0	20.0	14.0	20.0						0.499	0.25	0.000000000	0.999	0.176	renal/urinary system phenotype; immune system phenotype; vision/eye phenotype; nervous system phenotype ; pigmentation phenotype; mortality/aging ; cardiovascular system phenotype ; liver/biliary system phenotype; behavior/neurological phenotype ; embryo phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype ; growth/size/body region phenotype; 			amygdala;appendix;prefrontal cortex;subthalamic nucleus;dorsal root ganglion;atrioventricular node;superior cervical ganglion;parietal lobe;globus pallidus;	Tight junction;Insulin signaling pathway	protein phosphorylation;protein targeting to membrane;cytoskeleton organization;actin filament organization;positive regulation of neuron projection development;vesicle-mediated transport;cell migration;peptidyl-serine phosphorylation;cellular response to insulin stimulus;negative regulation of glial cell apoptotic process;establishment of apical/basal cell polarity;intracellular signal transduction;eye photoreceptor cell development;negative regulation of apoptotic process;negative regulation of neuron apoptotic process;establishment or maintenance of epithelial cell apical/basal polarity;cell-cell junction organization;positive regulation of Notch signaling pathway;positive regulation of glucose import;secretion;Golgi vesicle budding;positive regulation of NF-kappaB transcription factor activity;positive regulation of glial cell proliferation;membrane organization;response to interleukin-1;bicellular tight junction assembly;regulation of postsynaptic membrane neurotransmitter receptor levels;positive regulation of protein localization to plasma membrane;positive regulation of endothelial cell apoptotic process	Golgi membrane;nucleus;nucleoplasm;endosome;cytosol;plasma membrane;bicellular tight junction;microtubule cytoskeleton;apical plasma membrane;cell leading edge;protein-containing complex;Schmidt-Lanterman incisure;intercellular bridge;extracellular exosome;Schaffer collateral - CA1 synapse;glutamatergic synapse	protein kinase activity;protein serine/threonine kinase activity;protein kinase C activity;protein binding;ATP binding;phospholipid binding;protein domain specific binding;metal ion binding	HSP90AB1[22939624];IL1RAP[21988832];MEOX2[unassigned1304];GLI1[23446420];DCAF7[27173435;unassigned1312];AMOT[24255178];SOX2[24525231];EIF4ENIF1[26496610];MAP1LC3B[20562859];ZNF609[26496610];MAP1LC3A[20562859];CASP8[21988832];RAC1[11260256];IKBKG[21988832];TRAPPC13[26496610];YWHAH[14676191;17979178];GABARAPL2[20562859];HSP90AA1[14676191];GABARAPL1[20562859];CEP135[26638075];TSC22D1[21900206];RIPK4[26972000];MASTL[26496610];YWHAZ[14676191];NIPSNAP1[14676191];NIPSNAP2[14676191];ELF3[26977885];PARD3[14676191];CDC37[14676191];RAPGEF2[14676191];SQSTM1[14676191;20808283;20562859;unassigned1304];LLGL1[14676191;24366813;26496610];LLGL2[14676191;20360068;26496610];PARD6G[11260256;14676191];PRKCZ[11260256;24375676;25852190];GABARAP[20562859];CDC42[11260256;14676191];PARD6B[11260256;14676191;26496610;unassigned1304];PARD6A[11257119;11260256;14676191;16189514;15590654;17057644;21516116;26496610;unassigned1304];SLX4[19596235];TTR[21900206];PNMA1[14676191];NACC1[unassigned1304];TMEM208[26496610];MARK4[14676191];MARK2[19615732];SSB[26496610];MYO10[14676191];USP21[19615732];FABP4[21900206];TMEM17[26638075];MAGED2[26496610];	169940518
55418	chr3	172835418	G	A	chr3:172835418	SPATA16	spermatogenesis associated 16	SNV	0/1	0.56	40_50	90	99.0	0/0	0.0	35_0	35	99.0			rs200483368,COSV63533586	EXONIC	YES	NM_031955.6	Transcript	protein_coding	missense_variant		2/11	NM_031955.6:c.104C>T	NP_114161.3:p.Ala35Val		-1.0		Uncertain_significance	criteria_provided,_single_submitter	Globozoospermia	?Spermatogenic failure 6, 102530 (3), Autosomal recessive	Male infertility due to globozoospermia	Disease-causing germline mutation(s) in	Globozoospermia;Autosomal recessive inheritance;Infertility		8.55106e-05	13.0	152028.0	0.0	32	0.97	PASS	amr	0.0005897	9.0	4.41034e-05	3.0	0.000278549	70.0	251302.0	0.0	100	1.0	PASS	amr	0.00153365	53.0	1.75957e-05	2.0	0.0002701	42	0.0	1.0	9e-05	1.0		11.31	0.719356	0.033	1	18	19	SIFT	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SPATA16	0.0	0.0	0.0	0.0	-33.0	0.0	22.0	0.0						0.942	0.0	0.000000000	0.0	-0.554	endocrine/exocrine gland phenotype; cellular phenotype; reproductive system phenotype; 			ciliary ganglion;testis - seminiferous tubule;testis - interstitial;atrioventricular node;testis;skeletal muscle;	.	multicellular organism development;spermatogenesis;biological_process;cell differentiation	Golgi apparatus	molecular_function	MYH9[30021884];	172835418
55565	chr3	184280039	CCG		chr3:184280039-184280041	EPHB3	EPH receptor B3	deletion	0/1	0.12	14_2	16	42.0	0/0	0.0	12_0	12	36.0			rs763165946	EXONIC	YES	NM_004443.4	Transcript	protein_coding	inframe_deletion		1/16	NM_004443.4:c.28_30del	NP_004434.2:p.Pro10del		1.0						.	.	.		6.66107e-06	1.0	150126.0	0.0	32	0.94	PASS	nfe	1.48624e-05	1.0	1.48624e-05	1.0	0.0114539	75.0	6548.0	0.0	0	0.0	PASS	eas	0.0263158	1.0	0.0120664	32.0	0.0000064	1						16.04	1.459166		0	0	0			EPHB3	0.0	0.0	0.0	0.0	-25.0	-27.0	-9.0	2.0						0.21	0.96				behavior/neurological phenotype ; mortality/aging ; reproductive system phenotype; vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype ; hearing/vestibular/ear phenotype; renal/urinary system phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; craniofacial phenotype; 			dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;cerebellum;	Axon guidance	angiogenesis;urogenital system development;transmembrane receptor protein tyrosine kinase signaling pathway;axon guidance;axonal fasciculation;cell migration;peptidyl-tyrosine phosphorylation;central nervous system projection neuron axonogenesis;corpus callosum development;regulation of cell-cell adhesion;retinal ganglion cell axon guidance;substrate adhesion-dependent cell spreading;regulation of GTPase activity;protein autophosphorylation;ephrin receptor signaling pathway;thymus development;digestive tract morphogenesis;regulation of axonogenesis;positive regulation of synapse assembly;roof of mouth development;dendritic spine development;dendritic spine morphogenesis	extracellular region;cytosol;plasma membrane;integral component of plasma membrane;dendrite;neuron projection;receptor complex	protein tyrosine kinase activity;transmembrane receptor protein tyrosine kinase activity;ephrin receptor activity;transmembrane-ephrin receptor activity;ATP binding;axon guidance receptor activity	AFDN[9707552];PKM[24606918];GBE1[21988832];HPCAL1[unassigned1304];HSF2BP[unassigned1304];NFRKB[21988832];	184280038
55589	chr3	185775234	A	G	chr3:185775234	ETV5	ETS variant 5	SNV	0/1	0.32	44_21	65	99.0	0/0	0.0	33_0	33	99.0			rs148669603	EXONIC	YES	NM_004454.3	Transcript	protein_coding	synonymous_variant		10/13	NM_004454.3:c.1017T>C	NP_004445.1:p.Cys339%3D		-1.0						.	.	.		0.000689891	105.0	152198.0	0.0	32	0.97	PASS	amr	0.00301126	46.0	0.000587959	40.0	0.000469667	118.0	251242.0	0.0	100	1.0	PASS	nfe	0.000598887	68.0	0.000598887	68.0	0.0002958	46	0.001	4.0				11.43	0.734672		0	0	0			ETV5	0.0	0.0	0.0	0.0	46.0	-13.0	-22.0	-41.0						0.0779	1.0	65.352745420			growth/size/body region phenotype; endocrine/exocrine gland phenotype; craniofacial phenotype; cellular phenotype; skeleton phenotype; renal/urinary system phenotype; embryo phenotype; respiratory system phenotype; behavior/neurological phenotype ; reproductive system phenotype; mortality/aging ; limbs/digits/tail phenotype; nervous system phenotype ; 			superior cervical ganglion;atrioventricular node;trigeminal ganglion;cingulate cortex;placenta;parietal lobe;cerebellum;	.	regulation of transcription by RNA polymerase II;neuromuscular synaptic transmission;locomotory behavior;cell differentiation;cellular response to oxidative stress;positive regulation of neuron differentiation;positive regulation of transcription by RNA polymerase II;male germ-line stem cell asymmetric division;regulation of synapse organization;positive regulation of glial cell proliferation;regulation of branching involved in mammary gland duct morphogenesis;skeletal muscle acetylcholine-gated channel clustering	nucleus;nucleoplasm;plasma membrane	RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;protein binding;transcription regulatory region DNA binding	CISH[21988832];SLC22A2[21988832];LRRK2[24947832];HDAC11[23752268];SEZ6L2[21988832];CYP3A5[21988832];MFHAS1[29513927];DHRS7[21988832];COP1[25117710];GRAP2[27107012];AMH[21988832];CCR5[21988832];HOXD9[21988832];	185775234
55677	chr3	194062550	C	A	chr3:194062550	CPN2	carboxypeptidase N subunit 2	SNV	0/0	0.0	118_0	118	99.0	0|1	0.47	71_62	133	99.0			rs145998351	EXONIC	YES	NM_001080513.4	Transcript	protein_coding	synonymous_variant		2/2	NM_001080513.4:c.882G>T	NP_001073982.3:p.Leu294%3D		-1.0						.	.	.		0.0011434	174.0	152178.0	0.0	33	0.95	PASS	nfe	0.00198419	135.0	0.00198419	135.0	0.00101454	255.0	251346.0	2.0	96	1.0	PASS	nfe	0.00170681	194.0	0.00170681	194.0	0.0009646	150	0.003	8.0				7.859	0.351989		0	0	0			CPN2	0.0	0.0	0.0	0.0	-19.0	-11.0	9.0	1.0						0.64	0.0	65.352745420			.			kidney;liver;superior cervical ganglion;skeletal muscle;	.	proteolysis;regulation of complement activation;regulation of catalytic activity;protein stabilization	extracellular region;extracellular space;extracellular matrix;extracellular exosome;blood microparticle	metallocarboxypeptidase activity;enzyme regulator activity	.	194062550
55711	chr3	195507174		GGTGGCGTGACCTGTGGATACTGAGGAAGTGTCGGTGACAGGAAGAGA	chr3:195507173-195507174	MUC4	mucin 4, cell surface associated	insertion	0/0	0.0	65_0	65	99.0	0/1	0.14	70_11	81	99.0			rs753498694	EXONIC	YES	NM_018406.7	Transcript	protein_coding	inframe_insertion		2/25	NM_018406.7:c.11277_11278insTCTCTTCCTGTCACCGACACTTCCTCAGTATCCACAGGTCACGCCACC	NP_060876.5:p.Thr3759_Pro3760insSerLeuProValThrAspThrSerSerValSerThrGlyHisAlaThr		-1.0						.	.	.		0.000830283	93.0	112010.0	0.0	32	0.82	PASS	afr	0.00144986	29.0	0.000763518	44.0	0.000679956	76.0	111772.0	1.0	100	0.6	RF	nfe	0.000711507	30.0	0.000711507	30.0	0.0000064	1						7.699	0.338553		0	0	0																	0.938					homeostasis/metabolism phenotype; digestive/alimentary phenotype; neoplasm; mortality/aging ; immune system phenotype; 			trachea;superior cervical ganglion;trigeminal ganglion;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;cell-matrix adhesion;regulation of signaling receptor activity;O-glycan processing;maintenance of gastrointestinal epithelium	extracellular space;Golgi lumen;plasma membrane;integral component of plasma membrane;membrane;extracellular matrix;vesicle;extracellular exosome	ErbB-2 class receptor binding;extracellular matrix constituent, lubricant activity	.	195507173
55723	chr3	195507381	G	A	chr3:195507381	MUC4	mucin 4, cell surface associated	sequence_alteration	0/1	0.44	36_28_0	64	99.0	0|2	0.0	9_0_25	34	99.0			rs1166329002	EXONIC	YES	NM_018406.7	Transcript	protein_coding	synonymous_variant		2/25	NM_018406.7:c.11070C>T	NP_060876.5:p.Ser3690%3D		-1.0						.	.	.		0.0066062	504.0	76292.0	91.0	12	0.32	PASS	amr	0.0081262	68.0	0.00783446	301.0	0.0250396	3537.0	141256.0	131.0	48	0.59	PASS	eas	0.0713978	664.0	0.0261704	1440.0								0.222	-0.371749		0	0	0			MUC4	0.0	0.0	0.01	0.0	-4.0	4.0	-4.0	44.0						0.938					homeostasis/metabolism phenotype; digestive/alimentary phenotype; neoplasm; mortality/aging ; immune system phenotype; 			trachea;superior cervical ganglion;trigeminal ganglion;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;cell-matrix adhesion;regulation of signaling receptor activity;O-glycan processing;maintenance of gastrointestinal epithelium	extracellular space;Golgi lumen;plasma membrane;integral component of plasma membrane;membrane;extracellular matrix;vesicle;extracellular exosome	ErbB-2 class receptor binding;extracellular matrix constituent, lubricant activity	.	195507381
55726	chr3	195507397	TC		chr3:195507397-195507398	MUC4	mucin 4, cell surface associated	sequence_alteration	0/1	0.59	31_45_0	76	99.0	2|2	0.0	1_0_25	26	39.0			rs1491212954	EXONIC	YES	NM_018406.7	Transcript	protein_coding	frameshift_variant		2/25	NM_018406.7:c.11053_11054del	NP_060876.5:p.Asp3685HisfsTer104		-1.0						.	.	.		0.00505955	390.0	77082.0	68.0	4	0.16	PASS	amr	0.00636427	55.0	0.00568325	226.0	0.020554	2790.0	135740.0	146.0	17	0.48	PASS	eas	0.0576599	548.0	0.0216645	1111.0	0.0000064	1						24.5	3.336765		0	0	0			MUC4	0.0	0.0	0.0	0.02	-11.0	37.0	29.0	-19.0						0.938					homeostasis/metabolism phenotype; digestive/alimentary phenotype; neoplasm; mortality/aging ; immune system phenotype; 			trachea;superior cervical ganglion;trigeminal ganglion;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;cell-matrix adhesion;regulation of signaling receptor activity;O-glycan processing;maintenance of gastrointestinal epithelium	extracellular space;Golgi lumen;plasma membrane;integral component of plasma membrane;membrane;extracellular matrix;vesicle;extracellular exosome	ErbB-2 class receptor binding;extracellular matrix constituent, lubricant activity	.	195507396
55801	chr3	195512598		GGTGGTGTGACCTGAGGATGCTGAGGAAGGGCTGGTGACAGGAAGAGGGGTGGTGTCACCTGTGGATGCTGAGGAAGGGCTGGTGACAGGAAGAGAGGTGGCGTGACCTGTGGACACTGAGGAAGCGTCGGTGACAGGAAGAGA	chr3:195512597-195512598	MUC4	mucin 4, cell surface associated	insertion	0/1	0.07	104_8	120	99.0	0/0	0.0	85_0	85	82.0				EXONIC	YES	NM_018406.7	Transcript	protein_coding	inframe_insertion		2/25	NM_018406.7:c.5853_5854insTCTCTTCCTGTCACCGACGCTTCCTCAGTGTCCACAGGTCACGCCACCTCTCTTCCTGTCACCAGCCCTTCCTCAGCATCCACAGGTGACACCACCCCTCTTCCTGTCACCAGCCCTTCCTCAGCATCCTCAGGTCACACCACC	NP_060876.5:p.Thr1951_Pro1952insSerLeuProValThrAspAlaSerSerValSerThrGlyHisAlaThrSerLeuProValThrSerProSerSerAlaSerThrGlyAspThrThrProLeuProValThrSerProSerSerAlaSerSerGlyHisThrThr		-1.0						.	.	.						25	0.65											100	0.61																	0	0	0																	0.938					homeostasis/metabolism phenotype; digestive/alimentary phenotype; neoplasm; mortality/aging ; immune system phenotype; 			trachea;superior cervical ganglion;trigeminal ganglion;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;cell-matrix adhesion;regulation of signaling receptor activity;O-glycan processing;maintenance of gastrointestinal epithelium	extracellular space;Golgi lumen;plasma membrane;integral component of plasma membrane;membrane;extracellular matrix;vesicle;extracellular exosome	ErbB-2 class receptor binding;extracellular matrix constituent, lubricant activity	.	195512597
55824	chr3	195514450	G	A	chr3:195514450	MUC4	mucin 4, cell surface associated	sequence_alteration	0|2	0.0	34_0_4	38	66.0	1|1	1.0	0_9_0	9	27.0			rs78359274,COSV62140537	EXONIC	YES	NM_018406.7	Transcript	protein_coding	missense_variant		2/25	NM_018406.7:c.4001C>T	NP_060876.5:p.Pro1334Leu		-1.0	.,.					.	.	.		0.0045083	75.0	16636.0	0.0	0	0.02	AS_VQSR	eas	0.00519031	3.0	0.00428357	40.0	0.0154104	644.0	41790.0	31.0	0	0.2	PASS	afr	0.0746855	95.0	0.0169479	237.0	0.0000064	1						15.95	1.442384	0.018	2	14	16	SIFT,PolyPhen	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC4	0.0	0.0	0.0	0.0	-9.0	2.0	31.0	-17.0						0.938			0.005	0.07	homeostasis/metabolism phenotype; digestive/alimentary phenotype; neoplasm; mortality/aging ; immune system phenotype; 			trachea;superior cervical ganglion;trigeminal ganglion;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;cell-matrix adhesion;regulation of signaling receptor activity;O-glycan processing;maintenance of gastrointestinal epithelium	extracellular space;Golgi lumen;plasma membrane;integral component of plasma membrane;membrane;extracellular matrix;vesicle;extracellular exosome	ErbB-2 class receptor binding;extracellular matrix constituent, lubricant activity	.	195514450
56182	chr4	1090624	C	T	chr4:1090624	RNF212	ring finger protein 212	SNV	0|1	0.29	35_14	49	99.0	0|1	0.39	41_26	67	99.0			rs142187515	EXONIC	YES	NM_001131034.4	Transcript	protein_coding	missense_variant		3/10	NM_001131034.4:c.175G>A	NP_001124506.1:p.Asp59Asn		-1.0	.,.,.				?Spermatogenic failure 62, 619673 (3), Autosomal recessive; Recombination rate QTL 1, 612042 (3)	.	.	.		0.00472237	719.0	152254.0	4.0	32	0.95	PASS	nfe	0.00774476	527.0	0.00774476	527.0	0.00464082	1167.0	251464.0	5.0	69	1.0	PASS	nfe	0.00676923	770.0	0.00676923	770.0	0.0045465	707	0.005	17.0	0.0069	65.0		7.023	0.285356	0.017	4	14	18	M-CAP_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred	SIFT,PolyPhen,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	RNF212	0.0	0.05	0.0	0.0	-7.0	3.0	3.0	-42.0							0.13	0.000000000	0.011	-0.291	reproductive system phenotype; endocrine/exocrine gland phenotype; 			.	.	meiotic gene conversion;synapsis;reciprocal meiotic recombination;protein sumoylation;chiasma assembly	synaptonemal complex	SUMO transferase activity;metal ion binding	.	1090624
56201	chr4	1309250	C	G	chr4:1309250	MAEA	macrophage erythroblast attacher	SNV	0/1	0.45	81_67	149	99.0	0/0	0.0	34_0	34	99.0			rs142120621	EXONIC	YES	NM_001017405.3	Transcript	protein_coding	synonymous_variant		3/9	NM_001017405.3:c.318C>G	NP_001017405.1:p.Leu106%3D		1.0						.	.	.		4.59994e-05	7.0	152176.0	0.0	32	0.97	PASS	nfe	8.82171e-05	6.0	8.82171e-05	6.0	5.97676e-05	15.0	250972.0	0.0	98	1.0	PASS	nfe	0.000132305	15.0	0.000132305	15.0	0.0000450	7						9.024	0.460654		0	0	0			MAEA	0.01	0.0	0.0	0.0	-47.0	-17.0	36.0	-23.0						0.434	0.84	80.666460494			behavior/neurological phenotype ; hematopoietic system phenotype; mortality/aging ; immune system phenotype; growth/size/body region phenotype; integument phenotype ; 			amygdala;prefrontal cortex;whole brain;superior cervical ganglion;cerebellum;	.	ubiquitin-dependent protein catabolic process;cytoskeleton organization;cell cycle;cell adhesion;regulation of mitotic cell cycle;protein ubiquitination;negative regulation of myeloid cell apoptotic process;negative regulation of apoptotic process;proteasome-mediated ubiquitin-dependent protein catabolic process;erythrocyte maturation;negative regulation of gluconeogenesis;enucleate erythrocyte development;cell division	ubiquitin ligase complex;nucleus;nucleoplasm;cytoplasm;spindle;actomyosin contractile ring;cytoskeleton;integral component of plasma membrane;nuclear matrix;GID complex	actin binding;ubiquitin-protein transferase activity;metal ion binding	DDX5[27173435;unassigned1312];WDR26[27173435;unassigned1312];AXIN1[17510365];HTRA2[27173435;unassigned1312];RANBP9[27173435;unassigned1312];ARMC8[27173435;unassigned1312];RMND5B[27173435;unassigned1312];MKLN1[27173435;unassigned1312];GID4[27173435;unassigned1312];RMND5A[unassigned1312];GID8[27173435;unassigned1312];RANBP10[27173435;unassigned1312];HIF1AN[26972000];EFHC2[27173435;unassigned1312];YPEL5[unassigned1312];TP53[22653443];RAB8A[unassigned1312];CCDC51[27173435;unassigned1312];S100A10[30021884];	1309250
56236	chr4	2044115	CGC		chr4:2044115-2044117	C4orf48	chromosome 4 open reading frame 48	deletion	0/1	0.07	13_1	14	3.0	0|1	0.15	11_2	13	51.0			rs760895336	EXONIC	YES	NM_001168243.1	Transcript	protein_coding	inframe_deletion		2/4	NM_001168243.1:c.149_151del	NP_001161715.1:p.Pro50del		1.0						.	.	.		0.000158825	24.0	151110.0	0.0	32	0.93	AS_VQSR	sas	0.00124275	6.0	7.3947e-05	5.0	0.0261505	358.0	13690.0	0.0	0	0.0	RF	amr	0.0313234	80.0	0.0265934	121.0	0.0000064	1	0.045	138.0				8.724	0.430939		0	0	0			C4orf48	0.0	0.0	0.0	0.0	-12.0	7.0	-13.0	-6.0											.			.	.	.	extracellular region	.	.	2044114
56238	chr4	2200366	G	A	chr4:2200366	POLN	DNA polymerase nu	SNV	0/0	0.0	39_0	39	99.0	0/1	0.48	45_42	87	99.0			rs140869775	EXONIC	YES	NM_181808.4	Transcript	protein_coding	missense_variant		6/26	NM_181808.4:c.793C>T	NP_861524.2:p.Pro265Ser		-1.0	.,.					.	.	.		0.00227829	346.0	151868.0	4.0	32	0.95	PASS	amr	0.00373918	57.0	0.00270556	184.0	0.00190627	479.0	251276.0	1.0	59	0.97	PASS	nfe	0.00294692	335.0	0.00294692	335.0	0.0019999	311	0.001	3.0				0.009	-0.803656	0.05	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	POLN	0.0	0.0	0.0	0.0	-24.0	-37.0	-9.0	47.0						0.543	0.0	0.000000000	0.001	-0.036	cellular phenotype; normal phenotype; reproductive system phenotype; 			.	.	double-strand break repair via homologous recombination;DNA-dependent DNA replication;translesion synthesis;interstrand cross-link repair	nucleus;nucleoplasm;nucleolus;cytoplasm	DNA binding;DNA-directed DNA polymerase activity;protein binding;cyclin binding	.	2200366
56246	chr4	2453961	C	T	chr4:2453961	CFAP99	cilia and flagella associated protein 99	SNV	0/1	0.45	66_53	119	99.0	0/0	0.0	35_0	35	99.0				EXONIC	YES	NM_001193282.4	Transcript	protein_coding	missense_variant		11/16	NM_001193282.4:c.1049C>T	NP_001180211.2:p.Ala350Val		1.0	.,.					.	.	.						31	0.96											100	0.57														23.1	2.762852	0.242	5	7	12	SIFT,M-CAP_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,MetaLR_pred,MetaSVM_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred	CFAP99	0.0	0.0	0.0	0.0	-10.0	-4.0	5.0	18.0								0.000000000	0.125	0.947	.			.	.	.	motile cilium	.	.	2453961
56267	chr4	3015511	C	T	chr4:3015511	GRK4	G protein-coupled receptor kinase 4	SNV	0/1	0.35	20_11	31	99.0	0/1	0.37	27_16	43	99.0			COSV61670496	EXONIC	YES	NM_182982.3	Transcript	protein_coding	synonymous_variant		8/16	NM_182982.3:c.697C>T	NP_892027.2:p.Leu233%3D		1.0						.	.	.		6.57125e-06	1.0	152178.0	0.0	31	0.97	PASS				0.0	0.0					55	0.89											0.00044	5.0		8.265	0.387816		0	0	0			GRK4	0.0	0.0	0.01	0.02	44.0	-45.0	-15.0	44.0						0.965	0.0	0.000000000			normal phenotype; 			pons;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;testis;globus pallidus;	.	G protein-coupled receptor internalization;protein phosphorylation;signal transduction;regulation of G protein-coupled receptor signaling pathway;regulation of rhodopsin mediated signaling pathway;receptor internalization	cytosol;cell cortex;dendrite;neuronal cell body;photoreceptor disc membrane	G protein-coupled receptor kinase activity;ATP binding;rhodopsin kinase activity	HSP90AB1[22939624];IKBKG[20098747];	3015511
56357	chr4	6086695	AA		chr4:6086695-6086696	JAKMIP1	janus kinase and microtubule interacting protein 1	deletion	0/1	0.43	2_3	7	33.0	0/0	0.0	13_0	13	4.0			rs56874913	SPLICING	YES	NM_001099433.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	4/20		NM_001099433.2:c.835-4_835-3del			-1.0						.	.	.		7.13199e-05	3.0	42064.0	0.0	15	0.47	PASS	afr	0.000312045	3.0	0.0	0.0					26	0.63														13.72	1.043631		0	0	0			JAKMIP1	0.0	0.0	0.0	0.0	-2.0	-20.0	-18.0	-25.0						0.291	0.99				behavior/neurological phenotype ; nervous system phenotype ; 			temporal lobe;subthalamic nucleus;cingulate cortex;globus pallidus;	.	protein transport;striatum development;cognition;positive regulation of developmental process;positive regulation of cytoplasmic translation	cytoplasm;microtubule;extrinsic component of membrane;ribonucleoprotein granule;ribonucleoprotein complex	RNA binding;mRNA binding;protein binding;microtubule binding;kinesin binding;kinase binding;translation regulator activity;GABA receptor binding	BLK[unassigned1304];CBX8[unassigned1304];DDX6[unassigned1304];CHRM3[28298427];YES1[unassigned1304];TSGA10IP[unassigned1304];MCRS1[unassigned1304];USP2[unassigned1304];HTT[17500595];IL16[unassigned1304];KSR2[27086506];NFKB1[20195357];MRPL11[unassigned1304];ZNHIT2[unassigned1304];SCNM1[unassigned1304];PSMB1[unassigned1304];C18orf25[unassigned1304];ENKD1[unassigned1304];	6086694
56396	chr4	6925654	C	G	chr4:6925654	TBC1D14	TBC1 domain family member 14	SNV	0/1	0.51	73_76	149	99.0	0/0	0.0	33_0	33	99.0			rs140427960	EXONIC	YES	NM_020773.3	Transcript	protein_coding	missense_variant		2/14	NM_020773.3:c.538C>G	NP_065824.2:p.Leu180Val		1.0	.,.					.	.	.		0.00309486	471.0	152188.0	0.0	32	0.98	PASS	nfe	0.00529163	360.0	0.00529163	360.0	0.0027782	698.0	251242.0	2.0	67	1.0	PASS	nfe	0.00486804	553.0	0.00486804	553.0	0.0028552	444	0.002	6.0				19.64	1.987863	0.087	4	15	19	MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	TBC1D14	0.0	0.0	0.0	0.0	-19.0	17.0	-1.0	5.0						0.411	0.91	0.000000000	0.997	1.008	mortality/aging ; 			.	.	intracellular protein transport;negative regulation of autophagy;recycling endosome to Golgi transport;activation of GTPase activity;regulation of cilium assembly;regulation of autophagosome assembly	nucleoplasm;autophagosome;Golgi apparatus;cytosol;intracellular membrane-bounded organelle;recycling endosome	GTPase activator activity;protein binding;Rab GTPase binding;protein kinase binding	SPARC[30021884];TFRC[22613832];MMGT1[30021884];TFEB[26496610];UBE3A[21900206];ATG13[22613832];CENPA[26496610];RAB11A[22613832];PML[26496610];RAB11B[22613832];EEF1G[30021884];NXF1[unassigned1304];ULK1[22613832];OCIAD2[30021884];RAB11FIP3[22613832];	6925654
56427	chr4	9784542	A	C	chr4:9784542	DRD5	dopamine receptor D5	SNV	0/0	0.0	59_0	59	99.0	0|1	0.13	96_14	111	99.0			rs2227851,COSV58576936	EXONIC	YES	NM_000798.5	Transcript	protein_coding	missense_variant		1/1	NM_000798.5:c.889A>C	NP_000789.1:p.Thr297Pro		1.0	GPCR, rhodopsin-like, 7TM				{Blepharospasm, primary benign}, 606798 (3), Autosomal dominant; {Attention deficit-hyperactivity disorder, susceptibility to}, 143465 (3), Autosomal dominant	.	.	Attention deficit hyperactivity disorder;Hyperactivity;Autosomal dominant inheritance;Middle age onset;Blepharospasm;Sporadic;Autosomal dominant inheritance	31188922,27653456,21178390,19397556					34	0.98							0.00557468	1088.0	195168.0	0.0	83	0.98	RF	afr	0.0169271	195.0	0.00932037	740.0	0.0000707	11	0.086	276.0	0.00026	3.0		25.6	3.667625	0.927	14	6	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred	DRD5	0.0	0.0	0.04	0.01	26.0	-18.0	-10.0	8.0						0.87	0.0		1.0	1.251	endocrine/exocrine gland phenotype; nervous system phenotype ; renal/urinary system phenotype; behavior/neurological phenotype ; cardiovascular system phenotype ; normal phenotype; mortality/aging ; 			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;	Calcium signaling pathway;Neuroactive ligand-receptor interaction	synaptic transmission, dopaminergic;response to amphetamine;regulation of systemic arterial blood pressure by vasopressin;norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure;cellular calcium ion homeostasis;G protein-coupled receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;activation of adenylate cyclase activity;adenylate cyclase-activating dopamine receptor signaling pathway;chemical synaptic transmission;associative learning;transmission of nerve impulse;negative regulation of NAD(P)H oxidase activity;wound healing;response to cocaine;positive regulation of adenylate cyclase activity;negative regulation of blood pressure;regulation of female receptivity;sensitization;phospholipase C-activating dopamine receptor signaling pathway;long-term synaptic depression;cellular response to catecholamine stimulus;reactive oxygen species metabolic process	plasma membrane;integral component of plasma membrane;brush border membrane;ciliary membrane;non-motile cilium	dopamine neurotransmitter receptor activity, coupled via Gs;G-protein alpha-subunit binding;dopamine neurotransmitter receptor activity;dopamine binding	NOTCH2NLA[unassigned1304];	9784542
56428	chr4	9784550	G	A	chr4:9784550	DRD5	dopamine receptor D5	SNV	0/0	0.0	59_0	59	99.0	0|1	0.12	98_14	113	99.0			rs2227844,COSV58576947	EXONIC	YES	NM_000798.5	Transcript	protein_coding	synonymous_variant		1/1	NM_000798.5:c.897G>A	NP_000789.1:p.Ser299%3D		1.0					{Blepharospasm, primary benign}, 606798 (3), Autosomal dominant; {Attention deficit-hyperactivity disorder, susceptibility to}, 143465 (3), Autosomal dominant	.	.	Attention deficit hyperactivity disorder;Hyperactivity;Autosomal dominant inheritance;Middle age onset;Blepharospasm;Sporadic;Autosomal dominant inheritance	31188922,19397556					34	0.98							0.00735405	1364.0	185476.0	0.0	85	0.98	PASS	afr	0.0241532	261.0	0.0118761	899.0	0.0001222	19	0.088	285.0	0.00035	4.0		3.898	0.078296		0	0	0			DRD5	0.0	0.0	0.01	0.02	-18.0	-26.0	-4.0	0.0						0.87	0.0				endocrine/exocrine gland phenotype; nervous system phenotype ; renal/urinary system phenotype; behavior/neurological phenotype ; cardiovascular system phenotype ; normal phenotype; mortality/aging ; 			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;	Calcium signaling pathway;Neuroactive ligand-receptor interaction	synaptic transmission, dopaminergic;response to amphetamine;regulation of systemic arterial blood pressure by vasopressin;norepinephrine-epinephrine vasoconstriction involved in regulation of systemic arterial blood pressure;cellular calcium ion homeostasis;G protein-coupled receptor signaling pathway;adenylate cyclase-activating G protein-coupled receptor signaling pathway;activation of adenylate cyclase activity;adenylate cyclase-activating dopamine receptor signaling pathway;chemical synaptic transmission;associative learning;transmission of nerve impulse;negative regulation of NAD(P)H oxidase activity;wound healing;response to cocaine;positive regulation of adenylate cyclase activity;negative regulation of blood pressure;regulation of female receptivity;sensitization;phospholipase C-activating dopamine receptor signaling pathway;long-term synaptic depression;cellular response to catecholamine stimulus;reactive oxygen species metabolic process	plasma membrane;integral component of plasma membrane;brush border membrane;ciliary membrane;non-motile cilium	dopamine neurotransmitter receptor activity, coupled via Gs;G-protein alpha-subunit binding;dopamine neurotransmitter receptor activity;dopamine binding	NOTCH2NLA[unassigned1304];	9784550
56438	chr4	13616129	C	T	chr4:13616129	BOD1L1	biorientation of chromosomes in cell division 1 like 1	SNV	0/1	0.53	37_41	78	99.0	0/1	0.57	32_44	77	99.0			rs144761044	EXONIC	YES	NM_148894.3	Transcript	protein_coding	missense_variant		4/26	NM_148894.3:c.865G>A	NP_683692.2:p.Glu289Lys		-1.0						.	.	.		0.000802442	122.0	152036.0	0.0	33	0.97	PASS	nfe	0.00123511	84.0	0.00123511	84.0	0.000773426	194.0	250832.0	0.0	65	1.0	PASS	nfe	0.00123557	140.0	0.00123557	140.0	0.0007653	119	0.001	3.0				25.1	3.522738	0.219	9	12	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	BOD1L1	0.0	0.0	0.0	0.0	-3.0	5.0	12.0	-9.0							1.0	0.000000000	0.998	1.026	.			.	.	DNA repair;cellular response to DNA damage stimulus;replication fork processing	nucleoplasm;chromosome	.	ANKRD13B[26496610];SEMA3B[26496610];CXXC1[26496610];KEAP1[26496610];SGF29[26496610];FAM83H[26496610];AKR7A2[26496610];PRDX5[26496610];TRIM29[26496610];RBBP5[26496610];MKNK1[26496610];WDR5[27705803];MTREX[26496610];GTSE1[26496610];HIST1H1C[30021884];NCBP1[26496610];SETD1A[26496610];DLEC1[30021884];CNPY3[30021884];PLEKHA7[28877994];VAV2[18654987];MYL6[26496610];KLHL7[26496610];TACC3[26496610];L1TD1[26496610];TAF6[26496610];	13616129
56449	chr4	15443985	C	A	chr4:15443985	C1QTNF7	C1q and TNF related 7	SNV	0/0	0.0	35_0	35	99.0	0/1	0.47	75_67	142	99.0			rs535929913,COSV54851067	EXONIC	YES	NM_001135170.2	Transcript	protein_coding	synonymous_variant		3/3	NM_001135170.2:c.453C>A	NP_001128642.1:p.Ile151%3D		1.0						.	.	.						32	0.96							7.95387e-06	2.0	251450.0	0.0	100	1.0	PASS	eas	5.43656e-05	1.0	0.0	0.0								8.927	0.450894		0	0	0			C1QTNF7	0.0	0.0	0.0	0.0	2.0	39.0	0.0	21.0						0.104	0.02	53.833943596			homeostasis/metabolism phenotype; liver/biliary system phenotype; hematopoietic system phenotype; immune system phenotype; 			superior cervical ganglion;trigeminal ganglion;skeletal muscle;	.	.	extracellular region;collagen trimer	.	.	15443985
56534	chr4	25777986		A	chr4:25777985-25777986	SEL1L3	SEL1L family member 3	insertion	0/0	0.0	34_0	34	99.0	0/1	0.2	37_9	46	99.0			rs35927722	SPLICING	YES	NM_015187.5	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	16/23		NM_015187.5:c.2586-4dup			-1.0						.	.	.		0.000455066	66.0	145034.0	1.0	32	0.95	PASS	amr	0.00274574	40.0	0.000166965	11.0	0.014733	2013.0	136632.0	0.0	38	0.88	RF	amr	0.0284612	472.0	0.0107465	706.0	0.0001222,0.0001543,0.0186941	19,24,2907						14.74	1.215424		0	0	0			SEL1L3	0.0	0.0	0.0	0.0	-3.0	-6.0	26.0	32.0						0.671	0.63				.			.	.	.	nucleus;nucleoplasm;integral component of membrane	.	TUBB4A[16169070];	25777985
56539	chr4	25864414	C	T	chr4:25864414	SEL1L3	SEL1L family member 3	SNV	0/0	0.0	24_0	24	72.0	0/1	0.5	7_7	14	99.0			rs931349946	EXONIC	YES	NM_015187.5	Transcript	protein_coding	synonymous_variant		1/24	NM_015187.5:c.45G>A	NP_056002.2:p.Gln15%3D		-1.0						.	.	.		0.000546922	82.0	149930.0	1.0	31	0.92	PASS	amr	0.00225494	34.0	0.000521314	35.0	0.0	0.0	50.0	0.0	0	0.0	AC0				0.0	0.0	0.0000064	1						8.425	0.402544		0	0	0			SEL1L3	0.0	0.0	0.0	0.0	38.0	-1.0	-21.0	-4.0						0.671	0.63				.			.	.	.	nucleus;nucleoplasm;integral component of membrane	.	TUBB4A[16169070];	25864414
56716	chr4	42003677	C	T	chr4:42003677	SLC30A9	solute carrier family 30 member 9	SNV	0|1	0.75	3_9	12	48.0	0/0	0.0	37_0	37	99.0			rs149368642,COSV99077766	EXONIC	YES	NM_006345.4	Transcript	protein_coding	missense_variant		2/18	NM_006345.4:c.154C>T	NP_006336.3:p.Pro52Ser		1.0					?Birk-Landau-Perez syndrome, 617595 (3), Autosomal recessive	Psychomotor regression-oculomotor apraxia-movement disorder-nephropathy syndrome	Disease-causing germline mutation(s) (loss of function) in	Renal insufficiency;Developmental regression;Oculomotor apraxia;Choreoathetosis;Ptosis;Hyperechogenic kidneys;Difficulty walking;Ataxia;Limb hypertonia;Dyskinesia;Cognitive impairment;Dystonia;Loss of speech;Hyperkalemia;Muscular hypotonia of the trunk;Tubulointerstitial nephritis;Autosomal recessive inheritance		0.00163246	248.0	151918.0	1.0	32	0.95	PASS	nfe	0.00265205	180.0	0.00265205	180.0	0.0020046	499.0	248928.0	0.0	55	0.81	PASS	sas	0.00290525	88.0	0.00266222	300.0	0.0019999	311	0.002	7.0				10.81	0.659276	0.034	4	17	21	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationAssessor_pred	SIFT,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SLC30A9	0.0	0.0	0.0	0.0	-44.0	-36.0	21.0	-36.0						0.798	0.0	0.000000000	0.005	-0.345	.			amygdala;prefrontal cortex;subthalamic nucleus;cingulate cortex;superior cervical ganglion;skeletal muscle;	.	nucleotide-excision repair;zinc ion transport;cellular zinc ion homeostasis;positive regulation of transcription by RNA polymerase II;cation transmembrane transport	nucleus;endoplasmic reticulum;cytoskeleton;integral component of membrane;cytoplasmic vesicle	DNA-binding transcription factor activity, RNA polymerase II-specific;chromatin binding;DNA-binding transcription factor activity;cation transmembrane transporter activity;nuclear receptor binding;nuclear receptor transcription coactivator activity	SDHAF4[27499296];	42003677
56760	chr4	47746603	A		chr4:47746603	CORIN	corin, serine peptidase	deletion	0/1	0.16	23_7	43	99.0	0/1	0.16	23_5	31	64.0			rs372683178	SPLICING	YES	NM_006587.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	4/21		NM_006587.4:c.618-3del			-1.0					Preeclampsia/eclampsia 5, 614595 (3)	Preeclampsia	Major susceptibility factor in	Eclampsia;Autosomal dominant inheritance;Preeclampsia;Headache;Elevated hepatic transaminase;Abnormality of the hepatic vasculature;Elevated diastolic blood pressure;Hypertension;Thrombocytopenia;Small for gestational age;Abnormality of the placenta;Proteinuria;Sleep disturbance;Chronic kidney disease;Acute kidney injury;Helicobacter pylori infection;Intrauterine growth retardation;Abdominal pain;Increased body mass index;Polycystic ovaries;Abnormality of vision;Type I diabetes mellitus;Elevated systolic blood pressure;Autoimmunity;Elevated serum creatinine		0.00289986	398.0	137248.0	0.0	32	0.87	AS_VQSR	nfe	0.00280712	177.0	0.00280712	177.0	0.338692	32591.0	96226.0	0.0	21	0.51	InbreedingCoeff	sas	0.388985	4506.0	0.324474	15284.0	0.0005788	90			0.24763	2820.0		0.299	-0.329303		0	0	0			CORIN	0.0	0.0	0.0	0.0	-2.0	-23.0	-18.0	-15.0						0.201	0.0				cardiovascular system phenotype ; pigmentation phenotype; renal/urinary system phenotype; muscle phenotype; integument phenotype ; growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			appendix;superior cervical ganglion;trigeminal ganglion;	.	regulation of systemic arterial blood pressure by atrial natriuretic peptide;female pregnancy;regulation of blood pressure;peptide hormone processing;regulation of renal sodium excretion;regulation of cardiac conduction	extracellular region;plasma membrane;cell surface;actin cytoskeleton;integral component of membrane;nuclear body	serine-type endopeptidase activity	CLDN5[unassigned1304];GPX8[unassigned1304];AQP6[unassigned1304];EMP1[unassigned1304];	47746602
56780	chr4	48485850	C	G	chr4:48485850	SLC10A4	solute carrier family 10 member 4	SNV	0/0	0.0	34_0	34	99.0	0/1	0.54	50_58	108	99.0			rs752991725,COSV56718772	EXONIC	YES	NM_152679.4	Transcript	protein_coding	missense_variant		1/3	NM_152679.4:c.272C>G	NP_689892.1:p.Pro91Arg		1.0						.	.	.		0.000381052	58.0	152210.0	0.0	32	0.98	PASS	amr	0.00124329	19.0	0.000235183	16.0	0.000879822	118.0	134118.0	0.0	15	0.42	PASS	amr	0.00157038	38.0	0.000393902	20.0	0.0002186	34	0.002	6.0				22.4	2.408478	0.065	1	18	19	SIFT	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SLC10A4	0.0	0.0	0.0	0.0	48.0	14.0	48.0	-21.0							0.17	0.000000000	0.041	-0.656	nervous system phenotype ; behavior/neurological phenotype ; 			ciliary ganglion;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	.	sodium ion transport;bile acid and bile salt transport;transmembrane transport	plasma membrane;integral component of membrane	bile acid:sodium symporter activity	SLC35A4[unassigned1304];DNAJC30[unassigned1304];	48485850
56883	chr4	57273847	C	G	chr4:57273847	PPAT	phosphoribosyl pyrophosphate amidotransferase	SNV	0|1	0.29	27_11	38	99.0	0/0	0.0	37_0	37	99.0			rs142893232	EXONIC	YES	NM_002703.5	Transcript	protein_coding	missense_variant		2/11	NM_002703.5:c.164G>C	NP_002694.3:p.Gly55Ala		-1.0	Glutamine amidotransferase type 2 domain&Amidophosphoribosyltransferase, N-terminal					.	.	.		0.00192568	293.0	152154.0	0.0	32	0.97	PASS	nfe	0.00313134	213.0	0.00313134	213.0	0.00210403	529.0	251422.0	2.0	67	1.0	PASS	sas	0.00375792	115.0	0.00269058	306.0	0.0020643	321	0.003	9.0	0.00543	10.0		23.9	3.149643	0.391	15	6	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	PPAT	0.0	0.0	0.01	0.0	35.0	-50.0	-31.0	34.0						0.216	0.99	0.000000000	0.85	1.005	.			dorsal root ganglion;globus pallidus;	Purine metabolism;Glutamate metabolism	G1/S transition of mitotic cell cycle;kidney development;purine nucleotide biosynthetic process;'de novo' IMP biosynthetic process;glutamine catabolic process;lactation;purine nucleobase biosynthetic process;nucleoside metabolic process;purine ribonucleoside monophosphate biosynthetic process;animal organ regeneration;cellular response to insulin stimulus;cellular response to drug;protein homotetramerization;maternal process involved in female pregnancy	cytosol	amidophosphoribosyltransferase activity;metal ion binding;4 iron, 4 sulfur cluster binding	ATXN1[23275563];MMS19[28178521];CIAO2B[28178521];SELENOI[21988832];OTUB1[26752685];	57273847
56945	chr4	69433763	T	A	chr4:69433763	UGT2B17	UDP glucuronosyltransferase family 2 member B17	SNV	1/1	0.97	0_28	29	84.0	0/0	0.0	21_0	21	28.0			rs143522336	EXONIC	YES	NM_001077.4	Transcript	protein_coding	missense_variant		2/7	NM_001077.4:c.440A>T	NP_001068.1:p.Asp147Val		-1.0					{Bone mineral density QTL 12, osteoporosis}, 612560 (3)	.	.	.		0.00522441	660.0	126330.0	146.0	20	0.54	PASS	amr	0.00787849	97.0	0.00714765	426.0	0.00677132	1376.0	203210.0	372.0	63	0.77	PASS	amr	0.0109484	323.0	0.00683742	693.0	0.0044050	685	0.012	36.0	0.01498	153.0		23.0	2.731613	0.789	11	6	17	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	UGT2B17	0.0	0.0	0.0	0.0	-15.0	45.0	-15.0	-32.0						0.777	0.01		0.087	0.967	.			appendix;superior cervical ganglion;skeletal muscle;	Pentose and glucuronate interconversions;Androgen and estrogen metabolism;Starch and sucrose metabolism;Retinol metabolism;Porphyrin and chlorophyll metabolism;Metabolism of xenobiotics by cytochrome P450;Drug metabolism - cytochrome P450;Drug metabolism - other enzymes	steroid metabolic process;cellular glucuronidation	endoplasmic reticulum membrane;membrane;integral component of membrane;organelle membrane;intracellular membrane-bounded organelle	retinoic acid binding;UDP-glycosyltransferase activity;glucuronosyltransferase activity	NCOR2[26175416];AR[26175416];NCOR1[26175416];PRKDC[26175416];	69433763
56952	chr4	70360880	GA		chr4:70360880-70360881	UGT2B4	UDP glucuronosyltransferase family 2 member B4	deletion	0/0	0.0	8_0	8	24.0	0|1	0.75	1_3	4	33.0				EXONIC	YES	NM_021139.3	Transcript	protein_coding	frameshift_variant		1/6	NM_021139.3:c.699_700del	NP_066962.2:p.Asp233GlufsTer5		-1.0						.	.	.		1.31389e-05	2.0	152220.0	0.0	32	0.97	PASS	amr	6.54622e-05	1.0	1.46977e-05	1.0					34	0.66											0.0001	1.0					0	0	0			UGT2B4	0.01	0.0	0.0	0.0	7.0	10.0	-8.0	-20.0						0.944	0.0	31.213032913			.			liver;superior cervical ganglion;trigeminal ganglion;fetal liver;	Pentose and glucuronate interconversions;Androgen and estrogen metabolism;Starch and sucrose metabolism;Retinol metabolism;Porphyrin and chlorophyll metabolism;Metabolism of xenobiotics by cytochrome P450;Drug metabolism - cytochrome P450;Drug metabolism - other enzymes	cellular glucuronidation	endoplasmic reticulum membrane;integral component of membrane;organelle membrane;intracellular membrane-bounded organelle	retinoic acid binding;UDP-glycosyltransferase activity;glucuronosyltransferase activity	STAT5A[21988832];	70360879
56955	chr4	70360883	CC		chr4:70360883-70360884	UGT2B4	UDP glucuronosyltransferase family 2 member B4	deletion	0/0	0.0	8_0	8	24.0	0|1	0.75	1_3	4	33.0				EXONIC	YES	NM_021139.3	Transcript	protein_coding	stop_gained,frameshift_variant		1/6	NM_021139.3:c.696_697del	NP_066962.2:p.Trp232Ter		-1.0						.	.	.		1.31397e-05	2.0	152210.0	0.0	32	0.97	PASS	amr	6.54793e-05	1.0	1.46981e-05	1.0					34	0.66											0.0001	1.0					0	0	0			UGT2B4	0.01	0.0	0.0	0.0	4.0	7.0	-11.0	-23.0						0.944	0.0	31.213032913			.			liver;superior cervical ganglion;trigeminal ganglion;fetal liver;	Pentose and glucuronate interconversions;Androgen and estrogen metabolism;Starch and sucrose metabolism;Retinol metabolism;Porphyrin and chlorophyll metabolism;Metabolism of xenobiotics by cytochrome P450;Drug metabolism - cytochrome P450;Drug metabolism - other enzymes	cellular glucuronidation	endoplasmic reticulum membrane;integral component of membrane;organelle membrane;intracellular membrane-bounded organelle	retinoic acid binding;UDP-glycosyltransferase activity;glucuronosyltransferase activity	STAT5A[21988832];	70360882
57067	chr4	77662693	C	T	chr4:77662693	SHROOM3	shroom family member 3	SNV	0/0	0.0	36_0	36	99.0	0/1	0.57	35_48	84	99.0				EXONIC	YES	NM_020859.4	Transcript	protein_coding	missense_variant		5/11	NM_020859.4:c.3367C>T	NP_065910.3:p.Pro1123Ser		1.0	.,.					.	.	.						32	0.98											60	0.56														2.985	0.023213	0.01	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SHROOM3	0.0	0.0	0.0	0.0	47.0	0.0	-30.0	-15.0						0.425	0.73	46.709396341	0.013	0.03	digestive/alimentary phenotype; nervous system phenotype ; skeleton phenotype; embryo phenotype; liver/biliary system phenotype; mortality/aging ; craniofacial phenotype; growth/size/body region phenotype; 			.	.	cell morphogenesis;neural tube closure;epithelial cell development;actin filament organization;pattern specification process;regulation of cell shape;actin cytoskeleton organization;cellular pigment accumulation;apical protein localization	cytoskeleton;microtubule;adherens junction;apical plasma membrane;cortical actin cytoskeleton;apical junction complex	actin filament binding	RAB32[26496610];SNW1[20467437];YWHAB[24255178];RPS6KA2[25852190];CDK2[25852190];CDC5L[20467437];ILK[25852190];MYH9[26496610];SFN[15778465];SIK2[25852190];ESR2[21182203];	77662693
57071	chr4	77818104	TGCAGGGTCGAATAA		chr4:77818104-77818118	SOWAHB	sosondowah ankyrin repeat domain family member B	deletion	0/1	0.4	79_53	132	99.0	0/0	0.0	38_0	38	99.0			rs568457238	EXONIC	YES	NM_001029870.3	Transcript	protein_coding	inframe_deletion		1/1	NM_001029870.3:c.885_899del	NP_001025041.1:p.His295_Leu299del		-1.0						.	.	.		0.00314007	478.0	152226.0	2.0	33	0.97	PASS	nfe	0.00392439	267.0	0.00392439	267.0	0.00285149	657.0	230406.0	2.0	24	0.65	PASS	sas	0.0038273	114.0	0.00355369	362.0	0.0002572	40	0.003	10.0				14.11	1.106179		0	0	0																		0.0	0.000000000			embryo phenotype; nervous system phenotype ; 			.	.	.	.	.	.	77818103
57103	chr4	79340225	G	A	chr4:79340225	FRAS1	Fraser extracellular matrix complex subunit 1	SNV	0/1	0.62	8_13	21	99.0	0/0	0.0	32_0	32	96.0				SPLICING	YES	NM_025074.7	Transcript	protein_coding	splice_region_variant,intron_variant	33/73		NM_025074.7:c.4540+8G>A			1.0					Fraser syndrome 1, 219000 (3), Autosomal recessive	Fraser syndrome;Renal agenesis, unilateral	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Cleft palate;Hypospadias;Facial cleft;Abnormal heart morphology;Aplasia/Hypoplasia of the sternum;Hypertelorism;Hypoplastic superior helix;Wide nose;Calvarial skull defect;Cryptophthalmos;Aplasia/Hypoplasia of the thumb;Abnormality of the small intestine;Depressed nasal bridge;Underdeveloped nasal alae;Intellectual disability;Renal hypoplasia/aplasia;Morphological abnormality of the middle ear;Laryngeal stenosis;Cryptorchidism;Choanal stenosis;Pulmonary hypoplasia;Absent eyelashes;Severe T-cell immunodeficiency;Autosomal recessive inheritance;Absent eyebrow;Dental malocclusion;Abnormality of the pinna;Wide pubic symphysis;Underdeveloped nasal alae;Anophthalmia;Midline nasal groove;Laryngeal atresia;Cupped ear;Low-set ears;Upper eyelid coloboma;Bilateral microphthalmos;Cleft ala nasi;Bicornuate uterus;Abnormality of the thymus;Aplasia/Hypoplasia of the phalanges of the hand;Wide intermamillary distance;Cleft upper lip;Hydrocephalus;Conductive hearing impairment;Abnormality of the anus;Subglottic stenosis;Clitoral hypertrophy;Atresia of the external auditory canal;Dental crowding;Malformed lacrimal duct;Abnormal umbilicus morphology;Microcephaly;Laryngeal web;Difficulty in tongue movements;Lacrimal duct aplasia;Encephalocele;Wide nasal bridge;Blindness;Cutaneous finger syndactyly;Depressed nasal bridge;Renal hypoplasia;Vaginal atresia;Myelomeningocele;Extension of hair growth on temples to lateral eyebrow;Abnormal cortical gyration;Corneal opacity;Micropenis;Abnormality of cardiovascular system morphology;Toe syndactyly;Microcephaly;Blindness;Anophthalmia;High palate;Abnormal lung lobation;Underdeveloped nasal alae;Depressed nasal bridge;Atresia of the external auditory canal;Bifid tongue;Hypoplasia of penis;Intellectual disability;Malformed lacrimal duct;Dental malocclusion;Bicornuate uterus;Death in infancy;Dental crowding;Ambiguous genitalia;Calvarial skull defect;Wide pubic symphysis;Umbilical hernia;Cleft ala nasi;Tracheal stenosis;External ear malformation;Urethral atresia;Renal hypoplasia;Ectopic anus;Hypertelorism;Low-set, posteriorly rotated ears;Scrotal hypoplasia;Cleft upper lip;Abnormal hair pattern;Wide nasal bridge;Conductive hearing impairment;Finger syndactyly;Cryptophthalmos;Encephalocele;Anal atresia;Laryngeal stenosis;Pulmonary hypoplasia;Subglottic stenosis;Vaginal atresia;Hypospadias;Anal stenosis;Cryptorchidism;Lacrimal duct aplasia;Multicystic kidney dysplasia;Myelomeningocele;Microphthalmia;Omphalocele;Female pseudohermaphroditism;Vertebral segmentation defect;Midline nasal groove;Wide intermamillary distance						32	0.96											32	0.59											9e-05	1.0		0.133	-0.444012		0	0	0			FRAS1	0.0	0.0	0.0	0.0	-7.0	-35.0	-3.0	-8.0	4.90028566392549e-05	0.002				0.806	0.0				growth/size/body region phenotype; integument phenotype ; craniofacial phenotype; cellular phenotype; skeleton phenotype; renal/urinary system phenotype; respiratory system phenotype; cardiovascular system phenotype ; mortality/aging ; digestive/alimentary phenotype; limbs/digits/tail phenotype; vision/eye phenotype; 			ciliary ganglion;pons;caudate nucleus;pancreas;subthalamic nucleus;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;cerebellum;	.	morphogenesis of an epithelium;metanephros morphogenesis;cell communication;protein transport;embryonic limb morphogenesis;skin development;roof of mouth development	basement membrane;plasma membrane;integral component of membrane;collagen-containing extracellular matrix	extracellular matrix structural constituent;metal ion binding	NEK4[25798074];DHX9[30021884];TCP1[30021884];HIST1H2BH[30021884];BCOR[27505670];MKI67[26949251];	79340225
57157	chr4	83372386	G	A	chr4:83372386	ENOPH1	enolase-phosphatase 1	SNV	0/1	0.41	56_40	97	99.0	0/1	0.38	48_30	78	99.0			rs148501831	EXONIC	YES	NM_021204.5	Transcript	protein_coding	missense_variant		3/6	NM_021204.5:c.377G>A	NP_067027.1:p.Arg126His		1.0	.,.,.					.	.	.		0.000479645	73.0	152196.0	0.0	32	0.98	PASS	nfe	0.000778976	53.0	0.000778976	53.0	0.000347056	87.0	250680.0	0.0	54	1.0	PASS	amr	0.000549737	19.0	0.000494857	56.0	0.0003858	60	0.001	2.0				5.66	0.187951	0.087	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ENOPH1	0.0	0.0	0.0	0.0	9.0	-40.0	3.0	12.0						0.459	0.0	0.000000000	0.981	0.208	.			caudate nucleus;ciliary ganglion;temporal lobe;amygdala;prefrontal cortex;cingulate cortex;superior cervical ganglion;pons;occipital lobe;subthalamic nucleus;whole brain;parietal lobe;spinal cord;globus pallidus;hypothalamus;medulla oblongata;thalamus;	Axon guidance;Cell adhesion molecules (CAMs)	dephosphorylation;L-methionine salvage from S-adenosylmethionine;L-methionine salvage from methylthioadenosine	nucleus;cytosol	magnesium ion binding;2,3-diketo-5-methylthiopentyl-1-phosphate enolase activity;2-hydroxy-3-keto-5-methylthiopentenyl-1-phosphate phosphatase activity;acireductone synthase activity	RAB10[21900206];BAG6[26496610];RPS27[16169070;21900206];TMEM63B[26496610];BAG3[26496610];ZNF280A[unassigned1304];KATNA1[26496610];TMEM132A[26496610];MYO19[26496610];TGM2[26496610];RNF41[unassigned1304];	83372386
57221	chr4	87684148	G	T	chr4:87684148	PTPN13	protein tyrosine phosphatase, non-receptor type 13	SNV	0/0	0.0	46_0	46	99.0	0/1	0.46	66_56	122	99.0			rs201633051,COSV104414310	EXONIC	YES	NM_080685.3	Transcript	protein_coding	missense_variant		24/48	NM_080685.3:c.3822G>T	NP_542416.1:p.Trp1274Cys		1.0	.,.,.,.,.	Likely_benign	no_assertion_criteria_provided	not_provided		.	.	.		0.00368591	560.0	151930.0	3.0	32	0.95	PASS	nfe	0.0055451	377.0	0.0055451	377.0	0.00396213	986.0	248856.0	6.0	100	1.0	PASS	nfe	0.0054125	610.0	0.0054125	610.0	0.0036012	560	0.007	24.0	0.00489	9.0		24.7	3.407909	0.285	7	14	21	PolyPhen,Polyphen2_HDIV_pred,MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	PTPN13	0.0	0.0	0.02	0.0	-21.0	-13.0	-42.0	-14.0						0.839	0.0	0.000000000	1.0	1.176	cellular phenotype; growth/size/body region phenotype; hematopoietic system phenotype; vision/eye phenotype; nervous system phenotype ; immune system phenotype; 			atrioventricular node;superior cervical ganglion;	.	protein dephosphorylation;phosphatidylinositol biosynthetic process;regulation of phosphatidylinositol 3-kinase signaling;peptidyl-tyrosine dephosphorylation;cellular response to cytokine stimulus	nucleus;nucleoplasm;cytoplasm;cytoskeleton;plasma membrane;lamellipodium;neuron projection;cell body;extracellular exosome	protein tyrosine phosphatase activity;protein binding;phosphatidylinositol 3-kinase regulatory subunit binding	RTKN[unassigned1312];YWHAB[24255178];MAST3[unassigned1312];DENND1A[unassigned1312];ZBTB21[unassigned1312];CBY1[unassigned1312];TUBA1A[27291054];SIPA1L1[unassigned1312];SH3PXD2A[unassigned1312];LAMP1[29568061];TUBB3[27291054];KIF13B[unassigned1312];NINL[26638075];RALGPS2[unassigned1312];KSR1[unassigned1312];KCTD3[unassigned1312];CDC25C[unassigned1312];TANC2[unassigned1312];LATS1[24255178];GIGYF1[unassigned1312];MTNR1A[26514267];EIF4E2[unassigned1312];RAPGEF6[12095257;14698303;17240990];SQSTM1[24316673];PPM1H[unassigned1312];GIGYF2[unassigned1312];RASSF10[24366813];PDCD10[17657516];INPP5E[unassigned1312];SRGAP2[unassigned1312];PDLIM4[10826496];EPS15[25728925];EGLN3[26972000];PLEKHA1[14516276];PLEKHA2[14516276];DENND4C[unassigned1312];CGN[unassigned1312];NFKBIA[14743216];SH3RF3[unassigned1312];NEURL4[29426014];LRFN4[22677168];TMEM17[26638075];APC[17240990];STK25[17657516];LRFN1[unassigned1312];NF1[unassigned1312];FAS[10918185;12724420];PKN2[11356191];LPIN3[unassigned1312];	87684148
57229	chr4	87967339	C	T	chr4:87967339	AFF1	AF4/FMR2 family member 1	SNV	0/0	0.0	34_0	34	99.0	0/1	0.4	41_27	68	99.0			rs138841791	EXONIC	YES	NM_001166693.2	Transcript	protein_coding	synonymous_variant		3/21	NM_001166693.2:c.60C>T	NP_001160165.1:p.Asn20%3D		1.0						Precursor B-cell acute lymphoblastic leukemia	Part of a fusion gene in	.		0.00260478	396.0	152028.0	1.0	32	0.96	PASS	nfe	0.0035145	239.0	0.0035145	239.0	0.00283858	712.0	250830.0	4.0	59	0.95	PASS	nfe	0.00365607	415.0	0.00365607	415.0	0.0024308	378	0.006	20.0				10.92	0.672205		0	0	0			AFF1	0.05	0.03	0.0	0.0	15.0	-3.0	15.0	0.0						0.657	0.48	49.099326297			growth/size/body region phenotype; endocrine/exocrine gland phenotype; behavior/neurological phenotype ; immune system phenotype; nervous system phenotype ; vision/eye phenotype; hematopoietic system phenotype; reproductive system phenotype; mortality/aging ; 			ciliary ganglion;appendix;thyroid;atrioventricular node;superior cervical ganglion;trigeminal ganglion;placenta;skeletal muscle;	.	regulation of transcription, DNA-templated	nucleus;transcription elongation factor complex;ELL-EAF complex	double-stranded DNA binding;DNA-binding transcription factor activity;protein binding	CCNT1[20153263];KMT2A[20153263];HDAC1[26496610];EAF1[21729782];SMAD9[15231748];MLLT1[20153263];MLLT3[21729782;23260655];MRPL12[30021884];AFF4[20153263;21729782];MED26[21729782];ELL2[21729782;26496610];CDK9[20153263;21729782;23455922;23602568];ZNF526[26496610];SLC16A6[26496610];MYH7[26496610];	87967339
57270	chr4	88929174	AGG		chr4:88929174-88929176	PKD2	polycystin 2, transient receptor potential cation channel	deletion	0/1	0.13	90_13	103	99.0	0/0	0.0	34_0	34	99.0			rs750077647	EXONIC	YES	NM_000297.4	Transcript	protein_coding	inframe_deletion		1/15	NM_000297.4:c.305_307del	NP_000288.1:p.Glu102del		1.0		Benign	criteria_provided,_single_submitter	Autosomal_dominant_polycystic_kidney_disease|not_provided	Polycystic kidney disease 2, 613095 (3), Autosomal dominant	Autosomal dominant polycystic kidney disease	Disease-causing germline mutation(s) in	Aortic root aneurysm;Polycystic liver disease;Nephrolithiasis;Decreased glomerular filtration rate;Pyelonephritis;Albuminuria;Recurrent urinary tract infections;Hematuria;Mitral valve prolapse;Dilatation of the cerebral artery;Reduced sperm motility;Pancreatic cysts;Stage 5 chronic kidney disease;Abnormal urinary electrolyte concentration;Elevated serum creatinine;Enlarged kidney;Hepatic cysts;Pain;Renal cyst;Hypertension;Pituitary growth hormone cell adenoma;Arachnoid cyst;Elevated serum creatinine;Polycystic kidney dysplasia;Facial asymmetry;Incomplete penetrance;Situs inversus totalis;Hypertension;Recurrent urinary tract infections;Progressive;Hepatic cysts;Stage 5 chronic kidney disease;Midface retrusion;Autosomal dominant inheritance		0.00019959	30.0	150308.0	0.0	32	0.94	AS_VQSR	amr	0.000331038	5.0	0.000252435	17.0	0.0243705	2381.0	97700.0	0.0	7	0.36	RF	eas	0.0582867	396.0	0.0277147	1049.0	0.0001350,0.0065014	21,1011			0.04729	539.0		14.44	1.162504		0	0	0			PKD2	0.0	0.0	0.0	0.0	10.0	-32.0	18.0	12.0						0.366	1.0				homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; liver/biliary system phenotype; embryo phenotype; renal/urinary system phenotype; immune system phenotype; digestive/alimentary phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; mortality/aging ; normal phenotype; respiratory system phenotype; 			uterus;trigeminal ganglion;	.	branching involved in ureteric bud morphogenesis;liver development;embryonic placenta development;heart looping;detection of nodal flow;calcium ion transport;cell cycle arrest;JAK-STAT cascade;determination of left/right symmetry;heart development;negative regulation of cell population proliferation;spinal cord development;neural tube development;positive regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity;cellular response to reactive oxygen species;metanephric part of ureteric bud development;sodium ion transmembrane transport;aorta development;regulation of cell population proliferation;cytoplasmic sequestering of transcription factor;positive regulation of nitric oxide biosynthetic process;positive regulation of transcription by RNA polymerase II;detection of mechanical stimulus;release of sequestered calcium ion into cytosol;protein tetramerization;protein homotetramerization;protein heterotetramerization;centrosome duplication;negative regulation of ryanodine-sensitive calcium-release channel activity;placenta blood vessel development;renal tubule morphogenesis;renal artery morphogenesis;calcium ion transmembrane transport;positive regulation of cell cycle arrest;cellular response to calcium ion;cellular response to cAMP;cellular response to hydrostatic pressure;cellular response to osmotic stress;cellular response to fluid shear stress;potassium ion transmembrane transport;determination of liver left/right asymmetry;metanephric mesenchyme development;mesonephric tubule development;mesonephric duct development;metanephric smooth muscle tissue development;metanephric cortex development;metanephric ascending thin limb development;metanephric cortical collecting duct development;metanephric distal tubule development;metanephric S-shaped body morphogenesis;regulation of calcium ion import;inorganic cation transmembrane transport;cell-cell signaling by wnt;negative regulation of G1/S transition of mitotic cell cycle	polycystin complex;cytoplasm;endoplasmic reticulum;endoplasmic reticulum membrane;Golgi apparatus;plasma membrane;integral component of plasma membrane;cell-cell junction;cilium;basal plasma membrane;membrane;lamellipodium;cytoplasmic vesicle membrane;motile cilium;filamentous actin;cation channel complex;ciliary basal body;basal cortex;ciliary membrane;extracellular exosome;integral component of cytoplasmic side of endoplasmic reticulum membrane;integral component of lumenal side of endoplasmic reticulum membrane;mitotic spindle;non-motile cilium	signaling receptor binding;voltage-gated ion channel activity;voltage-gated calcium channel activity;voltage-gated sodium channel activity;voltage-gated potassium channel activity;cation channel activity;calcium channel activity;potassium channel activity;calcium ion binding;protein binding;cytoskeletal protein binding;outward rectifier potassium channel activity;voltage-gated cation channel activity;identical protein binding;protein homodimerization activity;actinin binding;HLH domain binding;ion channel binding;calcium-induced calcium release activity;ATPase binding;phosphoprotein binding;muscle alpha-actinin binding	BCAP31[19153608];TRPC1[10097141];KRTAP10-8[25416956];HSF2BP[unassigned1304];GCC2[unassigned1312];PKD2[20168298;19556541;21622852];PKD1[20168298;10097141;19556541;21642537;30093605];KRT40[25416956];DIAPH1[18388856;15123714];PLSCR1[25416956];HAX1[10760273];MAGEA8[25416956];CYSRT1[unassigned1304];TMEM248[26496610];ID2[16311606];SRPRA[26496610];KRTAP6-2[unassigned1304];MDFI[unassigned1304];	88929173
57463	chr4	103592537	C	G	chr4:103592537	MANBA	mannosidase beta	SNV	0/1	0.56	13_18	32	99.0	0/0	0.0	33_0	33	99.0			rs762175890	EXONIC	YES	NM_005908.4	Transcript	protein_coding	missense_variant		9/17	NM_005908.4:c.1131G>C	NP_005899.3:p.Gln377His		-1.0	Glycoside hydrolase family 2, catalytic domain,Glycoside hydrolase family 2, catalytic domain,Glycoside hydrolase family 2, catalytic domain,.,Glycoside hydrolase family 2, catalytic domain	Uncertain_significance	criteria_provided,_single_submitter	Beta-D-mannosidosis	Mannosidosis, beta, 248510 (3), Autosomal recessive	Beta-mannosidosis	Disease-causing germline mutation(s) in	Intellectual disability;Hearing impairment;Abnormal facial shape;Recurrent respiratory infections;Hypoplasia of the abdominal wall musculature;Seizure;Hyperactivity;Angiokeratoma;Generalized hypotonia;Hearing impairment;Neurological speech impairment;Tortuosity of conjunctival vessels;Seizure;Abnormality of metabolism/homeostasis;Autosomal recessive inheritance;Abnormal facial shape;Increased urinary disaccharide excretion;Intellectual disability;Aggressive behavior;Recurrent infections;Demyelinating peripheral neuropathy		3.94997e-05	6.0	151900.0	0.0	32	0.96	PASS	nfe	8.82275e-05	6.0	8.82275e-05	6.0	3.58712e-05	9.0	250898.0	0.0	52	0.98	PASS	afr	6.18888e-05	1.0	4.40746e-05	5.0	0.0000322	5	0.0	1.0	0.00018	2.0		22.9	2.68198	0.161	11	10	21	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-XF_coding_pred	MANBA	0.0	0.01	0.0	0.0	18.0	-1.0	-3.0	1.0						0.513	0.0	0.000000000	0.996	1.026	hematopoietic system phenotype; cardiovascular system phenotype ; reproductive system phenotype; liver/biliary system phenotype; immune system phenotype; renal/urinary system phenotype; digestive/alimentary phenotype; nervous system phenotype ; endocrine/exocrine gland phenotype; cellular phenotype; 			.	N-Glycan degradation;Glycan structures - degradation	cellular protein modification process;glycoprotein catabolic process;oligosaccharide catabolic process;neutrophil degranulation;mannan catabolic process	lysosome;plasma membrane;azurophil granule membrane;lysosomal lumen;intracellular membrane-bounded organelle	beta-mannosidase activity;mannose binding	.	103592537
57530	chr4	109670466	C	T	chr4:109670466	ETNPPL	ethanolamine-phosphate phospho-lyase	SNV	0/0	0.0	34_0	34	99.0	0/1	0.42	53_38	91	99.0			rs140880189,COSV99625287	EXONIC	YES	NM_031279.4	Transcript	protein_coding	synonymous_variant		8/13	NM_031279.4:c.855G>A	NP_112569.2:p.Pro285%3D		-1.0						.	.	.		0.000374684	57.0	152128.0	0.0	32	0.96	PASS	amr	0.00098322	15.0	0.000499809	34.0	0.000290321	73.0	251446.0	0.0	90	1.0	PASS	nfe	0.000501187	57.0	0.000501187	57.0	0.0003022	47	0.0	1.0	0.00054	1.0		0.061	-0.550061		0	0	0			ETNPPL	0.0	0.0	0.03	0.0	-2.0	40.0	-12.0	-9.0							0.0	8.891714048			.			.	.	phosphatidylethanolamine biosynthetic process	cellular_component;mitochondrial matrix	transaminase activity;pyridoxal phosphate binding;ethanolamine-phosphate phospho-lyase activity	.	109670466
57579	chr4	110667485	T	C	chr4:110667485	CFI	complement factor I	SNV	0/0	0.0	34_0	34	99.0	0/1	0.41	39_27	66	99.0			rs41278047,CM1210593	EXONIC	YES	NM_001375278.1	Transcript	protein_coding	missense_variant		12/15	NM_001375278.1:c.1346A>G	NP_001362207.1:p.Lys449Arg		-1.0	.,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Atypical_hemolytic-uremic_syndrome_3|Thrombotic_microangiopathy|not_specified|not_provided	{Hemolytic uremic syndrome, atypical, susceptibility to, 3}, 612923 (3), Autosomal dominant; {Macular degeneration, age-related, 13, susceptibility to}, 615439 (3), Autosomal dominant; Complement factor I deficiency, 610984 (3), Autosomal recessive	Immunodeficiency with factor I anomaly;HELLP syndrome;De novo thrombotic microangiopathy after kidney transplantation;Familial drusen;Atypical hemolytic-uremic syndrome with I factor anomaly	Disease-causing germline mutation(s) in;Candidate gene tested in;Biomarker tested in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Disseminated intravascular coagulation;Maternal hypertension;Pulmonary edema;Fatigue;Microangiopathic hemolytic anemia;Decreased mean corpuscular hemoglobin concentration;Generalized edema;Nausea;Acute kidney injury;Epigastric pain;Eclampsia;Preeclampsia;Elevated hepatic transaminase;Cerebral hemorrhage;Thrombocytopenia;Vomiting;Hypofibrinogenemia;Abdominal pain;Increased body weight;Poor wound healing;Prolonged prothrombin time;Hemoglobinuria;Hypotension;Pleural effusion;Back pain;Increased lactate dehydrogenase level;Headache;Placental abruption;Proteinuria;Shoulder pain;Elevated serum creatinine;Autosomal dominant inheritance;Proteinuria;Anuria;Increased blood urea nitrogen;Hemolytic-uremic syndrome;Hematuria;Acute kidney injury;Thrombocytopenia;Hypertension;Microangiopathic hemolytic anemia;Autosomal dominant inheritance;Macular scar;Choroidal neovascularization;Progressive visual loss;Choroidal neovascularization;Drusen;Decreased serum complement C3;Recurrent meningococcal disease;Recurrent urinary tract infections;Recurrent streptococcus pneumoniae infections;Renal insufficiency;Sinusitis;Arthritis;Recurrent otitis media;Decreased serum complement factor H;Recurrent Haemophilus influenzae infections;Decreased serum complement factor I;Recurrent sinusitis;Recurrent skin infections;Juvenile onset;Glomerulonephritis;Decreased serum complement factor B;Vasculitis;Autosomal recessive inheritance;Recurrent meningitis;Pyelonephritis	31635417	0.00251606	383.0	152222.0	2.0	32	0.97	PASS	sas	0.00248242	12.0	0.00191081	130.0	0.0038858	977.0	251428.0	17.0	100	1.0	PASS	sas	0.00333181	102.0	0.00254075	289.0	0.0031575	491	0.003	9.0	0.00395	45.0		0.056	-0.562409	0.071	2	15	17	M-CAP_pred,FATHMM_pred	LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CFI	0.0	0.0	0.0	0.08	9.0	-6.0	-45.0	-8.0						0.157	0.0	0.000000000	0.0	0.177	renal/urinary system phenotype; hematopoietic system phenotype; homeostasis/metabolism phenotype; 			.	Complement and coagulation cascades	proteolysis;receptor-mediated endocytosis;complement activation, classical pathway;regulation of complement activation;innate immune response	extracellular region;extracellular space;membrane;extracellular exosome	serine-type endopeptidase activity;scavenger receptor activity;protein binding;metal ion binding	.	110667485
57592	chr4	110791526	A	G	chr4:110791526	LRIT3	leucine rich repeat, Ig-like and transmembrane domains 3	SNV	0/1	0.54	74_86	160	99.0	0/0	0.0	94_0	94	99.0			rs35997283	EXONIC	YES	NM_198506.5	Transcript	protein_coding	missense_variant		4/4	NM_198506.5:c.1621A>G	NP_940908.3:p.Ile541Val		1.0	Fibronectin type III&Fibronectin type III,Fibronectin type III&Fibronectin type III	Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_specified|not_provided	Night blindness, congenital stationary (complete), 1F, autosomal recessive, 615058 (3), Autosomal recessive	Congenital stationary night blindness	Disease-causing germline mutation(s) in	Myopia;Autosomal recessive inheritance;Congenital stationary night blindness;Strabismus;High myopia;Strabismus;Reduced visual acuity;Abnormality of macular pigmentation;Nyctalopia;Optic disc hypoplasia;Nystagmus		0.00461801	703.0	152230.0	7.0	32	0.96	PASS	nfe	0.00765771	521.0	0.00765771	521.0	0.00509278	1279.0	251140.0	8.0	90	1.0	PASS	nfe	0.00806338	915.0	0.00806338	915.0	0.0052282	813	0.007	23.0	0.00546	52.0		19.89	2.020104	0.194	6	13	19	SIFT,LRT_pred,MutationAssessor_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	LRIT3	0.0	0.0	0.0	0.0	-23.0	20.0	-1.0	-7.0							0.0	0.000000000	0.997	0.281	vision/eye phenotype; 			pons;ciliary ganglion;testis - interstitial;subthalamic nucleus;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;	.	visual perception;regulation of fibroblast growth factor receptor signaling pathway;response to stimulus	endoplasmic reticulum membrane;integral component of membrane;dendrite;perikaryon	.	.	110791526
58377	chr4	121702463	G	A	chr4:121702463	PRDM5	PR/SET domain 5	SNV	0/1	0.65	12_24	37	99.0	0/0	0.0	27_0	27	72.0			rs185134294	SPLICING	YES	NM_001379104.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	11/15		NM_001379104.1:c.1316-5C>T			-1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Brittle_cornea_syndrome_2|not_specified|not_provided	Brittle cornea syndrome 2, 614170 (3), Autosomal recessive	Brittle cornea syndrome	Disease-causing germline mutation(s) in	Visual loss;Myalgia;Scoliosis;Hyperextensible skin;Mitral valve prolapse;Sensorineural hearing impairment;Blue sclerae;Joint hyperflexibility;High myopia;Hernia;Abnormality of hair pigmentation;Corneal scarring;Glaucoma;Retinal detachment;Bruising susceptibility;Hallux valgus;Corneal erosion;Neonatal hypotonia;Conductive hearing impairment;Corneal dystrophy;Abnormality of epiphysis morphology;Pulmonic stenosis;Arachnodactyly;Hip dysplasia;Keratoglobus;Cleft palate;Soft skin;Camptodactyly;Osteoporosis;Gait disturbance;Increased susceptibility to fractures;Abnormality of the dentition;Pes planus;Myalgia;Joint hypermobility;Myopia;Keratoglobus;Recurrent fractures;Blue sclerae;Umbilical hernia;Inguinal hernia;Megalocornea;Hearing impairment;Sclerocornea;Gait disturbance;Flat cornea;Keratoconus;Autosomal recessive inheritance		0.00205136	312.0	152094.0	1.0	32	0.97	PASS	nfe	0.00358802	244.0	0.00358802	244.0	0.00183739	456.0	248178.0	1.0	59	0.95	PASS	nfe	0.00336534	375.0	0.00336534	375.0	0.0018649	290	0.002	5.0	0.00255	29.0		12.61	0.885815		0	0	0			PRDM5	0.1	0.0	0.0	0.0	-5.0	-10.0	-49.0	-4.0	0.0002406848023808	0.004	11.576	-1.82	9.756	0.411	0.74				skeleton phenotype; 			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;globus pallidus;	.	negative regulation of transcription by RNA polymerase II;mitotic cell cycle;histone deacetylation;negative regulation of transcription, DNA-templated;histone H3-K9 methylation;cellular response to leukemia inhibitory factor	nucleus;nucleolus;nuclear body	RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;protein binding;methyltransferase activity;chromatin DNA binding;sequence-specific DNA binding;transcription regulatory region DNA binding;metal ion binding;repressing transcription factor binding	VIPR1[unassigned1304];TFAP4[25416956];RASD1[unassigned1304];HDAC1[17636019];ADPRHL2[unassigned1304];GFI1[17636019];EHMT2[17636019];TYK2[unassigned1304];FBXO44[unassigned1304];FAAP20[unassigned1304];CLCN1[unassigned1304];	121702463
58378	chr4	122254003	T	C	chr4:122254003	QRFPR	pyroglutamylated RFamide peptide receptor	SNV	0/0	0.0	30_0	30	90.0	0/1	0.35	17_9	26	99.0			rs144384829	EXONIC	YES	NM_198179.3	Transcript	protein_coding	missense_variant		4/6	NM_198179.3:c.770A>G	NP_937822.2:p.His257Arg		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.		0.000893315	136.0	152242.0	1.0	32	0.96	PASS	amr	0.00379482	58.0	0.000367431	25.0	0.00082856	208.0	251038.0	1.0	48	0.99	PASS	amr	0.00167766	58.0	0.000343782	39.0	0.0006302	98	0.001	3.0				22.8	2.604383	0.117	7	14	21	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	QRFPR	0.0	0.0	0.03	0.0	37.0	-27.0	-27.0	32.0						0.917	0.0	0.000000000	0.99	1.118	skeleton phenotype; 			ciliary ganglion;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	.	G protein-coupled receptor signaling pathway;neuropeptide signaling pathway	plasma membrane;integral component of membrane	G protein-coupled receptor activity;neuropeptide Y receptor activity	NTM[unassigned1304];GJA8[unassigned1304];	122254003
58416	chr4	125591285	G	C	chr4:125591285	ANKRD50	ankyrin repeat domain 50	SNV	0/1	0.52	63_68	131	99.0	0/0	0.0	34_0	34	99.0			rs200351787	EXONIC	YES	NM_020337.3	Transcript	protein_coding	synonymous_variant		4/5	NM_020337.3:c.3147C>G	NP_065070.1:p.Leu1049%3D		-1.0						.	.	.		7.89121e-05	12.0	152068.0	0.0	32	0.97	PASS	amr	0.000262158	4.0	0.000117637	8.0	4.80042e-05	12.0	249978.0	0.0	68	0.94	PASS	nfe	7.95812e-05	9.0	7.95812e-05	9.0	0.0000514	8	0.0	1.0				2.782	0.010384		0	0	0			ANKRD50	0.0	0.0	0.0	0.0	-40.0	-11.0	-39.0	14.0						0.493	0.92	79.334888294			.			.	.	protein transport;retrograde transport, endosome to plasma membrane	endosome	protein binding	ANKRD28[23414517];ZNF250[unassigned1304];PEX5[26871637];ASZ1[unassigned1304];CLNK[25814554];SCRIB[24550280];HIF1AN[26972000;unassigned1304];ZDHHC17[24705354];	125591285
58446	chr4	140625183	C	T	chr4:140625183	MGST2	microsomal glutathione S-transferase 2	SNV	0/0	0.0	33_0	33	99.0	0/1	0.48	31_29	60	99.0			rs147869298	EXONIC	YES	NM_001204366.2	Transcript	protein_coding	stop_gained		5/6	NM_001204366.2:c.325C>T	NP_001191295.1:p.Arg109Ter		1.0	.,.					.	.	.		0.000880849	134.0	152126.0	0.0	31	0.96	PASS	nfe	0.00136708	93.0	0.00136708	93.0	0.00116916	294.0	251462.0	1.0	100	1.0	PASS	nfe	0.00189028	215.0	0.00189028	215.0	0.0013119	204	0.002	8.0	0.00202	23.0		37.0	7.293644		3	3	6	MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	LRT_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MGST2	0.01	0.29	0.0	0.0	40.0	-13.0	-13.0	39.0							0.06	0.000000000	0.001	0.091	mortality/aging ; cellular phenotype; homeostasis/metabolism phenotype; 			.	Glutathione metabolism;Metabolism of xenobiotics by cytochrome P450;Drug metabolism - cytochrome P450	lipid metabolic process;glutathione biosynthetic process;xenobiotic metabolic process;response to organonitrogen compound;leukotriene biosynthetic process;response to lipopolysaccharide;positive regulation of catalytic activity;membrane lipid catabolic process;positive regulation of inflammatory response;cellular oxidant detoxification;glutathione derivative biosynthetic process	nuclear envelope;endoplasmic reticulum;endoplasmic reticulum membrane;plasma membrane;membrane;integral component of membrane;organelle membrane;intracellular membrane-bounded organelle	glutathione transferase activity;leukotriene-C4 synthase activity;glutathione peroxidase activity;protein binding;enzyme activator activity	JUN[25609649];CCL3L1[unassigned1304];PNKP[unassigned1304];MGST2[unassigned1304];CLEC14A[unassigned1304];CREB3[25910212];PLN[unassigned1304];DNAJC30[unassigned1304];SGCB[unassigned1304];CREB3L1[unassigned1304];TMEM207[unassigned1304];CTXN3[unassigned1304];GJA8[unassigned1304];SEC22B[unassigned1304];SEC22A[unassigned1304];BCL2L2[unassigned1304];VAMP3[unassigned1304];ASIC1[unassigned1304];	140625183
58450	chr4	140811086	GCTGCTGCTGCTGC		chr4:140811086-140811099	MAML3	mastermind like transcriptional coactivator 3	sequence_alteration	1/2	0.09	0_58_6	65	43.0	1|1	0.01	0_78_1	83	99.0			rs753947128	EXONIC	YES	NM_018717.5	Transcript	protein_coding	frameshift_variant		2/5	NM_018717.5:c.1491_1504del	NP_061187.3:p.Gln498AlafsTer24		-1.0						.	.	.		4.67933e-05	7.0	149594.0	0.0	7	0.26	PASS	amr	0.000197446	3.0	5.90458e-05	4.0	0.000327234	70.0	213914.0	0.0	100	0.97	RF	nfe	0.000274111	26.0	0.000274111	26.0	0.0000064	1						31.0	4.314802		0	0	0																	0.595	0.33				nervous system phenotype ; embryo phenotype; normal phenotype; mortality/aging ; cardiovascular system phenotype ; craniofacial phenotype; cellular phenotype; growth/size/body region phenotype; 			ciliary ganglion;dorsal root ganglion;atrioventricular node;superior cervical ganglion;	Notch signaling pathway	transcription initiation from RNA polymerase II promoter;Notch signaling pathway;positive regulation of transcription of Notch receptor target;positive regulation of Notch signaling pathway;positive regulation of transcription by RNA polymerase II	nucleus;nucleoplasm;nuclear speck	transcription coactivator activity	CDC20[17353931];NOTCH1[23022380];HIST1H2BH[30021884];	140811085
58453	chr4	141446696	T	C	chr4:141446696	ELMOD2	ELMO domain containing 2	SNV	0/0	0.0	33_0	33	99.0	0/1	0.51	21_22	43	99.0			rs142469105	EXONIC	YES	NM_153702.4	Transcript	protein_coding	synonymous_variant		2/9	NM_153702.4:c.114T>C	NP_714913.1:p.Tyr38%3D		1.0						.	.	.		0.000972635	148.0	152164.0	0.0	33	0.97	PASS	nfe	0.00169068	115.0	0.00169068	115.0	0.000981628	246.0	250604.0	0.0	51	0.93	PASS	nfe	0.00180696	205.0	0.00180696	205.0	0.0009517	148	0.002	5.0	0.00094	9.0		9.382	0.497725		0	0	0			ELMOD2	0.0	0.0	0.05	0.2	-41.0	0.0	28.0	0.0						0.47	0.8	5.505832032			adipose tissue phenotype ; homeostasis/metabolism phenotype; vision/eye phenotype; behavior/neurological phenotype ; skeleton phenotype; limbs/digits/tail phenotype; 			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;atrioventricular node;	.	positive regulation of GTPase activity;regulation of defense response to virus;defense response to virus	membrane	GTPase activator activity	NEK4[25798074];HOXC4[21988832];	141446696
58720	chr4	144797952	C	A	chr4:144797952	GYPE	glycophorin E (MNS blood group)	SNV	0/0	0.0	27_0	27	81.0	0/1	0.29	25_10	35	99.0			rs766244851	EXONIC	YES	NM_198682.3	Transcript	protein_coding	missense_variant		3/4	NM_198682.3:c.193G>T	NP_941391.2:p.Val65Phe		-1.0	.,.					.	.	.						32	0.97							8.08434e-06	2.0	247392.0	0.0	65	0.89	PASS	amr	5.82988e-05	2.0	0.0	0.0					9e-05	1.0		10.66	0.640762	0.034	0	18	18		SIFT,PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	GYPE	0.0	0.0	0.01	0.0	10.0	9.0	10.0	-48.0							0.0		0.035	0.054	.			superior cervical ganglion;trigeminal ganglion;skin;fetal liver;parietal lobe;	Hematopoietic cell lineage	.	plasma membrane;integral component of plasma membrane	.	.	144797952
58813	chr4	153268228	A		chr4:153268228	FBXW7	F-box and WD repeat domain containing 7	deletion	0|1	0.4	12_8	20	99.0	0/1	0.08	21_2	26	6.0			rs745908066	SPLICING	YES	NM_001349798.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	5/13		NM_001349798.2:c.585-5del			-1.0						.	.	.		0.00711171	349.0	49074.0	0.0	32	0.89	AS_VQSR	nfe	0.00834147	188.0	0.00834147	188.0	0.327887	32552.0	99278.0	0.0	25	0.65	InbreedingCoeff	sas	0.354425	4005.0	0.336183	15964.0	0.0000257,0.1845226,0.0001286	4,28694,20			0.24717	2753.0		1.435	-0.096897		0	0	0			FBXW7	0.0	0.0	0.0	0.0	-4.0	-30.0	-13.0	4.0						0.0563	1.0				cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; endocrine/exocrine gland phenotype; integument phenotype ; growth/size/body region phenotype; embryo phenotype; immune system phenotype; vision/eye phenotype; nervous system phenotype ; digestive/alimentary phenotype; neoplasm; mortality/aging ; normal phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; respiratory system phenotype; liver/biliary system phenotype; 			pons;temporal lobe;amygdala;occipital lobe;prefrontal cortex;subthalamic nucleus;cingulate cortex;trigeminal ganglion;parietal lobe;globus pallidus;medulla oblongata;	Neurodegenerative Diseases;Ubiquitin mediated proteolysis	protein polyubiquitination;vasculogenesis;vasculature development;sister chromatid cohesion;Notch signaling pathway;negative regulation of gene expression;negative regulation of triglyceride biosynthetic process;regulation of lipid storage;ubiquitin recycling;viral process;protein ubiquitination;lung development;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;positive regulation of protein ubiquitination;protein destabilization;negative regulation of DNA endoreduplication;regulation of protein localization;proteasome-mediated ubiquitin-dependent protein catabolic process;post-translational protein modification;positive regulation of epidermal growth factor-activated receptor activity;negative regulation of Notch signaling pathway;protein stabilization;positive regulation of ubiquitin-protein transferase activity;lipid homeostasis;positive regulation of ERK1 and ERK2 cascade;regulation of cell migration involved in sprouting angiogenesis;positive regulation of proteasomal protein catabolic process;regulation of cell cycle G1/S phase transition;negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding;regulation of autophagy of mitochondrion;positive regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway;positive regulation of protein targeting to mitochondrion;positive regulation of ubiquitin-dependent protein catabolic process;negative regulation of hepatocyte proliferation;negative regulation of SREBP signaling pathway;negative regulation of osteoclast development	nucleus;nucleoplasm;nucleolus;cytoplasm;mitochondrion;endoplasmic reticulum;Golgi apparatus;cytosol;SCF ubiquitin ligase complex;perinuclear region of cytoplasm;Parkin-FBXW7-Cul1 ubiquitin ligase complex	ubiquitin-protein transferase activity;protein binding;cyclin binding;protein binding, bridging;ubiquitin protein ligase binding;identical protein binding;ubiquitin binding;phosphothreonine residue binding;ubiquitin-protein transferase activator activity	HEMGN[24412244];GALNT12[24412244];HSP90AB1[22939624];STOML1[23082202];BEX1[25640309];NOTCH1[23022380;17909182;20823234;25344755];ARL6IP1[16169070];SHC1[24412244];IL24[25640309];CUL1[14603323;23108047];XPA[24412244];PPP3R2[24412244];NUDCD2[25036637];MYC[17157259;17314511;23791182];DVL1[24412244];AKT1[24412244];TRIM25[25640309];SEC61B[24412244];NANS[24412244];HRAS[24412244];SKP1[15070733;21620836;22632967;23791182;19412162;20596027];TMOD1[24412244];LINGO1[16169070];SMAD1[24412244];BCAS3[25640309];SHPRH[16169070];MAP2K1[24412244];TGFB1[24412244];FBXW7[21620836;23791182];IGFBP3[24412244];WDR97[16169070];FANCC[24412244];SUMF2[16169070];NFKB2[14743216];MMS22L[16169070];MYCN[19111882];MAPKAPK3[24412244];CCNE1[11533444];CDK2[23082202];MDM2[20708156];CCDC6[23108047];SCGB3A1[25640309];EIF3E[20890303];ANP32B[24412244];ANGPTL4[25640309];FBP1[24412244];ZNF510[24412244];FBP2[24412244];	153268227
58820	chr4	153691316	G	A	chr4:153691316	TIGD4	tigger transposable element derived 4	SNV	0/0	0.0	36_0	36	99.0	0/1	0.46	76_65	141	99.0			rs34696355	EXONIC	YES	NM_145720.4	Transcript	protein_coding	stop_gained		2/2	NM_145720.4:c.841C>T	NP_663772.1:p.Arg281Ter		-1.0	DDE superfamily endonuclease domain					.	.	.		0.00272797	415.0	152128.0	1.0	32	0.98	PASS	nfe	0.00464624	316.0	0.00464624	316.0	0.00244901	615.0	251122.0	5.0	78	1.0	PASS	nfe	0.00388293	441.0	0.00388293	441.0	0.0027588	429	0.004	13.0				34.0	5.844495		5	1	6	LRT_pred,MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	fathmm-XF_coding_pred	TIGD4	0.0	0.0	0.0	0.0	-34.0	-44.0	-44.0	36.0						0.945	0.0	0.000000000	0.996	0.194	.			appendix;superior cervical ganglion;skin;trigeminal ganglion;atrioventricular node;	.	.	nucleus	DNA binding	TRAF2[unassigned1304];	153691316
58942	chr4	169227683	G	A	chr4:169227683	DDX60	DExD/H-box helicase 60	SNV	0/1	0.43	32_24	56	99.0	0/1	0.46	48_41	89	99.0			rs141448687	EXONIC	YES	NM_017631.6	Transcript	protein_coding	synonymous_variant		5/38	NM_017631.6:c.453C>T	NP_060101.3:p.Asn151%3D		-1.0						.	.	.		0.000151165	23.0	152152.0	0.0	32	0.97	PASS	afr	0.000458871	19.0	4.4093e-05	3.0	6.76289e-05	17.0	251372.0	0.0	95	1.0	PASS	afr	0.00043061	7.0	2.63917e-05	3.0	0.0000643	10						0.195	-0.390153		0	0	0			DDX60	0.0	0.0	0.0	0.0	-16.0	13.0	41.0	-45.0						0.945	0.0	53.833943596			immune system phenotype; mortality/aging ; normal phenotype; homeostasis/metabolism phenotype; 			.	.	response to virus;innate immune response;defense response to virus;positive regulation of MDA-5 signaling pathway;positive regulation of RIG-I signaling pathway	cytoplasm;cytosol;intermediate filament cytoskeleton	double-stranded DNA binding;double-stranded RNA binding;single-stranded RNA binding;helicase activity;protein binding;ATP binding	FYCO1[26496610];SORT1[26496610];CDK2AP1[26496610];	169227683
58993	chr4	170077835		A	chr4:170077834-170077835	SH3RF1	SH3 domain containing ring finger 1	insertion	0/0	0.0	23_0	23	20.0	0/1	0.22	18_5	23	55.0			rs146400483	SPLICING	YES	NM_020870.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	2/11		NM_020870.4:c.394-5dup			-1.0						.	.	.		4.06091e-05	6.0	147750.0	0.0	32	0.86	PASS	nfe	6.0163e-05	4.0	6.0163e-05	4.0	0.0119155	1692.0	142000.0	0.0	30	0.72	RF	amr	0.020123	301.0	0.0100303	689.0	0.0000707,0.0063921,0.0000643	11,994,10						5.071	0.149751		0	0	0			SH3RF1	0.0	0.0	0.0	0.0	-5.0	-16.0	-4.0	-16.0						0.303	0.05				.			ciliary ganglion;pons;atrioventricular node;trigeminal ganglion;superior cervical ganglion;	.	neuron migration;apoptotic process;negative regulation of apoptotic process;negative regulation of cysteine-type endopeptidase activity involved in apoptotic process;regulation of CD4-positive, alpha-beta T cell differentiation;positive regulation of JNK cascade;protein autoubiquitination;regulation of CD8-positive, alpha-beta T cell proliferation;negative regulation of extrinsic apoptotic signaling pathway	Golgi apparatus;cytosol;lamellipodium;perinuclear region of cytoplasm	MAP-kinase scaffold activity;protein binding;metal ion binding;ubiquitin protein ligase activity	SEMA6A[12421765];YWHAB[24255178];SIAH2[21586138;25438054];TANK[unassigned1774];ADAM15[16374509];AKT2[17535800];MYC[21150319];UBC[20696164];AKT1[17535800];RAC1[20696164;20936779];PAK2[16374509];NINL[26638075];MAP4K3[20936779];	170077834
59023	chr4	175896871	C	T	chr4:175896871	ADAM29	ADAM metallopeptidase domain 29	SNV	0/1	0.55	58_72	131	99.0	0/0	0.0	35_0	35	99.0			rs61753554	EXONIC	YES	NM_001278125.1	Transcript	protein_coding	synonymous_variant		6/6	NM_001278125.1:c.195C>T	NP_001265054.1:p.Ile65%3D		1.0						.	.	.		0.00674414	1026.0	152132.0	16.0	32	0.97	PASS	nfe	0.0085994	585.0	0.0085994	585.0	0.00855496	2125.0	248394.0	30.0	40	0.85	PASS	nfe	0.0093034	1046.0	0.0093034	1046.0	0.0081991	1275	0.005	15.0				0.943	-0.159357		0	0	0			ADAM29	0.0	0.0	0.0	0.0	19.0	9.0	-35.0	9.0						0.967	0.0	0.817637940			.			testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;testis;skeletal muscle;	.	proteolysis;spermatogenesis	integral component of plasma membrane	metalloendopeptidase activity;metallopeptidase activity	.	175896871
59054	chr4	177056360	C	A	chr4:177056360	WDR17	WD repeat domain 17	SNV	0/1	0.5	19_19	38	99.0	0/1	0.42	39_28	67	99.0			rs151159548	EXONIC	YES	NM_170710.5	Transcript	protein_coding	missense_variant		9/31	NM_170710.5:c.1272C>A	NP_733828.2:p.Asn424Lys		1.0	.,Anaphase-promoting complex subunit 4, WD40 domain&WD40-repeat-containing domain,Anaphase-promoting complex subunit 4, WD40 domain&WD40-repeat-containing domain					.	.	.		0.000844305	128.0	151604.0	0.0	32	0.95	PASS	sas	0.00144748	7.0	0.00113885	77.0	0.00112027	281.0	250832.0	1.0	89	1.0	PASS	nfe	0.00136926	155.0	0.00136926	155.0	0.0009775	152	0.002	7.0				18.18	1.796701	0.157	6	14	20	SIFT,LRT_pred,MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred	PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	WDR17	0.0	0.0	0.0	0.0	38.0	-43.0	28.0	-6.0						0.994	0.0	0.000000000	0.999	0.119	.			ciliary ganglion;pons;subthalamic nucleus;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;skeletal muscle;globus pallidus;	.	.	.	.	KAT6B[unassigned1304];ETS1[20195357];	177056360
59254	chr4	187549831	C	T	chr4:187549831	FAT1	FAT atypical cadherin 1	SNV	0/1	0.52	29_34	65	99.0	0/1	0.43	47_36	83	99.0			rs376412122,COSV71676155	EXONIC	YES	NM_005245.4	Transcript	protein_coding	synonymous_variant		8/27	NM_005245.4:c.4410G>A	NP_005236.2:p.Ala1470%3D		-1.0						.	.	.		1.97239e-05	3.0	152100.0	0.0	33	0.97	PASS	sas	0.000207039	1.0	1.47016e-05	1.0	4.01735e-06	1.0	248920.0	0.0	85	1.0	PASS	nfe	8.87185e-06	1.0	8.87185e-06	1.0								0.457	-0.26724		0	0	0			FAT1	0.0	0.0	0.0	0.0	-27.0	44.0	31.0	1.0						0.712	0.0	81.571935412			immune system phenotype; renal/urinary system phenotype; skeleton phenotype; hearing/vestibular/ear phenotype; nervous system phenotype ; vision/eye phenotype; mortality/aging ; cardiovascular system phenotype ; pigmentation phenotype; behavior/neurological phenotype ; homeostasis/metabolism phenotype; muscle phenotype; craniofacial phenotype; growth/size/body region phenotype; 			kidney;superior cervical ganglion;	.	epithelial cell morphogenesis;actin filament organization;cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;establishment or maintenance of cell polarity;cell-cell signaling;anatomical structure morphogenesis;cell migration;establishment or maintenance of epithelial cell apical/basal polarity;camera-type eye morphogenesis;cell-cell adhesion	nucleus;plasma membrane;integral component of plasma membrane;cell-cell junction;focal adhesion;apical plasma membrane;lamellipodium;filopodium;perinuclear region of cytoplasm;extracellular exosome	calcium ion binding;protein binding	ENAH[16979624];HOMER1[16979624];RPS6KA2[25852190];CBX1[21888893];ILK[25852190];HOMER3[16979624];CFTR[17110338];NIPSNAP1[26496610];EZH2[26496610];	187549831
59264	chr4	190874234	C	T	chr4:190874234	FRG1	FSHD region gene 1	SNV	0/1	0.44	26_21	48	99.0	0/1	0.32	41_19	60	99.0			rs200620299,COSV56995288	EXONIC	YES	NM_004477.3	Transcript	protein_coding	missense_variant		4/9	NM_004477.3:c.271C>T	NP_004468.1:p.Pro91Ser		1.0	.,.					Facioscapulohumeral dystrophy	Candidate gene tested in	Facial palsy;Intellectual disability;Sensorineural hearing impairment;Scapular winging;Beevor's sign;Slow progression;Childhood onset;Exudative retinal detachment;Shoulder girdle muscle atrophy;Scapulohumeral muscular dystrophy;Abdominal wall muscle weakness;Tongue atrophy;Elevated serum creatine kinase;Retinal telangiectasia;External ophthalmoplegia;Calf muscle hypertrophy;Shoulder girdle muscle weakness;Dysphagia;Seizure;Restrictive ventilatory defect;Autosomal dominant inheritance;Abnormal eyelash morphology;Hyperlordosis;Abnormality of cardiovascular system morphology;Elevated serum creatine kinase;Palpebral edema;Skeletal muscle atrophy;Sensorineural hearing impairment;EMG abnormality;Abnormal retinal vascular morphology;Mask-like facies						33	0.97							0.424997	52346.0	123168.0	0.0	24	0.6	InbreedingCoeff_RF	afr	0.458353	3808.0	0.428914	24316.0	0.0001222	19	0.017	49.0	0.34076	627.0		25.6	3.659337	0.646	12	6	18	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_addAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_noAF_pred,ClinPred_pred	FRG1	0.0	0.0	0.0	0.0	5.0	-11.0	47.0	46.0						0.975	0.0		0.998	1.025	.			.	.	mRNA splicing, via spliceosome;rRNA processing;muscle organ development	nucleolus;Cajal body;Z disc;striated muscle dense body;catalytic step 2 spliceosome	RNA binding;protein binding;actin filament binding	JUN[25609649];SART3[19615732];HIST1H3A[29568061];RBPMS[21516116];CWC22[22365833];EXOSC8[25416956];LZTS2[25416956];MKI67[26949251];KRT40[25416956];PTBP3[22575643];GNMT[unassigned1304];	190874234
59269	chr4	190876192	A	C	chr4:190876192	FRG1	FSHD region gene 1	SNV	0/1	0.1	35_4	39	42.0	0|1	0.22	29_8	37	99.0			rs200322789,COSV56995610	SPLICING	YES	NM_004477.3	Transcript	protein_coding	missense_variant,splice_region_variant		5/9	NM_004477.3:c.318A>C	NP_004468.1:p.Arg106Ser		1.0	.,.					Facioscapulohumeral dystrophy	Candidate gene tested in	Facial palsy;Intellectual disability;Sensorineural hearing impairment;Scapular winging;Beevor's sign;Slow progression;Childhood onset;Exudative retinal detachment;Shoulder girdle muscle atrophy;Scapulohumeral muscular dystrophy;Abdominal wall muscle weakness;Tongue atrophy;Elevated serum creatine kinase;Retinal telangiectasia;External ophthalmoplegia;Calf muscle hypertrophy;Shoulder girdle muscle weakness;Dysphagia;Seizure;Restrictive ventilatory defect;Autosomal dominant inheritance;Abnormal eyelash morphology;Hyperlordosis;Abnormality of cardiovascular system morphology;Elevated serum creatine kinase;Palpebral edema;Skeletal muscle atrophy;Sensorineural hearing impairment;EMG abnormality;Abnormal retinal vascular morphology;Mask-like facies						31	0.94							0.000949915	204.0	214756.0	0.0	47	0.98	RF	amr	0.00229525	63.0	0.000875621	85.0	0.0219608	3415	0.001	3.0	0.0213	32.0		25.7	3.685563	0.489	10	8	18	SIFT,PolyPhen,LRT_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,ClinPred_pred	FRG1	0.01	0.0	0.0	0.0	-33.0	0.0	-33.0	4.0	0.190623098934942	0.382	4.782	0.081	4.863	0.975	0.0		0.968	1.226	.			.	.	mRNA splicing, via spliceosome;rRNA processing;muscle organ development	nucleolus;Cajal body;Z disc;striated muscle dense body;catalytic step 2 spliceosome	RNA binding;protein binding;actin filament binding	JUN[25609649];SART3[19615732];HIST1H3A[29568061];RBPMS[21516116];CWC22[22365833];EXOSC8[25416956];LZTS2[25416956];MKI67[26949251];KRT40[25416956];PTBP3[22575643];GNMT[unassigned1304];	190876192
59270	chr4	190876204	G	A	chr4:190876204	FRG1	FSHD region gene 1	SNV	0/1	0.26	37_14	53	99.0	0|1	0.23	34_10	44	99.0			rs3207892,COSV56995628,COSV56997801	EXONIC	YES	NM_004477.3	Transcript	protein_coding	synonymous_variant		5/9	NM_004477.3:c.330G>A	NP_004468.1:p.Lys110%3D		1.0						Facioscapulohumeral dystrophy	Candidate gene tested in	Facial palsy;Intellectual disability;Sensorineural hearing impairment;Scapular winging;Beevor's sign;Slow progression;Childhood onset;Exudative retinal detachment;Shoulder girdle muscle atrophy;Scapulohumeral muscular dystrophy;Abdominal wall muscle weakness;Tongue atrophy;Elevated serum creatine kinase;Retinal telangiectasia;External ophthalmoplegia;Calf muscle hypertrophy;Shoulder girdle muscle weakness;Dysphagia;Seizure;Restrictive ventilatory defect;Autosomal dominant inheritance;Abnormal eyelash morphology;Hyperlordosis;Abnormality of cardiovascular system morphology;Elevated serum creatine kinase;Palpebral edema;Skeletal muscle atrophy;Sensorineural hearing impairment;EMG abnormality;Abnormal retinal vascular morphology;Mask-like facies		0.0	0.0	151812.0	0.0	33	0.96	AC0_AS_VQSR				0.0	0.0	0.442297	60730.0	137306.0	0.0	56	0.99	InbreedingCoeff_RF	eas	0.462784	5086.0	0.44136	27698.0	0.0000836	13	0.019	62.0	0.19212	317.0		11.31	0.719942		0	0	0			FRG1	0.01	0.0	0.0	0.0	35.0	1.0	-45.0	22.0						0.975	0.0				.			.	.	mRNA splicing, via spliceosome;rRNA processing;muscle organ development	nucleolus;Cajal body;Z disc;striated muscle dense body;catalytic step 2 spliceosome	RNA binding;protein binding;actin filament binding	JUN[25609649];SART3[19615732];HIST1H3A[29568061];RBPMS[21516116];CWC22[22365833];EXOSC8[25416956];LZTS2[25416956];MKI67[26949251];KRT40[25416956];PTBP3[22575643];GNMT[unassigned1304];	190876204
59271	chr4	190876242	G	A	chr4:190876242	FRG1	FSHD region gene 1	SNV	0/1	0.35	59_32	91	99.0	0/1	0.4	50_34	84	99.0			rs1061653,COSV56995306	EXONIC	YES	NM_004477.3	Transcript	protein_coding	missense_variant		5/9	NM_004477.3:c.368G>A	NP_004468.1:p.Gly123Glu		1.0	.,.					Facioscapulohumeral dystrophy	Candidate gene tested in	Facial palsy;Intellectual disability;Sensorineural hearing impairment;Scapular winging;Beevor's sign;Slow progression;Childhood onset;Exudative retinal detachment;Shoulder girdle muscle atrophy;Scapulohumeral muscular dystrophy;Abdominal wall muscle weakness;Tongue atrophy;Elevated serum creatine kinase;Retinal telangiectasia;External ophthalmoplegia;Calf muscle hypertrophy;Shoulder girdle muscle weakness;Dysphagia;Seizure;Restrictive ventilatory defect;Autosomal dominant inheritance;Abnormal eyelash morphology;Hyperlordosis;Abnormality of cardiovascular system morphology;Elevated serum creatine kinase;Palpebral edema;Skeletal muscle atrophy;Sensorineural hearing impairment;EMG abnormality;Abnormal retinal vascular morphology;Mask-like facies		6.63905e-06	1.0	150624.0	0.0	33	0.96	AS_VQSR	afr	2.44153e-05	1.0	0.0	0.0	0.493998	116047.0	234914.0	0.0	100	1.0	InbreedingCoeff	eas	0.49786	8607.0	0.493245	53157.0	0.0016784	261	0.053	156.0	0.27885	493.0		22.9	2.698922	0.473	8	8	16	LRT_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred	FRG1	0.0	0.01	0.0	0.0	21.0	-3.0	-16.0	-1.0						0.975	0.0		0.992	0.173	.			.	.	mRNA splicing, via spliceosome;rRNA processing;muscle organ development	nucleolus;Cajal body;Z disc;striated muscle dense body;catalytic step 2 spliceosome	RNA binding;protein binding;actin filament binding	JUN[25609649];SART3[19615732];HIST1H3A[29568061];RBPMS[21516116];CWC22[22365833];EXOSC8[25416956];LZTS2[25416956];MKI67[26949251];KRT40[25416956];PTBP3[22575643];GNMT[unassigned1304];	190876242
59275	chr4	190878563	C	A	chr4:190878563	FRG1	FSHD region gene 1	SNV	0/1	0.27	56_22	81	99.0	0/1	0.18	36_8	44	83.0			rs137858630,COSV56995314	EXONIC	YES	NM_004477.3	Transcript	protein_coding	missense_variant		6/9	NM_004477.3:c.443C>A	NP_004468.1:p.Ala148Asp		1.0	.,.,.					Facioscapulohumeral dystrophy	Candidate gene tested in	Facial palsy;Intellectual disability;Sensorineural hearing impairment;Scapular winging;Beevor's sign;Slow progression;Childhood onset;Exudative retinal detachment;Shoulder girdle muscle atrophy;Scapulohumeral muscular dystrophy;Abdominal wall muscle weakness;Tongue atrophy;Elevated serum creatine kinase;Retinal telangiectasia;External ophthalmoplegia;Calf muscle hypertrophy;Shoulder girdle muscle weakness;Dysphagia;Seizure;Restrictive ventilatory defect;Autosomal dominant inheritance;Abnormal eyelash morphology;Hyperlordosis;Abnormality of cardiovascular system morphology;Elevated serum creatine kinase;Palpebral edema;Skeletal muscle atrophy;Sensorineural hearing impairment;EMG abnormality;Abnormal retinal vascular morphology;Mask-like facies						34	0.97							0.0935486	12195.0	130360.0	1.0	33	0.72	RF	afr	0.264151	1624.0	0.077421	4581.0	0.0009903	154	0.028	91.0	0.13661	250.0		24.0	3.170174	0.792	12	6	18	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LRT_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,ClinPred_pred	FRG1	0.0	0.0	0.0	0.0	-10.0	19.0	-1.0	-10.0						0.975	0.0		1.0	0.934	.			.	.	mRNA splicing, via spliceosome;rRNA processing;muscle organ development	nucleolus;Cajal body;Z disc;striated muscle dense body;catalytic step 2 spliceosome	RNA binding;protein binding;actin filament binding	JUN[25609649];SART3[19615732];HIST1H3A[29568061];RBPMS[21516116];CWC22[22365833];EXOSC8[25416956];LZTS2[25416956];MKI67[26949251];KRT40[25416956];PTBP3[22575643];GNMT[unassigned1304];	190878563
59277	chr4	190878654	C	G	chr4:190878654	FRG1	FSHD region gene 1	SNV	0/1	0.4	52_38	94	99.0	0/1	0.36	32_18	50	99.0			rs78653319,COSV56995165	EXONIC	YES	NM_004477.3	Transcript	protein_coding	missense_variant		6/9	NM_004477.3:c.534C>G	NP_004468.1:p.Ile178Met		1.0	.,.,.					Facioscapulohumeral dystrophy	Candidate gene tested in	Facial palsy;Intellectual disability;Sensorineural hearing impairment;Scapular winging;Beevor's sign;Slow progression;Childhood onset;Exudative retinal detachment;Shoulder girdle muscle atrophy;Scapulohumeral muscular dystrophy;Abdominal wall muscle weakness;Tongue atrophy;Elevated serum creatine kinase;Retinal telangiectasia;External ophthalmoplegia;Calf muscle hypertrophy;Shoulder girdle muscle weakness;Dysphagia;Seizure;Restrictive ventilatory defect;Autosomal dominant inheritance;Abnormal eyelash morphology;Hyperlordosis;Abnormality of cardiovascular system morphology;Elevated serum creatine kinase;Palpebral edema;Skeletal muscle atrophy;Sensorineural hearing impairment;EMG abnormality;Abnormal retinal vascular morphology;Mask-like facies						36	0.98							0.475414	80015.0	168306.0	2.0	89	0.95	InbreedingCoeff_RF	sas	0.481503	10777.0	0.475573	36719.0	0.0023858	371	0.044	118.0	0.2293	421.0		17.29	1.671258	0.174	3	14	17	PolyPhen,MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	FRG1	0.0	0.0	0.0	0.0	26.0	-19.0	48.0	3.0						0.975	0.0		0.991	-0.227	.			.	.	mRNA splicing, via spliceosome;rRNA processing;muscle organ development	nucleolus;Cajal body;Z disc;striated muscle dense body;catalytic step 2 spliceosome	RNA binding;protein binding;actin filament binding	JUN[25609649];SART3[19615732];HIST1H3A[29568061];RBPMS[21516116];CWC22[22365833];EXOSC8[25416956];LZTS2[25416956];MKI67[26949251];KRT40[25416956];PTBP3[22575643];GNMT[unassigned1304];	190878654
59465	chr5	13944510	C	T	chr5:13944510	DNAH5	dynein axonemal heavy chain 5	SNV	0/0	0.0	37_0	37	99.0	0|1	0.5	42_43	86	99.0			rs747161968	EXONIC	YES	NM_001369.3	Transcript	protein_coding	missense_variant		1/79	NM_001369.3:c.38G>A	NP_001360.1:p.Ser13Asn		-1.0					Ciliary dyskinesia, primary, 3, with or without situs inversus, 608644 (3), Autosomal recessive	Primary ciliary dyskinesia	Disease-causing germline mutation(s) in	Hydrocephalus;Pectus excavatum;Chronic otitis media;Tachypnea;Impaired nasal mucociliary clearance;Delayed speech and language development;Asthma;Atelectasis;Headache;Ectopic pregnancy;Nasal polyposis;Clubbing of fingers;Pulmonary obstruction;Asplenia;Scoliosis;Reduced sperm motility;Respiratory distress;Immotile cilia;Chronic sinusitis;Infertility;Chronic bronchitis;Corneal dystrophy;Glue ear;Pneumonia;Spontaneous abortion;Conductive hearing impairment;Recurrent respiratory infections;Situs inversus totalis;Cough;Bronchiectasis;Ventriculomegaly;Rhinitis;Halitosis;Recurrent respiratory infections;Situs inversus totalis;Autosomal recessive inheritance;Ciliary dyskinesia		3.28532e-05	5.0	152192.0	0.0	33	0.96	PASS	nfe	7.3484e-05	5.0	7.3484e-05	5.0	1.59467e-05	4.0	250836.0	0.0	87	1.0	PASS	amr	8.67955e-05	3.0	8.81663e-06	1.0	0.0000129	2	0.001	2.0	9e-05	1.0		25.9	3.725257	0.084	9	12	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,ClinPred_pred,fathmm-MKL_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-XF_coding_pred	DNAH5	0.0	0.0	0.0	0.0	-2.0	-19.0	-24.0	-16.0						0.942	0.0	0.000000000	0.991	1.026	behavior/neurological phenotype ; respiratory system phenotype; liver/biliary system phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; mortality/aging ; digestive/alimentary phenotype; nervous system phenotype ; hearing/vestibular/ear phenotype; renal/urinary system phenotype; skeleton phenotype; immune system phenotype; cellular phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; craniofacial phenotype; 			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;	.	cilium movement;microtubule-based movement;determination of left/right symmetry;heart development;lateral ventricle development;flagellated sperm motility;outer dynein arm assembly;cilium assembly	microtubule;axoneme;dynein complex;outer dynein arm;9+2 motile cilium	ATP binding;ATP-dependent microtubule motor activity, minus-end-directed;dynein light chain binding;dynein intermediate chain binding;dynein light intermediate chain binding	EIF4A2[17353931];HIST1H2AH[30021884];HIST3H3[30021884];HIST1H2AE[30021884];RRBP1[30021884];HIST1H2BH[30021884];UBA52[30021884];BICD2[30021884];HIST2H2BE[30021884];PATL2[30021884];PLEC[30021884];	13944510
59510	chr5	31299660	A	T	chr5:31299660	CDH6	cadherin 6	SNV	0/1	0.56	29_37	66	99.0	0/1	0.43	39_30	70	99.0			rs759433625	EXONIC	YES	NM_004932.4	Transcript	protein_coding	missense_variant		5/12	NM_004932.4:c.733A>T	NP_004923.1:p.Met245Leu		1.0	Cadherin-like&Cadherin-like,Cadherin-like&Cadherin-like					.	.	.						32	0.96							3.98127e-06	1.0	251176.0	0.0	85	1.0	PASS	sas	3.26648e-05	1.0	0.0	0.0	0.0000064	1						21.5	2.212093	0.233	4	15	19	LRT_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	CDH6	0.0	0.0	0.0	0.0	-15.0	-46.0	-31.0	47.0						0.386	0.98	0.000000000	1.0	1.312	renal/urinary system phenotype; 			caudate nucleus;dorsal root ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;medulla oblongata;thalamus;	.	cell morphogenesis;cell-cell junction assembly;cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;Notch signaling pathway;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules;adherens junction organization;cell-cell adhesion mediated by cadherin;cell-cell adhesion	plasma membrane;cell-cell adherens junction;cell surface;integral component of membrane;catenin complex	calcium ion binding;cytoskeletal protein binding;protein homodimerization activity;cadherin binding	.	31299660
59706	chr5	55407268	C	T	chr5:55407268	ANKRD55	ankyrin repeat domain 55	SNV	0/1	0.37	76_44	120	99.0	0/1	0.56	59_74	133	99.0			rs143094717	EXONIC	YES	NM_024669.3	Transcript	protein_coding	missense_variant		10/12	NM_024669.3:c.1307G>A	NP_078945.2:p.Ser436Asn		-1.0	.,.,.					Oligoarticular juvenile idiopathic arthritis;Rheumatoid factor-negative juvenile idiopathic arthritis	Major susceptibility factor in;Major susceptibility factor in	Iridocyclitis;Arthralgia;Joint swelling;Elevated C-reactive protein level;Antinuclear antibody positivity;Juvenile rheumatoid arthritis;Elevated erythrocyte sedimentation rate;Joint dislocation;Limitation of joint mobility;Juvenile rheumatoid arthritis;Polyarticular arthritis;Elevated C-reactive protein level;Joint swelling;Dental malocclusion;Elevated erythrocyte sedimentation rate;Apraxia;Antinuclear antibody positivity;Arthralgia		0.000230033	35.0	152152.0	0.0	32	0.96	PASS	amr	0.000393236	6.0	0.000323415	22.0	0.000290714	73.0	251106.0	0.0	77	1.0	PASS	nfe	0.000484821	55.0	0.000484821	55.0	0.0003666	57						26.5	3.84155	0.555	8	11	19	SIFT,PolyPhen,LRT_pred,MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	ANKRD55	0.0	0.0	0.0	0.0	-9.0	48.0	31.0	1.0						0.836	0.0	0.000000000	1.0	1.026	.			pons;ciliary ganglion;testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;trigeminal ganglion;testis;skeletal muscle;	.	.	.	.	CLIC3[unassigned1304];ZMYND19[unassigned1304];CABP5[unassigned1304];FHL2[unassigned1304];PTK6[unassigned1304];HSF2BP[unassigned1304];CFAP206[unassigned1304];FRS3[unassigned1304];BACH2[unassigned1304];ABI2[unassigned1304];HGS[unassigned1304];NOXA1[unassigned1304];BOLA2[unassigned1304];NCK2[unassigned1304];TEKT4[unassigned1304];ANKS1A[unassigned1304];PFDN5[unassigned1304];TRIM23[unassigned1304];BANP[unassigned1304];	55407268
59715	chr5	56778496	A	G	chr5:56778496	ACTBL2	actin, beta like 2	SNV	0/1	0.55	56_68	124	99.0	0/1	0.42	63_45	108	99.0			rs114700949	EXONIC	YES	NM_001017992.4	Transcript	protein_coding	synonymous_variant		1/1	NM_001017992.4:c.39T>C	NP_001017992.1:p.Asn13%3D		-1.0						.	.	.		0.00479334	729.0	152086.0	2.0	32	0.96	PASS	nfe	0.00652788	444.0	0.00652788	444.0	0.00581846	1457.0	250410.0	14.0	60	0.99	PASS	nfe	0.00688427	777.0	0.00688427	777.0	0.0009903,0.0044886	154,698	0.005	17.0				8.907	0.448965		0	0	0			ACTBL2	0.0	0.0	0.0	0.0	7.0	-49.0	-2.0	12.0						0.259	0.0	0.000000000			.			.	.	biological_process	extracellular space;cytoplasm;cytoskeleton;extracellular exosome;glutamatergic synapse	molecular_function;protein binding;ATP binding	PPP1R15A[29109149];ERRFI1[24189400];KDM5B[24937458];CTR9[26496610];ECI2[29426014];ARRB1[17620599];UBE3A[29426014];ARRB2[17620599];STK4[23386615];GABARAP[20562859];GOLGA2[29568061];LIMA1[30021884];MAP1LC3B[20562859];MAP1LC3A[20562859];HTR7[19486527];HIST1H3A[29568061];ERBB3[24189400];CEP97[27173435;unassigned1312];GABARAPL2[20562859];GABARAPL1[20562859];ZNF185[30021884];NEK4[25798074];PRKCD[26496610];FN1[19738201];OCRL[25107275];NFKB1[25609649];PPP1R3C[28330616];MYH9[26496610];	56778496
59765	chr5	65008851	T	C	chr5:65008851	SGTB	small glutamine rich tetratricopeptide repeat containing beta	SNV	0/1	0.44	29_23	52	99.0	0/1	0.26	32_11	43	99.0			rs146508029	EXONIC	YES	NM_019072.3	Transcript	protein_coding	synonymous_variant		3/11	NM_019072.3:c.141A>G	NP_061945.1:p.Pro47%3D		-1.0						.	.	.		9.85273e-05	15.0	152242.0	0.0	33	0.97	PASS	amr	0.000327311	5.0	5.87838e-05	4.0	6.37069e-05	16.0	251150.0	0.0	58	0.97	PASS	amr	0.000203004	7.0	5.27909e-05	6.0	0.0000836	13	0.0	1.0				12.12	0.821003		0	0	0			SGTB	0.02	0.0	0.0	0.0	40.0	-2.0	29.0	40.0						0.197	0.99	94.080074736			.			.	.	posttranslational protein targeting to endoplasmic reticulum membrane;ubiquitin-dependent ERAD pathway;positive regulation of chaperone-mediated protein folding	cytosol;membrane;TRC complex	protein binding;protein-containing complex scaffold activity	GALNT11[unassigned1304];PAGE3[unassigned1304];ITPRIP[unassigned1304];SERPINE1[25416956;unassigned1304];TXNDC12[25416956;unassigned1304];COMP[unassigned1304];EFEMP2[16189514;25416956;unassigned1304];SMCHD1[30021884];BAIAP2L1[26496610];EVA1A[unassigned1304];CREB3L3[unassigned1304];LAMP3[21988832];SIL1[unassigned1304];IL6R[unassigned1304];MAP3K4[26496610];SPINK4[unassigned1304];ATP6V1G1[26496610];SERPINF1[unassigned1304];LMO2[unassigned1304];ADIPOQ[unassigned1304];KRT1[unassigned1304];DICER1[26496610];DEXI[unassigned1304];PRAP1[unassigned1304];BTC[unassigned1304];SELENOM[unassigned1304];EMCN[unassigned1304];SLPI[unassigned1304];PDE12[26496610];ZNF318[26496610];MSH5[26496610];ERF[26496610];ERP29[unassigned1304];UHRF1BP1[26496610];WDFY3[26496610];TLN2[26496610];ZG16[unassigned1304];PPIB[21516116;unassigned1304];IL6ST[25416956;unassigned1304];TLN1[26496610];ABCG4[unassigned1304];PPIC[unassigned1304];WFDC12[unassigned1304];GYPA[unassigned1304];CCL3L1[unassigned1304];SDC4[unassigned1304];CSH2[unassigned1304];CSH1[unassigned1304];KCNE5[unassigned1304];LHB[unassigned1304];UAP1[26496610];CD99L2[unassigned1304];HSP90B1[unassigned1304];PSORS1C2[unassigned1304];BAG6[26496610];CD79B[unassigned1304];CYB5R1[unassigned1304];TMEM123[unassigned1304];ITPRIPL1[unassigned1304];PODXL[unassigned1304];ZNF668[26496610];RNF170[unassigned1304];BRIX1[26496610];MORC2[26496610];RAI2[16189514;25416956];PLXNA3[26496610];SPTBN2[26496610];FGF21[unassigned1304];KLHDC2[26496610];SYT4[unassigned1304];SDF2L1[unassigned1304];DEFA6[unassigned1304];ZG16B[unassigned1304];RNASE10[unassigned1304];FZD7[unassigned1304];HSPA6[26496610];OSBPL2[26496610];TNFSF13[unassigned1304];GGH[unassigned1304];ABCA7[26496610];MED13L[26496610];ARHGAP32[26496610];NCEH1[26496610];COL1A2[26871637];SERPINI2[21516116;unassigned1304];PDCL[26496610];LCN2[unassigned1304];HYOU1[26496610];BLMH[26496610];PLXNB1[26496610];GTF2IRD1[26496610];CALR[unassigned1304];LAT[unassigned1304];EIF4G1[26496610];FBN1[unassigned1304];RET[26496610];C2CD5[26496610];ECM1[unassigned1304];ITGB4[26496610];PINX1[26496610];HEXA[26496610];ETFA[26496610];DMKN[unassigned1304];CD3D[unassigned1304];AKAP12[26496610];C5orf46[unassigned1304];MYDGF[unassigned1304];SGCA[unassigned1304];PRB1[unassigned1304];RB1CC1[26496610];C1QTNF6[unassigned1304];PRB3[unassigned1304];C1QTNF5[unassigned1304];FLOT1[26496610];RACK1[26496610];TMEM108[unassigned1304];FLOT2[26496610];COL10A1[unassigned1304];MAN2C1[26496610];EIF2B1[26496610];RRP15[26496610];GET4[26496610];SRGN[unassigned1304];TNFRSF19[unassigned1304];KIAA1143[26496610];SIRT5[26496610];NME3[unassigned1304];GPX7[unassigned1304];ACTR8[26496610];C1QL4[unassigned1304];OSMR[unassigned1304];WDR35[26496610];UPK3A[unassigned1304];GIP[unassigned1304];RNF144A[unassigned1304];DNAJC2[26496610];CD200R1[unassigned1304];RCN1[unassigned1304];RABEP1[26496610];ESPL1[26496610];ASPH[unassigned1304];ETF1[26496610];TFF1[unassigned1304];CDH15[unassigned1304];CHMP5[26496610];C1QA[unassigned1304];USP15[26496610];DDX24[26496610];FURIN[26496610];HSPA13[unassigned1304];ECPAS[26496610];PGRMC1[unassigned1304];MTA1[26496610];PDF[26496610];CTAG1A[unassigned1304];USP1[26496610];NHS[26496610];AGR2[unassigned1304];SPP1[unassigned1304];HEATR3[26496610];RAD54L[26496610];AGR3[unassigned1304];SLC25A20[26496610];SRSF10[26496610];ZNF286A[26496610];UBL4A[26496610;unassigned1304];PNPLA8[26496610];SGTA[unassigned1304];TMUB1[unassigned1304];VEGFC[unassigned1304];SOD3[unassigned1304];ASS1[26496610];MTOR[26496610];COLQ[unassigned1304];ADAT2[unassigned1304];DNAJA4[26496610];SYT11[unassigned1304];ETNK1[unassigned1304];VWC2[unassigned1304];ACIN1[26496610];CMPK[unassigned1304];NAXD[unassigned1304];PPIL3[26496610];CD68[unassigned1304];LAMTOR5[26496610];	65008851
59838	chr5	74965092	G	A	chr5:74965092	ANKDD1B	ankyrin repeat and death domain containing 1B	SNV	0/0	0.0	35_0	35	99.0	0/1	0.46	38_32	70	99.0			rs139309851	EXONIC	YES	NM_001276713.2	Transcript	protein_coding	missense_variant		13/14	NM_001276713.2:c.1409G>A	NP_001263642.1:p.Arg470His		1.0	Death domain	Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00386308	588.0	152210.0	2.0	32	0.96	PASS	nfe	0.0062906	428.0	0.0062906	428.0	0.00583333	49.0	8400.0	0.0	0	0.01	PASS	nfe	0.00670333	39.0	0.00670333	39.0	0.0009453	147	0.002	5.0				12.97	0.934876		2	11	13	M-CAP_pred,FATHMM_pred	SIFT,PolyPhen,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ANKDD1B	0.01	0.07	0.0	0.0	16.0	-15.0	16.0	-15.0									0.238	-0.479	.			.	.	signal transduction	.	.	.	74965092
59847	chr5	76029285	C	A	chr5:76029285	F2R	coagulation factor II thrombin receptor	SNV	0/1	0.55	34_42	77	99.0	0/0	0.0	34_0	34	99.0			rs2227799,CM1612515	EXONIC	YES	NM_001992.5	Transcript	protein_coding	missense_variant		2/2	NM_001992.5:c.1235C>A	NP_001983.2:p.Ser412Tyr		1.0						.	.	.		0.000453416	69.0	152178.0	0.0	32	0.97	PASS	amr	0.0014396	22.0	0.000308696	21.0	0.000400831	100.0	249482.0	0.0	70	0.99	PASS	amr	0.00121591	42.0	0.000373685	42.0	0.0003408	53	0.002	6.0				24.9	3.488537	0.294	10	11	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,DEOGEN2_pred,fathmm-MKL_coding_pred	LRT_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	F2R	0.0	0.0	0.0	0.0	-17.0	44.0	-23.0	-24.0						0.364	0.04	0.000000000	1.0	0.962	homeostasis/metabolism phenotype; cellular phenotype; cardiovascular system phenotype ; growth/size/body region phenotype; reproductive system phenotype; mortality/aging ; vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype ; limbs/digits/tail phenotype; skeleton phenotype; renal/urinary system phenotype; immune system phenotype; liver/biliary system phenotype; embryo phenotype; neoplasm; 			pons;superior cervical ganglion;trigeminal ganglion;	Calcium signaling pathway;Neuroactive ligand-receptor interaction;Complement and coagulation cascades;Regulation of actin cytoskeleton	activation of MAPKK activity;connective tissue replacement involved in inflammatory response wound healing;negative regulation of glomerular filtration;activation of cysteine-type endopeptidase activity involved in apoptotic process;inflammatory response;G protein-coupled receptor signaling pathway;phospholipase C-activating G protein-coupled receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;protein kinase C-activating G protein-coupled receptor signaling pathway;establishment of synaptic specificity at neuromuscular junction;blood coagulation;positive regulation of cell population proliferation;negative regulation of cell population proliferation;response to wounding;anatomical structure morphogenesis;positive regulation of phosphatidylinositol 3-kinase signaling;platelet activation;regulation of blood coagulation;positive regulation of blood coagulation;positive regulation of cell migration;response to lipopolysaccharide;regulation of interleukin-1 beta production;positive regulation of collagen biosynthetic process;positive regulation of Rho protein signal transduction;positive regulation of I-kappaB kinase/NF-kappaB signaling;positive regulation of cysteine-type endopeptidase activity involved in apoptotic process;positive regulation of MAPK cascade;negative regulation of neuron apoptotic process;positive regulation of GTPase activity;cell-cell junction maintenance;positive regulation of transcription, DNA-templated;positive regulation of vasoconstriction;positive regulation of smooth muscle contraction;positive regulation of JAK-STAT cascade;homeostasis of number of cells within a tissue;release of sequestered calcium ion into cytosol;positive regulation of release of sequestered calcium ion into cytosol;positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G protein-coupled signaling pathway;positive regulation of calcium ion transport;regulation of sensory perception of pain;platelet dense granule organization;positive regulation of ERK1 and ERK2 cascade;thrombin-activated receptor signaling pathway;trans-synaptic signaling by endocannabinoid, modulating synaptic transmission;negative regulation of renin secretion into blood stream;positive regulation of interleukin-8 secretion;positive regulation of interleukin-6 secretion	extracellular region;early endosome;late endosome;Golgi apparatus;plasma membrane;integral component of plasma membrane;caveola;cell surface;platelet dense tubular network;neuromuscular junction;postsynaptic membrane	G-protein alpha-subunit binding;G protein-coupled receptor activity;signaling receptor binding;protein binding;thrombin-activated receptor activity;G-protein beta-subunit binding	GNA13[23773523];PROCR[20826780;17299037];MMP1[25241761];CAV1[20826780];F2R[17376866];CHRD[21988832];TMED2[21219331];ATP13A2[22645275];CAPN1[25241761];F2[18250335];F2RL2[17376866];	76029285
59988	chr5	82816284	T	C	chr5:82816284	VCAN	versican	SNV	0/1	0.37	27_16	43	99.0	0/0	0.0	38_0	38	99.0			rs76418670	EXONIC	YES	NM_004385.5	Transcript	protein_coding	missense_variant		7/15	NM_004385.5:c.2159T>C	NP_004376.2:p.Val720Ala		1.0	.,.,.	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Vitreoretinopathy|Wagner_syndrome|not_provided	Wagner syndrome 1, 143200 (3), Autosomal dominant	Wagner disease	Disease-causing germline mutation(s) in	Cataract;Chorioretinal atrophy;Visual loss;Visual field defect;Autosomal dominant inheritance;Optic atrophy;Myopia;Retinal pigment epithelial atrophy;Peripheral tractional retinal detachment;Exudative vitreoretinopathy;Optically empty vitreous;Vitreoretinopathy;Glaucoma		0.00213816	325.0	152000.0	0.0	33	0.97	PASS	nfe	0.00358971	244.0	0.00358971	244.0	0.00201284	503.0	249896.0	2.0	76	1.0	PASS	nfe	0.00357542	403.0	0.00357542	403.0	0.0021350	332	0.002	7.0	0.00299	34.0		0.001	-2.771251	0.026	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	VCAN	0.0	0.0	0.0	0.0	-6.0	36.0	8.0	-2.0						0.00813	1.0	0.000000000	0.002	-4.829	homeostasis/metabolism phenotype; growth/size/body region phenotype; embryo phenotype; skeleton phenotype; nervous system phenotype ; limbs/digits/tail phenotype; mortality/aging ; normal phenotype; cardiovascular system phenotype ; 			.	Cell adhesion molecules (CAMs)	skeletal system development;osteoblast differentiation;cell adhesion;multicellular organism development;central nervous system development;cell recognition;extracellular matrix organization;chondroitin sulfate biosynthetic process;chondroitin sulfate catabolic process;dermatan sulfate biosynthetic process;post-translational protein modification;cellular protein metabolic process	extracellular region;extracellular space;endoplasmic reticulum lumen;Golgi lumen;membrane;extracellular matrix;lysosomal lumen;collagen-containing extracellular matrix	calcium ion binding;protein binding;glycosaminoglycan binding;hyaluronic acid binding;extracellular matrix structural constituent conferring compression resistance;carbohydrate binding	SRGN[23601700];HSFX1[25036637];RAB19[unassigned1304];FAM20C[22582013];MMP9[23601700];	82816284
59994	chr5	82948596	A	G	chr5:82948596	HAPLN1	hyaluronan and proteoglycan link protein 1	SNV	0/0	0.0	34_0	34	99.0	0/1	0.56	43_55	98	99.0			rs559408235	EXONIC	YES	NM_001884.4	Transcript	protein_coding	missense_variant		3/5	NM_001884.4:c.148T>C	NP_001875.1:p.Phe50Leu		-1.0	Immunoglobulin V-set domain&Immunoglobulin-like domain&Immunoglobulin subtype,Immunoglobulin V-set domain&Immunoglobulin-like domain&Immunoglobulin subtype,Immunoglobulin V-set domain&Immunoglobulin-like domain&Immunoglobulin subtype,Immunoglobulin V-set domain&Immunoglobulin-like domain&Immunoglobulin subtype,Immunoglobulin V-set domain&Immunoglobulin-like domain&Immunoglobulin subtype,Immunoglobulin V-set domain&Immunoglobulin-like domain&Immunoglobulin subtype,Immunoglobulin V-set domain&Immunoglobulin-like domain&Immunoglobulin subtype					.	.	.		5.26067e-05	8.0	152072.0	0.0	32	0.96	PASS	amr	0.00013101	2.0	7.35164e-05	5.0	6.77194e-05	17.0	251036.0	0.0	49	0.99	PASS	amr	0.000376179	13.0	2.64373e-05	3.0	0.0000643	10	0.002	5.0	0.00126	12.0		22.4	2.406715	0.289	4	15	19	LRT_pred,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	HAPLN1	0.0	0.0	0.0	0.0	44.0	47.0	4.0	-33.0						0.341	0.26	0.000000000	0.999	1.312	behavior/neurological phenotype ; hematopoietic system phenotype; mortality/aging ; limbs/digits/tail phenotype; hearing/vestibular/ear phenotype; skeleton phenotype; growth/size/body region phenotype; craniofacial phenotype; 			trigeminal ganglion;atrioventricular node;superior cervical ganglion;heart;	.	skeletal system development;cell adhesion;central nervous system development;extracellular matrix organization	extracellular region;extracellular matrix;synapse;collagen-containing extracellular matrix	hyaluronic acid binding;extracellular matrix structural constituent conferring compression resistance	MAPT[26402096];	82948596
60073	chr5	90106221	C	T	chr5:90106221	ADGRV1	adhesion G protein-coupled receptor V1	SNV	0/1	0.43	39_30	69	99.0	0/1	0.43	51_39	90	99.0			rs763414194,CD0911275,COSV67995786	EXONIC	YES	NM_032119.4	Transcript	protein_coding	synonymous_variant		74/90	NM_032119.4:c.15144C>T	NP_115495.3:p.Ser5048%3D		1.0					Usher syndrome, type 2C, 605472 (3), Autosomal recessive, Digenic dominant; Usher syndrome, type 2C, GPR98/PDZD7 digenic, 605472 (3), Autosomal recessive, Digenic dominant; ?Febrile seizures, familial, 4, 604352 (3), Autosomal dominant	Usher syndrome type 2;Generalized epilepsy with febrile seizures-plus	Disease-causing germline mutation(s) in;Candidate gene tested in	Cataract;Schizophrenia;Visual loss;Scotoma;Hemianopia;Nystagmus;Depressivity;Abnormal electroretinogram;Nyctalopia;Anxiety;Aplasia/Hypoplasia of the cerebellum;Hallucinations;Abnormality of dental enamel;Microdontia;Iris hypopigmentation;Ataxia;Carious teeth;Sensorineural hearing impairment;Cerebral cortical atrophy;Subcortical cerebral atrophy;Abnormality of dental color;Myopia;Childhood onset;Febrile seizure (within the age range of 3 months to 6 years);Infantile onset;Atonic seizure;Generalized tonic seizure;Bilateral tonic-clonic seizure;Heterogeneous;Autosomal dominant inheritance;Rod-cone dystrophy;Congenital sensorineural hearing impairment;Autosomal recessive inheritance;Generalized myoclonic seizure;Pes planus;Muscular hypotonia;Anxiety;Limited knee extension;Talipes valgus;Obsessive-compulsive trait;Focal impaired awareness seizure;Generalized cerebral atrophy/hypoplasia;Atonic seizure;Tremor;Cortical dysplasia;Generalized non-motor (absence) seizure;Febrile seizure (within the age range of 3 months to 6 years);Incoordination;Autistic behavior;Ataxia;Atypical absence status epilepticus;EEG with spike-wave complexes;Cognitive impairment;Bilateral tonic-clonic seizure;Poor fine motor coordination;Developmental regression;Bradykinesia;Tibial torsion		6.57419e-06	1.0	152110.0	0.0	32	0.97	PASS	nfe	1.46985e-05	1.0	1.46985e-05	1.0	8.04059e-06	2.0	248738.0	0.0	76	0.95	PASS	amr	2.90343e-05	1.0	8.86981e-06	1.0	0.0000129	2			9e-05	1.0		3.425	0.050041		0	0	0			ADGRV1	0.0	0.0	0.0	0.0	-8.0	-14.0	-2.0	27.0								1.307091054			hearing/vestibular/ear phenotype; nervous system phenotype ; vision/eye phenotype; behavior/neurological phenotype ; mortality/aging ; 			.	.	.	.	.	USH1C[16301216];PTBP3[22575643];	90106221
60081	chr5	94842719		A	chr5:94842718-94842719	TTC37	tetratricopeptide repeat domain 37	insertion	0/1	0.33	8_4	12	71.0	0/0	0.0	22_0	22	60.0			rs745805590	SPLICING	YES	NM_014639.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	29/42		NM_014639.4:c.3015-4dup			-1.0		Uncertain_significance	criteria_provided,_single_submitter	not_provided	Trichohepatoenteric syndrome 1, 222470 (3), Autosomal recessive	Syndromic diarrhea	Disease-causing germline mutation(s) in	Hepatic fibrosis;Jaundice;Bifid uvula;Renal cortical microcysts;Thrombocytosis;Fine hair;Increased mean platelet volume;Short stature;Narrow mouth;Frontal bossing;Ventricular septal defect;Galactosuria;Failure to thrive;Neurodevelopmental delay;Abnormality of the pancreas;Small for gestational age;Depressed nasal ridge;Hypospadias;Long philtrum;Downslanted palpebral fissures;Underdeveloped supraorbital ridges;Autosomal recessive inheritance;Microtia;Wide nose;Hepatic failure;Hepatomegaly;Low-set ears;Curly hair;Polyhydramnios;Prominent forehead;Hypermethioninemia;Cognitive impairment;Aortic regurgitation;Hypertelorism;Sparse hair;Hypoalbuminemia;Villous atrophy;Large placenta;Abnormality of iron homeostasis;Increased serum iron;Woolly hair;Pulmonic stenosis;Abnormalities of placenta or umbilical cord;Intractable diarrhea;Trichorrhexis nodosa;Abnormality of the immune system;Intrauterine growth retardation;Tetralogy of Fallot;Anteverted nares;Cirrhosis;Wide mouth;Brittle hair;Proptosis;Hypoplasia of the thymus;Dependency on intravenous nutrition;Broad forehead;Dry skin;Bloody diarrhea;Wide nasal bridge;Thrombocytosis;Recurrent infections;Peripheral pulmonary artery stenosis;Hepatomegaly;Hepatic fibrosis;Cafe-au-lait spot;Colitis;Polycystic kidney dysplasia;Prominent forehead;Patent ductus arteriosus;Glaucoma;Ventricular septal defect;Villous atrophy;Generalized hypopigmentation;Atrial septal defect;Aortic regurgitation;Intrauterine growth retardation;Cirrhosis;Abnormal facial shape;Uncombable hair;Hypertelorism;Small for gestational age;Short stature;Global developmental delay;Hypopigmentation of hair;Lymphopenia;Inguinal hernia;Bicuspid aortic valve;Immunodeficiency;Renal hypoplasia;Gastritis;Intellectual disability, mild;Abnormality of iron homeostasis;Hepatoblastoma;Hypothyroidism;Tetralogy of Fallot;Trichorrhexis nodosa;Panhypogammaglobulinemia;Increased mean platelet volume;Splenomegaly;Intractable diarrhea;Woolly hair;Brittle hair		0.00129195	187.0	144742.0	0.0	32	0.94	PASS	sas	0.00325945	15.0	0.00111716	73.0	0.0800872	7126.0	88978.0	0.0	60	0.99	InbreedingCoeff	sas	0.137484	1071.0	0.0615066	2701.0	0.0001286,0.0416838,0.0000450	20,6482,7			0.01695	193.0		10.34	0.60364		0	0	0			TTC37	0.0	0.06	0.0	0.0	-3.0	-22.0	-22.0	3.0						0.944	0.0				.			prefrontal cortex;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;atrioventricular node;	.	exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay	nucleus;nucleoplasm;cytoplasm;cytosol;transcriptionally active chromatin;Ski complex	protein binding	NPM1[26496610];RPL10[26496610];SMAD9[15231748];HNRNPU[26496610];IMMT[30021884];WDR61[16024656];HSCB[28380382];NEURL4[29426014];OGDH[30021884];PAF1[16024656];CEP162[26638075];SKIV2L[16024656];HIST1H2BH[30021884];	94842718
60162	chr5	96315272	A	G	chr5:96315272	LNPEP	leucyl and cystinyl aminopeptidase	SNV	0/1	0.47	57_51	108	99.0	0/1	0.45	81_65	146	99.0				EXONIC	YES	NM_005575.3	Transcript	protein_coding	synonymous_variant		2/18	NM_005575.3:c.450A>G	NP_005566.2:p.Leu150%3D		1.0						.	.	.						32	0.97											97	1.0														0.245	-0.357941		0	0	0			LNPEP	0.0	0.0	0.0	0.0	-34.0	46.0	29.0	-50.0						0.358	1.0	44.499700990			homeostasis/metabolism phenotype; growth/size/body region phenotype; adipose tissue phenotype ; behavior/neurological phenotype ; cardiovascular system phenotype ; 			ciliary ganglion;superior cervical ganglion;placenta;	Renin-angiotensin system	protein polyubiquitination;antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent;proteolysis;cell-cell signaling;female pregnancy;protein catabolic process;peptide catabolic process;SMAD protein signal transduction;negative regulation of cold-induced thermogenesis	extracellular region;cytoplasm;lysosomal membrane;cytosol;integral component of plasma membrane;membrane;cytoplasmic vesicle membrane;early endosome lumen;perinuclear region of cytoplasm	aminopeptidase activity;protein binding;metallopeptidase activity;zinc ion binding;peptide binding;metalloaminopeptidase activity	NDUFA13[26496610];AQP6[unassigned1304];GPR42[unassigned1304];GCC1[26496610];HSD17B11[unassigned1304];TMEM263[26496610];ASGR2[unassigned1304];DMBX1[unassigned1304];TGOLN2[29568061];TNKS2[22153077];CTAG1A[unassigned1304];LAMP1[29568061];SLC39A9[unassigned1304];UBQLN1[unassigned1304];DROSHA[26496610];HEATR3[26496610];STOM[unassigned1304];GGT7[unassigned1304];MMGT1[unassigned1304];SLC35E3[unassigned1304];GPX8[unassigned1304];UNC93A[unassigned1304];SSMEM1[unassigned1304];FAM210B[unassigned1304];TMEM17[26638075];REEP4[unassigned1304];TMEM216[26638075];TMEM56[unassigned1304];CANX[26496610;29568061];REL[25416956];LCN2[unassigned1304];RAB9A[29568061];TCF4[25416956];FATE1[25416956;unassigned1304];RAB5A[29568061];TMEM35A[unassigned1304];GLYR1[unassigned1304];BET1[29568061];	96315272
60171	chr5	98109867	CTG		chr5:98109867-98109869	RGMB	repulsive guidance molecule BMP co-receptor b	deletion	0/0	0.06	44_3	47	6.0	0/1	0.12	21_3	24	63.0			rs770214076	EXONIC	YES	NM_001366509.1	Transcript	protein_coding	inframe_deletion		3/5	NM_001366509.1:c.232_234del	NP_001353438.1:p.Leu78del		1.0						.	.	.		6.58415e-06	1.0	151880.0	0.0	34	0.97	PASS	amr	6.55308e-05	1.0	0.0	0.0	0.00469968	364.0	77452.0	0.0	4	0.19	RF	afr	0.0123457	16.0	0.00503778	140.0	0.0000064	1	0.022	68.0				17.68	1.729641		0	0	0			RGMB	0.0	0.0	0.0	0.01	5.0	25.0	40.0	44.0						0.22	0.06				mortality/aging ; 			ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;cerebellum;	.	cell adhesion;signal transduction;BMP signaling pathway;positive regulation of transcription, DNA-templated	endoplasmic reticulum-Golgi intermediate compartment;plasma membrane;membrane raft;anchored component of plasma membrane	protein binding;coreceptor activity;identical protein binding	BMP2[25938661];	98109866
60180	chr5	98128923	C	G	chr5:98128923	RGMB	repulsive guidance molecule BMP co-receptor b	SNV	0/1	0.58	52_74	127	99.0	0/0	0.0	34_0	34	99.0			COSV104609767	EXONIC	YES	NM_001366509.1	Transcript	protein_coding	missense_variant		5/5	NM_001366509.1:c.903C>G	NP_001353438.1:p.Ile301Met		1.0	Repulsive guidance molecule, C-terminal,Repulsive guidance molecule, C-terminal					.	.	.						32	0.98											72	0.99														20.7	2.102404	0.535	15	6	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,ClinPred_pred	PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	RGMB	0.0	0.0	0.0	0.0	50.0	-33.0	-5.0	-9.0						0.22	0.06	15.137584244	0.763	0.081	mortality/aging ; 			ciliary ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;cerebellum;	.	cell adhesion;signal transduction;BMP signaling pathway;positive regulation of transcription, DNA-templated	endoplasmic reticulum-Golgi intermediate compartment;plasma membrane;membrane raft;anchored component of plasma membrane	protein binding;coreceptor activity;identical protein binding	BMP2[25938661];	98128923
60268	chr5	112769675	C	A	chr5:112769675	TSSK1B	testis specific serine kinase 1B	SNV	0/1	0.52	72_79	151	99.0	0/0	0.0	36_0	36	99.0			rs34696815	EXONIC	YES	NM_032028.4	Transcript	protein_coding	missense_variant		1/1	NM_032028.4:c.862G>T	NP_114417.1:p.Gly288Trp		-1.0						.	.	.		0.0053023	807.0	152198.0	6.0	32	0.97	PASS	nfe	0.00793814	540.0	0.00793814	540.0	0.00477955	1192.0	249396.0	7.0	67	0.99	PASS	nfe	0.00724715	819.0	0.00724715	819.0	0.0045851	713	0.007	23.0				17.67	1.727571	0.179	5	14	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,MutationAssessor_pred,MutationTaster_pred	Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TSSK1B	0.0	0.0	0.0	0.03	42.0	0.0	2.0	37.0						0.711	0.0	0.000000000	0.007	-0.439	.			.	.	protein phosphorylation;multicellular organism development;spermatid development;peptidyl-serine phosphorylation;intracellular signal transduction	acrosomal vesicle;nucleus;cytoplasm;motile cilium	magnesium ion binding;protein serine/threonine kinase activity;protein binding;ATP binding;protein-containing complex binding	TSKS[unassigned1304];HSP90AB1[22939624];EFS[25416956;unassigned1304];FAM229B[unassigned1304];MEOX2[unassigned1304];FOXN1[unassigned1304];	112769675
60317	chr5	115238691		C	chr5:115238690-115238691	AP3S1	adaptor related protein complex 3 subunit sigma 1	insertion	0/0	0.0	16_0	16	33.0	0|1	0.27	17_7	26	99.0			rs779073678,COSV57473239	SPLICING	YES	NM_001364119.1	Transcript	protein_coding	splice_donor_variant	5/6		NM_001364119.1:c.453+1_453+2insC			1.0						.	.	.		0.00025549	38.0	148734.0	0.0	32	0.82	AS_VQSR	amr	0.000470114	7.0	0.000210678	14.0	0.00275818	641.0	232400.0	0.0	30	0.84	PASS	nfe	0.00311631	325.0	0.00311631	325.0	0.0000064	1						33.0	4.99243		0	0	0			AP3S1	0.0	0.0	0.0	0.99	29.0	-1.0	29.0	-1.0						0.613	0.0				homeostasis/metabolism phenotype; hearing/vestibular/ear phenotype; cardiovascular system phenotype ; 			.	.	intracellular protein transport;anterograde axonal transport;insulin receptor signaling pathway;anterograde synaptic vesicle transport	Golgi apparatus;AP-type membrane coat adaptor complex;AP-3 adaptor complex;transport vesicle;cytoplasmic vesicle membrane;intracellular membrane-bounded organelle;axon cytoplasm	transporter activity;protein binding	KIAA1107[26496610];GOLM1[27569582];EPB41L3[24366813];EMC2[26496610];PCDHB15[26496610];CD14[26496610];DLD[29128334];ZWINT[26496610];	115238690
60338	chr5	115238692		GGCTTAGCAGGAGCTCTAGCCCGTGCTGTATCAGCTGTA	chr5:115238691-115238692	AP3S1	adaptor related protein complex 3 subunit sigma 1	insertion	0/0	0.0	15_0	15	0.0	0|1	0.27	17_7	26	99.0			rs781607458	SPLICING	YES	NM_001364119.1	Transcript	protein_coding	splice_region_variant,intron_variant	5/6		NM_001364119.1:c.453+2_453+3insGGCTTAGCAGGAGCTCTAGCCCGTGCTGTATCAGCTGTA			1.0						.	.	.		0.000416714	37.0	88790.0	0.0	30	0.69	AS_VQSR	amr	0.000782298	7.0	0.000347671	14.0	0.00328769	448.0	136266.0	0.0	29	0.82	RF	nfe	0.00394111	227.0	0.00394111	227.0	0.0000064	1						15.26	1.312671		0	0	0																	0.613	0.0				homeostasis/metabolism phenotype; hearing/vestibular/ear phenotype; cardiovascular system phenotype ; 			.	.	intracellular protein transport;anterograde axonal transport;insulin receptor signaling pathway;anterograde synaptic vesicle transport	Golgi apparatus;AP-type membrane coat adaptor complex;AP-3 adaptor complex;transport vesicle;cytoplasmic vesicle membrane;intracellular membrane-bounded organelle;axon cytoplasm	transporter activity;protein binding	KIAA1107[26496610];GOLM1[27569582];EPB41L3[24366813];EMC2[26496610];PCDHB15[26496610];CD14[26496610];DLD[29128334];ZWINT[26496610];	115238691
60581	chr5	131309041	C	A	chr5:131309041	ACSL6	acyl-CoA synthetase long chain family member 6	SNV	0/1	0.52	52_58	111	99.0	0/0	0.0	35_0	35	99.0			COSV57296473,COSV57297250	EXONIC	YES	NM_001009185.3	Transcript	protein_coding	missense_variant		12/21	NM_001009185.3:c.1121G>T	NP_001009185.1:p.Arg374Leu		-1.0	.,.,.,.,.,.,AMP-dependent synthetase/ligase,.,AMP-dependent synthetase/ligase,AMP-dependent synthetase/ligase				Myelodysplastic syndrome (3); Myelogenous leukemia, acute (3)	.	.	.						32	0.98											56	1.0											0.0001	1.0		23.8	3.093321	0.601	15	6	21	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,DEOGEN2_pred	ACSL6	0.03	0.02	0.0	0.0	-12.0	10.0	7.0	44.0						0.803	0.09	0.000000000	1.0	1.026	.			amygdala;superior cervical ganglion;testis;skeletal muscle;	Fatty acid metabolism;PPAR signaling pathway;Adipocytokine signaling pathway	long-chain fatty acid metabolic process;acyl-CoA metabolic process;neuroblast proliferation;long-chain fatty-acyl-CoA biosynthetic process	mitochondrial outer membrane;peroxisomal membrane;endoplasmic reticulum membrane;plasma membrane;integral component of membrane	long-chain fatty acid-CoA ligase activity;ATP binding;protein homodimerization activity;decanoate-CoA ligase activity	PCMTD2[unassigned1304];ZNF655[unassigned1304];ZNF16[21874239];	131309041
60607	chr5	131729380	G	A	chr5:131729380	SLC22A5	solute carrier family 22 member 5	SNV	0/1	0.56	26_33	59	99.0	0/0	0.0	33_0	33	99.0			rs28383481,CM061984	EXONIC	YES	NM_001308122.2	Transcript	protein_coding	missense_variant		10/11	NM_001308122.2:c.1535G>A	NP_001295051.1:p.Arg512His		1.0	Major facilitator superfamily domain&Major facilitator superfamily domain,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Renal_carnitine_transport_defect|not_specified|not_provided	Carnitine deficiency, systemic primary, 212140 (3), Autosomal recessive	Systemic primary carnitine deficiency	Disease-causing germline mutation(s) in	Confusion;Vomiting;Bilateral tonic-clonic seizure with focal onset;Hepatomegaly;Elevated hepatic transaminase;Neck muscle weakness;Clumsiness;Acute encephalopathy;Hepatic steatosis;Muscle weakness;Failure to thrive;Hyperammonemia;Muscular hypotonia;Decreased carnitine level in liver;Confusion;Decreased plasma carnitine;Encephalopathy;Hypoglycemia;Generalized hypotonia;Vomiting;Elevated hepatic transaminase;Autosomal recessive inheritance;Hypertrophic cardiomyopathy;Congestive heart failure;Cardiomegaly;Hepatomegaly;Endocardial fibroelastosis;Lethargy;Excessive daytime somnolence;Reduced muscle carnitine level;Myopathy;Muscle weakness;Coma;Recurrent hypoglycemia;Impaired gluconeogenesis	23757202,16652335	0.00341799	520.0	152136.0	1.0	32	0.96	PASS	amr	0.00713444	109.0	0.00521875	355.0	0.00324926	817.0	251442.0	6.0	100	1.0	PASS	amr	0.00482798	167.0	0.00466065	530.0	0.0033440	520	0.002	5.0	0.00342	39.0		28.7	4.113886	0.619	10	11	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,ClinPred_pred,fathmm-XF_coding_pred	SLC22A5	0.0	0.0	0.0	0.0	45.0	-33.0	-13.0	0.0						0.403	0.0	0.000000000	1.0	1.176	growth/size/body region phenotype; homeostasis/metabolism phenotype; liver/biliary system phenotype; cardiovascular system phenotype ; mortality/aging ; reproductive system phenotype; renal/urinary system phenotype; 			kidney;superior cervical ganglion;atrioventricular node;skeletal muscle;	Biosynthesis of unsaturated fatty acids;PPAR signaling pathway	sodium ion transport;drug transmembrane transport;quaternary ammonium group transport;carnitine transport;drug transport;quorum sensing involved in interaction with host;positive regulation of intestinal epithelial structure maintenance;sodium-dependent organic cation transport;carnitine transmembrane transport	plasma membrane;integral component of membrane;apical plasma membrane;brush border membrane;extracellular exosome	protein binding;ATP binding;carnitine transmembrane transporter activity;drug transmembrane transporter activity;symporter activity;quaternary ammonium group transmembrane transporter activity;PDZ domain binding	JUN[25609649];NEK4[25798074];KRT27[unassigned1304];MTUS2[unassigned1304];KRT34[unassigned1304];NOTCH2NLA[unassigned1304];	131729380
60697	chr5	137271589	A	C	chr5:137271589	PKD2L2	polycystin 2 like 2, transient receptor potential cation channel	SNV	0/0	0.0	30_0	30	69.0	0/1	0.54	16_19	35	99.0			rs373884287	EXONIC	YES	NM_001300921.2	Transcript	protein_coding	missense_variant		13/15	NM_001300921.2:c.1775A>C	NP_001287850.1:p.Glu592Ala		1.0	.,.,.,.					.	.	.		9.85403e-05	15.0	152222.0	0.0	32	0.97	PASS	nfe	0.000146968	10.0	0.000146968	10.0	0.000157176	39.0	248130.0	0.0	43	0.89	PASS	amr	0.000586063	20.0	0.000106332	12.0	0.0001158	18	0.0	1.0				29.4	4.196109	0.381	14	7	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred	MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,LIST-S2_pred,fathmm-XF_coding_pred	PKD2L2	0.0	0.0	0.0	0.14	-12.0	9.0	47.0	9.0						0.893	0.0	0.000000000	0.998	1.312	homeostasis/metabolism phenotype; behavior/neurological phenotype ; 			dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	.	biological_process;detection of mechanical stimulus;calcium ion transmembrane transport	membrane;integral component of membrane	calcium channel activity;calcium ion binding	.	137271589
60762	chr5	137727041	G	A	chr5:137727041	KDM3B	lysine demethylase 3B	SNV	0/0	0.0	33_0	33	99.0	0/1	0.45	74_61	136	99.0			rs138862008	EXONIC	YES	NM_016604.4	Transcript	protein_coding	missense_variant		8/24	NM_016604.4:c.1720G>A	NP_057688.3:p.Val574Ile		1.0					Diets-Jongmans syndrome, 618846 (3), Autosomal dominant	.	.	.		4.60084e-05	7.0	152146.0	0.0	32	0.97	PASS	sas	0.000206954	1.0	5.87907e-05	4.0	3.58317e-05	9.0	251174.0	0.0	59	1.0	PASS	eas	0.000271857	5.0	2.6428e-05	3.0	0.0000322	5						0.175	-0.405153	0.039	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	KDM3B	0.0	0.0	0.0	0.0	-31.0	13.0	-15.0	32.0							1.0	0.000000000	0.853	-0.663	.			ciliary ganglion;subthalamic nucleus;atrioventricular node;cingulate cortex;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;cerebellum;	.	histone H3-K9 demethylation;oxidation-reduction process;response to cisplatin;cellular oxidant detoxification	chromatin;nucleus;nucleoplasm	transcription regulatory region sequence-specific DNA binding;antioxidant activity;chromatin DNA binding;histone demethylase activity;histone demethylase activity (H3-K9 specific);metal ion binding;dioxygenase activity	ZNF512B[15231748];SPAG8[23455924];AK1[26496610];DEPDC1[26496610];MYH9[26496610];CHMP4B[26496610];HIF1AN[26972000];HSCB[28380382];USP18[19615732];LMNB2[26496610];	137727041
60770	chr5	138724189	G	A	chr5:138724189	MZB1	marginal zone B and B1 cell specific protein	SNV	0/0	0.0	37_0	37	99.0	0/1	0.48	41_38	79	99.0			rs189193994,COSV56172655	EXONIC	YES	NM_016459.4	Transcript	protein_coding	missense_variant		2/4	NM_016459.4:c.263C>T	NP_057543.2:p.Thr88Met		-1.0	Domain of unknown function DUF3456					.	.	.		0.000157712	24.0	152176.0	0.0	33	0.97	PASS	amr	0.000588851	9.0	2.93979e-05	2.0	0.000244398	57.0	233226.0	0.0	48	0.66	PASS	amr	0.000396583	13.0	0.000123591	13.0	0.0001801	28	0.001	3.0				6.705	0.261167	0.034	1	17	18	MutationAssessor_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MZB1	0.0	0.0	0.0	0.01	14.0	19.0	12.0	-39.0							0.0	0.000000000	0.075	-0.134	.			.	.	positive regulation of immunoglobulin biosynthetic process;apoptotic process;positive regulation of cell population proliferation;regulation of B cell proliferation;integrin activation;regulation of cell population proliferation;regulation of insulin receptor signaling pathway	extracellular region;endoplasmic reticulum lumen;endoplasmic reticulum chaperone complex	.	TSG101[unassigned1304];MAPK6[21900206];	138724189
60789	chr5	139422565	GCT		chr5:139422565-139422567	NRG2	neuregulin 2	deletion	0/0	0.0	39_0	39	99.0	0/1	0.12	22_3	25	60.0			rs557310960	EXONIC	YES	NM_013982.3	Transcript	protein_coding	inframe_deletion		1/11	NM_013982.3:c.88_90del	NP_053585.1:p.Ser30del		-1.0						.	.	.		6.62225e-06	1.0	151006.0	0.0	31	0.97	PASS	nfe	1.48293e-05	1.0	1.48293e-05	1.0	0.0034656	465.0	134176.0	0.0	21	0.51	RF	afr	0.00837989	51.0	0.00393716	206.0	0.0015112	235	0.012	38.0				19.64	1.988393		0	0	0			NRG2	0.0	0.0	0.0	0.0	31.0	1.0	42.0	-43.0							1.0	0.000000000			reproductive system phenotype; mortality/aging ; growth/size/body region phenotype; 			pons;superior cervical ganglion;atrioventricular node;uterus corpus;trigeminal ganglion;parietal lobe;skeletal muscle;cerebellum;	ErbB signaling pathway	MAPK cascade;signal transduction;nervous system development;regulation of signaling receptor activity;peptidyl-tyrosine phosphorylation;intracellular signal transduction;ERBB2 signaling pathway;phosphatidylinositol phosphorylation;positive regulation of protein kinase B signaling;regulation of cell motility	extracellular region;extracellular space;plasma membrane;integral component of membrane	protein tyrosine kinase activity;Ras guanyl-nucleotide exchange factor activity;signaling receptor binding;growth factor activity;phosphatidylinositol-4,5-bisphosphate 3-kinase activity	.	139422564
60800	chr5	139745527	T	C	chr5:139745527	SLC4A9	solute carrier family 4 member 9	SNV	0/0	0.0	33_0	33	99.0	0/1	0.43	62_48	111	99.0				EXONIC	YES	NM_001258428.2	Transcript	protein_coding	missense_variant		13/22	NM_001258428.2:c.1891T>C	NP_001245357.1:p.Ser631Pro		1.0	.,.,Bicarbonate transporter, C-terminal					.	.	.						32	0.98											100	1.0														27.9	4.029068	0.626	19	2	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PrimateAI_pred,LIST-S2_pred	SLC4A9	0.0	0.04	0.0	0.0	-14.0	48.0	-22.0	46.0						0.681	0.0	68.425167686	1.0	1.138	renal/urinary system phenotype; digestive/alimentary phenotype; 			ciliary ganglion;atrioventricular node;superior cervical ganglion;	.	inorganic anion transport;bicarbonate transport;regulation of intracellular pH;anion transmembrane transport	plasma membrane;integral component of plasma membrane;apical part of cell	inorganic anion exchanger activity;sodium:bicarbonate symporter activity;anion:anion antiporter activity	.	139745527
60874	chr5	140203608	T	A	chr5:140203608	PCDHA5	protocadherin alpha 5	SNV	0/0	0.0	44_0	44	99.0	0/1	0.43	52_39	91	99.0			rs201009574	EXONIC	YES	NM_018908.3	Transcript	protein_coding	missense_variant		1/4	NM_018908.3:c.2248T>A	NP_061731.1:p.Ser750Thr		1.0	.,.,.					.	.	.		3.28766e-05	5.0	152084.0	0.0	32	0.97	PASS	amr	0.000130924	2.0	2.94092e-05	2.0	3.18215e-05	8.0	251402.0	0.0	68	1.0	PASS	amr	0.000202394	7.0	8.79461e-06	1.0	0.0000129	2						15.0	1.265015	0.167	8	11	19	PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	PCDHA5	0.0	0.0	0.0	0.0	-22.0	9.0	-8.0	20.0						0.804	0.0	0.000000000	0.026	0.185	.			.	.	cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;nervous system development	integral component of plasma membrane	calcium ion binding	CRK[17474147];	140203608
60917	chr5	140221065	G	A	chr5:140221065	PCDHA8	protocadherin alpha 8	SNV	0|1	0.12	158_22	180	99.0	0|1	0.14	134_22	157	99.0			rs62384462,COSV65338230	EXONIC	YES	NM_018911.3	Transcript	protein_coding	synonymous_variant		1/4	NM_018911.3:c.159G>A	NP_061734.1:p.Gly53%3D		1.0						.	.	.		0.000475678	69.0	145056.0	0.0	33	0.95	AS_VQSR	sas	0.00199734	9.0	0.000385351	25.0	0.000871146	183.0	210068.0	3.0	100	0.99	RF	afr	0.00210909	29.0	0.000900052	86.0	0.0000064	1	0.038	114.0				9.791	0.542116		0	0	0			PCDHA8	0.0	0.0	0.0	0.0	-47.0	-8.0	18.0	-1.0						0.904	0.0				.			.	.	cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;nervous system development	integral component of plasma membrane	calcium ion binding	CRK[17474147];	140221065
60931	chr5	140221071	G	T	chr5:140221071	PCDHA8	protocadherin alpha 8	SNV	0|1	0.13	160_24	184	99.0	0/0	0.0	153_0	153	99.0			rs62384463,COSV65334917	EXONIC	YES	NM_018911.3	Transcript	protein_coding	missense_variant		1/4	NM_018911.3:c.165G>T	NP_061734.1:p.Glu55Asp		1.0	.,Cadherin, N-terminal&Cadherin-like					.	.	.		0.000236512	35.0	147984.0	0.0	33	0.96	PASS	sas	0.00132509	6.0	0.000258547	17.0	0.00124773	276.0	221202.0	1.0	100	0.99	RF	amr	0.00327526	97.0	0.00100687	102.0	0.0000129	2	0.03	90.0				17.02	1.627673	0.171	3	13	16	MutationTaster_pred,PROVEAN_pred,LIST-S2_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PCDHA8	0.0	0.0	0.0	0.0	45.0	-14.0	3.0	-6.0						0.904	0.0		0.966	-0.149	.			.	.	cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;nervous system development	integral component of plasma membrane	calcium ion binding	CRK[17474147];	140221071
60960	chr5	140221195	G	C	chr5:140221195	PCDHA8	protocadherin alpha 8	SNV	0/1	0.16	146_28	175	99.0	0/1	0.25	128_42	170	99.0			rs199713478,COSV65334771	EXONIC	YES	NM_018911.3	Transcript	protein_coding	missense_variant		1/4	NM_018911.3:c.289G>C	NP_061734.1:p.Gly97Arg		1.0	.,Cadherin, N-terminal&Cadherin-like					.	.	.		0.00414513	539.0	130032.0	2.0	33	0.91	PASS	sas	0.00490196	20.0	0.00397344	231.0	0.0483906	11044.0	228226.0	4.0	100	1.0	RF	eas	0.101311	1546.0	0.0380967	4000.0	0.0037877	589	0.009	30.0				23.2	2.848299	0.324	6	12	18	SIFT,Polyphen2_HDIV_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,fathmm-MKL_coding_pred	PolyPhen,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	PCDHA8	0.0	0.0	0.0	0.0	-48.0	47.0	32.0	-5.0						0.904	0.0		1.0	1.154	.			.	.	cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;nervous system development	integral component of plasma membrane	calcium ion binding	CRK[17474147];	140221195
61049	chr5	140475763	C	G	chr5:140475763	PCDHB2	protocadherin beta 2	SNV	0/0	0.0	151_0	151	72.0	0/1	0.2	120_30	152	99.0			rs142417694,COSV50564509	EXONIC	YES	NM_018936.4	Transcript	protein_coding	synonymous_variant		1/1	NM_018936.4:c.1389C>G	NP_061759.1:p.Arg463%3D		1.0						.	.	.		0.000160735	24.0	149314.0	0.0	32	0.97	PASS	afr	0.000271538	11.0	0.00013461	9.0	0.00098591	233.0	236330.0	0.0	100	1.0	PASS	nfe	0.00156612	165.0	0.00156612	165.0	0.0000064	1	0.012	37.0				3.754	0.069693		0	0	0			PCDHB2	0.0	0.0	0.0	0.0	12.0	4.0	-21.0	-10.0						0.945					.			.	.	cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;chemical synaptic transmission;nervous system development;synapse assembly;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	integral component of plasma membrane;integral component of membrane	calcium ion binding	.	140475763
61058	chr5	140573844	C	T	chr5:140573844	PCDHB10	protocadherin beta 10	SNV	0/1	0.29	117_47	164	99.0	0/0	0.0	45_0	45	99.0			rs782178558,COSV53376398	EXONIC	YES	NM_018930.4	Transcript	protein_coding	synonymous_variant		1/1	NM_018930.4:c.1719C>T	NP_061753.1:p.Thr573%3D		1.0						.	.	.		5.27391e-05	8.0	151690.0	0.0	30	0.89	PASS	amr	0.000131234	2.0	1.47332e-05	1.0	0.32549	58889.0	180924.0	4.0	51	0.78	InbreedingCoeff	nfe	0.347375	28170.0	0.347375	28170.0	0.0002186	34	0.003	9.0				5.664	0.188252		0	0	0			PCDHB10	0.0	0.0	0.0	0.0	46.0	-20.0	-34.0	45.0						0.956	0.0				.			.	.	cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;chemical synaptic transmission;synapse assembly;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	integral component of plasma membrane;integral component of membrane	calcium ion binding	MTNR1A[26514267];MTNR1B[26514267];ATP13A2[22645275];	140573844
61064	chr5	140579574	A	G	chr5:140579574	PCDHB11	protocadherin beta 11	SNV	0/0	0.0	47_0	47	99.0	0/1	0.57	43_58	101	99.0			rs141724856	EXONIC	YES	NM_018931.3	Transcript	protein_coding	missense_variant		1/1	NM_018931.3:c.227A>G	NP_061754.1:p.Gln76Arg		1.0	Cadherin, N-terminal&Cadherin-like&Cadherin-like					.	.	.		0.000361405	55.0	152184.0	0.0	32	0.96	PASS	nfe	0.000661512	45.0	0.000661512	45.0	0.000465238	117.0	251484.0	0.0	100	1.0	PASS	nfe	0.000791153	90.0	0.000791153	90.0	0.0005466	85	0.001	4.0				5.619	0.185297	0.061	0	18	18		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PCDHB11	0.0	0.0	0.0	0.0	49.0	-7.0	6.0	32.0						0.86	0.0	0.000000000	0.001	-0.34	.			trigeminal ganglion;superior cervical ganglion;skeletal muscle;	Pyruvate metabolism	cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;chemical synaptic transmission;nervous system development;synapse assembly;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	integral component of plasma membrane;integral component of membrane	calcium ion binding	USP15[17353931];ATIC[17353931];WNK1[17353931];MGST3[29568061];SIRT4[25525879];MRPL58[20186120];HSCB[28380382];RAB11A[17353931];TRMT61B[29568061];HSPD1[29568061];PDK1[29568061];	140579574
61068	chr5	140588810	A	T	chr5:140588810	PCDHB12	protocadherin beta 12	SNV	0/0	0.0	35_0	35	99.0	0/1	0.45	42_35	77	99.0			rs187438401	EXONIC	YES	NM_018932.4	Transcript	protein_coding	stop_gained		1/1	NM_018932.4:c.331A>T	NP_061755.1:p.Lys111Ter		1.0	Cadherin, N-terminal&Cadherin-like					.	.	.		3.94275e-05	6.0	152178.0	0.0	32	0.97	PASS	amr	0.000130924	2.0	4.40878e-05	3.0	3.18725e-05	8.0	251000.0	0.0	100	1.0	PASS	amr	0.000173461	6.0	1.75936e-05	2.0	0.0000193	3	0.0	1.0				33.0	5.409153		4	1	5	MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	fathmm-XF_coding_pred	PCDHB12	0.0	0.0	0.0	0.0	15.0	-8.0	-2.0	35.0						0.879	0.0	0.000000000	0.123	0.31	.			.	.	cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;nervous system development	integral component of plasma membrane	calcium ion binding	COPS4[unassigned1304];KRT19[unassigned1304];HIST1H2BO[unassigned1304];EMC2[unassigned1304];KLHL17[unassigned1304];USH1C[unassigned1304];ZSCAN23[unassigned1304];CCDC172[unassigned1304];BLZF1[unassigned1304];	140588810
61075	chr5	140731528	C	T	chr5:140731528	PCDHGB1	protocadherin gamma subfamily B, 1	SNV	0/0	0.0	35_0	35	99.0	0/1	0.56	38_48	86	99.0			rs375476706	EXONIC	YES	NM_018922.3	Transcript	protein_coding	synonymous_variant		1/4	NM_018922.3:c.1701C>T	NP_061745.1:p.Gly567%3D		1.0						.	.	.		0.000729083	111.0	152246.0	0.0	33	0.98	PASS	amr	0.00248463	38.0	0.00048498	33.0	0.000795784	196.0	246298.0	0.0	79	0.98	PASS	amr	0.00208926	72.0	0.000566822	63.0	0.0005595	87	0.002	7.0				6.432	0.241269		0	0	0			PCDHGB1	0.0	0.0	0.0	0.0	35.0	26.0	-30.0	48.0						0.4	0.17	31.839475325			.			.	.	cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules	integral component of plasma membrane;growth cone	calcium ion binding	.	140731528
61091	chr5	140768996	CCACGAGCAGCTGCGCGCCTTCGA		chr5:140768996-140769019	PCDHGB4	protocadherin gamma subfamily B, 4	deletion	0/0	0.0	41_0	41	99.0	0/1	0.35	108_58	166	99.0			rs554190431	EXONIC	YES	NM_003736.4	Transcript	protein_coding	inframe_deletion		1/4	NM_003736.4:c.1557_1580del	NP_003727.1:p.Asp519_Phe526del		1.0						.	.	.		0.000945738	144.0	152262.0	1.0	32	0.99	PASS	amr	0.00346586	53.0	0.000631981	43.0	0.00130502	324.0	248272.0	0.0	100	0.99	PASS	amr	0.0030426	105.0	0.000908767	102.0	0.0000900	14	0.0	1.0				21.8	2.253094		0	0	0																	0.516	0.0	0.000000000			.			.	.	cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules;calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules	integral component of plasma membrane;membrane	calcium ion binding	.	140768995
61156	chr5	140812597	T	C	chr5:140812597	PCDHGA12	protocadherin gamma subfamily A, 12	SNV	0/0	0.0	34_0	34	99.0	0|1	0.57	42_56	98	99.0			rs116611363	EXONIC	YES	NM_003735.3	Transcript	protein_coding	synonymous_variant		1/4	NM_003735.3:c.2271T>C	NP_003726.1:p.Val757%3D		1.0						.	.	.		0.00420803	640.0	152090.0	1.0	33	0.97	PASS	nfe	0.00663118	451.0	0.00663118	451.0	0.00413131	1039.0	251494.0	5.0	100	1.0	PASS	nfe	0.00640778	729.0	0.00640778	729.0	0.0037491	583	0.011	36.0				0.124	-0.453277		0	0	0			PCDHGA12	0.0	0.0	0.0	0.0	2.0	25.0	-3.0	50.0						0.625	0.0	10.328767441			.			.	.	cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules	integral component of plasma membrane;cell-cell junction	calcium ion binding	.	140812597
61178	chr5	140812600	C	T	chr5:140812600	PCDHGA12	protocadherin gamma subfamily A, 12	SNV	0/0	0.0	34_0	34	99.0	0|1	0.57	42_56	98	99.0			rs115990854	EXONIC	YES	NM_003735.3	Transcript	protein_coding	synonymous_variant		1/4	NM_003735.3:c.2274C>T	NP_003726.1:p.Ser758%3D		1.0						.	.	.		0.00419969	639.0	152154.0	1.0	33	0.97	PASS	nfe	0.00661648	450.0	0.00661648	450.0	0.00413131	1039.0	251494.0	5.0	100	1.0	PASS	nfe	0.00640778	729.0	0.00640778	729.0	0.0037427	582	0.011	36.0				2.535	-0.005893		0	0	0			PCDHGA12	0.0	0.0	0.0	0.0	22.0	-32.0	-6.0	47.0						0.625	0.0	1.364899713			.			.	.	cell adhesion;homophilic cell adhesion via plasma membrane adhesion molecules	integral component of plasma membrane;cell-cell junction	calcium ion binding	.	140812600
61298	chr5	142150487	G	A	chr5:142150487	ARHGAP26	Rho GTPase activating protein 26	SNV	0/1	0.56	20_25	45	99.0	0/1	0.65	24_44	68	99.0			rs138018413	SPLICING	YES	NM_015071.6	Transcript	protein_coding	splice_region_variant,intron_variant	1/22		NM_015071.6:c.154+7G>A			1.0					Leukemia, juvenile myelomonocytic, somatic, 607785 (3)	.	.	Autosomal dominant inheritance;Somatic mutation;Juvenile myelomonocytic leukemia		0.000788675	120.0	152154.0	0.0	33	0.97	PASS	nfe	0.00127941	87.0	0.00127941	87.0	0.00096977	232.0	239232.0	0.0	34	0.77	PASS	sas	0.00151413	45.0	0.00140064	151.0	0.0009132	142	0.002	7.0	0.00136	13.0		13.62	1.028756		0	0	0			ARHGAP26	0.0	0.0	0.0	0.0	-17.0	-49.0	-3.0	-30.0	0.0001563488258474	0.0				0.452	1.0				muscle phenotype; 			pons;atrioventricular node;trigeminal ganglion;superior cervical ganglion;placenta;skeletal muscle;heart;	.	signal transduction;nervous system development;actin cytoskeleton organization;positive regulation of GTPase activity;regulation of small GTPase mediated signal transduction	cellular_component;cytosol;cytoskeleton;focal adhesion	GTPase activator activity;protein binding;phospholipid binding	ARHGAP10[unassigned1312];PKN3[11432776];NRXN1[unassigned1312];CTR9[unassigned1312];CDC42EP2[25416956;26871637];ELOA[unassigned1312];TULP1[27173435;unassigned1312];MYO16[21946561];SRPK1[23602568];	142150487
61373	chr5	149929294	A	G	chr5:149929294	NDST1	N-deacetylase and N-sulfotransferase 1	SNV	0/1	0.48	59_54	113	99.0	0/0	0.0	37_0	37	99.0			rs771780923	EXONIC	YES	NM_001543.5	Transcript	protein_coding	missense_variant		13/15	NM_001543.5:c.2371A>G	NP_001534.1:p.Met791Val		1.0	.,Sulfotransferase domain				Mental retardation, autosomal recessive 46, 616116 (3), Autosomal recessive	Autosomal recessive non-syndromic intellectual disability	Disease-causing germline mutation(s) in	Growth delay;Aggressive behavior;Agitation;Sleep disturbance;Poor speech;Seizure;Global developmental delay;Autosomal recessive inheritance;Intellectual disability;Generalized hypotonia;Dystonia;Cerebral atrophy;Cerebral visual impairment;Autistic behavior;Intellectual disability, mild;Generalized hypotonia;Hypoplasia of the corpus callosum;Poor speech;Multifocal epileptiform discharges;Large basal ganglia;Stereotypy;Hypsarrhythmia;Microcephaly;Motor delay;Hyperactivity;Absent septum pellucidum;Delayed speech and language development;Intellectual disability, moderate;Chorea;Nasogastric tube feeding;Impulsivity;Sleep disturbance;Epileptic spasm;Short attention span;Global developmental delay;Depressivity;Intellectual disability, severe;Cortical dysplasia;Polymicrogyria;Abnormal facial shape;Generalized-onset seizure;Dyskinesia;Focal-onset seizure;Spasticity		3.28485e-05	5.0	152214.0	0.0	32	0.97	PASS	amr	6.5445e-05	1.0	5.87959e-05	4.0	3.18142e-05	8.0	251460.0	0.0	93	0.99	PASS	amr	0.000144567	5.0	1.75827e-05	2.0	0.0000322	5			0.00061	7.0		18.73	1.870601	0.155	1	18	19	LRT_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	NDST1	0.0	0.0	0.0	0.0	-20.0	2.0	20.0	2.0						0.0415	1.0	0.000000000	0.998	1.312	endocrine/exocrine gland phenotype; taste/olfaction phenotype; growth/size/body region phenotype; craniofacial phenotype; muscle phenotype; cellular phenotype; immune system phenotype; homeostasis/metabolism phenotype; liver/biliary system phenotype; respiratory system phenotype; embryo phenotype; mortality/aging ; hematopoietic system phenotype; cardiovascular system phenotype ; vision/eye phenotype; hearing/vestibular/ear phenotype; nervous system phenotype ; digestive/alimentary phenotype; renal/urinary system phenotype; skeleton phenotype; 			pons;fetal thyroid;tongue;testis - interstitial;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	Heparan sulfate biosynthesis;Glycan structures - biosynthesis 1	glycosaminoglycan biosynthetic process;protein sulfation;inflammatory response;heparan sulfate proteoglycan biosynthetic process;heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process;heparin biosynthetic process	Golgi membrane;Golgi apparatus;integral component of membrane	protein binding;[heparan sulfate]-glucosamine N-sulfotransferase activity;deacetylase activity;heparan sulfate sulfotransferase activity;heparan sulfate N-acetylglucosaminyltransferase activity;N-acetylglucosamine deacetylase activity	XRCC5[26496610];TMEM132A[26496610];	149929294
61400	chr5	150885564	C	T	chr5:150885564	FAT2	FAT atypical cadherin 2	SNV	0/0	0.0	35_0	35	99.0	0/1	0.54	61_76	140	99.0			rs142209223,COSV55826259	EXONIC	YES	NM_001447.3	Transcript	protein_coding	synonymous_variant		24/24	NM_001447.3:c.12612G>A	NP_001438.1:p.Pro4204%3D		-1.0					Spinocerebellar ataxia 45, 617769 (3), Autosomal dominant	.	.	Dysarthria;Slow progression;Gait ataxia;Limb ataxia;Adult onset;Nystagmus;Autosomal dominant inheritance;Cerebellar atrophy		0.00118937	181.0	152182.0	0.0	33	0.98	PASS	amr	0.00444677	68.0	0.00144105	98.0	0.000984723	210.0	213258.0	0.0	31	0.64	PASS	amr	0.00177961	50.0	0.00141035	140.0	0.0009968	155	0.005	17.0				0.016	-0.722145		0	0	0			FAT2	0.0	0.0	0.0	0.0	-41.0	-29.0	21.0	-27.0						0.642	0.0	47.413770065			normal phenotype; 			cerebellum peduncles;cerebellum;	.	homophilic cell adhesion via plasma membrane adhesion molecules;epithelial cell migration;cell-substrate adhesion	Golgi apparatus;plasma membrane;cell-cell adherens junction;integral component of membrane;extracellular exosome	calcium ion binding	.	150885564
61440	chr5	156589848	C	T	chr5:156589848	FAM71B	family with sequence similarity 71 member B	SNV	0/1	0.45	86_71	158	99.0	0/1	0.47	78_68	146	99.0			rs35758261,COSV99074227	EXONIC	YES	NM_130899.3	Transcript	protein_coding	synonymous_variant		2/2	NM_130899.3:c.1428G>A	NP_570969.2:p.Thr476%3D		-1.0						.	.	.		0.00440972	671.0	152164.0	1.0	32	0.98	PASS	nfe	0.00713047	485.0	0.00713047	485.0	0.0043956	1104.0	251160.0	5.0	100	1.0	PASS	nfe	0.00683893	776.0	0.00683893	776.0	0.0037298	580	0.009	27.0				0.033	-0.631049		0	0	0			FAM71B	0.0	0.0	0.0	0.0	-3.0	-23.0	25.0	-33.0						0.641	0.0	21.873700008			.			ciliary ganglion;pons;testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;testis;skeletal muscle;globus pallidus;	.	.	nucleus	.	.	156589848
61441	chr5	156590389	A	G	chr5:156590389	FAM71B	family with sequence similarity 71 member B	SNV	0/1	0.47	79_71	150	99.0	0/1	0.47	73_66	140	99.0			rs35827085	EXONIC	YES	NM_130899.3	Transcript	protein_coding	missense_variant		2/2	NM_130899.3:c.887T>C	NP_570969.2:p.Met296Thr		-1.0						.	.	.		0.00439467	669.0	152230.0	1.0	32	0.98	PASS	nfe	0.00709877	483.0	0.00709877	483.0	0.00436613	1097.0	251252.0	5.0	100	1.0	PASS	nfe	0.00682062	775.0	0.00682062	775.0	0.0037298	580	0.008	26.0				5.629	0.185938	0.071	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FAM71B	0.0	0.0	0.0	0.0	6.0	-27.0	-32.0	7.0						0.641	0.0	0.000000000	0.001	0.307	.			ciliary ganglion;pons;testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;testis;skeletal muscle;globus pallidus;	.	.	nucleus	.	.	156590389
61510	chr5	159839531		AAAAAA	chr5:159839530-159839531	SLU7	SLU7 homolog, splicing factor	insertion	1/1	0.5	0_1_0	2	13.0	0/2	0.2	0_1_4	5	32.0			rs57812151	SPLICING	YES	NM_001364517.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	5/15		NM_001364517.2:c.616-10_616-5dup			-1.0						.	.	.		0.00383682	370.0	96434.0	2.0	6	0.15	PASS	eas	0.00931373	38.0	0.00393476	179.0					19	0.49									0.001	2.0				0.452	-0.268857		0	0	0																	0.892	0.0				integument phenotype ; immune system phenotype; mortality/aging ; hematopoietic system phenotype; 			.	.	RNA splicing, via transesterification reactions;alternative mRNA splicing, via spliceosome;mRNA 3'-splice site recognition;mRNA splicing, via spliceosome;RNA export from nucleus;mRNA export from nucleus;intracellular protein transport;mRNA 3'-end processing;cellular response to heat	nucleus;nucleoplasm;spliceosomal complex;cytoplasm;cytosol;membrane;nuclear speck;small nuclear ribonucleoprotein complex;intracellular membrane-bounded organelle;catalytic step 2 spliceosome	second spliceosomal transesterification activity;protein binding;zinc ion binding;pre-mRNA 3'-splice site binding	SF3B2[22365833];ZCCHC10[22365833];KDM1A[23455924];FHL3[unassigned1304];TNF[20195357];PRPF8[22365833];KRT40[25416956];NSD3[23455924];GOLGA2[25416956;unassigned1304];BAG2[22365833];CCDC85B[16189514];PCBP2[22365833];CEP70[25416956];HIST1H1E[30021884];IKBKG[unassigned1304];LZTS2[25416956];LONRF1[unassigned1304];HMGN2[30021884];PIBF1[unassigned1304];PRMT6[23455924];PRMT5[23455924];FOXJ2[25609649];KSR2[27086506];MCC[unassigned1304];DEF6[unassigned1304];HIST2H2BE[30021884];JMJD6[23455924];THAP1[25416956];AIMP2[unassigned1304];PRPF3[22365833];PPIG[22365833];PPIL3[16189514;22365833;25416956];NFKBID[unassigned1304];UBA52[30021884];	159839530
61544	chr5	162909667	A	G	chr5:162909667	HMMR	hyaluronan mediated motility receptor	SNV	0/1	0.53	25_28	53	99.0	0/1	0.32	34_16	50	99.0			rs72808225	EXONIC	YES	NM_001142556.2	Transcript	protein_coding	missense_variant		13/18	NM_001142556.2:c.1405A>G	NP_001136028.1:p.Ser469Gly		1.0	.,.,.,.				{Breast cancer, susceptibility to}, 114480 (3), Somatic mutation, Autosomal dominant	.	.	Somatic mutation;Autosomal dominant inheritance;Heterogeneous;Breast carcinoma		0.00266066	405.0	152218.0	1.0	33	0.97	PASS	nfe	0.00493885	336.0	0.00493885	336.0	0.00320709	805.0	251006.0	6.0	50	0.96	PASS	nfe	0.00634451	720.0	0.00634451	720.0	0.0041478	645	0.001	3.0	0.00084	8.0		7.792	0.346308	0.096	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	HMMR	0.0	0.05	0.0	0.0	-11.0	42.0	0.0	-11.0						0.998	0.0	0.000000000	0.002	-1.682	reproductive system phenotype; endocrine/exocrine gland phenotype; neoplasm; 			ciliary ganglion;testis - seminiferous tubule;testis - interstitial;tumor;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;fetal liver;testis;	ECM-receptor interaction	regulation of G2/M transition of mitotic cell cycle;hyaluronan catabolic process	centrosome;cytosol;plasma membrane;cell surface;microtubule cytoskeleton;membrane	protein binding;hyaluronic acid binding	ITIH5[25640309];KHDRBS1[30021884];ABCB1[30021884];TMEM63B[26496610];DCTN1[26638075];IL24[25640309];BRCA1[22110403];BACH1[26496610];AURKA[22110403];PCM1[26638075];TBK1[21903422];TUBA1A[27291054];CEP170[26638075];RAB28[unassigned1312];HIST1H1B[30021884];EIF5B[30021884];JUN[25609649];CSNK1A1[23455922];GREB1[25640309];SPICE1[26638075];CSNK1E[23455922];DYNLL1[26496610];PTBP3[22575643];TPX2[22110403];NIN[26638075];MORN4[25416956;unassigned1304];NAT2[25640309];SARNP[30021884];CDH13[25640309];THRSP[25640309];HIST1H2BH[30021884];	162909667
61565	chr5	167687388	G	A	chr5:167687388	TENM2	teneurin transmembrane protein 2	SNV	0/1	0.53	36_41	77	99.0	0/1	0.43	31_23	54	99.0			rs535094080,COSV69144350	EXONIC	YES	NM_001122679.2	Transcript	protein_coding	synonymous_variant		29/30	NM_001122679.2:c.7506G>A	NP_001116151.1:p.Leu2502%3D		1.0						.	.	.		0.00028923	44.0	152128.0	1.0	33	0.97	PASS	sas	0.0085027	41.0	2.93988e-05	2.0	0.00120768	301.0	249238.0	5.0	62	1.0	PASS	sas	0.00957454	293.0	3.53951e-05	4.0	0.0010739	167						4.447	0.111152		0	0	0			TENM2	0.0	0.0	0.0	0.0	5.0	30.0	30.0	40.0							1.0	93.630426228			vision/eye phenotype; nervous system phenotype ; 			.	.	negative regulation of transcription by RNA polymerase II;heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules;signal transduction;neuron development;positive regulation of filopodium assembly;cell-cell adhesion	nucleus;endoplasmic reticulum;Golgi apparatus;plasma membrane;integral component of plasma membrane;PML body;cell junction;filopodium;dendrite;growth cone;neuron projection;dendritic spine;synapse;postsynaptic membrane	calcium ion binding;protein homodimerization activity;protein heterodimerization activity;cell adhesion molecule binding	LAMP1[29568061];MYC[21150319];	167687388
61582	chr5	169412916	G	A	chr5:169412916	DOCK2	dedicator of cytokinesis 2	SNV	0/1	0.49	43_42	85	99.0	0/1	0.53	33_37	70	99.0				EXONIC	YES	NM_004946.3	Transcript	protein_coding	missense_variant		29/52	NM_004946.3:c.2983G>A	NP_004937.1:p.Val995Ile		1.0	.,.				Immunodeficiency 40, 616433 (3), Autosomal recessive	DOCK2 deficiency	Disease-causing germline mutation(s) (loss of function) in	Autosomal recessive inheritance;Congenital onset;Lymphopenia;Immunodeficiency						32	0.97											54	0.87														18.57	1.849221	0.085	6	14	20	LRT_pred,MutationAssessor_pred,MutationTaster_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-XF_coding_pred	DOCK2	0.0	0.0	0.0	0.0	-36.0	-4.0	10.0	-1.0						0.335	1.0	93.958930461	0.998	0.189	cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; behavior/neurological phenotype ; mortality/aging ; hematopoietic system phenotype; hearing/vestibular/ear phenotype; nervous system phenotype ; renal/urinary system phenotype; 			tonsil;thymus;white blood cells;tumor;lymph node;whole blood;bone marrow;	.	membrane raft polarization;establishment of T cell polarity;immunological synapse formation;myeloid dendritic cell activation involved in immune response;chemotaxis;small GTPase mediated signal transduction;actin cytoskeleton organization;neutrophil degranulation;positive regulation of GTPase activity;macropinocytosis;positive thymic T cell selection;negative thymic T cell selection;alpha-beta T cell proliferation;regulation of defense response to virus by virus;positive regulation of phagocytosis	extracellular region;cytosol;cytoskeleton;membrane;specific granule lumen;extracellular exosome	GTPase activator activity;protein binding;Rac guanyl-nucleotide exchange factor activity;T cell receptor binding	PLEKHF2[unassigned1304];KHDRBS2[25416956;unassigned1304];KHDRBS3[unassigned1304];TENM4[unassigned1304];CALCOCO2[25416956];CCNDBP1[25416956];PCSK5[unassigned1304];KRT40[25416956;unassigned1304];TGM1[unassigned1304];CYSRT1[unassigned1304];GOLGA6L9[unassigned1304];RAC2[14737186];KRTAP4-2[25416956];HOXA1[unassigned1304];KRTAP3-3[unassigned1304];RAC1[12134158;15723800];KRTAP3-1[unassigned1304];KRTAP1-1[unassigned1304];TRIM23[25416956];CARD10[unassigned1304];KRTAP5-9[25416956;unassigned1304];KRTAP12-3[unassigned1304];FYB1[19798671];KRTAP9-4[25416956];KRTAP10-7[unassigned1304];KRTAP9-3[unassigned1304];KRTAP5-7[unassigned1304];KRTAP9-2[25416956];KRTAP10-9[25416956];KRTAP10-8[25416956;unassigned1304];KRTAP17-1[unassigned1304];MTUS2[25416956;unassigned1304];KRT34[unassigned1304];NOTCH2NLA[25416956;unassigned1304];KRT31[unassigned1304];CDC25B[17353931];PLSCR1[25416956];SNW1[20467437];HNRNPK[25416956;unassigned1304];ELMO1[14737186];CD247[25241761];MDFI[25416956;unassigned1304];	169412916
61857	chr6	598032	T		chr6:598032	EXOC2	exocyst complex component 2	deletion	0/1	0.33	4_2	6	47.0	0/0	0.0	8_0	8	24.0				EXONIC	YES	NM_018303.6	Transcript	protein_coding	frameshift_variant		10/28	NM_018303.6:c.1062del	NP_060773.3:p.Lys354AsnfsTer4		-1.0					Neurodevelopmental disorder with dysmorphic facies and cerebellar hypoplasia, 619306 (3), Autosomal recessive	.	.	.						33	0.97											31	0.88														22.9	2.696381		0	0	0			EXOC2	0.0	0.0	0.0	0.0	11.0	-11.0	-10.0	-7.0						0.754	0.0	48.768084866			.			ciliary ganglion;dorsal root ganglion;atrioventricular node;globus pallidus;	.	exocytosis;Golgi to plasma membrane transport;protein transport;vesicle-mediated transport;regulation of entry of bacterium into host cell	exocyst;cytosol;plasma membrane;membrane;Flemming body	protein binding;Ral GTPase binding;protein kinase binding;protein N-terminus binding	RALB[27173435;unassigned1312];EXOC8[unassigned1312];EXOC7[unassigned1312];ESX1[21988832];RIPK4[26972000];EXOC6B[27173435;unassigned1312];CDC5L[20467437];EGFR[25594178];SNW1[20467437];EXOC4[21241894;27173435;unassigned1312];EXOC3[27173435;unassigned1312];EXOC6[27173435;unassigned1312];EXOC5[27173435;unassigned1312];SERGEF[14980502];EXOC1[27173435;unassigned1312;19885391];	598031
61860	chr6	1390277	GCC		chr6:1390277-1390279	FOXF2	forkhead box F2	deletion	0/1	0.24	13_4	17	99.0	0/0	0.0	39_0	39	99.0			rs747033801	EXONIC	YES	NM_001452.2	Transcript	protein_coding	inframe_deletion		1/2	NM_001452.2:c.121_123del	NP_001443.1:p.Ala41del		1.0						.	.	.		0.00123305	179.0	145168.0	0.0	31	0.87	PASS	afr	0.00321792	129.0	0.000349884	23.0	0.0666647	2269.0	34036.0	0.0	1	0.19	PASS	eas	0.0940265	85.0	0.0637103	783.0	0.0000064,0.0092795,0.0000064	1,1443,1	0.001	4.0	0.00842	82.0		13.13	0.956997		0	0	0			FOXF2	0.0	0.0	0.0	0.0	-43.0	-21.0	46.0	43.0											growth/size/body region phenotype; homeostasis/metabolism phenotype; vision/eye phenotype; craniofacial phenotype; mortality/aging ; behavior/neurological phenotype ; skeleton phenotype; nervous system phenotype ; digestive/alimentary phenotype; 			ciliary ganglion;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;	.	epithelial to mesenchymal transition;extracellular matrix organization;establishment of planar polarity of embryonic epithelium;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;embryonic digestive tract development;embryonic camera-type eye morphogenesis;genitalia development;roof of mouth development	nucleus;transcription factor complex	RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;transcription factor binding;sequence-specific DNA binding	ABL1[17474147];FOXJ2[25609649];FYN[17474147];	1390276
61864	chr6	1390978	CAC		chr6:1390978-1390980	FOXF2	forkhead box F2	deletion	0/1	0.15	50_9	60	99.0	0/0	0.0	34_0	34	99.0			rs746854384	EXONIC	YES	NM_001452.2	Transcript	protein_coding	inframe_deletion		1/2	NM_001452.2:c.814_816del	NP_001443.1:p.His272del		1.0						.	.	.		0.000171323	26.0	151760.0	1.0	32	0.97	PASS	eas	0.0042735	22.0	0.0	0.0	0.00432841	95.0	21948.0	0.0	2	0.03	PASS	eas	0.00686185	15.0	0.00463429	46.0	0.0000836,0.0004244	13,66	0.005	16.0	0.00037	4.0		21.9	2.280918		0	0	0			FOXF2	0.0	0.0	0.0	0.0	-40.0	-12.0	46.0	30.0											growth/size/body region phenotype; homeostasis/metabolism phenotype; vision/eye phenotype; craniofacial phenotype; mortality/aging ; behavior/neurological phenotype ; skeleton phenotype; nervous system phenotype ; digestive/alimentary phenotype; 			ciliary ganglion;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;	.	epithelial to mesenchymal transition;extracellular matrix organization;establishment of planar polarity of embryonic epithelium;negative regulation of transcription, DNA-templated;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;embryonic digestive tract development;embryonic camera-type eye morphogenesis;genitalia development;roof of mouth development	nucleus;transcription factor complex	RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;transcription factor binding;sequence-specific DNA binding	ABL1[17474147];FOXJ2[25609649];FYN[17474147];	1390977
61867	chr6	1612018	CGG		chr6:1612018-1612020	FOXC1	forkhead box C1	deletion	0/1	0.12	52_7	59	99.0	0/0	0.0	37_0	37	99.0			rs398123612	EXONIC	YES	NM_001453.3	Transcript	protein_coding	inframe_deletion		1/1	NM_001453.3:c.1359_1361del	NP_001444.2:p.Gly456del		1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	Axenfeld-Rieger_syndrome_type_3|not_specified	Axenfeld-Rieger syndrome, type 3, 602482 (3), Autosomal dominant; Anterior segment dysgenesis 3, multiple subtypes, 601631 (3), Autosomal dominant	Isolated aniridia;Peters anomaly;Axenfeld-Rieger syndrome;Rieger anomaly;Axenfeld anomaly	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Concave nasal ridge;Sensorineural hearing impairment;Posterior embryotoxon;Cerebellar vermis hypoplasia;Hypodontia;Hypertelorism;Midface retrusion;Ectopia pupillae;Microdontia;Atrial septal defect;Hypoplasia of the iris;Glaucoma;Proptosis;Malar flattening;Heterogeneous;Patent ductus arteriosus;Autosomal dominant inheritance;Autosomal dominant inheritance;Rieger anomaly;Peters anomaly;Enlarged cisterna magna;Glaucoma;Posterior embryotoxon;Ectopia pupillae;Axenfeld anomaly;Hypoplastic iris stroma;Abnormal iris vasculature;Cerebellar vermis hypoplasia;Posterior embryotoxon;Redundant skin;Hypertelorism;Depressed nasal bridge;Hearing impairment;Hypospadias;Hypoplasia of the maxilla;Glaucoma;Aplasia/Hypoplasia of the iris;Abnormality of cardiovascular system morphology;Microdontia;Growth delay;Everted lower lip vermilion;Telecanthus;Wide nasal bridge;Abnormality of the hypothalamus-pituitary axis;Midface retrusion;Abnormal anterior chamber morphology;Hypodontia;Prominent forehead;Anal stenosis;Nystagmus;Peters anomaly;Visual loss;Cataract;Aplasia/Hypoplasia of the macula;Glaucoma;Aniridia;Subcapsular cataract;Developmental glaucoma;Nystagmus;Anterior synechiae of the anterior chamber;Strabismus;Thinning of Descemet membrane;Peters anomaly;Central opacification of the cornea	25741868,23757202,27463523	0.00265061	379.0	142986.0	1.0	28	0.78	PASS	afr	0.00875466	338.0	0.000339464	22.0	0.0159235	1032.0	64810.0	0.0	2	0.21	PASS	eas	0.0297834	66.0	0.0171681	428.0	0.0000386,0.0012218	6,190			0.0051	57.0		19.2	1.93148		0	0	0			FOXC1	0.01	0.0	0.0	0.0	-23.0	12.0	-4.0	-12.0											endocrine/exocrine gland phenotype; integument phenotype ; growth/size/body region phenotype; craniofacial phenotype; muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; respiratory system phenotype; liver/biliary system phenotype; embryo phenotype; pigmentation phenotype; mortality/aging ; normal phenotype; reproductive system phenotype; cardiovascular system phenotype ; vision/eye phenotype; nervous system phenotype ; limbs/digits/tail phenotype; digestive/alimentary phenotype; renal/urinary system phenotype; skeleton phenotype; 			.	.	negative regulation of transcription by RNA polymerase II;angiogenesis;ovarian follicle development;eye development;ureteric bud development;in utero embryonic development;somitogenesis;kidney development;lymph vessel development;endochondral ossification;blood vessel remodeling;regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II;Notch signaling pathway;heart development;cell population proliferation;germ cell migration;anatomical structure morphogenesis;positive regulation of epithelial to mesenchymal transition;mesenchymal cell development;neural crest cell development;cell migration;negative regulation of angiogenesis;cerebellum development;cell differentiation;collagen fibril organization;glycosaminoglycan metabolic process;lacrimal gland development;embryonic heart tube development;maintenance of lens transparency;vascular endothelial growth factor signaling pathway;odontogenesis of dentin-containing tooth;camera-type eye development;positive regulation of DNA binding;positive regulation of keratinocyte differentiation;positive regulation of transcription, DNA-templated;negative regulation of mitotic cell cycle;positive regulation of transcription by RNA polymerase II;regulation of organ growth;vascular endothelial growth factor receptor signaling pathway;paraxial mesoderm formation;artery morphogenesis;regulation of blood vessel size;ventricular cardiac muscle tissue morphogenesis;cardiac muscle cell proliferation;chemokine-mediated signaling pathway;cellular response to epidermal growth factor stimulus;glomerular epithelium development;negative regulation of lymphangiogenesis;positive regulation of hematopoietic progenitor cell differentiation;positive regulation of hematopoietic stem cell differentiation;negative regulation of apoptotic process involved in outflow tract morphogenesis;positive regulation of core promoter binding;cellular response to chemokine	nucleus;nucleoplasm;nuclear heterochromatin;cytosol	RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;transcription coactivator binding;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;transcription coactivator activity;protein binding;transcription factor binding;DNA binding, bending;sequence-specific DNA binding;transcription regulatory region DNA binding;promoter-specific chromatin binding	FOXA1[25303530];RARG[25303530];VARS[25609649];LDB1[25609649];NDUFA11[25609649];UBP1[25609649];PPP2R2A[26496610;28330616];HOXC13[25609649];MECP2[25609649];SALL1[25609649];PPP2R1A[26496610];C1QBP[18676636];PITX2[16449236];FOXD4[25609649];RECQL[25609649];FOS[25303530];AIM2[25665578];DDX39A[25609649];HOXB9[25609649];CREB1[25609649];RARA[25303530];TP53[25609649];FOXC2[25609649];FOXC1[25609649];NFIX[25609649];DLX5[25609649];SATB1[25609649];SATB2[25609649];HOXD13[25609649];GATA3[25303530];C5orf24[25609649];FOXS1[25609649];FLNA[15684392];EGLN3[26972000];TFAP2C[25303530];JUN[25303530];POU2F1[25609649];PYHIN1[25665578];SMARCA5[25609649];FOXJ2[25609649];PBX2[25609649];SMARCA1[25609649];ESR1[25303530];PBX1[15684392;25609649];GATAD2B[25609649];MEIS1[25609649];TFCP2[25609649];NFIC[25609649];PPP2R2D[28330616];BCOR[27505670];	1612017
61913	chr6	7910932	CAG		chr6:7910932-7910934	TXNDC5	thioredoxin domain containing 5	deletion	0/0	0.0	29_0	29	72.0	0/1	0.21	11_3	14	93.0			rs775841007	EXONIC	YES	NM_030810.5	Transcript	protein_coding	inframe_deletion		1/10	NM_030810.5:c.76_78del	NP_110437.2:p.Leu26del		-1.0						.	.	.		2.70959e-05	4.0	147624.0	0.0	32	0.93	PASS	nfe	6.03282e-05	4.0	6.03282e-05	4.0	0.010184	93.0	9132.0	0.0	0	0.0	PASS	sas	0.0263158	14.0	0.00812065	28.0	0.0000064	1	0.0	1.0				16.39	1.521626		0	0	0			TXNDC5	0.0	0.0	0.0	0.0	-42.0	-39.0	6.0	25.0						0.977	0.0				endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; cardiovascular system phenotype ; reproductive system phenotype; 			.	.	negative regulation of apoptotic process;apoptotic cell clearance;neutrophil degranulation;cell redox homeostasis	extracellular region;endoplasmic reticulum;endoplasmic reticulum lumen;azurophil granule lumen;lysosomal lumen;extracellular exosome	protein binding;isomerase activity	ATF2[22304920];HDAC10[23752268];NEXMIF[unassigned1304];RORB[unassigned1304];RBPJ[25609649];DCAF7[27173435;unassigned1312];EFEMP2[unassigned1304];EFEMP1[25416956];CYSRT1[unassigned1304];KRTAP3-1[unassigned1304];TRIM23[25416956];FST[unassigned1304];ECH1[29426014];YOD1[19615732];CDPF1[unassigned1304];MID2[unassigned1304];KCTD9[unassigned1304];SLPI[unassigned1304];KRTAP4-12[25416956;unassigned1304];KRTAP4-11[unassigned1304];ZNF438[unassigned1304];TRIB3[unassigned1304];BLZF1[25416956;unassigned1304];GLYR1[unassigned1304];ZNF552[unassigned1304];KPRP[unassigned1304];FBLIM1[unassigned1304];PDGFA[unassigned1304];FBLN1[unassigned1304];KRT40[25416956;unassigned1304];ANAPC11[unassigned1304];PRDX4[21057456];KRTAP4-4[unassigned1304];HOXC4[unassigned1304];KRTAP4-2[25416956;unassigned1304];TXNDC5[unassigned1304];JUN[25609649];KRTAP12-3[unassigned1304];RAB3IP[unassigned1304];DDIT4L[unassigned1304];NOTCH2NLA[25416956;unassigned1304];FOXN1[25609649];TXNRD3NB[unassigned1304];ALS2CR12[25416956];LHX3[unassigned1304];TRIP6[25416956];LCN2[unassigned1304];LHX4[25416956];ZNF655[unassigned1304];HSPB8[unassigned1304];MEI4[unassigned1304];FHL5[unassigned1304];PEAR1[unassigned1304];PCSK6[unassigned1304];PCSK5[unassigned1304];MEOX1[unassigned1304];PPCDC[unassigned1304];GMPPB[25416956;unassigned1304];ESM1[unassigned1304];UPK1B[unassigned1304];METTL14[29507755];TCTN3[26638075];ADAMTSL4[unassigned1304];TCTN1[26638075];VWC2L[unassigned1304];METTL15[unassigned1304];KRTAP1-1[unassigned1304];RSPO4[unassigned1304];GUSBP1[unassigned1304];KRTAP9-3[unassigned1304];KSR1[27086506];KRTAP9-2[unassigned1304];H2AFX[20000738];KRT34[unassigned1304];PAX6[unassigned1304];KRT31[unassigned1304];KRTAP9-8[unassigned1304];KRT39[unassigned1304];KRT38[25416956;unassigned1304];CEACAM6[unassigned1304];KRT37[unassigned1304];ZNF780A[30021884];ZMYND12[unassigned1304];MDFI[unassigned1304];HDAC2[23752268];GRN[unassigned1304];ASB12[unassigned1304];RNF4[unassigned1304];KRTAP2-3[unassigned1304];TRIM42[25416956;unassigned1304];BEND7[unassigned1304];UBQLN2[unassigned1304];PLA2G2F[unassigned1304];RNF20[30021884];WWOX[unassigned1304];KRTAP10-5[25416956];KRTAP10-7[25416956;unassigned1304];IL37[unassigned1304];KRTAP10-9[25416956;unassigned1304];KRTAP10-8[25416956;unassigned1304];SPRY4[unassigned1304];VEGFB[unassigned1304];MORN5[unassigned1304];LNX1[unassigned1304];VWC2[unassigned1304];SPRY2[25416956];BCAR1[28007913];LIMS1[unassigned1304];	7910931
61918	chr6	8430133	T	G	chr6:8430133	SLC35B3	solute carrier family 35 member B3	SNV	0/1	0.42	26_19	45	99.0	0/1	0.35	28_16	46	99.0			rs149595280	EXONIC	YES	NM_015948.5	Transcript	protein_coding	synonymous_variant		3/11	NM_015948.5:c.261A>C	NP_057032.2:p.Gly87%3D		-1.0						.	.	.		0.000861287	131.0	152098.0	0.0	33	0.96	PASS	amr	0.00170313	26.0	0.00139669	95.0	0.000711041	170.0	239086.0	1.0	24	0.62	PASS	nfe	0.00123132	131.0	0.00123132	131.0	0.0006495	101	0.003	9.0				11.76	0.775475		0	0	0			SLC35B3	0.0	0.0	0.0	0.05	20.0	-2.0	-26.0	-36.0						0.867	0.0	95.686810169			.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;atrioventricular node;globus pallidus;	.	3'-phosphoadenosine 5'-phosphosulfate biosynthetic process;3'-phospho-5'-adenylyl sulfate transmembrane transport	Golgi membrane;integral component of Golgi membrane;integral component of endoplasmic reticulum membrane	transmembrane transporter activity;3'-phosphoadenosine 5'-phosphosulfate transmembrane transporter activity	TMEM17[26638075];	8430133
61950	chr6	11538539	T	C	chr6:11538539	TMEM170B	transmembrane protein 170B	SNV	0|1	0.48	53_49	102	99.0	0|1	0.64	23_42	66	99.0			rs1402257953	EXONIC	YES	NM_001100829.3	Transcript	protein_coding	missense_variant		1/3	NM_001100829.3:c.29T>C	NP_001094299.1:p.Met10Thr		1.0						.	.	.						32	0.95							9.11876e-06	1.0	109664.0	0.0	7	0.19	RF	sas	5.97229e-05	1.0	0.0	0.0								19.15	1.925311	0.163	4	13	17	MutationTaster_pred,PrimateAI_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	TMEM170B	0.0	0.0	0.0	0.0	-22.0	20.0	22.0	20.0							0.67		1.0	1.123	.			.	.	Wnt signaling pathway;negative regulation of canonical Wnt signaling pathway	plasma membrane;integral component of membrane	protein binding	.	11538539
62100	chr6	19838106	GGC		chr6:19838106-19838108	ID4	inhibitor of DNA binding 4, HLH protein	deletion	0|1	0.27	19_7	26	99.0	0/0	0.0	14_0	14	42.0			rs537169414	EXONIC	YES	NM_001546.4	Transcript	protein_coding	inframe_deletion		1/3	NM_001546.4:c.138_140del	NP_001537.1:p.Ala48del		1.0						.	.	.		8.05629e-05	12.0	148952.0	0.0	32	0.94	PASS	nfe	7.46648e-05	5.0	7.46648e-05	5.0	0.00805698	69.0	8564.0	0.0	0	0.0	PASS	amr	0.0833333	3.0	0.00743931	19.0	0.0000064,0.0000386	1,6			0.00021	2.0		18.27	1.809593		0	0	0			ID4	0.0	0.0	0.0	0.0	-1.0	23.0	23.0	28.0							0.15				reproductive system phenotype; mortality/aging ; behavior/neurological phenotype ; skeleton phenotype; nervous system phenotype ; endocrine/exocrine gland phenotype; adipose tissue phenotype ; integument phenotype ; growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			.	TGF-beta signaling pathway	G1/S transition of mitotic cell cycle;negative regulation of transcription by RNA polymerase II;regulation of transcription by RNA polymerase II;neuroblast proliferation;circadian rhythm;positive regulation of cell population proliferation;hippocampus development;cerebral cortex neuron differentiation;central nervous system myelination;neuron differentiation;cellular protein localization;negative regulation of DNA binding;fat cell differentiation;negative regulation of fat cell differentiation;negative regulation of neuron differentiation;positive regulation of osteoblast differentiation;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;negative regulation of astrocyte differentiation;negative regulation of oligodendrocyte differentiation;regulation of cell cycle;prostate gland epithelium morphogenesis;prostate gland stromal morphogenesis;seminal vesicle morphogenesis	nucleus;cytoplasm	DNA-binding transcription factor activity, RNA polymerase II-specific;RNA polymerase II transcription factor binding;DNA-binding transcription factor activity;transcription corepressor activity;protein binding;transcription factor binding;protein dimerization activity	SRC[17474147];GRB2[17474147];TCF4[25609649];PIK3R1[17474147];PLCG1[17474147];CRK[17474147];NCK1[17474147];	19838105
62106	chr6	21595252	CATGGGGGCGGC		chr6:21595252-21595263	SOX4	SRY-box 4	deletion	0|1	0.45	24_20	44	99.0	0/1	0.45	21_17	38	99.0			rs747523746	EXONIC	YES	NM_003107.3	Transcript	protein_coding	inframe_deletion		1/1	NM_003107.3:c.496_507del	NP_003098.1:p.His166_Gly169del		1.0					Coffin-Siris syndrome 10, 618506 (3), Autosomal dominant	.	.	Hypoplasia of the corpus callosum;Wide mouth;Feeding difficulties in infancy;Wide nasal bridge;Aplasia/Hypoplasia of the distal phalanx of the 5th finger;Depressed nasal ridge;Intrauterine growth retardation;Ectopic kidney;Joint hyperflexibility;Bilateral single transverse palmar creases;Abnormality of the intervertebral disk;Congenital diaphragmatic hernia;Partial agenesis of the corpus callosum;Hypoplastic fifth toenail;Strabismus;Scoliosis;Microcephaly;Epicanthus;Depressed nasal bridge;Abnormality of the clavicle;Muscular hypotonia;Cryptorchidism;Lacrimation abnormality;Long eyelashes;Dandy-Walker malformation;Short distal phalanx of finger;Aplasia/Hypoplasia of the patella;Thick eyebrow;Global developmental delay;Cataract;Cutis marmorata;Spina bifida occulta;Kyphosis;Renal hypoplasia/aplasia;Coarse facial features;Cleft palate;Short philtrum;Aplasia/Hypoplasia of the distal phalanx of the 5th toe;Recurrent respiratory infections;Coxa valga;Abnormality of the hip bone;Abnormality of the dentition;Elbow dislocation;Hydronephrosis;Thick lower lip vermilion;Generalized hirsutism;Hearing impairment;Short stature;Ptosis;Abnormality of cardiovascular system morphology;Seizure;Hypoplastic fifth fingernail;Aplasia/Hypoplasia of the cerebellum;Nystagmus;Slow-growing hair;Intellectual disability;Anteverted nares;Generalized hypotonia;Wide mouth;Intellectual disability;Spastic tetraparesis;Low-set ears;Laryngomalacia;Posteriorly rotated ears;Epicanthus;Ventricular septal defect;Persistence of primary teeth;Clinodactyly;Autosomal dominant inheritance;Microcephaly		0.00338204	512.0	151388.0	1.0	32	0.95	PASS	nfe	0.00589953	400.0	0.00589953	400.0	0.00269287	265.0	98408.0	1.0	8	0.03	PASS	nfe	0.00477078	210.0	0.00477078	210.0	0.0000965	15	0.0	1.0				18.37	1.822807		0	0	0																		0.38				digestive/alimentary phenotype; limbs/digits/tail phenotype; nervous system phenotype ; vision/eye phenotype; immune system phenotype; renal/urinary system phenotype; skeleton phenotype; embryo phenotype; behavior/neurological phenotype ; respiratory system phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; normal phenotype; mortality/aging ; endocrine/exocrine gland phenotype; craniofacial phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; integument phenotype ; 			thymus;fetal brain;uterus corpus;atrioventricular node;prostate;	.	skeletal system development;neural tube formation;pro-B cell differentiation;mitral valve morphogenesis;cardiac ventricle formation;cardiac right ventricle morphogenesis;atrial septum primum morphogenesis;noradrenergic neuron differentiation;regulation of transcription, DNA-templated;DNA damage response, signal transduction by p53 class mediator resulting in cell cycle arrest;heart development;positive regulation of cell population proliferation;negative regulation of cell population proliferation;glial cell proliferation;spinal cord development;spinal cord motor neuron differentiation;glial cell development;cell differentiation;T cell differentiation;endocrine pancreas development;negative regulation of protein ubiquitination;regulation of protein stability;positive regulation of insulin secretion;somatic stem cell population maintenance;ascending aorta morphogenesis;glucose homeostasis;DNA damage response, detection of DNA damage;positive regulation of apoptotic process;positive regulation of translation;positive regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;sympathetic nervous system development;protein stabilization;limb bud formation;ventricular septum morphogenesis;negative regulation of cell death;neuroepithelial cell differentiation;kidney morphogenesis;cellular response to glucose stimulus;positive regulation of canonical Wnt signaling pathway;positive regulation of N-terminal peptidyl-lysine acetylation	nucleus;nucleoplasm;cytoplasm;mitochondrion;nuclear transcription factor complex	transcription regulatory region sequence-specific DNA binding;RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA-binding transcription factor activity;transcription coactivator activity;protein binding;protein heterodimerization activity	SPAG9[unassigned1312];USP15[unassigned1312];CREBBP[19234109];MCM4[unassigned1312];EP300[19234109];GATA3[22751141];EPS15L1[unassigned1312];MCM6[unassigned1312];TP53[19234109];MCM2[unassigned1312];	21595251
62278	chr6	27277868	A	T	chr6:27277868	POM121L2	POM121 transmembrane nucleoporin like 2	SNV	0/1	0.41	93_64	157	99.0	0/0	0.0	42_0	42	99.0			rs148139460	EXONIC	YES	NM_033482.3	Transcript	protein_coding	synonymous_variant		1/1	NM_033482.3:c.2082T>A	NP_258443.2:p.Pro694%3D		-1.0						.	.	.		0.00194402	296.0	152262.0	2.0	33	0.98	PASS	amr	0.00444677	68.0	0.000734905	50.0	0.00100483	159.0	158236.0	2.0	91	0.6	PASS	afr	0.00406504	33.0	0.000845144	52.0	0.0004116	64	0.003	10.0				0.248	-0.355923		0	0	0			POM121L2	0.0	0.0	0.0	0.0	-31.0	-3.0	-30.0	2.0								57.098212335			.			.	.	protein import into nucleus	nuclear pore	nuclear localization sequence binding;structural constituent of nuclear pore	.	27277868
62364	chr6	35810384		A	chr6:35810383-35810384	SRPK1	SRSF protein kinase 1	insertion	0/1	0.21	21_6	29	83.0	0/0	0.09	44_5	55	22.0			rs371577081	SPLICING	YES	NM_003137.5	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	13/15		NM_003137.5:c.1621-3dup			-1.0						.	.	.		0.000440366	62.0	140792.0	0.0	31	0.89	PASS	sas	0.00132743	6.0	0.000341329	22.0	0.045645	4771.0	104524.0	0.0	22	0.61	PASS	amr	0.0889565	1023.0	0.0343598	1754.0	0.0001479,0.0194722,0.0000965	23,3028,15						15.92	1.437712		0	0	0			SRPK1	0.0	0.0	0.0	0.0	-2.0	-48.0	-20.0	-21.0						0.603	0.0				.			pons;testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;fetal liver;testis;skeletal muscle;globus pallidus;	.	spliceosomal complex assembly;protein phosphorylation;chromosome segregation;RNA splicing;regulation of gene expression;viral process;sperm chromatin condensation;intracellular signal transduction;positive regulation of viral genome replication;negative regulation of viral genome replication;innate immune response;regulation of mRNA splicing, via spliceosome;regulation of mRNA processing	nucleus;cytoplasm;endoplasmic reticulum;cytosol;plasma membrane;nuclear matrix	magnesium ion binding;RNA binding;protein kinase activity;protein serine/threonine kinase activity;protein binding;ATP binding	AHCYL1[23602568];SLC4A1AP[23602568];SMARCB1[30108113];EIF4A3[23602568];IFIT5[23602568];MKI67[26949251];ALKBH3[23602568];PNN[23602568];CHEK2[23602568];MAGOH[23602568];LUC7L[23602568];ARL6IP4[23602568];RPL37[25852190];SNRPD3[30021884];SRRM2[23602568;25852190];GABARAPL1[23602568];TAAR8[23602568];SFMBT1[23602568];C16orf78[23602568];EWSR1[25852190];ADPRH[23602568];FAM76B[23602568];MAGEB1[23602568];PFN1[23602568];TP53[21130767];EPHA3[23602568];SF1[26420826];MAOB[21988832];DHX8[23602568];SLAIN2[23602568];GABARAP[23602568];CRHR1[23602568];CIAO1[23602568];MMTAG2[23602568];LARP1[23602568];FAM124A[23602568];PCBP1[23602568];KCNN2[23602568];OR6B3[23602568];LYAR[17353931];C6orf201[23602568];ARGLU1[23602568];LINC00312[23602568];SRPK2[21157427];SRPK3[23602568];ZRSR2[23602568];JUN[25609649];PRPF38A[22365833;23602568];ZRANB2[23602568];PTK2[23602568];OCEL1[23602568];WDR55[23602568];VANGL1[23602568];GNPTG[23602568];HNRNPM[25852190];ADI1[23602568];RNPS1[17353931;23602568];HNRNPC[23602568];DUS1L[23602568];CLIC5[23602568];HBS1L[23602568];ECM1[23602568];SETD3[23602568];ODF3L2[23602568];CAB39L[23602568];MRPS11[23602568];NKAP[23602568];PHF7[23602568];ZNF321P[23602568];EPB41L4A[23602568];MAP1LC3A[23602568];SPANXN4[23602568];RSRC1[23602568];IKBKG[20098747];NELFE[23602568];TFEB[23602568];FOS[23602568];DUSP6[23602568];MRPL43[23602568];C11orf87[23602568];CDC42EP4[23602568];CDC42EP3[23602568];PELI1[23602568];PABPC1[23602568];KPTN[23602568];SERPINB10[23602568];ASAH1[23602568];STAU1[23602568];PELI2[23602568];PSMA7[23602568];LCE3D[23602568];BCLAF1[23602568];TCEAL2[23602568];KIAA1841[23602568];JHY[23602568];MBNL3[23602568];SRSF10[23602568];PAK4[23602568];SRSF12[23602568];PEX19[21988832];RSRC2[23602568];NUDT21[23602568];NOL4L[23602568];APEX1[23602568];HDGF[21907836];YPEL3[23602568];YPEL2[23602568];CEP19[26638075];FGF1[23602568];C11orf52[23602568];RIMS4[23602568];AMMECR1L[23602568];APMAP[23602568];KPNA2[23602568];HMGN3[23602568];ZNF444[23602568];C18orf25[23602568];PDGFRA[23602568];CDKL3[23602568];SERF1A[23602568];SPAG11B[23602568];CEP135[26638075];FBXO15[23602568];UBE2E2[23602568];ILF3[25852190];SRSF2[21157427;23602568];SRSF3[23602568];MAPKAPK5[23602568];PPIG[23602568];SREK1[23602568];SRSF6[23602568];SRSF7[23602568];PPIA[23602568];FKBP3[23602568];SRSF8[23602568];DDX5[25852190];RBM8A[23602568];YTHDC1[23602568];COX15[29128334];ARHGAP12[23602568];UBD[23602568];ZKSCAN8[23602568];SAFB2[19674106];SUDS3[23602568];CHTOP[25852190];CBX5[23602568];NOP16[23602568];NEK4[25798074];VDR[23602568];FUS[25852190];TNFRSF10C[23602568];PYM1[25852190];ESRRG[23602568];NSG1[23602568];ARHGAP26[23602568];ESR1[21182205];CLK4[23602568];CHERP[23602568];CLK1[23602568];CDK7[23602568];SON[23602568];STK26[23602568];RSRP1[23602568];FGF12[23602568];C15orf39[23602568];FLT1[23602568];HSP90AB1[22939624];WDR1[23602568];YWHAB[15324660;17353931];DDX47[23602568];LRRK2[17400507];FHL1[23602568];LAMC1[23602568];USP39[23602568];NXT2[23602568];CSAG1[23602568];YBX3[25852190];RBM4[17284590];METTL14[23602568];SNRNP70[23602568];NCK2[23602568];FLOT1[23602568];DGCR8[23602568];EMILIN1[23602568];LBR[19674106];TRIM65[23602568];YWHAG[15324660;17353931];CHUK[23602568];H2AFY[23602568];PDPK1[23602568];SPATS2[23602568];KCNAB1[23602568];SAFB[19674106];NSMCE4A[23602568];THRAP3[23602568];ZNF514[23602568];DNAJC8[23602568];ZMYND11[23602568];RBM23[23602568];NSRP1[23602568];LUC7L2[23602568];RBMS2[23602568];C9orf72[23602568];CAMK2D[23602568];SRSF1[10196197;23602568];DDX21[15034300];U2AF1[22365833;23602568];TULP2[23602568];AURKC[23602568];AURKA[23602568];HIRIP3[23602568];TAF1B[23602568];TRA2B[23602568];ERBB2[23602568];MKNK2[23602568];POLR2E[23602568];DROSHA[23602568];HNRNPA1[23602568];SEC23B[23602568];ABCF1[23602568];RBM39[23602568];PPIL1[23602568];KRR1[23602568];LIMK1[23602568];DAW1[23602568];MAPK14[23602568];MAPK12[23602568];ASXL1[23602568];P2RX6[23602568];EIF3M[23602568];NOVA1[23602568];RPS6KB2[23602568];ACIN1[23602568];BCAR1[28007913];	35810383
62374	chr6	35980088	A	G	chr6:35980088	SLC26A8	solute carrier family 26 member 8	SNV	0/0	0.0	34_0	34	99.0	0/1	0.46	32_27	59	99.0			rs199880055	EXONIC	YES	NM_001193476.2	Transcript	protein_coding	missense_variant		3/20	NM_001193476.2:c.250T>C	NP_001180405.1:p.Cys84Arg		-1.0	.,.,.,.				Spermatogenic failure 3, 606766 (3), Autosomal dominant	Non-syndromic male infertility due to sperm motility disorder	Disease-causing germline mutation(s) in	Infertility;Autosomal dominant inheritance		0.000322004	49.0	152172.0	0.0	32	0.96	PASS	amr	0.000720555	11.0	0.000485066	33.0	0.000356607	88.0	246770.0	1.0	67	0.8	PASS	amr	0.00058168	19.0	0.00055993	63.0	0.0004116	64	0.003	8.0				25.2	3.557844	0.478	11	10	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred	SLC26A8	0.07	0.0	0.01	0.0	8.0	-18.0	0.0	2.0						0.043	0.0	0.000000000	0.998	1.312	cellular phenotype; reproductive system phenotype; 			testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;testis;	.	anion transport;chloride transport;multicellular organism development;sulfate transport;bicarbonate transport;oxalate transport;flagellated sperm motility;sperm capacitation;meiotic cell cycle;sulfate transmembrane transport;chloride transmembrane transport	plasma membrane;integral component of plasma membrane	chloride channel activity;protein binding;secondary active sulfate transmembrane transporter activity;bicarbonate transmembrane transporter activity;chloride transmembrane transporter activity;sulfate transmembrane transporter activity;anion:anion antiporter activity;oxalate transmembrane transporter activity	RACGAP1[11278976];CFTR[22121115];	35980088
62380	chr6	36341333	G	A	chr6:36341333	ETV7	ETS variant 7	SNV	0/1	0.59	17_24	41	99.0	0/0	0.0	39_0	39	99.0			rs151176815	EXONIC	YES	NM_016135.4	Transcript	protein_coding	synonymous_variant		4/8	NM_016135.4:c.330C>T	NP_057219.1:p.Leu110%3D		-1.0						.	.	.		0.000970012	142.0	146390.0	0.0	30	0.9	PASS	nfe	0.00157171	104.0	0.00157171	104.0	0.000759734	104.0	136890.0	1.0	10	0.23	PASS	nfe	0.00131396	72.0	0.00131396	72.0	0.0005080	79	0.001	4.0				7.861	0.35216		0	0	0			ETV7	0.0	0.0	0.0	0.0	-4.0	49.0	23.0	-30.0						0.802	0.0	0.000000000			.			ciliary ganglion;subthalamic nucleus;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	negative regulation of transcription by RNA polymerase II;regulation of transcription by RNA polymerase II;transcription by RNA polymerase II;animal organ morphogenesis;cell differentiation	nucleus;nucleoplasm	RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;protein binding	RPTOR[24036451];LRPAP1[21988832];VTN[21988832];RICTOR[24036451];	36341333
62405	chr6	36710085	G	C	chr6:36710085	CPNE5	copine 5	SNV	0/1	0.49	45_43	88	99.0	0/1	0.46	55_46	101	99.0			COSV99783064	EXONIC	YES	NM_020939.2	Transcript	protein_coding	missense_variant		21/21	NM_020939.2:c.1742C>G	NP_065990.1:p.Ala581Gly		-1.0	.,.					.	.	.						32	0.97											46	0.95														17.31	1.674771	0.046	2	17	19	LRT_pred,MutationTaster_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CPNE5	0.0	0.0	0.0	0.0	7.0	-35.0	-45.0	-24.0						0.569	0.08	60.463066037	0.991	1.083	immune system phenotype; hematopoietic system phenotype; 			.	.	cellular response to calcium ion;positive regulation of dendrite extension	plasma membrane;neuron projection;perikaryon;extracellular exosome	molecular_function;calcium-dependent phospholipid binding	.	36710085
62480	chr6	39267514	C	T	chr6:39267514	KCNK17	potassium two pore domain channel subfamily K member 17	SNV	0/1	0.38	49_30	80	99.0	0/1	0.42	53_38	91	99.0				SPLICING	YES	NM_031460.4	Transcript	protein_coding	splice_acceptor_variant	4/4		NM_031460.4:c.689-1G>A			-1.0						.	.	.						32	0.97											79	0.95														33.0	5.05332		0	0	0			KCNK17	0.51	0.99	0.0	0.0	-2.0	-1.0	-31.0	-19.0	0.999968430223941	0.872	1.454	8.75	10.204	0.911	0.0				.			.	.	potassium ion transport;stabilization of membrane potential;regulation of ion transmembrane transport;potassium ion transmembrane transport	plasma membrane;integral component of plasma membrane	voltage-gated ion channel activity;potassium channel activity;potassium ion leak channel activity	.	39267514
62558	chr6	42832562	T	G	chr6:42832562	GLTSCR1L		SNV	0/1	0.47	87_77	164	99.0	0/1	0.4	77_53	131	99.0			rs144252837	EXONIC	YES	NM_001318819.2	Transcript	protein_coding	missense_variant		14/14	NM_001318819.2:c.2618T>G	NP_001305748.1:p.Met873Arg		1.0	.,.,.									0.00178168	271.0	152104.0	0.0	32	0.97	PASS	nfe	0.00314613	214.0	0.00314613	214.0	0.00174597	439.0	251436.0	0.0	91	1.0	PASS	nfe	0.00269966	307.0	0.00269966	307.0	0.0017427	271	0.001	3.0				7.387	0.313622	0.136	0	18	18		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	GLTSCR1L	0.0	0.0	0.0	0.0	1.0	24.0	22.0	-16.0							1.0	0.000000000	0.775	0.14										42832562
62571	chr6	42897358	TGC		chr6:42897358-42897360	CNPY3	canopy FGF signaling regulator 3	deletion	0/1	0.24	24_8	33	99.0	0/0	0.0	35_0	35	99.0			rs570105218	EXONIC	YES	NM_001318842.1	Transcript	protein_coding	inframe_deletion		1/7	NM_001318842.1:c.74_76del	NP_001305771.1:p.Leu25del		1.0					Developmental and epileptic encephalopathy 60, 617929 (3), Autosomal recessive	West syndrome	Disease-causing germline mutation(s) in	Intellectual disability, profound;Spastic tetraplegia;Hypsarrhythmia;Seizure;Epileptic encephalopathy;Autosomal recessive inheritance;Myoclonus;Infantile spasms;Developmental regression;Hypsarrhythmia;Abnormality of skin morphology		0.000256714	39.0	151920.0	0.0	33	0.98	PASS	afr	0.000676361	28.0	8.83444e-05	6.0	0.00657864	846.0	128598.0	0.0	29	0.56	PASS	afr	0.00767578	50.0	0.00744246	379.0	0.0000257,0.0019935,0.0001029,0.0070738	4,310,16,1100			0.00381	39.0		15.01	1.266643		0	0	0			CNPY3	0.0	0.0	0.0	0.0	39.0	-26.0	9.0	2.0						0.335	0.47	0.000000000			hematopoietic system phenotype; mortality/aging ; immune system phenotype; growth/size/body region phenotype; 			.	.	toll-like receptor signaling pathway;innate immune response	endoplasmic reticulum lumen	signaling receptor binding	CREB3[21516116];CLDN5[unassigned1304];KCNJ6[unassigned1304];XPOT[30021884];GOLM1[unassigned1304];TCTN1[26638075];BOD1L1[30021884];PKDREJ[30021884];FAM209A[unassigned1304];PLEC[30021884];	42897357
62580	chr6	42897358	TGC		chr6:42897358-42897360	CNPY3-GNMT		deletion	0/1	0.24	24_8	33	99.0	0/0	0.0	35_0	35	99.0			rs570105218	EXONIC	YES	NM_001318857.2	Transcript	protein_coding	inframe_deletion		1/5	NM_001318857.2:c.74_76del	NP_001305786.1:p.Leu25del		1.0										0.000256714	39.0	151920.0	0.0	33	0.98	PASS	afr	0.000676361	28.0	8.83444e-05	6.0	0.00657864	846.0	128598.0	0.0	29	0.56	PASS	afr	0.00767578	50.0	0.00744246	379.0	0.0000257,0.0019935,0.0001029,0.0070738	4,310,16,1100			0.00381	39.0		15.01	1.266643		0	0	0			CNPY3	0.0	0.0	0.0	0.0	39.0	-26.0	9.0	2.0								0.000000000												42897357
62627	chr6	43414147	C	T	chr6:43414147	ABCC10	ATP binding cassette subfamily C member 10	SNV	0/1	0.36	69_38	107	99.0	0/0	0.0	35_0	35	99.0			rs75799355,COSV55091177	EXONIC	YES	NM_001198934.2	Transcript	protein_coding	synonymous_variant		16/22	NM_001198934.2:c.3507C>T	NP_001185863.1:p.Ile1169%3D		1.0						.	.	.		0.00157776	240.0	152114.0	0.0	32	0.96	PASS	nfe	0.00257391	175.0	0.00257391	175.0	0.00143047	359.0	250966.0	0.0	54	1.0	PASS	nfe	0.00229071	260.0	0.00229071	260.0	0.0014469	225	0.002	7.0				1.038	-0.145227		0	0	0			ABCC10	0.0	0.0	0.01	0.05	13.0	-38.0	-21.0	37.0						0.0669	0.0	38.693310833			homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; mortality/aging ; growth/size/body region phenotype; hematopoietic system phenotype; immune system phenotype; 			dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;	ABC transporters	transmembrane transport;ATP hydrolysis coupled anion transmembrane transport	lysosomal membrane;plasma membrane;membrane;integral component of membrane	ATP binding;ATPase activity, coupled to transmembrane movement of substances;ATPase-coupled anion transmembrane transporter activity	.	43414147
62724	chr6	44255454	G	A	chr6:44255454	TCTE1	t-complex-associated-testis-expressed 1	SNV	0|1	0.44	88_70	160	99.0	0|1	0.6	53_82	137	99.0			rs760165572	EXONIC	YES	NM_182539.4	Transcript	protein_coding	missense_variant		2/5	NM_182539.4:c.109C>T	NP_872345.2:p.Leu37Phe		-1.0						.	.	.		1.31403e-05	2.0	152204.0	0.0	32	0.95	PASS	nfe	2.93962e-05	2.0	2.93962e-05	2.0	1.59052e-05	4.0	251490.0	0.0	88	1.0	PASS	nfe	3.51593e-05	4.0	3.51593e-05	4.0	0.0000129	2	0.0	1.0	0.00018	2.0		2.873	0.016204	0.034	0	18	18		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TCTE1	0.0	0.0	0.0	0.0	-25.0	45.0	2.0	-34.0						0.887	0.0	0.000000000	0.0	-0.101	reproductive system phenotype; cellular phenotype; 			.	.	flagellated sperm motility	cytoplasm;cytoskeleton;sperm flagellum	.	LIN54[26638075];MOCS2[26638075];KDM1A[26638075];CHD8[26638075];KIAA1671[26638075];ZBTB21[26638075];CCP110[26638075];FAM208A[26638075];ETFA[26638075];ETFB[26638075];NR3C1[26638075];TCTN3[26638075];SAP130[26638075];ARFIP1[26638075];NFRKB[26638075];NDEL1[26638075];KLF12[26638075];DST[26638075];CKAP2[26638075];GAB1[26638075];MTUS1[26638075];KNL1[26638075];ARFGAP3[26638075];WDR34[26638075];MASTL[26638075];TEX2[26638075];CDC25C[26638075];EMSY[26638075];NRBP1[26638075];CTTNBP2NL[26638075];HCFC1[26638075];DYNC1LI1[26638075];DYNC1LI2[26638075];ELF2[26638075];MAP7D3[26638075];NUP50[26638075];ZNF318[26638075];EXOC4[26638075];LRIF1[26638075];CACTIN[26638075];RAPGEF6[26638075];DYNC1I2[26638075];BLM[26638075];CDCA2[26638075];KMT2A[26638075];NUFIP2[26638075];LUZP1[26638075];DCTN1[26638075];ADD3[26638075];ESS2[26638075];NCAPH[26638075];ADD1[26638075];ARHGAP21[26638075];WDCP[26638075];RAB11FIP1[26638075];PPP4C[26638075];HECTD1[26638075];DNAJB6[26638075];TCTEX1D2[26638075];TP53BP2[26638075];DVL2[26638075];ARGLU1[26638075];ZC3H14[26638075];PMS1[26638075];SPEN[26638075];DYNC1H1[26638075];CIZ1[26638075];IQSEC1[26638075];SYNRG[26638075];PLEKHA5[26638075];WAPL[26638075];IBTK[26638075];MIS18A[26638075];WDR60[26638075];KIAA0586[26638075];AAK1[26638075];DYNLRB1[26638075];CPVL[26638075];OGT[26638075];CUL4B[26638075];	44255454
62763	chr6	46679262	C	T	chr6:46679262	PLA2G7	phospholipase A2 group VII	SNV	0/1	0.52	28_30	58	99.0	0/1	0.51	27_28	55	99.0			rs139384606	EXONIC	YES	NM_005084.4	Transcript	protein_coding	missense_variant		7/12	NM_005084.4:c.634G>A	NP_005075.3:p.Glu212Lys		-1.0	.,.				Platelet-activating factor acetylhydrolase deficiency, 614278 (3), Autosomal recessive; {Asthma, susceptibility to}, 600807 (3), Autosomal dominant; {Atopy, susceptibility to}, 147050 (3), Autosomal dominant	.	.	Platelet-activating factor acetylhydrolase deficiency;Autosomal recessive inheritance;Increased level of platelet-activating factor;Autosomal dominant inheritance;Multifactorial inheritance;Asthma;Autosomal dominant inheritance;Asthma;Increased circulating IgE level;Eczema;Allergic rhinitis		0.000289116	44.0	152188.0	0.0	32	0.97	PASS	nfe	0.000220465	15.0	0.000220465	15.0	0.000151204	38.0	251316.0	0.0	100	1.0	PASS	nfe	0.00027281	31.0	0.00027281	31.0	0.0001608	25			0.00018	2.0		22.2	2.337199	0.127	3	17	20	SIFT,PolyPhen,MutationAssessor_pred	Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PLA2G7	0.0	0.0	0.0	0.24	-3.0	44.0	-3.0	-29.0						1.0	0.0	0.000000000	0.009	0.947	immune system phenotype; mortality/aging ; 			.	.	lipid catabolic process;low-density lipoprotein particle remodeling;lipid oxidation;plasma lipoprotein particle oxidation;platelet activating factor metabolic process;positive regulation of inflammatory response;positive regulation of monocyte chemotaxis	extracellular region;cytoplasm;low-density lipoprotein particle	1-alkyl-2-acetylglycerophosphocholine esterase activity;phospholipid binding;hydrolase activity, acting on ester bonds;calcium-independent phospholipase A2 activity	ESR1[21182203];	46679262
62779	chr6	47846237	G	A	chr6:47846237	PTCHD4	patched domain containing 4	SNV	0/1	0.41	75_53	129	99.0	0/1	0.49	65_64	130	99.0			rs139611066	EXONIC	YES	NM_001013732.4	Transcript	protein_coding	synonymous_variant		3/3	NM_001013732.4:c.2343C>T	NP_001013754.3:p.Thr781%3D		-1.0						.	.	.		0.000328973	50.0	151988.0	0.0	32	0.96	PASS	afr	0.000531581	22.0	2.9417e-05	2.0	0.000464241	116.0	249870.0	0.0	50	0.98	PASS	afr	0.000739736	12.0	0.000106498	12.0	0.0002894	45						11.0	0.681759		0	0	0			PTCHD4	0.0	0.0	0.0	0.0	37.0	-8.0	-6.0	37.0							0.0	27.998062047			.			.	.	biological_process	cellular_component;integral component of membrane	molecular_function	.	47846237
62784	chr6	49489475	C		chr6:49489475	GLYATL3	glycine-N-acyltransferase like 3	deletion	0/1	0.37	19_11	30	99.0	0/1	0.54	11_14	26	99.0			rs778691238	EXONIC	YES	NM_001010904.2	Transcript	protein_coding	frameshift_variant		5/6	NM_001010904.2:c.432del	NP_001010904.1:p.Ser145ValfsTer10		1.0						.	.	.		7.88478e-05	12.0	152192.0	0.0	32	0.96	PASS	afr	0.000120639	5.0	5.87889e-05	4.0	0.000130222	20.0	153584.0	0.0	25	0.56	PASS	afr	0.000252781	2.0	0.000151393	9.0	0.0000129	2	0.0	1.0				32.0	4.666865		0	0	0			GLYATL3	0.0	0.0	0.0	0.2	43.0	-2.0	-3.0	10.0								0.000000000			.			.	.	.	mitochondrion	glycine N-acyltransferase activity	PPP4C[19156129];	49489474
62792	chr6	51613051	A	G	chr6:51613051	PKHD1	PKHD1, fibrocystin/polyductin	SNV	0/1	0.49	76_74	150	99.0	0/1	0.52	59_66	126	99.0			rs183674012,COSV100583342	EXONIC	YES	NM_138694.4	Transcript	protein_coding	synonymous_variant		58/67	NM_138694.4:c.9363T>C	NP_619639.3:p.Asn3121%3D		-1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Autosomal_recessive_polycystic_kidney_disease|not_provided	Polycystic kidney disease 4, with or without hepatic disease, 263200 (3), Autosomal recessive	Autosomal recessive polycystic kidney disease;Caroli disease	Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Hepatic cysts;Hypoplasia of the ear cartilage;Respiratory insufficiency;Congenital hepatic fibrosis;Depressed nasal ridge;Pancreatic cysts;Micrognathia;Renal insufficiency;Renal hypoplasia/aplasia;Biliary tract abnormality;Multiple renal cysts;Low-set, posteriorly rotated ears;Macrotia;Portal hypertension;Autosomal recessive inheritance;Dehydration;Pancreatic cysts;Neonatal death;Renal insufficiency;Oligohydramnios;Tubulointerstitial fibrosis;Hepatomegaly;Esophageal varix;Splenomegaly;Periportal fibrosis;Renal cyst;Hypertension;Pulmonary hypoplasia;Enlarged kidney;Polycystic kidney dysplasia;Absence of renal corticomedullary differentiation;Hepatic cysts;Potter facies		0.000466596	71.0	152166.0	0.0	32	0.97	PASS	amr	0.00346995	53.0	0.000161684	11.0	0.000250996	63.0	251000.0	0.0	100	1.0	PASS	amr	0.000810045	28.0	0.000238234	27.0	0.0002251	35	0.001	3.0	0.00175	20.0		3.287	0.041764		0	0	0			PKHD1	0.0	0.0	0.0	0.0	32.0	-40.0	-39.0	34.0						0.00772	0.0	5.235035379			cellular phenotype; endocrine/exocrine gland phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; growth/size/body region phenotype; normal phenotype; mortality/aging ; digestive/alimentary phenotype; nervous system phenotype ; renal/urinary system phenotype; immune system phenotype; liver/biliary system phenotype; respiratory system phenotype; 			pons;ciliary ganglion;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;	.	kidney development;cellular calcium ion homeostasis;positive regulation of cell population proliferation;regulation of centrosome duplication;regulation of TOR signaling;negative regulation of NF-kappaB transcription factor activity;homeostatic process;negative regulation of apoptotic process;negative regulation of cellular component movement;negative regulation of protein kinase B signaling;cilium assembly;regulation of ERK1 and ERK2 cascade;cell-cell adhesion	chromosome, centromeric region;cytoplasm;centrosome;cilium;integral component of membrane;apical plasma membrane;anchored component of external side of plasma membrane;ciliary basal body;perinuclear region of cytoplasm;extracellular exosome;mitotic spindle	protein binding;signaling receptor activity	CAMLG[16243292];RPLP2[30021884];	51613051
62860	chr6	55922521	G	A	chr6:55922521	COL21A1	collagen type XXI alpha 1 chain	SNV	0/1	0.64	38_67	105	99.0	0/0	0.0	39_0	39	99.0			rs200348432,COSV55153368	EXONIC	YES	NM_001318751.2	Transcript	protein_coding	synonymous_variant		31/31	NM_001318751.2:c.2808C>T	NP_001305680.1:p.Cys936%3D		-1.0						.	.	.		0.00117785	179.0	151972.0	0.0	32	0.96	PASS	sas	0.00270046	13.0	0.00179449	122.0	0.00131273	325.0	247576.0	2.0	33	0.91	PASS	sas	0.00229599	70.0	0.00183906	206.0	0.0014662	228	0.003	10.0				0.234	-0.364382		0	0	0			COL21A1	0.0	0.0	0.0	0.0	-21.0	7.0	8.0	-21.0						0.08	0.0	31.839475325			.			atrioventricular node;fetal lung;	.	growth plate cartilage chondrocyte morphogenesis	extracellular region;collagen trimer;extracellular space;endoplasmic reticulum lumen;cytosol;extracellular matrix;collagen-containing extracellular matrix	extracellular matrix structural constituent conferring tensile strength	.	55922521
62957	chr6	57244780	G	A	chr6:57244780	PRIM2	DNA primase subunit 2	SNV	0/1	0.36	43_24	67	99.0	0/1	0.42	59_44	104	99.0			rs5011403,COSV67291502	EXONIC	YES	NM_000947.5	Transcript	protein_coding	missense_variant		6/14	NM_000947.5:c.541G>A	NP_000938.2:p.Glu181Lys		1.0						.	.	.		1.31617e-05	2.0	151956.0	0.0	30	0.96	PASS	amr	6.54965e-05	1.0	1.47128e-05	1.0	0.499472	97508.0	195222.0	15.0	37	0.6	InbreedingCoeff	amr	0.5	14399.0	0.499189	41220.0	0.0364171	5663	0.199	619.0				20.4	2.068049		3	7	10	BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,LIST-S2_pred,fathmm-XF_coding_pred	PRIM2	0.0	0.0	0.0	0.0	3.0	-48.0	9.0	14.0							0.0	95.193827403	0.469	1.176	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];	57244780
62966	chr6	57246884	A	G	chr6:57246884	PRIM2	DNA primase subunit 2	SNV	0/1	0.46	63_54	117	99.0	0/1	0.49	68_67	136	99.0			rs6913546,COSV67291508	EXONIC	YES	NM_000947.5	Transcript	protein_coding	missense_variant		7/14	NM_000947.5:c.611A>G	NP_000938.2:p.Asp204Gly		1.0						.	.	.						31	0.97							0.499907	124265.0	248576.0	0.0	66	1.0	InbreedingCoeff	afr	0.5	7736.0	0.499902	56324.0	0.0364042	5661	0.182	569.0				16.74	1.580964		1	9	10	fathmm-MKL_coding_pred	SIFT,PolyPhen,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-XF_coding_pred	PRIM2	0.0	0.0	0.0	0.0	0.0	-21.0	-1.0	13.0							0.0	32.921440911	0.969	-1.039	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];	57246884
63011	chr6	57398154	C	C	chr6:57398154	PRIM2	DNA primase subunit 2	SNV	0|1	0.88	9_84	95	99.0	0|1	0.88	16_122	139	99.0			rs80081867	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		10/14	NM_000947.5:c.857T>C	NP_000938.2:p.Pro286%3D		1.0						.	.	.						32	0.97							0.491001	114422.0	233038.0	8.0	82	1.0	InbreedingCoeff	nfe	0.492382	52611.0	0.492382	52611.0	0.0202889	3155	0.211	665.0				23.0	2.732579		0	0	0			PRIM2	0.0	0.0	0.0	0.0	-22.0	14.0	-14.0	14.0							0.0	32.921440911			.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];	57398154
63012	chr6	57398157	G	G	chr6:57398157	PRIM2	DNA primase subunit 2	SNV	0|1	0.89	9_86	97	99.0	0|1	0.88	16_126	143	99.0			rs9476080	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		10/14	NM_000947.5:c.860A>G	NP_000938.2:p.Cys287%3D		1.0						.	.	.						32	0.97							0.490922	114596.0	233430.0	8.0	85	1.0	InbreedingCoeff	nfe	0.492318	52681.0	0.492318	52681.0	0.0201088	3127	0.211	664.0				22.7	2.563688		0	0	0			PRIM2	0.01	0.0	0.0	0.0	11.0	2.0	11.0	-25.0							0.0	32.921440911			.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];	57398157
63013	chr6	57398163	G	G	chr6:57398163	PRIM2	DNA primase subunit 2	SNV	0|1	0.89	9_92	103	99.0	0|1	0.89	16_131	148	99.0			rs9476081	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		10/14	NM_000947.5:c.866A>G	NP_000938.2:p.Arg289%3D		1.0						.	.	.						32	0.97							0.489434	113859.0	232634.0	9.0	92	1.0	InbreedingCoeff	nfe	0.491147	52373.0	0.491147	52373.0	0.0201795	3138	0.201	632.0				20.8	2.125118		0	0	0			PRIM2	0.0	0.0	0.0	0.0	-31.0	5.0	-1.0	5.0							0.0	14.937332107			.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];	57398163
63014	chr6	57398187		A	chr6:57398186-57398187	PRIM2	DNA primase subunit 2	insertion	0/1	0.34	84_44	130	99.0	0/1	0.32	126_61	188	99.0			rs147954160	EXONIC	YES	NM_000947.5	Transcript	protein_coding	frameshift_variant		10/14	NM_000947.5:c.893dup	NP_000938.2:p.Asn298LysfsTer45		1.0						.	.	.						32	0.97							0.461417	63838.0	138352.0	0.0	100	1.0	InbreedingCoeff_RF	nfe	0.46781	30373.0	0.46781	30373.0	0.0030224,0.0221538	470,3445	0.032	100.0				35.0	5.952242		0	0	0			PRIM2	0.0	0.0	0.0	0.0	-18.0	36.0	-18.0	34.0							0.0	57.919392056			.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];	57398186
63015	chr6	57398201	C	C	chr6:57398201	PRIM2	DNA primase subunit 2	SNV	0/1	0.87	17_122	141	99.0	0/1	0.86	27_167	195	99.0			rs62398997	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		10/14	NM_000947.5:c.904T>C	NP_000938.2:p.Arg302%3D		1.0						.	.	.						32	0.97							0.492428	110296.0	223984.0	14.0	100	1.0	InbreedingCoeff	sas	0.493805	14028.0	0.493387	50059.0	0.0356068	5537	0.164	516.0				20.6	2.094072		0	0	0			PRIM2	0.0	0.0	0.0	0.0	-33.0	39.0	19.0	39.0							0.0	44.368133529			.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];	57398201
63016	chr6	57398226	G	G	chr6:57398226	PRIM2	DNA primase subunit 2	SNV	1/2	0.55	16_78_45	141	99.0	1/2	0.56	30_104_50	185	99.0			rs77436138	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		10/14	NM_000947.5:c.929T>G	NP_000938.2:p.Gly310%3D		1.0						.	.	.						32	0.97							0.344938	70181.0	203460.0	1.0	100	1.0	InbreedingCoeff	nfe	0.357232	33289.0	0.357232	33289.0	0.0099161	1542	0.065	191.0				21.8	2.262626		0	0	0			PRIM2	0.0	0.0	0.0	0.0	7.0	38.0	45.0	-6.0							0.0	0.000000000			.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];	57398226
63017	chr6	57398226	G	A	chr6:57398226	PRIM2	DNA primase subunit 2	SNV	1/2	0.32	16_78_45	141	99.0	1/2	0.27	30_104_50	185	99.0			rs77436138	EXONIC	YES	NM_000947.5	Transcript	protein_coding	missense_variant		10/14	NM_000947.5:c.929T>A	NP_000938.2:p.Gly310Asp		1.0						.	.	.						32	0.97							0.147262	29962.0	203460.0	0.0	100	1.0	InbreedingCoeff	afr	0.195757	2344.0	0.136426	12713.0	0.0045594	709	0.061	180.0				24.8	3.438127		2	0	2	SIFT,PolyPhen		PRIM2	0.0	0.0	0.0	0.0	-17.0	38.0	-12.0	-6.0							0.0	0.000000000			.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];	57398226
63018	chr6	57398264	G	G	chr6:57398264	PRIM2	DNA primase subunit 2	SNV	0/1	0.87	12_96	110	43.0	0/1	0.82	25_119	145	99.0			rs62398998	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		10/14	NM_000947.5:c.967A>G	NP_000938.2:p.Ala323%3D		1.0						.	.	.						33	0.97							0.496516	116143.0	233916.0	26.0	95	1.0	InbreedingCoeff	nfe	0.497011	53214.0	0.497011	53214.0	0.0342049	5319	0.148	446.0				19.35	1.950996		0	0	0			PRIM2	0.03	0.0	0.0	0.0	0.0	-24.0	-44.0	33.0							0.0	44.368133529			.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];	57398264
63019	chr6	57398270	C	T	chr6:57398270	PRIM2	DNA primase subunit 2	SNV	0/1	0.27	73_28	102	99.0	0/1	0.24	100_32	133	99.0			rs62398999,COSV67291773	EXONIC	YES	NM_000947.5	Transcript	protein_coding	stop_gained		10/14	NM_000947.5:c.973C>T	NP_000938.2:p.Gln325Ter		1.0						.	.	.						32	0.96							0.464235	84383.0	181768.0	0.0	91	1.0	InbreedingCoeff	nfe	0.470419	39471.0	0.470419	39471.0	0.0313047	4868	0.118	339.0				37.0	7.262467		3	0	3	BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred		PRIM2	0.0	0.01	0.01	0.01	-50.0	-6.0	-50.0	47.0							0.0	44.368133529	1.0	1.012	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];	57398270
63033	chr6	57467084	A	G	chr6:57467084	PRIM2	DNA primase subunit 2	SNV	0|1	0.31	60_27	88	99.0	0|1	0.21	77_20	97	99.0			rs9885913,COSV67291485	EXONIC	YES	NM_000947.5	Transcript	protein_coding	missense_variant		11/14	NM_000947.5:c.1025A>G	NP_000938.2:p.Asp342Gly		1.0						.	.	.		6.57151e-06	1.0	152172.0	0.0	32	0.96	PASS	eas	0.000192604	1.0	0.0	0.0	0.499564	115649.0	231500.0	0.0	61	1.0	InbreedingCoeff	sas	0.499932	14647.0	0.499404	51957.0	0.0187905	2922	0.196	605.0				25.1	3.526431		8	3	11	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred	PRIM2	0.04	0.0	0.0	0.0	6.0	-4.0	-1.0	5.0							0.0	48.768084866	1.0	1.221	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];	57467084
63034	chr6	57467093	A	G	chr6:57467093	PRIM2	DNA primase subunit 2	SNV	0|1	0.29	65_27	93	99.0	0|1	0.22	85_24	109	99.0			rs9885916,COSV67291488	EXONIC	YES	NM_000947.5	Transcript	protein_coding	missense_variant		11/14	NM_000947.5:c.1034A>G	NP_000938.2:p.Tyr345Cys		1.0						.	.	.						32	0.96							0.499516	116545.0	233316.0	0.0	65	1.0	InbreedingCoeff	sas	0.499966	14686.0	0.499363	52484.0	0.0187905	2922	0.095	252.0				25.7	3.693188		8	3	11	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred	PRIM2	0.0	0.0	0.0	0.0	-13.0	-3.0	35.0	-4.0							0.0	21.873700008	0.998	1.221	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];	57467093
63035	chr6	57467100	C	C	chr6:57467100	PRIM2	DNA primase subunit 2	SNV	0/1	0.65	35_68	104	99.0	0/1	0.59	48_69	117	99.0			rs4535533	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		11/14	NM_000947.5:c.1041G>C	NP_000938.2:p.Tyr347%3D		1.0						.	.	.		1.97249e-05	3.0	152092.0	0.0	32	0.95	PASS	eas	0.000192753	1.0	0.0	0.0	0.500016	124606.0	249204.0	4.0	69	1.0	InbreedingCoeff	nfe	0.500027	56501.0	0.500027	56501.0	0.0253884	3948	0.097	254.0				9.193	0.477967		0	0	0			PRIM2	0.01	0.01	0.0	0.0	15.0	-10.0	-11.0	-10.0							0.0	21.873700008			.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];	57467100
63036	chr6	57467107	C	T	chr6:57467107	PRIM2	DNA primase subunit 2	SNV	0/1	0.27	81_30	112	99.0	0/1	0.26	91_32	123	99.0			rs9885751,COSV67291491	EXONIC	YES	NM_000947.5	Transcript	protein_coding	missense_variant		11/14	NM_000947.5:c.1048C>T	NP_000938.2:p.Arg350Cys		1.0						.	.	.		6.5735e-05	10.0	152126.0	0.0	32	0.96	PASS,PASS	amr,nfe	0.000327311	5.0	0.0	0.0	0.49948	118154.0	236554.0	0.0	73	1.0	InbreedingCoeff	sas	0.5	14697.0	0.499328	53504.0	0.0218901	3404	0.095	251.0				17.94	1.765823		8	3	11	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred	PRIM2	0.0	0.0	0.0	0.0	-17.0	-27.0	-18.0	-17.0							0.0		1.0	0.957	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];	57467107
63038	chr6	57467175	G	G	chr6:57467175	PRIM2	DNA primase subunit 2	SNV	0/1	0.44	73_57	131	99.0	0/1	0.44	89_69	158	99.0			rs4406234	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		11/14	NM_000947.5:c.1116A>G	NP_000938.2:p.Leu372%3D		1.0						.	.	.						32	0.95							0.49998	122649.0	245308.0	0.0	88	1.0	InbreedingCoeff	eas	0.5	8824.0	0.499982	55860.0	0.0310024	4821	0.179	552.0				13.36	0.99013		0	0	0			PRIM2	0.0	0.0	0.0	0.0	-18.0	15.0	31.0	35.0							0.0				.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];	57467175
63066	chr6	57512476	A	A	chr6:57512476	PRIM2	DNA primase subunit 2	SNV	0/1	0.68	23_50	73	99.0	0/1	0.74	21_62	84	99.0			rs4307164	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		14/14	NM_000947.5:c.1304G>A	NP_000938.2:p.Asp435%3D		1.0						.	.	.		6.57333e-06	1.0	152130.0	0.0	29	0.91	PASS	afr	2.41359e-05	1.0	0.0	0.0	0.50025	123968.0	247812.0	62.0	96	1.0	InbreedingCoeff	eas	0.501058	9001.0	0.50034	55898.0	0.0310153	4823	0.188	592.0				15.1	1.282483		0	0	0			PRIM2	0.01	0.0	0.0	0.0	-4.0	47.0	41.0	-5.0							0.0				.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];	57512476
63067	chr6	57512529	C	A	chr6:57512529	PRIM2	DNA primase subunit 2	SNV	0/1	0.27	99_38	139	99.0	0/1	0.25	112_37	151	99.0			rs5001076,COSV67291545	EXONIC	YES	NM_000947.5	Transcript	protein_coding	missense_variant		14/14	NM_000947.5:c.1357C>A	NP_000938.2:p.Arg453Ser		1.0						.	.	.	25961151	6.57479e-06	1.0	152096.0	0.0	30	0.95	PASS				0.0	0.0	0.499037	117630.0	235714.0	0.0	100	1.0	InbreedingCoeff	sas	0.499966	14610.0	0.498797	53509.0	0.0185847	2890	0.185	568.0				13.61	1.026598		2	7	9	SIFT,LIST-S2_pred	PolyPhen,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	PRIM2	0.0	0.0	0.0	0.0	2.0	-6.0	-30.0	15.0							0.0		0.985	0.961	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];	57512529
63068	chr6	57512565	C	C	chr6:57512565	PRIM2	DNA primase subunit 2	SNV	0/1	0.72	53_140	195	99.0	0/1	0.71	55_138	194	99.0			rs4294008	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		14/14	NM_000947.5:c.1393T>C	NP_000938.2:p.Pro465%3D		1.0						.	.	.						31	0.95							0.500261	124593.0	249056.0	65.0	100	1.0	InbreedingCoeff	eas	0.501391	9012.0	0.500292	56445.0	0.0364299	5665	0.192	608.0				0.382	-0.293619		0	0	0			PRIM2	0.0	0.0	0.0	0.0	-42.0	13.0	-40.0	-48.0							0.0				.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];	57512565
63069	chr6	57512678	A	A	chr6:57512678	PRIM2	DNA primase subunit 2	SNV	0/1	0.64	61_112	174	99.0	0/1	0.62	69_111	180	99.0			rs4398719	EXONIC	YES	NM_000947.5	Transcript	protein_coding	synonymous_variant		14/14	NM_000947.5:c.1506G>A	NP_000938.2:p.Glu502%3D		1.0						.	.	.						31	0.96							0.500181	124336.0	248582.0	46.0	100	1.0	InbreedingCoeff	eas	0.500835	9001.0	0.500214	56200.0	0.0337419	5247	0.204	645.0				5.254	0.161463		0	0	0			PRIM2	0.0	0.0	0.0	0.0	32.0	25.0	32.0	24.0							0.0				.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;uterus corpus;superior cervical ganglion;skeletal muscle;	Purine metabolism;Pyrimidine metabolism;DNA replication	G1/S transition of mitotic cell cycle;DNA replication, synthesis of RNA primer;telomere maintenance via semi-conservative replication	nucleoplasm;alpha DNA polymerase:primase complex	single-stranded DNA binding;DNA primase activity;metal ion binding;4 iron, 4 sulfur cluster binding	JUN[25609649];KDM1A[23455924];SUV39H1[23455924];PRIM1[unassigned1304];RPA1[17673209];CHM[19615732];RPA2[20643958];HSCB[28380382];YWHAZ[15161933];BAG6[26496610];POLA1[12138179];CDK8[29568061];POLA2[12138179];MMS19[28178521];CIAO2B[28178521];RECK[unassigned1304];	57512678
63135	chr6	64431525	C	G	chr6:64431525	EYS	eyes shut homolog	SNV	0/1	0.4	26_17	43	99.0	0/1	0.48	34_32	66	99.0			rs1163416783	EXONIC	YES	NM_001292009.2	Transcript	protein_coding	missense_variant		44/44	NM_001292009.2:c.8465G>C	NP_001278938.1:p.Gly2822Ala		-1.0	.,Laminin G domain&Laminin G domain&Laminin G domain				Retinitis pigmentosa 25, 602772 (3), Autosomal recessive	Retinitis pigmentosa	Disease-causing germline mutation(s) in	Undetectable electroretinogram;Nyctalopia;Optic disc pallor;Attenuation of retinal blood vessels;Rod-cone dystrophy;Autosomal recessive inheritance;Chorioretinal atrophy;Photophobia;Constriction of peripheral visual field;Bone spicule pigmentation of the retina;Posterior subcapsular cataract;Hyperinsulinemia;Optic atrophy;Nystagmus;Abnormal retinal vascular morphology;Obesity;Hypoplasia of penis;Cataract;Abnormality of retinal pigmentation;Keratoconus;Progressive night blindness;Ophthalmoplegia;Abnormal testis morphology;Atypical scarring of skin;Hyperreflexia;Sensorineural hearing impairment;Blindness;Type II diabetes mellitus;Conductive hearing impairment;Photophobia;Intellectual disability;Anteverted nares;Abnormal electroretinogram;Wide nasal bridge;Hypogonadism;Glaucoma		6.57782e-06	1.0	152026.0	0.0	32	0.97	PASS	nfe	1.47067e-05	1.0	1.47067e-05	1.0	1.27322e-05	2.0	157082.0	0.0	87	0.6	PASS	nfe	3.28526e-05	2.0	3.28526e-05	2.0					0.00018	2.0		24.0	3.176654	0.35	12	8	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,ClinPred_pred,fathmm-MKL_coding_pred	MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-XF_coding_pred	EYS	0.0	0.0	0.0	0.0	36.0	-37.0	-7.0	-1.0						0.0537	0.0	0.000000000	0.964	0.877	.			ciliary ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;skin;	.	skeletal muscle tissue regeneration;detection of light stimulus involved in visual perception	extracellular exosome	molecular_function;calcium ion binding	.	64431525
63328	chr6	83075484	C	T	chr6:83075484	TPBG	trophoblast glycoprotein	SNV	0/1	0.58	66_92	158	99.0	0/0	0.0	33_0	33	99.0			rs376116704	EXONIC	YES	NM_006670.5	Transcript	protein_coding	missense_variant		3/3	NM_006670.5:c.806C>T	NP_006661.1:p.Ala269Val		1.0	.,.,.					.	.	.		1.31397e-05	2.0	152210.0	0.0	33	0.98	PASS	afr	2.41289e-05	1.0	1.46959e-05	1.0	3.97842e-06	1.0	251356.0	0.0	76	1.0	PASS	afr	6.15157e-05	1.0	0.0	0.0	0.0000064	1						29.2	4.165006	0.446	10	10	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationTaster_pred,PROVEAN_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	TPBG	0.0	0.0	0.0	0.0	-20.0	-24.0	7.0	20.0						0.296	0.12	0.000000000	0.998	1.026	nervous system phenotype ; mortality/aging ; cellular phenotype; 			.	.	cell adhesion;positive regulation of synapse assembly	endoplasmic reticulum;integral component of plasma membrane;cell surface	.	GIPC1[11798178];	83075484
63343	chr6	83847340	G	A	chr6:83847340	DOPEY1		SNV	0/1	0.4	46_31	77	99.0	0/0	0.0	34_0	34	99.0			rs140576384	EXONIC	YES	NM_001199942.2	Transcript	protein_coding	synonymous_variant		21/40	NM_001199942.2:c.3552G>A	NP_001186871.1:p.Thr1184%3D		1.0										0.000434022	66.0	152066.0	0.0	32	0.97	PASS	afr	0.00132818	55.0	0.000132341	9.0	0.000155651	39.0	250560.0	0.0	68	0.99	PASS	afr	0.00135485	22.0	9.72333e-05	11.0	0.0001865	29						0.003	-0.951614		0	0	0			DOPEY1	0.0	0.0	0.0	0.01	14.0	31.0	-31.0	49.0						0.677	1.0	14.914055813												83847340
63458	chr6	88374496	G	A	chr6:88374496	ORC3	origin recognition complex subunit 3	SNV	0/1	0.47	28_25	53	99.0	0/0	0.0	34_0	34	99.0			rs760493322	EXONIC	YES	NM_181837.3	Transcript	protein_coding	synonymous_variant		18/20	NM_181837.3:c.1872G>A	NP_862820.1:p.Pro624%3D		1.0						.	.	.		6.57237e-06	1.0	152152.0	0.0	32	0.97	PASS	nfe	1.47003e-05	1.0	1.47003e-05	1.0	3.58012e-05	9.0	251388.0	0.0	50	0.99	PASS	amr	0.00011566	4.0	4.39808e-05	5.0	0.0000129	2						11.06	0.689504		0	0	0			ORC3	0.0	0.0	0.0	0.0	14.0	-28.0	-41.0	1.0							0.0	32.921440911			limbs/digits/tail phenotype; nervous system phenotype ; skeleton phenotype; mortality/aging ; cellular phenotype; 			occipital lobe;testis - seminiferous tubule;testis - interstitial;prefrontal cortex;testis;spinal cord;hypothalamus;	Cell cycle	G1/S transition of mitotic cell cycle;DNA replication;pre-replicative complex assembly involved in nuclear cell cycle DNA replication;DNA replication initiation;neural precursor cell proliferation	nuclear chromosome, telomeric region;origin recognition complex;nucleoplasm;nuclear pre-replicative complex;nuclear origin of replication recognition complex;nuclear body;DNA replication preinitiation complex	DNA replication origin binding;protein binding	MDC1[29656893];MCM7[15232106];FOXE1[25609649];MCM10[15232106];BRCA1[17525332];KLC1[26496610];NOP9[26496610];ORC5[15232106;17716973];FOXQ1[25609649];ORC4[15232106;17716973];CDC45[15232106];ORC6[15232106;17716973];ORC1[15232106;17716973;26496610;16549788;22398447];ORC2[17716973;26496610;16549788];MCMBP[24299456];QSOX2[26496610];KIFAP3[26496610];TEAD2[25609649];CBX5[20689044];PLK1[26496610];CDC5L[20467437];CDC6[15232106];FOXL1[25609649];LRWD1[26496610];ILF2[20808282];SNW1[20467437];CCNE2[15232106];VAPA[26496610];CAT[29568061];TACC3[26496610];MCM5[15232106];	88374496
63463	chr6	89638945	C	T	chr6:89638945	RNGTT	RNA guanylyltransferase and 5'-phosphatase	SNV	0/0	0.0	4_0	4	0.0	0/1	0.31	11_5	16	99.0			rs149938605	EXONIC	YES	NM_003800.5	Transcript	protein_coding	synonymous_variant		3/16	NM_003800.5:c.216G>A	NP_003791.3:p.Arg72%3D		-1.0						.	.	.		0.00126271	190.0	150470.0	0.0	31	0.93	PASS	nfe	0.00212527	144.0	0.00212527	144.0	0.000976735	243.0	248788.0	0.0	40	0.91	PASS	nfe	0.00163361	184.0	0.00163361	184.0	0.0009903	154	0.002	6.0				8.516	0.41103		0	0	0			RNGTT	0.0	0.0	0.0	0.0	41.0	0.0	-49.0	1.0						0.263	0.76	65.017561937			.			ciliary ganglion;appendix;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;	.	transcription by RNA polymerase II;7-methylguanosine mRNA capping;RNA processing;viral process;peptidyl-tyrosine dephosphorylation;polynucleotide 5' dephosphorylation	nucleus;nucleoplasm	mRNA guanylyltransferase activity;polynucleotide 5'-phosphatase activity;protein tyrosine phosphatase activity;protein binding;GTP binding;protein tyrosine/serine/threonine phosphatase activity;RNA guanylyltransferase activity;triphosphatase activity	JUN[25609649];INTU[27173435;unassigned1312];APPBP2[unassigned1304];MYC[17314511];TP53BP1[29656893];MKI67[26949251];NCK1[25137142];	89638945
63467	chr6	89791068	C	T	chr6:89791068	PNRC1	proline rich nuclear receptor coactivator 1	SNV	0/1	0.61	18_30	49	99.0	0/1	0.32	32_15	47	99.0			rs2231273,COSV100259987	EXONIC	YES	NM_006813.3	Transcript	protein_coding	missense_variant		1/2	NM_006813.3:c.455C>T	NP_006804.1:p.Ala152Val		1.0						.	.	.		0.00677783	1030.0	151966.0	4.0	32	0.95	PASS	nfe	0.00989021	672.0	0.00989021	672.0	0.00783112	368.0	46992.0	4.0	2	0.03	PASS	nfe	0.0121075	209.0	0.0121075	209.0	0.0008038	125	0.004	13.0				11.5	0.74303	0.035	0	18	18		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PNRC1	0.0	0.0	0.0	0.0	-40.0	3.0	-38.0	11.0							0.84		0.063	0.802	.			.	.	.	nucleus	protein binding	UPF1[19150429];MAPK8[21900206];NPM1[30021884];RARA[17641689];POLR3F[17612402];DCP1A[26496610];PNRC1[17612402];CRKL[26496610];	89791068
63483	chr6	100988267		A	chr6:100988266-100988267	ASCC3	activating signal cointegrator 1 complex subunit 3	insertion	0/1	0.3	15_9	30	99.0	0/0	0.0	15_0	15	10.0			rs753164821	SPLICING	YES	NM_006828.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	36/41		NM_006828.4:c.5551-4dup			-1.0						.	.	.		0.00211763	273.0	128918.0	0.0	31	0.84	PASS	afr	0.00447919	161.0	0.00082536	49.0	0.106656	12088.0	113336.0	0.0	34	0.84	InbreedingCoeff	eas	0.135777	1115.0	0.0959004	5006.0	0.0004437,0.0000643,0.0004244,0.0001222,0.0000514	69,10,66,19,8			0.00473	53.0		13.81	1.058196		0	0	0			ASCC3	0.0	0.0	0.0	0.0	-10.0	-6.0	-29.0	-13.0						0.78	0.0				homeostasis/metabolism phenotype; skeleton phenotype; limbs/digits/tail phenotype; 			trigeminal ganglion;	Starch and sucrose metabolism;Folate biosynthesis	DNA dealkylation involved in DNA repair;cell population proliferation;DNA duplex unwinding	nucleus;nucleoplasm;cytosol;membrane;nuclear speck;activating signal cointegrator 1 complex	RNA binding;protein binding;ATP binding;ATP-dependent helicase activity;ATP-dependent 3'-5' DNA helicase activity	NOTCH1[23022380];KSR1[27086506];PYCR1[30021884];IQGAP1[26496610];CEP128[26638075];SUMO3[17000644];OTUD6B[19615732];G3BP1[19615732];G3BP2[19615732];CDK1[26496610];EIF3H[19615732];CEP170[26638075];VIM[30021884];SKIL[15231748];CC2D2A[26638075];BCAR1[28007913];	100988266
63485	chr6	101215224	AA		chr6:101215224-101215225	ASCC3	activating signal cointegrator 1 complex subunit 3	sequence_alteration	1/2	0.15	0_4_22	26	40.0	2/2	0.0	0_0_34	34	99.0			rs11345864	SPLICING	YES	NM_006828.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	8/41		NM_006828.4:c.1396-4_1396-3del			-1.0						.	.	.		0.000132162	20.0	151330.0	0.0	0	0.0	PASS	amr	0.00118828	18.0	1.47254e-05	1.0	9.34253e-05	23.0	246186.0	0.0	39	0.54	PASS	amr	0.000117405	4.0	5.37038e-05	6.0	0.0026237	408			0.00473	54.0		8.549	0.414142		0	0	0			ASCC3	0.0	0.0	0.0	0.0	-11.0	-2.0	19.0	-11.0						0.78	0.0				homeostasis/metabolism phenotype; skeleton phenotype; limbs/digits/tail phenotype; 			trigeminal ganglion;	Starch and sucrose metabolism;Folate biosynthesis	DNA dealkylation involved in DNA repair;cell population proliferation;DNA duplex unwinding	nucleus;nucleoplasm;cytosol;membrane;nuclear speck;activating signal cointegrator 1 complex	RNA binding;protein binding;ATP binding;ATP-dependent helicase activity;ATP-dependent 3'-5' DNA helicase activity	NOTCH1[23022380];KSR1[27086506];PYCR1[30021884];IQGAP1[26496610];CEP128[26638075];SUMO3[17000644];OTUD6B[19615732];G3BP1[19615732];G3BP2[19615732];CDK1[26496610];EIF3H[19615732];CEP170[26638075];VIM[30021884];SKIL[15231748];CC2D2A[26638075];BCAR1[28007913];	101215223
63581	chr6	109700847	T	C	chr6:109700847	CD164	CD164 molecule	SNV	0/0	0.0	33_0	33	99.0	0/1	0.42	40_29	69	99.0			rs145357332	EXONIC	YES	NM_006016.6	Transcript	protein_coding	missense_variant		2/6	NM_006016.6:c.194A>G	NP_006007.2:p.Asn65Ser		-1.0	.,.,.,.,.,.	Likely_benign	criteria_provided,_single_submitter	not_provided	?Deafness, autosomal dominant 66, 616969 (3), Autosomal dominant	Autosomal dominant non-syndromic sensorineural deafness type DFNA	Disease-causing germline mutation(s) in	Autosomal dominant inheritance;Variable expressivity;Sensorineural hearing impairment		0.000847502	129.0	152212.0	0.0	32	0.97	PASS	sas	0.00124275	6.0	0.000984831	67.0	0.00115463	289.0	250296.0	1.0	52	0.9	PASS	nfe	0.00102161	116.0	0.00102161	116.0	0.0008939	139	0.001	3.0				10.18	0.584706	0.032	1	19	20	PROVEAN_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CD164	0.0	0.0	0.0	0.0	6.0	-28.0	-22.0	7.0						0.423	0.4	0.000000000	0.645	1.118	.			kidney;trachea;thyroid;placenta;fetal liver;	.	immune response;cell adhesion;heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules;negative regulation of cell adhesion;signal transduction;multicellular organism development;muscle organ development;negative regulation of cell population proliferation;hemopoiesis	extracellular region;lysosome;lysosomal membrane;endosome;plasma membrane;integral component of plasma membrane;endosome membrane;cytoplasmic vesicle	protein binding	ANKRD28[23414517];MYO5B[17673908];ACKR3[24094005];CXCR4[24094005];GRB2[18624398];HOXA1[unassigned1304];HSCB[24606901];NOTCH2NLA[25416956;unassigned1304];	109700847
63626	chr6	110012665	C	T	chr6:110012665	FIG4	FIG4 phosphoinositide 5-phosphatase	SNV	0/0	0.0	45_0	45	99.0	0/1	0.47	52_47	99	99.0			rs141040807	EXONIC	YES	NM_014845.6	Transcript	protein_coding	synonymous_variant		1/23	NM_014845.6:c.27C>T	NP_055660.1:p.Ile9%3D		1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Charcot-Marie-Tooth_disease,_type_4J|Amyotrophic_lateral_sclerosis_type_11|Charcot-Marie-Tooth_disease|Charcot-Marie-Tooth_disease_type_4|not_specified|not_provided	Yunis-Varon syndrome, 216340 (3), Autosomal recessive; ?Polymicrogyria, bilateral temporooccipital, 612691 (3), Autosomal recessive; Amyotrophic lateral sclerosis 11, 612577 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 4J, 611228 (3), Autosomal recessive	Amyotrophic lateral sclerosis;Charcot-Marie-Tooth disease type 4J;Yunis-Varon syndrome;Bilateral parasagittal parieto-occipital polymicrogyria	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Autosomal recessive inheritance;Ankle flexion contracture;Distal sensory impairment;Peripheral hypomyelination;Distal arthrogryposis;Motor delay;Distal muscle weakness;Variable expressivity;Onion bulb formation;Decreased motor nerve conduction velocity;Progressive;Frequent falls;Gait disturbance;Areflexia;Decreased nerve conduction velocity;Hyporeflexia;Axonal loss;Laryngospasm;Nausea and vomiting;Dyspnea;Anxiety;Pain;Paralysis;Agitation;Generalized muscle weakness;Depressivity;Amyotrophic lateral sclerosis;Xerostomia;Fatigable weakness of respiratory muscles;Muscle spasm;Fatigable weakness of swallowing muscles;Skeletal muscle atrophy;Neurodegeneration;Emotional lability;Spasticity;Respiratory failure;Fatigue;High forehead;Short philtrum;Generalized neonatal hypotonia;Ventricular septal defect;Aplasia/Hypoplasia of the scapulae;Tetralogy of Fallot;Tapered finger;Short stature;Neuronal loss in central nervous system;Increased nuchal translucency;Hypospadias;Postnatal growth retardation;Hypertelorism;Aplasia/Hypoplasia of the nails;Hip dislocation;Redundant neck skin;Sparse eyelashes;Pyloric stenosis;Slender long bones with narrow diaphyses;Broad secondary alveolar ridge;Sparse scalp hair;Abnormal parietal bone morphology;High, narrow palate;Rocker bottom foot;Anteverted nares;Cataract;Flared metaphysis;Global developmental delay;Absent thumb;Abnormality of dental structure;Thin vermilion border;Hearing impairment;Pachygyria;Hypoplastic labia majora;Upslanted palpebral fissure;Glossoptosis;Clitoral hypertrophy;Cryptorchidism;Absent sternal ossification;Renovascular hypertension;Dolichocephaly;Hypoplasia of the frontal lobes;Cardiomegaly;Aplasia of the 1st metacarpal;Hydrops fetalis;Pulmonary arterial hypertension;Aplasia/Hypoplasia of the nipples;Cerebellar hypoplasia;Wide cranial sutures;Aplasia of the distal phalanx of the hallux;Bilateral external ear deformity;Micrognathia;Aplasia/hypoplasia of the 1st metatarsal;Short ribs;Aplasia/Hypoplasia of the clavicles;Sclerocornea;Renal artery stenosis;Short chin;Aplasia of the distal phalanges of the hand;Low-set ears;Agenesis of corpus callosum;Syndactyly;Sparse eyebrow;Shortening of all distal phalanges of the toes;Short middle phalanx of finger;Decreased skull ossification;Atrial septal defect;Severe failure to thrive;Abnormality of the occipital bone;Arrhinencephaly;Bilateral microphthalmos;Single transverse palmar crease;Premature loss of primary teeth;Hydrocephalus;Gingival recession;Congenital microcephaly;Short upper lip;Metatarsus adductus;Polyhydramnios;Abnormal pelvis bone morphology;Narrow nasal base;Micropenis;Proptosis;Cardiomyopathy;Short proximal phalanx of hallux;Micropenis;Hypoplastic facial bones;Aplasia/Hypoplasia of the distal phalanges of the hand;Autosomal recessive inheritance;Absent thumb;Aplasia/Hypoplasia of the middle phalanges of the hand;Sclerocornea;Large fontanelles;Upslanted palpebral fissure;Decreased skull ossification;Microcephaly;Premature loss of primary teeth;Aplasia/Hypoplasia of the nails;Generalized hypotonia;Short upper lip;Aplastic clavicle;Micrognathia;Pachygyria;Cerebellar hypoplasia;Severe failure to thrive;Tapered finger;Tapered toe;Sparse scalp hair;Ventricular septal defect;Absent sternal ossification;Dolichocephaly;Toe syndactyly;Small earlobe;Hypospadias;Agenesis of corpus callosum;Cardiomyopathy;Aplasia/Hypoplasia of the hallux;Pulmonary arterial hypertension;Intrauterine growth retardation;Anteverted nares;Broad secondary alveolar ridge;Cryptorchidism;Hypertelorism;Low-set ears;Cataract;Polyhydramnios;Pyloric stenosis;Arrhinencephaly;Single transverse palmar crease;Hearing impairment;Proptosis;Abnormality of the scapula;Premature birth;Tetralogy of Fallot;Absent nipple;Abnormality of blood and blood-forming tissues;Thin vermilion border;Sparse eyelashes;Tapered toe;Severe global developmental delay;Short philtrum;Sparse and thin eyebrow;Hip dislocation;Short finger;Abnormality of the neck;Short toe;Short clavicles;Hydrops fetalis;Autosomal dominant inheritance;Amyotrophic lateral sclerosis;Skeletal muscle atrophy;Bulbar signs;Upper motor neuron dysfunction;Ventriculomegaly;Aggressive behavior;Status epilepticus;Focal impaired awareness seizure;Autosomal recessive inheritance;Delirium;Visual hallucinations;Polymicrogyria;Variable expressivity		0.00389593	593.0	152210.0	1.0	32	0.97	PASS	nfe	0.00576182	392.0	0.00576182	392.0	0.00477078	968.0	202902.0	6.0	79	0.58	PASS	nfe	0.00567494	497.0	0.00567494	497.0	0.0034340	534	0.003	9.0	0.00159	18.0		13.71	1.042156		0	0	0			FIG4	0.0	0.0	0.0	0.0	3.0	13.0	43.0	39.0						0.977	0.0	84.987012863			nervous system phenotype ; skeleton phenotype; immune system phenotype; behavior/neurological phenotype ; pigmentation phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; growth/size/body region phenotype; mortality/aging ; integument phenotype ; craniofacial phenotype; muscle phenotype; 			pons;ciliary ganglion;caudate nucleus;temporal lobe;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;cingulate cortex;atrioventricular node;parietal lobe;globus pallidus;medulla oblongata;	.	phosphatidylinositol biosynthetic process;vacuole organization;locomotory behavior;positive regulation of neuron projection development;dephosphorylation;negative regulation of myelination;myelin assembly;phosphatidylinositol-3-phosphate biosynthetic process;pigmentation;neuron development	Golgi membrane;endoplasmic reticulum;lipid droplet;endosome membrane;early endosome membrane;late endosome membrane;intracellular membrane-bounded organelle;recycling endosome	phosphatidylinositol-3-phosphatase activity;protein binding;phosphatidylinositol-4-phosphate phosphatase activity;phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity	VAC14[19037259;unassigned1304];GORASP2[unassigned1304];	110012665
63628	chr6	110087924	T	A	chr6:110087924	FIG4	FIG4 phosphoinositide 5-phosphatase	SNV	0/0	0.0	31_0	31	90.0	0/1	0.47	18_16	34	99.0			rs199522051	SPLICING	YES	NM_014845.6	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	14/22		NM_014845.6:c.1584-8T>A			1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Charcot-Marie-Tooth_disease,_type_4J|Amyotrophic_lateral_sclerosis_type_11|Charcot-Marie-Tooth_disease|Charcot-Marie-Tooth_disease_type_4|not_specified|not_provided	Yunis-Varon syndrome, 216340 (3), Autosomal recessive; ?Polymicrogyria, bilateral temporooccipital, 612691 (3), Autosomal recessive; Amyotrophic lateral sclerosis 11, 612577 (3), Autosomal dominant; Charcot-Marie-Tooth disease, type 4J, 611228 (3), Autosomal recessive	Amyotrophic lateral sclerosis;Charcot-Marie-Tooth disease type 4J;Yunis-Varon syndrome;Bilateral parasagittal parieto-occipital polymicrogyria	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in	Autosomal recessive inheritance;Ankle flexion contracture;Distal sensory impairment;Peripheral hypomyelination;Distal arthrogryposis;Motor delay;Distal muscle weakness;Variable expressivity;Onion bulb formation;Decreased motor nerve conduction velocity;Progressive;Frequent falls;Gait disturbance;Areflexia;Decreased nerve conduction velocity;Hyporeflexia;Axonal loss;Laryngospasm;Nausea and vomiting;Dyspnea;Anxiety;Pain;Paralysis;Agitation;Generalized muscle weakness;Depressivity;Amyotrophic lateral sclerosis;Xerostomia;Fatigable weakness of respiratory muscles;Muscle spasm;Fatigable weakness of swallowing muscles;Skeletal muscle atrophy;Neurodegeneration;Emotional lability;Spasticity;Respiratory failure;Fatigue;High forehead;Short philtrum;Generalized neonatal hypotonia;Ventricular septal defect;Aplasia/Hypoplasia of the scapulae;Tetralogy of Fallot;Tapered finger;Short stature;Neuronal loss in central nervous system;Increased nuchal translucency;Hypospadias;Postnatal growth retardation;Hypertelorism;Aplasia/Hypoplasia of the nails;Hip dislocation;Redundant neck skin;Sparse eyelashes;Pyloric stenosis;Slender long bones with narrow diaphyses;Broad secondary alveolar ridge;Sparse scalp hair;Abnormal parietal bone morphology;High, narrow palate;Rocker bottom foot;Anteverted nares;Cataract;Flared metaphysis;Global developmental delay;Absent thumb;Abnormality of dental structure;Thin vermilion border;Hearing impairment;Pachygyria;Hypoplastic labia majora;Upslanted palpebral fissure;Glossoptosis;Clitoral hypertrophy;Cryptorchidism;Absent sternal ossification;Renovascular hypertension;Dolichocephaly;Hypoplasia of the frontal lobes;Cardiomegaly;Aplasia of the 1st metacarpal;Hydrops fetalis;Pulmonary arterial hypertension;Aplasia/Hypoplasia of the nipples;Cerebellar hypoplasia;Wide cranial sutures;Aplasia of the distal phalanx of the hallux;Bilateral external ear deformity;Micrognathia;Aplasia/hypoplasia of the 1st metatarsal;Short ribs;Aplasia/Hypoplasia of the clavicles;Sclerocornea;Renal artery stenosis;Short chin;Aplasia of the distal phalanges of the hand;Low-set ears;Agenesis of corpus callosum;Syndactyly;Sparse eyebrow;Shortening of all distal phalanges of the toes;Short middle phalanx of finger;Decreased skull ossification;Atrial septal defect;Severe failure to thrive;Abnormality of the occipital bone;Arrhinencephaly;Bilateral microphthalmos;Single transverse palmar crease;Premature loss of primary teeth;Hydrocephalus;Gingival recession;Congenital microcephaly;Short upper lip;Metatarsus adductus;Polyhydramnios;Abnormal pelvis bone morphology;Narrow nasal base;Micropenis;Proptosis;Cardiomyopathy;Short proximal phalanx of hallux;Micropenis;Hypoplastic facial bones;Aplasia/Hypoplasia of the distal phalanges of the hand;Autosomal recessive inheritance;Absent thumb;Aplasia/Hypoplasia of the middle phalanges of the hand;Sclerocornea;Large fontanelles;Upslanted palpebral fissure;Decreased skull ossification;Microcephaly;Premature loss of primary teeth;Aplasia/Hypoplasia of the nails;Generalized hypotonia;Short upper lip;Aplastic clavicle;Micrognathia;Pachygyria;Cerebellar hypoplasia;Severe failure to thrive;Tapered finger;Tapered toe;Sparse scalp hair;Ventricular septal defect;Absent sternal ossification;Dolichocephaly;Toe syndactyly;Small earlobe;Hypospadias;Agenesis of corpus callosum;Cardiomyopathy;Aplasia/Hypoplasia of the hallux;Pulmonary arterial hypertension;Intrauterine growth retardation;Anteverted nares;Broad secondary alveolar ridge;Cryptorchidism;Hypertelorism;Low-set ears;Cataract;Polyhydramnios;Pyloric stenosis;Arrhinencephaly;Single transverse palmar crease;Hearing impairment;Proptosis;Abnormality of the scapula;Premature birth;Tetralogy of Fallot;Absent nipple;Abnormality of blood and blood-forming tissues;Thin vermilion border;Sparse eyelashes;Tapered toe;Severe global developmental delay;Short philtrum;Sparse and thin eyebrow;Hip dislocation;Short finger;Abnormality of the neck;Short toe;Short clavicles;Hydrops fetalis;Autosomal dominant inheritance;Amyotrophic lateral sclerosis;Skeletal muscle atrophy;Bulbar signs;Upper motor neuron dysfunction;Ventriculomegaly;Aggressive behavior;Status epilepticus;Focal impaired awareness seizure;Autosomal recessive inheritance;Delirium;Visual hallucinations;Polymicrogyria;Variable expressivity	25741868	0.000860551	131.0	152228.0	0.0	32	0.97	PASS	sas	0.00103348	5.0	0.00101405	69.0	0.00115414	290.0	251270.0	1.0	66	1.0	PASS	nfe	0.00102946	117.0	0.00102946	117.0	0.0008617	134	0.001	2.0	0.00062	7.0		10.92	0.672748		0	0	0			FIG4	0.0	0.0	0.0	0.0	18.0	8.0	-27.0	36.0	0.0002910749479729	0.048	9.632	0.756	10.389	0.977	0.0				nervous system phenotype ; skeleton phenotype; immune system phenotype; behavior/neurological phenotype ; pigmentation phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; growth/size/body region phenotype; mortality/aging ; integument phenotype ; craniofacial phenotype; muscle phenotype; 			pons;ciliary ganglion;caudate nucleus;temporal lobe;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;cingulate cortex;atrioventricular node;parietal lobe;globus pallidus;medulla oblongata;	.	phosphatidylinositol biosynthetic process;vacuole organization;locomotory behavior;positive regulation of neuron projection development;dephosphorylation;negative regulation of myelination;myelin assembly;phosphatidylinositol-3-phosphate biosynthetic process;pigmentation;neuron development	Golgi membrane;endoplasmic reticulum;lipid droplet;endosome membrane;early endosome membrane;late endosome membrane;intracellular membrane-bounded organelle;recycling endosome	phosphatidylinositol-3-phosphatase activity;protein binding;phosphatidylinositol-4-phosphate phosphatase activity;phosphatidylinositol-3,5-bisphosphate 5-phosphatase activity	VAC14[19037259;unassigned1304];GORASP2[unassigned1304];	110087924
63775	chr6	119252910	A		chr6:119252910	MCM9	minichromosome maintenance 9 homologous recombination repair factor	sequence_alteration	0/2	0.27	10_1_4	15	62.0	0/1	0.0	11_3_0	14	42.0			rs768549255	SPLICING	YES	NM_001378357.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	2/13		NM_001378357.1:c.-15-7del			-1.0					Ovarian dysgenesis 4, 616185 (3), Autosomal recessive	46,XX ovarian dysgenesis-short stature syndrome	Disease-causing germline mutation(s) (loss of function) in	Autosomal recessive inheritance;Primary amenorrhea;Delayed skeletal maturation;Short stature;Decreased body weight		0.000148807	21.0	141122.0	0.0	32	0.95	PASS	afr	0.000495825	19.0	3.11158e-05	2.0	0.00817665	661.0	80840.0	0.0	15	0.34	RF	nfe	0.0101917	386.0	0.0101917	386.0	0.0046365	721			0.00074	7.0		9.351	0.49448		0	0	0			MCM9	0.03	0.0	0.0	0.0	-14.0	-6.0	-21.0	-44.0							0.0				liver/biliary system phenotype; reproductive system phenotype; hematopoietic system phenotype; neoplasm; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			ciliary ganglion;testis - seminiferous tubule;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;globus pallidus;cerebellum;	.	double-strand break repair via homologous recombination;DNA replication;cellular response to DNA damage stimulus;female gamete generation;DNA duplex unwinding;recombinational interstrand cross-link repair;mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication;protein localization to chromatin	nucleus;chromosome;MCM8-MCM9 complex	DNA binding;DNA helicase activity;chromatin binding;protein binding;ATP binding;enzyme binding;MutLbeta complex binding;MutSalpha complex binding;MutSbeta complex binding;protein-containing complex binding	MCMBP[25036637];MESD[unassigned1304];	119252909
63783	chr6	119252910	A	AA	chr6:119252910	MCM9	minichromosome maintenance 9 homologous recombination repair factor	sequence_alteration	0/2	0.07	10_1_4	15	62.0	0/1	0.21	11_3_0	14	42.0			rs768549255	SPLICING	YES	NM_001378357.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	2/13		NM_001378357.1:c.-15-7dup			-1.0					Ovarian dysgenesis 4, 616185 (3), Autosomal recessive	46,XX ovarian dysgenesis-short stature syndrome	Disease-causing germline mutation(s) (loss of function) in	Autosomal recessive inheritance;Primary amenorrhea;Delayed skeletal maturation;Short stature;Decreased body weight		0.000205578	29.0	141066.0	0.0	32	0.95	AS_VQSR	afr	0.000182691	7.0	0.000108949	7.0	0.0375557	3036.0	80840.0	0.0	15	0.34	RF	amr	0.0586456	504.0	0.0290701	1101.0	0.0000836,0.0000129,0.0055433	13,2,862			0.00074	7.0		11.02	0.684417		0	0	0			MCM9	0.01	0.0	0.0	0.0	-14.0	-6.0	-14.0	-44.0							0.0				liver/biliary system phenotype; reproductive system phenotype; hematopoietic system phenotype; neoplasm; endocrine/exocrine gland phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			ciliary ganglion;testis - seminiferous tubule;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;globus pallidus;cerebellum;	.	double-strand break repair via homologous recombination;DNA replication;cellular response to DNA damage stimulus;female gamete generation;DNA duplex unwinding;recombinational interstrand cross-link repair;mismatch repair involved in maintenance of fidelity involved in DNA-dependent DNA replication;protein localization to chromatin	nucleus;chromosome;MCM8-MCM9 complex	DNA binding;DNA helicase activity;chromatin binding;protein binding;ATP binding;enzyme binding;MutLbeta complex binding;MutSalpha complex binding;MutSbeta complex binding;protein-containing complex binding	MCMBP[25036637];MESD[unassigned1304];	119252909
63815	chr6	121412192	A		chr6:121412192	TBC1D32	TBC1 domain family member 32	deletion	0/0	0.0	12_0	12	11.0	0/1	0.21	11_3	14	43.0			rs397887772	SPLICING	YES	NM_001367759.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	32/33		NM_001367759.1:c.3589-5del			-1.0						.	.	.		0.000493911	73.0	147800.0	0.0	23	0.54	PASS	eas	0.00313972	16.0	0.000345688	23.0	0.0184347	2492.0	135180.0	0.0	35	0.76	PASS	sas	0.0295736	387.0	0.0176245	1174.0	0.0000064,0.0339091	1,5273						6.783	0.267007		0	0	0			TBC1D32	0.03	0.06	0.0	0.0	-47.0	-4.0	-4.0	3.0							0.0				growth/size/body region phenotype; nervous system phenotype ; craniofacial phenotype; vision/eye phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; pigmentation phenotype; embryo phenotype; respiratory system phenotype; immune system phenotype; renal/urinary system phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; 			.	.	lens development in camera-type eye;retinal pigment epithelium development;determination of left/right symmetry;heart development;embryonic digit morphogenesis;cilium assembly;smoothened signaling pathway involved in dorsal/ventral neural tube patterning;protein localization to cilium;non-motile cilium assembly	cytoplasm;cilium	.	HDAC1[unassigned1312];RB1CC1[20562859];XYLT2[unassigned1312];FOXJ1[25609649];RFX3[unassigned1312];CFAP20[27173435;unassigned1312];HIST1H1B[30021884];	121412191
63870	chr6	126307717	T	A	chr6:126307717	TRMT11	tRNA methyltransferase 11 homolog	SNV	0/0	0.0	45_0	45	99.0	0/1	0.5	54_54	108	99.0			rs139696952,COSV100543349	EXONIC	YES	NM_001031712.3	Transcript	protein_coding	synonymous_variant		1/13	NM_001031712.3:c.21T>A	NP_001026882.2:p.Leu7%3D		1.0						.	.	.		0.000381078	58.0	152200.0	0.0	33	0.99	PASS	nfe	0.000793767	54.0	0.000793767	54.0	0.000480872	103.0	214194.0	0.0	30	0.6	PASS	nfe	0.000908809	88.0	0.000908809	88.0	0.0003666	57	0.0	1.0				9.123	0.470711		0	0	0			TRMT11	0.0	0.0	0.09	0.0	28.0	6.0	5.0	-8.0						0.907	0.0	67.312300464			.			temporal lobe;superior cervical ganglion;trigeminal ganglion;	Androgen and estrogen metabolism;Histidine metabolism;Tyrosine metabolism;Tryptophan metabolism;Aminophosphonate metabolism;Selenoamino acid metabolism	tRNA methylation	.	tRNA binding;tRNA (guanine-N2-)-methyltransferase activity	WDR48[19615732];MGST3[29568061];RPL27A[30021884];LHX4[unassigned1304];HSCB[28380382];TRMT61B[29568061];HSPD1[29568061];PDK1[29568061];	126307717
63950	chr6	131948817	A		chr6:131948817	MED23	mediator complex subunit 23	deletion	0/1	0.3	20_9	30	99.0	0/1	0.22	14_6	27	65.0			rs200823095	SPLICING	YES	NM_001376517.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/29		NM_001376517.1:c.40-5del			-1.0		Likely_benign	criteria_provided,_single_submitter	History_of_neurodevelopmental_disorder	Intellectual developmental disorder, autosomal recessive 18, with or without epilepsy, 614249 (3), Autosomal recessive	Autosomal recessive non-syndromic intellectual disability	Disease-causing germline mutation(s) in	Intellectual disability;Autosomal recessive inheritance;Dystonia;Cerebral atrophy;Cerebral visual impairment;Autistic behavior;Intellectual disability, mild;Generalized hypotonia;Hypoplasia of the corpus callosum;Poor speech;Multifocal epileptiform discharges;Large basal ganglia;Stereotypy;Hypsarrhythmia;Microcephaly;Motor delay;Hyperactivity;Absent septum pellucidum;Delayed speech and language development;Intellectual disability, moderate;Chorea;Nasogastric tube feeding;Impulsivity;Sleep disturbance;Epileptic spasm;Short attention span;Global developmental delay;Depressivity;Intellectual disability, severe;Cortical dysplasia;Polymicrogyria;Abnormal facial shape;Generalized-onset seizure;Dyskinesia;Focal-onset seizure;Spasticity		0.00158372	209.0	131968.0	0.0	17	0.48	PASS	amr	0.00202825	27.0	0.00116861	70.0	0.0813771	12216.0	150116.0	0.0	43	0.82	InbreedingCoeff	nfe	0.100698	6778.0	0.100698	6778.0	0.0022443,0.0000193,0.1008849	349,3,15688			0.0838	948.0		7.216	0.300416		0	0	0			MED23	0.0	0.0	0.01	0.0	-9.0	-4.0	-41.0	-35.0						0.412	0.15				nervous system phenotype ; cardiovascular system phenotype ; normal phenotype; mortality/aging ; embryo phenotype; cellular phenotype; growth/size/body region phenotype; 			trigeminal ganglion;superior cervical ganglion;parietal lobe;skeletal muscle;	.	regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II;transcription initiation from RNA polymerase II promoter;positive regulation of nucleic acid-templated transcription	nucleoplasm;transcription factor complex	transcription coactivator activity;protein binding	MED1[20098423];CDK19[15175163;23602568];NOTCH1[23022380];FOXJ3[12421765];MED19[15175163;14576168;21729782];MED9[15175163;14638676];MED4[21293490];MED16[24882805];MED26[15175163;21729782];HIF1A[23746844];MED29[15175163];ESR2[21182203];PUM2[12421765];MED12[26496610];CDK8[18418385;23602568;26496610;20098423;29568061];KAT2A[18418385];MED14[24882805];MED25[24882805];NEURL4[29426014];MED13[12421765];BCL6[16147992];NUDCD1[29021621];MED10[15175163;14576168;24882805];WDTC1[12421765];	131948816
64021	chr6	136582417	G	A	chr6:136582417	BCLAF1	BCL2 associated transcription factor 1	SNV	0/1	0.19	43_10	54	99.0	0/0	0.09	32_3	35	0.0			rs62431283,COSV50356765	EXONIC	YES	NM_014739.3	Transcript	protein_coding	missense_variant		12/13	NM_014739.3:c.2743C>T	NP_055554.1:p.Arg915Cys		-1.0	.,.,.,.,.,.	Benign	criteria_provided,_single_submitter	not_specified		.	.	.	24033266					32	0.97							0.484593	73380.0	151426.0	4.0	78	1.0	InbreedingCoeff_RF	sas	0.493946	10036.0	0.481553	32945.0	0.0012861	200	0.038	119.0				28.9	4.133855	0.296	10	10	20	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,ClinPred_pred	BCLAF1	0.0	0.0	0.0	0.0	-45.0	14.0	-31.0	-14.0						0.873			1.0	1.176	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype ; respiratory system phenotype; hematopoietic system phenotype; mortality/aging ; 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];	136582417
64036	chr6	136582497	G	T	chr6:136582497	BCLAF1	BCL2 associated transcription factor 1	SNV	0/1	0.41	74_54	132	99.0	0/1	0.3	72_34	112	99.0			rs62431284,COSV50356777	EXONIC	YES	NM_014739.3	Transcript	protein_coding	missense_variant		12/13	NM_014739.3:c.2663C>A	NP_055554.1:p.Thr888Asn		-1.0	.,.,.,.,.,.	Benign	criteria_provided,_single_submitter	not_specified		.	.	.	24033266					32	0.96							0.497374	123282.0	247866.0	7.0	100	1.0	InbreedingCoeff	sas	0.499901	15221.0	0.498292	56311.0	0.0161025	2504	0.192	598.0				26.3	3.807733	0.191	10	10	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationTaster_pred,PrimateAI_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	BCLAF1	0.0	0.0	0.0	0.0	-18.0	18.0	19.0	18.0						0.873			1.0	1.176	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype ; respiratory system phenotype; hematopoietic system phenotype; mortality/aging ; 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];	136582497
64069	chr6	136590613	T	C	chr6:136590613	BCLAF1	BCL2 associated transcription factor 1	SNV	0/1	0.23	40_13	57	99.0	0/1	0.25	51_18	73	99.0			rs62431285,COSV50357156	EXONIC	YES	NM_014739.3	Transcript	protein_coding	synonymous_variant		9/13	NM_014739.3:c.2181A>G	NP_055554.1:p.Pro727%3D		-1.0						.	.	.						32	0.96							0.491388	85872.0	174754.0	5.0	58	0.98	InbreedingCoeff	sas	0.497785	12363.0	0.491509	37278.0	0.0009325	145	0.142	425.0				12.26	0.839719		0	0	0			BCLAF1	0.0	0.0	0.0	0.0	-5.0	11.0	-38.0	12.0						0.873		38.845186932			homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype ; respiratory system phenotype; hematopoietic system phenotype; mortality/aging ; 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];	136590613
64104	chr6	136590640	A	C	chr6:136590640	BCLAF1	BCL2 associated transcription factor 1	SNV	0/1	0.33	56_29	89	99.0	0/1	0.25	71_25	100	99.0			rs62431286,COSV50356784	EXONIC	YES	NM_014739.3	Transcript	protein_coding	missense_variant		9/13	NM_014739.3:c.2154T>G	NP_055554.1:p.Ser718Arg		-1.0	.,.,.,.,.,.,.,.					.	.	.						32	0.96							0.49863	110650.0	221908.0	11.0	68	0.99	InbreedingCoeff	sas	0.499541	14137.0	0.498956	50200.0	0.0067715	1053	0.153	480.0				26.9	3.904407	0.142	10	10	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,ClinPred_pred	BCLAF1	0.0	0.0	0.0	0.0	41.0	46.0	41.0	-15.0						0.873		92.679029450	1.0	1.312	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype ; respiratory system phenotype; hematopoietic system phenotype; mortality/aging ; 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];	136590640
64109	chr6	136590698	C	T	chr6:136590698	BCLAF1	BCL2 associated transcription factor 1	SNV	0/1	0.32	59_29	92	99.0	0/1	0.23	82_25	111	99.0			rs62431287,COSV50356735	EXONIC	YES	NM_014739.3	Transcript	protein_coding	missense_variant		9/13	NM_014739.3:c.2096G>A	NP_055554.1:p.Arg699His		-1.0	.,.,.,.,.,.,.,.	Benign	criteria_provided,_single_submitter	not_specified		.	.	.	24033266	1.31784e-05	2.0	151764.0	0.0	32	0.96	PASS	afr	2.41791e-05	1.0	1.47384e-05	1.0	0.496865	113151.0	227730.0	8.0	59	0.99	InbreedingCoeff	sas	0.499158	14221.0	0.498828	52359.0	0.0036784	572	0.156	483.0				28.0	4.039401	0.239	8	12	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,PROVEAN_pred,PrimateAI_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	BCLAF1	0.02	0.0	0.0	0.0	-7.0	48.0	41.0	-17.0						0.873		5.235035379	0.994	1.026	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype ; respiratory system phenotype; hematopoietic system phenotype; mortality/aging ; 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];	136590698
64148	chr6	136590712	C	T	chr6:136590712	BCLAF1	BCL2 associated transcription factor 1	SNV	0/1	0.32	55_28	87	99.0	0/1	0.23	80_25	109	99.0			rs62431288,COSV50356842	EXONIC	YES	NM_014739.3	Transcript	protein_coding	synonymous_variant		9/13	NM_014739.3:c.2082G>A	NP_055554.1:p.Arg694%3D		-1.0						.	.	.						32	0.96							0.498789	114871.0	230300.0	10.0	53	0.99	InbreedingCoeff	sas	0.499653	14407.0	0.498715	52011.0	0.0024437	380	0.158	491.0				10.79	0.656695		0	0	0			BCLAF1	0.01	0.0	0.0	0.0	-21.0	21.0	-31.0	22.0						0.873		70.294532650			homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype ; respiratory system phenotype; hematopoietic system phenotype; mortality/aging ; 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];	136590712
64181	chr6	136594292	T	C	chr6:136594292	BCLAF1	BCL2 associated transcription factor 1	SNV	0/1	0.22	71_20	91	99.0	0/0	0.1	53_6	59	28.0			rs7381749,COSV50356789	EXONIC	YES	NM_014739.3	Transcript	protein_coding	missense_variant		7/13	NM_014739.3:c.1886A>G	NP_055554.1:p.Asn629Ser		-1.0	.,.,.,.,.,.,.,.					.	.	.						32	0.97							0.355031	79446.0	223772.0	8.0	91	0.99	InbreedingCoeff_RF	sas	0.398456	11768.0	0.378029	38435.0	0.0033375	519	0.153	482.0				20.1	2.034701	0.173	6	12	18	LRT_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	BCLAF1	0.0	0.0	0.0	0.0	31.0	-23.0	1.0	21.0						0.873		27.998062047	1.0	1.138	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype ; respiratory system phenotype; hematopoietic system phenotype; mortality/aging ; 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];	136594292
64214	chr6	136597004	A	G	chr6:136597004	BCLAF1	BCL2 associated transcription factor 1	SNV	0/1	0.21	73_20	97	99.0	0/0	0.0	135_0	135	0.0			rs7762367,COSV62140111	EXONIC	YES	NM_014739.3	Transcript	protein_coding	synonymous_variant		5/13	NM_014739.3:c.1659T>C	NP_055554.1:p.Pro553%3D		-1.0						.	.	.						31	0.95							0.497564	98674.0	198314.0	2.0	86	1.0	InbreedingCoeff	sas	0.499663	13335.0	0.496987	44037.0	0.0102184	1589	0.17	526.0				8.363	0.396725		0	0	0			BCLAF1	0.0	0.0	0.0	0.0	-2.0	19.0	-33.0	-23.0						0.873					homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype ; respiratory system phenotype; hematopoietic system phenotype; mortality/aging ; 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];	136597004
64267	chr6	136597281	A	T	chr6:136597281	BCLAF1	BCL2 associated transcription factor 1	SNV	0|1	0.48	49_48	99	99.0	0|1	0.45	50_41	92	99.0			rs1967445,COSV62140199	EXONIC	YES	NM_014739.3	Transcript	protein_coding	missense_variant		5/13	NM_014739.3:c.1382T>A	NP_055554.1:p.Leu461His		-1.0	.,.,.,.,.,.,.					.	.	.						31	0.93							0.498904	124699.0	249946.0	4.0	100	1.0	InbreedingCoeff	sas	0.499967	15266.0	0.499665	56628.0	0.0051060	794	0.204	646.0				21.8	2.251941	0.023	4	15	19	Polyphen2_HDIV_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	BCLAF1	0.0	0.0	0.0	0.0	20.0	-6.0	46.0	34.0						0.873			1.0	1.312	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype ; respiratory system phenotype; hematopoietic system phenotype; mortality/aging ; 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];	136597281
64284	chr6	136597288	A	C	chr6:136597288	BCLAF1	BCL2 associated transcription factor 1	SNV	0|1	0.49	47_48	97	99.0	0|1	0.46	53_46	100	99.0			rs1967446,COSV62140206	EXONIC	YES	NM_014739.3	Transcript	protein_coding	missense_variant		5/13	NM_014739.3:c.1375T>G	NP_055554.1:p.Tyr459Asp		-1.0	.,.,.,.,.,.,.					.	.	.						31	0.93							0.49902	124724.0	249938.0	4.0	100	1.0	InbreedingCoeff	amr	0.499971	17171.0	0.499735	56632.0	0.0181732	2826	0.196	620.0				22.9	2.697426	0.414	5	13	18	LRT_pred,MutationTaster_pred,BayesDel_addAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_noAF_pred,ClinPred_pred	BCLAF1	0.0	0.0	0.0	0.0	31.0	-13.0	31.0	39.0						0.873			1.0	1.312	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype ; respiratory system phenotype; hematopoietic system phenotype; mortality/aging ; 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];	136597288
64300	chr6	136597649		TTTTAAGAACTTCCCA	chr6:136597648-136597649	BCLAF1	BCL2 associated transcription factor 1	insertion	0/1	0.25	21_7	28	99.0	0/0	0.0	46_0	46	90.0				SPLICING	YES	NM_014739.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	4/12		NM_014739.3:c.1017-3_1017-2insTGGGAAGTTCTTAAAA			-1.0						.	.	.						31	0.95											32	0.71							0.0000064	1						16.01	1.453131		0	0	0																	0.873					homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype ; respiratory system phenotype; hematopoietic system phenotype; mortality/aging ; 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];	136597648
64390	chr6	136599822	C	G	chr6:136599822	BCLAF1	BCL2 associated transcription factor 1	SNV	0/1	0.3	63_30	100	99.0	0/1	0.21	68_20	95	99.0			rs9942517,COSV62140218	EXONIC	YES	NM_014739.3	Transcript	protein_coding	missense_variant		4/13	NM_014739.3:c.197G>C	NP_055554.1:p.Gly66Ala		-1.0	.,.,.,.,.,.,.,.					.	.	.		0.000212501	31.0	145882.0	0.0	31	0.94	AS_VQSR	afr	0.000771523	29.0	1.48863e-05	1.0	0.499672	125038.0	250240.0	0.0	89	1.0	InbreedingCoeff	amr	0.499971	17212.0	0.499558	56486.0	0.0227004	3530	0.211	669.0				25.4	3.608464	0.387	14	6	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,PROVEAN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,ClinPred_pred	BCLAF1	0.0	0.0	0.0	0.0	30.0	32.0	46.0	-18.0						0.873			1.0	1.026	homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype ; respiratory system phenotype; hematopoietic system phenotype; mortality/aging ; 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];	136599822
64398	chr6	136599836	G	A	chr6:136599836	BCLAF1	BCL2 associated transcription factor 1	SNV	0|1	0.25	57_21	85	99.0	0|1	0.19	64_16	86	99.0			rs9942518,COSV62141128	EXONIC	YES	NM_014739.3	Transcript	protein_coding	synonymous_variant		4/13	NM_014739.3:c.183C>T	NP_055554.1:p.Tyr61%3D		-1.0						.	.	.						31	0.95							0.4981	123489.0	247920.0	0.0	84	1.0	InbreedingCoeff	amr	0.499883	17097.0	0.499406	56321.0	0.0204689	3183	0.186	584.0				11.49	0.742209		0	0	0			BCLAF1	0.0	0.0	0.01	0.0	32.0	18.0	32.0	-32.0						0.873					homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype ; respiratory system phenotype; hematopoietic system phenotype; mortality/aging ; 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];	136599836
64436	chr6	136599842	G	A	chr6:136599842	BCLAF1	BCL2 associated transcription factor 1	SNV	0|1	0.23	55_19	81	99.0	0|1	0.2	60_16	82	99.0			rs9942519,COSV62141130	EXONIC	YES	NM_014739.3	Transcript	protein_coding	synonymous_variant		4/13	NM_014739.3:c.177C>T	NP_055554.1:p.Arg59%3D		-1.0						.	.	.		0.000761543	114.0	149696.0	0.0	31	0.95	PASS	afr	0.00271284	107.0	1.47193e-05	1.0	0.499668	124948.0	250062.0	2.0	80	0.99	InbreedingCoeff	amr	0.499971	17197.0	0.499513	56423.0	0.0208355	3240	0.186	584.0				8.487	0.408339		0	0	0			BCLAF1	0.0	0.0	0.0	0.0	-9.0	12.0	26.0	-38.0						0.873					homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; limbs/digits/tail phenotype; immune system phenotype; behavior/neurological phenotype ; respiratory system phenotype; hematopoietic system phenotype; mortality/aging ; 			white blood cells;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;smooth muscle;globus pallidus;	.	apoptotic process;positive regulation of apoptotic process;regulation of DNA-templated transcription in response to stress;negative regulation of transcription, DNA-templated;cellular response to leukemia inhibitory factor;positive regulation of DNA-templated transcription, initiation;positive regulation of response to DNA damage stimulus;positive regulation of intrinsic apoptotic signaling pathway	nucleus;nucleoplasm;cytoplasm;nuclear speck	DNA binding;RNA binding;protein binding	MCM7[23764002];FMR1[26496610];EIF4A3[23084401];HDAC11[23752268];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];VIRMA[26496610];PNN[18794151];CASP10[23541952];MAGOH[23084401];SNIP1[18794151];EMD[15009215];YWHAG[15324660;17353931];PDGFRB[26496610];CSNK2A1[22113938];PRMT1[26496610];PRKCD[17938203];THOC1[26496610];THOC3[26496610];THOC2[26496610];PPHLN1[26496610];THOC5[26496610];THOC7[26496610];THOC6[26496610];SFPQ[20932480];RP1[30021884];RBMXL1[26496610];DDX39B[26496610];THRAP3[18794151;26496610];ZC3H11A[26496610];DLD[29128334];SRSF9[26496610];POLDIP3[26496610];FXR1[26496610];PABPN1[26496610];ZC3H18[29298432];MTA3[26028330];CBX8[21282530];SRPK2[23602568];SPEN[26496610];MYH7B[26496610];CHTOP[26496610];NEK4[25798074];ALYREF[26496610];CDC5L[20467437];ESR1[21182205];ESR2[21182203];CLK3[23602568];CLK2[23602568];SRPK1[23602568];COQ2[29128334];SNW1[20467437;18794151];CDKN2AIPNL[26496610];BCL2[23541952];GRB2[12577067];RNPS1[17353931];CDK12[26496610];APOBEC3B[26496610];	136599842
64484	chr6	139202137	T	C	chr6:139202137	ECT2L	epithelial cell transforming 2 like	SNV	0/1	0.42	56_40	96	99.0	0/0	0.0	33_0	33	99.0			rs138935097	EXONIC	YES	NM_001077706.3	Transcript	protein_coding	missense_variant		15/22	NM_001077706.3:c.1709T>C	NP_001071174.1:p.Val570Ala		1.0	Dbl homology (DH) domain&Dbl homology (DH) domain&Dbl homology (DH) domain&Dbl homology (DH) domain,Dbl homology (DH) domain&Dbl homology (DH) domain&Dbl homology (DH) domain&Dbl homology (DH) domain,Dbl homology (DH) domain&Dbl homology (DH) domain&Dbl homology (DH) domain&Dbl homology (DH) domain	not_provided	no_assertion_provided	not_specified		.	.	.	24728327	0.00485539	738.0	151996.0	6.0	31	0.95	PASS	nfe	0.00813475	553.0	0.00813475	553.0	0.00421281	1050.0	249240.0	5.0	90	0.99	PASS	nfe	0.00713047	806.0	0.00713047	806.0	0.0041607	647	0.01	31.0				13.45	1.002539	0.051	0	18	18		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ECT2L	0.01	0.0	0.0	0.0	-43.0	41.0	20.0	-2.0						0.982	0.0	0.000000000	0.255	0.952	.			.	.	regulation of Rho protein signal transduction	.	Rho guanyl-nucleotide exchange factor activity	HNRNPCL2[30021884];HMGA1[30021884];HNRNPC[30021884];	139202137
64498	chr6	142409658	G	A	chr6:142409658	NMBR	neuromedin B receptor	SNV	0/1	0.47	70_63	134	99.0	0/0	0.0	38_0	38	99.0			rs117568543	EXONIC	YES	NM_002511.4	Transcript	protein_coding	synonymous_variant		2/4	NM_002511.4:c.138C>T	NP_002502.2:p.Ile46%3D		-1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00200573	305.0	152064.0	2.0	31	0.93	PASS	nfe	0.00339686	231.0	0.00339686	231.0	0.00216709	544.0	251028.0	3.0	100	1.0	PASS	nfe	0.00322757	366.0	0.00322757	366.0	0.0022507	350	0.001	4.0				11.62	0.758665		0	0	0			NMBR	0.0	0.0	0.0	0.0	-32.0	40.0	18.0	0.0						0.635	0.0	15.049795784			behavior/neurological phenotype ; homeostasis/metabolism phenotype; 			ciliary ganglion;dorsal root ganglion;skin;atrioventricular node;superior cervical ganglion;trigeminal ganglion;	Neuroactive ligand-receptor interaction	G protein-coupled receptor signaling pathway;phospholipase C-activating G protein-coupled receptor signaling pathway;bombesin receptor signaling pathway	cytosol;plasma membrane;integral component of plasma membrane	G protein-coupled receptor activity;bombesin receptor activity	MOB1A[17353931];OAT[17353931];	142409658
64499	chr6	143094170	C	G	chr6:143094170	HIVEP2	human immunodeficiency virus type I enhancer binding protein 2	SNV	0/0	0.0	41_0	41	99.0	0/1	0.48	71_70	145	99.0				EXONIC	YES	NM_006734.4	Transcript	protein_coding	missense_variant		5/10	NM_006734.4:c.1706G>C	NP_006725.3:p.Arg569Thr		-1.0	.,.,.				Mental retardation, autosomal dominant 43, 616977 (3), Autosomal dominant	Autosomal dominant non-syndromic intellectual disability	Disease-causing germline mutation(s) (loss of function) in	Hypoplasia of the corpus callosum;Anxiety;Impulsivity;Global developmental delay;Tapered finger;Narrow mouth;Microcephaly;Prominent nasal bridge;Abnormal facial shape;Cerebral atrophy;Gastroesophageal reflux;Feeding difficulties;Generalized hypotonia;Constipation;Hyperactivity;Seizure;Intellectual disability;Infantile onset;Autosomal dominant inheritance;Wide nasal bridge;Autistic behavior;Absent speech						33	0.98											100	1.0														21.0	2.141106	0.179	7	13	20	LRT_pred,MutationAssessor_pred,MutationTaster_pred,DEOGEN2_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-XF_coding_pred	HIVEP2	0.0	0.0	0.0	0.0	-33.0	23.0	-19.0	5.0						0.016	1.0	53.531521588	0.952	1.026	hematopoietic system phenotype; behavior/neurological phenotype ; immune system phenotype; nervous system phenotype ; growth/size/body region phenotype; integument phenotype ; endocrine/exocrine gland phenotype; 			caudate nucleus;amygdala;temporal lobe;prefrontal cortex;cingulate cortex;trigeminal ganglion;superior cervical ganglion;pons;occipital lobe;fetal brain;subthalamic nucleus;whole brain;atrioventricular node;parietal lobe;globus pallidus;medulla oblongata;	.	regulation of transcription by RNA polymerase II	nucleoplasm	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	YWHAE[20936779];MTNR1A[26514267];FBXW11[19615732];WNK1[20936779];RAC3[20195357];BTRC[19615732];OGT[27705803];YWHAG[20936779];	143094170
64580	chr6	150209806	A		chr6:150209806	RAET1E	retinoic acid early transcript 1E	deletion	1/1	0.56	1_9	16	28.0	0/1	0.27	6_3	11	46.0			rs3036672	SPLICING	YES	NM_139165.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	3/3		NM_139165.2:c.623-3del			-1.0						.	.	.		0.00143231	129.0	90064.0	0.0	0	0.26	PASS	amr	0.00175791	14.0	0.00145098	64.0					25	0.67							0.0000193,0.0259800	3,4040						0.41	-0.283113		0	0	0			RAET1E	0.0	0.01	0.0	0.0	35.0	-2.0	35.0	-2.0						0.759	0.0				.			pons;ciliary ganglion;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	T cell mediated cytotoxicity;immune response;natural killer cell activation;natural killer cell mediated cytotoxicity;susceptibility to natural killer cell mediated cytotoxicity;positive regulation of natural killer cell mediated cytotoxicity;regulation of immune response	extracellular region;extracellular space;plasma membrane;external side of plasma membrane;integral component of membrane	protein binding;natural killer cell lectin-like receptor binding	KLRK1[28559451;18544572;19436053;19658097];	150209805
64586	chr6	150267671	G	T	chr6:150267671	ULBP2	UL16 binding protein 2	SNV	0/0	0.0	36_0	36	99.0	0/1	0.42	54_41	98	99.0			rs192707406	EXONIC	YES	NM_025217.4	Transcript	protein_coding	missense_variant		3/5	NM_025217.4:c.513G>T	NP_079493.1:p.Lys171Asn		1.0	MHC class I-like antigen recognition-like					.	.	.		9.19854e-05	14.0	152198.0	0.0	31	0.95	PASS	sas	0.000413736	2.0	7.34797e-05	5.0	0.000178931	45.0	251494.0	0.0	100	1.0	PASS	sas	0.000391952	12.0	0.000175793	20.0	0.0001994	31	0.001	3.0				16.66	1.568593	0.176	6	13	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,PROVEAN_pred,LIST-S2_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ULBP2	0.0	0.0	0.02	0.0	-47.0	15.0	15.0	-1.0							0.0		0.001	0.056	.			.	Natural killer cell mediated cytotoxicity	T cell mediated cytotoxicity;immune response;viral process;natural killer cell activation;natural killer cell mediated cytotoxicity;susceptibility to natural killer cell mediated cytotoxicity	extracellular region;extracellular space;endoplasmic reticulum;plasma membrane;external side of plasma membrane;cell surface;anchored component of plasma membrane	protein binding;natural killer cell lectin-like receptor binding	PDGFRA[21988832];KLRK1[28559451;19424970];DERL3[unassigned1304];YIPF6[unassigned1304];	150267671
64587	chr6	150387164	T	C	chr6:150387164	ULBP3	UL16 binding protein 3	SNV	0/0	0.0	34_0	34	99.0	0/1	0.51	71_73	144	99.0			rs761516474	EXONIC	YES	NM_024518.3	Transcript	protein_coding	missense_variant		2/5	NM_024518.3:c.223A>G	NP_078794.1:p.Met75Val		-1.0	MHC class I-like antigen recognition-like,MHC class I-like antigen recognition-like					.	.	.		2.62778e-05	4.0	152220.0	0.0	32	0.97	PASS	afr	7.23659e-05	3.0	0.0	0.0	5.96445e-05	15.0	251490.0	0.0	100	1.0	PASS	amr	0.000317993	11.0	2.63704e-05	3.0	0.0000579	9	0.0	1.0				0.001	-1.756404	0.079	0	17	17		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ULBP3	0.07	0.0	0.0	0.0	16.0	-16.0	1.0	9.0						0.837	0.0	0.000000000	0.0	-2.032	.			.	Natural killer cell mediated cytotoxicity	T cell mediated cytotoxicity;immune response;viral process;natural killer cell activation;natural killer cell mediated cytotoxicity;susceptibility to natural killer cell mediated cytotoxicity;regulation of immune response	extracellular space;plasma membrane;external side of plasma membrane;anchored component of plasma membrane	protein binding;natural killer cell lectin-like receptor binding	KLRK1[11754823;28559451;18544572];SHARPIN[unassigned1774];RBCK1[unassigned1774];TANK[unassigned1774];	150387164
64657	chr6	154489256	A		chr6:154489256	IPCEF1	interaction protein for cytohesin exchange factors 1	deletion	0/1	0.3	16_7	23	99.0	0|0	0.0	21_0	24	62.0			rs371421932	SPLICING	YES	NM_001130699.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	11/12		NM_001130699.2:c.911-8del			-1.0						.	.	.		0.000239994	34.0	141670.0	0.0	32	0.93	PASS	sas	0.000444444	2.0	0.000107981	7.0	0.0479319	4800.0	100142.0	0.0	28	0.68	RF	sas	0.069308	635.0	0.0400209	2069.0	0.0367836,0.0000064	5720,1						1.084	-0.138847		0	0	0			IPCEF1	0.02	0.0	0.0	0.0	-10.0	-7.0	-19.0	-25.0						0.544	0.4				.			temporal lobe;thyroid;occipital lobe;prefrontal cortex;subthalamic nucleus;superior cervical ganglion;cingulate cortex;parietal lobe;globus pallidus;medulla oblongata;thalamus;	.	response to oxidative stress;oxygen transport;cellular oxidant detoxification	cytosol;plasma membrane	peroxidase activity;oxygen carrier activity;protein binding;protein domain specific binding	CYTH3[unassigned1304];CYTH2[unassigned1304];CYTH4[unassigned1304];CEP70[unassigned1304];CYTH1[unassigned1304];	154489255
64698	chr6	157100024	GAG		chr6:157100024-157100026	ARID1B	AT-rich interaction domain 1B	deletion	0/1	0.18	40_9	49	99.0	0/0	0.0	38_0	38	99.0			rs747790383	EXONIC	YES	NM_001374828.1	Transcript	protein_coding	inframe_deletion		1/20	NM_001374828.1:c.1232_1234del	NP_001361757.1:p.Gly411del		1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	History_of_neurodevelopmental_disorder|not_specified|not_provided	Coffin-Siris syndrome 1, 135900 (3), Autosomal dominant	Coffin-Siris syndrome;6q25 microdeletion syndrome	Disease-causing germline mutation(s) in;Role in the phenotype of	Hypoplasia of the corpus callosum;Wide mouth;Feeding difficulties in infancy;Wide nasal bridge;Aplasia/Hypoplasia of the distal phalanx of the 5th finger;Depressed nasal ridge;Intrauterine growth retardation;Ectopic kidney;Joint hyperflexibility;Bilateral single transverse palmar creases;Abnormality of the intervertebral disk;Congenital diaphragmatic hernia;Partial agenesis of the corpus callosum;Hypoplastic fifth toenail;Strabismus;Scoliosis;Microcephaly;Epicanthus;Depressed nasal bridge;Abnormality of the clavicle;Muscular hypotonia;Cryptorchidism;Lacrimation abnormality;Long eyelashes;Dandy-Walker malformation;Short distal phalanx of finger;Aplasia/Hypoplasia of the patella;Thick eyebrow;Global developmental delay;Cataract;Cutis marmorata;Spina bifida occulta;Kyphosis;Renal hypoplasia/aplasia;Coarse facial features;Cleft palate;Short philtrum;Aplasia/Hypoplasia of the distal phalanx of the 5th toe;Recurrent respiratory infections;Coxa valga;Abnormality of the hip bone;Abnormality of the dentition;Elbow dislocation;Hydronephrosis;Thick lower lip vermilion;Generalized hirsutism;Hearing impairment;Short stature;Ptosis;Abnormality of cardiovascular system morphology;Seizure;Hypoplastic fifth fingernail;Aplasia/Hypoplasia of the cerebellum;Nystagmus;Slow-growing hair;Intellectual disability;Plagiocephaly;Agenesis of corpus callosum;Cleft palate;Global developmental delay;Sensorineural hearing impairment;Short stature;Epicanthus;Neonatal hypotonia;Failure to thrive;Intellectual disability, mild;Abnormality of vision;Long philtrum;Clinodactyly of the 5th finger;Micrognathia;Upslanted palpebral fissure;Abnormality of cardiovascular system morphology;Low-set, posteriorly rotated ears;Wide nasal bridge;Ventriculomegaly;Rocker bottom foot;Hypertelorism;Camptodactyly of finger;External genital hypoplasia;Seizure;Malar flattening;High palate;Abnormality of the pinna;Downslanted palpebral fissures;Microcephaly;High palate;Postnatal growth retardation;Hemangioma;Hypotelorism;Preauricular skin tag;Astigmatism;Downslanted palpebral fissures;Low-set ears;Kyphosis;Renal hypoplasia;Prominent interphalangeal joints;Cryptorchidism;Coarse facial features;Facial hypertrichosis;Patent ductus arteriosus;Hydronephrosis;Intussusception;Posteriorly rotated ears;Ectopic kidney;Severe expressive language delay;Intellectual disability;Wide mouth;Scoliosis;Hypoplastic fifth fingernail;Autosomal dominant inheritance;Microcephaly;Short stature;Dandy-Walker malformation;Feeding difficulties in infancy;Spina bifida occulta;Lumbosacral hirsutism;Hypospadias;Aggressive behavior;Cutis marmorata;Global developmental delay;Thick eyebrow;Hoarse voice;Seizure;Choanal atresia;Short sternum;Sparse scalp hair;Sacral dimple;Long eyelashes;Recurrent respiratory infections;Cleft palate;Prominent fingertip pads;Aplasia/Hypoplasia of the patella;Nystagmus;Visual impairment;Inguinal hernia;Short distal phalanx of the 5th toe;Muscular hypotonia;Obsessive-compulsive behavior;Thick lower lip vermilion;Ventricular septal defect;Anonychia;Short distal phalanx of the 5th finger;Myopia;Delayed eruption of teeth;Atrial septal defect;Delayed skeletal maturation;Congenital diaphragmatic hernia;Partial agenesis of the corpus callosum;Hypoplasia of the corpus callosum;Autistic behavior;Short philtrum;Aplasia of the uterus;Single transverse palmar crease;Autosomal recessive inheritance;Thin upper lip vermilion;Abnormality of the pinna;Duodenal ulcer;Gastric ulcer;Ptosis;Hypoplastic fifth fingernail;Joint laxity;Tetralogy of Fallot;High pitched voice;Dislocated radial head;Broad nasal tip;Strabismus;Intrauterine growth retardation;Short chin;Hearing impairment;Intestinal malrotation;Umbilical hernia;Coxa valga;Depressed nasal bridge		0.00190346	272.0	142898.0	0.0	29	0.84	PASS	eas	0.00297493	14.0	0.000927357	60.0	0.0140313	468.0	33354.0	0.0	2	0.01	PASS	eas	0.0239726	7.0	0.0127038	134.0	0.0007331,0.0000386	114,6			0.01754	184.0		14.31	1.140116		0	0	0			ARID1B	0.0	0.0	0.0	0.0	-13.0	5.0	39.0	43.0						0.343	1.0				renal/urinary system phenotype; immune system phenotype; nervous system phenotype ; mortality/aging ; hematopoietic system phenotype; cardiovascular system phenotype ; behavior/neurological phenotype ; homeostasis/metabolism phenotype; muscle phenotype; growth/size/body region phenotype; 			ciliary ganglion;dorsal root ganglion;cingulate cortex;superior cervical ganglion;atrioventricular node;trigeminal ganglion;globus pallidus;cerebellum;	.	chromatin remodeling;regulation of transcription by RNA polymerase II;nervous system development;chromatin-mediated maintenance of transcription	nucleoplasm;cytosol;plasma membrane;SWI/SNF complex;nBAF complex	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;transcription coactivator activity;protein binding	YAP1[24255178];MDC1[29656893];GABARAPL1[20562859];SMARCC1[24421395];STIL[26638075];SMARCD3[18765789];SMARCB1[30108113];ECH1[29426014];ECI2[29426014];SPICE1[26638075];SMAD9[15231748];PYGM[23414517];ENO1[23414517];SMARCA2[12200431];RELB[14743216];SMARCA4[12200431];NEURL4[29426014];SUMO3[17000644];DPF3[18765789];ZNF503[30021884];B9D2[26638075];HIF1AN[29426014];TP53BP1[29656893];	157100023
64842	chr6	160390311	G		chr6:160390311	IGF2R	insulin like growth factor 2 receptor	deletion	0/0	0.0	7_0	7	18.0	0|1	0.29	5_2	7	48.0			rs1309957534	EXONIC	YES	NM_000876.4	Transcript	protein_coding	frameshift_variant		1/48	NM_000876.4:c.36del	NP_000867.3:p.Ala14ArgfsTer75		1.0					Hepatocellular carcinoma, somatic, 114550 (3)	.	.	Hepatocellular carcinoma;Micronodular cirrhosis;Somatic mutation;Autosomal dominant inheritance;Subacute progressive viral hepatitis;Heterogeneous						33	0.94							0.0	0.0	4578.0	0.0	0	0.0	AC0				0.0	0.0											0	0	0			IGF2R	0.0	0.0	0.0	0.0	29.0	50.0	-26.0	50.0						0.339	1.0				limbs/digits/tail phenotype; nervous system phenotype ; skeleton phenotype; renal/urinary system phenotype; embryo phenotype; behavior/neurological phenotype ; liver/biliary system phenotype; respiratory system phenotype; cardiovascular system phenotype ; hematopoietic system phenotype; normal phenotype; mortality/aging ; reproductive system phenotype; endocrine/exocrine gland phenotype; craniofacial phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; 			whole blood;skeletal muscle;	.	liver development;post-Golgi vesicle-mediated transport;receptor-mediated endocytosis;lysosomal transport;signal transduction;G protein-coupled receptor signaling pathway;spermatogenesis;post-embryonic development;animal organ regeneration;response to retinoic acid;positive regulation of apoptotic process;neutrophil degranulation;insulin-like growth factor receptor signaling pathway;membrane organization	nuclear envelope lumen;lysosomal membrane;endosome;early endosome;late endosome;Golgi apparatus;trans-Golgi network;plasma membrane;integral component of plasma membrane;focal adhesion;cell surface;membrane;clathrin coat;transport vesicle;clathrin-coated vesicle;endocytic vesicle;trans-Golgi network transport vesicle;clathrin-coated vesicle membrane;secretory granule membrane;trans-Golgi network membrane;perinuclear region of cytoplasm;extracellular exosome	G-protein alpha-subunit binding;retinoic acid binding;insulin-like growth factor-activated receptor activity;protein binding;insulin-like growth factor binding;mannose binding;enzyme binding;insulin-like growth factor II binding;kringle domain binding;signaling receptor activity;identical protein binding;phosphoprotein binding	RAB5C[26496610];VPS26A[15078903];HSCB[28380382];GGA2[11390366;11387475];EEA1[16977309;29568061];TGOLN2[16977309;29568061];GGA1[11390366;11387475;20676133];GGA3[11387475;16977309];ATXN1[23275563];APOL6[30021884];LAMP1[29568061];USP50[19615732];VPS35[15078903];GTSE1[26496610];RPL19[30021884];HIST1H1C[30021884];VCAM1[22623428];XRCC5[26496610];IGF2[18046459;17850746];FN1[19738201];OCRL[25107275];IGF2R[22681933];TMEM17[26638075];PACS1[16977309];TRAF6[17353931];TMEM216[26638075];CANX[29568061];CHMP4B[26496610];RAB9A[29568061];RAB5A[29568061];BET1[29568061];	160390310
64848	chr6	161160094	T	C	chr6:161160094	PLG	plasminogen	SNV	0/0	0.0	33_0	33	99.0	0/1	0.33	30_15	46	99.0			rs192519670,CS1617814	SPLICING	YES	NM_000301.5	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	15/18		NM_000301.5:c.1878-6T>C			1.0		Benign	criteria_provided,_single_submitter	not_provided	Dysplasminogenemia, 217090 (3), Autosomal recessive; Angioedema, hereditary, 4, 619360 (3), Autosomal dominant; Plasminogen deficiency, type I, 217090 (3), Autosomal recessive	Hypoplasminogenemia;Ligneous conjunctivitis	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Abnormality of the respiratory system;Abnormality of the skin;Gingival overgrowth;Gingivitis;Duodenal ulcer;Periodontitis;Abnormality of vision;Nephrolithiasis;Dandy-Walker malformation;Abnormality of the ovary;Hydrocephalus;Decreased level of plasminogen;Abnormal fallopian tube morphology;Abnormality of the middle ear;Cervicitis;Gingivitis;Abnormality of metabolism/homeostasis;Duodenal ulcer;Conjunctivitis;Gingival overgrowth;Autosomal recessive inheritance;Nephritis;Hydrocephalus;Recurrent upper respiratory tract infections;Blindness;Cerebellar hypoplasia;Abnormality of the larynx;Abnormality of the ear;Periodontitis;Nephrolithiasis;Abnormality of the skin;Macrocephaly;Infantile onset;Dandy-Walker malformation		0.00176848	269.0	152108.0	0.0	31	0.94	PASS	amr	0.00288109	44.0	0.00282295	192.0	0.00163835	412.0	251472.0	0.0	100	1.0	PASS	nfe	0.00287462	327.0	0.00287462	327.0	0.0017041	265	0.004	14.0	0.00408	36.0		2.27	-0.024539		0	0	0			PLG	0.0	0.09	0.0	0.0	-50.0	6.0	6.0	30.0	2.82737023829989e-05	0.0	10.693	0.41	11.102	0.211	0.0				neoplasm; hematopoietic system phenotype; cardiovascular system phenotype ; reproductive system phenotype; mortality/aging ; respiratory system phenotype; liver/biliary system phenotype; renal/urinary system phenotype; immune system phenotype; vision/eye phenotype; digestive/alimentary phenotype; nervous system phenotype ; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype ; homeostasis/metabolism phenotype; cellular phenotype; 			kidney;liver;trigeminal ganglion;superior cervical ganglion;fetal lung;fetal liver;skeletal muscle;	Complement and coagulation cascades	platelet degranulation;proteolysis;blood coagulation;negative regulation of cell population proliferation;negative regulation of cell-substrate adhesion;extracellular matrix disassembly;fibrinolysis;cellular protein metabolic process;tissue remodeling;interaction with symbiont;negative regulation of fibrinolysis;positive regulation of fibrinolysis;modification by host of symbiont morphology or physiology via secreted substance;interaction with symbiont via secreted substance involved in symbiotic interaction;negative regulation of cell-cell adhesion mediated by cadherin	extracellular region;extracellular space;plasma membrane;cell surface;platelet alpha granule lumen;extrinsic component of external side of plasma membrane;other organism cell membrane;collagen-containing extracellular matrix;extracellular exosome;blood microparticle	endopeptidase activity;serine-type endopeptidase activity;signaling receptor binding;protein binding;serine-type peptidase activity;enzyme binding;kinase binding;protein domain specific binding;apolipoprotein binding;chaperone binding;proteasome core complex binding;protein antigen binding	CYFIP2[21988832];APP[28106549];SMAD4[21988832];SMAD3[21988832];PLGRKT[21940822];YTHDC1[21988832];PCOLCE[24117177];MAPK14[21988832];RAP2A[18624398];METTL14[29507755];PRDX4[21988832];MARVELD2[26822058];LOX[30082873];APOH[16480936];EP300[21988832];RBBP6[18624398];IGHA1[15174051];	161160094
64859	chr6	161519351	CTGCTG		chr6:161519351-161519356	MAP3K4	mitogen-activated protein kinase kinase kinase 4	sequence_alteration	1/2	0.18	2_13_56	71	99.0	1/2	0.1	0_4_36	40	54.0			rs5881391	EXONIC	YES	NM_005922.4	Transcript	protein_coding	inframe_deletion		17/27	NM_005922.4:c.3566_3571del	NP_005913.3:p.Ala1198_Ala1199del		1.0						.	.	.		0.000173811	26.0	149588.0	0.0	11	0.31	PASS	nfe	0.000252788	17.0	0.000252788	17.0	0.0661851	6230.0	94130.0	0.0	34	0.72	PASS	sas	0.0996684	1022.0	0.058015	2448.0	0.0007781,0.2484566	121,38636						19.28	1.94183		0	0	0																	0.579	1.0				nervous system phenotype ; limbs/digits/tail phenotype; skeleton phenotype; immune system phenotype; embryo phenotype; mortality/aging ; reproductive system phenotype; growth/size/body region phenotype; hematopoietic system phenotype; homeostasis/metabolism phenotype; endocrine/exocrine gland phenotype; 			testis - seminiferous tubule;prefrontal cortex;cingulate cortex;uterus corpus;testis;	MAPK signaling pathway;GnRH signaling pathway	MAPK cascade;activation of MAPKK activity;placenta development;response to UV-C;regulation of gene expression;male germ-line sex determination;signal transduction by protein phosphorylation;stress-activated protein kinase signaling cascade;activation of protein kinase activity;positive regulation of telomere maintenance via telomerase;intracellular signal transduction;positive regulation of JUN kinase activity;positive regulation of telomerase activity;chorionic trophoblast cell differentiation;positive regulation of p38MAPK cascade;positive regulation of telomere capping	cytoplasm;perinuclear region of cytoplasm	protein serine/threonine kinase activity;MAP kinase kinase kinase activity;protein binding;ATP binding;metal ion binding	INTS14[26496610];GOLT1B[26496610];SH3KBP1[16256071];AP4E1[26496610];CDC42[25241761];BAG6[26496610];RAP1B[26496610];SYNCRIP[26496610];MAPK8[26496610];TBK1[29251827];BAG3[26496610];UBC[16256071];CNTRL[20936779];TPR[20936779];PTK2B[15601262];POLR2F[26496610];FLNB[19270716];KIF21A[26496610];MAP3K4[12052864];MAP2K6[12052864;25241761];MAP2K3[25241761];GADD45B[12052864;16256071];ANXA2[15601262];SGTB[26496610];GADD45A[12052864];SORT1[26496610];KIF23[26496610];KIF7[26496610];YWHAZ[20936779];USF1[26496610];GADD45G[12052864];MAPK13[25241761];NEDD1[26496610];MFHAS1[29513927];RPS25[30021884];BOP1[30021884];HNRNPD[26496610];SRPRA[26496610];PTPN6[15601262];CNTROB[26496610];	161519350
64873	chr6	162864358	T		chr6:162864358	PARK2		deletion	0/1	0.35	46_25	71	99.0	0/1	0.42	45_32	77	99.0			rs754809877,CD991831	EXONIC	YES	NM_004562.3	Transcript	protein_coding	frameshift_variant		2/12	NM_004562.3:c.155del	NP_004553.2:p.Asn52MetfsTer29		-1.0		Pathogenic	criteria_provided,_multiple_submitters,_no_conflicts	Parkinson_disease_2|Young-onset_Parkinson_disease|not_provided						0.000289192	44.0	152148.0	1.0	32	0.95	PASS	amr	0.00170224	26.0	0.000117592	8.0	0.000262613	66.0	251320.0	0.0	83	1.0	PASS	amr	0.00109852	38.0	0.000246444	28.0	0.0002251	35	0.002	6.0	0.00254	29.0		33.0	4.837991		0	0	0			PARK2	0.02	0.0	0.0	0.01	16.0	11.0	-19.0	-15.0						0.0588	0.02	0.000000000												162864357
64918	chr6	167754360	C	A	chr6:167754360	TTLL2	tubulin tyrosine ligase like 2	SNV	0/1	0.51	58_60	118	99.0	0/1	0.58	56_79	137	99.0			rs77767783	EXONIC	YES	NM_031949.5	Transcript	protein_coding	synonymous_variant		3/3	NM_031949.5:c.972C>A	NP_114155.4:p.Leu324%3D		1.0						.	.	.		0.000617901	94.0	152128.0	1.0	32	0.96	PASS	afr	0.00188333	78.0	4.41073e-05	3.0	0.000234602	59.0	251490.0	0.0	100	1.0	PASS	afr	0.00203002	33.0	8.78997e-05	10.0	0.0001415	22	0.001	2.0				4.887	0.13817		0	0	0			TTLL2	0.03	0.0	0.0	0.0	27.0	3.0	27.0	18.0						0.88	0.0	44.499700990			.			ciliary ganglion;testis - interstitial;superior cervical ganglion;	.	cellular protein modification process	.	ATP binding;ligase activity	.	167754360
64959	chr6	168366692	GGA		chr6:168366692-168366694	AFDN	afadin, adherens junction formation factor	deletion	0/1	0.12	67_9	76	99.0	0/0	0.0	44_0	44	99.0			rs753711058	EXONIC	YES	NM_001386888.1	Transcript	protein_coding	inframe_deletion		32/34	NM_001386888.1:c.5241_5243del	NP_001373817.1:p.Glu1747del		1.0						.	.	.		0.00024501	37.0	151014.0	0.0	32	0.96	PASS	afr	0.000438105	18.0	0.000147449	10.0	0.000803323	111.0	138176.0	0.0	77	0.57	RF	afr	0.00131195	9.0	0.00033869	18.0	0.0000514,0.0009389,0.0000064	8,146,1	0.013	42.0				20.7	2.10523		0	0	0			MLLT4	0.0	0.01	0.0	0.06	-14.0	-47.0	-16.0	-48.0								43.124604506			nervous system phenotype ; embryo phenotype; cardiovascular system phenotype ; growth/size/body region phenotype; mortality/aging ; cellular phenotype; 			.	Adherens junction;Tight junction;Leukocyte transendothelial migration	cell adhesion;signal transduction;cell-cell signaling;negative regulation of cell migration;regulation of protein localization;adherens junction organization;positive regulation of GTPase activity;cell-cell adhesion mediated by cadherin;establishment of protein localization to plasma membrane;bicellular tight junction assembly;establishment of endothelial intestinal barrier;positive regulation of cell-cell adhesion mediated by cadherin	nucleoplasm;cytosol;plasma membrane;cell-cell junction;cell-cell adherens junction;nuclear speck;cell junction;cell-cell contact zone;tight junction	protein binding;protein C-terminus binding;Ras GTPase binding;cadherin binding;cell adhesion molecule binding;actin filament binding	EPHB6[9707552];YWHAB[15324660];DENND1A[unassigned1312];ZBTB21[unassigned1312];CBY1[unassigned1312];TESK2[unassigned1312];ARRB2[17620599];FAM110A[unassigned1312];SYDE1[unassigned1312];SIPA1L1[unassigned1312];SH3PXD2A[unassigned1312];FAM110B[unassigned1312];FAM53C[unassigned1312];KIF13B[unassigned1312];EPHB2[9707552];YWHAG[15324660;17353931];EPHB3[9707552];YWHAH[17979178];MAGI1[unassigned1312];EPHA7[9707552];KSR1[unassigned1312];LMO2[12067721];KCTD3[unassigned1312];YWHAZ[15161933];CDC25B[unassigned1312];BCR[17491594];GIGYF1[unassigned1312];MRAS[10446149];ZNF638[unassigned1312];TBC1D25[unassigned1312];EIF4E2[unassigned1312];EZR[29568061];DBN1[23750010];SRC[17491594];AGAP1[unassigned1312];LIMA1[unassigned1312];CTNNA1[23750010];SRGAP2[unassigned1312];SRSF12[unassigned1312];SMAD2[15231748];ANKRD34A[unassigned1312];JUN[25609649];VCAM1[22623428;19738201];USP21[unassigned1312];RAB3IP[unassigned1312];FN1[19738201];DCLK1[unassigned1312];TJP1[23750010];RIT1[10545207];LRFN1[unassigned1312];CAPZA2[26496610];NECTIN4[15811349];NECTIN3[15811349;11024295];NECTIN2[10225955;15811349;23750010];BCAR1[28007913];NECTIN1[10225955;15811349];CDK16[unassigned1312];	168366691
64993	chr7	810235	G	A	chr7:810235	DNAAF5	dynein axonemal assembly factor 5	SNV	0/1	0.49	49_48	97	99.0	0/1	0.57	41_54	95	99.0			rs140229424	EXONIC	YES	NM_017802.4	Transcript	protein_coding	synonymous_variant		9/13	NM_017802.4:c.1911G>A	NP_060272.3:p.Thr637%3D		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided	Ciliary dyskinesia, primary, 18, 614874 (3), Autosomal recessive	Primary ciliary dyskinesia	Disease-causing germline mutation(s) in	Male infertility;Rhinitis;Abnormal ciliary motility;Recurrent sinusitis;Recurrent otitis media;Chronic bronchitis;Ciliary dyskinesia;Respiratory insufficiency due to defective ciliary clearance;Autosomal recessive inheritance;Infantile onset;Situs inversus totalis;Nonmotile sperm;Absent outer dynein arms;Hydrocephalus;Pectus excavatum;Chronic otitis media;Tachypnea;Impaired nasal mucociliary clearance;Delayed speech and language development;Asthma;Atelectasis;Headache;Ectopic pregnancy;Nasal polyposis;Clubbing of fingers;Pulmonary obstruction;Asplenia;Scoliosis;Reduced sperm motility;Respiratory distress;Immotile cilia;Chronic sinusitis;Infertility;Chronic bronchitis;Corneal dystrophy;Glue ear;Pneumonia;Spontaneous abortion;Conductive hearing impairment;Recurrent respiratory infections;Situs inversus totalis;Cough;Bronchiectasis;Ventriculomegaly;Rhinitis;Halitosis		1.97138e-05	3.0	152178.0	0.0	33	0.97	PASS	eas	0.000385802	2.0	0.0	0.0	3.19254e-05	8.0	250584.0	0.0	50	0.99	PASS	eas	0.000108849	2.0	1.76778e-05	2.0	0.0000322	5			0.00018	2.0		1.524	-0.087724		0	0	0			DNAAF5	0.0	0.0	0.0	0.0	2.0	-6.0	18.0	20.0								14.758933081			.			.	.	cilium movement;outer dynein arm assembly;inner dynein arm assembly	cytoplasm;motile cilium	dynein intermediate chain binding	GSTK1[17353931];BRF2[17353931];TSC22D1[17353931];MAGED1[17353931];ZBTB16[16169070];NEK6[17353931];PNKP[17353931];PLK1[26496610];ILK[17353931];CIAO1[17353931];PTP4A3[17353931];PGRMC1[17353931];FEZ1[16169070];MYC[17353931];CASP4[17353931];SAP18[17353931];CHMP4B[26496610];STOM[27173435;unassigned1312];MAGEA6[17353931];ARF6[17353931];PHLDA3[17353931];EZH2[26496610];	810235
65209	chr7	2297066	C	T	chr7:2297066	SNX8	sorting nexin 8	SNV	0/1	0.43	60_46	106	99.0	0/0	0.0	44_0	44	99.0				EXONIC	YES	NM_013321.4	Transcript	protein_coding	missense_variant		9/11	NM_013321.4:c.1068G>A	NP_037453.1:p.Met356Ile		-1.0						.	.	.						34	0.99											56	0.82														22.6	2.530445	0.14	6	13	19	LRT_pred,MutationTaster_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	SNX8	0.0	0.0	0.0	0.0	-19.0	18.0	25.0	-32.0						0.147	0.17	31.525865979	0.997	1.022	.			.	.	intracellular protein transport;early endosome to Golgi transport	cytosol;retromer complex;early endosome membrane;intracellular membrane-bounded organelle	protein binding;phosphatidylinositol binding;identical protein binding	ARL6IP1[unassigned1304];PIK3R1[17474147];SNX33[23085988];MYDGF[30021884];SNX18[23085988];SNX1[23085988];ABL1[17474147];FYN[17474147];GRB2[17474147];SNX9[23085988];C14orf119[unassigned1304];REEP6[unassigned1304];RABAC1[unassigned1304];SNX8[23085988];NCK1[17474147];	2297066
65254	chr7	3991419		CCT	chr7:3991418-3991419	SDK1	sidekick cell adhesion molecule 1	insertion	0/0	0.0	35_0	35	99.0	0/1	0.48	47_44	91	99.0			rs557107791	EXONIC	YES	NM_152744.4	Transcript	protein_coding	inframe_insertion		7/45	NM_152744.4:c.1019_1021dup	NP_689957.3:p.Leu340dup		1.0						.	.	.		0.000716248	109.0	152182.0	0.0	32	0.97	PASS	sas	0.00269934	13.0	0.00098486	67.0	0.0012311	309.0	250996.0	1.0	60	0.99	PASS	sas	0.00225402	69.0	0.00144399	164.0	0.0012283	191	0.001	2.0							0	0	0																	0.433	0.01	0.000000000,1.169758090			.			.	.	homophilic cell adhesion via plasma membrane adhesion molecules;synapse assembly;retina layer formation;cell-cell junction organization;behavioral response to cocaine;regulation of dendritic spine development	plasma membrane;integral component of membrane;cell junction;synapse	identical protein binding	MYC[21150319];PRPF40A[15231748];	3991418
65309	chr7	5336643	C	T	chr7:5336643	SLC29A4	solute carrier family 29 member 4	SNV	0/1	0.56	47_59	106	99.0	0/1	0.41	66_46	112	99.0			rs772771027	EXONIC	YES	NM_001040661.3	Transcript	protein_coding	synonymous_variant		7/11	NM_001040661.3:c.696C>T	NP_001035751.1:p.Leu232%3D		1.0						.	.	.						32	0.96							4.08794e-05	10.0	244622.0	0.0	52	0.97	PASS	amr	0.000232032	8.0	9.03636e-06	1.0	0.0000193	3			0.00054	1.0		11.98	0.803444		0	0	0			SLC29A4	0.0	0.01	0.0	0.0	31.0	-32.0	-2.0	14.0						0.566	0.0				nervous system phenotype ; 			.	.	monoamine transport;nucleoside transmembrane transport	plasma membrane;integral component of membrane;apical plasma membrane	nucleoside transmembrane transporter activity;monoamine transmembrane transporter activity	.	5336643
65313	chr7	5401628	C	T	chr7:5401628	TNRC18	trinucleotide repeat containing 18	SNV	0/1	0.56	44_56	100	99.0	0/0	0.0	41_0	41	99.0			rs369633677,COSV68165699	EXONIC	YES	NM_001080495.3	Transcript	protein_coding	missense_variant		13/30	NM_001080495.3:c.4432G>A	NP_001073964.2:p.Ala1478Thr		-1.0	.,.,.					.	.	.		5.25679e-05	8.0	152184.0	0.0	33	0.98	PASS	afr	9.64739e-05	4.0	5.88045e-05	4.0	4.45853e-05	11.0	246718.0	0.0	38	0.93	PASS	nfe	7.17978e-05	8.0	7.17978e-05	8.0	0.0000450	7						23.3	2.887898	0.064	5	16	21	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	TNRC18	0.0	0.0	0.0	0.0	36.0	21.0	-35.0	-46.0							1.0	0.000000000	0.891	1.024	.			ciliary ganglion;pons;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;globus pallidus;thalamus;	.	.	nucleus;nucleoplasm;mitochondrion;cytosol;nuclear membrane	chromatin binding	BECN1[22081109];XRCC6[26496610];SIN3B[26496610];HDAC1[23752268;26496610];HIST1H1E[30021884];COPS7A[26496610];NIPSNAP1[26496610];SAP30[26496610];	5401628
65322	chr7	5545119	C	T	chr7:5545119	FBXL18	F-box and leucine rich repeat protein 18	SNV	0/0	0.0	37_0	37	99.0	0/1	0.35	71_38	109	99.0			rs34161358,COSV66668000	EXONIC	YES	NM_001321213.2	Transcript	protein_coding	missense_variant		2/5	NM_001321213.2:c.161G>A	NP_001308142.1:p.Arg54His		-1.0	.,F-box domain&F-box domain					.	.	.		0.0044752	681.0	152172.0	2.0	31	0.95	PASS	amr	0.00858341	131.0	0.00615887	419.0	0.00387097	966.0	249550.0	5.0	83	1.0	PASS	nfe	0.00599421	679.0	0.00599421	679.0	0.0040192	625	0.011	34.0				11.93	0.797483	0.081	1	17	18	SIFT	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FBXL18	0.0	0.01	0.0	0.0	-14.0	21.0	8.0	1.0						0.56	0.0	0.000000000	0.36	-0.259	.			pons;ciliary ganglion;testis - seminiferous tubule;subthalamic nucleus;dorsal root ganglion;atrioventricular node;superior cervical ganglion;parietal lobe;globus pallidus;bone marrow;	.	G2/M transition of mitotic cell cycle;protein polyubiquitination;SCF-dependent proteasomal ubiquitin-dependent protein catabolic process;post-translational protein modification;regulation of cell cycle	nucleus;cytosol;SCF ubiquitin ligase complex	ubiquitin-protein transferase activity;ubiquitin protein ligase activity	HSP90AB1[22939624];RBPMS[25416956;27107012];CALCOCO2[16189514;25416956];FHL3[25416956];MTUS2[25416956];WWP1[25416956];WWP2[25416956];TRAF1[25416956];NOTCH2NLA[25416956];DHRS2[30021884];KRT40[25416956];MID2[25416956];GOLGA2[25416956];PLSCR1[16189514];PSTPIP1[25416956];PSMA3[25416956];HNRNPK[25416956];TFCP2[25416956];PNMA1[25416956;27107012];TRAF4[25416956];KRTAP4-12[16189514];MDFI[19060904;25416956];SKP1[27705803];	5545119
65387	chr7	11500300	C	T	chr7:11500300	THSD7A	thrombospondin type 1 domain containing 7A	SNV	0/1	0.56	25_32	57	99.0	0/0	0.0	35_0	35	99.0			rs1477721012	EXONIC	YES	NM_015204.3	Transcript	protein_coding	missense_variant		11/28	NM_015204.3:c.2594G>A	NP_056019.1:p.Arg865Gln		-1.0	.,.					.	.	.						32	0.97							8.298e-06	2.0	241022.0	0.0	22	0.6	PASS	eas	5.76302e-05	1.0	9.18476e-06	1.0					9e-05	1.0		23.7	3.058602	0.236	4	16	20	SIFT,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-XF_coding_pred	THSD7A	0.0	0.0	0.01	0.04	-4.0	-11.0	-4.0	-11.0							1.0	85.266433510	0.998	1.008	.			ciliary ganglion;appendix;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;placenta;medulla oblongata;	.	angiogenesis;cell differentiation;actin cytoskeleton reorganization	extracellular region;plasma membrane;integral component of membrane;cell projection	.	SLC16A1[30021884];ELOVL5[unassigned1304];GOLM1[unassigned1304];AQP6[unassigned1304];ASAP2[12421765];LHFPL1[unassigned1304];LYVE1[unassigned1304];TMUB2[unassigned1304];ARL13B[unassigned1304];VMA21[unassigned1304];SKIL[15231748];RBMX[30021884];CD33[unassigned1304];	11500300
65459	chr7	16676083	A		chr7:16676083	ANKMY2	ankyrin repeat and MYND domain containing 2	sequence_alteration	0/1	0.0	10_4_0	18	52.0	0/2	0.4	12_0_8	20	99.0			rs34755603	SPLICING	YES	NM_020319.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	1/9		NM_020319.3:c.68-3del			-1.0						.	.	.		0.00235105	319.0	135684.0	0.0	24	0.58	AS_VQSR	nfe	0.00218857	137.0	0.00218857	137.0	0.243026	27322.0	112424.0	0.0	16	0.38	InbreedingCoeff	eas	0.274034	2269.0	0.250861	12242.0	0.0000322,0.0003666,0.0663070	5,57,10311						0.572	-0.234103		0	0	0			ANKMY2	0.0	0.0	0.0	0.0	-2.0	-14.0	-42.0	-1.0						0.541	0.0				.			pons;amygdala;occipital lobe;subthalamic nucleus;superior cervical ganglion;trigeminal ganglion;cingulate cortex;parietal lobe;globus pallidus;medulla oblongata;	.	.	cilium	protein binding;enzyme binding;metal ion binding	ACD[21044950];HSP90AB1[25036637];PLGRKT[29568061];DNAAF1[27173435;unassigned1312];TINF2[21044950];POT1[21044950];FKBP5[25036637];	16676082
65469	chr7	16725651	G	C	chr7:16725651	BZW2	basic leucine zipper and W2 domains 2	SNV	0/1	0.63	23_39	62	99.0	0/1	0.5	22_22	44	99.0			rs369538600	EXONIC	YES	NM_001159767.2	Transcript	protein_coding	missense_variant		6/12	NM_001159767.2:c.527G>C	NP_001153239.1:p.Ser176Thr		1.0	.,.,.,.,.,.,.					.	.	.		3.94628e-05	6.0	152042.0	0.0	31	0.92	PASS	nfe	8.82664e-05	6.0	8.82664e-05	6.0	7.25865e-05	18.0	247980.0	0.0	63	0.81	PASS	nfe	0.000133533	15.0	0.000133533	15.0	0.0000707	11						19.64	1.988588	0.08	4	15	19	SIFT,MutationTaster_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	BZW2	0.0	0.0	0.0	0.0	6.0	1.0	14.0	10.0						0.184	1.0	0.000000000	0.997	-0.142	homeostasis/metabolism phenotype; growth/size/body region phenotype; adipose tissue phenotype ; behavior/neurological phenotype ; skeleton phenotype; cardiovascular system phenotype ; 			placenta;skeletal muscle;	.	nervous system development;cell differentiation	cytoplasm;membrane	protein binding;cadherin binding	GSK3B[21900206];EIF2B4[unassigned1312];EIF2B2[unassigned1312];NEK4[25798074];FN1[19738201];HTT[17500595];HSCB[28380382];EIF2S2[25147208];BZW1[17353931];DUX4[26816005];PSTPIP1[17353931];SMDT1[unassigned1312];SNW1[20467437];PHKG2[23455922];EIF2B1[unassigned1312];	16725651
65707	chr7	26248177		CTGACAAACCAAGAGGATT	chr7:26248176-26248177	CBX3	chromobox 3	insertion	0/1	0.14	15_3	22	69.0	0/0	0.0	20_0	20	45.0				SPLICING	YES	NM_007276.5	Transcript	protein_coding	splice_donor_variant	4/5		NM_007276.5:c.330+1_330+2insCTGACAAACCAAGAGGATT			1.0						.	.	.		0.0	0.0	151338.0	0.0	31	0.92	AC0				0.0	0.0					40	0.85														24.5	3.338199		0	0	0																	0.337	0.63				endocrine/exocrine gland phenotype; reproductive system phenotype; mortality/aging ; 			testis - seminiferous tubule;testis - interstitial;tumor;superior cervical ganglion;testis;	.	chromatin remodeling;cellular response to DNA damage stimulus;negative regulation of transcription, DNA-templated;rhythmic process;negative regulation of G0 to G1 transition	chromosome, centromeric region;condensed chromosome, centromeric region;nuclear chromosome, telomeric region;chromatin;nucleus;nuclear envelope;nuclear inner membrane;nucleoplasm;nuclear euchromatin;nuclear heterochromatin;spindle;nuclear pericentric heterochromatin;site of DNA damage	protein binding;enzyme binding;protein domain specific binding;identical protein binding;histone methyltransferase binding	RB1[27705803];CCDC71L[27705803];EHMT2[27705803];ZNF292[27705803];EHMT1[27705803];DUX4[26816005];HTR7[19486527];TRIM28[10330177;20936779;21888893;27705803];POGZ[20562864;21888893;27705803];STK16[unassigned1304];KPNA6[27705803];TRIM24[21531907];POTEE[21888893];HIST1H2AD[21888893];ADNP2[21888893;27705803;unassigned1304];KPNA4[21888893];ZNF689[27705803];ATXN7L2[16713569];PRKACA[21888893];HMGN2[30021884];ZNF283[21888893];KMT5C[19486527];ZNF16[21888893];SGO1[18716626];VDAC1[29128334];LRIF1[21888893;27705803;unassigned1304];ADNP[21888893;27705803];LAP3[unassigned1304];RAD54L2[unassigned1304];PRR14[27705803;unassigned1304];ZNF552[21888893];L3MBTL1[17540172];ZNF670[21888893];L3MBTL2[27705803];PRKDC[21888893];MAX[27705803];MRPL12[unassigned1304];RLF[27705803];PMF1[27705803];MYL12B[27705803];DSN1[27705803];HIST1H3A[16415788;20871592];NLRP3[26496610];SCAI[27705803];XRCC6[21888893];JUN[25609649];CBX5[20562864;21888893;27705803];VCAM1[22623428];CBX3[21888893;19486527];CBX1[21888893;27705803];H3F3A[27705803];FN1[19738201];SMARCA4[21888893];HIST1H4A[21888893];GTF2IRD1[26275350];BAP1[19615732];SPRR1B[27705803];KDM5C[17468742];LRRK2[23075850];SUV39H1[27705803;unassigned1304];CHD5[21888893];HTR2C[28298427];CHD4[21888893;27705803;28977666];CHD3[21888893;28977666];SMG6[21888893];ZNF280D[21888893;27705803;unassigned1304];SENP7[27705803];CHAF1B[27705803];METTL14[29507755];CHAF1A[19498464;27705803];ZMYM3[27705803];ZMYM4[27705803];ADAMTSL4[unassigned1304];ZNF280C[27705803;unassigned1304];CHAMP1[21888893;27705803;26496610];WDR5[27705803];ZNF644[27705803];LBR[8663349];YAF2[27705803];RING1[27705803];KSR1[27086506];ARG1[27705803];DYNLL1[27705803];MSL1[27705803];TFDP1[27705803];RCN2[27705803];INCENP[21346195];SCGB2A1[27705803];AHDC1[27705803];HDAC2[27705803];SP100[unassigned1304];ZNF518B[27705803];MIS12[27705803];ZNF518A[27705803];WIZ[27705803];ZNF8[21888893];NSL1[21888893;27705803];RNF2[27705803];NSD3[20936779];RBBP4[27705803];ZSWIM9[27705803];E2F6[27705803];ATE1[21888893];ZNF462[27705803];PCGF6[27705803];ZNF460[21888893];GDF15[unassigned1304];MGA[20936779;27705803];RPL35A[27705803];MAD2L2[27705803];RYBP[27705803];HIST3H3[21888893];TRIM33[20603019];	26248176
65723	chr7	27204773	C	G	chr7:27204773	HOXA9	homeobox A9	SNV	0/1	0.47	69_62	131	99.0	0/0	0.0	34_0	34	99.0			rs200450890,COSV58655867	EXONIC	YES	NM_152739.4	Transcript	protein_coding	missense_variant		1/2	NM_152739.4:c.304G>C	NP_689952.1:p.Ala102Pro		-1.0	Hox9, N-terminal activation domain,.					.	.	.		0.00409895	624.0	152234.0	5.0	33	0.99	PASS	amr	0.00739045	113.0	0.00605473	412.0	0.00365278	805.0	220380.0	5.0	22	0.58	PASS	nfe	0.00529988	518.0	0.00529988	518.0	0.0029581	460	0.008	24.0				22.8	2.628124	0.201	7	12	19	LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	HOXA9	0.0	0.0	0.0	0.0	-14.0	18.0	-9.0	-13.0						0.212	0.0	0.000000000	1.0	1.013	immune system phenotype; skeleton phenotype; limbs/digits/tail phenotype; reproductive system phenotype; hematopoietic system phenotype; integument phenotype ; growth/size/body region phenotype; endocrine/exocrine gland phenotype; 			superior cervical ganglion;trigeminal ganglion;skeletal muscle;	.	transcription, DNA-templated;multicellular organism development;spermatogenesis;single fertilization;male gonad development;anterior/posterior pattern specification;proximal/distal pattern formation;mammary gland development;embryonic forelimb morphogenesis;endothelial cell activation;negative regulation of myeloid cell differentiation;positive regulation of transcription by RNA polymerase II;embryonic skeletal system development;uterus development;definitive hemopoiesis	nucleus;transcription factor complex	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;protein binding;enzyme binding	SUZ12[23455154];PRMT5[22269951];PLSCR1[16189514];RBPMS[16189514];KRTAP9-3[unassigned1304];HDAC1[23455154];TRIP6[16189514;19060904];PTBP3[22575643];	27204773
65775	chr7	29606036	G	T	chr7:29606036	PRR15	proline rich 15	SNV	0/0	0.0	89_0	89	99.0	0/1	0.45	51_41	92	99.0			rs775125430	EXONIC	YES	NM_175887.3	Transcript	protein_coding	missense_variant		2/2	NM_175887.3:c.91G>T	NP_787083.1:p.Val31Leu		1.0						.	.	.		6.5697e-05	10.0	152214.0	0.0	33	0.98	PASS	amr	0.000326968	5.0	5.87941e-05	4.0	3.46819e-05	8.0	230668.0	0.0	33	0.71	PASS	amr	8.89891e-05	3.0	3.98343e-05	4.0	0.0000193	3	0.001	3.0				10.61	0.635705	0.011	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRR15	0.0	0.0	0.0	0.0	18.0	-5.0	-2.0	-1.0							0.45	0.000000000	0.028	-0.127	.			.	.	multicellular organism development	.	.	.	29606036
65798	chr7	30325166	GCGGCGGCC		chr7:30325166-30325174	ZNRF2	zinc and ring finger 2	deletion	0/1	0.31	9_4	13	99.0	0|1	0.71	4_10	14	99.0			rs1304693741	EXONIC	YES	NM_147128.4	Transcript	protein_coding	inframe_deletion		1/5	NM_147128.4:c.205_213del	NP_667339.1:p.Ala69_Ala71del		1.0						.	.	.		0.00331964	472.0	142184.0	2.0	30	0.81	PASS	sas	0.00717602	34.0	0.00169745	109.0	0.0384615	1.0	26.0	0.0	0	0.0	RF	nfe	0.0384615	1.0	0.0384615	1.0	0.0000643	10						16.65	1.566302		0	0	0																		0.59				.			testis - interstitial;	.	protein polyubiquitination	cytoplasm;lysosomal membrane;cytosol;plasma membrane;endosome membrane;cell junction;cytoplasmic vesicle membrane;protein-containing complex;presynaptic membrane	ubiquitin-protein transferase activity;metal ion binding;ubiquitin protein ligase activity	UBE2N[27173435;unassigned1312];	30325165
65853	chr7	33384197	C	T	chr7:33384197	BBS9	Bardet-Biedl syndrome 9	SNV	0/1	0.55	24_30	55	99.0	0/1	0.42	43_31	74	99.0			rs138072724,COSV54166336	EXONIC	YES	NM_001348041.4	Transcript	protein_coding	missense_variant		12/23	NM_001348041.4:c.1280C>T	NP_001334970.1:p.Ala427Val		1.0	.,.,.,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Bardet-Biedl_syndrome_9|Bardet-Biedl_syndrome|not_specified|not_provided	Bardet-Biedl syndrome 9, 615986 (3), Autosomal recessive	Bardet-Biedl syndrome	Disease-causing germline mutation(s) in	Hearing impairment;Cryptorchidism;Hypoplasia of the ovary;Low-set, posteriorly rotated ears;Hypogonadism;Nephrotic syndrome;Nystagmus;Multicystic kidney dysplasia;Generalized hirsutism;Short stature;Obesity;Abnormal electroretinogram;Hepatic fibrosis;Pigmentary retinopathy;Neurological speech impairment;Short neck;Downslanted palpebral fissures;Postaxial hand polydactyly;Finger syndactyly;Skeletal muscle atrophy;Hypertension;Intellectual disability;Prominent nasal bridge;Hypoplasia of penis;Medial flaring of the eyebrow;Rod-cone dystrophy;Obesity;Polydactyly;Variable expressivity;Autosomal recessive inheritance;Intellectual disability	25741868	0.00574524	874.0	152126.0	6.0	31	0.97	PASS	nfe	0.00908663	618.0	0.00908663	618.0	0.00493463	1241.0	251488.0	4.0	100	1.0	PASS	nfe	0.00755085	859.0	0.00755085	859.0	0.0047008	731	0.004	14.0	0.00403	46.0		25.9	3.733417	0.137	9	11	20	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	BBS9	0.0	0.14	0.0	0.11	0.0	-4.0	-4.0	49.0						0.157	0.0	0.000000000	0.649	1.026	limbs/digits/tail phenotype; skeleton phenotype; adipose tissue phenotype ; growth/size/body region phenotype; 			ciliary ganglion;testis - seminiferous tubule;testis - interstitial;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;testis;skeletal muscle;globus pallidus;medulla oblongata;	.	visual perception;protein transport;fat cell differentiation;response to stimulus;cilium assembly;protein localization to cilium	pericentriolar material;cytosol;cilium;membrane;centriolar satellite;BBSome;ciliary transition zone;ciliary membrane	molecular_function;protein binding	BBS2[17574030;22500027;22139371;27173435;unassigned1312;20080638;29039417];IQCB1[25552655];BBS1[17574030;22500027;27173435;unassigned1312;20080638;29039417];C2CD3[24997988];ARL6[22139371];THYN1[30021884];LZTFL1[22072986;27173435;unassigned1312];PTBP3[22575643];TUBA1C[26496610];TTC8[17574030;27173435;unassigned1312;29039417];BBS10[20080638];BBS12[20080638];L1TD1[26496610];BBS7[22500027;27173435;unassigned1312;20080638];BBS5[17574030;27173435;unassigned1312;20080638;29039417];CLUAP1[27173435;unassigned1312];CEP290[25552655];BBS4[17574030;27173435;unassigned1312;20080638;29039417];	33384197
66100	chr7	48147890	A	G	chr7:48147890	UPP1	uridine phosphorylase 1	SNV	0/0	0.0	35_0	35	99.0	0/1	0.67	35_76	113	99.0			rs762478345	EXONIC	YES	NM_001362774.2	Transcript	protein_coding	missense_variant		10/10	NM_001362774.2:c.869A>G	NP_001349703.1:p.Glu290Gly		1.0	Nucleoside phosphorylase domain,Nucleoside phosphorylase domain					.	.	.		1.9707e-05	3.0	152230.0	0.0	33	0.97	PASS	amr	6.54365e-05	1.0	2.93927e-05	2.0					69	1.0							0.0000064	1	0.0	1.0				23.6	3.029762	0.174	14	5	19	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,LRT_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_noAF_pred	UPP1	0.0	0.0	0.0	0.0	-20.0	-36.0	0.0	25.0						0.206	0.0	0.000000000	0.197	1.312	homeostasis/metabolism phenotype; cellular phenotype; behavior/neurological phenotype ; renal/urinary system phenotype; skeleton phenotype; immune system phenotype; nervous system phenotype ; 			lung;superior cervical ganglion;	Pyrimidine metabolism;Drug metabolism - other enzymes	nucleobase-containing compound metabolic process;uridine catabolic process;nucleotide catabolic process;cellular response to glucose starvation;pyrimidine nucleoside salvage;UMP salvage;pyrimidine nucleoside catabolic process	nucleus;nucleoplasm;cytosol	uridine phosphorylase activity	VPS18[26496610];NUDCD1[29021621];TP53BP1[29656893];	48147890
67054	chr7	57188144	C	T	chr7:57188144	ZNF479	zinc finger protein 479	SNV	0|1	0.22	7_2	9	63.0	0/0	0.0	15_0	15	45.0			rs782563666,COSV100483081	EXONIC	YES	NM_033273.2	Transcript	protein_coding	synonymous_variant		5/5	NM_033273.2:c.978G>A	NP_150376.1:p.Arg326%3D		-1.0						.	.	.		0.000750682	99.0	131880.0	0.0	31	0.88	PASS	sas	0.00278059	11.0	0.00059404	36.0	0.00391864	788.0	201090.0	0.0	20	0.53	RF	amr	0.00624684	173.0	0.00460056	403.0	0.0000129	2	0.002	7.0				0.1	-0.483373		0	0	0			ZNF479	0.0	0.0	0.0	0.0	29.0	0.0	-1.0	1.0						0.854	0.01				.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	BRAP[25820252];GOLGA6L9[unassigned1304];KRTAP5-7[unassigned1304];KRTAP10-6[unassigned1304];MDFI[unassigned1304];STX1A[unassigned1304];	57188144
67056	chr7	57188148	C	T	chr7:57188148	ZNF479	zinc finger protein 479	SNV	0|1	0.22	7_2	9	63.0	0/0	0.0	15_0	15	45.0			rs782402962,COSV99044427	EXONIC	YES	NM_033273.2	Transcript	protein_coding	missense_variant		5/5	NM_033273.2:c.974G>A	NP_150376.1:p.Cys325Tyr		-1.0	Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type,Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type,Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type					.	.	.		0.00070362	90.0	127910.0	0.0	31	0.86	PASS	amr	0.00179768	22.0	0.000588671	35.0	0.00331377	656.0	197962.0	0.0	19	0.48	PASS	amr	0.00551065	150.0	0.00383097	330.0	0.0000064	1	0.001	2.0				0.001	-1.395386	0.201	0	17	17		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF479	0.0	0.0	0.0	0.0	-4.0	25.0	-3.0	-5.0						0.854	0.01		0.001	-1.646	.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	BRAP[25820252];GOLGA6L9[unassigned1304];KRTAP5-7[unassigned1304];KRTAP10-6[unassigned1304];MDFI[unassigned1304];STX1A[unassigned1304];	57188148
67061	chr7	64292143	T	A	chr7:64292143	ZNF138	zinc finger protein 138	SNV	0/1	0.79	3_11	14	41.0	0/1	0.7	6_14	20	99.0			rs533947771	EXONIC	YES	NM_001271639.2	Transcript	protein_coding	missense_variant		4/4	NM_001271639.2:c.523T>A	NP_001258568.2:p.Ser175Thr		1.0	Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type,.,Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type					.	.	.		1.31446e-05	2.0	152154.0	0.0	33	0.97	AS_VQSR	amr	6.54622e-05	1.0	1.47003e-05	1.0					55	0.98							0.0000129	2	0.0	1.0				0.017	-0.717499	0.055	0	15	15		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF138	0.0	0.0	0.0	0.0	-19.0	35.0	50.0	35.0						0.818	0.0	0.000000000	0.0	-3.102	.			atrioventricular node;superior cervical ganglion;parietal lobe;medulla oblongata;	.	regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;metal ion binding	ZBTB8A[25416956;unassigned1304];KRTAP12-3[unassigned1304];TRIM41[25416956;unassigned1304];KRTAP10-7[unassigned1304];KRTAP10-6[unassigned1304];DHPS[25416956];KRTAP10-8[25416956;unassigned1304];BCCIP[unassigned1304];ELOA2[unassigned1304];KRT40[25416956];MAPK9[unassigned1304];LHX6[unassigned1304];MDFI[25416956;unassigned1304];	64292143
67100	chr7	65426055	A		chr7:65426055	GUSB	glucuronidase beta	deletion	0/1	0.16	28_7	43	90.0	0/1	0.19	19_8	43	99.0			rs750022485	SPLICING	YES	NM_000181.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	11/11		NM_000181.4:c.1790-5del			-1.0		Benign	criteria_provided,_single_submitter	Mucopolysaccharidosis_type_7|not_specified|not_provided	Mucopolysaccharidosis VII, 253220 (3), Autosomal recessive	Mucopolysaccharidosis type 7	Disease-causing germline mutation(s) in	Hearing impairment;Short neck;Metatarsus adductus;Short stature;Gingival overgrowth;Hypoplasia of the odontoid process;Coarse facial features;Postnatal growth retardation;Recurrent upper respiratory tract infections;Hepatomegaly;J-shaped sella turcica;Platyspondyly;Macrocephaly;Talipes equinovarus;Proximal tapering of metacarpals;Hydrops fetalis;Heparan sulfate excretion in urine;Anterior beaking of lumbar vertebrae;Dysostosis multiplex;Intellectual disability;Anterior beaking of lower thoracic vertebrae;Pectus carinatum;Umbilical hernia;Dermatan sulfate excretion in urine;Neurodegeneration;Decreased pulmonary function;Inguinal hernia;Genu valgum;Autosomal recessive inheritance;Hydrocephalus;Splenomegaly;Acetabular dysplasia;Thick eyebrow;Scoliosis;Poor speech;Corneal opacity;Hirsutism;Abnormal heart valve morphology;Narrow greater sciatic notch;Flexion contracture;Thoracolumbar kyphosis;Cardiomyopathy;Widely spaced teeth;Metatarsus adductus;Diaphyseal thickening;Joint stiffness;Abnormality of the hip bone;Coarse facial features;Enlarged thorax;Arteriovenous malformation;Corneal opacity;Ascites;Recurrent respiratory infections;Abnormal pleura morphology;Scoliosis;Anterior beaking of lower thoracic vertebrae;Anterior beaking of lumbar vertebrae;Splenomegaly;Inguinal hernia;Epiphyseal stippling;Flat face;Lymphedema;Mucopolysacchariduria;Intellectual disability;Hydrops fetalis;Muscular hypotonia;Short neck;Hepatitis;Umbilical hernia		0.00534383	569.0	106478.0	0.0	31	0.89	AS_VQSR	amr	0.00523819	53.0	0.00449712	225.0	0.428309	68311.0	159490.0	0.0	81	1.0	InbreedingCoeff	amr	0.450198	10459.0	0.430781	31466.0	0.0014019,0.0003022	218,47			0.21357	2427.0		6.625	0.255236		0	0	0			GUSB	0.0	0.0	0.0	0.0	-7.0	-4.0	-14.0	-12.0						0.0891	0.0				hematopoietic system phenotype; normal phenotype; mortality/aging ; reproductive system phenotype; behavior/neurological phenotype ; skeleton phenotype; renal/urinary system phenotype; limbs/digits/tail phenotype; hearing/vestibular/ear phenotype; craniofacial phenotype; growth/size/body region phenotype; integument phenotype ; adipose tissue phenotype ; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; cellular phenotype; 			liver;placenta;testis;	Pentose and glucuronate interconversions;Starch and sucrose metabolism;Glycosaminoglycan degradation;Porphyrin and chlorophyll metabolism;Drug metabolism - other enzymes;Glycan structures - degradation	carbohydrate metabolic process;glycosaminoglycan catabolic process;glucuronoside catabolic process;hyaluronan catabolic process;neutrophil degranulation	extracellular region;extracellular space;membrane;azurophil granule lumen;lysosomal lumen;intracellular membrane-bounded organelle;extracellular exosome;ficolin-1-rich granule lumen	beta-glucuronidase activity;signaling receptor binding;protein domain specific binding;carbohydrate binding	GIT2[21988832];CANX[29568061];HSCB[28380382];A2M[17174955];GUSB[18268347];	65426054
67345	chr7	76112294	G	A	chr7:76112294	DTX2	deltex E3 ubiquitin ligase 2	SNV	0/1	0.6	68_100	168	99.0	0/1	0.48	69_64	133	99.0			rs754463201,COSV56862397	EXONIC	YES	NM_020892.3	Transcript	protein_coding	synonymous_variant		5/12	NM_020892.3:c.738G>A	NP_065943.2:p.Pro246%3D		1.0						.	.	.		1.97174e-05	3.0	152150.0	0.0	34	0.98	PASS	nfe	2.94023e-05	2.0	2.94023e-05	2.0	1.99682e-05	5.0	250398.0	0.0	92	0.99	PASS	eas	5.43715e-05	1.0	3.54114e-05	4.0	0.0000064	1						0.949	-0.158509		0	0	0			DTX2	0.0	0.0	0.0	0.0	42.0	-11.0	-12.0	-1.0						0.514	0.11				.			.	Notch signaling pathway	Notch signaling pathway;protein ubiquitination	nucleoplasm;cytoplasm;nuclear membrane	protein binding;zinc ion binding;transferase activity	"UBE2D4[16189514;19549727;25416956;unassigned1304];BOLA2-SMG1P6[unassigned1304];UBE2D2[unassigned1304];UBE2D3[25416956;unassigned1304];FOXI1[unassigned1304];UBE2D1[21516116;25416956;unassigned1304];KLHDC7B[unassigned1304];IKZF3[unassigned1304];MBD3L1[unassigned1304];GOLGA2[25416956];EIF4ENIF1[21516116;25416956];ALKBH4[21516116;25416956;unassigned1304];ABHD11[unassigned1304];RUSC1[unassigned1304];POGZ[unassigned1304];ZNF85[unassigned1304];KRTAP7-1[unassigned1304];HOXA1[unassigned1304];OIP5[unassigned1304];TEKT5[unassigned1304];LOC401296[unassigned1304];MRGPRG-AS1[unassigned1304];HPCAL1[16189514;unassigned1304];ARID5A[unassigned1304];ARMC7[unassigned1304];C22orf39[unassigned1304];HPCAL4[16189514;25416956;unassigned1304];NIF3L1[unassigned1304];DOK3[unassigned1304];RFX6[16189514;25416956];CLUHP3[unassigned1304];HGS[unassigned1304];CLPP[unassigned1304];TRIB3[unassigned1304];HOXB2[unassigned1304];GLYR1[unassigned1304];USP54[unassigned1304];PPP1R32[unassigned1304];HPCA[unassigned1304];DTX2[25416956];KLC3[25416956];BCL2L11[unassigned1304];SOHLH1[unassigned1304];SFN[15778465];C10orf55[unassigned1304];LINC00311[unassigned1304];RBM11[unassigned1304];C19orf54[unassigned1304];PRR32[unassigned1304];RBPMS[16189514;25416956];BICRAL[unassigned1304];KRTAP8-1[unassigned1304];""Em[unassigned1304];LRP2BP[unassigned1304];SEPSECS[unassigned1304];HIST1H4A[30021884];QARS[25416956];TRIP6[25416956];PRR34[unassigned1304];ZNF774[unassigned1304];EIF4G1[unassigned1304];C1orf94[25416956];PLEKHF2[25416956];DAZAP2[unassigned1304];RHOXF2[16189514;unassigned1304];KRTAP26-1[25416956];FHL2[25416956];MED19[unassigned1304];FHL5[unassigned1304];ECSIT[unassigned1304];FER1L6-AS1[unassigned1304];LASP1[unassigned1304];ABHD16A[25416956;unassigned1304];SUMO1[25416956];NUDCD1[29021621];NCS1[16189514;21516116;25416956;unassigned1304];FBXL19-AS1[unassigned1304];ZNF764[unassigned1304];COA6[unassigned1304];KRTAP11-1[unassigned1304];PLEKHG4[unassigned1304];KRTAP15-1[unassigned1304];FCRL4[unassigned1304];LRRC75A-AS1[unassigned1304];KRTAP19-1[unassigned1304];TMEM42[unassigned1304];PAX5[unassigned1304];KRTAP19-6[unassigned1304];MSS51[unassigned1304];KRTAP19-7[unassigned1304];PLSCR1[16189514];VSNL1[16189514;25416956;unassigned1304];ZNF833P[unassigned1304];SEC22A[21516116;25416956;unassigned1304];TRIM54[25416956;unassigned1304];VGLL3[unassigned1304];KANK2[unassigned1304];STX12[25416956;unassigned1304];SEC23A[unassigned1304];HDC[25416956];MVP[unassigned1304];NCALD[16189514;21516116;25416956];HSFY1[unassigned1304];PSMB4[unassigned1304];FAM168A[25416956];SLC22A18AS[unassigned1304];HLX[unassigned1304];ZNF503[unassigned1304];KRTAP6-1[unassigned1304];TENT2[unassigned1304];UBQLN4[16713569];SEC23B[25416956];ZNF620[unassigned1304];LINC01600[unassigned1304];C20orf85[unassigned1304];ARNT2[unassigned1304];SPAG8[25416956];EYA2[unassigned1304];CCDC57[unassigned1304];GLYCTK[25416956;unassigned1304];TBX15[unassigned1304];TRIM35[unassigned1304];LNX1[unassigned1304];RIMBP3[25416956];TRIP13[16189514];COQ8A[25910212];SPG21[21516116;25416956;unassigned1304];"	76112294
67420	chr7	77539632	C	A	chr7:77539632	PHTF2	putative homeodomain transcription factor 2	SNV	0/1	0.47	50_46	97	99.0	0/1	0.53	34_38	72	99.0			rs375131045	EXONIC	YES	NM_001366089.1	Transcript	protein_coding	missense_variant		8/19	NM_001366089.1:c.682C>A	NP_001353018.1:p.Gln228Lys		1.0	.,.,.,.,.,.,.,.					.	.	.		5.25597e-05	8.0	152208.0	0.0	32	0.97	PASS	nfe	0.000117595	8.0	0.000117595	8.0	4.01223e-05	10.0	249238.0	0.0	52	1.0	PASS	nfe	8.84956e-05	10.0	8.84956e-05	10.0	0.0000514	8	0.0	1.0				23.3	2.888567	0.128	11	9	20	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred	PHTF2	0.0	0.0	0.0	0.0	4.0	-41.0	4.0	24.0						0.142	0.02	0.000000000	1.0	1.026	homeostasis/metabolism phenotype; hematopoietic system phenotype; 			ciliary ganglion;superior cervical ganglion;trigeminal ganglion;skeletal muscle;globus pallidus;	.	.	nucleus;endoplasmic reticulum	DNA binding	DHRS2[30021884];	77539632
67468	chr7	81598292	A		chr7:81598292	CACNA2D1	calcium voltage-gated channel auxiliary subunit alpha2delta 1	deletion	0/1	0.5	3_3	6	68.0	0/0	0.0	10_0	10	30.0			rs762936617	SPLICING	YES	NM_001366867.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	28/38		NM_001366867.1:c.2345-3del			-1.0		Benign	criteria_provided,_single_submitter	Brugada_syndrome		Brugada syndrome;Familial short QT syndrome	Major susceptibility factor in;Disease-causing germline mutation(s) (loss of function) in	Syncope;Palpitations;Shortened QT interval;Bradycardia;Atrial fibrillation;Ventricular fibrillation;Sudden cardiac death;Atrioventricular block;Trifascicular block;Supraventricular tachycardia;Right bundle branch block;ST segment elevation;Syncope;Paroxysmal ventricular tachycardia;First degree atrioventricular block;Ventricular fibrillation;Cardiac arrest;Sick sinus syndrome		0.000121945	18.0	147608.0	0.0	32	0.92	PASS	eas	0.000392003	2.0	9.05087e-05	6.0	0.00330254	630.0	190762.0	0.0	55	0.89	RF	sas	0.00680212	154.0	0.00236264	215.0					0.0066	74.0		5.738	0.193149		0	0	0			CACNA2D1	0.0	0.01	0.0	0.03	-2.0	-6.0	-28.0	-36.0						0.258	1.0				renal/urinary system phenotype; nervous system phenotype ; cardiovascular system phenotype ; behavior/neurological phenotype ; muscle phenotype; 			superior cervical ganglion;skeletal muscle;	MAPK signaling pathway	calcium ion transport;regulation of calcium ion transport;regulation of ventricular cardiac muscle cell membrane repolarization;calcium ion transport into cytosol;calcium ion transmembrane transport via high voltage-gated calcium channel;cardiac muscle cell action potential involved in contraction;membrane depolarization during bundle of His cell action potential;regulation of heart rate by cardiac conduction;calcium ion import across plasma membrane;regulation of membrane repolarization during action potential;positive regulation of high voltage-gated calcium channel activity;regulation of calcium ion transmembrane transport via high voltage-gated calcium channel;cellular response to amyloid-beta	plasma membrane;voltage-gated calcium channel complex;sarcoplasmic reticulum;extracellular exosome;L-type voltage-gated calcium channel complex	voltage-gated calcium channel activity;metal ion binding;voltage-gated calcium channel activity involved in cardiac muscle cell action potential;voltage-gated calcium channel activity involved in bundle of His cell action potential	MYH7B[26496610];CNOT2[26496610];H3F3A[30021884];HNRNPU[26496610];HIST1H2BH[30021884];BCAR1[28007913];	81598291
67551	chr7	89909179	T	C	chr7:89909179	CFAP69	cilia and flagella associated protein 69	SNV	0/1	0.56	19_25	45	99.0	0/1	0.49	29_28	57	99.0			rs201599221	EXONIC	YES	NM_001039706.3	Transcript	protein_coding	synonymous_variant		12/23	NM_001039706.3:c.1344T>C	NP_001034795.2:p.Leu448%3D		1.0					Spermatogenic failure 24, 617959 (3), Autosomal recessive	Non-syndromic male infertility due to sperm motility disorder	Disease-causing germline mutation(s) in	Reduced sperm motility;Autosomal recessive inheritance;Coiled sperm flagella;Short sperm flagella;Microcephalic sperm head;Tapered sperm head		0.000183968	28.0	152200.0	0.0	32	0.96	PASS	nfe	0.000264628	18.0	0.000264628	18.0	0.000223115	54.0	242028.0	0.0	30	0.72	PASS	nfe	0.000323508	36.0	0.000323508	36.0	0.0001929	30	0.001	2.0				9.48	0.508158		0	0	0			CFAP69	0.0	0.0	0.0	0.0	-17.0	11.0	28.0	16.0								13.685474238			growth/size/body region phenotype; taste/olfaction phenotype; reproductive system phenotype; skeleton phenotype; nervous system phenotype ; limbs/digits/tail phenotype; 			.	.	spermatogenesis;sensory perception of smell;cell differentiation;olfactory behavior;positive regulation of flagellated sperm motility;positive regulation of fertilization;response to odorant	cytoplasm;sperm midpiece;non-motile cilium	.	SEPT1[30021884];	89909179
67576	chr7	92979352	G	A	chr7:92979352	VPS50	VPS50, EARP/GARPII complex subunit	SNV	0/1	0.36	9_5	14	99.0	0/1	0.23	10_3	13	65.0			rs148939966	SPLICING	YES	NM_017667.4	Transcript	protein_coding	splice_region_variant,intron_variant	25/27		NM_017667.4:c.2463+7G>A			1.0					Neurodevelopmental disorder with microcephaly, seizures, and neonatal cholestasis, 619685 (3), Autosomal recessive	.	.	.		0.000289116	44.0	152188.0	0.0	32	0.97	PASS	amr	0.000458295	7.0	0.000396837	27.0	0.00025269	62.0	245360.0	0.0	30	0.83	PASS	nfe	0.000483196	54.0	0.000483196	54.0	0.0002830	44	0.0	1.0				1.514	-0.088774		0	0	0			VPS50	0.0	0.0	0.01	0.0	2.0	-6.0	-7.0	-25.0											.			.	.	protein transport;endocytic recycling;retrograde transport, endosome to Golgi	cytosol;membrane;recycling endosome;extracellular exosome;EARP complex	SNARE binding;protein binding	KDM1A[unassigned1312];GOLIM4[26496610];YEATS4[unassigned1312];HSCB[28380382];PSMD9[unassigned1312];RABGEF1[unassigned1312];GOLGA5[unassigned1312];NUF2[unassigned1312];SDF4[26496610];OIP5[unassigned1312];HMG20A[unassigned1312];CCHCR1[unassigned1312];CCDC93[unassigned1312];CTNNBL1[30021884];GRIPAP1[unassigned1312];EIPR1[26496610;unassigned1312];HAUS6[unassigned1312];PHF20L1[26496610];DDX19B[26496610];RAPGEF2[26496610];PHLDB3[unassigned1312];VAMP4[25799061];CLOCK[unassigned1312];VAMP3[25799061];STX12[25799061];SF3B2[26496610];CRABP2[26496610];LAMA1[26496610];PKN3[unassigned1312];TUFT1[unassigned1312];MAX[unassigned1312];STX16[25799061];PHF21A[unassigned1312];ARNTL[unassigned1312];TFPT[unassigned1312];VPS51[26496610;unassigned1312;25799061];VPS53[26496610;unassigned1312;25799061];VPS52[26496610;25799061];VTI1A[25799061];STX6[25799061];RPRD1A[unassigned1312];GIT2[unassigned1312];RABGAP1L[unassigned1312];BRF1[26496610];CAVIN1[unassigned1312];NCKAP5L[unassigned1312];SCLT1[26638075];FANCG[26496610];THAP11[unassigned1312];ZNF33A[26496610];PPIL3[26496610];R3HDM1[26496610];NRDE2[26496610];DZIP3[unassigned1312];RCOR1[unassigned1312];	92979352
67633	chr7	96635389	GCA		chr7:96635389-96635391	DLX6	distal-less homeobox 6	deletion	0/1	0.15	58_11	71	99.0	0/0	0.04	46_2	48	54.0			rs747232821	EXONIC	YES	NM_005222.4	Transcript	protein_coding	inframe_deletion		1/3	NM_005222.4:c.120_122del	NP_005213.3:p.Gln44del		1.0						Isolated split hand-split foot malformation	Disease-causing germline mutation(s) in	Sensorineural hearing impairment;Split hand;Absent hand;Finger syndactyly;Oligodactyly;Aniridia		8.04387e-05	12.0	149182.0	0.0	29	0.89	AS_VQSR	amr	6.64452e-05	1.0	2.98e-05	2.0	0.00202204	287.0	141936.0	0.0	30	0.57	PASS	eas	0.003684	36.0	0.00220478	127.0	0.0042314,0.0000064	658,1			0.01454	165.0		20.3	2.055201		0	0	0			DLX6	0.0	0.0	0.0	0.0	-17.0	34.0	-31.0	2.0						0.257	0.84	0.000000000			craniofacial phenotype; growth/size/body region phenotype; integument phenotype ; respiratory system phenotype; skeleton phenotype; digestive/alimentary phenotype; hearing/vestibular/ear phenotype; nervous system phenotype ; limbs/digits/tail phenotype; mortality/aging ; embryo phenotype; 			trigeminal ganglion;superior cervical ganglion;	.	skeletal system development;regulation of transcription by RNA polymerase II;nervous system development;cell differentiation;embryonic limb morphogenesis;epithelial cell differentiation;inner ear morphogenesis;positive regulation of transcription by RNA polymerase II;anatomical structure formation involved in morphogenesis;positive regulation of epithelial cell proliferation;roof of mouth development;head development	nucleus	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;sequence-specific DNA binding	HSP90AB1[22939624];DDIT4L[unassigned1304];	96635388
67636	chr7	96635421	CGC		chr7:96635421-96635423	DLX6	distal-less homeobox 6	deletion	0/1	0.14	44_7	51	99.0	0/1	0.15	35_6	41	99.0			rs559903070	EXONIC	YES	NM_005222.4	Transcript	protein_coding	inframe_deletion		1/3	NM_005222.4:c.158_160del	NP_005213.3:p.Pro53del		1.0						Isolated split hand-split foot malformation	Disease-causing germline mutation(s) in	Sensorineural hearing impairment;Split hand;Absent hand;Finger syndactyly;Oligodactyly;Aniridia		0.000327829	49.0	149468.0	0.0	29	0.8	PASS	amr	0.000861269	13.0	0.000208625	14.0	0.00469683	563.0	119868.0	0.0	28	0.56	PASS	afr	0.0106245	49.0	0.00435098	204.0	0.0000064,0.0013504	1,210			0.02201	250.0					0	0	0			DLX6	0.0	0.0	0.0	0.0	5.0	2.0	5.0	-45.0						0.257	0.84	0.000000000			craniofacial phenotype; growth/size/body region phenotype; integument phenotype ; respiratory system phenotype; skeleton phenotype; digestive/alimentary phenotype; hearing/vestibular/ear phenotype; nervous system phenotype ; limbs/digits/tail phenotype; mortality/aging ; embryo phenotype; 			trigeminal ganglion;superior cervical ganglion;	.	skeletal system development;regulation of transcription by RNA polymerase II;nervous system development;cell differentiation;embryonic limb morphogenesis;epithelial cell differentiation;inner ear morphogenesis;positive regulation of transcription by RNA polymerase II;anatomical structure formation involved in morphogenesis;positive regulation of epithelial cell proliferation;roof of mouth development;head development	nucleus	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;sequence-specific DNA binding	HSP90AB1[22939624];DDIT4L[unassigned1304];	96635420
67643	chr7	97736519	CTG		chr7:97736519-97736521	LMTK2	lemur tyrosine kinase 2	deletion	0/1	0.14	25_4	29	93.0	0/0	0.0	29_0	29	81.0			rs146333850	EXONIC	YES	NM_014916.4	Transcript	protein_coding	inframe_deletion		1/14	NM_014916.4:c.46_48del	NP_055731.2:p.Leu16del		1.0						.	.	.		6.59065e-05	10.0	151730.0	0.0	32	0.97	PASS	nfe	0.000117848	8.0	0.000117848	8.0	0.0251882	1198.0	47562.0	0.0	4	0.07	RF	eas	0.0331453	47.0	0.0263158	470.0	0.0000064,0.0028874	1,449						17.25	1.665201		0	0	0			LMTK2	0.0	0.0	0.0	0.0	4.0	40.0	-38.0	38.0						0.103	0.99				reproductive system phenotype; mortality/aging ; cellular phenotype; endocrine/exocrine gland phenotype; 			trigeminal ganglion;superior cervical ganglion;skeletal muscle;	.	receptor recycling;protein phosphorylation;transmembrane receptor protein tyrosine kinase signaling pathway;peptidyl-serine phosphorylation;peptidyl-threonine phosphorylation;peptidyl-tyrosine phosphorylation;endocytic recycling;negative regulation of phosphoprotein phosphatase activity;transferrin transport;early endosome to late endosome transport;protein autophosphorylation	early endosome;Golgi apparatus;cytosol;integral component of plasma membrane;integral component of membrane;growth cone;neuronal cell body;receptor complex;perinuclear region of cytoplasm;recycling endosome	protein serine/threonine kinase activity;transmembrane receptor protein tyrosine kinase activity;protein phosphatase inhibitor activity;protein binding;ATP binding;myosin VI binding	PPP1R2[12393858];PPP1CC[21382349;24366813;26496610;28330616];CAMK2D[29426014];SORT1[26496610];	97736518
67700	chr7	98655108	C	T	chr7:98655108	SMURF1	SMAD specific E3 ubiquitin protein ligase 1	SNV	0/1	0.44	54_44	99	99.0	0/0	0.0	37_0	37	99.0			rs1024029009	EXONIC	YES	NM_020429.3	Transcript	protein_coding	synonymous_variant		4/19	NM_020429.3:c.270G>A	NP_065162.1:p.Gln90%3D		-1.0						.	.	.		1.31441e-05	2.0	152160.0	0.0	31	0.96	PASS	nfe	2.93979e-05	2.0	2.93979e-05	2.0	8.84291e-06	2.0	226170.0	0.0	45	0.74	PASS	nfe	9.30458e-06	1.0	9.30458e-06	1.0								12.6	0.884731		0	0	0			SMURF1	0.0	0.0	0.0	0.0	33.0	-1.0	-21.0	33.0						0.239	1.0	87.553170684			growth/size/body region phenotype; behavior/neurological phenotype ; embryo phenotype; mortality/aging ; normal phenotype; nervous system phenotype ; hearing/vestibular/ear phenotype; limbs/digits/tail phenotype; skeleton phenotype; 			testis - seminiferous tubule;testis - interstitial;subthalamic nucleus;trigeminal ganglion;superior cervical ganglion;atrioventricular node;testis;skeletal muscle;globus pallidus;	Ubiquitin mediated proteolysis;TGF-beta signaling pathway	protein polyubiquitination;ubiquitin-dependent protein catabolic process;protein export from nucleus;transforming growth factor beta receptor signaling pathway;ectoderm development;protein ubiquitination;cell differentiation;negative regulation of ossification;BMP signaling pathway;negative regulation of transforming growth factor beta receptor signaling pathway;negative regulation of BMP signaling pathway;ubiquitin-dependent SMAD protein catabolic process;receptor catabolic process;protein localization to cell surface;proteasome-mediated ubiquitin-dependent protein catabolic process;positive regulation of protein catabolic process;Wnt signaling pathway, planar cell polarity pathway;parkin-mediated stimulation of mitophagy in response to mitochondrial depolarization;engulfment of target by autophagosome;substrate localization to autophagosome;protein targeting to vacuole involved in autophagy;protein localization to plasma membrane;positive regulation of dendrite extension;positive regulation of ubiquitin-dependent protein catabolic process	nucleoplasm;cytoplasm;mitochondrion;cytosol;plasma membrane;axon;neuronal cell body;extracellular exosome	ubiquitin-protein transferase activity;protein binding;phospholipid binding;activin binding;ubiquitin protein ligase activity;I-SMAD binding;R-SMAD binding	RNF11[15231748];ECSIT[25241761];ING1[20621832];ING2[20621832];CHEK1[25249323];DVL2[19379695];SMAD2[15231748];SMAD1[15231748;19914168;21708152];SMAD3[15231748];FBXL15[21572392];SMAD5[15231748];GNG11[25241761];RHOA[15710384;21708152];RUNX2[16299379];KLF2[21382345];RHOB[25249323];SMAD7[20937913;22921829];PSMC5[23032291];TRAF4[19937093];PSME3[20580715];UBE2N[25260751];PLEKHO1[20580715;23032291;21382345];UBA1[25260751];UBE2V1[25260751];TRIB2[25311538];	98655108
67730	chr7	99084738	G	A	chr7:99084738	ZNF789	zinc finger protein 789	SNV	0/1	0.39	47_30	77	99.0	0/0	0.0	34_0	34	99.0			rs1458599864,COSV58874978	EXONIC	YES	NM_213603.3	Transcript	protein_coding	missense_variant		5/5	NM_213603.3:c.905G>A	NP_998768.2:p.Arg302Gln		1.0	Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type&Zinc finger C2H2-type					.	.	.						33	0.98											64	0.99														4.244	0.09893	0.131	0	18	18		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF789	0.01	0.0	0.0	0.0	8.0	-20.0	-37.0	7.0						0.867	0.0	14.758933081	1.0	1.006	.			testis - interstitial;atrioventricular node;	.	regulation of transcription by RNA polymerase II	nucleoplasm	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;metal ion binding	HEXIM2[unassigned1304];	99084738
67742	chr7	99097613	C	G	chr7:99097613	ZNF394	zinc finger protein 394	SNV	0/0	0.0	34_0	34	99.0	0/1	0.57	65_88	154	99.0			rs201107533	EXONIC	YES	NM_032164.4	Transcript	protein_coding	missense_variant		1/3	NM_032164.4:c.104G>C	NP_115540.2:p.Gly35Ala		-1.0	.,.					.	.	.		0.000341517	52.0	152262.0	1.0	32	0.98	PASS	nfe	0.000529023	36.0	0.000529023	36.0	0.000385666	96.0	248920.0	1.0	52	0.99	PASS	nfe	0.000768551	87.0	0.000768551	87.0	0.0003408	53	0.001	2.0				15.49	1.357208	0.18	3	18	21	PolyPhen,MutationAssessor_pred,PROVEAN_pred	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZNF394	0.0	0.0	0.0	0.0	-18.0	-27.0	-10.0	-38.0						0.737	0.04	0.000000000	0.015	1.026	homeostasis/metabolism phenotype; 			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;metal ion binding	ZBTB47[unassigned1304];RNPS1[unassigned1304];SCAND1[unassigned1304];CCNDBP1[25416956];CLK2[25416956];	99097613
68000	chr7	100054503	C	T	chr7:100054503	C7orf61	chromosome 7 open reading frame 61	SNV	0/0	0.0	36_0	36	99.0	0/1	0.63	38_65	103	99.0			rs201441317,COSV100190247	EXONIC	YES	NM_001004323.3	Transcript	protein_coding	missense_variant		3/3	NM_001004323.3:c.493G>A	NP_001004323.1:p.Val165Ile		-1.0						.	.	.		0.000447027	68.0	152116.0	0.0	32	0.96	PASS	amr	0.001443	22.0	0.000529241	36.0	0.00033836	84.0	248256.0	0.0	50	0.95	PASS	nfe	0.000480119	54.0	0.000480119	54.0	0.0002637	41	0.0	1.0				0.001	-1.41335	0.024	0	17	17		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	C7orf61	0.0	0.0	0.0	0.0	-11.0	-32.0	-40.0	22.0						0.607	0.01	0.000000000	0.006	-2.055	.			.	.	.	nucleus	.	.	100054503
68004	chr7	100159926	G	A	chr7:100159926	AGFG2	ArfGAP with FG repeats 2	SNV	0/0	0.0	36_0	36	99.0	0/1	0.4	76_51	127	99.0			rs147498213,COSV99499279	EXONIC	YES	NM_006076.5	Transcript	protein_coding	missense_variant		7/12	NM_006076.5:c.922G>A	NP_006067.3:p.Ala308Thr		1.0						.	.	.		0.00696069	1059.0	152140.0	12.0	32	0.96	PASS	nfe	0.00752853	512.0	0.00752853	512.0	0.00678733	1701.0	250614.0	24.0	69	0.99	PASS	nfe	0.0072515	821.0	0.0072515	821.0	0.0058712	913	0.006	19.0				7.553	0.32673	0.009	1	17	18	MutationTaster_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	AGFG2	0.0	0.01	0.0	0.0	5.0	-44.0	3.0	26.0						0.666	0.0	0.000000000	0.001	-2.662	.			pons;dorsal root ganglion;atrioventricular node;trigeminal ganglion;superior cervical ganglion;globus pallidus;	.	biological_process;positive regulation of GTPase activity	membrane	molecular_function;GTPase activator activity;metal ion binding	.	100159926
68009	chr7	100170601	G	C	chr7:100170601	SAP25	Sin3A associated protein 25	SNV	0/1	0.59	53_75	128	99.0	0/1	0.39	74_48	122	99.0			rs771815094	EXONIC	YES	NM_001348680.2	Transcript	protein_coding	synonymous_variant		4/6	NM_001348680.2:c.393C>G	NP_001335609.1:p.Gly131%3D		-1.0						.	.	.		0.000151228	23.0	152088.0	0.0	32	0.96	PASS	amr	0.00091659	14.0	2.94221e-05	2.0	0.000162777	19.0	116724.0	0.0	9	0.26	PASS	amr	0.000639827	13.0	6.57232e-05	3.0	0.0000064	1	0.001	3.0				11.79	0.779975		0	0	0			SAP25	0.1	0.02	0.0	0.0	1.0	35.0	1.0	-32.0											.			.	.	regulation of transcription, DNA-templated	nucleus;cytoplasm	.	SIN3A[16449650];	100170601
68025	chr7	100225847	C	T	chr7:100225847	TFR2	transferrin receptor 2	SNV	0/1	0.45	43_35	78	99.0	0/0	0.0	49_0	49	99.0			rs139178017,CS127748	SPLICING	YES	NM_003227.4	Transcript	protein_coding	splice_region_variant,synonymous_variant		11/18	NM_003227.4:c.1473G>A	NP_003218.2:p.Glu491%3D		-1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Hereditary_hemochromatosis|Hemochromatosis_type_3|not_provided	Hemochromatosis, type 3, 604250 (3), Autosomal recessive	Hemochromatosis type 3	Disease-causing germline mutation(s) (loss of function) in	Elevated hepatic transaminase;Lymphopenia;Purpura;Fatigue;Autosomal recessive inheritance;Increased serum ferritin;Anemia;Amenorrhea;Increased serum iron;Neutropenia;Hyperpigmentation of the skin;Arthritis;Cardiomyopathy;Hypogonadotropic hypogonadism;Cirrhosis;Impotence	24777453,27863252	0.00271807	413.0	151946.0	3.0	31	0.91	PASS	nfe	0.00362042	246.0	0.00362042	246.0	0.00310747	781.0	251330.0	3.0	100	1.0	PASS	nfe	0.00450482	512.0	0.00450482	512.0	0.0031382	488	0.004	12.0	0.00587	67.0		25.3	3.579506		0	0	0			TFR2	0.0	0.0	0.52	0.45	-22.0	48.0	-21.0	0.0	0.999987422782991	1.0	-5.23	8.355	3.126	0.713	0.0	65.017561937			hematopoietic system phenotype; liver/biliary system phenotype; immune system phenotype; growth/size/body region phenotype; homeostasis/metabolism phenotype; 			ciliary ganglion;liver;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;cingulate cortex;atrioventricular node;fetal liver;fetal lung;skeletal muscle;	.	iron ion transport;cellular iron ion homeostasis;receptor-mediated endocytosis;acute-phase response;response to iron ion;transferrin transport;positive regulation of endocytosis;positive regulation of transcription by RNA polymerase II;iron ion homeostasis;cellular response to iron ion;positive regulation of peptide hormone secretion;positive regulation of protein maturation	plasma membrane;integral component of plasma membrane;external side of plasma membrane;cytoplasmic vesicle;HFE-transferrin receptor complex	transferrin receptor activity;protein binding;transferrin transmembrane transporter activity;co-receptor binding	SOCS3[21988832];OLFM4[unassigned1304];SEC22A[unassigned1304];	100225847
68107	chr7	100468269	C	T	chr7:100468269	TRIP6	thyroid hormone receptor interactor 6	SNV	0|1	0.65	42_77	119	99.0	0/0	0.0	67_0	67	99.0			rs150669875,COSV52340844	EXONIC	YES	NM_003302.3	Transcript	protein_coding	synonymous_variant		6/9	NM_003302.3:c.903C>T	NP_003293.2:p.His301%3D		1.0						.	.	.		0.000769018	117.0	152142.0	0.0	33	0.97	PASS	afr	0.00270375	112.0	0.0	0.0	0.000230658	58.0	251454.0	0.0	75	1.0	PASS	afr	0.0028916	47.0	3.51648e-05	4.0	0.0002379	37						0.809	-0.18228		0	0	0			TRIP6	0.06	0.0	0.0	0.0	37.0	24.0	0.0	12.0						0.294	0.66	38.693310833			.			superior cervical ganglion;	.	positive regulation of cell migration;focal adhesion assembly;positive regulation of NIK/NF-kappaB signaling	nucleus;cytosol;cytoskeleton;plasma membrane;focal adhesion	RNA binding;interleukin-1 receptor binding;protein binding;kinase binding;metal ion binding;thyroid hormone receptor binding	MAPKBP1[25416956];CNTF[25416956];TRAF3IP2[25416956];TTLL10[25416956];ATN1[16713569];AQP1[16189514;25416956;unassigned1304];TXN2[25416956];CEP128[26638075];RPS14[17353931];HOXA9[16189514;19060904];HYKK[25416956];TRIM29[25416956];STK16[25416956];MGC50722[unassigned1304];HOXA1[16189514];OIP5[25416956];TEKT4[25416956];ZNF688[26871637];TBC1D22B[unassigned1304];EXOC3-AS1[16189514;25416956;unassigned1304];ZBP1[25416956];PDGFRB[25416956];TRAPPC2L[25416956];CEP135[26638075];TPM3[25416956];PPP1R16A[16189514;19060904];LMO2[25416956];USP2[unassigned1304];RFX3[25416956];EPDR1[unassigned1304];SCRIB[16137684];CMBL[17353931];RPGRIP1L[26638075];KCTD5[17353931];FRS3[25416956;unassigned1304];SHISA6[unassigned1304];KCTD9[unassigned1304];ILF3[16189514];HOXB9[25416956];CEP57L1[25416956];HGS[unassigned1304];SIK3[21516116;25416956];TSSK3[unassigned1304];NSMF[unassigned1304];VCL[16189514;21516116];GNE[unassigned1304];KPRP[unassigned1304];POM121[16189514;unassigned1304];BEX2[unassigned1304];CCDC24[unassigned1304];GLIS3[unassigned1304];DTX2[25416956];GATA1[25910212];KIR2DL4[25416956];FAM124B[16189514];NEU4[25416956];ATXN1[16713569];RNF213[25416956];BAG3[unassigned1304];GSE1[25416956];OTX1[unassigned1304];SLC15A3[25416956];PATZ1[unassigned1304];HOXC8[unassigned1304];ZNF785[unassigned1304];IP6K3[unassigned1304];TXNDC5[25416956];ZNF541[unassigned1304];TFAP2C[24835590];TCAF1[25416956];STIL[26638075];AFAP1L1[17353931];SETDB1[unassigned1304];STAC[18654987];ODF2[26638075];INCA1[25416956];MEMO1[25416956];NR1D2[unassigned1304];LYZ[17353931];CTAG2[25416956];VASN[unassigned1304];MOB1A[17353931];TRIP6[17353931];SNAI1[unassigned1304];PIN1[25416956];TAB1[21988832];CNTROB[26638075];PIGS[unassigned1304];TTC23[unassigned1304];CCDC120[unassigned1304];ITGB4[unassigned1304];KRTAP26-1[25416956];WT1-AS[25416956];FHL3[16189514];FASLG[25416956];SMG9[unassigned1304];FARS2[unassigned1304];ADAMTSL4[25416956];TMSB4X[25416956];ZIC1[unassigned1304];NCK2[16189514;25416956;unassigned1304];CEP170[26638075];PLEKHN1[unassigned1304];IKBKG[unassigned1774];POM121L1P[25416956];METTL17[21516116;25416956];AXIN1[26871637];IL16[21516116];RAD23A[25416956];TENT5C[16189514];RHOA[25416956];AES[unassigned1304];C11orf87[unassigned1304];IQCN[16189514];FAM222B[unassigned1304];HCK[unassigned1304];RBL1[17353931];THRAP3[17353931];EFHC1[25910212];SAXO1[25416956];SSX2IP[26638075];FOXD4L1[unassigned1304];SLC25A6[25416956];CREB5[25416956];CATSPER1[16189514;25416956;unassigned1304];OTUB2[25416956];PRKAA1[25416956];PRKAA2[25416956];XRCC6BP1[25416956];TSGA10IP[unassigned1304];NEDD9[25416956];GPS2[unassigned1304];CRYBA4[25910212];GDPD5[25416956];TANK[unassigned1774];MRM3[17353931];GNAI2[25416956];RANBP3L[unassigned1304];MIEN1[unassigned1304];CCL5[21988832];STOM[17353931];SCAND1[unassigned1304];PDLIM4[10826496];MISP[unassigned1304];ZNF581[unassigned1304];ZNF580[unassigned1304];HEL-S-42[25416956];GAD1[26871637];TIE1[unassigned1304];MIIP[unassigned1304];KLK15[25416956];DMRT3[25416956];RRP1B[20926688];PTPN14[unassigned1304];BYSL[21516116;25416956];PER1[unassigned1304];GFI1B[16713569];ABI2[25416956];PSMC4[17353931];SERBP1[17353931];ZYX[11423549];ATP5PO[25416956];LNX1[unassigned1304];TRIP11[17353931];MSRB3[25416956];P4HB[17353931];BCAR1[11782456];CEP44[26638075];	100468269
68300	chr7	100550079	G	C	chr7:100550079	MUC3A	mucin 3A, cell surface associated	SNV	0/1	0.44	76_122	277	99.0	0/1	0.38	83_96	250	99.0			rs28379747,COSV60211612	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.660A>C	NP_005951.1:p.Ser220%3D		1.0						.	.	.						0	0.0							0.419673	91169.0	217238.0	1.0	100	0.98	InbreedingCoeff	nfe	0.426656	42599.0	0.426656	42599.0	0.0257550	4005	0.077	232.0				0.781	-0.187401		0	0	0			MUC3A	0.0	0.0	0.0	0.0	12.0	-31.0	-6.0	-39.0								83.460541628			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550079
68306	chr7	100550290	A		chr7:100550290	MUC3A	mucin 3A, cell surface associated	deletion	0/1	0.12	104_16	135	99.0	0/0	0.0	83_0	83	99.0				EXONIC	YES	NM_005960.2	Transcript	protein_coding	frameshift_variant		2/16	NM_005960.2:c.871del	NP_005951.1:p.Thr291ProfsTer9		1.0						.	.	.						49	0.99											100	0.98														14.94	1.253422		0	0	0			MUC3A	0.0	0.02	0.0	0.0	48.0	0.0	49.0	46.0								0.000000000			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550289
68313	chr7	100550376	C	T	chr7:100550376	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.12	145_19	165	99.0	0/0	0.0	83_0	83	99.0			rs764198010	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.957C>T	NP_005951.1:p.Thr319%3D		1.0						.	.	.						0	0.46							0.0	0.0	207670.0	0.0	57	0.72	AC0				0.0	0.0	0.0007524	117						4.134	0.092324		0	0	0			MUC3A	0.02	0.0	0.0	0.0	21.0	5.0	-6.0	-38.0								30.376663156			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550376
68314	chr7	100550384	C	T	chr7:100550384	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.12	143_19	164	99.0	0/0	0.0	83_0	83	99.0			rs77636516,COSV60215662	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.965C>T	NP_005951.1:p.Pro322Leu		1.0	.,.					.	.	.						61	1.0							0.0	0.0	202512.0	0.0	53	0.68	AC0				0.0	0.0	0.0000129	2						8.607	0.419695	0.369	2	10	12	SIFT,PROVEAN_pred	MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC3A	0.03	0.0	0.0	0.0	13.0	-38.0	15.0	-46.0								31.211350972	0.001	-0.38	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550384
68315	chr7	100550438	C	T	chr7:100550438	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.3	159_68	230	99.0	0|1	0.2	116_30	147	99.0			rs1368284480	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1019C>T	NP_005951.1:p.Pro340Leu		1.0	.,.					.	.	.		0.0	0.0	152310.0	0.0	64	1.0	AC0_AS_VQSR				0.0	0.0	0.00044837	67.0	149430.0	0.0	25	0.56	PASS	nfe	0.000731446	45.0	0.000731446	45.0	0.0000064	1						6.855	0.272454		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	-0.322	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550438
68318	chr7	100550445	C	T	chr7:100550445	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.31	148_68	218	99.0	0|1	0.21	116_32	149	99.0			rs761179735	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1026C>T	NP_005951.1:p.Ser342%3D		1.0						.	.	.						64	1.0							0.000690485	101.0	146274.0	0.0	23	0.54	RF	nfe	0.00107099	64.0	0.00107099	64.0	0.0000064	1						3.389	0.047878		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550445
68319	chr7	100550446	A	G	chr7:100550446	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.31	147_68	217	99.0	0|1	0.22	116_33	150	99.0			rs769060224	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1027A>G	NP_005951.1:p.Thr343Ala		1.0	.,.					.	.	.						64	1.0							0.000666149	96.0	144112.0	0.0	23	0.54	PASS	nfe	0.00105871	62.0	0.00105871	62.0	0.0000064	1						1.858	-0.05691		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	-1.685	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550446
68320	chr7	100550447	C	T	chr7:100550447	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.21	169_45	216	99.0	0|1	0.08	137_12	150	91.0			rs776762595	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1028C>T	NP_005951.1:p.Thr343Ile		1.0	.,.					.	.	.						64	1.0							3.29572e-05	5.0	151712.0	0.0	23	0.53	RF	afr	0.000126135	1.0	3.15159e-05	2.0	0.0018649	290	0.001	2.0				3.294	0.042135		1	5	6	SIFT	MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	0.911	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550447
68321	chr7	100550449	G	C	chr7:100550449	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.32	145_69	216	99.0	0|1	0.21	121_33	155	99.0			rs765526058	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1030G>C	NP_005951.1:p.Val344Leu		1.0	.,.					.	.	.						65	1.0							0.00083786	120.0	143222.0	0.0	21	0.52	RF	nfe	0.00137646	80.0	0.00137646	80.0	0.0041349	643						1.31	-0.110655		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	0.132	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550449
68322	chr7	100550452	A	T	chr7:100550452	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.21	171_47	220	99.0	0|1	0.09	141_14	156	99.0			rs763292509	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1033A>T	NP_005951.1:p.Thr345Ser		1.0	.,.					.	.	.						65	1.0							3.35534e-05	5.0	149016.0	0.0	21	0.52	PASS	sas	8.53534e-05	2.0	4.84888e-05	3.0	0.0018713	291	0.001	3.0				3.853	0.075613		1	5	6	SIFT	MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	0.135	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550452
68323	chr7	100550457	C	T	chr7:100550457	MUC3A	mucin 3A, cell surface associated	SNV	0/1	0.31	142_68	217	99.0	0/1	0.22	122_35	160	99.0			rs781058334	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1038C>T	NP_005951.1:p.Asp346%3D		1.0						.	.	.						59	0.94							0.00116456	162.0	139108.0	0.0	19	0.5	PASS	nfe	0.00208988	117.0	0.00208988	117.0	0.0039227	610						1.938	-0.050239		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550457
68328	chr7	100550471	T	C	chr7:100550471	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.31	147_68	217	99.0	0|1	0.23	139_42	182	99.0			rs769206651	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1052T>C	NP_005951.1:p.Ile351Thr		1.0	.,.					.	.	.		0.0	0.0	76306.0	0.0	44	0.59	AC0_AS_VQSR				0.0	0.0	0.00174656	234.0	133978.0	0.0	16	0.44	RF	nfe	0.00295946	159.0	0.00295946	159.0	0.0000836	13						5.21	0.15863		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	-0.593	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550471
68330	chr7	100550484	A	C	chr7:100550484	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.32	141_66	209	99.0	0|1	0.23	147_45	194	99.0			rs1370678290	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1065A>C	NP_005951.1:p.Thr355%3D		1.0						.	.	.						60	1.0											0	0.0							0.0006824	18						4.775	0.13122		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550484
68331	chr7	100550486	G	A	chr7:100550486	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.35	142_77	221	99.0	0|1	0.28	145_58	205	99.0			rs1247094027	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1067G>A	NP_005951.1:p.Ser356Asn		1.0	.,.					.	.	.						50	0.93											0	0.0							0.0001158	18						4.886	0.138135		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.004	-0.204	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550486
68332	chr7	100550490	G	A	chr7:100550490	MUC3A	mucin 3A, cell surface associated	SNV	0/1	0.2	176_45	223	99.0	0|1	0.11	182_23	207	99.0			rs796897629	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1071G>A	NP_005951.1:p.Met357Ile		1.0	.,.					.	.	.		2.77223e-05	3.0	108216.0	0.0	54	0.78	AS_VQSR	afr	0.00010193	3.0	0.0	0.0					0	0.0							0.0017749	276	0.002	7.0				0.952	-0.158		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.001	-0.289	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550490
68333	chr7	100550508	A	T	chr7:100550508	MUC3A	mucin 3A, cell surface associated	SNV	0/1	0.56	87_110	198	99.0	0|1	0.41	127_88	217	99.0			rs146219126	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1089A>T	NP_005951.1:p.Thr363%3D		1.0						.	.	.						48	0.98											0	0.0							0.0007203	19						0.236	-0.362879		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550508
68334	chr7	100550510	A	T	chr7:100550510	MUC3A	mucin 3A, cell surface associated	SNV	0/1	0.37	85_71	192	99.0	0/1	0.3	124_64	216	99.0			rs796842434	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1091A>T	NP_005951.1:p.Glu364Val		1.0	.,.					.	.	.						43	0.74											0	0.0							0.0006066	16						1.968	-0.047793		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	-2.719	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550510
68336	chr7	100550514	T	C	chr7:100550514	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.37	121_71	193	99.0	0|1	0.29	152_64	219	99.0			rs78262970	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1095T>C	NP_005951.1:p.Thr365%3D		1.0						.	.	.						57	1.0											0	0.0							0.0049283	130						4.532	0.116329		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550514
68338	chr7	100550520	C	T	chr7:100550520	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.37	119_70	190	99.0	0|1	0.28	149_60	212	99.0			rs77013428	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1101C>T	NP_005951.1:p.Leu367%3D		1.0						.	.	.		6.56607e-06	1.0	152298.0	0.0	58	1.0	PASS	nfe	1.46946e-05	1.0	1.46946e-05	1.0					0	0.0							0.0007582,0.0000379	20,1						1.432	-0.097223		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550520
68339	chr7	100550522	C	G	chr7:100550522	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.38	114_69	184	99.0	0|1	0.29	152_62	217	99.0			rs76664943	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1103C>G	NP_005951.1:p.Pro368Arg		1.0	.,.					.	.	.						58	1.0											0	0.0							0.0007961	21						4.263	0.100092		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	-0.879	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550522
68340	chr7	100550543	C	T	chr7:100550543	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.38	110_68	178	99.0	0|1	0.31	139_62	203	99.0			rs76777205	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1124C>T	NP_005951.1:p.Pro375Leu		1.0	.,.					.	.	.		0.0	0.0	131696.0	0.0	53	0.89	AC0_AS_VQSR				0.0	0.0					0	0.0							0.0005307	14						8.885	0.446771		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.001	0.678	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550543
68341	chr7	100550544	A	C	chr7:100550544	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.38	110_68	178	99.0	0|1	0.3	139_60	201	99.0			rs75037819	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1125A>C	NP_005951.1:p.Pro375%3D		1.0						.	.	.						61	1.0											0	0.0							0.0007961	21						3.341	0.045008		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550544
68342	chr7	100550552	A	T	chr7:100550552	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.37	103_61	164	99.0	0|1	0.29	130_55	187	99.0			rs77957081	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1133A>T	NP_005951.1:p.Glu378Val		1.0	.,.					.	.	.						61	0.99											0	0.0							0.0006445	17						8.979	0.456111		1	5	6	SIFT	MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.041	0.871	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550552
68343	chr7	100550562	G	A	chr7:100550562	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.35	98_52	150	99.0	0|1	0.29	127_52	181	99.0			rs78069287	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1143G>A	NP_005951.1:p.Thr381%3D		1.0						.	.	.		4.92174e-05	7.0	142226.0	0.0	61	0.96	PASS	afr	7.78412e-05	3.0	6.24844e-05	4.0					0	0.0							0.0003412	9						0.975	-0.154468		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550562
68344	chr7	100550563	A	G	chr7:100550563	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.35	97_52	149	99.0	0|1	0.29	128_52	182	99.0			rs77561545	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1144A>G	NP_005951.1:p.Thr382Ala		1.0	.,.					.	.	.						61	1.0											0	0.0							0.0003412	9						5.23	0.159892		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	-0.505	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550563
68345	chr7	100550564	C	T	chr7:100550564	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.34	95_48	143	99.0	0|1	0.29	126_52	180	99.0			rs75269566	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1145C>T	NP_005951.1:p.Thr382Ile		1.0	.,.					.	.	.						61	0.99											0	0.0							0.0003412	9						6.819	0.269763		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.001	0.684	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550564
68346	chr7	100550568	T	A	chr7:100550568	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.37	84_50	134	99.0	0|1	0.31	111_50	162	99.0			rs78115301	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1149T>A	NP_005951.1:p.Pro383%3D		1.0						.	.	.						62	1.0											0	0.0							0.0003033	8						6.053	0.214483		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550568
68348	chr7	100550571	G	A	chr7:100550571	MUC3A	mucin 3A, cell surface associated	SNV	0/1	0.38	79_50	132	99.0	0|1	0.31	113_51	165	99.0			rs146166922	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1152G>A	NP_005951.1:p.Met384Ile		1.0	.,.					.	.	.						48	1.0											0	0.0							0.0003412	9						3.63	0.062332		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	-3.567	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550571
68349	chr7	100550589	C	G	chr7:100550589	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.37	75_44	119	99.0	0|1	0.2	113_29	143	99.0			rs80123018	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1170C>G	NP_005951.1:p.Thr390%3D		1.0						.	.	.		0.00108932	1.0	918.0	0.0	0	0.01	PASS	amr	0.00806452	1.0	0.0	0.0					0	0.0							0.0003412	9						4.205	0.096616		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550589
68350	chr7	100550595	T	C	chr7:100550595	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.36	72_41	113	99.0	0|1	0.19	109_26	136	99.0			rs80315860	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1176T>C	NP_005951.1:p.Thr392%3D		1.0						.	.	.						64	0.98											0	0.0							0.0004928	13						0.037	-0.61723		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550595
68351	chr7	100550596	G	A	chr7:100550596	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.36	72_41	113	99.0	0|1	0.19	109_26	136	99.0			rs74991890	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		2/16	NM_005960.2:c.1177G>A	NP_005951.1:p.Glu393Lys		1.0	.,.					.	.	.		8.67182e-06	1.0	115316.0	0.0	60	0.82	PASS				0.0	0.0					0	0.0							0.0003412	9	0.0	1.0				3.804	0.07266		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	-0.464	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550596
68353	chr7	100550607	C	A	chr7:100550607	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.42	64_47	111	99.0	0|1	0.15	109_20	130	99.0			rs77396152	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1188C>A	NP_005951.1:p.Ser396%3D		1.0						.	.	.						65	0.94											0	0.0							0.0011752	31	0.001	2.0				0.068	-0.535252		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550607
68354	chr7	100550619	C	T	chr7:100550619	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.43	56_43	99	99.0	0/0	0.0	174_0	174	0.0			rs78047302	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		2/16	NM_005960.2:c.1200C>T	NP_005951.1:p.Pro400%3D		1.0						.	.	.						40	0.55											0	0.0							0.0002275	6						7.112	0.29232		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550619
68355	chr7	100550766	C	C	chr7:100550766	MUC3A	mucin 3A, cell surface associated	SNV	1|1	1.0	0_14	14	42.0	1|1	1.0	0_16	16	48.0			rs28654698	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		3/16	NM_005960.2:c.5862A>C	NP_005951.1:p.Ser1954%3D		1.0						.	.	.						0	0.0							0.524064	53878.0	102808.0	4217.0	42	0.91	InbreedingCoeff	nfe	0.532526	27833.0	0.532526	27833.0	0.0015948,0.0000193	248,3	0.013	34.0				4.441	0.11081		0	0	0																						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550766
68359	chr7	100550816	G	A	chr7:100550816	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.5	8_8	16	99.0	0|1	0.83	2_10	12	54.0			rs62483690	EXONIC	YES	NM_005960.2	Transcript	protein_coding	coding_sequence_variant	4/15		NM_005960.2:c.1389+2G>A			1.0						.	.	.						0	0.02							0.111315	9726.0	87374.0	0.0	100	0.98	RF	nfe	0.16352	6150.0	0.16352	6150.0	0.0001286	20	0.011	34.0				4.767	0.130725		0	0	0														-25.479	0.536	-24.942						.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550816
68360	chr7	100550827	T	C	chr7:100550827	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.47	9_8	17	99.0	0|1	0.73	4_11	15	99.0			rs760531164	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		5/16	NM_005960.2:c.6919T>C	NP_005951.1:p.Phe2307Leu		1.0	.,.					.	.	.		0.0	0.0	150066.0	0.0	453	0.99	AC0				0.0	0.0	0.0204796	3872.0	189066.0	0.0	100	0.98	RF	nfe	0.0309787	2519.0	0.0309787	2519.0	0.1120679	17427						5.643	0.186838		0	6	6		SIFT,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred																		0.0	-2.421	.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100550827
68379	chr7	100552017	T	T	chr7:100552017	MUC3A	mucin 3A, cell surface associated	SNV	0/1	0.3	126_54	182	99.0	0/1	0.28	126_49	176	99.0			rs1554457672,rs9691167	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		5/16	NM_005960.2:c.8109C>T	NP_005951.1:p.Phe2703%3D		1.0						.	.	.						0	0.0							0.337996	59999.0	177514.0	91.0	33	0.63	InbreedingCoeff	eas	0.385389	6288.0	0.361906	30998.0	0.0415488	6461	0.098	279.0				1.462	-0.09414		0	0	0																			18.631753385			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100552017
68387	chr7	100552251	C	C	chr7:100552251	MUC3A	mucin 3A, cell surface associated	SNV	0/1	0.78	47_172	220	99.0	0/1	0.77	34_119	154	99.0			rs1306209366,rs9691900,COSV60218624	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		5/16	NM_005960.2:c.8343T>C	NP_005951.1:p.Ser2781%3D		1.0						.	.	.						0	0.0							0.604686	110770.0	183186.0	19230.0	51	0.67	InbreedingCoeff_RF	eas	0.648305	10863.0	0.618662	53956.0	0.0535613,0.0036784	8329,572	0.234	731.0				1.263	-0.116167		0	0	0																			25.450761380			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100552251
68441	chr7	100607851	G	G	chr7:100607851	MUC3A	mucin 3A, cell surface associated	SNV	0/1	0.5	122_121	243	99.0	0/1	0.54	81_96	179	99.0			rs6960854	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		9/16	NM_005960.2:c.9339C>G	NP_005951.1:p.Leu3113%3D		1.0						.	.	.						0	0.0							0.506417	115698.0	228464.0	1470.0	53	0.98	InbreedingCoeff	sas	0.5297	16016.0	0.503168	53045.0	0.0281600	4379	0.191	592.0	0.50542	932.0		0.804	-0.183199		0	0	0																			36.222312096			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100607851
68442	chr7	100607871	T	T	chr7:100607871	MUC3A	mucin 3A, cell surface associated	SNV	0/1	0.25	156_52	208	99.0	0/1	0.29	100_41	142	99.0			rs6960868,COSV60214561	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		9/16	NM_005960.2:c.9359C>T	NP_005951.1:p.Val3120%3D		1.0						.	.	.						0	0.0							0.48172	101747.0	211216.0	725.0	44	0.97	InbreedingCoeff	afr	0.501103	6815.0	0.492856	48709.0	0.0205718	3199	0.169	514.0	0.44306	817.0		0.576	-0.232979		0	0	0																			76.912027051			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100607871
68503	chr7	100608370	C	C	chr7:100608370	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.54	91_110	202	99.0	0|1	0.52	80_87	168	99.0			rs73714276,COSV60212649	SPLICING	YES	NM_005960.2	Transcript	protein_coding	splice_region_variant,synonymous_variant		10/16	NM_005960.2:c.9446A>C	NP_005951.1:p.Ala3149%3D		1.0						.	.	.						0	0.0							0.499642	90680.0	181490.0	232.0	73	0.77	InbreedingCoeff	afr	0.503881	5063.0	0.500058	43396.0	0.0219223	3409	0.15	481.0	0.49187	907.0		22.5	2.449534		0	0	0														10.068	-0.911	9.158			66.875343337			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100608370
68545	chr7	100608778	C	C	chr7:100608778	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.46	115_98	213	99.0	0|1	0.51	77_81	158	99.0			rs73163792	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		11/16	NM_005960.2:c.9498T>C	NP_005951.1:p.Pro3166%3D		1.0						.	.	.						0	0.0							0.499785	111517.0	223130.0	16.0	51	0.97	InbreedingCoeff	afr	0.499926	6798.0	0.499903	51641.0	0.0176973	2752	0.104	314.0	0.49729	917.0		13.05	0.945263		0	0	0																			36.222312096			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100608778
68550	chr7	100608779	T	T	chr7:100608779	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.46	115_98	213	99.0	0|1	0.51	77_81	158	99.0			rs73163793	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		11/16	NM_005960.2:c.9499C>T	NP_005951.1:p.Leu3167%3D		1.0						.	.	.						0	0.0							0.49978	111412.0	222922.0	16.0	51	0.97	InbreedingCoeff	afr	0.499926	6792.0	0.499864	51595.0	0.0176330	2742	0.08	245.0	0.49729	917.0		10.86	0.664641		0	0	0																			36.222312096			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100608779
68560	chr7	100608823	G	T	chr7:100608823	MUC3A	mucin 3A, cell surface associated	SNV	0/1	0.23	179_55	235	99.0	0/1	0.24	146_45	191	99.0			rs35790618,COSV60217016	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		11/16	NM_005960.2:c.9543G>T	NP_005951.1:p.Ser3181%3D		1.0						.	.	.						0	0.0							0.249954	38426.0	153732.0	10.0	49	0.97	InbreedingCoeff_RF	amr	0.352382	8121.0	0.26018	18005.0	0.0178195	2771	0.091	275.0	0.22234	410.0		13.93	1.077165		0	0	0																			13.184926778			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100608823
68572	chr7	100608826	G	G	chr7:100608826	MUC3A	mucin 3A, cell surface associated	SNV	0/1	0.49	117_113	231	99.0	0/1	0.55	83_101	184	99.0			rs73163794,rs756600581	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		11/16	NM_005960.2:c.9546C>G	NP_005951.1:p.Gly3182%3D		1.0						.	.	.						0	0.0							0.499338	108575.0	217438.0	12.0	48	0.97	InbreedingCoeff	afr	0.499546	6600.0	0.499443	50216.0	0.0356968	5551	0.158	489.0	0.49295	909.0		14.73	1.214737		0	0	0																			13.184926778			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100608826
68579	chr7	100608868	G	G	chr7:100608868	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.53	89_102	192	99.0	0|1	0.62	56_93	149	99.0			rs67377634,COSV60215686	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		11/16	NM_005960.2:c.9588A>G	NP_005951.1:p.Leu3196%3D		1.0						.	.	.						0	0.0							0.494375	96768.0	195738.0	9.0	33	0.9	InbreedingCoeff	afr	0.495696	5759.0	0.495236	44807.0	0.0186941	2907	0.176	541.0	0.48536	895.0		13.16	0.960759		0	0	0																			63.343682261			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100608868
68587	chr7	100608884	A	A	chr7:100608884	MUC3A	mucin 3A, cell surface associated	SNV	0|1	0.55	77_96	174	99.0	0|1	0.64	49_89	138	99.0			rs73163797,COSV60213519	EXONIC	YES	NM_005960.2	Transcript	protein_coding	synonymous_variant		11/16	NM_005960.2:c.9604G>A	NP_005951.1:p.Thr3202%3D		1.0						.	.	.						0	0.0							0.492477	90404.0	183570.0	8.0	28	0.8	InbreedingCoeff	sas	0.494121	12607.0	0.493238	41288.0	0.0127971	1990	0.152	447.0	0.47939	884.0		8.662	0.424945		0	0	0																			0.485211871			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100608884
68788	chr7	100610069	T	A	chr7:100610069	MUC3A	mucin 3A, cell surface associated	SNV	0/1	0.24	107_46	192	99.0	0/1	0.23	104_43	187	99.0			rs10258821,COSV60210855,COSV60211223	EXONIC	YES	NM_005960.2	Transcript	protein_coding	missense_variant		14/16	NM_005960.2:c.9895C>A	NP_005951.1:p.Tyr3299Asn		1.0						.	.	.						0	0.0							0.0563665	12627.0	224016.0	0.0	100	0.98	InbreedingCoeff	eas	0.195257	3285.0	0.0425755	4419.0	0.0107650	1674	0.106	347.0	0.03633	67.0		10.76	0.653219		0	2	2		SIFT,PolyPhen																	3.450155638			.			ciliary ganglion;pons;dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;skin;atrioventricular node;prostate;skeletal muscle;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing	extracellular region;Golgi lumen;plasma membrane;integral component of membrane	extracellular matrix structural constituent;extracellular matrix constituent, lubricant activity	MYC[21150319];	100610069
68873	chr7	100678029	G	C	chr7:100678029	MUC17	mucin 17, cell surface associated	SNV	0|1	0.15	94_16	110	99.0	0/0	0.0	34_0	34	99.0			rs142558659,COSV60289286	EXONIC	YES	NM_001040105.2	Transcript	protein_coding	missense_variant		3/13	NM_001040105.2:c.3332G>C	NP_001035194.1:p.Arg1111Thr		1.0						.	.	.		0.0035342	396.0	112048.0	0.0	36	0.89	AS_VQSR	afr	0.00836561	203.0	0.00170888	95.0	9.30943e-06	2.0	214836.0	0.0	100	1.0	RF	eas	0.000140667	2.0	0.0	0.0	0.0000707	11						0.001	-1.668513	0.011	0	17	17		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC17	0.0	0.0	0.0	0.0	-41.0	-5.0	7.0	0.0						0.93			0.0	-1.932	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;cellular homeostasis	Golgi lumen;plasma membrane;external side of plasma membrane;integral component of membrane;apical plasma membrane;collagen-containing extracellular matrix	protein binding;PDZ domain binding;extracellular matrix constituent, lubricant activity	.	100678029
68874	chr7	100678032	T	C	chr7:100678032	MUC17	mucin 17, cell surface associated	SNV	0|1	0.14	94_15	109	99.0	0/0	0.0	34_0	34	99.0			rs147173571,COSV60288737	EXONIC	YES	NM_001040105.2	Transcript	protein_coding	missense_variant		3/13	NM_001040105.2:c.3335T>C	NP_001035194.1:p.Leu1112Pro		1.0						.	.	.		0.00215407	260.0	120702.0	0.0	36	0.93	AS_VQSR	afr	0.0048228	132.0	0.00104245	61.0	4.45911e-06	1.0	224260.0	0.0	100	1.0	RF	nfe	9.43663e-06	1.0	9.43663e-06	1.0	0.0000707	11						0.087	-0.50257	0.077	0	17	17		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC17	0.0	0.0	0.0	0.0	-8.0	22.0	-3.0	4.0						0.93			0.0	-9.791	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;cellular homeostasis	Golgi lumen;plasma membrane;external side of plasma membrane;integral component of membrane;apical plasma membrane;collagen-containing extracellular matrix	protein binding;PDZ domain binding;extracellular matrix constituent, lubricant activity	.	100678032
68885	chr7	100683087	T	G	chr7:100683087	MUC17	mucin 17, cell surface associated	SNV	0|1	0.15	29_5	34	99.0	0/0	0.0	38_0	38	99.0			rs752029816,COSV60280229	EXONIC	YES	NM_001040105.2	Transcript	protein_coding	missense_variant		3/13	NM_001040105.2:c.8390T>G	NP_001035194.1:p.Val2797Gly		1.0						.	.	.		0.00397767	456.0	114640.0	0.0	32	0.82	AS_VQSR	afr	0.00783141	220.0	0.00240038	130.0	1.25628e-05	3.0	238800.0	0.0	100	1.0	PASS	sas	3.47005e-05	1.0	9.14528e-06	1.0	0.0005530	86						0.001	-1.443606	0.197	0	18	18		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MUC17	0.0	0.0	0.0	0.0	0.0	28.0	-1.0	35.0						0.93		0.000000000	0.0	-2.727	.			ciliary ganglion;dorsal root ganglion;trigeminal ganglion;	.	stimulatory C-type lectin receptor signaling pathway;O-glycan processing;cellular homeostasis	Golgi lumen;plasma membrane;external side of plasma membrane;integral component of membrane;apical plasma membrane;collagen-containing extracellular matrix	protein binding;PDZ domain binding;extracellular matrix constituent, lubricant activity	.	100683087
69122	chr7	103180848	C	G	chr7:103180848	RELN	reelin	SNV	0/1	0.42	68_50	118	99.0	0/0	0.0	34_0	34	99.0			rs201422815	EXONIC	YES	NM_005045.4	Transcript	protein_coding	missense_variant		44/65	NM_005045.4:c.6726G>C	NP_005036.2:p.Arg2242Ser		-1.0	.,.,.	Uncertain_significance	criteria_provided,_multiple_submitters,_no_conflicts	Norman-Roberts_syndrome|Epilepsy,_familial_temporal_lobe,_7|Familial_temporal_lobe_epilepsy_1|not_provided	{Epilepsy, familial temporal lobe, 7}, 616436 (3), Autosomal dominant; Lissencephaly 2 (Norman-Roberts type), 257320 (3), Autosomal recessive	Lissencephaly syndrome, Norman-Roberts type;Autosomal dominant epilepsy with auditory features	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Bilateral tonic-clonic seizure with focal onset;Autosomal dominant inheritance;Focal impaired awareness seizure;Focal sensory seizure with auditory features;Incomplete penetrance;Focal aware seizure;Autosomal dominant inheritance;Incomplete penetrance;Focal sensory seizure with auditory features;Lymphedema;4-layered lissencephaly;Generalized-onset seizure;Hypoplasia of the pons;Sloping forehead;Thick cerebral cortex;Cerebellar hypoplasia;Microcephaly;Prominent nasal bridge;Global developmental delay;Muscular hypotonia;Autosomal recessive inheritance	18414213	0.000190614	29.0	152140.0	0.0	33	0.96	PASS	amr	0.00176817	27.0	1.47016e-05	1.0	0.000226813	57.0	251308.0	0.0	100	1.0	PASS	amr	0.00138784	48.0	5.27983e-05	6.0	0.0001093	17	0.004	12.0	0.0043	49.0		19.8	2.008194	0.215	8	13	21	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationTaster_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,fathmm-XF_coding_pred	RELN	0.06	0.02	0.0	0.0	-22.0	0.0	23.0	-20.0						0.175	1.0	0.000000000	1.0	1.026	reproductive system phenotype; mortality/aging ; behavior/neurological phenotype ; nervous system phenotype ; digestive/alimentary phenotype; vision/eye phenotype; integument phenotype ; growth/size/body region phenotype; cellular phenotype; muscle phenotype; 			ciliary ganglion;amygdala;olfactory bulb;appendix;superior cervical ganglion;trigeminal ganglion;fetal liver;cerebellum peduncles;cerebellum;pons;dorsal root ganglion;atrioventricular node;skeletal muscle;	Cell Communication;Focal adhesion;ECM-receptor interaction	cell morphogenesis involved in differentiation;neuron migration;proteolysis;cell adhesion;axon guidance;central nervous system development;brain development;long-term memory;associative learning;glial cell differentiation;positive regulation of neuron projection development;positive regulation of phosphatidylinositol 3-kinase signaling;dendrite development;peptidyl-tyrosine phosphorylation;spinal cord patterning;ventral spinal cord development;hippocampus development;cerebral cortex tangential migration;layer formation in cerebral cortex;positive regulation of TOR signaling;positive regulation of CREB transcription factor activity;reelin-mediated signaling pathway;positive regulation of protein kinase activity;response to pain;positive regulation of peptidyl-tyrosine phosphorylation;regulation of behavior;modulation of chemical synaptic transmission;positive regulation of small GTPase mediated signal transduction;positive regulation of synaptic transmission, glutamatergic;long-term synaptic potentiation;positive regulation of dendritic spine morphogenesis;positive regulation of protein tyrosine kinase activity;positive regulation of synapse maturation;NMDA glutamate receptor clustering;postsynaptic density protein 95 clustering;receptor localization to synapse;lateral motor column neuron migration;positive regulation of long-term synaptic potentiation;positive regulation of lateral motor column neuron migration;regulation of NMDA receptor activity;positive regulation of excitatory postsynaptic potential;positive regulation of AMPA receptor activity	extracellular region;extracellular space;cytoplasm;plasma membrane;dendrite;extracellular matrix	serine-type peptidase activity;metal ion binding;lipoprotein particle receptor binding;very-low-density lipoprotein particle receptor binding	.	103180848
69128	chr7	103191732	G	A	chr7:103191732	RELN	reelin	SNV	0/0	0.0	39_0	39	99.0	0/1	0.5	21_21	42	99.0			rs114019779	EXONIC	YES	NM_005045.4	Transcript	protein_coding	synonymous_variant		41/65	NM_005045.4:c.6084C>T	NP_005036.2:p.Gly2028%3D		-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Norman-Roberts_syndrome|Epilepsy,_familial_temporal_lobe,_7|not_specified|not_provided	{Epilepsy, familial temporal lobe, 7}, 616436 (3), Autosomal dominant; Lissencephaly 2 (Norman-Roberts type), 257320 (3), Autosomal recessive	Lissencephaly syndrome, Norman-Roberts type;Autosomal dominant epilepsy with auditory features	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Bilateral tonic-clonic seizure with focal onset;Autosomal dominant inheritance;Focal impaired awareness seizure;Focal sensory seizure with auditory features;Incomplete penetrance;Focal aware seizure;Autosomal dominant inheritance;Incomplete penetrance;Focal sensory seizure with auditory features;Lymphedema;4-layered lissencephaly;Generalized-onset seizure;Hypoplasia of the pons;Sloping forehead;Thick cerebral cortex;Cerebellar hypoplasia;Microcephaly;Prominent nasal bridge;Global developmental delay;Muscular hypotonia;Autosomal recessive inheritance	25741868,23757202	0.00489661	745.0	152146.0	8.0	32	0.96	PASS	nfe	0.00755505	514.0	0.00755505	514.0	0.00452351	1132.0	250248.0	4.0	100	0.95	PASS	nfe	0.00682525	773.0	0.00682525	773.0	0.0046365	721	0.009	31.0	0.00851	97.0		0.428	-0.276826		0	0	0			RELN	0.04	0.0	0.0	0.0	-15.0	11.0	45.0	-30.0						0.175	1.0	21.873700008			reproductive system phenotype; mortality/aging ; behavior/neurological phenotype ; nervous system phenotype ; digestive/alimentary phenotype; vision/eye phenotype; integument phenotype ; growth/size/body region phenotype; cellular phenotype; muscle phenotype; 			ciliary ganglion;amygdala;olfactory bulb;appendix;superior cervical ganglion;trigeminal ganglion;fetal liver;cerebellum peduncles;cerebellum;pons;dorsal root ganglion;atrioventricular node;skeletal muscle;	Cell Communication;Focal adhesion;ECM-receptor interaction	cell morphogenesis involved in differentiation;neuron migration;proteolysis;cell adhesion;axon guidance;central nervous system development;brain development;long-term memory;associative learning;glial cell differentiation;positive regulation of neuron projection development;positive regulation of phosphatidylinositol 3-kinase signaling;dendrite development;peptidyl-tyrosine phosphorylation;spinal cord patterning;ventral spinal cord development;hippocampus development;cerebral cortex tangential migration;layer formation in cerebral cortex;positive regulation of TOR signaling;positive regulation of CREB transcription factor activity;reelin-mediated signaling pathway;positive regulation of protein kinase activity;response to pain;positive regulation of peptidyl-tyrosine phosphorylation;regulation of behavior;modulation of chemical synaptic transmission;positive regulation of small GTPase mediated signal transduction;positive regulation of synaptic transmission, glutamatergic;long-term synaptic potentiation;positive regulation of dendritic spine morphogenesis;positive regulation of protein tyrosine kinase activity;positive regulation of synapse maturation;NMDA glutamate receptor clustering;postsynaptic density protein 95 clustering;receptor localization to synapse;lateral motor column neuron migration;positive regulation of long-term synaptic potentiation;positive regulation of lateral motor column neuron migration;regulation of NMDA receptor activity;positive regulation of excitatory postsynaptic potential;positive regulation of AMPA receptor activity	extracellular region;extracellular space;cytoplasm;plasma membrane;dendrite;extracellular matrix	serine-type peptidase activity;metal ion binding;lipoprotein particle receptor binding;very-low-density lipoprotein particle receptor binding	.	103191732
69130	chr7	103202407	AAA		chr7:103202407-103202409	RELN	reelin	sequence_alteration	1/2	0.09	2_2_15	23	43.0	0/1	0.38	1_3_0	8	29.0			rs34125550	SPLICING	YES	NM_005045.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	34/64		NM_005045.4:c.5211-9_5211-7del			-1.0		Benign	criteria_provided,_single_submitter	not_specified|not_provided	{Epilepsy, familial temporal lobe, 7}, 616436 (3), Autosomal dominant; Lissencephaly 2 (Norman-Roberts type), 257320 (3), Autosomal recessive	Lissencephaly syndrome, Norman-Roberts type;Autosomal dominant epilepsy with auditory features	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Bilateral tonic-clonic seizure with focal onset;Autosomal dominant inheritance;Focal impaired awareness seizure;Focal sensory seizure with auditory features;Incomplete penetrance;Focal aware seizure;Autosomal dominant inheritance;Incomplete penetrance;Focal sensory seizure with auditory features;Lymphedema;4-layered lissencephaly;Generalized-onset seizure;Hypoplasia of the pons;Sloping forehead;Thick cerebral cortex;Cerebellar hypoplasia;Microcephaly;Prominent nasal bridge;Global developmental delay;Muscular hypotonia;Autosomal recessive inheritance		0.000268853	28.0	104146.0	0.0	7	0.32	PASS	eas	0.000738552	2.0	0.000338346	18.0					28	0.61							0.0001608,0.0126106,0.0000450	25,1961,7			0.0068	75.0		6.923	0.277643		0	0	0			RELN	0.08	0.1	0.0	0.0	-6.0	-15.0	25.0	0.0						0.175	1.0				reproductive system phenotype; mortality/aging ; behavior/neurological phenotype ; nervous system phenotype ; digestive/alimentary phenotype; vision/eye phenotype; integument phenotype ; growth/size/body region phenotype; cellular phenotype; muscle phenotype; 			ciliary ganglion;amygdala;olfactory bulb;appendix;superior cervical ganglion;trigeminal ganglion;fetal liver;cerebellum peduncles;cerebellum;pons;dorsal root ganglion;atrioventricular node;skeletal muscle;	Cell Communication;Focal adhesion;ECM-receptor interaction	cell morphogenesis involved in differentiation;neuron migration;proteolysis;cell adhesion;axon guidance;central nervous system development;brain development;long-term memory;associative learning;glial cell differentiation;positive regulation of neuron projection development;positive regulation of phosphatidylinositol 3-kinase signaling;dendrite development;peptidyl-tyrosine phosphorylation;spinal cord patterning;ventral spinal cord development;hippocampus development;cerebral cortex tangential migration;layer formation in cerebral cortex;positive regulation of TOR signaling;positive regulation of CREB transcription factor activity;reelin-mediated signaling pathway;positive regulation of protein kinase activity;response to pain;positive regulation of peptidyl-tyrosine phosphorylation;regulation of behavior;modulation of chemical synaptic transmission;positive regulation of small GTPase mediated signal transduction;positive regulation of synaptic transmission, glutamatergic;long-term synaptic potentiation;positive regulation of dendritic spine morphogenesis;positive regulation of protein tyrosine kinase activity;positive regulation of synapse maturation;NMDA glutamate receptor clustering;postsynaptic density protein 95 clustering;receptor localization to synapse;lateral motor column neuron migration;positive regulation of long-term synaptic potentiation;positive regulation of lateral motor column neuron migration;regulation of NMDA receptor activity;positive regulation of excitatory postsynaptic potential;positive regulation of AMPA receptor activity	extracellular region;extracellular space;cytoplasm;plasma membrane;dendrite;extracellular matrix	serine-type peptidase activity;metal ion binding;lipoprotein particle receptor binding;very-low-density lipoprotein particle receptor binding	.	103202406
69150	chr7	104782762	T	A	chr7:104782762	SRPK2	SRSF protein kinase 2	SNV	0/1	0.36	62_35	97	99.0	0/1	0.37	62_37	99	99.0			rs536793006	EXONIC	YES	NM_001350740.2	Transcript	protein_coding	missense_variant		11/16	NM_001350740.2:c.1347A>T	NP_001337669.1:p.Glu449Asp		-1.0	.,Protein kinase domain&Protein kinase domain,Protein kinase domain&Protein kinase domain					.	.	.		0.000124824	19.0	152214.0	0.0	32	0.97	PASS	amr	0.000981418	15.0	2.93953e-05	2.0	0.000119302	30.0	251462.0	0.0	100	1.0	PASS	amr	0.000607077	21.0	7.91223e-05	9.0	0.0000772	12	0.002	5.0				20.2	2.042178	0.038	4	13	17	LRT_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred	M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	SRPK2	0.0	0.0	0.0	0.0	-14.0	14.0	-33.0	-48.0						0.475	1.0	0.000000000	0.999	1.138	mortality/aging ; normal phenotype; hematopoietic system phenotype; immune system phenotype; 			ciliary ganglion;amygdala;temporal lobe;olfactory bulb;testis - seminiferous tubule;prefrontal cortex;trigeminal ganglion;superior cervical ganglion;cingulate cortex;testis;cerebellum peduncles;pons;occipital lobe;subthalamic nucleus;testis - interstitial;whole brain;atrioventricular node;parietal lobe;globus pallidus;medulla oblongata;hypothalamus;thalamus;	.	spliceosomal complex assembly;angiogenesis;protein phosphorylation;positive regulation of cell population proliferation;RNA splicing;regulation of gene expression;positive regulation of gene expression;cell differentiation;nuclear speck organization;intracellular signal transduction;positive regulation of neuron apoptotic process;positive regulation of viral genome replication;negative regulation of viral genome replication;innate immune response;positive regulation of cell cycle;regulation of mRNA splicing, via spliceosome;regulation of mRNA processing	nucleus;nucleoplasm;nucleolus;cytoplasm;cytosol	magnesium ion binding;RNA binding;protein serine/threonine kinase activity;protein binding;ATP binding;14-3-3 protein binding	AHCYL1[23602568];EIF4A3[23602568];FCF1[23602568];IFIT5[23602568];MKI67[26949251];ALKBH3[23602568];PNN[23602568];SNRPD1[23602568];MAGOH[23602568];LUC7L[23602568];ARL6IP4[23602568];CCDC97[23602568];HOMER3[23602568];PRR20D[unassigned1304];SRRM2[23602568];GABARAPL1[23602568];RPL22[23602568];C16orf78[23602568];SRRM1[23602568];DDX39A[23602568];DDX39B[23602568];ADPRH[23602568];FAM76B[23602568];MAGEB1[23602568];OR5A1[23602568];HOXB6[unassigned1304];RWDD2B[23602568];DHX8[23602568];SLAIN2[23602568];RTF1[23602568];GABARAP[23602568];FXR1[unassigned1304];MMTAG2[23602568];FXR2[25416956];EPB41L1[23602568];PCBP1[23602568];ZSCAN12[unassigned1304];KCNN2[23602568];ARGLU1[22365833;23602568];RPL39L[23602568];APOBEC3C[23602568];SRPK2[25416956];ZRSR2[23602568;25416956;unassigned1304];SDR42E1[23602568];RPL41[23602568];JUN[25609649];PRPF38A[22365833;23602568;25416956];ZRANB2[23602568];OCEL1[23602568];SRPK1[21157427];HNRNPM[23602568];TDP2[23602568];RNPS1[17353931;22365833;25416956;unassigned1304];HNRNPC[23602568];CLIC5[23602568];HBS1L[23602568];HNRNPCL1[23602568];ARPC1B[23602568];MRPS11[23602568];STON1[23602568];ZNF321P[23602568];TAF7L[23602568];COIL[unassigned1304];BCE1[23602568];EPB41L4A[23602568];RSRC1[23602568];DHX15[23602568];NELFE[23602568];CD53[23602568];BRD3[23602568];PABPC4[23602568];MRPS6[23602568];VAV2[18654987];AES[25416956];PSMA3[23602568];CDC42EP4[23602568];CLDN19[23602568];PELI1[23602568];HNRNPH2[23602568];PABPC1[23602568];TRUB1[23602568];LCE3D[23602568];BCLAF1[23602568];TCOF1[23602568];SRSF10[23602568];SRSF11[unassigned1304];PAK4[23602568];SRSF12[23602568];MPP3[23602568];NPM2[23602568];EGLN2[23602568];RSRC2[23602568];ATAT1[23602568];NUDT21[23602568];RIT1[23602568];RIT2[23602568];LRRN4CL[23602568];APEX1[23602568];ALMS1[23602568];YPEL3[23602568];TJP2[23602568];YPEL2[23602568];C1orf174[23602568];ZSCAN9[25416956;unassigned1304];CCDC28A[23602568];FOXQ1[25609649];AMMECR1L[23602568];HMCES[23602568];SNIP1[22365833;unassigned1304];LZTS2[23602568];SNRNP35[23602568];HMGN3[23602568];C18orf25[23602568];TMEM14A[23602568];TPD52[23602568];NOM1[unassigned1304];SERF1A[23602568];SUPT16H[23602568];EIF1AY[23602568];CASK[23602568];UBE2E2[23602568];PRPF4B[23602568];VRK1[23602568];ERN1[23602568];SELENOS[23602568];SRSF2[23602568];SNRNP27[22365833;23602568;25416956];SRSF3[23602568];MAPKAPK5[23602568];SRSF5[23602568];SREK1[23602568];SNRPC[23602568];SRSF6[23602568];SRSF7[23602568];PPIA[23602568];SNRPA[23602568];SRSF8[23602568;unassigned1304];SNRPB[23602568];SRSF9[23602568];DDX6[23602568];RBM8A[23602568];CHRNA5[23602568];YTHDC1[23602568];NOP2[23602568];GTF2E1[23602568];ARHGAP12[23602568];MARCH10[23602568];UBD[23602568];ADGRG5[23602568];ZMAT4[23602568];ABL1[23602568];CHTOP[23602568];CPSF6[23602568];CBX5[23602568];NOP16[23602568];TNFRSF10C[23602568];NSG1[23602568];FOXN3[23602568];ADAP1[23602568];ESR1[21182205];CLK3[23602568;25416956];FAM90A1[23602568];CHERP[23602568];CLK2[25416956];CLK1[23602568];DRAP1[23602568];CDK7[23602568];SON[23602568];RSRP1[23602568];CLASRP[23602568];FGF12[23602568];DIDO1[23602568];DDX46[22365833;23602568];YWHAB[19592491;23602568];NGLY1[23602568];ARRB2[17620599];CHD2[23602568];NXT2[23602568];CSAG1[23602568];POLB[23602568];PTBP1[23602568];SNRNP70[22365833;23602568];MDK[23602568];NCK2[23602568];WDR5[23602568];EVI5L[23602568];CTNNBL1[22365833];RBM15[23602568];CHUK[23602568];FOXL2[25609649];DDX50[23602568];NSMCE4A[23602568];THRAP3[23602568];NUP50[23602568];SNURF[23602568];LUC7L3[23602568];NCBP3[23602568];DNAJC8[23602568];C4orf46[23602568];RBM23[22365833;23602568];NSRP1[23602568];LUC7L2[23602568];PRKAA1[23602568];LUZP4[25416956];SRSF1[23602568];DDX21[23602568];FOXK2[25609649];U2AF1[22365833;23602568;25416956];SRI[23602568];DBF4B[23602568];RNF4[23602568];AURKA[23602568];TTN[23602568];ENOX2[23602568];CAND1[23602568];HIRIP3[23602568];U2AF2[16189514;23602568;unassigned1304];TRA2B[23602568;unassigned1304];TRA2A[23602568];DROSHA[23602568];RBBP6[23602568];DNAJB7[23602568];EPS8L3[23602568];CACNG2[23602568];SEC23B[23602568];RBM39[22365833;23602568;25416956];MCOLN3[23602568];PPIL1[23602568];TRIM41[23602568];LCA5[23602568];DAW1[23602568];BAIAP2[23602568];ERCC3[23602568];TNIP2[23602568];MAB21L2[23602568];DRG1[23602568];ACIN1[22365833;23602568];CCM2[23602568];PDE7B[23602568];CBLN4[23602568];BCAR1[28007913];	104782762
69196	chr7	106836378	A	C	chr7:106836378	HBP1	HMG-box transcription factor 1	SNV	0/1	0.35	69_37	106	99.0	0/0	0.0	38_0	38	99.0			rs772267804	EXONIC	YES	NM_001244262.2	Transcript	protein_coding	missense_variant		9/11	NM_001244262.2:c.1197A>C	NP_001231191.1:p.Gln399His		1.0	.,.,.,.					.	.	.		0.000184114	28.0	152080.0	0.0	33	0.97	PASS	amr	0.00144092	22.0	4.41112e-05	3.0	0.000139237	35.0	251370.0	0.0	84	1.0	PASS	amr	0.000896213	31.0	0.0	0.0	0.0000450	7	0.001	2.0				22.3	2.376851	0.142	9	11	20	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,fathmm-XF_coding_pred	HBP1	0.0	0.0	0.0	0.0	-13.0	2.0	-8.0	22.0						0.218	0.77	0.000000000	1.0	1.312	.			pons;atrioventricular node;superior cervical ganglion;	.	regulation of transcription by RNA polymerase II;cell cycle arrest;Wnt signaling pathway	nucleoplasm;nuclear speck	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;RNA binding;protein binding	RB1[23859194];SMAD1[15231748];TMEM37[21988832];CASP8[25640309];EWSR1[16713569];PRKAR2B[26496610];RB1CC1[25640309];KIF1BP[16713569];ESR1[25640309];ZNF212[18255255];CD2AP[18654987];	106836378
69253	chr7	107569899	A	G	chr7:107569899	LAMB1	laminin subunit beta 1	SNV	0/1	0.49	40_40	81	99.0	0/0	0.0	37_0	37	99.0			rs1470093433	EXONIC	YES	NM_002291.3	Transcript	protein_coding	missense_variant		30/34	NM_002291.3:c.4703T>C	NP_002282.2:p.Ile1568Thr		-1.0	.,.				Lissencephaly 5, 615191 (3), Autosomal recessive	Cobblestone lissencephaly without muscular or ocular involvement	Disease-causing germline mutation(s) in	Type II lissencephaly;Leukoencephalopathy;Hypoplasia of the brainstem;Intellectual disability;Cerebellar hypoplasia;Porencephalic cyst;Abnormality of the cerebral white matter;Cataract;Occipital encephalocele;Severe global developmental delay;Variable expressivity;Psychomotor retardation;Hearing impairment;Seizure;Spastic paraplegia;Progressive;Subcortical band heterotopia;Optic atrophy;Generalized hypotonia;Autosomal recessive inheritance;Macrocephaly;Gray matter heterotopia;Hydrocephalus						32	0.97							3.97924e-06	1.0	251304.0	0.0	97	1.0	PASS	amr	2.89134e-05	1.0	0.0	0.0	0.0000064	1			9e-05	1.0		23.2	2.818362	0.201	6	12	18	M-CAP_pred,MutationTaster_pred,MetaRNN_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred	LAMB1	0.0	0.0	0.0	0.0	16.0	-7.0	-42.0	29.0						0.631	0.0	0.000000000	0.998	1.312	muscle phenotype; mortality/aging ; embryo phenotype; behavior/neurological phenotype ; limbs/digits/tail phenotype; nervous system phenotype ; 			ciliary ganglion;olfactory bulb;dorsal root ganglion;atrioventricular node;smooth muscle;adipose tissue;fetal lung;	Cell Communication;Focal adhesion;ECM-receptor interaction;Prion disease;Small cell lung cancer	cell adhesion;neuronal-glial interaction involved in cerebral cortex radial glia guided migration;extracellular matrix organization;positive regulation of cell migration;neuron projection development;substrate adhesion-dependent cell spreading;endodermal cell differentiation;odontogenesis;post-translational protein modification;cellular protein metabolic process;positive regulation of epithelial cell proliferation	extracellular region;basement membrane;laminin-1 complex;laminin-2 complex;extracellular space;endoplasmic reticulum lumen;laminin-8 complex;laminin-10 complex;perinuclear region of cytoplasm;collagen-containing extracellular matrix;extracellular exosome	structural molecule activity;extracellular matrix structural constituent;protein binding	PDIA3[17170699];TGFB1[20936779];SEPT12[25775403];PYHIN1[25665578];CACNA1A[21078624];KIF11[26496610];ESR2[21182203];GPR152[unassigned1304];CD79A[unassigned1304];GFI1B[16713569];KARS[24983501];ATXN7[21078624];UBQLN1[unassigned1304];DAG1[unassigned1793];FGFR1OP[26496610];ATXN7L2[16713569];	107569899
69355	chr7	121616330	A		chr7:121616330	PTPRZ1	protein tyrosine phosphatase, receptor type Z1	deletion	0|1	0.22	7_2	9	63.0	0/0	0.0	24_0	24	66.0				SPLICING	YES	NM_002851.3	Transcript	protein_coding	splice_region_variant,intron_variant	5/29		NM_002851.3:c.552+8del			1.0						.	.	.						32	0.97											35	0.9																	0	0	0			PTPRZ1	0.0	0.0	0.0	0.0	-50.0	-35.0	-7.0	-35.0						0.535	0.99				integument phenotype ; normal phenotype; behavior/neurological phenotype ; immune system phenotype; nervous system phenotype ; 			.	Epithelial cell signaling in Helicobacter pylori infection	hematopoietic progenitor cell differentiation;protein dephosphorylation;axonogenesis;central nervous system development;learning or memory;cytokine-mediated signaling pathway;peptidyl-tyrosine dephosphorylation;oligodendrocyte differentiation;regulation of oligodendrocyte progenitor proliferation	plasma membrane;integral component of plasma membrane;intrinsic component of plasma membrane;synapse;perineuronal net	protein tyrosine phosphatase activity;transmembrane receptor protein tyrosine phosphatase activity;protein binding	ALK[17681947];PTPRZ1[15978577];LCK[19167335];ITGB3[20639902];PXN[19167335];ERBB2[19167335];WAS[19167335];CNTN1[21969550];CSK[19167335];ITGAV[20639902];TNF[20195357];	121616329
69378	chr7	121738927	AAA		chr7:121738927-121738929	AASS	aminoadipate-semialdehyde synthase	deletion	0/0	0.25	1_1	4	3.0	0/1	0.31	8_4	13	99.0			rs34474265	SPLICING	YES	NM_005763.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	13/23		NM_005763.4:c.1407-9_1407-7del			-1.0					Hyperlysinemia, 238700 (3), Autosomal recessive	Saccharopinuria;Hyperlysinemia	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Delayed speech and language development;Seizure;Hyperlysinemia;Ectopia lentis;Autosomal recessive inheritance;Abnormality of the genitourinary system;Hyperactivity;Cognitive impairment;Intellectual disability;Anemia;Muscular hypotonia;Short attention span;Infantile onset;Intellectual disability, mild		4.12006e-05	4.0	97086.0	0.0	21	0.72	PASS	nfe	6.10874e-05	3.0	6.10874e-05	3.0					21	0.53							0.0000064,0.0003601	1,56			0.00609	65.0					0	0	0			AASS	0.01	0.04	0.0	0.0	33.0	-6.0	-6.0	-45.0						0.355	0.0				.			atrioventricular node;superior cervical ganglion;	Lysine biosynthesis;Lysine degradation	lysine catabolic process;lysine biosynthetic process via aminoadipic acid;L-lysine catabolic process to acetyl-CoA via saccharopine;protein tetramerization;oxidation-reduction process	cytoplasm;mitochondrion;mitochondrial matrix;intracellular membrane-bounded organelle	saccharopine dehydrogenase activity;saccharopine dehydrogenase (NADP+, L-lysine-forming) activity;saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity	MYC[17314511];MRPL58[20186120];HSCB[28380382];TRMT61B[29568061];HSPD1[29568061];PDK1[29568061];	121738926
69464	chr7	123301995		GAG	chr7:123301994-123301995	LMOD2	leiomodin 2	insertion	0/1	0.34	23_12	35	99.0	0/0	0.0	34_0	34	99.0			rs759412133	EXONIC	YES	NM_207163.3	Transcript	protein_coding	inframe_insertion		2/3	NM_207163.3:c.370_372dup	NP_997046.1:p.Glu124dup		1.0						.	.	.		0.000210463	32.0	152046.0	0.0	32	0.96	PASS	amr	0.00124557	19.0	2.94204e-05	2.0	9.10628e-05	14.0	153740.0	0.0	36	0.6	PASS	afr	0.00023546	2.0	3.25203e-05	2.0	0.0000064	1						15.42	1.343778		0	0	0																	0.399	0.0	0.000000000,3.766453665			growth/size/body region phenotype; muscle phenotype; cellular phenotype; behavior/neurological phenotype ; respiratory system phenotype; cardiovascular system phenotype ; mortality/aging ; 			superior cervical ganglion;skeletal muscle;	.	muscle contraction;actin filament polymerization;myofibril assembly;positive regulation of actin filament polymerization;actin nucleation;sarcomere organization;pointed-end actin filament capping	striated muscle thin filament;actin filament;myofibril;sarcomere;M band	actin binding;actin monomer binding;tropomyosin binding	.	123301994
69486	chr7	128409176	G	T	chr7:128409176	CALU	calumenin	SNV	0/0	0.0	33_0	33	99.0	0/1	0.48	38_35	73	99.0			rs765925964	EXONIC	YES	NM_001199671.2	Transcript	protein_coding	missense_variant		8/8	NM_001199671.2:c.927G>T	NP_001186600.1:p.Gln309His		1.0	.,.,.,.					.	.	.		1.97189e-05	3.0	152138.0	0.0	31	0.94	PASS	amr	6.5445e-05	1.0	2.94031e-05	2.0	2.78538e-05	7.0	251312.0	0.0	40	0.97	PASS	amr	0.000173611	6.0	8.79693e-06	1.0	0.0000450	7						24.4	3.30588	0.726	16	5	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	CALU	0.01	0.01	0.0	0.0	-3.0	1.0	-3.0	-25.0						0.422	0.45	0.000000000	1.0	1.176	.			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;adipose tissue;smooth muscle;uterus corpus;placenta;	.	biological_process;post-translational protein modification;cellular protein metabolic process	extracellular region;endoplasmic reticulum;endoplasmic reticulum lumen;endoplasmic reticulum membrane;Golgi apparatus;membrane;sarcoplasmic reticulum lumen;melanosome	calcium ion binding;protein binding	ATF2[22304920];INTS12[30021884];SMARCB1[30108113];GOLT1B[26496610];MAST3[25852190];COX4I1[29568061];HDAC11[23752268];IRS4[25036637];ARAF[25852190];ILK[25852190];TMEM52[30021884];MAP1LC3A[20562859];TUBA1A[29568061];TCTN3[26638075];TCTN1[26638075];GTSE1[26496610];IQCB1[21565611];PRMT5[23455924];CSNK2A1[22113938];ZPBP[21988832];MLF1[25036637];ASPM[26496610];FAM20C[26091039];UMPS[21988832];RAF1[25852190;26496610];PPEF1[28330616];CFTR[17110338];FKBP5[25036637];OTUB1[26752685];CYP3A5[30021884];AURKA[20360068];TTN[30021884];BAG6[26496610];TGOLN2[29568061];STK33[30021884];IRAK1[25852190];UBQLN1[25416956];STK38L[30108113];COX14[29568061];CTNNAL1[21988832];ZNF462[27705803];HSPA5[24189400];NEK4[25798074];LIMK2[25852190];XRCC3[26496610];SUCO[26496610];RAB11A[29568061];MFHAS1[29513927];DIAPH1[30021884];DNAJA4[25036637];RAB9A[29568061];SFXN1[29568061];CNTROB[26496610];BCAR1[28007913];BET1[29568061];	128409176
69584	chr7	128829040	CTG		chr7:128829040-128829042	SMO	smoothened, frizzled class receptor	deletion	0/0	0.0	20_0	20	60.0	0|1	0.14	24_4	28	96.0			rs570242755	EXONIC	YES	NM_005631.5	Transcript	protein_coding	inframe_deletion		1/12	NM_005631.5:c.67_69del	NP_005622.1:p.Leu23del		1.0					Pallister-Hall-like syndrome, 241800 (3), Autosomal recessive; Basal cell carcinoma, somatic, 605462 (3); Curry-Jones syndrome, somatic mosaic, 601707 (3)	Curry-Jones syndrome	Disease-causing somatic mutation(s) in	Basal cell carcinoma;Microphthalmia;Duplication of thumb phalanx;Arnold-Chiari type I malformation;Hemimegalencephaly;Somatic mosaicism;Preaxial hand polydactyly;Hirsutism;Chronic constipation;Global developmental delay;Coloboma;Cutaneous finger syndactyly;Abnormality of the skin;Cutaneous syndactyly of toes;Facial asymmetry;Ventriculomegaly;Intestinal malrotation;Blepharophimosis;Polymicrogyria;Agenesis of corpus callosum;Craniosynostosis;Anal stenosis;Broad thumb;Syndactyly;Intellectual disability;Iris coloboma;Ventriculomegaly;Microphthalmia;Finger syndactyly;Broad thumb;Generalized hirsutism;Hypopigmented skin patches;Intestinal malrotation;Hypertelorism;Preaxial hand polydactyly;Toe syndactyly;Craniosynostosis;Aplasia/Hypoplasia of the skin;Optic nerve coloboma;Foot polydactyly;Facial asymmetry;Agenesis of corpus callosum		3.30434e-05	5.0	151316.0	0.0	32	0.96	PASS	eas	0.000193424	1.0	4.42961e-05	3.0	0.0	0.0	364.0	0.0	0	0.0	AC0				0.0	0.0	0.0000386,0.0000064	6,1			0.00064	6.0		20.4	2.066716		0	0	0			SMO	0.0	0.0	0.0	0.0	-27.0	20.0	-27.0	1.0						0.242	0.06				cardiovascular system phenotype ; normal phenotype; mortality/aging ; respiratory system phenotype; embryo phenotype; skeleton phenotype; vision/eye phenotype; digestive/alimentary phenotype; muscle phenotype; limbs/digits/tail phenotype; hearing/vestibular/ear phenotype; nervous system phenotype ; growth/size/body region phenotype; homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; 			superior cervical ganglion;atrioventricular node;trigeminal ganglion;adrenal cortex;cerebellum peduncles;	Hedgehog signaling pathway;Basal cell carcinoma	negative regulation of transcription by RNA polymerase II;vasculogenesis;osteoblast differentiation;in utero embryonic development;cell fate specification;neural crest cell migration;heart looping;positive regulation of neuroblast proliferation;positive regulation of mesenchymal cell proliferation;determination of left/right asymmetry in lateral mesoderm;type B pancreatic cell development;G protein-coupled receptor signaling pathway;smoothened signaling pathway;positive regulation of hh target transcription factor activity;ventral midline determination;central nervous system development;midgut development;anterior/posterior pattern specification;positive regulation of gene expression;negative regulation of gene expression;dentate gyrus development;cerebellar cortex morphogenesis;thalamus development;dorsal/ventral neural tube patterning;smoothened signaling pathway involved in ventral spinal cord patterning;smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation;central nervous system neuron differentiation;cerebral cortex development;negative regulation of epithelial cell differentiation;hair follicle morphogenesis;protein localization to nucleus;multicellular organism growth;positive regulation of multicellular organism growth;positive regulation of protein import into nucleus;odontogenesis of dentin-containing tooth;negative regulation of apoptotic process;negative regulation of DNA binding;positive regulation of smoothened signaling pathway;positive regulation of transcription by RNA polymerase II;positive regulation of organ growth;astrocyte activation;skeletal muscle fiber development;forebrain morphogenesis;homeostasis of number of cells within a tissue;positive regulation of epithelial cell proliferation;protein stabilization;myoblast migration;negative regulation of hair follicle development;detection of cell density by contact stimulus involved in contact inhibition;atrial septum morphogenesis;mammary gland epithelial cell differentiation;epithelial-mesenchymal cell signaling;somite development;pancreas morphogenesis;left/right axis specification;cellular response to cholesterol;commissural neuron axon guidance;renal system development;mesenchymal to epithelial transition involved in metanephric renal vesicle formation;positive regulation of branching involved in ureteric bud morphogenesis;regulation of stem cell population maintenance;regulation of heart morphogenesis	Golgi apparatus;plasma membrane;caveola;cilium;integral component of membrane;dendrite;endocytic vesicle membrane;intracellular membrane-bounded organelle;ciliary membrane;extracellular exosome;ciliary tip	G protein-coupled receptor activity;patched binding;protein binding;drug binding	LEPROT[28298427];RPN2[28298427];SLC41A3[28298427];ILK[23877428];ARRB1[23877428];EMC10[28298427];ARRB2[23877428];ARV1[28298427];HMGN4[28298427];JPH3[28298427];TSPAN7[28298427];HMOX1[28298427];S1PR5[28298427];HMOX2[28298427];WLS[28298427];GABARAPL2[28298427];GABBR1[28298427];NDFIP1[28298427];TIMMDC1[28298427];C4orf3[28298427];PTCH1[11278759];NIPA1[28298427];PLPP7[28298427];BCL6[16147992];SSPN[28298427];FKBP8[28298427];C18orf32[28298427];ITGB1BP1[28298427];TMCC2[28298427];NGEF[28298427];	128829039
69651	chr7	135291649	A	G	chr7:135291649	NUP205	nucleoporin 205	SNV	0/1	0.43	21_16	37	99.0	0/1	0.49	26_25	51	99.0			rs78254699	EXONIC	YES	NM_015135.3	Transcript	protein_coding	missense_variant		21/43	NM_015135.3:c.3056A>G	NP_055950.2:p.Asn1019Ser		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided	?Nephrotic syndrome, type 13, 616893 (3), Autosomal recessive	Familial idiopathic steroid-resistant nephrotic syndrome with focal segmental hyalinosis	Disease-causing germline mutation(s) in	Stage 5 chronic kidney disease;Autosomal recessive inheritance;Steroid-resistant nephrotic syndrome;Focal segmental glomerulosclerosis		0.000801798	122.0	152158.0	0.0	32	0.98	PASS	nfe	0.00144054	98.0	0.00144054	98.0	0.00105506	265.0	251170.0	0.0	59	0.99	PASS	nfe	0.00194464	221.0	0.00194464	221.0	0.0009839	153	0.001	3.0				22.2	2.34514	0.145	5	15	20	LRT_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	NUP205	0.0	0.0	0.0	0.01	-8.0	-14.0	14.0	-14.0						0.502	1.0	0.000000000	0.997	1.284	.			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;	.	mRNA export from nucleus;nucleocytoplasmic transport;nuclear pore organization;viral process;nuclear pore complex assembly	nuclear envelope;nuclear pore;membrane;nuclear membrane;nuclear periphery;nuclear pore inner ring	protein binding;structural constituent of nuclear pore	GSK3B[29568061];AHCTF1[24315095];NUP107[26496610];FOXI2[25609649];CEP164[26638075];ILK[17353931];PHB2[17353931];TOMM20[29568061];HOXC10[21988832];CEP128[26638075];TOMM22[29568061];FOXQ1[25609649];FBL[29568061];TUBA1A[29568061];LAMP1[29568061];TCTN3[26638075];MYC[17353931];CNTRL[26638075];TCTN1[26638075];PHLDA3[17353931];RPS6[29568061];FOXL2[25609649];FOXL1[25609649];AURKAIP1[29568061];NUP58[26496610];KPNB1[26496610];SEH1L[26496610];MAGED1[17353931];FOXG1[25609649];TPTE[28330616];AURKB[29568061];TGOLN2[29568061];CLN3[20562859];USP50[19615732];STOM[27173435;unassigned1312];E2F3[22157815];COX14[29568061];HNRNPA1[22446626];FDFT1[30021884];FOXB1[25609649];VCAM1[22623428;19738201];UBE2I[26496610];FN1[19738201];NUP153[26496610];RRP1B[20926688];ESR2[21182203;25604459];RAB11A[29568061];CDK8[29568061];CDK7[29568061];RAB9A[29568061];CD247[24502978];RAB5A[29568061];BET1[29568061];	135291649
69660	chr7	135418738	C	T	chr7:135418738	FAM180A	family with sequence similarity 180 member A	SNV	0/1	0.36	54_30	84	99.0	0/0	0.0	49_0	49	99.0			rs145204532	EXONIC	YES	NM_001369697.2	Transcript	protein_coding	synonymous_variant		3/3	NM_001369697.2:c.507G>A	NP_001356626.1:p.Pro169%3D		-1.0						.	.	.		0.000111682	17.0	152218.0	0.0	33	0.98	PASS	eas	0.000771605	4.0	0.000132279	9.0	0.000102831	25.0	243118.0	0.0	30	0.8	PASS	eas	0.00065388	12.0	0.000100076	11.0	0.0000772	12						0.131	-0.44593		0	0	0			FAM180A	0.0	0.0	0.0	0.0	2.0	35.0	-3.0	28.0						0.161	0.34	0.686640560			.			.	.	.	extracellular region	.	.	135418738
69685	chr7	138720474	C	G	chr7:138720474	ZC3HAV1L	zinc finger CCCH-type containing, antiviral 1 like	SNV	0/1	0.5	30_30	60	99.0	0/1	0.42	43_31	74	99.0			rs776856943	EXONIC	YES	NM_080660.4	Transcript	protein_coding	missense_variant		1/5	NM_080660.4:c.290G>C	NP_542391.2:p.Gly97Ala		-1.0						.	.	.						33	0.99											4	0.17							0.0000064	1						16.83	1.595683	0.088	1	17	18	M-CAP_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	ZC3HAV1L	0.0	0.0	0.0	0.01	4.0	47.0	29.0	-50.0							0.04		0.997	1.004	.			.	.	.	cytosol	.	JUN[25609649];KSR1[27086506];GABARAP[20562859];OTUB1[26752685];	138720474
69763	chr7	141386421	G	T	chr7:141386421	KIAA1147	KIAA1147	SNV	0/1	0.42	25_18	43	99.0	0/1	0.34	25_13	38	99.0			rs775361873	EXONIC	YES	NM_001080392.2	Transcript	protein_coding	missense_variant		2/9	NM_001080392.2:c.306C>A	NP_001073861.1:p.Asp102Glu		-1.0	.,Tripartite DENN domain					.	.	.		4.60187e-05	7.0	152112.0	0.0	32	0.97	PASS	nfe	0.000102905	7.0	0.000102905	7.0	2.82065e-05	7.0	248170.0	0.0	46	0.89	PASS	nfe	6.21857e-05	7.0	6.21857e-05	7.0	0.0000064	1						20.2	2.05045	0.094	3	12	15	LRT_pred,MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	KIAA1147	0.0	0.0	0.0	0.0	37.0	-8.0	-7.0	22.0							0.0	0.000000000	0.999	1.176	.			.	.	.	.	.	SETBP1[25416956];	141386421
69816	chr7	142457343	C	T	chr7:142457343	PRSS1	serine protease 1	SNV	0|1	0.26	69_24	93	99.0	0|1	0.2	49_12	61	99.0			rs374597855,COSV61195079	EXONIC	YES	NM_002769.5	Transcript	protein_coding	missense_variant		1/5	NM_002769.5:c.8C>T	NP_002760.1:p.Pro3Leu		1.0	.,.,.				Pancreatitis, hereditary, 167800 (3), Autosomal dominant	Hereditary chronic pancreatitis	Disease-causing germline mutation(s) (gain of function) in	Recurrent pancreatitis;Abdominal pain;Abnormal enzyme/coenzyme activity;Pancreatic calcification;Elevated C-reactive protein level;Splanchnic vein thrombosis;Leukocytosis;Diabetes mellitus;Jaundice;Diabetes mellitus;Abdominal pain;Exocrine pancreatic insufficiency;Pancreatitis;Autosomal dominant inheritance;Abnormal thrombosis;Pleural effusion;Pancreatic pseudocyst;Fever;Steatorrhea;Pancreatic calcification						34	0.95							0.0	0.0	251482.0	0.0	100	1.0	AC0_RF				0.0	0.0	0.0001286	20	0.001	3.0	0.0085	97.0		5.876	0.20241	0.057	1	16	17	FATHMM_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRSS1	0.0	0.0	0.0	0.0	27.0	32.0	32.0	29.0						0.125	0.0		0.061	0.941	.			ciliary ganglion;beta cell islets;pancreas;superior cervical ganglion;bone marrow;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;extracellular matrix disassembly	extracellular region;extracellular space;collagen-containing extracellular matrix;blood microparticle	serine-type endopeptidase activity;serine-type peptidase activity;metal ion binding	VPS18[26496610];WTAP[29507755];PPP2R2B[19156129];ALB[15174051];HUWE1[26496610];STK38L[24366813];GRB2[17474147];NFKB1[25609649];SNCA[26496610];	142457343
69818	chr7	142457347	C	T	chr7:142457347	PRSS1	serine protease 1	SNV	0|1	0.26	70_24	94	99.0	0|1	0.19	50_12	62	99.0			rs749968829,COSV61195089,COSV61195896	EXONIC	YES	NM_002769.5	Transcript	protein_coding	synonymous_variant		1/5	NM_002769.5:c.12C>T	NP_002760.1:p.Leu4%3D		1.0					Pancreatitis, hereditary, 167800 (3), Autosomal dominant	Hereditary chronic pancreatitis	Disease-causing germline mutation(s) (gain of function) in	Recurrent pancreatitis;Abdominal pain;Abnormal enzyme/coenzyme activity;Pancreatic calcification;Elevated C-reactive protein level;Splanchnic vein thrombosis;Leukocytosis;Diabetes mellitus;Jaundice;Diabetes mellitus;Abdominal pain;Exocrine pancreatic insufficiency;Pancreatitis;Autosomal dominant inheritance;Abnormal thrombosis;Pleural effusion;Pancreatic pseudocyst;Fever;Steatorrhea;Pancreatic calcification						34	0.95							0.0	0.0	251488.0	0.0	100	1.0	AC0_RF				0.0	0.0	0.0000064	1	0.001	2.0	0.0085	97.0		6.977	0.281866		0	0	0			PRSS1	0.0	0.0	0.0	0.0	23.0	28.0	32.0	28.0						0.125	0.0				.			ciliary ganglion;beta cell islets;pancreas;superior cervical ganglion;bone marrow;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;extracellular matrix disassembly	extracellular region;extracellular space;collagen-containing extracellular matrix;blood microparticle	serine-type endopeptidase activity;serine-type peptidase activity;metal ion binding	VPS18[26496610];WTAP[29507755];PPP2R2B[19156129];ALB[15174051];HUWE1[26496610];STK38L[24366813];GRB2[17474147];NFKB1[25609649];SNCA[26496610];	142457347
69820	chr7	142457365	G	T	chr7:142457365	PRSS1	serine protease 1	SNV	0|1	0.24	68_21	89	99.0	0|1	0.16	58_11	69	99.0			rs779260304,COSV61193659	EXONIC	YES	NM_002769.5	Transcript	protein_coding	synonymous_variant		1/5	NM_002769.5:c.30G>T	NP_002760.1:p.Val10%3D		1.0					Pancreatitis, hereditary, 167800 (3), Autosomal dominant	Hereditary chronic pancreatitis	Disease-causing germline mutation(s) (gain of function) in	Recurrent pancreatitis;Abdominal pain;Abnormal enzyme/coenzyme activity;Pancreatic calcification;Elevated C-reactive protein level;Splanchnic vein thrombosis;Leukocytosis;Diabetes mellitus;Jaundice;Diabetes mellitus;Abdominal pain;Exocrine pancreatic insufficiency;Pancreatitis;Autosomal dominant inheritance;Abnormal thrombosis;Pleural effusion;Pancreatic pseudocyst;Fever;Steatorrhea;Pancreatic calcification						34	0.95											100	1.0							0.0001286	20	0.0	1.0	0.00938	107.0		2.174	-0.031643		0	0	0			PRSS1	0.0	0.0	0.0	0.0	5.0	10.0	5.0	10.0						0.125	0.0				.			ciliary ganglion;beta cell islets;pancreas;superior cervical ganglion;bone marrow;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;extracellular matrix disassembly	extracellular region;extracellular space;collagen-containing extracellular matrix;blood microparticle	serine-type endopeptidase activity;serine-type peptidase activity;metal ion binding	VPS18[26496610];WTAP[29507755];PPP2R2B[19156129];ALB[15174051];HUWE1[26496610];STK38L[24366813];GRB2[17474147];NFKB1[25609649];SNCA[26496610];	142457365
69895	chr7	142459679	G	A	chr7:142459679	PRSS1	serine protease 1	SNV	0/1	0.14	108_18	126	99.0	0/1	0.23	99_29	128	99.0			rs376671702,COSV61190117	EXONIC	YES	NM_002769.5	Transcript	protein_coding	synonymous_variant		3/5	NM_002769.5:c.255G>A	NP_002760.1:p.Glu85%3D		1.0		Benign	criteria_provided,_single_submitter	Hereditary_pancreatitis	Pancreatitis, hereditary, 167800 (3), Autosomal dominant	Hereditary chronic pancreatitis	Disease-causing germline mutation(s) (gain of function) in	Recurrent pancreatitis;Abdominal pain;Abnormal enzyme/coenzyme activity;Pancreatic calcification;Elevated C-reactive protein level;Splanchnic vein thrombosis;Leukocytosis;Diabetes mellitus;Jaundice;Diabetes mellitus;Abdominal pain;Exocrine pancreatic insufficiency;Pancreatitis;Autosomal dominant inheritance;Abnormal thrombosis;Pleural effusion;Pancreatic pseudocyst;Fever;Steatorrhea;Pancreatic calcification		0.000334735	46.0	137422.0	0.0	31	0.91	AS_VQSR	afr	0.000677545	24.0	0.000126755	8.0	0.000499276	111.0	222322.0	0.0	100	1.0	RF	nfe	0.00096493	93.0	0.00096493	93.0	0.0014726	229	0.003	9.0				8.256	0.38693		0	0	0			PRSS1	0.0	0.01	0.0	0.0	17.0	-44.0	2.0	-45.0						0.125	0.0				.			ciliary ganglion;beta cell islets;pancreas;superior cervical ganglion;bone marrow;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;extracellular matrix disassembly	extracellular region;extracellular space;collagen-containing extracellular matrix;blood microparticle	serine-type endopeptidase activity;serine-type peptidase activity;metal ion binding	VPS18[26496610];WTAP[29507755];PPP2R2B[19156129];ALB[15174051];HUWE1[26496610];STK38L[24366813];GRB2[17474147];NFKB1[25609649];SNCA[26496610];	142459679
69925	chr7	142460335	A	G	chr7:142460335	PRSS1	serine protease 1	SNV	0/1	0.61	56_87	143	99.0	0/1	0.64	56_100	156	99.0			rs201550522,CM138023,COSV61190021	EXONIC	YES	NM_002769.5	Transcript	protein_coding	missense_variant		4/5	NM_002769.5:c.508A>G	NP_002760.1:p.Lys170Glu		1.0	Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Hereditary_pancreatitis|Inborn_genetic_diseases|not_specified	Pancreatitis, hereditary, 167800 (3), Autosomal dominant	Hereditary chronic pancreatitis	Disease-causing germline mutation(s) (gain of function) in	Recurrent pancreatitis;Abdominal pain;Abnormal enzyme/coenzyme activity;Pancreatic calcification;Elevated C-reactive protein level;Splanchnic vein thrombosis;Leukocytosis;Diabetes mellitus;Jaundice;Diabetes mellitus;Abdominal pain;Exocrine pancreatic insufficiency;Pancreatitis;Autosomal dominant inheritance;Abnormal thrombosis;Pleural effusion;Pancreatic pseudocyst;Fever;Steatorrhea;Pancreatic calcification	31510946	0.000322034	49.0	152158.0	2.0	40	0.98	PASS	sas	0.00892857	43.0	0.0	0.0	0.418793	98150.0	234364.0	2.0	100	1.0	InbreedingCoeff	nfe	0.433882	46618.0	0.433882	46618.0	0.0081413	1266	0.115	362.0	0.42504	4848.0		0.001	-1.424741	0.115	1	16	17	FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRSS1	0.0	0.0	0.0	0.0	10.0	-41.0	47.0	1.0						0.125	0.0		0.0	-6.171	.			ciliary ganglion;beta cell islets;pancreas;superior cervical ganglion;bone marrow;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;extracellular matrix disassembly	extracellular region;extracellular space;collagen-containing extracellular matrix;blood microparticle	serine-type endopeptidase activity;serine-type peptidase activity;metal ion binding	VPS18[26496610];WTAP[29507755];PPP2R2B[19156129];ALB[15174051];HUWE1[26496610];STK38L[24366813];GRB2[17474147];NFKB1[25609649];SNCA[26496610];	142460335
69926	chr7	142460339	G	A	chr7:142460339	PRSS1	serine protease 1	SNV	0/1	0.28	103_40	143	99.0	0/1	0.22	121_34	155	99.0			rs200973660,COSV61190094	EXONIC	YES	NM_002769.5	Transcript	protein_coding	missense_variant		4/5	NM_002769.5:c.512G>A	NP_002760.1:p.Cys171Tyr		1.0	Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain				Pancreatitis, hereditary, 167800 (3), Autosomal dominant	Hereditary chronic pancreatitis	Disease-causing germline mutation(s) (gain of function) in	Recurrent pancreatitis;Abdominal pain;Abnormal enzyme/coenzyme activity;Pancreatic calcification;Elevated C-reactive protein level;Splanchnic vein thrombosis;Leukocytosis;Diabetes mellitus;Jaundice;Diabetes mellitus;Abdominal pain;Exocrine pancreatic insufficiency;Pancreatitis;Autosomal dominant inheritance;Abnormal thrombosis;Pleural effusion;Pancreatic pseudocyst;Fever;Steatorrhea;Pancreatic calcification		0.0	0.0	152164.0	0.0	40	0.98	AC0_AS_VQSR				0.0	0.0	0.0198022	3379.0	170638.0	0.0	100	1.0	PASS	afr	0.0666952	624.0	0.0277602	1931.0	0.0003473	54	0.02	66.0	0.02858	326.0		23.8	3.082968	0.877	16	3	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaRNN_pred,PrimateAI_pred,ClinPred_pred	PRSS1	0.0	0.0	0.41	0.0	-45.0	43.0	-3.0	-1.0						0.125	0.0		0.015	1.076	.			ciliary ganglion;beta cell islets;pancreas;superior cervical ganglion;bone marrow;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;extracellular matrix disassembly	extracellular region;extracellular space;collagen-containing extracellular matrix;blood microparticle	serine-type endopeptidase activity;serine-type peptidase activity;metal ion binding	VPS18[26496610];WTAP[29507755];PPP2R2B[19156129];ALB[15174051];HUWE1[26496610];STK38L[24366813];GRB2[17474147];NFKB1[25609649];SNCA[26496610];	142460339
69927	chr7	142460369	G	A	chr7:142460369	PRSS1	serine protease 1	SNV	0|1	0.54	51_59	110	99.0	0|1	0.62	46_74	120	99.0			rs201719096,COSV61190000	EXONIC	YES	NM_002769.5	Transcript	protein_coding	missense_variant		4/5	NM_002769.5:c.542G>A	NP_002760.1:p.Ser181Asn		1.0	Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain	Benign	no_assertion_criteria_provided	Hereditary_pancreatitis|not_specified	Pancreatitis, hereditary, 167800 (3), Autosomal dominant	Hereditary chronic pancreatitis	Disease-causing germline mutation(s) (gain of function) in	Recurrent pancreatitis;Abdominal pain;Abnormal enzyme/coenzyme activity;Pancreatic calcification;Elevated C-reactive protein level;Splanchnic vein thrombosis;Leukocytosis;Diabetes mellitus;Jaundice;Diabetes mellitus;Abdominal pain;Exocrine pancreatic insufficiency;Pancreatitis;Autosomal dominant inheritance;Abnormal thrombosis;Pleural effusion;Pancreatic pseudocyst;Fever;Steatorrhea;Pancreatic calcification		6.57281e-05	10.0	152142.0	0.0	40	0.98	PASS	eas	0.00116777	6.0	1.46972e-05	1.0	0.3847	72676.0	188916.0	0.0	100	1.0	InbreedingCoeff_RF	nfe	0.412377	38149.0	0.412377	38149.0	0.0038906	605	0.11	348.0	0.42679	4868.0		0.168	-0.410767	0.014	1	16	17	FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRSS1	0.0	0.0	0.0	0.01	29.0	1.0	32.0	49.0						0.125	0.0		0.0	-1.318	.			ciliary ganglion;beta cell islets;pancreas;superior cervical ganglion;bone marrow;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;extracellular matrix disassembly	extracellular region;extracellular space;collagen-containing extracellular matrix;blood microparticle	serine-type endopeptidase activity;serine-type peptidase activity;metal ion binding	VPS18[26496610];WTAP[29507755];PPP2R2B[19156129];ALB[15174051];HUWE1[26496610];STK38L[24366813];GRB2[17474147];NFKB1[25609649];SNCA[26496610];	142460369
69928	chr7	142460374	A	G	chr7:142460374	PRSS1	serine protease 1	SNV	0|1	0.25	80_26	106	99.0	0|1	0.19	95_22	117	99.0			rs200070487,COSV61197124	EXONIC	YES	NM_002769.5	Transcript	protein_coding	missense_variant		4/5	NM_002769.5:c.547A>G	NP_002760.1:p.Met183Val		1.0	Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain				Pancreatitis, hereditary, 167800 (3), Autosomal dominant	Hereditary chronic pancreatitis	Disease-causing germline mutation(s) (gain of function) in	Recurrent pancreatitis;Abdominal pain;Abnormal enzyme/coenzyme activity;Pancreatic calcification;Elevated C-reactive protein level;Splanchnic vein thrombosis;Leukocytosis;Diabetes mellitus;Jaundice;Diabetes mellitus;Abdominal pain;Exocrine pancreatic insufficiency;Pancreatitis;Autosomal dominant inheritance;Abnormal thrombosis;Pleural effusion;Pancreatic pseudocyst;Fever;Steatorrhea;Pancreatic calcification	29299148	0.0	0.0	152136.0	0.0	39	0.98	AC0_AS_VQSR				0.0	0.0	4.26683e-06	1.0	234366.0	0.0	100	1.0	RF	afr	7.3014e-05	1.0	0.0	0.0	0.0003858	60	0.004	13.0	0.05558	634.0		22.6	2.507962	0.577	17	2	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaRNN_pred,PrimateAI_pred	PRSS1	0.0	0.0	0.01	0.0	-12.0	44.0	44.0	-38.0						0.125	0.0		0.374	1.2	.			ciliary ganglion;beta cell islets;pancreas;superior cervical ganglion;bone marrow;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;extracellular matrix disassembly	extracellular region;extracellular space;collagen-containing extracellular matrix;blood microparticle	serine-type endopeptidase activity;serine-type peptidase activity;metal ion binding	VPS18[26496610];WTAP[29507755];PPP2R2B[19156129];ALB[15174051];HUWE1[26496610];STK38L[24366813];GRB2[17474147];NFKB1[25609649];SNCA[26496610];	142460374
69929	chr7	142460379	C	T	chr7:142460379	PRSS1	serine protease 1	SNV	0|1	0.24	78_24	102	99.0	0|1	0.19	93_22	115	99.0			rs767583768,COSV61197470	EXONIC	YES	NM_002769.5	Transcript	protein_coding	synonymous_variant		4/5	NM_002769.5:c.552C>T	NP_002760.1:p.Phe184%3D		1.0					Pancreatitis, hereditary, 167800 (3), Autosomal dominant	Hereditary chronic pancreatitis	Disease-causing germline mutation(s) (gain of function) in	Recurrent pancreatitis;Abdominal pain;Abnormal enzyme/coenzyme activity;Pancreatic calcification;Elevated C-reactive protein level;Splanchnic vein thrombosis;Leukocytosis;Diabetes mellitus;Jaundice;Diabetes mellitus;Abdominal pain;Exocrine pancreatic insufficiency;Pancreatitis;Autosomal dominant inheritance;Abnormal thrombosis;Pleural effusion;Pancreatic pseudocyst;Fever;Steatorrhea;Pancreatic calcification						39	0.98							0.0	0.0	238230.0	0.0	100	1.0	AC0_RF				0.0	0.0	0.0002958	46			0.05287	603.0		5.573	0.182252		0	0	0			PRSS1	0.0	0.0	0.0	0.02	3.0	-47.0	-41.0	39.0						0.125	0.0				.			ciliary ganglion;beta cell islets;pancreas;superior cervical ganglion;bone marrow;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;extracellular matrix disassembly	extracellular region;extracellular space;collagen-containing extracellular matrix;blood microparticle	serine-type endopeptidase activity;serine-type peptidase activity;metal ion binding	VPS18[26496610];WTAP[29507755];PPP2R2B[19156129];ALB[15174051];HUWE1[26496610];STK38L[24366813];GRB2[17474147];NFKB1[25609649];SNCA[26496610];	142460379
69930	chr7	142460388	C	T	chr7:142460388	PRSS1	serine protease 1	SNV	0|1	0.22	68_19	87	99.0	0|1	0.19	83_19	102	99.0			rs1804561,COSV61190876	EXONIC	YES	NM_002769.5	Transcript	protein_coding	synonymous_variant		4/5	NM_002769.5:c.561C>T	NP_002760.1:p.Gly187%3D		1.0		Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Hereditary_pancreatitis|not_specified	Pancreatitis, hereditary, 167800 (3), Autosomal dominant	Hereditary chronic pancreatitis	Disease-causing germline mutation(s) (gain of function) in	Recurrent pancreatitis;Abdominal pain;Abnormal enzyme/coenzyme activity;Pancreatic calcification;Elevated C-reactive protein level;Splanchnic vein thrombosis;Leukocytosis;Diabetes mellitus;Jaundice;Diabetes mellitus;Abdominal pain;Exocrine pancreatic insufficiency;Pancreatitis;Autosomal dominant inheritance;Abnormal thrombosis;Pleural effusion;Pancreatic pseudocyst;Fever;Steatorrhea;Pancreatic calcification		6.57134e-06	1.0	152176.0	0.0	39	0.98	PASS	nfe	1.46985e-05	1.0	1.46985e-05	1.0	1.24092e-05	3.0	241756.0	0.0	100	1.0	RF	eas	5.47645e-05	1.0	1.84942e-05	2.0	0.0012861	200			0.04541	518.0		13.39	0.994169		0	0	0			PRSS1	0.0	0.0	0.59	0.15	-6.0	13.0	-6.0	30.0						0.125	0.0				.			ciliary ganglion;beta cell islets;pancreas;superior cervical ganglion;bone marrow;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;extracellular matrix disassembly	extracellular region;extracellular space;collagen-containing extracellular matrix;blood microparticle	serine-type endopeptidase activity;serine-type peptidase activity;metal ion binding	VPS18[26496610];WTAP[29507755];PPP2R2B[19156129];ALB[15174051];HUWE1[26496610];STK38L[24366813];GRB2[17474147];NFKB1[25609649];SNCA[26496610];	142460388
69953	chr7	142460744	G	C	chr7:142460744	PRSS1	serine protease 1	SNV	0|1	0.12	74_10	84	99.0	0|1	0.14	64_11	76	99.0			rs150930992,COSV61190193	EXONIC	YES	NM_002769.5	Transcript	protein_coding	missense_variant		5/5	NM_002769.5:c.617G>C	NP_002760.1:p.Cys206Ser		1.0	Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain	Benign	criteria_provided,_single_submitter	Hereditary_pancreatitis	Pancreatitis, hereditary, 167800 (3), Autosomal dominant	Hereditary chronic pancreatitis	Disease-causing germline mutation(s) (gain of function) in	Recurrent pancreatitis;Abdominal pain;Abnormal enzyme/coenzyme activity;Pancreatic calcification;Elevated C-reactive protein level;Splanchnic vein thrombosis;Leukocytosis;Diabetes mellitus;Jaundice;Diabetes mellitus;Abdominal pain;Exocrine pancreatic insufficiency;Pancreatitis;Autosomal dominant inheritance;Abnormal thrombosis;Pleural effusion;Pancreatic pseudocyst;Fever;Steatorrhea;Pancreatic calcification						37	0.97							0.000328605	70.0	213022.0	0.0	100	1.0	RF	afr	0.00137652	17.0	0.000362334	35.0	0.0023086	359	0.026	78.0	0.01572	179.0		21.1	2.151828	0.481	13	5	18	SIFT,PolyPhen,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred	PRSS1	0.0	0.0	0.0	0.0	11.0	-25.0	-25.0	-5.0						0.125	0.0		0.092	-1.355	.			ciliary ganglion;beta cell islets;pancreas;superior cervical ganglion;bone marrow;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;extracellular matrix disassembly	extracellular region;extracellular space;collagen-containing extracellular matrix;blood microparticle	serine-type endopeptidase activity;serine-type peptidase activity;metal ion binding	VPS18[26496610];WTAP[29507755];PPP2R2B[19156129];ALB[15174051];HUWE1[26496610];STK38L[24366813];GRB2[17474147];NFKB1[25609649];SNCA[26496610];	142460744
69954	chr7	142460752	C	G	chr7:142460752	PRSS1	serine protease 1	SNV	0|1	0.12	75_10	85	99.0	0|1	0.13	71_11	84	99.0			rs140793689,COSV61190202	EXONIC	YES	NM_002769.5	Transcript	protein_coding	missense_variant		5/5	NM_002769.5:c.625C>G	NP_002760.1:p.Gln209Glu		1.0	Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain				Pancreatitis, hereditary, 167800 (3), Autosomal dominant	Hereditary chronic pancreatitis	Disease-causing germline mutation(s) (gain of function) in	Recurrent pancreatitis;Abdominal pain;Abnormal enzyme/coenzyme activity;Pancreatic calcification;Elevated C-reactive protein level;Splanchnic vein thrombosis;Leukocytosis;Diabetes mellitus;Jaundice;Diabetes mellitus;Abdominal pain;Exocrine pancreatic insufficiency;Pancreatitis;Autosomal dominant inheritance;Abnormal thrombosis;Pleural effusion;Pancreatic pseudocyst;Fever;Steatorrhea;Pancreatic calcification						36	0.97							0.000174013	37.0	212628.0	0.0	100	1.0	RF	afr	0.000558927	7.0	0.000145382	14.0	0.0023536	366	0.015	46.0	0.01466	167.0		0.001	-1.180296	0.014	1	16	17	FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRSS1	0.0	0.0	0.0	0.0	1.0	3.0	-33.0	3.0						0.125	0.0		0.0	-3.751	.			ciliary ganglion;beta cell islets;pancreas;superior cervical ganglion;bone marrow;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;extracellular matrix disassembly	extracellular region;extracellular space;collagen-containing extracellular matrix;blood microparticle	serine-type endopeptidase activity;serine-type peptidase activity;metal ion binding	VPS18[26496610];WTAP[29507755];PPP2R2B[19156129];ALB[15174051];HUWE1[26496610];STK38L[24366813];GRB2[17474147];NFKB1[25609649];SNCA[26496610];	142460752
69959	chr7	142583330	C	C	chr7:142583330	TRPV6	transient receptor potential cation channel subfamily V member 6	SNV	1/1	1.0	0_52	52	99.0	1/1	1.0	0_72	72	99.0			rs17881456	EXONIC	YES	NM_018646.6	Transcript	protein_coding	synonymous_variant		1/15	NM_018646.6:c.52T>G	NP_061116.5:p.Ala18%3D		-1.0		Benign	criteria_provided,_single_submitter	not_provided	Hyperparathyroidism, transient neonatal, 618188 (3), Autosomal recessive	Neonatal severe primary hyperparathyroidism	Disease-causing germline mutation(s) in	Autosomal recessive inheritance;Feeding difficulties;Delayed speech and language development;Polyhydramnios;Femoral bowing;Elevated alkaline phosphatase;Short ribs;Osteopenia;Motor delay;Respiratory distress;Narrow chest;Thin ribs						0	0.0											0	0.0							0.1718927,0.0000379	26730,1	0.254	674.0				15.79	1.414152	0.499	0	0	0			TRPV6	0.0	0.0	0.0	0.0	-23.0	-8.0	-23.0	30.0						0.351	0.0				cellular phenotype; reproductive system phenotype; 			ciliary ganglion;subthalamic nucleus;placenta;globus pallidus;	.	calcium ion transport;regulation of calcium ion-dependent exocytosis;response to calcium ion;calcium ion homeostasis;calcium ion transmembrane transport;calcium ion import across plasma membrane	plasma membrane;integral component of plasma membrane	ion channel activity;calcium channel activity;protein binding;calmodulin binding;metal ion binding	PTPN1[17197020;15894168];CALB1[16763551];	142583330
70015	chr7	148543694	AA		chr7:148543694-148543695	EZH2	enhancer of zeste 2 polycomb repressive complex 2 subunit	sequence_alteration	2/2	0.0	0_0_25	25	75.0	1/2	0.33	0_7_13	21	99.0			rs3214332	SPLICING	YES	NM_004456.5	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	2/19		NM_004456.5:c.118-5_118-4del			-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Weaver_syndrome	Weaver syndrome, 277590 (3), Autosomal dominant	Weaver syndrome	Disease-causing germline mutation(s) in	Dimple chin;Short ribs;Joint contracture of the hand;Seizure;Muscular hypotonia;Dysarthria;Overlapping toe;Radial deviation of finger;Behavioral abnormality;Intellectual disability;Limited knee extension;Metatarsus adductus;Broad thumb;Epicanthus;Abnormally low-pitched voice;Generalized hypotonia;Dysharmonic bone age;Prominent fingertip pads;Flared humeral metaphysis;Hypoplastic iliac wing;Hydrocele testis;Sparse hair;Round face;Scoliosis;Inguinal hernia;Umbilical hernia;Delayed speech and language development;Cutis laxa;Slurred speech;Limited elbow extension;Depressed nasal bridge;Hypertonia;Dilation of lateral ventricles;Retrognathia;Coxa valga;Inverted nipples;Accelerated skeletal maturation;Flared femoral metaphysis;Calcaneovalgus deformity;Diastasis recti;Thin nail;Macrotia;Short fourth metatarsal;Macrocephaly;Absent septum pellucidum;Fine hair;Camptodactyly;Hypertelorism;Long philtrum;Pes cavus;Cryptorchidism;Downslanted palpebral fissures;Large hands;Deep-set nails;Global developmental delay;Clinodactyly;Autosomal dominant inheritance;Talipes equinovarus;Strabismus;Mandibular prognathia;Spasticity;Kyphosis;Spasticity;Thin nail;Inguinal hernia;Broad foot;Fine hair;Scoliosis;Pes cavus;Downslanted palpebral fissures;Deep-set nails;Redundant skin;Large hands;Broad forehead;Abnormally low-pitched voice;Sandal gap;Hypoplasia of penis;Deep philtrum;Broad thumb;Hypertelorism;Hoarse voice;Joint stiffness;Joint hyperflexibility;Accelerated skeletal maturation;Micrognathia;Finger syndactyly;Abnormality of cardiovascular system morphology;Retrognathia;Abnormality of the metaphysis;Tall stature;Macrotia;Intellectual disability;Cryptorchidism;Global developmental delay;Camptodactyly of finger;Long philtrum;Abnormal fingernail morphology;Hypoplastic toenails;Talipes equinovarus;Feeding difficulties in infancy;Macrocephaly;Round face;Low-set, posteriorly rotated ears	18414213	4.65568e-05	7.0	150354.0	0.0	0	0.07	PASS	nfe	7.40324e-05	5.0	7.40324e-05	5.0	0.00289703	579.0	199860.0	0.0	18	0.44	RF	amr	0.00455607	121.0	0.00262772	240.0	0.0069837	1086			0.01596	182.0		6.731	0.263146		0	0	0			EZH2	0.02	0.05	0.0	0.0	-5.0	-14.0	-3.0	3.0						0.0135	1.0				growth/size/body region phenotype; integument phenotype ; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; hematopoietic system phenotype; cardiovascular system phenotype ; mortality/aging ; normal phenotype; neoplasm; embryo phenotype; behavior/neurological phenotype ; immune system phenotype; skeleton phenotype; nervous system phenotype ; 			ciliary ganglion;testis - seminiferous tubule;tumor;testis - interstitial;dorsal root ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;fetal liver;testis;	.	negative regulation of transcription by RNA polymerase II;DNA methylation;chromatin organization;regulation of transcription, DNA-templated;positive regulation of cell population proliferation;positive regulation of epithelial to mesenchymal transition;regulation of gliogenesis;skeletal muscle satellite cell maintenance involved in skeletal muscle regeneration;cardiac muscle hypertrophy in response to stress;histone methylation;cerebellar cortex development;hippocampus development;response to estradiol;negative regulation of transcription elongation from RNA polymerase II promoter;cellular response to trichostatin A;hepatocyte homeostasis;regulation of circadian rhythm;positive regulation of MAP kinase activity;negative regulation of DNA-binding transcription factor activity;positive regulation of GTPase activity;negative regulation of epidermal cell differentiation;negative regulation of gene expression, epigenetic;negative regulation of transcription, DNA-templated;negative regulation of retinoic acid receptor signaling pathway;rhythmic process;negative regulation of striated muscle cell differentiation;cellular response to hydrogen peroxide;G1 to G0 transition;negative regulation of G0 to G1 transition;histone H3-K27 methylation;protein localization to chromatin;positive regulation of protein serine/threonine kinase activity;liver regeneration;histone H3-K27 trimethylation;positive regulation of dendrite development;positive regulation of cell cycle G1/S phase transition;response to tetrachloromethane;negative regulation of G1/S transition of mitotic cell cycle	nuclear chromatin;nucleus;nucleoplasm;cytoplasm;ESC/E(Z) complex;pronucleus	RNA polymerase II proximal promoter sequence-specific DNA binding;RNA polymerase II core promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;chromatin binding;protein binding;protein-lysine N-methyltransferase activity;histone-lysine N-methyltransferase activity;chromatin DNA binding;histone methyltransferase activity;ribonucleoprotein complex binding;histone methyltransferase activity (H3-K27 specific);primary miRNA binding;promoter-specific chromatin binding	ITSN2[26496610];ATF2[22439931];KDM1A[23455924];EHMT2[26496610];FNBP1L[26496610];MKI67[26496610];RPS6KA5[21900206];SOX17[27728805];MYC[23079660];RPL36[26496610];TNFSF11[21900206];OIP5[26496610];HIST1H2AG[21179169];MAP3K7[21900206];CCDC93[26496610];TLE1[22439931];WSB2[16169070];DNAAF5[26496610];ATP1B1[21900206];MAPK8IP2[21900206];WDR76[26496610];RBX1[23238014;26496610];AR[22531786;27728805];MYCN[27728805];MAPKAPK3[21900206];DNAJB11[21900206];CSNK2B[23555304];SMS[16169070];RIN3[25814554];ERG[22531786];GEMIN7[26496610];DNMT1[16357870;22094255];RPN2[16169070];WDR61[16169070];DNAJC21[26496610];MAP3K20[21900206];SSR1[26496610];CEP192[26496610];SMN1[21900206];KLHDC2[16169070];NOP14[26496610];API5[26496610];H3F3A[27705803;24183680];GADD45G[21900206];POLA2[16169070];CDK6[22094256];BCL6[27505670];H2AFY2[19734898];REEP4[26496610];BHLHE40[23555304];AGO2[19955415];FAT1[26496610];MKRN2[26496610];PIN4[16169070];PHF19[27705803];PHF1[11571280;27705803;26496610;23142980];SUV39H1[23455924];CDCA7L[26496610];BRCA1[23624935];BMI1[23238014;23540691];MRPL2[26496610];XPO1[19955415];SIN3A[27705803];DNMT3B[16357870;22094255;24074865;27728808];TK1[21900206];JARID2[27705803;26496610;20075857];NINL[16169070];PRMT5[23455924];H2AFY[19734898];EED[22094255;22439931;22897849;27705803;26496610;unassigned1304;21078963];DNMT3A[16357870;24074865];ATRX[25417162];SIRT1[22094255];SEPT2[26496610];NME1[27728805];DDB1[23238014];AEBP2[27705803;26496610];RASA1[21900206];MTF2[27705803];RARA[17560333];PML-RAR[17560333];PFDN1[21900206];LCOR[27705803;26496610];CEP63[25416956;unassigned1304];GTF3C1[16169070];HDAC3[23079660];HDAC1[22439931];ATP1A1[16169070];RNF2[23238014];PSMB6[16169070];TAF1D[21900206];RBBP4[27705803;26496610];CCDC85B[16189514];HLX[23455154];SNRPB2[26496610];RBBP7[27705803;26496610];SUZ12[22439931;23079660;23238014;23684459;27705803;24183680;26496610;27728805;19734898;20075857;20543829];CENPV[26496610];CDKN2C[26496610];KRTAP10-9[unassigned1304];STAT3[23684459];HUWE1[26496610];EPOP[27705803;26496610];PML[17560333];ASXL1[22897849];BCOR[27505670];SYT-SSX2[22439931];C7orf25[21900206];CUL4B[23238014];	148543693
70021	chr7	148876260	C	T	chr7:148876260	ZNF398	zinc finger protein 398	SNV	0/1	0.44	76_61	139	99.0	0/1	0.56	55_70	125	99.0			rs115588763	EXONIC	YES	NM_170686.3	Transcript	protein_coding	synonymous_variant		6/6	NM_170686.3:c.1296C>T	NP_733787.1:p.Cys432%3D		1.0						.	.	.		0.00149895	228.0	152106.0	2.0	32	0.96	PASS	amr	0.00458956	70.0	0.000426295	29.0	0.000974363	244.0	250420.0	0.0	100	1.0	PASS	afr	0.00240444	39.0	0.000512802	58.0	0.0007910	123	0.002	7.0				10.25	0.593621		0	0	0			ZNF398	0.01	0.0	0.0	0.0	7.0	-30.0	-42.0	-27.0						0.282	0.96	53.377070016			.			dorsal root ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;globus pallidus;cerebellum;	.	regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II;positive regulation of transcription, DNA-templated	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;metal ion binding	PLEKHF2[25416956];TRIM41[unassigned1304];CABP5[unassigned1304];CIB3[25416956;unassigned1304];GPATCH2L[25416956];MAGOHB[25416956;unassigned1304];CHD2[unassigned1304];CLK2[25416956;unassigned1304];AQP1[unassigned1304];NUDT22[unassigned1304];MFAP1[25416956;unassigned1304];ELMO1[25416956];C1orf109[21516116;25416956];NCDN[unassigned1304];EMD[unassigned1304];OPTN[25416956];ZNF783[25416956;unassigned1304];	148876260
70022	chr7	148947510	C	T	chr7:148947510	ZNF212	zinc finger protein 212	SNV	0/1	0.5	61_60	121	99.0	0/1	0.42	70_51	121	99.0			rs140725635	EXONIC	YES	NM_012256.4	Transcript	protein_coding	synonymous_variant		2/5	NM_012256.4:c.285C>T	NP_036388.2:p.Ala95%3D		1.0						.	.	.		0.00162363	247.0	152128.0	1.0	32	0.96	PASS	nfe	0.00247008	168.0	0.00247008	168.0	0.00129264	325.0	251424.0	1.0	100	1.0	PASS	nfe	0.00206641	235.0	0.00206641	235.0	0.0014662	228	0.003	8.0				10.28	0.596118		0	0	0			ZNF212	0.0	0.0	0.0	0.0	22.0	40.0	-11.0	23.0						0.883	0.0	10.328767441			.			ciliary ganglion;kidney;dorsal root ganglion;trigeminal ganglion;testis;skeletal muscle;	.	regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;zinc ion binding;identical protein binding	ZNF331[18255255];KANK2[unassigned1304];SUV39H2[23455924];PRKAA2[unassigned1304];FHL2[18255255];ZNF3[18255255];RND1[18255255];GYS1[unassigned1304];ZNF408[18255255];CREB3L2[18255255];DPF2[18255255];CSK[18255255];NKX2-3[18255255];ZNF783[25416956;unassigned1304];ENPP7[unassigned1304];SF3A3[25416956];SAP30BP[18255255];MLH1[unassigned1304];GNL1[18255255];DUSP6[18255255];FAM90A1[25416956;unassigned1304];BYSL[unassigned1304];NFKBIA[18255255];PTP4A1[18255255];LNX1[unassigned1304];HBP1[18255255];ATF3[18255255];ZNF212[18255255];GAS8[unassigned1304];ATF4[18255255];	148947510
70169	chr7	150489245	G	A	chr7:150489245	TMEM176B	transmembrane protein 176B	SNV	0/0	0.0	38_0	38	99.0	0/1	0.58	29_44	76	99.0			rs139047290	EXONIC	YES	NM_001362691.2	Transcript	protein_coding	missense_variant		8/9	NM_001362691.2:c.667C>T	NP_001349620.1:p.Arg223Cys		-1.0	.,.,.,.,.,.					.	.	.		0.000157747	24.0	152142.0	0.0	31	0.95	PASS	nfe	0.000249919	17.0	0.000249919	17.0	0.000115348	29.0	251414.0	0.0	74	1.0	PASS	nfe	0.0001934	22.0	0.0001934	22.0	0.0000965	15						11.07	0.69057	0.056	0	17	17		LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TMEM176B	0.02	0.03	0.0	0.01	-33.0	15.0	-33.0	-32.0						0.978	0.0	0.000000000	0.003	-0.491	nervous system phenotype ; behavior/neurological phenotype ; 			kidney;liver;	.	animal organ morphogenesis;cell differentiation;negative regulation of dendritic cell differentiation	integral component of membrane;nuclear membrane	.	TMEM176A[unassigned1304];	150489245
70191	chr7	150714163	G	A	chr7:150714163	ATG9B	autophagy related 9B	SNV	0/1	0.6	51_77	128	99.0	0/0	0.0	38_0	38	99.0			rs202120062	EXONIC	YES	NM_001317056.1	Transcript	protein_coding	missense_variant		9/15	NM_001317056.1:c.2249C>T	NP_001303985.1:p.Pro750Leu		-1.0	.,.					.	.	.		0.000828577	126.0	152068.0	0.0	32	0.96	PASS	amr	0.00176771	27.0	0.00125018	85.0	0.000714096	167.0	233862.0	0.0	42	0.68	PASS	nfe	0.00132396	139.0	0.00132396	139.0	0.0006109	95	0.0	1.0				18.14	1.791489		5	10	15	SIFT,LRT_pred,M-CAP_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,MetaLR_pred,MetaSVM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	ATG9B	0.0	0.0	0.0	0.0	-22.0	-40.0	-40.0	47.0							0.0	0.000000000	0.024	1.176	.			.	.	autophagosome assembly;autophagy of mitochondrion;protein localization to phagophore assembly site;late nucleophagy	phagophore assembly site;autophagosome membrane;autophagosome;integral component of membrane;cytoplasmic vesicle	.	HOXA1[unassigned1304];OTX1[unassigned1304];	150714163
70197	chr7	150716016	C	T	chr7:150716016	ATG9B	autophagy related 9B	SNV	0/1	0.29	34_14	48	99.0	0/1	0.42	32_23	55	99.0			rs757469880	EXONIC	YES	NM_001317056.1	Transcript	protein_coding	missense_variant		6/15	NM_001317056.1:c.1409G>A	NP_001303985.1:p.Arg470Gln		-1.0	.,.					.	.	.		3.28939e-05	5.0	152004.0	0.0	33	0.97	PASS	nfe	7.35749e-05	5.0	7.35749e-05	5.0	8.95095e-05	12.0	134064.0	0.0	10	0.16	PASS	nfe	0.000188848	11.0	0.000188848	11.0	0.0000386	6	0.0	1.0				24.0	3.170014		8	9	17	SIFT,PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,PrimateAI_pred,LIST-S2_pred,fathmm-MKL_coding_pred	Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	ATG9B	0.0	0.0	0.0	0.0	37.0	-8.0	-2.0	38.0							0.0	0.000000000	0.998	1.015	.			.	.	autophagosome assembly;autophagy of mitochondrion;protein localization to phagophore assembly site;late nucleophagy	phagophore assembly site;autophagosome membrane;autophagosome;integral component of membrane;cytoplasmic vesicle	.	HOXA1[unassigned1304];OTX1[unassigned1304];	150716016
70201	chr7	150730899	C	T	chr7:150730899	ABCB8	ATP binding cassette subfamily B member 8	SNV	0/0	0.0	34_0	34	99.0	0/1	0.5	64_63	127	99.0			rs145393109	EXONIC	YES	NM_001282291.2	Transcript	protein_coding	synonymous_variant		3/17	NM_001282291.2:c.354C>T	NP_001269220.1:p.Ala118%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00178809	272.0	152118.0	0.0	32	0.97	PASS	afr	0.00596532	247.0	0.000132333	9.0	0.000626361	157.0	250654.0	1.0	61	1.0	PASS	afr	0.00584615	95.0	0.000247731	28.0	0.0007395	115	0.001	3.0				10.3	0.598464		0	0	0			ABCB8	0.01	0.0	0.0	0.03	-11.0	7.0	-19.0	-50.0						0.118	0.0	1.190313358			cardiovascular system phenotype ; homeostasis/metabolism phenotype; muscle phenotype; 			skeletal muscle;cerebellum peduncles;	ABC transporters	transmembrane transport	nucleus;nucleolus;mitochondrion;mitochondrial envelope;mitochondrial inner membrane;membrane;integral component of membrane;ATP-binding cassette (ABC) transporter complex	transporter activity;ATP binding;ATPase activity, coupled to transmembrane movement of substances	NOA1[16169070];SAT1[16169070];	150730899
70215	chr7	150761966	G	A	chr7:150761966	SLC4A2	solute carrier family 4 member 2	SNV	0/0	0.0	40_0	40	99.0	0/1	0.48	45_43	89	99.0			rs142748851	EXONIC	YES	NM_001199692.3	Transcript	protein_coding	missense_variant		5/23	NM_001199692.3:c.491G>A	NP_001186621.1:p.Arg164Gln		1.0	.,.,.,.,.					.	.	.		0.000230024	35.0	152158.0	0.0	33	0.97	PASS	amr	0.000523697	8.0	0.000220549	15.0	0.000246756	62.0	251260.0	0.0	81	1.0	PASS	amr	0.000694485	24.0	0.000272863	31.0	0.0002315	36	0.002	6.0				23.5	2.966822	0.044	6	15	21	PolyPhen,Polyphen2_HDIV_pred,M-CAP_pred,MutationAssessor_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	SLC4A2	0.0	0.02	0.0	0.0	2.0	-18.0	-49.0	-10.0						0.0699	1.0	0.000000000	0.927	1.083	growth/size/body region phenotype; endocrine/exocrine gland phenotype; craniofacial phenotype; cellular phenotype; skeleton phenotype; behavior/neurological phenotype ; hematopoietic system phenotype; normal phenotype; mortality/aging ; reproductive system phenotype; digestive/alimentary phenotype; hearing/vestibular/ear phenotype; immune system phenotype; 			placenta;skeletal muscle;	.	anion transport;spermatogenesis;inorganic anion transport;bicarbonate transport;digestive tract development;regulation of intracellular pH;anion transmembrane transport	plasma membrane;integral component of plasma membrane;focal adhesion;membrane;basolateral plasma membrane;apical plasma membrane	inorganic anion exchanger activity;anion transmembrane transporter activity;anion:anion antiporter activity;enzyme binding	LIN54[17531812];ATXN1[23275563];ATL3[26496610];THOC2[26496610];ELL2[26496610];	150761966
70234	chr7	150892685		C	chr7:150892684-150892685	IQCA1L	IQ motif containing with AAA domain 1 like	insertion	0/1	0.52	39_42	81	99.0	0/1	0.55	40_48	88	99.0				SPLICING	YES	NM_001304419.2	Transcript	protein_coding	frameshift_variant,splice_region_variant,intron_variant			NM_001304419.2:c.1373-1_1373insG	NP_001291348.1:p.Glu458GlyfsTer46		-1.0						.	.	.						16	0.62											0	0.0							0.0423459,0.4435514	1117,11700						6.887	0.274911		0	0	0			IQCA1L	0.0	0.0	0.0	0.01	6.0	3.0	1.0	-22.0											.			.	.	.	.	ATP binding	RPL4[30021884];HIST1H1B[30021884];	150892684
70278	chr7	151927025	A	G	chr7:151927025	KMT2C	lysine methyltransferase 2C	SNV	0/1	0.29	55_22	77	99.0	0/1	0.22	101_28	129	99.0			rs77735469,COSV51274668	EXONIC	YES	NM_170606.3	Transcript	protein_coding	missense_variant		18/59	NM_170606.3:c.2959T>C	NP_733751.2:p.Tyr987His		-1.0	Zinc finger, PHD-finger&Zinc finger, RING-type&Zinc finger, PHD-type,Zinc finger, PHD-finger&Zinc finger, RING-type&Zinc finger, PHD-type				Kleefstra syndrome 2, 617768 (3), Autosomal dominant	Kleefstra syndrome due to a point mutation	Disease-causing germline mutation(s) (loss of function) in	Global developmental delay;Self-injurious behavior;Thick eyebrow;Microcephaly;Bifid uvula;Abnormal facial shape;Seizure;Everted lower lip vermilion;Delayed speech and language development;Scoliosis;Growth delay;Midface retrusion;Autistic behavior;Generalized hypotonia;Kyphosis;Muscular hypotonia;Intellectual disability;Plagiocephaly;Autosomal dominant inheritance;Autosomal dominant germline de novo mutation						44	0.99							0.408208	61023.0	149490.0	1.0	29	0.65	InbreedingCoeff_RF	afr	0.445751	4889.0	0.395374	27673.0	0.0003215	50	0.008	26.0	0.01615	29.0		27.3	3.950474	0.453	17	2	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaRNN_pred,ClinPred_pred	KMT2C	0.0	0.0	0.01	0.04	-9.0	21.0	-17.0	-5.0							1.0		0.999	1.305	cellular phenotype; growth/size/body region phenotype; vision/eye phenotype; reproductive system phenotype; mortality/aging ; 			.	.	regulation of megakaryocyte differentiation;positive regulation of transcription by RNA polymerase II;histone H3-K4 methylation	nucleus;nucleoplasm;histone methyltransferase complex;MLL3/4 complex	DNA binding;transcription coactivator activity;RNA binding;protein binding;transferase activity, transferring acyl groups;histone-lysine N-methyltransferase activity;histone binding;histone methyltransferase activity (H3-K4 specific);metal ion binding	JUN[20936779];PAXIP1[17500065];TSC22D1[21900206];RING1[27705803];CLPB[30021884];NCOA6[12482968;23870121;17021013;19047629;19433796];AK1[17353931];ASH2L[12482968;23870121;17500065;26886794];MAPK14[20936779];CDC73[19136632];PAGR1[17500065];ERP44[26496610];TCOF1[30021884];RBBP5[12482968;17500065;26886794];MTNR1B[26514267];WDR5[27705803;17500065];CALR[30021884];PABPC1[30021884];TP53[19433796];APPL2[25814554];	151927025
70296	chr7	151945007	C	T	chr7:151945007	KMT2C	lysine methyltransferase 2C	SNV	0/1	0.48	57_54	112	99.0	0/1	0.55	41_53	97	99.0			rs2479172,COSV51279050	EXONIC	YES	NM_170606.3	Transcript	protein_coding	missense_variant		14/59	NM_170606.3:c.2512G>A	NP_733751.2:p.Gly838Ser		-1.0	.,.				Kleefstra syndrome 2, 617768 (3), Autosomal dominant	Kleefstra syndrome due to a point mutation	Disease-causing germline mutation(s) (loss of function) in	Global developmental delay;Self-injurious behavior;Thick eyebrow;Microcephaly;Bifid uvula;Abnormal facial shape;Seizure;Everted lower lip vermilion;Delayed speech and language development;Scoliosis;Growth delay;Midface retrusion;Autistic behavior;Generalized hypotonia;Kyphosis;Muscular hypotonia;Intellectual disability;Plagiocephaly;Autosomal dominant inheritance;Autosomal dominant germline de novo mutation		0.00267097	344.0	128792.0	0.0	48	0.95	AS_VQSR	sas	0.00653766	25.0	0.00135606	81.0	0.493976	116518.0	235878.0	0.0	100	1.0	InbreedingCoeff	afr	0.499186	7973.0	0.49016	51060.0	0.0127907	1989	0.085	269.0				31.0	4.34322	0.395	15	5	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,MetaRNN_pred,DEOGEN2_pred,ClinPred_pred	KMT2C	0.0	0.0	0.01	0.16	-2.0	-5.0	36.0	-20.0							1.0		1.0	1.026	cellular phenotype; growth/size/body region phenotype; vision/eye phenotype; reproductive system phenotype; mortality/aging ; 			.	.	regulation of megakaryocyte differentiation;positive regulation of transcription by RNA polymerase II;histone H3-K4 methylation	nucleus;nucleoplasm;histone methyltransferase complex;MLL3/4 complex	DNA binding;transcription coactivator activity;RNA binding;protein binding;transferase activity, transferring acyl groups;histone-lysine N-methyltransferase activity;histone binding;histone methyltransferase activity (H3-K4 specific);metal ion binding	JUN[20936779];PAXIP1[17500065];TSC22D1[21900206];RING1[27705803];CLPB[30021884];NCOA6[12482968;23870121;17021013;19047629;19433796];AK1[17353931];ASH2L[12482968;23870121;17500065;26886794];MAPK14[20936779];CDC73[19136632];PAGR1[17500065];ERP44[26496610];TCOF1[30021884];RBBP5[12482968;17500065;26886794];MTNR1B[26514267];WDR5[27705803;17500065];CALR[30021884];PABPC1[30021884];TP53[19433796];APPL2[25814554];	151945007
70298	chr7	151945140	C	T	chr7:151945140	KMT2C	lysine methyltransferase 2C	SNV	0/1	0.23	110_33	144	99.0	0/1	0.19	183_42	226	99.0			rs2537263,COSV51275902	EXONIC	YES	NM_170606.3	Transcript	protein_coding	synonymous_variant		14/59	NM_170606.3:c.2379G>A	NP_733751.2:p.Ser793%3D		-1.0					Kleefstra syndrome 2, 617768 (3), Autosomal dominant	Kleefstra syndrome due to a point mutation	Disease-causing germline mutation(s) (loss of function) in	Global developmental delay;Self-injurious behavior;Thick eyebrow;Microcephaly;Bifid uvula;Abnormal facial shape;Seizure;Everted lower lip vermilion;Delayed speech and language development;Scoliosis;Growth delay;Midface retrusion;Autistic behavior;Generalized hypotonia;Kyphosis;Muscular hypotonia;Intellectual disability;Plagiocephaly;Autosomal dominant inheritance;Autosomal dominant germline de novo mutation		3.28317e-05	5.0	152292.0	0.0	44	1.0	PASS	nfe	5.87769e-05	4.0	5.87769e-05	4.0	0.431736	74908.0	173504.0	0.0	100	1.0	InbreedingCoeff	afr	0.476452	6070.0	0.403139	29234.0	0.0051831	806	0.077	216.0				6.995	0.283243		0	0	0			KMT2C	0.0	0.0	0.0	0.0	-29.0	10.0	39.0	-13.0							1.0				cellular phenotype; growth/size/body region phenotype; vision/eye phenotype; reproductive system phenotype; mortality/aging ; 			.	.	regulation of megakaryocyte differentiation;positive regulation of transcription by RNA polymerase II;histone H3-K4 methylation	nucleus;nucleoplasm;histone methyltransferase complex;MLL3/4 complex	DNA binding;transcription coactivator activity;RNA binding;protein binding;transferase activity, transferring acyl groups;histone-lysine N-methyltransferase activity;histone binding;histone methyltransferase activity (H3-K4 specific);metal ion binding	JUN[20936779];PAXIP1[17500065];TSC22D1[21900206];RING1[27705803];CLPB[30021884];NCOA6[12482968;23870121;17021013;19047629;19433796];AK1[17353931];ASH2L[12482968;23870121;17500065;26886794];MAPK14[20936779];CDC73[19136632];PAGR1[17500065];ERP44[26496610];TCOF1[30021884];RBBP5[12482968;17500065;26886794];MTNR1B[26514267];WDR5[27705803;17500065];CALR[30021884];PABPC1[30021884];TP53[19433796];APPL2[25814554];	151945140
70300	chr7	151945167	G	T	chr7:151945167	KMT2C	lysine methyltransferase 2C	SNV	0/1	0.28	87_34	122	99.0	0/1	0.32	135_63	199	99.0			rs2537264,COSV51349661	EXONIC	YES	NM_170606.3	Transcript	protein_coding	synonymous_variant		14/59	NM_170606.3:c.2352C>A	NP_733751.2:p.Ser784%3D		-1.0					Kleefstra syndrome 2, 617768 (3), Autosomal dominant	Kleefstra syndrome due to a point mutation	Disease-causing germline mutation(s) (loss of function) in	Global developmental delay;Self-injurious behavior;Thick eyebrow;Microcephaly;Bifid uvula;Abnormal facial shape;Seizure;Everted lower lip vermilion;Delayed speech and language development;Scoliosis;Growth delay;Midface retrusion;Autistic behavior;Generalized hypotonia;Kyphosis;Muscular hypotonia;Intellectual disability;Plagiocephaly;Autosomal dominant inheritance;Autosomal dominant germline de novo mutation		0.000566085	81.0	143088.0	0.0	43	0.98	PASS	sas	0.00137363	6.0	0.000323635	21.0	0.476504	95420.0	200250.0	0.0	100	1.0	InbreedingCoeff	afr	0.495272	7332.0	0.46463	39724.0	0.0038841	604	0.04	111.0				4.968	0.143285		0	0	0			KMT2C	0.0	0.0	0.0	0.0	31.0	-17.0	18.0	12.0							1.0				cellular phenotype; growth/size/body region phenotype; vision/eye phenotype; reproductive system phenotype; mortality/aging ; 			.	.	regulation of megakaryocyte differentiation;positive regulation of transcription by RNA polymerase II;histone H3-K4 methylation	nucleus;nucleoplasm;histone methyltransferase complex;MLL3/4 complex	DNA binding;transcription coactivator activity;RNA binding;protein binding;transferase activity, transferring acyl groups;histone-lysine N-methyltransferase activity;histone binding;histone methyltransferase activity (H3-K4 specific);metal ion binding	JUN[20936779];PAXIP1[17500065];TSC22D1[21900206];RING1[27705803];CLPB[30021884];NCOA6[12482968;23870121;17021013;19047629;19433796];AK1[17353931];ASH2L[12482968;23870121;17500065;26886794];MAPK14[20936779];CDC73[19136632];PAGR1[17500065];ERP44[26496610];TCOF1[30021884];RBBP5[12482968;17500065;26886794];MTNR1B[26514267];WDR5[27705803;17500065];CALR[30021884];PABPC1[30021884];TP53[19433796];APPL2[25814554];	151945167
70305	chr7	151962168	C	A	chr7:151962168	KMT2C	lysine methyltransferase 2C	SNV	0/0	0.0	51_0	51	99.0	0/1	0.21	192_52	244	99.0			rs138908625,COSV51275204,COSV51445818	EXONIC	YES	NM_170606.3	Transcript	protein_coding	missense_variant		8/59	NM_170606.3:c.1139G>T	NP_733751.2:p.Arg380Leu		-1.0	Zinc finger, PHD-finger&Zinc finger, RING-type&Zinc finger, RING-type&Zinc finger, PHD-type,Zinc finger, PHD-finger&Zinc finger, RING-type&Zinc finger, RING-type&Zinc finger, PHD-type	Benign/Likely_benign	no_assertion_criteria_provided	not_specified|not_provided	Kleefstra syndrome 2, 617768 (3), Autosomal dominant	Kleefstra syndrome due to a point mutation	Disease-causing germline mutation(s) (loss of function) in	Global developmental delay;Self-injurious behavior;Thick eyebrow;Microcephaly;Bifid uvula;Abnormal facial shape;Seizure;Everted lower lip vermilion;Delayed speech and language development;Scoliosis;Growth delay;Midface retrusion;Autistic behavior;Generalized hypotonia;Kyphosis;Muscular hypotonia;Intellectual disability;Plagiocephaly;Autosomal dominant inheritance;Autosomal dominant germline de novo mutation		0.00077579	115.0	148236.0	0.0	34	0.98	PASS	sas	0.00173536	8.0	0.000389222	26.0	0.00149626	341.0	227902.0	0.0	100	1.0	PASS	afr	0.00398077	53.0	0.00128193	132.0	0.0000257	4	0.015	50.0	0.0017	3.0		24.1	3.219967	0.205	16	3	19	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,MetaRNN_pred,ClinPred_pred	KMT2C	0.03	0.0	0.02	0.01	-6.0	46.0	-5.0	-45.0							1.0		1.0	1.026	cellular phenotype; growth/size/body region phenotype; vision/eye phenotype; reproductive system phenotype; mortality/aging ; 			.	.	regulation of megakaryocyte differentiation;positive regulation of transcription by RNA polymerase II;histone H3-K4 methylation	nucleus;nucleoplasm;histone methyltransferase complex;MLL3/4 complex	DNA binding;transcription coactivator activity;RNA binding;protein binding;transferase activity, transferring acyl groups;histone-lysine N-methyltransferase activity;histone binding;histone methyltransferase activity (H3-K4 specific);metal ion binding	JUN[20936779];PAXIP1[17500065];TSC22D1[21900206];RING1[27705803];CLPB[30021884];NCOA6[12482968;23870121;17021013;19047629;19433796];AK1[17353931];ASH2L[12482968;23870121;17500065;26886794];MAPK14[20936779];CDC73[19136632];PAGR1[17500065];ERP44[26496610];TCOF1[30021884];RBBP5[12482968;17500065;26886794];MTNR1B[26514267];WDR5[27705803;17500065];CALR[30021884];PABPC1[30021884];TP53[19433796];APPL2[25814554];	151962168
70306	chr7	151962269	C	T	chr7:151962269	KMT2C	lysine methyltransferase 2C	SNV	0/0	0.0	51_0	51	99.0	0/1	0.2	120_30	150	99.0			rs770240292,COSV51330395	EXONIC	YES	NM_170606.3	Transcript	protein_coding	synonymous_variant		8/59	NM_170606.3:c.1038G>A	NP_733751.2:p.Val346%3D		-1.0					Kleefstra syndrome 2, 617768 (3), Autosomal dominant	Kleefstra syndrome due to a point mutation	Disease-causing germline mutation(s) (loss of function) in	Global developmental delay;Self-injurious behavior;Thick eyebrow;Microcephaly;Bifid uvula;Abnormal facial shape;Seizure;Everted lower lip vermilion;Delayed speech and language development;Scoliosis;Growth delay;Midface retrusion;Autistic behavior;Generalized hypotonia;Kyphosis;Muscular hypotonia;Intellectual disability;Plagiocephaly;Autosomal dominant inheritance;Autosomal dominant germline de novo mutation		0.000120794	18.0	149014.0	0.0	34	0.98	AS_VQSR	sas	0.000860956	4.0	1.49134e-05	1.0	0.000114607	28.0	244314.0	0.0	79	1.0	RF	afr	0.000528751	8.0	0.000162705	18.0	0.0000064	1	0.004	12.0				6.099	0.21762		0	0	0			KMT2C	0.0	0.0	0.0	0.0	16.0	20.0	8.0	1.0							1.0				cellular phenotype; growth/size/body region phenotype; vision/eye phenotype; reproductive system phenotype; mortality/aging ; 			.	.	regulation of megakaryocyte differentiation;positive regulation of transcription by RNA polymerase II;histone H3-K4 methylation	nucleus;nucleoplasm;histone methyltransferase complex;MLL3/4 complex	DNA binding;transcription coactivator activity;RNA binding;protein binding;transferase activity, transferring acyl groups;histone-lysine N-methyltransferase activity;histone binding;histone methyltransferase activity (H3-K4 specific);metal ion binding	JUN[20936779];PAXIP1[17500065];TSC22D1[21900206];RING1[27705803];CLPB[30021884];NCOA6[12482968;23870121;17021013;19047629;19433796];AK1[17353931];ASH2L[12482968;23870121;17500065;26886794];MAPK14[20936779];CDC73[19136632];PAGR1[17500065];ERP44[26496610];TCOF1[30021884];RBBP5[12482968;17500065;26886794];MTNR1B[26514267];WDR5[27705803;17500065];CALR[30021884];PABPC1[30021884];TP53[19433796];APPL2[25814554];	151962269
70307	chr7	151962294	G	A	chr7:151962294	KMT2C	lysine methyltransferase 2C	SNV	0/0	0.0	51_0	51	99.0	0|1	0.12	74_10	84	99.0			rs763762478,COSV51280129	SPLICING	YES	NM_170606.3	Transcript	protein_coding	missense_variant,splice_region_variant		8/59	NM_170606.3:c.1013C>T	NP_733751.2:p.Ser338Leu		-1.0	.,.				Kleefstra syndrome 2, 617768 (3), Autosomal dominant	Kleefstra syndrome due to a point mutation	Disease-causing germline mutation(s) (loss of function) in	Global developmental delay;Self-injurious behavior;Thick eyebrow;Microcephaly;Bifid uvula;Abnormal facial shape;Seizure;Everted lower lip vermilion;Delayed speech and language development;Scoliosis;Growth delay;Midface retrusion;Autistic behavior;Generalized hypotonia;Kyphosis;Muscular hypotonia;Intellectual disability;Plagiocephaly;Autosomal dominant inheritance;Autosomal dominant germline de novo mutation		2.01294e-05	3.0	149036.0	0.0	34	0.98	AS_VQSR	sas	0.000214408	1.0	1.48987e-05	1.0	2.01316e-05	5.0	248366.0	0.0	59	0.99	RF	afr	0.000191302	3.0	8.90583e-06	1.0	0.0000064	1						25.1	3.539553	0.106	15	5	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred	KMT2C	0.0	0.03	0.0	0.0	-5.0	0.0	-24.0	-17.0	0.0268982790430987	0.306	4.492	1.131	5.623		1.0		0.99	1.176	cellular phenotype; growth/size/body region phenotype; vision/eye phenotype; reproductive system phenotype; mortality/aging ; 			.	.	regulation of megakaryocyte differentiation;positive regulation of transcription by RNA polymerase II;histone H3-K4 methylation	nucleus;nucleoplasm;histone methyltransferase complex;MLL3/4 complex	DNA binding;transcription coactivator activity;RNA binding;protein binding;transferase activity, transferring acyl groups;histone-lysine N-methyltransferase activity;histone binding;histone methyltransferase activity (H3-K4 specific);metal ion binding	JUN[20936779];PAXIP1[17500065];TSC22D1[21900206];RING1[27705803];CLPB[30021884];NCOA6[12482968;23870121;17021013;19047629;19433796];AK1[17353931];ASH2L[12482968;23870121;17500065;26886794];MAPK14[20936779];CDC73[19136632];PAGR1[17500065];ERP44[26496610];TCOF1[30021884];RBBP5[12482968;17500065;26886794];MTNR1B[26514267];WDR5[27705803;17500065];CALR[30021884];PABPC1[30021884];TP53[19433796];APPL2[25814554];	151962294
70308	chr7	151962296	T	C	chr7:151962296	KMT2C	lysine methyltransferase 2C	SNV	0/0	0.0	51_0	51	99.0	0|1	0.12	74_10	84	99.0			rs751158858,COSV51280169	SPLICING	YES	NM_170606.3	Transcript	protein_coding	splice_acceptor_variant	7/58		NM_170606.3:c.1013-2A>G			-1.0		Uncertain_significance	criteria_provided,_single_submitter	Kleefstra_syndrome_2	Kleefstra syndrome 2, 617768 (3), Autosomal dominant	Kleefstra syndrome due to a point mutation	Disease-causing germline mutation(s) (loss of function) in	Global developmental delay;Self-injurious behavior;Thick eyebrow;Microcephaly;Bifid uvula;Abnormal facial shape;Seizure;Everted lower lip vermilion;Delayed speech and language development;Scoliosis;Growth delay;Midface retrusion;Autistic behavior;Generalized hypotonia;Kyphosis;Muscular hypotonia;Intellectual disability;Plagiocephaly;Autosomal dominant inheritance;Autosomal dominant germline de novo mutation		2.6734e-05	4.0	149622.0	0.0	34	0.98	AS_VQSR	sas	0.000425894	2.0	1.48827e-05	1.0	1.60967e-05	4.0	248498.0	0.0	57	0.99	RF	afr	0.00019009	3.0	8.90615e-06	1.0	0.0000064	1						33.0	4.861279		0	0	0			KMT2C	0.59	0.94	0.0	0.0	-7.0	-2.0	-7.0	-26.0	0.999965251569602	0.856	-2.332	7.955	5.623		1.0				cellular phenotype; growth/size/body region phenotype; vision/eye phenotype; reproductive system phenotype; mortality/aging ; 			.	.	regulation of megakaryocyte differentiation;positive regulation of transcription by RNA polymerase II;histone H3-K4 methylation	nucleus;nucleoplasm;histone methyltransferase complex;MLL3/4 complex	DNA binding;transcription coactivator activity;RNA binding;protein binding;transferase activity, transferring acyl groups;histone-lysine N-methyltransferase activity;histone binding;histone methyltransferase activity (H3-K4 specific);metal ion binding	JUN[20936779];PAXIP1[17500065];TSC22D1[21900206];RING1[27705803];CLPB[30021884];NCOA6[12482968;23870121;17021013;19047629;19433796];AK1[17353931];ASH2L[12482968;23870121;17500065;26886794];MAPK14[20936779];CDC73[19136632];PAGR1[17500065];ERP44[26496610];TCOF1[30021884];RBBP5[12482968;17500065;26886794];MTNR1B[26514267];WDR5[27705803;17500065];CALR[30021884];PABPC1[30021884];TP53[19433796];APPL2[25814554];	151962296
70435	chr8	408457	T	C	chr8:408457	FBXO25	F-box protein 25	SNV	0/1	0.54	68_79	147	99.0	0/0	0.0	34_0	34	99.0			rs1252033954	EXONIC	YES	NM_183421.2	Transcript	protein_coding	missense_variant		8/11	NM_183421.2:c.749T>C	NP_904357.1:p.Ile250Thr		1.0	.,.,.,.					.	.	.						33	0.98							3.97728e-06	1.0	251428.0	0.0	71	1.0	PASS	nfe	8.79384e-06	1.0	8.79384e-06	1.0			0.0	1.0				20.4	2.070478	0.141	5	14	19	MutationTaster_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	FBXO25	0.0	0.0	0.0	0.0	45.0	-15.0	-24.0	13.0						0.639	0.31	0.000000000	0.299	1.086	.			testis - seminiferous tubule;testis - interstitial;superior cervical ganglion;testis;	.	protein ubiquitination	ubiquitin ligase complex;nucleus;nucleolus;SCF ubiquitin ligase complex	actin binding;ubiquitin-protein transferase activity	ORC4[21988832];HSP90AA1[25036637];PPP5C[25036637];CAND1[20473970];HSP90AB1[22939624;25036637];CUL1[16278047;20473970];EP300[21988832];ACTB[20473970];SKP1[16278047;20473970;unassigned1304];FKBP5[25036637];	408457
70522	chr8	6728299	G	A	chr8:6728299	DEFB1	defensin beta 1	SNV	0/1	0.49	47_47	95	99.0	0/1	0.55	42_51	93	99.0			rs5743490,COSV99858896	EXONIC	YES	NM_005218.4	Transcript	protein_coding	synonymous_variant		2/2	NM_005218.4:c.111C>T	NP_005209.1:p.Cys37%3D		-1.0						.	.	.	30290772,15588320	0.0040668	619.0	152208.0	2.0	33	0.97	PASS	amr	0.00772352	118.0	0.00634921	432.0	0.00372668	937.0	251430.0	1.0	48	1.0	PASS	amr	0.00613178	212.0	0.00564475	642.0	0.0038906	605	0.014	47.0	0.00925	17.0		0.047	-0.584862		0	0	0			DEFB1	0.0	0.03	0.0	0.0	-9.0	49.0	47.0	-19.0						0.66	0.0	0.000000000			immune system phenotype; renal/urinary system phenotype; mortality/aging ; 			salivary gland;ciliary ganglion;kidney;liver;beta cell islets;tongue;pancreas;superior cervical ganglion;skin;	.	innate immune response in mucosa;chemotaxis;immune response;G protein-coupled receptor signaling pathway;response to bacterium;antimicrobial humoral response;antibacterial humoral response;cAMP-mediated signaling;calcium-mediated signaling using intracellular calcium source;defense response to bacterium;innate immune response;defense response to Gram-negative bacterium;defense response to Gram-positive bacterium;positive regulation of flagellated sperm motility involved in capacitation;antimicrobial humoral immune response mediated by antimicrobial peptide	extracellular region;extracellular space;Golgi lumen;extrinsic component of membrane;extracellular exosome;sperm midpiece;microvesicle	protein binding;CCR6 chemokine receptor binding;identical protein binding	MAP4K2[21900206];ASPH[unassigned1304];	6728299
70534	chr8	8176388		GGGGCG	chr8:8176387-8176388	PRAG1	PEAK1 related, kinase-activating pseudokinase 1	insertion	1/1	0.79	0_19	24	57.0	1/1	0.7	0_14	20	42.0			rs143409664	EXONIC	YES	NM_001369759.1	Transcript	protein_coding	inframe_insertion		6/6	NM_001369759.1:c.3504_3509dup	NP_001356688.1:p.Pro1172_Ala1173dup		-1.0						.	.	.		0.000240974	24.0	99596.0	0.0	8	0.24	PASS	eas	0.000621504	2.0	0.000263435	12.0	0.297855	9277.0	31146.0	1998.0	6	0.07	RF	eas	0.314852	619.0	0.286614	4278.0	0.0000064,0.0000900,0.0038777	1,14,603	0.007	21.0	0.11268	48.0		13.65	1.032322		0	0	0																						mortality/aging ; 			.	.	protein phosphorylation;regulation of cell shape;regulation of Notch signaling pathway;negative regulation of neuron projection development;cell migration;positive regulation of Rho protein signal transduction;regulation of cell motility	nucleus;cytoplasm;focal adhesion	protein kinase activity;protein binding;ATP binding;identical protein binding	HSP90AB1[22939624];PSAP[16169070];SFN[15778465];UBE3A[21900206];CHGB[16169070];CRKL[26496610];	8176387
70537	chr8	8998332	C	G	chr8:8998332	PPP1R3B	protein phosphatase 1 regulatory subunit 3B	SNV	0/1	0.49	41_40	82	99.0	0/1	0.39	66_42	108	99.0			rs960859034	EXONIC	YES	NM_001201329.2	Transcript	protein_coding	missense_variant		2/2	NM_001201329.2:c.830G>C	NP_001188258.1:p.Gly277Ala		-1.0	.,.					.	.	.		1.97202e-05	3.0	152128.0	0.0	32	0.97	PASS	amr	0.000196386	3.0	0.0	0.0	1.19371e-05	3.0	251318.0	0.0	61	1.0	PASS	amr	5.7857e-05	2.0	0.0	0.0			0.0	1.0				24.8	3.440928	0.241	10	10	20	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,M-CAP_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	PPP1R3B	0.0	0.0	0.0	0.0	-38.0	18.0	31.0	0.0						0.536	0.02	0.000000000	0.912	1.026	reproductive system phenotype; behavior/neurological phenotype ; homeostasis/metabolism phenotype; growth/size/body region phenotype; 			ciliary ganglion;subthalamic nucleus;trigeminal ganglion;superior cervical ganglion;	Insulin signaling pathway	glycogen metabolic process;regulation of glycogen biosynthetic process;regulation of glycogen catabolic process;protein dephosphorylation;regulation of phosphoprotein phosphatase activity	protein phosphatase type 1 complex;glycogen granule;intracellular membrane-bounded organelle	protein binding;protein phosphatase regulator activity;enzyme binding;[phosphorylase] phosphatase activity	IFNAR2[21988832];PPP1CB[23414517];DHX15[29021621];PYGM[23414517];NUP153[26496610];PPP1CA[15231748;unassigned1304];PLEC[23414517];	8998332
70544	chr8	10467620	C	T	chr8:10467620	RP1L1	RP1 like 1	SNV	0/0	0.0	62_0	62	99.0	0|1	0.21	65_17	82	99.0			COSV66751569,COSV66760202	EXONIC	YES	NM_178857.6	Transcript	protein_coding	missense_variant		4/4	NM_178857.6:c.3988G>A	NP_849188.4:p.Gly1330Arg		-1.0					Occult macular dystrophy, 613587 (3), Autosomal dominant; Retinitis pigmentosa 88, 618826 (3), Autosomal recessive	Occult macular dystrophy	Disease-causing germline mutation(s) in	Macular dystrophy;Autosomal dominant inheritance;Slow decrease in visual acuity;Abnormal multifocal electroretinogram		0.0	0.0	149874.0	0.0	44	0.97	AC0_AS_VQSR				0.0	0.0					100	0.99														0.036	-0.619462	0.054	0	18	18		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	RP1L1	0.0	0.0	0.0	0.0	-2.0	-1.0	-1.0	31.0						0.523		0.000000000	0.001	-0.241	nervous system phenotype ; vision/eye phenotype; 			.	.	visual perception;axoneme assembly;intracellular signal transduction;photoreceptor cell development;photoreceptor cell maintenance;retina development in camera-type eye	photoreceptor outer segment;microtubule;axoneme;photoreceptor connecting cilium	.	ARL3[18588884];FYN[17474147];GRB2[17474147];NCK1[17474147];	10467620
70547	chr8	11172536	G	C	chr8:11172536	MTMR9	myotubularin related protein 9	SNV	0/1	0.43	52_40	92	99.0	0/1	0.48	57_53	110	99.0			rs139630635	EXONIC	YES	NM_015458.4	Transcript	protein_coding	missense_variant		7/10	NM_015458.4:c.1076G>C	NP_056273.2:p.Arg359Pro		1.0	Myotubularin-like phosphatase domain&Myotubularin-like phosphatase domain,.	Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00390989	595.0	152178.0	2.0	32	0.97	PASS	amr	0.00739432	113.0	0.00593873	404.0	0.00326301	820.0	251302.0	3.0	76	1.0	PASS	nfe	0.00556279	632.0	0.00556279	632.0	0.0034404	535	0.001	4.0	0.00184	21.0		23.9	3.138267	0.607	14	6	20	SIFT,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,Polyphen2_HDIV_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,ClinPred_pred	MTMR9	0.0	0.0	0.0	0.0	-50.0	-49.0	-50.0	37.0						0.0637	0.21	0.000000000	0.915	1.176	.			ciliary ganglion;amygdala;temporal lobe;testis - seminiferous tubule;prefrontal cortex;trigeminal ganglion;cingulate cortex;superior cervical ganglion;testis;cerebellum peduncles;pons;occipital lobe;subthalamic nucleus;dorsal root ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;	.	phosphatidylinositol biosynthetic process;negative regulation of autophagy;positive regulation of phosphatase activity;dephosphorylation;protein stabilization;regulation of phosphatidylinositol dephosphorylation	cytoplasm;cytosol;protein-containing complex	phosphatidylinositol-3-phosphatase activity;protein binding;protein phosphatase binding;enzyme regulator activity;phosphatidylinositol-3,5-bisphosphate 3-phosphatase activity	NECAB2[unassigned1304];VAC14[25416956];KDM1A[23455924];INCA1[unassigned1304];MTMR8[16189514;22647598];MTMR9[16189514;25416956];NMI[25416956;unassigned1304];FAM169A[unassigned1304];GRAMD4[unassigned1304];MTMR6[21516116;25416956;unassigned1304];MTMR7[25416956;unassigned1304];MOS[25416956];KIAA1328[unassigned1304];EWSR1[16189514];KRT27[unassigned1304];LNX1[25416956];EMILIN1[16189514;19447967;21516116;25416956;unassigned1304];ZNF655[unassigned1304];DEPDC5[unassigned1304];SPG21[16189514];GLYR1[unassigned1304];PTPN3[unassigned1304];	11172536
70551	chr8	11405588	C	G	chr8:11405588	BLK	BLK proto-oncogene, Src family tyrosine kinase	SNV	0/1	0.36	64_36	100	99.0	0/1	0.39	58_37	95	99.0			rs149393791,COSV52049487,COSV52056810	EXONIC	YES	NM_001715.3	Transcript	protein_coding	missense_variant		4/13	NM_001715.3:c.223C>G	NP_001706.2:p.Arg75Gly		1.0	SH3 domain&SH3 domain&SH3 domain&SH3 domain,SH3 domain&SH3 domain&SH3 domain&SH3 domain,SH3 domain&SH3 domain&SH3 domain&SH3 domain	Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Maturity-onset_diabetes_of_the_young,_type_11|not_provided	Maturity-onset diabetes of the young, type 11, 613375 (3), Autosomal dominant	Systemic lupus erythematosus;MODY	Major susceptibility factor in;Disease-causing germline mutation(s) in	Obesity;Overweight;Glycosuria;Renal cyst;Hyperinsulinemic hypoglycemia;Retinopathy;Intrauterine growth retardation;Neonatal hypoglycemia;Pancreatic hypoplasia;Hepatocellular adenoma;Elevated hemoglobin A1c;Nephropathy;Large for gestational age;Exocrine pancreatic insufficiency;Transient neonatal diabetes mellitus;Abnormal oral glucose tolerance;Abnormal C-peptide level;Hypoinsulinemia;Hyperglycemia;Maturity-onset diabetes of the young;Diabetes mellitus;Obesity;Autosomal dominant inheritance;Overweight		0.00101919	155.0	152082.0	1.0	32	0.95	PASS	amr	0.00261814	40.0	0.000382297	26.0	0.000791366	199.0	251464.0	0.0	96	1.0	PASS	amr	0.00196634	68.0	0.000483482	55.0	0.0006173	96	0.002	7.0	0.00219	25.0		13.78	1.052935	0.018	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	BLK	0.0	0.0	0.0	0.06	1.0	12.0	44.0	35.0						0.403	0.0	0.000000000	0.75	-0.373	reproductive system phenotype; normal phenotype; hematopoietic system phenotype; immune system phenotype; hearing/vestibular/ear phenotype; endocrine/exocrine gland phenotype; 			tonsil;	.	transmembrane receptor protein tyrosine kinase signaling pathway;cell differentiation;positive regulation of insulin secretion;intracellular signal transduction;peptidyl-tyrosine autophosphorylation;B cell receptor signaling pathway;regulation of B cell receptor signaling pathway	cytosol;extrinsic component of cytoplasmic side of plasma membrane	protein tyrosine kinase activity;non-membrane spanning protein tyrosine kinase activity;signaling receptor binding;protein binding;ATP binding	HSP90AB1[22939624];FLT3[28086240];SLA[unassigned1304];HSF2BP[unassigned1304];PHB2[25852190];YBX3[25852190];IKZF3[unassigned1304];CRKL[unassigned1304];ATP5IF1[25852190];SNRPD1[25852190];GRB10[unassigned1304];GAB1[24728074];ZBTB32[unassigned1304];MID2[unassigned1304];AR[24728074];PKM[24606918];KIT[24728074];PICK1[unassigned1304];EEF1E1[25852190];MET[24728074];GAPDH[25852190];BIRC2[unassigned1304];ATP5MD[25852190];ZBTB8A[unassigned1304];PXN[unassigned1304];ZBTB42[unassigned1304];PIK3R3[unassigned1304];PIK3R1[unassigned1304];CBL[8621719];JAKMIP1[unassigned1304];EGFR[16273093;24658140];HSP90B1[25852190];FXR1[unassigned1304];SOCS3[unassigned1304];ATP5F1A[25852190];EFS[25416956;unassigned1304];ATP5F1B[25852190];FXR2[unassigned1304];ERBB2[16273093];ANKRD54[25852190];ATP5MG[25852190];ATP5MF[25852190];ATP5ME[25852190];ATP5PF[25852190];ATP5PD[25852190];ATP5PB[25852190];STAT3[25416956;unassigned1304];DDIT4L[unassigned1304];GNG12[25852190];EEF2[25852190];ATP5F1C[25852190];ATP5F1D[25852190];ATP5F1E[25852190];ALS2CR12[unassigned1304];TDP2[unassigned1304];ATP5PO[25852190];SSBP3[unassigned1304];ZNF774[unassigned1304];	11405588
71014	chr8	23190993	G	A	chr8:23190993	LOXL2	lysyl oxidase like 2	SNV	0/1	0.58	64_90	154	99.0	0/1	0.44	79_63	142	99.0			rs752798008	EXONIC	YES	NM_002318.3	Transcript	protein_coding	missense_variant		5/14	NM_002318.3:c.887C>T	NP_002309.1:p.Pro296Leu		-1.0	SRCR domain&SRCR domain&SRCR-like domain					Progressive symmetric erythrokeratodermia;Keratoderma hereditarium mutilans with ichthyosis	Candidate gene tested in;Disease-causing germline mutation(s) in	.		2.62798e-05	4.0	152208.0	0.0	33	0.97	PASS	nfe	4.40891e-05	3.0	4.40891e-05	3.0	1.98886e-05	5.0	251400.0	0.0	100	1.0	PASS	eas	0.000108755	2.0	1.75917e-05	2.0	0.0000064	1						25.7	3.690693	0.605	14	6	20	SIFT,LRT_pred,M-CAP_pred,MetaLR_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,Polyphen2_HDIV_pred,MetaSVM_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred	LOXL2	0.0	0.0	0.02	0.0	-29.0	46.0	-7.0	-11.0						0.77	0.0	0.000000000	0.475	1.176	liver/biliary system phenotype; neoplasm; mortality/aging ; cardiovascular system phenotype ; cellular phenotype; homeostasis/metabolism phenotype; immune system phenotype; integument phenotype ; 			.	.	negative regulation of transcription by RNA polymerase II;response to hypoxia;epithelial to mesenchymal transition;endothelial cell proliferation;sprouting angiogenesis;cellular protein modification process;receptor-mediated endocytosis;cell adhesion;aging;positive regulation of epithelial to mesenchymal transition;peptidyl-lysine oxidation;electron transport chain;collagen fibril organization;positive regulation of chondrocyte differentiation;endothelial cell migration;negative regulation of transcription, DNA-templated;response to copper ion;heterochromatin organization;negative regulation of stem cell population maintenance	chromatin;basement membrane;extracellular space;nucleus;nucleoplasm;endoplasmic reticulum;membrane;collagen-containing extracellular matrix	protein-lysine 6-oxidase activity;scavenger receptor activity;copper ion binding;calcium ion binding;protein binding;electron transfer activity;oligosaccharide binding	PDIA3[17170699];EGFL7[18497746];MARCKSL1[24863880];LOX[30082873];DAPK1[29513927];DHX15[29021621];	23190993
71060	chr8	27151632	T	A	chr8:27151632	TRIM35	tripartite motif containing 35	SNV	0/1	0.36	75_42	118	99.0	0/1	0.43	55_42	97	99.0			rs149727000,COSV100542641	EXONIC	YES	NM_171982.5	Transcript	protein_coding	missense_variant		3/6	NM_171982.5:c.727A>T	NP_741983.2:p.Met243Leu		-1.0	.,.					.	.	.		0.00506657	771.0	152174.0	5.0	32	0.97	PASS	nfe	0.00682032	464.0	0.00682032	464.0	0.0050757	1276.0	251394.0	5.0	60	1.0	PASS	nfe	0.00670255	762.0	0.00670255	762.0	0.0049388	768	0.004	13.0				15.27	1.316043	0.049	0	18	18		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TRIM35	0.0	0.0	0.0	0.0	-41.0	0.0	31.0	-35.0						0.598	0.0	0.000000000	0.988	-0.199	.			atrioventricular node;trigeminal ganglion;	.	apoptotic process;positive regulation of apoptotic process;innate immune response;negative regulation of mitotic cell cycle;negative regulation of viral release from host cell	nucleus;cytoplasm	molecular_function;zinc ion binding	KANK2[unassigned1304];HIP2[19549727];TSG101[19549727];SHC3[unassigned1304];SMARCB1[unassigned1304];UBE2D4[19549727];UBE2D2[19549727];UBE2D3[19549727];CABP2[unassigned1304];UBE2D1[19549727];DTX2[unassigned1304];NRF1[unassigned1304];LOC151121[unassigned1304];PPP2CA[unassigned1304];PARD6B[unassigned1304];PHF24[unassigned1304];PRR20D[unassigned1304];BANP[unassigned1304];ENKD1[unassigned1304];LMO1[unassigned1304];PRKAB2[unassigned1304];TCEANC[unassigned1304];ADIPOQ[unassigned1304];GNMT[unassigned1304];UBE2W[19549727];TRAPPC6A[unassigned1304];QARS[unassigned1304];LCK[unassigned1304];UBE2U[19690564];HNRNPA2B1[unassigned1304];COL8A1[unassigned1304];TSSK3[unassigned1304];UBE2K[unassigned1304];TRIM10[unassigned1304];TRIM11[22493164];ZNF410[unassigned1304];	27151632
71085	chr8	30890253	C	T	chr8:30890253	PURG	purine rich element binding protein G	SNV	0/1	0.55	30_36	66	99.0	0/0	0.0	33_0	33	99.0				EXONIC	YES	NM_001323311.2	Transcript	protein_coding	missense_variant		2/2	NM_001323311.2:c.46G>A	NP_001310240.1:p.Gly16Arg		-1.0	.,.,.					.	.	.						32	0.95											6	0.19														23.3	2.875381	0.404	5	14	19	SIFT,M-CAP_pred,MutationTaster_pred,PrimateAI_pred,fathmm-MKL_coding_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	PURG	0.0	0.0	0.0	0.0	45.0	-41.0	-3.0	-11.0						0.145	0.93		1.0	0.947	.			ciliary ganglion;superior cervical ganglion;atrioventricular node;parietal lobe;	.	negative regulation of transcription by RNA polymerase II	nucleus	RNA polymerase II regulatory region sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;double-stranded DNA binding;RNA binding;purine-rich negative regulatory element binding;sequence-specific DNA binding	.	30890253
71090	chr8	30938513	A	G	chr8:30938513	WRN	Werner syndrome RecQ like helicase	SNV	0/1	0.23	17_5	22	99.0	0/0	0.0	41_0	41	99.0			rs1800390,COSV104591464	EXONIC	YES	NM_000553.6	Transcript	protein_coding	missense_variant		9/35	NM_000553.6:c.970A>G	NP_000544.2:p.Thr324Ala		1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Malignant_tumor_of_breast|Werner_syndrome|not_specified|not_provided	Werner syndrome, 277700 (3), Autosomal recessive	Werner syndrome	Disease-causing germline mutation(s) in	Meningioma;Progeroid facial appearance;Scleroderma;Convex nasal ridge;Osteoporosis;Short stature;Abnormal hair morphology;Diabetes mellitus;Osteosarcoma;Retinal degeneration;Premature arteriosclerosis;Hypogonadism;Cataract;Subcutaneous calcification;Autosomal recessive inheritance;Slender build;Neoplasm of the small intestine;Chondrocalcinosis;Congestive heart failure;Hyperkeratosis;Squamous cell carcinoma;Gastrointestinal carcinoma;Telangiectasia of the skin;Sparse scalp hair;Spontaneous abortion;Pulmonary artery stenosis;Type II diabetes mellitus;Osteoporosis;Convex nasal ridge;Atherosclerosis;Decreased fertility;Small hand;Neoplasm of the lung;Aplasia/Hypoplasia of the testes;Laryngomalacia;White forelock;Skeletal muscle atrophy;Pili torti;Short stature;Renal neoplasm;Rocker bottom foot;Increased bone mineral density;Cataract;Lack of skin elasticity;Breast carcinoma;Abnormality of the cerebral vasculature;Meningioma;Abnormal hair whorl;Hypertension;Aplasia/Hypoplasia of the skin;Acral lentiginous melanoma;Hypogonadism;Thyroid carcinoma;Abnormality of retinal pigmentation;Secondary amenorrhea;Premature graying of hair;Subcutaneous calcification;Insulin resistance;Myocardial infarction;Sarcoma;Joint stiffness;Lipoatrophy;Ovarian neoplasm;Skin ulcer;Abnormality of the voice;Abnormality of the thorax;Neoplasm of the oral cavity;Narrow face	24728327,16786514	0.00269382	410.0	152200.0	2.0	32	0.97	PASS	sas	0.0084851	41.0	0.00380748	259.0	0.00356955	897.0	251292.0	9.0	86	1.0	PASS	sas	0.00904874	277.0	0.00418889	476.0	0.0034983	544	0.004	12.0	0.00492	56.0		0.106	-0.475098	0.037	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	WRN	0.07	0.0	0.0	0.0	-5.0	21.0	-5.0	-19.0						0.988	0.0	0.000000000	0.355	-0.376	neoplasm; hematopoietic system phenotype; cardiovascular system phenotype ; reproductive system phenotype; mortality/aging ; vision/eye phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype ; growth/size/body region phenotype; integument phenotype ; craniofacial phenotype; 			skeletal muscle;	.	telomere maintenance;double-strand break repair via homologous recombination;DNA synthesis involved in DNA repair;replicative cell aging;DNA metabolic process;DNA replication;DNA repair;base-excision repair;double-strand break repair;DNA recombination;cellular response to DNA damage stimulus;response to oxidative stress;brain development;aging;cell aging;determination of adult lifespan;cellular response to starvation;response to UV-C;multicellular organism aging;replication fork processing;DNA duplex unwinding;regulation of growth rate;regulation of apoptotic process;G-quadruplex DNA unwinding;positive regulation of hydrolase activity;telomeric D-loop disassembly;cellular response to gamma radiation;nucleic acid phosphodiester bond hydrolysis;t-circle formation;positive regulation of strand invasion;protein localization to nucleolus	chromosome, telomeric region;nucleus;nucleoplasm;replication fork;DNA replication factor A complex;chromosome;nucleolus;cytoplasm;centrosome;nuclear speck;site of double-strand break;neuron projection	magnesium ion binding;four-way junction DNA binding;Y-form DNA binding;bubble DNA binding;DNA binding;DNA helicase activity;chromatin binding;ATP-dependent DNA helicase activity;helicase activity;exonuclease activity;protein binding;ATP binding;3'-5' exonuclease activity;four-way junction helicase activity;ATPase activity;manganese ion binding;MutLalpha complex binding;protein homodimerization activity;3'-5' DNA helicase activity;ATP-dependent 3'-5' DNA helicase activity;protein-containing complex binding;G-quadruplex DNA binding;forked DNA-dependent helicase activity;telomeric D-loop binding;telomeric G-quadruplex DNA binding;3'-flap-structured DNA binding;8-hydroxy-2'-deoxyguanosine DNA binding	VCP[15037256];BLM[11919194];FEN1[11598021;14688284;14657243];WDR48[19615732];ARL3[27173435;unassigned1312];SUV39H1[25931448];BRCA1[29656893];WRN[10783163];UBC[18588880];NLRP2[15733840];E2F3[22157815];POLL[27173435;unassigned1312];CTNNBL1[30021884];TMPO[25931448];XRCC6[10783163;14734561;11328876;26496610];CREBBP[18203716];SUPT16H[unassigned1312];CBX5[25931448];PARP1[14734561;14596914];XRCC5[10783163;14734561;11328876;21679440;26496610];H2AFX[15733840;20802463];TINF2[26496610];RPA1[10373438;15965237;15735006;24126761];RPA2[20802463;24126761];TERF2[12181313];SIRT1[19343720;18203716];RAD52[12750383];RAD51[18562274];RPA3[24126761;unassigned1312];TP53[11427532;15735006];	30938513
71092	chr8	30945421	G	C	chr8:30945421	WRN	Werner syndrome RecQ like helicase	SNV	0/0	0.0	5_0	5	15.0	0/1	0.5	1_2	4	26.0			COSV53301969	EXONIC	YES	NM_000553.6	Transcript	protein_coding	missense_variant		12/35	NM_000553.6:c.1561G>C	NP_000544.2:p.Glu521Gln		1.0					Werner syndrome, 277700 (3), Autosomal recessive	Werner syndrome	Disease-causing germline mutation(s) in	Meningioma;Progeroid facial appearance;Scleroderma;Convex nasal ridge;Osteoporosis;Short stature;Abnormal hair morphology;Diabetes mellitus;Osteosarcoma;Retinal degeneration;Premature arteriosclerosis;Hypogonadism;Cataract;Subcutaneous calcification;Autosomal recessive inheritance;Slender build;Neoplasm of the small intestine;Chondrocalcinosis;Congestive heart failure;Hyperkeratosis;Squamous cell carcinoma;Gastrointestinal carcinoma;Telangiectasia of the skin;Sparse scalp hair;Spontaneous abortion;Pulmonary artery stenosis;Type II diabetes mellitus;Osteoporosis;Convex nasal ridge;Atherosclerosis;Decreased fertility;Small hand;Neoplasm of the lung;Aplasia/Hypoplasia of the testes;Laryngomalacia;White forelock;Skeletal muscle atrophy;Pili torti;Short stature;Renal neoplasm;Rocker bottom foot;Increased bone mineral density;Cataract;Lack of skin elasticity;Breast carcinoma;Abnormality of the cerebral vasculature;Meningioma;Abnormal hair whorl;Hypertension;Aplasia/Hypoplasia of the skin;Acral lentiginous melanoma;Hypogonadism;Thyroid carcinoma;Abnormality of retinal pigmentation;Secondary amenorrhea;Premature graying of hair;Subcutaneous calcification;Insulin resistance;Myocardial infarction;Sarcoma;Joint stiffness;Lipoatrophy;Ovarian neoplasm;Skin ulcer;Abnormality of the voice;Abnormality of the thorax;Neoplasm of the oral cavity;Narrow face						32	0.97											79	0.99														12.35	0.851722	0.021	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	WRN	0.0	0.0	0.0	0.01	-14.0	-41.0	5.0	27.0						0.988	0.0	14.661465370	0.054	0.227	neoplasm; hematopoietic system phenotype; cardiovascular system phenotype ; reproductive system phenotype; mortality/aging ; vision/eye phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; skeleton phenotype; immune system phenotype; homeostasis/metabolism phenotype; cellular phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype ; growth/size/body region phenotype; integument phenotype ; craniofacial phenotype; 			skeletal muscle;	.	telomere maintenance;double-strand break repair via homologous recombination;DNA synthesis involved in DNA repair;replicative cell aging;DNA metabolic process;DNA replication;DNA repair;base-excision repair;double-strand break repair;DNA recombination;cellular response to DNA damage stimulus;response to oxidative stress;brain development;aging;cell aging;determination of adult lifespan;cellular response to starvation;response to UV-C;multicellular organism aging;replication fork processing;DNA duplex unwinding;regulation of growth rate;regulation of apoptotic process;G-quadruplex DNA unwinding;positive regulation of hydrolase activity;telomeric D-loop disassembly;cellular response to gamma radiation;nucleic acid phosphodiester bond hydrolysis;t-circle formation;positive regulation of strand invasion;protein localization to nucleolus	chromosome, telomeric region;nucleus;nucleoplasm;replication fork;DNA replication factor A complex;chromosome;nucleolus;cytoplasm;centrosome;nuclear speck;site of double-strand break;neuron projection	magnesium ion binding;four-way junction DNA binding;Y-form DNA binding;bubble DNA binding;DNA binding;DNA helicase activity;chromatin binding;ATP-dependent DNA helicase activity;helicase activity;exonuclease activity;protein binding;ATP binding;3'-5' exonuclease activity;four-way junction helicase activity;ATPase activity;manganese ion binding;MutLalpha complex binding;protein homodimerization activity;3'-5' DNA helicase activity;ATP-dependent 3'-5' DNA helicase activity;protein-containing complex binding;G-quadruplex DNA binding;forked DNA-dependent helicase activity;telomeric D-loop binding;telomeric G-quadruplex DNA binding;3'-flap-structured DNA binding;8-hydroxy-2'-deoxyguanosine DNA binding	VCP[15037256];BLM[11919194];FEN1[11598021;14688284;14657243];WDR48[19615732];ARL3[27173435;unassigned1312];SUV39H1[25931448];BRCA1[29656893];WRN[10783163];UBC[18588880];NLRP2[15733840];E2F3[22157815];POLL[27173435;unassigned1312];CTNNBL1[30021884];TMPO[25931448];XRCC6[10783163;14734561;11328876;26496610];CREBBP[18203716];SUPT16H[unassigned1312];CBX5[25931448];PARP1[14734561;14596914];XRCC5[10783163;14734561;11328876;21679440;26496610];H2AFX[15733840;20802463];TINF2[26496610];RPA1[10373438;15965237;15735006;24126761];RPA2[20802463;24126761];TERF2[12181313];SIRT1[19343720;18203716];RAD52[12750383];RAD51[18562274];RPA3[24126761;unassigned1312];TP53[11427532;15735006];	30945421
71126	chr8	32505910	AG		chr8:32505910-32505911	NRG1	neuregulin 1	deletion	0/1	0.15	42_8	53	99.0	0/1	0.22	39_11	50	99.0			rs146965117	SPLICING	YES	NM_001322205.2	Transcript	protein_coding	splice_region_variant,intron_variant	1/8		NM_001322205.2:c.667+22_667+23del			1.0					{?Schizophrenia, susceptibility to}, 603013 (1)	Hereditary thrombophilia due to congenital histidine-rich (poly-L) glycoprotein deficiency	Disease-causing germline mutation(s) in	Autosomal dominant inheritance;Recurrent thromboembolism;Hypercoagulability		0.000342158	51.0	149054.0	0.0	31	0.94	PASS	nfe	0.000328525	22.0	0.000328525	22.0	0.177657	21306.0	119928.0	0.0	36	0.86	InbreedingCoeff_RF	sas	0.240749	3396.0	0.170444	9506.0	0.0001929,0.0007460,0.1270321	30,116,19754			0.26604	2952.0		17.05	1.632465		0	0	0																	0.325	0.95				homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; growth/size/body region phenotype; integument phenotype ; endocrine/exocrine gland phenotype; respiratory system phenotype; behavior/neurological phenotype ; nervous system phenotype ; vision/eye phenotype; cardiovascular system phenotype ; reproductive system phenotype; mortality/aging ; embryo phenotype; 			ciliary ganglion;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;testis;skeletal muscle;	ErbB signaling pathway	MAPK cascade;activation of MAPK activity;cell morphogenesis;cardiac conduction system development;ventricular trabecula myocardium morphogenesis;cell communication;activation of transmembrane receptor protein tyrosine kinase activity;nervous system development;synapse assembly;locomotory behavior;positive regulation of cell population proliferation;regulation of signaling receptor activity;positive regulation of gene expression;neural crest cell development;peptidyl-tyrosine phosphorylation;glial cell fate commitment;chemorepulsion involved in interneuron migration from the subpallium to the cortex;myelination in peripheral nervous system;mammary gland development;activation of protein kinase B activity;intracellular signal transduction;ERBB signaling pathway;ERBB2 signaling pathway;ERBB3 signaling pathway;wound healing;negative regulation of protein catabolic process;regulation of protein homodimerization activity;regulation of protein heterodimerization activity;neurotransmitter receptor metabolic process;negative regulation of transcription, DNA-templated;positive regulation of Ras protein signal transduction;phosphatidylinositol phosphorylation;neuron fate commitment;oligodendrocyte differentiation;negative regulation of secretion;positive regulation of striated muscle cell differentiation;positive regulation of protein kinase B signaling;cardiac muscle cell differentiation;cardiac muscle cell myoblast differentiation;endocardial cell differentiation;positive regulation of protein tyrosine kinase activity;positive regulation of calcineurin-NFAT signaling cascade;postsynapse to nucleus signaling pathway;regulation of cell motility;positive regulation of cardiac muscle cell differentiation;negative regulation of neuron migration	extracellular region;extracellular space;nucleoplasm;cytoplasm;integral component of plasma membrane;membrane;axon;neuromuscular junction;glutamatergic synapse;GABA-ergic synapse	transcription coregulator activity;protein tyrosine kinase activity;Ras guanyl-nucleotide exchange factor activity;signaling receptor binding;cytokine activity;ErbB-2 class receptor binding;integrin binding;growth factor activity;protein tyrosine kinase activator activity;transmembrane receptor protein tyrosine kinase activator activity;receptor tyrosine kinase binding;ErbB-3 class receptor binding;chemorepellent activity;phosphatidylinositol-4,5-bisphosphate 3-kinase activity	LAPTM4B[unassigned1304];JAGN1[unassigned1304];CD72[unassigned1304];ERBB3[7592681;17697999];TMEM54[unassigned1304];ERBB2[7592681];PLP1[unassigned1304];CDC5L[20467437];HIST1H2BH[30021884];EGFR[24658140];ASGR2[unassigned1304];MS4A4A[unassigned1304];	32505909
71165	chr8	37689093	G	A	chr8:37689093	ADGRA2	adhesion G protein-coupled receptor A2	SNV	0/0	0.0	33_0	33	99.0	0/1	0.43	52_40	93	99.0			rs142198191	EXONIC	YES	NM_032777.10	Transcript	protein_coding	missense_variant		8/19	NM_032777.10:c.1085G>A	NP_116166.9:p.Arg362His		1.0	.,GPCR, family 2, extracellular hormone receptor domain					.	.	.		1.31399e-05	2.0	152208.0	0.0	33	0.98	PASS	amr	6.5445e-05	1.0	1.46972e-05	1.0	3.19803e-05	8.0	250154.0	0.0	49	0.98	PASS	afr	0.000123655	2.0	2.66033e-05	3.0	0.0000386	6						26.1	3.775884	0.497	14	6	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	LRT_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	ADGRA2	0.0	0.0	0.0	0.0	-43.0	12.0	12.0	13.0								0.000000000	0.817	1.176	craniofacial phenotype; growth/size/body region phenotype; normal phenotype; digestive/alimentary phenotype; nervous system phenotype ; embryo phenotype; respiratory system phenotype; cardiovascular system phenotype ; mortality/aging ; 			.	.	sprouting angiogenesis;G protein-coupled receptor signaling pathway;central nervous system development;positive regulation of endothelial cell migration;Wnt signaling pathway;endothelial cell migration;regulation of angiogenesis;regulation of chemotaxis;regulation of establishment of blood-brain barrier;positive regulation of canonical Wnt signaling pathway;negative regulation of vascular endothelial growth factor signaling pathway	plasma membrane;cell surface;integral component of membrane;filopodium;Wnt signalosome	G protein-coupled receptor activity;protein binding	DLG1[15021905;24550280];CCNDBP1[unassigned1304];	37689093
71214	chr8	38677369	G	T	chr8:38677369	TACC1	transforming acidic coiled-coil containing protein 1	SNV	0/1	0.48	63_58	122	99.0	0/0	0.0	33_0	33	99.0			COSV52526622,COSV52529943	EXONIC	YES	NM_001352778.2	Transcript	protein_coding	missense_variant		5/15	NM_001352778.2:c.655G>T	NP_001339707.1:p.Val219Phe		1.0	.,.,.,.,.,.,.,.,.,.					Gliosarcoma;Giant cell glioblastoma	Part of a fusion gene in;Part of a fusion gene in	.						32	0.97											87	0.99														11.65	0.761794	0.042	2	16	18	MutationAssessor_pred,PROVEAN_pred	Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	TACC1	0.0	0.0	0.0	0.0	-49.0	37.0	-2.0	-1.0						0.755	0.02	19.863609894	0.284	1.172	.			amygdala;olfactory bulb;occipital lobe;subthalamic nucleus;prefrontal cortex;dorsal root ganglion;atrioventricular node;cingulate cortex;superior cervical ganglion;parietal lobe;	.	microtubule cytoskeleton organization;mitotic spindle organization;cell population proliferation;cerebral cortex development;cell division	nucleus;cytoplasm;microtubule organizing center;membrane;midbody	protein binding	KDM1A[23455924];SH2D4A[25416956;unassigned1304];THRA[unassigned1304];PLGRKT[29568061];MGST3[29568061];HTT[23275563;17500595];YEATS4[11903063];LYST[26496610];TOMM20[29568061];AURKB[15064709];ZNF48[unassigned1304];AURKA[14603251];TOMM22[29568061];BAIAP2L1[26496610];TUBA1A[27291054];RB1CC1[26496610];STX5[25416956];COX14[29568061];BTRC[25416956;26871637;unassigned1304];BRD3[26496610];ZFHX3[unassigned1304];THAP12[25416956;unassigned1304];TDRD7[14603251];MEMO1[21516116;25416956;unassigned1304];CKAP5[14603251;11903063;26496610];LSM7[14603251;12165861];VAPA[26496610];ERCC4[unassigned1304];CANX[29568061];SNRPG[14603251;12165861];TACC2[26496610];FAM50B[unassigned1304];	38677369
71277	chr8	41529994	G	A	chr8:41529994	ANK1	ankyrin 1	SNV	0/1	0.46	82_71	153	99.0	0/0	0.0	39_0	39	99.0			rs149859024,COSV55885635	EXONIC	YES	NM_001142446.2	Transcript	protein_coding	synonymous_variant		39/43	NM_001142446.2:c.5097C>T	NP_001135918.1:p.Asp1699%3D		-1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Spherocytosis|Spherocytosis_type_1|not_specified|not_provided	Spherocytosis, type 1, 182900 (3), Autosomal recessive, Autosomal dominant	8p11.2 deletion syndrome;Hereditary spherocytosis	Role in the phenotype of;Disease-causing germline mutation(s) in	Patent ductus arteriosus;Seizure;Iris coloboma;Nystagmus;Atrial septal defect;Short stature;Micrognathia;Epicanthus;Mitral valve prolapse;Microcephaly;Abnormality of the hypothalamus-pituitary axis;Retinal dystrophy;Preauricular pit;Splenomegaly;Hypogonadotropic hypogonadism;Anosmia;Global developmental delay;Cryptorchidism;Blepharophimosis;Intellectual disability;Feeding difficulties;Hypertelorism;High palate;Sacral dimple;Azoospermia;Spherocytosis;Talipes equinovarus;Microcornea;Supernumerary ribs;Hypoplasia of penis;External ear malformation;Depressed nasal bridge;Upslanted palpebral fissure;Hemolytic anemia;Restrictive cardiomyopathy;Pallor;Abdominal pain;Fever;Hypercoagulability;Growth delay;Reticulocytosis;Extramedullary hematopoiesis;Spherocytosis;Chills;Jaundice;Hepatomegaly;Abdominal distention;Ataxia;Myalgia;Gout;Splenomegaly;Hypofibrinogenemia;Muscle weakness;Maculopapular exanthema;Cholelithiasis;Spontaneous hemolytic crises;Increased red cell osmotic fragility;Increased mean corpuscular hemoglobin concentration;Skin ulcer;Hyperbilirubinemia;Autosomal dominant inheritance;Cholelithiasis;Hemolytic anemia;Splenomegaly;Reticulocytosis;Hyperbilirubinemia;Autosomal recessive inheritance;Spherocytosis;Jaundice	25741868	0.00435	662.0	152184.0	1.0	33	0.97	PASS	nfe	0.00740893	504.0	0.00740893	504.0	0.00405182	1019.0	251492.0	5.0	100	1.0	PASS	nfe	0.00651326	741.0	0.00651326	741.0	0.0038134	593	0.003	10.0	0.00237	27.0		7.317	0.308214		0	0	0			ANK1	0.03	0.0	0.02	0.0	-50.0	50.0	47.0	-7.0						0.109	1.0	0.000000000			liver/biliary system phenotype; behavior/neurological phenotype ; reproductive system phenotype; mortality/aging ; hematopoietic system phenotype; cardiovascular system phenotype ; pigmentation phenotype; nervous system phenotype ; immune system phenotype; skeleton phenotype; renal/urinary system phenotype; integument phenotype ; growth/size/body region phenotype; endocrine/exocrine gland phenotype; muscle phenotype; homeostasis/metabolism phenotype; 			ciliary ganglion;pons;tongue;superior cervical ganglion;trigeminal ganglion;fetal liver;skeletal muscle;cerebellum peduncles;cerebellum;bone marrow;medulla oblongata;	.	exocytosis;endoplasmic reticulum to Golgi vesicle-mediated transport;cytoskeleton organization;signal transduction;positive regulation of organelle organization;maintenance of epithelial cell apical/basal polarity;protein localization to plasma membrane	nucleus;cytosol;cytoskeleton;plasma membrane;cytoplasmic side of plasma membrane;spectrin-associated cytoskeleton;membrane;basolateral plasma membrane;sarcoplasmic reticulum;Z disc;axolemma;M band;sarcolemma;axon initial segment;postsynaptic membrane	structural molecule activity;structural constituent of cytoskeleton;protein binding;cytoskeletal adaptor activity;enzyme binding;protein phosphatase binding;spectrin binding;ion channel binding;ATPase binding	OBSCN[12527750;16962094;25416956];SLC30A8[unassigned1304];TMEM203[unassigned1304];FXYD3[unassigned1304];DWORF[unassigned1304];NRM[unassigned1304];HSPB1[25277244];EMP1[unassigned1304];RBFA[unassigned1304];EMD[unassigned1304];	41529994
71282	chr8	41573266	G	A	chr8:41573266	ANK1	ankyrin 1	SNV	0/0	0.0	35_0	35	99.0	0/1	0.5	56_58	115	99.0			rs34387324	EXONIC	YES	NM_001142446.2	Transcript	protein_coding	synonymous_variant		14/43	NM_001142446.2:c.1605C>T	NP_001135918.1:p.Ala535%3D		-1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Spherocytosis|Spherocytosis_type_1|not_specified|not_provided	Spherocytosis, type 1, 182900 (3), Autosomal recessive, Autosomal dominant	8p11.2 deletion syndrome;Hereditary spherocytosis	Role in the phenotype of;Disease-causing germline mutation(s) in	Patent ductus arteriosus;Seizure;Iris coloboma;Nystagmus;Atrial septal defect;Short stature;Micrognathia;Epicanthus;Mitral valve prolapse;Microcephaly;Abnormality of the hypothalamus-pituitary axis;Retinal dystrophy;Preauricular pit;Splenomegaly;Hypogonadotropic hypogonadism;Anosmia;Global developmental delay;Cryptorchidism;Blepharophimosis;Intellectual disability;Feeding difficulties;Hypertelorism;High palate;Sacral dimple;Azoospermia;Spherocytosis;Talipes equinovarus;Microcornea;Supernumerary ribs;Hypoplasia of penis;External ear malformation;Depressed nasal bridge;Upslanted palpebral fissure;Hemolytic anemia;Restrictive cardiomyopathy;Pallor;Abdominal pain;Fever;Hypercoagulability;Growth delay;Reticulocytosis;Extramedullary hematopoiesis;Spherocytosis;Chills;Jaundice;Hepatomegaly;Abdominal distention;Ataxia;Myalgia;Gout;Splenomegaly;Hypofibrinogenemia;Muscle weakness;Maculopapular exanthema;Cholelithiasis;Spontaneous hemolytic crises;Increased red cell osmotic fragility;Increased mean corpuscular hemoglobin concentration;Skin ulcer;Hyperbilirubinemia;Autosomal dominant inheritance;Cholelithiasis;Hemolytic anemia;Splenomegaly;Reticulocytosis;Hyperbilirubinemia;Autosomal recessive inheritance;Spherocytosis;Jaundice	25741868	0.00392118	597.0	152250.0	6.0	33	0.98	PASS	nfe	0.00653989	445.0	0.00653989	445.0	0.00390516	982.0	251462.0	3.0	100	1.0	PASS	nfe	0.00687448	782.0	0.00687448	782.0	0.0040964	637	0.005	16.0	0.00421	48.0		1.719	-0.069197		0	0	0			ANK1	0.0	0.0	0.0	0.0	-26.0	-7.0	-26.0	-28.0						0.109	1.0	4.668241250			liver/biliary system phenotype; behavior/neurological phenotype ; reproductive system phenotype; mortality/aging ; hematopoietic system phenotype; cardiovascular system phenotype ; pigmentation phenotype; nervous system phenotype ; immune system phenotype; skeleton phenotype; renal/urinary system phenotype; integument phenotype ; growth/size/body region phenotype; endocrine/exocrine gland phenotype; muscle phenotype; homeostasis/metabolism phenotype; 			ciliary ganglion;pons;tongue;superior cervical ganglion;trigeminal ganglion;fetal liver;skeletal muscle;cerebellum peduncles;cerebellum;bone marrow;medulla oblongata;	.	exocytosis;endoplasmic reticulum to Golgi vesicle-mediated transport;cytoskeleton organization;signal transduction;positive regulation of organelle organization;maintenance of epithelial cell apical/basal polarity;protein localization to plasma membrane	nucleus;cytosol;cytoskeleton;plasma membrane;cytoplasmic side of plasma membrane;spectrin-associated cytoskeleton;membrane;basolateral plasma membrane;sarcoplasmic reticulum;Z disc;axolemma;M band;sarcolemma;axon initial segment;postsynaptic membrane	structural molecule activity;structural constituent of cytoskeleton;protein binding;cytoskeletal adaptor activity;enzyme binding;protein phosphatase binding;spectrin binding;ion channel binding;ATPase binding	OBSCN[12527750;16962094;25416956];SLC30A8[unassigned1304];TMEM203[unassigned1304];FXYD3[unassigned1304];DWORF[unassigned1304];NRM[unassigned1304];HSPB1[25277244];EMP1[unassigned1304];RBFA[unassigned1304];EMD[unassigned1304];	41573266
71322	chr8	42798560	C	T	chr8:42798560	HOOK3	hook microtubule tethering protein 3	SNV	0/1	0.35	36_19	55	99.0	0/0	0.0	34_0	34	99.0			rs779857594	EXONIC	YES	NM_032410.4	Transcript	protein_coding	synonymous_variant		5/22	NM_032410.4:c.372C>T	NP_115786.1:p.Gly124%3D		1.0						.	.	.		2.62978e-05	4.0	152104.0	0.0	32	0.95	PASS	afr	4.82952e-05	2.0	2.93997e-05	2.0	3.62161e-05	8.0	220896.0	0.0	29	0.6	PASS	afr	6.57808e-05	1.0	5.69573e-05	6.0	0.0000386	6						11.77	0.7774		0	0	0			HOOK3	0.0	0.0	0.0	0.0	-1.0	-31.0	42.0	28.0						0.17	1.0	70.600993745			skeleton phenotype; limbs/digits/tail phenotype; hematopoietic system phenotype; respiratory system phenotype; behavior/neurological phenotype ; homeostasis/metabolism phenotype; growth/size/body region phenotype; adipose tissue phenotype ; 			.	Glycolysis / Gluconeogenesis;Fructose and mannose metabolism;Galactose metabolism;Starch and sucrose metabolism;Streptomycin biosynthesis;Aminosugars metabolism	endosome organization;lysosome organization;endosome to lysosome transport;protein transport;interkinetic nuclear migration;cytoskeleton-dependent intracellular transport;cytoplasmic microtubule organization;microtubule anchoring at centrosome;early endosome to late endosome transport;negative regulation of neurogenesis;Golgi localization;protein localization to centrosome;neuronal stem cell population maintenance	pericentriolar material;cytoplasm;cis-Golgi network;centrosome;cytosol;microtubule;HOPS complex;centriolar satellite;FHF complex	protein binding;microtubule binding;dynactin binding;identical protein binding;dynein light chain binding;dynein intermediate chain binding;dynein light intermediate chain binding	TGOLN2[29568061];MSR1[17237231];CTIF[unassigned1304];HOOK1[unassigned1304];KRT27[unassigned1304];AKTIP[23414517];KRT13[unassigned1304];PNMA5[unassigned1304];CEP63[26638075];MEOX2[unassigned1304];SSX2IP[26638075];	42798560
71362	chr8	48650410	C	G	chr8:48650410	CEBPD	CCAAT enhancer binding protein delta	SNV	0/1	0.62	19_32	52	99.0	0/0	0.0	36_0	36	99.0			rs113725090	EXONIC	YES	NM_005195.4	Transcript	protein_coding	missense_variant		1/1	NM_005195.4:c.273G>C	NP_005186.2:p.Lys91Asn		-1.0						.	.	.		0.000212625	32.0	150500.0	0.0	32	0.94	PASS	nfe	0.000400403	27.0	0.000400403	27.0	0.000173471	27.0	155646.0	0.0	13	0.27	PASS	nfe	0.000346558	25.0	0.000346558	25.0	0.0000900	14						17.19	1.654459	0.1	2	17	19	M-CAP_pred,PrimateAI_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CEBPD	0.01	0.0	0.0	0.0	9.0	-1.0	11.0	0.0							0.54	0.000000000	0.978	0.062	renal/urinary system phenotype; immune system phenotype; behavior/neurological phenotype ; respiratory system phenotype; integument phenotype ; mortality/aging ; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			.	.	transcription by RNA polymerase II;cytokine-mediated signaling pathway;positive regulation of transcription by RNA polymerase II	nucleoplasm	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;protein binding	CEBPA[20102225];CEBPB[20102225];BATF3[20102225];CEBPD[20102225];SPAG5[20805509];CEBPG[20102225];IPO4[20805509];BATF[20102225];XPO1[20805509];FANCD2[20805509];DDIT3[20102225];UBR5[20805509];TRIM26[20805509];ATF4[20102225];	48650410
71405	chr8	49986690	A	G	chr8:49986690	C8orf22		SNV	0/0	0.0	36_0	36	99.0	0/1	0.18	28_6	34	87.0			rs184442562	EXONIC	YES	NM_001256598.2	Transcript	protein_coding	missense_variant		3/5	NM_001256598.2:c.128A>G	NP_001243527.1:p.Gln43Arg		1.0	.,.,.,.									0.00154362	235.0	152240.0	1.0	33	0.98	PASS	nfe	0.00246928	168.0	0.00246928	168.0	0.00130912	326.0	249022.0	2.0	65	0.99	PASS	sas	0.00206084	63.0	0.00194873	220.0	0.0012733	198	0.003	9.0				7.935	0.358517	0.035	0	15	15		SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	C8orf22	0.02	0.0	0.0	0.0	-15.0	2.0	0.0	2.0						0.66	0.38	0.000000000	0.962	1.118										49986690
71415	chr8	52733076	T	C	chr8:52733076	PCMTD1	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1	SNV	0/0	0.0	73_0	73	0.0	0/1	0.2	32_8	41	99.0			rs77409139,COSV62123303	EXONIC	YES	NM_052937.4	Transcript	protein_coding	synonymous_variant		6/6	NM_052937.4:c.909A>G	NP_443169.2:p.Glu303%3D		-1.0						.	.	.						33	0.96							0.277768	46725.0	168216.0	3.0	50	0.98	InbreedingCoeff_RF	nfe	0.319159	25301.0	0.319159	25301.0	0.0012154	189						10.17	0.584336		0	0	0			PCMTD1	0.0	0.01	0.0	0.0	3.0	14.0	45.0	35.0						0.848	0.0				.			.	.	protein methylation	cytoplasm;membrane	protein-L-isoaspartate (D-aspartate) O-methyltransferase activity	JUN[25609649];SCHIP1[20195357];	52733076
71420	chr8	52733128	T	G	chr8:52733128	PCMTD1	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1	SNV	0/1	0.59	48_77	130	99.0	0/1	0.61	37_63	103	99.0			rs62506083,COSV62119079	EXONIC	YES	NM_052937.4	Transcript	protein_coding	missense_variant		6/6	NM_052937.4:c.857A>C	NP_443169.2:p.Asn286Thr		-1.0	.,.,.					.	.	.		0.0	0.0	152064.0	0.0	33	0.96	AC0				0.0	0.0	0.499884	120555.0	241166.0	139.0	68	1.0	InbreedingCoeff	amr	0.50054	16684.0	0.500156	54624.0	0.0077876	1211	0.108	323.0				21.1	2.15931	0.119	6	14	20	Polyphen2_HDIV_pred,LRT_pred,MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,Polyphen2_HVAR_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	PCMTD1	0.0	0.01	0.0	0.0	-45.0	-26.0	-17.0	-7.0						0.848	0.0		0.998	1.138	.			.	.	protein methylation	cytoplasm;membrane	protein-L-isoaspartate (D-aspartate) O-methyltransferase activity	JUN[25609649];SCHIP1[20195357];	52733128
71425	chr8	52733148	C	T	chr8:52733148	PCMTD1	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1	SNV	0/1	0.25	95_34	134	99.0	0/1	0.18	95_22	120	99.0			rs76104220,COSV62118975	EXONIC	YES	NM_052937.4	Transcript	protein_coding	synonymous_variant		6/6	NM_052937.4:c.837G>A	NP_443169.2:p.Lys279%3D		-1.0						.	.	.						33	0.96							0.407484	36742.0	90168.0	0.0	67	1.0	InbreedingCoeff	sas	0.428054	4843.0	0.399636	15390.0	0.0001801	28	0.041	131.0				11.1	0.693696		0	0	0			PCMTD1	0.0	0.0	0.0	0.0	50.0	-46.0	-37.0	-27.0						0.848	0.0				.			.	.	protein methylation	cytoplasm;membrane	protein-L-isoaspartate (D-aspartate) O-methyltransferase activity	JUN[25609649];SCHIP1[20195357];	52733148
71431	chr8	52733228	G	A	chr8:52733228	PCMTD1	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1	SNV	0/1	0.32	76_39	120	99.0	0/1	0.3	75_33	111	99.0			rs73592211,COSV62119714	EXONIC	YES	NM_052937.4	Transcript	protein_coding	missense_variant		6/6	NM_052937.4:c.757C>T	NP_443169.2:p.Arg253Cys		-1.0	.,.,.					.	.	.		6.57428e-06	1.0	152108.0	0.0	33	0.96	PASS	nfe	1.46998e-05	1.0	1.46998e-05	1.0	0.451148	78682.0	174404.0	0.0	69	1.0	InbreedingCoeff_RF	nfe	0.4608	38615.0	0.4608	38615.0	0.0016656	259	0.095	297.0				23.5	2.968995	0.519	8	10	18	LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	PCMTD1	0.0	0.01	0.0	0.0	-11.0	50.0	15.0	7.0						0.848	0.0		0.996	1.176	.			.	.	protein methylation	cytoplasm;membrane	protein-L-isoaspartate (D-aspartate) O-methyltransferase activity	JUN[25609649];SCHIP1[20195357];	52733228
71434	chr8	52733231	G	A	chr8:52733231	PCMTD1	protein-L-isoaspartate (D-aspartate) O-methyltransferase domain containing 1	SNV	0/1	0.19	87_22	114	99.0	0/1	0.22	84_24	110	99.0			rs75748152,COSV62119338	EXONIC	YES	NM_052937.4	Transcript	protein_coding	stop_gained		6/6	NM_052937.4:c.754C>T	NP_443169.2:p.Arg252Ter		-1.0	.,.,.					.	.	.						33	0.96							0.204033	25456.0	124764.0	0.0	66	1.0	InbreedingCoeff_RF	nfe	0.251062	13717.0	0.251062	13717.0	0.0004180	65	0.067	201.0				40.0	7.942069		5	1	6	LRT_pred,MutationTaster_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	fathmm-XF_coding_pred	PCMTD1	0.0	0.05	0.0	0.0	31.0	47.0	12.0	16.0						0.848	0.0		0.998	1.176	.			.	.	protein methylation	cytoplasm;membrane	protein-L-isoaspartate (D-aspartate) O-methyltransferase activity	JUN[25609649];SCHIP1[20195357];	52733231
71443	chr8	57080950		A	chr8:57080949-57080950	PLAG1	PLAG1 zinc finger	insertion	0/1	0.4	3_2	5	42.0	0/0	0.0	5_0	5	9.0			rs1023307529	SPLICING	YES	NM_002655.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	3/4		NM_002655.3:c.-117-5dup			-1.0					Adenomas, salivary gland pleomorphic, somatic, 181030 (3); Silver-Russell syndrome 4, 618907 (3), Autosomal dominant	Pleomorphic salivary gland adenoma	Part of a fusion gene in	Autosomal dominant inheritance;Somatic mutation;Salivary gland neoplasm		0.000153667	23.0	149674.0	0.0	32	0.97	PASS	afr	0.00046667	19.0	4.45461e-05	3.0					0	0.0							0.0007203,0.0013269	19,35			0.00011	1.0		17.25	1.664409		0	0	0			PLAG1	0.05	0.0	0.0	0.0	-4.0	30.0	-25.0	-4.0						0.102	0.83				reproductive system phenotype; embryo phenotype; vision/eye phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; 			ciliary ganglion;	.	transcription, DNA-templated;regulation of transcription, DNA-templated;negative regulation of gene expression;gland morphogenesis;multicellular organism growth;positive regulation of transcription by RNA polymerase II;positive regulation of glial cell proliferation;prostate gland growth	nucleus;nuclear speck	RNA polymerase II proximal promoter sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription activator activity, RNA polymerase II-specific;DNA binding;DNA-binding transcription factor activity;metal ion binding	SMAD3[15231748];ALB[15174051];	57080949
71516	chr8	69020558	C	T	chr8:69020558	PREX2	phosphatidylinositol-3,4,5-trisphosphate dependent Rac exchange factor 2	SNV	0/0	0.0	34_0	34	99.0	0/1	0.35	30_16	46	99.0			rs61753700,COSV55763767	EXONIC	YES	NM_024870.4	Transcript	protein_coding	missense_variant		24/40	NM_024870.4:c.2930C>T	NP_079146.2:p.Ser977Leu		1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00571169	869.0	152144.0	7.0	32	0.97	PASS	amr	0.00929806	142.0	0.00783524	533.0	0.0060939	1524.0	250086.0	15.0	35	0.95	PASS	nfe	0.00766548	866.0	0.00766548	866.0	0.0060256	937	0.013	42.0				21.5	2.220269	0.042	1	16	17	fathmm-MKL_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	PREX2	0.0	0.0	0.0	0.06	8.0	-46.0	-48.0	8.0						0.582	0.0	0.000000000	0.348	-0.929	growth/size/body region phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype ; nervous system phenotype ; 			temporal lobe;dorsal root ganglion;superior cervical ganglion;skeletal muscle;	.	G protein-coupled receptor signaling pathway;adult locomotory behavior;phosphatidylinositol 3-kinase signaling;regulation of Rho protein signal transduction;positive regulation of GTPase activity;dendrite morphogenesis	cytosol;plasma membrane	GTPase activator activity;Rac guanyl-nucleotide exchange factor activity	SMAD2[20195357];MYC[21150319];HIST1H2BH[30021884];MTOR[17565979];PPP1CA[19389623];	69020558
71550	chr8	70744856	G	A	chr8:70744856	SLCO5A1	solute carrier organic anion transporter family member 5A1	SNV	0/1	0.48	62_57	119	99.0	0/0	0.0	44_0	44	99.0			rs61730155,COSV52666337	EXONIC	YES	NM_030958.3	Transcript	protein_coding	missense_variant		2/10	NM_030958.3:c.53C>T	NP_112220.2:p.Pro18Leu		-1.0	.,.,.					.	.	.		0.00451303	687.0	152226.0	5.0	34	0.98	PASS	nfe	0.00812877	553.0	0.00812877	553.0	0.00402613	985.0	244652.0	2.0	44	0.94	PASS	nfe	0.00738011	823.0	0.00738011	823.0	0.0038649	601	0.005	17.0	0.00546	52.0		0.038	-0.613693	0.047	0	19	19		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SLCO5A1	0.0	0.0	0.0	0.0	-12.0	42.0	5.0	-27.0						0.772	0.0	0.000000000	0.0	-1.575	.			ciliary ganglion;appendix;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;	.	sodium-independent organic anion transport;transmembrane transport	integral component of plasma membrane	sodium-independent organic anion transmembrane transporter activity	HNRNPK[30021884];	70744856
71618	chr8	82615258	G	A	chr8:82615258	ZFAND1	zinc finger AN1-type containing 1	SNV	0/1	0.6	16_24	40	99.0	0/0	0.0	34_0	34	99.0			rs145427652	EXONIC	YES	NM_024699.3	Transcript	protein_coding	synonymous_variant		7/8	NM_024699.3:c.582C>T	NP_078975.2:p.Asp194%3D		-1.0						.	.	.		0.000716172	109.0	152198.0	0.0	33	0.97	PASS	amr	0.00124476	19.0	0.000705633	48.0	0.00101538	244.0	240304.0	0.0	20	0.51	PASS	nfe	0.00102046	111.0	0.00102046	111.0	0.0009903	154	0.002	7.0				10.47	0.618944		0	0	0			ZFAND1	0.0	0.0	0.0	0.0	1.0	18.0	-49.0	-48.0						0.255	0.0	36.386046693			.			thyroid;tumor;	.	cellular response to oxidative stress;cellular response to heat;stress granule disassembly;cellular response to osmotic stress;positive regulation of intracellular protein transport;cellular response to arsenite ion	cytoplasmic stress granule	protein binding;zinc ion binding;proteasome binding	GPR35[28298427];	82615258
71668	chr8	87556968	G	A	chr8:87556968	CPNE3	copine 3	SNV	0/1	0.62	8_15	24	99.0	0/0	0.0	24_0	24	72.0			rs139489122,COSV52209464	SPLICING	YES	NM_003909.5	Transcript	protein_coding	missense_variant,splice_region_variant		9/17	NM_003909.5:c.634G>A	NP_003900.1:p.Val212Met		1.0	C2 domain&C2 domain&C2 domain&Copine, C2B domain,C2 domain&C2 domain&C2 domain&Copine, C2B domain					.	.	.		0.00648965	984.0	151626.0	6.0	32	0.96	PASS	nfe	0.00854223	580.0	0.00854223	580.0	0.00825655	1475.0	178646.0	8.0	34	0.57	PASS	nfe	0.00997071	885.0	0.00997071	885.0	0.0071059	1105	0.009	29.0				33.0	4.810147	0.703	11	7	18	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	CPNE3	0.0	0.0	0.0	0.0	3.0	6.0	4.0	-1.0	0.998887455807114	0.918	8.693	0.718	9.411	0.943	0.0	0.000000000	1.0	1.176	.			ciliary ganglion;superior cervical ganglion;trigeminal ganglion;skeletal muscle;bone marrow;	.	protein phosphorylation;lipid metabolic process;vesicle-mediated transport;positive regulation of cell migration;ERBB2 signaling pathway;neutrophil degranulation;glycerophospholipid biosynthetic process;cellular response to calcium ion;cellular response to growth factor stimulus	nucleus;nucleolus;cytoplasm;mitochondrion;cytosol;plasma membrane;focal adhesion;cell junction;azurophil granule membrane;extracellular exosome	RNA binding;protein serine/threonine kinase activity;transporter activity;protein binding;calcium-dependent phospholipid binding;receptor tyrosine kinase binding;calcium-dependent protein binding	EIF5B[unassigned1312];GPI[unassigned1312];TRAP1[unassigned1312];PHF2[30021884];FEN1[30021884];USP42[19615732];EXOC8[30021884];TINF2[21044950];ANXA5[unassigned1312];CCDC146[30021884];SCLT1[26638075];PA2G4[unassigned1312];HSCB[28380382];HDAC8[23752268];TERF1[21044950];SND1[unassigned1312];HPGDS[30021884];SNW1[20467437];QARS[16169070];UBE2N[unassigned1312];TERF2IP[21044950];POT1[21044950];SNRPB2[unassigned1312];	87556968
71674	chr8	88885374	G	A	chr8:88885374	DCAF4L2	DDB1 and CUL4 associated factor 4 like 2	SNV	0/1	0.5	57_57	114	99.0	0/0	0.0	39_0	39	99.0			rs149030322	EXONIC	YES	NM_152418.4	Transcript	protein_coding	synonymous_variant		1/1	NM_152418.4:c.826C>T	NP_689631.1:p.Leu276%3D		-1.0						.	.	.		0.000768766	117.0	152192.0	0.0	32	0.97	PASS	sas	0.00206782	10.0	0.000999412	68.0	0.00122943	309.0	251336.0	3.0	89	1.0	PASS	sas	0.00261301	80.0	0.00114402	130.0	0.0010868	169	0.006	19.0				0.949	-0.158469		0	0	0			DCAF4L2	0.0	0.0	0.0	0.0	-16.0	8.0	10.0	-31.0						0.776	0.0	27.450840706			.			ciliary ganglion;testis - seminiferous tubule;trigeminal ganglion;superior cervical ganglion;placenta;	.	.	.	.	NUDC[25036637];	88885374
71789	chr8	99441203	C	T	chr8:99441203	KCNS2	potassium voltage-gated channel modifier subfamily S member 2	SNV	0/1	0.49	80_76	156	99.0	0/0	0.0	34_0	34	99.0			rs145439108,COSV54641837	EXONIC	YES	NM_020697.4	Transcript	protein_coding	synonymous_variant		2/2	NM_020697.4:c.996C>T	NP_065748.1:p.Leu332%3D		1.0						.	.	.		0.00338397	515.0	152188.0	0.0	32	0.97	PASS	nfe	0.00518828	353.0	0.00518828	353.0	0.00323998	814.0	251236.0	3.0	73	1.0	PASS	nfe	0.00459588	522.0	0.00459588	522.0	0.0032732	509	0.004	12.0				9.999	0.565439		0	0	0			KCNS2	0.0	0.0	0.0	0.0	38.0	-21.0	-12.0	15.0						0.0659	0.53	94.890354182			normal phenotype; 			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;	.	potassium ion transport;protein homooligomerization;potassium ion transmembrane transport;regulation of delayed rectifier potassium channel activity	plasma membrane;voltage-gated potassium channel complex;integral component of membrane;perinuclear region of cytoplasm	voltage-gated potassium channel activity;protein binding	CYSRT1[unassigned1304];FATE1[25416956;unassigned1304];NOTCH2NLA[unassigned1304];	99441203
71796	chr8	100454804	A	G	chr8:100454804	VPS13B	vacuolar protein sorting 13 homolog B	SNV	0/1	0.49	32_31	63	99.0	0/0	0.0	35_0	35	99.0			rs61759485	EXONIC	YES	NM_017890.5	Transcript	protein_coding	missense_variant		23/62	NM_017890.5:c.3386A>G	NP_060360.3:p.Lys1129Arg		1.0	.,.	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Cohen_syndrome|History_of_neurodevelopmental_disorder|not_specified|not_provided	Cohen syndrome, 216550 (3), Autosomal recessive	Cohen syndrome	Disease-causing germline mutation(s) in	Myopia;Intrauterine growth retardation;Kyphosis;Prominent nasal bridge;Iris coloboma;Sandal gap;Gingival overgrowth;Microcephaly;Aplasia/Hypoplasia of the earlobes;Clinodactyly of the 5th finger;Narrow palm;Micrognathia;Nystagmus;Joint hyperflexibility;Cat cry;Chorioretinal dystrophy;Tapered finger;Abnormality of retinal pigmentation;Muscular hypotonia;Neutropenia;Abnormality of skin pigmentation;Hypoplasia of the zygomatic bone;Pectus excavatum;Reduced number of teeth;Neurological speech impairment;Cryptorchidism;Arachnodactyly;Finger syndactyly;Failure to thrive in infancy;High, narrow palate;Macrodontia;Scoliosis;Thick eyebrow;Preauricular skin tag;Hypoplasia of the maxilla;Obesity;Short philtrum;Mitral valve prolapse;Short stature;Open mouth;Feeding difficulties in infancy;Optic atrophy;Weak cry;Aplasia/Hypoplasia of the tongue;Genu valgum;Downslanted palpebral fissures;Intellectual disability;Slender toe;Long eyelashes;Cubitus valgus;Delayed puberty;Ventricular septal defect;Abnormality of the hip bone;Seizure;Low anterior hairline;Microphthalmia;Sensorineural hearing impairment;Strabismus;Global developmental delay;Thick hair;Decreased fetal movement;Joint hypermobility;Pes planus;Convex nasal ridge;Mitral valve prolapse;Microcephaly;Short metatarsal;Bone spicule pigmentation of the retina;Single transverse palmar crease;Visual impairment;Short metacarpal;Neutropenia;Lumbar hyperlordosis;Downslanted palpebral fissures;Narrow palm;Thick corpus callosum;Hypoplasia of the maxilla;Feeding difficulties in infancy;Seizure;Growth hormone deficiency;Neonatal hypotonia;Childhood-onset truncal obesity;Open mouth;Optic atrophy;Chorioretinal dystrophy;Autosomal recessive inheritance;Prominent nasal bridge;Thoracic scoliosis;Micrognathia;Cubitus valgus;Short stature;Reduced visual acuity;Cerebellar hypoplasia;Intellectual disability;Bull's eye maculopathy;Myopia;High, narrow palate;Nyctalopia;Motor delay;Tapered finger;Laryngomalacia;Delayed puberty;Facial hypotonia;Generalized hypotonia;Short philtrum;Macrodontia of permanent maxillary central incisor;Narrow palm;Thick eyebrow;Genu valgum;Small for gestational age;Leukopenia	25741868,23757202	0.00441582	672.0	152180.0	1.0	32	0.97	PASS	nfe	0.00612983	417.0	0.00612983	417.0	0.00464128	1166.0	251224.0	5.0	86	1.0	PASS	nfe	0.00687512	781.0	0.00687512	781.0	0.0049323	767	0.004	14.0	0.00631	72.0		21.4	2.192808	0.107	5	16	21	SIFT,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MutationTaster_pred,fathmm-MKL_coding_pred	PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	VPS13B	0.0	0.0	0.02	0.0	1.0	-19.0	0.0	-19.0						0.933	0.0	0.000000000	0.989	-0.05	.			pons;ciliary ganglion;appendix;subthalamic nucleus;dorsal root ganglion;cingulate cortex;trigeminal ganglion;atrioventricular node;superior cervical ganglion;skeletal muscle;	.	protein transport	.	.	TGOLN2[29568061];HSPA8[30021884];DNAJC7[26496610];HIST3H3[30021884];CSNK1E[23455922];HIST1H1A[30021884];BET1[29568061];	100454804
71815	chr8	101719034	CTAAAAAATAAGAACATTTTGTATTTTTATCTTGCTCTTTCAAATTGGTGATCAATTTTTAAAGGAAGGATTAAGACTCAC		chr8:101719034-101719114	PABPC1	poly(A) binding protein cytoplasmic 1	deletion	0|1	0.21	72_20	95	99.0	0/0	0.0	44_0	44	99.0			rs1587146453	SPLICING	YES	NM_002568.4	Transcript	protein_coding	splice_acceptor_variant,splice_donor_variant,splice_donor_5th_base_variant,splice_polypyrimidine_tract_variant,intron_variant	10/14		NM_002568.4:c.1447+1_1448-1del			-1.0						.	.	.		0.00104923	135.0	128666.0	0.0	32	0.82	PASS	afr	0.00206976	68.0	0.000613309	36.0	0.000481501	98.0	203530.0	0.0	43	0.96	RF	afr	0.00180449	23.0	0.000357569	33.0	0.0001222	19						24.7	3.427801		0	0	0																		1.0				.			salivary gland;tonsil;trachea;white blood cells;tongue;testis - seminiferous tubule;testis - interstitial;tumor;adipose tissue;whole blood;testis;	.	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;mRNA splicing, via spliceosome;mRNA polyadenylation;translational initiation;gene silencing by RNA;regulation of mRNA stability;positive regulation of viral genome replication;positive regulation of translation;mRNA stabilization;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	nucleus;cytoplasm;cytosol;focal adhesion;cytoplasmic stress granule;membrane;cytoplasmic ribonucleoprotein granule;extracellular exosome;catalytic step 2 spliceosome;ribonucleoprotein complex	RNA binding;mRNA 3'-UTR binding;protein binding;protein C-terminus binding;poly(A) binding;poly(U) RNA binding;translation activator activity	EIF4A2[17353931];EIF4A1[20133758];IRS1[23770097];EIF4A3[23084401];CTNND1[28877994];PARK7[29128334];IFIT1[21642987];DUX4[26816005];IFIT3[21642987];IFIT2[21642987];TUBB3[27291054];GABARAPL2[20562859];GABARAPL1[20562859];HLA-B[17353931];DICER1[21858095];PRKAB1[17353931];JMJD6[24498420];ATXN2L[23209657];VDAC1[29128334];RBM8A[16452507];COX15[29128334];KMT2C[30021884];STK4[23386615];NDRG1[17220478];GSPT2[18447585;23340509;14685257];GSPT1[18256688;20418951];GABARAP[20562859];ATXN2[15663938;17392519;20181956];PCBP1[10373504];PCBP2[10373504];ZC3H18[29298432];SRPK2[23602568];CBX6[21282530];JUN[25609649];SMAD3[18729074];VCAM1[22623428];PDHA1[29128334];NBEAL2[29187380];ESR1[21182205];MEX3C[22863774];CLK3[23602568];NFKB2[14743216];CLK2[23602568];SRPK1[23602568];SNW1[20467437];HNRNPK[22365833];PAN3[23340509;17595167];AGO4[19167051];AGO1[17932509;19716330];LHX1[30021884];CDK2[17353931];AGO2[17932509;19716330;28877994];HNRNPD[16556936];GRB2[12577067];EIF4G3[9857202];MAP3K14[14743216];EIF4G1[9857202;12086624;19716330;16772376];BCAR3[17353931];SMG1[16452507];DDX3X[18596238;21883093;22872150];PINX1[17353931];ARRB2[17620599];YBX1[22118625];USE1[19369418];RBM4[22365833;17284590];MAP1LC3A[20562859];DNM1L[29128334];IKBKE[17353931];YWHAG[15324660;17353931];L1RE1[24267889];UPF1[21145460;19417104;23665581];NCBP1[23665581];H2AFX[20000738];DYNLL1[17353931];TRAF6[17353931];SGK1[17353931];DLD[29128334];STAU1[15121898];RPL10[26496610];WBP4[16055720];PARN[17595167];DLST[29128334];U2AF1[22365833];TOB2[23340509];TOB1[20595394];HSD17B10[29128334];NXF1[18596238];PUF60[17353931];IFI16[25665578];PABPN1[23665581];NSD1[30021884];IGF2BP1[19029303];PAIP2[16601676;14685257];EIF4E[23665581];PAIP1[9548260;11997512;14685257;24396066;11051545];WWOX[16055720];RRP1B[20926688];PLEKHA7[28877994];MAPK13[19135240];TNRC6C[21063388;19716330;21981923;20181956;23340509;20098421];PPP2R2B[19156129];MNDA[25665578];TNRC6A[21063388;28877994];BCAR1[28007913];TNRC6B[21063388;21981923];	101719033
71817	chr8	101719121	G	A	chr8:101719121	PABPC1	poly(A) binding protein cytoplasmic 1	SNV	0|1	0.23	41_12	53	99.0	0/0	0.0	44_0	44	97.0			rs79986761,COSV59397539	EXONIC	YES	NM_002568.4	Transcript	protein_coding	missense_variant		10/15	NM_002568.4:c.1441C>T	NP_002559.2:p.Arg481Cys		-1.0	.,.,.,.					.	.	.		0.00511191	708.0	138500.0	0.0	33	0.93	AS_VQSR	afr	0.00701419	257.0	0.00446599	281.0	0.0889775	13074.0	146936.0	0.0	60	1.0	RF	sas	0.140126	2221.0	0.0917162	5868.0	0.0000129	2	0.004	13.0				26.2	3.793684	0.658	9	10	19	LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,ClinPred_pred,LIST-S2_pred	PABPC1	0.0	0.0	0.0	0.08	2.0	24.0	2.0	-6.0							1.0	85.046826914	1.0	1.09	.			salivary gland;tonsil;trachea;white blood cells;tongue;testis - seminiferous tubule;testis - interstitial;tumor;adipose tissue;whole blood;testis;	.	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;mRNA splicing, via spliceosome;mRNA polyadenylation;translational initiation;gene silencing by RNA;regulation of mRNA stability;positive regulation of viral genome replication;positive regulation of translation;mRNA stabilization;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	nucleus;cytoplasm;cytosol;focal adhesion;cytoplasmic stress granule;membrane;cytoplasmic ribonucleoprotein granule;extracellular exosome;catalytic step 2 spliceosome;ribonucleoprotein complex	RNA binding;mRNA 3'-UTR binding;protein binding;protein C-terminus binding;poly(A) binding;poly(U) RNA binding;translation activator activity	EIF4A2[17353931];EIF4A1[20133758];IRS1[23770097];EIF4A3[23084401];CTNND1[28877994];PARK7[29128334];IFIT1[21642987];DUX4[26816005];IFIT3[21642987];IFIT2[21642987];TUBB3[27291054];GABARAPL2[20562859];GABARAPL1[20562859];HLA-B[17353931];DICER1[21858095];PRKAB1[17353931];JMJD6[24498420];ATXN2L[23209657];VDAC1[29128334];RBM8A[16452507];COX15[29128334];KMT2C[30021884];STK4[23386615];NDRG1[17220478];GSPT2[18447585;23340509;14685257];GSPT1[18256688;20418951];GABARAP[20562859];ATXN2[15663938;17392519;20181956];PCBP1[10373504];PCBP2[10373504];ZC3H18[29298432];SRPK2[23602568];CBX6[21282530];JUN[25609649];SMAD3[18729074];VCAM1[22623428];PDHA1[29128334];NBEAL2[29187380];ESR1[21182205];MEX3C[22863774];CLK3[23602568];NFKB2[14743216];CLK2[23602568];SRPK1[23602568];SNW1[20467437];HNRNPK[22365833];PAN3[23340509;17595167];AGO4[19167051];AGO1[17932509;19716330];LHX1[30021884];CDK2[17353931];AGO2[17932509;19716330;28877994];HNRNPD[16556936];GRB2[12577067];EIF4G3[9857202];MAP3K14[14743216];EIF4G1[9857202;12086624;19716330;16772376];BCAR3[17353931];SMG1[16452507];DDX3X[18596238;21883093;22872150];PINX1[17353931];ARRB2[17620599];YBX1[22118625];USE1[19369418];RBM4[22365833;17284590];MAP1LC3A[20562859];DNM1L[29128334];IKBKE[17353931];YWHAG[15324660;17353931];L1RE1[24267889];UPF1[21145460;19417104;23665581];NCBP1[23665581];H2AFX[20000738];DYNLL1[17353931];TRAF6[17353931];SGK1[17353931];DLD[29128334];STAU1[15121898];RPL10[26496610];WBP4[16055720];PARN[17595167];DLST[29128334];U2AF1[22365833];TOB2[23340509];TOB1[20595394];HSD17B10[29128334];NXF1[18596238];PUF60[17353931];IFI16[25665578];PABPN1[23665581];NSD1[30021884];IGF2BP1[19029303];PAIP2[16601676;14685257];EIF4E[23665581];PAIP1[9548260;11997512;14685257;24396066;11051545];WWOX[16055720];RRP1B[20926688];PLEKHA7[28877994];MAPK13[19135240];TNRC6C[21063388;19716330;21981923;20181956;23340509;20098421];PPP2R2B[19156129];MNDA[25665578];TNRC6A[21063388;28877994];BCAR1[28007913];TNRC6B[21063388;21981923];	101719121
71819	chr8	101719138	C	T	chr8:101719138	PABPC1	poly(A) binding protein cytoplasmic 1	SNV	0/1	0.23	43_13	56	99.0	0/0	0.0	49_0	49	62.0			rs79940439,COSV59397547	EXONIC	YES	NM_002568.4	Transcript	protein_coding	missense_variant		10/15	NM_002568.4:c.1424G>A	NP_002559.2:p.Arg475Gln		-1.0	.,.,.,.					.	.	.		0.00232242	321.0	138218.0	0.0	33	0.93	PASS	afr	0.00350896	128.0	0.00202011	127.0	0.237459	42848.0	180444.0	0.0	74	1.0	InbreedingCoeff_RF	sas	0.309228	7017.0	0.24684	19098.0	0.0000643	10	0.034	104.0				24.4	3.301404	0.192	6	12	18	MutationTaster_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,ClinPred_pred,LIST-S2_pred	PABPC1	0.0	0.0	0.0	0.09	-23.0	7.0	-1.0	-23.0							1.0	85.046826914	1.0	1.026	.			salivary gland;tonsil;trachea;white blood cells;tongue;testis - seminiferous tubule;testis - interstitial;tumor;adipose tissue;whole blood;testis;	.	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;mRNA splicing, via spliceosome;mRNA polyadenylation;translational initiation;gene silencing by RNA;regulation of mRNA stability;positive regulation of viral genome replication;positive regulation of translation;mRNA stabilization;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	nucleus;cytoplasm;cytosol;focal adhesion;cytoplasmic stress granule;membrane;cytoplasmic ribonucleoprotein granule;extracellular exosome;catalytic step 2 spliceosome;ribonucleoprotein complex	RNA binding;mRNA 3'-UTR binding;protein binding;protein C-terminus binding;poly(A) binding;poly(U) RNA binding;translation activator activity	EIF4A2[17353931];EIF4A1[20133758];IRS1[23770097];EIF4A3[23084401];CTNND1[28877994];PARK7[29128334];IFIT1[21642987];DUX4[26816005];IFIT3[21642987];IFIT2[21642987];TUBB3[27291054];GABARAPL2[20562859];GABARAPL1[20562859];HLA-B[17353931];DICER1[21858095];PRKAB1[17353931];JMJD6[24498420];ATXN2L[23209657];VDAC1[29128334];RBM8A[16452507];COX15[29128334];KMT2C[30021884];STK4[23386615];NDRG1[17220478];GSPT2[18447585;23340509;14685257];GSPT1[18256688;20418951];GABARAP[20562859];ATXN2[15663938;17392519;20181956];PCBP1[10373504];PCBP2[10373504];ZC3H18[29298432];SRPK2[23602568];CBX6[21282530];JUN[25609649];SMAD3[18729074];VCAM1[22623428];PDHA1[29128334];NBEAL2[29187380];ESR1[21182205];MEX3C[22863774];CLK3[23602568];NFKB2[14743216];CLK2[23602568];SRPK1[23602568];SNW1[20467437];HNRNPK[22365833];PAN3[23340509;17595167];AGO4[19167051];AGO1[17932509;19716330];LHX1[30021884];CDK2[17353931];AGO2[17932509;19716330;28877994];HNRNPD[16556936];GRB2[12577067];EIF4G3[9857202];MAP3K14[14743216];EIF4G1[9857202;12086624;19716330;16772376];BCAR3[17353931];SMG1[16452507];DDX3X[18596238;21883093;22872150];PINX1[17353931];ARRB2[17620599];YBX1[22118625];USE1[19369418];RBM4[22365833;17284590];MAP1LC3A[20562859];DNM1L[29128334];IKBKE[17353931];YWHAG[15324660;17353931];L1RE1[24267889];UPF1[21145460;19417104;23665581];NCBP1[23665581];H2AFX[20000738];DYNLL1[17353931];TRAF6[17353931];SGK1[17353931];DLD[29128334];STAU1[15121898];RPL10[26496610];WBP4[16055720];PARN[17595167];DLST[29128334];U2AF1[22365833];TOB2[23340509];TOB1[20595394];HSD17B10[29128334];NXF1[18596238];PUF60[17353931];IFI16[25665578];PABPN1[23665581];NSD1[30021884];IGF2BP1[19029303];PAIP2[16601676;14685257];EIF4E[23665581];PAIP1[9548260;11997512;14685257;24396066;11051545];WWOX[16055720];RRP1B[20926688];PLEKHA7[28877994];MAPK13[19135240];TNRC6C[21063388;19716330;21981923;20181956;23340509;20098421];PPP2R2B[19156129];MNDA[25665578];TNRC6A[21063388;28877994];BCAR1[28007913];TNRC6B[21063388;21981923];	101719138
71821	chr8	101719201	A	G	chr8:101719201	PABPC1	poly(A) binding protein cytoplasmic 1	SNV	0|1	0.22	45_13	58	99.0	0/0	0.0	43_0	43	45.0			rs72681439,COSV59397560	EXONIC	YES	NM_002568.4	Transcript	protein_coding	missense_variant		10/15	NM_002568.4:c.1361T>C	NP_002559.2:p.Ile454Thr		-1.0	.,.,.,.					.	.	.		0.000587308	82.0	139620.0	0.0	32	0.93	PASS	nfe	0.000900588	57.0	0.000900588	57.0	0.266447	51225.0	192252.0	0.0	64	1.0	InbreedingCoeff_RF	sas	0.323653	7690.0	0.283471	23616.0	0.0022057	343	0.059	176.0				22.7	2.58197	0.307	6	12	18	LRT_pred,MutationTaster_pred,BayesDel_addAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_noAF_pred,ClinPred_pred	PABPC1	0.03	0.0	0.0	0.0	24.0	-9.0	31.0	-9.0							1.0	93.347314204	1.0	1.312	.			salivary gland;tonsil;trachea;white blood cells;tongue;testis - seminiferous tubule;testis - interstitial;tumor;adipose tissue;whole blood;testis;	.	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;mRNA splicing, via spliceosome;mRNA polyadenylation;translational initiation;gene silencing by RNA;regulation of mRNA stability;positive regulation of viral genome replication;positive regulation of translation;mRNA stabilization;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	nucleus;cytoplasm;cytosol;focal adhesion;cytoplasmic stress granule;membrane;cytoplasmic ribonucleoprotein granule;extracellular exosome;catalytic step 2 spliceosome;ribonucleoprotein complex	RNA binding;mRNA 3'-UTR binding;protein binding;protein C-terminus binding;poly(A) binding;poly(U) RNA binding;translation activator activity	EIF4A2[17353931];EIF4A1[20133758];IRS1[23770097];EIF4A3[23084401];CTNND1[28877994];PARK7[29128334];IFIT1[21642987];DUX4[26816005];IFIT3[21642987];IFIT2[21642987];TUBB3[27291054];GABARAPL2[20562859];GABARAPL1[20562859];HLA-B[17353931];DICER1[21858095];PRKAB1[17353931];JMJD6[24498420];ATXN2L[23209657];VDAC1[29128334];RBM8A[16452507];COX15[29128334];KMT2C[30021884];STK4[23386615];NDRG1[17220478];GSPT2[18447585;23340509;14685257];GSPT1[18256688;20418951];GABARAP[20562859];ATXN2[15663938;17392519;20181956];PCBP1[10373504];PCBP2[10373504];ZC3H18[29298432];SRPK2[23602568];CBX6[21282530];JUN[25609649];SMAD3[18729074];VCAM1[22623428];PDHA1[29128334];NBEAL2[29187380];ESR1[21182205];MEX3C[22863774];CLK3[23602568];NFKB2[14743216];CLK2[23602568];SRPK1[23602568];SNW1[20467437];HNRNPK[22365833];PAN3[23340509;17595167];AGO4[19167051];AGO1[17932509;19716330];LHX1[30021884];CDK2[17353931];AGO2[17932509;19716330;28877994];HNRNPD[16556936];GRB2[12577067];EIF4G3[9857202];MAP3K14[14743216];EIF4G1[9857202;12086624;19716330;16772376];BCAR3[17353931];SMG1[16452507];DDX3X[18596238;21883093;22872150];PINX1[17353931];ARRB2[17620599];YBX1[22118625];USE1[19369418];RBM4[22365833;17284590];MAP1LC3A[20562859];DNM1L[29128334];IKBKE[17353931];YWHAG[15324660;17353931];L1RE1[24267889];UPF1[21145460;19417104;23665581];NCBP1[23665581];H2AFX[20000738];DYNLL1[17353931];TRAF6[17353931];SGK1[17353931];DLD[29128334];STAU1[15121898];RPL10[26496610];WBP4[16055720];PARN[17595167];DLST[29128334];U2AF1[22365833];TOB2[23340509];TOB1[20595394];HSD17B10[29128334];NXF1[18596238];PUF60[17353931];IFI16[25665578];PABPN1[23665581];NSD1[30021884];IGF2BP1[19029303];PAIP2[16601676;14685257];EIF4E[23665581];PAIP1[9548260;11997512;14685257;24396066;11051545];WWOX[16055720];RRP1B[20926688];PLEKHA7[28877994];MAPK13[19135240];TNRC6C[21063388;19716330;21981923;20181956;23340509;20098421];PPP2R2B[19156129];MNDA[25665578];TNRC6A[21063388;28877994];BCAR1[28007913];TNRC6B[21063388;21981923];	101719201
71823	chr8	101721705	G	T	chr8:101721705	PABPC1	poly(A) binding protein cytoplasmic 1	SNV	0|1	0.21	50_13	63	99.0	0|0	0.06	47_3	51	36.0			rs201017624,COSV59397581	EXONIC	YES	NM_002568.4	Transcript	protein_coding	missense_variant		8/15	NM_002568.4:c.1227C>A	NP_002559.2:p.Phe409Leu		-1.0	.,.,.,.					.	.	.		0.000244999	34.0	138776.0	0.0	33	0.92	AS_VQSR	eas	0.000851789	4.0	6.36801e-05	4.0	4.58846e-05	11.0	239732.0	0.0	90	1.0	PASS	nfe	8.31854e-05	9.0	8.31854e-05	9.0	0.0082827	1288	0.017	55.0				23.6	3.002086	0.535	7	11	18	LRT_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,BayesDel_addAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	PABPC1	0.0	0.0	0.0	0.01	-19.0	7.0	8.0	-18.0							1.0	84.298476076	1.0	0.225	.			salivary gland;tonsil;trachea;white blood cells;tongue;testis - seminiferous tubule;testis - interstitial;tumor;adipose tissue;whole blood;testis;	.	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;mRNA splicing, via spliceosome;mRNA polyadenylation;translational initiation;gene silencing by RNA;regulation of mRNA stability;positive regulation of viral genome replication;positive regulation of translation;mRNA stabilization;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	nucleus;cytoplasm;cytosol;focal adhesion;cytoplasmic stress granule;membrane;cytoplasmic ribonucleoprotein granule;extracellular exosome;catalytic step 2 spliceosome;ribonucleoprotein complex	RNA binding;mRNA 3'-UTR binding;protein binding;protein C-terminus binding;poly(A) binding;poly(U) RNA binding;translation activator activity	EIF4A2[17353931];EIF4A1[20133758];IRS1[23770097];EIF4A3[23084401];CTNND1[28877994];PARK7[29128334];IFIT1[21642987];DUX4[26816005];IFIT3[21642987];IFIT2[21642987];TUBB3[27291054];GABARAPL2[20562859];GABARAPL1[20562859];HLA-B[17353931];DICER1[21858095];PRKAB1[17353931];JMJD6[24498420];ATXN2L[23209657];VDAC1[29128334];RBM8A[16452507];COX15[29128334];KMT2C[30021884];STK4[23386615];NDRG1[17220478];GSPT2[18447585;23340509;14685257];GSPT1[18256688;20418951];GABARAP[20562859];ATXN2[15663938;17392519;20181956];PCBP1[10373504];PCBP2[10373504];ZC3H18[29298432];SRPK2[23602568];CBX6[21282530];JUN[25609649];SMAD3[18729074];VCAM1[22623428];PDHA1[29128334];NBEAL2[29187380];ESR1[21182205];MEX3C[22863774];CLK3[23602568];NFKB2[14743216];CLK2[23602568];SRPK1[23602568];SNW1[20467437];HNRNPK[22365833];PAN3[23340509;17595167];AGO4[19167051];AGO1[17932509;19716330];LHX1[30021884];CDK2[17353931];AGO2[17932509;19716330;28877994];HNRNPD[16556936];GRB2[12577067];EIF4G3[9857202];MAP3K14[14743216];EIF4G1[9857202;12086624;19716330;16772376];BCAR3[17353931];SMG1[16452507];DDX3X[18596238;21883093;22872150];PINX1[17353931];ARRB2[17620599];YBX1[22118625];USE1[19369418];RBM4[22365833;17284590];MAP1LC3A[20562859];DNM1L[29128334];IKBKE[17353931];YWHAG[15324660;17353931];L1RE1[24267889];UPF1[21145460;19417104;23665581];NCBP1[23665581];H2AFX[20000738];DYNLL1[17353931];TRAF6[17353931];SGK1[17353931];DLD[29128334];STAU1[15121898];RPL10[26496610];WBP4[16055720];PARN[17595167];DLST[29128334];U2AF1[22365833];TOB2[23340509];TOB1[20595394];HSD17B10[29128334];NXF1[18596238];PUF60[17353931];IFI16[25665578];PABPN1[23665581];NSD1[30021884];IGF2BP1[19029303];PAIP2[16601676;14685257];EIF4E[23665581];PAIP1[9548260;11997512;14685257;24396066;11051545];WWOX[16055720];RRP1B[20926688];PLEKHA7[28877994];MAPK13[19135240];TNRC6C[21063388;19716330;21981923;20181956;23340509;20098421];PPP2R2B[19156129];MNDA[25665578];TNRC6A[21063388;28877994];BCAR1[28007913];TNRC6B[21063388;21981923];	101721705
71825	chr8	101721709	T	A	chr8:101721709	PABPC1	poly(A) binding protein cytoplasmic 1	SNV	0|1	0.2	52_13	65	99.0	0|0	0.06	48_3	52	39.0			rs146200489,COSV59397589,COSV59399247	EXONIC	YES	NM_002568.4	Transcript	protein_coding	missense_variant		8/15	NM_002568.4:c.1223A>T	NP_002559.2:p.Tyr408Phe		-1.0	.,.,.,.					.	.	.		0.000342551	47.0	137206.0	0.0	33	0.92	AS_VQSR	sas	0.00116063	5.0	9.6609e-05	6.0	0.000279306	66.0	236300.0	0.0	91	1.0	RF	nfe	0.000572802	61.0	0.000572802	61.0	0.0000064	1	0.0	1.0				22.9	2.661157	0.442	7	11	18	LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	PABPC1	0.0	0.0	0.0	0.0	3.0	4.0	-22.0	4.0							1.0	84.298476076	1.0	1.138	.			salivary gland;tonsil;trachea;white blood cells;tongue;testis - seminiferous tubule;testis - interstitial;tumor;adipose tissue;whole blood;testis;	.	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;mRNA splicing, via spliceosome;mRNA polyadenylation;translational initiation;gene silencing by RNA;regulation of mRNA stability;positive regulation of viral genome replication;positive regulation of translation;mRNA stabilization;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	nucleus;cytoplasm;cytosol;focal adhesion;cytoplasmic stress granule;membrane;cytoplasmic ribonucleoprotein granule;extracellular exosome;catalytic step 2 spliceosome;ribonucleoprotein complex	RNA binding;mRNA 3'-UTR binding;protein binding;protein C-terminus binding;poly(A) binding;poly(U) RNA binding;translation activator activity	EIF4A2[17353931];EIF4A1[20133758];IRS1[23770097];EIF4A3[23084401];CTNND1[28877994];PARK7[29128334];IFIT1[21642987];DUX4[26816005];IFIT3[21642987];IFIT2[21642987];TUBB3[27291054];GABARAPL2[20562859];GABARAPL1[20562859];HLA-B[17353931];DICER1[21858095];PRKAB1[17353931];JMJD6[24498420];ATXN2L[23209657];VDAC1[29128334];RBM8A[16452507];COX15[29128334];KMT2C[30021884];STK4[23386615];NDRG1[17220478];GSPT2[18447585;23340509;14685257];GSPT1[18256688;20418951];GABARAP[20562859];ATXN2[15663938;17392519;20181956];PCBP1[10373504];PCBP2[10373504];ZC3H18[29298432];SRPK2[23602568];CBX6[21282530];JUN[25609649];SMAD3[18729074];VCAM1[22623428];PDHA1[29128334];NBEAL2[29187380];ESR1[21182205];MEX3C[22863774];CLK3[23602568];NFKB2[14743216];CLK2[23602568];SRPK1[23602568];SNW1[20467437];HNRNPK[22365833];PAN3[23340509;17595167];AGO4[19167051];AGO1[17932509;19716330];LHX1[30021884];CDK2[17353931];AGO2[17932509;19716330;28877994];HNRNPD[16556936];GRB2[12577067];EIF4G3[9857202];MAP3K14[14743216];EIF4G1[9857202;12086624;19716330;16772376];BCAR3[17353931];SMG1[16452507];DDX3X[18596238;21883093;22872150];PINX1[17353931];ARRB2[17620599];YBX1[22118625];USE1[19369418];RBM4[22365833;17284590];MAP1LC3A[20562859];DNM1L[29128334];IKBKE[17353931];YWHAG[15324660;17353931];L1RE1[24267889];UPF1[21145460;19417104;23665581];NCBP1[23665581];H2AFX[20000738];DYNLL1[17353931];TRAF6[17353931];SGK1[17353931];DLD[29128334];STAU1[15121898];RPL10[26496610];WBP4[16055720];PARN[17595167];DLST[29128334];U2AF1[22365833];TOB2[23340509];TOB1[20595394];HSD17B10[29128334];NXF1[18596238];PUF60[17353931];IFI16[25665578];PABPN1[23665581];NSD1[30021884];IGF2BP1[19029303];PAIP2[16601676;14685257];EIF4E[23665581];PAIP1[9548260;11997512;14685257;24396066;11051545];WWOX[16055720];RRP1B[20926688];PLEKHA7[28877994];MAPK13[19135240];TNRC6C[21063388;19716330;21981923;20181956;23340509;20098421];PPP2R2B[19156129];MNDA[25665578];TNRC6A[21063388;28877994];BCAR1[28007913];TNRC6B[21063388;21981923];	101721709
71827	chr8	101721727	G	A	chr8:101721727	PABPC1	poly(A) binding protein cytoplasmic 1	SNV	0/1	0.24	66_21	87	99.0	0/0	0.0	62_0	62	62.0			rs139094790,COSV59397382	EXONIC	YES	NM_002568.4	Transcript	protein_coding	missense_variant		8/15	NM_002568.4:c.1205C>T	NP_002559.2:p.Pro402Leu		-1.0	.,.,.,.					.	.	.		0.00278078	371.0	133416.0	0.0	33	0.91	AS_VQSR	sas	0.00383325	16.0	0.00242493	146.0	0.0288208	4817.0	167136.0	0.0	100	1.0	PASS	sas	0.0580956	1014.0	0.0254499	1977.0	0.0829818	12904	0.013	39.0				25.6	3.668466	0.401	9	9	18	SIFT,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred	PABPC1	0.0	0.0	0.0	0.0	-15.0	1.0	47.0	-40.0							1.0	0.000000000	0.991	1.176	.			salivary gland;tonsil;trachea;white blood cells;tongue;testis - seminiferous tubule;testis - interstitial;tumor;adipose tissue;whole blood;testis;	.	nuclear-transcribed mRNA catabolic process, nonsense-mediated decay;mRNA splicing, via spliceosome;mRNA polyadenylation;translational initiation;gene silencing by RNA;regulation of mRNA stability;positive regulation of viral genome replication;positive regulation of translation;mRNA stabilization;positive regulation of nuclear-transcribed mRNA poly(A) tail shortening;positive regulation of nuclear-transcribed mRNA catabolic process, deadenylation-dependent decay;negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	nucleus;cytoplasm;cytosol;focal adhesion;cytoplasmic stress granule;membrane;cytoplasmic ribonucleoprotein granule;extracellular exosome;catalytic step 2 spliceosome;ribonucleoprotein complex	RNA binding;mRNA 3'-UTR binding;protein binding;protein C-terminus binding;poly(A) binding;poly(U) RNA binding;translation activator activity	EIF4A2[17353931];EIF4A1[20133758];IRS1[23770097];EIF4A3[23084401];CTNND1[28877994];PARK7[29128334];IFIT1[21642987];DUX4[26816005];IFIT3[21642987];IFIT2[21642987];TUBB3[27291054];GABARAPL2[20562859];GABARAPL1[20562859];HLA-B[17353931];DICER1[21858095];PRKAB1[17353931];JMJD6[24498420];ATXN2L[23209657];VDAC1[29128334];RBM8A[16452507];COX15[29128334];KMT2C[30021884];STK4[23386615];NDRG1[17220478];GSPT2[18447585;23340509;14685257];GSPT1[18256688;20418951];GABARAP[20562859];ATXN2[15663938;17392519;20181956];PCBP1[10373504];PCBP2[10373504];ZC3H18[29298432];SRPK2[23602568];CBX6[21282530];JUN[25609649];SMAD3[18729074];VCAM1[22623428];PDHA1[29128334];NBEAL2[29187380];ESR1[21182205];MEX3C[22863774];CLK3[23602568];NFKB2[14743216];CLK2[23602568];SRPK1[23602568];SNW1[20467437];HNRNPK[22365833];PAN3[23340509;17595167];AGO4[19167051];AGO1[17932509;19716330];LHX1[30021884];CDK2[17353931];AGO2[17932509;19716330;28877994];HNRNPD[16556936];GRB2[12577067];EIF4G3[9857202];MAP3K14[14743216];EIF4G1[9857202;12086624;19716330;16772376];BCAR3[17353931];SMG1[16452507];DDX3X[18596238;21883093;22872150];PINX1[17353931];ARRB2[17620599];YBX1[22118625];USE1[19369418];RBM4[22365833;17284590];MAP1LC3A[20562859];DNM1L[29128334];IKBKE[17353931];YWHAG[15324660;17353931];L1RE1[24267889];UPF1[21145460;19417104;23665581];NCBP1[23665581];H2AFX[20000738];DYNLL1[17353931];TRAF6[17353931];SGK1[17353931];DLD[29128334];STAU1[15121898];RPL10[26496610];WBP4[16055720];PARN[17595167];DLST[29128334];U2AF1[22365833];TOB2[23340509];TOB1[20595394];HSD17B10[29128334];NXF1[18596238];PUF60[17353931];IFI16[25665578];PABPN1[23665581];NSD1[30021884];IGF2BP1[19029303];PAIP2[16601676;14685257];EIF4E[23665581];PAIP1[9548260;11997512;14685257;24396066;11051545];WWOX[16055720];RRP1B[20926688];PLEKHA7[28877994];MAPK13[19135240];TNRC6C[21063388;19716330;21981923;20181956;23340509;20098421];PPP2R2B[19156129];MNDA[25665578];TNRC6A[21063388;28877994];BCAR1[28007913];TNRC6B[21063388;21981923];	101721727
71965	chr8	105393432	G	T	chr8:105393432	DPYS	dihydropyrimidinase	SNV	0/1	0.44	55_44	99	99.0	0/0	0.0	35_0	35	99.0			rs1432443257	EXONIC	YES	NM_001385.3	Transcript	protein_coding	missense_variant		9/10	NM_001385.3:c.1554C>A	NP_001376.1:p.His518Gln		-1.0					Dihydropyrimidinuria, 222748 (3), Autosomal recessive	Dihydropyrimidinuria	Disease-causing germline mutation(s) (loss of function) in	Abnormal facial shape;Extrapyramidal dyskinesia;Metabolic acidosis;Excessive daytime somnolence;Seizure;Growth delay;Talipes equinovarus;Intellectual disability;Abnormal pyramidal sign;Autosomal recessive inheritance;Plagiocephaly;Lethargy;Feeding difficulties in infancy;Morphological abnormality of the pyramidal tract;Abnormality of the cerebral white matter;Short phalanx of finger;Delayed speech and language development;Anal atresia;Reduced dihydropyrimidine dehydrogenase level		6.57229e-06	1.0	152154.0	0.0	32	0.97	PASS	nfe	1.47016e-05	1.0	1.47016e-05	1.0	3.97738e-06	1.0	251422.0	0.0	100	1.0	PASS	amr	2.89101e-05	1.0	0.0	0.0			0.0	1.0	9e-05	1.0		0.092	-0.494611	0.01	1	18	19	FATHMM_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	DPYS	0.0	0.0	0.01	0.0	-20.0	5.0	-20.0	-30.0						0.267	0.0	0.000000000	0.0	-1.231	.			kidney;liver;superior cervical ganglion;fetal liver;	Pyrimidine metabolism;beta-Alanine metabolism;Pantothenate and CoA biosynthesis;Drug metabolism - other enzymes	pyrimidine nucleobase catabolic process;thymine catabolic process;uracil catabolic process;beta-alanine metabolic process;pyrimidine nucleoside catabolic process;protein homotetramerization	cytosol;extracellular exosome	uracil binding;thymine binding;dihydropyrimidinase activity;zinc ion binding;amino acid binding;phosphoprotein binding	APPBP2[unassigned1304];	105393432
71996	chr8	110530675	G	A	chr8:110530675	PKHD1L1	PKHD1 like 1	SNV	0/0	0.0	33_0	33	99.0	0/1	0.36	44_25	70	99.0			rs146831382	EXONIC	YES	NM_177531.6	Transcript	protein_coding	missense_variant		73/78	NM_177531.6:c.11969G>A	NP_803875.2:p.Gly3990Glu		1.0	.,.					.	.	.	28007035	0.000900782	137.0	152090.0	2.0	32	0.97	PASS	nfe	0.00149991	102.0	0.00149991	102.0	0.000891955	219.0	245528.0	0.0	52	0.99	PASS	nfe	0.00177286	199.0	0.00177286	199.0	0.0010096	157	0.002	6.0				9.715	0.533702	0.15	3	16	19	MutationAssessor_pred,FATHMM_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	PKHD1L1	0.0	0.0	0.0	0.0	20.0	-41.0	-2.0	-25.0						0.053	0.0	0.000000000	0.092	1.176	.			.	.	immune response	extracellular space;cytosol;cilium;integral component of membrane	signaling receptor activity	.	110530675
72132	chr8	126095506		A	chr8:126095505-126095506	WASHC5	WASH complex subunit 5	insertion	0/1	0.24	22_7	29	77.0	0/0	0.0	17_0	17	51.0			rs745362878	SPLICING	YES	NM_014846.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	2/28		NM_014846.4:c.187-6dup			-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_provided	Ritscher-Schinzel syndrome 1, 220210 (3), Autosomal recessive; Spastic paraplegia 8, autosomal dominant, 603563 (3), Autosomal dominant	3C syndrome;Autosomal dominant spastic paraplegia type 8	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Spinal cord lesion;Spastic gait;Muscle spasm;Upper limb spasticity;Clonus;Peroneal muscle atrophy;Urinary urgency;Limb dysmetria;Urinary incontinence;Impaired vibration sensation in the lower limbs;Babinski sign;Degeneration of the lateral corticospinal tracts;Lower limb muscle weakness;Progressive pes cavus;Limb ataxia;Difficulty walking;Progressive spastic paraplegia;Lower limb spasticity;Impaired vibration sensation in the lower limbs;Spastic paraplegia;Babinski sign;Urinary urgency;Progressive;Lower limb muscle weakness;Autosomal dominant inheritance;Urinary incontinence;Spastic gait;Urinary bladder sphincter dysfunction;Upper limb spasticity;Hyperreflexia;Insidious onset;Degeneration of the lateral corticospinal tracts;Adult onset;Pes cavus;Glaucoma;Ectopic anus;Abnormality of the fontanelles or cranial sutures;Ventricular septal defect;Abnormality of neuronal migration;High, narrow palate;Feeding difficulties in infancy;Low-set ears;Recurrent respiratory infections;Inguinal hernia;Pulmonic stenosis;Downslanted palpebral fissures;Muscular hypotonia;Micrognathia;Hydrocephalus;Hand polydactyly;Neurological speech impairment;Single umbilical artery;Hydronephrosis;Dandy-Walker malformation;Finger syndactyly;Aplasia/Hypoplasia of the nipples;Hypertelorism;Prominent occiput;Cleft palate;Short nose;Macrocephaly;Tetralogy of Fallot;Preauricular skin tag;Abnormal mitral valve morphology;Hypoplastic fingernail;Short stature;Short neck;Hypoplasia of penis;Aortic valve stenosis;Wide nasal bridge;Adrenal hypoplasia;Chorioretinal coloboma;Postnatal growth retardation;Global developmental delay;Scoliosis;Abnormality of the hip bone;Hemivertebrae;Hypospadias;Brachydactyly;Intestinal malrotation;Atrioventricular canal defect;Aplasia/Hypoplasia of the cerebellum;Abnormal tricuspid valve morphology;Iris coloboma;Depressed nasal bridge;Missing ribs;Hypoplastic left heart;Frontal bossing;Anal atresia;Atrial septal defect;Gastroesophageal reflux;Optic atrophy;Death in infancy;Facial hemangioma;Intellectual disability;Kyphosis;Low-set ears;Ventricular septal defect;Downslanted palpebral fissures;Depressed nasal bridge;Muscular hypotonia;Prominent occiput;Hypertelorism;Missing ribs;Tetralogy of Fallot;Posterior fossa cyst;Syndactyly;Adrenal hypoplasia;Micrognathia;High forehead;Global developmental delay;Growth hormone deficiency;Dandy-Walker malformation;Cleft palate;Single umbilical artery;Hypoplastic left heart;Generalized hypotonia;Aortic valve stenosis;Autosomal recessive inheritance;Pulmonic stenosis;Double outlet right ventricle;Atrial septal defect;Hypospadias;Broad forehead;Hydrocephalus;Low posterior hairline;Hydronephrosis;Brachycephaly;Broad forehead;Coloboma;Hemivertebrae;Anal atresia;Intrauterine growth retardation		4.00235e-05	6.0	149912.0	0.0	32	0.96	PASS	sas	0.000209996	1.0	7.42038e-05	5.0	0.000410996	90.0	218980.0	0.0	41	0.95	RF	sas	0.000730544	19.0	0.000333484	34.0	0.0001415,0.0001479	22,23	0.003	10.0	0.00026	3.0		14.3	1.137352		0	0	0			KIAA0196	0.0	0.0	0.0	0.0	-5.0	36.0	-12.0	-19.0											growth/size/body region phenotype; pigmentation phenotype; mortality/aging ; hematopoietic system phenotype; 			.	.	oocyte maturation;positive regulation of neuron projection development;protein transport;endosomal transport;polar body extrusion after meiotic divisions;spindle assembly involved in meiosis	nucleoplasm;early endosome;endoplasmic reticulum;cytosol;neuron projection;neuronal cell body;WASH complex	protein binding	TGOLN2[29568061];SNX1[20923837];FKBP15[20923837];TBC1D5[20923837];CAPZA2[26496610];RAB9A[29568061];VPS26A[26496610];VPS26B[26496610];EZR[29568061];CEP128[26638075];HSPD1[30021884];	126095505
72134	chr8	128429134	G	C	chr8:128429134	POU5F1B	POU class 5 homeobox 1B	SNV	0/1	0.46	54_47	102	99.0	0/1	0.5	57_58	115	99.0				EXONIC	YES	NM_001159542.2	Transcript	protein_coding	synonymous_variant		1/1	NM_001159542.2:c.1023G>C	NP_001153014.1:p.Gly341%3D		1.0						.	.	.						32	0.95											89	0.65														0.207	-0.381474		0	0	0			POU5F1B	0.0	0.0	0.0	0.0	-16.0	-28.0	15.0	-28.0							0.0				.			.	.	regulation of transcription, DNA-templated;regulation of transcription by RNA polymerase II	nucleoplasm;mitochondrion;cytosol	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription factor activity;sequence-specific DNA binding	.	128429134
72360	chr8	142437037	A	G	chr8:142437037	PTP4A3	protein tyrosine phosphatase type IVA, member 3	SNV	0/1	0.54	43_50	93	99.0	0/1	0.56	37_47	84	99.0				SPLICING	YES	NM_032611.3	Transcript	protein_coding	splice_acceptor_variant	3/5		NM_032611.3:c.199-2A>G			1.0						.	.	.						33	0.98											43	0.95														34.0	5.567474		0	0	0			PTP4A3	0.78	0.99	0.02	0.0	-30.0	2.0	40.0	12.0	0.999967305459904	0.938	4.653	7.955	12.608	0.333	0.13				homeostasis/metabolism phenotype; growth/size/body region phenotype; neoplasm; mortality/aging ; 			superior cervical ganglion;trigeminal ganglion;skeletal muscle;heart;	.	regulation of transcription, DNA-templated;Notch signaling pathway;peptidyl-tyrosine dephosphorylation;positive regulation of vascular permeability;endothelial cell migration;regulation of vascular endothelial growth factor signaling pathway;positive regulation of NIK/NF-kappaB signaling;positive regulation of establishment of protein localization;cellular response to leukemia inhibitory factor	nucleus;cytoplasm;early endosome;plasma membrane	protein tyrosine phosphatase activity;prenylated protein tyrosine phosphatase activity;protein binding;protein tyrosine/serine/threonine phosphatase activity	IPO11[17353931];NUP188[17353931];UBE3C[17353931];TMEM41B[17353931];LTN1[17353931];IPO4[17353931];CCAR2[17353931];SMC2[17353931];NUBP2[17353931];TOMM22[17353931];EFTUD2[17353931];FNTA[17353931];PSMD3[17353931];FNTB[17353931];CHP1[17353931];PSPH[17353931];SEC63[17353931];GTF2I[17353931];TANGO6[17353931];TPM4[28330616];UBE4A[17353931];DNAAF5[17353931];ATP1B3[17353931];ATAD3A[17353931];CLPX[17353931];NUP93[17353931];DPM1[17353931];MSH2[17353931];ZW10[17353931];DNAJB11[17353931];GEMIN4[17353931];PDXDC1[17353931];CUL2[17353931];NCAPG[17353931];HACD3[17353931];PDS5A[17353931];PRPSAP1[17353931];BAG2[17353931];SSR1[17353931];ATP6V1H[17353931];MDN1[17353931];GCN1[17353931];TBC1D15[17353931];FANCI[17353931];GGT7[17353931];SURF4[17353931];DNAJC11[17353931];HNRNPM[17353931];CDK2[17353931];SRPRB[17353931];MMS19[17353931];EIF4G2[17353931];ABCD3[17353931];MCM7[17353931];ATP2A2[17353931];TTC27[17353931];UFL1[17353931];SEC61A1[17353931];AIFM1[17353931];OPA1[17353931];XPO5[17353931];TNPO2[17353931];TNPO3[17353931];UNC45A[17353931];PDCD6IP[17353931];SSR4[17353931];SSR3[17353931];AHSA1[17353931];TIMM23[17353931];TUBG2[17353931];DDOST[17353931];TTI1[17353931];PTP4A2[28330616];PTP4A3[17353931];TMEM33[17353931];Tcr-alpha[17353931];KIF1BP[17353931];MCM3[17353931];STRAP[17353931];PCNA[17353931];OAT[17353931];HEATR1[17353931];USO1[17353931];ATP1A4[17353931];DDX20[17353931];SLC3A2[17353931];HSD17B11[17353931];ECPAS[17353931];POLD1[17353931];HEATR3[17353931];NCDN[17353931];CNNM3[17353931];ARFGEF1[17353931];STAT1[17353931];GBF1[17353931];XPO7[17353931];LRPPRC[17353931];DNAJA1[17353931];MYO1B[17353931];MYO1C[17353931];RAB3GAP2[17353931];EPPK1[17353931];ATXN10[17353931];RAB3GAP1[17353931];MAD2L1[17353931];	142437037
72471	chr8	144810314	G	A	chr8:144810314	FAM83H	family with sequence similarity 83 member H	SNV	0/1	0.48	97_92	190	99.0	0/0	0.0	43_0	43	99.0			rs1554623148	EXONIC	YES	NM_198488.5	Transcript	protein_coding	synonymous_variant		5/5	NM_198488.5:c.1317C>T	NP_940890.4:p.Asp439%3D		-1.0					Amelogenesis imperfecta, type IIIA, 130900 (3), Autosomal dominant	Hypocalcified amelogenesis imperfecta	Disease-causing germline mutation(s) in	Anterior open bite;Amelogenesis imperfecta;Autosomal dominant inheritance;Dental malocclusion						33	0.96							8.54964e-06	2.0	233928.0	0.0	51	0.93	PASS	amr	5.87199e-05	2.0	0.0	0.0					9e-05	1.0		4.653	0.123707		0	0	0			FAM83H	0.01	0.0	0.0	0.0	-16.0	32.0	33.0	-31.0							0.88	0.058439387			skeleton phenotype; behavior/neurological phenotype ; mortality/aging ; craniofacial phenotype; integument phenotype ; growth/size/body region phenotype; 			.	.	positive regulation of cell migration;biomineral tissue development;protein localization to cytoskeleton;intermediate filament cytoskeleton organization	cytoplasm;keratin filament	protein kinase binding;keratin filament binding	UNC45A[25036637];HSP90AA1[19875381];CEP135[26638075];CSNK1A1[23455922;26496610];ODF2[26638075];SEC16A[26496610];CLTC[26496610];BOD1L1[26496610];ORMDL1[26496610];DDX54[26496610];CSNK1D[26496610];CSNK1E[23455922;26496610];PPHLN1[26496610];BRCA1[29656893];CHTF18[26496610];NOP9[26496610];PTBP3[22575643];GAK[26496610];RUSC1[26496610];CNTROB[26638075];IKBKG[unassigned1774];GTSE1[26496610];LYAR[26496610];NINL[26638075];	144810314
72505	chr8	144994028	C	T	chr8:144994028	PLEC	plectin	SNV	0/1	0.51	59_62	121	99.0	0/1	0.54	69_82	152	99.0			rs34132016	EXONIC	YES	NM_201380.4	Transcript	protein_coding	missense_variant		32/32	NM_201380.4:c.10372G>A	NP_958782.1:p.Gly3458Arg		-1.0	.,.,.,.,.,.,.,.,.,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Epidermolysis_bullosa_simplex,_Ogna_type|Epidermolysis_bullosa_simplex_with_muscular_dystrophy|Epidermolysis_bullosa_simplex_with_pyloric_atresia|Limb-girdle_muscular_dystrophy,_type_2Q|Epidermolysis_bullosa_simplex_with_nail_dystrophy|not_specified|not_provided	?Epidermolysis bullosa simplex 5D, generalized intermediate, autosomal recessive, 616487 (3), Autosomal recessive; Epidermolysis bullosa simplex 5B, with muscular dystrophy, 226670 (3), Autosomal recessive; Epidermolysis bullosa simplex 5C, with pyloric atresia, 612138 (3), Autosomal recessive; Epidermolysis bullosa simplex 5A, Ogna type, 131950 (3), Autosomal dominant; Muscular dystrophy, limb-girdle, autosomal recessive 17, 613723 (3), Autosomal recessive	Epidermolysis bullosa simplex with pyloric atresia;Autosomal recessive limb-girdle muscular dystrophy type 2Q;Epidermolysis bullosa simplex with muscular dystrophy;Epidermolysis bullosa simplex, Ogna type	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Bruising susceptibility;Abnormal blistering of the skin;Onychogryposis;Skin erosion;Lumbar hyperlordosis;Muscular dystrophy;Motor delay;Difficulty climbing stairs;Skeletal muscle atrophy;Flexion contracture;Generalized muscle weakness;Autosomal recessive inheritance;Elevated serum creatine kinase;Rapidly progressive;Gowers sign;Fatigable weakness;Papule;Ptosis;Hypoplastic fingernail;Skin vesicle;Fatigue;Dermal atrophy;Abnormality of dental enamel;Mutism;Ophthalmoplegia;Aphasia;Myopathy;Oculomotor nerve palsy;Muscle flaccidity;Alopecia;Echolalia;Dysphasia;Hyperconvex fingernails;Urethral stricture;Carious teeth;Milia;Punctate keratitis;Scarring alopecia of scalp;Hypoplasia of dental enamel;Keratitis;Neonatal respiratory distress;Short stature;Abnormal blistering of the skin;Nail dystrophy;Increased connective tissue;Nail dysplasia;Muscular dystrophy;Autosomal recessive inheritance;Anemia;Palmoplantar hyperkeratosis;Skin fragility with non-scarring blistering;Hypoplastic dermoepidermal hemidesmosomes;Autosomal dominant inheritance;Bruising susceptibility;Onychogryposis of toenails;Abnormal blistering of the skin;Fragile skin;Polyhydramnios;Underdeveloped nasal alae;Flexion contracture;Congenital onset;Microtia;Autosomal recessive inheritance;Deeply set eye;Plantar hyperkeratosis;Autosomal recessive inheritance;Nail dystrophy;Dysphagia;Limitation of joint mobility;Aplasia cutis congenita;Anemia;Glomerulosclerosis;Renal dysplasia;Ureterocele;Aplasia of the bladder;Dehydration;Hydronephrosis;Sepsis;Polyhydramnios;Premature birth;Abnormality of the stomach;Failure to thrive;Skin erosion;Oral mucosal blisters;Difficulty climbing stairs;Calf muscle hypertrophy;Skeletal muscle atrophy;Achilles tendon contracture;Bilateral facial palsy;Bilateral ptosis;Gowers sign;Frequent falls;Generalized muscle weakness;Elevated serum creatine kinase;Dysphagia;Increased lactate dehydrogenase level;Global developmental delay;Areflexia;Exertional dyspnea;Atelectasis;Loss of ability to walk;Nasal speech;Bronchiolitis;Progressive proximal muscle weakness;Proximal upper limb muscle hypertrophy;Distal lower limb muscle weakness;Decreased cervical spine flexion due to contractures of posterior cervical muscles;Delayed gross motor development;Pelvic girdle muscle weakness;Right bundle branch block;Axial muscle atrophy;EMG: myopathic abnormalities;Pulmonary fibrosis;Autosomal recessive inheritance;Esophageal atresia;Nail dysplasia;Nail dystrophy;Congenital onset;Abnormality of the genitourinary system;Ectropion;Arthrogryposis multiplex congenita;Congenital pyloric atresia;Death in infancy;Elevated maternal serum alpha-fetoprotein;Axillary pterygium;Fragile skin;Intractable diarrhea;Polyhydramnios;Aplasia cutis congenita;Junctional split;Anonychia;Atrophic scars;Hypoplasia of dental enamel;Milia;Facial palsy;Skin ulcer;Toe syndactyly;Congenital localized absence of skin;Spinal dysraphism;Aplasia cutis congenita over the scalp vertex;Prolonged bleeding time;Finger syndactyly;Calvarial skull defect;Abnormality of bone mineral density	25741868	0.00551775	840.0	152236.0	5.0	33	0.98	PASS	nfe	0.00878843	598.0	0.00878843	598.0	0.00572259	1418.0	247790.0	7.0	100	0.99	PASS	nfe	0.00908718	1018.0	0.00908718	1018.0	0.0056783	883	0.01	29.0	0.01026	117.0		0.44	-0.272919	0.044	0	18	18		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PLEC	0.0	0.0	0.0	0.0	-2.0	20.0	-2.0	20.0						0.00999	0.02	0.000000000	0.001	-2.021	integument phenotype ; growth/size/body region phenotype; cellular phenotype; homeostasis/metabolism phenotype; muscle phenotype; normal phenotype; mortality/aging ; cardiovascular system phenotype ; hematopoietic system phenotype; behavior/neurological phenotype ; immune system phenotype; nervous system phenotype ; 			lung;ciliary ganglion;prefrontal cortex;atrioventricular node;placenta;skeletal muscle;	.	hemidesmosome assembly;wound healing;intermediate filament cytoskeleton organization	cytoplasm;cytosol;intermediate filament;plasma membrane;brush border;focal adhesion;membrane;sarcoplasm;hemidesmosome;sarcolemma;costamere;intermediate filament cytoskeleton;perinuclear region of cytoplasm;extracellular exosome	RNA binding;actin binding;structural molecule activity;structural constituent of cytoskeleton;protein binding;structural constituent of muscle;ankyrin binding;cadherin binding	ZNF451[30021884];GALNT14[30021884];UBE2D2[unassigned1312];OR4K17[30021884];PPP1CB[26496610];TUBB3[27291054];PPIP5K2[unassigned1312];PSMD3[30021884];SSX6[30021884];ZNF721[30021884];SYNPO[26496610];KRT6C[30021884];GBP6[30021884];GABARAPL1[20562859];PRKCH[30021884];KRT8[30021884];KAZN[30021884];OCRL[25107275];ANK3[21223964];CNPY3[30021884];GPR37L1[30021884];PPP1R3B[23414517];EWSR1[22240165];GPR161[30021884];PAPPA[30021884];MAP1A[30021884];KCTD13[19615732];SBDS[30021884];ROR1[30021884];DNA2[30021884];SQSTM1[20562859];SCG2[30021884];MXRA5[30021884];MAGEB4[30021884];CCDC27[30021884];KHDRBS1[30021884];CTTNBP2[30021884];ITPR1[30021884];IQGAP1[26496610];ADH6[30021884];MBTD1[30021884];PGBD4[30021884];TP53BP2[30021884];DVL3[unassigned1312];NUP88[unassigned1312];KIF3C[30021884];TAC1[30021884];N4BP2[30021884];QSER1[unassigned1312];MOAP1[30021884];SNAPIN[23414517];VCAM1[22623428];PDHA1[29128334];FANCM[30021884];FUS[22240165];TRAPPC5[30021884];SMAD9[15231748];ESR1[21182205];ESR2[25604459;21951318];SNUPN[30021884];PAN2[19615732];CS[30021884];ANLN[26496610];CCDC88A[unassigned1312];SNW1[20467437];WNK1[unassigned1312;30021884];AAK1[unassigned1312];GRB2[12577067];CDK12[30021884];ATR[30021884];AHCTF1[30021884];HIP1[30021884];MCM7[23764002];C2CD3[30021884];ITGB4[19242489];CTSZ[30021884];IFNA2[30021884];KIF14[30021884];MTR[30021884];PHF8[26496610];MAP1LC3B[20562859];METTL14[29507755];ACTR1A[30021884];TUBA1A[27291054];EXO1[30021884];TRPS1[30021884];MYO18B[30021884];MYO18A[26496610];ACP2[30021884];RBM6[30021884];PRMT5[30021884];TSC22D1[17353931];UTP11[30021884];DIS3[30021884];TRAF2[unassigned1774];URB2[30021884];ASH1L[30021884];ARFGAP3[unassigned1312];NIPSNAP1[26496610];PTBP3[22575643];TMIGD1[30021884];KIFC1[30021884];THRAP3[30021884];PEX5[30021884];CASQ2[30021884];MYH9[26496610];MAPRE1[26496610];INA[30021884];DNAH3[30021884];PPP1R15A[30021884];BECN1[22081109];LAMA5[30021884];AHNAK[unassigned1312];LUZP1[unassigned1312];DNAH5[30021884];DLST[29128334];RRBP1[30021884];TANK[unassigned1774];AXDND1[30021884];RECQL4[30021884];LIMA1[26496610];FGD5[30021884];FLNA[26496610];STAT6[30021884];FILIP1L[30021884];BUB1[26496610];PDLIM7[26496610];SLC25A25[30021884];R3HDML[30021884];SEC24B[unassigned1312];TAF15[22240165];URGCP[unassigned1312];USP20[19615732];STAT1[26966684];EYA4[unassigned1312];PLEKHA5[20936779];CDC5L[20467437];RSRC2[30021884];MYO19[26496610];TJP1[16944923];MCM3AP[30021884];KRT18[30021884];ACTC1[30021884];MYBBP1A[30021884];KANSL3[30021884];CAPZA2[26496610];HIST3H3[30021884];KRT14[30021884];ANKS4B[30021884];NCAPD3[30021884];PLCD1[30021884];CCDC62[30021884];	144994028
72612	chr8	145726216	ACT		chr8:145726216-145726218	PPP1R16A	protein phosphatase 1 regulatory subunit 16A	deletion	0/0	0.0	40_0	40	99.0	0/1	0.45	38_31	69	99.0			rs542669955	SPLICING	YES	NM_032902.7	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	10/12		NM_032902.7:c.908-9_908-7del			1.0						.	.	.		0.00215461	328.0	152232.0	5.0	34	0.98	PASS	amr	0.00510004	78.0	0.00216094	147.0	0.00223903	427.0	190708.0	2.0	30	0.57	PASS	amr	0.00627161	185.0	0.0023176	185.0	0.0000386,0.0002379	6,37	0.009	28.0				9.945	0.559319		0	0	0			PPP1R16A	0.03	0.01	0.0	0.0	30.0	27.0	11.0	29.0						0.515	0.05				.			thyroid;liver;	.	regulation of phosphoprotein phosphatase activity	plasma membrane	protein binding;protein phosphatase regulator activity	MYOM1[unassigned1304];TTC23[unassigned1304];DDX27[16169070];ATP23[unassigned1304];CDCA7L[unassigned1304];SUV39H1[unassigned1304];MRPL12[unassigned1304];PAPSS1[16169070];PPP1CB[21516116;25416956;unassigned1304;28330616];PPP1CC[unassigned1304];ZFYVE26[unassigned1304];PUF60[16169070];KAT5[unassigned1304];CDH24[16169070];FSD1[16169070];UNKL[unassigned1304];BATF2[unassigned1304];PRKAB2[unassigned1304];CCDC116[unassigned1304];TXNRD1[16169070];PBDC1[16169070];NEK6[unassigned1304];CKMT1A[unassigned1304];PPP1R16A[25416956];RFLNB[16169070];TFIP11[21516116];NUTF2[unassigned1304];IL16[unassigned1304];C3orf36[unassigned1304];KRTAP19-5[unassigned1304];RGMA[16169070];HLA-E[16169070];PPP1CA[22321011];AES[25416956];PHP14[16169070];SCNM1[unassigned1304];TRIP6[16189514;19060904];NDUFAB1[unassigned1304];TPP2[25416956];TSSK3[unassigned1304];ZNF414[unassigned1304];PRPF31[unassigned1304];LY6H[16169070];C1orf216[unassigned1304];IDO1[16169070];AVPI1[unassigned1304];	145726215
72667	chr8	145738486	G	A	chr8:145738486	RECQL4	RecQ like helicase 4	SNV	0/1	0.46	66_59	127	99.0	0/1	0.47	56_50	106	99.0			rs377593129,COSV52883620	EXONIC	YES	NM_004260.4	Transcript	protein_coding	synonymous_variant		16/22	NM_004260.4:c.2499C>T	NP_004251.4:p.His833%3D		-1.0		Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Baller-Gerold_syndrome|not_provided	Baller-Gerold syndrome, 218600 (3), Autosomal recessive; Rothmund-Thomson syndrome, type 2, 268400 (3), Autosomal recessive; RAPADILINO syndrome, 266280 (3), Autosomal recessive	Baller-Gerold syndrome;RAPADILINO syndrome;Rothmund-Thomson syndrome type 2	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Nystagmus;Prominent nasal bridge;Poikiloderma;Frontal bossing;Anal atresia;Abnormal localization of kidney;Short nose;Proptosis;Bowing of the long bones;Epicanthus;Aplasia/Hypoplasia of the patella;Scoliosis;Narrow mouth;Conductive hearing impairment;Anteriorly placed anus;Brachyturricephaly;Hypertelorism;Large fontanelles;Narrow nasal bridge;Cleft palate;Micrognathia;Lymphoma;Failure to thrive in infancy;Malabsorption;Hypotelorism;Hydronephrosis;Osteosarcoma;Vesicoureteral reflux;Intrauterine growth retardation;Hand oligodactyly;Abnormality of the metacarpal bones;High palate;Urogenital fistula;Aplasia/Hypoplasia of the thumb;Abnormality of the carpal bones;Abnormal cardiac septum morphology;Aplasia/Hypoplasia of the radius;Short stature;Broad forehead;Narrow face;Hypoplasia of teeth;Myelodysplasia;Osteosarcoma;Hypogonadism;Anemia;Neutropenia;Absent eyebrow;Short thumb;Skeletal dysplasia;Squamous cell carcinoma;Basal cell carcinoma;Poikiloderma;Sparse hair;Hypoplasia of the radius;Brittle hair;Palmoplantar keratoderma;Diarrhea;Cataract;Concave nasal ridge;Frontal bossing;Prematurely aged appearance;Osteopenia;Microdontia;Cutaneous photosensitivity;Absent eyelashes;Growth delay;Nausea and vomiting;Nail dystrophy;Autosomal recessive inheritance;Coronal craniosynostosis;Strabismus;Patellar hypoplasia;Hypoplasia of the ulna;Narrow mouth;High palate;Abnormal heart morphology;Optic atrophy;Perineal fistula;Carpal bone aplasia;Limited shoulder movement;Abnormality of cardiovascular system morphology;Conductive hearing impairment;Short humerus;Short stature;Rectovaginal fistula;Epicanthus;Myopia;Ulnar bowing;Underdeveloped nasal alae;Agenesis of corpus callosum;Absent radius;Abnormal vertebral morphology;Midface capillary hemangioma;Hypertelorism;Aplasia/Hypoplasia of the thumb;Abnormality of the kidney;Bicoronal synostosis;Seizure;Sagittal craniosynostosis;Micrognathia;Polymicrogyria;Aphalangy of the hands;Low-set, posteriorly rotated ears;Flat forehead;Spina bifida occulta;Downslanted palpebral fissures;Hydrocephalus;Brachyturricephaly;Rib fusion;Choanal stenosis;Bifid uvula;Prominent nasal bridge;Hypoplasia of the radius;Intellectual disability;Limited elbow movement;Scoliosis;Anal atresia;Aplasia of metacarpal bones;Carpal synostosis;Anteriorly placed anus;Lambdoidal craniosynostosis;Anomalous splenoportal venous system;Telangiectasia;Squamous cell carcinoma;Premature graying of hair;Cryptorchidism;Basal cell carcinoma;Glaucoma;Delayed eruption of teeth;Short thumb;Strabismus;Short nose;Mandibular prognathia;Cutaneous photosensitivity;Nail dystrophy;Osteoporosis;Microdontia;Kyphoscoliosis;Small hand;Microphthalmia;Frontal bossing;Sparse hair;Agenesis of permanent teeth;Small for gestational age;Short palm;Anteriorly placed anus;Short stature;Alopecia;Osteosarcoma;Talipes equinovarus;Short foot;Intellectual disability;Autosomal recessive inheritance;Microcornea;Congenital hip dislocation;Hypogonadism;Annular pancreas;Dermal atrophy;Zonular cataract;Increased number of teeth;Poikiloderma;Forearm reduction defects;Autosomal recessive inheritance;Narrow palpebral fissure;Aplasia/Hypoplasia of the patella;Hearing impairment;Slender nose;Short chin;Joint dislocation;High, narrow palate;Stiff interphalangeal joints;Mottled pigmentation;Aplasia/Hypoplasia of the radius;Short stature;Diarrhea;Long face;High palate;Absent thumb;Cleft palate;Blepharophimosis		5.26302e-05	8.0	152004.0	0.0	34	0.98	PASS	nfe	7.35251e-05	5.0	7.35251e-05	5.0	2.87723e-05	6.0	208534.0	0.0	18	0.45	PASS	eas	6.00168e-05	1.0	4.29295e-05	4.0	0.0000579	9			0.00026	3.0		0.092	-0.495086		0	0	0			RECQL4	0.01	0.01	0.0	0.04	-9.0	46.0	6.0	-36.0								18.484268124			endocrine/exocrine gland phenotype; adipose tissue phenotype ; growth/size/body region phenotype; integument phenotype ; craniofacial phenotype; skeleton phenotype; immune system phenotype; cellular phenotype; behavior/neurological phenotype ; embryo phenotype; pigmentation phenotype; neoplasm; hematopoietic system phenotype; mortality/aging ; digestive/alimentary phenotype; limbs/digits/tail phenotype; 			skeletal muscle;	.	telomere maintenance;double-strand break repair via homologous recombination;DNA strand renaturation;DNA replication;DNA repair;base-excision repair;DNA recombination;multicellular organism development;positive regulation of cell population proliferation;positive regulation of G2/M transition of mitotic cell cycle;DNA duplex unwinding;positive regulation of DNA replication;telomeric D-loop disassembly	chromosome, telomeric region;nucleus;chromosome;cytoplasm;membrane	bubble DNA binding;DNA binding;single-stranded DNA binding;helicase activity;protein binding;ATP binding;four-way junction helicase activity;oxidized purine DNA binding;annealing helicase activity;ATP-dependent 3'-5' DNA helicase activity;telomeric D-loop binding	ACD[21044950];RAD51[18562274];PPP2R2B[19156129];TERF2IP[21044950];POT1[21044950];BRCA1[29656893];TERF1[21044950];PRSS23[16169070];PLEC[30021884];	145738486
72793	chr9	977295	G	C	chr9:977295	DMRT3	doublesex and mab-3 related transcription factor 3	SNV	0|1	0.44	27_22	50	99.0	0/1	0.56	26_33	59	99.0			rs371952660	EXONIC	YES	NM_021240.4	Transcript	protein_coding	synonymous_variant		1/2	NM_021240.4:c.294G>C	NP_067063.1:p.Pro98%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		46,XY partial gonadal dysgenesis	Candidate gene tested in	Primary amenorrhea;Abnormal sex determination;Azoospermia;Ambiguous genitalia;Sparse axillary hair;Elevated circulating follicle stimulating hormone level;Urogenital sinus anomaly;Streak ovary;Female external genitalia in individual with 46,XY karyotype;Decreased testicular size;Clitoral hypertrophy;Micropenis;Testicular gonadoblastoma;Decreased fertility in females;Male infertility;Vanishing testis;Elevated circulating luteinizing hormone level;Nephrotic syndrome;Delayed puberty;Absence of secondary sex characteristics;Abnormality of cardiovascular system morphology;Abnormality of the scrotum;Hypergonadotropic hypogonadism;Hypoplasia of the vagina;Hypospadias;Gonadal dysgenesis;Sparse pubic hair;Adrenal insufficiency;Decreased serum testosterone level;Osteoporosis;Primary gonadal insufficiency;Gynecomastia;Ovarian gonadoblastoma;Decreased serum estradiol;Delayed skeletal maturation;Abnormality of the labia;Cryptorchidism;Nephroblastoma		0.00518386	781.0	150660.0	4.0	33	0.95	PASS	nfe	0.00744722	503.0	0.00744722	503.0	0.00687718	720.0	104694.0	8.0	9	0.1	PASS	nfe	0.00891148	447.0	0.00891148	447.0	0.0038134	593	0.003	9.0			1.0	10.85	0.663583		0	0	0			DMRT3	0.0	0.0	0.0	0.0	49.0	-7.0	-24.0	-7.0						0.579	0.0	3.072167549			craniofacial phenotype; reproductive system phenotype; mortality/aging ; nervous system phenotype ; skeleton phenotype; behavior/neurological phenotype ; 			testis - interstitial;	.	regulation of transcription by RNA polymerase II;sex differentiation;adult walking behavior;transmission of nerve impulse;ventral spinal cord interneuron specification;regulation of odontogenesis of dentin-containing tooth;male sex differentiation	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;protein binding;sequence-specific DNA binding;metal ion binding;protein heterodimerization activity	"GPSM1[unassigned1304];PLEKHF2[unassigned1304];AKAP8L[unassigned1304];ATN1[unassigned1304];FHL3[unassigned1304];HSF2BP[unassigned1304];FHL5[unassigned1304];MEOX2[unassigned1304];SAT1[25416956;unassigned1304];LASP1[unassigned1304];CYSRT1[unassigned1304];UBASH3B[25416956];C11orf1[unassigned1304];RUSC1[unassigned1304];KRTAP1-5[unassigned1304];MYOZ3[unassigned1304];KRTAP3-3[unassigned1304];OIP5[unassigned1304];TRIM27[25416956;unassigned1304];PRR20D[unassigned1304];KRTAP3-1[unassigned1304];KRTAP1-1[unassigned1304];TRIM23[25416956];KRTAP5-9[25416956];KRTAP9-3[unassigned1304];KRTAP5-7[unassigned1304];NHLRC4[unassigned1304];KRTAP9-2[unassigned1304];LMO2[unassigned1304];KRT35[unassigned1304];MTUS2[25416956;unassigned1304];KRT34[unassigned1304];TSC1[unassigned1304];TRAF1[25416956];KRT31[25416956;unassigned1304];ZFY[unassigned1304];KRTAP19-5[unassigned1304];FRS3[unassigned1304];MID2[25416956;unassigned1304];AES[unassigned1304];PLSCR1[25416956];PSMA3[25416956];CLUHP3[unassigned1304];RFX6[unassigned1304];HGS[unassigned1304];KRT38[unassigned1304];PSME3[unassigned1304];KRT36[unassigned1304];ASPG[unassigned1304];ZNF438[unassigned1304];ATP6V0D1[unassigned1304];PFDN5[unassigned1304];ZMYND12[unassigned1304];MDFI[25416956;unassigned1304];KPRP[unassigned1304];GRN[unassigned1304];KHDRBS3[25416956];USP54[unassigned1304];PRDM14[unassigned1304];CCNDBP1[25416956];KRT40[25416956;unassigned1304];KRTAP6-2[unassigned1304];KRTAP2-3[unassigned1304];TFAP2A[24835590];WWOX[unassigned1304];SPAG8[unassigned1304];KRTAP10-7[25416956];RBPMS[25416956];KRTAP10-9[25416956;unassigned1304];KRTAP10-8[25416956;unassigned1304];INCA1[25416956;unassigned1304];""Em[unassigned1304];NOTCH2NLA[25416956;unassigned1304];TTC19[unassigned1304];FOXN1[unassigned1304];TRIP6[25416956];REL[25416956;unassigned1304];TCF4[25416956];NFKBID[unassigned1304];"	977295
73054	chr9	13183486	T	C	chr9:13183486	MPDZ	multiple PDZ domain crumbs cell polarity complex component	SNV	0/0	0.0	33_0	33	99.0	0/1	0.57	38_51	90	99.0			rs34704118	EXONIC	YES	NM_001375413.1	Transcript	protein_coding	synonymous_variant		19/48	NM_001375413.1:c.2580A>G	NP_001362342.1:p.Leu860%3D		-1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	not_specified|not_provided	Hydrocephalus, congenital, 2, with or without brain or eye anomalies, 615219 (3), Autosomal recessive	Congenital communicating hydrocephalus	Disease-causing germline mutation(s) in	Strabismus;Frontal bossing;Motor delay;Posteriorly rotated ears;Seizure;Colpocephaly;Bulbous nose;Lissencephaly;Abnormal facial shape;Autosomal recessive inheritance;Sensorineural hearing impairment;Downslanted palpebral fissures;Macrocephaly;Optic atrophy;Macular hypoplasia;Simplified gyral pattern;Gray matter heterotopia;Ventriculomegaly;Intellectual disability;Variable expressivity;Iris coloboma;Communicating hydrocephalus;Congenital onset	19175764,18414213	0.0040338	613.0	151966.0	0.0	32	0.95	PASS	nfe	0.00628533	427.0	0.00628533	427.0	0.00439758	1089.0	247636.0	2.0	36	0.95	PASS	nfe	0.00643815	722.0	0.00643815	722.0	0.0044436	691	0.009	31.0	0.00605	69.0		8.943	0.452491		0	0	0			MPDZ	0.01	0.0	0.0	0.0	-15.0	-2.0	1.0	-22.0						0.998		0.000000000			behavior/neurological phenotype ; hearing/vestibular/ear phenotype; 			ciliary ganglion;amygdala;prefrontal cortex;superior cervical ganglion;trigeminal ganglion;pons;occipital lobe;atrioventricular node;spinal cord;parietal lobe;globus pallidus;hypothalamus;thalamus;	Tight junction	cell adhesion;viral process	cytoplasm;bicellular tight junction;postsynaptic density;apical plasma membrane;apicolateral plasma membrane;dendrite;cytoplasmic vesicle;Schmidt-Lanterman incisure;postsynaptic membrane	protein binding;protein C-terminus binding	YAP1[24366813;24255178];HTR2B[11150294];HTR2C[11150294];LIN7A[24366813];VPS26A[26496610];HTR2A[11150294];AMOT[19615732;24255178];SNX3[26496610];CYSLTR2[30126976];OR2AG1[19909339];ABCA1[16192269];OR1D2[19909339];PLEKHA1[14516276;11802782];PLEKHA2[14516276];XRCC5[26496610];KIF22[26496610];MPP5[24366813];SSTR3[19071123];NR4A1[20195357];MTNR1A[26514267];COPS5[18850735];LRFN4[22677168];AMOTL2[24255178];TP53[22653443];CRK[26496610];VCL[26496610];OR3A1[19909339];	13183486
73168	chr9	18906883	C	T	chr9:18906883	ADAMTSL1	ADAMTS like 1	SNV	0/1	0.59	43_61	104	99.0	0/1	0.38	50_31	81	99.0			rs746731054,COSV65883728,COSV65885375	EXONIC	YES	NM_001040272.6	Transcript	protein_coding	missense_variant		28/29	NM_001040272.6:c.5155C>T	NP_001035362.3:p.Arg1719Cys		1.0	.,.					Microcephaly-facial dysmorphism-ocular anomalies-multiple congenital anomalies syndrome	Disease-causing germline mutation(s) in	Bilateral sensorineural hearing impairment;Delayed myelination;Prominent metopic ridge;Vertebrobasilar dolichoectasia;Microcephaly;Nephrolithiasis;Migraine;Thyroid hypoplasia;Congenital hypothyroidism;Short philtrum;Tapered finger;Primary congenital glaucoma;Mandibular prognathia;Tented upper lip vermilion;Delayed eruption of permanent teeth;Buphthalmos;Brachycephaly;Rieger anomaly;Macrotia;Square face;Wide nasal bridge;Myopia;Abnormality of the palmar creases;Retinal detachment;Calcaneovalgus deformity		6.56987e-06	1.0	152210.0	0.0	33	0.98	PASS	nfe	1.46998e-05	1.0	1.46998e-05	1.0	1.20538e-05	3.0	248884.0	0.0	55	0.99	PASS	sas	3.26968e-05	1.0	1.77393e-05	2.0	0.0000129	2						32.0	4.79776	0.367	16	5	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred	ADAMTSL1	0.0	0.0	0.0	0.18	27.0	0.0	-2.0	27.0						0.673	0.0	0.000000000	1.0	1.026	.			ciliary ganglion;pons;subthalamic nucleus;dorsal root ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;skeletal muscle;	.	proteolysis	extracellular region;endoplasmic reticulum lumen	peptidase activity	.	18906883
73326	chr9	32986032	AAAAAAAAACAAAAAAAAAAAC		chr9:32986032-32986053	APTX	aprataxin	deletion	0|0	0.0	16_0	17	50.0	0/1	0.32	32_15	47	99.0			rs778542759	SPLICING	YES	NM_001368997.1	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	4/7		NM_001368997.1:c.484-25_484-4del			-1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	Ataxia-oculomotor_apraxia_type_1|not_specified|not_provided	Ataxia, early-onset, with oculomotor apraxia and hypoalbuminemia, 208920 (3), Autosomal recessive	Ataxia-oculomotor apraxia type 1	Disease-causing germline mutation(s) in	Peripheral axonal degeneration;Adult onset;Cerebellar atrophy;Hypercholesterolemia;Choreoathetosis;Distal amyotrophy;Gait ataxia;Oculomotor apraxia;Dysarthria;Muscle weakness;Pes cavus;Autosomal recessive inheritance;Mental deterioration;Cognitive impairment;Hyporeflexia;Progressive external ophthalmoplegia;Tremor;Axonal degeneration;Hypometric saccades;Scoliosis;Gaze-evoked nystagmus;Areflexia;Truncal ataxia;Hypoalbuminemia;Dementia;Limb ataxia;Ataxia;Distal sensory impairment;Juvenile onset;Dystonia;Decreased number of large peripheral myelinated nerve fibers;Ataxia;Peripheral neuropathy;Medial flaring of the eyebrow;Gait disturbance		0.0017659	85.0	48134.0	0.0	3	0.41	AS_VQSR	nfe	0.00233966	51.0	0.00233966	51.0	0.0849831	10088.0	118706.0	56.0	46	0.76	RF	nfe	0.112201	6426.0	0.112201	6426.0	0.0000643,0.0000257,0.0000193	10,4,3			0.02549	286.0		11.76	0.775585		0	0	0																	0.277	0.0				homeostasis/metabolism phenotype; cellular phenotype; 			ciliary ganglion;dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;medulla oblongata;	.	single strand break repair;DNA ligation;double-strand break repair;cellular response to DNA damage stimulus;dephosphorylation;regulation of protein stability;response to hydrogen peroxide;nucleic acid phosphodiester bond hydrolysis	chromatin;nuclear chromatin;nucleus;nucleoplasm;nucleolus;cytoplasm	chromatin binding;damaged DNA binding;double-stranded DNA binding;single-stranded DNA binding;double-stranded RNA binding;protein binding;phosphoglycolate phosphatase activity;mismatched DNA binding;DNA 5'-adenosine monophosphate hydrolase activity;metal ion binding;protein N-terminus binding;phosphoprotein binding;DNA-3'-diphospho-5'-guanosine diphosphatase;single-strand break-containing DNA binding	TSPYL2[16713569];MAPKBP1[16713569];CALCOCO1[16713569];PARP1[15555565;15044383];XRCC4[15380105;16439205;16713569];RBM8A[26496610];SORT1[26496610];CEP350[16713569];XRCC1[15555565;15380105;15367657;16713569;15044383;26496610];PNMA3[unassigned1304];SYT17[16713569];SYNCRIP[26496610];PNMA1[25416956;25910212];ZNF639[16713569];FLAD1[unassigned1304];NCL[15044383];HIVEP1[16713569];PICK1[16713569];TRIM37[16713569];MBP[16713569];CNTROB[16713569];TP53[15044383];	32986031
73488	chr9	33385287	T	C	chr9:33385287	AQP7	aquaporin 7	SNV	0/1	0.23	63_19	82	99.0	0/1	0.15	60_11	71	69.0			rs74557595,COSV53004903	SPLICING	YES	NM_001376191.1	Transcript	protein_coding	missense_variant,splice_region_variant		9/9	NM_001376191.1:c.745A>G	NP_001363120.1:p.Asn249Asp		-1.0	.,.,.				[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.						32	0.96							0.00413101	783.0	189542.0	0.0	66	0.93	RF	eas	0.00828991	105.0	0.00306937	270.0	0.0003151	49	0.043	123.0	0.02089	214.0		11.44	0.736246	0.02	0	16	16		SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred										0.000272391422788	0.03	10.146	-0.423	9.723	0.227	0.0		0.012	0.067	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];	33385287
73604	chr9	33385667	A	G	chr9:33385667	AQP7	aquaporin 7	SNV	0/1	0.31	99_44	144	99.0	0/1	0.12	113_15	129	57.0			rs79779983,COSV53002866	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	synonymous_variant		8/9	NM_001376191.1:c.723T>C	NP_001363120.1:p.Gly241%3D		-1.0					[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.						32	0.97							0.0194069	3051.0	157212.0	0.0	100	1.0	RF	afr	0.0216599	202.0	0.0211162	1378.0	0.0093117	1448	0.021	62.0	0.01976	225.0		8.123	0.375034		0	0	0																	0.227	0.0				renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];	33385667
73613	chr9	33385690	G	T	chr9:33385690	AQP7	aquaporin 7	SNV	0|1	0.26	110_39	150	99.0	0|1	0.09	124_12	137	99.0			rs139024279,COSV53002906	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	missense_variant		8/9	NM_001376191.1:c.700C>A	NP_001363120.1:p.Arg234Ser		-1.0	.,.,.,.,.,.,.	Benign	criteria_provided,_single_submitter	not_specified	[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.	24033266	1.97267e-05	3.0	152078.0	0.0	32	0.97	PASS	nfe	4.41163e-05	3.0	4.41163e-05	3.0	0.00368508	787.0	213564.0	0.0	100	1.0	PASS	nfe	0.00410381	395.0	0.00410381	395.0	0.0416581	6478	0.008	24.0	0.0194	221.0		23.4	2.906002	0.551	11	8	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred															0.227	0.0		0.64	1.176	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];	33385690
73632	chr9	33385698	A	G	chr9:33385698	AQP7	aquaporin 7	SNV	0|1	0.22	117_33	151	99.0	0|1	0.08	123_11	135	92.0			rs145516206,COSV53002949	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	missense_variant		8/9	NM_001376191.1:c.692T>C	NP_001363120.1:p.Leu231Pro		-1.0	.,.,.,.,.,.,.				[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.						32	0.97							0.00236866	524.0	221222.0	0.0	100	1.0	RF	nfe	0.002902	288.0	0.002902	288.0	0.0407578	6338	0.005	17.0	0.01834	209.0		24.2	3.253676	0.738	12	7	19	SIFT,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred															0.227	0.0		0.997	0.326	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];	33385698
73641	chr9	33385750	C	T	chr9:33385750	AQP7	aquaporin 7	SNV	0|1	0.14	108_18	127	99.0	0/0	0.0	121_0	121	99.0			rs114484742,COSV53003053	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	missense_variant		8/9	NM_001376191.1:c.640G>A	NP_001363120.1:p.Gly214Arg		-1.0	.,.,.,.,.,.,.	Benign	criteria_provided,_single_submitter	not_specified	[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.	24033266	9.19891e-05	14.0	152192.0	0.0	32	0.97	PASS	amr	0.000196258	3.0	8.81808e-05	6.0	0.00532544	1170.0	219700.0	0.0	100	1.0	RF	afr	0.0250652	346.0	0.00648776	631.0	0.0477287	7422	0.014	44.0	0.03402	388.0		22.3	2.379962	0.612	10	8	18	SIFT,LRT_pred,MutationTaster_pred,PROVEAN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,Polyphen2_HDIV_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred															0.227	0.0		0.028	1.026	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];	33385750
73649	chr9	33385784	C	G	chr9:33385784	AQP7	aquaporin 7	SNV	0|1	0.26	117_41	158	99.0	0|1	0.22	107_31	139	99.0			rs114937176,COSV53004992	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	missense_variant		8/9	NM_001376191.1:c.606G>C	NP_001363120.1:p.Glu202Asp		-1.0	.,.,.,.,.,.,.,.				[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.						32	0.97							0.0781421	8688.0	111182.0	0.0	100	1.0	InbreedingCoeff	afr	0.12771	1025.0	0.107072	4872.0	0.0006945	108	0.113	354.0	0.07671	875.0		17.46	1.697112	0.14	4	13	17	SIFT,FATHMM_pred,DEOGEN2_pred,fathmm-MKL_coding_pred	PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred															0.227	0.0		0.528	1.026	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];	33385784
73662	chr9	33385786	C	G	chr9:33385786	AQP7	aquaporin 7	SNV	0|1	0.26	117_41	158	99.0	0|1	0.22	107_31	139	99.0			rs76908057,COSV53003344,COSV53003709	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	missense_variant		8/9	NM_001376191.1:c.604G>C	NP_001363120.1:p.Glu202Gln		-1.0	.,.,.,.,.,.,.,.				[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.						32	0.97							0.086125	9461.0	109852.0	0.0	100	1.0	InbreedingCoeff	afr	0.134791	1091.0	0.117276	5295.0	0.0006817	106	0.127	400.0	0.0775	884.0		10.71	0.646639	0.086	1	16	17	FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred															0.227	0.0		0.121	-0.186	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];	33385786
73675	chr9	33385808	G	T	chr9:33385808	AQP7	aquaporin 7	SNV	0|1	0.17	138_28	166	99.0	0|1	0.21	125_33	159	99.0			rs62542744,COSV53004056	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	missense_variant		8/9	NM_001376191.1:c.582C>A	NP_001363120.1:p.Asn194Lys		-1.0	.,.,.,.,.,.,.,.				[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.						32	0.97							0.0102406	1122.0	109564.0	0.0	86	1.0	InbreedingCoeff_RF	afr	0.0148219	109.0	0.0122493	573.0	0.0001286	20	0.02	58.0	0.05146	587.0		23.3	2.865385	0.709	12	7	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred															0.227	0.0		0.238	1.176	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];	33385808
73686	chr9	33385815	T	C	chr9:33385815	AQP7	aquaporin 7	SNV	0|1	0.18	139_30	169	99.0	0|1	0.22	124_35	160	99.0			rs62542745,COSV53005643	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	missense_variant		8/9	NM_001376191.1:c.575A>G	NP_001363120.1:p.Gln192Arg		-1.0	.,.,.,.,.,.,.,.				[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.						32	0.97							0.0309309	3035.0	98122.0	0.0	85	1.0	InbreedingCoeff_RF	nfe	0.0353608	1472.0	0.0353608	1472.0	0.0001543	24	0.02	60.0	0.05234	597.0		12.87	0.92134	0.111	2	15	17	LRT_pred,FATHMM_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred															0.227	0.0		0.571	1.138	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];	33385815
73702	chr9	33385863	G	T	chr9:33385863	AQP7	aquaporin 7	SNV	0/1	0.31	77_34	111	99.0	0/1	0.39	72_46	119	99.0			rs62542746,COSV53003796	SPLICING	YES	NM_001376191.1	Transcript	protein_coding	missense_variant,splice_region_variant		8/9	NM_001376191.1:c.527C>A	NP_001363120.1:p.Ala176Glu		-1.0	.,.,.,.,.,.,.,.				[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		2.62902e-05	4.0	152148.0	0.0	33	0.97	PASS	nfe	4.41073e-05	3.0	4.41073e-05	3.0	0.374555	46710.0	124708.0	0.0	52	0.97	InbreedingCoeff	nfe	0.409083	24698.0	0.409083	24698.0	0.0069387	1079	0.126	397.0	0.11266	1285.0		10.21	0.588029	0.111	5	12	17	FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred										0.0002674219597193	0.034	3.039	0.059	3.097	0.227	0.0		0.001	-1.508	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];	33385863
73859	chr9	33386400	A	G	chr9:33386400	AQP7	aquaporin 7	SNV	0|1	0.18	62_14	77	99.0	0|1	0.23	56_17	73	99.0			rs771895202,COSV53004383	SPLICING	YES	NM_001376191.1	Transcript	protein_coding	splice_donor_variant	6/8		NM_001376191.1:c.406+2T>C			-1.0		Benign	criteria_provided,_single_submitter	not_specified	[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.	24033266					32	0.97							0.0116749	1853.0	158716.0	0.0	30	0.72	PASS	nfe	0.0171972	1275.0	0.0171972	1275.0	0.0016205	252	0.1	322.0	0.3985	4083.0		25.6	3.664875		0	0	0												0.999847007062202	0.836	0.586	7.754	8.34	0.227	0.0				renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];	33386400
73865	chr9	33386430	C	T	chr9:33386430	AQP7	aquaporin 7	SNV	0/1	0.13	73_11	85	91.0	0/1	0.2	70_17	87	99.0			rs74589499,COSV53004415	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	synonymous_variant		6/9	NM_001376191.1:c.378G>A	NP_001363120.1:p.Ala126%3D		-1.0					[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		5.91568e-05	9.0	152138.0	0.0	32	0.97	PASS	afr	0.000120802	5.0	4.40917e-05	3.0	0.00944502	1741.0	184330.0	0.0	52	0.75	RF	nfe	0.014824	1259.0	0.014824	1259.0	0.0226875	3528	0.072	229.0	0.2684	2750.0		0.267	-0.345504		0	0	0																	0.227	0.0				renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];	33386430
73881	chr9	33386465	A	G	chr9:33386465	AQP7	aquaporin 7	SNV	0|1	0.2	90_23	114	99.0	0|1	0.25	103_35	138	99.0			rs74668961,COSV53003174	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	missense_variant		6/9	NM_001376191.1:c.343T>C	NP_001363120.1:p.Tyr115His		-1.0	.,.,.,.,.,.,.	Benign	criteria_provided,_single_submitter	not_specified	[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.	24033266					32	0.97							0.00728821	1159.0	159024.0	0.0	77	0.82	RF	nfe	0.0112786	826.0	0.0112786	826.0	0.0405199	6301	0.14	443.0	0.14484	1484.0		23.9	3.157079	0.68	13	6	19	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred															0.227	0.0		0.085	1.312	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];	33386465
73894	chr9	33386469	C	T	chr9:33386469	AQP7	aquaporin 7	SNV	0|1	0.19	97_23	121	99.0	0|1	0.25	107_35	142	99.0			rs78695486,COSV53016926,COSV53018087	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	synonymous_variant		6/9	NM_001376191.1:c.339G>A	NP_001363120.1:p.Pro113%3D		-1.0					[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		0.000282504	43.0	152210.0	0.0	32	0.97	PASS	afr	0.000241266	10.0	0.000132271	9.0	0.00794843	1132.0	142418.0	0.0	78	0.84	PASS	nfe	0.0113985	751.0	0.0113985	751.0	0.0497801	7741	0.178	568.0	0.1343	1376.0		1.007	-0.149692		0	0	0																	0.227	0.0				renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];	33386469
73907	chr9	33386510	C	T	chr9:33386510	AQP7	aquaporin 7	SNV	0|1	0.29	74_30	105	99.0	0|1	0.31	81_36	117	99.0			rs77962308,COSV53003236	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	missense_variant		6/9	NM_001376191.1:c.298G>A	NP_001363120.1:p.Ala100Thr		-1.0	.,.,.,.,.,.,.				[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		0.0	0.0	152216.0	0.0	32	0.98	AC0				0.0	0.0	0.209967	18501.0	88114.0	1.0	59	0.88	InbreedingCoeff	afr	0.272746	1307.0	0.248104	9751.0	0.0019678	306	0.065	207.0	0.13029	1335.0		0.027	-0.657105	0.02	1	16	17	FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred															0.227	0.0		0.003	-0.618	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];	33386510
73913	chr9	33386511	A	G	chr9:33386511	AQP7	aquaporin 7	SNV	0|1	0.29	74_30	104	99.0	0|1	0.31	81_36	117	99.0			rs72707424,COSV53016707	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	synonymous_variant		6/9	NM_001376191.1:c.297T>C	NP_001363120.1:p.Phe99%3D		-1.0					[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		0.0	0.0	152250.0	0.0	32	0.98	AC0				0.0	0.0	0.22178	19058.0	85932.0	1.0	60	0.88	InbreedingCoeff_RF	afr	0.292079	1357.0	0.262456	10061.0	0.0019742	307	0.067	214.0	0.13215	1354.0		2.951	0.0211		0	0	0																	0.227	0.0				renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];	33386511
73928	chr9	33386526	G	A	chr9:33386526	AQP7	aquaporin 7	SNV	0/1	0.32	64_30	94	99.0	0/1	0.32	73_35	108	99.0			rs79202054,COSV53016746	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	synonymous_variant		6/9	NM_001376191.1:c.282C>T	NP_001363120.1:p.Asn94%3D		-1.0					[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		0.00010509	16.0	152250.0	0.0	32	0.98	PASS	afr	0.000265239	11.0	2.93945e-05	2.0	0.281051	28914.0	102878.0	0.0	46	0.84	InbreedingCoeff_RF	afr	0.342291	2038.0	0.316725	14843.0	0.0005145	80	0.132	406.0	0.21316	2184.0		2.514	-0.007382		0	0	0																	0.227	0.0				renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];	33386526
74080	chr9	33386989	C	G	chr9:33386989	AQP7	aquaporin 7	SNV	0/1	0.32	86_41	127	99.0	0/1	0.31	94_43	137	99.0			rs77244521,COSV53008689	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	synonymous_variant		5/9	NM_001376191.1:c.246G>C	NP_001363120.1:p.Val82%3D		-1.0					[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.						32	0.97							0.479246	49117.0	102488.0	0.0	100	1.0	InbreedingCoeff	sas	0.491116	6910.0	0.468693	19043.0	0.0101605	1580	0.066	180.0	0.3617	3706.0		5.499	0.177348		0	0	0																	0.227	0.0				renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];	33386989
74095	chr9	33387004	T	C	chr9:33387004	AQP7	aquaporin 7	SNV	0/1	0.31	90_41	131	99.0	0/1	0.32	96_45	141	99.0			rs76863051,COSV53008126	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	synonymous_variant		5/9	NM_001376191.1:c.231A>G	NP_001363120.1:p.Gly77%3D		-1.0					[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		0.0	0.0	152164.0	0.0	32	0.97	AC0_AS_VQSR				0.0	0.0	0.493278	57828.0	117232.0	0.0	100	1.0	InbreedingCoeff_RF	sas	0.497163	8237.0	0.490189	23133.0	0.0086429	1344	0.086	234.0	0.35633	3651.0		10.99	0.681162		0	0	0																	0.227	0.0				renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];	33387004
74106	chr9	33387047	T	G	chr9:33387047	AQP7	aquaporin 7	SNV	0/1	0.38	52_32	84	99.0	0/1	0.43	66_49	115	99.0			rs4008658,COSV53003999	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	missense_variant		5/9	NM_001376191.1:c.188A>C	NP_001363120.1:p.Lys63Thr		-1.0	.,.,.,.,.				[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		5.91677e-05	9.0	152110.0	0.0	32	0.97	PASS	amr	0.000523629	8.0	1.46994e-05	1.0	0.498584	107424.0	215458.0	0.0	96	1.0	InbreedingCoeff	sas	0.499298	13509.0	0.498478	49118.0	0.0137296	2135	0.087	236.0	0.32657	3346.0		0.013	-0.748308	0.012	1	16	17	FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred															0.227	0.0		0.0	-2.606	renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];	33387047
74121	chr9	33387073	G	A	chr9:33387073	AQP7	aquaporin 7	SNV	0/1	0.38	35_21	56	99.0	0/1	0.33	53_26	79	99.0			rs73645276,COSV53011131	EXONIC	YES	NM_001376191.1	Transcript	protein_coding	synonymous_variant		5/9	NM_001376191.1:c.162C>T	NP_001363120.1:p.Ser54%3D		-1.0					[Glycerol quantitative trait locus], 614411 (3), Autosomal recessive	.	.	.		7.22809e-05	11.0	152184.0	0.0	32	0.97	PASS	sas	0.000620861	3.0	7.34905e-05	5.0	0.495225	73940.0	149306.0	0.0	83	1.0	InbreedingCoeff_RF	sas	0.496021	8726.0	0.494118	33184.0	0.0130993	2037	0.107	297.0	0.31593	3237.0		10.97	0.677901		0	0	0																	0.227	0.0				renal/urinary system phenotype; growth/size/body region phenotype; reproductive system phenotype; homeostasis/metabolism phenotype; cellular phenotype; adipose tissue phenotype ; endocrine/exocrine gland phenotype; 			.	PPAR signaling pathway	generation of precursor metabolites and energy;water transport;excretion;glycerol transport;transmembrane transport	cytoplasm;plasma membrane;integral component of plasma membrane;cell-cell junction	urea transmembrane transporter activity;water channel activity;glycerol channel activity	CLCN7[unassigned1304];SLC5A8[25416956];MFSD6[unassigned1304];ABHD16A[unassigned1304];COMT[unassigned1304];	33387073
74210	chr9	33794798	GA		chr9:33794798-33794799	PRSS3	serine protease 3	deletion	0|1	0.22	74_21	97	99.0	0|1	0.16	92_18	110	99.0			rs773515866	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	frameshift_variant		2/6	NM_001197097.3:c.15_16del	NP_001184026.3:p.Glu5AspfsTer28		1.0						.	.	.						34	0.97							0.00150754	207.0	137310.0	0.0	29	0.58	RF	nfe	0.00116686	60.0	0.00116686	60.0	0.0018263	284	0.0	1.0				2.63	0.000467		0	0	0																	0.152	0.0				.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];	33794797
74217	chr9	33794809	G	A	chr9:33794809	PRSS3	serine protease 3	SNV	0|1	0.2	84_22	108	99.0	0|1	0.16	102_19	121	99.0			rs201061108,COSV61553847	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	missense_variant		2/6	NM_001197097.3:c.20G>A	NP_001184026.3:p.Ser7Asn		1.0	.,.					.	.	.		0.00502982	528.0	104974.0	0.0	33	0.9	AS_VQSR	afr	0.00751445	195.0	0.00376522	180.0	0.00133869	184.0	137448.0	0.0	31	0.58	RF	nfe	0.0013455	69.0	0.0013455	69.0	0.0014212	221	0.007	23.0				1.782	-0.06355	0.01	1	13	14	FATHMM_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred															0.152	0.0		0.003	-0.387	.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];	33794809
74218	chr9	33794812	G	T	chr9:33794812	PRSS3	serine protease 3	SNV	0|1	0.21	84_23	109	99.0	0|1	0.16	102_19	121	99.0			rs199873220,COSV61553850	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	missense_variant		2/6	NM_001197097.3:c.23G>T	NP_001184026.3:p.Gly8Val		1.0	.,.					.	.	.		0.00600644	619.0	103056.0	0.0	33	0.89	AS_VQSR	afr	0.00890746	226.0	0.00466315	219.0	0.0015264	197.0	129062.0	0.0	32	0.58	RF	nfe	0.00154205	74.0	0.00154205	74.0	0.0049323	767	0.008	26.0				3.552	0.057653	0.028	1	13	14	FATHMM_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred															0.152	0.0		0.003	-0.036	.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];	33794812
74413	chr9	33796799	A	T	chr9:33796799	PRSS3	serine protease 3	SNV	0|1	0.17	63_13	77	99.0	0/1	0.23	53_16	69	99.0			rs200709040,COSV61553597	SPLICING	YES	NM_001197097.3	Transcript	protein_coding	missense_variant,splice_region_variant		3/6	NM_001197097.3:c.241A>T	NP_001184026.3:p.Thr81Ser		1.0	.,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,.,.					.	.	.		0.000631186	75.0	118824.0	0.0	34	0.84	AS_VQSR	sas	0.000785752	3.0	0.000489947	27.0	0.00172707	356.0	206130.0	0.0	81	1.0	RF	nfe	0.00195451	177.0	0.00195451	177.0	0.0019935,0.0000064	310,1	0.015	48.0				6.21	0.225431	0.114	1	17	18	FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRSS3	0.0	0.0	0.03	0.01	-37.0	41.0	-32.0	1.0	0.0250244649468014	0.436	9.901	1.034	10.934	0.152	0.0		0.556	-0.834	.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];	33796799
74502	chr9	33797881	G	A	chr9:33797881	PRSS3	serine protease 3	SNV	0|1	0.11	103_13	117	99.0	0|1	0.11	85_11	97	99.0			rs372122039,COSV61554648	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	synonymous_variant		4/6	NM_001197097.3:c.297G>A	NP_001184026.3:p.Glu99%3D		1.0						.	.	.		0.0	0.0	149816.0	0.0	35	0.97	AC0_AS_VQSR				0.0	0.0	2.19892e-05	5.0	227384.0	0.0	100	1.0	RF	afr	0.000225394	3.0	0.0	0.0	0.0003473	54	0.019	58.0				7.26	0.303749		0	0	0			PRSS3	0.0	0.02	0.0	0.0	22.0	48.0	-45.0	48.0						0.152	0.0				.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];	33797881
74517	chr9	33797929		CC	chr9:33797928-33797929	PRSS3	serine protease 3	insertion	0/1	0.24	114_38	160	99.0	0/1	0.17	90_20	118	99.0			rs779080843,COSV61553068,COSV61555268	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	frameshift_variant		4/6	NM_001197097.3:c.344_345insCC	NP_001184026.3:p.Arg115SerfsTer11		1.0						.	.	.						34	0.85											100	1.0							0.0018135	282						16.69	1.573405		0	0	0																	0.152	0.0				.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];	33797928
74518	chr9	33797931	AC		chr9:33797931-33797932	PRSS3	serine protease 3	deletion	0|1	0.33	112_58	174	99.0	0|1	0.25	91_30	122	99.0			rs797012348	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	frameshift_variant		4/6	NM_001197097.3:c.349_350del	NP_001184026.3:p.Thr117SerfsTer4		1.0						.	.	.		0.00141055	155.0	109886.0	0.0	32	0.77	PASS	afr	0.00240983	62.0	0.000946348	49.0	0.0	0.0	251460.0	0.0	100	1.0	AC0_RF				0.0	0.0	0.0018263	284	0.011	36.0				16.44	1.53065		0	0	0			PRSS3	0.1	0.0	0.0	0.0	-1.0	-27.0	-11.0	47.0						0.152	0.0				.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];	33797930
74538	chr9	33797987	G	T	chr9:33797987	PRSS3	serine protease 3	SNV	0|1	0.32	149_71	225	99.0	0|1	0.26	132_46	179	99.0			rs137945391,COSV61553457	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	missense_variant		4/6	NM_001197097.3:c.403G>T	NP_001184026.3:p.Ala135Ser		1.0	.,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,.,.					.	.	.						39	0.99							0.0	0.0	245756.0	0.0	100	1.0	AC0_RF				0.0	0.0	0.0020321	316	0.014	44.0				0.006	-0.865741	0.033	2	17	19	M-CAP_pred,FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRSS3	0.02	0.0	0.0	0.0	40.0	1.0	5.0	-1.0						0.152	0.0		0.001	-0.522	.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];	33797987
74552	chr9	33797999	A	G	chr9:33797999	PRSS3	serine protease 3	SNV	0|1	0.31	155_72	232	99.0	0|1	0.24	141_45	188	99.0			rs142141488,COSV61553468	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	missense_variant		4/6	NM_001197097.3:c.415A>G	NP_001184026.3:p.Thr139Ala		1.0	.,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,.,.					.	.	.						41	0.99							0.0	0.0	245684.0	0.0	100	1.0	AC0_RF				0.0	0.0	0.0019228	299	0.014	43.0				0.115	-0.46413	0.155	2	17	19	PROVEAN_pred,FATHMM_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRSS3	0.0	0.02	0.0	0.0	1.0	28.0	-5.0	-9.0						0.152	0.0		0.002	0.025	.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];	33797999
74558	chr9	33798037	T	C	chr9:33798037	PRSS3	serine protease 3	SNV	0|1	0.09	168_18	191	99.0	0|1	0.22	135_38	175	99.0			rs774408268,COSV61554351	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	synonymous_variant		4/6	NM_001197097.3:c.453T>C	NP_001184026.3:p.Thr151%3D		1.0						.	.	.		0.00245692	278.0	113150.0	0.0	38	0.92	AS_VQSR	afr	0.00402943	115.0	0.00134548	70.0	0.0	0.0	247586.0	0.0	100	1.0	AC0_RF				0.0	0.0	0.0018006	280	0.002	7.0				4.945	0.141812		0	0	0			PRSS3	0.01	0.0	0.03	0.0	-10.0	43.0	40.0	2.0						0.152	0.0				.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];	33798037
74564	chr9	33798042	G	C	chr9:33798042	PRSS3	serine protease 3	SNV	0|1	0.08	167_14	186	46.0	0|1	0.22	130_37	169	99.0			rs141382822,COSV61553491	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	missense_variant		4/6	NM_001197097.3:c.458G>C	NP_001184026.3:p.Cys153Ser		1.0	.,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,.,.					.	.	.						41	0.99							4.14206e-06	1.0	241426.0	0.0	100	1.0	PASS	nfe	9.11959e-06	1.0	9.11959e-06	1.0	0.0107200	1667	0.003	10.0				21.2	2.171422	0.652	17	3	20	SIFT,PolyPhen,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	Polyphen2_HDIV_pred,MetaRNN_pred,LIST-S2_pred	PRSS3	0.0	0.01	0.0	0.01	13.0	-15.0	42.0	35.0						0.152	0.0		0.034	0.795	.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];	33798042
74634	chr9	33798574	G	A	chr9:33798574	PRSS3	serine protease 3	SNV	0/1	0.08	83_7	90	44.0	0|1	0.23	64_19	84	99.0			rs201773718,COSV61552937	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	missense_variant		5/6	NM_001197097.3:c.587G>A	NP_001184026.3:p.Ser196Asn		1.0	.,Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain&Serine proteases, trypsin domain,.,.					.	.	.		0.000736648	84.0	114030.0	0.0	31	0.82	AS_VQSR	afr	0.00191755	52.0	0.000355512	19.0	0.0260244	2383.0	91568.0	0.0	100	1.0	InbreedingCoeff_RF	nfe	0.0368014	1371.0	0.0368014	1371.0	0.0001222	19	0.005	15.0				6.877	0.274178	0.049	1	17	18	FATHMM_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PRSS3	0.0	0.0	0.01	0.01	30.0	1.0	46.0	-34.0						0.152	0.0		0.093	0.021	.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];	33798574
74638	chr9	33798596	T	C	chr9:33798596	PRSS3	serine protease 3	SNV	0/1	0.1	72_8	80	79.0	0|1	0.25	50_17	68	99.0			rs377148991,COSV61553136	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	synonymous_variant		5/6	NM_001197097.3:c.609T>C	NP_001184026.3:p.Leu203%3D		1.0						.	.	.						33	0.97							0.152961	15613.0	102072.0	0.0	100	1.0	InbreedingCoeff_RF	nfe	0.176702	7783.0	0.176702	7783.0	0.0001350	21	0.049	141.0				8.524	0.411789		0	0	0			PRSS3	0.0	0.0	0.02	0.0	4.0	-21.0	24.0	-12.0						0.152	0.0				.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];	33798596
74661	chr9	33799163	C	A	chr9:33799163	PRSS3	serine protease 3	SNV	0|1	0.14	43_7	50	99.0	0/1	0.13	45_7	53	99.0			rs376841271,COSV61554200	EXONIC	YES	NM_001197097.3	Transcript	protein_coding	synonymous_variant		6/6	NM_001197097.3:c.771C>A	NP_001184026.3:p.Ile257%3D		1.0						.	.	.		0.00014672	20.0	136314.0	0.0	33	0.91	AS_VQSR	sas	0.000666963	3.0	6.42158e-05	4.0	0.0180565	3008.0	166588.0	0.0	76	1.0	PASS	amr	0.0292649	668.0	0.0198742	1447.0	0.1133026	17619	0.013	39.0				1.93	-0.050869		0	0	0			PRSS3	0.0	0.0	0.0	0.0	36.0	12.0	-36.0	23.0						0.152	0.0				.			tongue;beta cell islets;subthalamic nucleus;pancreas;whole brain;superior cervical ganglion;trigeminal ganglion;skeletal muscle;cerebellum peduncles;cerebellum;	Neuroactive ligand-receptor interaction	proteolysis;digestion;cobalamin metabolic process;antimicrobial humoral response;zymogen activation;neutrophil degranulation;endothelial cell migration	extracellular region;extracellular space;tertiary granule lumen	serine-type endopeptidase activity;calcium ion binding;protein binding;serine-type peptidase activity	CASP14[24872419];JUN[25609649];METTL14[29507755];WTAP[29507755];SHC1[24189400];ALB[15174051];PSAP[24872419];METTL3[29507755];IGHA1[15174051];TANK[unassigned1774];NFKB1[25609649];	33799163
74760	chr9	35608953	A	G	chr9:35608953	TESK1	testis associated actin remodelling kinase 1	SNV	0/0	0.0	34_0	34	99.0	0/1	0.54	64_77	142	99.0			rs369029131	EXONIC	YES	NM_006285.3	Transcript	protein_coding	synonymous_variant		10/10	NM_006285.3:c.1095A>G	NP_006276.2:p.Pro365%3D		1.0						.	.	.		3.94457e-05	6.0	152108.0	0.0	32	0.97	PASS	nfe	8.82509e-05	6.0	8.82509e-05	6.0	9.94653e-05	25.0	251344.0	0.0	93	1.0	PASS	nfe	0.000211045	24.0	0.000211045	24.0	0.0000965	15	0.0	1.0				10.8	0.657773		0	0	0			TESK1	0.0	0.14	0.0	0.0	-49.0	2.0	36.0	-28.0						0.142	1.0	53.125397364			.			testis - seminiferous tubule;testis - interstitial;testis;parietal lobe;skeletal muscle;adrenal cortex;globus pallidus;	.	spermatogenesis;peptidyl-tyrosine phosphorylation;actin cytoskeleton organization;negative regulation of protein autophosphorylation;regulation of protein localization;positive regulation of stress fiber assembly;negative regulation of protein serine/threonine kinase activity	nucleus;cytoplasm;cytosol;cytoplasmic vesicle	protein serine/threonine kinase activity;protein serine/threonine/tyrosine kinase activity;protein tyrosine kinase activity;protein binding;ATP binding;protein C-terminus binding;protein kinase binding;metal ion binding	YY1[21988832];PFKL[21988832];HSP90AB1[22939624];YWHAB[11555644];ABCB4[21988832];SPRY4[12027893];ARAF[21988832];	35608953
74780	chr9	35906605		CCACCACCCCCACCACACCCCTCACCACCTCCACCACCACCACCC	chr9:35906604-35906605	HRCT1	histidine rich carboxyl terminus 1	insertion	0/0	0.0	31_0	31	4.0	0|1	0.18	30_8	44	99.0				EXONIC	YES	NM_001039792.2	Transcript	protein_coding	inframe_insertion		1/1	NM_001039792.2:c.322_323insACCACCCCCACCACACCCCTCACCACCTCCACCACCACCACCCCC	NP_001034881.1:p.His107_Arg108insHisHisProHisHisThrProHisHisLeuHisHisHisHisPro		1.0						.	.	.		0.00011789	4.0	33930.0	0.0	15	0.58	AS_VQSR	sas	0.000978474	1.0	0.000168011	3.0					15	0.44																	0	0	0																	0.156	0.16	0.000000000			.			.	.	.	integral component of membrane	.	.	35906604
74782	chr9	35957578	T	C	chr9:35957578	OR2S2	olfactory receptor family 2 subfamily S member 2 (gene/pseudogene)	SNV	0/0	0.0	93_0	93	99.0	0/1	0.46	70_60	131	99.0			rs140281775	EXONIC	YES	NM_019897.2	Transcript	protein_coding	missense_variant		1/1	NM_019897.2:c.518A>G	NP_063950.2:p.Asn173Ser		-1.0	GPCR, rhodopsin-like, 7TM					.	.	.						32	0.97							2.38614e-05	6.0	251452.0	0.0	100	1.0	PASS	nfe	4.39622e-05	5.0	4.39622e-05	5.0	0.0000129	2	0.0	1.0				12.8	0.911314	0.142	2	18	20	SIFT,PROVEAN_pred	PolyPhen,Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	OR2S2	0.0	0.0	0.01	0.0	-1.0	-26.0	-20.0	-42.0						0.892	0.0	0.000000000	0.071	0.966	.			.	Olfactory transduction	G protein-coupled receptor signaling pathway;sensory perception of smell;detection of chemical stimulus involved in sensory perception of smell	plasma membrane;integral component of membrane	G protein-coupled receptor activity;olfactory receptor activity	.	35957578
74823	chr9	39176063	G	A	chr9:39176063	CNTNAP3	contactin associated protein like 3	SNV	0/1	0.52	27_29	56	99.0	0/0	0.0	41_0	41	99.0			rs142785222	EXONIC	YES	NM_033655.5	Transcript	protein_coding	synonymous_variant		7/24	NM_033655.5:c.954C>T	NP_387504.2:p.Pro318%3D		-1.0						.	.	.		0.00385208	5.0	1298.0	0.0	2	0.0	AS_VQSR	afr	0.00714286	2.0	0.00395257	2.0	0.00502161	1257.0	250318.0	16.0	72	0.99	PASS	nfe	0.00656187	743.0	0.00656187	743.0	0.0041800	650	0.009	28.0				1.462	-0.094133		0	0	0			CNTNAP3	0.01	0.0	0.0	0.0	21.0	-6.0	21.0	-22.0							0.07				behavior/neurological phenotype ; 			.	.	cell adhesion;cell recognition	extracellular region;plasma membrane;integral component of membrane	.	.	39176063
74958	chr9	75773648	C	T	chr9:75773648	ANXA1	annexin A1	SNV	0/0	0.0	39_0	39	99.0	0/1	0.44	51_42	95	99.0			rs376171580,COSV99974073	EXONIC	YES	NM_000700.3	Transcript	protein_coding	missense_variant		3/13	NM_000700.3:c.104C>T	NP_000691.1:p.Ala35Val		1.0	.,.,.,.					.	.	.		8.54386e-05	13.0	152156.0	0.0	32	0.97	PASS	amr	0.000392824	6.0	8.8186e-05	6.0	9.95849e-05	25.0	251042.0	0.0	70	1.0	PASS	amr	0.000405351	14.0	7.93329e-05	9.0	0.0000450	7	0.001	4.0				22.1	2.325077	0.069	3	16	19	LRT_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred	ANXA1	0.0	0.0	0.0	0.02	-25.0	-37.0	-2.0	1.0						0.826	0.0	0.000000000	0.977	1.026	skeleton phenotype; immune system phenotype; nervous system phenotype ; digestive/alimentary phenotype; neoplasm; mortality/aging ; cardiovascular system phenotype ; hematopoietic system phenotype; cellular phenotype; homeostasis/metabolism phenotype; craniofacial phenotype; endocrine/exocrine gland phenotype; adipose tissue phenotype ; growth/size/body region phenotype; 			ciliary ganglion;tonsil;tongue;adipose tissue;placenta;	.	neutrophil homeostasis;adaptive immune response;monocyte chemotaxis;regulation of leukocyte migration;phagocytosis;inflammatory response;signal transduction;cell surface receptor signaling pathway;G protein-coupled receptor signaling pathway;G protein-coupled receptor signaling pathway, coupled to cyclic nucleotide second messenger;regulation of cell shape;response to X-ray;myoblast migration involved in skeletal muscle regeneration;peptide cross-linking;cytokine-mediated signaling pathway;insulin secretion;keratinocyte differentiation;prostate gland development;endocrine pancreas development;positive regulation of vesicle fusion;positive regulation of prostaglandin biosynthetic process;actin cytoskeleton reorganization;response to estradiol;DNA duplex unwinding;regulation of interleukin-1 production;positive regulation of interleukin-2 production;positive regulation of neutrophil apoptotic process;cellular response to vascular endothelial growth factor stimulus;gliogenesis;positive regulation of T cell proliferation;regulation of cell population proliferation;response to drug;negative regulation of apoptotic process;response to peptide hormone;estrous cycle;innate immune response;positive regulation of T-helper 1 cell differentiation;negative regulation of T-helper 2 cell differentiation;negative regulation of exocytosis;alpha-beta T cell differentiation;regulation of hormone secretion;arachidonic acid secretion;regulation of inflammatory response;cellular response to hydrogen peroxide;hepatocyte differentiation;prolactin secretion;response to interleukin-1;cellular response to glucocorticoid stimulus;granulocyte chemotaxis;positive regulation of cell migration involved in sprouting angiogenesis;positive regulation of wound healing;neutrophil clearance;cell-cell adhesion;positive regulation of G1/S transition of mitotic cell cycle;negative regulation of phospholipase A2 activity;negative regulation of interleukin-8 secretion	cornified envelope;phagocytic cup;extracellular region;extracellular space;nucleus;nucleoplasm;cytoplasm;endosome;cytosol;actin filament;plasma membrane;cell-cell adherens junction;focal adhesion;cell surface;basolateral plasma membrane;apical plasma membrane;lateral plasma membrane;extrinsic component of membrane;cytoplasmic vesicle membrane;extrinsic component of external side of plasma membrane;extrinsic component of endosome membrane;motile cilium;early endosome membrane;mitochondrial membrane;vesicle;protein-containing complex;sarcolemma;mast cell granule;collagen-containing extracellular matrix;extracellular exosome;synaptic membrane	single-stranded DNA binding;single-stranded RNA binding;signaling receptor binding;structural molecule activity;calcium ion binding;protein binding;phospholipid binding;calcium-dependent phospholipid binding;phospholipase A2 inhibitor activity;protein binding, bridging;double-stranded DNA-dependent ATPase activity;protein homodimerization activity;calcium-dependent protein binding;cadherin binding involved in cell-cell adhesion;DNA/DNA annealing activity	ATF2[22304920];USPL1[19615732];GOLT1B[26496610];FAF1[21900206];RPLP0[23754495];UBE2D1[21900206];HSPB1[25277244];DDX41[23754495];KIF11[26496610];CSAD[21900206];ACTB[15047060];CCAR2[23754495];ACTG1[23754495];CEP128[26638075];RPS14[23754495];TFG[26496610];DHX15[23754495];FLOT2[23754495];IKBKG[21383699];DLAT[23754495];DDX17[23754495];TLE3[23754495];GABARAPL1[20562859];RBM14[23754495];MAP1S[24366813];METTL3[29507755];YWHAZ[15161933];PPM1B[17353931];SLX1A[19596235];LRIF1[21900206];SQSTM1[20562859];GAPDH[21900206];PPIA[26496610];OTUB1[21900206];DCTN1[26638075];KMT2B[21900206];STK4[24366813;23386615];EGFR[15581623;20029029;24189400];RELA[21383699];WDCP[23754495];RASSF10[24366813];PABPN1[23754495];TP53BP2[24366813];RIPK1[21383699];APBB1[21900206];CCT7[21900206];LNPK[unassigned1304];USP25[19615732];C1orf123[21900206];XRCC6[21900206];VCAM1[22623428];PKLR[23754495];WTAP[29507755];CEP152[26638075];HMGA1[18850631];RPA1[21900206];FN1[19738201];KLHL23[21900206];PTPN11[23754495];MEIS2[25416956];NFKB1[25609649];SOD1[29128334];NFKBIA[14743216];COL1A1[23754495];CYLD[23754495];CCDC88A[26496610];ERG28[21900206];COPS6[21900206];DAB2[23754495];DLG3[17353931];UNC119[21900206];PTPN6[23754495];RBMX[23754495];BCAR1[28007913];HSPA1A[23754495];CEP89[26638075];	75773648
75037	chr9	85863069	G	A	chr9:85863069	FRMD3	FERM domain containing 3	SNV	0/1	0.51	90_94	185	99.0	0/1	0.53	67_77	145	99.0			rs190298518,COSV104409713	EXONIC	YES	NM_174938.6	Transcript	protein_coding	missense_variant		14/14	NM_174938.6:c.1558C>T	NP_777598.3:p.Arg520Trp		-1.0	.,.,.,.,.					.	.	.		0.00165587	252.0	152186.0	0.0	32	0.96	PASS	sas	0.00476783	23.0	0.00142576	97.0	0.00167944	419.0	249488.0	1.0	97	1.0	PASS	sas	0.00441176	135.0	0.001404	159.0	0.0015369	239	0.002	5.0				22.6	2.499401	0.124	4	15	19	MutationTaster_pred,FATHMM_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	FRMD3	0.0	0.0	0.0	0.01	-21.0	-2.0	2.0	-2.0						0.228	0.2	0.000000000	0.992	0.245	.			dorsal root ganglion;superior cervical ganglion;atrioventricular node;trigeminal ganglion;skeletal muscle;globus pallidus;	.	actomyosin structure organization	cytoskeleton;integral component of membrane	cytoskeletal protein binding	CYB5B[unassigned1304];CMTM7[unassigned1304];SLC35A4[unassigned1304];JAGN1[unassigned1304];NRM[unassigned1304];TMEM97[unassigned1304];ATP5F1D[24366813];SERP2[unassigned1304];OXA1L[24366813];TMEM201[unassigned1304];SERP1[unassigned1304];PLPP4[unassigned1304];ATP5PO[24366813];TMEM218[unassigned1304];ZFPL1[unassigned1304];	85863069
75051	chr9	86258357	G	A	chr9:86258357	IDNK	IDNK, gluconokinase	SNV	0/0	0.0	43_0	43	99.0	0/1	0.55	30_37	67	99.0			rs140430693	EXONIC	YES	NM_001001551.4	Transcript	protein_coding	missense_variant		5/5	NM_001001551.4:c.226G>A	NP_001001551.2:p.Gly76Arg		1.0	.,.,.					.	.	.		0.00742424	1127.0	151800.0	8.0	31	0.94	PASS	nfe	0.00988613	672.0	0.00988613	672.0	0.00821383	2038.0	248118.0	7.0	34	0.9	PASS	nfe	0.0104464	1171.0	0.0104464	1171.0	0.0077747	1209	0.012	39.0				23.0	2.747126	0.283	8	10	18	LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	SIFT,PolyPhen,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	IDNK	0.01	0.01	0.0	0.0	-11.0	-5.0	-13.0	40.0							0.48	0.000000000	0.994	1.004	behavior/neurological phenotype ; vision/eye phenotype; 			.	.	biological_process;phosphorylation;D-gluconate catabolic process	.	molecular_function;ATP binding;gluconokinase activity	.	86258357
75054	chr9	86354664	A		chr9:86354664	GKAP1	G kinase anchoring protein 1	deletion	0/1	0.25	15_5	20	70.0	0/1	0.36	17_13	36	99.0			rs748846032	SPLICING	YES	NM_025211.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	12/12		NM_025211.4:c.1054-5del			-1.0						.	.	.		0.00747659	1019.0	136292.0	1.0	31	0.87	PASS	nfe	0.00794818	497.0	0.00794818	497.0	0.382525	54330.0	142030.0	1.0	24	0.67	InbreedingCoeff	sas	0.415284	7711.0	0.384429	24066.0	0.0004437,0.1915578	69,29788						15.44	1.348395		0	0	0			GKAP1	0.01	0.0	0.0	0.0	-4.0	-12.0	-43.0	-47.0						0.188	0.12				.			.	.	signal transduction;positive regulation of insulin receptor signaling pathway	Golgi apparatus	protein binding;identical protein binding	KANK2[unassigned1304];L3MBTL2[unassigned1304];ZCCHC10[unassigned1304];HIF1A[26496610];HDDC3[25416956];HSD11B1[21988832];MMTAG2[unassigned1304];SDCBP[unassigned1304];FAM124B[unassigned1304];FXR2[16189514];KAT5[unassigned1304];SOX18[21988832];UBQLN1[16713569];SH3BP4[18654987];NPHP4[unassigned1312];DYR[25416956];ECT2[unassigned1312];UBQLN4[16713569];TEFM[unassigned1312];CLUH[unassigned1312];RPGRIP1L[26638075;27173435;unassigned1312];RPP25L[unassigned1312];KIF18A[26496610];PHOSPHO2[unassigned1304];MFAP1[25416956];HGS[16189514];GKAP1[25416956;unassigned1304];RCOR3[unassigned1304];NES[26496610];VCL[26496610];	86354663
75085	chr9	91606540		CCGGGCGCCCCGGCACCG	chr9:91606539-91606540	C9orf47	chromosome 9 open reading frame 47	insertion	0/1	0.28	34_13	47	99.0	0/0	0.0	33_0	33	99.0				EXONIC	YES	NM_001001938.4	Transcript	protein_coding	inframe_insertion		2/3	NM_001001938.4:c.405_422dup	NP_001001938.1:p.Arg138_Pro143dup		1.0						.	.	.						32	0.96											13	0.43																	0	0	0																		0.09	8.382688146			.			.	.	.	extracellular region	.	.	91606539
75096	chr9	91964685	A	G	chr9:91964685	SECISBP2	SECIS binding protein 2	SNV	0/0	0.0	34_0	34	99.0	0/1	0.67	23_47	70	99.0			rs571273217	SPLICING	YES	NM_024077.5	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	12/16		NM_024077.5:c.1739-6A>G			1.0					Thyroid hormone metabolism, abnormal, 609698 (3), Autosomal recessive	Short stature-delayed bone age due to thyroid hormone metabolism deficiency	Disease-causing germline mutation(s) in	Increased thyroid-stimulating hormone level;Autosomal recessive inheritance;Delayed skeletal maturation;Short stature		1.97389e-05	3.0	151984.0	0.0	33	0.98	PASS	sas	0.000207555	1.0	0.0	0.0	4.77365e-05	12.0	251380.0	0.0	100	1.0	PASS	amr	0.000231294	8.0	3.51815e-05	4.0	0.0000450	7			0.00018	2.0		0.78	-0.187631		0	0	0			SECISBP2	0.03	0.03	0.0	0.0	12.0	6.0	-1.0	43.0	2.26281613926593e-05	0.002	6.973	0.464	7.437	0.878	0.0				embryo phenotype; pigmentation phenotype; hematopoietic system phenotype; mortality/aging ; vision/eye phenotype; limbs/digits/tail phenotype; skeleton phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; 			.	.	selenocysteine incorporation;striatum development;neuron development;negative regulation of nuclear-transcribed mRNA catabolic process, nonsense-mediated decay	nucleus;mitochondrion;ribonucleoprotein complex	RNA binding;mRNA 3'-UTR binding;protein binding;selenocysteine insertion sequence binding;ribonucleoprotein complex binding	GOLGA2[25416956];CCT6A[30021884];EGLN3[26972000];PCM1[26638075];FAM168A[unassigned1304];HIST1H2AH[30021884];SPICE1[26638075];SMAD9[15231748];ATXN7L3[16713569];	91964685
75223	chr9	95279986	G	A	chr9:95279986	ECM2	extracellular matrix protein 2	SNV	0/1	0.57	33_44	77	99.0	0/0	0.0	34_0	34	99.0			rs147710026,COSV60741322	EXONIC	YES	NM_001393.4	Transcript	protein_coding	missense_variant		3/10	NM_001393.4:c.464C>T	NP_001384.1:p.Pro155Leu		-1.0	.,VWFC domain&VWFC domain&VWFC domain&VWFC domain,VWFC domain&VWFC domain&VWFC domain&VWFC domain,VWFC domain&VWFC domain&VWFC domain&VWFC domain					.	.	.		0.00110462	168.0	152088.0	0.0	32	0.96	PASS	nfe	0.00177941	121.0	0.00177941	121.0	0.00155886	392.0	251466.0	0.0	92	1.0	PASS	nfe	0.00218909	249.0	0.00218909	249.0	0.0013376	208	0.004	13.0	0.00359	41.0		25.9	3.730258	0.861	15	6	21	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	ECM2	0.0	0.0	0.0	0.02	-46.0	-24.0	-50.0	-17.0						0.836	0.0	0.000000000	0.931	1.176	.			ciliary ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;	.	cell-matrix adhesion;positive regulation of cell-substrate adhesion;extracellular matrix organization	interstitial matrix;extracellular matrix	integrin binding;heparin binding;collagen V binding	FAM20C[22582013];	95279986
75228	chr9	95378152	C	T	chr9:95378152	IPPK	inositol-pentakisphosphate 2-kinase	SNV	0/1	0.5	42_42	84	99.0	0/0	0.0	45_0	45	99.0			rs149821597,COSV99845365	EXONIC	YES	NM_022755.6	Transcript	protein_coding	missense_variant		13/13	NM_022755.6:c.1438G>A	NP_073592.1:p.Glu480Lys		-1.0	.,.					.	.	.		2.62833e-05	4.0	152188.0	0.0	33	0.97	PASS	nfe	5.87993e-05	4.0	5.87993e-05	4.0	6.36213e-05	16.0	251488.0	0.0	64	1.0	PASS	amr	0.000231281	8.0	5.27389e-05	6.0	0.0000579	9	0.001	2.0				22.8	2.63223	0.11	3	16	19	MutationTaster_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-XF_coding_pred	IPPK	0.0	0.0	0.0	0.01	-33.0	1.0	8.0	-32.0						0.265	0.97		0.962	1.026	mortality/aging ; 			ciliary ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skin;testis;skeletal muscle;	.	inositol phosphate biosynthetic process;inositol phosphate metabolic process;inositol phosphorylation;positive regulation of transcription of nucleolar large rRNA by RNA polymerase I	nucleus;nucleoplasm;nucleolus;cytosol	protein binding;ATP binding;protein-containing complex scaffold activity;inositol pentakisphosphate 2-kinase activity	.	95378152
75290	chr9	96408046	T	C	chr9:96408046	PHF2	PHD finger protein 2	SNV	0/1	0.58	32_45	77	99.0	0/0	0.0	34_0	34	99.0			rs183448716	EXONIC	YES	NM_005392.4	Transcript	protein_coding	synonymous_variant		4/22	NM_005392.4:c.435T>C	NP_005383.3:p.Tyr145%3D		1.0						.	.	.		0.000197096	30.0	152210.0	0.0	33	0.98	PASS	sas	0.00124069	6.0	0.000264574	18.0	0.000199641	49.0	245440.0	0.0	30	0.73	PASS	sas	0.00104652	31.0	0.000117007	13.0	0.0002186	34			0.00035	4.0		0.839	-0.176804		0	0	0			PHF2	0.0	0.0	0.02	0.0	-41.0	48.0	21.0	0.0						0.352	0.99	97.389913582			nervous system phenotype ; mortality/aging ; integument phenotype ; adipose tissue phenotype ; growth/size/body region phenotype; 			superior cervical ganglion;placenta;skeletal muscle;cerebellum;	.	liver development;protein demethylation;histone H3-K9 demethylation;oxidation-reduction process;negative regulation of chromatin silencing at rDNA	kinetochore;condensed chromosome kinetochore;nucleus;nucleoplasm;nucleolus	transcription coactivator activity;iron ion binding;protein binding;zinc ion binding;histone demethylase activity;histone demethylase activity (H3-K9 specific);methylated histone binding;dioxygenase activity	CPNE3[30021884];HIST2H2BE[30021884];	96408046
75407	chr9	104433048	T	C	chr9:104433048	GRIN3A	glutamate ionotropic receptor NMDA type subunit 3A	SNV	0/0	0.0	110_0	110	99.0	0/1	0.47	71_64	137	99.0			rs75981117,CM1414146	EXONIC	YES	NM_133445.3	Transcript	protein_coding	missense_variant		3/9	NM_133445.3:c.1646A>G	NP_597702.2:p.Asn549Ser		-1.0						.	.	.	25450229,27480506	0.00278559	424.0	152212.0	2.0	32	0.96	PASS	nfe	0.00467441	318.0	0.00467441	318.0	0.00285114	716.0	251128.0	1.0	100	1.0	PASS	nfe	0.00453776	515.0	0.00453776	515.0	0.0028166	438	0.007	22.0	0.00421	48.0		22.6	2.536761	0.335	8	11	19	SIFT,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	GRIN3A	0.0	0.0	0.0	0.0	-1.0	-22.0	1.0	-22.0						0.232	0.12	0.000000000	0.973	1.138	normal phenotype; vision/eye phenotype; nervous system phenotype ; 			ciliary ganglion;trigeminal ganglion;atrioventricular node;superior cervical ganglion;	Neuroactive ligand-receptor interaction	calcium ion transport;dendrite development;ionotropic glutamate receptor signaling pathway;response to ethanol;regulation of postsynaptic membrane potential;prepulse inhibition;calcium ion transmembrane transport;regulation of synaptic vesicle exocytosis	plasma membrane;postsynaptic density;membrane;integral component of membrane;NMDA selective glutamate receptor complex;cell junction;neuron projection;neuronal cell body;synapse;postsynaptic membrane;glutamatergic synapse	NMDA glutamate receptor activity;calcium channel activity;protein binding;glycine binding;identical protein binding;protein phosphatase 2A binding;transmitter-gated ion channel activity involved in regulation of postsynaptic membrane potential	.	104433048
75409	chr9	105767464	G	A	chr9:105767464	CYLC2	cylicin 2	SNV	0/0	0.0	35_0	35	99.0	0/1	0.46	41_36	78	99.0			rs10990424,COSV99058674	EXONIC	YES	NM_001340.5	Transcript	protein_coding	missense_variant		5/8	NM_001340.5:c.551G>A	NP_001331.1:p.Gly184Asp		1.0	.,.,.					.	.	.		0.00341382	518.0	151736.0	1.0	32	0.96	PASS	nfe	0.00519561	353.0	0.00519561	353.0	0.00353265	855.0	242028.0	2.0	33	0.8	PASS	nfe	0.00572878	628.0	0.00572878	628.0	0.0034661	539	0.008	24.0				0.057	-0.560343	0.064	0	18	18		SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CYLC2	0.0	0.0	0.0	0.0	24.0	-45.0	11.0	-1.0						0.937	0.0	0.000000000	0.002	0.149	.			.	.	cytoskeleton organization;multicellular organism development;spermatogenesis;cell differentiation	nucleus;cytoskeletal calyx	structural constituent of cytoskeleton	SMAD2[24412244];MAP2K4[24412244];CDKN2A[24412244];MCC[24412244];MLH1[24412244];EGFR[24412244];MLH3[24412244];AURKA[24412244];RSL1D1[30021884];HNRNPM[30021884];NRAS[24412244];STK11[24412244];ERBB2[24412244];BUB1[24412244];MUTYH[24412244];	105767464
75410	chr9	106860779	A	C	chr9:106860779	SMC2	structural maintenance of chromosomes 2	SNV	0/1	0.5	6_6	12	99.0	0/0	0.0	34_0	34	99.0			rs61755310	EXONIC	YES	NM_001042550.2	Transcript	protein_coding	missense_variant		4/25	NM_001042550.2:c.371A>C	NP_001036015.1:p.Asn124Thr		1.0	RecF/RecN/SMC, N-terminal&Smc2, ATP-binding cassette domain,RecF/RecN/SMC, N-terminal&Smc2, ATP-binding cassette domain,RecF/RecN/SMC, N-terminal&Smc2, ATP-binding cassette domain	Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00440297	670.0	152170.0	2.0	33	0.97	PASS	nfe	0.00704453	479.0	0.00704453	479.0	0.0041344	979.0	236794.0	2.0	54	0.65	PASS	nfe	0.00716689	784.0	0.00716689	784.0	0.0046301	720	0.007	22.0				23.4	2.930389	0.401	8	11	19	SIFT,LRT_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	SMC2	0.0	0.0	0.0	0.0	7.0	14.0	28.0	7.0						0.175	1.0	0.000000000	1.0	1.312	nervous system phenotype ; mortality/aging ; cellular phenotype; 			pons;ciliary ganglion;subthalamic nucleus;testis - interstitial;dorsal root ganglion;superior cervical ganglion;skin;atrioventricular node;fetal liver;skeletal muscle;globus pallidus;	.	mitotic chromosome condensation;meiotic chromosome condensation;meiotic chromosome segregation;cell division;kinetochore organization	nuclear chromosome;condensed chromosome;condensin complex;nucleus;nucleoplasm;nucleolus;cytoplasm;cytosol;extracellular exosome	single-stranded DNA binding;protein binding;ATP binding;protein heterodimerization activity	SMARCB1[30108113];KDM1A[26751641];CCP110[unassigned1312];JMJD1C[30021884];FOXM1[25609649];SMC3[26496610];SMC4[17113138;17268547;30021884];FOXQ1[25609649];TUBA1A[29568061];TUBB3[27291054];MYC[17353931;17314511];CHEK2[23178491];CASP4[17353931];IKBKG[14743216];GPR135[30021884];GSTK1[17353931];H2AFZ[21633354];ABCC5[21988832];TFE3[17353931];HLA-B[17353931];FOXL2[25609649];HLA-A[17353931;26439010];FOXL1[25609649];FOXP3[25609649];PTP4A3[17353931];IRF3[25609649];MAP7D2[30021884];ARF6[17353931];NCAPH[17268547;26496610;21633354];FOXS1[25609649];RAD21[17113138];STK38L[30108113];DISC1[17043677];FOXB1[25609649];JUN[25609649];CBX5[16847100];NEK6[17353931];NCAPH2[17268547];CEP152[26638075];CDC5L[20467437];NFATC1[25609649];GTF2H3[30021884];MEX3C[22863774];TNFRSF10D[17353931];GULP1[21988832];FOXR1[25609649];NEURL4[29426014];SNW1[20467437];KIF4B[30021884];CAPZA2[26496610];NCAPD3[26496610];BET1[29568061];	106860779
75441	chr9	108397456	A	G	chr9:108397456	FKTN	fukutin	SNV	0/0	0.0	35_0	35	99.0	0/1	0.45	59_50	111	99.0			rs141918432	EXONIC	YES	NM_001351496.2	Transcript	protein_coding	missense_variant		12/12	NM_001351496.2:c.1297A>G	NP_001338425.1:p.Thr433Ala		1.0	.,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Ventricular_tachycardia|Cardiomyopathy|Walker-Warburg_congenital_muscular_dystrophy|Congenital_muscular_dystrophy-dystroglycanopathy_with_brain_and_eye_anomalies,_type_A4|Dilated_cardiomyopathy_1X|not_specified|Cardiovascular_phenotype|not_provided	Muscular dystrophy-dystroglycanopathy (limb-girdle), type C, 4, 611588 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital with brain and eye anomalies), type A, 4, 253800 (3), Autosomal recessive; Muscular dystrophy-dystroglycanopathy (congenital without mental retardation), type B, 4, 613152 (3), Autosomal recessive; Cardiomyopathy, dilated, 1X, 611615 (3), Autosomal recessive	Familial isolated dilated cardiomyopathy;Autosomal recessive limb-girdle muscular dystrophy type 2M;Congenital muscular dystrophy without intellectual disability;Muscle-eye-brain disease;Walker-Warburg syndrome;Congenital muscular dystrophy, Fukuyama type	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Infantile onset;Generalized hypotonia;Motor delay;Congenital muscular dystrophy;Elevated serum creatine kinase;Autosomal recessive inheritance;Muscular dystrophy;Proximal muscle weakness;Autosomal recessive inheritance;Dilated cardiomyopathy;Hypermetropia;Areflexia;Dilated cardiomyopathy;Encephalocele;Flexion contracture;Skeletal muscle atrophy;Myocardial fibrosis;Type II lissencephaly;Muscular hypotonia;Congenital muscular dystrophy;Calf muscle hypertrophy;Retinal detachment;Generalized hypotonia;Holoprosencephaly;Scoliosis;Strabismus;Atrial septal defect;Exaggerated startle response;Hypoplasia of the pyramidal tract;Seizure;Spinal rigidity;Intellectual disability;Retinal dysplasia;Optic atrophy;Respiratory insufficiency;Hypoplasia of the brainstem;Agenesis of corpus callosum;Autosomal recessive inheritance;Cataract;Infantile onset;Pulmonic stenosis;Cerebellar hypoplasia;Transposition of the great arteries;Muscle weakness;Pachygyria;Cerebellar cyst;Hydrocephalus;Microphthalmia;Elevated serum creatine kinase;Agyria;Myopia;Polymicrogyria;Dolichocephaly;Brachycephaly;Retinal dysplasia;Intellectual disability, severe;Cataract;Myopathy;Gait disturbance;Weak cry;Visual impairment;Glaucoma;Muscular dystrophy;Optic atrophy;Aplasia/Hypoplasia of the corpus callosum;Muscular hypotonia;Hypoglycosylation of alpha-dystroglycan;Pectus excavatum;Camptodactyly of finger;Plagiocephaly;Delayed speech and language development;Intrauterine growth retardation;Ventriculomegaly;Myopia;Seizure;EEG abnormality;Hydrocephalus;Type II lissencephaly;Global developmental delay;Dilated cardiomyopathy;EMG abnormality;Mask-like facies;Congenital contracture;Cerebellar dysplasia;Type II lissencephaly;Retinal dysplasia;Polymicrogyria;Posterior fossa cyst;Microcephaly;Atresia of the external auditory canal;Dandy-Walker malformation;Congenital muscular dystrophy;Buphthalmos;Intellectual disability, profound;Glaucoma;Hypoplasia of the corpus callosum;Agenesis of corpus callosum;Microphthalmia;Megalocornea;Coloboma;Microtia;Cleft upper lip;Hypoplastic male external genitalia;Occipital encephalocele;Autosomal recessive inheritance;Agyria;Cleft palate;Corneal opacity;Elevated serum creatine kinase;Excessive daytime sleepiness;Optic nerve hypoplasia;Heterogeneous;Seizure;Cerebellar hypoplasia;Anal atresia;Meningoencephalocele;Hydrocephalus;Myopia;Retinal atrophy;Global developmental delay;Blindness;Renal dysplasia;Severe muscular hypotonia;Cataract;Muscular hypotonia;Hypoplasia of the brainstem;Peters anomaly;Retinal detachment;Pachygyria;Intellectual disability, severe;Palmoplantar keratoderma;EMG abnormality;Lipoatrophy;Dilated cardiomyopathy;Elevated serum creatine kinase;Abnormality of neutrophils;Sensorineural hearing impairment;Myopathy;Autosomal recessive inheritance;Flexion contracture;Gowers sign;Skeletal muscle hypertrophy;Generalized hypotonia;Muscular dystrophy;Abnormal glycosylation;Muscular hypotonia;Variable expressivity;Elevated serum creatine kinase;Motor delay;Progressive;Infantile onset;Pectus excavatum;Hyporeflexia;Talipes equinovarus;Hyperlordosis;Hydrocephalus;Areflexia;Low-set ears;Retinal detachment;Polymicrogyria;Anophthalmia;Skeletal muscle atrophy;Chorioretinal dysplasia;Cataract;Bifid uvula;Macrocephaly;Submucous cleft hard palate;Corneal opacity;Global developmental delay;Muscular hypotonia;Absent septum pellucidum;Metatarsus valgus;Seizure;Pachygyria;Intellectual disability;Macrogyria;Glaucoma;Microphthalmia;Dandy-Walker malformation;Aplasia/Hypoplasia involving the skeletal musculature;Cryptorchidism;Muscular dystrophy;Microcephaly;Protruding ear;Hyporeflexia;Agenesis of corpus callosum;Hypoplasia of penis;Abnormal aldolase level;Retinal dystrophy;Cerebellar hypoplasia;Specific learning disability;Abnormal circulating creatine kinase concentration;Muscle weakness;Posteriorly rotated ears;Iris coloboma;Optic atrophy;Abnormal lactate dehydrogenase level;Microcornea;Retinal dysplasia;Aplasia/Hypoplasia of the cerebellum;Glaucoma;Myopathy;Cataract;Myopia;Gait disturbance;Hypertonia;Cognitive impairment;Muscular hypotonia;Visual impairment;Hydrocephalus;Abnormality of the voice;EMG abnormality;Elevated serum creatine kinase;Optic atrophy;Seizure;Hemiplegia/hemiparesis;Strabismus;Holoprosencephaly;EEG abnormality;Meningocele;Neurological speech impairment;Mildly elevated creatine kinase;Abnormality of the cerebral white matter;Facial diplegia;Myalgia;Ventriculomegaly;Gray matter heterotopia;Proximal amyotrophy;Cerebellar atrophy;Microcephaly;Achilles tendon contracture;Toe walking;Neonatal hypotonia;Fatty replacement of skeletal muscle;Difficulty walking;Congenital muscular dystrophy;Generalized muscle weakness;Cerebellar cyst;EMG: myopathic abnormalities;Reduced muscle fiber alpha dystroglycan;Frequent falls;Muscle spasm;Pachygyria;Kyphoscoliosis;Limb-girdle muscle atrophy;Motor delay;Generalized hypotonia	11501948	0.00216811	330.0	152206.0	1.0	32	0.98	PASS	nfe	0.00335186	228.0	0.00335186	228.0	0.00202841	510.0	251428.0	2.0	100	1.0	PASS	nfe	0.00283172	322.0	0.00283172	322.0	0.0017877	278	0.0	1.0	0.00053	6.0		15.48	1.355588	0.101	2	17	19	MutationTaster_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	FKTN	0.0	0.0	0.0	0.0	0.0	-35.0	-27.0	-7.0						0.322	0.0	0.000000000	0.76	1.312	behavior/neurological phenotype ; embryo phenotype; mortality/aging ; nervous system phenotype ; homeostasis/metabolism phenotype; immune system phenotype; cellular phenotype; growth/size/body region phenotype; muscle phenotype; 			pons;caudate nucleus;amygdala;prefrontal cortex;cingulate cortex;parietal lobe;medulla oblongata;	.	protein O-linked glycosylation;nervous system development;muscle organ development;negative regulation of cell population proliferation;protein O-linked mannosylation;negative regulation of JNK cascade;regulation of protein glycosylation	extracellular space;nucleus;endoplasmic reticulum;Golgi apparatus;cis-Golgi network;integral component of Golgi membrane	protein binding;transferase activity	.	108397456
75461	chr9	111956668	G	A	chr9:111956668	EPB41L4B	erythrocyte membrane protein band 4.1 like 4B	SNV	0/1	0.47	40_35	75	99.0	0/0	0.0	42_0	42	99.0			rs41278379	EXONIC	YES	NM_019114.5	Transcript	protein_coding	synonymous_variant		21/26	NM_019114.5:c.2055C>T	NP_061987.3:p.Asp685%3D		-1.0						.	.	.		0.00584911	890.0	152160.0	1.0	33	0.96	PASS	amr	0.00720178	110.0	0.00686442	467.0	0.00385373	959.0	248850.0	0.0	48	0.98	PASS	nfe	0.00559427	631.0	0.00559427	631.0	0.0009646	150	0.007	23.0				8.391	0.399392		0	0	0			EPB41L4B	0.13	0.06	0.0	0.0	-14.0	36.0	-14.0	9.0						0.0301	1.0	0.000000000			hearing/vestibular/ear phenotype; growth/size/body region phenotype; 			ciliary ganglion;thyroid;pancreas;dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skeletal muscle;globus pallidus;	.	positive regulation of gene expression;regulation of keratinocyte proliferation;actomyosin structure organization;wound healing;positive regulation of cell adhesion;positive regulation of keratinocyte migration	cytoplasm;cytosol;cytoskeleton;plasma membrane;bicellular tight junction;apical part of cell	structural constituent of cytoskeleton;cytoskeletal protein binding	CDC42[26496610];ERP44[26496610];PARD6B[26496610];LAMC3[21988832];KIF22[26496610];FADD[unassigned1774];PPIA[26496610];WAPL[26496610];LLGL2[26496610];	111956668
75522	chr9	113128845		AA	chr9:113128844-113128845	SVEP1	sushi, von Willebrand factor type A, EGF and pentraxin domain containing 1	insertion	0/1	0.09	5_23_3	33	57.0	1/2	0.41	3_10_9	22	99.0			rs56790407	SPLICING	YES	NM_153366.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	47/47		NM_153366.4:c.10695-6_10695-5dup			-1.0						.	.	.		0.00117463	158.0	134510.0	0.0	12	0.51	PASS	amr	0.00165116	22.0	0.0009347	58.0	0.00939821	853.0	90762.0	1.0	10	0.35	InbreedingCoeff	afr	0.019155	107.0	0.00852895	327.0	0.0002315,0.0000193,0.0002444,0.0000514,0.0027781	36,3,38,8,432						5.679	0.189232		0	0	0																	0.325	0.59				integument phenotype ; adipose tissue phenotype ; homeostasis/metabolism phenotype; mortality/aging ; limbs/digits/tail phenotype; 			ciliary ganglion;pons;trigeminal ganglion;superior cervical ganglion;atrioventricular node;adipose tissue;placenta;skeletal muscle;globus pallidus;	.	cell adhesion	extracellular region;cytoplasm;membrane	chromatin binding;calcium ion binding	ATF7IP[15231748];MTNR1A[26514267];SMAD3[15231748];ZFYVE9[15231748];SMAD9[15231748];SKIL[15231748];	113128844
75555	chr9	114840837	G	A	chr9:114840837	SUSD1	sushi domain containing 1	SNV	0/1	0.31	46_21	67	99.0	0/1	0.33	49_24	73	99.0			rs147151457,COSV62585572	EXONIC	YES	NM_001282640.2	Transcript	protein_coding	synonymous_variant		12/18	NM_001282640.2:c.1734C>T	NP_001269569.1:p.Ser578%3D		-1.0		Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.000111732	17.0	152150.0	0.0	31	0.96	PASS	amr	0.000196489	3.0	0.000146985	10.0	0.000183567	46.0	250590.0	0.0	47	0.93	PASS	nfe	0.000264555	30.0	0.000264555	30.0	0.0001479	23	0.001	3.0				8.971	0.455297		0	0	0			SUSD1	0.0	0.0	0.0	0.0	-13.0	39.0	45.0	-19.0						0.485	0.0	57.919392056			.			ciliary ganglion;trigeminal ganglion;superior cervical ganglion;atrioventricular node;skeletal muscle;globus pallidus;	.	.	integral component of membrane	calcium ion binding	ATF7IP[15231748];EGFR[24189400];	114840837
75650	chr9	117810651	G	A	chr9:117810651	TNC	tenascin C	SNV	0/1	0.48	65_60	125	99.0	0/1	0.37	52_30	82	99.0			rs146504512	EXONIC	YES	NM_002160.4	Transcript	protein_coding	synonymous_variant		16/28	NM_002160.4:c.4740C>T	NP_002151.2:p.Thr1580%3D		-1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	not_provided	Deafness, autosomal dominant 56, 615629 (3), Autosomal dominant	Autosomal dominant non-syndromic sensorineural deafness type DFNA	Disease-causing germline mutation(s) in	Hearing impairment;Autosomal dominant inheritance		0.00316813	482.0	152140.0	3.0	32	0.97	PASS	afr	0.00851875	353.0	0.000735035	50.0	0.00165978	417.0	251238.0	4.0	94	1.0	PASS	afr	0.00873739	142.0	0.00110908	126.0	0.0016463	256	0.006	21.0	0.0076	14.0		8.905	0.448712		0	0	0			TNC	0.0	0.0	0.0	0.0	-16.0	4.0	-48.0	-4.0						0.625	0.0	64.645072503			homeostasis/metabolism phenotype; nervous system phenotype ; normal phenotype; behavior/neurological phenotype ; 			ciliary ganglion;lung;kidney;uterus;trachea;fetal brain;dorsal root ganglion;superior cervical ganglion;adipose tissue;prostate;fetal lung;	Cell Communication;Focal adhesion;ECM-receptor interaction	osteoblast differentiation;cell adhesion;negative regulation of cell adhesion;neuromuscular junction development;positive regulation of cell population proliferation;response to wounding;response to mechanical stimulus;positive regulation of gene expression;peripheral nervous system axon regeneration;extracellular matrix organization;wound healing;odontogenesis of dentin-containing tooth;post-translational protein modification;cellular protein metabolic process;response to ethanol;bud outgrowth involved in lung branching;mesenchymal-epithelial cell signaling involved in prostate gland development;prostate gland epithelium morphogenesis;cellular response to retinoic acid;cellular response to vitamin D;response to fibroblast growth factor;cellular response to prostaglandin D stimulus	extracellular region;basement membrane;interstitial matrix;extracellular space;endoplasmic reticulum lumen;focal adhesion;membrane;collagen-containing extracellular matrix;perisynaptic extracellular matrix	extracellular matrix structural constituent;protein binding;syndecan binding	COL5A1[20979576];TNC[29150600];MAPT[26402096];TLR4[29150600];	117810651
75655	chr9	119115167	G	A	chr9:119115167	PAPPA	pappalysin 1	SNV	0/0	0.0	34_0	34	99.0	0/1	0.46	42_37	80	99.0			rs55901693,COSV104652665	EXONIC	YES	NM_002581.5	Transcript	protein_coding	missense_variant		16/22	NM_002581.5:c.4147G>A	NP_002572.2:p.Val1383Met		1.0	Sushi/SCR/CCP domain&Sushi/SCR/CCP domain&Sushi/SCR/CCP domain&Sushi/SCR/CCP domain					.	.	.		0.00686768	1045.0	152162.0	5.0	33	0.97	PASS	nfe	0.00637898	434.0	0.00637898	434.0	0.00683012	1716.0	251240.0	19.0	42	0.99	PASS	nfe	0.00523694	595.0	0.00523694	595.0	0.0054597	849	0.004	13.0				29.3	4.176109	0.631	11	9	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MutationAssessor_pred,MutationTaster_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	PAPPA	0.0	0.0	0.0	0.0	2.0	-12.0	-3.0	28.0						0.471	0.97	0.000000000	0.997	1.176	growth/size/body region phenotype; homeostasis/metabolism phenotype; cardiovascular system phenotype ; normal phenotype; skeleton phenotype; 			cingulate cortex;smooth muscle;trigeminal ganglion;superior cervical ganglion;placenta;heart;	.	proteolysis;female pregnancy;response to follicle-stimulating hormone;cellular protein metabolic process;response to glucocorticoid	extracellular region;extracellular space	metalloendopeptidase activity;metallopeptidase activity;zinc ion binding	SMAD2[15231748];ATF7IP[15231748];IGHM[15174051];IGHG1[15174051];SMAD3[15231748];SMAD9[15231748];SKIL[15231748];PLEC[30021884];	119115167
75783	chr9	124441035	C	T	chr9:124441035	DAB2IP	DAB2 interacting protein	SNV	0/1	0.58	54_74	128	99.0	0/1	0.47	58_51	109	99.0			rs201300206,COSV52258956	EXONIC	YES	NM_032552.4	Transcript	protein_coding	missense_variant		2/17	NM_032552.4:c.119C>T	NP_115941.2:p.Ser40Leu		1.0	.,.,.,.					.	.	.		0.00141217	215.0	152248.0	1.0	32	0.97	PASS	amr	0.00235479	36.0	0.0020281	138.0	0.00124781	284.0	227598.0	1.0	19	0.47	PASS	amr	0.00195616	63.0	0.0018483	191.0	0.0013054	203	0.003	10.0				23.6	3.024728	0.121	4	14	18	SIFT,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred	DAB2IP	0.0	0.0	0.0	0.01	25.0	-44.0	31.0	25.0						0.00482	1.0	0.000000000	0.959	1.026	homeostasis/metabolism phenotype; cellular phenotype; nervous system phenotype ; 			ciliary ganglion;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;cerebellum peduncles;globus pallidus;cerebellum;	.	negative regulation of transcription by RNA polymerase II;MAPK cascade;activation of MAPKKK activity;angiogenesis;negative regulation of protein phosphorylation;inflammatory response;cell cycle;I-kappaB phosphorylation;activation of JUN kinase activity;negative regulation of cell population proliferation;extrinsic apoptotic signaling pathway via death domain receptors;negative regulation of endothelial cell migration;negative regulation of epithelial cell migration;negative regulation of epithelial to mesenchymal transition;positive regulation of neuron projection development;negative regulation of phosphatidylinositol 3-kinase signaling;negative regulation of angiogenesis;cell motility involved in cerebral cortex radial glia guided migration;layer formation in cerebral cortex;negative regulation of vascular endothelial growth factor receptor signaling pathway;negative regulation of NF-kappaB transcription factor activity;negative regulation of toll-like receptor 4 signaling pathway;negative regulation of GTPase activity;cellular response to unfolded protein;tube formation;cellular response to vascular endothelial growth factor stimulus;vascular endothelial growth factor receptor-2 signaling pathway;reelin-mediated signaling pathway;regulation of growth;negative regulation of epidermal growth factor receptor signaling pathway;positive regulation of apoptotic process;regulation of GTPase activity;regulation of I-kappaB kinase/NF-kappaB signaling;negative regulation of I-kappaB kinase/NF-kappaB signaling;regulation of protein complex assembly;negative regulation of MAP kinase activity;positive regulation of MAPK cascade;regulation of protein heterodimerization activity;positive regulation of JUN kinase activity;positive regulation of GTPase activity;negative regulation of phosphatidylinositol 3-kinase activity;cellular protein catabolic process;innate immune response;positive regulation of protein catabolic process;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of JNK cascade;negative regulation of Ras protein signal transduction;negative regulation of fibroblast proliferation;neuron projection morphogenesis;negative regulation of epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;negative regulation of G0 to G1 transition;negative regulation of ERK1 and ERK2 cascade;positive regulation of cell cycle arrest;cellular response to lipopolysaccharide;cellular response to interleukin-1;cellular response to tumor necrosis factor;cellular response to epidermal growth factor stimulus;negative regulation of protein serine/threonine kinase activity;positive regulation of protein serine/threonine kinase activity;endothelial cell apoptotic process;negative regulation of canonical Wnt signaling pathway;positive regulation of synapse maturation;positive regulation of dendrite development;regulation of p38MAPK cascade;negative regulation of vascular endothelial growth factor signaling pathway;positive regulation of proteasomal protein catabolic process;negative regulation of cellular protein catabolic process;positive regulation of IRE1-mediated unfolded protein response;positive regulation of neuron migration;positive regulation of apoptotic signaling pathway	cytoplasm;cytosol;plasma membrane;endocytic vesicle;axon;dendrite;neuronal cell body membrane;neuronal cell body;cerebellar mossy fiber;climbing fiber;parallel fiber;AIP1-IRE1 complex	GTPase activator activity;death receptor binding;protein binding;SH3 domain binding;kinase binding;protein kinase binding;mitogen-activated protein kinase kinase binding;mitogen-activated protein kinase kinase kinase binding;phosphatidylinositol-3-phosphate binding;signaling adaptor activity;Toll-like receptor 4 binding;phosphatidylinositol 3-kinase regulatory subunit binding;identical protein binding;protein homodimerization activity;vascular endothelial growth factor receptor 2 binding;phosphatidylinositol 3-kinase binding;protein-containing complex binding;cadherin binding;protein phosphatase 2A binding;phosphatidylinositol-4-phosphate binding;14-3-3 protein binding	GSK3B[20080667];RNASEH2B[26496610];RAB4B[26496610];EXOSC9[26496610];DAB2IP[12813029];CBY1[unassigned1312];AXIN1[20080667];ANKS1A[unassigned1304];UGGT1[26496610];IWS1[26496610];MAP3K5[12813029];	124441035
75785	chr9	124461666	C	T	chr9:124461666	DAB2IP	DAB2 interacting protein	SNV	0/1	0.44	33_26	59	99.0	0/0	0.0	48_0	48	99.0			rs200769141	EXONIC	YES	NM_032552.4	Transcript	protein_coding	synonymous_variant		3/17	NM_032552.4:c.207C>T	NP_115941.2:p.Asp69%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00308172	461.0	149592.0	1.0	31	0.9	PASS	nfe	0.00475892	319.0	0.00475892	319.0	0.00328056	593.0	180762.0	1.0	22	0.57	PASS	nfe	0.00415744	338.0	0.00415744	338.0	0.0025401	395	0.001	4.0				11.43	0.734317		0	0	0			DAB2IP	0.0	0.0	0.0	0.0	12.0	-15.0	-2.0	-38.0						0.00482	1.0	0.000000000			homeostasis/metabolism phenotype; cellular phenotype; nervous system phenotype ; 			ciliary ganglion;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;cerebellum peduncles;globus pallidus;cerebellum;	.	negative regulation of transcription by RNA polymerase II;MAPK cascade;activation of MAPKKK activity;angiogenesis;negative regulation of protein phosphorylation;inflammatory response;cell cycle;I-kappaB phosphorylation;activation of JUN kinase activity;negative regulation of cell population proliferation;extrinsic apoptotic signaling pathway via death domain receptors;negative regulation of endothelial cell migration;negative regulation of epithelial cell migration;negative regulation of epithelial to mesenchymal transition;positive regulation of neuron projection development;negative regulation of phosphatidylinositol 3-kinase signaling;negative regulation of angiogenesis;cell motility involved in cerebral cortex radial glia guided migration;layer formation in cerebral cortex;negative regulation of vascular endothelial growth factor receptor signaling pathway;negative regulation of NF-kappaB transcription factor activity;negative regulation of toll-like receptor 4 signaling pathway;negative regulation of GTPase activity;cellular response to unfolded protein;tube formation;cellular response to vascular endothelial growth factor stimulus;vascular endothelial growth factor receptor-2 signaling pathway;reelin-mediated signaling pathway;regulation of growth;negative regulation of epidermal growth factor receptor signaling pathway;positive regulation of apoptotic process;regulation of GTPase activity;regulation of I-kappaB kinase/NF-kappaB signaling;negative regulation of I-kappaB kinase/NF-kappaB signaling;regulation of protein complex assembly;negative regulation of MAP kinase activity;positive regulation of MAPK cascade;regulation of protein heterodimerization activity;positive regulation of JUN kinase activity;positive regulation of GTPase activity;negative regulation of phosphatidylinositol 3-kinase activity;cellular protein catabolic process;innate immune response;positive regulation of protein catabolic process;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of JNK cascade;negative regulation of Ras protein signal transduction;negative regulation of fibroblast proliferation;neuron projection morphogenesis;negative regulation of epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;negative regulation of G0 to G1 transition;negative regulation of ERK1 and ERK2 cascade;positive regulation of cell cycle arrest;cellular response to lipopolysaccharide;cellular response to interleukin-1;cellular response to tumor necrosis factor;cellular response to epidermal growth factor stimulus;negative regulation of protein serine/threonine kinase activity;positive regulation of protein serine/threonine kinase activity;endothelial cell apoptotic process;negative regulation of canonical Wnt signaling pathway;positive regulation of synapse maturation;positive regulation of dendrite development;regulation of p38MAPK cascade;negative regulation of vascular endothelial growth factor signaling pathway;positive regulation of proteasomal protein catabolic process;negative regulation of cellular protein catabolic process;positive regulation of IRE1-mediated unfolded protein response;positive regulation of neuron migration;positive regulation of apoptotic signaling pathway	cytoplasm;cytosol;plasma membrane;endocytic vesicle;axon;dendrite;neuronal cell body membrane;neuronal cell body;cerebellar mossy fiber;climbing fiber;parallel fiber;AIP1-IRE1 complex	GTPase activator activity;death receptor binding;protein binding;SH3 domain binding;kinase binding;protein kinase binding;mitogen-activated protein kinase kinase binding;mitogen-activated protein kinase kinase kinase binding;phosphatidylinositol-3-phosphate binding;signaling adaptor activity;Toll-like receptor 4 binding;phosphatidylinositol 3-kinase regulatory subunit binding;identical protein binding;protein homodimerization activity;vascular endothelial growth factor receptor 2 binding;phosphatidylinositol 3-kinase binding;protein-containing complex binding;cadherin binding;protein phosphatase 2A binding;phosphatidylinositol-4-phosphate binding;14-3-3 protein binding	GSK3B[20080667];RNASEH2B[26496610];RAB4B[26496610];EXOSC9[26496610];DAB2IP[12813029];CBY1[unassigned1312];AXIN1[20080667];ANKS1A[unassigned1304];UGGT1[26496610];IWS1[26496610];MAP3K5[12813029];	124461666
75787	chr9	124522400	G	A	chr9:124522400	DAB2IP	DAB2 interacting protein	SNV	0/1	0.53	83_94	177	99.0	0/1	0.37	91_55	148	99.0			rs34839326	EXONIC	YES	NM_032552.4	Transcript	protein_coding	synonymous_variant		6/17	NM_032552.4:c.768G>A	NP_115941.2:p.Lys256%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00235939	359.0	152158.0	1.0	33	0.97	PASS	amr	0.00359901	55.0	0.00349856	238.0	0.00255297	641.0	251080.0	2.0	100	1.0	PASS	sas	0.00336425	103.0	0.00334015	379.0	0.0023858	371	0.009	26.0				11.3	0.718356		0	0	0			DAB2IP	0.0	0.0	0.0	0.02	-42.0	-8.0	-42.0	27.0						0.00482	1.0	79.697520579			homeostasis/metabolism phenotype; cellular phenotype; nervous system phenotype ; 			ciliary ganglion;subthalamic nucleus;dorsal root ganglion;superior cervical ganglion;trigeminal ganglion;atrioventricular node;skeletal muscle;cerebellum peduncles;globus pallidus;cerebellum;	.	negative regulation of transcription by RNA polymerase II;MAPK cascade;activation of MAPKKK activity;angiogenesis;negative regulation of protein phosphorylation;inflammatory response;cell cycle;I-kappaB phosphorylation;activation of JUN kinase activity;negative regulation of cell population proliferation;extrinsic apoptotic signaling pathway via death domain receptors;negative regulation of endothelial cell migration;negative regulation of epithelial cell migration;negative regulation of epithelial to mesenchymal transition;positive regulation of neuron projection development;negative regulation of phosphatidylinositol 3-kinase signaling;negative regulation of angiogenesis;cell motility involved in cerebral cortex radial glia guided migration;layer formation in cerebral cortex;negative regulation of vascular endothelial growth factor receptor signaling pathway;negative regulation of NF-kappaB transcription factor activity;negative regulation of toll-like receptor 4 signaling pathway;negative regulation of GTPase activity;cellular response to unfolded protein;tube formation;cellular response to vascular endothelial growth factor stimulus;vascular endothelial growth factor receptor-2 signaling pathway;reelin-mediated signaling pathway;regulation of growth;negative regulation of epidermal growth factor receptor signaling pathway;positive regulation of apoptotic process;regulation of GTPase activity;regulation of I-kappaB kinase/NF-kappaB signaling;negative regulation of I-kappaB kinase/NF-kappaB signaling;regulation of protein complex assembly;negative regulation of MAP kinase activity;positive regulation of MAPK cascade;regulation of protein heterodimerization activity;positive regulation of JUN kinase activity;positive regulation of GTPase activity;negative regulation of phosphatidylinositol 3-kinase activity;cellular protein catabolic process;innate immune response;positive regulation of protein catabolic process;negative regulation of transcription, DNA-templated;positive regulation of transcription by RNA polymerase II;positive regulation of JNK cascade;negative regulation of Ras protein signal transduction;negative regulation of fibroblast proliferation;neuron projection morphogenesis;negative regulation of epithelial cell proliferation;intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress;negative regulation of G0 to G1 transition;negative regulation of ERK1 and ERK2 cascade;positive regulation of cell cycle arrest;cellular response to lipopolysaccharide;cellular response to interleukin-1;cellular response to tumor necrosis factor;cellular response to epidermal growth factor stimulus;negative regulation of protein serine/threonine kinase activity;positive regulation of protein serine/threonine kinase activity;endothelial cell apoptotic process;negative regulation of canonical Wnt signaling pathway;positive regulation of synapse maturation;positive regulation of dendrite development;regulation of p38MAPK cascade;negative regulation of vascular endothelial growth factor signaling pathway;positive regulation of proteasomal protein catabolic process;negative regulation of cellular protein catabolic process;positive regulation of IRE1-mediated unfolded protein response;positive regulation of neuron migration;positive regulation of apoptotic signaling pathway	cytoplasm;cytosol;plasma membrane;endocytic vesicle;axon;dendrite;neuronal cell body membrane;neuronal cell body;cerebellar mossy fiber;climbing fiber;parallel fiber;AIP1-IRE1 complex	GTPase activator activity;death receptor binding;protein binding;SH3 domain binding;kinase binding;protein kinase binding;mitogen-activated protein kinase kinase binding;mitogen-activated protein kinase kinase kinase binding;phosphatidylinositol-3-phosphate binding;signaling adaptor activity;Toll-like receptor 4 binding;phosphatidylinositol 3-kinase regulatory subunit binding;identical protein binding;protein homodimerization activity;vascular endothelial growth factor receptor 2 binding;phosphatidylinositol 3-kinase binding;protein-containing complex binding;cadherin binding;protein phosphatase 2A binding;phosphatidylinositol-4-phosphate binding;14-3-3 protein binding	GSK3B[20080667];RNASEH2B[26496610];RAB4B[26496610];EXOSC9[26496610];DAB2IP[12813029];CBY1[unassigned1312];AXIN1[20080667];ANKS1A[unassigned1304];UGGT1[26496610];IWS1[26496610];MAP3K5[12813029];	124522400
75798	chr9	125655309	AA		chr9:125655309-125655310	RC3H2	ring finger and CCCH-type domains 2	sequence_alteration	0/2	0.0	9_0_3	12	38.0	0/1	0.25	12_4_0	16	65.0			rs747020595	SPLICING	YES	NM_001100588.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	2/20		NM_001100588.3:c.232-5_232-4del			-1.0						.	.	.		0.000285288	39.0	136704.0	0.0	32	0.9	PASS	amr	0.000222189	3.0	0.000221912	14.0	0.0359608	4761.0	132394.0	0.0	25	0.67	InbreedingCoeff	amr	0.0466636	821.0	0.0342991	2112.0	0.0000064,0.0181539	1,2823						11.86	0.78784		0	0	0			RC3H2	0.0	0.0	0.0	0.0	-40.0	-10.0	-39.0	-25.0						0.0705	1.0				immune system phenotype; renal/urinary system phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; 			pons;pituitary;subthalamic nucleus;prefrontal cortex;superior cervical ganglion;cingulate cortex;atrioventricular node;trigeminal ganglion;parietal lobe;	.	protein polyubiquitination;B cell homeostasis;regulation of transcription by RNA polymerase II;post-embryonic development;posttranscriptional regulation of gene expression;multicellular organism growth;T cell proliferation;T cell homeostasis;lung alveolus development;lymph node development;spleen development;T cell receptor signaling pathway;limb development;T follicular helper cell differentiation;positive regulation of NIK/NF-kappaB signaling;negative regulation of T-helper 17 cell differentiation;regulation of miRNA metabolic process	P-body;cell surface;membrane;intracellular membrane-bounded organelle	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;RNA binding;double-stranded RNA binding;mRNA binding;ubiquitin-protein transferase activity;RNA stem-loop binding;metal ion binding	TRIM8[22493164];TIA1[20412057];UBE2I[19549727];MMGT1[26496610];UBE2N[19549727];OGT[27705803];	125655308
75808	chr9	125655309	AA	AAA	chr9:125655309-125655310	RC3H2	ring finger and CCCH-type domains 2	sequence_alteration	0/2	0.25	9_0_3	12	38.0	0/1	0.0	12_4_0	16	65.0			rs747020595	SPLICING	YES	NM_001100588.3	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	2/20		NM_001100588.3:c.232-4_232-3insT			-1.0						.	.	.		0.00360995	494.0	136844.0	1.0	32	0.9	PASS	sas	0.00509731	22.0	0.00315113	199.0	0.0429551	5687.0	132394.0	0.0	25	0.67	InbreedingCoeff	eas	0.0600446	593.0	0.0412174	2538.0	0.0001158,0.0000193,0.0000900,0.0001093,0.0333496	18,3,14,17,5186						11.5	0.742825		0	0	0			RC3H2	0.0	0.01	0.0	0.0	-3.0	-10.0	-39.0	-25.0						0.0705	1.0				immune system phenotype; renal/urinary system phenotype; hematopoietic system phenotype; mortality/aging ; respiratory system phenotype; homeostasis/metabolism phenotype; growth/size/body region phenotype; 			pons;pituitary;subthalamic nucleus;prefrontal cortex;superior cervical ganglion;cingulate cortex;atrioventricular node;trigeminal ganglion;parietal lobe;	.	protein polyubiquitination;B cell homeostasis;regulation of transcription by RNA polymerase II;post-embryonic development;posttranscriptional regulation of gene expression;multicellular organism growth;T cell proliferation;T cell homeostasis;lung alveolus development;lymph node development;spleen development;T cell receptor signaling pathway;limb development;T follicular helper cell differentiation;positive regulation of NIK/NF-kappaB signaling;negative regulation of T-helper 17 cell differentiation;regulation of miRNA metabolic process	P-body;cell surface;membrane;intracellular membrane-bounded organelle	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;RNA binding;double-stranded RNA binding;mRNA binding;ubiquitin-protein transferase activity;RNA stem-loop binding;metal ion binding	TRIM8[22493164];TIA1[20412057];UBE2I[19549727];MMGT1[26496610];UBE2N[19549727];OGT[27705803];	125655308
75849	chr9	127975785	A	G	chr9:127975785	RABEPK	Rab9 effector protein with kelch motifs	SNV	0/1	0.53	21_26	49	99.0	0/0	0.0	44_0	44	99.0			rs149635799	EXONIC	YES	NM_005833.4	Transcript	protein_coding	synonymous_variant		4/8	NM_005833.4:c.348A>G	NP_005824.2:p.Leu116%3D		1.0						.	.	.		0.000308869	47.0	152168.0	0.0	32	0.97	PASS	amr	0.000983091	15.0	0.000411547	28.0	0.000171308	43.0	251010.0	0.0	53	0.94	PASS	nfe	0.000281621	32.0	0.000281621	32.0	0.0001479	23	0.001	2.0				6.999	0.283526		0	0	0			RABEPK	0.0	0.0	0.0	0.03	-34.0	-31.0	13.0	16.0						0.995	0.0	14.563512483			.			pons;caudate nucleus;trigeminal ganglion;	.	receptor-mediated endocytosis;vesicle docking involved in exocytosis	endosome;cytosol;endosome membrane;transport vesicle;trans-Golgi network membrane	.	POR[21900206];TMEM98[21900206];PRKRA[21900206];ZYX[21900206];GLUL[21988832];	127975785
75895	chr9	129595262	C	T	chr9:129595262	ZBTB43	zinc finger and BTB domain containing 43	SNV	0/1	0.54	64_76	140	99.0	0/0	0.0	34_0	34	99.0			rs139882729	EXONIC	YES	NM_014007.4	Transcript	protein_coding	synonymous_variant		3/3	NM_014007.4:c.474C>T	NP_054726.1:p.Gly158%3D		1.0						.	.	.		0.00046026	70.0	152088.0	0.0	32	0.96	PASS	amr	0.0018989	29.0	0.000455641	31.0	0.000488535	122.0	249726.0	0.0	66	0.98	PASS	amr	0.00118944	41.0	0.000541375	61.0	0.0003666	57	0.003	9.0				10.59	0.632597		0	0	0			ZBTB43	0.0	0.0	0.0	0.0	29.0	-16.0	-21.0	46.0							0.88	0.765020659			.			.	.	regulation of transcription by RNA polymerase II	nucleus	DNA-binding transcription factor activity, RNA polymerase II-specific;DNA binding;protein binding;metal ion binding	DDX6[unassigned1304];ZNF250[unassigned1304];ZBTB24[25416956];ZBTB43[25416956];CIB3[unassigned1304];ARRB1[16189514;unassigned1304];MCM10[16189514];ARR3[25416956];GMCL2[unassigned1304];PSMD3[25416956;unassigned1304];DIP2A[25416956];ZNF587[unassigned1304];AP1M1[25416956;unassigned1304];LMO1[25416956;unassigned1304];CDKL3[unassigned1304];LMO4[25416956];CCDC13[unassigned1304];LMO3[16189514;unassigned1304];ELOA2[16189514];TRAF2[16189514];AEN[25416956];SYT6[25416956;unassigned1304];MORF4L1[unassigned1304];FAM161A[25416956];MORF4L2[25416956];ZNF417[16189514;unassigned1304];LNX1[16189514;unassigned1304];TCEA2[unassigned1304];	129595262
75896	chr9	129856144	C	G	chr9:129856144	ANGPTL2	angiopoietin like 2	SNV	0/1	0.44	61_49	112	99.0	0/0	0.0	33_0	33	99.0			rs139697219	EXONIC	YES	NM_012098.3	Transcript	protein_coding	synonymous_variant		3/5	NM_012098.3:c.879G>C	NP_036230.1:p.Leu293%3D		-1.0						.	.	.		0.00193949	295.0	152102.0	0.0	32	0.96	PASS	amr	0.00392979	60.0	0.00283757	193.0	0.00160259	403.0	251468.0	2.0	96	1.0	PASS	amr	0.00263112	91.0	0.00250523	285.0	0.0014083	219	0.005	16.0				9.717	0.533897		0	0	0			ANGPTL2	0.0	0.0	0.0	0.0	-7.0	-34.0	-33.0	0.0						0.321	0.18	38.465108544			immune system phenotype; hematopoietic system phenotype; homeostasis/metabolism phenotype; cellular phenotype; growth/size/body region phenotype; integument phenotype ; adipose tissue phenotype ; 			.	.	multicellular organism development	extracellular space;collagen-containing extracellular matrix;extracellular exosome	signaling receptor binding;protein binding	ANGPTL2[24899623];LILRB2[24899623;22660330];	129856144
76122	chr9	131367749	G	A	chr9:131367749	SPTAN1	spectrin alpha, non-erythrocytic 1	SNV	0/0	0.0	33_0	33	99.0	0/1	0.59	36_51	87	99.0			rs574740801	EXONIC	YES	NM_001375318.1	Transcript	protein_coding	missense_variant		32/59	NM_001375318.1:c.4075G>A	NP_001362247.1:p.Asp1359Asn		1.0	.,.,.,.,.	Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Peripheral_neuropathy|Early_infantile_epileptic_encephalopathy_5|Early_infantile_epileptic_encephalopathy_with_suppression_bursts|not_provided	Developmental and epileptic encephalopathy 5, 613477 (3), Autosomal dominant	West syndrome	Disease-causing germline mutation(s) in	Atrophy/Degeneration affecting the brainstem;Hypoplasia of the corpus callosum;Autosomal dominant inheritance;Infantile onset;Hypsarrhythmia;Intellectual disability, profound;Spastic tetraplegia;Generalized hypotonia;Cerebral atrophy;CNS hypomyelination;Intellectual disability, severe;Progressive microcephaly;Hyperreflexia;Cerebellar atrophy;Seizure;Variable expressivity;Epileptic encephalopathy;Myoclonus;Infantile spasms;Developmental regression;Hypsarrhythmia;Abnormality of skin morphology	25741868	8.54106e-05	13.0	152206.0	0.0	32	0.96	PASS	amr	0.00052356	8.0	1.46981e-05	1.0	6.36649e-05	16.0	251316.0	0.0	100	1.0	PASS	amr	0.000173511	6.0	5.2803e-05	6.0	0.0000514	8			0.00018	2.0		31.0	4.353654	0.545	13	6	19	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,M-CAP_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	MetaLR_pred,MetaSVM_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	SPTAN1	0.0	0.0	0.0	0.0	-1.0	5.0	-38.0	7.0						0.116	1.0	0.000000000	0.993	1.167	craniofacial phenotype; cellular phenotype; growth/size/body region phenotype; nervous system phenotype ; embryo phenotype; mortality/aging ; normal phenotype; cardiovascular system phenotype ; 			caudate nucleus;ciliary ganglion;amygdala;temporal lobe;prefrontal cortex;skin;cingulate cortex;superior cervical ganglion;trigeminal ganglion;cerebellum peduncles;cerebellum;pons;fetal brain;occipital lobe;subthalamic nucleus;dorsal root ganglion;whole brain;atrioventricular node;parietal lobe;spinal cord;globus pallidus;medulla oblongata;thalamus;	Tight junction	MAPK cascade;endoplasmic reticulum to Golgi vesicle-mediated transport;cytoskeleton organization;axon guidance;neutrophil degranulation;actin filament capping	extracellular region;cytosol;spectrin;microtubule cytoskeleton;membrane;specific granule lumen;intracellular membrane-bounded organelle;extracellular exosome;extracellular vesicle;tertiary granule lumen	actin binding;Ras guanyl-nucleotide exchange factor activity;structural constituent of cytoskeleton;calcium ion binding;protein binding;calmodulin binding;cadherin binding	APP[16049941];SH3GL3[30021884];DBR1[30021884];CD81[26212323];TAMM41[30021884];JADE1[30021884];DUX4[26816005];SMC4[30021884];WASHC2A[30021884];PPP1CB[26496610];HTR7[19486527];MYB[18548008];SYNPO[26496610];LZTS2[30021884];GABARAPL2[20562859];ATG3[30021884];GABARAPL1[20562859];ECH1[29426014];OMD[30021884];PTOV1[16169070];OCRL[25107275];SHISA9[30021884];SLC9A2[30021884];ZFYVE16[30021884];NCL[30021884];ZSCAN26[26496610];HIST1H2BH[30021884];ERG[21575865];VCL[26496610];FKBP5[30021884];IQGAP1[26496610];STK4[23386615];PCDH19[30021884];GABARAP[20562859];SAV1[24255178];CALD1[30021884];APOB[30021884];SPTBN1[12820899;17088250;30021884];JUN[25609649];ATP8B3[30021884];NEK4[25798074];FANCA[10551855];MICAL3[27528609];FANCC[10551855;19102630];ESR1[21182205];FANCG[19102630];NFKB1[20195357];FANCF[19102630];ICK[30021884];ANLN[26496610];ALS2CR12[30021884];OCLN[30021884];SNW1[20467437];AGO3[19167051];MYO5C[26496610];CDK2[26496610];GRB2[12577067];TAB2[14743216];PIN4[16169070];DZIP3[30021884];HSP90AB1[16263121];YWHAB[20598904];LRRK1[24947832];ARRB1[17620599];ARRB2[17620599];MAP1LC3B[20562859];METTL14[29507755];MAP1LC3A[20562859];MYO18A[26496610];IKBKE[14743216];JAK1[30021884];CCDC112[30021884];RIPK3[14743216];YWHAZ[15161933];SPTB[12820899];GAK[26496610];PPM1A[30021884];NSA2[30021884];MYH9[26496610];EVL[16336193];MAPRE3[22275434];CEP63[17043677];MAPT[26402096];SOS1[20936779];MAPRE1[26496610];CACTIN[30021884];DBN1[26496610];EXOC1[17043677];MYH7[26496610];ZNF197[30021884];TSSC4[16169070];DDX24[16169070];TTC41P[30021884];DNAH6[30021884];SLC5A11[30021884];DDX21[30021884];RNF7[30021884];ADD1[26496610];MAPK9[23602568];LIMA1[26496610];FLNA[26496610];DISC1[17043677];MAPK6[21900206];RPL17[30021884];PDLIM7[26496610];MAP3K3[14743216];MON2[30021884];STAT1[20936779;26966684];PLEKHA5[20936779];CDC5L[20467437];MLH1[20706999];MYO19[26496610];PLEKHA7[28877994];TJP1[16944923];CENPE[26496610];MYO1C[26496610];CAPZA2[26496610];TRIP11[30021884];BCAR1[28007913];	131367749
76214	chr9	133729620	T	G	chr9:133729620	ABL1	ABL proto-oncogene 1, non-receptor tyrosine kinase	SNV	0/0	0.0	36_0	36	99.0	0/1	0.45	31_27	60	99.0			rs111886835,COSV100583886	EXONIC	YES	NM_007313.2	Transcript	protein_coding	synonymous_variant		2/11	NM_007313.2:c.306T>G	NP_009297.2:p.Thr102%3D		1.0		Benign	criteria_provided,_single_submitter	not_specified|not_provided	Leukemia, Philadelphia chromosome-positive, resistant to imatinib, 608232 (3), Somatic mutation; Congenital heart defects and skeletal malformations syndrome, 617602 (3), Autosomal dominant	Chronic myeloid leukemia;Precursor B-cell acute lymphoblastic leukemia;Precursor T-cell acute lymphoblastic leukemia	Part of a fusion gene in;Part of a fusion gene in;Part of a fusion gene in	Poor appetite;Splenomegaly;Leukocytosis;Thrombocytosis;Fatigue;Thrombocytopenia;Abnormal basophil morphology;Myeloproliferative disorder;Fever;Ph-positive acute lymphoblastic leukemia;Chronic myelogenous leukemia;Somatic mutation;Reduced leukocyte alkaline phosphatase;Cutis marmorata;Coarctation of aorta;Broad forehead;Dental crowding;Soft skin;Thin skin;Short nose;Pes planus;Short stature;Narrow nose;Narrow maxilla;Camptodactyly;High palate;Finger clinodactyly;Pointed chin;Cryptorchidism;Failure to thrive;Carious teeth;Hypospadias;Constipation;Intestinal malrotation;Arachnodactyly;Intrauterine growth retardation;Ventricular septal defect;Autosomal dominant inheritance;Long nose;Congenital diaphragmatic hernia;Deeply set eye;Global developmental delay;Short chin;Atrial septal defect;Anal atresia;Pneumothorax;Scoliosis;Pectus excavatum		0.00523763	797.0	152168.0	4.0	32	0.97	PASS	sas	0.0066335	32.0	0.00646812	440.0	0.00642613	1604.0	249606.0	17.0	41	0.87	PASS	nfe	0.00683512	772.0	0.00683512	772.0	0.0053825	837	0.008	24.0	0.0084	80.0		12.51	0.872189		0	0	0			ABL1	0.0	0.0	0.0	0.0	-24.0	-43.0	-43.0	-33.0						0.00331	1.0	86.631992253			cardiovascular system phenotype ; hematopoietic system phenotype; mortality/aging ; normal phenotype; embryo phenotype; respiratory system phenotype; liver/biliary system phenotype; behavior/neurological phenotype ; immune system phenotype; skeleton phenotype; digestive/alimentary phenotype; nervous system phenotype ; craniofacial phenotype; vision/eye phenotype; growth/size/body region phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; 			superior cervical ganglion;	ErbB signaling pathway;Cell cycle;Axon guidance;Pathogenic Escherichia coli infection;EPEC;Chronic myeloid leukemia	mitotic cell cycle;neural tube closure;B-1 B cell homeostasis;positive regulation of protein phosphorylation;B cell proliferation involved in immune response;transitional one stage B cell differentiation;mismatch repair;regulation of transcription, DNA-templated;cellular protein modification process;protein phosphorylation;autophagy;cellular response to DNA damage stimulus;DNA damage induced protein phosphorylation;response to oxidative stress;cell cycle arrest;epidermal growth factor receptor signaling pathway;positive regulation of cytosolic calcium ion concentration;integrin-mediated signaling pathway;intrinsic apoptotic signaling pathway in response to DNA damage;post-embryonic development;regulation of autophagy;positive regulation of endothelial cell migration;peptidyl-tyrosine phosphorylation;cerebellum morphogenesis;negative regulation of cell-cell adhesion;microspike assembly;actin cytoskeleton organization;regulation of endocytosis;cell differentiation;regulation of cell adhesion;negative regulation of BMP signaling pathway;regulation of axon extension;regulation of microtubule polymerization;regulation of Cdc42 protein signal transduction;regulation of actin cytoskeleton organization;positive regulation of osteoblast proliferation;substrate adhesion-dependent cell spreading;cellular response to oxidative stress;platelet-derived growth factor receptor-beta signaling pathway;peptidyl-tyrosine autophosphorylation;Fc-gamma receptor signaling pathway involved in phagocytosis;neuropilin signaling pathway;regulation of cell population proliferation;signal transduction in response to DNA damage;positive regulation of apoptotic process;positive regulation of I-kappaB kinase/NF-kappaB signaling;negative regulation of I-kappaB kinase/NF-kappaB signaling;endothelial cell migration;establishment of protein localization;regulation of T cell differentiation;negative regulation of mitotic cell cycle;positive regulation of mitotic cell cycle;alpha-beta T cell differentiation;protein autophosphorylation;spleen development;thymus development;collateral sprouting;positive regulation of peptidyl-tyrosine phosphorylation;activated T cell proliferation;T cell receptor signaling pathway;B cell receptor signaling pathway;neuromuscular process controlling balance;positive regulation of muscle cell differentiation;positive regulation of release of sequestered calcium ion into cytosol;positive regulation of oxidoreductase activity;negative regulation of ubiquitin-protein transferase activity;positive regulation of stress fiber assembly;mitochondrial depolarization;positive regulation of focal adhesion assembly;Bergmann glial cell differentiation;neuroepithelial cell differentiation;cellular response to hydrogen peroxide;negative regulation of ERK1 and ERK2 cascade;positive regulation of ERK1 and ERK2 cascade;cellular response to lipopolysaccharide;negative regulation of protein serine/threonine kinase activity;cardiovascular system development;positive regulation of cell migration involved in sprouting angiogenesis;actin filament branching;positive regulation of substrate adhesion-dependent cell spreading;positive regulation of interleukin-2 secretion;negative regulation of long-term synaptic potentiation;negative regulation of phospholipase C activity;positive regulation of neuron death;regulation of hematopoietic stem cell differentiation;positive regulation of interferon-gamma secretion;regulation of extracellular matrix organization;cellular response to dopamine;positive regulation of microtubule binding;positive regulation of actin filament binding;regulation of modification of synaptic structure;positive regulation blood vessel branching;activation of protein kinase C activity;positive regulation of Wnt signaling pathway, planar cell polarity pathway;regulation of cell motility;regulation of actin cytoskeleton reorganization;positive regulation of actin cytoskeleton reorganization;negative regulation of endothelial cell apoptotic process;negative regulation of cellular senescence;regulation of response to DNA damage stimulus	nucleus;nucleoplasm;nucleolus;cytoplasm;mitochondrion;cytosol;actin cytoskeleton;nuclear body;dendrite;cell leading edge;nuclear membrane;protein-containing complex;neuronal cell body;perinuclear region of cytoplasm;postsynapse	magnesium ion binding;phosphotyrosine residue binding;DNA binding;actin monomer binding;nicotinate-nucleotide adenylyltransferase activity;protein kinase activity;protein tyrosine kinase activity;non-membrane spanning protein tyrosine kinase activity;protein kinase C binding;protein binding;ATP binding;protein C-terminus binding;kinase activity;SH3 domain binding;syntaxin binding;manganese ion binding;neuropilin binding;SH2 domain binding;ephrin receptor binding;actin filament binding;mitogen-activated protein kinase binding;proline-rich region binding	TSKS[17474147];APP[11279131];CNTFR[17474147];HNRNPR[17474147];MKI67[17474147];CRKL[16443220;24412932;22286129];FAM110A[17474147];VPREB1[17474147];CDC27[17474147];GJA8[unassigned1304];NCKAP5[17474147];TMPO[17474147];CDON[19470755];EIF2A[25852190];DAPK1[29513927];PRKCD[16631755];CD2AP[17474147];UHMK1[17474147];AR[24728074];CTAGE5[17474147];EWSR1[25852190];SUB1[25852190];RIN3[17474147];TLN2[19234221];RIN1[15886098;9144171];SF1[26420826];SLC22A3[17474147];AIRE[17474147];BAZ2A[17474147];PIK3R1[17474147];GNS[17474147];TGOLN2[17474147];SNX3[17474147];ABR[17474147];C6[17474147];PRDX1[17352427];EPB41L3[17474147];NKX2-1[17474147];SFN[15696159];PLCG1[17474147];SPRR2A[18155796];HOXC8[17474147];SNX8[17474147];PCDHA7[17474147];SRPK2[23602568];STAT5A[22286129];XRCC6[25852190];FYB1[17474147];FOXF2[17474147];TMEM74B[17474147];CYP4F2[17474147];LRBA[17474147];HNRNPM[25852190];WNK2[17474147];ATM[11375976;9168117];GTF2IRD1[17474147];GRB2[17474147];RPS21[25852190];TP73[11278685;19442657];RTL8C[17474147];SUV39H2[17474147];RPLP1[25852190];HEXA[17474147];SNX12[17474147];BRCA1[17352427];BRCA2[17474147];SHB[17112510];PPP3CA[17474147];MED14[17474147];PRX[17474147];DLGAP1[17474147];NELFB[17474147];DLGAP3[17474147];DLGAP2[17474147];DLGAP4[17474147];MAP4K1[17474147;9346925];AHSG[17474147];PAX3[17474147];TERF1[11375976];KRT31[unassigned1304];VAV1[19234221];HCK[10849448];MED25[19290556];KIFC2[17474147];CCKBR[17474147];KIT[24728074];RAPGEF1[17474147;16443220];DNASE1L2[17474147];SF3B4[17474147];GPR45[17474147];PRICKLE3[17474147];AKAP6[17474147];CENPA[17474147];EGFR[16273093;24658140];APOL5[17474147];FLNA[17474147];FLNC[17474147];CSMD2[17474147];EPS15[17474147];GABBR1[17474147];GAD1[17474147];GSX2[17474147];DKKL1[17474147];BMP8B[17474147];SORBS1[11374898];SORBS3[16831423];ABI2[17101133];SNX17[17474147];ABI1[9593709;11418237;17101133;18328268;20598684];CTNNB1[17318191];F2RL2[17474147];PARK7[23831022];CELSR3[17474147];RIMS1[17474147];EP300[16648821];RPP38[17474147];CAST[17474147];PDIA2[17474147];CDKL5[17474147];GTF3A[17474147];LIG3[17474147];GRIP2[17474147];SELENON[17474147];ILF3[25852190];ACAP1[17474147];ADAM15[11741929];MSH4[16397227];MSH5[16397227;19442657;22401567];NOTCH3[17474147];LRRC59[25852190];SEMA7A[17474147];CUL7[17474147];DDX5[25852190];DLX4[17474147];NXPH3[17474147];KMT2B[17474147];CHRD[17474147];LTBP2[17474147];EFNA5[17474147];RTN4[17474147];NCKIPSD[17474147];ORC1[17474147];G3BP2[17474147];NEK8[17474147];OSBPL5[17474147];BRPF3[17474147];FUS[25852190];CAV1[20808760];SYNJ2[17474147];MAVS[19914245];NBEA[17474147];SP1[17474147];OGN[17474147];BCL2L1[16631755];YWHAE[15696159;25852190];CNTNAP1[17474147];DOCK3[17474147];HSP90AB1[22939624];YWHAB[15696159;25852190];FLT3[28086240];LRRK2[24947832];ITGB2[19234221];LRRK1[20697350;24947832];DDX41[17474147];DUSP15[17474147];PKD1[17474147];YWHAQ[25852190];SCARF2[17474147];YWHAG[15696159;25852190;30021884];YWHAH[15696159;25852190];NCK1[17474147];ARHGEF11[17474147];VPS13A[17474147];MEPE[17474147];YWHAZ[15696159;25852190];CKAP5[17474147];DNM1[17474147];CKAP4[25852190];DNM2[17474147];PTBP3[22575643];DNM3[17474147];EEF1G[25852190];PKM[24606918];TOP1[15448168];SOS2[17474147];SHANK3[17474147];CRK[17474147;12384576;21602891;24412932;17515907];HCN4[17474147];SLC24A1[17474147];SRC[17318191;17474147];TULP4[17474147];ASAP1[17474147];LRP2[17474147];CBL[15556646];ASB16[17474147];MUC1[16888623];NFS1[17474147];EFS[17474147];ERBB3[16273093];SH3BP1[17352427];ERBB4[16273093];POLD1[17474147];NPVF[17474147];ERBB2[16273093];RGS20[17474147];FYN[17474147];WASF1[10970852];SNCA[24412932];PTPN1[16537444];HSPE1[25852190];GSTZ1[17474147];P2RX7[17474147];NFASC[17474147];RAD51[19427856];TRIM39[17474147];ST5[9632734];DRG1[25852190];PTPN4[17474147];HCN2[17474147];	133729620
76381	chr9	135763825	G	A	chr9:135763825	SPACA9	sperm acrosome associated 9	SNV	0/1	0.55	70_85	155	99.0	0/0	0.0	37_0	37	99.0			rs142240079	EXONIC	YES	NM_001316897.2	Transcript	protein_coding	missense_variant		4/4	NM_001316897.2:c.496G>A	NP_001303826.1:p.Val166Met		1.0	.,.					.	.	.		0.000328709	50.0	152110.0	0.0	32	0.96	PASS	amr	0.00137471	21.0	0.000132322	9.0	0.000365594	91.0	248910.0	0.0	71	0.96	PASS	amr	0.000984993	34.0	0.000242057	27.0	0.0002894	45	0.001	3.0				33.0	5.063228	0.697	8	11	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,M-CAP_pred,MutationTaster_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	LRT_pred,MetaLR_pred,MetaSVM_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-XF_coding_pred	C9orf9	0.0	0.0	0.43	0.99	-12.0	-1.0	3.0	-1.0	0.999969242257053	0.894						0.000000000	0.996	1.176	.			.	.	.	acrosomal vesicle;nucleus;cytoplasmic microtubule;ciliary basal body;sperm flagellum;ciliary base	protein binding;calcium-dependent protein binding	KRTAP10-5[25416956];EFEMP2[unassigned1304];DDX24[16169070];TSC22D1[21900206];KRTAP10-7[25416956];KRTAP10-9[25416956];KRTAP10-8[25416956];HIST3H3[30021884];EXOC5[25416956];SEPHS1[16169070];KRTAP1-1[unassigned1304];	135763825
76388	chr9	135773001	AA		chr9:135773001-135773002	TSC1	TSC complex subunit 1	sequence_alteration	1/2	0.5	0_3_3	6	69.0	0/1	0.43	4_3_0	7	74.0			rs5901000	SPLICING	YES	NM_000368.5	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	20/22		NM_000368.5:c.2626-5_2626-4del			-1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	Tuberous_sclerosis_1|not_specified|not_provided	Focal cortical dysplasia, type II, somatic, 607341 (3); Tuberous sclerosis-1, 191100 (3), Autosomal dominant; Lymphangioleiomyomatosis, 606690 (3)	Tuberous sclerosis complex;Isolated focal cortical dysplasia type IIb;Adult hepatocellular carcinoma;Lymphangioleiomyomatosis	Disease-causing germline mutation(s) in;Disease-causing somatic mutation(s) in;Candidate gene tested in;Disease-causing somatic mutation(s) in	Somatic mutation;Pulmonary lymphangiomyomatosis;Renal angiomyolipoma;Preauricular hair displacement;Dental enamel pits;Cortical tubers;Pulmonary lymphangiomyomatosis;Achromatic retinal patches;Premature chromatid separation;Wolff-Parkinson-White syndrome;Hypothyroidism;Infantile spasms;Astrocytoma;Cafe-au-lait spot;Autosomal dominant inheritance;Cerebral calcification;Seizure;Attention deficit hyperactivity disorder;Subungual fibromas;Renal cyst;Precocious puberty;Optic nerve glioma;Hemimegalencephaly;Autism;Shagreen patch;Gingival fibromatosis;Subcutaneous nodule;Intellectual disability;Specific learning disability;Subependymal nodules;Chordoma;Renal cell carcinoma;Adenoma sebaceum;Ependymoma;Hypomelanotic macule;Cardiac rhabdomyoma;Hydrocephalus;Abdominal pain;Emphysema;Shagreen patch;Fever;Hemoptysis;Ungual fibroma;Seizure;Fatigue;Lymphedema;Hematuria;Chylopericardium;Abnormal morphology of female internal genitalia;Pulmonary lymphangiomyomatosis;Optic atrophy;Retinal hamartoma;Multiple renal cysts;Ascites;Pneumothorax;Renal angiomyolipoma;Abnormality of skin pigmentation;Atelectasis;Recurrent respiratory infections;Pulmonary infiltrates;Restrictive ventilatory defect;Cough;Abnormal urinary color;Chest pain;Macule;Chylothorax;Lymphadenopathy;Dyspnea;Gastrointestinal hemorrhage;Cognitive impairment;Focal impaired awareness seizure;Intellectual disability;Sporadic;Cognitive impairment;Adult onset;Focal white matter lesions;Focal cortical dysplasia type II;Infantile onset;Astrocytosis;Somatic mutation;Hemiparesis;Cortical dysplasia;Hemimegalencephaly;Anxiety;Epidermoid cyst;Pancreatic endocrine tumor;Sleep disturbance;Depressivity;Hypertension;Poor speech;Cortical tubers;Generalized abnormality of skin;Autism;Attention deficit hyperactivity disorder;Infantile spasms;Renal cell carcinoma;Hypomelanotic macule;Respiratory failure;Subependymal giant-cell astrocytoma;Respiratory tract infection;Retinal astrocytic hamartoma;Aortic aneurysm;Chorioretinal hypopigmentation;Ungual fibroma;Parathyroid adenoma;Self-injurious behavior;Internal hemorrhage;Aggressive behavior;Status epilepticus;Subependymal nodules;Repetitive compulsive behavior;Cortical dysplasia;Parathyroid hyperplasia;Skin plaque;Shagreen patch;Polycystic kidney dysplasia;Pituitary adenoma;Hepatic cysts;Hemoptysis;Abnormal social behavior;Angiofibromas;Impulsivity;Pulmonary lymphangiomyomatosis;Renal angiomyolipoma;Cardiac rhabdomyoma;Stage 5 chronic kidney disease;Noncommunicating hydrocephalus;Neurodevelopmental delay;Intellectual disability;Pheochromocytoma;Respiratory distress;Carcinoid tumor;Specific learning disability;Confetti-like hypopigmented macules;Focal-onset seizure	29261847	6.72262e-05	7.0	104126.0	0.0	16	0.52	PASS	amr	0.000100847	1.0	9.17835e-05	5.0	0.0473397	4915.0	103824.0	0.0	58	0.8	PASS	afr	0.0679027	564.0	0.053476	2743.0	0.0000386,0.0493299	6,7671			0.00588	65.0		3.515	0.055457		0	0	0			TSC1	0.0	0.0	0.0	0.0	-7.0	20.0	-11.0	-10.0						0.00544	1.0				homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; endocrine/exocrine gland phenotype; growth/size/body region phenotype; integument phenotype ; embryo phenotype; skeleton phenotype; renal/urinary system phenotype; vision/eye phenotype; nervous system phenotype ; neoplasm; cardiovascular system phenotype ; reproductive system phenotype; mortality/aging ; respiratory system phenotype; liver/biliary system phenotype; behavior/neurological phenotype ; 			caudate nucleus;prefrontal cortex;cingulate cortex;superior cervical ganglion;trigeminal ganglion;cerebellum peduncles;pons;occipital lobe;subthalamic nucleus;dorsal root ganglion;atrioventricular node;parietal lobe;skeletal muscle;globus pallidus;medulla oblongata;	mTOR signaling pathway;Insulin signaling pathway	kidney development;neural tube closure;regulation of cell-matrix adhesion;adaptive immune response;rRNA export from nucleus;regulation of translation;potassium ion transport;cell-matrix adhesion;negative regulation of cell population proliferation;adult locomotory behavior;negative regulation of neuron projection development;positive regulation of macroautophagy;negative regulation of macroautophagy;negative regulation of translation;hippocampus development;cerebral cortex development;cell projection organization;negative regulation of TOR signaling;negative regulation of ATPase activity;response to insulin;negative regulation of GTPase activity;myelination;memory T cell differentiation;regulation of phosphoprotein phosphatase activity;negative regulation of cell size;regulation of protein kinase activity;glucose import;negative regulation of insulin receptor signaling pathway;synapse organization;protein stabilization;protein heterooligomerization;regulation of stress fiber assembly;positive regulation of stress fiber assembly;regulation of cell cycle;positive regulation of focal adhesion assembly;cardiac muscle cell differentiation;activation of GTPase activity;cellular response to oxygen-glucose deprivation;regulation of neuron death;negative regulation of oxidative stress-induced neuron death	nucleus;cytoplasm;lipid droplet;cytosol;actin filament;plasma membrane;cell cortex;postsynaptic density;membrane;lamellipodium;growth cone;protein-containing complex;TSC1-TSC2 complex;perinuclear region of cytoplasm;chaperone complex	protein binding;Hsp70 protein binding;GTPase activating protein binding;ATPase inhibitor activity;protein N-terminus binding;chaperone binding;Hsp90 protein binding	C1orf94[unassigned1304];RHOXF2[unassigned1304];CCDC120[unassigned1304];KDM1A[23455924];YWHAB[15324660];SMG9[unassigned1304];HR[unassigned1304];ETS1[20195357];PPP1R18[unassigned1304];ACTB[17355907];AQP1[unassigned1304];IKBKB[17693255];FAM110A[unassigned1304];CHCHD2[unassigned1304];GOLGA4[30021884];FTH1[17355907];POGZ[unassigned1304];ZIC1[unassigned1304];MYOZ3[unassigned1304];ZNF765[unassigned1304];PITX1[unassigned1304];YWHAG[15324660;17353931];TNS2[25814554];APPL2[25814554];YWHAH[17979178];SAMD11[unassigned1304];VENTX[unassigned1304];PRMT6[23455924];MYLIP[unassigned1304];DAPK1[21134130];LMO2[unassigned1304];FOXH1[unassigned1304];ARID5A[unassigned1304];VPS37C[unassigned1304];TSC2[17693255;9809973;9580671;20412061;21134130;25263562];TSC1[17355907];VEZF1[unassigned1304];HBA1[17355907];FRS3[unassigned1304];IGFN1[unassigned1304];PATL1[unassigned1304];AES[unassigned1304];ACTA2[17355907];LENG1[unassigned1304];FAM222B[unassigned1304];SFPQ[17355907];HSH2D[25814554];GPANK1[unassigned1304];DOK5[25814554];RASA1[17355907];RIN3[25814554];RIN1[unassigned1304];SDCCAG8[17355907];VGLL3[unassigned1304];BEX3[17355907];CD63[17355907];BECN1[20562859];SAMD7[unassigned1304];SHC3[unassigned1304];NDUFB10[17355907];PPP1R32[unassigned1304];TSGA10IP[unassigned1304];CSH1[17355907];SH2D2A[25814554];CSTF2[unassigned1304];GLIS2[unassigned1304];ATXN1[23275563;unassigned1304];BAG3[unassigned1304];PATZ1[unassigned1304];HOXC8[unassigned1304];ZNF587[unassigned1304];RAB11FIP5[17355907];ENKD1[unassigned1304];NGFR[17355907];TCF7L2[unassigned1304];SPAG8[unassigned1304];TFAP2D[unassigned1304];RBPMS[unassigned1304];RASSF7[17355907];POU6F2[unassigned1304];DMRT3[unassigned1304];TBX6[unassigned1304];MAPK14[20368287];SUOX[unassigned1304];ZNF417[unassigned1304];ID3[17355907];EIF3F[17355907];MNAT1[17355907];CCL28[unassigned1304];	135773000
76403	chr9	135946594	A	G	chr9:135946594	CEL	carboxyl ester lipase	SNV	0|1	0.33	86_42	128	99.0	0/0	0.0	33_0	33	99.0			rs202205757	EXONIC	YES	NM_001807.6	Transcript	protein_coding	missense_variant		11/11	NM_001807.6:c.1705A>G	NP_001798.3:p.Thr569Ala		1.0	Mucin-like domain				Maturity-onset diabetes of the young, type VIII, 609812 (3), Autosomal dominant	MODY	Disease-causing germline mutation(s) in	Obesity;Overweight;Glycosuria;Renal cyst;Hyperinsulinemic hypoglycemia;Retinopathy;Intrauterine growth retardation;Neonatal hypoglycemia;Pancreatic hypoplasia;Hepatocellular adenoma;Elevated hemoglobin A1c;Nephropathy;Large for gestational age;Exocrine pancreatic insufficiency;Transient neonatal diabetes mellitus;Abnormal oral glucose tolerance;Abnormal C-peptide level;Hypoinsulinemia;Hyperglycemia;Autosomal dominant inheritance;Abdominal pain;Maturity-onset diabetes of the young;Abnormality of exocrine pancreas physiology		0.00051963	72.0	138560.0	2.0	30	0.89	PASS	amr	0.00126689	18.0	0.000554763	35.0	0.000184323	43.0	233286.0	0.0	90	0.77	PASS	amr	0.000324292	11.0	0.000186581	20.0	0.0004116	64	0.001	3.0	0.0007	8.0		0.001	-1.325822	0.061	1	17	18	M-CAP_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CEL	0.0	0.0	0.0	0.0	-14.0	-7.0	18.0	5.0							0.0		0.0	-4.216	homeostasis/metabolism phenotype; growth/size/body region phenotype; adipose tissue phenotype ; liver/biliary system phenotype; digestive/alimentary phenotype; 			pituitary;beta cell islets;pancreas;fetal liver;	Bile acid biosynthesis;Glycerolipid metabolism	lipid metabolic process;cholesterol catabolic process;neuron cell-cell adhesion;fatty acid catabolic process;protein esterification;pancreatic juice secretion;intestinal cholesterol absorption;lipid digestion;intestinal lipid catabolic process;synaptic vesicle endocytosis;modulation of chemical synaptic transmission;postsynaptic membrane assembly;presynaptic membrane assembly	extracellular region;extracellular space;cytoplasm;integral component of plasma membrane;cell surface;synapse;extracellular exosome;presynapse	catalytic activity;sterol esterase activity;triglyceride lipase activity;protein binding;heparin binding;hydrolase activity;signaling receptor activity;neurexin family protein binding;acylglycerol lipase activity	BPGM[21988832];	135946594
76404	chr9	135946596	T	C	chr9:135946596	CEL	carboxyl ester lipase	SNV	0|1	0.33	86_42	128	99.0	0/0	0.0	33_0	33	99.0			rs373542594,COSV60826207	EXONIC	YES	NM_001807.6	Transcript	protein_coding	synonymous_variant		11/11	NM_001807.6:c.1707T>C	NP_001798.3:p.Thr569%3D		1.0					Maturity-onset diabetes of the young, type VIII, 609812 (3), Autosomal dominant	MODY	Disease-causing germline mutation(s) in	Obesity;Overweight;Glycosuria;Renal cyst;Hyperinsulinemic hypoglycemia;Retinopathy;Intrauterine growth retardation;Neonatal hypoglycemia;Pancreatic hypoplasia;Hepatocellular adenoma;Elevated hemoglobin A1c;Nephropathy;Large for gestational age;Exocrine pancreatic insufficiency;Transient neonatal diabetes mellitus;Abnormal oral glucose tolerance;Abnormal C-peptide level;Hypoinsulinemia;Hyperglycemia;Autosomal dominant inheritance;Abdominal pain;Maturity-onset diabetes of the young;Abnormality of exocrine pancreas physiology		0.000662429	89.0	134354.0	2.0	30	0.87	PASS	amr	0.00180636	25.0	0.000746777	46.0	0.000231941	54.0	232818.0	0.0	92	0.76	PASS	amr	0.000472674	16.0	0.000243041	26.0	0.0005466	85	0.001	4.0	0.00123	14.0		0.013	-0.753284		0	0	0			CEL	0.0	0.0	0.0	0.0	-16.0	16.0	49.0	16.0							0.0				homeostasis/metabolism phenotype; growth/size/body region phenotype; adipose tissue phenotype ; liver/biliary system phenotype; digestive/alimentary phenotype; 			pituitary;beta cell islets;pancreas;fetal liver;	Bile acid biosynthesis;Glycerolipid metabolism	lipid metabolic process;cholesterol catabolic process;neuron cell-cell adhesion;fatty acid catabolic process;protein esterification;pancreatic juice secretion;intestinal cholesterol absorption;lipid digestion;intestinal lipid catabolic process;synaptic vesicle endocytosis;modulation of chemical synaptic transmission;postsynaptic membrane assembly;presynaptic membrane assembly	extracellular region;extracellular space;cytoplasm;integral component of plasma membrane;cell surface;synapse;extracellular exosome;presynapse	catalytic activity;sterol esterase activity;triglyceride lipase activity;protein binding;heparin binding;hydrolase activity;signaling receptor activity;neurexin family protein binding;acylglycerol lipase activity	BPGM[21988832];	135946596
76405	chr9	135946887	C	G	chr9:135946887	CEL	carboxyl ester lipase	SNV	1/1	1.0	0_7	7	21.0	0/0	0.0	28_0	28	0.0			rs35171271,COSV60826968	EXONIC	YES	NM_001807.6	Transcript	protein_coding	synonymous_variant		11/11	NM_001807.6:c.1998C>G	NP_001798.3:p.Gly666%3D		1.0		Likely_benign	no_assertion_criteria_provided	not_specified	Maturity-onset diabetes of the young, type VIII, 609812 (3), Autosomal dominant	MODY	Disease-causing germline mutation(s) in	Obesity;Overweight;Glycosuria;Renal cyst;Hyperinsulinemic hypoglycemia;Retinopathy;Intrauterine growth retardation;Neonatal hypoglycemia;Pancreatic hypoplasia;Hepatocellular adenoma;Elevated hemoglobin A1c;Nephropathy;Large for gestational age;Exocrine pancreatic insufficiency;Transient neonatal diabetes mellitus;Abnormal oral glucose tolerance;Abnormal C-peptide level;Hypoinsulinemia;Hyperglycemia;Autosomal dominant inheritance;Abdominal pain;Maturity-onset diabetes of the young;Abnormality of exocrine pancreas physiology		0.000786362	56.0	71214.0	1.0	11	0.15	PASS	afr	0.00136846	24.0	0.000774527	27.0					1	0.0							0.0000064,0.0000064	1,1						0.277	-0.339974		0	0	0			CEL	0.0	0.0	0.0	0.0	-11.0	22.0	-11.0	22.0							0.0				homeostasis/metabolism phenotype; growth/size/body region phenotype; adipose tissue phenotype ; liver/biliary system phenotype; digestive/alimentary phenotype; 			pituitary;beta cell islets;pancreas;fetal liver;	Bile acid biosynthesis;Glycerolipid metabolism	lipid metabolic process;cholesterol catabolic process;neuron cell-cell adhesion;fatty acid catabolic process;protein esterification;pancreatic juice secretion;intestinal cholesterol absorption;lipid digestion;intestinal lipid catabolic process;synaptic vesicle endocytosis;modulation of chemical synaptic transmission;postsynaptic membrane assembly;presynaptic membrane assembly	extracellular region;extracellular space;cytoplasm;integral component of plasma membrane;cell surface;synapse;extracellular exosome;presynapse	catalytic activity;sterol esterase activity;triglyceride lipase activity;protein binding;heparin binding;hydrolase activity;signaling receptor activity;neurexin family protein binding;acylglycerol lipase activity	BPGM[21988832];	135946887
76415	chr9	135982143	G	A	chr9:135982143	RALGDS	ral guanine nucleotide dissociation stimulator	SNV	0/1	0.54	22_26	48	99.0	0/1	0.57	36_48	84	99.0			rs190238332	SPLICING	YES	NM_006266.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	7/17		NM_006266.4:c.1414-8C>T			-1.0						.	.	.		0.00350817	534.0	152216.0	1.0	32	0.98	PASS	nfe	0.00620315	422.0	0.00620315	422.0	0.00433229	1040.0	240058.0	4.0	66	0.75	PASS	nfe	0.00743677	801.0	0.00743677	801.0	0.0048487	754	0.001	4.0	0.00193	22.0		0.231	-0.365988		0	0	0			RALGDS	0.0	0.0	0.0	0.0	26.0	-11.0	-39.0	-11.0	4.39509779214716e-05	0.002	9.38	-0.174	9.206	0.515	0.3				neoplasm; homeostasis/metabolism phenotype; 			.	Colorectal cancer;Pancreatic cancer	Ras protein signal transduction;regulation of catalytic activity	nucleus;cytosol;brush border	guanyl-nucleotide exchange factor activity;protein binding;GTPase regulator activity	KRTAP10-8[unassigned1304];RRAS2[21988832];PRKCZ[23175184];RAP1B[21988832;22705156];CDC42[23175184];RIT1[10545207];RAP1A[23236378];CYSRT1[unassigned1304];CDH1[23175184];KDR[23175184];CTNNB1[23175184];KRAS[21988832];HOXA1[unassigned1304];CD68[21988832];RAF1[19075231];HRAS[20936779;25241761;24441586];CC2D2B[30021884];MAPK3[25241761];	135982143
76423	chr9	136030656	C	T	chr9:136030656	GBGT1	globoside alpha-1,3-N-acetylgalactosaminyltransferase 1 (FORS blood group)	SNV	0/1	0.38	57_36	94	99.0	0/0	0.0	34_0	34	99.0			rs146249736,COSV64404490	EXONIC	YES	NM_021996.6	Transcript	protein_coding	missense_variant		6/7	NM_021996.6:c.268G>A	NP_068836.2:p.Val90Ile		-1.0	.,.,.,.					.	.	.		0.000289272	44.0	152106.0	0.0	32	0.96	PASS	sas	0.000414594	2.0	0.000161741	11.0	0.000311499	78.0	250402.0	0.0	62	0.99	PASS	nfe	0.000230093	26.0	0.000230093	26.0	0.0002379	37	0.001	3.0	0.00123	14.0		15.3	1.321352	0.067	2	16	18	M-CAP_pred,MutationTaster_pred	SIFT,PolyPhen,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	GBGT1	0.0	0.03	0.0	0.0	-2.0	43.0	-8.0	14.0						0.846	0.0	0.000000000,0.000000000	0.566	0.119	mortality/aging ; 			.	Glycosphingolipid biosynthesis - globoseries;Glycan structures - biosynthesis 2	carbohydrate metabolic process;protein glycosylation;glycolipid biosynthetic process;lipid glycosylation	Golgi membrane;Golgi apparatus;integral component of membrane;vesicle	transferase activity, transferring glycosyl groups;metal ion binding;globoside alpha-N-acetylgalactosaminyltransferase activity	.	136030656
76511	chr9	136333052	C	T	chr9:136333052	CACFD1	calcium channel flower domain containing 1	SNV	0/1	0.43	58_44	102	99.0	0/0	0.0	33_0	33	99.0			rs143531436,COSV99390502	EXONIC	YES	NM_001242369.2	Transcript	protein_coding	synonymous_variant		4/6	NM_001242369.2:c.330C>T	NP_001229298.1:p.Val110%3D		1.0						.	.	.		0.00250999	382.0	152192.0	1.0	33	0.98	PASS	amr	0.00477561	73.0	0.00367463	250.0	0.00236938	594.0	250698.0	1.0	48	1.0	PASS	nfe	0.00379069	429.0	0.00379069	429.0	0.0021671	337	0.006	20.0				0.486	-0.258171		0	0	0			CACFD1	0.0	0.0	0.0	0.0	18.0	-9.0	18.0	48.0							0.01	26.021934218			homeostasis/metabolism phenotype; cellular phenotype; behavior/neurological phenotype ; neoplasm; 			.	.	biological_process;vesicle-mediated transport	cellular_component;integral component of membrane	molecular_function;protein binding	SH3GLB1[unassigned1304];NDRG4[unassigned1304];TMEM159[21516116;25416956];MTERF3[unassigned1304];PNKP[unassigned1304];HSFX1[unassigned1304];RBFA[unassigned1304];PITPNC1[unassigned1304];	136333052
76549	chr9	137622315	C	T	chr9:137622315	COL5A1	collagen type V alpha 1 chain	SNV	0/1	0.5	30_30	60	99.0	0/0	0.0	36_0	36	99.0			rs61729497	EXONIC	YES	NM_000093.5	Transcript	protein_coding	synonymous_variant		7/66	NM_000093.5:c.1158C>T	NP_000084.3:p.Ser386%3D		1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Ehlers-Danlos_syndrome,_classic_type|Ehlers-Danlos_syndrome,_classic_type_I|Ehlers-Danlos_syndrome,_type_7A|not_specified|Cardiovascular_phenotype|not_provided	Ehlers-Danlos syndrome, classic type, 1, 130000 (3), Autosomal dominant; Fibromuscular dysplasia, multifocal, 619329 (3), Autosomal dominant	Ehlers-Danlos syndrome, vascular type;Ehlers-Danlos syndrome type 2;Ehlers-Danlos syndrome type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Hyperextensible skin;Fragile skin;Subcutaneous spheroids;Joint hypermobility;Soft, doughy skin;Autosomal dominant inheritance;Epicanthus;Bruising susceptibility;Congenital hip dislocation;Cigarette-paper scars;Generalized joint laxity;Hernia;Molluscoid pseudotumors;Talipes equinovarus;Ectopia lentis;Myopia;Atrial septal defect;Narrow face;Blue sclerae;Abnormality of the gingiva;Triangular face;Retinal detachment;Microcornea;Premature birth;Hypertension;Fatigue;High, narrow palate;Abnormal renal tubule morphology;Eczema;Joint dislocation;Hyperextensible skin;Erythema;Aplasia/Hypoplasia of the abdominal wall musculature;Muscular hypotonia;Malar prominence;Corneal dystrophy;Inguinal hernia;Cognitive impairment;Open bite;Wide nasal bridge;Umbilical hernia;Shagreen patch;Epicanthus;Reduced number of teeth;Reduced consciousness/confusion;Microdontia;Kyphosis;Pectus carinatum;Long thorax;Atypical scarring of skin;Papule;Pes planus;Hypotension;Dental malocclusion;Keratoglobus;Cachexia;Urticaria;Migraine;Abnormal nasal morphology;Asthma;Arachnodactyly;Pneumothorax;Arterial dissection;Joint hyperflexibility;Osteoarthritis;Genital hernia;Mitral valve prolapse;Petechiae;Hiatus hernia;Hypoplasia of the ear cartilage;Acrocyanosis;Venous insufficiency;Hyperlordosis;Emphysema;Muscle weakness;Ascending tubular aorta aneurysm;Myalgia;Glaucoma;Thin skin;Bruising susceptibility;Tricuspid valve prolapse;Abnormality of the tongue;Spina bifida occulta;Striae distensae;Scoliosis;Short stature;Hyperextensible skin;Short stature;Molluscoid pseudotumors;Narrow maxilla;Inguinal hernia;Myopia;Joint dislocation;Mitral valve prolapse;Irregularly spaced teeth;Hyperextensibility at elbow;Osteoarthritis;Ectopia lentis;Autosomal dominant inheritance;Bruising susceptibility;Cigarette-paper scars;Premature birth following premature rupture of fetal membranes;Hyperextensibility of the finger joints;Umbilical hernia;Subcutaneous spheroids;Pes planus;Infantile muscular hypotonia;Hyperextensibility of the knee;Lop ear;Aortic root aneurysm;Blue sclerae;Bowel diverticulosis;Soft skin;Poor wound healing;Epicanthus;Fragile skin		0.00170157	259.0	152212.0	2.0	34	0.98	PASS	afr	0.00564318	234.0	5.87959e-05	4.0	0.000636713	159.0	249720.0	2.0	100	0.99	PASS	afr	0.00657731	106.0	0.000133597	15.0	0.0006495	101	0.001	4.0	0.00132	15.0		2.607	-0.001088		0	0	0			COL5A1	0.0	0.0	0.0	0.0	-21.0	6.0	6.0	28.0						0.0114	1.0	14.558179596			integument phenotype ; embryo phenotype; normal phenotype; mortality/aging ; cardiovascular system phenotype ; vision/eye phenotype; 			ciliary ganglion;uterus;smooth muscle;adipose tissue;atrioventricular node;placenta;fetal lung;heart;	Cell Communication;Focal adhesion;ECM-receptor interaction	blood vessel development;heart morphogenesis;cell adhesion;cell migration;extracellular matrix organization;collagen fibril organization;collagen biosynthetic process;wound healing, spreading of epidermal cells;tendon development;skin development;integrin biosynthetic process;eye morphogenesis;regulation of cellular component organization;supramolecular fiber organization;negative regulation of endodermal cell differentiation	extracellular region;collagen type V trimer;basement membrane;extracellular space;endoplasmic reticulum lumen;extracellular matrix;collagen-containing extracellular matrix	integrin binding;extracellular matrix structural constituent;protein binding;heparin binding;extracellular matrix structural constituent conferring tensile strength;proteoglycan binding;metal ion binding;platelet-derived growth factor binding	GALNT7[20979576];PTPN1[26496610];TGFB1[20979576];MMP2[20979576];CSNK2A2[26496610];FN1[20979576];TNC[20979576];PCOLCE[20979576];COL1A1[20979576];COL1A2[20979576];BMP1[20979576];COL6A2[20979576];COL6A1[20979576];COL6A3[20979576];TIMP1[20979576];SUGP2[30021884];TGM2[26496610];	137622315
76568	chr9	137698027	C	T	chr9:137698027	COL5A1	collagen type V alpha 1 chain	SNV	0/1	0.58	31_45	77	99.0	0/0	0.0	35_0	35	99.0			rs146461106	SPLICING	YES	NM_000093.5	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	41/65		NM_000093.5:c.3259-8C>T			1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Connective_tissue_disorder|Ehlers-Danlos_syndrome,_classic_type_I|not_provided	Ehlers-Danlos syndrome, classic type, 1, 130000 (3), Autosomal dominant; Fibromuscular dysplasia, multifocal, 619329 (3), Autosomal dominant	Ehlers-Danlos syndrome, vascular type;Ehlers-Danlos syndrome type 2;Ehlers-Danlos syndrome type 1	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Hyperextensible skin;Fragile skin;Subcutaneous spheroids;Joint hypermobility;Soft, doughy skin;Autosomal dominant inheritance;Epicanthus;Bruising susceptibility;Congenital hip dislocation;Cigarette-paper scars;Generalized joint laxity;Hernia;Molluscoid pseudotumors;Talipes equinovarus;Ectopia lentis;Myopia;Atrial septal defect;Narrow face;Blue sclerae;Abnormality of the gingiva;Triangular face;Retinal detachment;Microcornea;Premature birth;Hypertension;Fatigue;High, narrow palate;Abnormal renal tubule morphology;Eczema;Joint dislocation;Hyperextensible skin;Erythema;Aplasia/Hypoplasia of the abdominal wall musculature;Muscular hypotonia;Malar prominence;Corneal dystrophy;Inguinal hernia;Cognitive impairment;Open bite;Wide nasal bridge;Umbilical hernia;Shagreen patch;Epicanthus;Reduced number of teeth;Reduced consciousness/confusion;Microdontia;Kyphosis;Pectus carinatum;Long thorax;Atypical scarring of skin;Papule;Pes planus;Hypotension;Dental malocclusion;Keratoglobus;Cachexia;Urticaria;Migraine;Abnormal nasal morphology;Asthma;Arachnodactyly;Pneumothorax;Arterial dissection;Joint hyperflexibility;Osteoarthritis;Genital hernia;Mitral valve prolapse;Petechiae;Hiatus hernia;Hypoplasia of the ear cartilage;Acrocyanosis;Venous insufficiency;Hyperlordosis;Emphysema;Muscle weakness;Ascending tubular aorta aneurysm;Myalgia;Glaucoma;Thin skin;Bruising susceptibility;Tricuspid valve prolapse;Abnormality of the tongue;Spina bifida occulta;Striae distensae;Scoliosis;Short stature;Hyperextensible skin;Short stature;Molluscoid pseudotumors;Narrow maxilla;Inguinal hernia;Myopia;Joint dislocation;Mitral valve prolapse;Irregularly spaced teeth;Hyperextensibility at elbow;Osteoarthritis;Ectopia lentis;Autosomal dominant inheritance;Bruising susceptibility;Cigarette-paper scars;Premature birth following premature rupture of fetal membranes;Hyperextensibility of the finger joints;Umbilical hernia;Subcutaneous spheroids;Pes planus;Infantile muscular hypotonia;Hyperextensibility of the knee;Lop ear;Aortic root aneurysm;Blue sclerae;Bowel diverticulosis;Soft skin;Poor wound healing;Epicanthus;Fragile skin		0.00142622	217.0	152150.0	0.0	33	0.98	PASS	afr	0.00492397	204.0	1.47042e-05	1.0	0.000342576	53.0	154710.0	0.0	53	0.58	PASS	afr	0.00494253	43.0	5.0913e-05	3.0	0.0001929	30	0.002	5.0	0.00062	7.0		0.674	-0.209517		0	0	0			COL5A1	0.02	0.0	0.0	0.0	18.0	-18.0	26.0	0.0	0.0001054828634895	0.0	8.795	-0.559	8.236	0.0114	1.0				integument phenotype ; embryo phenotype; normal phenotype; mortality/aging ; cardiovascular system phenotype ; vision/eye phenotype; 			ciliary ganglion;uterus;smooth muscle;adipose tissue;atrioventricular node;placenta;fetal lung;heart;	Cell Communication;Focal adhesion;ECM-receptor interaction	blood vessel development;heart morphogenesis;cell adhesion;cell migration;extracellular matrix organization;collagen fibril organization;collagen biosynthetic process;wound healing, spreading of epidermal cells;tendon development;skin development;integrin biosynthetic process;eye morphogenesis;regulation of cellular component organization;supramolecular fiber organization;negative regulation of endodermal cell differentiation	extracellular region;collagen type V trimer;basement membrane;extracellular space;endoplasmic reticulum lumen;extracellular matrix;collagen-containing extracellular matrix	integrin binding;extracellular matrix structural constituent;protein binding;heparin binding;extracellular matrix structural constituent conferring tensile strength;proteoglycan binding;metal ion binding;platelet-derived growth factor binding	GALNT7[20979576];PTPN1[26496610];TGFB1[20979576];MMP2[20979576];CSNK2A2[26496610];FN1[20979576];TNC[20979576];PCOLCE[20979576];COL1A1[20979576];COL1A2[20979576];BMP1[20979576];COL6A2[20979576];COL6A1[20979576];COL6A3[20979576];TIMP1[20979576];SUGP2[30021884];TGM2[26496610];	137698027
76725	chr9	139959231	G	A	chr9:139959231	SAPCD2	suppressor APC domain containing 2	SNV	0/0	0.0	50_0	50	99.0	0/1	0.55	34_41	75	99.0			rs140919217	EXONIC	YES	NM_178448.4	Transcript	protein_coding	synonymous_variant		6/6	NM_178448.4:c.1065C>T	NP_848543.2:p.Thr355%3D		-1.0						.	.	.		0.00604571	920.0	152174.0	8.0	33	0.98	PASS	nfe	0.0073644	501.0	0.0073644	501.0	0.00721356	1596.0	221250.0	20.0	67	0.61	PASS	nfe	0.00889067	863.0	0.00889067	863.0	0.0062957	979	0.003	8.0				3.184	0.035495		0	0	0			SAPCD2	0.03	0.01	0.0	0.0	5.0	-4.0	6.0	-7.0							0.0				normal phenotype; 			.	.	establishment of mitotic spindle orientation;positive regulation of cell population proliferation;regulation of establishment of planar polarity;symmetric cell division;negative regulation of protein localization to cell cortex	nucleus;nucleolus;cytosol;bicellular tight junction;apical plasma membrane;apical junction complex;apical cortex	protein binding	RALBP1[unassigned1304];KRT3[unassigned1304];EXOC7[unassigned1304];USHBP1[unassigned1304];GMNN[unassigned1304];RASSF9[24366813];TANK[unassigned1774];BFSP2[unassigned1304];CYSRT1[unassigned1304];UBA1[26496610];C1orf109[unassigned1304];GPRASP2[unassigned1304];MDFI[unassigned1304];VCL[unassigned1304];ATF4[unassigned1304];	139959231
76741	chr9	140008463	C	G	chr9:140008463	DPP7	dipeptidyl peptidase 7	SNV	0/1	0.4	47_31	78	99.0	0/0	0.0	33_0	33	99.0			rs771968258	EXONIC	YES	NM_013379.3	Transcript	protein_coding	synonymous_variant		4/13	NM_013379.3:c.339G>C	NP_037511.2:p.Ser113%3D		-1.0						.	.	.		6.59083e-05	10.0	151726.0	0.0	30	0.91	PASS	sas	0.00124224	6.0	2.94829e-05	2.0	0.000139906	25.0	178692.0	0.0	16	0.35	PASS	sas	0.000846706	21.0	3.62845e-05	3.0	0.0001222	19						9.712	0.533373		0	0	0			DPP7	0.21	0.02	0.0	0.0	-19.0	17.0	32.0	-10.0						0.501	0.0	36.374705716			.			.	.	proteolysis;neutrophil degranulation	extracellular region;Golgi apparatus;cytosol;vesicle;azurophil granule lumen;intracellular membrane-bounded organelle;extracellular exosome	serine-type peptidase activity;dipeptidyl-peptidase activity	TFAP2A[24835590];TFAP2C[24835590];XRN1[15231747];SPHK1[25216046];	140008463
76785	chr9	140167363	G	A	chr9:140167363	NELFB	negative elongation factor complex member B	SNV	0/1	0.47	25_22	47	99.0	0/0	0.0	43_0	43	99.0			rs548870615	EXONIC	YES	NM_015456.5	Transcript	protein_coding	missense_variant		13/13	NM_015456.5:c.1870G>A	NP_056271.3:p.Ala624Thr		1.0	.,.					.	.	.		0.000118223	18.0	152254.0	0.0	34	0.99	PASS	sas	0.00144868	7.0	8.81886e-05	6.0	0.000337838	47.0	139120.0	0.0	14	0.41	PASS	sas	0.00184101	39.0	7.87216e-05	4.0	0.0001158	18						12.93	0.928548	0.063	1	14	15	LIST-S2_pred	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	NELFB	0.0	0.0	0.0	0.0	29.0	-7.0	-37.0	-7.0							0.75	0.000000000	0.0	-0.56	embryo phenotype; mortality/aging ; 			.	.	transcription by RNA polymerase II;transcription elongation from RNA polymerase II promoter;negative regulation of transcription elongation from RNA polymerase II promoter	nucleoplasm;cytoplasm;NELF complex	RNA binding;protein binding	KHDRBS3[20195357];YWHAB[24255178];MGST1[20195357];PIK3R1[17474147];BRCA1[11739404];HIST1H3A[29568061];TCEAL2[20195357];POLR2C[18562274];ABL1[17474147];FYN[17474147];DENR[20195357];PLCG1[17474147];NELFA[12612062;26496610];NELFCD[12612062;unassigned1304];TP53BP1[29656893];MAPK6[21900206];NELFE[14667819;12612062;26496610;unassigned1304];NCK1[17474147];PACSIN1[20195357];HSPA9[20195357];JUN[25609649];NCBP1[26496610];NCBP2[26382858];SMARCA5[20195357];CDC5L[20467437];TPRX1[unassigned1304];SNW1[20467437];RAD51[25640309];GRB2[17474147];	140167363
76832	chr9	140729243	C	T	chr9:140729243	EHMT1	euchromatic histone lysine methyltransferase 1	SNV	0/1	0.61	38_59	97	99.0	0/1	0.52	35_38	73	99.0			rs141797498	EXONIC	YES	NM_024757.5	Transcript	protein_coding	synonymous_variant		27/27	NM_024757.5:c.3735C>T	NP_079033.4:p.Arg1245%3D		1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	Kleefstra_syndrome_1|History_of_neurodevelopmental_disorder|not_specified|not_provided	Kleefstra syndrome 1, 610253 (3), Autosomal dominant	Kleefstra syndrome due to a point mutation;Kleefstra syndrome due to 9q34 microdeletion	Disease-causing germline mutation(s) (loss of function) in;Role in the phenotype of	Tetralogy of Fallot;Depressivity;Muscular hypotonia;Short nose;Aortic valve stenosis;Ventriculomegaly;Feeding difficulties;Inguinal hernia;Highly arched eyebrow;Global developmental delay;Anteverted nares;Synophrys;Hypoplasia of penis;Sleep disturbance;Macroglossia;Femoral hernia;Status epilepticus;Subcortical cerebral atrophy;Hypertelorism;Growth delay;Downturned corners of mouth;Failure to thrive;Generalized non-motor (absence) seizure;Everted lower lip vermilion;Coarctation of aorta;Aortic regurgitation;Apathy;Aphasia;Epileptic spasm;Echolalia;Microcephaly;Agenesis of corpus callosum;Flat occiput;Irritability;Anxiety;Obesity;Cerebral cortical hemiatrophy;Renal insufficiency;Absent septum pellucidum;Mutism;Midface retrusion;Vesicoureteral reflux;Autism;Dysphasia;Abnormal cardiac septum morphology;Specific learning disability;Cryptorchidism;Protruding tongue;Intellectual disability;Brachycephaly;Hearing impairment;Stereotypy;Seizure;Macroglossia;Anteverted nares;Flat face;Brachycephaly;Obesity;Natal tooth;Aggressive behavior;Autosomal dominant inheritance;Persistence of primary teeth;Coarse facial features;Midface retrusion;Talipes equinovarus;Cryptorchidism;Synophrys;Gastroesophageal reflux;Micropenis;Abnormality of the pinna;Sporadic;Everted lower lip vermilion;Microcephaly;Sleep disturbance;Brachydactyly;Hearing impairment;Intellectual disability, severe;Generalized hypotonia;Single transverse palmar crease;Delayed speech and language development;U-Shaped upper lip vermilion;Hypertelorism;Apathy;Conotruncal defect;Mandibular prognathia;Protruding tongue;Malar flattening;Recurrent respiratory infections;Hypospadias;Obsessive-compulsive behavior;Abnormal renal morphology;Autism;Upslanted palpebral fissure;Tracheobronchomalacia	25741868,23757202	0.00183367	279.0	152154.0	2.0	34	0.98	PASS	amr	0.00287883	44.0	0.00249926	170.0	0.00142432	354.0	248540.0	2.0	82	1.0	PASS	nfe	0.00228845	254.0	0.00228845	254.0	0.0013697	213	0.009	30.0	0.00403	46.0		11.87	0.789128		0	0	0			EHMT1	0.0	0.0	0.0	0.0	17.0	-18.0	-19.0	16.0						0.0183	1.0	72.713528661			homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; growth/size/body region phenotype; adipose tissue phenotype ; liver/biliary system phenotype; behavior/neurological phenotype ; immune system phenotype; skeleton phenotype; nervous system phenotype ; vision/eye phenotype; cardiovascular system phenotype ; hematopoietic system phenotype; mortality/aging ; normal phenotype; embryo phenotype; 			pons;subthalamic nucleus;atrioventricular node;trigeminal ganglion;skeletal muscle;globus pallidus;	Lysine degradation	negative regulation of transcription by RNA polymerase II;DNA methylation;chromatin organization;histone methylation;peptidyl-lysine monomethylation;peptidyl-lysine dimethylation;negative regulation of transcription, DNA-templated;regulation of embryonic development;histone H3-K9 methylation;response to fungicide;negative regulation of G0 to G1 transition;histone H3-K27 methylation;positive regulation of cold-induced thermogenesis	nucleus;nucleoplasm;chromosome;nuclear body	p53 binding;protein binding;methyltransferase activity;zinc ion binding;protein-lysine N-methyltransferase activity;histone-lysine N-methyltransferase activity;histone methyltransferase activity (H3-K9 specific);histone methyltransferase activity (H3-K27 specific);C2H2 zinc finger domain binding	HDAC2[21258344];HDAC1[26496610];EHMT2[21258344;27705803;26028330;21430779];SUV39H1[21430779];GMNN[26496610];HTT[17500595];WIZ[26496610];RELA[21131967];ATXN1[23275563];HIST1H3A[29568061];HIF1AN[26972000];ZNF644[26496610];NKX3-1[27339988];ZNF462[27705803];CBX5[20562864];SETDB1[21430779];CBX3[27705803];CBX1[27705803];CDC5L[20467437];HASPIN[26496610];MAD2L2[29789392];CDK8[29568061];CDK7[29568061];BCL6[16147992];MPHOSPH8[20871592;26496610];	140729243
76836	chr9	140777306	C	G	chr9:140777306	CACNA1B	calcium voltage-gated channel subunit alpha1 B	SNV	0/1	0.51	71_75	146	99.0	0/1	0.36	96_55	151	99.0			rs4422842,COSV53112319	EXONIC	YES	NM_000718.4	Transcript	protein_coding	missense_variant		3/47	NM_000718.4:c.501C>G	NP_000709.1:p.Asn167Lys		1.0	.,Ion transport domain,Ion transport domain,Ion transport domain,Ion transport domain,Ion transport domain	Benign	criteria_provided,_multiple_submitters,_no_conflicts	Neurodevelopmental_disorder_with_seizures_and_nonepileptic_hyperkinetic_movements|not_provided	Neurodevelopmental disorder with seizures and nonepileptic hyperkinetic movements, 618497 (3), Autosomal recessive	.	.	Tremor;Retinal degeneration;Ataxia;High forehead;Spasticity;Global developmental delay;Cerebral atrophy;Microcephaly;Encephalopathy;Decreased fetal movement;Delayed speech and language development;Generalized hypotonia;Developmental regression;Short stature;Downslanted palpebral fissures;Abnormal myelination;Intellectual disability;Failure to thrive;Dyskinesia;Feeding difficulties;Autism;Unsteady gait;EEG with multifocal slow activity;Abnormal corpus callosum morphology;Hyporeflexia;Impulsivity;Abnormality of vision;Status epilepticus;Difficulty walking;Rigidity;Myoclonus;Hypsarrhythmia;Optic atrophy;Gastroesophageal reflux;Ptosis;Mental deterioration;Attention deficit hyperactivity disorder;Nystagmus;Poor head control;Limb hypertonia;Hypodontia;Central hypotonia;Cerebral visual impairment;Epileptic encephalopathy;Inability to walk;Choreoathetosis;Myoclonus;Autosomal recessive inheritance;Global developmental delay;Developmental regression;Absent speech;Cerebral atrophy;Dystonia;Strabismus;Recurrent respiratory infections;Nystagmus;Hyperkinetic movements;Postnatal microcephaly;Seizure	20352079,29396286,19503611					32	0.96							0.499956	124620.0	249262.0	1.0	100	1.0	InbreedingCoeff	amr	0.500029	17265.0	0.5	56519.0	0.0029002,0.0338512	451,5264	0.161	500.0				16.35	1.514016	0.639	14	6	20	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	MetaRNN_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred,fathmm-XF_coding_pred	CACNA1B	0.0	0.04	0.01	0.06	29.0	-26.0	0.0	29.0							0.98	32.616318093	0.941	-1.553	integument phenotype ; growth/size/body region phenotype; homeostasis/metabolism phenotype; behavior/neurological phenotype ; mortality/aging ; cardiovascular system phenotype ; nervous system phenotype ; 			kidney;atrioventricular node;parietal lobe;	MAPK signaling pathway;Calcium signaling pathway;Taste transduction;Type II diabetes mellitus	calcium ion transport;chemical synaptic transmission;neurotransmitter secretion;locomotory behavior;regulation of heart contraction;regulation of blood pressure;regulation of ion transmembrane transport;response to pain;modulation of chemical synaptic transmission;membrane depolarization;regulation of calcium ion transport;calcium ion import;calcium ion transmembrane transport;response to amyloid-beta	plasma membrane;voltage-gated calcium channel complex;dendrite;neuronal cell body;presynapse	amyloid-beta binding;voltage-gated calcium channel activity;calcium channel activity;calcium ion binding;protein binding;ATP binding;protein C-terminus binding;high voltage-gated calcium channel activity	RXRB[20195357];MTNR1A[26514267];MRFAP1[17353931];APBA1[16007100];	140777306
76881	chrX	8763196	CTT		chrX:8763196-8763198	FAM9A	family with sequence similarity 9 member A	deletion	0/1	0.38	8_5	13	99.0	0|1	0.08	21_2	25	96.0			rs758797747	EXONIC	YES	NM_001171186.1	Transcript	protein_coding	inframe_deletion		7/10	NM_001171186.1:c.752_754del	NP_001164657.1:p.Glu251del		-1.0						.	.	.		0.00587856	638.0	108530.0	3.0	21	0.57	PASS	nfe	0.00868418	454.0	0.00868418	454.0	0.0052535	570.0	108499.0	3.0	14	0.38	PASS	nfe	0.00923056	411.0	0.00923056	411.0	0.0028938,0.0008167	450,127	0.001	3.0				5.061	0.149129		0	0	0			FAM9A	0.0	0.0	0.0	0.0	36.0	24.0	-1.0	2.0						0.276	0.0				.			.	.	spermatogenesis;spermatid development;meiotic cell cycle	synaptonemal complex;nucleolus	protein binding	HIST1H2BN[unassigned1304];INTS12[unassigned1304];KDM1A[23455924];NAB2[unassigned1304];MLLT3[unassigned1304];RNF4[unassigned1304];GMCL2[unassigned1304];NXF1[unassigned1304];SDCBP[unassigned1304];RNF151[unassigned1304];CTNNA3[unassigned1304];KMT5A[23455924];PRR20D[unassigned1304];RUNX1T1[unassigned1304];ESRRA[unassigned1304];FAM9B[unassigned1304];NPM1[30021884];PHC1[unassigned1304];TRIM41[unassigned1304];HOMER1[unassigned1304];PRMT1[23455924];MCRS1[unassigned1304];STAC3[unassigned1304];TRAF2[unassigned1304];ESRRG[unassigned1304];LCE1E[unassigned1304];ZDHHC17[24705354];JMJD6[23455924];THAP1[unassigned1304];ZBTB6[unassigned1304];TXLNA[unassigned1304];ARPC3[unassigned1304];TRAF5[unassigned1304];PICK1[unassigned1304];ZNF775[unassigned1304];	8763195
76884	chrX	9935569	T	C	chrX:9935569	CLDN34	claudin 34	SNV	0/1	0.47	106_95	201	99.0	0/1	0.48	84_80	166	99.0			rs1292985740	EXONIC	YES	NM_001195081.2	Transcript	protein_coding	missense_variant		1/1	NM_001195081.2:c.172T>C	NP_001182010.1:p.Cys58Arg		1.0						.	.	.		4.48374e-05	5.0	111514.0	0.0	23	0.6	PASS	amr	9.60984e-05	1.0	5.64897e-05	3.0	9.1716e-05	9.0	98129.0	0.0	56	0.57	PASS	amr	0.000155513	3.0	7.77867e-05	3.0								22.8	2.648911	0.548	5	7	12	SIFT,PolyPhen,MetaRNN_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	MetaLR_pred,MetaSVM_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred	CLDN34	0.0	0.0	0.0	0.0	-4.0	26.0	-4.0	-13.0								0.000000000	0.279	0.767	.			.	.	.	plasma membrane;bicellular tight junction;integral component of membrane	structural molecule activity	.	9935569
76915	chrX	15618958	T	C	chrX:15618958	ACE2	angiotensin I converting enzyme 2	SNV	0/1	0.48	57_53	110	99.0	0/1	0.63	28_47	75	99.0			rs4646116	EXONIC	YES	NM_021804.3	Transcript	protein_coding	missense_variant		2/19	NM_021804.3:c.77A>G	NP_068576.1:p.Lys26Arg		-1.0	.,.	Likely_benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00446943	500.0	111871.0	1.0	23	0.6	PASS	nfe	0.00672743	358.0	0.00672743	358.0	0.00397098	728.0	183330.0	0.0	49	0.94	PASS	nfe	0.00589916	483.0	0.00589916	483.0	0.0035497	552	0.003	11.0				8.188	0.38084	0.017	0	18	18		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	ACE2	0.0	0.0	0.0	0.0	47.0	22.0	5.0	-1.0						0.0718	1.0	0.000000000	0.204	-0.182	digestive/alimentary phenotype; renal/urinary system phenotype; immune system phenotype; respiratory system phenotype; pigmentation phenotype; mortality/aging ; integument phenotype ; cardiovascular system phenotype ; growth/size/body region phenotype; muscle phenotype; cellular phenotype; homeostasis/metabolism phenotype; 			kidney;testis - seminiferous tubule;testis - interstitial;atrioventricular node;trigeminal ganglion;superior cervical ganglion;testis;skeletal muscle;	Renin-angiotensin system	regulation of cytokine production;angiotensin maturation;angiotensin-mediated drinking behavior;regulation of systemic arterial blood pressure by renin-angiotensin;tryptophan transport;regulation of vasoconstriction;receptor biosynthetic process;regulation of cell population proliferation;viral entry into host cell;receptor-mediated virion attachment to host cell;regulation of inflammatory response;positive regulation of amino acid transport;positive regulation of cardiac muscle contraction;regulation of blood vessel diameter;positive regulation of gap junction assembly;regulation of cardiac conduction;positive regulation of reactive oxygen species metabolic process	extracellular region;extracellular space;cytoplasm;plasma membrane;cell surface;integral component of membrane;brush border membrane;membrane raft;extracellular exosome	virus receptor activity;endopeptidase activity;carboxypeptidase activity;metallocarboxypeptidase activity;protein binding;metallopeptidase activity;exopeptidase activity;peptidyl-dipeptidase activity;zinc ion binding	CALM1[18070603];	15618958
77021	chrX	19380976	AAA		chrX:19380976-19380978	MAP3K15	mitogen-activated protein kinase kinase kinase 15	sequence_alteration	1/2	0.22	2_4_5	18	47.0	0/2	0.0	2_0_6	10	17.0			rs34487219	SPLICING	YES	NM_001001671.4	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	25/28		NM_001001671.4:c.3567-10_3567-8del			-1.0						.	.	.		2.37589e-05	2.0	84179.0	0.0	17	0.43	PASS				0.0	0.0	0.00275364	218.0	79168.0	0.0	25	0.61	InbreedingCoeff	afr	0.00821144	64.0	0.0019104	71.0	0.0000064,0.0000129	1,2			0.01667	189.0		1.898	-0.053565		0	0	0			MAP3K15	0.0	0.0	0.0	0.0	-24.0	-7.0	-24.0	-7.0							0.0				cardiovascular system phenotype ; renal/urinary system phenotype; cellular phenotype; 			.	.	MAPK cascade;activation of MAPKK activity	.	protein kinase activity;MAP kinase kinase kinase activity;ATP binding;metal ion binding	PRKAB2[20562859];HSP90AB1[22939624];CDC37[25036637];	19380975
77067	chrX	25025287	G	A	chrX:25025287	ARX	aristaless related homeobox	SNV	0/1	0.47	72_64	136	99.0	0/1	0.49	54_52	106	99.0			rs760617042	EXONIC	YES	NM_139058.3	Transcript	protein_coding	synonymous_variant		4/5	NM_139058.3:c.1389C>T	NP_620689.1:p.Ser463%3D		-1.0					Proud syndrome, 300004 (3), X-linked; Hydranencephaly with abnormal genitalia, 300215 (3), X-linked; Partington syndrome, 309510 (3), X-linked recessive; Developmental and epileptic encephalopathy 1, 308350 (3), X-linked recessive; Lissencephaly, X-linked 2, 300215 (3), X-linked; Intellectual developmental disorder, X-linked 29, 300419 (3), X-linked recessive	Early infantile epileptic encephalopathy;West syndrome;Corpus callosum agenesis-abnormal genitalia syndrome;X-linked spasticity-intellectual disability-epilepsy syndrome;X-linked non-syndromic intellectual disability;X-linked lissencephaly with abnormal genitalia;Infantile epileptic-dyskinetic encephalopathy;Partington syndrome	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) (loss of function) in;Disease-causing germline mutation(s) in	Strabismus;Agenesis of corpus callosum;Agenesis of corpus callosum;Low anterior hairline;Overlapping toe;X-linked inheritance;Seizure;Nystagmus;Coarse facial features;Intellectual disability, progressive;Renal dysplasia;Hyperconvex nail;Optic atrophy;Neonatal hypotonia;Tapered finger;Protruding ear;Hypospadias;Spastic tetraplegia;High palate;Scoliosis;Broad alveolar ridges;Cryptorchidism;Tetraplegia;Intellectual disability, severe;Prominent supraorbital ridges;Synophrys;Abnormally large globe;Visual impairment;Limb joint contracture;Microcephaly;Global developmental delay;Short stature;Hirsutism;Renal dysplasia;Ureterocele;Strabismus;Micropenis;Hypsarrhythmia;Depressed nasal bridge;Autistic behavior;Generalized tonic seizure;Focal seizures, afebril;Generalized non-motor (absence) seizure;Precocious puberty;Absent thumbnail;EEG with burst suppression;Cerebellar atrophy;Uni- and bilateral multifocal epileptiform discharges;Myoclonus;Developmental regression;Spasticity;Umbilical hernia;EEG with spike-wave complexes;Broad finger;Microcephaly;Self-injurious behavior;Bilateral tonic-clonic seizure;Febrile seizure (within the age range of 3 months to 6 years);Broad phalanx of the toes;Sloping forehead;Diffuse cerebral atrophy;Pachygyria;Generalized clonic seizure;Infantile spasms;Sleep disturbance;Intellectual disability;Atonic seizure;Diffuse white matter abnormalities;Dystonia;Hypoplasia of the corpus callosum;Infantile muscular hypotonia;Short finger;Hyperactivity;Ventricular septal defect;Episodic ataxia;Poor head control;Failure to thrive;Anteverted nares;Cleft palate;Dyskinesia;Delayed myelination;Global developmental delay;Choreoathetosis;Tremor;Rigidity;Status epilepticus;Spasticity;Hemiplegia;Muscle stiffness;Intellectual disability;Ventriculomegaly;Hypohidrosis;Ambiguous genitalia;Spasticity;Global developmental delay;Exocrine pancreatic insufficiency;Muscular hypotonia;Microcephaly;Prominent forehead;Death in infancy;Patent ductus arteriosus;Seizure;Cryptorchidism;Intellectual disability;Hypoplasia of penis;Agenesis of corpus callosum;Pachygyria;Aganglionic megacolon;Micrognathia;Malabsorption;Ventricular septal defect;Seizure;Intellectual disability, moderate;Limb dystonia;Facial telangiectasia;Lower limb spasticity;Intellectual disability, mild;Triangular face;Macroorchidism;Dysarthria;EEG abnormality;Delayed speech and language development;Gait disturbance;Renal dysplasia;Generalized hirsutism;Abnormality of the hip bone;Nystagmus;Agenesis of corpus callosum;Coarse facial features;Tetraplegia;Short stature;Protruding ear;Severe global developmental delay;Cerebral cortical atrophy;Intellectual disability, severe;Abnormal hair pattern;Seizure;Microcephaly;Strabismus;Spasticity;Hypospadias;Inguinal hernia;Scoliosis;Renal hypoplasia/aplasia;Dysarthria;Triangular face;Focal dystonia;X-linked recessive inheritance;EEG abnormality;Intellectual disability;Limb dystonia;Flexion contracture;Lower limb spasticity;Seizure;Delayed speech and language development;Global developmental delay;Attention deficit hyperactivity disorder;Thin upper lip vermilion;Periorbital fullness;Babinski sign;2-3 toe syndactyly;Pes planus;Clinodactyly of the 2nd toe;Depressed nasal bridge;Midface retrusion;Delayed eruption of teeth;Bilateral tonic-clonic seizure;Shortening of all distal phalanges of the fingers;Intellectual disability, severe;Long philtrum;Obesity;Poor speech;Broad nasal tip;Intellectual disability, profound;Thick lower lip vermilion;Small for gestational age;Generalized non-motor (absence) seizure;Long palpebral fissure;Delayed speech and language development;Drooling;Facial palsy;Meckel diverticulum;Moderate sensorineural hearing impairment;Mild neurosensory hearing impairment;Autistic behavior;Intellectual disability, moderate;Widened subarachnoid space;Urinary incontinence;Pyloric stenosis;Macrocephaly;Downslanted palpebral fissures;Dyskinesia;Intellectual disability;Hyperreflexia;Generalized myoclonic seizure;Ventriculomegaly;X-linked recessive inheritance;Dyspnea;Spasticity;Dystonia;Dysphagia;Microcephaly;Muscular hypotonia of the trunk;Epileptic encephalopathy;Hypsarrhythmia;Hypertonia;Choreoathetosis;Myoclonus;Infantile spasms;Developmental regression;Hypsarrhythmia;Abnormality of skin morphology;Thin upper lip vermilion;Seizure;Micrognathia;Gliosis;Prominent nasal bridge;Long upper lip;High forehead;Severe global developmental delay;Feeding difficulties in infancy;Low-set ears;Micropenis;Hyperreflexia;Spasticity;High palate;Agenesis of corpus callosum;Diarrhea;Thin upper lip vermilion;Muscular hypotonia;Ventriculomegaly;Decreased testicular size;Wide anterior fontanel;Long philtrum;Generalized hypotonia;Pachygyria;Duane anomaly;Wide nasal bridge;Ambiguous genitalia;Specific learning disability;X-linked inheritance;Profound global developmental delay;Long palpebral fissure;Intellectual disability;X-linked recessive inheritance;Seizure;Periorbital fullness		5.38199e-05	6.0	111483.0	0.0	23	0.59	PASS	amr	0.000280873	3.0	5.66572e-05	3.0	2.7072e-05	4.0	147754.0	0.0	19	0.5	PASS	nfe	4.83855e-05	3.0	4.83855e-05	3.0	0.0000386	6	0.001	2.0	0.00098	11.0		12.61	0.885531		0	0	0			ARX	0.0	0.0	0.0	0.0	2.0	-45.0	2.0	-20.0							0.75	92.307684391			growth/size/body region phenotype; integument phenotype ; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; cellular phenotype; muscle phenotype; mortality/aging ; normal phenotype; reproductive system phenotype; behavior/neurological phenotype ; nervous system phenotype ; 			.	.	negative regulation of transcription by RNA polymerase II;axon guidance;positive regulation of gene expression;globus pallidus development;cerebral cortex tangential migration;embryonic olfactory bulb interneuron precursor migration;cell proliferation in forebrain;cerebral cortex GABAergic interneuron migration;regulation of cell population proliferation;lipid digestion;positive regulation of organ growth;neuron development;epithelial cell fate commitment	nucleus	RNA polymerase II regulatory region sequence-specific DNA binding;RNA polymerase II distal enhancer sequence-specific DNA binding;DNA-binding transcription factor activity, RNA polymerase II-specific;DNA-binding transcription repressor activity, RNA polymerase II-specific;chromatin binding	CYFIP1[26496610];MIGA1[26496610];SEC16A[26496610];CLTC[26496610];STK39[26496610];CLTB[26496610];CLTA[26496610];CD99L2[26496610];AP2A1[26496610];PIK3C2A[26496610];CLINT1[26496610];RBM4[26496610];KLC2[26496610];TACC3[26496610];APOB[26496610];MRRF[26496610];GTSE1[26496610];	25025287
77107	chrX	34149712	A	G	chrX:34149712	FAM47A	family with sequence similarity 47 member A	SNV	0/1	0.46	63_53	116	99.0	0/1	0.6	50_76	126	99.0			rs765088776	EXONIC	YES	NM_203408.4	Transcript	protein_coding	synonymous_variant		1/1	NM_203408.4:c.684T>C	NP_981953.2:p.Pro228%3D		-1.0						.	.	.		2.22735e-05	2.0	89793.0	0.0	20	0.51	PASS	sas	0.000533618	1.0	2.27495e-05	1.0	2.78928e-05	5.0	179258.0	0.0	59	0.98	PASS	nfe	4.97754e-05	4.0	4.97754e-05	4.0	0.0000129	2						0.097	-0.487121		0	0	0			FAM47A	0.0	0.0	0.0	0.0	5.0	-31.0	27.0	-31.0						0.515	0.75	0.000000000			.			.	.	.	.	.	NCK2[unassigned1304];	34149712
77109	chrX	36011322	C	G	chrX:36011322	CFAP47	cilia and flagella associated protein 47	SNV	0|1	0.52	14_15	29	99.0	0/1	0.44	10_8	18	99.0			rs189284303	EXONIC	YES	NM_001304548.2	Transcript	protein_coding	missense_variant		18/64	NM_001304548.2:c.2983C>G	NP_001291477.1:p.Leu995Val		1.0					Spermatogenic failure, X-linked, 3, 301059 (3), X-linked recessive	.	.	.		0.000295548	33.0	111657.0	0.0	22	0.6	PASS	amr	0.00267252	28.0	3.76627e-05	2.0					0	0.0							0.0000379	1	0.001	3.0				11.95	0.799512		2	6	8	PolyPhen,fathmm-MKL_coding_pred	SIFT,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,LIST-S2_pred																		0.151	0.876	.			.	.	.	.	.	RPL35[30021884];ESR1[25604459];ESR2[25604459];	36011322
77194	chrX	47424734	C	A	chrX:47424734	ARAF	A-Raf proto-oncogene, serine/threonine kinase	SNV	0/1	0.54	46_54	100	99.0	0/0	0.0	42_0	42	99.0			rs143159753	EXONIC	YES	NM_001256196.2	Transcript	protein_coding	missense_variant		6/16	NM_001256196.2:c.551C>A	NP_001243125.1:p.Thr184Asn		1.0	.,.,.					.	.	.		0.00123209	138.0	112005.0	1.0	23	0.59	PASS	amr	0.00682659	72.0	0.00105334	56.0	0.000783167	143.0	182592.0	0.0	36	0.9	PASS	amr	0.00197889	54.0	0.000981246	80.0	0.0006495	101	0.004	14.0				19.54	1.976014	0.11	9	10	19	LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_noAF_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,Polyphen2_HDIV_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,ClinPred_pred,LIST-S2_pred	ARAF	0.0	0.0	0.0	0.0	2.0	8.0	15.0	-9.0						0.172	0.62	0.000000000	1.0	1.022	growth/size/body region phenotype; endocrine/exocrine gland phenotype; digestive/alimentary phenotype; muscle phenotype; mortality/aging ; hematopoietic system phenotype; behavior/neurological phenotype ; immune system phenotype; 			liver;skeletal muscle;	ErbB signaling pathway;Natural killer cell mediated cytotoxicity;Long-term potentiation;Long-term depression;Regulation of actin cytoskeleton;Insulin signaling pathway;Colorectal cancer;Renal cell carcinoma;Pancreatic cancer;Endometrial cancer;Glioma;Prostate cancer;Melanoma;Bladder cancer;Chronic myeloid leukemia;Acute myeloid leukemia;Non-small cell lung cancer	MAPK cascade;cellular protein modification process;regulation of TOR signaling;regulation of proteasomal ubiquitin-dependent protein catabolic process;positive regulation of peptidyl-serine phosphorylation;negative regulation of apoptotic process	cellular_component;mitochondrion;cytosol	protein kinase activity;protein serine/threonine kinase activity;protein binding;ATP binding;metal ion binding	YWHAE[20936779;25852190];SLC25A1[25852190];DIDO1[21988832];HSP90AB1[22939624;25036637];YWHAB[24255178;25852190];TECR[25852190];CHD6[20936779];TESK1[21988832];CBY1[unassigned1312];HSPB1[25852190];YBX3[25852190];RPL39P5[25852190];PPP6C[25852190];TUBB6[25852190];EFEMP1[12620389];TUBA1A[29568061];NUDCD1[25036637];YWHAQ[25852190];TRIM28[25852190];AIFM1[25852190];PBK[12620389];MYO18A[20936779];SDF4[25852190];NELFCD[12620389;21988832];RPL37[25852190];NUDT14[12620389];HRAS[12620389;24441586];EMD[25852190];JAK3[26496610];YWHAG[15324660;17353931;25852190];YWHAH[17979178;25852190;26496610];MAP2K1[17979178;24746704;26496610];HSP90AA1[25036637];MAP2K2[11909642;21988832;24746704;25852190;unassigned1304];RIPK4[26972000];RRAS2[12620389];AGTRAP[25416956];AARSD1[25036637];RABGGTB[12620389];YWHAZ[19933840;20052757;20936779;25852190];TIRAP[21903422];MLF1[25036637];TUBA4A[25852190];DPM1[25852190];ACTA2[25852190];RCN1[25852190];PRPF6[12620389];PKM[12620389;25241761];RCN2[25852190];CDC37[24189400;25036637];CSNK2B[10094392];KIF1BP[25852190];IRF7[21903422];RAF1[20130576];FKBP5[25036637;25852190];SLC25A13[25852190];ATP5MD[25852190];LRRC59[25852190];DDX5[25852190];KLHL12[16189514];PIK3R1[10967104];TIMM50[12620389;25852190];HSP90B1[25852190];NRAS[unassigned1304];ATP5F1B[25852190];BAG2[25852190];TCOF1[30021884];IRAK2[21903422];CTNNA1[25852190];SFN[15778465;25852190];E2F6[21988832];SLC25A22[25852190];HIPK4[23602568];RAB3IP[unassigned1312];TIMM44[12620389];BRAF[17979178;25241761;20130576];MLH1[20706999];EEF2[25852190];ASS1[12620389];DNAJA1[25852190];COPS3[12620389];PPP5C[25036637];CPS1[12620389];WNK1[21988832];DNAJA2[25852190];CALU[25852190];KRAS[25416956;25852190];STUB1[25852190];CCDC22[26496610];	47424734
77418	chrX	55044000	C	T	chrX:55044000	ALAS2	5'-aminolevulinate synthase 2	SNV	0/1	0.47	59_54	114	99.0	0/0	0.0	34_0	34	99.0			rs956102453	EXONIC	YES	NM_000032.5	Transcript	protein_coding	missense_variant		7/11	NM_000032.5:c.922G>A	NP_000023.2:p.Asp308Asn		-1.0	.,Aminotransferase, class I/classII&Tetrapyrrole biosynthesis, 5-aminolevulinic acid synthase,Aminotransferase, class I/classII&Tetrapyrrole biosynthesis, 5-aminolevulinic acid synthase,.	Uncertain_significance	criteria_provided,_single_submitter	not_provided	Anemia, sideroblastic, 1, 300751 (3), X-linked recessive; Protoporphyria, erythropoietic, X-linked, 300752 (3), X-linked	X-linked erythropoietic protoporphyria;X-linked sideroblastic anemia	Disease-causing germline mutation(s) (gain of function) in;Disease-causing germline mutation(s) in	Elevated hepatic transaminase;Hyperpigmentation of the skin;Splenomegaly;Abnormality of iron homeostasis;Muscle weakness;Glucose intolerance;Dyspnea;Fatigue;Anemia;Pallor;Sideroblastic anemia;Hypochromic microcytic anemia;X-linked recessive inheritance;Macrocytic anemia;Variable expressivity;Elevated hepatic transaminase;Cholelithiasis;Cutaneous photosensitivity;Increased erythrocyte protoporphyrin concentration;X-linked dominant inheritance;Iron deficiency anemia;Childhood onset		1.79619e-05	2.0	111347.0	0.0	22	0.6	PASS	nfe	3.76641e-05	2.0	3.76641e-05	2.0	5.44995e-06	1.0	183488.0	0.0	84	1.0	PASS	nfe	1.22051e-05	1.0	1.22051e-05	1.0					0.0007	8.0		21.2	2.170229	0.184	4	14	18	M-CAP_pred,MetaLR_pred,FATHMM_pred,LIST-S2_pred	SIFT,PolyPhen,LRT_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,fathmm-MKL_coding_pred	ALAS2	0.0	0.01	0.0	0.0	-12.0	50.0	26.0	50.0							0.97		0.998	0.103	mortality/aging ; hematopoietic system phenotype; embryo phenotype; integument phenotype ; homeostasis/metabolism phenotype; 			superior cervical ganglion;fetal lung;fetal liver;skeletal muscle;bone marrow;	Glycine, serine and threonine metabolism;Porphyrin and chlorophyll metabolism	response to hypoxia;protoporphyrinogen IX biosynthetic process;heme biosynthetic process;cellular iron ion homeostasis;erythrocyte differentiation;oxygen homeostasis;hemoglobin biosynthetic process	mitochondrion;mitochondrial inner membrane;mitochondrial matrix	5-aminolevulinate synthase activity;protein binding;glycine binding;pyridoxal phosphate binding;coenzyme binding	GRB2[18624398];BANP[25416956;unassigned1304;25910212];	55044000
77470	chrX	57458438	G	A	chrX:57458438	FAAH2	fatty acid amide hydrolase 2	SNV	0/1	0.46	19_16	35	99.0	0/0	0.0	34_0	34	99.0			rs138462668,COSV66506899	EXONIC	YES	NM_174912.4	Transcript	protein_coding	missense_variant		8/11	NM_174912.4:c.1084G>A	NP_777572.2:p.Ala362Thr		1.0	Amidase signature domain					.	.	.		0.00146751	161.0	109710.0	0.0	21	0.56	PASS	nfe	0.00252823	133.0	0.00252823	133.0	0.00113413	205.0	180755.0	0.0	38	0.81	PASS	nfe	0.00183166	148.0	0.00183166	148.0	0.0010611	165	0.007	22.0	0.00523	59.0		10.09	0.574221	0.111	0	18	18		SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	FAAH2	0.0	0.0	0.0	0.1	32.0	-9.0	-23.0	32.0						0.922	0.0	0.000000000	0.048	-4.838	.			.	.	arachidonic acid metabolic process	lipid droplet;integral component of membrane	fatty acid amide hydrolase activity;oleamide hydrolase activity;anandamide amidohydrolase activity	.	57458438
77543	chrX	69282968	C	T	chrX:69282968	OTUD6A	OTU deubiquitinase 6A	SNV	0/1	0.48	112_106	219	99.0	0/1	0.57	71_96	167	99.0			rs144364776,COSV57973641	EXONIC	YES	NM_207320.3	Transcript	protein_coding	synonymous_variant		1/1	NM_207320.3:c.594C>T	NP_997203.1:p.Phe198%3D		1.0		Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00436373	488.0	111831.0	4.0	23	0.62	PASS	nfe	0.00505098	268.0	0.00505098	268.0	0.0040494	740.0	182743.0	3.0	77	0.99	PASS	nfe	0.00581082	474.0	0.00581082	474.0	0.0039613	616	0.012	36.0				1.225	-0.120656		0	0	0			OTUD6A	0.0	0.0	0.0	0.0	-9.0	-24.0	2.0	36.0							0.57	0.000000000			behavior/neurological phenotype ; hematopoietic system phenotype; immune system phenotype; homeostasis/metabolism phenotype; 			.	.	protein deubiquitination;protein K29-linked deubiquitination;protein K11-linked deubiquitination;protein K27-linked deubiquitination;protein K33-linked deubiquitination	.	thiol-dependent ubiquitin-specific protease activity	MYCL[unassigned1304];POM121[unassigned1304];EMX2[unassigned1304];TRIM7[unassigned1304];NUP62[unassigned1304];VPS52[unassigned1304];DPYSL3[unassigned1304];SSBP1[unassigned1304];DYNLL1[unassigned1304];DYNLL2[unassigned1304];PDLIM7[unassigned1304];	69282968
77655	chrX	85128186	C	A	chrX:85128186	CHM	CHM, Rab escort protein 1	SNV	0/1	0.35	20_11	31	99.0	0/1	0.36	23_13	36	99.0			rs148301015	EXONIC	YES	NM_000390.4	Transcript	protein_coding	synonymous_variant		14/15	NM_000390.4:c.1641G>T	NP_000381.1:p.Leu547%3D		-1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	Choroideremia|not_specified|not_provided	Choroideremia, 303100 (3), X-linked	Choroideremia	Disease-causing germline mutation(s) in	Abnormal electroretinogram;Progressive visual loss;Abnormality of retinal pigmentation;Nyctalopia;Myopia;Choroideremia;X-linked dominant inheritance;Nyctalopia;Progressive visual loss;Chorioretinal atrophy;Constriction of peripheral visual field;Chorioretinal degeneration;X-linked inheritance		0.00230586	258.0	111889.0	0.0	23	0.61	PASS	nfe	0.00367156	195.0	0.00367156	195.0	0.00231839	399.0	172102.0	1.0	25	0.63	PASS	nfe	0.0036615	276.0	0.0036615	276.0	0.0024501	381	0.005	18.0	0.00826	94.0		0.773	-0.188926		0	0	0			CHM	0.0	0.0	0.0	0.0	-24.0	31.0	31.0	1.0							1.0	31.618098065			growth/size/body region phenotype; homeostasis/metabolism phenotype; embryo phenotype; cardiovascular system phenotype ; normal phenotype; mortality/aging ; pigmentation phenotype; nervous system phenotype ; vision/eye phenotype; 			pons;trigeminal ganglion;superior cervical ganglion;skeletal muscle;	.	protein targeting to membrane;small GTPase mediated signal transduction;visual perception;protein geranylgeranylation;regulation of apoptotic process;positive regulation of GTPase activity;post-translational protein modification	cytosol;Rab-protein geranylgeranyltransferase complex	Rab geranylgeranyltransferase activity;GDP-dissociation inhibitor activity;GTPase activator activity;Rab GTPase binding	NUP188[19615732];FAF1[19615732];FAM122B[19615732];SART1[19615732];MAGED4B[19615732];NUP62[19615732];UFD1[19615732];RAB8A[26824392];NUP214[19615732];MIOS[19615732];WDR75[19615732];ARMC8[19615732];RABGGTA[21905166];NUP93[19615732];DDX19B[19615732];PRKD3[19615732];MAP1B[19615732];PRKD2[19615732];NUP98[19615732];PRIM2[19615732];WDR26[19615732];SEH1L[19615732];RBM8A[19615732];PRIM1[19615732];MYCBP2[19615732];WDR24[19615732];HSP90B1[19615732];NUP88[19615732];SF3A3[19615732];MPST[19615732];ATE1[19615732];SF3A1[19615732];WDR59[19615732];SF3A2[19615732];ESR2[21182203];CS[19615732];SMU1[19615732];TJP1[19615732];RAB10[26824392];POLA1[19615732];POLA2[19615732];COPS6[19615732];POLR3A[19615732];POLR3B[19615732];RAB12[26824392];POLR3E[19615732];AGGF1[19615732];RAB9A[29568061];POLR3H[19615732];COPS8[19615732];NUPL2[19615732];RAB5A[29568061];TJP2[19615732];	85128186
77708	chrX	101910862	A	C	chrX:101910862	GPRASP1	G protein-coupled receptor associated sorting protein 1	SNV	0/1	0.51	73_77	150	99.0	0/1	0.59	64_93	158	99.0			rs138906495	EXONIC	YES	NM_001184727.2	Transcript	protein_coding	missense_variant		6/6	NM_001184727.2:c.2021A>C	NP_001171656.1:p.Lys674Thr		1.0	.,.,.,.					.	.	.		5.36653e-05	6.0	111804.0	0.0	23	0.6	PASS	amr	9.48227e-05	1.0	7.527e-05	4.0	4.91779e-05	9.0	183009.0	0.0	85	0.99	PASS	nfe	0.000110379	9.0	0.000110379	9.0	0.0000322	5	0.0	1.0				8.716	0.430139	0.028	1	16	17	SIFT	PolyPhen,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	GPRASP1	0.01	0.0	0.0	0.0	18.0	2.0	29.0	0.0						0.81	0.5	0.000000000	0.004	-0.538	behavior/neurological phenotype ; 			amygdala;occipital lobe;prefrontal cortex;subthalamic nucleus;cingulate cortex;globus pallidus;hypothalamus;medulla oblongata;thalamus;	.	endosome to lysosome transport;G protein-coupled receptor catabolic process	cytosol	protein binding	OPRD1[15086532];CHRM2[15086532];CAMK2D[29426014];CHRM1[15086532];HSPA5[30021884];BECN2[23954414];OPRL1[15086532];OPRK1[15086532];ADRB1[15086532];OPRM1[15086532];HTR7[15086532];CALCR[15086532];TBXA2R[15086532];ATXN7[21078624];MARK2[19615732];HIST1H1B[30021884];	101910862
77714	chrX	102754936		CTT	chrX:102754935-102754936	RAB40A	RAB40A, member RAS oncogene family	insertion	0/1	0.12	73_10	83	99.0	0/0	0.0	57_0	57	99.0			rs746943459,COSV58490648	EXONIC	YES	NM_080879.3	Transcript	protein_coding	inframe_insertion		3/3	NM_080879.3:c.749_750insAAG	NP_543155.2:p.Lys250_Ser251insArg		-1.0						.	.	.		0.00231498	258.0	111448.0	1.0	23	0.61	AS_VQSR	nfe	0.0040828	215.0	0.0040828	215.0	0.000289912	53.0	182814.0	0.0	100	1.0	RF	nfe	0.000491388	40.0	0.000491388	40.0	0.0000257,0.0002315	4,36						10.17	0.584055		0	0	0																	0.612	0.07				.			ciliary ganglion;	.	intracellular protein transport;protein ubiquitination;Rab protein signal transduction	Golgi membrane;plasma membrane	GTPase activity;GTP binding	HSP90AB1[22939624];	102754935
77752	chrX	107377648	AA		chrX:107377648-107377649	ATG4A	autophagy related 4A cysteine peptidase	deletion	0/1	0.37	24_14	38	99.0	0/1	0.5	22_23	46	99.0			rs756492011	SPLICING	YES	NM_052936.5	Transcript	protein_coding	splice_region_variant,intron_variant	6/12		NM_052936.5:c.467+9_467+10del			1.0						.	.	.		0.00248745	279.0	112163.0	0.0	24	0.62	PASS	nfe	0.00407642	217.0	0.00407642	217.0	0.00249522	445.0	178341.0	3.0	28	0.74	PASS	nfe	0.00408914	329.0	0.00408914	329.0	0.0022443	349	0.002	6.0				14.9	1.245861		0	0	0			ATG4A	0.0	0.0	0.03	0.02	6.0	-39.0	-2.0	-6.0						0.545	0.99				.			dorsal root ganglion;atrioventricular node;superior cervical ganglion;trigeminal ganglion;skeletal muscle;	.	autophagosome assembly;proteolysis;protein transport;protein delipidation	cytoplasm	cysteine-type endopeptidase activity;protein binding;cysteine-type peptidase activity	CDKL3[25416956];MAP1LC3B[20010802];GABARAPL1[25416956;unassigned1304];MAP1LC3A[20562859];USP43[26496610];NUF2[26496610];THOC1[26496610];SYN1[26496610];PDK1[26496610];	107377647
77869	chrX	118603756	T	A	chrX:118603756	SLC25A5	solute carrier family 25 member 5	SNV	0/1	0.17	89_18	108	99.0	0|1	0.21	60_16	76	99.0			rs780390657,COSV58625189	EXONIC	YES	NM_001152.5	Transcript	protein_coding	missense_variant		2/4	NM_001152.5:c.244T>A	NP_001143.2:p.Phe82Ile		1.0						.	.	.		0.00515525	525.0	101838.0	0.0	30	0.81	PASS	nfe	0.00723652	335.0	0.00723652	335.0	0.0	0.0	181771.0	0.0	94	0.99	AC0_RF				0.0	0.0	0.0000064	1	0.0	1.0				25.8	3.71059	0.786	14	6	20	SIFT,PolyPhen,LRT_pred,M-CAP_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,MetaLR_pred,MutationAssessor_pred,FATHMM_pred,MetaRNN_pred	SLC25A5	0.0	0.01	0.0	0.01	34.0	12.0	37.0	-27.0							0.86		1.0	1.032	cellular phenotype; 			.	Calcium signaling pathway	chromosome segregation;positive regulation of cell population proliferation;adenine transport;ADP transport;ATP transport;viral process;regulation of insulin secretion;transmembrane transport;negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway;cellular response to leukemia inhibitory factor	nucleus;mitochondrion;mitochondrial inner membrane;integral component of plasma membrane;membrane;mitochondrial nucleoid;myelin sheath;membrane raft;MMXD complex	RNA binding;ATP:ADP antiporter activity;protein binding;adenine transmembrane transporter activity;ubiquitin protein ligase binding	RNH1[21276451];MT-CO1[23260140];TONSL[21113133];DUX4[26816005];CISD3[27499296];CHCHD2[27499296];HTR7[19486527];CCND1[26496610];TUBB3[27291054];MAGOH[23084401];CHCHD1[27499296];GABARAPL2[20562859];GABARAPL1[20562859];CMC1[23260140];SDHC[24983503];SDHD[24983503];DICER1[21858095];SDHA[24983503;29128334];SDHB[24983503];TUFM[24983503];COX6B1[27499296];IFT88[27173435];SOAT1[29128334];VDAC1[29128334];EZR[29568061];COX15[29128334];PHB[24983503];GABARAP[20562859];NCSTN[26496610];RIPK1[14743216];COX14[23260140];RDH13[23260140];C6orf203[27499296];A2M[17174955];SMAD2[18729074];HSPA9[24983503];SURF1[23260140];JUN[25609649];VCAM1[22623428];CBX4[21282530];NEK4[25798074];ARHGAP28[30021884];ESR1[21182205];MEX3C[22863774];COQ7[27499296];ESR2[25604459];NFKB1[25609649];NFKBIA[14743216];COQ3[27499296];COQ2[29128334];NDUFAF8[27499296];ADCK2[27499296];AGO4[19167051];AGO1[17932509];NDUFAF4[27499296];AGO2[17932509];CDK1[29128334];GRB2[21706016];SLC35F6[19154410];TRADD[14743216];LRRK2[21370995;24725412];FASTKD3[20869947];TUBA1C[26496610];MAP1LC3B[20562859];TMEM223[23260140];METTL14[29507755];MAP1LC3A[20562859];MRPL40[23260140];TUBA1A[29568061];OPA3[27499296];NCK2[23322602];FLOT1[24983503];FLOT2[24983503];IKBKG[14743216];RIPK3[14743216];RIPK4[26972000];SIRT4[17715127];TRAF2[14743216];TRAF1[14743216];MRPL48[23260140];TIMM21[23260140];TNFRSF1B[14743216];MRPL46[23260140];COQ10A[27499296];TNFRSF1A[14743216];BDP1[30021884];SMIM20[23260140];SLC25A6[23260140];OTUB1[26752685];PRKAA1[16306228];DLST[29128334];MRPL58[20186120];RELA[14743216];EGFR[15657067];HSPD1[24983503];ATP5F1A[24983503;27499296];ATP5F1B[24983503];C21orf33[27499296];MIC13[27499296];E2F3[22157815];OXCT2[27499296];MAPK6[26972000];PAK5[27499296];MAP3K3[14743216];MAP3K1[14743216];SPRYD4[27499296];RRP1B[20926688];GPAM[27499296];XPNPEP3[27499296];HDGF[21907836];CD247[24502978];COQ8A[27499296];PMFBP1[30021884];	118603756
77924	chrX	123518300	C	T	chrX:123518300	TENM1	teneurin transmembrane protein 1	SNV	0/1	0.43	49_37	86	99.0	0/1	0.4	59_39	98	99.0			rs780121085	EXONIC	YES	NM_001163278.1	Transcript	protein_coding	missense_variant		30/32	NM_001163278.1:c.6481G>A	NP_001156750.1:p.Asp2161Asn		-1.0	.,.					Isolated congenital anosmia	Disease-causing germline mutation(s) in	.						22	0.6							1.64068e-05	3.0	182851.0	0.0	72	0.96	PASS	eas	0.000144383	2.0	0.0	0.0	0.0000193	3						23.3	2.863213	0.5	13	7	20	Polyphen2_HDIV_pred,LRT_pred,M-CAP_pred,MetaLR_pred,MetaSVM_pred,MutationTaster_pred,PROVEAN_pred,FATHMM_pred,MetaRNN_pred,PrimateAI_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	SIFT,PolyPhen,Polyphen2_HVAR_pred,MutationAssessor_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred	TENM1	0.0	0.0	0.0	0.0	-3.0	16.0	17.0	-29.0							1.0	0.000000000	0.986	1.026	.			.	.	regulation of transcription by RNA polymerase III;immune response;heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules;neuropeptide signaling pathway;nervous system development;negative regulation of cell population proliferation;positive regulation of actin filament polymerization;positive regulation of peptidyl-serine phosphorylation;positive regulation of MAP kinase activity;neuron development;positive regulation of filopodium assembly;positive regulation of intracellular protein transport	extracellular region;nucleus;cytoplasm;endoplasmic reticulum;Golgi apparatus;cytoskeleton;plasma membrane;integral component of plasma membrane;nuclear matrix;nuclear speck;neuron projection;perinuclear region of cytoplasm	heparin binding;protein homodimerization activity;protein heterodimerization activity;cell adhesion molecule binding	NEK4[25798074];HIST2H2BE[30021884];	123518300
77941	chrX	131188749	C	T	chrX:131188749	STK26	serine/threonine kinase 26	SNV	0/1	0.56	41_52	93	99.0	0/0	0.0	34_0	34	99.0			rs56044451,COSV61231488	EXONIC	YES	NM_016542.4	Transcript	protein_coding	missense_variant		3/12	NM_016542.4:c.133C>T	NP_057626.2:p.Arg45Cys		1.0	Protein kinase domain&Protein kinase, ATP binding site&Protein kinase domain&Protein kinase domain&MST4, kinase domain,Protein kinase domain&Protein kinase, ATP binding site&Protein kinase domain&Protein kinase domain&MST4, kinase domain,Protein kinase domain&Protein kinase, ATP binding site&Protein kinase domain&Protein kinase domain&MST4, kinase domain,.	Benign	criteria_provided,_single_submitter	not_provided		.	.	.		0.00465112	519.0	111586.0	1.0	23	0.62	PASS	nfe	0.00623481	331.0	0.00623481	331.0	0.00549258	1005.0	182974.0	2.0	50	0.97	PASS	nfe	0.00741313	605.0	0.00741313	605.0	0.0052475	816	0.006	19.0				25.3	3.599929	0.556	8	8	16	SIFT,LRT_pred,MutationTaster_pred,PROVEAN_pred,PrimateAI_pred,BayesDel_noAF_pred,LIST-S2_pred,fathmm-MKL_coding_pred	PolyPhen,MetaLR_pred,MetaSVM_pred,FATHMM_pred,MetaRNN_pred,DEOGEN2_pred,BayesDel_addAF_pred,ClinPred_pred	STK26	0.0	0.0	0.0	0.0	34.0	-50.0	-26.0	0.0								0.000000000	0.998	1.026	.			.	.	MAPK cascade;protein phosphorylation;apoptotic process;cellular response to starvation;signal transduction by protein phosphorylation;microvillus assembly;negative regulation of cell migration;stress-activated protein kinase signaling cascade;activation of protein kinase activity;response to hydrogen peroxide;regulation of apoptotic process;protein autophosphorylation;neuron projection morphogenesis;regulation of hydrogen peroxide-induced cell death	Golgi membrane;cytoplasm;Golgi apparatus;Golgi-associated vesicle;cytosol;vesicle membrane;membrane;apical plasma membrane;perinuclear region of cytoplasm;extracellular exosome;cell periphery	magnesium ion binding;protein kinase activity;protein serine/threonine kinase activity;protein binding;ATP binding;identical protein binding;protein homodimerization activity	TRAF3IP3[18782753];CAB39[21423148;23434407];CTTNBP2[18782753;23455922];DCTN1[26638075];IKZF3[21516116];STRN4[18782753;23455922];STRN3[18782753;23455922;24366813;26496610];GOLGA2[15037601;unassigned1304];PPP2CA[18782753;23455922];TEPSIN[26496610];STRIP1[18782753];PPP2CB[23455922];STRIP2[23455922];GRB14[25814554];PDCD10[18782753;23455922;unassigned1304;23541896;23665169];PPP2R1A[18782753;23455922;28330616];FGFR1OP2[26496610];TRIM27[21516116];GRINL1A[16169070];CEP76[21516116];NCBP2[26382858];CEP152[26638075];DYNLL1[23455922];CTTNBP2NL[18782753;23455922];SRPK1[23602568];MOB4[19156129;18782753;23455922];SIKE1[23455922];SNW1[20467437];STK24[18782753;23455922];STK25[18782753;23455922];STK26[11741893;23434407];SLMAP[18782753;23455922;24366813];TAOK1[23455922];STRN[18782753;23455922;24366813;26496610];NCBP3[26382858];NDUFAF1[24344204];TNIK[22797597];DLD[29128334];	131188749
77949	chrX	132888208	AA		chrX:132888208-132888209	GPC3	glypican 3	sequence_alteration	0/1	0.15	21_6_5	40	81.0	0/2	0.0	18_0_9	35	99.0			rs370737647	SPLICING	YES	NM_001164617.2	Transcript	protein_coding	splice_region_variant,splice_polypyrimidine_tract_variant,intron_variant	2/8		NM_001164617.2:c.338-6_338-5del			-1.0		Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	not_specified|not_provided	Wilms tumor, somatic, 194070 (3); Simpson-Golabi-Behmel syndrome, type 1, 312870 (3), X-linked recessive	Nephroblastoma;Simpson-Golabi-Behmel syndrome	Biomarker tested in;Disease-causing germline mutation(s) (loss of function) in	Hematuria;Neoplasm of the liver;Hypertension;Abdominal pain;Nephroblastoma;Neoplasm of the lung;Weight loss;Lymphadenopathy;Fever;Aniridia;Inguinal hernia;Transposition of the great arteries;Hypospadias;Intestinal malrotation;Nephroblastoma;Cryptorchidism;Cervical ribs;Diastasis recti;Umbilical hernia;X-linked recessive inheritance;Flared iliac wings;Six lumbar vertebrae;Ventricular septal defect;Cleft palate;Polysplenia;Hepatomegaly;Renal cyst;Broad thumb;Pulmonic stenosis;Duplication of renal pelvis;Depressed nasal bridge;Hydrocephalus;Supernumerary nipple;Short distal phalanx of finger;Hepatomegaly;2-3 finger syndactyly;Ventricular septal defect;Agenesis of corpus callosum;Hypospadias;Dental malocclusion;Broad secondary alveolar ridge;Preauricular skin tag;Accelerated skeletal maturation;Cleft palate;Cerebellar vermis hypoplasia;Meckel diverticulum;Flared iliac wings;Cryptorchidism;Macrocephaly;Epicanthus;Anteverted nares;Broad secondary alveolar ridge;Coarse facial features;Broad foot;Pectus excavatum;Short nose;Accelerated skeletal maturation;Short palm;Short greater sciatic notch;Broad palm;Supernumerary nipple;Enlarged kidney;Two carpal ossification centers present at birth;Inguinal hernia;X-linked recessive inheritance;Pancreatic islet-cell hyperplasia;Submucous cleft lip;2-3 finger syndactyly;Meckel diverticulum;Hearing impairment;Cerebellar vermis hypoplasia;Macroglossia;Submucous cleft lip;Short foot;Scoliosis;Cervical ribs;Intestinal malrotation;Postaxial hand polydactyly;Talipes equinovarus;Preauricular pit;Wide nasal bridge;Hypertelorism;Broad toe;Broad thumb;Dental malocclusion;Short distal phalanx of finger;Wide mouth;Birth length greater than 97th percentile;Short nose;Generalized hypotonia;Preauricular pit;Cardiomyopathy;Transposition of the great arteries;Downslanted palpebral fissures;Hydrocephalus;Epicanthus;Scoliosis;Pulmonic stenosis;Patent ductus arteriosus;Polysplenia;Six lumbar vertebrae;Patent ductus arteriosus;Two carpal ossification centers present at birth;Birth length greater than 97th percentile;Nephroblastoma;Hearing impairment;Anteverted nares;Duplication of renal pelvis;Muscular hypotonia;Splenomegaly;Splenomegaly;Arrhythmia;Macrocephaly;Diastasis recti;Macroglossia;Umbilical hernia;Coarse facial features;Abnormal lung lobation;Pectus excavatum;Postaxial polydactyly;Talipes equinovarus;Agenesis of corpus callosum;Preauricular skin tag;Arrhythmia;Enlarged kidney;Renal cyst;Posterior helix pit;Pancreatic islet-cell hyperplasia;Congenital diaphragmatic hernia;Small nail;Vertebral segmentation defect;Cardiomyopathy;Congenital diaphragmatic hernia;Downslanted palpebral fissures;Wide mouth;Narrow greater sciatic notch;Hypertelorism;Nephroblastoma;Somatic mutation;Autosomal dominant inheritance;Heterogeneous;Accelerated skeletal maturation;Ventricular septal defect;Small nail;Cryptorchidism;Downslanted palpebral fissures;Polyhydramnios;Cardiomyopathy;Bundle branch block;Dandy-Walker malformation;Webbed neck;Hepatoblastoma;Mandibular prognathia;Short neck;Agenesis of corpus callosum;Short toe;Nephroblastoma;Macrocephaly;Supernumerary nipple;Prolonged QT interval;Umbilical hernia;Postaxial hand polydactyly;Hypoglycemia;Increased circulating IgE level;Macroglossia;Congenital hip dislocation;Polysplenia;Cleft palate;Omphalocele;Multicystic kidney dysplasia;Toe syndactyly;Tall stature;Talipes equinovarus;Pectus excavatum;Atrial septal defect;Muscular hypotonia;Inguinal hernia;Hoarse voice;Camptodactyly of finger;Broad thumb;Pancreatic islet-cell hyperplasia;Anteverted nares;Splenomegaly;Abnormality of the helix;Coarse facial features;Neurological speech impairment;Low-set, posteriorly rotated ears;Broad foot;High, narrow palate;Nail dysplasia;Aplasia/Hypoplasia of the abdominal wall musculature;Wide nasal bridge;Hydronephrosis;Hypertelorism;Hepatomegaly;Ureteral duplication;Wide mouth;Hypoplasia of penis;Global developmental delay;Epicanthus;Finger syndactyly;Clinodactyly of the 5th finger;Congenital diaphragmatic hernia;Neuroblastoma;Seizure;Hypospadias;Cleft upper lip;Abnormality of the ribs;Intellectual disability;Short foot;Short nose;Scoliosis;Hydroureter;Death in infancy;Short 2nd finger;Vertebral fusion	24033266	0.000248681	19.0	76403.0	0.0	20	0.49	PASS	amr	0.000553097	4.0	0.000184643	7.0	0.0263107	1899.0	72176.0	0.0	35	0.76	InbreedingCoeff	amr	0.0583059	709.0	0.0195105	621.0	0.0000193	3			0.06763	690.0		13.88	1.069549		0	0	0			GPC3	0.0	0.0	0.0	0.0	-4.0	-6.0	-50.0	-37.0							0.99				growth/size/body region phenotype; integument phenotype ; homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; digestive/alimentary phenotype; limbs/digits/tail phenotype; pigmentation phenotype; cardiovascular system phenotype ; hematopoietic system phenotype; mortality/aging ; reproductive system phenotype; respiratory system phenotype; embryo phenotype; skeleton phenotype; renal/urinary system phenotype; immune system phenotype; 			.	.	retinoid metabolic process;branching involved in ureteric bud morphogenesis;glycosaminoglycan biosynthetic process;glycosaminoglycan catabolic process;response to bacterium;anatomical structure morphogenesis;anterior/posterior axis specification;body morphogenesis;negative regulation of peptidase activity;bone mineralization;osteoclast differentiation;lung development;positive regulation of BMP signaling pathway;embryonic hindlimb morphogenesis;cell migration involved in gastrulation;post-translational protein modification;cellular protein metabolic process;positive regulation of protein catabolic process;positive regulation of endocytosis;negative regulation of smoothened signaling pathway;positive regulation of smoothened signaling pathway;negative regulation of growth;positive regulation of glucose import;negative regulation of epithelial cell proliferation;regulation of canonical Wnt signaling pathway;coronary vasculature development;cell proliferation involved in kidney development;mesenchymal cell proliferation involved in ureteric bud development;mesonephric duct morphogenesis;cell proliferation involved in metanephros development;negative regulation of canonical Wnt signaling pathway;positive regulation of canonical Wnt signaling pathway;regulation of non-canonical Wnt signaling pathway;positive regulation of Wnt signaling pathway, planar cell polarity pathway	endoplasmic reticulum lumen;Golgi lumen;plasma membrane;intrinsic component of plasma membrane;lysosomal lumen;anchored component of plasma membrane;collagen-containing extracellular matrix	protein binding;peptidyl-dipeptidase inhibitor activity	APP[28106549];NPM1[30021884];RIPK4[26972000];NOTUM[25731175];PLEKHA7[28877994];APPL1[23414517];	132888207
78137	chrX	152087570	AGG		chrX:152087570-152087572	ZNF185	zinc finger protein 185 with LIM domain	deletion	0/1	0.14	73_12	86	99.0	0/0	0.0	34_0	34	99.0			rs781814997	EXONIC	YES	NM_001178106.1	Transcript	protein_coding	inframe_deletion		7/24	NM_001178106.1:c.494_496del	NP_001171577.1:p.Glu165del		1.0						.	.	.		0.000408197	45.0	110241.0	0.0	23	0.6	PASS	eas	0.00743707	26.0	0.000152358	8.0	0.00430929	527.0	122294.0	0.0	36	0.83	PASS	eas	0.0126709	114.0	0.004135	228.0	0.0000257,0.0336519,0.0001029	4,5233,16						5.55	0.180742		0	0	0			ZNF185	0.0	0.03	0.0	0.0	7.0	-24.0	21.0	-18.0						0.269	0.0	0.000000000,17.430255104			.			tongue;	.	.	cytoplasm;focal adhesion;actin cytoskeleton	zinc ion binding;actin filament binding	CBX8[unassigned1304];MCM7[23764002];ACTBL2[30021884];LMO2[unassigned1304];PIH1D2[unassigned1304];HSF2BP[unassigned1304];AARSD1[unassigned1304];PRR23B[unassigned1304];CEP76[unassigned1304];PRPF8[30021884];	152087569
78145	chrX	152771326	C	T	chrX:152771326	BGN	biglycan	SNV	0/1	0.45	41_35	77	99.0	0/1	0.51	30_31	61	99.0			rs146322407	EXONIC	YES	NM_001711.6	Transcript	protein_coding	synonymous_variant		4/8	NM_001711.6:c.357C>T	NP_001702.1:p.Leu119%3D		1.0		Benign	criteria_provided,_multiple_submitters,_no_conflicts	not_provided	Meester-Loeys syndrome, 300989 (3), X-linked; Spondyloepimetaphyseal dysplasia, X-linked, 300106 (3), X-linked recessive	X-linked spondyloepimetaphyseal dysplasia	Disease-causing germline mutation(s) in	Hypoplasia of the odontoid process;Cone-shaped epiphyses of the phalanges of the hand;Platyspondyly;Disproportionate short-trunk short stature;Cone-shaped metacarpal epiphyses;Short long bone;Cone-shaped distal radial epiphysis;Spondyloepimetaphyseal dysplasia;Short foot;Anterior wedging of T12;Short metacarpal;Kyphosis;Short palm;Anterior wedging of T11;Radial deviation of the hand;Limited elbow extension;Delayed ossification of carpal bones;Lumbar hyperlordosis;Broad phalanx;Brachydactyly;Coxa valga;Broad long bone diaphyses;Posterior rib cupping;Prominent styloid process of ulna;Short phalanx of finger;Flared iliac wings;Hypoplasia of the maxilla;Pectus carinatum;Long fibula;Flat acetabular roof;Metaphyseal irregularity;Long ulna;X-linked recessive inheritance;Cone-shaped epiphyses fused within their metaphyses;Broad metacarpals;Short clavicles;Narrow pelvis bone;Cervical spine instability;Bifid uvula;Ventriculomegaly;Downslanted palpebral fissures;Aortic dissection;Pulmonary artery aneurysm;Malar flattening;Joint hypermobility;X-linked inheritance;Proptosis;Joint dislocation;Dilatation of the cerebral artery;Relative macrocephaly;Mitral regurgitation;Hypertelorism;Frontal bossing;Abnormality of the sternum;Pes planus;Camptodactyly		0.00236109	264.0	111813.0	0.0	23	0.61	PASS	amr	0.00641449	68.0	0.00276946	147.0	0.0023219	420.0	180886.0	1.0	47	0.86	PASS	amr	0.00523292	143.0	0.00283279	227.0	0.0018842	293	0.01	32.0	0.01228	117.0		5.927	0.205804		0	0	0			BGN	0.08	0.0	0.0	0.0	19.0	-7.0	6.0	39.0						0.0632	0.92	16.880076239			growth/size/body region phenotype; integument phenotype ; homeostasis/metabolism phenotype; cellular phenotype; craniofacial phenotype; muscle phenotype; limbs/digits/tail phenotype; reproductive system phenotype; mortality/aging ; behavior/neurological phenotype ; skeleton phenotype; immune system phenotype; 			ciliary ganglion;superior cervical ganglion;trigeminal ganglion;placenta;adrenal gland;adrenal cortex;heart;	.	blood vessel remodeling;biological_process;peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan;extracellular matrix organization;chondroitin sulfate biosynthetic process;chondroitin sulfate catabolic process;dermatan sulfate biosynthetic process	extracellular region;Golgi lumen;cell surface;transport vesicle;extracellular matrix;sarcolemma;lysosomal lumen;collagen-containing extracellular matrix;extracellular exosome	extracellular matrix structural constituent;glycosaminoglycan binding;extracellular matrix structural constituent conferring compression resistance;extracellular matrix binding	NUDCD2[25036637];HSPB2[26465331];PCOLCE[24117177];TLR4[24480070];TLR2[24480070];	152771326
78158	chrX	153006137	G	A	chrX:153006137	ABCD1	ATP binding cassette subfamily D member 1	SNV	0/0	0.0	34_0	34	99.0	0|1	0.12	87_12	99	99.0			rs76180859,COSV54383694	EXONIC	YES	NM_000033.4	Transcript	protein_coding	missense_variant		7/10	NM_000033.4:c.1744G>A	NP_000024.2:p.Val582Ile		1.0	ABC transporter-like&ABC transporter-like&AAA+ ATPase domain	Benign	criteria_provided,_multiple_submitters,_no_conflicts	Adrenoleukodystrophy|History_of_neurodevelopmental_disorder|not_specified|not_provided	Adrenoleukodystrophy, 300100 (3), X-linked recessive; Adrenomyeloneuropathy, adult, 300100 (3), X-linked recessive	X-linked cerebral adrenoleukodystrophy;Adrenomyeloneuropathy;CADDS	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Role in the phenotype of	Hyperpigmentation of the skin;Impotence;Paraparesis;Hearing impairment;Progressive;Loss of speech;Visual loss;X-linked recessive inheritance;Neurodegeneration;Urinary incontinence;Slurred speech;Abnormality of the cerebral white matter;Bowel incontinence;Dementia;Limb ataxia;Primary adrenal insufficiency;Psychosis;Polyneuropathy;Alopecia;Attention deficit hyperactivity disorder;Truncal ataxia;Incoordination;Impaired vibration sensation at ankles;Hypogonadism;Blindness;Spastic paraplegia;Elevated circulating long chain fatty acid concentration;Seizure;Urinary bladder sphincter dysfunction;Lower limb muscle weakness;Bulbar palsy		8.8776e-06	1.0	112643.0	0.0	24	0.63	PASS	nfe	1.87892e-05	1.0	1.87892e-05	1.0	6.47245e-05	10.0	154501.0	0.0	95	0.99	PASS	nfe	0.000105772	7.0	0.000105772	7.0	0.1138877	17710	0.063	200.0	0.00237	27.0		7.842	0.350521	0.03	3	14	17	MetaLR_pred,FATHMM_pred,DEOGEN2_pred	SIFT,PolyPhen,LRT_pred,MetaSVM_pred,MutationAssessor_pred,MutationTaster_pred,PROVEAN_pred,MetaRNN_pred,PrimateAI_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	ABCD1	0.0	0.0	0.0	0.0	2.0	-21.0	2.0	15.0						0.0188	0.98		0.551	-0.056	hematopoietic system phenotype; normal phenotype; mortality/aging ; reproductive system phenotype; behavior/neurological phenotype ; immune system phenotype; nervous system phenotype ; vision/eye phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; 			superior cervical ganglion;skeletal muscle;	ABC transporters	regulation of oxidative phosphorylation;fatty acid beta-oxidation;peroxisome organization;peroxisomal long-chain fatty acid import;fatty-acyl-CoA transport;peroxisomal membrane transport;fatty acid elongation;regulation of fatty acid beta-oxidation;positive regulation of fatty acid beta-oxidation;fatty acid beta-oxidation using acyl-CoA oxidase;alpha-linolenic acid metabolic process;very long-chain fatty-acyl-CoA catabolic process;long-chain fatty acid catabolic process;very long-chain fatty acid catabolic process;myelin maintenance;linoleic acid metabolic process;regulation of mitochondrial depolarization;transmembrane transport;fatty acid homeostasis;sterol homeostasis;negative regulation of cytokine production involved in inflammatory response;regulation of cellular response to oxidative stress;negative regulation of reactive oxygen species biosynthetic process;neuron projection maintenance;positive regulation of unsaturated fatty acid biosynthetic process	cytoplasm;lysosomal membrane;peroxisome;peroxisomal membrane;integral component of peroxisomal membrane;endoplasmic reticulum membrane;cytosol;membrane;mitochondrial membrane;perinuclear region of cytoplasm	transporter activity;long-chain fatty acid transporter activity;protein binding;ATP binding;fatty-acyl-CoA transmembrane transporter activity;ATPase activity;enzyme binding;ATPase activity, coupled to transmembrane movement of substances;identical protein binding;protein homodimerization activity;ADP binding	ABCD2[24658140];ABCD3[10551832];PEX19[20531392];VAPA[26496610];RPSA[21988832];VPS26B[26496610];ABCD1[10551832];HNRNPAB[30021884];RAB7A[26496610];	153006137
78160	chrX	153006141	T	A	chrX:153006141	ABCD1	ATP binding cassette subfamily D member 1	SNV	0/0	0.0	34_0	34	99.0	0|1	0.12	89_12	101	99.0			rs79383557,CM107892,COSV54383707	EXONIC	YES	NM_000033.4	Transcript	protein_coding	missense_variant		7/10	NM_000033.4:c.1748T>A	NP_000024.2:p.Val583Glu		1.0	ABC transporter-like&ABC transporter-like&AAA+ ATPase domain	Benign/Likely_benign	criteria_provided,_multiple_submitters,_no_conflicts	Adrenoleukodystrophy|History_of_neurodevelopmental_disorder|not_specified	Adrenoleukodystrophy, 300100 (3), X-linked recessive; Adrenomyeloneuropathy, adult, 300100 (3), X-linked recessive	X-linked cerebral adrenoleukodystrophy;Adrenomyeloneuropathy;CADDS	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in;Role in the phenotype of	Hyperpigmentation of the skin;Impotence;Paraparesis;Hearing impairment;Progressive;Loss of speech;Visual loss;X-linked recessive inheritance;Neurodegeneration;Urinary incontinence;Slurred speech;Abnormality of the cerebral white matter;Bowel incontinence;Dementia;Limb ataxia;Primary adrenal insufficiency;Psychosis;Polyneuropathy;Alopecia;Attention deficit hyperactivity disorder;Truncal ataxia;Incoordination;Impaired vibration sensation at ankles;Hypogonadism;Blindness;Spastic paraplegia;Elevated circulating long chain fatty acid concentration;Seizure;Urinary bladder sphincter dysfunction;Lower limb muscle weakness;Bulbar palsy						25	0.63							9.74266e-05	15.0	153962.0	0.0	95	0.99	PASS	afr	0.00017792	2.0	0.0001366	9.0	0.1138749	17708	0.066	212.0	0.00237	27.0		24.9	3.470945	0.974	16	3	19	SIFT,PolyPhen,Polyphen2_HDIV_pred,Polyphen2_HVAR_pred,LRT_pred,MetaLR_pred,MetaSVM_pred,MutationAssessor_pred,PROVEAN_pred,FATHMM_pred,DEOGEN2_pred,BayesDel_addAF_pred,BayesDel_noAF_pred,ClinPred_pred,LIST-S2_pred,fathmm-MKL_coding_pred	MutationTaster_pred,MetaRNN_pred,PrimateAI_pred	ABCD1	0.0	0.0	0.0	0.0	2.0	-40.0	32.0	11.0						0.0188	0.98		0.38	1.137	hematopoietic system phenotype; normal phenotype; mortality/aging ; reproductive system phenotype; behavior/neurological phenotype ; immune system phenotype; nervous system phenotype ; vision/eye phenotype; endocrine/exocrine gland phenotype; homeostasis/metabolism phenotype; 			superior cervical ganglion;skeletal muscle;	ABC transporters	regulation of oxidative phosphorylation;fatty acid beta-oxidation;peroxisome organization;peroxisomal long-chain fatty acid import;fatty-acyl-CoA transport;peroxisomal membrane transport;fatty acid elongation;regulation of fatty acid beta-oxidation;positive regulation of fatty acid beta-oxidation;fatty acid beta-oxidation using acyl-CoA oxidase;alpha-linolenic acid metabolic process;very long-chain fatty-acyl-CoA catabolic process;long-chain fatty acid catabolic process;very long-chain fatty acid catabolic process;myelin maintenance;linoleic acid metabolic process;regulation of mitochondrial depolarization;transmembrane transport;fatty acid homeostasis;sterol homeostasis;negative regulation of cytokine production involved in inflammatory response;regulation of cellular response to oxidative stress;negative regulation of reactive oxygen species biosynthetic process;neuron projection maintenance;positive regulation of unsaturated fatty acid biosynthetic process	cytoplasm;lysosomal membrane;peroxisome;peroxisomal membrane;integral component of peroxisomal membrane;endoplasmic reticulum membrane;cytosol;membrane;mitochondrial membrane;perinuclear region of cytoplasm	transporter activity;long-chain fatty acid transporter activity;protein binding;ATP binding;fatty-acyl-CoA transmembrane transporter activity;ATPase activity;enzyme binding;ATPase activity, coupled to transmembrane movement of substances;identical protein binding;protein homodimerization activity;ADP binding	ABCD2[24658140];ABCD3[10551832];PEX19[20531392];VAPA[26496610];RPSA[21988832];VPS26B[26496610];ABCD1[10551832];HNRNPAB[30021884];RAB7A[26496610];	153006141
78277	chrX	153657134	GGC		chrX:153657134-153657136	ATP6AP1	ATPase H+ transporting accessory protein 1	deletion	0/0	0.0	41_0	41	99.0	0/1	0.16	32_6	38	99.0			rs781797236	EXONIC	YES	NM_001183.6	Transcript	protein_coding	inframe_deletion		1/10	NM_001183.6:c.114_116del	NP_001174.2:p.Ala41del		1.0		Uncertain_significance	criteria_provided,_single_submitter	not_provided	Immunodeficiency 47, 300972 (3), X-linked recessive	.	.	X-linked recessive inheritance;Decreased circulating antibody level;Prolonged neonatal jaundice;Sensorineural hearing impairment;Cirrhosis;Splenomegaly;Hypermetropia;Seizure;Hepatic steatosis;Leukopenia;Elevated hepatic transaminase;Hepatomegaly;Variable expressivity;Recurrent bacterial infections;Intellectual disability		0.00011592	13.0	112146.0	0.0	24	0.62	PASS	nfe	0.000225904	12.0	0.000225904	12.0	0.00251519	137.0	54469.0	0.0	4	0.11	RF	amr	0.00302364	33.0	0.00253141	54.0	0.0001672	26						9.409	0.500627		0	0	0			ATP6AP1	0.0	0.0	0.0	0.03	-40.0	24.0	46.0	37.0						0.0342	0.83				embryo phenotype; nervous system phenotype ; mortality/aging ; 			.	Oxidative phosphorylation;Vibrio cholerae infection;Epithelial cell signaling in Helicobacter pylori infection	cellular iron ion homeostasis;insulin receptor signaling pathway;ATP hydrolysis coupled proton transport;regulation of cellular pH;transferrin transport;ion transmembrane transport;cellular response to increased oxygen levels;positive regulation of osteoblast differentiation;positive regulation of bone resorption;pH reduction;positive regulation of exocytosis;establishment of organelle localization;positive regulation of ERK1 and ERK2 cascade;proton transmembrane transport;positive regulation of osteoclast development	endoplasmic reticulum membrane;endosome membrane;integral component of membrane;proton-transporting two-sector ATPase complex;endoplasmic reticulum-Golgi intermediate compartment membrane;proton-transporting V-type ATPase, V1 domain;plasma membrane proton-transporting V-type ATPase complex;extracellular exosome	transporter activity;ATP binding;Rab GTPase binding;proton-transporting ATP synthase activity, rotational mechanism;proton-transporting ATPase activity, rotational mechanism	EVC2[26638075];MYEF2[26496610];GOLT1B[26496610];NR1I2[21988832];ATP6AP2[26496610];HBA1[16169070];PLEKHA7[28877994];TMEM17[26638075];TCTN3[26638075];TMEM67[26638075];TCTN2[26638075];TMEM216[26638075];ERBB2[25640309];CANX[29568061];ANG[16169070];MAPK6[26972000];DBN1[26496610];RAB7A[26496610];	153657133
78293	chrX	154005089	GAA		chrX:154005089-154005091	DKC1	dyskerin pseudouridine synthase 1	deletion	0/1	0.14	36_6	42	99.0	0/0	0.0	33_0	33	99.0			rs782576893	EXONIC	YES	NM_001363.5	Transcript	protein_coding	inframe_deletion		15/15	NM_001363.5:c.1512_1514del	NP_001354.1:p.Lys505del		1.0		Conflicting_interpretations_of_pathogenicity	criteria_provided,_conflicting_interpretations	Dyskeratosis_congenita,_X-linked|Dyskeratosis_congenita|not_specified|not_provided	Dyskeratosis congenita, X-linked, 305000 (3), X-linked recessive	Dyskeratosis congenita;Hoyeraal-Hreidarsson syndrome	Disease-causing germline mutation(s) in;Disease-causing germline mutation(s) in	Abnormality of coagulation;Immunodeficiency;Hyporeflexia;Generalized hypopigmentation of hair;Sparse scalp hair;Short stature;Abnormal leukocyte morphology;Anemia;Global developmental delay;Hypertonia;Oral leukoplakia;Dermal atrophy;Intellectual disability;Cerebral cortical atrophy;Cerebral calcification;Cerebellar hypoplasia;Bone marrow hypocellularity;Thrombocytopenia;Ataxia;Intrauterine growth retardation;Microcephaly;Excessive wrinkled skin;Failure to thrive;Generalized hyperpigmentation;Nail dystrophy;Ventriculomegaly;Premature graying of hair;Neoplasm;Nail dystrophy;Ataxia;Sparse eyelashes;Carious teeth;Optic atrophy;Oral leukoplakia;Hyperhidrosis;Phimosis;X-linked recessive inheritance;Squamous cell carcinoma;Conjunctivitis;Intrauterine growth retardation;Anemia;Dermal atrophy;Myelodysplasia;Hyperpigmentation of the skin;Pterygium of nails;Urethral stenosis;Pancytopenia;Pulmonary fibrosis;Restrictive ventilatory defect;Esophageal stricture;Cerebellar hypoplasia;Horseshoe kidney;Strabismus;Leukopenia;Osteoporosis;Hodgkin lymphoma;Cryptorchidism;Global developmental delay;Thrombocytopenia;Cataract;Reticulated skin pigmentation;Decreased testicular size;Hypospadias;Anal mucosal leukoplakia;Premature loss of teeth;Blepharitis;Split nail;Microcephaly;Alopecia;Bone marrow hypocellularity;Epiphora;Carcinoma;Pterygium;Short stature;Ridged nail;Immunodeficiency;Intellectual disability;Acute myeloid leukemia;Cirrhosis;Premature graying of hair;Rough bone trabeculation;Splenomegaly;Abnormal eyelash morphology;Carious teeth;Recurrent respiratory infections;Aplasia/Hypoplasia of the skin;Displacement of the urethral meatus;Hypermelanotic macule;Abnormal testis morphology;Anemia;Osteoporosis;Abnormality of the pharynx;Abnormality of neutrophils;Oral leukoplakia;Nail dystrophy;Intrauterine growth retardation;Thrombocytopenia;Alopecia;Abnormal blistering of the skin;Malabsorption;Tracheoesophageal fistula;Aplastic/hypoplastic toenail;Anorectal anomaly;Hepatic failure;Lymphoma;Urethral stenosis;Hyperhidrosis;Taurodontia;Palmoplantar keratoderma;Sparse hair;White hair;Hypodontia;Hepatomegaly;Abnormal morphology of female internal genitalia;Cirrhosis;Neoplasm of the pancreas;Scoliosis;Hypoplasia of the maxilla;Diabetes mellitus;Skin ulcer;Cataract;Skin vesicle;Hypopigmented skin patches;Cerebral calcification;Recurrent fractures;Bone marrow hypocellularity;Short stature;Abnormality of coagulation;Avascular necrosis;Abnormal fingernail morphology;Telangiectasia of the skin;Cellular immunodeficiency;Blepharitis;Abnormal eyebrow morphology;Global developmental delay;Esophageal stenosis;Hearing impairment;Premature graying of hair;Periodontitis		0.00095775	105.0	109632.0	0.0	22	0.6	PASS	amr	0.00174199	18.0	0.00106791	56.0	0.00424531	545.0	128377.0	0.0	46	0.92	PASS	amr	0.0059517	104.0	0.00398433	236.0	0.0000772,0.0012797,0.0201345	12,199,3131			0.05827	597.0		16.11	1.472764		0	0	0			DKC1	0.01	0.04	0.01	0.0	-36.0	-9.0	33.0	-48.0							1.0	0.000000000			embryo phenotype; respiratory system phenotype; normal phenotype; mortality/aging ; reproductive system phenotype; hematopoietic system phenotype; neoplasm; immune system phenotype; renal/urinary system phenotype; integument phenotype ; growth/size/body region phenotype; adipose tissue phenotype ; cellular phenotype; homeostasis/metabolism phenotype; 			.	.	enzyme-directed rRNA pseudouridine synthesis;box H/ACA snoRNA 3'-end processing;rRNA processing;RNA processing;telomere maintenance via telomerase;cell population proliferation;rRNA pseudouridine synthesis;snRNA pseudouridine synthesis;positive regulation of telomere maintenance via telomerase;positive regulation of telomerase activity;scaRNA localization to Cajal body;telomerase RNA stabilization;positive regulation of establishment of protein localization to telomere;positive regulation of protein localization to Cajal body;regulation of telomerase RNA localization to Cajal body;positive regulation of telomerase RNA localization to Cajal body;mRNA pseudouridine synthesis	fibrillar center;nucleus;nucleoplasm;telomerase holoenzyme complex;nucleolus;cytoplasm;box H/ACA snoRNP complex;box H/ACA scaRNP complex;box H/ACA telomerase RNP complex	telomerase activity;RNA binding;protein binding;pseudouridine synthase activity;box H/ACA snoRNA binding;telomerase RNA binding	WDR48[19615732];MCM7[23764002];COX15[29128334];HDAC11[23752268];NOLC1[19179534];DDX21[25470060];DLST[29128334];ARRB1[17620599];ARRB2[17620599];PARK7[29128334];HSD17B10[29128334];GABARAP[20562859];SYNCRIP[26496610];FBL[29568061];HMBOX1[23685356];TERT[18358808;19179534;23474713];IFI16[25665578];RUVBL2[18358808;19179534];RUVBL1[18358808;19179534];EPB41L3[24366813];GAR1[19179534;26496610];SSR1[16169070];MAPK6[21900206];LYAR[17353931];MPP1[26496610];LYPLA2[16169070];JUN[25609649];CSNK2A1[22113938];RRP1B[20926688];C8orf33[30021884];ESR1[21182205];EEF1G[16169070];COQ2[29128334];SOAT1[29128334];ZFP62[30021884];TBXAS1[30021884];NHP2[19179534];HNRNPD[26496610];NAF1[19179534;16601202;16618814;26496610];MNDA[25665578];VDAC1[29128334];EIF3F[16169070];DLD[29128334];NOP10[19179534;23474713];WRAP53[19179534;25467444;26496610];	154005088
